{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "ALZHEIMER'S DISEASE BIOMARKER OBSERVATORY {BMO}:\n",
    "\n",
    "BIOMARKER DATA CAPTURE INTIAL PART [PART 1]\n",
    "\n",
    "PROFESSOR : JORGE FONSECA\n",
    "\n",
    "STUDENTS: KAJAL DHIMMAR AND SHUBHAM KOLASE\n",
    "\n",
    "CONTACT INFORMATION OF KAJAL DHIMMAR\n",
    "\n",
    "EMAIL: dhimmar@unlv.nevada.edu\n",
    "PHONE NUMBER: 385-489-4611"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Step 1:To obtain an API key from PubMed:\n",
    "----------------------------------------\n",
    "\n",
    "\n",
    "You need to register for a free NCBI account on their website.\n",
    "https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2F\n",
    "\n",
    "Once you have created your account, follow these steps:\n",
    "\n",
    "Once logged in, go to the NCBI account settings, where you can generate or copy your API key.\n",
    "\n",
    "\n",
    "This key should be included in your requests to the PubMed API to increase your query limit and access full API capabilities."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Overview of the Alzheimer's Disease Research Project Script:\n",
    "--------------------------------------------------------------\n",
    "_______\n",
    "\n",
    "PART 1:\n",
    "________\n",
    "\n",
    "This notebook is a part of our Alzheimer’s disease research project, focusing on retrieving and analyzing academic articles from PubMed. Below is an explanation of the main sections and functionality within the script, aimed at helping future team members understand and continue this work seamlessly.\n",
    "\n",
    "Initial Approach and Error Handling:\n",
    "-----------------------------------\n",
    "We began by using basic API calls to PubMed with the requests and json libraries. The goal was to search for articles related to \"Alzheimer's disease.\" However, this approach encountered errors while decoding the JSON responses, prompting a need for a more reliable method.\n",
    "\n",
    "Transition to Pymed Library:\n",
    "---------------------------\n",
    "To resolve the initial issues, we transitioned to using the pymed library, which offers a more robust interface for querying PubMed. This library allowed us to effectively search for and retrieve articles related to \"Alzheimer's disease\" by setting up a PubMed object and defining the appropriate search query.\n",
    "\n",
    "Query Optimization:\n",
    "------------------\n",
    "We experimented with various query versions, such as \"Alzheimer's\" and \"Alzheimer,\" to identify the most effective search terms. While the number of retrieved articles was similar, the specific articles varied. After these tests, we decided to standardize our query to \"Alzheimer's disease\" for consistency.\n",
    "\n",
    "Article Count and Detail Retrieval:\n",
    "----------------------------------\n",
    "The script includes functions to search for articles and retrieve their details. This process involved counting the number of articles available for our query and extracting relevant information. We encountered issues with incomplete data in some articles, which led us to refine our error handling and ensure only complete data was processed.\n",
    "\n",
    "Advanced Search Techniques:\n",
    "---------------------------\n",
    "To improve the relevance of our search results, we discussed and implemented advanced search techniques. This included using boolean operators (AND, OR, NOT) and parentheses to refine our queries, focusing on specific areas such as fluid biomarkers and cerebrospinal fluid.\n",
    "\n",
    "Data Storage:\n",
    "-------------\n",
    "A significant milestone was storing 5000 articles into a CSV file, which demonstrated the effectiveness and scalability of our data retrieval process. This step ensured that we could manage and analyze large volumes of data efficiently.\n",
    "\n",
    "Full-Text Access Implementation:\n",
    "--------------------------------\n",
    "While PubMed primarily provides abstracts and references, we needed full-text articles for deeper analysis. The script includes functions to fetch full-text articles using PubMed Central (PMC) IDs. These functions send requests to PubMed Central, handle XML data parsing, and extract necessary article details, including titles, abstracts, publication years, keywords, MeSH terms, authors, and PMC IDs.\n",
    "\n",
    "Conclusion:\n",
    "-----------\n",
    "The notebook is designed to provide a comprehensive approach to data retrieval and processing from PubMed, tailored specifically for Alzheimer’s disease research. It includes robust error handling, optimized search queries, and full-text access capabilities, ensuring that future team members can easily understand and build upon this work."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "CODING PART:"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "For this, We first acess the API key, we tried to get some data to see if our code works or not, but  it seems like there is an error.\n",
    "\n",
    "Error Message: Error decoding JSON response from PubMed fetch: Extra data: line 2 column 1 (char 9)\n",
    "\n",
    "Realize trying to fetch the data in json format, but how can we forget that article data does not  always come in a single line? It is possible"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'bytes'>\n",
      "<?xml version=\"1.0\" ?>\n",
      "<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2024//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd\">\n",
      "<PubmedArticleSet>\n",
      "<PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39276310</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1573-7209</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Angiogenesis</Title><ISOAbbreviation>Angiogenesis</ISOAbbreviation></Journal><ArticleTitle>The influences of ApoE isoforms on endothelial adherens junctions and actin cytoskeleton responding to mCRP.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s10456-024-09946-4</ELocationID><Abstract><AbstractText>Apolipoprotein E4 (ApoE4) plays an important role responding to monomeric C-reactive protein (mCRP) via binding to CD31 leading to cerebrovascular damage and Alzheimer's disease (AD). Using phosphor-proteomic profiling, we found altered cytoskeleton proteins in the microvasculature of AD brains, including increased levels of hyperphosphorylated tau (pTau) and the actin-related protein, LIMA1. To address the hypothesis that cytoskeletal changes serve as early pathological signatures linked with CD31 in brain endothelia in ApoE4 carriers, ApoE4 knock-in mice intraperitoneal injected with mCRP revealed that mCRP increased the expressions of phosphorylated CD31 (pCD31) and LIMA1, and facilitate the binding of pCD31 to LIMA1. mCRP combined with recombinant APOE4 protein decreased interaction of CD31 and VE-Cadherin at adherens junctions (AJs), along with altered the expression of various actin cytoskeleton proteins, causing microvasculature damage. Notably, the APOE2 protein attenuated these changes. Overall, our study demonstrates that ApoE4 responds to mCRP to disrupt the endothelial AJs which link with the actin cytoskeleton and this pathway could play a key role in the barrier dysfunction leading to AD risk.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Zhang</LastName><ForeName>Zhengrong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Lin</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Gan</LastName><ForeName>Qini</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lei</LastName><ForeName>Maohua</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gong</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Section of Computational Biomedicine, Department of Medicine, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Henrique</LastName><ForeName>Jessica Salles</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Han</LastName><ForeName>Jingyan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section of Vascular Biology, Department of Medicine, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tian</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Xiaman Medical College, Xiaman, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tao</LastName><ForeName>Qiushan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Potempa</LastName><ForeName>Lawrence A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Roosevelt University College of Pharmacy, Schaumburg, IL60173, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stein</LastName><ForeName>Thor D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. tdstein@bu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer's Disease Research Center, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. tdstein@bu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Boston Healthcare System, Boston, MA02130, USA. tdstein@bu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Bedford Healthcare System, Bedford, MA01730, USA. tdstein@bu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Emili</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. aemili@bu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qiu</LastName><ForeName>Wei Qiao</ForeName><Initials>WQ</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. wqiu67@bu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer's Disease Research Center, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. wqiu67@bu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. wqiu67@bu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>R01 AG054546</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Angiogenesis</MedlineTA><NlmUniqueID>9814575</NlmUniqueID><ISSNLinking>0969-6970</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease (AD)</Keyword><Keyword MajorTopicYN=\"N\">Apolipoprotein E (ApoE)</Keyword><Keyword MajorTopicYN=\"N\">CD31 and pCD31</Keyword><Keyword MajorTopicYN=\"N\">Cerebrovascular</Keyword><Keyword MajorTopicYN=\"N\">Endothelia</Keyword><Keyword MajorTopicYN=\"N\">F-actin</Keyword><Keyword MajorTopicYN=\"N\">LIM Domain and Actin Binding 1 (LIMA1)</Keyword><Keyword MajorTopicYN=\"N\">Monomeric C-reactive protein (mCRP)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39276310</ArticleId><ArticleId IdType=\"doi\">10.1007/s10456-024-09946-4</ArticleId><ArticleId IdType=\"pii\">10.1007/s10456-024-09946-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Iadecola C, Gottesman RF (2018) Cerebrovascular alterations in Alzheimer disease. Circ Res 123(4):406&#x2013;408</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30355253</ArticleId><ArticleId IdType=\"pmc\">6214471</ArticleId><ArticleId IdType=\"doi\">10.1161/CIRCRESAHA.118.313400</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia FJ, Sun N, Lee H, Godlewski B, Mathys H, Galani K, Zhou B, Jiang X, Ng AP, Mantero J, Tsai LH, Bennett DA, Sahin M, Kellis M, Heiman M (2022) Single-cell dissection of the human brain vasculature. Nature 603(7903):893&#x2013;899</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35158371</ArticleId><ArticleId IdType=\"pmc\">9680899</ArticleId><ArticleId IdType=\"doi\">10.1038/s41586-022-04521-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock MH, Tsai LH (2023) Insights into Alzheimer&#x2019;s disease from single-cell genomic approaches. Nat Neurosci 26(2):181&#x2013;195</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36593328</ArticleId><ArticleId IdType=\"pmc\">10155598</ArticleId><ArticleId IdType=\"doi\">10.1038/s41593-022-01222-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant A, Li Z, Jayakumar R, Serrano-Pozo A, Woost B, Hu M, Woodbury ME, Wachter A, Lin G, Kwon T, Talanian RV, Biber K, Karran EH, Hyman BT, Das S, Bennett RE (2023) Endothelial cells are heterogeneous in different brain regions and are dramatically altered in Alzheimer&#x2019;s disease. J Neurosci 43(24):4541&#x2013;4557</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37208174</ArticleId><ArticleId IdType=\"pmc\">10278684</ArticleId><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.0237-23.2023</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao W, Zheng H (2018) Peripheral immune system in aging and Alzheimer&#x2019;s disease. Mol Neurodegener 13(1):51</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30285785</ArticleId><ArticleId IdType=\"pmc\">6169078</ArticleId><ArticleId IdType=\"doi\">10.1186/s13024-018-0284-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Gan Q, Han J, Tao Q, Qiu WQ, Madri JA (2023) CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer&#x2019;s disease. J Cereb Blood Flow Metab. https://doi.org/10.1177/0271678X231170041</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0271678X231170041</ArticleId><ArticleId IdType=\"pubmed\">38069842</ArticleId><ArticleId IdType=\"pmc\">10870959</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J, Johnson ECB, Dammer EB, Duong DM, Gearing M, Lah JJ, Levey AI, Wingo TS, Seyfried NT (2018) Effects of APOE genotype on brain proteomic network and cell type changes in Alzheimer&#x2019;s disease. Front Mol Neurosci 11:454</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30618606</ArticleId><ArticleId IdType=\"pmc\">6305300</ArticleId><ArticleId IdType=\"doi\">10.3389/fnmol.2018.00454</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Na H, Gan Q, Tao Q, Alekseyev Y, Hu J, Yan Z, Yang JB, Tian H, Zhu S, Li Q, Rajab IM, Blusztajn JK, Wolozin B, Emili A, Zhang X, Stein T, Potempa LA, Qiu WQ (2021) Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: a risk factor for Alzheimer&#x2019;s disease? Aging Cell. https://doi.org/10.1111/acel.13501</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/acel.13501</ArticleId><ArticleId IdType=\"pubmed\">34972247</ArticleId><ArticleId IdType=\"pmc\">8761015</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Fan J, Zhao Z, Wang C, Wan LQ (2021) Effects of Alzheimer&#x2019;s disease-related proteins on the chirality of brain endothelial cells. Cell Mol Bioeng 14(3):231&#x2013;240</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34109002</ArticleId><ArticleId IdType=\"pmc\">8175509</ArticleId><ArticleId IdType=\"doi\">10.1007/s12195-021-00669-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamatovic SM, Johnson AM, Keep RF, Andjelkovic AV (2016) Junctional proteins of the blood-brain barrier: new insights into function and dysfunction. Tissue Barriers 4(1):e1154641</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27141427</ArticleId><ArticleId IdType=\"pmc\">4836471</ArticleId><ArticleId IdType=\"doi\">10.1080/21688370.2016.1154641</ArticleId></ArticleIdList></Reference><Reference><Citation>Komarova YA, Kruse K, Mehta D, Malik AB (2017) Protein interactions at endothelial junctions and signaling mechanisms regulating endothelial permeability. Circ Res 120(1):179&#x2013;206</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28057793</ArticleId><ArticleId IdType=\"pmc\">5225667</ArticleId><ArticleId IdType=\"doi\">10.1161/CIRCRESAHA.116.306534</ArticleId></ArticleIdList></Reference><Reference><Citation>Privratsky JR, Newman PJ (2014) PECAM-1: regulator of endothelial junctional integrity. Cell Tissue Res 355(3):607&#x2013;619</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24435645</ArticleId><ArticleId IdType=\"pmc\">3975704</ArticleId><ArticleId IdType=\"doi\">10.1007/s00441-013-1779-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodakuntla S, Jijumon AS, Villablanca C, Gonzalez-Billault C, Janke C (2019) Microtubule-associated proteins: structuring the cytoskeleton. Trends Cell Biol 29(10):804&#x2013;819</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31416684</ArticleId><ArticleId IdType=\"doi\">10.1016/j.tcb.2019.07.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Letort G, Ennomani H, Gressin L, Th&#xe9;ry M, Blanchoin L (2015) Dynamic reorganization of the actin cytoskeleton. F1000Res. https://doi.org/10.12688/f1000research.6374.1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.12688/f1000research.6374.1</ArticleId><ArticleId IdType=\"pubmed\">26989473</ArticleId><ArticleId IdType=\"pmc\">4784019</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Zhang L, Pu H, Mao L, Hu X, Jiang X, Xu N, Stetler RA, Zhang F, Liu X, Leak RK, Keep RF, Ji X, Chen J (2016) Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury. Nat Commun 7:10523</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26813496</ArticleId><ArticleId IdType=\"pmc\">4737895</ArticleId><ArticleId IdType=\"doi\">10.1038/ncomms10523</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha M, Aldirawi M, M&#xe4;rz S, Seebach J, Odenthal-Schnittler M, Bondareva O, Bojovic V, Schmandra T, Wirth B, Mietkowska M, Rottner K, Schnittler H (2019) EPLIN-&#x3b1; and -&#x3b2; isoforms modulate endothelial cell dynamics through a spatiotemporally differentiated interaction with actin. Cell Rep 29(4):1010-1026.e6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31644899</ArticleId><ArticleId IdType=\"doi\">10.1016/j.celrep.2019.09.043</ArticleId></ArticleIdList></Reference><Reference><Citation>Caprio V, Badimon L, Di Napoli M, Fang WH, Ferris GR, Guo B, Iemma RS, Liu D, Zeinolabediny Y, Slevin M (2018) pCRP-mCRP dissociation mechanisms as potential targets for the development of small-molecule anti-inflammatory chemotherapeutics. Front Immunol 9:1089</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29892284</ArticleId><ArticleId IdType=\"pmc\">5985513</ArticleId><ArticleId IdType=\"doi\">10.3389/fimmu.2018.01089</ArticleId></ArticleIdList></Reference><Reference><Citation>Potempa LA, Yao ZY, Ji SR, Filep JG, Wu Y (2015) Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification. Biophysics reports 1:18&#x2013;33</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26942216</ArticleId><ArticleId IdType=\"doi\">10.1007/s41048-015-0003-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama S, Du Clos TW, Gewurz H, Mold C (1984) Inhibition of antibody responses to phosphocholine by C-reactive protein. J Immunol 132(3):1336&#x2013;1340</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6363539</ArticleId><ArticleId IdType=\"doi\">10.4049/jimmunol.132.3.1336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YK, Uchida H, Smith H, Ito A, Sanchez T (2019) The isolation and molecular characterization of cerebral microvessels. Nat Protoc 14(11):3059&#x2013;3081</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31586162</ArticleId><ArticleId IdType=\"doi\">10.1038/s41596-019-0212-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485(7399):512&#x2013;516</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22622580</ArticleId><ArticleId IdType=\"pmc\">4047116</ArticleId><ArticleId IdType=\"doi\">10.1038/nature11087</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum BC, Emili A (2021) Omics Notebook: robust, reproducible and flexible automated multiomics exploratory analysis and reporting. Bioinform Adv. https://doi.org/10.1093/bioadv/vbab024</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/bioadv/vbab024</ArticleId><ArticleId IdType=\"pubmed\">36700091</ArticleId><ArticleId IdType=\"pmc\">9710639</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545&#x2013;15550</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16199517</ArticleId><ArticleId IdType=\"pmc\">1239896</ArticleId><ArticleId IdType=\"doi\">10.1073/pnas.0506580102</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkevich EI, Rudik AV, Dmitriev AV, Lagunin AA, Filimonov DA (2021) Predict of metabolic stability of xenobiotics by the PASS and GUSAR programs. Biomed Khim 67(3):295&#x2013;299</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34142537</ArticleId><ArticleId IdType=\"doi\">10.18097/pbmc20216703295</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP (2007) GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics 23(23):3251&#x2013;3253</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17644558</ArticleId><ArticleId IdType=\"doi\">10.1093/bioinformatics/btm369</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef H, Czupalla CJ, Lee D, Butcher EC, Wyss-Coray T (2018) Papain-based single cell isolation of primary murine brain endothelial cells using flow cytometry. Bio Protoc. https://doi.org/10.21769/BioProtoc.3091</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.21769/BioProtoc.3091</ArticleId><ArticleId IdType=\"pubmed\">31032379</ArticleId><ArticleId IdType=\"pmc\">6482965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying SC, Gewurz H, Kinoshita CM, Potempa LA, Siegel JN (1989) Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies. J Immunol 143(1):221&#x2013;228</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2471736</ArticleId><ArticleId IdType=\"doi\">10.4049/jimmunol.143.1.221</ArticleId></ArticleIdList></Reference><Reference><Citation>Zieba A, Ponten F, Uhl&#xe9;n M, Landegren U (2018) In situ protein detection with enhanced specificity using DNA-conjugated antibodies and proximity ligation. Mod Pathol 31(2):253&#x2013;263</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28937142</ArticleId><ArticleId IdType=\"doi\">10.1038/modpathol.2017.102</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O, Blennow K, Zetterberg H, Dage J (2023) Blood biomarkers for Alzheimer&#x2019;s disease in clinical practice and trials. Nat Aging 3(5):506&#x2013;519</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37202517</ArticleId><ArticleId IdType=\"pmc\">10979350</ArticleId><ArticleId IdType=\"doi\">10.1038/s43587-023-00403-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Meydani M (2001) Nutrition interventions in aging and age-associated disease. Ann N Y Acad Sci 928:226&#x2013;235</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11795514</ArticleId><ArticleId IdType=\"doi\">10.1111/j.1749-6632.2001.tb05652.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Laboy Cintron D, Muir AM, Scott A, McDonald M, Monaghan KG, Santiago-Sim T, Wentzensen IM, De Luca C, Brancati F, Harris DJ, Goueli C, Stottmann R, Prada CE, Biderman Waberski M, Mefford HC (2022) A recurrent, de novo pathogenic variant in ARPC4 disrupts actin filament formation and causes microcephaly and speech delay. HGG Adv 3(1):100072</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35047857</ArticleId></ArticleIdList></Reference><Reference><Citation>G. Sa, Z. Liu, J. Ren, Q. Wan, X. Xiong, Z. Yu, H. Chen, Y. Zhao, S. He, [Not Available], Cell. Signal. 61 (2019) 39-47</Citation></Reference><Reference><Citation>Illescas M, Pe&#xf1;as A, Arenas J, Mart&#xed;n MA, Ugalde C (2021) Regulation of mitochondrial function by the actin cytoskeleton. Front Cell Dev Biol 9:795838</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34993202</ArticleId><ArticleId IdType=\"pmc\">8725978</ArticleId><ArticleId IdType=\"doi\">10.3389/fcell.2021.795838</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Caballero M, Zecchin A, Souffreau J, Truong AK, Teuwen LA, Vermaelen W, Mart&#xed;n-P&#xe9;rez R, de Zeeuw P, Bouch&#xe9; A, Vinckier S, Cornelissen I, Eelen G, Ghesqui&#xe8;re B, Mazzone M, Dewerchin M, Carmeliet P (2019) Role and therapeutic potential of dietary ketone bodies in lymph vessel growth. Nat Metab 1(7):666&#x2013;675</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32694649</ArticleId><ArticleId IdType=\"doi\">10.1038/s42255-019-0087-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnaiger E (2009) Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. Int J Biochem Cell Biol 41(10):1837&#x2013;1845</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19467914</ArticleId><ArticleId IdType=\"doi\">10.1016/j.biocel.2009.03.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluysmans S, Vasileva E, Spadaro D, Shah J, Rouaud F, Citi S (2017) The role of apical cell-cell junctions and associated cytoskeleton in mechanotransduction. Biol Cell 109(4):139&#x2013;161</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28220498</ArticleId><ArticleId IdType=\"doi\">10.1111/boc.201600075</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnoor M (2015) Endothelial actin-binding proteins and actin dynamics in leukocyte transendothelial migration. J Immunol 194(8):3535&#x2013;3541</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25848070</ArticleId><ArticleId IdType=\"doi\">10.4049/jimmunol.1403250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluiter TJ, van Buul JD, Huveneers S, Quax PHA, de Vries MR (2021) Endothelial barrier function and leukocyte transmigration in atherosclerosis. Biomedicines 9(4):328</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33804952</ArticleId><ArticleId IdType=\"pmc\">8063931</ArticleId><ArticleId IdType=\"doi\">10.3390/biomedicines9040328</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino-Debrac D (2013) Mechanotransduction at the basis of endothelial barrier function. Tissue Barriers 1(2):e24180</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24665386</ArticleId><ArticleId IdType=\"pmc\">3879236</ArticleId><ArticleId IdType=\"doi\">10.4161/tisb.24180</ArticleId></ArticleIdList></Reference><Reference><Citation>Givens C, Tzima E (2016) Endothelial mechanosignaling: does one sensor fit all? Antioxid Redox Signal 25(7):373&#x2013;388</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27027326</ArticleId><ArticleId IdType=\"pmc\">5011625</ArticleId><ArticleId IdType=\"doi\">10.1089/ars.2015.6493</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong CN, Vestweber D (2020) Mechanisms ensuring endothelial junction integrity beyond VE-cadherin. Front Physiol 11:519</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32670077</ArticleId><ArticleId IdType=\"pmc\">7326147</ArticleId><ArticleId IdType=\"doi\">10.3389/fphys.2020.00519</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA (2005) A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437(7057):426&#x2013;431</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16163360</ArticleId><ArticleId IdType=\"doi\">10.1038/nature03952</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Ponce A, Cital&#xe1;n-Madrid AF, Vel&#xe1;zquez-Avila M, Vargas-Robles H, Schnoor M (2015) The role of actin-binding proteins in the control of endothelial barrier integrity. Thromb Haemost 113(1):20&#x2013;36</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25183310</ArticleId><ArticleId IdType=\"doi\">10.1160/TH14-04-0298</ArticleId></ArticleIdList></Reference><Reference><Citation>Woollard KJ, Phillips DC, Griffiths HR (2002) Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells. Clin Exp Immunol 130(2):256&#x2013;262</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12390313</ArticleId><ArticleId IdType=\"pmc\">1906519</ArticleId><ArticleId IdType=\"doi\">10.1046/j.1365-2249.2002.01978.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Na H, Yang JB, Zhang Z, Gan Q, Tian H, Rajab IM, Potempa LA, Tao Q, Qiu WQ (2023) Peripheral apolipoprotein E proteins and their binding to LRP1 antagonize Alzheimer&#x2019;s disease pathogenesis in the brain during peripheral chronic inflammation. Neurobiol Aging 127:54&#x2013;69</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37060729</ArticleId><ArticleId IdType=\"pmc\">10198819</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2023.02.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav T, Gau D, Roy P (2022) Mitochondria-actin cytoskeleton crosstalk in cell migration. J Cell Physiol 237(5):2387&#x2013;2403</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35342955</ArticleId><ArticleId IdType=\"pmc\">9945482</ArticleId><ArticleId IdType=\"doi\">10.1002/jcp.30729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YY, Fu ZY, Wei J, Qi W, Baituola G, Luo J, Meng YJ, Guo SY, Yin H, Jiang SY, Li YF, Miao HH, Liu Y, Wang Y, Li BL, Ma YT, Song BL (2018) A LIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption. Science 360(6393):1087&#x2013;1092</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29880681</ArticleId><ArticleId IdType=\"doi\">10.1126/science.aao6575</ArticleId></ArticleIdList></Reference><Reference><Citation>Mares J, Costa AP, Dartora WJ, Wartchow KM, Lazarian A, Bennett DA, Nuriel T, Menon V, McIntire LBJ (2024) Brain and serum lipidomic profiles implicate lands cycle acyl chain remodeling association with APOE&#x3b5;4 and mild cognitive impairment. Front Aging Neurosci 16:1419253</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38938596</ArticleId><ArticleId IdType=\"pmc\">11210445</ArticleId><ArticleId IdType=\"doi\">10.3389/fnagi.2024.1419253</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampugnani MG (2010) Endothelial adherens junctions and the actin cytoskeleton: an &#x2018;infinity net&#x2019;? J Biol 9(3):16</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20377920</ArticleId><ArticleId IdType=\"pmc\">2871513</ArticleId><ArticleId IdType=\"doi\">10.1186/jbiol232</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson S, Vessby B, Ostlund-Lindqvist AM (1988) Apolipoprotein-E-binding proteins of rat liver endothelial cells. Biochim Biophys Acta 962(1):73&#x2013;80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3416008</ArticleId><ArticleId IdType=\"doi\">10.1016/0005-2760(88)90097-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu BY, Bae YH, Mui KL, Liu SL, Assoian RK (2015) Apolipoprotein E3 inhibits Rho to regulate the mechanosensitive expression of Cox2. PLoS ONE 10(6):e0128974</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26068461</ArticleId><ArticleId IdType=\"pmc\">4465925</ArticleId><ArticleId IdType=\"doi\">10.1371/journal.pone.0128974</ArticleId></ArticleIdList></Reference><Reference><Citation>Marottoli FM, Zhang H, Flores-Barrera E, de la Villarmois EA, Damen FC, Miguelez Fern&#xe1;ndez AMM, Blesson HV, Chaudhary R, Nguyen AL, Nwokeji AE, Talati R, John AS, Madadakere K, Lutz SE, Cai K, Tseng KY, Tai LM (2023) Endothelial cell APOE3 regulates neurovascular, neuronal, and behavioral function. Arterioscler Thromb Vasc Biol. https://doi.org/10.1161/ATVBAHA.123.319816</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/ATVBAHA.123.319816</ArticleId><ArticleId IdType=\"pubmed\">37650329</ArticleId><ArticleId IdType=\"pmc\">10521805</ArticleId></ArticleIdList></Reference><Reference><Citation>Suica VI, Uyy E, Boteanu RM, Ivan L, Antohe F (2015) Alteration of actin dependent signaling pathways associated with membrane microdomains in hyperlipidemia. Proteome Sci 13:30</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26628893</ArticleId><ArticleId IdType=\"pmc\">4666118</ArticleId><ArticleId IdType=\"doi\">10.1186/s12953-015-0087-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoglund Z, Ruiz-Uribe N, Del Sastre E, Woost B, Bader E, Bailey J, Hyman BT, Zwang T, Bennett RE (2024) Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer&#x2019;s disease. Acta Neuropathol 147(1):101</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38884806</ArticleId><ArticleId IdType=\"pmc\">11182845</ArticleId><ArticleId IdType=\"doi\">10.1007/s00401-024-02751-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross D, Vial C, Maccioni RB (1993) A tau-like protein interacts with stress fibers and microtubules in human and rodent cultured cell lines. J Cell Sci 105(Pt 1):51&#x2013;60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7689576</ArticleId><ArticleId IdType=\"doi\">10.1242/jcs.105.1.51</ArticleId></ArticleIdList></Reference><Reference><Citation>DiTella M, Feiguin F, Morfini G, C&#xe1;ceres A (1994) Microfilament-associated growth cone component depends upon Tau for its intracellular localization. Cell Motil Cytoskeleton 29(2):117&#x2013;130</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7820862</ArticleId><ArticleId IdType=\"doi\">10.1002/cm.970290204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempf M, Clement A, Faissner A, Lee G, Brandt R (1996) Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner. J Neurosci 16(18):5583&#x2013;5592</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8795614</ArticleId><ArticleId IdType=\"pmc\">6578978</ArticleId><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.16-18-05583.1996</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson JE, Ince PG, Shaw PJ, Heath PR, Raman R, Garwood CJ, Gelsthorpe C, Baxter L, Forster G, Matthews FE, Brayne C, Wharton SB (2011) Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer&#x2019;s pathology and APOE genotype. Neurobiol Aging 32(10):1795&#x2013;1807</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21705112</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2011.04.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Stein TD, Wang Y, Ang TFA, Tao Q, Lunetta KL, Massaro J, Akhter-Khan SC, Mez J, Au R, Farrer LA, Zhang X, Qiu WQ (2023) Blood levels of MCP-1 modulate the genetic risks of Alzheimer&#x2019;s disease mediated by HLA-DRB1 and APOE for Alzheimer&#x2019;s disease. Alzheimers Dement 19(5):1925&#x2013;1937</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36396603</ArticleId><ArticleId IdType=\"doi\">10.1002/alz.12851</ArticleId></ArticleIdList></Reference><Reference><Citation>Merched A, Serot JM, Visvikis S, Aguillon D, Faure G, Siest G (1998) Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer&#x2019;s patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett 425(2):225&#x2013;228</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9559653</ArticleId><ArticleId IdType=\"doi\">10.1016/S0014-5793(98)00234-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray M, Zhang W (2010) Analysis of Alzheimer&#x2019;s disease severity across brain regions by topological analysis of gene co-expression networks. BMC Syst Biol 4:136</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20925940</ArticleId><ArticleId IdType=\"pmc\">2976747</ArticleId><ArticleId IdType=\"doi\">10.1186/1752-0509-4-136</ArticleId></ArticleIdList></Reference><Reference><Citation>You Y, Muraoka S, Jedrychowski MP, Hu J, McQuade AK, Young-Pearse T, Aslebagh R, Shaffer SA, Gygi SP, Blurton-Jones M, Poon WW, Ikezu T (2022) Human neural cell type-specific extracellular vesicle proteome defines disease-related molecules associated with activated astrocytes in Alzheimer&#x2019;s disease brain. J Extracell Vesicles 11(1):e12183</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35029059</ArticleId><ArticleId IdType=\"pmc\">8758831</ArticleId><ArticleId IdType=\"doi\">10.1002/jev2.12183</ArticleId></ArticleIdList></Reference><Reference><Citation>Balczon R, Pittet JF, Wagener BM, Moser SA, Voth S, Vorhees CV, Williams MT, Bridges JP, Alvarez DF, Koloteva A, Xu Y, Zha XM, Audia JP, Stevens T, Lin MT (2019) Infection-induced endothelial amyloids impair memory. FASEB J 33(9):10300&#x2013;10314</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31211919</ArticleId><ArticleId IdType=\"pmc\">6704457</ArticleId><ArticleId IdType=\"doi\">10.1096/fj.201900322R</ArticleId></ArticleIdList></Reference><Reference><Citation>Melkov&#xe1; K, Zapletal V, Narasimhan S, Jansen S, Hritz J, &#x160;krabana R, Zweckstetter M, Ringkj&#xf8;bing Jensen M, Blackledge M, &#x17d;&#xed;dek L (2019) Structure and functions of microtubule associated proteins Tau and MAP2c: similarities and differences. Biomolecules 9(3):105</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30884818</ArticleId><ArticleId IdType=\"pmc\">6468450</ArticleId><ArticleId IdType=\"doi\">10.3390/biom9030105</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, Feany MB (2007) Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 9(2):139&#x2013;148</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17187063</ArticleId><ArticleId IdType=\"doi\">10.1038/ncb1528</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogterom M, Koenderink GH (2019) Actin-microtubule crosstalk in cell biology. Nat Rev Mol Cell Biol 20(1):38&#x2013;54</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30323238</ArticleId><ArticleId IdType=\"doi\">10.1038/s41580-018-0067-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirst C, Skriabine S, Vieites-Prado A, Topilko T, Bertin P, Gerschenfeld G, Verny F, Topilko P, Michalski N, Tessier-Lavigne M, Renier N (2020) Mapping the fine-scale organization and plasticity of the brain vasculature. Cell 180(4):780-795.e25</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32059781</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2020.01.028</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39276018</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Electronic\">1469-896X</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>33</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Protein science : a publication of the Protein Society</Title><ISOAbbreviation>Protein Sci</ISOAbbreviation></Journal><ArticleTitle>AlzDiscovery: A computational tool to identify Alzheimer's disease-causing missense mutations using protein structure information.</ArticleTitle><Pagination><StartPage>e5147</StartPage><MedlinePgn>e5147</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1002/pro.5147</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is one of the most common forms of dementia and neurodegenerative diseases, characterized by the formation of neuritic plaques and neurofibrillary tangles. Many different proteins participate in this complicated pathogenic mechanism, and missense mutations can alter the folding and functions of these proteins, significantly increasing the risk of AD. However, many methods to identify AD-causing variants did not consider the effect of mutations from the perspective of a protein three-dimensional environment. Here, we present a machine learning-based analysis to classify the AD-causing mutations from their benign counterparts in 21 AD-related proteins leveraging both sequence- and structure-based features. Using computational tools to estimate the effect of mutations on protein stability, we first observed a bias of the pathogenic mutations with significant destabilizing effects on family AD-related proteins. Combining this insight, we built a generic predictive model, and improved the performance by tuning the sample weights in the training process. Our final model achieved the performance on area under the receiver operating characteristic curve up to 0.95 in the blind test and 0.70 in an independent clinical validation, outperforming all the state-of-the-art methods. Feature interpretation indicated that the hydrophobic environment and polar interaction contacts were crucial to the decision on pathogenic phenotypes of missense mutations. Finally, we presented a user-friendly web server, AlzDiscovery, for researchers to browse the predicted phenotypes of all possible missense mutations on these 21 AD-related proteins. Our study will be a valuable resource for AD screening and the development of personalized treatment.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Protein Science published by Wiley Periodicals LLC on behalf of The Protein Society.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Pan</LastName><ForeName>Qisheng</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Parra</LastName><ForeName>Georgina Becerra</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Myung</LastName><ForeName>Yoochan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Portelli</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nguyen</LastName><ForeName>Thanh Binh</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ascher</LastName><ForeName>David B</ForeName><Initials>DB</Initials><Identifier Source=\"ORCID\">0000-0003-2948-2413</Identifier><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>GNT1174405</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Protein Sci</MedlineTA><NlmUniqueID>9211750</NlmUniqueID><ISSNLinking>0961-8368</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D020125\" MajorTopicYN=\"Y\">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000069550\" MajorTopicYN=\"N\">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D019295\" MajorTopicYN=\"N\">Computational Biology</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012984\" MajorTopicYN=\"N\">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011487\" MajorTopicYN=\"N\">Protein Conformation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">AlphaFold2</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">machine learning</Keyword><Keyword MajorTopicYN=\"N\">missense mutation</Keyword><Keyword MajorTopicYN=\"N\">protein structure</Keyword><Keyword MajorTopicYN=\"N\">web server</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>7</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39276018</ArticleId><ArticleId IdType=\"doi\">10.1002/pro.5147</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen&#x2010;2. Curr Protoc Hum Genet. 2013; Chapter 7: Unit7 20. PMID: 23315928 {Medline}.</Citation></Reference><Reference><Citation>Alonso Adel C, Mederlyova A, Novak M, Grundke&#x2010;Iqbal I, Iqbal K. Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem. 2004;279:34873&#x2013;34881. PMID: 15190058 {Medline}.</Citation></Reference><Reference><Citation>Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI&#x2010;BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389&#x2013;3402. PMID: 9254694 {Medline}.</Citation></Reference><Reference><Citation>Amino acid, peptide, and protein volume in solution. Annu Rev Biophys Bioeng. 1984;13:145&#x2013;165. PMID: 6378067 {Medline}, 191, 219.</Citation></Reference><Reference><Citation>Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, et al. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2004;32:D115&#x2013;D119. PMID: 14681372 {Medline}.</Citation></Reference><Reference><Citation>Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011;377:1019&#x2013;1031. PMID: 21371747 {Medline}.</Citation></Reference><Reference><Citation>Bhaskar K, Yen SH, Lee G. Disease&#x2010;related modifications in tau affect the interaction between Fyn and tau. J Biol Chem. 2005;280:35119&#x2013;35125. PMID: 16115884 {Medline}.</Citation></Reference><Reference><Citation>Bossaerts L, Hendrickx Van de Craen E, Cacace R, Asselbergh B, van Broeckhoven C. Rare missense mutations in ABCA7 might increase Alzheimer's disease risk by plasma membrane exclusion. Acta Neuropathol Commun. 2022;10:43 PMID: 35361255 {Medline}.</Citation></Reference><Reference><Citation>Brandes N, Goldman G, Wang CH, Ye CJ, Ntranos V. Genome&#x2010;wide prediction of disease variant effects with a deep protein language model. Nat Genet. 2023;55:1512&#x2013;1522. PMID: 37563329 {Medline}.</Citation></Reference><Reference><Citation>Brownjohn PW, Smith J, Solanki R, Lohmann E, Houlden H, Hardy J, et al. Functional studies of missense TREM2 mutations in human stem cell&#x2010;derived microglia. Stem Cell Rep. 2018;10:1294&#x2013;1307. PMID: 29606617 {Medline}.</Citation></Reference><Reference><Citation>Caldararu O, Mehra R, Blundell TL, Kepp KP. Systematic investigation of the data set dependency of protein stability predictors. J Chem Inf Model. 2020;60:4772&#x2013;4784. PMID: 32786698 {Medline}.</Citation></Reference><Reference><Citation>Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10:421 PMID: 20003500 {Medline}.</Citation></Reference><Reference><Citation>Charton M, Charton BI. The dependence of the Chou&#x2010;Fasman parameters on amino acid side chain structure. J Theor Biol. 1983;102:121&#x2013;134. PMID: 6876837 {Medline}.</Citation></Reference><Reference><Citation>Cheng J, Novati G, Pan J, Bycroft C, Zemgulyte A, Applebaum T, et al. Accurate proteome&#x2010;wide missense variant effect prediction with AlphaMissense. Science. 2023;381:eadg7492 PMID: 37733863 {Medline}.</Citation></Reference><Reference><Citation>Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31:2745&#x2013;2747. PMID: 25851949 {Medline}.</Citation></Reference><Reference><Citation>Cock PJ, Antao T, Chang JT, Chapman BA, Cox CJ, Dalke A, et al. Biopython: freely available python tools for computational molecular biology and bioinformatics. Bioinformatics. 2009;25:1422&#x2013;1423. PMID: 19304878 {Medline}.</Citation></Reference><Reference><Citation>Dasuri K, Ebenezer P, Zhang L, Fernandez&#x2010;Kim SO, Bruce&#x2010;Keller AJ, Markesbery WR, et al. Increased protein hydrophobicity in response to aging and Alzheimer disease. Free Radic Biol Med. 2010;48:1330&#x2013;1337. PMID: 20188163 {Medline}.</Citation></Reference><Reference><Citation>Do HN, Devkota S, Bhattarai A, Wolfe MS, Miao Y. Effects of presenilin&#x2010;1 familial Alzheimer's disease mutations on gamma&#x2010;secretase activation for cleavage of amyloid precursor protein. Commun Biol. 2023;6:174 PMID: 36788318 {Medline}.</Citation></Reference><Reference><Citation>Dosztanyi Z. Prediction of protein disorder based on IUPred. Protein Sci. 2018;27:331&#x2013;340. PMID: 29076577 {Medline}.</Citation></Reference><Reference><Citation>Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, et al. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12:292&#x2013;323. PMID: 27012484 {Medline}.</Citation></Reference><Reference><Citation>Erdos G, Pajkos M, Dosztanyi Z. IUPred3: prediction of protein disorder enhanced with unambiguous experimental annotation and visualization of evolutionary conservation. Nucleic Acids Res. 2021;49:W297&#x2013;W303. PMID: 34048569 {Medline}.</Citation></Reference><Reference><Citation>Fang M, Su Z, Abolhassani H, Itan Y, Jin X, Hammarstrom L. VIPPID: a gene&#x2010;specific single nucleotide variant pathogenicity prediction tool for primary immunodeficiency diseases. Brief Bioinform. 2022;23: PMID: 35598327 {Medline}.</Citation></Reference><Reference><Citation>Fowler DM, Adams DJ, Gloyn AL, Hahn WC, Marks DS, Muffley LA, et al. An atlas of variant effects to understand the genome at nucleotide resolution. Genome Biol. 2023;24:147 PMID: 37394429 {Medline}.</Citation></Reference><Reference><Citation>Frieden C, Wang H, Ho CMW. A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain&#x2010;domain interactions. Proc Natl Acad Sci U S A. 2017;114:6292&#x2013;6297. PMID: 28559318 {Medline}.</Citation></Reference><Reference><Citation>Ganesan K, Kulandaisamy A, Binny Priya S, Gromiha MM. HuVarBase: a human variant database with comprehensive information at gene and protein levels. PLoS One. 2019;14:e0210475. PMID: 30703169 {Medline}.</Citation></Reference><Reference><Citation>Grant MA, Lazo ND, Lomakin A, Condron MM, Arai H, Yamin G, et al. Familial Alzheimer's disease mutations alter the stability of the amyloid beta&#x2010;protein monomer folding nucleus. Proc Natl Acad Sci U S A. 2007;104:16522&#x2013;16527. PMID: 17940047 {Medline}.</Citation></Reference><Reference><Citation>Gratuze M, Leyns CEG, Holtzman DM. New insights into the role of TREM2 in Alzheimer's disease. Mol Neurodegener. 2018;13:66 PMID: 30572908 {Medline}.</Citation></Reference><Reference><Citation>Gray VE, Hause RJ, Luebeck J, Shendure J, Fowler DM. Quantitative missense variant effect prediction using large&#x2010;scale mutagenesis data. Cell Syst. 2018;6:116&#x2013;124 e113. PMID: 29226803 {Medline}.</Citation></Reference><Reference><Citation>Hall&#x2010;Roberts H, Agarwal D, Obst J, Smith TB, Monzon&#x2010;Sandoval J, di Daniel E, et al. TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC&#x2010;derived macrophages. Alzheimers Res Ther. 2020;12:151 PMID: 33198789 {Medline}.</Citation></Reference><Reference><Citation>Hecht M, Bromberg Y, Rost B. Better prediction of functional effects for sequence variants. BMC Genomics. 2015;16(Suppl 8):S1 PMID: 26110438 {Medline}.</Citation></Reference><Reference><Citation>Jagota M, Ye C, Albors C, Rastogi R, Koehl A, Ioannidis N, et al. Cross&#x2010;protein transfer learning substantially improves disease variant prediction. Genome Biol. 2023;24:182 PMID: 37550700 {Medline}.</Citation></Reference><Reference><Citation>Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D, et al. Coding variants in TREM2 increase risk for Alzheimer's disease. Hum Mol Genet. 2014;23:5838&#x2013;5846. PMID: 24899047 {Medline}.</Citation></Reference><Reference><Citation>Joosten RP, te Beek TA, Krieger E, Hekkelman ML, Hooft RW, Schneider R, et al. A series of PDB related databases for everyday needs. Nucleic Acids Res. 2011;39:D411&#x2013;D419. PMID: 21071423 {Medline}.</Citation></Reference><Reference><Citation>Jubb HC, Higueruelo AP, Ochoa&#x2010;Montano B, Pitt WR, Ascher DB, Blundell TL. Arpeggio: a web server for calculating and visualising interatomic interactions in protein structures. J Mol Biol. 2017;429:365&#x2013;371. PMID: 27964945 {Medline}.</Citation></Reference><Reference><Citation>Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583&#x2013;589. PMID: 34265844 {Medline}.</Citation></Reference><Reference><Citation>Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen&#x2010;bonded and geometrical features. Biopolymers. 1983;22:2577&#x2013;2637. PMID: 6667333 {Medline}.</Citation></Reference><Reference><Citation>Kawashima S, Ogata H, Kanehisa M. AAindex: amino acid index database. Nucleic Acids Res. 1999;27:368&#x2013;369. PMID: 9847231 {Medline}.</Citation></Reference><Reference><Citation>Kelleher RJ 3rd, Shen J. Presenilin&#x2010;1 mutations and Alzheimer's disease. Proc Natl Acad Sci U S A. 2017;114:629&#x2013;631. PMID: 28082723 {Medline}.</Citation></Reference><Reference><Citation>Kim W, Hecht MH. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide. Proc Natl Acad Sci U S A. 2006;103:15824&#x2013;15829. PMID: 17038501 {Medline}, 19164, 19169.</Citation></Reference><Reference><Citation>Kinoshita J, Clark T. Alzforum. Methods Mol Biol. 2007;401:365&#x2013;381. PMID: 18368375 {Medline}.</Citation></Reference><Reference><Citation>Klein P, Kanehisa M, DeLisi C. Prediction of protein function from sequence properties. Discriminant analysis of a data base. Biochim Biophys Acta. 1984;787:221&#x2013;226. PMID: 6547351 {Medline}.</Citation></Reference><Reference><Citation>Knopman DS, Amieva H, Petersen RC, Chetelat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7:33 PMID: 33986301 {Medline}.</Citation></Reference><Reference><Citation>Kulandaisamy A, Parvathy Dharshini SA, Gromiha MM. Alz&#x2010;disc: a tool to discriminate disease&#x2010;causing and neutral mutations in Alzheimer's disease. Comb Chem High Throughput Screen. 2023;26:769&#x2013;777. PMID: 35619290 {Medline}.</Citation></Reference><Reference><Citation>Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062&#x2013;D1067. PMID: 29165669 {Medline}.</Citation></Reference><Reference><Citation>Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980&#x2013;D985. PMID: 24234437 {Medline}.</Citation></Reference><Reference><Citation>Li G, Panday SK, Alexov E. SAAFEC&#x2010;SEQ: a sequence&#x2010;based method for predicting the effect of single point mutations on protein thermodynamic stability. Int J Mol Sci. 2021;22: PMID: 33435356 {Medline}.</Citation></Reference><Reference><Citation>Mariani V, Biasini M, Barbato A, Schwede T. lDDT: a local superposition&#x2010;free score for comparing protein structures and models using distance difference tests. Bioinformatics. 2013;29:2722&#x2013;2728. PMID: 23986568 {Medline}.</Citation></Reference><Reference><Citation>Marti&#x2010;Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct. 2000;29:291&#x2013;325. PMID: 10940251 {Medline}.</Citation></Reference><Reference><Citation>Meirovitch H, Rackovsky S, Scheraga HA. Empirical studies of hydrophobicity. 1. Effect of protein size on the hydrophobic behavior of amino acids. Macromolecules. 1980;13:1398&#x2013;1405.</Citation></Reference><Reference><Citation>Munro D, Singh M. DeMaSk: a deep mutational scanning substitution matrix and its use for variant impact prediction. Bioinformatics. 2021;36:5322&#x2013;5329. PMID: 33325500 {Medline}.</Citation></Reference><Reference><Citation>Myung Y, Rodrigues CHM, Ascher DB, Pires DEV. mCSM&#x2010;AB2: guiding rational antibody design using graph&#x2010;based signatures. Bioinformatics. 2020;36:1453&#x2013;1459. PMID: 31665262 {Medline}.</Citation></Reference><Reference><Citation>Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812&#x2013;3814. PMID: 12824425 {Medline}.</Citation></Reference><Reference><Citation>Notin P, Kollasch AW, Ritter D, van Niekerk L, Paul S, Spinner H, et al. ProteinGym: large&#x2010;scale benchmarks for protein design and fitness prediction. bioRxiv. 2023; PMID: 38106144 {Medline}.</Citation></Reference><Reference><Citation>Pan Q, Nguyen TB, Ascher DB, Pires DEV. Systematic evaluation of computational tools to predict the effects of mutations on protein stability in the absence of experimental structures. Brief Bioinform. 2022;23: PMID: 35189634 {Medline}.</Citation></Reference><Reference><Citation>Pan Q, Portelli S, Nguyen TB, Ascher DB. Characterization on the oncogenic effect of the missense mutations of p53 via machine learning. Brief Bioinform. 2023;25: PMID: 38018912 {Medline}.</Citation></Reference><Reference><Citation>Panegyres PK, Chen HY. Differences between early and late onset Alzheimer's disease. Am J Neurodegener Dis. 2013;2:300&#x2013;306. PMID: 24319647 {Medline}.</Citation></Reference><Reference><Citation>Pires DE, Ascher DB, Blundell TL. mCSM: predicting the effects of mutations in proteins using graph&#x2010;based signatures. Bioinformatics. 2014;30:335&#x2013;342. PMID: 24281696 {Medline}.</Citation></Reference><Reference><Citation>Portelli S, Albanaz A, Pires DEV, Ascher DB. Identifying the molecular drivers of ALS&#x2010;implicated missense mutations. J Med Genet. 2023;60:484&#x2013;490. PMID: 36180205 {Medline}.</Citation></Reference><Reference><Citation>Portelli S, Barr L, de Sa AGC, Pires DEV, Ascher DB. Distinguishing between PTEN clinical phenotypes through mutation analysis. Comput Struct Biotechnol J. 2021;19:3097&#x2013;3109. PMID: 34141133 {Medline}.</Citation></Reference><Reference><Citation>Rezaei&#x2010;Ghaleh N, Amininasab M, Giller K, Becker S. Familial Alzheimer's disease&#x2010;related mutations differentially alter stability of amyloid&#x2010;beta aggregates. J Phys Chem Lett. 2023;14:1427&#x2013;1435. PMID: 36734539 {Medline}.</Citation></Reference><Reference><Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier&#x2010;Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405&#x2013;424. PMID: 25741868 {Medline}.</Citation></Reference><Reference><Citation>Rodrigues CHM, Pires DEV, Ascher DB. DynaMut2: assessing changes in stability and flexibility upon single and multiple point missense mutations. Protein Sci. 2021;30:60&#x2013;69. PMID: 32881105 {Medline}.</Citation></Reference><Reference><Citation>Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, et al. Structural alterations in the peptide backbone of beta&#x2010;amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem. 1993;268:3072&#x2013;3083. PMID: 8428986 {Medline}.</Citation></Reference><Reference><Citation>Rose AS, Bradley AR, Valasatava Y, Duarte JM, Prlic A, Rose PW. NGL viewer: web&#x2010;based molecular graphics for large complexes. Bioinformatics. 2018;34:3755&#x2013;3758. PMID: 29850778 {Medline}.</Citation></Reference><Reference><Citation>Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234:779&#x2013;815. PMID: 8254673 {Medline}.</Citation></Reference><Reference><Citation>Sayed FA, Kodama L, Fan L, Carling GK, Udeochu JC, Le D, et al. AD&#x2010;linked R47H&#x2010;TREM2 mutation induces disease&#x2010;enhancing microglial states via AKT hyperactivation. Sci Transl Med. 2021;13:eabe3947 PMID: 34851693 {Medline}.</Citation></Reference><Reference><Citation>Sayers EW, Bolton EE, Brister JR, Canese K, Chan J, Comeau DC, et al. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2022;50:D20&#x2013;D26. PMID: 34850941 {Medline}.</Citation></Reference><Reference><Citation>Scheltens P, de Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer's disease. Lancet. 2021;397:1577&#x2013;1590. PMID: 33667416 {Medline}.</Citation></Reference><Reference><Citation>Sgourakis NG, Yan Y, McCallum SA, Wang C, Garcia AE. The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD/NMR study. J Mol Biol. 2007;368:1448&#x2013;1457. PMID: 17397862 {Medline}.</Citation></Reference><Reference><Citation>Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA, et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet. 1996;5:985&#x2013;988. PMID: 8817335 {Medline}.</Citation></Reference><Reference><Citation>Sirkis DW, Bonham LW, Aparicio RE, Geier EG, Ramos EM, Wang Q, et al. Rare TREM2 variants associated with Alzheimer's disease display reduced cell surface expression. Acta Neuropathol Commun. 2016;4:98 PMID: 27589997 {Medline}.</Citation></Reference><Reference><Citation>Smigielski EM, Sirotkin K, Ward M, Sherry ST. dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res. 2000;28:352&#x2013;355. PMID: 10592272 {Medline}.</Citation></Reference><Reference><Citation>Somavarapu AK, Kepp KP. Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer's disease. J Neurochem. 2016;137:101&#x2013;111. PMID: 26756738 {Medline}.</Citation></Reference><Reference><Citation>Lohr T, Kohlhoff K, Heller GT, Camilloni C, Vendruscolo M. A small molecule stabilises the disordered native state of the Alzheimer's A&#x3b2; peptide. ACS Chem Neurosci. 2022;13:1738&#x2013;1745. PMID: 35649268 {Medline}.</Citation></Reference><Reference><Citation>van Gils JHM, van Dijk E, Peduzzo A, Hofmann A, Vettore N, Schutzmann MP, et al. The hydrophobic effect characterises the thermodynamic signature of amyloid fibril growth. PLoS Comput Biol. 2020;16:e1007767 PMID: 32365068 {Medline}.</Citation></Reference><Reference><Citation>Vasquez M, Nemethy G, Scheraga HA. Computed conformational states of the 20 naturally occurring amino acid residues and of the prototype residue &#x3b1;&#x2010;aminobutyric acid. Macromolecules. 1983;16:1043&#x2013;1049.</Citation></Reference><Reference><Citation>Wakutani Y, Watanabe K, Adachi Y, Wada&#x2010;Isoe K, Urakami K, Ninomiya H, et al. Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004;75:1039&#x2013;1042. PMID: 15201367 {Medline}.</Citation></Reference><Reference><Citation>Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell. 2015;160:1061&#x2013;1071. PMID: 25728668 {Medline}.</Citation></Reference><Reference><Citation>Wattmo C, Minthon L, Wallin AK. Mild versus moderate stages of Alzheimer's disease: three&#x2010;year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Alzheimers Res Ther. 2016;8:7 PMID: 26883213 {Medline}.</Citation></Reference><Reference><Citation>Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics. 2016;54:5&#x2013;6. PMID: 27322406 {Medline}.</Citation></Reference><Reference><Citation>Wu Y, Li R, Sun S, Weile J, Roth FP. Improved pathogenicity prediction for rare human missense variants. Am J Hum Genet. 2021;108:1891&#x2013;1906. PMID: 34551312 {Medline}, 2389.</Citation></Reference><Reference><Citation>Zamyatnin AA. Protein volume in solution. Prog Biophys Mol Biol. 1972;24:107&#x2013;123. PMID: 4566650 {Medline}.</Citation></Reference><Reference><Citation>Zhang W, Jiao B, Xiao T, Liu X, Liao X, Xiao X, et al. Association of rare variants in neurodegenerative genes with familial Alzheimer's disease. Ann Clin Transl Neurol. 2020;7:1985&#x2013;1995. PMID: 32941707 {Medline}.</Citation></Reference><Reference><Citation>Zhou Y, Pan Q, Pires DEV, Rodrigues CHM, Ascher DB. DDMut: predicting effects of mutations on protein stability using deep learning. Nucleic Acids Res PMID: 37283042 {Medline}. 2023;51:W122&#x2013;W128.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39275969</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1468-1331</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>Difference in trajectories according to early amyloid accumulation in cognitively unimpaired elderly.</ArticleTitle><Pagination><StartPage>e16482</StartPage><MedlinePgn>e16482</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1111/ene.16482</ELocationID><Abstract><AbstractText Label=\"BACKGROUND AND PURPOSE\" NlmCategory=\"OBJECTIVE\">Amyloid &#x3b2; (A&#x3b2;), a major biomarker of Alzheimer's disease, leads to tau accumulation, neurodegeneration and cognitive decline. Modelling the trajectory of A&#x3b2; accumulation in cognitively unimpaired (CU) individuals is crucial, as treatments targeting A&#x3b2; are anticipated. The evolution of A&#x3b2; levels was investigated to determine whether it could lead to classification into different groups by studying longitudinal A&#x3b2; changes in older CU individuals, and differences between the groups were compared.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">A total of 297 CU participants were included from the Alzheimer's Disease Neuroimaging Initiative database, and these participants underwent apolipoprotein E (APOE) genotyping, neuropsychological testing, brain magnetic resonance imaging, and an average of 3.03 follow-up <sup>18</sup>F-florbetapir positron emission tomography scans. Distinct A&#x3b2; trajectory patterns were classified using latent class growth analysis, and longitudinal cognitive performances across these patterns were assessed with a linear mixed effects model.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">The optimal model consisted of three classes, with a high entropy value of 0.947. The classes were designated as follows: class 1, non-accumulation group (n&#x2009;&#x2009;=&#x2009;197); class 2, late accumulation group (n&#x2009;&#x2009;=&#x2009;70); and class 3, early accumulation group (n&#x2009;&#x2009;=&#x2009;30). The late accumulation and early accumulation groups had more APOE &#x3b5;4 carriers than the non-accumulation group. The longitudinal analysis of cognitive performance revealed that the early accumulation group showed the steepest decline (modified Preclinical Alzheimer's Cognitive Composite with digit symbol substitution [mPACCdigit], p&#x2009;&lt;&#x2009;0.001; modified Preclinical Alzheimer's Cognitive Composite with trails B [mPACCtrailsB], p&#x2009;&lt;&#x2009;0.001) and the late accumulation group showed a steeper decline (mPACCdigit, p&#x2009;=&#x2009;0.014; mPACCtrailsB, p&#x2009;=&#x2009;0.007) compared to the non-accumulation group.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">Our study showed the heterogeneity of A&#x3b2; accumulation trajectories in CU older individuals. The prognoses for cognitive decline differ according to the A&#x3b2; trajectory patterns.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Young Ju</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Centre, Samsung Medical Centre, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yun</LastName><ForeName>Jihwan</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0002-2436-4947</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Seo</LastName><ForeName>Sang Won</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Centre, Samsung Medical Centre, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Jun Pyo</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Centre, Samsung Medical Centre, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jang</LastName><ForeName>Hyemin</ForeName><Initials>H</Initials><Identifier Source=\"ORCID\">0000-0003-3152-1274</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital, Seoul National University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Hee Jin</ForeName><Initials>HJ</Initials><Identifier Source=\"ORCID\">0000-0002-3186-9441</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Centre, Samsung Medical Centre, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Na</LastName><ForeName>Duk L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Centre, Samsung Medical Centre, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Woo</LastName><ForeName>Sookyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biostatistics Team, Samsung Biomedical Research Institute, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chun</LastName><ForeName>Min Young</ForeName><Initials>MY</Initials><Identifier Source=\"ORCID\">0000-0003-3731-6132</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><CollectiveName>Alzheimer's Disease Neuroimaging Initiative</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>6-2023-0145</GrantID><Agency>Yonsei University College of Medicine</Agency><Country/></Grant><Grant><GrantID>RS-2020-KH106434</GrantID><Agency>Ministry of Health &amp; Welfare and Ministry of Science and ICT Republic of Korea</Agency><Country/></Grant><Grant><GrantID>RS-2022-KH127756</GrantID><Agency>Ministry of Health &amp; Welfare and Ministry of Science and ICT Republic of Korea</Agency><Country/></Grant><Grant><GrantID>NRF-2019R1A5A2027340</GrantID><Agency>Korea government</Agency><Country/></Grant><Grant><GrantID>RS-2021-II212068</GrantID><Agency>Korea government</Agency><Country/></Grant><Grant><GrantID>2024-ER1003-00</GrantID><Agency>\"Korea National Institute of Health\" research project</Agency><Country/></Grant><Grant><GrantID>#SMX1240561</GrantID><Agency>Samsung Medical Center</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">amyloid</Keyword><Keyword MajorTopicYN=\"N\">cognition</Keyword><Keyword MajorTopicYN=\"N\">latent class growth analysis</Keyword><Keyword MajorTopicYN=\"N\">longitudinal study</Keyword><Keyword MajorTopicYN=\"N\">positron emission tomography</Keyword><Keyword MajorTopicYN=\"N\">trajectory</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39275969</ArticleId><ArticleId IdType=\"doi\">10.1111/ene.16482</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Jack CR Jr, Bennett DA, Blennow K, et&#xa0;al. NIA&#x2010;AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14(4):535&#x2010;562. doi:10.1016/j.jalz.2018.02.018</Citation></Reference><Reference><Citation>Price JL, Morris JC. Tangles and plaques in nondemented aging and &#x2018;preclinical&#x2019; Alzheimer's disease. Ann Neurol. 1999;45(3):358&#x2010;368. doi:10.1002/1531-8249(199903)45:3&lt;358::aid-ana12&gt;3.0.co;2-x</Citation></Reference><Reference><Citation>Jessen F, Amariglio RE, van Boxtel M, et&#xa0;al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014;10(6):844&#x2010;852. doi:10.1016/j.jalz.2014.01.001</Citation></Reference><Reference><Citation>Jack CR Jr, Albert MS, Knopman DS, et&#xa0;al. Introduction to the recommendations from the National Institute on Aging&#x2013;Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):257&#x2010;262. doi:10.1016/j.jalz.2011.03.004</Citation></Reference><Reference><Citation>Wattmo C, Minthon L, Wallin AK. Mild versus moderate stages of Alzheimer's disease: three&#x2010;year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Alzheimers Res Ther. 2016;8(1):7. doi:10.1186/s13195-016-0174-1</Citation></Reference><Reference><Citation>Vivot A, Glymour MM, Tzourio C, Amouyel P, Chene G, Dufouil C. Association of Alzheimer's related genotypes with cognitive decline in multiple domains: results from the three&#x2010;city Dijon study. Mol Psychiatry. 2015;20(10):1173&#x2010;1178. doi:10.1038/mp.2015.62</Citation></Reference><Reference><Citation>Chen Y, Denny KG, Harvey D, et&#xa0;al. Progression from normal cognition to mild cognitive impairment in a diverse clinic&#x2010;based and community&#x2010;based elderly cohort. Alzheimers Dement. 2017;13(4):399&#x2010;405. doi:10.1016/j.jalz.2016.07.151</Citation></Reference><Reference><Citation>Albert M, Zhu Y, Moghekar A, et&#xa0;al. Predicting progression from normal cognition to mild cognitive impairment for individuals at 5&#x2009;years. Brain. 2018;141(3):877&#x2010;887. doi:10.1093/brain/awx365</Citation></Reference><Reference><Citation>Nagin DS, Odgers CL. Group&#x2010;based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109&#x2010;138. doi:10.1146/annurev.clinpsy.121208.131413</Citation></Reference><Reference><Citation>Teipel SJ, Cavedo E, Lista S, et&#xa0;al. Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers: an INSIGHT&#x2010;preAD study. Alzheimers Dement. 2018;14(9):1126&#x2010;1136. doi:10.1016/j.jalz.2018.04.004</Citation></Reference><Reference><Citation>Small BJ, Backman L. Longitudinal trajectories of cognitive change in preclinical Alzheimer's disease: a growth mixture modeling analysis. Cortex. 2007;43(7):826&#x2010;834. doi:10.1016/s0010-9452(08)70682-8</Citation></Reference><Reference><Citation>Kim YJ, Kim SE, Hahn A, et&#xa0;al. Classification and prediction of cognitive trajectories of cognitively unimpaired individuals. Front Aging Neurosci. 2023;15:1122927. doi:10.3389/fnagi.2023.1122927</Citation></Reference><Reference><Citation>Jagust WJ, Landau S, Shaw L, et&#xa0;al. Relationships between biomarkers in aging and dementia. Neurology. 2009;73(15):1193&#x2010;1199.</Citation></Reference><Reference><Citation>Jagust WJ, Bandy D, Chen K, et&#xa0;al. The Alzheimer's disease neuroimaging initiative positron emission tomography core. Alzheimers Dement. 2010;6(3):221&#x2010;229. doi:10.1016/j.jalz.2010.03.003</Citation></Reference><Reference><Citation>Donohue MC, Sperling RA, Salmon DP, et&#xa0;al. The preclinical Alzheimer cognitive composite: measuring amyloid&#x2010;related decline. JAMA Neurol. 2014;71(8):961&#x2010;970. doi:10.1001/jamaneurol.2014.803</Citation></Reference><Reference><Citation>Muthen B, Muthen LK. Integrating person&#x2010;centered and variable&#x2010;centered analyses: growth mixture modeling with latent trajectory classes. Alcohol Clin Exp Res. 2000;24(6):882&#x2010;891.</Citation></Reference><Reference><Citation>Jung T, Wickrama KAS. An introduction to latent class growth analysis and growth mixture modeling. Soc Personal Psychol Compass. 2008;2(1):302&#x2010;317. doi:10.1111/j.1751-9004.2007.00054.x</Citation></Reference><Reference><Citation>Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6(2):461&#x2010;464.</Citation></Reference><Reference><Citation>Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19(6):716&#x2010;723. doi:10.1109/TAC.1974.1100705</Citation></Reference><Reference><Citation>Lo Y, Mendell NR, Rubin DB. Testing the number of components in a normal mixture. Biometrika. 2001;88(3):767&#x2010;778. doi:10.1093/biomet/88.3.767</Citation></Reference><Reference><Citation>McLachlan G, Peel D. Finite Mixture Models. Wiley Series in Probability and Statistics. John Wiley; 2000.</Citation></Reference><Reference><Citation>Clark SL, Muth&#xe9;n B. Relating Latent Class Analysis Results to Variables not Included in the Analysis. University of California; 2009.</Citation></Reference><Reference><Citation>Muth&#xe9;n LK, Muth&#xe9;n BO. Mplus User's Guide. 8th ed. Muth&#xe9;n &amp; Muth&#xe9;n; 2019.</Citation></Reference><Reference><Citation>Villeneuve SC, Houot M, Cacciamani F, et&#xa0;al. Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease. Alzheimers Dement (N Y). 2019;5:553&#x2010;562. doi:10.1016/j.trci.2019.08.009</Citation></Reference><Reference><Citation>Hayden KM, Kuchibhatla M, Romero HR, et&#xa0;al. Pre&#x2010;clinical cognitive phenotypes for Alzheimer disease: a latent profile approach. Am J Geriatr Psychiatry. 2014;22(11):1364&#x2010;1374. doi:10.1016/j.jagp.2013.07.008</Citation></Reference><Reference><Citation>Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106&#x2010;118. doi:10.1038/nrneurol.2012.263</Citation></Reference><Reference><Citation>Jansen WJ, Ossenkoppele R, Knol DL, et&#xa0;al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta&#x2010;analysis. JAMA. 2015;313(19):1924&#x2010;1938. doi:10.1001/jama.2015.4668</Citation></Reference><Reference><Citation>Kim JP, Chun MY, Kim SJ, et&#xa0;al. Distinctive temporal trajectories of Alzheimer's disease biomarkers according to sex and APOE genotype: importance of striatal amyloid. Front Aging Neurosci. 2022;14:829202. doi:10.3389/fnagi.2022.829202</Citation></Reference><Reference><Citation>Pletnikova O, Kageyama Y, Rudow G, et&#xa0;al. The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype. Neurobiol Aging. 2018;71:72&#x2010;80. doi:10.1016/j.neurobiolaging.2018.07.007</Citation></Reference><Reference><Citation>Lim YY, Kalinowski P, Pietrzak RH, et&#xa0;al. Association of beta&#x2010;amyloid and apolipoprotein E epsilon4 with memory decline in preclinical Alzheimer disease. JAMA Neurol. 2018;75(4):488&#x2010;494. doi:10.1001/jamaneurol.2017.4325</Citation></Reference><Reference><Citation>Mormino EC, Betensky RA, Hedden T, et&#xa0;al. Amyloid and APOE epsilon4 interact to influence short&#x2010;term decline in preclinical Alzheimer disease. Neurology. 2014;82(20):1760&#x2010;1767. doi:10.1212/WNL.0000000000000431</Citation></Reference><Reference><Citation>Mishra S, Blazey TM, Holtzman DM, et&#xa0;al. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE epsilon4 genotype. Brain. 2018;141(6):1828&#x2010;1839. doi:10.1093/brain/awy103</Citation></Reference><Reference><Citation>Brugulat&#x2010;Serrat A, S&#xe1;nchez&#x2010;Benavides G, Cacciaglia R, et&#xa0;al. APOE&#x2010;&#x3b5;4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle&#x2010;aged individuals. EJNMMI Res. 2023;13(1):18. doi:10.1186/s13550-023-00967-6</Citation></Reference><Reference><Citation>Long JM, Coble DW, Xiong C, et&#xa0;al. Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes. Brain. 2022;145(12):4506&#x2010;4518. doi:10.1093/brain/awac250</Citation></Reference><Reference><Citation>Vos SJ, Xiong C, Visser PJ, et&#xa0;al. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. Lancet Neurol. 2013;12(10):957&#x2010;965. doi:10.1016/S1474-4422(13)70194-7</Citation></Reference><Reference><Citation>Landau SM, Lu M, Joshi AD, et&#xa0;al. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of beta&#x2010;amyloid. Ann Neurol. 2013;74(6):826&#x2010;836. doi:10.1002/ana.23908</Citation></Reference><Reference><Citation>Bischof GN, Jacobs HIL. Subthreshold amyloid and its biological and clinical meaning: long way ahead. Neurology. 2019;93(2):72&#x2010;79. doi:10.1212/WNL.0000000000007747</Citation></Reference><Reference><Citation>Leal SL, Lockhart SN, Maass A, Bell RK, Jagust WJ. Subthreshold amyloid predicts tau deposition in aging. J Neurosci. 2018;38(19):4482&#x2010;4489. doi:10.1523/JNEUROSCI.0485-18.2018</Citation></Reference><Reference><Citation>Landau SM, Horng A, Jagust WJ. Alzheimer's Disease Neuroimaging Initiative. Memory decline accompanies subthreshold amyloid accumulation. Neurology. 2018;90(17):e1452&#x2010;e1460. doi:10.1212/WNL.0000000000005354</Citation></Reference><Reference><Citation>Jack CR Jr, Wiste HJ, Knopman DS, et&#xa0;al. Rates of beta&#x2010;amyloid accumulation are independent of hippocampal neurodegeneration. Neurology. 2014;82(18):1605&#x2010;1612. doi:10.1212/WNL.0000000000000386</Citation></Reference><Reference><Citation>Pegueroles J, Vilaplana E, Montal V, et&#xa0;al. Longitudinal brain structural changes in preclinical Alzheimer's disease. Alzheimers Dement. 2017;13(5):499&#x2010;509. doi:10.1016/j.jalz.2016.08.010</Citation></Reference><Reference><Citation>Gordon BA, Blazey T, Su Y, et&#xa0;al. Longitudinal beta&#x2010;amyloid deposition and hippocampal volume in preclinical Alzheimer disease and suspected non&#x2010;Alzheimer disease pathophysiology. JAMA Neurol. 2016;73(10):1192&#x2010;1200. doi:10.1001/jamaneurol.2016.2642</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39275926</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1099-1263</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of applied toxicology : JAT</Title><ISOAbbreviation>J Appl Toxicol</ISOAbbreviation></Journal><ArticleTitle>The ameliorative potential of metformin against aluminum-induced neurotoxicity: Insights from in vitro studies.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1002/jat.4695</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is increasingly recognized as a metabolic disorder, often referred to as type 3 diabetes, due to its strong association with insulin resistance. Chronic exposure to aluminum, a known neurotoxin, has been identified as a significant risk factor in the development and progression of AD. This study explores the potential of metformin, a common anti-diabetic drug, to mitigate aluminum-induced neurotoxicity in an in vitro model of AD. Our findings reveal that metformin significantly reduces oxidative stress markers such as malonaldehyde, carbonyl groups, and reactive oxygen species while enhancing antioxidant defenses. Metformin modulates critical signaling pathways, including glycogen synthase kinase 3 beta (GSK3-&#x3b2;)/RAC-alpha serine/threonine protein kinase (RAC-alpha serine/threonine protein kinase (Akt1)/protein phosphatase 2A (PP2A) and Wnt/&#x3b2;-catenin, decreasing Tau protein levels and promoting neurogenesis. These results suggest that metformin may offer a novel therapeutic approach for AD, particularly in cases where aluminum exposure is a contributing factor.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Journal of Applied Toxicology published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Sanajou</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0002-6751-5266</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Toxicology, Istanbul Aydin University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yir&#xfc;n</LastName><ForeName>Anil</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-4050-8832</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Toxicology, Cukurova University, Adana, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Demirel</LastName><ForeName>G&#xf6;ksun</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0002-2994-5505</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Toxicology, Cukurova University, Adana, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Erkeko&#x11f;lu</LastName><ForeName>Pinar</ForeName><Initials>P</Initials><Identifier Source=\"ORCID\">0000-0003-4713-7672</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>&#x15e;ahin</LastName><ForeName>G&#xf6;n&#xfc;l</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0003-3742-6841</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Baydar</LastName><ForeName>Terken</ForeName><Initials>T</Initials><Identifier Source=\"ORCID\">0000-0002-5497-9600</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>TSA-2021-14186</GrantID><Agency>Hacettepe University Research Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Appl Toxicol</MedlineTA><NlmUniqueID>8109495</NlmUniqueID><ISSNLinking>0260-437X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">GSK3&#x2010;&#x3b2;</Keyword><Keyword MajorTopicYN=\"N\">Wnt signaling</Keyword><Keyword MajorTopicYN=\"N\">aluminum</Keyword><Keyword MajorTopicYN=\"N\">metformin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39275926</ArticleId><ArticleId IdType=\"doi\">10.1002/jat.4695</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Agholme, L., Lindstr&#xf6;m, T., K&#xe5;gedal, K., Marcusson, J., &amp; Hallbeck, M. (2010). An in vitro model for neuroscience: Differentiation of SH&#x2010;SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. Journal of Alzheimer's Disease, 20(4), 1069&#x2013;1082. https://doi.org/10.3233/JAD-2010-091363</Citation></Reference><Reference><Citation>Akerboom, T. P. M., &amp; Sies, H. (1981). Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods in Enzymology, 77(C), 373&#x2013;382. https://doi.org/10.1016/s0076-6879(81)77050-2</Citation></Reference><Reference><Citation>Barini, E., Antico, O., Zhao, Y., Asta, F., Tucci, V., Catelani, T., Marotta, R., Xu, H., &amp; Gasparini, L. (2016). Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy. Molecular Neurodegeneration, 11(1), 1&#x2013;20. https://doi.org/10.1186/S13024-016-0082-7/FIGURES/6</Citation></Reference><Reference><Citation>Basso, A. D., Solit, D. B., Chiosis, G., Giri, B., Tsichlis, P., &amp; Rosen, N. (2002). Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. Journal of Biological Chemistry, 277(42), 39858&#x2013;39866. https://doi.org/10.1074/jbc.M206322200</Citation></Reference><Reference><Citation>Bell, M., Bachmann, S., Klimek, J., Langerscheidt, F., &amp; Zempel, H. (2021). Axonal TAU sorting requires the C&#x2010;terminus of TAU but is independent of ANKG and TRIM46 enrichment at the AIS. Neuroscience, 461, 155&#x2013;171. https://doi.org/10.1016/j.neuroscience.2021.01.041</Citation></Reference><Reference><Citation>Cai, Z., &amp; Yan, L.&#x2010;J. (2013). Protein oxidative modifications: Beneficial roles in disease and health. Journal of Biochemical and Pharmacological Research, 1(1), 15. /pmc/articles/PMC3646577/&#x2013;26.</Citation></Reference><Reference><Citation>Cao, L., Tan, L., Wang, H.&#x2010;F., Jiang, T., Zhu, X.&#x2010;C., Lu, H., Tan, M.&#x2010;S., &amp; Yu, J.&#x2010;T. (2016). Dietary patterns and risk of dementia: A systematic review and meta&#x2010;analysis of cohort studies. Molecular Neurobiology, 53, 6144&#x2013;6154. https://doi.org/10.1007/s12035-015-9516-4</Citation></Reference><Reference><Citation>Chen, Y., Zhang, J., Zhang, B., &amp; Gong, C.&#x2010;X. (2016). Targeting insulin signaling for the treatment of Alzheimer's disease. Current Topics in Medicinal Chemistry, 16(5), 485&#x2013;492. https://doi.org/10.2174/1568026615666150813142423</Citation></Reference><Reference><Citation>Correia, S., Carvalho, C., Santos, M. S., Proenca, T., Nunes, E., Duarte, A. I., Monteiro, P., Seica, R., Oliveira, C. R., &amp; Moreira, P. I. (2008). Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes. Medicinal Chemistry, 4(4), 358&#x2013;364. https://doi.org/10.2174/157340608784872299</Citation></Reference><Reference><Citation>De La Monte, S. M., &amp; Wands, J. R. (2008). Alzheimer's disease is type 3 diabetes&#x2013;evidence reviewed. Journal of Diabetes Science and Technology (Online), 2(6), 1101&#x2013;1113. https://doi.org/10.1177/193229680800200619</Citation></Reference><Reference><Citation>de Medeiros, L. M., De Bastiani, M. A., Rico, E. P., Schonhofen, P., Pfaffenseller, B., Wollenhaupt&#x2010;Aguiar, B., Grun, L., Barb&#xe9;&#x2010;Tuana, F., Zimmer, E. R., Castro, M. A. A., Parsons, R. B., &amp; Klamt, F. (2019). Cholinergic differentiation of human neuroblastoma SH&#x2010;SY5Y cell line and its potential use as an in vitro model for Alzheimer's disease studies. Molecular Neurobiology, 56(11), 7355&#x2013;7367. https://doi.org/10.1007/s12035-019-1605-3</Citation></Reference><Reference><Citation>Demirel, G., Sanajou, S., Yir&#xfc;n, A., &#xc7;akir, D. A., Berkkan, A., Baydar, T., &amp; Erkeko&#x11f;lu, P. (2024). Evaluation of possible neuroprotective effects of virgin coconut oil on aluminum&#x2010;induced neurotoxicity in an in vitro Alzheimer's disease model. Journal of Applied Toxicology, 44(4), 609&#x2013;622. https://doi.org/10.1002/jat.4564</Citation></Reference><Reference><Citation>Dickey, C. A., Koren, J., Zhang, Y.&#x2010;J., Xu, Y., Jinwal, U. K., Birnbaum, M. J., Monks, B., Sun, M., Cheng, J. Q., Patterson, C., Bailey, R. M., Dunmore, J., Soresh, S., Leon, C., Morgan, D., &amp; Petrucelli, L. (2008). Akt and CHIP coregulate tau degradation through coordinated interactions. Proceedings of the National Academy of Sciences, 105(9), 3622&#x2013;3627. https://doi.org/10.1073/pnas.0709180105</Citation></Reference><Reference><Citation>El Massry, M., Alaeddine, L. M., Ali, L., Saad, C., &amp; Eid, A. A. (2021). Metformin: A growing journey from glycemic control to the treatment of Alzheimer's disease and depression. Current Medicinal Chemistry, 28(12), 2328&#x2013;2345. https://doi.org/10.2174/0929867327666200908114902</Citation></Reference><Reference><Citation>Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Ce&#xf1;a, V., Gallego, C., &amp; Comella, J. X. (2000). Sequential treatment of SH&#x2010;SY5Y cells with retinoic acid and brain&#x2010;derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor&#x2010;dependent, human neuron&#x2010;like cells. Journal of Neurochemistry, 75(3), 991&#x2013;1003. https://doi.org/10.1046/j.1471-4159.2000.0750991.x</Citation></Reference><Reference><Citation>Exley, C. (1999). A molecular mechanism of aluminium&#x2010;induced Alzheimer's disease? Journal of Inorganic Biochemistry, 76(2), 133&#x2013;140. https://doi.org/10.1016/S0162-0134(99)00125-7</Citation></Reference><Reference><Citation>Exley, C. (2004). The pro&#x2010;oxidant activity of aluminum. Free Radical Biology and Medicine, 36(3), 380&#x2013;387. https://doi.org/10.1016/j.freeradbiomed.2003.11.017</Citation></Reference><Reference><Citation>Exley, C., &amp; Ellen Burgess, J. (1996). Aluminum toxicokinetics. Journal of Toxicology and Environmental Health, 48(6), 569&#x2013;584. https://doi.org/10.1080/009841096161078</Citation></Reference><Reference><Citation>Goedert, M., Jakes, R., Qi, Z., Wang, J. H., &amp; Cohen, P. (1995). Protein phosphatase 2A is the major enzyme in brain that dephosphorylates &#x3c4; protein phosphorylated by proline&#x2010;directed protein kinases or cyclic AMP&#x2010;dependent protein kinase. Journal of Neurochemistry, 65(6), 2804&#x2013;2807. https://doi.org/10.1046/J.1471-4159.1995.65062804.X</Citation></Reference><Reference><Citation>Gupta, A., Bisht, B., &amp; Dey, C. S. (2011). Peripheral insulin&#x2010;sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's&#x2010;like changes. Neuropharmacology, 60(6), 910&#x2013;920. https://doi.org/10.1016/J.NEUROPHARM.2011.01.033</Citation></Reference><Reference><Citation>Huang, X., Li, S., Lu, W., &amp; Xiong, L. (2022). Metformin activates Wnt/&#x3b2;&#x2010;catenin for the treatment of diabetic osteoporosis. BMC Endocrine Disorders, 22(1), 1&#x2013;7. https://doi.org/10.1186/S12902-022-01103-6/FIGURES/3</Citation></Reference><Reference><Citation>Inestrosa, N. C., &amp; Toledo, E. M. (2008). The role of Wnt signaling in neuronal dysfunction in Alzheimer's disease. Molecular Neurodegeneration, 3(1), 9. https://doi.org/10.1186/1750-1326-3-9</Citation></Reference><Reference><Citation>J&#xe4;ms&#xe4;, A., Hasslund, K., Cowburn, R. F., B&#xe4;ckstr&#xf6;m, A., &amp; Vas&#xe4;nge, M. (2004). The retinoic acid and brain&#x2010;derived neurotrophic factor differentiated SH&#x2010;SY5Y cell line as a model for Alzheimer's disease&#x2010;like tau phosphorylation. Biochemical and Biophysical Research Communications, 319(3), 993&#x2013;1000. https://doi.org/10.1016/j.bbrc.2004.05.075</Citation></Reference><Reference><Citation>Kickstein, E., Krauss, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J., Williamson, R., Fuchs, M., K&#xf6;hler, A., Glossmann, H., Schneider, R., Sutherland, C., &amp; Schweiger, S. (2010). Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proceedings of the National Academy of Sciences, 107(50), 21830&#x2013;21835. https://doi.org/10.1073/pnas.0912793107</Citation></Reference><Reference><Citation>Koenig, A. M. (2016). Effects of the insulin sensitizer metformin on Alzheimer's disease biomarkers: Results of a brief crossover pilot study. Alzheimer's &amp; Dementia, 12(7S_Part_8), 413. https://doi.org/10.1016/j.jalz.2016.06.778</Citation></Reference><Reference><Citation>Krieg, R. C., Dong, Y., Schwamborn, K., &amp; Knuechel, R. (2005). Protein quantification and its tolerance for different interfering reagents using the BCA&#x2010;method with regard to 2D SDS PAGE. Journal of Biochemical and Biophysical Methods, 65(1), 13&#x2013;19. https://doi.org/10.1016/J.JBBM.2005.08.005</Citation></Reference><Reference><Citation>Kunicka&#x2010;Styczy&#x144;ska, A., Sikora, M., &amp; Kalemba, D. (2011). Lavender, tea tree and lemon oils as antimicrobials in washing liquids and soft body balms. International Journal of Cosmetic Science, 33(1), 53&#x2013;61. https://doi.org/10.1111/j.1468-2494.2010.00582.x</Citation></Reference><Reference><Citation>Lamoia, T. E., &amp; Shulman, G. I. (2021). Cellular and molecular mechanisms of metformin action. Endocrine Reviews, 42(1), 77&#x2013;96. https://doi.org/10.1210/ENDREV/BNAA023</Citation></Reference><Reference><Citation>Mailloux, R., Lemire, J., &amp; Appanna, V. (2007). Aluminum&#x2010;induced mitochondrial dysfunction leads to lipid accumulation in human hepatocytes: A link to obesity. Cellular Physiology and Biochemistry, 20(5), 627&#x2013;638. https://doi.org/10.1159/000107546</Citation></Reference><Reference><Citation>Miller, N. J., Rice&#x2010;Evans, C., Davies, M. J., Gopinathan, V., &amp; Milner, A. (1993). A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clinical Science, 84(4), 407&#x2013;412. https://doi.org/10.1042/CS0840407</Citation></Reference><Reference><Citation>Palomer, E., Buechler, J., &amp; Salinas, P. C. (2019). Wnt signaling deregulation in the aging and Alzheimer's brain. Frontiers in Cellular Neuroscience, 13, 227. https://doi.org/10.3389/fncel.2019.00227</Citation></Reference><Reference><Citation>Razani, E., Pourbagheri&#x2010;Sigaroodi, A., Safaroghli&#x2010;Azar, A., Zoghi, A., Shanaki&#x2010;Bavarsad, M., &amp; Bashash, D. (2021). The PI3K/Akt signaling axis in Alzheimer's disease: A valuable target to stimulate or suppress? Cell Stress &amp; Chaperones, 26(6), 871&#x2013;887. https://doi.org/10.1007/S12192-021-01231-3</Citation></Reference><Reference><Citation>Richard, M. J., Portal, B., Meo, J., Coudray, C., Hadjian, A., &amp; Favier, A. (1992). Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clinical Chemistry, 38(5), 704&#x2013;709. https://doi.org/10.1093/clinchem/38.5.704</Citation></Reference><Reference><Citation>Sanajou, S., Erkeko&#x11f;lu, P., &#x15e;ahin, G., &amp; Baydar, T. (2023). Role of aluminum exposure on Alzheimer's disease and related glycogen synthase kinase pathway. Drug and Chemical Toxicology, 46(3), 510&#x2013;522. https://doi.org/10.1080/01480545.2022.2065291</Citation></Reference><Reference><Citation>Sanajou, S., Yir&#xfc;n, A., Arca &#xc7;ak&#x131;r, D., Demirel, G., &#x15e;ahin, G., Erkeko&#x11f;lu, P., &amp; Baydar, T. (2024). Unraveling the neuroprotective mechanisms of naltrexone against aluminum&#x2010;induced neurotoxicity. Drug and Chemical Toxicology, 1&#x2013;12. https://doi.org/10.1080/01480545.2024.2303975</Citation></Reference><Reference><Citation>Sanajou, S., Yir&#xfc;n, A., Demirel, G., &#xc7;akir, D. A., &#x15e;ahin, G., Erkeko&#x11f;lu, P., &amp; Baydar, T. (2023). Antioxidant dihydrolipolic acid protects against in vitro aluminum&#x2010;induced toxicity. Journal of Applied Toxicology, 43, 1793&#x2013;1805. https://doi.org/10.1002/jat.4513</Citation></Reference><Reference><Citation>Shang, N., Zhang, P., Wang, S., Chen, J., Fan, R., Chen, J., Huang, T., Wang, Y., Duncan, J., Zhang, L., Niu, Q., &amp; Zhang, Q. (2020). Aluminum&#x2010;induced cognitive impairment and PI3K/Akt/mTOR signaling pathway involvement in occupational aluminum workers. Neurotoxicity Research, 38(2), 344&#x2013;358. https://doi.org/10.1007/S12640-020-00230-Z</Citation></Reference><Reference><Citation>Sun, X., Cao, Z., Zhang, Q., Liu, S., Xu, F., Che, J., Zhu, Y., Li, Y., Pan, C., &amp; Liang, W. (2015). Aluminum trichloride impairs bone and downregulates Wnt/&#x3b2;&#x2010;catenin signaling pathway in young growing rats. Food and Chemical Toxicology, 86, 154&#x2013;162. https://doi.org/10.1016/J.FCT.2015.10.005</Citation></Reference><Reference><Citation>Vial, G., Detaille, D., &amp; Guigas, B. (2019). Role of mitochondria in the mechanism(s) of action of metformin. Frontiers in Endocrinology, 10(MAY), 294. https://doi.org/10.3389/fendo.2019.00294</Citation></Reference><Reference><Citation>Yir&#xfc;n, A., &#xc7;ak&#x131;r, D. A., Sanajou, S., Erdemli K&#xf6;se, S. B., &#xd6;zyurt, A. B., Zeybek, D., Bozdemir, &#xd6;., Baydar, T., &amp; Erkekoglu, P. (2023). Evaluation of the effects of herpes simplex glycoprotein B on complement system and cytokines in in vitro models of Alzheimer's disease. Journal of Applied Toxicology, 43(9), 1368&#x2013;1378. https://doi.org/10.1002/jat.4471</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39275911</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1468-1331</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>'Knock down the brain': a nonlinear analysis of electroencephalography to study the effects of sub-concussion in boxers.</ArticleTitle><Pagination><StartPage>e16411</StartPage><MedlinePgn>e16411</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1111/ene.16411</ELocationID><Abstract><AbstractText Label=\"BACKGROUND AND PURPOSE\" NlmCategory=\"OBJECTIVE\">Boxing is associated with a high risk of head injuries and increases the likelihood of chronic traumatic encephalopathy. This study explores the effects of sub-concussive impacts on boxers by applying both linear and nonlinear analysis methods to electroencephalogram (EEG) data.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">Twenty-one boxers were selected (mean&#x2009;&#xb1;&#x2009;SD, age 28.38&#x2009;&#xb1;&#x2009;5.5&#x2009;years; weight 67.55&#x2009;&#xb1;&#x2009;8.90&#x2009;kg; years of activity 6.76&#x2009;&#xb1;&#x2009;5.45; education 14.19&#x2009;&#xb1;&#x2009;3.08&#x2009;years) and divided into 'beginner' and 'advanced' groups. The Montreal Cognitive Assessment and the Frontal Assessment Battery were administered; EEG data were collected in both eyes-open (EO) and eyes-closed (EC) conditions during resting states. Analyses of EEG data included normalized power spectral density (nPSD), power law exponent (PLE), detrended fluctuation analysis and multiscale entropy. Statistical analyses were used to compare the groups.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Significant differences in nPSD and PLE were observed between the beginner and advanced boxers, with advanced boxers showing decreased mean nPSD and PLE (nPSD 4-7&#x2009;Hz, p&#x2009;=&#x2009;0.013; 8-13&#x2009;Hz, p&#x2009;=&#x2009;0.003; PLE frontal lobe F3 EC, p&#x2009;=&#x2009;0.010). Multiscale entropy analysis indicated increased entropy at lower frequencies and decreased entropy at higher frequencies in advanced boxers (F3 EC, p&#x2009;=&#x2009;0.024; occipital lobe O1 EO, p&#x2009;=&#x2009;0.029; occipital lobe O2 EO, p&#x2009;=&#x2009;0.036). These changes are similar to those seen in Alzheimer's disease.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">Nonlinear analysis of EEG data shows potential as a neurophysiological biomarker for detecting the asymptomatic phase of chronic traumatic encephalopathy in boxers. This methodology could help monitor athletes' health and reduce the risk of future neurological injuries in sports.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>De Donato</LastName><ForeName>Renato</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0003-1983-0146</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maiorana</LastName><ForeName>Natale Vincenzo</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vergari</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>De Sandi</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Naci</LastName><ForeName>Anisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Aglieco</LastName><ForeName>Giada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Albizzati</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Guidetti</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ferrara</LastName><ForeName>Rosanna</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bocci</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASST Santi Paolo e Carlo, University Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Barbieri</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ferrucci</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0001-5109-9483</Identifier><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology and Emato-Oncology, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Priori</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-1549-3851</Identifier><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASST Santi Paolo e Carlo, University Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>Grant Number: 01</GrantID><Agency>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">boxing concussion</Keyword><Keyword MajorTopicYN=\"N\">chronic traumatic encephalopathy</Keyword><Keyword MajorTopicYN=\"N\">dementia</Keyword><Keyword MajorTopicYN=\"N\">nonlinear EEG</Keyword><Keyword MajorTopicYN=\"N\">sub&#x2010;concussion</Keyword><Keyword MajorTopicYN=\"N\">traumatic brain injuries</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>5</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39275911</ArticleId><ArticleId IdType=\"doi\">10.1111/ene.16411</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Nagahiro S, Mizobuchi Y. Current topics in sports&#x2010;related head injuries: a review. Neurol Med Chir (Tokyo). 2014;54(11):878&#x2010;886. doi:10.2176/nmc.ra.2014-0224</Citation></Reference><Reference><Citation>Koh JO, Cassidy JD, Watkinson EJ. Incidence of concussion in contact sports: a systematic review of the evidence. Brain Inj. 2003;17(10):901&#x2010;917. doi:10.1080/0269905031000088869</Citation></Reference><Reference><Citation>Powell JW, Barber&#x2010;foss KD. Traumatic Brain Injury in High School Athletes. JAMA. Original Contribution. 1999;282(10):958&#x2010;963.</Citation></Reference><Reference><Citation>Rabadi MH, Jordan BD. The cumulative effect of repetitive concussion in sports. Clin J Sport Med. 2001;11(3):194&#x2010;198. doi:10.1097/00042752-200107000-00011</Citation></Reference><Reference><Citation>Finch CF, Clapperton AJ, McCrory P. Increasing incidence of hospitalisation for sport&#x2010;related concussion in Victoria, Australia. Med J Aust. 2013;198(8):427&#x2010;430. doi:10.5694/mja12.11217</Citation></Reference><Reference><Citation>Rosenthal JA, Foraker RE, Collins CL, Comstock RD. National high school athlete concussion rates from 2005&#x2013;2006 to 2011&#x2013;2012. Am J Sports Med. 2014;42(7):1710&#x2010;1715. doi:10.1177/0363546514530091</Citation></Reference><Reference><Citation>Ruff RM. 20th anniversary article mild traumatic brain injury and neural recovery: rethinking the debate. NeuroRehabilitation. 2011;28:167&#x2010;180. doi:10.3233/NRE-2011-0646</Citation></Reference><Reference><Citation>Schneider DK, Galloway R, Bazarian JJ, et&#xa0;al. Diffusion tensor imaging in athletes sustaining repetitive head impacts: a systematic review of prospective studies. J Neurotrauma. 2019;36(20):2831&#x2010;2849. doi:10.1089/neu.2019.6398</Citation></Reference><Reference><Citation>McAllister T, McCrea M. Long&#x2010;term cognitive and neuropsychiatric consequences of repetitive concussion and head&#x2010;impact exposure. J Athl Train. 2017;52(3):309&#x2010;317. doi:10.4085/1062-6050-52.1.14</Citation></Reference><Reference><Citation>Mainwaring L, Ferdinand Pennock KM, Mylabathula S, Alavie BZ. Subconcussive head impacts in sport: a systematic review of the evidence. Int J Psychophysiol. 2018;132:39&#x2010;54. doi:10.1016/j.ijpsycho.2018.01.007</Citation></Reference><Reference><Citation>Gardner A, Iverson GL, McCrory P. Chronic traumatic encephalopathy in sport: a systematic review. Br J Sports Med. 2014;48(2):84&#x2010;90. doi:10.1136/bjsports-2013-092646</Citation></Reference><Reference><Citation>Alosco ML, Stern RA. The Long&#x2010;Term Consequences of Repetitive Head Impacts: Chronic Traumatic Encephalopathy. Vol 167. 1st ed. Elsevier B.V; 2019. doi:10.1016/B978-0-12-804766-8.00018-2</Citation></Reference><Reference><Citation>Martland HS. Punch drunk. JAMA. 1928;91(15):1103&#x2010;1107.</Citation></Reference><Reference><Citation>Castellani RJ, Perry G. Dementia Pugilistica Revisited. J Alzheimers Dis. 2017;60(4):1209&#x2010;1221. doi:10.3233/JAD-170669</Citation></Reference><Reference><Citation>Tarazi A, Tator CH, Tartaglia MC. Chronic traumatic encephalopathy and movement disorders: update. Curr Neurol Neurosci Rep. 2016;16(5):1&#x2010;8. doi:10.1007/s11910-016-0648-3</Citation></Reference><Reference><Citation>Armstrong RA, Mckee AC, Stein TD, Alvarez VE, Cairns NJ. A quantitative study of tau pathology in 11 cases of chronic traumatic encephalopathy. Neuropathol Appl Neurobiol. 2017;43:154&#x2010;166. doi:10.1111/nan.12323</Citation></Reference><Reference><Citation>Mckee AC et&#xa0;al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2012;136(1):43&#x2010;64. doi:10.1093/brain/aws307</Citation></Reference><Reference><Citation>Mez J, Daneshvar DH, Kiernan PT, et&#xa0;al. Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA. 2017;02118(4):360&#x2010;370. doi:10.1001/jama.2017.8334</Citation></Reference><Reference><Citation>Kokjohn TA, Maarouf CL, Daugs ID, et&#xa0;al. Neurochemical profile of dementia pugilistica. J Neurotrauma. 2013;30(11):981&#x2010;997. doi:10.1089/neu.2012.2699</Citation></Reference><Reference><Citation>Asken BM, Sullan MJ, Snyder AR, et&#xa0;al. Factors influencing clinical correlates of chronic traumatic encephalopathy (CTE): a review. Neuropsychol Rev. 2016;26(4):340&#x2010;363. doi:10.1007/s11065-016-9327-z</Citation></Reference><Reference><Citation>Broglio SP, Eckner JT, Paulson HL, Kutcher JS. Cognitive decline and aging: the role of concussive and subconcussive impacts. Exerc Sport Sci Rev. 2012;40(3):138&#x2010;144. doi:10.1097/JES.0b013e3182524273</Citation></Reference><Reference><Citation>Steven P, DeKosky T, Milos D, Ikonomovic MD, Sam Gandy MD. Traumatic brain injury&#x2014;football, warfare, and long&#x2010;term effects. N Engl J Med. 2010;363(14):1293&#x2010;1296.</Citation></Reference><Reference><Citation>Lewine JD, Plis S, Ulloa A, et&#xa0;al. Quantitative EEG biomarkers for mild traumatic brain injury. J Clin Neurophysiol. 2019;36(4):298&#x2010;305. doi:10.1097/WNP.0000000000000588</Citation></Reference><Reference><Citation>Munia TTK, Haider A, Schneider C, Romanick M, Fazel&#x2010;Rezai R. A novel EEG based spectral analysis of persistent brain function alteration in athletes with concussion history. Sci Rep. 2017;7(1):1&#x2010;13. doi:10.1038/s41598-017-17414-x</Citation></Reference><Reference><Citation>Santangelo G, Siciliano M, Pedone R, et&#xa0;al. Normative data for the Montreal Cognitive Assessment in an Italian population sample. Neurol Sci. 2015;36(4):585&#x2010;591. doi:10.1007/s10072-014-1995-y</Citation></Reference><Reference><Citation>Appollonio I, Leone M, Isella V, et&#xa0;al. The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci. 2005;26(2):108&#x2010;116. doi:10.1007/s10072-005-0443-4</Citation></Reference><Reference><Citation>Welch PD. The use of fast Fourier transform for the estimation of power spectra: a method based on time averaging over short, modified periodograms. IEEE Trans Audio Electroacoust. 1967;2:70&#x2010;73.</Citation></Reference><Reference><Citation>Demuru M, La Cava SM, Pani SM, Fraschini M. A comparison between power spectral density and network metrics: an EEG study. Biomed Signal Process Control. 2020;57:101760. doi:10.1016/j.bspc.2019.101760</Citation></Reference><Reference><Citation>Colombo MA, Napolitani M, Boly M, et&#xa0;al. The spectral exponent of the resting EEG indexes the presence of consciousness during unresponsiveness induced by propofol, xenon, and ketamine. NeuroImage. 2019;189:631&#x2010;644. doi:10.1016/j.neuroimage.2019.01.024</Citation></Reference><Reference><Citation>Peng CK, Buldyrev SV, Goldberger AL, et&#xa0;al. Long&#x2010;range correlations in nucleotide sequences. Nature. 1992;359:710&#x2010;713. file:///C:/Users/ASUS/Desktop/Rujukan PhD/p21/xiong1993.pdf.</Citation></Reference><Reference><Citation>Shao YH, Gu GF, Jiang ZQ, Zhou WX, Sornette D. Comparing the performance of FA, DFA and DMA using different synthetic long&#x2010;range correlated time series. Sci Rep. 2012;2:1&#x2010;5. doi:10.1038/srep00835</Citation></Reference><Reference><Citation>Ferrara R. Nonlinear analysis of neurophysiological time series: methodological evaluation and clinical application in Parkinson's and Alzheimer's diseases. Master's Dissertation. Politecnico di Milano. Biomed Eng. 2021:1&#x2010;137.</Citation></Reference><Reference><Citation>Costa M, Goldberger AL, Peng CK. Multiscale entropy analysis of complex physiologic time series. Phys Rev Lett. 2002;89(6):6&#x2010;9. doi:10.1103/PhysRevLett.89.068102</Citation></Reference><Reference><Citation>Weintraub S, Carrillo MC, Farias ST, et&#xa0;al. Measuring cognition and function in the preclinical stage of Alzheimer's disease. Alzheimer's Dement Transl Res Clin Interv. 2018;4:64&#x2010;75. doi:10.1016/j.trci.2018.01.003</Citation></Reference><Reference><Citation>Takahashi RH, Nagao T, Gouras GK. Plaque formation and the intraneuronal accumulation of &#x3b2;&#x2010;amyloid in Alzheimer's disease. Pathol Int. 2017;67(4):185&#x2010;193. doi:10.1111/pin.12520</Citation></Reference><Reference><Citation>Thies W, Bleiler L. 2012 Alzheimer's disease facts and figures. Alzheimers Dement. 2012;8(2):131&#x2010;168. doi:10.1016/j.jalz.2012.02.001</Citation></Reference><Reference><Citation>Vy&#x161;ata O, Proch&#xe1;zka A, Mare&#x161; J, et&#xa0;al. Change in the characteristics of EEG color noise in Alzheimer's disease. Clin EEG Neurosci. 2014;45(3):147&#x2010;151. doi:10.1177/1550059413491558</Citation></Reference><Reference><Citation>Stam CJ, Montez T, Jones BF, et&#xa0;al. Disturbed fluctuations of resting state EEG synchronization in Alzheimer's disease. Clin Neurophysiol. 2005;116(3):708&#x2010;715. doi:10.1016/j.clinph.2004.09.022</Citation></Reference><Reference><Citation>Mizuno T, Takahashi T, Cho RY, et&#xa0;al. Assessment of EEG dynamical complexity in Alzheimer's disease using multiscale entropy. Clin Neurophysiol. 2010;121(9):1438&#x2010;1446. doi:10.1016/j.clinph.2010.03.025</Citation></Reference><Reference><Citation>Escudero J, Ab&#xe1;solo D, Hornero R, Espino P, L&#xf3;pez M. Analysis of electroencephalograms in Alzheimer's disease patients with multiscale entropy. Physiol Meas. 2006;27(11):1091&#x2010;1106. doi:10.1088/0967-3334/27/11/004</Citation></Reference><Reference><Citation>Yang AC, Huang CC, Yeh HL, et&#xa0;al. Complexity of spontaneous BOLD activity in default mode network is correlated with cognitive function in normal male elderly: a multiscale entropy analysis. Neurobiol Aging. 2013;34(2):428&#x2010;438. doi:10.1016/j.neurobiolaging.2012.05.004</Citation></Reference><Reference><Citation>Sharma A, Rai JK, Tewari RP. Relative measures to characterize EEG signals for early detection of Alzheimer. 5th Int Conf Signal Process Integr Networks. 2018;43&#x2010;48. doi:10.1109/SPIN.2018.8474288</Citation></Reference><Reference><Citation>Nimmy John T, Subha Dharmapalan P, Ramshekhar Menon N. Exploration of time&#x2010;frequency reassignment and homologous inter&#x2010;hemispheric asymmetry analysis of MCI&#x2010;AD brain activity. BMC Neurosci. 2019;20(1):1&#x2010;14. doi:10.1186/s12868-019-0519-3</Citation></Reference><Reference><Citation>Reyes&#x2010;Coronel C, Waser M, Garn H, et&#xa0;al. Predicting rapid cognitive decline in Alzheimer's disease patients using quantitative EEG markers and neuropsychological test scores. Proc Annu Int Conf IEEE Eng Med Biol Soc EMBS. 2016;2016:6078&#x2010;6081. doi:10.1109/EMBC.2016.7592115</Citation></Reference><Reference><Citation>Saing T, Dick M, Nelson PT, Kim RC, Cribbs DH, Head E. Frontal cortex neuropathology in dementia pugilistica. J Neurotrauma. 2012;29(6):1054&#x2010;1070. doi:10.1089/neu.2011.1957</Citation></Reference><Reference><Citation>Falcon B, Zivanov J, Zhang W, et&#xa0;al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature. 2019;568(7752):420&#x2010;423. doi:10.1038/s41586-019-1026-5</Citation></Reference><Reference><Citation>Fickling SD, Poel DN, Dorman JC, D'Arcy RCN, Munce TA. Subconcussive changes in youth football players: objective evidence using brain vital signs and instrumented accelerometers. Brain Commun. 2022;4(2):1&#x2010;11. doi:10.1093/braincomms/fcab286</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import json\n",
    "import base64\n",
    "# PubMed search query\n",
    "query = \"Alzheimer's disease\"\n",
    "\n",
    "# PubMed API base URL\n",
    "base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "\n",
    "# PubMed search endpoint\n",
    "search_url = base_url + \"esearch.fcgi\"\n",
    "\n",
    "# API key (replace with your actual API key)\n",
    "api_key = \"14360a5489f9c6515569fae147b5295a3608\"\n",
    "\n",
    "# Construct parameters for the search request\n",
    "search_params = {\n",
    "    \"db\": \"pubmed\",\n",
    "    \"term\": query,\n",
    "    \"retmode\": \"json\",\n",
    "    \"api_key\": api_key,\n",
    "    \"retmax\": 5  # Limiting to the first 5 results for this example\n",
    "}\n",
    "\n",
    "# Make the request to PubMed API\n",
    "response = requests.get(search_url, params=search_params)\n",
    "\n",
    "# Check if the request was successful\n",
    "if response.status_code == 200:\n",
    "    try:\n",
    "        # Parse the JSON response\n",
    "        search_results = response.json()\n",
    "        \n",
    "        # Extract relevant information from the search results\n",
    "        article_ids = search_results[\"esearchresult\"][\"idlist\"]\n",
    "        \n",
    "        # PubMed fetch endpoint\n",
    "        fetch_url = base_url + \"efetch.fcgi\"\n",
    "        \n",
    "        # Construct parameters for fetching article details\n",
    "        fetch_params = {\n",
    "            \"db\": \"pubmed\",\n",
    "            \"retmode\": \"xml\",\n",
    "            \"rettype\": \"abstract\",\n",
    "            \"api_key\": api_key,\n",
    "            \"id\": \",\".join(article_ids)  # Comma-separated list of article IDs\n",
    "        }\n",
    "        \n",
    "        # Make the request to fetch article details\n",
    "        fetch_response = requests.get(fetch_url, params=fetch_params)\n",
    "        \n",
    "        # Check if the request was successful\n",
    "        if fetch_response.status_code == 200:\n",
    "            try:\n",
    "                # Parse the JSON response\n",
    "                # article_details = fetch_response.json()\n",
    "                article_details = fetch_response.content\n",
    "                print(type(article_details))\n",
    "                article_text = article_details.decode('utf-8')\n",
    "                print(article_text)\n",
    "                # Extract and print titles of the articles\n",
    "                # for article in article_details[\"PubmedArticle\"]:\n",
    "                #     title = article[\"MedlineCitation\"][\"Article\"][\"ArticleTitle\"]\n",
    "                #     print(title)\n",
    "            except json.JSONDecodeError as e:\n",
    "                print(\"Error decoding JSON response from PubMed fetch:\", e)\n",
    "        else:\n",
    "            print(\"Error fetching article details:\", fetch_response.status_code)\n",
    "    except json.JSONDecodeError as e:\n",
    "        print(\"Error decoding JSON response from PubMed search:\", e)\n",
    "else:\n",
    "    print(\"Error searching PubMed:\", response.status_code)\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Then,we use the pymed library, a Python interface for accessing PubMed's database, to search for and retrieve information on academic articles related to Alzheimer's disease. \n",
    "\n",
    "It works:)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Defaulting to user installation because normal site-packages is not writeable\n",
      "Collecting pymed\n",
      "  Downloading pymed-0.8.9-py3-none-any.whl (9.6 kB)\n",
      "Requirement already satisfied: requests>=2.20.0 in /home/abrehamtadesse/.local/lib/python3.10/site-packages (from pymed) (2.32.3)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /usr/lib/python3/dist-packages (from requests>=2.20.0->pymed) (3.3)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in /home/abrehamtadesse/.local/lib/python3.10/site-packages (from requests>=2.20.0->pymed) (3.3.2)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /usr/lib/python3/dist-packages (from requests>=2.20.0->pymed) (2020.6.20)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/lib/python3/dist-packages (from requests>=2.20.0->pymed) (1.26.5)\n",
      "Installing collected packages: pymed\n",
      "Successfully installed pymed-0.8.9\n"
     ]
    }
   ],
   "source": [
    "! pip install pymed\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# USING PYMED LIBRARY"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Title: Epidemiological Principles in Claims of Causality: An Enquiry into Repetitive Head Impacts (RHI) and Chronic Traumatic Encephalopathy (CTE).\n",
      "Abstract: Determining whether repetitive head impacts (RHI) cause the development of chronic traumatic encephalopathy (CTE)-neuropathological change (NC) and whether pathological changes cause clinical syndromes are topics of considerable interest to the global sports medicine community. In 2022, an article was published that used the Bradford Hill criteria to evaluate the claim that RHI cause CTE. The publication garnered international media attention and has since been promoted as definitive proof that causality has been established. Our counterpoint presents an appraisal of the published article in terms of the claims made and the scientific literature used in developing those claims. We conclude that the evidence provided does not justify the causal claims. We discuss how causes are conceptualised in modern epidemiology and highlight shortcomings in the current definitions and measurement of exposures (RHI) and outcomes (CTE). We address the Bradford Hill arguments that are used as evidence in the original review and conclude that assertions of causality having been established are premature. Members of the scientific community must be cautious of making causal claims until the proposed exposures and outcomes are well defined and consistently measured, and findings from appropriately designed studies have been published. Evaluating and reflecting on the quality of research is a crucial step in providing accurate evidence-based information to the public.\n",
      "\n",
      "Title: Evaluation of the effect of taurine on the matrix metalloproteinase-9 and the expression changes of miRNA-21 and miRNA-146a in SH-SY5Y cell line.\n",
      "Abstract: Alzheimer's disease (AD), a brain disorder, is the leading cause of dementia among older adults. Taurine, an amino acid abundantly present in the brain, and shows potential neuroprotective properties. Therefore, we investigated the effects of taurine on Matrix Metalloproteinase-9 (MMP-9) levels and the expression changes of miRNA-21 and miRNA-146a in the SH-SY5Y cell line.\n",
      "Taurine's impact on the SH-SY5Y cell line was evaluated via the 2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. MMP-9 levels were measured using an enzyme-linked immunosorbent assay (ELISA) kit, while the expression of miRNA-21 and miRNA-146a genes was assessed through Real-Time PCR analysis.\n",
      "The MTT assay revealed no toxic effects on SH-SY5Y cells with increasing concentrations of taurine. Analysis of gene expression indicated a rise in miRNA-21 expression and a decline in miRNA-146 expression with increasing taurine concentration, with the most notable change observed at 1 mg/mL taurine (p<0.001). ELISA results demonstrated a significant increase in MMP-9 levels in the SH-SY5Y cell line treated with 1 mg/mL taurine compared to the untreated group (p<0.001).\n",
      "Our study revealed that taurine can alter the expression of miRNA-146a and miRNA-21. In conclusion, taurine therapy presents promising therapeutic avenues for treating AD or mitigating severe symptoms. Nonetheless, further research is necessary to comprehensively grasp the precise mechanisms at play.\n",
      "\n",
      "Title: \n",
      "Abstract: \n",
      "\n",
      "Title: Live-cell visualization of tau aggregation in human neurons.\n",
      "Abstract: Alzheimer's disease (AD) and more than twenty other dementias, termed tauopathies, are pathologically defined by insoluble aggregates of the microtubule-associated protein tau (MAPT). Although tau aggregation correlates with AD symptomology, the specific tau species, i.e., monomers, soluble oligomers, and insoluble aggregates that induce neurotoxicity are incompletely understood. We developed a light-responsive tau protein (optoTAU) and used viscosity-sensitive AggFluor probes to investigate the consequence(s) of tau aggregation in human neurons and identify modifiers of tau aggregation in AD and other tauopathies. We determined that optoTAU reproduces biological and structural properties of tau aggregation observed in human brains and the pathophysiological transition in tau solubility in live cells. We also provide proof-of-concept for the utilization of optoTAU as a pharmacological platform to identify modifiers of tau aggregation. These findings have broad implications for the characterization of aggregation-prone proteins and investigation of the complex relationship between protein solubility, cellular function, and disease progression.\n",
      "\n",
      "Title: Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease.\n",
      "Abstract: Identifying concomitant Lewy body (LB) pathology through seed amplification assays (SAA) might enhance the diagnostic and prognostic work-up of Alzheimer's disease (AD) in clinical practice and trials. This study examined whether LB pathology exacerbates AD-related disease progression in 795 cognitively impaired individuals (Mild Cognitive Impairment and dementia) from the longitudinal multi-center observational ADNI cohort. Participants were on average 75 years of age (SD = 7.89), 40.8% were female, 184 (23.1%) had no biomarker evidence of AD/LB pathology, 39 (4.9%) had isolated LB pathology (AD-LB+), 395 (49.7%) had only AD pathology (AD+LB-), and 177 (22.3%) had both pathologies (AD+LB+). The AD+LB+ group showed worst baseline performance for most cognitive outcomes and compared to the AD+LB- group faster global cognitive decline and more cortical hypometabolism, particularly in posterior brain regions. Neuropathological examination (n = 61) showed high sensitivity (26/27, 96.3%) and specificity (27/28, 96.4%) of the SAA-test. We showed that co-existing LB-positivity exacerbates cognitive decline and cortical brain hypometabolism in AD. In vivo LB pathology detection could enhance prognostic evaluations in clinical practice and could have implications for clinical AD trial design.\n",
      "\n",
      "Title: Temporal trends in mortality and causes of death in patients with incident atrial fibrillation: a nationwide register study from 2010 to 2018.\n",
      "Abstract: Atrial fibrillation (AF) is associated with increased mortality. Previous studies have reported conflicting results in temporal trends of mortality after AF diagnosis. We aim to address this disparity by investigating the 1-year mortality and causes of death in Finnish patients diagnosed with AF between 2010 and 2017.\n",
      "The Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) study is a nationwide retrospective register-based cohort study.\n",
      "The FinACAF study has gathered information on all Finnish AF patients between 2004 and 2018, with information from all national healthcare registers and data from all levels of care (primary, secondary and tertiary care).\n",
      "We included patients with an incident AF diagnosis (International Classification of Diseases, 10th Revision code I48) between 2010 and 2017. To ensure a cohort of only incident AF, we excluded patients who used any oral anticoagulant during the year before cohort entry as well as patients with a recorded use of warfarin between 2004 and 2006. Patients under 20 years of age were excluded, and patients with permanent migration abroad before 1 January 2019 were excluded, N=157 658.\n",
      "1-year all-cause, cardiovascular (CV) and cause-specific mortality following AF diagnosis.\n",
      "The study cohort consisted of 157 658 incident AF cases (50.1% male, mean age 72.9 years). Both all-cause and CV mortality declined from cohort entry years 2010-2017 (from 12.9% to 10.6%, mortality rate ratio (MRR) 0.77; 95% CI 0.73 to 0.82 in cohort entry year 2017 with 2010 as reference; and from 7.4% to 5.2%, MRR 0.68; 95% CI 0.63 to 0.74, respectively). Overall mortality and CV mortality were lower in women than in men throughout the study period (MRR 0.66; 95% CI 0.63 to 0.69 and MRR 0.53; 95% CI 0.50 to 0.56, respectively). Deaths attributable to ischaemic heart disease decreased during the study period (from 30.7% to 21.6%, MRR 0.51; 95% CI 0.49 to 0.62 in 2017 vs 2010), whereas dementia and Alzheimer's disease increased as a cause of death over time (6.2% to 9.9%, MRR 1.19; 95% CI 0.96 to 1.48 in 2017 vs 2010). The CHA\n",
      "Our study reiterates that mortality after diagnosis of AF has decreased. The CHA\n",
      "\n",
      "Title: Role of histone deacetylases and their inhibitors in neurological diseases.\n",
      "Abstract: Histone deacetylases (HDACs) are zinc-dependent deacetylases that remove acetyl groups from lysine residues of histones or form protein complexes with other proteins for transcriptional repression, changing chromatin structure tightness, and inhibiting gene expression. Recent in vivo and in vitro studies have amply demonstrated the critical role of HDACs in the cell biology of the nervous system during both physiological and pathological processes and have provided new insights into the conduct of research on neurological disease targets. In addition, in vitro and in vivo studies on HDAC inhibitors show promise for the treatment of various diseases. This review summarizes the regulatory mechanisms of HDAC and the important role of its downstream targets in nervous system diseases, and summarizes the therapeutic mechanisms and efficacy of HDAC inhibitors in various nervous system diseases. Additionally, the current pharmacological situation, problems, and developmental prospects of HDAC inhibitors are described. A better understanding of the pathogenic mechanisms of HDACs in the nervous system may reveal new targets for therapeutic interventions in diseases and help to relieve healthcare pressure through preventive measures.\n",
      "\n",
      "Title: A developmental gradient reveals biosynthetic pathways to eukaryotic toxins in monocot geophytes.\n",
      "Abstract: Numerous eukaryotic toxins that accumulate in geophytic plants are valuable in the clinic, yet their biosynthetic pathways have remained elusive. A notable example is the >150 Amaryllidaceae alkaloids (AmAs), including galantamine, an FDA-approved treatment for Alzheimer's disease. We show that while AmAs accumulate to high levels in many daffodil tissues, biosynthesis is localized to nascent, growing tissue at the leaf base. A similar trend is found in the production of steroidal alkaloids (e.g., cyclopamine) in corn lily. This model of active biosynthesis enabled the elucidation of a complete set of biosynthetic genes that can be used to produce AmAs. Taken together, our work sheds light on the developmental and enzymatic logic of diverse alkaloid biosynthesis in daffodils. More broadly, it suggests a paradigm for biosynthesis regulation in monocot geophytes, where plants are protected from herbivory through active charging of newly formed cells with eukaryotic toxins that persist as above-ground tissue develops.\n",
      "\n",
      "Title: Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function.\n",
      "Abstract: Protein aggregation causes a wide range of neurodegenerative diseases. Targeting and removing aggregates, but not the functional protein, is a considerable therapeutic challenge. Here, we describe a therapeutic strategy called \"RING-Bait,\" which employs an aggregating protein sequence combined with an E3 ubiquitin ligase. RING-Bait is recruited into aggregates, whereupon clustering dimerizes the RING domain and activates its E3 function, resulting in the degradation of the aggregate complex. We exemplify this concept by demonstrating the specific degradation of tau aggregates while sparing soluble tau. Unlike immunotherapy, RING-Bait is effective against both seeded and cell-autonomous aggregation. RING-Bait removed tau aggregates seeded from Alzheimer's disease (AD) and progressive supranuclear palsy (PSP) brain extracts and was also effective in primary neurons. We used a brain-penetrant adeno-associated virus (AAV) to treat P301S tau transgenic mice, reducing tau pathology and improving motor function. A RING-Bait strategy could be applied to other neurodegenerative proteinopathies by replacing the Bait sequence to match the target aggregate.\n",
      "\n",
      "Title: The association between cigarette smoking and dementia with Lewy bodies.\n",
      "Abstract: Cigarette smoking is associated with a reduced risk of Parkinson's disease (PD). As dementia with Lewy bodies (DLB) and PD share core neuropathologic features, we set out to examine the relationship between smoking and DLB.\n",
      "Diagnosis at baseline visit and smoking history of participants ≥50 years old in the National Alzheimer's Coordinating Center (NACC) cohort were evaluated in this cross-sectional study. Odds of diagnosis of cognitive impairment due to DLB, PD, vascular dementia (VD), or Alzheimer's disease (AD) compared to normal cognition based on smoking status and duration were determined using logistic regression.\n",
      "37,478 participants were included (mean age 72 years (SD 9), 57 % female). The odds of DLB were reduced in all smoking status groups compared to never smokers (OR (95 % CI)): ever smokers 0.850 (0.745-0.971), former smokers 0.871 (0.761-0.997), current smokers 0.640 (0.419-0.947)) and in all smoking duration groups. As expected, the odds of PD were reduced in all smoking groups and fell with longer smoking duration. The odds of VD were increased in the current smoking group and rose with greater smoking duration. The odds of AD were unchanged in current smokers, decreased in ever and former smokers, and increased with longer cumulative smoking duration.\n",
      "Cigarette smoking is associated with lower odds of diagnosis of DLB at baseline visit in the NACC cohort. In the context of the well-established reduced risk of PD among smokers, this preliminary evidence of a potential protective effect of smoking on DLB warrants further study.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "from pymed import PubMed\n",
    "\n",
    "# Create a PubMed object\n",
    "pubmed = PubMed(tool=\"PubMed Scraper\", email=\"dhimmar@unlv.nevada.edu\") # YOUR EMAIL\n",
    "\n",
    "# Search for articles related to Alzheimer's disease\n",
    "query = \"Alzheimer's disease\"\n",
    "results = pubmed.query(query, max_results=10)\n",
    "\n",
    "# Print titles and abstracts of the retrieved articles\n",
    "for article in results:\n",
    "    print(\"Title:\", article.title)\n",
    "    print(\"Abstract:\", article.abstract)\n",
    "    print()\n",
    "\n",
    "    # article.\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Let see how many articles we have on pubmed for \"Alzheimer's Disease\"."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total articles found for query 'Alzheimer's disease': 215399\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "\n",
    "# Query parameters\n",
    "query = \"Alzheimer's disease\"\n",
    "base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "search_url = f\"{base_url}esearch.fcgi\"\n",
    "api_key = \"\"  # Replace with your actual API key\n",
    "params = {\n",
    "    \"db\": \"pubmed\",\n",
    "    \"term\": query,\n",
    "    \"retmode\": \"json\",\n",
    "    \"api_key\": api_key,\n",
    "}\n",
    "\n",
    "# Make the request to PubMed API\n",
    "response = requests.get(search_url, params=params)\n",
    "\n",
    "if response.status_code == 200:\n",
    "    data = response.json()\n",
    "    total_count = data[\"esearchresult\"][\"count\"]\n",
    "    print(f\"Total articles found for query '{query}': {total_count}\")\n",
    "else:\n",
    "    print(\"Failed to fetch article count:\", response.status_code)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "But we wanted to use API's \n",
    "\n",
    "So to to handle the efetch response in XML format, since it seems JSON might not be supported or correctly returning for our specific query,\n",
    "\n",
    "We used Python's built-in xml.etree.ElementTree library to parse the XML response. \n",
    "\n",
    "The approach worked.\n",
    "\n",
    "We only requested data for 5 articles and just a title to see if the code work and we dont want to overload in a first try"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Gazing Beyond the Horizon: A Systematic Review Unveiling the Theranostic Potential of Quantum Dots in Alzheimer's Disease.\n",
      "Exploring the link between comorbidities and Alzheimer's dementia in the Australian Imaging, Biomarker & Lifestyle (AIBL) study.\n",
      "None\n",
      "Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis.\n",
      "Microglia, Trem2, and Neurodegeneration.\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import xml.etree.ElementTree as ET\n",
    "\n",
    "# PubMed search query\n",
    "query = \"Alzheimer's disease\"\n",
    "\n",
    "# PubMed API base URL\n",
    "base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "\n",
    "# PubMed search endpoint\n",
    "search_url = base_url + \"esearch.fcgi\"\n",
    "\n",
    "# API key (replace with your actual API key)\n",
    "api_key = \"\"\n",
    "\n",
    "# Construct parameters for the search request\n",
    "search_params = {\n",
    "    \"db\": \"pubmed\",\n",
    "    \"term\": query,\n",
    "    \"retmode\": \"xml\",  # Changed to xml for this step, if necessary\n",
    "    \"api_key\": api_key,\n",
    "    \"retmax\": 5  # Limiting to the first 5 results for this example\n",
    "}\n",
    "\n",
    "# Make the request to PubMed API\n",
    "response = requests.get(search_url, params=search_params)\n",
    "\n",
    "# Process the search response\n",
    "if response.status_code == 200:\n",
    "    search_results = response.text\n",
    "    root = ET.fromstring(search_results)\n",
    "    article_ids = [id_elem.text for id_elem in root.findall('.//IdList/Id')]\n",
    "\n",
    "    if article_ids:\n",
    "        # PubMed fetch endpoint\n",
    "        fetch_url = base_url + \"efetch.fcgi\"\n",
    "\n",
    "        # Construct parameters for fetching article details\n",
    "        fetch_params = {\n",
    "            \"db\": \"pubmed\",\n",
    "            \"retmode\": \"xml\",\n",
    "            \"api_key\": api_key,\n",
    "            \"id\": \",\".join(article_ids)  # Comma-separated list of article IDs\n",
    "        }\n",
    "\n",
    "        # Make the request to fetch article details\n",
    "        fetch_response = requests.get(fetch_url, params=fetch_params)\n",
    "\n",
    "        # Check if the request was successful\n",
    "        if fetch_response.status_code == 200:\n",
    "            fetch_results = fetch_response.text\n",
    "            fetch_root = ET.fromstring(fetch_results)\n",
    "            \n",
    "            # Extract and print titles of the articles\n",
    "            for article in fetch_root.findall('.//PubmedArticle/MedlineCitation/Article'):\n",
    "                title = article.find('ArticleTitle').text\n",
    "                print(title)\n",
    "        else:\n",
    "            print(\"Error fetching article details:\", fetch_response.status_code)\n",
    "    else:\n",
    "        print(\"No articles found for the given query.\")\n",
    "else:\n",
    "    print(\"Error searching PubMed:\", response.status_code)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Want more Details from the article, such as abstract text, Keywords and Publication year?????\n",
    "\n",
    "We modyfy our code and set a limit of 100"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Title: Gazing Beyond the Horizon: A Systematic Review Unveiling the Theranostic Potential of Quantum Dots in Alzheimer's Disease.\n",
      "Abstract: Alzheimer's disease (AD), a neurodegenerative disorder characterized by cognitive decline, poses a significant healthcare challenge worldwide. The accumulation of amyloid-beta (Aβ) plaques and hyperphosphorylated tau protein drives neuronal degeneration and neuroinflammation, perpetuating disease progression. Despite advancements in understanding the cellular and molecular mechanisms, treatment hurdles persist, emphasizing the need for innovative intervention strategies. Quantum dots (QDs) emerge as promising nanotechnological tools with unique photo-physical properties, offering advantages over conventional imaging modalities. This systematic review endeavors to elucidate the theranostic potential of QDs in AD by synthesizing preclinical and clinical evidence. A comprehensive search across electronic databases yielded 20 eligible studies investigating the diagnostic, therapeutic, or combined theranostic applications of various QDs in AD. The findings unveil the diverse roles of QDs, including inhibiting Aβ and tau aggregation, modulating amyloidogenesis pathways, restoring membrane fluidity, and enabling simultaneous detection of AD biomarkers. The review highlights the potential of QDs in targeting multiple pathological hallmarks, delivering therapeutic payloads across the blood-brain barrier, and facilitating real-time imaging and high-throughput screening. While promising, challenges such as biocompatibility, surface modifications, and clinical translation warrant further investigation. This systematic review provides a comprehensive synthesis of the theranostic potential of QDs in AD, paving the way for translational research and clinical implementation.\n",
      "Keywords: alzheimer's disease, amyloid-beta, biomarkers, drug delivery, nanotechnology, nanotheranostics, neuroinflammation, quantum dots, tau protein, theranostics\n",
      "Publication Year: 2024\n",
      "Authors: Sinha, Tanya, Bokhari, Syed Faqeer Hussain, Khan, Muhammad Usman, Sarim Shaheer, Muhammad, Amir, Maaz, Zia, Beenish Fatima, Bakht, Danyal, Javed, Muhammad Arsham, Almadhoun, Mohammed Khaleel I Kh, Burhanuddin, Mohammad, Puli, Sai Teja\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Exploring the link between comorbidities and Alzheimer's dementia in the Australian Imaging, Biomarker & Lifestyle (AIBL) study.\n",
      "Abstract: Mounting evidence suggests that certain comorbidities may influence the clinical evolution of Alzheimer's dementia (AD).\n",
      "Keywords: Alzheimer's dementia, cognitive impairment, comorbidity, mild cognitive impairment,  cross‐sectional\n",
      "Publication Year: 2024\n",
      "Authors: Nguyen, Catherine Quynh Nhu, Ma, Liwei, Low, Yi Ling Clare, Tan, Edwin C K, Fowler, Christopher, Masters, Colin L, Jin, Liang, Pan, Yijun\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: None\n",
      "Abstract: While recent advances in diagnostics and therapeutics offer promising new approaches for Alzheimer's disease (AD) diagnosis and treatment, there is still an unmet need for an effective remedy, suggesting new avenues of research are required. Besides many plausible etiologies for AD pathogenesis, mounting evidence supports a possible role for microbial infections. Various microbes have been identified in the postmortem brain tissues of human AD patients. Among bacterial pathogens in AD, \n",
      "Keywords: Alzheimer's disease, Chlamydia pneumoniae, amyloid beta-protein (Aβ) plaque, infection, microbes\n",
      "Publication Year: 2024\n",
      "Authors: Subedi, Lalita, Gaire, Bhakta Prasad, Koronyo, Yosef, Koronyo-Hamaoui, Maya, Crother, Timothy R\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis.\n",
      "Abstract: Parkinson's disease (PD) is associated with increased mortality risk (MR), reflecting progression of motor and nonmotor symptoms. PD psychosis (PDP), a common nonmotor symptom, increases with prolonged disease and elevates the MR of PD even further. Pimavanserin is the only FDA-approved treatment for PDP. This review summarizes real-world evidence around the MR of patients with PDP treated with pimavanserin versus off-label atypical antipsychotics.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Isaacson, Stuart H, Pahwa, Rajesh, Pagan, Fernando, Abler, Victor, Truong, Daniel\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Microglia, Trem2, and Neurodegeneration.\n",
      "Abstract: Microglia are a specialized type of neuroimmune cells that undergo morphological and molecular changes through multiple signaling pathways in response to pathological protein aggregates, neuronal death, tissue injury, or infections. Microglia express Trem2, which serves as a receptor for a multitude of ligands enhancing their phagocytic activity. Trem2 has emerged as a critical modulator of microglial activity, especially in many neurodegenerative disorders. Human \n",
      "Keywords: Alzheimer disease, Trem2, mTOR, microglia, neurodegeneration, β-amyloid\n",
      "Publication Year: 2024\n",
      "Authors: Shi, Qian, Gutierrez, Raul A, Bhat, Manzoor A\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Comprehensive comparative analysis of the periodontal pathogen Porphyromonas gingivalis: exploring the pan-genome, the reconstruction of the gene regulatory network and genome-scale metabolic network.\n",
      "Abstract: Porphyromonas gingivalis is a nonmotile, obligate anaerobic, Gram-negative bacterium known for its association with periodontal disease and its involvement in systemic diseases such as atherosclerosis, cardiovascular disease, colon cancer and Alzheimer's disease. This bacterium produces several virulence factors, including capsules, fimbriae, lipopolysaccharides, proteolytic enzymes and hemagglutinins. A comparative genomic analysis revealed the open pangenome of P. gingivalis and identified complete type IV secretion systems (T4SS) in strain KCOM2805 and almost complete type VI secretion systems (T6SS) in strains KCOM2798 and ATCC49417, which is a new discovery as previous studies did not find the proteins involved in secretion systems IV and VI. Conservation of some virulence factors between different strains was observed, regardless of their genetic diversity and origin. In addition, we performed for the first time a reconstruction analysis of the gene regulatory network (GRN), identifying transcription factors and proteins involved in the regulatory mechanisms of bacterial pathogenesis. In particular, QseB regulates the expression of hemagglutinin and arginine deaminase, while Rex may suppress the release of gingipain through interactions with PorV and the formatum/nitrate transporter. Our study highlights the central role of conserved virulence factors and regulatory pathways, particularly QseB and Rex, in P. gingivalis and provides insights into potential therapeutic targets.\n",
      "Keywords: Porphyromonas gingivalis, Type IV secretion system, comparative genomics, periodontitis\n",
      "Publication Year: 2024\n",
      "Authors: Miranda-López, Diana C, Pérez-Rueda, Ernesto, Rojas-Vargas, Jorge, Cortez, Cecilia Hernández, Saldaña-Padilla, Andres, Castelán-Sánchez, Hugo G, Castro-Escarpulli, Graciela\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Detecting the effect of genetic diversity on brain composition in an Alzheimer's disease mouse model.\n",
      "Abstract: Alzheimer's disease (AD) is broadly characterized by neurodegeneration, pathology accumulation, and cognitive decline. There is considerable variation in the progression of clinical symptoms and pathology in humans, highlighting the importance of genetic diversity in the study of AD. To address this, we analyze cell composition and amyloid-beta deposition of 6- and 14-month-old AD-BXD mouse brains. We utilize the analytical QUINT workflow- a suite of software designed to support atlas-based quantification, which we expand to deliver a highly effective method for registering and quantifying cell and pathology changes in diverse disease models. In applying the expanded QUINT workflow, we quantify near-global age-related increases in microglia, astrocytes, and amyloid-beta, and we identify strain-specific regional variation in neuron load. To understand how individual differences in cell composition affect the interpretation of bulk gene expression in AD, we combine hippocampal immunohistochemistry analyses with bulk RNA-sequencing data. This approach allows us to categorize genes whose expression changes in response to AD in a cell and/or pathology load-dependent manner. Ultimately, our study demonstrates the use of the QUINT workflow to standardize the quantification of immunohistochemistry data in diverse mice, - providing valuable insights into regional variation in cellular load and amyloid deposition in the AD-BXD model.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Gurdon, Brianna, Yates, Sharon C, Csucs, Gergely, Groeneboom, Nicolaas E, Hadad, Niran, Telpoukhovskaia, Maria, Ouellette, Andrew, Ouellette, Tionna, O'Connell, Kristen M S, Singh, Surjeet, Murdy, Thomas J, Merchant, Erin, Bjerke, Ingvild, Kleven, Heidi, Schlegel, Ulrike, Leergaard, Trygve B, Puchades, Maja A, Bjaalie, Jan G, Kaczorowski, Catherine C\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Causal effect of blood osteocalcin on the risk of Alzheimer's disease and the mediating role of energy metabolism.\n",
      "Abstract: Growing evidence suggests an association between osteocalcin (OCN), a peptide derived from bone and involved in regulating glucose and lipid metabolism, and the risk of Alzheimer's disease (AD). However, the causality of these associations and the underlying mechanisms remain uncertain. We utilized a Mendelian randomization (MR) approach to investigate the causal effects of blood OCN levels on AD and to assess the potential involvement of glucose and lipid metabolism. Independent instrumental variables strongly associated (P < 5E-08) with blood OCN levels were obtained from three independent genome-wide association studies (GWAS) on the human blood proteome (N = 3301 to 35,892). Two distinct summary statistics datasets on AD from the International Genomics of Alzheimer's Project (IGAP, N = 63,926) and a recent study including familial-proxy AD patients (FPAD, N = 472,868) were used. Summary-level data for fasting glucose (FG), 2h-glucose post-challenge, fasting insulin, HbA1c, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, total cholesterol (TC), and triglycerides were incorporated to evaluate the potential role of glucose and lipid metabolism in mediating the impact of OCN on AD risk. Our findings consistently demonstrate a significantly negative correlation between genetically determined blood OCN levels and the risk of AD (IGAP: odds ratio [OR, 95%CI] = 0.83[0.72-0.96], P = 0.013; FPAD: OR = 0.81 [0.70-0.93], P = 0.002). Similar estimates with the same trend direction were obtained using other statistical approaches. Furthermore, employing multivariable MR analysis, we found that the causal relationship between OCN levels and AD was disappeared after adjustment of FG and TC (IGAP: OR = 0.97[0.80-1.17], P = 0.753; FPAD: OR = 0.98 [0.84-1.15], P = 0.831). There were no apparent instances of horizontal pleiotropy, and leave-one-out analysis showed good stability of the estimates. Our study provides evidence supporting a protective effect of blood OCN levels on AD, which is primarily mediated through regulating FG and TC levels. Further studies are warranted to elucidate the underlying physio-pathological mechanisms.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Guo, Xingzhi, Yang, Yu-Ying, Zhou, Rong, Tian, Ge, Shan, Chang, Liu, Jian-Min, Li, Rui\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Progress on early diagnosing Alzheimer's disease.\n",
      "Abstract: Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects both cognition and non-cognition functions. The disease follows a continuum, starting with preclinical stages, progressing to mild cognitive and behavioral impairment, ultimately leading to dementia. Early detection of AD is crucial for better diagnosis and more effective treatment. However, the current AD diagnostic tests of biomarkers using cerebrospinal fluid and/or brain imaging are invasive or expensive, and mostly are still not able to detect early disease state. Consequently, there is an urgent need to develop new diagnostic techniques with higher sensitivity and specificity during the preclinical stages of AD. Various non-cognitive manifestations, including behavioral abnormalities, sleep disturbances, sensory dysfunctions, and physical changes, have been observed in the preclinical AD stage before occurrence of notable cognitive decline. Recent research advances have identified several biofluid biomarkers as early indicators of AD. This review focuses on these non-cognitive changes and newly discovered biomarkers in AD, specifically addressing the preclinical stages of the disease. Furthermore, it is of importance to explore the potential for developing a predictive system or network to forecast disease onset and progression at the early stage of AD.\n",
      "Keywords: Alzheimer’s disease, biomarkers, early diagnosis, non-cognitive symptoms\n",
      "Publication Year: 2024\n",
      "Authors: Chen, Yixin, Al-Nusaif, Murad, Li, Song, Tan, Xiang, Yang, Huijia, Cai, Huaibin, Le, Weidong\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury.\n",
      "Abstract: This study investigated trajectory profiles and the association of concentrations of the biomarkers neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in ventricular cerebrospinal fluid (CSF) with clinical outcome at 1 year and 10-15 years after a severe traumatic brain injury (sTBI).\n",
      "Keywords: Brain injuries, Glasgow Outcome Scale, Glial fibrillary acidic protein, Intermediate filaments, Neurofilament proteins, Traumatic\n",
      "Publication Year: 2024\n",
      "Authors: Andersson, Emma, Öst, Martin, Dalla, Keti, Zetterberg, Henrik, Blennow, Kaj, Nellgård, Bengt\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Consensus Paper: Cerebellum and Reward.\n",
      "Abstract: Cerebellum is a key-structure for the modulation of motor, cognitive, social and affective functions, contributing to automatic behaviours through interactions with the cerebral cortex, basal ganglia and spinal cord. The predictive mechanisms used by the cerebellum cover not only sensorimotor functions but also reward-related tasks. Cerebellar circuits appear to encode temporal difference error and reward prediction error. From a chemical standpoint, cerebellar catecholamines modulate the rate of cerebellar-based cognitive learning, and mediate cerebellar contributions during complex behaviours. Reward processing and its associated emotions are tuned by the cerebellum which operates as a controller of adaptive homeostatic processes based on interoceptive and exteroceptive inputs. Lobules VI-VII/areas of the vermis are candidate regions for the cortico-subcortical signaling pathways associated with loss aversion and reward sensitivity, together with other nodes of the limbic circuitry. There is growing evidence that the cerebellum works as a hub of regional dysconnectivity across all mood states and that mental disorders involve the cerebellar circuitry, including mood and addiction disorders, and impaired eating behaviors where the cerebellum might be involved in longer time scales of prediction as compared to motor operations. Cerebellar patients exhibit aberrant social behaviour, showing aberrant impulsivity/compulsivity. The cerebellum is a master-piece of reward mechanisms, together with the striatum, ventral tegmental area (VTA) and prefrontal cortex (PFC). Critically, studies on reward processing reinforce our view that a fundamental role of the cerebellum is to construct internal models, perform predictions on the impact of future behaviour and compare what is predicted and what actually occurs.\n",
      "Keywords: Addiction, Ataxias, Catecholamines, Cerebellum, Emotions, Mood, Predictions, Reward, Social interactions\n",
      "Publication Year: 2024\n",
      "Authors: Manto, Mario, Adamaszek, Michael, Apps, Richard, Carlson, Erik, Guarque-Chabrera, Julian, Heleven, Elien, Kakei, Shinji, Khodakhah, Kamran, Kuo, Sheng-Han, Lin, Chi-Ying R, Joshua, Mati, Miquel, Marta, Mitoma, Hiroshi, Larry, Noga, Péron, Julie Anne, Pickford, Jasmine, Schutter, Dennis J L G, Singh, Manpreet K, Tan, Tommy, Tanaka, Hirokazu, Tsai, Peter, Van Overwalle, Frank, Yamashiro, Kunihiko\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: The regulating effect of curcumin on NF-κB pathway in neurodegenerative diseases: a review of the underlying mechanisms.\n",
      "Abstract: Neurodegenerative diseases are part of the central nervous system (CNS) disorders that indicate their presence with neuronal loss, neuroinflammation, and increased oxidative stress. Several pathophysiological factors and biomarkers are involved in this inflammatory process causing these neurological disorders. The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is an inflammation element, which induced transcription and appears to be one of the important players in physiological procedures, especially nervous disorders. NF-κB can impact upon series of intracellular actions and induce or inhibit many inflammation-related pathways. Multiple reports have focused on the modification of NF-κB activity, controlling its expression, translocation, and signaling pathway in neurodegenerative disorders and injuries like Alzheimer's disease (AD), spinal cord injuries (SCI), and Parkinson's disease (PD). Curcumin has been noted to be a popular anti-oxidant and anti-inflammatory substance and is the foremost natural compound produced by turmeric. According to various studies, when playing an anti-inflammatory role, it interacts with several modulating proteins of long-standing disease signaling pathways and has an unprovocative consequence on pro-inflammatory cytokines. This review article determined to figure out curcumin's role in limiting the promotion of neurodegenerative disease via influencing the NF-κB signaling route. Preclinical studies were gathered from plenty of scientific platforms including PubMed, Scopus, Cochrane, and Google Scholar to evaluate this hypothesis. Extracted findings from the literature review explained the repressing impact of Curcumin on the NF-κB signaling pathway and, occasionally down-regulating the cytokine expression. Yet, there is an essential need for further analysis and specific clinical experiments to fully understand this subject.\n",
      "Keywords: Alzheimer’s disease, Herbal medicine, Neuroinflammation, Parkinson’s disease, Phytopharmacology\n",
      "Publication Year: 2024\n",
      "Authors: Esmaealzadeh, Niusha, Miri, Mahdis Sadat, Mavaddat, Helia, Peyrovinasab, Amirreza, Ghasemi Zargar, Sara, Sirous Kabiri, Shirin, Razavi, Seyed Mehrad, Abdolghaffari, Amir Hossein\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Analysis of gene expression in the postmortem brain of neurotypical Black Americans reveals contributions of genetic ancestry.\n",
      "Abstract: Ancestral differences in genomic variation affect the regulation of gene expression; however, most gene expression studies have been limited to European ancestry samples or adjusted to identify ancestry-independent associations. Here, we instead examined the impact of genetic ancestry on gene expression and DNA methylation in the postmortem brain tissue of admixed Black American neurotypical individuals to identify ancestry-dependent and ancestry-independent contributions. Ancestry-associated differentially expressed genes (DEGs), transcripts and gene networks, while notably not implicating neurons, are enriched for genes related to the immune response and vascular tissue and explain up to 26% of heritability for ischemic stroke, 27% of heritability for Parkinson disease and 30% of heritability for Alzheimer's disease. Ancestry-associated DEGs also show general enrichment for the heritability of diverse immune-related traits but depletion for psychiatric-related traits. We also compared Black and non-Hispanic white Americans, confirming most ancestry-associated DEGs. Our results delineate the extent to which genetic ancestry affects differences in gene expression in the human brain and the implications for brain illness risk.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Benjamin, Kynon J M, Chen, Qiang, Eagles, Nicholas J, Huuki-Myers, Louise A, Collado-Torres, Leonardo, Stolz, Joshua M, Pertea, Geo, Shin, Joo Heon, Paquola, Apuã C M, Hyde, Thomas M, Kleinman, Joel E, Jaffe, Andrew E, Han, Shizhong, Weinberger, Daniel R\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Downregulation of miR-181c-5p in Alzheimer's disease weakens the response of microglia to Aβ phagocytosis.\n",
      "Abstract: Alzheimer's disease (AD) is an age-associated neurodegenerative disease. Recently, studies have demonstrated the potential involvement of microRNA-181c-5p (miR-181c-5p) in AD. However, the mechanism through which miR-181c-5p is responsible for the onset and progression of this disease remains unclear, and our study aimed to explore this problem. Differential expression analysis of the AD dataset was performed to identify dysregulated genes. Based on hypergeometric analysis, AD differential the upstream regulation genes miR-181c-5p was found. We constructed a model where SH-SY5Y and BV2 cells were exposed to Aβ1-42 to simulate AD. Levels of tumor necrosis factor-alpha, interleukin-6, and IL-1β were determined using enzyme-linked immunosorbent assay or reverse transcription quantitative polymerase chain reaction. Phosphorylation levels of p-P38 and P38 were detected by Western blot. The level of apoptosis in BV2 cells under Aβ1-42 stress was exacerbated by miR-181c-5p mimic. Downregulated miR-181c-5p impaired the phagocytosis and degradation of Aβ by BV2 cells. The release of proinflammatory cytokines in BV2 cells with Aβ1-42 stress was alleviated by miR-181c-5p upregulation. Additionally, miR-181c-5p downregulation alleviated the phosphorylation of P38 in Aβ1-42-induced SH-SY5Y cells. In conclusion, miR-181c-5p improves the phagocytosis of Aβ by microglial cells in AD patients, thereby reducing neuroinflammation.\n",
      "Keywords: Alzheimer’s disease, Apoptosis, Aβ, Neurotoxicity, miR-181c-5p\n",
      "Publication Year: 2024\n",
      "Authors: Li, Rongjie, Yao, Shanshan, Wei, Feijie, Chen, Meixiang, Zhong, Yuanli, Zou, Chun, Chen, Liechun, Wei, Lichun, Yang, Chunxia, Zhang, Xiyuan, Liu, Ying\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: CSF amino acid profiles in ICV-streptozotocin-induced sporadic Alzheimer's disease in male Wistar rat: a metabolomics and systems biology perspective.\n",
      "Abstract: Alzheimer's disease (AD) is an increasingly important public health concern due to the increasing proportion of older individuals within the general population. The impairment of processes responsible for adequate brain energy supply primarily determines the early features of the aging process. Restricting brain energy supply results in brain hypometabolism prior to clinical symptoms and is anatomically and functionally associated with cognitive impairment. The present study investigated changes in metabolic profiles induced by intracerebroventricular-streptozotocin (ICV-STZ) in an AD-like animal model. To this end, male Wistar rats received a single injection of STZ (3 mg·kg\n",
      "Keywords: glucose metabolism, neurometabolic, sporadic Alzheimer's Disease, streptozotocin, systems biology\n",
      "Publication Year: 2024\n",
      "Authors: Barzegar Behrooz, Amir, Latifi-Navid, Hamid, Lotfi, Jabar, Khodagholi, Fariba, Shojaei, Shahla, Ghavami, Saeid, Fahanik Babaei, Javad\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Altering plasma lipids and liver enzyme activities via hippocampal injections of hen Lysozyme amyloid aggregates in an Alzheimer's disease mouse model: Insights into the therapeutic role of Bis (Indolyl) phenylmethane.\n",
      "Abstract: Alzheimer's disease (AD) is a prevalent form of dementia in the elderly. There is currently no effective treatment available for this disease. Diagnosis of AD typically relies on clinical manifestations and specific biomarkers. The present study investigated the impact of inducing Alzheimer's disease (AD) in mice through the injection of lysozyme amyloids formed in the presence or absence of Bis (Indolyl) phenylmethane (BIPM) on alterations in plasma lipid profiles and liver enzyme activities. 24 adult Wistar rats were divided into control, Scopolamine, Lysozyme, BIPM groups and the blood samples were obtained from the groups for biochemical analysis. The findings of the study revealed significant changes in the plasma lipid profiles and liver enzyme markers of the Lysozyme group compared to the control group. The Lysozyme group exhibited elevated triglycerides (n = 6, P < 0.02) and LDL levels (n = 6, P < 0.02), reduced HDL (n = 6, P < 0.05) and cholesterol levels (n = 6, P < 0.02), and altered serum glutamic oxaloacetic transaminase (SGOT) level (n = 6, P < 0.05) compared to controls. While the level of serum glutamic pyruvic transaminase (SGPT) did not change significantly compared to the control. BIPM groups showed no significant changes in lipid or enzyme levels compared to controls. Overall, our research has shown that BIPM has the ability to modify the structure of HEWL aggregates, thereby improving the detrimental effects associated with AD caused by these aggregates. Analyzing lipid profiles and liver enzyme markers presents a promising avenue for targeted therapeutic approaches. These alterations observed in the plasma may potentially serve as candidate biomarkers for diagnosing this disease.\n",
      "Keywords: Amyloid inhibition, Bis (Indolyl) phenylmethane, Lipid profile, Liver enzymes, Lysozyme aggregates\n",
      "Publication Year: 2024\n",
      "Authors: Fazelinejad, Hassan, Zahedi, Elham, Khadivi, Mehdi\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Sexual activity and Respiratory Disease: a systematic review.\n",
      "Abstract: Sex and gender are related concepts, but they have distinct meanings and implications. Respiratory diseases are a major driver of morbi-mortality. It is frequent that respirologists, primary care doctors, or other specialists, when dealing with respiratory patients, and aiming for a holistic management of their patients, they all skip any question or matter associated with sexual activity or behavior.\n",
      "Keywords: COPD, Gender, Lung health, Respiratory disease, Sex, Sexual activity, Sexual intercourse\n",
      "Publication Year: 2024\n",
      "Authors: Soriano, Joan B, Polverino, Francesca\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Telemedicine and Disparities in Mental Health Service Use Among Community-Dwelling Older Adults With Alzheimer Disease and Related Dementias.\n",
      "Abstract: To examine disparities in mental health (MH) service utilization, via in-person and telemedicine (ie, tele-MH), by individuals' race, ethnicity, and community socioeconomic status, among community-dwelling older adults with Alzheimer disease and related dementias (ADRD) before and after the expansion of the Centers for Medicare and Medicaid Services' (CMS's) telemedicine policy.\n",
      "Keywords: ADRD, health disparities, mental health utilization, telemedicine\n",
      "Publication Year: 2024\n",
      "Authors: Cai, Shubing, Qin, Qiuyuan, Veazie, Peter, Temkin-Greener, Helena\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Gene-gene functional relationships in Alzheimer's disease: CELF1 regulates KLC1 alternative splicing.\n",
      "Abstract: The causes of Alzheimer's disease (AD) are poorly understood, although many genes are known to be involved in this pathology. To gain insights into the underlying molecular mechanisms, it is essential to identify the relationships between individual AD genes. Previous work has shown that the splice variant E of KLC1 (KLC1_vE) promotes AD, and that the CELF1 gene, which encodes an RNA-binding protein involved in splicing regulation, is at a risk locus for AD. Here, we identified a functional link between CELF1 and KLC1 in AD pathogenesis. Transcriptomic data from human samples from different ethnic groups revealed that CELF1 mRNA levels are low in AD brains, and the splicing pattern of KLC1 is strongly correlated with CELF1 expression levels. Specifically, KLC1_vE is negatively correlated with CELF1. Depletion and overexpression experiments in cultured cells demonstrated that the CELF1 protein down-regulates KLC1_vE. In a cross-linking and immunoprecipitation sequencing (CLIP-seq) database, CELF1 directly binds to KLC1 RNA, following which it likely modulates terminal exon usage, hence KLC1_vE formation. These findings reveal a new pathogenic pathway where a risk allele of CELF1 is associated with reduced CELF1 expression, which up-regulates KLC1_vE to promote AD.\n",
      "Keywords: Alternative splicing, Alzheimer's disease, CELF1, KLC1, Pathogenic pathway\n",
      "Publication Year: 2024\n",
      "Authors: Kikuchi, Masataka, Viet, Justine, Nagata, Kenichi, Sato, Masahiro, David, Geraldine, Audic, Yann, Silverman, Michael A, Yamamoto, Mitsuko, Akatsu, Hiroyasu, Hashizume, Yoshio, Takeda, Shuko, Akamine, Shoshin, Miyamoto, Tesshin, Uozumi, Ryota, Gotoh, Shiho, Mori, Kohji, Ikeda, Manabu, Paillard, Luc, Morihara, Takashi\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Subthalamic nucleus-language network connectivity predicts dopaminergic modulation of speech function in Parkinson's disease.\n",
      "Abstract: Speech impediments are a prominent yet understudied symptom of Parkinson's disease (PD). While the subthalamic nucleus (STN) is an established clinical target for treating motor symptoms, these interventions can lead to further worsening of speech. The interplay between dopaminergic medication, STN circuitry, and their downstream effects on speech in PD is not yet fully understood. Here, we investigate the effect of dopaminergic medication on STN circuitry and probe its association with speech and cognitive functions in PD patients. We found that changes in intrinsic functional connectivity of the STN were associated with alterations in speech functions in PD. Interestingly, this relationship was characterized by altered functional connectivity of the dorsolateral and ventromedial subdivisions of the STN with the language network. Crucially, medication-induced changes in functional connectivity between the STN's dorsolateral subdivision and key regions in the language network, including the left inferior frontal cortex and the left superior temporal gyrus, correlated with alterations on a standardized neuropsychological test requiring oral responses. This relation was not observed in the written version of the same test. Furthermore, changes in functional connectivity between STN and language regions predicted the medication's downstream effects on speech-related cognitive performance. These findings reveal a previously unidentified brain mechanism through which dopaminergic medication influences speech function in PD. Our study sheds light into the subcortical-cortical circuit mechanisms underlying impaired speech control in PD. The insights gained here could inform treatment strategies aimed at mitigating speech deficits in PD and enhancing the quality of life for affected individuals.\n",
      "Keywords: dopamine, functional connectivity, language, speech, subthalamic nuclei\n",
      "Publication Year: 2024\n",
      "Authors: Cai, Weidong, Young, Christina B, Yuan, Rui, Lee, Byeongwook, Ryman, Sephira, Kim, Jeehyun, Yang, Laurice, Levine, Taylor F, Henderson, Victor W, Poston, Kathleen L, Menon, Vinod\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET.\n",
      "Abstract: The use of amyloid-PET in dementia workup is upcoming. At the same time, amyloid-PET is costly and limitedly available. While the appropriate use criteria (AUC) aim for optimal use of amyloid-PET, their limited sensitivity hinders the translation to clinical practice. Therefore, there is a need for tools that guide selection of patients for whom amyloid-PET has the most clinical utility. We aimed to develop a computerized decision support approach to select patients for amyloid-PET.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Rhodius-Meester, Hanneke F M, van Maurik, Ingrid S, Collij, Lyduine E, van Gils, Aniek M, Koikkalainen, Juha, Tolonen, Antti, Pijnenburg, Yolande A L, Berkhof, Johannes, Barkhof, Frederik, van de Giessen, Elsmarieke, Lötjönen, Jyrki, van der Flier, Wiesje M\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: A confounder controlled machine learning approach: Group analysis and classification of schizophrenia and Alzheimer's disease using resting-state functional network connectivity.\n",
      "Abstract: Resting-state functional magnetic resonance imaging (rs-fMRI) has increasingly been used to study both Alzheimer's disease (AD) and schizophrenia (SZ). While most rs-fMRI studies being conducted in AD and SZ compare patients to healthy controls, it is also of interest to directly compare AD and SZ patients with each other to identify potential biomarkers shared between the disorders. However, comparing patient groups collected in different studies can be challenging due to potential confounds, such as differences in the patient's age, scan protocols, etc. In this study, we compared and contrasted resting-state functional network connectivity (rs-FNC) of 162 patients with AD and late mild cognitive impairment (LMCI), 181 schizophrenia patients, and 315 cognitively normal (CN) subjects. We used confounder-controlled rs-FNC and applied machine learning algorithms (including support vector machine, logistic regression, random forest, and k-nearest neighbor) and deep learning models (i.e., fully-connected neural networks) to classify subjects in binary and three-class categories according to their diagnosis labels (e.g., AD, SZ, and CN). Our statistical analysis revealed that FNC between the following network pairs is stronger in AD compared to SZ: subcortical-cerebellum, subcortical-cognitive control, cognitive control-cerebellum, and visual-sensory motor networks. On the other hand, FNC is stronger in SZ than AD for the following network pairs: subcortical-visual, subcortical-auditory, subcortical-sensory motor, cerebellum-visual, sensory motor-cognitive control, and within the cerebellum networks. Furthermore, we observed that while AD and SZ disorders each have unique FNC abnormalities, they also share some common functional abnormalities that can be due to similar neurobiological mechanisms or genetic factors contributing to these disorders' development. Moreover, we achieved an accuracy of 85% in classifying subjects into AD and SZ where default mode, visual, and subcortical networks contributed the most to the classification and accuracy of 68% in classifying subjects into AD, SZ, and CN with the subcortical domain appearing as the most contributing features to the three-way classification. Finally, our findings indicated that for all classification tasks, except AD vs. SZ, males are more predictable than females.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Hassanzadeh, Reihaneh, Abrol, Anees, Pearlson, Godfrey, Turner, Jessica A, Calhoun, Vince D\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Precise Modulation of Pericyte Dysfunction by a Multifunctional Nanoprodrug to Ameliorate Alzheimer's Disease.\n",
      "Abstract: Pericyte dysfunction severely undermines cerebrovascular integrity and exacerbates neurodegeneration in Alzheimer's disease (AD). However, pericyte-targeted therapy is a yet-untapped frontier for AD. Inspired by the elevation of vascular cell adhesion molecule-1 (VCAM-1) and reactive oxygen species (ROS) levels in pericyte lesions, we fabricated a multifunctional nanoprodrug by conjugating the hybrid peptide VLC, a fusion of the VCAM-1 high-affinity peptide VHS and the neuroprotective apolipoprotein mimetic peptide COG1410, to curcumin (Cur) through phenylboronic ester bond (VLC@Cur-NPs) to alleviate complex pericyte-related pathological changes. Importantly, VLC@Cur-NPs effectively homed to pericyte lesions via VLC and released their contents upon ROS stimulation to maximize their regulatory effects. Consequently, VLC@Cur-NPs markedly increased pericyte regeneration to form a positive feedback loop and thus improved neurovascular function and ultimately alleviated memory defects in APP/PS1 transgenic mice. We present a promising therapeutic strategy for AD that can precisely modulate pericytes and has the potential to treat other cerebrovascular diseases.\n",
      "Keywords: Alzheimer’s disease, hybrid peptide VLC, nanoprodrug, neurovascular integrity, pericyte dysfunction\n",
      "Publication Year: 2024\n",
      "Authors: Yang, Peng, Li, Yixian, Qian, Kang, Zhou, Lingling, Cheng, Yunlong, Wu, Jing, Xu, Minjun, Wang, Tianying, Yang, Xiyu, Mu, Yongkang, Liu, Xuan, Zhang, Qizhi\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer's Diseases.\n",
      "Abstract: Alzheimer's disease (AD) is a neurological condition currently with 47 million people suffering from it globally. AD might have many reasons such as genetic issues, environmental factors, and Aβ accumulation, which is the biomarker of the disease. Since the primary reason is unknown, there is no targeted treatment at the moment, but ongoing research aims to slow its progression by managing amyloid-beta peptide production rather than symptomatic improvement. Since phytochemicals have been demonstrated to possess antioxidant, anti-inflammatory, and neuroprotective properties, they may target multiple pathological factors and can reduce the risk of the disease. Curcumin, as a phytochemical found in turmeric known for its antioxidant, free radical scavenging properties, and as an antiamyloid in treating AD, has come under investigation. Although its low bioavailability limits its efficacy, a prominent drug delivery system (DDS) is desired to overcome it. Hence, the potency of lipid-based nanoparticles encapsulating curcumin (LNPs-CUR) is considered in this study as a promising DDS. In vivo studies in animal models indicate LNPs-CUR effectively slow amyloid plaque formation, leading to cognitive enhancement and reduced toxicity compared to free CUR. However, a deeper understanding of CUR's pharmacokinetics and safety profile is crucial before LNPs-CUR can be considered as a medicine. Future investigations may explore the combination of NPs with other therapeutic agents to increase their efficacy in AD cases. This review provides the current position of CUR in the AD therapy paradigm, the DDS suggestions for CUR, and the previous research from the point of analytical view focused on the advantages and challenges.\n",
      "Keywords: Alzheimer’s disease (AD), Amyloid Plaque, Curcumin, Drug Delivery Systems (DDS), Lipid-based nanoparticles (LNPs), Neuroprotection C\n",
      "Publication Year: 2024\n",
      "Authors: Far, Bahareh Farasati, Safaei, Maryam, Pourmolaei, Ali, Adibamini, Shaghyegh, Shirdel, Shiva, Shirdel, Shabnam, Emadi, Reza, Kaushik, Ajeet Kumar\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: A commentary on \"The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs\".\n",
      "Abstract: No abstract available\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: He, Yawen, Jiang, Zhiyang, Zhang, Yonghua\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Immunotherapy in Alzheimer's disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline.\n",
      "Abstract: Gantenerumab, a human monoclonal antibody (mAb), has been thought of as a potential agent to treat Alzheimer's disease (AD) by specifically targeting regions of the amyloid-β (Aβ) peptide sequence. Aβ protein accumulation in the brain leads to amyloid plaques, causing neuroinflammation, oxidative stress, neuronal damage, and neurotransmitter dysfunction, thereby causing cognitive decline in AD. Gantenerumab involves disrupting Aβ aggregation and promoting the breakdown of larger Aβ aggregates into smaller fragments, which facilitates the action of Aβ-degrading enzymes in the brain, thus slowing down the progression of AD. Moreover, Gantenerumab acts as an opsonin, coating Aβ plaques and enhancing their recognition by immune cells, which, combined with its ability to improve the activity of microglia, makes it an intriguing candidate for promoting Aβ plaque clearance. Indeed, the multifaceted effects of Gantenerumab, including Aβ disaggregation, enhanced immune recognition, and improved microglia activity, may position it as a promising therapeutic approach for AD. Of note, reports suggest that Gantenerumab, albeit its capacity to reduce or eliminate Aβ, has not demonstrated effectiveness in reducing cognitive decline. This review, after providing an overview of immunotherapy approaches that target Aβ in AD, explores the efficacy of Gantenerumab in reducing Aβ levels and cognitive decline.\n",
      "Keywords: Alzheimer’s disease, amyloid-β, cognitive decline, gantenerumab, immunotherapy, monoclonal antibody\n",
      "Publication Year: 2024\n",
      "Authors: Azargoonjahromi, Ali\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Meta-analysis of the association between \n",
      "Abstract: To conduct a meta-analysis investigating the relationship between the chromosome 9 open reading frame 72 (\n",
      "Keywords: Alzheimer’s disease, Parkinson’s disease, corticobasal degeneration, meta-analysis, multiple system atrophyC9orf72 repeat, progressive supranuclear palsy\n",
      "Publication Year: 2024\n",
      "Authors: Jin, Pingfei, Li, Yong, Li, Yao\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: AAV mediated carboxyl terminus of Hsp70 interacting protein overexpression mitigates the cognitive and pathological phenotypes of APP/PS1 mice.\n",
      "Abstract: JOURNAL/nrgr/04.03/01300535-202501000-00033/figure1/v/2024-05-14T021156Z/r/image-tiff The E3 ubiquitin ligase, carboxyl terminus of heat shock protein 70 (Hsp70) interacting protein (CHIP), also functions as a co-chaperone and plays a crucial role in the protein quality control system. In this study, we aimed to investigate the neuroprotective effect of overexpressed CHIP on Alzheimer's disease. We used an adeno-associated virus vector that can cross the blood-brain barrier to mediate CHIP overexpression in APP/PS1 mouse brain. CHIP overexpression significantly ameliorated the performance of APP/PS1 mice in the Morris water maze and nest building tests, reduced amyloid-β plaques, and decreased the expression of both amyloid-β and phosphorylated tau. CHIP also alleviated the concentration of microglia and astrocytes around plaques. In APP/PS1 mice of a younger age, CHIP overexpression promoted an increase in ADAM10 expression and inhibited β-site APP cleaving enzyme 1, insulin degrading enzyme, and neprilysin expression. Levels of HSP70 and HSP40, which have functional relevance to CHIP, were also increased. Single nuclei transcriptome sequencing in the hippocampus of CHIP overexpressed mice showed that the lysosomal pathway and oligodendrocyte-related biological processes were up-regulated, which may also reflect a potential mechanism for the neuroprotective effect of CHIP. Our research shows that CHIP effectively reduces the behavior and pathological manifestations of APP/PS1 mice. Indeed, overexpression of CHIP could be a beneficial approach for the treatment of Alzheimer's disease.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2025\n",
      "Authors: Hu, Zhengwei, Yang, Jing, Zhang, Shuo, Li, Mengjie, Zuo, Chunyan, Mao, Chengyuan, Zhang, Zhongxian, Tang, Mibo, Shi, Changhe, Xu, Yuming\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Emerging structures and dynamic mechanisms of γ-secretase for Alzheimer's disease.\n",
      "Abstract: γ-Secretase, called \"the proteasome of the membrane,\" is a membrane-embedded protease complex that cleaves 150+ peptide substrates with central roles in biology and medicine, including amyloid precursor protein and the Notch family of cell-surface receptors. Mutations in γ-secretase and amyloid precursor protein lead to early-onset familial Alzheimer's disease. γ-Secretase has thus served as a critical drug target for treating familial Alzheimer's disease and the more common late-onset Alzheimer's disease as well. However, critical gaps remain in understanding the mechanisms of processive proteolysis of substrates, the effects of familial Alzheimer's disease mutations, and allosteric modulation of substrate cleavage by γ-secretase. In this review, we focus on recent studies of structural dynamic mechanisms of γ-secretase. Different mechanisms, including the \"Fit-Stay-Trim,\" \"Sliding-Unwinding,\" and \"Tilting-Unwinding,\" have been proposed for substrate proteolysis of amyloid precursor protein by γ-secretase based on all-atom molecular dynamics simulations. While an incorrect registry of the Notch1 substrate was identified in the cryo-electron microscopy structure of Notch1-bound γ-secretase, molecular dynamics simulations on a resolved model of Notch1-bound γ-secretase that was reconstructed using the amyloid precursor protein-bound γ-secretase as a template successfully captured γ-secretase activation for proper cleavages of both wildtype and mutant Notch, being consistent with biochemical experimental findings. The approach could be potentially applied to decipher the processing mechanisms of various substrates by γ-secretase. In addition, controversy over the effects of familial Alzheimer's disease mutations, particularly the issue of whether they stabilize or destabilize γ-secretase-substrate complexes, is discussed. Finally, an outlook is provided for future studies of γ-secretase, including pathways of substrate binding and product release, effects of modulators on familial Alzheimer's disease mutations of the γ-secretase-substrate complexes. Comprehensive understanding of the functional mechanisms of γ-secretase will greatly facilitate the rational design of effective drug molecules for treating familial Alzheimer's disease and perhaps Alzheimer's disease in general.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2025\n",
      "Authors: Miao, Yinglong, Wolfe, Michael S\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: High mobility group box 1 in the central nervous system: regeneration hidden beneath inflammation.\n",
      "Abstract: High-mobility group box 1 was first discovered in the calf thymus as a DNA-binding nuclear protein and has been widely studied in diverse fields, including neurology and neuroscience. High-mobility group box 1 in the extracellular space functions as a pro-inflammatory damage-associated molecular pattern, which has been proven to play an important role in a wide variety of central nervous system disorders such as ischemic stroke, Alzheimer's disease, frontotemporal dementia, Parkinson's disease, multiple sclerosis, epilepsy, and traumatic brain injury. Several drugs that inhibit high-mobility group box 1 as a damage-associated molecular pattern, such as glycyrrhizin, ethyl pyruvate, and neutralizing anti-high-mobility group box 1 antibodies, are commonly used to target high-mobility group box 1 activity in central nervous system disorders. Although it is commonly known for its detrimental inflammatory effect, high-mobility group box 1 has also been shown to have beneficial pro-regenerative roles in central nervous system disorders. In this narrative review, we provide a brief summary of the history of high-mobility group box 1 research and its characterization as a damage-associated molecular pattern, its downstream receptors, and intracellular signaling pathways, how high-mobility group box 1 exerts the repair-favoring roles in general and in the central nervous system, and clues on how to differentiate the pro-regenerative from the pro-inflammatory role. Research targeting high-mobility group box 1 in the central nervous system may benefit from differentiating between the two functions rather than overall suppression of high-mobility group box 1.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2025\n",
      "Authors: Kim, Hanki, Kim, Bum Jun, Koh, Seungyon, Cho, Hyo Jin, Jin, Xuelian, Kim, Byung Gon, Choi, Jun Young\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Targeting epigenetic mechanisms in amyloid-β-mediated Alzheimer's pathophysiology: unveiling therapeutic potential.\n",
      "Abstract: Alzheimer's disease is a prominent chronic neurodegenerative condition characterized by a gradual decline in memory leading to dementia. Growing evidence suggests that Alzheimer's disease is associated with accumulating various amyloid-β oligomers in the brain, influenced by complex genetic and environmental factors. The memory and cognitive deficits observed during the prodromal and mild cognitive impairment phases of Alzheimer's disease are believed to primarily result from synaptic dysfunction. Throughout life, environmental factors can lead to enduring changes in gene expression and the emergence of brain disorders. These changes, known as epigenetic modifications, also play a crucial role in regulating the formation of synapses and their adaptability in response to neuronal activity. In this context, we highlight recent advances in understanding the roles played by key components of the epigenetic machinery, specifically DNA methylation, histone modification, and microRNAs, in the development of Alzheimer's disease, synaptic function, and activity-dependent synaptic plasticity. Moreover, we explore various strategies, including enriched environments, exposure to non-invasive brain stimulation, and the use of pharmacological agents, aimed at improving synaptic function and enhancing long-term potentiation, a process integral to epigenetic mechanisms. Lastly, we deliberate on the development of effective epigenetic agents and safe therapeutic approaches for managing Alzheimer's disease. We suggest that addressing Alzheimer's disease may require distinct tailored epigenetic drugs targeting different disease stages or pathways rather than relying on a single drug.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2025\n",
      "Authors: Li, Jennie Z, Ramalingam, Nagendran, Li, Shaomin\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Isolation of Mitochondria for Mitochondrial Supercomplex Analysis from Small Tissue and Cell Culture Samples.\n",
      "Abstract: Over the last decades, the evidence accumulated about the existence of respiratory supercomplexes (SCs) has changed our understanding of the mitochondrial electron transport chain organization, giving rise to the proposal of the \"plasticity model.\" This model postulates the coexistence of different proportions of SCs and complexes depending on the tissue or the cellular metabolic status. The dynamic nature of the assembly in SCs would allow cells to optimize the use of available fuels and the efficiency of electron transfer, minimizing reactive oxygen species generation and favoring the ability of cells to adapt to environmental changes. More recently, abnormalities in SC assembly have been reported in different diseases such as neurodegenerative disorders (Alzheimer's and Parkinson's disease), Barth Syndrome, Leigh syndrome, or cancer. The role of SC assembly alterations in disease progression still needs to be confirmed. Nevertheless, the availability of enough amounts of samples to determine the SC assembly status is often a challenge. This happens with biopsy or tissue samples that are small or have to be divided for multiple analyses, with cell cultures that have slow growth or come from microfluidic devices, with some primary cultures or rare cells, or when the effect of particular costly treatments has to be analyzed (with nanoparticles, very expensive compounds, etc.). In these cases, an efficient and easy-to-apply method is required. This paper presents a method adapted to obtain enriched mitochondrial fractions from small amounts of cells or tissues to analyze the structure and function of mitochondrial SCs by native electrophoresis followed by in-gel activity assays or western blot.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Moreno-Loshuertos, Raquel, Fernández-Silva, Patricio\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Rationale and design of a double-blinded, randomized placebo-controlled trial of 40 Hz light neurostimulation therapy for depression (FELIX).\n",
      "Abstract: Major depressive disorder (MDD) is a debilitating condition that affects more than 300 million people worldwide. Current treatments are based on a trial-and-error approach, and reliable biomarkers are needed for more informed and personalized treatment solutions. One of the potential biomarkers, gamma-frequency (30-80 Hz) brainwaves, are hypothesized to originate from the excitatory-inhibitory interaction between the pyramidal cells and interneurons. The imbalance between this interaction is described as a crucial pathological mechanism in neuropsychiatric conditions, including MDD, and the modulation of this pathological interaction has been investigated as a potential target. Previous studies attempted to induce gamma activity in the brain using rhythmic light and sound stimuli (GENUS - Gamma Entrainment Using Sensory stimuli) that resulted in neuroprotective effects in Alzheimer's disease (AD) patients and animal models. Here, we investigate the antidepressant, cognitive, and electrophysiological effects of the novel light therapy approach using 40 Hz masked flickering light for patients diagnosed with MDD.\n",
      "Keywords: 40 Hz stimulation, Light stimulation, cognition, gamma brainwaves, major depressive disorder, visual flicker\n",
      "Publication Year: 2024\n",
      "Authors: Sakalauskaitė, Laura, Hansen, Luna S, Dubois, Julie Margrethe, Ploug Larsen, Malina, Feijóo, Gustavo Miguel, Carstensen, Marcus S, Woznica Miskowiak, Kamilla, Nguyen, Mai, Harder Clemmensen, Line Katrine, Petersen, Paul Michael, Martiny, Klaus\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: How Irregular Geometry and Complex Feed Waveform Affect Pulsating Arterial Mass Transfer.\n",
      "Abstract: Alzheimer's disease is a progressive degenerative condition that has various levels of effect on one's memory. It is thought to be caused by a buildup of protein in small fluid-filled spaces in the brain called perivascular spaces (PVS). The PVS often takes on the form of an annular region around arteries and is used as a protein-clearing system for the brain. To analyze the modes of mass transfer in the PVS, a digitized scan of a mouse brain PVS segment was meshed and used for computational fluid dynamics (CFD) studies. Tandem analyses were then carried out and compared between the mouse PVS section and a cylinder with commensurate dimensionless parameters and hydraulic resistance. The geometry pair was used to first validate the CFD model and then assess mass transfer in various advection states: no flow, constant flow, sinusoidal flow, sinusoidal flow with zero net solvent flux, and an anatomically correct asymmetrical periodic flow. Two mass transfer situations were considered, one being a protein build-up and the other being a protein blend-down. The results showed that, for all the flows in question and both protein scenarios, there was nearly no protein clearance benefit by the anatomically correct PVS geometry. Surprisingly, solute blend-down was diffusion-dominated even for high Peclet numbers. Findings herein lead to the conclusion that minimal risk would be incurred by incorporating PVS geometry into existing reduce-order modeling arterial networks.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Strasser, Wayne\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis.\n",
      "Abstract: As individuals age, they may develop Alzheimer's disease (AD), which is characterized by difficulties in speech, memory loss, and other issues related to neural function. Cycloastragenol is an active ingredient of Astragalus trojanus and has been used to treat inflammation, aging, heart disease, and cancer.\n",
      "Keywords: Acetylcholinesterase (AchE), Alzheimer’s disease (AD), B-cell lymphoma 2 (BCL2), Bcl-2-associated x protein (BAX), Caspase-3, Nuclear factor erythroid 2-related factor 2 (Nrf2), Nuclear factor κB (NFκB), Tumor necrosis factor-α (TNF-α)., heme oxygenase-1 (HO-1)\n",
      "Publication Year: 2024\n",
      "Authors: Alharbi, Kadi M, Alshehri, Shahad A, Almarwani, Wasayf A, Aljohani, Khulud K, Albalawi, Ajwan Z, Alatawi, Areej S, Al-Atwi, Shekha M, Alhwyty, Lama S, Hassan, Hanan M, Al-Gayyar, Mohammed M H\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Exploring Therapeutic Frontiers: Unveiling the Potential of Natural Diterpenoid Derivatives in Addressing Neurological Disorders.\n",
      "Abstract: Neurological disorders present a formidable challenge in healthcare, necessitating the continuous exploration of innovative therapeutic avenues. This review delves into the burgeoning field of natural diterpenoid derivatives and their promising role in addressing neurological disorders. Derived from natural sources, these compounds exhibit a diverse range of pharmacological properties, positioning them as potential agents for treating conditions such as Alzheimer's and Parkinson's disease. The review highlights recent advancements, shedding light on the multifaceted mechanisms through which diterpenoid derivatives exert their effects, from antiinflammatory to neuroprotective actions. As the scientific community navigates the translational journey from bench to bedside, integrating these natural compounds into neurotherapeutics emerges as a compelling prospect. This exploration of the therapeutic frontiers of natural diterpenoid derivatives signifies a significant step towards innovative and effective strategies in the management of neurological disorders. It highlights the potential of natural compounds to revolutionize neurotherapeutics.\n",
      "Keywords: Neurological disorders, diterpenes, diterpenoids, natural products, neurodegenerative properties, pharmacological potential.\n",
      "Publication Year: 2024\n",
      "Authors: Singh, Kuldeep, Gupta, Jeetendra Kumar, Jain, Divya, Kumar, Shivendra, Saha, Sunam, Sharma, Ashwani\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Biosynthesis of Nanoparticles with Green Tea for Inhibition of β-Amyloid Fibrillation Coupled with Ligands Analysis.\n",
      "Abstract: Inhibition of amyloid β protein fragment (Aβ) aggregation is considered to be one of the most effective strategies for the treatment of Alzheimer's disease. (-)-Epigallocatechin-3-gallate (EGCG) has been found to be effective in this regard; however, owing to its low bioavailability, nanodelivery is recommended for practical applications. Compared to chemical reduction methods, biosynthesis avoids possible biotoxicity and cumbersome preparation processes.\n",
      "Keywords: (-)-epigallocatechin-3-gallate, amyloid β protein, gold nanoparticles, green synthesis, green tea, liquid chromatography tandem triple quadrupole mass spectrometry\n",
      "Publication Year: 2024\n",
      "Authors: Zhang, Mai, Li, Yan, Han, Chunli, Chu, Shiying, Yu, Peng, Cheng, Wenbo\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: The microbiome shapes immunity in a sex-specific manner in mouse models of Alzheimer's disease.\n",
      "Abstract: Preclinical studies reveal that the microbiome broadly affects immune responses and the deposition and/or clearance of amyloid-beta (Aβ) in mouse models of Alzheimer's disease (AD). Whether the microbiome shapes central and peripheral immune profiles in AD models remains unknown.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Bostick, John W, Connerly, Trista J, Thron, Taren, Needham, Brittany D, de Castro Fonseca, Matheus, Kaddurah-Daouk, Rima, Knight, Rob, Mazmanian, Sarkis K\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: How short peptides can disassemble ultra-stable tau fibrils extracted from Alzheimer's disease brain by a strain-relief mechanism.\n",
      "Abstract: Reducing fibrous aggregates of protein tau is a possible strategy for halting progression of Alzheimer's dis-ease (AD). Previously we found that in vitro the D-peptide D-TLKIVWC disassembles tau fibrils from AD brains (AD-tau) into benign segments with no energy source present beyond ambient thermal agitation. This disassembly by a short peptide was unexpected, given that AD-tau is sufficiently stable to withstand disas-sembly in boiling SDS detergent. To consider D peptide-mediated disassembly as a potential therapeutic for AD, it is essential to understand the mechanism and energy source of the disassembly action. We find as-sembly of D-peptides into amyloid-like fibrils is essential for tau fibril disassembly. Cryo-EM and atomic force microscopy reveal that these D-peptide fibrils have a right-handed twist and embrace tau fibrils which have a left-handed twist. In binding to the AD-tau fibril, the oppositely twisted D-peptide fibril produces a strain, which is relieved by the disassembly of both fibrils. This strain-relief mechanism appears to operate in other examples of amyloid fibril disassembly and provides a new direction for the development of first-in-class therapeutics for amyloid diseases.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Eisenberg, David, Hou, Ke, Ge, Peng, Sawaya, Michael, Dolinsky, Joshua, Yang, Yuan, Jiang, Yi Xiao, Lutter, Liisa, Boyer, David, Cheng, Xinyi, Pi, Justin, Zhang, Jeffrey, Lu, Jiahui, Yang, Shixin, Yu, Zhiheng, Feigon, Juli\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: The impact of APOE ε4 in Alzheimer's disease: a meta-analysis of voxel-based morphometry studies.\n",
      "Abstract: Alzheimer's disease (AD) is the most prevalent form of dementia, exerting substantial personal and societal impacts. The apolipoprotein E (APOE) ε4 allele is a known genetic factor that increases the risk of AD, contributing to more severe brain atrophy and exacerbated symptoms.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Bailey, Madison, Ilchovska, Zlatomira Georgieva, Hosseini, Akram A, Jung, JeYoung\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Compositional structural brain signatures capture Alzheimer's genetic risk on brain structure along the disease \n",
      "Abstract: Traditional brain imaging genetics studies have primarily focused on how genetic factors influence the volume of specific brain regions, often neglecting the overall complexity of brain architecture and its genetic underpinnings.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Genius, Patricia, Calle, M Luz, Rodríguez-Fernández, Blanca, Minguillon, Carolina, Cacciaglia, Raffaele, Garrido-Martin, Diego, Esteller, Manel, Navarro, Arcadi, Gispert, Juan Domingo, Vilor-Tejedor, Natalia\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: PTPRS is a novel marker for early tau pathology and synaptic integrity in Alzheimer's disease.\n",
      "Abstract: We examined the role of protein tyrosine phosphatase receptor sigma (PTPRS) in the context of Alzheimer's disease and synaptic integrity. Publicly available datasets (BRAINEAC, ROSMAP, ADC1) and a cohort of asymptomatic but \"at risk\" individuals (PREVENT-AD) were used to explore the relationship between PTPRS and various Alzheimer's disease biomarkers. We identified that PTPRS rs10415488 variant C shows features of neuroprotection against early tau pathology and synaptic degeneration in Alzheimer's disease. This single nucleotide polymorphism correlated with higher PTPRS transcript abundance and lower P-tau181 and GAP-43 levels in the CSF. In the brain, PTPRS protein abundance was significantly correlated with the quantity of two markers of synaptic integrity: SNAP25 and SYT-1. We also found the presence of sexual dimorphism for PTPRS, with higher CSF concentrations in males than females. Male carriers for variant C were found to have a 10-month delay in the onset of AD. We thus conclude that PTPRS acts as a neuroprotective receptor in Alzheimer's disease. Its protective effect is most important in males, in whom it postpones the age of onset of the disease.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Poirier, Alexandre, Picard, Cynthia, Labonté, Anne, Aubry, Isabelle, Auld, Daniel, Zetterberg, Henrik, Blennow, Kaj, Tremblay, Michel L, Poirier, Judes\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Prioritizing disease-related rare variants by integrating gene expression data.\n",
      "Abstract: Rare variants, comprising a vast majority of human genetic variations, are likely to have more deleterious impact on human diseases compared to common variants. Here we present carrier statistic, a statistical framework to prioritize disease-related rare variants by integrating gene expression data. By quantifying the impact of rare variants on gene expression, carrier statistic can prioritize those rare variants that have large functional consequence in the diseased patients. Through simulation studies and analyzing real multi-omics dataset, we demonstrated that carrier statistic is applicable in studies with limited sample size (a few hundreds) and achieves substantially higher sensitivity than existing rare variants association methods. Application to Alzheimer's disease reveals 16 rare variants within 15 genes with extreme carrier statistics. We also found strong excess of rare variants among the top prioritized genes in diseased patients compared to that in healthy individuals. The carrier statistic method can be applied to various rare variant types and is adaptable to other omics data modalities, offering a powerful tool for investigating the molecular mechanisms underlying complex diseases.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Guo, Hanmin, Urban, Alexander Eckehart, Wong, Wing Hung\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Resiliency to Alzheimer's disease neuropathology can be distinguished from dementia using cortical astrogliosis imaging.\n",
      "Abstract: Despite the presence of significant Alzheimer's disease (AD) pathology, characterized by amyloid β (Aβ) plaques and phosphorylated tau (pTau) tangles, some cognitively normal elderly individuals do not inevitably develop dementia. These findings give rise to the notion of cognitive 'resilience', suggesting maintained cognitive function despite the presence of AD neuropathology, highlighting the influence of factors beyond classical pathology. Cortical astroglial inflammation, a ubiquitous feature of symptomatic AD, shows a strong correlation with cognitive impairment severity, potentially contributing to the diversity of clinical presentations. However, noninvasively imaging neuroinflammation, particularly astrogliosis, using MRI remains a significant challenge. Here we sought to address this challenge and to leverage multidimensional (MD) MRI, a powerful approach that combines relaxation with diffusion MR contrasts, to map cortical astrogliosis in the human brain by accessing sub-voxel information. Our goal was to test whether MD-MRI can map astroglial pathology in the cerebral cortex, and if so, whether it can distinguish cognitive resiliency from dementia in the presence of hallmark AD neuropathological changes. We adopted a multimodal approach by integrating histological and MRI analyses using human postmortem brain samples. \n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Barsoum, Stephanie, Latimer, Caitlin S, Nolan, Amber L, Barrett, Alexander, Chang, Koping, Troncoso, Juan, Keene, C Dirk, Benjamini, Dan\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Single cell RNA sequencing reveals immunomodulatory mechanism of stem cell factor and granulocyte colony-stimulating factor treatment in the brains of aged APP/PS1 mice.\n",
      "Abstract: Alzheimer's disease (AD) leads to progressive neurodegeneration and dementia. AD primarily affects older adults with neuropathological changes including amyloid-beta (Aβ) deposition, neuroinflammation, and neurodegeneration. We have previously demonstrated that systemic treatment with stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF) (SCF+G-CSF), reduces Aβ load, increases Aβ uptake by activated microglia and monocytes/macrophages (Mo/Mac), reduces neuroinflammation, and restores dendrites and synapses in the brains of aged APPswe/PS1dE9 (APP/PS1) mice. However, the mechanisms underlying SCF+G-CSF-enhanced brain repair in aged APP/PS1 mice remain unclear. This study used a transcriptomic approach to explore the mechanisms by which SCF+G-CSF treatment alters the functions of microglia and Mo/Mac in the brains of 28-month-old APP/PS1 mice. After 5-day injections of SCF+G-CSF, single-cell RNA sequencing was performed on CD11b \n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Gardner, Robert S, Kyle, Michele, Hughes, Karen, Zhao, Li-Ru\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Disentangling associations between complex traits and cell types with \n",
      "Abstract: Integrating single-cell RNA sequencing (scRNA-seq) with Genome-Wide Association Studies (GWAS) can help reveal GWAS-associated cell types, furthering our understanding of the cell-type-specific biological processes underlying complex traits and disease. However, current methods have technical limitations that hinder them from making systematic, scalable, interpretable disease-cell-type associations. In order to rapidly and accurately pinpoint associations, we develop a novel framework, \n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Lai, Qiliang, Dannenfelser, Ruth, Roussarie, Jean-Pierre, Yao, Vicky\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Resveratrol in Neurodegeneration, in Neurodegenerative Diseases, and in the Redox Biology of the Mitochondria.\n",
      "Abstract: Neurodegeneration is a process leading to the progressive loss of structure and functions of neurons. Many neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease have shown many common points at the subcellular level. Neurons are metabolically active cells and need a high amount of energy. Mitochondria are known as the energy synthesis center for cells, involved in the synthesis of adenosine triphosphate by oxidative phosphorylation. Rather than just being an energy synthesis center, it has critical importance for many cellular functions such as calcium homeostasis, cell proliferation, cell growth, and apoptosis. In the process of mitochondrial dysfunction, cellular functions are disrupted and cells enter the apoptotic or necrotic pathway. Resveratrol (trans-3,5,4-trihydoxystilbene), a plant-derived polyphenol found in the seed of grapes, berries, peanuts, and wine, has many biological effects such as inhibition of lipid peroxidation, scavenging of free radicals, changes in eicosanoid synthesis, inhibition of platelet aggregation, anti-inflammatory and anticancer activity, and regulation of lipid metabolism. Through the reviewed literature, the current study investigated the protective role of resveratrol in neurodegenerative diseases. Studies show that resveratrol moderates mitochondrial function, redox status, and cellular dynamics in both \n",
      "Keywords: No keywords available\n",
      "Publication Year: 2023\n",
      "Authors: Danışman, Betül, Ercan Kelek, Sevim, Aslan, Mutay\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Modeling of age-related neurological disease: utility of zebrafish.\n",
      "Abstract: Many age-related neurological diseases still lack effective treatments, making their understanding a critical and urgent issue in the globally aging society. To overcome this challenge, an animal model that accurately mimics these diseases is essential. To date, many mouse models have been developed to induce age-related neurological diseases through genetic manipulation or drug administration. These models help in understanding disease mechanisms and finding potential therapeutic targets. However, some age-related neurological diseases cannot be fully replicated in human pathology due to the different aspects between humans and mice. Although zebrafish has recently come into focus as a promising model for studying aging, there are few genetic zebrafish models of the age-related neurological disease. This review compares the aging phenotypes of humans, mice, and zebrafish, and provides an overview of age-related neurological diseases that can be mimicked in mouse models and those that cannot. We presented the possibility that reproducing human cerebral small vessel diseases during aging might be difficult in mice, and zebrafish has potential to be another animal model of such diseases due to their similarity of aging phenotype to humans.\n",
      "Keywords: Alzheimer’s disease, aging, cerebral blood vessel, lifespan, memory, mouse, zebrafish\n",
      "Publication Year: 2024\n",
      "Authors: Kanoh, Tohgo, Mizoguchi, Takamasa, Tonoki, Ayako, Itoh, Motoyuki\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: A bibliometric analysis on the health behaviors related to mild cognitive impairment.\n",
      "Abstract: Mild cognitive impairment (MCI) is commonly defined as a transitional subclinical state between normal aging and dementia. A growing body of research indicates that health behaviors may play a protective role against cognitive decline and could potentially slow down the progression from MCI to dementia. The aim of this study is to conduct a bibliometric analysis of literature focusing on health behaviors and MCI to summarize the factors and evidence regarding the influence of health behaviors on MCI.\n",
      "Keywords: bibliometric analysis, cognitive impairment, exercise, health behavior, mild cognitive impairment\n",
      "Publication Year: 2024\n",
      "Authors: Xiao, Liping, Zhou, Chunyi, Zhang, Shibo, Wang, Yuncui\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Genetically predicted fatty liver disease and risk of psychiatric disorders: A mendelian randomization study.\n",
      "Abstract: Non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ArLD) constitute the primary forms of chronic liver disease, and their incidence is progressively increasing with changes in lifestyle habits. Earlier studies have documented a correlation between the occurrence and development of prevalent mental disorders and fatty liver.\n",
      "Keywords: Alcohol-related liver disease, Mendelian randomization, Non-alcoholic fatty liver disease, Psychiatric disorders, Single nucleotide polymorphisms\n",
      "Publication Year: 2024\n",
      "Authors: Xu, Wei-Ming, Zhang, Hai-Fu, Feng, Yong-Hang, Li, Shuo-Jun, Xie, Bi-Yun\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: EFhd2 co-aggregates with monomeric and filamentous tau \n",
      "Abstract: Tauopathies are characterized by the abnormal buildup of tau protein, with early oligomeric forms associated with neurodegeneration and the later neurofibrillary tangles possibly conferring neuroprotection. The molecular mechanisms governing the formation of these tau species are unclear. Lately, there has been an increased focus on examining the interactions between tau and other proteins, along with their influence on the aggregation of tau. Our previous work revealed EFhd2's association with pathological tau in animal models and tauopathy brains. Herein, we examined the impact of EFhd2 on monomeric and filamentous tau \n",
      "Keywords: Alzheimer’s disease, EFhd2, neurofibrillary tangles, protein aggregation, tau, tauopathies\n",
      "Publication Year: 2024\n",
      "Authors: Soliman, Ahlam S, Umstead, Andrew, Lamp, Jared, Vega, Irving E\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Data leakage in deep learning studies of translational EEG.\n",
      "Abstract: A growing number of studies apply deep neural networks (DNNs) to recordings of human electroencephalography (EEG) to identify a range of disorders. In many studies, EEG recordings are split into segments, and each segment is randomly assigned to the training or test set. As a consequence, data from individual subjects appears in both the training and the test set. Could high test-set accuracy reflect data leakage from subject-specific patterns in the data, rather than patterns that identify a disease? We address this question by testing the performance of DNN classifiers using segment-based holdout (in which segments from one subject can appear in both the training and test set), and comparing this to their performance using subject-based holdout (where all segments from one subject appear exclusively in either the training set or the test set). In two datasets (one classifying Alzheimer's disease, and the other classifying epileptic seizures), we find that performance on previously-unseen subjects is strongly overestimated when models are trained using segment-based holdout. Finally, we survey the literature and find that the majority of translational DNN-EEG studies use segment-based holdout. Most published DNN-EEG studies may dramatically overestimate their classification performance on new subjects.\n",
      "Keywords: Alzheimer's disease, cross-validation, data leakage, deep neural networks, electroencephalography, epilepsy\n",
      "Publication Year: 2024\n",
      "Authors: Brookshire, Geoffrey, Kasper, Jake, Blauch, Nicholas M, Wu, Yunan Charles, Glatt, Ryan, Merrill, David A, Gerrol, Spencer, Yoder, Keith J, Quirk, Colin, Lucero, Ché\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Oral Administration of \n",
      "Abstract: Probiotics are functional microorganisms that exhibit various biological activities, such as allergic reactions, inflammation, and aging. The aim of this study is to evaluate the effects of \n",
      "Keywords: Alzheimer’s disease, Bifidobacterium lactis, cognitive deficits, probiotics\n",
      "Publication Year: 2024\n",
      "Authors: Choi, Jong Kyu, Kwon, Oh Yun, Lee, Seung Ho\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Subjective hearing loss is not associated with an increased risk of Alzheimer's disease dementia.\n",
      "Abstract: Hearing loss is a risk-factor for dementia but the reasons for this are unclear. Subjective hearing loss is related to increased future dementia risk, however, this metric has not been previously examined with cognitive, neuroimaging and biochemical measures that are relevant to Alzheimer's disease. We assessed Cognitively Normal and Mild Cognitively Impaired participants from the Alzheimer's Disease Neuroimaging Initiative with subjective hearing loss to examine if they had faster decline in episodic memory scores, hippocampal volume and greater pTau positivity. The likelihood of a dementia diagnosis in hearing impaired participants over a 5-year period was also assessed. There were no statistically significant differences between the hearing subgroups over a 5-year period nor were there in conversions to a dementia diagnosis. Objective hearing loss metrics may provide a more reliable link between hearing loss and dementia risk.\n",
      "Keywords: Alzheimer's disease, Cognition, Dementia, Hearing loss, Neuroimaging\n",
      "Publication Year: 2024\n",
      "Authors: Lad, Meher, Taylor, John-Paul, Griffiths, Tim D\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Biomarkers of Neurodegeneration and Alzheimer's Disease Neuropathology in Adolescents and Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: A Proof-of-Concept Study.\n",
      "Abstract: Adult-onset diabetes increases one's risk of neurodegenerative disease including Alzheimer's disease (AD); however, the risk associated with youth-onset diabetes (Y-DM) remains underexplored. We quantified plasma biomarkers of neurodegeneration and AD in participants with Y-DM from the SEARCH cohort at adolescence and young adulthood (Type 1, n = 25; Type 2, n = 25; 59% female; adolescence, age = 15 y/o [2.6]; adulthood, age = 27.4 y/o [2.2]), comparing them with controls (adolescence, n = 25, age = 14.8 y/o [2.7]; adulthood, n = 21, age = 24.9 y/o [2.8]). Plasma biomarkers, including glial fibrillary acidic protein (GFAP), neurofilament light chain protein (NfL), phosphorylated tau-181 (pTau181), and amyloid beta (Aβ40, Aβ42), were measured via Simoa. A subset of participants (n = 7; age = 27.5 y/o [5.7]) and six controls (age = 25.1 y/o [4.5]) underwent PET scans to quantify brain amyloid and tau densities in AD sensitive brain regions. Y-DM adolescents exhibited lower plasma levels of Aβ40, Aβ42, and GFAP, and higher pTau181 compared to controls (\n",
      "Keywords: Alzheimer’s disease, amyloid, neurodegeneration, plasma biomarkers, tau, youth-onset diabetes\n",
      "Publication Year: 2024\n",
      "Authors: Shapiro, Allison L B, Coughlan, Christina, Bettcher, Brianne M, Pauley, Meghan E, Kim, Jeongchul, Bjornstad, Petter, Rajic, Benjamin, Truong, Jennifer, Bell, Christopher, Choi, Ye Ji, Walker, Keenan A, Potter, Huntington, Liese, Angela D, Dabelea, Dana, Whitlow, Christopher T\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: A pathway linking pulse pressure to dementia in adults with Down syndrome.\n",
      "Abstract: Adults with Down syndrome are less likely to have hypertension than neurotypical adults. However, whether blood pressure measures are associated with brain health and clinical outcomes in this population has not been studied in detail. Here, we assessed whether pulse pressure is associated with markers of cerebrovascular disease and is linked to a diagnosis of dementia in adults with Down syndrome via structural imaging markers of cerebrovascular disease and atrophy. The study included participants with Down syndrome from the Alzheimer's Disease - Down Syndrome study (\n",
      "Keywords: Alzheimer’s disease, Down syndrome, aging, pulse pressure, white matter hyperintensities\n",
      "Publication Year: 2024\n",
      "Authors: Rizvi, Batool, Lao, Patrick J, Sathishkumar, Mithra, Taylor, Lisa, Queder, Nazek, McMillan, Liv, Edwards, Natalie C, Keator, David B, Doran, Eric, Hom, Christy, Nguyen, Dana, Rosas, H Diana, Lai, Florence, Schupf, Nicole, Gutierrez, Jose, Silverman, Wayne, Lott, Ira T, Mapstone, Mark, Wilcock, Donna M, Head, Elizabeth, Yassa, Michael A, Brickman, Adam M\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: ADME/PK Insights of Crocetin: A Molecule Having an Unusual Chemical Structure with Druglike Features.\n",
      "Abstract: Crocetin is a promising phyto-based molecule to treat Alzheimer's disease (AD). The chemical structure of crocetin is incongruent with various standard structural features of CNS drugs. As poor pharmacokinetic behavior is the major hurdle for any candidate to become a drug, we elucidated its druggable characteristics by implementing in silico, in vitro, and in vivo approaches, as limited ADME/PK information is available. Results demonstrate several attributes of crocetin based on rules of drug-likeness, lipophilicity, p\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Manhas, Diksha, Dhiman, Sumit, Kour, Harpreet, Kour, Dilpreet, Sharma, Kuhu, Wazir, Priya, Vij, Bhavna, Kumar, Ajay, Sawant, Sanghapal D, Ahmed, Zabeer, Nandi, Utpal\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Sleep functional connectivity, hyperexcitability, and cognition in Alzheimer's disease.\n",
      "Abstract: Sleep disturbances are common in Alzheimer's disease (AD) and may reflect pathologic changes in brain networks. To date, no studies have examined changes in sleep functional connectivity (FC) in AD or their relationship with network hyperexcitability and cognition.\n",
      "Keywords: biomarkers, electrophysiology, neurodegeneration, sleep physiology\n",
      "Publication Year: 2024\n",
      "Authors: Moguilner, Sebastian G, Berezuk, Courtney, Bender, Alex C, Pellerin, Kyle R, Gomperts, Stephen N, Cash, Sydney S, Sarkis, Rani A, Lam, Alice D\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Alzheimer's disease early screening and staged detection with plasma proteome using machine learning and convolutional neural network.\n",
      "Abstract: Alzheimer's disease (AD) stands as the prevalent progressive neurodegenerative disease, precipitating cognitive impairment and even memory loss. Amyloid biomarkers have been extensively used in the diagnosis of AD. However, amyloid proteins offer limited information about the disease process and accurate diagnosis depends on the presence of a substantial accumulation of amyloid deposition which significantly impedes the early screening of AD. In this study, we have combined plasma proteomics with an ensemble learning model (CatBoost) to develop a cost-effective and non-invasive diagnostic method for AD. A longitudinal panel has been identified that can serve as reliable biomarkers across the entire progression of AD. Simultaneously, we have developed a neural network algorithm that utilizes plasma proteins to detect stages of Alzheimer's disease. Based on the developed longitudinal panel, the CatBoost model achieved an area under the operating curve of at least 0.90 in distinguishing mild cognitive impairment from cognitively normal. The neural network model was utilized for the detection of three stages of AD, and the results demonstrated that the neural network model exhibited an accuracy as high as 0.83, surpassing that of the traditional machine learning model.\n",
      "Keywords: Alzheimer's disease, early screening, longitudinal panel, neural network, plasma proteomics\n",
      "Publication Year: 2024\n",
      "Authors: Qin, Hengyu, Shi, Xiumin, Zhu, Yibo, Ma, Jiacheng, Deng, Xiaohong, Wang, Lu\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Clinical observation on treatment of Alzheimer's disease with Sun's scalp-abdominal acupuncture combined with donepezil hydrochloride.\n",
      "Abstract: To observe the effect of scalp-abdominal acupuncture combined with donepezil hydrochloride on cognition and life ability of patients with Alzheimer's disease (AD), so as to evaluate its clinical efficacy.\n",
      "Keywords: Abdominal acupuncture, Alzheimer’s disease, Electroacupuncture, Scalp acupuncture\n",
      "Publication Year: 2024\n",
      "Authors: Zhang, Si-Qi, Ma, Shuai, Yang, Tian-Song, Zhang, Miao\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials.\n",
      "Abstract: Recent randomized controlled trials (RCTs) have shown a benefit of brexpiprazole in managing agitation in patients with Alzheimer's disease (AD). However, its efficacy and safety remain unclear. We systematically searched PubMed, Embase, and Cochrane Library for RCTs comparing brexpiprazole with placebo in patients with agitation and AD. Three studies comprising 1,048 patients were included. In patients with agitation and AD, brexpiprazole significantly improved the Cohen-Mansfield Agitation Inventory total score (CMAI) at any dose (MD -3.05; 95% CI -5.12, -0.98; p < 0.01; I\n",
      "Keywords: Alzheimer’s disease, Antipsychotic, Brexpiprazole, Dementia, Meta-analysis\n",
      "Publication Year: 2024\n",
      "Authors: Marinheiro, Gabriel, Dantas, Julyana Medeiros, Mutarelli, Antonio, Menegaz de Almeida, Artur, Monteiro, Gabriel de Almeida, Zerlotto, Djinane Spinosa, Telles, João Paulo Mota\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Parvalbumin interneuron cell-to-network plasticity: mechanisms and therapeutic avenues.\n",
      "Abstract: Alzheimer's disease (AD) and schizophrenia (SCZ) represent two major neuropathological conditions with a high disease burden. Despite their distinct etiologies, patients suffering from AD or SCZ share a common burden of disrupted memory functions unattended by current therapies. Recent preclinical analyses highlight cell-type-specific contributions of parvalbumin interneurons (PVIs), particularly the plasticity of their cellular excitability, towards intact neuronal network function (cell-to-network plasticity) and memory performance. Here we argue that deficits of PVI cell-to-network plasticity may underlie memory deficits in AD and SCZ, and we explore two therapeutic avenues: the targeting of PVI-specific neuromodulation, including by neuropeptides, and the recruitment of network synchrony in the gamma frequency range (40 Hz) by external stimulation. We finally propose that these approaches be merged under consideration of recent insights into human brain physiology.\n",
      "Keywords: Alzheimer's disease, gamma oscillations, memory, neuronal plasticity, parvalbumin interneurons, schizophrenia\n",
      "Publication Year: 2024\n",
      "Authors: Hadler, Michael D, Alle, Henrik, Geiger, Jörg R P\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Specific Association of Worry With Amyloid-β But Not Tau in Cognitively Unimpaired Older Adults.\n",
      "Abstract: Anxiety disorders and subsyndromal anxiety symptoms are highly prevalent in late life. Recent studies support that anxiety may be a neuropsychiatric symptom during preclinical Alzheimer's disease (AD) and that higher anxiety is associated with more rapid cognitive decline and progression to cognitive impairment. However, the associations of specific anxiety symptoms with AD pathologies and with co-occurring subjective and objective cognitive changes have not yet been established.\n",
      "Keywords: Anxiety, amyloid-β, preclinical Alzheimer's disease, tau, worry\n",
      "Publication Year: 2024\n",
      "Authors: Lee, Soyoung, Zide, Benjamin S, Palm, Stephan T, Drew, William J, Sperling, Reisa A, Jacobs, Heidi I L, Siddiqi, Shan H, Donovan, Nancy J\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: The Sixth Sense: Self-nucleic acid sensing in the brain.\n",
      "Abstract: Our innate immune system uses pattern recognition receptors (PRRs) as a first line of defense to detect microbial ligands and initiate an immune response. Viral nucleic acids are key ligands for the activation of many PRRs and the induction of downstream inflammatory and antiviral effects. Initially it was thought that endogenous (self) nucleic acids rarely activated these PRRs, however emerging evidence indicates that endogenous nucleic acids are able to activate host PRRs in homeostasis and disease. In fact, many regulatory mechanisms are in place to finely control and regulate sensing of self-nucleic acids by PRRs. Sensing of self-nucleic acids is particularly important in the brain, as perturbations to nucleic acid sensing commonly leads to neuropathology. This review will highlight the role of nucleic acid sensors in the brain, both in disease and homeostasis. We also indicate the source of endogenous stimulatory nucleic acids where known and summarize future directions for the study of this growing field.\n",
      "Keywords: Brain, DNA sensing PRRs: cGAS, AIM2, TLR9, Neurodegeneration: Aicardi-Goutieres syndrome (AGS), Alzheimer's disease, Amyotrophic lateral sclerosis, Stroke, Traumatic brain injury, Neurodevelopment, Neuroinflammation, Nuecleic acid immunity, Pattern recognition receptors (PRRs), RNA sensing PRRs: MDA5, RIG-I, PKR, TLR3, TLR7/8\n",
      "Publication Year: 2024\n",
      "Authors: Dorrity, Tyler J, Shin, Heegwon, Gertie, Jake A, Chung, Hachung\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: The regulation of BAI1 in astrocytes through the STAT3/EZH2 axis relieves neuronal apoptosis in rats with Alzheimer's disease.\n",
      "Abstract: Alzheimer's disease (AD) is a common neurodegenerative disease. Previous studies have identified the critical role of astrocytes in the progression of AD. The focus of this study revolves around clarifying the regulatory mechanism of the STAT3/EZH2/BAI1 axis in astrocytes in AD. We successfully developed a rat model of AD, and measured the learning and cognitive ability of the rats by Morris water maze experiment. HE and Nissl's staining were used for histomorphological identification of the rat hippocampus. Meanwhile, immunofluorescence and immunohistochemistry were used to detect astrocyte activation and brain-specific angiogenesis inhibitor-1 (BAI1) expression in rat hippocampal tissue, respectively. The role of STAT3/EZH2/BAI1 regulating axis in astrocyte activation and neuronal cell apoptosis was verified by establishing the co-culture system of astrocytes and nerve cells in vitro. Western Blot (WB) was used to detect the expression of associated proteins, and enzyme-linked immunosorbent assay (ELISA) was used to detect astrocyte neurotrophic factor secretion. Hochest/PI staining and flow cytometry were used to observe neuronal apoptosis. Compared with the sham group, AD rats showed significantly decreased cognitive and learning abilities, noticeable hippocampal tissue damage, and significantly low levels of BAI1 expression. In in vitro models, BAI1 was found to inhibit astrocyte activation and enhance the secretion of neurotrophins, resulting in decrease of neurone apoptosis. The regulation of BAI1 by the STAT3/EZH2 axis was shown to affect astrocyte activation and neuronal cell apoptosis. In conclusion, this study represents the pioneering discovery that regulated by the STAT3/EZH2 axis, BAI1 suppresses astrocyte activation, thus reducing neuronal apoptosis.\n",
      "Keywords: Alzheimer’s disease, BAI1, Neurone apoptosis, STAT3/EZH2\n",
      "Publication Year: 2024\n",
      "Authors: Zhou, Qiong, Xu, Linsheng\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice.\n",
      "Abstract: Aggregation and misfolding of amyloid beta (Aβ) and tau proteins, suggested to arise from post-translational modification processes, are thought to be the main cause of Alzheimer's disease (AD). Additionally, a plethora of evidence exists that links metabolic dysfunctions such as obesity, type 2 diabetes (T2D), and dyslipidemia to the pathogenesis of AD. We thus investigated the combinatory effect of T2D and human glutaminyl cyclase activity (pyroglutamylation), on the pathology of AD and whether astaxanthin (ASX) treatment ameliorates accompanying pathophysiological manifestations.\n",
      "Keywords: Alzheimer’s disease, astaxanthin, metabolic perturbation, pyroglutamylation, type 2 diabetes\n",
      "Publication Year: 2024\n",
      "Authors: Babalola, Joshua Adekunle, Stracke, Anika, Loeffler, Tina, Schilcher, Irene, Spyridon, Sideromenos, Flunkert, Stefanie, Neddens, Joerg, Lignell, Ake, Prokesch, Manuela, Pazenboeck, Ute, Strobl, Herbert, Tadic, Jelena, Leitinger, Gerd, Lass, Achim, Hutter-Paier, Birgit, Hoefler, Gerald\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Classical and non-classical effects of angiotensin converting enzyme: how increased ACE enhances myeloid immune function.\n",
      "Abstract: As part of the classical renin-angiotensin system, the peptidase angiotensin converting enzyme (ACE) makes angiotensin II which has myriad effects on systemic cardiovascular function, inflammation, and cellular proliferation. Less well known is that macrophages and neutrophils make ACE in response to immune activation which has marked effects on myeloid cell function independent of angiotensin II. Here, we discuss both classical (angiotensin) and non-classical functions of ACE and highlight mice called ACE 10/10 in which genetic manipulation increases ACE expression by macrophages and makes these mice much more resistant to models of tumors, infection, atherosclerosis, and Alzheimer's disease. In another model called NeuACE mice, neutrophils make increased ACE and these mice are much more resistant to infection. In contrast, ACE inhibitors reduce neutrophil killing of bacteria in mice and humans. Increased expression of ACE induces a marked increase in macrophage oxidative metabolism, particularly mitochondrial oxidation of lipids, secondary to increased PPARα expression, and results in increased myeloid cell ATP. ACE present in sperm has a similar metabolic effect and the lack of ACE activity in these cells reduces both sperm motility and fertilization capacity. These non-classical effects of ACE are not due to the actions of angiotensin II but to an unknown molecule, probably a peptide, that triggers a profound change in myeloid cell metabolism and function. Purifying and characterizing this peptide could offer a new treatment for several diseases and prove potentially lucrative.\n",
      "Keywords: Alzheimer’s disease, angiotensin II, angiotensin converting enzyme, atherosclerosis, cancer, immunology, infectious disease, macrophage, neutrophil\n",
      "Publication Year: 2024\n",
      "Authors: Bernstein, Kenneth E, Cao, DuoYao, Shibata, Tomohiro, Saito, Suguru, Bernstein, Ellen A, Nishi, Erika, Yamashita, Michifumi, Tourtellotte, Warren G, Zhao, Tuantuan V, Khan, Zakir\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Edaravone Dexborneol ameliorates the cognitive deficits of APP/PS1 mice by inhibiting TLR4/MAPK signaling pathway via upregulating TREM2.\n",
      "Abstract: Currently, there are no effective therapeutic agents available to treat Alzheimer's disease (AD). However, edaravone dexborneol (EDB), a novel composite agent used to treat acute ischemic stroke, has recently been shown to exert efficacious neuroprotective effects. However, whether EDB can ameliorate cognitive deficits in AD currently remains unclear. To this end, we explored the effects of EDB on AD and its potential mechanisms using an AD animal model (male APP/PS1 mice) treated with EDB for 10 weeks starting at 6 months of age. Subsequent analyses revealed that EDB-treated APP/PS1 mice exhibited improved cognitive abilities compared to untreated APP/PS1 mice. Administration of EDB in APP/PS1 mice further alleviated neuropathological alterations of the hippocampus, including Aβ deposition, pyramidal cell karyopyknosis, and oxidative damage, and significantly decreased the levels of inflammatory cytokines (IL-1β, IL-6 and TNF-α) and COX-2 in the hippocampus of APP/PS1 mice. Transcriptome sequencing analysis demonstrated the critical role of the inflammatory reaction in EDB treatment in APP/PS1 mice, indicating that the alleviation of the inflammatory reaction by EDB in the hippocampus of APP/PS1 mice was linked to the action of the TREM2/TLR4/MAPK signaling pathway. Further in vitro investigations showed that EDB suppressed neuroinflammation in LPS-stimulated BV2 cells by inhibiting the TLR4/MAPK signaling pathway and upregulating TREM2 expression. Thus, the findings of the present study demonstrate that EDB is a promising therapeutic agent for AD-related cognitive dysfunction.\n",
      "Keywords: Alzheimer's disease, Cognitive deficits, Edaravone dexborneol, Neuroinflammation, TLR4/MAPK signaling pathway, TREM2\n",
      "Publication Year: 2024\n",
      "Authors: Wang, Jinyang, Du, Longyuan, Zhang, Tianyun, Chu, Yun, Wang, Yue, Wang, Yu, Ji, Xiaoming, Kang, Yunxiao, Cui, Rui, Zhang, Guoliang, Liu, Junyan, Shi, Geming\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Isoform-specific effects of neuronal inhibition of AMPK catalytic subunit on LTD impairments in a mouse model of Alzheimer's disease.\n",
      "Abstract: Synaptic dysfunction is highly correlated with cognitive impairments in Alzheimer's disease (AD), the most common dementia syndrome in the elderly. Long-term potentiation (LTP) and long-term depression (LTD) are two primary forms of synaptic plasticity with opposite direction of synaptic efficiency change. Both LTD and LTD are considered to mediate the cellular process of learning and memory. Substantial studies demonstrate AD-associated deficiency of both LTP and LTD. Meanwhile, the molecular signaling mechanisms underlying impairment of synaptic plasticity, particularly LTD, are poorly understood. By taking advantage of the novel transgenic mouse models recently developed in our lab, here we aimed to investigate the roles of AMP-activated protein kinase (AMPK), a central molecular senor that plays a critical role in maintaining cellular energy homeostasis, in regulation of LTD phenotypes in AD. We found that brain-specific suppression of the AMPKα1 isoform (but not AMPKα2 isoform) was able to alleviate mGluR-LTD deficits in APP/PS1 AD mouse model. Moreover, suppression of either AMPKα isoform failed to alleviate AD-related NMDAR-dependent LTD deficits. Taken together with our recent studies on roles of AMPK signaling in AD pathophysiology, the data indicate isoform-specific roles of AMPK in mediating AD-associated synaptic and cognitive impairments.\n",
      "Keywords: AMPK, Alzheimer’s disease, Energy metabolism, LTD, Synaptic plasticity\n",
      "Publication Year: 2024\n",
      "Authors: Yang, Qian, Zhou, Xueyan, Ma, Tao\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Comparative analysis of machine learning algorithms for Alzheimer's disease classification using EEG signals and genetic information.\n",
      "Abstract: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory impairments, and behavioral changes. The presence of abnormal beta-amyloid plaques and tau protein tangles in the brain is known to be associated with AD. However, current limitations of imaging technology hinder the direct detection of these substances. Consequently, researchers are exploring alternative approaches, such as indirect assessments involving monitoring brain signals, cognitive decline levels, and blood biomarkers. Recent studies have highlighted the potential of integrating genetic information into these approaches to enhance early detection and diagnosis, offering a more comprehensive understanding of AD pathology beyond the constraints of existing imaging methods. Our study utilized electroencephalography (EEG) signals, genotypes, and polygenic risk scores (PRSs) as features for machine learning models. We compared the performance of gradient boosting (XGB), random forest (RF), and support vector machine (SVM) to determine the optimal model. Statistical analysis revealed significant correlations between EEG signals and clinical manifestations, demonstrating the ability to distinguish the complexity of AD from other diseases by using genetic information. By integrating EEG with genetic data in an SVM model, we achieved exceptional classification performance, with an accuracy of 0.920 and an area under the curve of 0.916. This study presents a novel approach of utilizing real-time EEG data and genetic background information for multimodal machine learning. The experimental results validate the effectiveness of this concept, providing deeper insights into the actual condition of patients with AD and overcoming the limitations associated with single-oriented data.\n",
      "Keywords: Alzheimer's disease, Electroencephalography, Genome-wide association study, Machine learning, Polygenic risk score\n",
      "Publication Year: 2024\n",
      "Authors: Yu, Wei-Yang, Sun, Ting-Hsuan, Hsu, Kai-Cheng, Wang, Chia-Chun, Chien, Shang-Yu, Tsai, Chon-Haw, Yang, Yu-Wan\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Graphene acid quantum dots: A highly active multifunctional carbon nano material that intervene in the trajectory towards neurodegeneration.\n",
      "Abstract: Carbon dots (CDs) are carbon nano materials (CNMs) that find use across several biological applications because of their water solubility, biocompatible nature, eco-friendliness, and ease of synthesis. Additionally, their physiochemical properties can be chemically tuned for further optimization towards specific applications. Here, we investigate the efficacy of C70-derived Graphene Acid Quantum Dots (GAQDs) in mitigating the transformation of soluble, monomeric Hen Egg-White Lysozyme (HEWL) to mature fibrils during its amyloidogenic trajectory. Our findings reveal that GAQDs exhibit dose-dependent inhibition of HEWL fibril formation (up to 70 % at 5 mg/mL) without affecting mitochondrial membrane potential or inducing apoptosis at the same density. Furthermore, GAQDs scavenged reactive oxygen species (ROS); achieving a 50 % reduction in ROS levels at a mere 100 µg/mL when exposed to a standard free radical generator. GAQDs were not only found to be biocompatible with a human neuroblastoma-derived SHSY-5Y cell line but also rescued the cells from rotenone-induced apoptosis. The GAQD-tolerance of SHSY-5Y cells coupled with their ability to restitute cells from rotenone-dependent apoptosis, when taken in conjunction with the biocompatibility data, indicate that GAQDs possess neuroprotective potential. The data position this class of CNMs as promising candidates for resolving aberrant cellular outputs that associate with the advent and progress of multifactorial neurodegenerative disorders including Parkinson's (PD) and Alzheimer's diseases (AD) wherein environmental causes are implicated (95 % etiology). The data suggest that GAQDs are a multifunctional carbon-based sustainable nano-platform at the intersection of nanotechnology and neuroprotection for advancing green chemistry-derived, sustainable healthcare solutions.\n",
      "Keywords: Amyloid fibrils, Biological imaging, Carbon nanomaterials, Graphene acid quantum dots, Parkinson’s disease, Reactive oxygen species\n",
      "Publication Year: 2024\n",
      "Authors: ElMorsy, Sherin M, Gutierrez, Denisse A, Valdez, Salvador, Kumar, Jyotish, Aguilera, Renato J, Noufal, Mohamed, Sarma, Hemen, Chinnam, Sampath, Narayan, Mahesh\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Trilobatin suppresses aging-induced cognitive impairment by targeting SIRT2: Involvement of remodeling gut microbiota to mediate the brain-gut axis.\n",
      "Abstract: Aging is associated with learning and memory disorder, affecting multiple brain areas, especially the hippocampus. Previous studies have demonstrated trilobatin (TLB), as a natural food additive, can extend the life of Caenorhabditis elegans and exhibit neuroprotection in Alzheimer's disease mice. However, the possible significance of TLB in anti-aging remains elusive.\n",
      "Keywords: Aging, Blood-brain barrier, Gut microbiota, Intestinal barrier, Sirtuin 2, Trilobatin\n",
      "Publication Year: 2024\n",
      "Authors: Xie, Dian-You, Lin, Mu, Luo, Yun-Mei, Dong, Lan, Wei, Yu, Gao, Jian-Mei, Zhu, Yi Zhun, Gong, Qi-Hai\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: PRG ameliorates cognitive impairment in Alzheimer's disease mice by regulating β-amyloid and targeting the ERK pathway.\n",
      "Abstract: PRG is derived from Phellinus ribis and is a homogeneous polysaccharide with well-defined structural information. PRG was found to have significant in vitro neurotrophic and neuroprotective activities. Thus, PRG might be a potential treatment for Alzheimer's disease. However, the related mechanisms of action are still unclear, so deeper in vivo experimental validation and the potential mechanisms need to be investigated.\n",
      "Keywords: Alzheimer's disease, Aβ1–42, Neuronutrition, PRG, Phellinus ribis, SAMP8 mice\n",
      "Publication Year: 2024\n",
      "Authors: Zhang, Zhiyuan, Wu, Haoran, Wang, Shuai, Li, Yuanyuan, Yang, Pei, Xu, Lingchuan, Liu, Yuhong, Liu, Maoxuan\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Diaminocyclopentane - l-Lysine Adducts: Potent and selective inhibitors of human O-GlcNAcase.\n",
      "Abstract: A new class of compounds, namely highly substituted diaminocyclopentane-l-lysine adducts, have been discovered as potent inhibitors of O-GlcNAcase, an enzyme crucial for protein de-O-glycosylation. These inhibitors exhibit exceptional selectivity and reversibility and are the first example of human O-GlcNAcase inhibitors that are structurally related to the transition state of the rate-limiting step with the \"aglycon\" still in bond-length proximity. The ease of their preparation, remarkable biological activities, stability, and non-toxicity make them promising candidates for the development of anti-tau-phosphorylation agents holding significant potential for the treatment of Alzheimer's disease.\n",
      "Keywords: Alzheimer’s disease, Diaminocyclopentane, Glycosidase, Hexosaminidase, Inhibition, O-GlcNAcase, Tau protein\n",
      "Publication Year: 2024\n",
      "Authors: Weber, Patrick, Bojarová, Pavla, Brouzdová, Jitka, Křen, Vladimír, Kulik, Natalia, Stütz, Arnold E, Thonhofer, Martin, Wrodnigg, Tanja M\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Periodontopathogen-Related Cell Autophagy-A Double-Edged Sword.\n",
      "Abstract: The periodontium is a highly organized ecosystem, and the imbalance between oral microorganisms and host defense leads to periodontal diseases. The periodontal pathogens, mainly Gram-negative anaerobic bacteria, colonize the periodontal niches or enter the blood circulation, resulting in periodontal tissue destruction and distal organ damage. This phenomenon links periodontitis with various systemic conditions, including cardiovascular diseases, malignant tumors, steatohepatitis, and Alzheimer's disease. Autophagy is an evolutionarily conserved cellular self-degradation process essential for eliminating internalized pathogens. Nowadays, increasing studies have been carried out in cells derived from periodontal tissues, immune system, and distant organs to investigate the relationship between periodontal pathogen infection and autophagy-related activities. On one hand, as a vital part of innate and adaptive immunity, autophagy actively participates in host resistance to periodontal bacterial infection. On the other, certain periodontal pathogens exploit autophagic vesicles or pathways to evade immune surveillance, therefore achieving survival within host cells. This review provides an overview of the autophagy process and focuses on periodontopathogen-related autophagy and their involvements in cells of different tissue origins, so as to comprehensively understand the role of autophagy in the occurrence and development of periodontal diseases and various periodontitis-associated systemic illnesses.\n",
      "Keywords: Porphyromonas gingivalis., autophagic cell death, autophagy, periodontal pathogen, periodontitis, systemic diseases\n",
      "Publication Year: 2024\n",
      "Authors: Ma, Li, Cao, Zhengguo\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly.\n",
      "Abstract: Alzheimer's disease (AD) is characterized by the accumulation of amyloid-β (Aβ) plaques, neurofibrillary tau tangles, and neurodegeneration in the brain parenchyma. Here, we aimed to (i) assess differences in blood and imaging biomarkers used to evaluate neurodegeneration among cognitively unimpaired APOE ε4 homozygotes, heterozygotes, and non-carriers with varying risk for sporadic AD, and (ii) to determine how different cerebral pathologies (i.e., Aβ deposition, medial temporal atrophy, and cerebrovascular pathology) contribute to blood biomarker concentrations in this sample.\n",
      "Keywords: Alzheimer’s disease, Blood biomarkers, PET imaging\n",
      "Publication Year: 2024\n",
      "Authors: Koivumäki, Mikko, Ekblad, Laura, Lantero-Rodriguez, Juan, Ashton, Nicholas J, Karikari, Thomas K, Helin, Semi, Parkkola, Riitta, Lötjönen, Jyrki, Zetterberg, Henrik, Blennow, Kaj, Rinne, Juha O, Snellman, Anniina\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Oral administration of coenzyme Q10 ameliorates memory impairment induced by nicotine-ethanol abstinence through restoration of biochemical changes in male rat hippocampal tissues.\n",
      "Abstract: Substance abuse among adolescents has become a growing issue throughout the world. The significance of research on this life period is based on the occurrence of neurobiological changes in adolescent brain which makes the individual more susceptible for risk-taking and impulsive behaviors. Alcohol and nicotine are among the most available drugs of abuse in adolescents. Prolonged consumption of nicotine and alcohol leads to drug dependence and withdrawal which induce various dysfunctions such as memory loss. Coenzyme Q10 (CoQ\n",
      "Keywords: Abstinence, Adolescence, Coenzyme Q10, Ethanol, Memory, Nicotine\n",
      "Publication Year: 2024\n",
      "Authors: Ahmadi-Soleimani, S Mohammad, Ghasemi, Seyedalireza, Rahmani, Mohamad Amin, Gharaei, Moein, Mohammadi Bezanaj, Maryam, Beheshti, Farimah\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: The impact of incident stroke on cognitive trajectories in later life.\n",
      "Abstract: Cognitive impairment is common after stroke, and a large proportion of stroke patients will develop dementia. However, there have been few large prospective studies which have assessed cognition both prior to and after stroke. This study aims to determine the extent to which incident stroke impacts different domains of cognitive function in a longitudinal cohort of older community-dwelling individuals.\n",
      "Keywords: Cognitive domains, Cognitive function, Dementia, Linear mixed model, Stroke, Trajectories\n",
      "Publication Year: 2024\n",
      "Authors: Vishwanath, Swarna, Hopper, Ingrid, Cloud, Geoffrey C, Chong, Trevor T-J, Shah, Raj C, Donnan, Geoffrey A, Williamson, Jeff D, Eaton, Charles B, Wolfe, Rory, Reid, Christopher M, Tonkin, Andrew M, Orchard, Suzanne G, Fitzgerald, Sharyn, Murray, Anne M, Woods, Robyn L, Nelson, Mark R, Sood, Ajay, Steves, Claire J, Ryan, Joanne\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Appendicular lean mass and the risk of stroke and Alzheimer's disease: a mendelian randomization study.\n",
      "Abstract: Appendicular lean mass (ALM) is a good predictive biomarker for sarcopenia. And previous studies have reported the association between ALM and stroke or Alzheimer's disease (AD), however, the causal relationship is still unclear, The purpose of this study was to evaluate whether genetically predicted ALM is causally associated with the risk of stroke and AD by performing Mendelian randomization (MR) analyses.\n",
      "Keywords: Alzheimer’s disease, Appendicular lean mass, Mendelian randomization, Sarcopenia, Stroke\n",
      "Publication Year: 2024\n",
      "Authors: Zhu, Yueli, Zhu, Feng, Guo, Xiaoming, Huang, Shunmei, Yang, Yunmei, Zhang, Qin\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Tear biomarkers.\n",
      "Abstract: An extensive exploration of lacrimal fluid molecular biomarkers in understanding and diagnosing a spectrum of ocular and systemic diseases is presented. The chapter provides an overview of lacrimal fluid composition, elucidating the roles of proteins, lipids, metabolites, and nucleic acids within the tear film. Pooled versus single-tear analysis is discussed to underline the benefits and challenges associated with both approaches, offering insights into optimal strategies for tear sample analysis. Subsequently, an in-depth analysis of tear collection methods is presented, with a focus on Schirmer's test strips and microcapillary tubes methods. Alternative tear collection techniques are also explored, shedding light on their applicability and advantages. Variability factors, including age, sex, and diurnal fluctuations, are examined in the context of their impact on tear biomarker analysis. The main body of the chapter is dedicated to discussing specific biomarkers associated with ocular discomfort and a wide array of ocular diseases. From dry eye disease and thyroid-associated ophthalmopathy to keratoconus, age-related macular degeneration, diabetic retinopathy, and glaucoma, the intricate relationship between molecular biomarkers and these conditions is thoroughly dissected. Expanding beyond ocular pathologies, the chapter explores the applicability of tear biomarkers in diagnosing systemic diseases such as multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, and cancer. This broader perspective underscores the potential of lacrimal fluid analysis in offering non-invasive diagnostic tools for conditions with far-reaching implications.\n",
      "Keywords: Disease-specific markers, Ocular surface diseases, Omic analysis, Tear composition, Tear film stability\n",
      "Publication Year: 2024\n",
      "Authors: Ponzini, Erika\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Geniposide effectively safeguards HT22 cells against Aβ-induced damage by activating mitophagy via the PINK1/Parkin signaling pathway.\n",
      "Abstract: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the significant involvement of amyloid-beta (Aβ) peptide in its pathogenesis. Geniposide, derived from the versatile medicinal of Gardenia jasminoides, is one of the active compounds studied extensively. The objective was to explore the impact of geniposide on Aβ\n",
      "Keywords: Alzheimer’s disease, Geniposide, Mitophagy, PINK1/Parkin pathway\n",
      "Publication Year: 2024\n",
      "Authors: Xi Ye, Jia, Ying Wu, Jia, Ai, Liang, Zhu, Min, Li, Yun, Yin, Dong, Huang, Qihui\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Aging, sex, metabolic and life experience factors: contributions to neuro-inflammaging in Alzheimer's disease research.\n",
      "Abstract: Alzheimer's disease (AD) is prevalent around the world, yet our understanding of the disease is still very limited. Recent work suggests that the cornerstone of AD may include the inflammation that accompanies it. Failure of a normal pro-inflammatory immune response to resolve may lead to persistent central inflammation that contributes to unsuccessful clearance of amyloid-beta plaques as they form, neuronal death, and ultimately cognitive decline. Individual metabolic, and dietary (lipid) profiles can differentially regulate this inflammatory process with aging, obesity, poor diet, early life stress and other inflammatory factors contributing to a greater risk of developing AD. Here, we integrate evidence for the interface between these factors, and how they contribute to a pro-inflammatory brain milieu. In particular, we discuss the importance of appropriate polyunsaturated fatty acids (PUFA) in the diet for the metabolism of specialised pro-resolving mediators (SPMs); raising the possibility for dietary strategies to improve AD outlook.\n",
      "Keywords: adipokine, early-life adversity, inflammation, lipids, microglia, n-3 polyunsaturated fatty acids, nutrition, oxylipin, sex, specialized pro-resolving mediators\n",
      "Publication Year: 2024\n",
      "Authors: Singhaarachchi, Pasindu Hansana, Antal, Peter, Calon, Frédéric, Culmsee, Carsten, Delpech, Jean-Christophe, Feldotto, Martin, Geertsema, Jorine, Hoeksema, Emmy E, Korosi, Aniko, Layé, Sophie, McQualter, Jonathan, de Rooij, Susanne R, Rummel, Christoph, Slayo, Mary, Sominsky, Luba, Spencer, Sarah J\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Navigating the Maze of Alzheimer's Disease by Exploring BACE1: Discovery, Current Scenario, and Future Prospects.\n",
      "Abstract: Alzheimer's disease (AD) is a chronic neurological condition that has become a leading cause of cognitive decline in elder individuals. Hardly any effective medication has been developed to halt the progression of AD due to the disease's complexity. Several theories have been put forward to clarify the mechanisms underlying AD etiology. The identification of amyloid plaques as a hallmark of AD has sparked the development of numerous drugs targeting the players involved in the amyloidogenic pathway, such as the β-site of amyloid precursor protein cleavage enzyme 1 (BACE1) blockers. Over the last ten years, preclinical and early experimental research has led several pharmaceutical companies to prioritize producing BACE1 inhibitors. Despite all these efforts, earlier discovered inhibitors were discontinued in consideration of another second-generation small molecules and recent BACE1 antagonists failed in the final stages of clinical trials because of the complications associated either with toxicity or effectiveness. In addition to discussing the difficulties associated with development of BACE1 inhibitors, this review aims to provide an overview of BACE1 and offer perspectives on the causes behind the failure of five recent BACE1 inhibitors, that would be beneficial for choosing effective treatment approaches in the future.\n",
      "Keywords: Alzheimer’s disease, Amyloid-beta (Aβ) peptides accumulation, Neurodegeneration, Small molecule inhibitors, β-site of amyloid precursor protein cleavage enzyme 1 (BACE1)\n",
      "Publication Year: 2024\n",
      "Authors: Iram, Faiza, Shahid, Mohammad, Ansari, Jaoud, Ashraf, Ghulam Md, Hassan, Md Imtaiyaz, Islam, Asimul\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Type 2 diabetes mellitus/obesity drugs: a neurodegenerative disorders savior or a bridge too far?\n",
      "Abstract: Glucagon-like peptide-1 (GLP-1) receptor agonist-based drugs (incretin mimetics) have meaningfully impacted current treatment of type 2 diabetes mellitus (T2DM), and their actions on satiety and weight loss have led to their use as an obesity medication. With multiple pleotropic actions beyond their insulinotropic and weight loss ones, including anti-inflammatory and anti-insulin-resistant effects selectively mediated by their receptors present within numerous organs, this drug class offers potential efficacy for an increasing number of systemic and neurological disorders whose current treatment is inadequate. Among these are a host of neurodegenerative disorders that are prevalent in the elderly, such as Parkinson's and Alzheimer's disease, which have bucked previous therapeutic approaches. An increasing preclinical, clinical, and epidemiological literature suggests that select incretin mimetics may provide an effective treatment strategy, but 'which ones' for 'which disorders' and 'when' remain key open questions.\n",
      "Keywords: Alzheimer’s disease, Glucagon-like peptide-1 (GLP-1), Parkinson’s disease, glucose-dependent insulinotropic polypeptide (GIP), incretin mimetic, insulin resistance, neurodegeneration, neuroinflammation, type 2 diabetes mellitus\n",
      "Publication Year: 2024\n",
      "Authors: Kopp, Katherine O, Glotfelty, Elliot J, Li, Yazhou, Lahiri, Debomoy K, Greig, Nigel H\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Understanding the (epi)genetic dysregulation in Parkinson's disease through an integrative brain competitive endogenous RNA network.\n",
      "Abstract: Parkinson's disease (PD) is a rapidly growing neurodegenerative disorder characterized by dopaminergic neuron loss in the substantia nigra pars compacta (SN) and aggregation of α-synuclein. Its aetiology involves a multifaceted interplay among genetic, environmental, and epigenetic factors. We integrated brain gene expression data from PD patients to construct a comprehensive regulatory network encompassing messenger RNAs (mRNAs), microRNAs (miRNAs), circular RNAs (circRNAs) and, for the first time, RNA binding proteins (RBPs). Expression data from the SN of PD patients and controls were systematically selected from public databases to identify combined differentially expressed genes (DEGs). Brain co-expression analysis revealed modules comprising significant DEGs that function cooperatively. The relationships among co-expressed DEGs, miRNAs, circRNAs, and RBPs revealed an intricate competitive endogenous RNA (ceRNA) network responsible for post-transcriptional dysregulation in PD. Many genes in the ceRNA network, including the TOMM20 and HMGCR genes, overlap with the most relevant genes in our previous Alzheimer's disease-associated ceRNA network, suggesting common underlying mechanisms between both conditions. Moreover, in the ceRNA subnetwork, the RBP Aly/REF export factor (ALYREF), which acts as an RNA 5-methylcytosine(m5C)-binding protein, stood out. Our data sheds new light on the potential role of brain ceRNA networks in PD pathogenesis.\n",
      "Keywords: Biomarkers, CeRNA, CircRNA, MiRNA, Parkinson’s disease, RNA binding protein\n",
      "Publication Year: 2024\n",
      "Authors: Piergiorge, Rafael Mina, Vasconcelos, Ana Tereza Ribeiro de, Santos-Rebouças, Cíntia Barros\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: The novel anti-fibrillary effects of volatile compounds α-asarone and β-caryophyllene on tau protein: Towards promising therapeutic agents for Alzheimer's disease.\n",
      "Abstract: The abnormal deposition of tau protein is one of the critical causes of tauopathies including Alzheimer's disease (AD). In recent years, there has been great interest in the use of essential oils and volatile compounds in aromatherapy for treating AD, since volatile compounds can directly reach the brain through intranasal administration. The volatile compounds α-asarone (ASA) and β-caryophyllene (BCP) have revealed various important neuroprotective properties, useful in treating AD. In this study, the volatile compounds ASA and BCP were assessed for their effectiveness in preventing tau fibrillation, disassembly of pre-formed tau fibrils, and disaggregation of tau aggregates. SDS-PAGE and AFM analyses revealed that ASA and BCP inhibited tau fibrillation/aggregation and decreased the mean size of tau oligomers. Tau samples treated with ASA and BCP, showed a reduction in ThT and ANS fluorescence intensities, and a decrease in the β-sheet content. Additionally, ASA and BCP disassembled the pre-formed tau fibrils to the granular and linear oligomeric intermediates. Treatment of neuroblastoma SH-SY5Y cells with tau samples treated with ASA and BCP, revealed protective effects as shown by reduced toxicity of the cells, due to the inhibition of tau fibrillation/aggregation. Overall, ASA and BCP appeared to be promising therapeutic candidates for AD.\n",
      "Keywords: Alzheimer's disease, Tau fibrillation, α-Asarone, β-Caryophyllene\n",
      "Publication Year: 2024\n",
      "Authors: Anbaraki, Afrooz, Dindar, Zahra, Mousavi-Jarrahi, Zahra, Ghasemi, Atiyeh, Moeini, Zahra, Evini, Mina, Saboury, Ali Akbar, Seyedarabi, Arefeh\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Gastrodin ameliorates synaptic impairment, mitochondrial dysfunction and oxidative stress in N2a/APP cells.\n",
      "Abstract: Alzheimer's disease is characterized by abnormal β-amyloid and tau accumulation, mitochondrial dysfunction, oxidative stress, and synaptic dysfunction. Here, we aimed to assess the mechanisms and signalling pathways in the neuroprotective effect of gastrodin, a phenolic glycoside, on murine neuroblastoma N2a cells expressing human Swedish mutant APP (N2a/APP). We found that gastrodin increased the levels of presynaptic-SNAP, synaptophysin, and postsynaptic-PSD95 and reduced phospho-tau Ser396, APP and Aβ\n",
      "Keywords: Amyloid precursor protein, ERK1/2, GSK-3β, Gastrodin, JNK, Mitochondrial, Oxidative stress, Tau\n",
      "Publication Year: 2024\n",
      "Authors: Tang, Zhi, Peng, Yaqian, Jiang, Yi, Wang, Li, Guo, Min, Chen, Zhuyi, Luo, Chao, Zhang, Ting, Xiao, Yan, Ni, Ruiqing, Qi, Xiaolan\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Elevated protease-activated receptor 4 (PAR4) gene expression in Alzheimer's disease predicts cognitive decline.\n",
      "Abstract: Platelet activation of protease-activated receptor 4 (PAR4) and thrombin are at the top of a chain of events leading to fibrin deposition, microinfarcts, blood-brain barrier disruption, and inflammation. We evaluated mRNA expression of the PAR4 gene F2RL3 in human brain and global cognitive performance in participants with and without cognitive impairment or dementia. Data were acquired from the Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP). F2RL3 mRNA was elevated in AD cases and was associated with worse retrospective longitudinal cognitive performance. Moreover, F2RL3 expression interacted with clinical AD diagnosis on longitudinal cognition whereas this relationship was attenuated in individuals without cognitive impairment. Additionally, when adjusting for the effects of AD neuropathology, F2RL3 expression remained a significant predictor of cognitive decline. F2RL3 expression correlated positively with transcript levels of proinflammatory markers including TNFα, IL-1β, NFκB, and fibrinogen α/β/γ. Together, these results reveal that F2RL3 mRNA expression is associated with multiple AD-relevant outcomes and its encoded product, PAR4, may play a role in disease pathogenesis.\n",
      "Keywords: Cerebrovascular disease, Cytokines, Inflammation, PAR4, Thrombin\n",
      "Publication Year: 2024\n",
      "Authors: Winfree, Rebecca L, Erreger, Kevin, Phillips, Jared, Seto, Mabel, Wang, Yanling, Schneider, Julie A, Bennett, David A, Schrag, Matthew S, Hohman, Timothy J, Hamm, Heidi E\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.\n",
      "Abstract: Alzheimer's disease (AD) is a neurodegenerative condition for which there is currently no available medication that can stop its progression. Previous studies suggest that mild cognitive impairment (MCI) is a phase that precedes the disease. Therefore, a better understanding of the molecular mechanisms behind MCI conversion to AD is needed.\n",
      "Keywords: Alzheimer's disease, Integrative omics, Machine learning, Metabolomics, Mild cognitive impairment, Proteomics\n",
      "Publication Year: 2024\n",
      "Authors: Gómez-Pascual, Alicia, Naccache, Talel, Xu, Jin, Hooshmand, Kourosh, Wretlind, Asger, Gabrielli, Martina, Lombardo, Marta Tiffany, Shi, Liu, Buckley, Noel J, Tijms, Betty M, Vos, Stephanie J B, Ten Kate, Mara, Engelborghs, Sebastiaan, Sleegers, Kristel, Frisoni, Giovanni B, Wallin, Anders, Lleó, Alberto, Popp, Julius, Martinez-Lage, Pablo, Streffer, Johannes, Barkhof, Frederik, Zetterberg, Henrik, Visser, Pieter Jelle, Lovestone, Simon, Bertram, Lars, Nevado-Holgado, Alejo J, Gualerzi, Alice, Picciolini, Silvia, Proitsi, Petroula, Verderio, Claudia, Botía, Juan A, Legido-Quigley, Cristina\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases.\n",
      "Abstract: Ferroptosis is a form of cell death mediated by iron and lipid peroxidation (LPO). Recent studies have provided compelling evidence to support the involvement of ferroptosis in the pathogenesis of various neurodegenerative diseases (NDDs), such as Alzheimer's disease (AD), Parkinson's disease (PD). Therefore, understanding the mechanisms that regulate ferroptosis in NDDs may improve disease management. Ferroptosis is regulated by multiple mechanisms, and different degradation pathways, including autophagy and the ubiquitinproteasome system (UPS), orchestrate the complex ferroptosis response by directly or indirectly regulating iron accumulation or lipid peroxidation. Ubiquitination plays a crucial role as a protein posttranslational modification in driving ferroptosis. Notably, E3 ubiquitin ligases (E3s) and deubiquitinating enzymes (DUBs) are key enzymes in the ubiquitin system, and their dysregulation is closely linked to the progression of NDDs. A growing body of evidence highlights the role of ubiquitin system enzymes in regulating ferroptosis sensitivity. However, reports on the interaction between ferroptosis and ubiquitin signaling in NDDs are scarce. In this review, we first provide a brief overview of the biological processes and roles of the UPS, summarize the core molecular mechanisms and potential biological functions of ferroptosis, and explore the pathophysiological relevance and therapeutic implications of ferroptosis in NDDs. In addition, reviewing the roles of E3s and DUBs in regulating ferroptosis in NDDs aims to provide new insights and strategies for the treatment of NDDs. These include E3- and DUB-targeted drugs and ferroptosis inhibitors, which can be used to prevent and ameliorate the progression of NDDs.\n",
      "Keywords: Deubiquitinating enzymes, E3 ubiquitin ligases, Ferroptosis, Therapy for neurodegenerative diseases\n",
      "Publication Year: 2024\n",
      "Authors: Lu, Linxia, Jifu, Cili, Xia, Jun, Wang, Jingtao\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Upregulation of neuronal ER-phagy improves organismal fitness and alleviates APP toxicity.\n",
      "Abstract: ER-phagy, a selective autophagy targeting the endoplasmic reticulum (ER) for lysosomal degradation through cargo receptors, plays a critical role in ER quality control and is linked to various diseases. However, its physiological and pathological roles remain largely unclear due to a lack of animal model studies. This study establishes Drosophila as an in vivo ER-phagy model. Starvation triggers ER-phagy across multiple fly tissues. Disturbing ER-phagy by either globally upregulating or downregulating ER-phagy receptors, Atl or Rtnl1, harms the fly. Notably, moderate upregulation of ER-phagy in fly brains by overexpressing Atl or Rtnl1 significantly attenuates age-associated neurodegenerations. Furthermore, in a Drosophila model of Alzheimer's disease expressing human amyloid precursor protein (APP), impaired ER-phagy is observed. Enhancing ER-phagy in the APP-expressing fly brain facilitates APP degradation, significantly alleviating disease symptoms. Therefore, our findings suggest that modulating ER-phagy may offer a therapeutic strategy to treat aging and diseases associated with ER protein aggregation.\n",
      "Keywords: APP, Atg8a, Atl, CP: Cell biology, CP: Molecular biology, ER-phagy, Rtnl1, aging, cargo receptor, macro-autophagy, neurodegeneration\n",
      "Publication Year: 2024\n",
      "Authors: Mou, Wenqing, Tang, Yinglu, Huang, Yunpeng, Wu, Zhihao, Cui, Yixian\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry.\n",
      "Abstract: Antibodies are essential research tools whose performance directly impacts research conclusions and reproducibility. Owing to its central role in Alzheimer's disease and other dementias, hundreds of distinct antibody clones have been developed against the microtubule-associated protein Tau and its multiple proteoforms. Despite this breadth of offer, limited understanding of their performance and poor antibody selectivity have hindered research progress. Here, we validate a large panel of Tau antibodies by Western blot (79 reagents) and immunohistochemistry (35 reagents). We address the reagents' ability to detect the target proteoform, selectivity, the impact of protein phosphorylation on antibody binding and performance in human brain samples. While most antibodies detected Tau at high levels, many failed to detect it at lower, endogenous levels. By WB, non-selective binding to other proteins affected over half of the antibodies tested, with several cross-reacting with the related MAP2 protein, whereas the \"oligomeric Tau\" T22 antibody reacted with monomeric Tau by WB, thus calling into question its specificity to Tau oligomers. Despite the presumption that \"total\" Tau antibodies are agnostic to post-translational modifications, we found that phosphorylation partially inhibits binding for many such antibodies, including the popular Tau-5 clone. We further combine high-sensitivity reagents, mass-spectrometry proteomics and cDNA sequencing to demonstrate that presumptive Tau \"knockout\" human cells continue to express residual protein arising through exon skipping, providing evidence of previously unappreciated gene plasticity. Finally, probing of human brain samples with a large panel of antibodies revealed the presence of C-term-truncated versions of all main Tau brain isoforms in both control and tauopathy donors. Ultimately, we identify a validated panel of Tau antibodies that can be employed in Western blotting and/or immunohistochemistry to reliably detect even low levels of Tau expression with high selectivity. This work represents an extensive resource that will enable the re-interpretation of published data, improve reproducibility in Tau research, and overall accelerate scientific progress.\n",
      "Keywords: Antibody validation, Immunohistochemistry, Phosphorylation, Splice isoforms, Tau, Western blot\n",
      "Publication Year: 2024\n",
      "Authors: Ellis, Michael J, Lekka, Christiana, Holden, Katie L, Tulmin, Hanna, Seedat, Faheem, O'Brien, Darragh P, Dhayal, Shalinee, Zeissler, Marie-Louise, Knudsen, Jakob G, Kessler, Benedikt M, Morgan, Noel G, Todd, John A, Richardson, Sarah J, Stefana, M Irina\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Integrating the Patient's Voice into the Research Agenda for Treatment of Chemosensory Disorders.\n",
      "Abstract: World-wide some 658 million people were infected with COVID-19 and millions suffer from chemosensory impairment associated with long COVID. Current treatments for taste and smell disorders are limited. Involving patients has the potential to catalyze the dynamic exchange and development of new ideas and approaches to facilitate biomedical research and therapeutics. We assessed patients' perceptions of the efficacy of treatments for chemosensory impairment using an online questionnaire completed by 5,815 people in the U.S. Logistic regression determined variables predictive of reported treatment efficacy for patients aged 18-24, 25-39, 40-60 and 60+ yrs. who were treated with nasal steroids, oral steroids, zinc, nasal rinse, smell training, theophylline, platelet rich plasma, and Omega 3. The most consistent predictor was age, with the majority of those 40-60 and 60+ reporting that nasal steroids, oral steroids, zinc, nasal rinse and smell training were only slightly effective or not effective at all. Many of these treatment strategies target regeneration and immune response, processes compromised by age. Only those under 40 reported more than slight efficacy of steroids or smell training. Findings emphasize the need to include patients of all ages in clinical trials. Older adults with olfactory impairment are at increased risk for Alzheimer's disease (AD). We speculate that olfactory impairment associated with long COVID introduces the potential for a significant rise in AD. Long COVID-associated chemosensory impairment increases the urgency for translational and clinical research on novel treatment strategies. Suggestions for high priority areas for epidemiological, basic, and clinical research on chemosensory impairment follow.\n",
      "Keywords: chemosensory disorders, patient engagement, post-acute COVID, research agenda, smell\n",
      "Publication Year: 2024\n",
      "Authors: Murphy, Claire, Dalton, Pamela, Boateng, Katie, Hunter, Stephanie, Silberman, Pamela, Trachtman, Jenifer, Schrandt, Suz, Naimi, Bita, Garvey, Emily, Joseph, Paule V, Frank, Conner, Albertazzi, Abigail, Nyquist, Gurston, Rawson, Nancy E\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: NADPH Oxidases in Neurodegenerative Disorders: Mechanisms and Therapeutic Opportunities.\n",
      "Abstract: The NADPH oxidase (NOX) enzyme family, located in the central nervous system (CNS), is recognized as a source of reactive oxygen species (ROS) in the brain. Despite its importance in cellular processes, excessive ROS generation leads to cell death and is involved in the pathogenesis of neurodegenerative disorders.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Fiadeiro, Mariana Bernardo, Diogo, João Campos, Silva, Ana Alexandra, Kim, Yoon-Seong, Cristovao, Ana Clara\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology.\n",
      "Abstract: Recent evidence suggests that Alzheimer's disease (AD) genetic risk variants (rs1582763 and rs6591561) of the MS4A locus are genome-wide significant regulators of soluble TREM2 levels such that the minor allele of the protective variant (rs1582763) is associated with higher sTREM2 and lower AD risk while the minor allele of (rs6591561) relates to lower sTREM2 and higher AD risk. Our group previously found that higher sTREM2 relates to higher Aβ\n",
      "Keywords: Alzheimer’s disease, Blood–brain barrier, CSF biomarkers, Inflammation, MS4A, Microglia, sTREM2\n",
      "Publication Year: 2024\n",
      "Authors: Winfree, Rebecca L, Nolan, Emma, Dumitrescu, Logan, Blennow, Kaj, Zetterberg, Henrik, Gifford, Katherine A, Pechman, Kimberly R, Seto, Mabel, Petyuk, Vladislav A, Wang, Yanling, Schneider, Julie, Bennett, David A, Jefferson, Angela L, Hohman, Timothy J\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people.\n",
      "Abstract: An elevated neutrophil-lymphocyte ratio (NLR) in blood has been associated with Alzheimer's disease (AD). However, an elevated NLR has also been implicated in many other conditions that are risk factors for AD, prompting investigation into whether the NLR is directly linked with AD pathology or a result of underlying comorbidities. Herein, we explored the relationship between the NLR and AD biomarkers in the cerebrospinal fluid (CSF) of cognitively unimpaired (CU) subjects. Adjusting for sociodemographics, APOE4, and common comorbidities, we investigated these associations in two cohorts: the Alzheimer's Disease Neuroimaging Initiative (ADNI) and the M.J. de Leon CSF repository at NYU. Specifically, we examined associations between the NLR and cross-sectional measures of amyloid-β42 (Aβ42), total tau (t-tau), and phosphorylated tau\n",
      "Keywords: Alzheimer’s disease, Amyloid-β, CSF, NLR, Neutrophil to lymphocyte ratio, P-tau, T-tau\n",
      "Publication Year: 2024\n",
      "Authors: Jacobs, Tovia, Jacobson, Sean R, Fortea, Juan, Berger, Jeffrey S, Vedvyas, Alok, Marsh, Karyn, He, Tianshe, Gutierrez-Jimenez, Eugenio, Fillmore, Nathanael R, Gonzalez, Moses, Figueredo, Luisa, Gaggi, Naomi L, Plaska, Chelsea Reichert, Pomara, Nunzio, Blessing, Esther, Betensky, Rebecca, Rusinek, Henry, Zetterberg, Henrik, Blennow, Kaj, Glodzik, Lidia, Wisniweski, Thomas M, de Leon, Mony J, Osorio, Ricardo S, Ramos-Cejudo, Jaime\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial.\n",
      "Abstract: p75 neurotrophin receptor (p75\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Shanks, Hayley R C, Chen, Kewei, Reiman, Eric M, Blennow, Kaj, Cummings, Jeffrey L, Massa, Stephen M, Longo, Frank M, Börjesson-Hanson, Anne, Windisch, Manfred, Schmitz, Taylor W\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: MST1 selective inhibitor Xmu-mp-1 ameliorates neuropathological changes in a rat model of sporadic Alzheimer's Disease by modulating Hippo-Wnt signaling crosstalk.\n",
      "Abstract: Alzheimer's disease (AD), the most prevalent form of dementia, is characterized by progressive cognitive impairment accompanied by aberrant neuronal apoptosis. Reports suggest that the pro-apoptotic mammalian set20-like kinase 1/2 (MST1/2) instigates neuronal apoptosis via activating the Hippo signaling pathway under various stress conditions, including AD. However, whether inhibiting MST1/2 has any therapeutic benefits in AD remains unknown. Thus, we tested the therapeutic effects of intervening MST1/2 activation via the pharmacological inhibitor Xmu-mp-1 in a sporadic AD rat model. Sporadic AD was established in adult rats by intracerebroventricular streptozotocin (ICV-STZ) injection (3 mg/kg body weight). Xmu-mp-1 (0.5 mg/kg/body weight) was administered once every 48 h for two weeks, and Donepezil (5 mg/kg body weight) was used as a reference standard drug. The therapeutic effects of Xmu-mp-1 on ICV-STZ rats were determined through various behavioral, biochemical, histopathological, and molecular tests. At the behavioral level, Xmu-mp-1 improved cognitive deficits in sporadic AD rats. Further, Xmu-mp-1 treatment reduced STZ-associated tau phosphorylation, amyloid-beta deposition, oxidative stress, neurotoxicity, neuroinflammation, synaptic dysfunction, neuronal apoptosis, and neurodegeneration. Mechanistically, Xmu-mp-1 exerted these neuroprotective actions by inactivating the Hippo signaling while potentiating the Wnt/β-Catenin signaling in the AD rats. Together, the results of the present study provide compelling support that Xmu-mp-1 negated the neuronal dysregulation in the rat model of sporadic AD. Therefore, inhibiting MST/Hippo signaling and modulating its crosstalk with the Wnt/β-Catenin pathway can be a promising alternative treatment strategy against AD pathology. This is the first study providing novel mechanistic insights into the therapeutic use of Xmu-mp-1 in sporadic AD.\n",
      "Keywords: Alzheimer’s disease, Apoptosis, Hippo Signaling, MST1, Streptozotocin, Wnt/β-Catenin signaling, Xmu-mp-1\n",
      "Publication Year: 2024\n",
      "Authors: Sahu, Manas Ranjan, Ahmad, Mir Hilal, Mondal, Amal Chandra\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Supervised latent factor modeling isolates cell-type-specific transcriptomic modules that underlie Alzheimer's disease progression.\n",
      "Abstract: Late onset Alzheimer's disease (AD) is a progressive neurodegenerative disease, with brain changes beginning years before symptoms surface. AD is characterized by neuronal loss, the classic feature of the disease that underlies brain atrophy. However, GWAS reports and recent single-nucleus RNA sequencing (snRNA-seq) efforts have highlighted that glial cells, particularly microglia, claim a central role in AD pathophysiology. Here, we tailor pattern-learning algorithms to explore distinct gene programs by integrating the entire transcriptome, yielding distributed AD-predictive modules within the brain's major cell-types. We show that these learned modules are biologically meaningful through the identification of new and relevant enriched signaling cascades. The predictive nature of our modules, especially in microglia, allows us to infer each subject's progression along a disease pseudo-trajectory, confirmed by post-mortem pathological brain tissue markers. Additionally, we quantify the interplay between pairs of cell-type modules in the AD brain, and localized known AD risk genes to enriched module gene programs. Our collective findings advocate for a transition from cell-type-specificity to gene modules specificity to unlock the potential of unique gene programs, recasting the roles of recently reported genome-wide AD risk loci.\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Hodgson, Liam, Li, Yue, Iturria-Medina, Yasser, Stratton, Jo Anne, Wolf, Guy, Krishnaswamy, Smita, Bennett, David A, Bzdok, Danilo\n",
      "---------------------------------------------------\n",
      "\n",
      "Title: Basal forebrain volume and metabolism in carriers of the Colombian mutation for autosomal dominant Alzheimer's disease.\n",
      "Abstract: We aimed to study atrophy and glucose metabolism of the cholinergic basal forebrain in non-demented mutation carriers for autosomal dominant Alzheimer's disease (ADAD). We determined the level of evidence for or against atrophy and impaired metabolism of the basal forebrain in 167 non-demented carriers of the Colombian PSEN1 E280A mutation and 75 age- and sex-matched non-mutation carriers of the same kindred using a Bayesian analysis framework. We analyzed baseline MRI, amyloid PET, and FDG-PET scans of the Alzheimer's Prevention Initiative ADAD Colombia Trial. We found moderate evidence against an association of carrier status with basal forebrain volume (Bayes factor (BF\n",
      "Keywords: No keywords available\n",
      "Publication Year: 2024\n",
      "Authors: Teipel, Stefan, Grazia, Alice, Dyrba, Martin, Grothe, Michel J, Pomara, Nunzio\n",
      "---------------------------------------------------\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import xml.etree.ElementTree as ET\n",
    "\n",
    "# PubMed search query\n",
    "query = \"Alzheimer's disease\"\n",
    "\n",
    "# PubMed API base URL\n",
    "base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "\n",
    "# PubMed search endpoint\n",
    "search_url = base_url + \"esearch.fcgi\"\n",
    "\n",
    "# API key (replace with your actual API key)\n",
    "api_key = \"\"\n",
    "\n",
    "\n",
    "# Construct parameters for the search request\n",
    "search_params = {\n",
    "    \"db\": \"pubmed\",\n",
    "    \"term\": query,\n",
    "    \"retmode\": \"xml\",\n",
    "    \"api_key\": api_key,\n",
    "    \"retmax\": 100  # Adjust as needed\n",
    "}\n",
    "\n",
    "# Make the request to PubMed API\n",
    "response = requests.get(search_url, params=search_params)\n",
    "\n",
    "if response.status_code == 200:\n",
    "    search_results = response.text\n",
    "    root = ET.fromstring(search_results)\n",
    "    article_ids = [id_elem.text for id_elem in root.findall('.//IdList/Id')]\n",
    "\n",
    "    if article_ids:\n",
    "        # PubMed fetch endpoint\n",
    "        fetch_url = base_url + \"efetch.fcgi\"\n",
    "\n",
    "        # Construct parameters for fetching article details\n",
    "        fetch_params = {\n",
    "            \"db\": \"pubmed\",\n",
    "            \"retmode\": \"xml\",\n",
    "            \"api_key\": api_key,\n",
    "            \"id\": \",\".join(article_ids)\n",
    "        }\n",
    "\n",
    "        # Make the request to fetch article details\n",
    "        fetch_response = requests.get(fetch_url, params=fetch_params)\n",
    "\n",
    "        if fetch_response.status_code == 200:\n",
    "            fetch_results = fetch_response.text\n",
    "            fetch_root = ET.fromstring(fetch_results)\n",
    "\n",
    "            # Iterate through each article in the response\n",
    "            for article in fetch_root.findall('.//PubmedArticle'):\n",
    "                title = article.find('.//ArticleTitle').text\n",
    "                abstract = article.find('.//Abstract/AbstractText')\n",
    "                abstract_text = abstract.text if abstract is not None else \"No abstract available\"\n",
    "                keywords_list = article.findall('.//KeywordList/Keyword')\n",
    "                keywords = [kw.text for kw in keywords_list]\n",
    "                pub_date = article.find('.//PubDate')\n",
    "                year = pub_date.find('Year').text if pub_date.find('Year') is not None else \"Year not available\"\n",
    "                authors_list = article.findall('.//AuthorList/Author')\n",
    "                authors = [f\"{author.find('LastName').text}, {author.find('ForeName').text}\" for author in authors_list if author.find('LastName') is not None and author.find('ForeName') is not None]\n",
    "\n",
    "                # Print the details for each article\n",
    "                print(f\"Title: {title}\")\n",
    "                print(f\"Abstract: {abstract_text}\")\n",
    "                print(f\"Keywords: {', '.join(keywords) if keywords else 'No keywords available'}\")\n",
    "                print(f\"Publication Year: {year}\")\n",
    "                print(f\"Authors: {', '.join(authors) if authors else 'No authors available'}\")\n",
    "                print(\"---------------------------------------------------\\n\")\n",
    "        else:\n",
    "            print(\"Error fetching article details:\", fetch_response.status_code)\n",
    "    else:\n",
    "        print(\"No articles found for the given query.\")\n",
    "else:\n",
    "    print(\"Error searching PubMed:\", response.status_code)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "one step further, We Use esearch to find out how many articles match our query. This tells us the total count without fetching the details yet."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "WE are using the same code we have use earlier, "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total articles found for query 'Alzheimer's': 231127\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "\n",
    "# Query parameters\n",
    "query = \"Alzheimer's\"\n",
    "base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "search_url = f\"{base_url}esearch.fcgi\"\n",
    "api_key = \"\"  # Replace with your actual API key\n",
    "params = {\n",
    "    \"db\": \"pubmed\",\n",
    "    \"term\": query,\n",
    "    \"retmode\": \"json\",\n",
    "    \"api_key\": api_key,\n",
    "}\n",
    "\n",
    "# Make the request to PubMed API\n",
    "response = requests.get(search_url, params=params)\n",
    "\n",
    "if response.status_code == 200:\n",
    "    data = response.json()\n",
    "    total_count = data[\"esearchresult\"][\"count\"]\n",
    "    print(f\"Total articles found for query '{query}': {total_count}\")\n",
    "else:\n",
    "    print(\"Failed to fetch article count:\", response.status_code)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This code We'll set a manageable batch size and use a loop to fetch article details in batches, showing how to process the first few batches as an example. Adjust BATCH_SIZE and the loop conditions as needed for our specific requirements.\n",
    "\n",
    "we don't want to violet any policies\n",
    "\n",
    "We just fetch the article ids first in  order to get a list of all articles. Then we can use that list to retrieve each individual article information\n",
    "\n",
    "so later on we use these ids to get the information we needed."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Fetching batch 1/51\n",
      "Batch 1 fetched and processed.\n",
      "<?xml version=\"1.0\" ?>\n",
      "<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2024//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd\">\n",
      "<PubmedArticleSet>\n",
      "<PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39277838</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1179-2035</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Sports medicine (Auckland, N.Z.)</Title><ISOAbbreviation>Sports Med</ISOAbbreviation></Journal><ArticleTitle>Epidemiological Principles in Claims of Causality: An Enquiry into Repetitive&#xa0;Head Impacts (RHI) and Chronic Traumatic Encephalopathy (CTE).</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s40279-024-02102-4</ELocationID><Abstract><AbstractText>Determining whether repetitive&#xa0;head impacts (RHI) cause the development of chronic traumatic encephalopathy (CTE)-neuropathological change (NC) and whether pathological changes cause clinical syndromes are topics of considerable interest to the global sports medicine community. In 2022, an article was published that used the Bradford Hill criteria to evaluate the claim that RHI cause CTE. The publication garnered international media attention and has since been promoted as definitive proof that causality has been established. Our counterpoint presents an appraisal of the published article in terms of the claims made and the scientific literature used in developing those claims. We conclude that the evidence provided does not justify the causal claims. We discuss how causes are conceptualised in modern epidemiology and highlight shortcomings in the current definitions and measurement of exposures (RHI) and outcomes (CTE). We address the Bradford Hill arguments that are used as evidence in the original review and conclude that assertions of causality having been established are premature. Members of the scientific community must be cautious of making causal claims until the proposed exposures and outcomes are well defined and consistently measured, and findings from appropriately designed studies have been published. Evaluating and reflecting on the quality of research is a crucial step in providing accurate evidence-based information to the public.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Fortington</LastName><ForeName>Lauren V</ForeName><Initials>LV</Initials><Identifier Source=\"ORCID\">0000-0003-2760-9249</Identifier><AffiliationInfo><Affiliation>School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia. lauren.fortington@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cassidy</LastName><ForeName>J David</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Castellani</LastName><ForeName>Rudolph J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Division of Neuropathology, Northwestern University Feinberg School of Medicine and Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gardner</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>McIntosh</LastName><ForeName>Andrew S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Monash University Accident Research Centre, Monash University, Clayton, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Austen</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Australasian Faculty of Occupational and Environmental Medicine, Royal Australasian College of Physicians, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Royal New Zealand College of Urgent Care, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>High Court of New Zealand, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kerr</LastName><ForeName>Zachary Yukio</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Department of Exercise and Sport Science, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Quarrie</LastName><ForeName>Kenneth L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>New Zealand Rugby, 100 Molesworth Street, Wellington, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sports Performance Research Institute New Zealand (SPRINZ), Auckland University of Technology, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Auckland Bioengineering Institute (ABI), The University of Auckland, Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Sports Med</MedlineTA><NlmUniqueID>8412297</NlmUniqueID><ISSNLinking>0112-1642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39277838</ArticleId><ArticleId IdType=\"doi\">10.1007/s40279-024-02102-4</ArticleId><ArticleId IdType=\"pii\">10.1007/s40279-024-02102-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nowinski CJ, Bureau SC, Buckland ME, et al. Applying the Bradford Hill criteria for causation to repetitive head impacts and chronic traumatic encephalopathy. Front Neurol. 2022;13: 938163. https://doi.org/10.3389/fneur.2022.938163 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2022.938163</ArticleId><ArticleId IdType=\"pubmed\">35937061</ArticleId><ArticleId IdType=\"pmc\">9355594</ArticleId></ArticleIdList></Reference><Reference><Citation>PA Media. &#x2018;Conclusive evidence&#x2019; repetitive head impacts can cause brain disease. The Guardian. 2022.</Citation></Reference><Reference><Citation>Manning J. Breakthrough study reveals repetitive head impacts are a definitive cause of CTE Sports organizations must acknowledge that head impacts cause CTE to protect children. Concussion Leg. Found. 2022.</Citation></Reference><Reference><Citation>Anderson E, Turner G, Hardwicke J, et al. Sport structured brain trauma is child abuse. Sport Ethics Philos Published Online First. 2023. https://doi.org/10.1080/17511321.2023.2284923 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/17511321.2023.2284923</ArticleId></ArticleIdList></Reference><Reference><Citation>Weed M. Informing evidence-based policy for sport-related concussion: are the consensus statements of the concussion in sport group fit for this purpose? Sport Ethics Philos. 2024. https://doi.org/10.1080/17511321.2024.2365401 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/17511321.2024.2365401</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning J. United States National Institutes of Health (NIH) concludes CTE is caused by repetitive traumatic brain injuries. 2022.</Citation></Reference><Reference><Citation>Parliament of Australia. Concussions and repeated head trauma in contact sports. 2022.</Citation></Reference><Reference><Citation>Kuhn AW, Yengo-Kahn AM, Kerr ZY, et al. Sports concussion research, chronic traumatic encephalopathy and the media: repairing the disconnect. Br J Sports Med. 2017;51:1732&#x2013;3. https://doi.org/10.1136/bjsports-2016-096508 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bjsports-2016-096508</ArticleId><ArticleId IdType=\"pubmed\">27587800</ArticleId></ArticleIdList></Reference><Reference><Citation>Popper KR, Eccles JC. Materialism criticized. In: Popper KR, Eccles JC, editors. The self and its brain. Berlin: Springer; 1977. p. 51&#x2013;99.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-3-642-61891-8_3</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore M. Causation in the Law. In: Zalta EN, editor. The Stanford encyclopedia of philosophy. Berlin: Metaphysics Research Lab, Stanford University; 2019.</Citation></Reference><Reference><Citation>Swain GR, Ward GK, Hartlaub PP. Death certificates: let&#x2019;s get it right. Am Fam Physician. 2005;71:652&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15742904</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall SW, Li G, et al. Chapter 38: Injury and violence epidemiology. In: Lash TL, VanderWeele TJ, Haneuse S, et al., editors. Modern Epidemiology. Philadelphia: Wolters Kluwer; 2021. p. 985&#x2013;1003.</Citation></Reference><Reference><Citation>Bahr R, Clarsen B, Derman W, et al. International Olympic Committee consensus statement: methods for recording and reporting of epidemiological data on injury and illness in sport 2020 (including STROBE Extension for Sport Injury and Illness Surveillance (STROBE-SIIS)). Br J Sports Med. 2020;54:372. https://doi.org/10.1136/bjsports-2019-101969 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bjsports-2019-101969</ArticleId><ArticleId IdType=\"pubmed\">32071062</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005;95:S144&#x2013;50. https://doi.org/10.2105/AJPH.2004.059204 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2105/AJPH.2004.059204</ArticleId><ArticleId IdType=\"pubmed\">16030331</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon JR, Greenamyre JT. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol Sci. 2011;124:225&#x2013;50. https://doi.org/10.1093/toxsci/kfr239 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/toxsci/kfr239</ArticleId><ArticleId IdType=\"pubmed\">21914720</ArticleId><ArticleId IdType=\"pmc\">3216414</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabi M, Tabassum N. Role of environmental toxicants on neurodegenerative disorders. Front Toxicol. 2022. https://doi.org/10.3389/ftox.2022.837579 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/ftox.2022.837579</ArticleId><ArticleId IdType=\"pubmed\">35647576</ArticleId><ArticleId IdType=\"pmc\">9131020</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396:413&#x2013;46. https://doi.org/10.1016/S0140-6736(20)30367-6 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)30367-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin FR, Metter EJ, O&#x2019;Brien RJ, et al. Hearing loss and incident dementia. Arch Neurol. 2011;68:214&#x2013;20. https://doi.org/10.1001/archneurol.2010.362 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archneurol.2010.362</ArticleId><ArticleId IdType=\"pubmed\">21320988</ArticleId><ArticleId IdType=\"pmc\">3277836</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson RS, Auduong P, Miller AT, et al. Hearing loss as a risk factor for dementia: a systematic review. Laryngoscope Investig Otolaryngol. 2017;2:69&#x2013;79. https://doi.org/10.1002/lio2.65 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/lio2.65</ArticleId><ArticleId IdType=\"pubmed\">28894825</ArticleId><ArticleId IdType=\"pmc\">5527366</ArticleId></ArticleIdList></Reference><Reference><Citation>Hume D. An Enquiry Concerning Human Understanding. 1748. https://www.gutenberg.org/files/9662/9662-h/9662-h.htm . Accessed 20 July 2023.</Citation></Reference><Reference><Citation>Susser M. What is a cause and how do we know one? A grammar for pragmatic epidemiology. Am J Epidemiol. 1991;133:635&#x2013;48. https://doi.org/10.1093/oxfordjournals.aje.a115939 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/oxfordjournals.aje.a115939</ArticleId><ArticleId IdType=\"pubmed\">2018019</ArticleId></ArticleIdList></Reference><Reference><Citation>Mill JS. A System of Logic. 1st ed. London: John W Parker and Son; 1856.</Citation></Reference><Reference><Citation>Hall W. The 1964 US Surgeon General&#x2019;s report on smoking and health. Addiction. 2022;117:3170&#x2013;5. https://doi.org/10.1111/add.16007 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/add.16007</ArticleId><ArticleId IdType=\"pubmed\">35852022</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimonovich M, Pearce A, Thomson H, et al. Assessing causality in epidemiology: revisiting Bradford Hill to incorporate developments in causal thinking. Eur J Epidemiol. 2021;36:873&#x2013;87. https://doi.org/10.1007/s10654-020-00703-7 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10654-020-00703-7</ArticleId><ArticleId IdType=\"pubmed\">33324996</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129&#x2013;36. https://doi.org/10.1126/science.847460 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.847460</ArticleId><ArticleId IdType=\"pubmed\">847460</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum F. The new public health. 4th ed. South Melbourne: Oxford University Press; 2015.</Citation></Reference><Reference><Citation>Rothman KJ. CAUSES. Am J Epidemiol. 1976;104:587&#x2013;92. https://doi.org/10.1093/oxfordjournals.aje.a112335 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/oxfordjournals.aje.a112335</ArticleId><ArticleId IdType=\"pubmed\">998606</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins J. A new approach to causal inference in mortality studies with a sustained exposure period&#x2014;application to control of the healthy worker survivor effect. Math Model. 1986;7:1393&#x2013;512. https://doi.org/10.1016/0270-0255(86)90088-6 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0270-0255(86)90088-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Philippe P, Mansi O. Nonlinearity in the epidemiology of complex health and disease processes. Theor Med Bioeth. 1998;19:591&#x2013;607. https://doi.org/10.1023/A:1009979306346 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1023/A:1009979306346</ArticleId><ArticleId IdType=\"pubmed\">10051792</ArticleId></ArticleIdList></Reference><Reference><Citation>Galea S, Riddle M, Kaplan GA. Causal thinking and complex system approaches in epidemiology. Int J Epidemiol. 2010;39:97&#x2013;106. https://doi.org/10.1093/ije/dyp296 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ije/dyp296</ArticleId><ArticleId IdType=\"pubmed\">19820105</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamee M, Anderson LC, Borry P, et al. Sport-related concussion research agenda beyond medical science: culture, ethics, science, policy. J Med Ethics. 2023. https://doi.org/10.1136/jme-2022-108812 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jme-2022-108812</ArticleId></ArticleIdList></Reference><Reference><Citation>IARC Monographs Preamble. https://videos.iarc.fr/videos/?video=MEDIA210219114535220 . Accessed 22 July 2023.</Citation></Reference><Reference><Citation>Weed DL. Commentary: causal inference in epidemiology: potential outcomes, pluralism and peer review. Int J Epidemiol. 2016;45:1838&#x2013;40. https://doi.org/10.1093/ije/dyw229 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ije/dyw229</ArticleId><ArticleId IdType=\"pubmed\">28130322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295&#x2013;300. https://doi.org/10.1177/003591576505800503 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/003591576505800503</ArticleId><ArticleId IdType=\"pubmed\">14283879</ArticleId><ArticleId IdType=\"pmc\">1898525</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb P, Bain C, Page A. Essential epidemiology: an introduction for students and health professionals. 3rd ed. Cambridge: Cambridge University Press; 2017.</Citation></Reference><Reference><Citation>Aschengrau A, Seage GR. Essentials of epidemiology in public health. 4th ed. Burlington: Jones &amp; Bartlett Learning; 2020.</Citation></Reference><Reference><Citation>Celentano DD, Szklo M, Gordis L. Gordis epidemiology. 6th ed. Philadelphia: Elsevier; 2019.</Citation></Reference><Reference><Citation>Nieuwenhuijsen MJ. Exposure assessment in environmental epidemiology. Oxford University Press; 2015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/med/9780199378784.001.0001</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainwaring L, Ferdinand Pennock KM, Mylabathula S, et al. Subconcussive head impacts in sport: a systematic review of the evidence. Int J Psychophysiol. 2018;132:39&#x2013;54. https://doi.org/10.1016/j.ijpsycho.2018.01.007 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijpsycho.2018.01.007</ArticleId><ArticleId IdType=\"pubmed\">29402530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowinski CJ, Rhim HC, McKee AC, et al. &#x2018;Subconcussive&#x2019; is a dangerous misnomer: hits of greater magnitude than concussive impacts may not cause symptoms. Br J Sports Med. 2024. https://doi.org/10.1136/bjsports-2023-107413 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bjsports-2023-107413</ArticleId><ArticleId IdType=\"pubmed\">38719575</ArticleId></ArticleIdList></Reference><Reference><Citation>Unacceptability bias. Cat. Bias. 2019. https://catalogofbias.org/biases/unacceptability-bias/ . Accessed 20 June 2024.</Citation></Reference><Reference><Citation>Recall bias. Cat. Bias. 2017. https://catalogofbias.org/biases/recall-bias/ . Accessed 20 June 2024.</Citation></Reference><Reference><Citation>Information bias. Cat. Bias. 2019. https://catalogofbias.org/biases/information-bias/ . Accessed 20 June 2024.</Citation></Reference><Reference><Citation>Availability bias. Cat. Bias. 2019. https://catalogofbias.org/biases/availability-bias/ . Accessed 2 July 2024.</Citation></Reference><Reference><Citation>Mez J, Daneshvar DH, Abdolmohammadi B, et al. Duration of American football play and chronic traumatic encephalopathy. Ann Neurol. 2020;87:16.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.25611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalton G, Schuman H. The effect of the question on survey responses: a review. J R Stat Soc Ser Gen. 1982;145:42. https://doi.org/10.2307/2981421 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2307/2981421</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneshvar DH, Nair ES, Baucom ZH, et al. Leveraging football accelerometer data to quantify associations between repetitive head impacts and chronic traumatic encephalopathy in males. Nat Commun. 2023;14:3470. https://doi.org/10.1038/s41467-023-39183-0 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-023-39183-0</ArticleId><ArticleId IdType=\"pubmed\">37340004</ArticleId><ArticleId IdType=\"pmc\">10281995</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta M, editor. A dictionary of epidemiology. A Dictionary of epidemiology. Oxford University Press; 2014.</Citation></Reference><Reference><Citation>Epidemiology for the uninitiated | The BMJ. BMJ BMJ Lead. Gen. Med. J. Res. Educ. Comment. https://www.bmj.com/about-bmj/resources-readers/publications/epidemiology-uninitiated . Accessed 1 July 2024.</Citation></Reference><Reference><Citation>Iverson GL, Castellani RJ, Cassidy JD, et al. Examining later-in-life health risks associated with sport-related concussion and repetitive head impacts: a systematic review of case-control and cohort studies. Br J Sports Med. 2023;57:810&#x2013;21. https://doi.org/10.1136/bjsports-2023-106890 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bjsports-2023-106890</ArticleId><ArticleId IdType=\"pubmed\">37316187</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieniek KF, Cairns NJ, Crary JF, et al. The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol. 2021;80:210&#x2013;9. https://doi.org/10.1093/jnen/nlab001 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jnen/nlab001</ArticleId><ArticleId IdType=\"pubmed\">33611507</ArticleId><ArticleId IdType=\"pmc\">7899277</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Cairns NJ, Dickson DW, et al. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol (Berl). 2016;131:75&#x2013;86. https://doi.org/10.1007/s00401-015-1515-z .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-015-1515-z</ArticleId><ArticleId IdType=\"pubmed\">26667418</ArticleId></ArticleIdList></Reference><Reference><Citation>Omalu B, Bailes J, Hamilton RL, et al. Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes. Neurosurgery. 2011;69:173&#x2013;83. https://doi.org/10.1227/NEU.0b013e318212bc7b .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1227/NEU.0b013e318212bc7b</ArticleId><ArticleId IdType=\"pubmed\">21358359</ArticleId></ArticleIdList></Reference><Reference><Citation>Mez J, Daneshvar DH, Kiernan PT, et al. Clinicopathological evaluation of chronic traumatic encephalopathy in players of American Football. JAMA. 2017;318:360&#x2013;70. https://doi.org/10.1001/jama.2017.8334 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2017.8334</ArticleId><ArticleId IdType=\"pubmed\">28742910</ArticleId><ArticleId IdType=\"pmc\">5807097</ArticleId></ArticleIdList></Reference><Reference><Citation>Montenigro PH, Baugh CM, Daneshvar DH, et al. Clinical subtypes of chronic traumatic encephalopathy: literature review and proposed research diagnostic criteria for traumatic encephalopathy syndrome. Alzheimers Res Ther. 2014;6:68. https://doi.org/10.1186/s13195-014-0068-z .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-014-0068-z</ArticleId><ArticleId IdType=\"pubmed\">25580160</ArticleId><ArticleId IdType=\"pmc\">4288217</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett BL, Wilmoth K, Cummings P, et al. The neuropathological and clinical diagnostic criteria of chronic traumatic encephalopathy: a critical examination in relation to other neurodegenerative diseases. J Alzheimers Dis. 2019;68:591&#x2013;608. https://doi.org/10.3233/JAD-181058 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-181058</ArticleId><ArticleId IdType=\"pubmed\">30856113</ArticleId></ArticleIdList></Reference><Reference><Citation>Mez J, Alosco ML, Daneshvar DH, et al. Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology. Alzheimers Dement. 2021;17:1709&#x2013;24. https://doi.org/10.1002/alz.12338 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.12338</ArticleId><ArticleId IdType=\"pubmed\">33826224</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz DI, Bernick C, Dodick DW, et al. National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for traumatic encephalopathy syndrome. Neurology. 2021;96:848&#x2013;63. https://doi.org/10.1212/WNL.0000000000011850 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000011850</ArticleId><ArticleId IdType=\"pubmed\">33722990</ArticleId><ArticleId IdType=\"pmc\">8166432</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry DP, Jo J, Williams K, et al. Examining the new consensus criteria for traumatic encephalopathy syndrome in community-dwelling older adults. J Neurotrauma. 2024. https://doi.org/10.1089/neu.2023.0601 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/neu.2023.0601</ArticleId><ArticleId IdType=\"pubmed\">38661540</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry DP, Bishay AE, Rigney GH, et al. Symptoms of traumatic encephalopathy syndrome are common in community-dwelling adults. Sports Med. 2024. https://doi.org/10.1007/s40279-024-02029-w .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40279-024-02029-w</ArticleId><ArticleId IdType=\"pubmed\">38918303</ArticleId><ArticleId IdType=\"pmc\">11393129</ArticleId></ArticleIdList></Reference><Reference><Citation>Iverson GL, Kissinger-Knox A, Huebschmann NA, et al. A narrative review of psychiatric features of traumatic encephalopathy syndrome as conceptualized in the 20th century. Front Neurol. 2023;14:1214814. https://doi.org/10.3389/fneur.2023.1214814 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2023.1214814</ArticleId><ArticleId IdType=\"pubmed\">37545715</ArticleId><ArticleId IdType=\"pmc\">10401603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash TL, VanderWeele TJ, Haneuse S, et al. Modern epidemiology. 4th ed. Philadelphia: LWW; 2021.</Citation></Reference><Reference><Citation>McNutt L-A, Wu C, Xue X, et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157:940&#x2013;3. https://doi.org/10.1093/aje/kwg074 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/kwg074</ArticleId><ArticleId IdType=\"pubmed\">12746247</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Cantu RC, Nowinski CJ, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol. 2009;68:709&#x2013;35. https://doi.org/10.1097/NEN.0b013e3181a9d503 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/NEN.0b013e3181a9d503</ArticleId><ArticleId IdType=\"pubmed\">19535999</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieniek KF, Ross OA, Cormier KA, et al. Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank. Acta Neuropathol (Berl). 2015;130:877&#x2013;89. https://doi.org/10.1007/s00401-015-1502-4 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-015-1502-4</ArticleId><ArticleId IdType=\"pubmed\">26518018</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab N, Wennberg R, Grenier K, et al. Association of position played and career duration and chronic traumatic encephalopathy at autopsy in elite football and hockey players. Neurology. 2021;96:e1835&#x2013;43. https://doi.org/10.1212/WNL.0000000000011668 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000011668</ArticleId><ArticleId IdType=\"pubmed\">33627496</ArticleId><ArticleId IdType=\"pmc\">8105967</ArticleId></ArticleIdList></Reference><Reference><Citation>Suter CM, Affleck AJ, Lee M, et al. Chronic traumatic encephalopathy in Australia: the first three years of the Australian Sports Brain Bank. Med J Aust. 2022;216:530&#x2013;1. https://doi.org/10.5694/mja2.51420 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5694/mja2.51420</ArticleId><ArticleId IdType=\"pubmed\">35144312</ArticleId><ArticleId IdType=\"pmc\">9305557</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinberg LT, Anghinah R, Nascimento CF, et al. Chronic traumatic encephalopathy presenting as Alzheimer&#x2019;s disease in a retired soccer player. J Alzheimers Dis. 2016;54:169&#x2013;74. https://doi.org/10.3233/JAD-160312 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-160312</ArticleId><ArticleId IdType=\"pubmed\">27472879</ArticleId><ArticleId IdType=\"pmc\">5293758</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart W, McNamara PH, Lawlor B, et al. Chronic traumatic encephalopathy: a potential late and under recognized consequence of rugby union? QJM. 2016;109:11&#x2013;5. https://doi.org/10.1093/qjmed/hcv070 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/qjmed/hcv070</ArticleId><ArticleId IdType=\"pubmed\">25998165</ArticleId></ArticleIdList></Reference><Reference><Citation>Arena JD, Smith DH, Lee EB, et al. Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer&#x2019;s disease. Brain. 2020;143:1572&#x2013;87. https://doi.org/10.1093/brain/awaa071 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awaa071</ArticleId><ArticleId IdType=\"pubmed\">32390044</ArticleId><ArticleId IdType=\"pmc\">7241956</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling H. Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players. Acta Neuropathol. 2017;16:337&#x2013;52.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-017-1680-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepreux S, Auriacombe S, Vital C, et al. Dementia pugilistica: a severe tribute to a career. 2015;6. https://doi.org/10.5414/NP300838</Citation></Reference><Reference><Citation>Ling H, Holton JL, Shaw K, et al. Histological evidence of chronic traumatic encephalopathy in a large series of neurodegenerative diseases. Acta Neuropathol (Berl). 2015;130:891&#x2013;3. https://doi.org/10.1007/s00401-015-1496-y .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-015-1496-y</ArticleId><ArticleId IdType=\"pubmed\">26497674</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieniek KF, Blessing MM, Heckman MG, et al. Association between contact sports participation and chronic traumatic encephalopathy: a retrospective cohort study. Brain Pathol. 2020;30:63&#x2013;74. https://doi.org/10.1111/bpa.12757 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/bpa.12757</ArticleId><ArticleId IdType=\"pubmed\">31199537</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameen-Ali KE, Bretzin A, Lee EB, et al. Detection of astrocytic tau pathology facilitates recognition of chronic traumatic encephalopathy neuropathologic change. Acta Neuropathol Commun. 2022;10:50. https://doi.org/10.1186/s40478-022-01353-4 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-022-01353-4</ArticleId><ArticleId IdType=\"pubmed\">35410438</ArticleId><ArticleId IdType=\"pmc\">8996534</ArticleId></ArticleIdList></Reference><Reference><Citation>Priemer DS, Iacono D, Rhodes CH, et al. Chronic traumatic encephalopathy in the brains of military personnel. N Engl J Med. 2022;386:2169&#x2013;77. https://doi.org/10.1056/NEJMoa2203199 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa2203199</ArticleId><ArticleId IdType=\"pubmed\">35675177</ArticleId></ArticleIdList></Reference><Reference><Citation>Postupna N, Rose SE, Gibbons LE, et al. The delayed neuropathological consequences of traumatic brain injury in a community-based sample. Front Neurol. 2021;12:624696. https://doi.org/10.3389/fneur.2021.624696</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2021.624696</ArticleId><ArticleId IdType=\"pubmed\">33796061</ArticleId><ArticleId IdType=\"pmc\">8008107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K, Kim S-I, Lee Y, et al. An autopsy proven child onset chronic traumatic encephalopathy. Exp Neurobiol. 2017;26:172&#x2013;7. https://doi.org/10.5607/en.2017.26.3.172 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5607/en.2017.26.3.172</ArticleId><ArticleId IdType=\"pubmed\">28680303</ArticleId><ArticleId IdType=\"pmc\">5491586</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaetz M. The multi-factorial origins of Chronic Traumatic Encephalopathy (CTE) symptomology in post-career athletes: The athlete post-career adjustment (AP-CA) model. Med Hypotheses. 2017;102:130&#x2013;43. https://doi.org/10.1016/j.mehy.2017.03.023 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2017.03.023</ArticleId><ArticleId IdType=\"pubmed\">28478818</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelps A, Mez J, Stern RA, et al. Risk factors for chronic traumatic encephalopathy: a proposed framework. Semin Neurol. 2020;40:439&#x2013;49. https://doi.org/10.1055/s-0040-1713633 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1055/s-0040-1713633</ArticleId><ArticleId IdType=\"pubmed\">32674182</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieniek KF, Blessing MM, Heckman MG, et al. Association between contact sports participation and chronic traumatic encephalopathy: a retrospective cohort study. Brain Pathol. 2019;12:63&#x2013;74.</Citation></Reference><Reference><Citation>Iverson GL, Luoto TM, Karhunen PJ, et al. Mild chronic traumatic encephalopathy neuropathology in people with no known participation in contact sports or history of repetitive neurotrauma. J Neuropathol Exp Neurol. 2019;78:615&#x2013;25. https://doi.org/10.1093/jnen/nlz045 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jnen/nlz045</ArticleId><ArticleId IdType=\"pubmed\">31169877</ArticleId><ArticleId IdType=\"pmc\">6581557</ArticleId></ArticleIdList></Reference><Reference><Citation>Iverson GL, Gardner AJ, Shultz SR, et al. Chronic traumatic encephalopathy neuropathology might not be inexorably progressive or unique to repetitive neurotrauma. Brain. 2019;142:3672&#x2013;93. https://doi.org/10.1093/brain/awz286 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awz286</ArticleId><ArticleId IdType=\"pubmed\">31670780</ArticleId><ArticleId IdType=\"pmc\">6906593</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldfinger MH, Ling H, Tilley BS, et al. The aftermath of boxing revisited: identifying chronic traumatic encephalopathy pathology in the original Corsellis boxer series. Acta Neuropathol (Berl). 2018;136:973&#x2013;4. https://doi.org/10.1007/s00401-018-1926-8 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-018-1926-8</ArticleId><ArticleId IdType=\"pubmed\">30377771</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash TL, Rothman KJ, et al. Chapter 14: Selection bias and generalizability. In: Lash TL, VanderWeele TJ, Haneuse S, et al., editors. Modern epidemiology. Philadelphia: Wolters Kluwer; 2021. p. 315&#x2013;31.</Citation></Reference><Reference><Citation>LeClair J, Weuve J, Fox MP, et al. Relationship between level of American Football playing and diagnosis of chronic traumatic encephalopathy in a selection bias analysis. Am J Epidemiol. 2022;191:1429&#x2013;43. https://doi.org/10.1093/aje/kwac075 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/kwac075</ArticleId><ArticleId IdType=\"pubmed\">35434739</ArticleId><ArticleId IdType=\"pmc\">9989358</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S. For and against methodologies: some perspectives on recent causal and statistical inference debates. Eur J Epidemiol. 2017;32:3&#x2013;20. https://doi.org/10.1007/s10654-017-0230-6 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10654-017-0230-6</ArticleId><ArticleId IdType=\"pubmed\">28220361</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash TL, et al. Chapter 29: Bias analysis. In: Lash TL, VanderWeele TJ, Haneuse S, et al., editors. Modern epidemiology. Philadelphia: Wolters Kluwer; 2021. p. 711&#x2013;54.</Citation></Reference><Reference><Citation>VanderWeele TJ, Lash TL, Rothman KJ, et al. Causal inference and scientific reasoning. In: Lash TL, VanderWeele TJ, Haneuse S, et al., editors. Modern epidemiology. Philadelphia: Wolters Kluwer; 2021. p. 17&#x2013;31.</Citation></Reference><Reference><Citation>Asken BM, Sullan MJ, Snyder AR, et al. Factors Influencing Clinical Correlates of Chronic Traumatic Encephalopathy (CTE): a Review. Neuropsychol Rev. 2016;26:340&#x2013;63. https://doi.org/10.1007/s11065-016-9327-z .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11065-016-9327-z</ArticleId><ArticleId IdType=\"pubmed\">27561662</ArticleId><ArticleId IdType=\"pmc\">5507554</ArticleId></ArticleIdList></Reference><Reference><Citation>van Amerongen S, Caton DK, Ossenkoppele R, et al. Rationale and design of the &#x201c;NEurodegeneration: Traumatic brain injury as Origin of the Neuropathology (NEwTON)&#x201d; study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathy. Alzheimers Res Ther. 2022;14:1&#x2013;11. https://doi.org/10.1186/s13195-022-01059-8 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-022-01059-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett BL, Kerr ZY, Walton SR, et al. Longitudinal trajectory of depression symptom severity and the influence of concussion history and physical function over a 19-year period among former National Football League (NFL) players: an NFL-LONG Study. J Neurol Neurosurg Psychiatry. 2022;93:272&#x2013;9. https://doi.org/10.1136/jnnp-2021-326602 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jnnp-2021-326602</ArticleId><ArticleId IdType=\"pubmed\">34663623</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapter 19: Epidemiology and Public Policy. Gordis epidemiology. Philadelphia, PA: Elsevier; 2019.</Citation></Reference><Reference><Citation>Patrick DL, Cheadle A, Thompson DC, et al. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84:1086&#x2013;93. https://doi.org/10.2105/AJPH.84.7.1086 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2105/AJPH.84.7.1086</ArticleId><ArticleId IdType=\"pubmed\">8017530</ArticleId><ArticleId IdType=\"pmc\">1614767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PN, Forey BA, Coombs KJ. Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer. 2012;12:1&#x2013;90. https://doi.org/10.1186/1471-2407-12-385 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2407-12-385</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand KP, Finkel AM. A decision-analytic approach to addressing the evidence about football and chronic traumatic encephalopathy. Semin Neurol. 2020;40:450&#x2013;60. https://doi.org/10.1055/s-0039-1688484 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1055/s-0039-1688484</ArticleId><ArticleId IdType=\"pubmed\">31311037</ArticleId></ArticleIdList></Reference><Reference><Citation>Alosco ML, Stern RA. Youth Exposure to repetitive head impacts from tackle football and long-term neurologic outcomes: a review of the literature, knowledge gaps and future directions, and societal and clinical implications. Semin Pediatr Neurol. 2019;30:107&#x2013;16. https://doi.org/10.1016/j.spen.2019.03.016 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.spen.2019.03.016</ArticleId><ArticleId IdType=\"pubmed\">31235012</ArticleId></ArticleIdList></Reference><Reference><Citation>Iverson GL, B&#xfc;ttner F, Caccese JB. Age of first exposure to contact and collision sports and later in life brain health: a narrative review. Front Neurol. 2021;12: 727089. https://doi.org/10.3389/fneur.2021.727089 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2021.727089</ArticleId><ArticleId IdType=\"pubmed\">34659092</ArticleId><ArticleId IdType=\"pmc\">8511696</ArticleId></ArticleIdList></Reference><Reference><Citation>Black AM, Macpherson AK, Hagel BE, et al. Policy change eliminating body checking in non-elite ice hockey leads to a threefold reduction in injury and concussion risk in 11- and 12-year-old players. Br J Sports Med. 2016;50:55&#x2013;61. https://doi.org/10.1136/bjsports-2015-095103 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bjsports-2015-095103</ArticleId><ArticleId IdType=\"pubmed\">26702018</ArticleId></ArticleIdList></Reference><Reference><Citation>Black AM, Hagel BE, Palacios-Derflingher L, et al. The risk of injury associated with body checking among Pee Wee ice hockey players: an evaluation of Hockey Canada&#x2019;s national body checking policy change. Br J Sports Med. 2017;51:1767&#x2013;72. https://doi.org/10.1136/bjsports-2016-097392 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bjsports-2016-097392</ArticleId><ArticleId IdType=\"pubmed\">28279963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingram BM, Kay MC, Vander Vegt CB, et al. The effect of body checking policy changes on concussion incidence in Canadian Male Youth Ice Hockey Players: a critically appraised topic. J Sport Rehabil. 2019;28:774&#x2013;7. https://doi.org/10.1123/jsr.2018-0102 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1123/jsr.2018-0102</ArticleId><ArticleId IdType=\"pubmed\">30300048</ArticleId></ArticleIdList></Reference><Reference><Citation>Krolikowski MP, Black AM, Palacios-Derflingher L, et al. The effect of the &#x2018;Zero Tolerance for Head Contact&#x2019; rule change on the risk of concussions in youth ice hockey players. Am J Sports Med. 2017;45:468&#x2013;73. https://doi.org/10.1177/0363546516669701 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0363546516669701</ArticleId><ArticleId IdType=\"pubmed\">27789471</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon DM, Badenhorst M, Brown J, et al. Concussion education for New Zealand high school rugby players: a mixed-method analysis of the impact on concussion knowledge, attitudes and reporting behaviours. Int J Sports Sci Coach. 2023. https://doi.org/10.1177/17479541231156159 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/17479541231156159</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedimyer AK, Chandran A, Kossman MK, et al. Concussion knowledge, attitudes, and norms: how do they relate? PLoS ONE. 2023;18: e0282061. https://doi.org/10.1371/journal.pone.0282061 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0282061</ArticleId><ArticleId IdType=\"pubmed\">36812182</ArticleId><ArticleId IdType=\"pmc\">9946210</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekkers OM, Vandenbroucke JP, Cevallos M, et al. COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology. PLOS Med. 2019;16: e1002742. https://doi.org/10.1371/journal.pmed.1002742 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pmed.1002742</ArticleId><ArticleId IdType=\"pubmed\">30789892</ArticleId><ArticleId IdType=\"pmc\">6383865</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemieniuk R, Guyatt G. What is GRADE? | BMJ Best Practice. https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/ . Accessed 13 Nov 2023.</Citation></Reference><Reference><Citation>Kristman VL, Borg J, Godbolt AK, et al. Methodological issues and research recommendations for prognosis after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis. Arch Phys Med Rehabil. 2014;95:S265-277. https://doi.org/10.1016/j.apmr.2013.04.026 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.apmr.2013.04.026</ArticleId><ArticleId IdType=\"pubmed\">24581912</ArticleId></ArticleIdList></Reference><Reference><Citation>Priestley DR, Staph J, Koneru SD, et al. Establishing ground truth in the traumatic brain injury literature: if replication is the answer, then what are the questions? Brain Commun. 2022;5:fcac322. https://doi.org/10.1093/braincomms/fcac322 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/braincomms/fcac322</ArticleId><ArticleId IdType=\"pubmed\">36601624</ArticleId><ArticleId IdType=\"pmc\">9806718</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajtmajer SM, Errington TM, Hillary FG. How failure to falsify in high-volume science contributes to the replication crisis. Elife. 2022;11: e78830. https://doi.org/10.7554/eLife.78830 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7554/eLife.78830</ArticleId><ArticleId IdType=\"pubmed\">35939392</ArticleId><ArticleId IdType=\"pmc\">9398444</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman EJ, Hein MJ, Baron SL, et al. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79:1970&#x2013;4. https://doi.org/10.1212/WNL.0b013e31826daf50 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0b013e31826daf50</ArticleId><ArticleId IdType=\"pubmed\">22955124</ArticleId><ArticleId IdType=\"pmc\">4098841</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay DF, Russell ER, Stewart K, et al. Neurodegenerative disease mortality among former professional soccer players. N Engl J Med. 2019;381:1801&#x2013;8. https://doi.org/10.1056/NEJMoa1908483 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa1908483</ArticleId><ArticleId IdType=\"pubmed\">31633894</ArticleId><ArticleId IdType=\"pmc\">8747032</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron SL, Hein MJ, Lehman E, et al. Body mass index, playing position, race, and the cardiovascular mortality of retired professional football players. Am J Cardiol. 2012;109:889&#x2013;96. https://doi.org/10.1016/j.amjcard.2011.10.050 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.amjcard.2011.10.050</ArticleId><ArticleId IdType=\"pubmed\">22284915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincoln AE, Vogel RA, Allen TW, et al. Risk and Causes of Death among Former National Football League Players (1986&#x2013;2012). Med Sci Sports Exerc. 2018;50:486&#x2013;93. https://doi.org/10.1249/MSS.0000000000001466 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1249/MSS.0000000000001466</ArticleId><ArticleId IdType=\"pubmed\">29077640</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman KA, Hain JA, Graham NSN, et al. Prospective cohort study of long-term neurological outcomes in retired elite athletes: the Advanced BiomaRker, Advanced Imaging and Neurocognitive (BRAIN) Health Study protocol. BMJ Open. 2024;14: e082902. https://doi.org/10.1136/bmjopen-2023-082902 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmjopen-2023-082902</ArticleId><ArticleId IdType=\"pubmed\">38663922</ArticleId><ArticleId IdType=\"pmc\">11043776</ArticleId></ArticleIdList></Reference><Reference><Citation>The Football Players Health Study. Harv. Footb. Play. Health Study. https://footballplayershealth.harvard.edu/ . Accessed 24 June 2024.</Citation></Reference><Reference><Citation>CLEAATS&#x2014;College LEvel Aging AThlete Study. https://cleaats.com/ . Accessed 24 June 2024.</Citation></Reference><Reference><Citation>Bernick C, Banks S, Phillips M, et al. Professional fighters brain health study: rationale and methods. Am J Epidemiol. 2013;178:280&#x2013;6. https://doi.org/10.1093/aje/kws456 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/kws456</ArticleId><ArticleId IdType=\"pubmed\">23735309</ArticleId></ArticleIdList></Reference><Reference><Citation>ICHIRF: International Concussion and Head Injury Research Foundation&#x2014;a clinic researching long term effects of head injuries and concussions. https://ichirf.org/ . Accessed 24 June 2024.</Citation></Reference><Reference><Citation>Mahar I, Alosco ML, McKee AC. Psychiatric phenotypes in chronic traumatic encephalopathy. Neurosci Biobehav Rev. 2017;83:622&#x2013;30. https://doi.org/10.1016/j.neubiorev.2017.08.023 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2017.08.023</ArticleId><ArticleId IdType=\"pubmed\">28888534</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuller C, Drawer S. The application of risk management in sport. Sports Med. 2004;34:349&#x2013;56. https://doi.org/10.2165/00007256-200434060-00001 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2165/00007256-200434060-00001</ArticleId><ArticleId IdType=\"pubmed\">15157119</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39277808</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1868-1891</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>16</Day></PubDate></JournalIssue><Title>Hormone molecular biology and clinical investigation</Title><ISOAbbreviation>Horm Mol Biol Clin Investig</ISOAbbreviation></Journal><ArticleTitle>Evaluation of the effect of taurine on the matrix metalloproteinase-9 and the expression changes of miRNA-21 and miRNA-146a in SH-SY5Y cell line.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1515/hmbci-2024-0005</ELocationID><Abstract><AbstractText Label=\"OBJECTIVES\" NlmCategory=\"OBJECTIVE\">Alzheimer's disease (AD), a brain disorder, is the leading cause of dementia among older adults. Taurine, an amino acid abundantly present in the brain, and shows potential neuroprotective properties. Therefore, we investigated the effects of taurine on Matrix Metalloproteinase-9 (MMP-9) levels and the expression changes of miRNA-21 and miRNA-146a in the SH-SY5Y cell line.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">Taurine's impact on the SH-SY5Y cell line was evaluated via the 2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. MMP-9 levels were measured using an enzyme-linked immunosorbent assay (ELISA) kit, while the expression of miRNA-21 and miRNA-146a genes was assessed through Real-Time PCR analysis.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">The MTT assay revealed no toxic effects on SH-SY5Y cells with increasing concentrations of taurine. Analysis of gene expression indicated a rise in miRNA-21 expression and a decline in miRNA-146 expression with increasing taurine concentration, with the most notable change observed at 1&#x202f;mg/mL taurine (p&lt;0.001). ELISA results demonstrated a significant increase in MMP-9 levels in the SH-SY5Y cell line treated with 1&#x202f;mg/mL taurine compared to the untreated group (p&lt;0.001).</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">Our study revealed that taurine can alter the expression of miRNA-146a and miRNA-21. In conclusion, taurine therapy presents promising therapeutic avenues for treating AD or mitigating severe symptoms. Nonetheless, further research is necessary to comprehensively grasp the precise mechanisms at play.</AbstractText><CopyrightInformation>&#xa9; 2024 Walter de Gruyter GmbH, Berlin/Boston.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Al-Attabi</LastName><ForeName>Abduladheem</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0001-8403-7465</Identifier><AffiliationInfo><Affiliation>College of Medicine, 294060 University of Thi-Qar , Al-Nasiriya, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mukhlif</LastName><ForeName>Bilal Abdulmajeed</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratories Techniques, College of Health and Medical Technology, University of Al Maarif, Al Anbar, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Al-Shami</LastName><ForeName>Karrar R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Forensic Sciences, College of Science, National University of Science and Technology, Dhi Qar, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Merza</LastName><ForeName>Muna S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Prosthetic Dental Techniques Department, Al-Mustaqbal, University College, Hillah, Babylon, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Alkubaisy</LastName><ForeName>Sami Awad</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Desert Studies Center, University of Anbar, Al-Anbar, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Abdulhadi</LastName><ForeName>Mohanad Ali</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, College of Medicine, University of Anbar, Ramadi City, Al-Anbar Governorate, Iraq.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Horm Mol Biol Clin Investig</MedlineTA><NlmUniqueID>101538885</NlmUniqueID><ISSNLinking>1868-1883</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">matrix metalloproteinase-9</Keyword><Keyword MajorTopicYN=\"N\">miRNA-146a</Keyword><Keyword MajorTopicYN=\"N\">miRNA-21</Keyword><Keyword MajorTopicYN=\"N\">taurine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>7</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39277808</ArticleId><ArticleId IdType=\"doi\">10.1515/hmbci-2024-0005</ArticleId><ArticleId IdType=\"pii\">hmbci-2024-0005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barber, AJ. Inflammaging in the Alzheimer&#x2019;s brain and beyond: insights from a transgenic mouse model on the sex-specific pathophysiology of Alzheimer&#x2019;s disease . Hanover, New Hampshire: Dartmouth Digital Commons; 2024.</Citation></Reference><Reference><Citation>Radagdam, S, Khaki-Khatibi, F, Rahbarghazi, R, Shademan, B, Nourazarian, SM, Nikanfar, M, et al.. Evaluation of dihydrotestosterone and dihydroprogesterone levels and gene expression of genes involved in neurosteroidogenesis in the SH-SY5Y Alzheimer disease cell model. Front Neurosci 2023;17:1163806. https://doi.org/10.3389/fnins.2023.1163806 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2023.1163806</ArticleId></ArticleIdList></Reference><Reference><Citation>Golde, TE. Disease-modifying therapies for Alzheimer&#x2019;s disease: more questions than answers. Neurotherapeutics 2023;19:209&#x2013;27. https://doi.org/10.1007/s13311-022-01201-2 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13311-022-01201-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Shademan, B, Zakeri, M, Abbasi, S, Avci, CB, Karamad, V, Sogutlu, F, et al.. Relationship between miRNA-21, miRNA-155, and miRNA-182 expression and inflammatory factors in cerebrospinal fluid from patients with multiple sclerosis. Clin Neurol Neurosurg 2023;232:107873. https://doi.org/10.1016/j.clineuro.2023.107873 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clineuro.2023.107873</ArticleId></ArticleIdList></Reference><Reference><Citation>Rov&#x10d;anin Dragovi&#x107;, I, Popovi&#x107;, N, &#x17d;dralevi&#x107;, M, Radulovi&#x107;, L, Vukovi&#x107;, T, Marzano, F, et al.. Inflammation-related microRNAs-146a and-155 are upregulated in mild cognitive impairment subjects among older age population in Montenegro. J Alzheim Dis 2022;90:625&#x2013;38. https://doi.org/10.3233/jad-220676 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/jad-220676</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, G, Huang, Y, Wang, LL, Zhang, YF, Xu, J, Zhou, Y, et al.. MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer&#x2019;s disease. Sci Rep 2016;6:26697. https://doi.org/10.1038/srep26697 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/srep26697</ArticleId></ArticleIdList></Reference><Reference><Citation>Yashooa, RK, Nabi, AQ. The miR-146a-5p and miR-125b-5p levels as biomarkers for early prediction of Alzheimer&#x2019;s disease. Human Gene 2022;34:201129. https://doi.org/10.1016/j.humgen.2022.201129 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.humgen.2022.201129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, C, Liu, J, Duan, F, Cong, L, Qi, X. The role of the microRNA regulatory network in Alzheimer&#x2019;s disease: a bioinformatics analysis. Arch Med Sci: AMS 2022;18:206. https://doi.org/10.5114/aoms/80619 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5114/aoms/80619</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia, G, Pinto, S, Ferreira, S, Lopes, D, Serrador, MJ, Fernandes, A, et al.. Emerging role of miR-21-5p in neuron&#x2013;glia dysregulation and exosome transfer using multiple models of Alzheimer&#x2019;s disease. Cells 2022;11:3377. https://doi.org/10.3390/cells11213377 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells11213377</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, W, Tan, Z, Chen, Y, Li, X, Liu, H. Clinical efficacy of modified shuyu pill for mild and moderate Alzheimer&#x2019;s disease and its effects on expression of IL-1&#x3b2;/NF-&#x3ba;B/miR-146a in peripheral blood. Chin J Integr Tradition Chin Western Med. 2019;39:668&#x2013;75.</Citation></Reference><Reference><Citation>Beygi, M, Oroojalian, F, Azizi-Arani, S, Hosseini, SS, Mokhtarzadeh, A, Kesharwani, P, et al.. Multifunctional nanotheranostics for overcoming the blood&#x2013;brain barrier. Adv Funct Mater 2024;34:2310881. https://doi.org/10.1002/adfm.202310881 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/adfm.202310881</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer, HR, Tuan, RS. Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies. Stem Cell Res Ther 2016;7:1&#x2013;4. https://doi.org/10.1186/s13287-016-0394-0 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13287-016-0394-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Radosinska, D, Radosinska, J. The link between matrix metalloproteinases and Alzheimer&#x2019;s disease pathophysiology. Mol Neurobiol 2024;27:1&#x2013;5. https://doi.org/10.1007/s12035-024-04315-0 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-024-04315-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh, SJ, Lee, HJ, Jeong, YJ, Nam, KR, Kang, KJ, Han, SJ, et al.. Evaluation of the neuroprotective effect of taurine in Alzheimer&#x2019;s disease using functional molecular imaging. Sci Rep 2020;10:15551. https://doi.org/10.1038/s41598-020-72755-4 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-020-72755-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Santa-Mar&#xed;a, I, Hern&#xe1;ndez, F, Moreno, FJ, Avila, J. Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-&#x3b2;-peptide aggregation. Neurosci Lett 2007;429:91&#x2013;4. https://doi.org/10.1016/j.neulet.2007.09.068 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2007.09.068</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, Y, Fan, W, Ma, Z, Wen, X, Wang, W, Wu, Q, et al.. Taurine improves functional and histological outcomes and reduces inflammation in traumatic brain injury. Neuroscience 2014;266:56&#x2013;65. https://doi.org/10.1016/j.neuroscience.2014.02.006 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroscience.2014.02.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossato, RC, Granato, AE, de Oliveira Moraes, CD, Salles, GN, Soares, CP. Neuroprotective effects of taurine on SH-SY5Y cells under hydrocortisone induced stress. Res Soc Dev 2021;10:e55510918426. https://doi.org/10.33448/rsd-v10i9.18426 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.33448/rsd-v10i9.18426</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, M, Bi, LF, Fang, JH, Su, XL, Da, GL, Kuwamori, T, et al.. Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 2004;26:267&#x2013;71. https://doi.org/10.1007/s00726-003-0059-z .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00726-003-0059-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzie, J, Prentice, H, Wu, J-Y. Neuroprotective mechanisms of taurine against ischemic stroke. Brain Sci 2013;3:877&#x2013;907. https://doi.org/10.3390/brainsci3020877 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/brainsci3020877</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa, S, Katto, M, Kouyama, H, Nishida, I, Kikumori, M, Taniguchi, Y, et al.. Repeated dose toxicity study of intravenous treatment with taurine for 13&#xa0;weeks and recovery test for 5&#xa0;weeks in rat. J Jpn Phamacol Ther 1991;19:275&#x2013;306.</Citation></Reference><Reference><Citation>Cantafora, A, Mantovani, A, Masella, R, Mechelli, L, Alvaro, D. Effect of taurine administration on liver lipids in Guinea pig. Experientia 1986;42:407&#x2013;8. https://doi.org/10.1007/bf02118631 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/bf02118631</ArticleId></ArticleIdList></Reference><Reference><Citation>Canfr&#xe1;n-Duque, A, Rotllan, N, Zhang, X, Fern&#xe1;ndez-Fuertes, M, Ram&#xed;rez-Hidalgo, C, Araldi, E, et al.. Macrophage deficiency of miR-21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis. EMBO Mol Med 2017;9:1244&#x2013;62. https://doi.org/10.15252/emmm.201607492 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.201607492</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng, MG, Liu, CF, Chen, LI, Feng, WB, Liu, M, Hai, H, et al.. MiR-21 attenuates apoptosis-triggered by amyloid-&#x3b2; via modulating PDCD4/PI3K/AKT/GSK-3&#x3b2; pathway in SH-SY5Y cells. Biomed Pharmacother 2018;101:1003&#x2013;7. https://doi.org/10.1016/j.biopha.2018.02.043 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2018.02.043</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, S, Hu, Y, Deng, S, Deng, J, Yu, X, Huang, G, et al.. miR-146a regulates inflammatory cytokine production in Porphyromonas gingivalis lipopolysaccharide-stimulated B&#xa0;cells by targeting IRAK1 but not TRAF6. Biochim Biophys Acta 2018;1864:925&#x2013;33. https://doi.org/10.1016/j.bbadis.2017.12.035 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2017.12.035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, W, Wang, Q, Guo, Y, Zhao, Y, Wang, X, Zhang, Z, et al.. Selenium suppresses inflammation by inducing microRNA-146a in Staphylococcus aureus-infected mouse mastitis model. Oncotarget 2017;8:110949. https://doi.org/10.18632/oncotarget.20740 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.20740</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldeira, C, Cunha, C, Vaz, AR, Falc&#xe3;o, AS, Barateiro, A, Seixas, E, et al.. Key aging-associated alterations in primary microglia response to beta-amyloid stimulation. Front Aging Neurosci 2017;9:277. https://doi.org/10.3389/fnagi.2017.00277 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2017.00277</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierksma, A, Lu, A, Salta, E, Vanden Eynden, E, Callaerts-Vegh, Z, D&#x2019;hooge, R, et al.. Deregulation of neuronal mirnas induced by amyloid-? or tau pathology. Mol Neurodegener 2018;13:54. https://doi.org/10.1186/s13024-018-0285-1 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-018-0285-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong, B, Ji, W, Chen, X, Li, P, Cheng, W, Zhao, Y, et al.. Recent advancements in strategies for abnormal protein clearance in Alzheimer&#x2019;s disease. Mini Rev Med Chem 2022;22:2260&#x2013;70. https://doi.org/10.2174/1389557522666220214092824 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1389557522666220214092824</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39277785</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1741-2684</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Dementia (London, England)</Title><ISOAbbreviation>Dementia (London)</ISOAbbreviation></Journal><ArticleTitle><i>\"You just can't do that in dementia care\":</i> Barriers to partnership working within dementia services for people from south Asian communities.</ArticleTitle><Pagination><StartPage>14713012241283189</StartPage><MedlinePgn>14713012241283189</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1177/14713012241283189</ELocationID><Abstract><AbstractText><b>Background:</b> People from South Asian communities are under-represented at all levels of dementia services. Consequently, there is pressure for the statutory sector to deliver services in partnership with Voluntary, Community, Faith and Social Enterprises (VCFSEs). This study set out to explore the constraints to effective partnership working which prevent dementia care from being delivered in an equitable way.<b>Methods:</b> Data collection consisted of two phases. First, we interviewed seven people with experience of partnership working and developed three fictional vignettes that were representative of the challenges they faced. We then used these vignettes to stimulate discussion in focus groups and interviews with 13 VCFSE and 16 statutory sector participants. Data was analysed using deductive thematic analysis.<b>Findings:</b> Three themes were developed during the analysis. First, White British-centric services focused on the challenges for statutory services in meeting the needs of South Asians, developing flexible, responsive services and making inclusive partnership working truly meaningful. Second, VCFSE participants (but not statutory service participants) associated a failure to deliver effective partnership working with unconscious bias operating within systems, leading to the devaluing of their expertise and to their views being ignored. Finally, participants emphasised the need to prioritise relationships if they were to meet the challenges of developing partnership working.<b>Conclusion:</b> We identified three constraints acting to prevent effective partnership working. First, the different meanings that statutory and VCFSE participants attach to challenges threatens their ability to develop a shared understanding of the needs of communities. Second, a reluctance to explicitly address service deficiencies can mean that stereotypes remain unaddressed. Finally, while both parties lacked power to change the fundamentals of service delivery, power and resources were also unbalanced with VCSFE services being more reliant on the statutory sector.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Cheston</LastName><ForeName>R</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0002-7466-3777</Identifier><AffiliationInfo><Affiliation>School of Social Sciences, University of the West of England, UK.</Affiliation><Identifier Source=\"RINGGOLD\">1981</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dodd</LastName><ForeName>E</ForeName><Initials>E</Initials><Identifier Source=\"ORCID\">0000-0002-9505-257X</Identifier><AffiliationInfo><Affiliation>School of Health and Social Wellbeing, University of the West of England, UK.</Affiliation><Identifier Source=\"RINGGOLD\">1981</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Smith</LastName><ForeName>P</ForeName><Initials>P</Initials><Identifier Source=\"ORCID\">0000-0002-2945-8694</Identifier><AffiliationInfo><Affiliation>Department of Psychology, University of Bath, UK.</Affiliation><Identifier Source=\"RINGGOLD\">1555</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Woodstoke</LastName><ForeName>N S</ForeName><Initials>NS</Initials><Identifier Source=\"ORCID\">0000-0002-5794-4577</Identifier><AffiliationInfo><Affiliation>School of Social Sciences, University of the West of England, UK.</Affiliation><Identifier Source=\"RINGGOLD\">1981</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jutlla</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Education, Health and Wellbeing, University of Wolverhampton, UK.</Affiliation><Identifier Source=\"RINGGOLD\">8695</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fry</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Applied Dementia Studies, Faculty of Health, University of Bradford, UK.</Affiliation><Identifier Source=\"RINGGOLD\">1905</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Truswell</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Dementia Alliance for Culture and Ethnicity, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Butt</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Race Equality Foundation, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Parveen</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Applied Dementia Studies, Faculty of Health, University of Bradford, UK.</Affiliation><Identifier Source=\"RINGGOLD\">1905</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dementia (London)</MedlineTA><NlmUniqueID>101128698</NlmUniqueID><ISSNLinking>1471-3012</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">accessibility of health services</Keyword><Keyword MajorTopicYN=\"N\">caregivers</Keyword><Keyword MajorTopicYN=\"N\">community health care</Keyword><Keyword MajorTopicYN=\"N\">minority health</Keyword><Keyword MajorTopicYN=\"N\">voluntary health agencies</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>0</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39277785</ArticleId><ArticleId IdType=\"doi\">10.1177/14713012241283189</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39277689</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2399-3642</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>Live-cell visualization of tau aggregation in human neurons.</ArticleTitle><Pagination><StartPage>1143</StartPage><MedlinePgn>1143</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s42003-024-06840-z</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) and more than twenty other dementias, termed tauopathies, are pathologically defined by insoluble aggregates of the microtubule-associated protein tau (MAPT). Although tau aggregation correlates with AD symptomology, the specific tau species, i.e., monomers, soluble oligomers, and insoluble aggregates that induce neurotoxicity are incompletely understood. We developed a light-responsive tau protein (optoTAU) and used viscosity-sensitive AggFluor probes to investigate the consequence(s) of tau aggregation in human neurons and identify modifiers of tau aggregation in AD and other tauopathies. We determined that optoTAU reproduces biological and structural properties of tau aggregation observed in human brains and the pathophysiological transition in tau solubility in live cells. We also provide proof-of-concept for the utilization of optoTAU as a pharmacological platform to identify modifiers of tau aggregation. These findings have broad implications for the characterization of aggregation-prone proteins and investigation of the complex relationship between protein solubility, cellular function, and disease progression.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Hurtle</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Donnelly</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LiveLikeLou Center for ALS Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Protein Conformational Diseases, Kenneth P. Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><Identifier Source=\"ORCID\">0000-0001-6686-1645</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, School of Science and Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Thathiah</LastName><ForeName>Amantha</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-3132-4409</Identifier><AffiliationInfo><Affiliation>Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. amantha@pitt.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. amantha@pitt.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. amantha@pitt.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Protein Conformational Diseases, Kenneth P. Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, PA, USA. amantha@pitt.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>T32 Ag024827</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016875\">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C054369\">MAPT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D066329\">Protein Aggregates</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D016875\" MajorTopicYN=\"Y\">tau Proteins</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009474\" MajorTopicYN=\"Y\">Neurons</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D066263\" MajorTopicYN=\"Y\">Protein Aggregation, Pathological</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D066329\" MajorTopicYN=\"N\">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D024801\" MajorTopicYN=\"N\">Tauopathies</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"N\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012995\" MajorTopicYN=\"N\">Solubility</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39277689</ArticleId><ArticleId IdType=\"doi\">10.1038/s42003-024-06840-z</ArticleId><ArticleId IdType=\"pii\">10.1038/s42003-024-06840-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hippius, H. &amp; Neund&#xf6;rfer, G. The discovery of Alzheimer&#x2019;s disease. Dialogues Clin. Neurosci. 5, 101&#x2013;108 (2003).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22034141</ArticleId><ArticleId IdType=\"pmc\">3181715</ArticleId><ArticleId IdType=\"doi\">10.31887/DCNS.2003.5.1/hhippius</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugger, B. N. &amp; Dickson, D. W. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 9, a028035 (2017).</Citation></Reference><Reference><Citation>Nelson, P. T. et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J. Neuropathol. Exp. Neurol. 71, 362&#x2013;381 (2012).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22487856</ArticleId><ArticleId IdType=\"doi\">10.1097/NEN.0b013e31825018f7</ArticleId></ArticleIdList></Reference><Reference><Citation>Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T. &amp; Hyman, B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer&#x2019;s disease. Neurology 42, 631&#x2013;639 (1992).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1549228</ArticleId><ArticleId IdType=\"doi\">10.1212/WNL.42.3.631</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs, K. A. et al. Beta-amyloid burden is not associated with rates of brain atrophy. Ann. Neurol. 63, 204&#x2013;212 (2008).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17894374</ArticleId><ArticleId IdType=\"pmc\">2735194</ArticleId><ArticleId IdType=\"doi\">10.1002/ana.21223</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal, K., Liu, F., Gong, C. X. &amp; Grundke-Iqbal, I. Tau in Alzheimer disease and related tauopathies. Curr. Alzheimer Res. 7, 656&#x2013;664 (2010).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20678074</ArticleId><ArticleId IdType=\"pmc\">3090074</ArticleId><ArticleId IdType=\"doi\">10.2174/156720510793611592</ArticleId></ArticleIdList></Reference><Reference><Citation>Zempel, H. &amp; Mandelkow, E. Lost after translation: missorting of Tau protein and consequences for Alzheimer disease. Trends Neurosci. 37, 721&#x2013;732 (2014).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25223701</ArticleId><ArticleId IdType=\"doi\">10.1016/j.tins.2014.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, J. L. &amp; Lee, V. M. Y. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat. Med. 20, 130&#x2013;138 (2014).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24504409</ArticleId><ArticleId IdType=\"pmc\">4011661</ArticleId><ArticleId IdType=\"doi\">10.1038/nm.3457</ArticleId></ArticleIdList></Reference><Reference><Citation>Alquezar, C., Arya, S. &amp; Kao, A. W. Tau post-translational modifications: dynamic transformers of Tau function, degradation, and aggregation. Front. Neurol. 11, 595532 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33488497</ArticleId><ArticleId IdType=\"doi\">10.3389/fneur.2020.595532</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. &amp; Mandelkow, E. Tau in physiology and pathology. Nat. Rev. Neurosci. 17, 5&#x2013;21 (2016).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26631930</ArticleId><ArticleId IdType=\"doi\">10.1038/nrn.2015.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Binder, L. I., Frankfurter, A. &amp; Rebhun, L. I. The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101, 1371&#x2013;1378 (1985).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3930508</ArticleId><ArticleId IdType=\"doi\">10.1083/jcb.101.4.1371</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian, W. et al. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. J. Alzheimers Dis. 19, 1221&#x2013;1229 (2010).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20308788</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-2010-1317</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodea, L.-G., Eckert, A., Ittner, L. M., Piguet, O. &amp; G&#xf6;tz, J. Tau physiology and pathomechanisms in frontotemporal lobar degeneration. J. Neurochem. 138, 71&#x2013;94 (2016).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27306859</ArticleId><ArticleId IdType=\"pmc\">5094566</ArticleId><ArticleId IdType=\"doi\">10.1111/jnc.13600</ArticleId></ArticleIdList></Reference><Reference><Citation>Long, J. M. &amp; Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312&#x2013;339 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31564456</ArticleId><ArticleId IdType=\"pmc\">6778042</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2019.09.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Limorenko, G. &amp; Lashuel, H. A. Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies. Chem. Soc. Rev. 51, 513&#x2013;565 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34889934</ArticleId><ArticleId IdType=\"doi\">10.1039/D1CS00127B</ArticleId></ArticleIdList></Reference><Reference><Citation>Congdon, E. E. &amp; Sigurdsson, E. M. Tau-targeting therapies for Alzheimer disease. Nat. Rev. Neurol. 14, 399&#x2013;415 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29895964</ArticleId><ArticleId IdType=\"pmc\">6463489</ArticleId><ArticleId IdType=\"doi\">10.1038/s41582-018-0013-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadhav, S. et al. A walk through tau therapeutic strategies. Acta Neuropathol. Commun. 7, 22 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30767766</ArticleId><ArticleId IdType=\"pmc\">6376692</ArticleId><ArticleId IdType=\"doi\">10.1186/s40478-019-0664-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings, J. Alzheimer&#x2019;s disease drug development pipeline: 2019. Alzheimers Dement 5, 272&#x2013;293 (2019).</Citation></Reference><Reference><Citation>Lim, C. H. et al. Application of optogenetic Amyloid-&#x3b2; distinguishes between metabolic and physical damages in neurodegeneration. eLife 9, e52589 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32228858</ArticleId><ArticleId IdType=\"pmc\">7145416</ArticleId><ArticleId IdType=\"doi\">10.7554/eLife.52589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. et al. The proline-rich domain promotes Tau liquid-liquid phase separation in cells. J. Cell Biol. 219, e202006054 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32997736</ArticleId><ArticleId IdType=\"pmc\">7594490</ArticleId><ArticleId IdType=\"doi\">10.1083/jcb.202006054</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;rard, M. et al. Optogenetic-mediated spatiotemporal control of &#x3b1;-synuclein aggregation disrupts nigrostriatal transmission and precipitates neurodegeneration. SSRN J. https://doi.org/10.2139/ssrn.3416893 (2019).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2139/ssrn.3416893</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann, J. R. et al. RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron 102, 321&#x2013;338.e8 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30826182</ArticleId><ArticleId IdType=\"pmc\">6472983</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neuron.2019.01.048</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan, C. M. &amp; Mudher, A. Are tau aggregates toxic or protective in tauopathies? Front. Neurol. 4, 114 (2013).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23964266</ArticleId><ArticleId IdType=\"pmc\">3741634</ArticleId><ArticleId IdType=\"doi\">10.3389/fneur.2013.00114</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, L. et al. Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy. Mol. Cell 81, 4209&#x2013;4227.e12 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34453888</ArticleId><ArticleId IdType=\"pmc\">8541906</ArticleId><ArticleId IdType=\"doi\">10.1016/j.molcel.2021.07.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawano, F., Suzuki, H., Furuya, A. &amp; Sato, M. Engineered pairs of distinct photoswitches for optogenetic control of cellular proteins. Nat. Commun. 6, 6256 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25708714</ArticleId><ArticleId IdType=\"doi\">10.1038/ncomms7256</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoltowski, B. D., Vaccaro, B. &amp; Crane, B. R. Mechanism-based tuning of a LOV domain photoreceptor. Nat. Chem. Biol. 5, 827&#x2013;834 (2009).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19718042</ArticleId><ArticleId IdType=\"pmc\">2865183</ArticleId><ArticleId IdType=\"doi\">10.1038/nchembio.210</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoltowski, B. D. &amp; Crane, B. R. Light activation of the LOV protein vivid generates a rapidly exchanging dimer. Biochemistry 47, 7012&#x2013;7019 (2008).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18553928</ArticleId><ArticleId IdType=\"doi\">10.1021/bi8007017</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferri&#xe8;re, F. et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat. Neurosci. 22, 65&#x2013;77 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30559480</ArticleId><ArticleId IdType=\"doi\">10.1038/s41593-018-0294-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolstenholme, C. H. et al. AggFluor: fluorogenic toolbox enables direct visualization of the multi-step protein aggregation process in live cells. J. Am. Chem. Soc. 142, 17515&#x2013;17523 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32915553</ArticleId><ArticleId IdType=\"pmc\">8088285</ArticleId><ArticleId IdType=\"doi\">10.1021/jacs.0c07245</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y. et al. Modulation of fluorescent protein chromophores to detect protein aggregation with turn-on fluorescence. J. Am. Chem. Soc. 140, 7381&#x2013;7384 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29883112</ArticleId><ArticleId IdType=\"pmc\">6258209</ArticleId><ArticleId IdType=\"doi\">10.1021/jacs.8b02176</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidler, P. M. et al. Structure-based inhibitors of tau aggregation. Nat. Chem. 10, 170&#x2013;176 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29359764</ArticleId><ArticleId IdType=\"doi\">10.1038/nchem.2889</ArticleId></ArticleIdList></Reference><Reference><Citation>Mocanu, M.-M. et al. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 28, 737&#x2013;748 (2008).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18199773</ArticleId><ArticleId IdType=\"pmc\">6670355</ArticleId><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.2824-07.2008</ArticleId></ArticleIdList></Reference><Reference><Citation>Barghorn, S. et al. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. Biochemistry 39, 11714&#x2013;11721 (2000).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10995239</ArticleId><ArticleId IdType=\"doi\">10.1021/bi000850r</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu&#xe9;e, L., Bussi&#xe8;re, T., Bu&#xe9;e-Scherrer, V., Delacourte, A. &amp; Hof, P. R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95&#x2013;130 (2000).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10967355</ArticleId><ArticleId IdType=\"doi\">10.1016/S0165-0173(00)00019-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinoza, M., de Silva, R., Dickson, D. W. &amp; Davies, P. Differential incorporation of tau isoforms in Alzheimer&#x2019;s disease. J. Alzheimers Dis. 14, 1&#x2013;16 (2008).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18525123</ArticleId><ArticleId IdType=\"pmc\">2882247</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-2008-14101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesseling, H. et al. Tau PTM profiles identify patient heterogeneity and stages of Alzheimer&#x2019;s disease. Cell 183, 1699&#x2013;1713.e13 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33188775</ArticleId><ArticleId IdType=\"pmc\">8168922</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2020.10.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Strang, K. H., Golde, T. E. &amp; Giasson, B. I. MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab. Invest. 99, 912&#x2013;928 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30742061</ArticleId><ArticleId IdType=\"pmc\">7289372</ArticleId><ArticleId IdType=\"doi\">10.1038/s41374-019-0197-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, F. &amp; Gong, C.-X. Tau exon 10 alternative splicing and tauopathies. Mol. Neurodegener. 3, 8 (2008).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18616804</ArticleId><ArticleId IdType=\"pmc\">2483273</ArticleId><ArticleId IdType=\"doi\">10.1186/1750-1326-3-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick, A. W. P. et al. Cryo-EM structures of tau filaments from Alzheimer&#x2019;s disease. Nature 547, 185&#x2013;190 (2017).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28678775</ArticleId><ArticleId IdType=\"pmc\">5552202</ArticleId><ArticleId IdType=\"doi\">10.1038/nature23002</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi, S. H. et al. A three-dimensional human neural cell culture model of Alzheimer&#x2019;s disease. Nature 515, 274&#x2013;278 (2014).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25307057</ArticleId><ArticleId IdType=\"pmc\">4366007</ArticleId><ArticleId IdType=\"doi\">10.1038/nature13800</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochmair, J. et al. Molecular crowding and RNA synergize to promote phase separation, microtubule interaction, and seeding of Tau condensates. EMBO J. 41, e108882 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35298090</ArticleId><ArticleId IdType=\"pmc\">9156969</ArticleId><ArticleId IdType=\"doi\">10.15252/embj.2021108882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh, A. et al. Alzheimer&#x2019;s disease-related dysregulation of mRNA translation causes key pathological features with ageing. Transl. Psychiatry 10, 192 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32546772</ArticleId><ArticleId IdType=\"pmc\">7297996</ArticleId><ArticleId IdType=\"doi\">10.1038/s41398-020-00882-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenno, L., Yizhar, O. &amp; Deisseroth, K. The development and application of optogenetics. Annu. Rev. Neurosci. 34, 389&#x2013;412 (2011).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21692661</ArticleId><ArticleId IdType=\"pmc\">6699620</ArticleId><ArticleId IdType=\"doi\">10.1146/annurev-neuro-061010-113817</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, H. et al. Optogenetic protein clustering through fluorescent protein tagging and extension of CRY2. Nat. Commun. 8, 30 (2017).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28646204</ArticleId><ArticleId IdType=\"pmc\">5482817</ArticleId><ArticleId IdType=\"doi\">10.1038/s41467-017-00060-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiens, M. D. &amp; Campbell, R. E. Surveying the landscape of optogenetic methods for detection of protein-protein interactions. Wiley Interdiscip. Rev. Syst. Biol. Med. 10, e1415 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29334187</ArticleId><ArticleId IdType=\"pmc\">5902417</ArticleId><ArticleId IdType=\"doi\">10.1002/wsbm.1415</ArticleId></ArticleIdList></Reference><Reference><Citation>Redchuk, T. A. et al. Optogenetic regulation of endogenous proteins. Nat. Commun. 11, 605 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32001718</ArticleId><ArticleId IdType=\"pmc\">6992714</ArticleId><ArticleId IdType=\"doi\">10.1038/s41467-020-14460-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte, C. G. et al. Optogenetic TDP-43 nucleation induces persistent insoluble species and progressive motor dysfunction in vivo. Neurobiol. Dis. 146, 105078 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32927062</ArticleId><ArticleId IdType=\"pmc\">9040199</ArticleId><ArticleId IdType=\"doi\">10.1016/j.nbd.2020.105078</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39277604</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2041-1723</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease.</ArticleTitle><Pagination><StartPage>8061</StartPage><MedlinePgn>8061</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41467-024-52299-1</ELocationID><Abstract><AbstractText>Identifying concomitant Lewy body (LB) pathology through seed amplification assays (SAA) might enhance the diagnostic and prognostic work-up of Alzheimer's disease (AD) in clinical practice and trials. This study examined whether LB pathology exacerbates AD-related disease progression in 795 cognitively impaired individuals (Mild Cognitive Impairment and dementia) from the longitudinal multi-center observational ADNI cohort. Participants were on average 75 years of age (SD&#x2009;=&#x2009;7.89), 40.8% were female, 184 (23.1%) had no biomarker evidence of AD/LB pathology, 39 (4.9%) had isolated LB pathology (AD-LB+), 395 (49.7%) had only AD pathology (AD+LB-), and 177 (22.3%) had both pathologies (AD+LB+). The AD+LB+ group showed worst baseline performance for most cognitive outcomes and compared to the AD+LB- group faster global cognitive decline and more cortical hypometabolism, particularly in posterior brain regions. Neuropathological examination (n&#x2009;=&#x2009;61) showed high sensitivity (26/27, 96.3%) and specificity (27/28, 96.4%) of the SAA-test. We showed that co-existing LB-positivity exacerbates cognitive decline and cortical brain hypometabolism in AD. In vivo LB pathology detection could enhance prognostic evaluations in clinical practice and could have implications for clinical AD trial design.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Collij</LastName><ForeName>Lyduine E</ForeName><Initials>LE</Initials><Identifier Source=\"ORCID\">0000-0001-6263-1762</Identifier><AffiliationInfo><Affiliation>Clinical memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Faculty of Medicine, Lund University, Lund, Sweden. lyduine.collij@med.lu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands. lyduine.collij@med.lu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Imaging, Amsterdam Neuroscience, Amsterdam, the Netherlands. lyduine.collij@med.lu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mastenbroek</LastName><ForeName>Sophie E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Clinical memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Imaging, Amsterdam Neuroscience, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mattsson-Carlgren</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Sk&#xe5;ne University Hospital, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Strandberg</LastName><ForeName>Olof</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Clinical memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Smith</LastName><ForeName>Ruben</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0001-7147-0112</Identifier><AffiliationInfo><Affiliation>Clinical memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Janelidze</LastName><ForeName>Shorena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Palmqvist</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0002-9267-1930</Identifier><AffiliationInfo><Affiliation>Clinical memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ossenkoppele</LastName><ForeName>Rik</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0003-1584-7477</Identifier><AffiliationInfo><Affiliation>Clinical memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Faculty of Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology, Alzheimercenter Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurodegeneration, Amsterdam Neuroscience, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hansson</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><Identifier Source=\"ORCID\">0000-0001-8467-7286</Identifier><AffiliationInfo><Affiliation>Clinical memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Faculty of Medicine, Lund University, Lund, Sweden. oskar.hansson@med.lu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden. oskar.hansson@med.lu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>#101108819</GrantID><Agency>EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Sk&#x142;odowska-Curie Actions (H2020 Excellent Science - Marie Sk&#x142;odowska-Curie Actions)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016448\">Multicenter Study</PublicationType><PublicationType UI=\"D064888\">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName><QualifierName UI=\"Q000000981\" MajorTopicYN=\"N\">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D060825\" MajorTopicYN=\"Y\">Cognitive Dysfunction</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000000981\" MajorTopicYN=\"N\">diagnostic imaging</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001921\" MajorTopicYN=\"Y\">Brain</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000000981\" MajorTopicYN=\"N\">diagnostic imaging</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000369\" MajorTopicYN=\"N\">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016631\" MajorTopicYN=\"N\">Lewy Bodies</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018450\" MajorTopicYN=\"N\">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015415\" MajorTopicYN=\"N\">Biomarkers</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D049268\" MajorTopicYN=\"N\">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008137\" MajorTopicYN=\"N\">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008279\" MajorTopicYN=\"N\">Magnetic Resonance Imaging</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39277604</ArticleId><ArticleId IdType=\"doi\">10.1038/s41467-024-52299-1</ArticleId><ArticleId IdType=\"pii\">10.1038/s41467-024-52299-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeTure, M. A. &amp; Dickson, D. W. The neuropathological diagnosis of Alzheimer&#x2019;s disease. Mol. Neurodegener. 14, 32 (2019).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-019-0333-5</ArticleId><ArticleId IdType=\"pubmed\">31375134</ArticleId><ArticleId IdType=\"pmc\">6679484</ArticleId></ArticleIdList></Reference><Reference><Citation>Spina, S. et al. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer&#x2019;s disease. Brain 144, 2186&#x2013;2198 (2021).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awab099</ArticleId><ArticleId IdType=\"pubmed\">33693619</ArticleId><ArticleId IdType=\"pmc\">8502474</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo, G. et al. &#x3b1;-Synuclein seed amplification assays for diagnosing synucleinopathies. Way Forw. 99, 195&#x2013;205 (2022).</Citation></Reference><Reference><Citation>Bargar, C. et al. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson&#x2019;s disease and dementia with Lewy bodies. Acta Neuropathol. Commun. 9, 62 (2021).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-021-01175-w</ArticleId><ArticleId IdType=\"pubmed\">33827706</ArticleId><ArticleId IdType=\"pmc\">8028088</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall, S. et al. Performance of &#x3b1;Synuclein RT-QuIC in relation to neuropathological staging of Lewy body disease. Acta Neuropathol. Commun. 10, 90 (2022).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-022-01388-7</ArticleId><ArticleId IdType=\"pubmed\">35733234</ArticleId><ArticleId IdType=\"pmc\">9219141</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi, M. et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 140, 49&#x2013;62 (2020).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-020-02160-8</ArticleId><ArticleId IdType=\"pubmed\">32342188</ArticleId><ArticleId IdType=\"pmc\">7299922</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold, M. R. et al. &#x3b1;-Synuclein seed amplification in CSF and brain from patients with different brain distributions of pathological &#x3b1;-Synuclein in the context of co-pathology and Non-LBD diagnoses. Ann. Neurol. 92, 650&#x2013;662 (2022).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.26453</ArticleId><ArticleId IdType=\"pubmed\">35808984</ArticleId><ArticleId IdType=\"pmc\">9489647</ArticleId></ArticleIdList></Reference><Reference><Citation>Siderowf, A. et al. Assessment of heterogeneity among participants in the Parkinson&#x2019;s Progression Markers Initiative cohort using &#x3b1;-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 22, 407&#x2013;417 (2023).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(23)00109-6</ArticleId><ArticleId IdType=\"pubmed\">37059509</ArticleId><ArticleId IdType=\"pmc\">10627170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, U. J. et al. Comparative study of cerebrospinal fluid &#x3b1;-synuclein seeding aggregation assays for diagnosis of Parkinson&#x2019;s disease. Mov. Disord. 34, 536&#x2013;544 (2019).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mds.27646</ArticleId><ArticleId IdType=\"pubmed\">30840785</ArticleId><ArticleId IdType=\"pmc\">6519150</ArticleId></ArticleIdList></Reference><Reference><Citation>Quadalti, C. et al. Clinical effects of Lewy body pathology in cognitively impaired individuals. Nat. Med. 29, 1964&#x2013;1970 (2023).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-023-02449-7</ArticleId><ArticleId IdType=\"pubmed\">37464058</ArticleId><ArticleId IdType=\"pmc\">10427416</ArticleId></ArticleIdList></Reference><Reference><Citation>Chetelat, G. et al. Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer&#x2019;s disease and other dementias. Lancet Neurol. 19, 951&#x2013;962 (2020).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(20)30314-8</ArticleId><ArticleId IdType=\"pubmed\">33098804</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley, R. F. et al. Sex, amyloid, and APOE &#x3b5;4 and risk of cognitive decline in preclinical Alzheimer&#x2019;s disease: findings from three well-characterized cohorts. Alzheimer&#x2019;s Dement. 14, 1193&#x2013;1203 (2018).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2018.04.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Landau, S. M. et al. Individuals with Alzheimer&#x2019;s disease and low tau burden: characteristics and implications. Alzheimer&#x2019;s Dement. 20, 2113&#x2013;2127 (2024).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryman, S. G. et al. Cognition at each stage of Lewy Body Disease with co-occurring Alzheimer&#x2019;s disease pathology. J. Alzheimers Dis. 80, 1243&#x2013;1256 (2021).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-201187</ArticleId><ArticleId IdType=\"pubmed\">33646154</ArticleId><ArticleId IdType=\"pmc\">8150665</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto, A. et al. CSF alpha-synuclein aggregates by seed amplification and clinical presentation of AD. Alzheimers Dement 19, 3754&#x2013;3759 (2023).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13109</ArticleId><ArticleId IdType=\"pubmed\">37102457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantarci, K. et al. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD. Neuroimage Clin. 31, 102754 (2021).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nicl.2021.102754</ArticleId><ArticleId IdType=\"pubmed\">34252877</ArticleId><ArticleId IdType=\"pmc\">8278422</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Rodr&#xed;guez, J. et al. Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology. Brain 146, 4520&#x2013;4531 (2023).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awad194</ArticleId><ArticleId IdType=\"pubmed\">37284793</ArticleId><ArticleId IdType=\"pmc\">10629761</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Rodr&#xed;guez, J. et al. Differential effects of Tau Stage, Lewy Body Pathology, and substantia Nigra degeneration on 18F-FDG PET patterns in clinical Alzheimer disease. J. Nucl. Med. 64, 274&#x2013;280 (2023).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2967/jnumed.122.264213</ArticleId><ArticleId IdType=\"pubmed\">36008119</ArticleId><ArticleId IdType=\"pmc\">9902861</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89, 88&#x2013;100 (2017).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000004058</ArticleId><ArticleId IdType=\"pubmed\">28592453</ArticleId><ArticleId IdType=\"pmc\">5496518</ArticleId></ArticleIdList></Reference><Reference><Citation>Bongianni, M. et al. &#x3b1;-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies. Ann. Clin. Transl. Neurol. 6, 2120&#x2013;2126 (2019).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/acn3.50897</ArticleId><ArticleId IdType=\"pubmed\">31599499</ArticleId><ArticleId IdType=\"pmc\">6801172</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin, J. et al. &#x3b1;&#x2010;Synuclein seed amplification assay detects Lewy body co&#x2010;pathology in autosomal dominant Alzheimer&#x2019;s disease late in the disease course and dependent on Lewy pathology burden. Alzheimer&#x2019;s Dement. 20, 4351&#x2013;4365 (2024).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotzbauer, P. T., Trojanowski, J. Q. &amp; Lee, V. M. Y. Lewy body pathology in Alzheimer&#x2019;s disease. J. Mol. Neurosci. 17, 225&#x2013;232 (2001).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1385/JMN:17:2:225</ArticleId><ArticleId IdType=\"pubmed\">11816795</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton, R. L. Lewy bodies in Alzheimer&#x2019;s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 10, 378&#x2013;384 (2000).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1750-3639.2000.tb00269.x</ArticleId><ArticleId IdType=\"pubmed\">10885656</ArticleId></ArticleIdList></Reference><Reference><Citation>Popescu, A., Lippa, C. F., Lee, V. M.-Y. &amp; Trojanowski, J. Q. Lewy Bodies in the Amygdala: increase of &#x3b1;-Synuclein aggregates in neurodegenerative diseases with Tau-based inclusions. Arch. Neurol. 61, 1915&#x2013;1919 (2004).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archneur.61.12.1915</ArticleId><ArticleId IdType=\"pubmed\">15596612</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippa, C. F. et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer&#x2019;s disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 153, 1365&#x2013;1370 (1998).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0002-9440(10)65722-7</ArticleId><ArticleId IdType=\"pubmed\">9811326</ArticleId><ArticleId IdType=\"pmc\">1853391</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist, S. et al. Cognitive effects of Lewy body pathology in clinically unimpaired individuals. Nat. Med. 29, 1971&#x2013;1978 (2023).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-023-02450-0</ArticleId><ArticleId IdType=\"pubmed\">37464059</ArticleId><ArticleId IdType=\"pmc\">10427420</ArticleId></ArticleIdList></Reference><Reference><Citation>McAleese, K. E. et al. TDP-43 pathology in Alzheimer&#x2019;s disease, dementia with Lewy bodies and ageing. Brain Pathol. 27, 472&#x2013;479 (2017).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/bpa.12424</ArticleId><ArticleId IdType=\"pubmed\">27495267</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs, K. A. et al. TDP-43 is a key player in the clinical features associated with Alzheimer&#x2019;s disease. Acta Neuropathol. 127, 811&#x2013;824 (2014).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-014-1269-z</ArticleId><ArticleId IdType=\"pubmed\">24659241</ArticleId><ArticleId IdType=\"pmc\">4172544</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs, K. A. et al. TAR DNA-binding protein 43 and pathological subtype of Alzheimer&#x2019;s disease impact clinical features. Ann. Neurol. 78, 697&#x2013;709 (2015).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.24493</ArticleId><ArticleId IdType=\"pubmed\">26224156</ArticleId><ArticleId IdType=\"pmc\">4623932</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow, K. et al. Predicting clinical decline and conversion to Alzheimer&#x2019;s disease or dementia using novel Elecsys A&#x3b2;(1&#x2013;42), pTau and tTau CSF immunoassays. Sci. Rep. 9, 19024 (2019).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-54204-z</ArticleId><ArticleId IdType=\"pubmed\">31836810</ArticleId><ArticleId IdType=\"pmc\">6911086</ArticleId></ArticleIdList></Reference><Reference><Citation>Donohue, M. C. et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 71, 961&#x2013;970 (2014).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaneurol.2014.803</ArticleId><ArticleId IdType=\"pubmed\">24886908</ArticleId><ArticleId IdType=\"pmc\">4439182</ArticleId></ArticleIdList></Reference><Reference><Citation>Donohue, M. C. et al. Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons. Jama 317, 2305&#x2013;2316 (2017).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2017.6669</ArticleId><ArticleId IdType=\"pubmed\">28609533</ArticleId><ArticleId IdType=\"pmc\">5736301</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi, S. E. et al. Development and validation of language and visuospatial composite scores in ADNI. Alzheimers Dement (N.Y.) 6, e12072 (2020).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/trc2.12072</ArticleId><ArticleId IdType=\"pubmed\">33313380</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagust, W. J. et al. The Alzheimer&#x2019;s Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement 6, 221&#x2013;229 (2010).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2010.03.003</ArticleId><ArticleId IdType=\"pubmed\">20451870</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewert, S. et al. Toward defining deep brain stimulation targets in MNI space: a subcortical atlas based on multimodal MRI, histology and structural connectivity. Neuroimage 170, 271&#x2013;282 (2018).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2017.05.015</ArticleId><ArticleId IdType=\"pubmed\">28536045</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin, E. E. et al. Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer&#x2019;s Disease Neuroimaging Initiative 2 participants. Alzheimers Dement 11, 815&#x2013;822 (2015).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2015.05.010</ArticleId><ArticleId IdType=\"pubmed\">26194314</ArticleId></ArticleIdList></Reference><Reference><Citation>Montine, T. J. et al. National Institute on aging-Alzheimer&#x2019;s Association guidelines for the neuropathologic assessment of Alzheimer&#x2019;s disease: a practical approach. Acta Neuropathol. 123, 1&#x2013;11 (2012).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-011-0910-3</ArticleId><ArticleId IdType=\"pubmed\">22101365</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65, 1863&#x2013;1872 (2005).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/01.wnl.0000187889.17253.b1</ArticleId><ArticleId IdType=\"pubmed\">16237129</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz, G. Estimating the dimension of a model. Ann. Stat. 6, 461&#x2013;464 (1978).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39277207</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2044-6055</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Temporal trends in mortality and causes of death in patients with incident atrial fibrillation: a nationwide register study from 2010 to 2018.</ArticleTitle><Pagination><StartPage>e080836</StartPage><MedlinePgn>e080836</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1136/bmjopen-2023-080836</ELocationID><Abstract><AbstractText Label=\"OBJECTIVES\" NlmCategory=\"OBJECTIVE\">Atrial fibrillation (AF) is associated with increased mortality. Previous studies have reported conflicting results in temporal trends of mortality after AF diagnosis. We aim to address this disparity by investigating the 1-year mortality and causes of death in Finnish patients diagnosed with AF between 2010 and 2017.</AbstractText><AbstractText Label=\"DESIGN\" NlmCategory=\"METHODS\">The Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) study is a nationwide retrospective register-based cohort study.</AbstractText><AbstractText Label=\"SETTING\" NlmCategory=\"METHODS\">The FinACAF study has gathered information on all Finnish AF patients between 2004 and 2018, with information from all national healthcare registers and data from all levels of care (primary, secondary and tertiary care).</AbstractText><AbstractText Label=\"PARTICIPANTS\" NlmCategory=\"METHODS\">We included patients with an incident AF diagnosis (International Classification of Diseases, 10th Revision code I48) between 2010 and 2017. To ensure a cohort of only incident AF, we excluded patients who used any oral anticoagulant during the year before cohort entry as well as patients with a recorded use of warfarin between 2004 and 2006. Patients under 20 years of age were excluded, and patients with permanent migration abroad before 1 January 2019 were excluded, N=157&#x2009;658.</AbstractText><AbstractText Label=\"PRIMARY OUTCOME MEASURES\" NlmCategory=\"METHODS\">1-year all-cause, cardiovascular (CV) and cause-specific mortality following AF diagnosis.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">The study cohort consisted of 157 658 incident AF cases (50.1% male, mean age 72.9 years). Both all-cause and CV mortality declined from cohort entry years 2010-2017 (from 12.9% to 10.6%, mortality rate ratio (MRR) 0.77; 95%&#x2009;CI 0.73 to 0.82 in cohort entry year 2017 with 2010 as reference; and from 7.4% to 5.2%, MRR 0.68; 95%&#x2009;CI 0.63 to 0.74, respectively). Overall mortality and CV mortality were lower in women than in men throughout the study period (MRR 0.66; 95%&#x2009;CI 0.63 to 0.69 and MRR 0.53; 95%&#x2009;CI 0.50 to 0.56, respectively). Deaths attributable to ischaemic heart disease decreased during the study period (from 30.7% to 21.6%, MRR 0.51; 95%&#x2009;CI 0.49 to 0.62 in 2017 vs 2010), whereas dementia and Alzheimer's disease increased as a cause of death over time (6.2% to 9.9%, MRR 1.19; 95%&#x2009;CI 0.96 to 1.48 in 2017 vs 2010). The CHA<sub>2</sub>DS<sub>2</sub>-VASc score associated strongly with 1-year survival (p&lt;0.0001).</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">Our study reiterates that mortality after diagnosis of AF has decreased. The CHA<sub>2</sub>DS<sub>2</sub>-VASc score highlights the need to treat comorbidities as it strongly associates with patient 1-year survival after initial AF diagnosis.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kouki</LastName><ForeName>Elis</ForeName><Initials>E</Initials><Identifier Source=\"ORCID\">0000-0002-5759-0916</Identifier><AffiliationInfo><Affiliation>University of Helsinki Faculty of Medicine, Helsinki, Finland elis.kouki@helsinki.fi.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Salmela</LastName><ForeName>Birgitta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Internal Medicine, P&#xe4;ij&#xe4;t-H&#xe4;me Central Hospital, Lahti, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Aro</LastName><ForeName>Aapo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Heart and Lung Center, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Halminen</LastName><ForeName>Olli</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Aalto University, Espoo, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Teppo</LastName><ForeName>Konsta</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>TYKS Turku University Hospital, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Haukka</LastName><ForeName>Jari</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0003-1450-6208</Identifier><AffiliationInfo><Affiliation>University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Putaala</LastName><ForeName>Jukka</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0002-6630-6104</Identifier><AffiliationInfo><Affiliation>University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Linna</LastName><ForeName>Mika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aalto University, Espoo, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Eastern Finland Faculty of Health Sciences, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mustonen</LastName><ForeName>Pirjo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>TYKS Turku University Hospital, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hartikainen</LastName><ForeName>Juha</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kuopio University Hospital, Kuopio, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Airaksinen</LastName><ForeName>Juhani K E</ForeName><Initials>JKE</Initials><Identifier Source=\"ORCID\">0000-0002-0193-568X</Identifier><AffiliationInfo><Affiliation>TYKS Turku University Hospital, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lehto</LastName><ForeName>Mika</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0002-8691-5142</Identifier><AffiliationInfo><Affiliation>Heart and Lung Center, Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Jorvi Hospital, Espoo, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000925\">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001281\" MajorTopicYN=\"Y\">Atrial Fibrillation</DescriptorName><QualifierName UI=\"Q000401\" MajorTopicYN=\"N\">mortality</QualifierName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012042\" MajorTopicYN=\"Y\">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005387\" MajorTopicYN=\"N\" Type=\"Geographic\">Finland</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002423\" MajorTopicYN=\"Y\">Cause of Death</DescriptorName><QualifierName UI=\"Q000639\" MajorTopicYN=\"N\">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012189\" MajorTopicYN=\"N\">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000369\" MajorTopicYN=\"N\">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000925\" MajorTopicYN=\"N\">Anticoagulants</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">adult cardiology</Keyword><Keyword MajorTopicYN=\"N\">cardiology</Keyword><Keyword MajorTopicYN=\"N\">cardiovascular disease</Keyword><Keyword MajorTopicYN=\"N\">electronic health records</Keyword></KeywordList><CoiStatement>Competing interests: EK: none. BS: Speaker: BMS, Boehringer Ingelheim, Pfizer; Advisory board: Pfizer. AA: Research grants: Finnish Foundation for Cardiovascular Research; Speaker: Abbott, Johnson &amp; Johnson, Sanofi, Bayer, Boehringer-Ingelheim. OH: none. KT: The Finnish Foundation for Cardiovascular Research. JHaukka: Consultant: Research Janssen R&amp;D; Speaker: Bayer Finland. JP: Consultant: Boehringer-Ingelheim, Bayer, BMS-Pfizer, Abbott/St. Jude Medical, Vital Signum, Nokia Technologies, Bittium, BcB Medical, Herantis Pharma, Medixine and Portola. Speaker: Boehringer-Ingelheim, Bayer, BMS-Pfizer and Terve Media; Research grants: BMS-Pfizer, Abbott/St. Jude Medical, Business Finland, and Amgen. MLinna: Speaker: BMS-Pfizer-alliance, Bayer, Boehringer-Ingelheim. PM: Consultant: Roche, BMS-Pfizer-alliance, Novartis Finland, Boehringer Ingelheim, MSD Finland. JHartikainen: Research grants: The Finnish Foundation for Cardiovascular Research, Advisory Board Member: BMS-Pfizeralliance, Novo Nordisk, Amgen. Speaker: Cardiome, Bayer. JKEA Research grants: The Finnish Foundation for Cardiovascular Research; Speaker: Bayer, Pfizer and Boehringer-Ingelheim. Member in the advisory boards: Bayer, Pfizer and AstraZeneca. MLehto: Consultant: BMS-Pfizer-alliance, Bayer, Boehringer-Ingelheim and MSD; Speaker: BMS-Pfizer-alliance, Bayer, Boehringer-Ingelheim, MSD, Terve Media and Orion Pharma. Research grants: Aarne Koskelo Foundation, The Finnish Foundation for Cardiovascular Research, and Helsinki and Uusimaa Hospital District research fund.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39277207</ArticleId><ArticleId IdType=\"doi\">10.1136/bmjopen-2023-080836</ArticleId><ArticleId IdType=\"pii\">bmjopen-2023-080836</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39276955</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1096-1186</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Pharmacological research</Title><ISOAbbreviation>Pharmacol Res</ISOAbbreviation></Journal><ArticleTitle>Role of histone deacetylases and their inhibitors in neurological diseases.</ArticleTitle><Pagination><StartPage>107410</StartPage><MedlinePgn>107410</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.phrs.2024.107410</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1043-6618(24)00355-4</ELocationID><Abstract><AbstractText>Histone deacetylases (HDACs) are zinc-dependent deacetylases that remove acetyl groups from lysine residues of histones or form protein complexes with other proteins for transcriptional repression, changing chromatin structure tightness, and inhibiting gene expression. Recent in vivo and in vitro studies have amply demonstrated the critical role of HDACs in the cell biology of the nervous system during both physiological and pathological processes and have provided new insights into the conduct of research on neurological disease targets. In addition, in vitro and in vivo studies on HDAC inhibitors show promise for the treatment of various diseases. This review summarizes the regulatory mechanisms of HDAC and the important role of its downstream targets in nervous system diseases, and summarizes the therapeutic mechanisms and efficacy of HDAC inhibitors in various nervous system diseases. Additionally, the current pharmacological situation, problems, and developmental prospects of HDAC inhibitors are described. A better understanding of the pathogenic mechanisms of HDACs in the nervous system may reveal new targets for therapeutic interventions in diseases and help to relieve healthcare pressure through preventive measures.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Li-Ying</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, PICU, Shengjing Hospital of China Medical University, Shenyang 110004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Sen-Yu</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, PICU, Shengjing Hospital of China Medical University, Shenyang 110004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wen</LastName><ForeName>Ri</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, PICU, Shengjing Hospital of China Medical University, Shenyang 110004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Tie-Ning</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, PICU, Shengjing Hospital of China Medical University, Shenyang 110004, China. Electronic address: cmuztn@vip.qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Ni</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, PICU, Shengjing Hospital of China Medical University, Shenyang 110004, China. Electronic address: yangni616@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Pharmacol Res</MedlineTA><NlmUniqueID>8907422</NlmUniqueID><ISSNLinking>1043-6618</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">4-phenylbutyric acid (PBA) (Pubchem CID:4775)</Keyword><Keyword MajorTopicYN=\"N\">5-Cinnamic acid (CNA)(Pubchem CID:444539)</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Belinostat (Pubchem CID:6918638)</Keyword><Keyword MajorTopicYN=\"N\">Benzamide(Pubchem CID:2331)</Keyword><Keyword MajorTopicYN=\"N\">Chidamide(Pubchem CID:9800555)</Keyword><Keyword MajorTopicYN=\"N\">Entinostat(Pubchem CID:4261)</Keyword><Keyword MajorTopicYN=\"N\">Givinostat/Duvyzat(Pubchem CID:9804992)</Keyword><Keyword MajorTopicYN=\"N\">Huntington&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">LMK235(Pubchem CID:71520717)</Keyword><Keyword MajorTopicYN=\"N\">MC1568(Pubchem CID:11381449)</Keyword><Keyword MajorTopicYN=\"N\">Panobinostat(Pubchem CID:6918837)</Keyword><Keyword MajorTopicYN=\"N\">Panobinostat(Pubchem CID:6918837).</Keyword><Keyword MajorTopicYN=\"N\">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Romidepsin(Pubchem CID:5352062)</Keyword><Keyword MajorTopicYN=\"N\">Sodium butyrate(Pubchem CID:5222465)</Keyword><Keyword MajorTopicYN=\"N\">Sodium phenylbutyrate(Pubchem CID:5258)</Keyword><Keyword MajorTopicYN=\"N\">Trichostatin A(Pubchem CID:444732)</Keyword><Keyword MajorTopicYN=\"N\">Ursodeoxycholic acid taurine(AMX0035)(Pubchem CID:129316491)</Keyword><Keyword MajorTopicYN=\"N\">Valproic acid(Pubchem CID:3121)</Keyword><Keyword MajorTopicYN=\"N\">Venlafaxine(Pubchem CID:5656)</Keyword><Keyword MajorTopicYN=\"N\">Vorinostat(Pubchem CID:5311)</Keyword><Keyword MajorTopicYN=\"N\">histone deacetylase</Keyword><Keyword MajorTopicYN=\"N\">histone deacetylase inhibitors</Keyword><Keyword MajorTopicYN=\"N\">neurological disease</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Declaration of interest The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39276955</ArticleId><ArticleId IdType=\"doi\">10.1016/j.phrs.2024.107410</ArticleId><ArticleId IdType=\"pii\">S1043-6618(24)00355-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39276773</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1097-4172</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>A developmental gradient reveals biosynthetic pathways to eukaryotic toxins in monocot geophytes.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0092-8674(24)00918-8</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.cell.2024.08.027</ELocationID><Abstract><AbstractText>Numerous eukaryotic toxins that accumulate in geophytic plants are valuable in the clinic, yet their biosynthetic pathways have remained elusive. A notable example is the &gt;150 Amaryllidaceae alkaloids (AmAs), including galantamine, an FDA-approved treatment for Alzheimer's disease. We show that while AmAs accumulate to high levels in many daffodil tissues, biosynthesis is localized to nascent, growing tissue at the leaf base. A similar trend is found in the production of steroidal alkaloids (e.g., cyclopamine) in corn lily. This model of active biosynthesis enabled the elucidation of a complete set of biosynthetic genes that can be used to produce AmAs. Taken together, our work sheds light on the developmental and enzymatic logic of diverse alkaloid biosynthesis in daffodils. More broadly, it suggests a paradigm for biosynthesis regulation in monocot geophytes, where plants are protected from herbivory through active charging of newly formed cells with eukaryotic toxins that persist as above-ground tissue develops.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Mehta</LastName><ForeName>Niraj</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Stanford University, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Meng</LastName><ForeName>Yifan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Stanford University, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zare</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Stanford University, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kamenetsky-Goldstein</LastName><ForeName>Rina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Plant Sciences, ARO, The Volcani Center, Rishon LeZion, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sattely</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA; HHMI, Stanford University, Stanford, CA 94305, USA. Electronic address: sattely@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">biosynthesis</Keyword><Keyword MajorTopicYN=\"N\">metabolism</Keyword><Keyword MajorTopicYN=\"N\">monocots</Keyword><Keyword MajorTopicYN=\"N\">plant toxins</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39276773</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2024.08.027</ArticleId><ArticleId IdType=\"pii\">S0092-8674(24)00918-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39276772</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1097-4172</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0092-8674(24)00912-7</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.cell.2024.08.024</ELocationID><Abstract><AbstractText>Protein aggregation causes a wide range of neurodegenerative diseases. Targeting and removing aggregates, but not the functional protein, is a considerable therapeutic challenge. Here, we describe a therapeutic strategy called \"RING-Bait,\" which employs an aggregating protein sequence combined with an E3 ubiquitin ligase. RING-Bait is recruited into aggregates, whereupon clustering dimerizes the RING domain and activates its E3 function, resulting in the degradation of the aggregate complex. We exemplify this concept by demonstrating the specific degradation of tau aggregates while sparing soluble tau. Unlike immunotherapy, RING-Bait is effective against both seeded and cell-autonomous aggregation. RING-Bait removed tau aggregates seeded from Alzheimer's disease (AD) and progressive supranuclear palsy (PSP) brain extracts and was also effective in primary neurons. We used a brain-penetrant adeno-associated virus (AAV) to treat P301S tau transgenic mice, reducing tau pathology and improving motor function. A RING-Bait strategy could be applied to other neurodegenerative proteinopathies by replacing the Bait sequence to match the target aggregate.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2024. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Miller</LastName><ForeName>Lauren V C</ForeName><Initials>LVC</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at the University of Cambridge, Department of Clinical Neurosciences, Hills Road, Cambridge CB2 0AH, UK; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK. Electronic address: lmiller@mrc-lmb.cam.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Papa</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK. Electronic address: gpapa@mrc-lmb.cam.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vaysburd</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cheng</LastName><ForeName>Shi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at the University of Cambridge, Department of Clinical Neurosciences, Hills Road, Cambridge CB2 0AH, UK; GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate, Regulation and Diseases, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sweeney</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Cancer Research UK Cambridge Institute, Robinson Way, Cambridge CB2 0RE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Smith</LastName><ForeName>Annabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at the University of Cambridge, Department of Clinical Neurosciences, Hills Road, Cambridge CB2 0AH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Franco</LastName><ForeName>Catarina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Katsinelos</LastName><ForeName>Taxiarchis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at the University of Cambridge, Department of Clinical Neurosciences, Hills Road, Cambridge CB2 0AH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Huang</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at the University of Cambridge, Department of Clinical Neurosciences, Hills Road, Cambridge CB2 0AH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sanford</LastName><ForeName>Sophie A I</ForeName><Initials>SAI</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at the University of Cambridge, Department of Clinical Neurosciences, Hills Road, Cambridge CB2 0AH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Benn</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at the University of Cambridge, Department of Clinical Neurosciences, Hills Road, Cambridge CB2 0AH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Farnsworth</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Higginson</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Joyner</LastName><ForeName>Holly</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>McEwan</LastName><ForeName>William A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at the University of Cambridge, Department of Clinical Neurosciences, Hills Road, Cambridge CB2 0AH, UK. Electronic address: wm305@cam.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>James</LastName><ForeName>Leo C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK. Electronic address: lcj@mrc-lmb.cam.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">TRIM21</Keyword><Keyword MajorTopicYN=\"N\">antibodies</Keyword><Keyword MajorTopicYN=\"N\">gene therapy</Keyword><Keyword MajorTopicYN=\"N\">neurobiology</Keyword><Keyword MajorTopicYN=\"N\">neurodegeneration</Keyword><Keyword MajorTopicYN=\"N\">protein engineering</Keyword><Keyword MajorTopicYN=\"N\">targeted protein degradation</Keyword><Keyword MajorTopicYN=\"N\">tauopathy</Keyword><Keyword MajorTopicYN=\"N\">ubiquitination</Keyword></KeywordList><CoiStatement>Declaration of interests L.V.C.M., G.P., W.A.M., and L.C.J. are listed as inventors on a patent containing data published in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39276772</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2024.08.024</ArticleId><ArticleId IdType=\"pii\">S0092-8674(24)00912-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39276722</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1873-5126</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>128</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>Parkinsonism &amp; related disorders</Title><ISOAbbreviation>Parkinsonism Relat Disord</ISOAbbreviation></Journal><ArticleTitle>The association between cigarette smoking and dementia with Lewy bodies.</ArticleTitle><Pagination><StartPage>107133</StartPage><MedlinePgn>107133</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.parkreldis.2024.107133</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1353-8020(24)01145-3</ELocationID><Abstract><AbstractText Label=\"INTRODUCTION\" NlmCategory=\"BACKGROUND\">Cigarette smoking is associated with a reduced risk of Parkinson's disease (PD). As dementia with Lewy bodies (DLB) and PD share core neuropathologic features, we set out to examine the relationship between smoking and DLB.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">Diagnosis at baseline visit and smoking history of participants &#x2265;50 years old in the National Alzheimer's Coordinating Center (NACC) cohort were evaluated in this cross-sectional study. Odds of diagnosis of cognitive impairment due to DLB, PD, vascular dementia (VD), or Alzheimer's disease (AD) compared to normal cognition based on smoking status and duration were determined using logistic regression.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">37,478 participants were included (mean age 72 years (SD 9), 57&#xa0;% female). The odds of DLB were reduced in all smoking status groups compared to never smokers (OR (95&#xa0;% CI)): ever smokers 0.850 (0.745-0.971), former smokers 0.871 (0.761-0.997), current smokers 0.640 (0.419-0.947)) and in all smoking duration groups. As expected, the odds of PD were reduced in all smoking groups and fell with longer smoking duration. The odds of VD were increased in the current smoking group and rose with greater smoking duration. The odds of AD were unchanged in current smokers, decreased in ever and former smokers, and increased with longer cumulative smoking duration.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">Cigarette smoking is associated with lower odds of diagnosis of DLB at baseline visit in the NACC cohort. In the context of the well-established reduced risk of PD among smokers, this preliminary evidence of a potential protective effect of smoking on DLB warrants further study.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Goodheart</LastName><ForeName>Anna E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Department of Neurology, Charlestown, MA, 02129, USA; Harvard Medical School, USA. Electronic address: agoodheart@mgb.org.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gomperts</LastName><ForeName>Stephen N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Department of Neurology, Charlestown, MA, 02129, USA; Harvard Medical School, USA. Electronic address: gomperts.stephen@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Parkinsonism Relat Disord</MedlineTA><NlmUniqueID>9513583</NlmUniqueID><ISSNLinking>1353-8020</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Cigarette smoking</Keyword><Keyword MajorTopicYN=\"N\">Dementia with Lewy bodies</Keyword><Keyword MajorTopicYN=\"N\">National Alzheimer's Coordinating Center</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Stephen Gomperts reports that financial support was provided by National Institutes of Health. Stephen Gomperts reports a relationship with The Michael J Fox Foundation that includes: funding grants. Stephen Gomperts reports a relationship with Farmer Family Foundation Parkinson's Research Initiative that includes: funding grants. Stephen Gomperts reports a relationship with US Office of&#xa0;Congressionally Directed Medical Research Programs&#xa0;that includes: funding grants. Stephen Gomperts has patent #PCT/US20/36433 pending to Massachusetts General Hospital.&#xa0;Stephen Gomperts reports a relationship with EIP Pharma that includes: consulting or advisory and clinical trial work. Stephen Gomperts reports a relationship with Hillhurst Biopharmaceuticals that includes: consulting or advisory and funding grants. Stephen Gomperts reports a relationship with ACADIA Pharmaceuticals Inc that includes: consulting or advisory. Stephen Gomperts reports a relationship with Janssen Pharmaceuticals Inc that includes: consulting or advisory. Stephen Gomperts reports a relationship with Biogen that includes: consulting or advisory. Stephen Gomperts reports a relationship with Athenium Analytics that includes: consulting or advisory. Stephen Gomperts reports a relationship with Clarivate Analytics US LLC that includes: consulting or advisory. Stephen Gomperts reports a relationship with Guidepoint Global that includes: consulting or advisory. Stephen Gomperts reports a relationship with Cowen Group Inc that includes: consulting or advisory. Anna Gooheart declares that she has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>18</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39276722</ArticleId><ArticleId IdType=\"doi\">10.1016/j.parkreldis.2024.107133</ArticleId><ArticleId IdType=\"pii\">S1353-8020(24)01145-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39276711</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1873-491X</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>160</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of nursing studies</Title><ISOAbbreviation>Int J Nurs Stud</ISOAbbreviation></Journal><ArticleTitle>Effects of a nurse-led staged integral art-based cognitive intervention for older adults on the Alzheimer's disease spectrum: A randomized controlled trial.</ArticleTitle><Pagination><StartPage>104902</StartPage><MedlinePgn>104902</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.ijnurstu.2024.104902</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0020-7489(24)00215-3</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Combined art activities can improve the neural network function within various brain regions involved in emotions, cognition, and behavior, thereby preventing or reversing cognitive decline. However, few studies have systematically examined its effects. Furthermore, the impact of nurse-led art-based cognitive intervention on cognitive and psychological health is unclear.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"OBJECTIVE\">To evaluate the effects of a nurse-led staged integral art-based cognitive intervention in older adults on the Alzheimer's disease spectrum.</AbstractText><AbstractText Label=\"DESIGN\" NlmCategory=\"METHODS\">This was a randomized wait-list controlled trial with allocation concealment and blinding of outcome assessors and data analysts. All data were collected between April 2021 and January 2023 and analyzed from January to March 2023.</AbstractText><AbstractText Label=\"SETTING\" NlmCategory=\"METHODS\">One memory clinic and four medical partnership communities.</AbstractText><AbstractText Label=\"PARTICIPANTS\" NlmCategory=\"METHODS\">A total of 144 participants with subjective or objective memory decline (aged &#x2265;60&#xa0;years).</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">Participants were randomized into an intervention group (n&#xa0;=&#xa0;72) and a wait-list control group (n&#xa0;=&#xa0;72), in a 1:1 ratio. The intervention group underwent a 16-week, 24-session nurse-led staged integral art-based cognitive intervention program, which was based on neurocognitive function training patterns. The control group underwent the program after the follow-up assessment. General and specific domains of cognitive function and other health-related outcomes were measured at baseline (T0), immediately after the intervention (T1), and at the 6-month follow-up (T2).</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Of the 144 participants (mean [SD] age, 71.6 [5.8] years; 50 [34.7&#xa0;%] males and 94 [65.3&#xa0;%] females), 130 and 115 completed the questionnaires at T1 and T2, respectively. The average attendance rate in the intervention group was 86.0&#xa0;%. At T1, the intervention group showed greater improvement than the control group did in general cognitive functions (MoCA, between-group mean difference, 1.4 [95&#xa0;% CIs, 0.4 to 2.5], p&#xa0;=&#xa0;0.009). Additionally, the intervention group demonstrated statistically significant improvement compared to the control group in language, memory, quality of life, sleep quality and physical activity level at T1. Statistically significant group differences remained in sleep quality (PSQI, between-group mean difference, -1.3 [95&#xa0;% CIs, -2.5 to -0.1], p&#xa0;=&#xa0;0.035) at the 6-month follow-up.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">In this randomized controlled trial of a nurse-led staged integral art-based cognitive intervention program, older adults on the Alzheimer's disease spectrum who participated in the program experienced improved cognition and psychological health.</AbstractText><AbstractText Label=\"REGISTRATION\" NlmCategory=\"BACKGROUND\">This study was registered with ChiCTR.org (ChiCTR2100044959) on April 3, 2021.</AbstractText><AbstractText Label=\"TWEETABLE ABSTRACT\" NlmCategory=\"CONCLUSIONS\">A nurse-led staged integral art-based intervention for older adults on the Alzheimer's disease spectrum experienced improved cognition and psychological health.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Yan</LastName><ForeName>Yuanjiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affilitated Provincial Hospital, Fuzhou, China; The School of Nursing, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Huang</LastName><ForeName>Chenshan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lin</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chen</LastName><ForeName>Mingfeng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Department, Fujian Provincial Hospital, Fuzhou Univeristy Affiliated Provincial Hospital, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Yunxian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, Fuzhou, China; The First People's Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xu</LastName><ForeName>Yifei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chao</LastName><ForeName>Yueqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Chufan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sun</LastName><ForeName>Wenqian</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Nafang</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ye</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lin</LastName><ForeName>Mojun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China. Electronic address: mjlin@mail.fjmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The School of Nursing, Fujian Medical University, Fuzhou, China. Electronic address: leehong99@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Nurs Stud</MedlineTA><NlmUniqueID>0400675</NlmUniqueID><ISSNLinking>0020-7489</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Aged</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">Art therapy</Keyword><Keyword MajorTopicYN=\"N\">Cognition</Keyword><Keyword MajorTopicYN=\"N\">Psychological health</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>18</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39276711</ArticleId><ArticleId IdType=\"doi\">10.1016/j.ijnurstu.2024.104902</ArticleId><ArticleId IdType=\"pii\">S0020-7489(24)00215-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39276492</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1090-2120</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>153</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Bioorganic chemistry</Title><ISOAbbreviation>Bioorg Chem</ISOAbbreviation></Journal><ArticleTitle>Recent advances in the natural product analogues for the treatment of neurodegenerative diseases.</ArticleTitle><Pagination><StartPage>107819</StartPage><MedlinePgn>107819</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.bioorg.2024.107819</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0045-2068(24)00724-7</ELocationID><Abstract><AbstractText>Neurodegenerative diseases (NDs) represent a hallmark of numerous incapacitating and untreatable conditions, the incidence of which is escalating swiftly, exemplified by Alzheimer's disease and Parkinson's disease. There is an urgent necessity to create pharmaceuticals that exhibit high efficacy and minimal toxicity in order to address these debilitating diseases. The structural complexity and diversity of natural products confer upon them a broad spectrum of biological activities, thereby significantly contributing to the history of drug discovery. Nevertheless, natural products present challenges in drug discovery, including time-consuming separation processes, low content, low bioavailability, and other related issues. To address these challenges, numerous analogs of natural products have been synthesized. This methodology enables the rapid synthesis of analogs of natural products with the potential to serve as lead compounds for drug development, thereby paving the way for the discovery of novel pharmaceuticals. This paper provides a summary of 127 synthetic analogues featuring various natural product structures, including flavonoids, alkaloids, coumarins, phenylpropanoids, terpenoids, polyphenols, and amides. The compounds are categorized based on their efficacy in treating various diseases. Furthermore, this article delves into the structure-activity relationship (SAR) of certain analogues, offering a thorough point of reference for the systematic development of pharmaceuticals aimed at addressing neurodegenerative conditions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Jinling</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China; Research Institute of Medicine &amp; Pharmacy, Qiqihar Medical University, Qiqihar 161006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jiang</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Shuping</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Mengmeng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hao</LastName><ForeName>Zhichao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Guan</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pan</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wu</LastName><ForeName>Jiatong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Yiqiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Structural Pharmacology &amp; TCM Chemical Biology, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China. Electronic address: 2022041@fjtcm.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chen</LastName><ForeName>Lixia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design &amp; Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: syzyclx@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Bingyou</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China. Electronic address: ybywater@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China. Electronic address: lifeliuyan@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Bioorg Chem</MedlineTA><NlmUniqueID>1303703</NlmUniqueID><ISSNLinking>0045-2068</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Natural products analogues</Keyword><Keyword MajorTopicYN=\"N\">Neurodegenerative diseases</Keyword><Keyword MajorTopicYN=\"N\">Parkinson&#x2019;s disease</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>18</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39276492</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bioorg.2024.107819</ArticleId><ArticleId IdType=\"pii\">S0045-2068(24)00724-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39276310</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1573-7209</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Angiogenesis</Title><ISOAbbreviation>Angiogenesis</ISOAbbreviation></Journal><ArticleTitle>The influences of ApoE isoforms on endothelial adherens junctions and actin cytoskeleton responding to mCRP.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s10456-024-09946-4</ELocationID><Abstract><AbstractText>Apolipoprotein E4 (ApoE4) plays an important role responding to monomeric C-reactive protein (mCRP) via binding to CD31 leading to cerebrovascular damage and Alzheimer's disease (AD). Using phosphor-proteomic profiling, we found altered cytoskeleton proteins in the microvasculature of AD brains, including increased levels of hyperphosphorylated tau (pTau) and the actin-related protein, LIMA1. To address the hypothesis that cytoskeletal changes serve as early pathological signatures linked with CD31 in brain endothelia in ApoE4 carriers, ApoE4 knock-in mice intraperitoneal injected with mCRP revealed that mCRP increased the expressions of phosphorylated CD31 (pCD31) and LIMA1, and facilitate the binding of pCD31 to LIMA1. mCRP combined with recombinant APOE4 protein decreased interaction of CD31 and VE-Cadherin at adherens junctions (AJs), along with altered the expression of various actin cytoskeleton proteins, causing microvasculature damage. Notably, the APOE2 protein attenuated these changes. Overall, our study demonstrates that ApoE4 responds to mCRP to disrupt the endothelial AJs which link with the actin cytoskeleton and this pathway could play a key role in the barrier dysfunction leading to AD risk.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Zhang</LastName><ForeName>Zhengrong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Lin</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Gan</LastName><ForeName>Qini</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lei</LastName><ForeName>Maohua</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gong</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX, 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Section of Computational Biomedicine, Department of Medicine, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Henrique</LastName><ForeName>Jessica Salles</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Han</LastName><ForeName>Jingyan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section of Vascular Biology, Department of Medicine, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tian</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Xiaman Medical College, Xiaman, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tao</LastName><ForeName>Qiushan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Potempa</LastName><ForeName>Lawrence A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Roosevelt University College of Pharmacy, Schaumburg, IL60173, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stein</LastName><ForeName>Thor D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. tdstein@bu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer's Disease Research Center, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. tdstein@bu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Boston Healthcare System, Boston, MA02130, USA. tdstein@bu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Bedford Healthcare System, Bedford, MA01730, USA. tdstein@bu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Emili</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. aemili@bu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qiu</LastName><ForeName>Wei Qiao</ForeName><Initials>WQ</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. wqiu67@bu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer's Disease Research Center, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. wqiu67@bu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Boston University Chobanian &amp; Avedisian School of Medicine, 72 East Concord Street, Boston, MA02118, USA. wqiu67@bu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>R01 AG054546</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Angiogenesis</MedlineTA><NlmUniqueID>9814575</NlmUniqueID><ISSNLinking>0969-6970</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease (AD)</Keyword><Keyword MajorTopicYN=\"N\">Apolipoprotein E (ApoE)</Keyword><Keyword MajorTopicYN=\"N\">CD31 and pCD31</Keyword><Keyword MajorTopicYN=\"N\">Cerebrovascular</Keyword><Keyword MajorTopicYN=\"N\">Endothelia</Keyword><Keyword MajorTopicYN=\"N\">F-actin</Keyword><Keyword MajorTopicYN=\"N\">LIM Domain and Actin Binding 1 (LIMA1)</Keyword><Keyword MajorTopicYN=\"N\">Monomeric C-reactive protein (mCRP)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39276310</ArticleId><ArticleId IdType=\"doi\">10.1007/s10456-024-09946-4</ArticleId><ArticleId IdType=\"pii\">10.1007/s10456-024-09946-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Iadecola C, Gottesman RF (2018) Cerebrovascular alterations in Alzheimer disease. Circ Res 123(4):406&#x2013;408</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30355253</ArticleId><ArticleId IdType=\"pmc\">6214471</ArticleId><ArticleId IdType=\"doi\">10.1161/CIRCRESAHA.118.313400</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia FJ, Sun N, Lee H, Godlewski B, Mathys H, Galani K, Zhou B, Jiang X, Ng AP, Mantero J, Tsai LH, Bennett DA, Sahin M, Kellis M, Heiman M (2022) Single-cell dissection of the human brain vasculature. Nature 603(7903):893&#x2013;899</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35158371</ArticleId><ArticleId IdType=\"pmc\">9680899</ArticleId><ArticleId IdType=\"doi\">10.1038/s41586-022-04521-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock MH, Tsai LH (2023) Insights into Alzheimer&#x2019;s disease from single-cell genomic approaches. Nat Neurosci 26(2):181&#x2013;195</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36593328</ArticleId><ArticleId IdType=\"pmc\">10155598</ArticleId><ArticleId IdType=\"doi\">10.1038/s41593-022-01222-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant A, Li Z, Jayakumar R, Serrano-Pozo A, Woost B, Hu M, Woodbury ME, Wachter A, Lin G, Kwon T, Talanian RV, Biber K, Karran EH, Hyman BT, Das S, Bennett RE (2023) Endothelial cells are heterogeneous in different brain regions and are dramatically altered in Alzheimer&#x2019;s disease. J Neurosci 43(24):4541&#x2013;4557</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37208174</ArticleId><ArticleId IdType=\"pmc\">10278684</ArticleId><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.0237-23.2023</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao W, Zheng H (2018) Peripheral immune system in aging and Alzheimer&#x2019;s disease. Mol Neurodegener 13(1):51</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30285785</ArticleId><ArticleId IdType=\"pmc\">6169078</ArticleId><ArticleId IdType=\"doi\">10.1186/s13024-018-0284-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Gan Q, Han J, Tao Q, Qiu WQ, Madri JA (2023) CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer&#x2019;s disease. J Cereb Blood Flow Metab. https://doi.org/10.1177/0271678X231170041</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0271678X231170041</ArticleId><ArticleId IdType=\"pubmed\">38069842</ArticleId><ArticleId IdType=\"pmc\">10870959</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J, Johnson ECB, Dammer EB, Duong DM, Gearing M, Lah JJ, Levey AI, Wingo TS, Seyfried NT (2018) Effects of APOE genotype on brain proteomic network and cell type changes in Alzheimer&#x2019;s disease. Front Mol Neurosci 11:454</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30618606</ArticleId><ArticleId IdType=\"pmc\">6305300</ArticleId><ArticleId IdType=\"doi\">10.3389/fnmol.2018.00454</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Na H, Gan Q, Tao Q, Alekseyev Y, Hu J, Yan Z, Yang JB, Tian H, Zhu S, Li Q, Rajab IM, Blusztajn JK, Wolozin B, Emili A, Zhang X, Stein T, Potempa LA, Qiu WQ (2021) Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: a risk factor for Alzheimer&#x2019;s disease? Aging Cell. https://doi.org/10.1111/acel.13501</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/acel.13501</ArticleId><ArticleId IdType=\"pubmed\">34972247</ArticleId><ArticleId IdType=\"pmc\">8761015</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Fan J, Zhao Z, Wang C, Wan LQ (2021) Effects of Alzheimer&#x2019;s disease-related proteins on the chirality of brain endothelial cells. Cell Mol Bioeng 14(3):231&#x2013;240</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34109002</ArticleId><ArticleId IdType=\"pmc\">8175509</ArticleId><ArticleId IdType=\"doi\">10.1007/s12195-021-00669-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamatovic SM, Johnson AM, Keep RF, Andjelkovic AV (2016) Junctional proteins of the blood-brain barrier: new insights into function and dysfunction. Tissue Barriers 4(1):e1154641</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27141427</ArticleId><ArticleId IdType=\"pmc\">4836471</ArticleId><ArticleId IdType=\"doi\">10.1080/21688370.2016.1154641</ArticleId></ArticleIdList></Reference><Reference><Citation>Komarova YA, Kruse K, Mehta D, Malik AB (2017) Protein interactions at endothelial junctions and signaling mechanisms regulating endothelial permeability. Circ Res 120(1):179&#x2013;206</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28057793</ArticleId><ArticleId IdType=\"pmc\">5225667</ArticleId><ArticleId IdType=\"doi\">10.1161/CIRCRESAHA.116.306534</ArticleId></ArticleIdList></Reference><Reference><Citation>Privratsky JR, Newman PJ (2014) PECAM-1: regulator of endothelial junctional integrity. Cell Tissue Res 355(3):607&#x2013;619</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24435645</ArticleId><ArticleId IdType=\"pmc\">3975704</ArticleId><ArticleId IdType=\"doi\">10.1007/s00441-013-1779-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodakuntla S, Jijumon AS, Villablanca C, Gonzalez-Billault C, Janke C (2019) Microtubule-associated proteins: structuring the cytoskeleton. Trends Cell Biol 29(10):804&#x2013;819</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31416684</ArticleId><ArticleId IdType=\"doi\">10.1016/j.tcb.2019.07.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Letort G, Ennomani H, Gressin L, Th&#xe9;ry M, Blanchoin L (2015) Dynamic reorganization of the actin cytoskeleton. F1000Res. https://doi.org/10.12688/f1000research.6374.1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.12688/f1000research.6374.1</ArticleId><ArticleId IdType=\"pubmed\">26989473</ArticleId><ArticleId IdType=\"pmc\">4784019</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Zhang L, Pu H, Mao L, Hu X, Jiang X, Xu N, Stetler RA, Zhang F, Liu X, Leak RK, Keep RF, Ji X, Chen J (2016) Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury. Nat Commun 7:10523</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26813496</ArticleId><ArticleId IdType=\"pmc\">4737895</ArticleId><ArticleId IdType=\"doi\">10.1038/ncomms10523</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha M, Aldirawi M, M&#xe4;rz S, Seebach J, Odenthal-Schnittler M, Bondareva O, Bojovic V, Schmandra T, Wirth B, Mietkowska M, Rottner K, Schnittler H (2019) EPLIN-&#x3b1; and -&#x3b2; isoforms modulate endothelial cell dynamics through a spatiotemporally differentiated interaction with actin. Cell Rep 29(4):1010-1026.e6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31644899</ArticleId><ArticleId IdType=\"doi\">10.1016/j.celrep.2019.09.043</ArticleId></ArticleIdList></Reference><Reference><Citation>Caprio V, Badimon L, Di Napoli M, Fang WH, Ferris GR, Guo B, Iemma RS, Liu D, Zeinolabediny Y, Slevin M (2018) pCRP-mCRP dissociation mechanisms as potential targets for the development of small-molecule anti-inflammatory chemotherapeutics. Front Immunol 9:1089</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29892284</ArticleId><ArticleId IdType=\"pmc\">5985513</ArticleId><ArticleId IdType=\"doi\">10.3389/fimmu.2018.01089</ArticleId></ArticleIdList></Reference><Reference><Citation>Potempa LA, Yao ZY, Ji SR, Filep JG, Wu Y (2015) Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification. Biophysics reports 1:18&#x2013;33</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26942216</ArticleId><ArticleId IdType=\"doi\">10.1007/s41048-015-0003-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama S, Du Clos TW, Gewurz H, Mold C (1984) Inhibition of antibody responses to phosphocholine by C-reactive protein. J Immunol 132(3):1336&#x2013;1340</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6363539</ArticleId><ArticleId IdType=\"doi\">10.4049/jimmunol.132.3.1336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YK, Uchida H, Smith H, Ito A, Sanchez T (2019) The isolation and molecular characterization of cerebral microvessels. Nat Protoc 14(11):3059&#x2013;3081</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31586162</ArticleId><ArticleId IdType=\"doi\">10.1038/s41596-019-0212-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485(7399):512&#x2013;516</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22622580</ArticleId><ArticleId IdType=\"pmc\">4047116</ArticleId><ArticleId IdType=\"doi\">10.1038/nature11087</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum BC, Emili A (2021) Omics Notebook: robust, reproducible and flexible automated multiomics exploratory analysis and reporting. Bioinform Adv. https://doi.org/10.1093/bioadv/vbab024</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/bioadv/vbab024</ArticleId><ArticleId IdType=\"pubmed\">36700091</ArticleId><ArticleId IdType=\"pmc\">9710639</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545&#x2013;15550</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16199517</ArticleId><ArticleId IdType=\"pmc\">1239896</ArticleId><ArticleId IdType=\"doi\">10.1073/pnas.0506580102</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkevich EI, Rudik AV, Dmitriev AV, Lagunin AA, Filimonov DA (2021) Predict of metabolic stability of xenobiotics by the PASS and GUSAR programs. Biomed Khim 67(3):295&#x2013;299</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34142537</ArticleId><ArticleId IdType=\"doi\">10.18097/pbmc20216703295</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP (2007) GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics 23(23):3251&#x2013;3253</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17644558</ArticleId><ArticleId IdType=\"doi\">10.1093/bioinformatics/btm369</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef H, Czupalla CJ, Lee D, Butcher EC, Wyss-Coray T (2018) Papain-based single cell isolation of primary murine brain endothelial cells using flow cytometry. Bio Protoc. https://doi.org/10.21769/BioProtoc.3091</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.21769/BioProtoc.3091</ArticleId><ArticleId IdType=\"pubmed\">31032379</ArticleId><ArticleId IdType=\"pmc\">6482965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying SC, Gewurz H, Kinoshita CM, Potempa LA, Siegel JN (1989) Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies. J Immunol 143(1):221&#x2013;228</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2471736</ArticleId><ArticleId IdType=\"doi\">10.4049/jimmunol.143.1.221</ArticleId></ArticleIdList></Reference><Reference><Citation>Zieba A, Ponten F, Uhl&#xe9;n M, Landegren U (2018) In situ protein detection with enhanced specificity using DNA-conjugated antibodies and proximity ligation. Mod Pathol 31(2):253&#x2013;263</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28937142</ArticleId><ArticleId IdType=\"doi\">10.1038/modpathol.2017.102</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O, Blennow K, Zetterberg H, Dage J (2023) Blood biomarkers for Alzheimer&#x2019;s disease in clinical practice and trials. Nat Aging 3(5):506&#x2013;519</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37202517</ArticleId><ArticleId IdType=\"pmc\">10979350</ArticleId><ArticleId IdType=\"doi\">10.1038/s43587-023-00403-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Meydani M (2001) Nutrition interventions in aging and age-associated disease. Ann N Y Acad Sci 928:226&#x2013;235</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11795514</ArticleId><ArticleId IdType=\"doi\">10.1111/j.1749-6632.2001.tb05652.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Laboy Cintron D, Muir AM, Scott A, McDonald M, Monaghan KG, Santiago-Sim T, Wentzensen IM, De Luca C, Brancati F, Harris DJ, Goueli C, Stottmann R, Prada CE, Biderman Waberski M, Mefford HC (2022) A recurrent, de novo pathogenic variant in ARPC4 disrupts actin filament formation and causes microcephaly and speech delay. HGG Adv 3(1):100072</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35047857</ArticleId></ArticleIdList></Reference><Reference><Citation>G. Sa, Z. Liu, J. Ren, Q. Wan, X. Xiong, Z. Yu, H. Chen, Y. Zhao, S. He, [Not Available], Cell. Signal. 61 (2019) 39-47</Citation></Reference><Reference><Citation>Illescas M, Pe&#xf1;as A, Arenas J, Mart&#xed;n MA, Ugalde C (2021) Regulation of mitochondrial function by the actin cytoskeleton. Front Cell Dev Biol 9:795838</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34993202</ArticleId><ArticleId IdType=\"pmc\">8725978</ArticleId><ArticleId IdType=\"doi\">10.3389/fcell.2021.795838</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Caballero M, Zecchin A, Souffreau J, Truong AK, Teuwen LA, Vermaelen W, Mart&#xed;n-P&#xe9;rez R, de Zeeuw P, Bouch&#xe9; A, Vinckier S, Cornelissen I, Eelen G, Ghesqui&#xe8;re B, Mazzone M, Dewerchin M, Carmeliet P (2019) Role and therapeutic potential of dietary ketone bodies in lymph vessel growth. Nat Metab 1(7):666&#x2013;675</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32694649</ArticleId><ArticleId IdType=\"doi\">10.1038/s42255-019-0087-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnaiger E (2009) Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. Int J Biochem Cell Biol 41(10):1837&#x2013;1845</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19467914</ArticleId><ArticleId IdType=\"doi\">10.1016/j.biocel.2009.03.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluysmans S, Vasileva E, Spadaro D, Shah J, Rouaud F, Citi S (2017) The role of apical cell-cell junctions and associated cytoskeleton in mechanotransduction. Biol Cell 109(4):139&#x2013;161</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28220498</ArticleId><ArticleId IdType=\"doi\">10.1111/boc.201600075</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnoor M (2015) Endothelial actin-binding proteins and actin dynamics in leukocyte transendothelial migration. J Immunol 194(8):3535&#x2013;3541</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25848070</ArticleId><ArticleId IdType=\"doi\">10.4049/jimmunol.1403250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluiter TJ, van Buul JD, Huveneers S, Quax PHA, de Vries MR (2021) Endothelial barrier function and leukocyte transmigration in atherosclerosis. Biomedicines 9(4):328</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33804952</ArticleId><ArticleId IdType=\"pmc\">8063931</ArticleId><ArticleId IdType=\"doi\">10.3390/biomedicines9040328</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino-Debrac D (2013) Mechanotransduction at the basis of endothelial barrier function. Tissue Barriers 1(2):e24180</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24665386</ArticleId><ArticleId IdType=\"pmc\">3879236</ArticleId><ArticleId IdType=\"doi\">10.4161/tisb.24180</ArticleId></ArticleIdList></Reference><Reference><Citation>Givens C, Tzima E (2016) Endothelial mechanosignaling: does one sensor fit all? Antioxid Redox Signal 25(7):373&#x2013;388</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27027326</ArticleId><ArticleId IdType=\"pmc\">5011625</ArticleId><ArticleId IdType=\"doi\">10.1089/ars.2015.6493</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong CN, Vestweber D (2020) Mechanisms ensuring endothelial junction integrity beyond VE-cadherin. Front Physiol 11:519</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32670077</ArticleId><ArticleId IdType=\"pmc\">7326147</ArticleId><ArticleId IdType=\"doi\">10.3389/fphys.2020.00519</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA (2005) A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437(7057):426&#x2013;431</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16163360</ArticleId><ArticleId IdType=\"doi\">10.1038/nature03952</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Ponce A, Cital&#xe1;n-Madrid AF, Vel&#xe1;zquez-Avila M, Vargas-Robles H, Schnoor M (2015) The role of actin-binding proteins in the control of endothelial barrier integrity. Thromb Haemost 113(1):20&#x2013;36</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25183310</ArticleId><ArticleId IdType=\"doi\">10.1160/TH14-04-0298</ArticleId></ArticleIdList></Reference><Reference><Citation>Woollard KJ, Phillips DC, Griffiths HR (2002) Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells. Clin Exp Immunol 130(2):256&#x2013;262</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12390313</ArticleId><ArticleId IdType=\"pmc\">1906519</ArticleId><ArticleId IdType=\"doi\">10.1046/j.1365-2249.2002.01978.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Na H, Yang JB, Zhang Z, Gan Q, Tian H, Rajab IM, Potempa LA, Tao Q, Qiu WQ (2023) Peripheral apolipoprotein E proteins and their binding to LRP1 antagonize Alzheimer&#x2019;s disease pathogenesis in the brain during peripheral chronic inflammation. Neurobiol Aging 127:54&#x2013;69</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37060729</ArticleId><ArticleId IdType=\"pmc\">10198819</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2023.02.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav T, Gau D, Roy P (2022) Mitochondria-actin cytoskeleton crosstalk in cell migration. J Cell Physiol 237(5):2387&#x2013;2403</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35342955</ArticleId><ArticleId IdType=\"pmc\">9945482</ArticleId><ArticleId IdType=\"doi\">10.1002/jcp.30729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YY, Fu ZY, Wei J, Qi W, Baituola G, Luo J, Meng YJ, Guo SY, Yin H, Jiang SY, Li YF, Miao HH, Liu Y, Wang Y, Li BL, Ma YT, Song BL (2018) A LIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption. Science 360(6393):1087&#x2013;1092</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29880681</ArticleId><ArticleId IdType=\"doi\">10.1126/science.aao6575</ArticleId></ArticleIdList></Reference><Reference><Citation>Mares J, Costa AP, Dartora WJ, Wartchow KM, Lazarian A, Bennett DA, Nuriel T, Menon V, McIntire LBJ (2024) Brain and serum lipidomic profiles implicate lands cycle acyl chain remodeling association with APOE&#x3b5;4 and mild cognitive impairment. Front Aging Neurosci 16:1419253</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38938596</ArticleId><ArticleId IdType=\"pmc\">11210445</ArticleId><ArticleId IdType=\"doi\">10.3389/fnagi.2024.1419253</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampugnani MG (2010) Endothelial adherens junctions and the actin cytoskeleton: an &#x2018;infinity net&#x2019;? J Biol 9(3):16</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20377920</ArticleId><ArticleId IdType=\"pmc\">2871513</ArticleId><ArticleId IdType=\"doi\">10.1186/jbiol232</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson S, Vessby B, Ostlund-Lindqvist AM (1988) Apolipoprotein-E-binding proteins of rat liver endothelial cells. Biochim Biophys Acta 962(1):73&#x2013;80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3416008</ArticleId><ArticleId IdType=\"doi\">10.1016/0005-2760(88)90097-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu BY, Bae YH, Mui KL, Liu SL, Assoian RK (2015) Apolipoprotein E3 inhibits Rho to regulate the mechanosensitive expression of Cox2. PLoS ONE 10(6):e0128974</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26068461</ArticleId><ArticleId IdType=\"pmc\">4465925</ArticleId><ArticleId IdType=\"doi\">10.1371/journal.pone.0128974</ArticleId></ArticleIdList></Reference><Reference><Citation>Marottoli FM, Zhang H, Flores-Barrera E, de la Villarmois EA, Damen FC, Miguelez Fern&#xe1;ndez AMM, Blesson HV, Chaudhary R, Nguyen AL, Nwokeji AE, Talati R, John AS, Madadakere K, Lutz SE, Cai K, Tseng KY, Tai LM (2023) Endothelial cell APOE3 regulates neurovascular, neuronal, and behavioral function. Arterioscler Thromb Vasc Biol. https://doi.org/10.1161/ATVBAHA.123.319816</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/ATVBAHA.123.319816</ArticleId><ArticleId IdType=\"pubmed\">37650329</ArticleId><ArticleId IdType=\"pmc\">10521805</ArticleId></ArticleIdList></Reference><Reference><Citation>Suica VI, Uyy E, Boteanu RM, Ivan L, Antohe F (2015) Alteration of actin dependent signaling pathways associated with membrane microdomains in hyperlipidemia. Proteome Sci 13:30</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26628893</ArticleId><ArticleId IdType=\"pmc\">4666118</ArticleId><ArticleId IdType=\"doi\">10.1186/s12953-015-0087-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoglund Z, Ruiz-Uribe N, Del Sastre E, Woost B, Bader E, Bailey J, Hyman BT, Zwang T, Bennett RE (2024) Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer&#x2019;s disease. Acta Neuropathol 147(1):101</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38884806</ArticleId><ArticleId IdType=\"pmc\">11182845</ArticleId><ArticleId IdType=\"doi\">10.1007/s00401-024-02751-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross D, Vial C, Maccioni RB (1993) A tau-like protein interacts with stress fibers and microtubules in human and rodent cultured cell lines. J Cell Sci 105(Pt 1):51&#x2013;60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7689576</ArticleId><ArticleId IdType=\"doi\">10.1242/jcs.105.1.51</ArticleId></ArticleIdList></Reference><Reference><Citation>DiTella M, Feiguin F, Morfini G, C&#xe1;ceres A (1994) Microfilament-associated growth cone component depends upon Tau for its intracellular localization. Cell Motil Cytoskeleton 29(2):117&#x2013;130</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7820862</ArticleId><ArticleId IdType=\"doi\">10.1002/cm.970290204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempf M, Clement A, Faissner A, Lee G, Brandt R (1996) Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner. J Neurosci 16(18):5583&#x2013;5592</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8795614</ArticleId><ArticleId IdType=\"pmc\">6578978</ArticleId><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.16-18-05583.1996</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson JE, Ince PG, Shaw PJ, Heath PR, Raman R, Garwood CJ, Gelsthorpe C, Baxter L, Forster G, Matthews FE, Brayne C, Wharton SB (2011) Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer&#x2019;s pathology and APOE genotype. Neurobiol Aging 32(10):1795&#x2013;1807</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21705112</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2011.04.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Stein TD, Wang Y, Ang TFA, Tao Q, Lunetta KL, Massaro J, Akhter-Khan SC, Mez J, Au R, Farrer LA, Zhang X, Qiu WQ (2023) Blood levels of MCP-1 modulate the genetic risks of Alzheimer&#x2019;s disease mediated by HLA-DRB1 and APOE for Alzheimer&#x2019;s disease. Alzheimers Dement 19(5):1925&#x2013;1937</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36396603</ArticleId><ArticleId IdType=\"doi\">10.1002/alz.12851</ArticleId></ArticleIdList></Reference><Reference><Citation>Merched A, Serot JM, Visvikis S, Aguillon D, Faure G, Siest G (1998) Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer&#x2019;s patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett 425(2):225&#x2013;228</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9559653</ArticleId><ArticleId IdType=\"doi\">10.1016/S0014-5793(98)00234-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray M, Zhang W (2010) Analysis of Alzheimer&#x2019;s disease severity across brain regions by topological analysis of gene co-expression networks. BMC Syst Biol 4:136</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20925940</ArticleId><ArticleId IdType=\"pmc\">2976747</ArticleId><ArticleId IdType=\"doi\">10.1186/1752-0509-4-136</ArticleId></ArticleIdList></Reference><Reference><Citation>You Y, Muraoka S, Jedrychowski MP, Hu J, McQuade AK, Young-Pearse T, Aslebagh R, Shaffer SA, Gygi SP, Blurton-Jones M, Poon WW, Ikezu T (2022) Human neural cell type-specific extracellular vesicle proteome defines disease-related molecules associated with activated astrocytes in Alzheimer&#x2019;s disease brain. J Extracell Vesicles 11(1):e12183</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35029059</ArticleId><ArticleId IdType=\"pmc\">8758831</ArticleId><ArticleId IdType=\"doi\">10.1002/jev2.12183</ArticleId></ArticleIdList></Reference><Reference><Citation>Balczon R, Pittet JF, Wagener BM, Moser SA, Voth S, Vorhees CV, Williams MT, Bridges JP, Alvarez DF, Koloteva A, Xu Y, Zha XM, Audia JP, Stevens T, Lin MT (2019) Infection-induced endothelial amyloids impair memory. FASEB J 33(9):10300&#x2013;10314</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31211919</ArticleId><ArticleId IdType=\"pmc\">6704457</ArticleId><ArticleId IdType=\"doi\">10.1096/fj.201900322R</ArticleId></ArticleIdList></Reference><Reference><Citation>Melkov&#xe1; K, Zapletal V, Narasimhan S, Jansen S, Hritz J, &#x160;krabana R, Zweckstetter M, Ringkj&#xf8;bing Jensen M, Blackledge M, &#x17d;&#xed;dek L (2019) Structure and functions of microtubule associated proteins Tau and MAP2c: similarities and differences. Biomolecules 9(3):105</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30884818</ArticleId><ArticleId IdType=\"pmc\">6468450</ArticleId><ArticleId IdType=\"doi\">10.3390/biom9030105</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, Feany MB (2007) Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 9(2):139&#x2013;148</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17187063</ArticleId><ArticleId IdType=\"doi\">10.1038/ncb1528</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogterom M, Koenderink GH (2019) Actin-microtubule crosstalk in cell biology. Nat Rev Mol Cell Biol 20(1):38&#x2013;54</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30323238</ArticleId><ArticleId IdType=\"doi\">10.1038/s41580-018-0067-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirst C, Skriabine S, Vieites-Prado A, Topilko T, Bertin P, Gerschenfeld G, Verny F, Topilko P, Michalski N, Tessier-Lavigne M, Renier N (2020) Mapping the fine-scale organization and plasticity of the brain vasculature. Cell 180(4):780-795.e25</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32059781</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2020.01.028</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39276018</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Electronic\">1469-896X</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>33</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Protein science : a publication of the Protein Society</Title><ISOAbbreviation>Protein Sci</ISOAbbreviation></Journal><ArticleTitle>AlzDiscovery: A computational tool to identify Alzheimer's disease-causing missense mutations using protein structure information.</ArticleTitle><Pagination><StartPage>e5147</StartPage><MedlinePgn>e5147</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">e5147</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1002/pro.5147</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is one of the most common forms of dementia and neurodegenerative diseases, characterized by the formation of neuritic plaques and neurofibrillary tangles. Many different proteins participate in this complicated pathogenic mechanism, and missense mutations can alter the folding and functions of these proteins, significantly increasing the risk of AD. However, many methods to identify AD-causing variants did not consider the effect of mutations from the perspective of a protein three-dimensional environment. Here, we present a machine learning-based analysis to classify the AD-causing mutations from their benign counterparts in 21 AD-related proteins leveraging both sequence- and structure-based features. Using computational tools to estimate the effect of mutations on protein stability, we first observed a bias of the pathogenic mutations with significant destabilizing effects on family AD-related proteins. Combining this insight, we built a generic predictive model, and improved the performance by tuning the sample weights in the training process. Our final model achieved the performance on area under the receiver operating characteristic curve up to 0.95 in the blind test and 0.70 in an independent clinical validation, outperforming all the state-of-the-art methods. Feature interpretation indicated that the hydrophobic environment and polar interaction contacts were crucial to the decision on pathogenic phenotypes of missense mutations. Finally, we presented a user-friendly web server, AlzDiscovery, for researchers to browse the predicted phenotypes of all possible missense mutations on these 21 AD-related proteins. Our study will be a valuable resource for AD screening and the development of personalized treatment.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Protein Science published by Wiley Periodicals LLC on behalf of The Protein Society.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Pan</LastName><ForeName>Qisheng</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Parra</LastName><ForeName>Georgina Becerra</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Myung</LastName><ForeName>Yoochan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Portelli</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nguyen</LastName><ForeName>Thanh Binh</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ascher</LastName><ForeName>David B</ForeName><Initials>DB</Initials><Identifier Source=\"ORCID\">0000-0003-2948-2413</Identifier><AffiliationInfo><Affiliation>The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>GNT1174405</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Protein Sci</MedlineTA><NlmUniqueID>9211750</NlmUniqueID><ISSNLinking>0961-8368</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D020125\" MajorTopicYN=\"Y\">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000069550\" MajorTopicYN=\"N\">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D019295\" MajorTopicYN=\"N\">Computational Biology</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012984\" MajorTopicYN=\"N\">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011487\" MajorTopicYN=\"N\">Protein Conformation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">AlphaFold2</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">machine learning</Keyword><Keyword MajorTopicYN=\"N\">missense mutation</Keyword><Keyword MajorTopicYN=\"N\">protein structure</Keyword><Keyword MajorTopicYN=\"N\">web server</Keyword></KeywordList><CoiStatement>The authors declared no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>7</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39276018</ArticleId><ArticleId IdType=\"doi\">10.1002/pro.5147</ArticleId><ArticleId IdType=\"pmc\">PMC11401060</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen&#x2010;2. Curr Protoc Hum Genet. 2013; Chapter 7: Unit7 20. PMID: 23315928 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4480630</ArticleId><ArticleId IdType=\"pubmed\">23315928</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso Adel C, Mederlyova A, Novak M, Grundke&#x2010;Iqbal I, Iqbal K. Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem. 2004;279:34873&#x2013;34881. PMID: 15190058 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15190058</ArticleId></ArticleIdList></Reference><Reference><Citation>Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI&#x2010;BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389&#x2013;3402. PMID: 9254694 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC146917</ArticleId><ArticleId IdType=\"pubmed\">9254694</ArticleId></ArticleIdList></Reference><Reference><Citation>Amino acid, peptide, and protein volume in solution. Annu Rev Biophys Bioeng. 1984;13:145&#x2013;165. PMID: 6378067 {Medline}, 191, 219.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6378067</ArticleId></ArticleIdList></Reference><Reference><Citation>Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, et al. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2004;32:D115&#x2013;D119. PMID: 14681372 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC308865</ArticleId><ArticleId IdType=\"pubmed\">14681372</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011;377:1019&#x2013;1031. PMID: 21371747 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21371747</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskar K, Yen SH, Lee G. Disease&#x2010;related modifications in tau affect the interaction between Fyn and tau. J Biol Chem. 2005;280:35119&#x2013;35125. PMID: 16115884 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16115884</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossaerts L, Hendrickx Van de Craen E, Cacace R, Asselbergh B, van Broeckhoven C. Rare missense mutations in ABCA7 might increase Alzheimer's disease risk by plasma membrane exclusion. Acta Neuropathol Commun. 2022;10:43 PMID: 35361255 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8973822</ArticleId><ArticleId IdType=\"pubmed\">35361255</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandes N, Goldman G, Wang CH, Ye CJ, Ntranos V. Genome&#x2010;wide prediction of disease variant effects with a deep protein language model. Nat Genet. 2023;55:1512&#x2013;1522. PMID: 37563329 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10484790</ArticleId><ArticleId IdType=\"pubmed\">37563329</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownjohn PW, Smith J, Solanki R, Lohmann E, Houlden H, Hardy J, et al. Functional studies of missense TREM2 mutations in human stem cell&#x2010;derived microglia. Stem Cell Rep. 2018;10:1294&#x2013;1307. PMID: 29606617 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5998752</ArticleId><ArticleId IdType=\"pubmed\">29606617</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldararu O, Mehra R, Blundell TL, Kepp KP. Systematic investigation of the data set dependency of protein stability predictors. J Chem Inf Model. 2020;60:4772&#x2013;4784. PMID: 32786698 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32786698</ArticleId></ArticleIdList></Reference><Reference><Citation>Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10:421 PMID: 20003500 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2803857</ArticleId><ArticleId IdType=\"pubmed\">20003500</ArticleId></ArticleIdList></Reference><Reference><Citation>Charton M, Charton BI. The dependence of the Chou&#x2010;Fasman parameters on amino acid side chain structure. J Theor Biol. 1983;102:121&#x2013;134. PMID: 6876837 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6876837</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, Novati G, Pan J, Bycroft C, Zemgulyte A, Applebaum T, et al. Accurate proteome&#x2010;wide missense variant effect prediction with AlphaMissense. Science. 2023;381:eadg7492 PMID: 37733863 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37733863</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31:2745&#x2013;2747. PMID: 25851949 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4528627</ArticleId><ArticleId IdType=\"pubmed\">25851949</ArticleId></ArticleIdList></Reference><Reference><Citation>Cock PJ, Antao T, Chang JT, Chapman BA, Cox CJ, Dalke A, et al. Biopython: freely available python tools for computational molecular biology and bioinformatics. Bioinformatics. 2009;25:1422&#x2013;1423. PMID: 19304878 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2682512</ArticleId><ArticleId IdType=\"pubmed\">19304878</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasuri K, Ebenezer P, Zhang L, Fernandez&#x2010;Kim SO, Bruce&#x2010;Keller AJ, Markesbery WR, et al. Increased protein hydrophobicity in response to aging and Alzheimer disease. Free Radic Biol Med. 2010;48:1330&#x2013;1337. PMID: 20188163 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3175611</ArticleId><ArticleId IdType=\"pubmed\">20188163</ArticleId></ArticleIdList></Reference><Reference><Citation>Do HN, Devkota S, Bhattarai A, Wolfe MS, Miao Y. Effects of presenilin&#x2010;1 familial Alzheimer's disease mutations on gamma&#x2010;secretase activation for cleavage of amyloid precursor protein. Commun Biol. 2023;6:174 PMID: 36788318 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9929099</ArticleId><ArticleId IdType=\"pubmed\">36788318</ArticleId></ArticleIdList></Reference><Reference><Citation>Dosztanyi Z. Prediction of protein disorder based on IUPred. Protein Sci. 2018;27:331&#x2013;340. PMID: 29076577 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5734386</ArticleId><ArticleId IdType=\"pubmed\">29076577</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, et al. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12:292&#x2013;323. PMID: 27012484 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6417794</ArticleId><ArticleId IdType=\"pubmed\">27012484</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdos G, Pajkos M, Dosztanyi Z. IUPred3: prediction of protein disorder enhanced with unambiguous experimental annotation and visualization of evolutionary conservation. Nucleic Acids Res. 2021;49:W297&#x2013;W303. PMID: 34048569 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8262696</ArticleId><ArticleId IdType=\"pubmed\">34048569</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M, Su Z, Abolhassani H, Itan Y, Jin X, Hammarstrom L. VIPPID: a gene&#x2010;specific single nucleotide variant pathogenicity prediction tool for primary immunodeficiency diseases. Brief Bioinform. 2022;23: PMID: 35598327 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9487673</ArticleId><ArticleId IdType=\"pubmed\">35598327</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler DM, Adams DJ, Gloyn AL, Hahn WC, Marks DS, Muffley LA, et al. An atlas of variant effects to understand the genome at nucleotide resolution. Genome Biol. 2023;24:147 PMID: 37394429 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10316620</ArticleId><ArticleId IdType=\"pubmed\">37394429</ArticleId></ArticleIdList></Reference><Reference><Citation>Frieden C, Wang H, Ho CMW. A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain&#x2010;domain interactions. Proc Natl Acad Sci U S A. 2017;114:6292&#x2013;6297. PMID: 28559318 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5474821</ArticleId><ArticleId IdType=\"pubmed\">28559318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesan K, Kulandaisamy A, Binny Priya S, Gromiha MM. HuVarBase: a human variant database with comprehensive information at gene and protein levels. PLoS One. 2019;14:e0210475. PMID: 30703169 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6354970</ArticleId><ArticleId IdType=\"pubmed\">30703169</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MA, Lazo ND, Lomakin A, Condron MM, Arai H, Yamin G, et al. Familial Alzheimer's disease mutations alter the stability of the amyloid beta&#x2010;protein monomer folding nucleus. Proc Natl Acad Sci U S A. 2007;104:16522&#x2013;16527. PMID: 17940047 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2034231</ArticleId><ArticleId IdType=\"pubmed\">17940047</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M, Leyns CEG, Holtzman DM. New insights into the role of TREM2 in Alzheimer's disease. Mol Neurodegener. 2018;13:66 PMID: 30572908 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6302500</ArticleId><ArticleId IdType=\"pubmed\">30572908</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray VE, Hause RJ, Luebeck J, Shendure J, Fowler DM. Quantitative missense variant effect prediction using large&#x2010;scale mutagenesis data. Cell Syst. 2018;6:116&#x2013;124 e113. PMID: 29226803 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5799033</ArticleId><ArticleId IdType=\"pubmed\">29226803</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall&#x2010;Roberts H, Agarwal D, Obst J, Smith TB, Monzon&#x2010;Sandoval J, di Daniel E, et al. TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC&#x2010;derived macrophages. Alzheimers Res Ther. 2020;12:151 PMID: 33198789 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7667762</ArticleId><ArticleId IdType=\"pubmed\">33198789</ArticleId></ArticleIdList></Reference><Reference><Citation>Hecht M, Bromberg Y, Rost B. Better prediction of functional effects for sequence variants. BMC Genomics. 2015;16(Suppl 8):S1 PMID: 26110438 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4480835</ArticleId><ArticleId IdType=\"pubmed\">26110438</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagota M, Ye C, Albors C, Rastogi R, Koehl A, Ioannidis N, et al. Cross&#x2010;protein transfer learning substantially improves disease variant prediction. Genome Biol. 2023;24:182 PMID: 37550700 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10408151</ArticleId><ArticleId IdType=\"pubmed\">37550700</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D, et al. Coding variants in TREM2 increase risk for Alzheimer's disease. Hum Mol Genet. 2014;23:5838&#x2013;5846. PMID: 24899047 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4189899</ArticleId><ArticleId IdType=\"pubmed\">24899047</ArticleId></ArticleIdList></Reference><Reference><Citation>Joosten RP, te Beek TA, Krieger E, Hekkelman ML, Hooft RW, Schneider R, et al. A series of PDB related databases for everyday needs. Nucleic Acids Res. 2011;39:D411&#x2013;D419. PMID: 21071423 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3013697</ArticleId><ArticleId IdType=\"pubmed\">21071423</ArticleId></ArticleIdList></Reference><Reference><Citation>Jubb HC, Higueruelo AP, Ochoa&#x2010;Montano B, Pitt WR, Ascher DB, Blundell TL. Arpeggio: a web server for calculating and visualising interatomic interactions in protein structures. J Mol Biol. 2017;429:365&#x2013;371. PMID: 27964945 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5282402</ArticleId><ArticleId IdType=\"pubmed\">27964945</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583&#x2013;589. PMID: 34265844 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8371605</ArticleId><ArticleId IdType=\"pubmed\">34265844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen&#x2010;bonded and geometrical features. Biopolymers. 1983;22:2577&#x2013;2637. PMID: 6667333 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6667333</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashima S, Ogata H, Kanehisa M. AAindex: amino acid index database. Nucleic Acids Res. 1999;27:368&#x2013;369. PMID: 9847231 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC148186</ArticleId><ArticleId IdType=\"pubmed\">9847231</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelleher RJ 3rd, Shen J. Presenilin&#x2010;1 mutations and Alzheimer's disease. Proc Natl Acad Sci U S A. 2017;114:629&#x2013;631. PMID: 28082723 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5278466</ArticleId><ArticleId IdType=\"pubmed\">28082723</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim W, Hecht MH. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide. Proc Natl Acad Sci U S A. 2006;103:15824&#x2013;15829. PMID: 17038501 {Medline}, 19164, 19169.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC1635087</ArticleId><ArticleId IdType=\"pubmed\">17038501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita J, Clark T. Alzforum. Methods Mol Biol. 2007;401:365&#x2013;381. PMID: 18368375 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18368375</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein P, Kanehisa M, DeLisi C. Prediction of protein function from sequence properties. Discriminant analysis of a data base. Biochim Biophys Acta. 1984;787:221&#x2013;226. PMID: 6547351 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6547351</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Amieva H, Petersen RC, Chetelat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7:33 PMID: 33986301 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8574196</ArticleId><ArticleId IdType=\"pubmed\">33986301</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulandaisamy A, Parvathy Dharshini SA, Gromiha MM. Alz&#x2010;disc: a tool to discriminate disease&#x2010;causing and neutral mutations in Alzheimer's disease. Comb Chem High Throughput Screen. 2023;26:769&#x2013;777. PMID: 35619290 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35619290</ArticleId></ArticleIdList></Reference><Reference><Citation>Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062&#x2013;D1067. PMID: 29165669 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5753237</ArticleId><ArticleId IdType=\"pubmed\">29165669</ArticleId></ArticleIdList></Reference><Reference><Citation>Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980&#x2013;D985. PMID: 24234437 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3965032</ArticleId><ArticleId IdType=\"pubmed\">24234437</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Panday SK, Alexov E. SAAFEC&#x2010;SEQ: a sequence&#x2010;based method for predicting the effect of single point mutations on protein thermodynamic stability. Int J Mol Sci. 2021;22: PMID: 33435356 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7827184</ArticleId><ArticleId IdType=\"pubmed\">33435356</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani V, Biasini M, Barbato A, Schwede T. lDDT: a local superposition&#x2010;free score for comparing protein structures and models using distance difference tests. Bioinformatics. 2013;29:2722&#x2013;2728. PMID: 23986568 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3799472</ArticleId><ArticleId IdType=\"pubmed\">23986568</ArticleId></ArticleIdList></Reference><Reference><Citation>Marti&#x2010;Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct. 2000;29:291&#x2013;325. PMID: 10940251 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10940251</ArticleId></ArticleIdList></Reference><Reference><Citation>Meirovitch H, Rackovsky S, Scheraga HA. Empirical studies of hydrophobicity. 1. Effect of protein size on the hydrophobic behavior of amino acids. Macromolecules. 1980;13:1398&#x2013;1405.</Citation></Reference><Reference><Citation>Munro D, Singh M. DeMaSk: a deep mutational scanning substitution matrix and its use for variant impact prediction. Bioinformatics. 2021;36:5322&#x2013;5329. PMID: 33325500 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8016454</ArticleId><ArticleId IdType=\"pubmed\">33325500</ArticleId></ArticleIdList></Reference><Reference><Citation>Myung Y, Rodrigues CHM, Ascher DB, Pires DEV. mCSM&#x2010;AB2: guiding rational antibody design using graph&#x2010;based signatures. Bioinformatics. 2020;36:1453&#x2013;1459. PMID: 31665262 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31665262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812&#x2013;3814. PMID: 12824425 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC168916</ArticleId><ArticleId IdType=\"pubmed\">12824425</ArticleId></ArticleIdList></Reference><Reference><Citation>Notin P, Kollasch AW, Ritter D, van Niekerk L, Paul S, Spinner H, et al. ProteinGym: large&#x2010;scale benchmarks for protein design and fitness prediction. bioRxiv. 2023; PMID: 38106144 {Medline}.</Citation></Reference><Reference><Citation>Pan Q, Nguyen TB, Ascher DB, Pires DEV. Systematic evaluation of computational tools to predict the effects of mutations on protein stability in the absence of experimental structures. Brief Bioinform. 2022;23: PMID: 35189634 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9155634</ArticleId><ArticleId IdType=\"pubmed\">35189634</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Q, Portelli S, Nguyen TB, Ascher DB. Characterization on the oncogenic effect of the missense mutations of p53 via machine learning. Brief Bioinform. 2023;25: PMID: 38018912 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10685404</ArticleId><ArticleId IdType=\"pubmed\">38018912</ArticleId></ArticleIdList></Reference><Reference><Citation>Panegyres PK, Chen HY. Differences between early and late onset Alzheimer's disease. Am J Neurodegener Dis. 2013;2:300&#x2013;306. PMID: 24319647 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3852569</ArticleId><ArticleId IdType=\"pubmed\">24319647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pires DE, Ascher DB, Blundell TL. mCSM: predicting the effects of mutations in proteins using graph&#x2010;based signatures. Bioinformatics. 2014;30:335&#x2013;342. PMID: 24281696 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3904523</ArticleId><ArticleId IdType=\"pubmed\">24281696</ArticleId></ArticleIdList></Reference><Reference><Citation>Portelli S, Albanaz A, Pires DEV, Ascher DB. Identifying the molecular drivers of ALS&#x2010;implicated missense mutations. J Med Genet. 2023;60:484&#x2013;490. PMID: 36180205 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36180205</ArticleId></ArticleIdList></Reference><Reference><Citation>Portelli S, Barr L, de Sa AGC, Pires DEV, Ascher DB. Distinguishing between PTEN clinical phenotypes through mutation analysis. Comput Struct Biotechnol J. 2021;19:3097&#x2013;3109. PMID: 34141133 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8180946</ArticleId><ArticleId IdType=\"pubmed\">34141133</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaei&#x2010;Ghaleh N, Amininasab M, Giller K, Becker S. Familial Alzheimer's disease&#x2010;related mutations differentially alter stability of amyloid&#x2010;beta aggregates. J Phys Chem Lett. 2023;14:1427&#x2013;1435. PMID: 36734539 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9940190</ArticleId><ArticleId IdType=\"pubmed\">36734539</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier&#x2010;Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405&#x2013;424. PMID: 25741868 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4544753</ArticleId><ArticleId IdType=\"pubmed\">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues CHM, Pires DEV, Ascher DB. DynaMut2: assessing changes in stability and flexibility upon single and multiple point missense mutations. Protein Sci. 2021;30:60&#x2013;69. PMID: 32881105 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7737773</ArticleId><ArticleId IdType=\"pubmed\">32881105</ArticleId></ArticleIdList></Reference><Reference><Citation>Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, et al. Structural alterations in the peptide backbone of beta&#x2010;amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem. 1993;268:3072&#x2013;3083. PMID: 8428986 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8428986</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose AS, Bradley AR, Valasatava Y, Duarte JM, Prlic A, Rose PW. NGL viewer: web&#x2010;based molecular graphics for large complexes. Bioinformatics. 2018;34:3755&#x2013;3758. PMID: 29850778 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6198858</ArticleId><ArticleId IdType=\"pubmed\">29850778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234:779&#x2013;815. PMID: 8254673 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8254673</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed FA, Kodama L, Fan L, Carling GK, Udeochu JC, Le D, et al. AD&#x2010;linked R47H&#x2010;TREM2 mutation induces disease&#x2010;enhancing microglial states via AKT hyperactivation. Sci Transl Med. 2021;13:eabe3947 PMID: 34851693 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9345574</ArticleId><ArticleId IdType=\"pubmed\">34851693</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayers EW, Bolton EE, Brister JR, Canese K, Chan J, Comeau DC, et al. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2022;50:D20&#x2013;D26. PMID: 34850941 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8728269</ArticleId><ArticleId IdType=\"pubmed\">34850941</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P, de Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer's disease. Lancet. 2021;397:1577&#x2013;1590. PMID: 33667416 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8354300</ArticleId><ArticleId IdType=\"pubmed\">33667416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgourakis NG, Yan Y, McCallum SA, Wang C, Garcia AE. The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD/NMR study. J Mol Biol. 2007;368:1448&#x2013;1457. PMID: 17397862 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC1978067</ArticleId><ArticleId IdType=\"pubmed\">17397862</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA, et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet. 1996;5:985&#x2013;988. PMID: 8817335 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8817335</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirkis DW, Bonham LW, Aparicio RE, Geier EG, Ramos EM, Wang Q, et al. Rare TREM2 variants associated with Alzheimer's disease display reduced cell surface expression. Acta Neuropathol Commun. 2016;4:98 PMID: 27589997 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5010724</ArticleId><ArticleId IdType=\"pubmed\">27589997</ArticleId></ArticleIdList></Reference><Reference><Citation>Smigielski EM, Sirotkin K, Ward M, Sherry ST. dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res. 2000;28:352&#x2013;355. PMID: 10592272 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC102496</ArticleId><ArticleId IdType=\"pubmed\">10592272</ArticleId></ArticleIdList></Reference><Reference><Citation>Somavarapu AK, Kepp KP. Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer's disease. J Neurochem. 2016;137:101&#x2013;111. PMID: 26756738 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26756738</ArticleId></ArticleIdList></Reference><Reference><Citation>Lohr T, Kohlhoff K, Heller GT, Camilloni C, Vendruscolo M. A small molecule stabilises the disordered native state of the Alzheimer's A&#x3b2; peptide. ACS Chem Neurosci. 2022;13:1738&#x2013;1745. PMID: 35649268 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9204762</ArticleId><ArticleId IdType=\"pubmed\">35649268</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gils JHM, van Dijk E, Peduzzo A, Hofmann A, Vettore N, Schutzmann MP, et al. The hydrophobic effect characterises the thermodynamic signature of amyloid fibril growth. PLoS Comput Biol. 2020;16:e1007767 PMID: 32365068 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7282669</ArticleId><ArticleId IdType=\"pubmed\">32365068</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasquez M, Nemethy G, Scheraga HA. Computed conformational states of the 20 naturally occurring amino acid residues and of the prototype residue &#x3b1;&#x2010;aminobutyric acid. Macromolecules. 1983;16:1043&#x2013;1049.</Citation></Reference><Reference><Citation>Wakutani Y, Watanabe K, Adachi Y, Wada&#x2010;Isoe K, Urakami K, Ninomiya H, et al. Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004;75:1039&#x2013;1042. PMID: 15201367 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC1739111</ArticleId><ArticleId IdType=\"pubmed\">15201367</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell. 2015;160:1061&#x2013;1071. PMID: 25728668 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4477963</ArticleId><ArticleId IdType=\"pubmed\">25728668</ArticleId></ArticleIdList></Reference><Reference><Citation>Wattmo C, Minthon L, Wallin AK. Mild versus moderate stages of Alzheimer's disease: three&#x2010;year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Alzheimers Res Ther. 2016;8:7 PMID: 26883213 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4756534</ArticleId><ArticleId IdType=\"pubmed\">26883213</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics. 2016;54:5&#x2013;6. PMID: 27322406 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5031415</ArticleId><ArticleId IdType=\"pubmed\">27322406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Li R, Sun S, Weile J, Roth FP. Improved pathogenicity prediction for rare human missense variants. Am J Hum Genet. 2021;108:1891&#x2013;1906. PMID: 34551312 {Medline}, 2389.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8546039</ArticleId><ArticleId IdType=\"pubmed\">34551312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamyatnin AA. Protein volume in solution. Prog Biophys Mol Biol. 1972;24:107&#x2013;123. PMID: 4566650 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">4566650</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Jiao B, Xiao T, Liu X, Liao X, Xiao X, et al. Association of rare variants in neurodegenerative genes with familial Alzheimer's disease. Ann Clin Transl Neurol. 2020;7:1985&#x2013;1995. PMID: 32941707 {Medline}.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7545599</ArticleId><ArticleId IdType=\"pubmed\">32941707</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Pan Q, Pires DEV, Rodrigues CHM, Ascher DB. DDMut: predicting effects of mutations on protein stability using deep learning. Nucleic Acids Res PMID: 37283042 {Medline}. 2023;51:W122&#x2013;W128.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10320186</ArticleId><ArticleId IdType=\"pubmed\">37283042</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39275969</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1468-1331</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>Difference in trajectories according to early amyloid accumulation in cognitively unimpaired elderly.</ArticleTitle><Pagination><StartPage>e16482</StartPage><MedlinePgn>e16482</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1111/ene.16482</ELocationID><Abstract><AbstractText Label=\"BACKGROUND AND PURPOSE\" NlmCategory=\"OBJECTIVE\">Amyloid &#x3b2; (A&#x3b2;), a major biomarker of Alzheimer's disease, leads to tau accumulation, neurodegeneration and cognitive decline. Modelling the trajectory of A&#x3b2; accumulation in cognitively unimpaired (CU) individuals is crucial, as treatments targeting A&#x3b2; are anticipated. The evolution of A&#x3b2; levels was investigated to determine whether it could lead to classification into different groups by studying longitudinal A&#x3b2; changes in older CU individuals, and differences between the groups were compared.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">A total of 297 CU participants were included from the Alzheimer's Disease Neuroimaging Initiative database, and these participants underwent apolipoprotein E (APOE) genotyping, neuropsychological testing, brain magnetic resonance imaging, and an average of 3.03 follow-up <sup>18</sup>F-florbetapir positron emission tomography scans. Distinct A&#x3b2; trajectory patterns were classified using latent class growth analysis, and longitudinal cognitive performances across these patterns were assessed with a linear mixed effects model.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">The optimal model consisted of three classes, with a high entropy value of 0.947. The classes were designated as follows: class 1, non-accumulation group (n&#x2009;&#x2009;=&#x2009;197); class 2, late accumulation group (n&#x2009;&#x2009;=&#x2009;70); and class 3, early accumulation group (n&#x2009;&#x2009;=&#x2009;30). The late accumulation and early accumulation groups had more APOE &#x3b5;4 carriers than the non-accumulation group. The longitudinal analysis of cognitive performance revealed that the early accumulation group showed the steepest decline (modified Preclinical Alzheimer's Cognitive Composite with digit symbol substitution [mPACCdigit], p&#x2009;&lt;&#x2009;0.001; modified Preclinical Alzheimer's Cognitive Composite with trails B [mPACCtrailsB], p&#x2009;&lt;&#x2009;0.001) and the late accumulation group showed a steeper decline (mPACCdigit, p&#x2009;=&#x2009;0.014; mPACCtrailsB, p&#x2009;=&#x2009;0.007) compared to the non-accumulation group.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">Our study showed the heterogeneity of A&#x3b2; accumulation trajectories in CU older individuals. The prognoses for cognitive decline differ according to the A&#x3b2; trajectory patterns.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Young Ju</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Centre, Samsung Medical Centre, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yun</LastName><ForeName>Jihwan</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0002-2436-4947</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Seo</LastName><ForeName>Sang Won</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Centre, Samsung Medical Centre, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Jun Pyo</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Centre, Samsung Medical Centre, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jang</LastName><ForeName>Hyemin</ForeName><Initials>H</Initials><Identifier Source=\"ORCID\">0000-0003-3152-1274</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital, Seoul National University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Hee Jin</ForeName><Initials>HJ</Initials><Identifier Source=\"ORCID\">0000-0002-3186-9441</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Centre, Samsung Medical Centre, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Na</LastName><ForeName>Duk L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Centre, Samsung Medical Centre, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Woo</LastName><ForeName>Sookyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biostatistics Team, Samsung Biomedical Research Institute, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chun</LastName><ForeName>Min Young</ForeName><Initials>MY</Initials><Identifier Source=\"ORCID\">0000-0003-3731-6132</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><CollectiveName>Alzheimer's Disease Neuroimaging Initiative</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>6-2023-0145</GrantID><Agency>Yonsei University College of Medicine</Agency><Country/></Grant><Grant><GrantID>RS-2020-KH106434</GrantID><Agency>Ministry of Health &amp; Welfare and Ministry of Science and ICT Republic of Korea</Agency><Country/></Grant><Grant><GrantID>RS-2022-KH127756</GrantID><Agency>Ministry of Health &amp; Welfare and Ministry of Science and ICT Republic of Korea</Agency><Country/></Grant><Grant><GrantID>NRF-2019R1A5A2027340</GrantID><Agency>Korea government</Agency><Country/></Grant><Grant><GrantID>RS-2021-II212068</GrantID><Agency>Korea government</Agency><Country/></Grant><Grant><GrantID>2024-ER1003-00</GrantID><Agency>\"Korea National Institute of Health\" research project</Agency><Country/></Grant><Grant><GrantID>#SMX1240561</GrantID><Agency>Samsung Medical Center</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">amyloid</Keyword><Keyword MajorTopicYN=\"N\">cognition</Keyword><Keyword MajorTopicYN=\"N\">latent class growth analysis</Keyword><Keyword MajorTopicYN=\"N\">longitudinal study</Keyword><Keyword MajorTopicYN=\"N\">positron emission tomography</Keyword><Keyword MajorTopicYN=\"N\">trajectory</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39275969</ArticleId><ArticleId IdType=\"doi\">10.1111/ene.16482</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Jack CR Jr, Bennett DA, Blennow K, et&#xa0;al. NIA&#x2010;AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14(4):535&#x2010;562. doi:10.1016/j.jalz.2018.02.018</Citation></Reference><Reference><Citation>Price JL, Morris JC. Tangles and plaques in nondemented aging and &#x2018;preclinical&#x2019; Alzheimer's disease. Ann Neurol. 1999;45(3):358&#x2010;368. doi:10.1002/1531-8249(199903)45:3&lt;358::aid-ana12&gt;3.0.co;2-x</Citation></Reference><Reference><Citation>Jessen F, Amariglio RE, van Boxtel M, et&#xa0;al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014;10(6):844&#x2010;852. doi:10.1016/j.jalz.2014.01.001</Citation></Reference><Reference><Citation>Jack CR Jr, Albert MS, Knopman DS, et&#xa0;al. Introduction to the recommendations from the National Institute on Aging&#x2013;Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):257&#x2010;262. doi:10.1016/j.jalz.2011.03.004</Citation></Reference><Reference><Citation>Wattmo C, Minthon L, Wallin AK. Mild versus moderate stages of Alzheimer's disease: three&#x2010;year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Alzheimers Res Ther. 2016;8(1):7. doi:10.1186/s13195-016-0174-1</Citation></Reference><Reference><Citation>Vivot A, Glymour MM, Tzourio C, Amouyel P, Chene G, Dufouil C. Association of Alzheimer's related genotypes with cognitive decline in multiple domains: results from the three&#x2010;city Dijon study. Mol Psychiatry. 2015;20(10):1173&#x2010;1178. doi:10.1038/mp.2015.62</Citation></Reference><Reference><Citation>Chen Y, Denny KG, Harvey D, et&#xa0;al. Progression from normal cognition to mild cognitive impairment in a diverse clinic&#x2010;based and community&#x2010;based elderly cohort. Alzheimers Dement. 2017;13(4):399&#x2010;405. doi:10.1016/j.jalz.2016.07.151</Citation></Reference><Reference><Citation>Albert M, Zhu Y, Moghekar A, et&#xa0;al. Predicting progression from normal cognition to mild cognitive impairment for individuals at 5&#x2009;years. Brain. 2018;141(3):877&#x2010;887. doi:10.1093/brain/awx365</Citation></Reference><Reference><Citation>Nagin DS, Odgers CL. Group&#x2010;based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109&#x2010;138. doi:10.1146/annurev.clinpsy.121208.131413</Citation></Reference><Reference><Citation>Teipel SJ, Cavedo E, Lista S, et&#xa0;al. Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers: an INSIGHT&#x2010;preAD study. Alzheimers Dement. 2018;14(9):1126&#x2010;1136. doi:10.1016/j.jalz.2018.04.004</Citation></Reference><Reference><Citation>Small BJ, Backman L. Longitudinal trajectories of cognitive change in preclinical Alzheimer's disease: a growth mixture modeling analysis. Cortex. 2007;43(7):826&#x2010;834. doi:10.1016/s0010-9452(08)70682-8</Citation></Reference><Reference><Citation>Kim YJ, Kim SE, Hahn A, et&#xa0;al. Classification and prediction of cognitive trajectories of cognitively unimpaired individuals. Front Aging Neurosci. 2023;15:1122927. doi:10.3389/fnagi.2023.1122927</Citation></Reference><Reference><Citation>Jagust WJ, Landau S, Shaw L, et&#xa0;al. Relationships between biomarkers in aging and dementia. Neurology. 2009;73(15):1193&#x2010;1199.</Citation></Reference><Reference><Citation>Jagust WJ, Bandy D, Chen K, et&#xa0;al. The Alzheimer's disease neuroimaging initiative positron emission tomography core. Alzheimers Dement. 2010;6(3):221&#x2010;229. doi:10.1016/j.jalz.2010.03.003</Citation></Reference><Reference><Citation>Donohue MC, Sperling RA, Salmon DP, et&#xa0;al. The preclinical Alzheimer cognitive composite: measuring amyloid&#x2010;related decline. JAMA Neurol. 2014;71(8):961&#x2010;970. doi:10.1001/jamaneurol.2014.803</Citation></Reference><Reference><Citation>Muthen B, Muthen LK. Integrating person&#x2010;centered and variable&#x2010;centered analyses: growth mixture modeling with latent trajectory classes. Alcohol Clin Exp Res. 2000;24(6):882&#x2010;891.</Citation></Reference><Reference><Citation>Jung T, Wickrama KAS. An introduction to latent class growth analysis and growth mixture modeling. Soc Personal Psychol Compass. 2008;2(1):302&#x2010;317. doi:10.1111/j.1751-9004.2007.00054.x</Citation></Reference><Reference><Citation>Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6(2):461&#x2010;464.</Citation></Reference><Reference><Citation>Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19(6):716&#x2010;723. doi:10.1109/TAC.1974.1100705</Citation></Reference><Reference><Citation>Lo Y, Mendell NR, Rubin DB. Testing the number of components in a normal mixture. Biometrika. 2001;88(3):767&#x2010;778. doi:10.1093/biomet/88.3.767</Citation></Reference><Reference><Citation>McLachlan G, Peel D. Finite Mixture Models. Wiley Series in Probability and Statistics. John Wiley; 2000.</Citation></Reference><Reference><Citation>Clark SL, Muth&#xe9;n B. Relating Latent Class Analysis Results to Variables not Included in the Analysis. University of California; 2009.</Citation></Reference><Reference><Citation>Muth&#xe9;n LK, Muth&#xe9;n BO. Mplus User's Guide. 8th ed. Muth&#xe9;n &amp; Muth&#xe9;n; 2019.</Citation></Reference><Reference><Citation>Villeneuve SC, Houot M, Cacciamani F, et&#xa0;al. Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease. Alzheimers Dement (N Y). 2019;5:553&#x2010;562. doi:10.1016/j.trci.2019.08.009</Citation></Reference><Reference><Citation>Hayden KM, Kuchibhatla M, Romero HR, et&#xa0;al. Pre&#x2010;clinical cognitive phenotypes for Alzheimer disease: a latent profile approach. Am J Geriatr Psychiatry. 2014;22(11):1364&#x2010;1374. doi:10.1016/j.jagp.2013.07.008</Citation></Reference><Reference><Citation>Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106&#x2010;118. doi:10.1038/nrneurol.2012.263</Citation></Reference><Reference><Citation>Jansen WJ, Ossenkoppele R, Knol DL, et&#xa0;al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta&#x2010;analysis. JAMA. 2015;313(19):1924&#x2010;1938. doi:10.1001/jama.2015.4668</Citation></Reference><Reference><Citation>Kim JP, Chun MY, Kim SJ, et&#xa0;al. Distinctive temporal trajectories of Alzheimer's disease biomarkers according to sex and APOE genotype: importance of striatal amyloid. Front Aging Neurosci. 2022;14:829202. doi:10.3389/fnagi.2022.829202</Citation></Reference><Reference><Citation>Pletnikova O, Kageyama Y, Rudow G, et&#xa0;al. The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype. Neurobiol Aging. 2018;71:72&#x2010;80. doi:10.1016/j.neurobiolaging.2018.07.007</Citation></Reference><Reference><Citation>Lim YY, Kalinowski P, Pietrzak RH, et&#xa0;al. Association of beta&#x2010;amyloid and apolipoprotein E epsilon4 with memory decline in preclinical Alzheimer disease. JAMA Neurol. 2018;75(4):488&#x2010;494. doi:10.1001/jamaneurol.2017.4325</Citation></Reference><Reference><Citation>Mormino EC, Betensky RA, Hedden T, et&#xa0;al. Amyloid and APOE epsilon4 interact to influence short&#x2010;term decline in preclinical Alzheimer disease. Neurology. 2014;82(20):1760&#x2010;1767. doi:10.1212/WNL.0000000000000431</Citation></Reference><Reference><Citation>Mishra S, Blazey TM, Holtzman DM, et&#xa0;al. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE epsilon4 genotype. Brain. 2018;141(6):1828&#x2010;1839. doi:10.1093/brain/awy103</Citation></Reference><Reference><Citation>Brugulat&#x2010;Serrat A, S&#xe1;nchez&#x2010;Benavides G, Cacciaglia R, et&#xa0;al. APOE&#x2010;&#x3b5;4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle&#x2010;aged individuals. EJNMMI Res. 2023;13(1):18. doi:10.1186/s13550-023-00967-6</Citation></Reference><Reference><Citation>Long JM, Coble DW, Xiong C, et&#xa0;al. Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes. Brain. 2022;145(12):4506&#x2010;4518. doi:10.1093/brain/awac250</Citation></Reference><Reference><Citation>Vos SJ, Xiong C, Visser PJ, et&#xa0;al. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. Lancet Neurol. 2013;12(10):957&#x2010;965. doi:10.1016/S1474-4422(13)70194-7</Citation></Reference><Reference><Citation>Landau SM, Lu M, Joshi AD, et&#xa0;al. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of beta&#x2010;amyloid. Ann Neurol. 2013;74(6):826&#x2010;836. doi:10.1002/ana.23908</Citation></Reference><Reference><Citation>Bischof GN, Jacobs HIL. Subthreshold amyloid and its biological and clinical meaning: long way ahead. Neurology. 2019;93(2):72&#x2010;79. doi:10.1212/WNL.0000000000007747</Citation></Reference><Reference><Citation>Leal SL, Lockhart SN, Maass A, Bell RK, Jagust WJ. Subthreshold amyloid predicts tau deposition in aging. J Neurosci. 2018;38(19):4482&#x2010;4489. doi:10.1523/JNEUROSCI.0485-18.2018</Citation></Reference><Reference><Citation>Landau SM, Horng A, Jagust WJ. Alzheimer's Disease Neuroimaging Initiative. Memory decline accompanies subthreshold amyloid accumulation. Neurology. 2018;90(17):e1452&#x2010;e1460. doi:10.1212/WNL.0000000000005354</Citation></Reference><Reference><Citation>Jack CR Jr, Wiste HJ, Knopman DS, et&#xa0;al. Rates of beta&#x2010;amyloid accumulation are independent of hippocampal neurodegeneration. Neurology. 2014;82(18):1605&#x2010;1612. doi:10.1212/WNL.0000000000000386</Citation></Reference><Reference><Citation>Pegueroles J, Vilaplana E, Montal V, et&#xa0;al. Longitudinal brain structural changes in preclinical Alzheimer's disease. Alzheimers Dement. 2017;13(5):499&#x2010;509. doi:10.1016/j.jalz.2016.08.010</Citation></Reference><Reference><Citation>Gordon BA, Blazey T, Su Y, et&#xa0;al. Longitudinal beta&#x2010;amyloid deposition and hippocampal volume in preclinical Alzheimer disease and suspected non&#x2010;Alzheimer disease pathophysiology. JAMA Neurol. 2016;73(10):1192&#x2010;1200. doi:10.1001/jamaneurol.2016.2642</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39275926</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1099-1263</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of applied toxicology : JAT</Title><ISOAbbreviation>J Appl Toxicol</ISOAbbreviation></Journal><ArticleTitle>The ameliorative potential of metformin against aluminum-induced neurotoxicity: Insights from in vitro studies.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1002/jat.4695</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is increasingly recognized as a metabolic disorder, often referred to as type 3 diabetes, due to its strong association with insulin resistance. Chronic exposure to aluminum, a known neurotoxin, has been identified as a significant risk factor in the development and progression of AD. This study explores the potential of metformin, a common anti-diabetic drug, to mitigate aluminum-induced neurotoxicity in an in vitro model of AD. Our findings reveal that metformin significantly reduces oxidative stress markers such as malonaldehyde, carbonyl groups, and reactive oxygen species while enhancing antioxidant defenses. Metformin modulates critical signaling pathways, including glycogen synthase kinase 3 beta (GSK3-&#x3b2;)/RAC-alpha serine/threonine protein kinase (RAC-alpha serine/threonine protein kinase (Akt1)/protein phosphatase 2A (PP2A) and Wnt/&#x3b2;-catenin, decreasing Tau protein levels and promoting neurogenesis. These results suggest that metformin may offer a novel therapeutic approach for AD, particularly in cases where aluminum exposure is a contributing factor.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Journal of Applied Toxicology published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Sanajou</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0002-6751-5266</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Toxicology, Istanbul Aydin University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yir&#xfc;n</LastName><ForeName>Anil</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-4050-8832</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Toxicology, Cukurova University, Adana, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Demirel</LastName><ForeName>G&#xf6;ksun</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0002-2994-5505</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Toxicology, Cukurova University, Adana, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Erkeko&#x11f;lu</LastName><ForeName>Pinar</ForeName><Initials>P</Initials><Identifier Source=\"ORCID\">0000-0003-4713-7672</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>&#x15e;ahin</LastName><ForeName>G&#xf6;n&#xfc;l</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0003-3742-6841</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Baydar</LastName><ForeName>Terken</ForeName><Initials>T</Initials><Identifier Source=\"ORCID\">0000-0002-5497-9600</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>TSA-2021-14186</GrantID><Agency>Hacettepe University Research Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Appl Toxicol</MedlineTA><NlmUniqueID>8109495</NlmUniqueID><ISSNLinking>0260-437X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">GSK3&#x2010;&#x3b2;</Keyword><Keyword MajorTopicYN=\"N\">Wnt signaling</Keyword><Keyword MajorTopicYN=\"N\">aluminum</Keyword><Keyword MajorTopicYN=\"N\">metformin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39275926</ArticleId><ArticleId IdType=\"doi\">10.1002/jat.4695</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Agholme, L., Lindstr&#xf6;m, T., K&#xe5;gedal, K., Marcusson, J., &amp; Hallbeck, M. (2010). An in vitro model for neuroscience: Differentiation of SH&#x2010;SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. Journal of Alzheimer's Disease, 20(4), 1069&#x2013;1082. https://doi.org/10.3233/JAD-2010-091363</Citation></Reference><Reference><Citation>Akerboom, T. P. M., &amp; Sies, H. (1981). Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods in Enzymology, 77(C), 373&#x2013;382. https://doi.org/10.1016/s0076-6879(81)77050-2</Citation></Reference><Reference><Citation>Barini, E., Antico, O., Zhao, Y., Asta, F., Tucci, V., Catelani, T., Marotta, R., Xu, H., &amp; Gasparini, L. (2016). Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy. Molecular Neurodegeneration, 11(1), 1&#x2013;20. https://doi.org/10.1186/S13024-016-0082-7/FIGURES/6</Citation></Reference><Reference><Citation>Basso, A. D., Solit, D. B., Chiosis, G., Giri, B., Tsichlis, P., &amp; Rosen, N. (2002). Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. Journal of Biological Chemistry, 277(42), 39858&#x2013;39866. https://doi.org/10.1074/jbc.M206322200</Citation></Reference><Reference><Citation>Bell, M., Bachmann, S., Klimek, J., Langerscheidt, F., &amp; Zempel, H. (2021). Axonal TAU sorting requires the C&#x2010;terminus of TAU but is independent of ANKG and TRIM46 enrichment at the AIS. Neuroscience, 461, 155&#x2013;171. https://doi.org/10.1016/j.neuroscience.2021.01.041</Citation></Reference><Reference><Citation>Cai, Z., &amp; Yan, L.&#x2010;J. (2013). Protein oxidative modifications: Beneficial roles in disease and health. Journal of Biochemical and Pharmacological Research, 1(1), 15. /pmc/articles/PMC3646577/&#x2013;26.</Citation></Reference><Reference><Citation>Cao, L., Tan, L., Wang, H.&#x2010;F., Jiang, T., Zhu, X.&#x2010;C., Lu, H., Tan, M.&#x2010;S., &amp; Yu, J.&#x2010;T. (2016). Dietary patterns and risk of dementia: A systematic review and meta&#x2010;analysis of cohort studies. Molecular Neurobiology, 53, 6144&#x2013;6154. https://doi.org/10.1007/s12035-015-9516-4</Citation></Reference><Reference><Citation>Chen, Y., Zhang, J., Zhang, B., &amp; Gong, C.&#x2010;X. (2016). Targeting insulin signaling for the treatment of Alzheimer's disease. Current Topics in Medicinal Chemistry, 16(5), 485&#x2013;492. https://doi.org/10.2174/1568026615666150813142423</Citation></Reference><Reference><Citation>Correia, S., Carvalho, C., Santos, M. S., Proenca, T., Nunes, E., Duarte, A. I., Monteiro, P., Seica, R., Oliveira, C. R., &amp; Moreira, P. I. (2008). Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes. Medicinal Chemistry, 4(4), 358&#x2013;364. https://doi.org/10.2174/157340608784872299</Citation></Reference><Reference><Citation>De La Monte, S. M., &amp; Wands, J. R. (2008). Alzheimer's disease is type 3 diabetes&#x2013;evidence reviewed. Journal of Diabetes Science and Technology (Online), 2(6), 1101&#x2013;1113. https://doi.org/10.1177/193229680800200619</Citation></Reference><Reference><Citation>de Medeiros, L. M., De Bastiani, M. A., Rico, E. P., Schonhofen, P., Pfaffenseller, B., Wollenhaupt&#x2010;Aguiar, B., Grun, L., Barb&#xe9;&#x2010;Tuana, F., Zimmer, E. R., Castro, M. A. A., Parsons, R. B., &amp; Klamt, F. (2019). Cholinergic differentiation of human neuroblastoma SH&#x2010;SY5Y cell line and its potential use as an in vitro model for Alzheimer's disease studies. Molecular Neurobiology, 56(11), 7355&#x2013;7367. https://doi.org/10.1007/s12035-019-1605-3</Citation></Reference><Reference><Citation>Demirel, G., Sanajou, S., Yir&#xfc;n, A., &#xc7;akir, D. A., Berkkan, A., Baydar, T., &amp; Erkeko&#x11f;lu, P. (2024). Evaluation of possible neuroprotective effects of virgin coconut oil on aluminum&#x2010;induced neurotoxicity in an in vitro Alzheimer's disease model. Journal of Applied Toxicology, 44(4), 609&#x2013;622. https://doi.org/10.1002/jat.4564</Citation></Reference><Reference><Citation>Dickey, C. A., Koren, J., Zhang, Y.&#x2010;J., Xu, Y., Jinwal, U. K., Birnbaum, M. J., Monks, B., Sun, M., Cheng, J. Q., Patterson, C., Bailey, R. M., Dunmore, J., Soresh, S., Leon, C., Morgan, D., &amp; Petrucelli, L. (2008). Akt and CHIP coregulate tau degradation through coordinated interactions. Proceedings of the National Academy of Sciences, 105(9), 3622&#x2013;3627. https://doi.org/10.1073/pnas.0709180105</Citation></Reference><Reference><Citation>El Massry, M., Alaeddine, L. M., Ali, L., Saad, C., &amp; Eid, A. A. (2021). Metformin: A growing journey from glycemic control to the treatment of Alzheimer's disease and depression. Current Medicinal Chemistry, 28(12), 2328&#x2013;2345. https://doi.org/10.2174/0929867327666200908114902</Citation></Reference><Reference><Citation>Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Ce&#xf1;a, V., Gallego, C., &amp; Comella, J. X. (2000). Sequential treatment of SH&#x2010;SY5Y cells with retinoic acid and brain&#x2010;derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor&#x2010;dependent, human neuron&#x2010;like cells. Journal of Neurochemistry, 75(3), 991&#x2013;1003. https://doi.org/10.1046/j.1471-4159.2000.0750991.x</Citation></Reference><Reference><Citation>Exley, C. (1999). A molecular mechanism of aluminium&#x2010;induced Alzheimer's disease? Journal of Inorganic Biochemistry, 76(2), 133&#x2013;140. https://doi.org/10.1016/S0162-0134(99)00125-7</Citation></Reference><Reference><Citation>Exley, C. (2004). The pro&#x2010;oxidant activity of aluminum. Free Radical Biology and Medicine, 36(3), 380&#x2013;387. https://doi.org/10.1016/j.freeradbiomed.2003.11.017</Citation></Reference><Reference><Citation>Exley, C., &amp; Ellen Burgess, J. (1996). Aluminum toxicokinetics. Journal of Toxicology and Environmental Health, 48(6), 569&#x2013;584. https://doi.org/10.1080/009841096161078</Citation></Reference><Reference><Citation>Goedert, M., Jakes, R., Qi, Z., Wang, J. H., &amp; Cohen, P. (1995). Protein phosphatase 2A is the major enzyme in brain that dephosphorylates &#x3c4; protein phosphorylated by proline&#x2010;directed protein kinases or cyclic AMP&#x2010;dependent protein kinase. Journal of Neurochemistry, 65(6), 2804&#x2013;2807. https://doi.org/10.1046/J.1471-4159.1995.65062804.X</Citation></Reference><Reference><Citation>Gupta, A., Bisht, B., &amp; Dey, C. S. (2011). Peripheral insulin&#x2010;sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's&#x2010;like changes. Neuropharmacology, 60(6), 910&#x2013;920. https://doi.org/10.1016/J.NEUROPHARM.2011.01.033</Citation></Reference><Reference><Citation>Huang, X., Li, S., Lu, W., &amp; Xiong, L. (2022). Metformin activates Wnt/&#x3b2;&#x2010;catenin for the treatment of diabetic osteoporosis. BMC Endocrine Disorders, 22(1), 1&#x2013;7. https://doi.org/10.1186/S12902-022-01103-6/FIGURES/3</Citation></Reference><Reference><Citation>Inestrosa, N. C., &amp; Toledo, E. M. (2008). The role of Wnt signaling in neuronal dysfunction in Alzheimer's disease. Molecular Neurodegeneration, 3(1), 9. https://doi.org/10.1186/1750-1326-3-9</Citation></Reference><Reference><Citation>J&#xe4;ms&#xe4;, A., Hasslund, K., Cowburn, R. F., B&#xe4;ckstr&#xf6;m, A., &amp; Vas&#xe4;nge, M. (2004). The retinoic acid and brain&#x2010;derived neurotrophic factor differentiated SH&#x2010;SY5Y cell line as a model for Alzheimer's disease&#x2010;like tau phosphorylation. Biochemical and Biophysical Research Communications, 319(3), 993&#x2013;1000. https://doi.org/10.1016/j.bbrc.2004.05.075</Citation></Reference><Reference><Citation>Kickstein, E., Krauss, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J., Williamson, R., Fuchs, M., K&#xf6;hler, A., Glossmann, H., Schneider, R., Sutherland, C., &amp; Schweiger, S. (2010). Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proceedings of the National Academy of Sciences, 107(50), 21830&#x2013;21835. https://doi.org/10.1073/pnas.0912793107</Citation></Reference><Reference><Citation>Koenig, A. M. (2016). Effects of the insulin sensitizer metformin on Alzheimer's disease biomarkers: Results of a brief crossover pilot study. Alzheimer's &amp; Dementia, 12(7S_Part_8), 413. https://doi.org/10.1016/j.jalz.2016.06.778</Citation></Reference><Reference><Citation>Krieg, R. C., Dong, Y., Schwamborn, K., &amp; Knuechel, R. (2005). Protein quantification and its tolerance for different interfering reagents using the BCA&#x2010;method with regard to 2D SDS PAGE. Journal of Biochemical and Biophysical Methods, 65(1), 13&#x2013;19. https://doi.org/10.1016/J.JBBM.2005.08.005</Citation></Reference><Reference><Citation>Kunicka&#x2010;Styczy&#x144;ska, A., Sikora, M., &amp; Kalemba, D. (2011). Lavender, tea tree and lemon oils as antimicrobials in washing liquids and soft body balms. International Journal of Cosmetic Science, 33(1), 53&#x2013;61. https://doi.org/10.1111/j.1468-2494.2010.00582.x</Citation></Reference><Reference><Citation>Lamoia, T. E., &amp; Shulman, G. I. (2021). Cellular and molecular mechanisms of metformin action. Endocrine Reviews, 42(1), 77&#x2013;96. https://doi.org/10.1210/ENDREV/BNAA023</Citation></Reference><Reference><Citation>Mailloux, R., Lemire, J., &amp; Appanna, V. (2007). Aluminum&#x2010;induced mitochondrial dysfunction leads to lipid accumulation in human hepatocytes: A link to obesity. Cellular Physiology and Biochemistry, 20(5), 627&#x2013;638. https://doi.org/10.1159/000107546</Citation></Reference><Reference><Citation>Miller, N. J., Rice&#x2010;Evans, C., Davies, M. J., Gopinathan, V., &amp; Milner, A. (1993). A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clinical Science, 84(4), 407&#x2013;412. https://doi.org/10.1042/CS0840407</Citation></Reference><Reference><Citation>Palomer, E., Buechler, J., &amp; Salinas, P. C. (2019). Wnt signaling deregulation in the aging and Alzheimer's brain. Frontiers in Cellular Neuroscience, 13, 227. https://doi.org/10.3389/fncel.2019.00227</Citation></Reference><Reference><Citation>Razani, E., Pourbagheri&#x2010;Sigaroodi, A., Safaroghli&#x2010;Azar, A., Zoghi, A., Shanaki&#x2010;Bavarsad, M., &amp; Bashash, D. (2021). The PI3K/Akt signaling axis in Alzheimer's disease: A valuable target to stimulate or suppress? Cell Stress &amp; Chaperones, 26(6), 871&#x2013;887. https://doi.org/10.1007/S12192-021-01231-3</Citation></Reference><Reference><Citation>Richard, M. J., Portal, B., Meo, J., Coudray, C., Hadjian, A., &amp; Favier, A. (1992). Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clinical Chemistry, 38(5), 704&#x2013;709. https://doi.org/10.1093/clinchem/38.5.704</Citation></Reference><Reference><Citation>Sanajou, S., Erkeko&#x11f;lu, P., &#x15e;ahin, G., &amp; Baydar, T. (2023). Role of aluminum exposure on Alzheimer's disease and related glycogen synthase kinase pathway. Drug and Chemical Toxicology, 46(3), 510&#x2013;522. https://doi.org/10.1080/01480545.2022.2065291</Citation></Reference><Reference><Citation>Sanajou, S., Yir&#xfc;n, A., Arca &#xc7;ak&#x131;r, D., Demirel, G., &#x15e;ahin, G., Erkeko&#x11f;lu, P., &amp; Baydar, T. (2024). Unraveling the neuroprotective mechanisms of naltrexone against aluminum&#x2010;induced neurotoxicity. Drug and Chemical Toxicology, 1&#x2013;12. https://doi.org/10.1080/01480545.2024.2303975</Citation></Reference><Reference><Citation>Sanajou, S., Yir&#xfc;n, A., Demirel, G., &#xc7;akir, D. A., &#x15e;ahin, G., Erkeko&#x11f;lu, P., &amp; Baydar, T. (2023). Antioxidant dihydrolipolic acid protects against in vitro aluminum&#x2010;induced toxicity. Journal of Applied Toxicology, 43, 1793&#x2013;1805. https://doi.org/10.1002/jat.4513</Citation></Reference><Reference><Citation>Shang, N., Zhang, P., Wang, S., Chen, J., Fan, R., Chen, J., Huang, T., Wang, Y., Duncan, J., Zhang, L., Niu, Q., &amp; Zhang, Q. (2020). Aluminum&#x2010;induced cognitive impairment and PI3K/Akt/mTOR signaling pathway involvement in occupational aluminum workers. Neurotoxicity Research, 38(2), 344&#x2013;358. https://doi.org/10.1007/S12640-020-00230-Z</Citation></Reference><Reference><Citation>Sun, X., Cao, Z., Zhang, Q., Liu, S., Xu, F., Che, J., Zhu, Y., Li, Y., Pan, C., &amp; Liang, W. (2015). Aluminum trichloride impairs bone and downregulates Wnt/&#x3b2;&#x2010;catenin signaling pathway in young growing rats. Food and Chemical Toxicology, 86, 154&#x2013;162. https://doi.org/10.1016/J.FCT.2015.10.005</Citation></Reference><Reference><Citation>Vial, G., Detaille, D., &amp; Guigas, B. (2019). Role of mitochondria in the mechanism(s) of action of metformin. Frontiers in Endocrinology, 10(MAY), 294. https://doi.org/10.3389/fendo.2019.00294</Citation></Reference><Reference><Citation>Yir&#xfc;n, A., &#xc7;ak&#x131;r, D. A., Sanajou, S., Erdemli K&#xf6;se, S. B., &#xd6;zyurt, A. B., Zeybek, D., Bozdemir, &#xd6;., Baydar, T., &amp; Erkekoglu, P. (2023). Evaluation of the effects of herpes simplex glycoprotein B on complement system and cytokines in in vitro models of Alzheimer's disease. Journal of Applied Toxicology, 43(9), 1368&#x2013;1378. https://doi.org/10.1002/jat.4471</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39275911</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1468-1331</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>'Knock down the brain': a nonlinear analysis of electroencephalography to study the effects of sub-concussion in boxers.</ArticleTitle><Pagination><StartPage>e16411</StartPage><MedlinePgn>e16411</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1111/ene.16411</ELocationID><Abstract><AbstractText Label=\"BACKGROUND AND PURPOSE\" NlmCategory=\"OBJECTIVE\">Boxing is associated with a high risk of head injuries and increases the likelihood of chronic traumatic encephalopathy. This study explores the effects of sub-concussive impacts on boxers by applying both linear and nonlinear analysis methods to electroencephalogram (EEG) data.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">Twenty-one boxers were selected (mean&#x2009;&#xb1;&#x2009;SD, age 28.38&#x2009;&#xb1;&#x2009;5.5&#x2009;years; weight 67.55&#x2009;&#xb1;&#x2009;8.90&#x2009;kg; years of activity 6.76&#x2009;&#xb1;&#x2009;5.45; education 14.19&#x2009;&#xb1;&#x2009;3.08&#x2009;years) and divided into 'beginner' and 'advanced' groups. The Montreal Cognitive Assessment and the Frontal Assessment Battery were administered; EEG data were collected in both eyes-open (EO) and eyes-closed (EC) conditions during resting states. Analyses of EEG data included normalized power spectral density (nPSD), power law exponent (PLE), detrended fluctuation analysis and multiscale entropy. Statistical analyses were used to compare the groups.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Significant differences in nPSD and PLE were observed between the beginner and advanced boxers, with advanced boxers showing decreased mean nPSD and PLE (nPSD 4-7&#x2009;Hz, p&#x2009;=&#x2009;0.013; 8-13&#x2009;Hz, p&#x2009;=&#x2009;0.003; PLE frontal lobe F3 EC, p&#x2009;=&#x2009;0.010). Multiscale entropy analysis indicated increased entropy at lower frequencies and decreased entropy at higher frequencies in advanced boxers (F3 EC, p&#x2009;=&#x2009;0.024; occipital lobe O1 EO, p&#x2009;=&#x2009;0.029; occipital lobe O2 EO, p&#x2009;=&#x2009;0.036). These changes are similar to those seen in Alzheimer's disease.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">Nonlinear analysis of EEG data shows potential as a neurophysiological biomarker for detecting the asymptomatic phase of chronic traumatic encephalopathy in boxers. This methodology could help monitor athletes' health and reduce the risk of future neurological injuries in sports.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>De Donato</LastName><ForeName>Renato</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0003-1983-0146</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maiorana</LastName><ForeName>Natale Vincenzo</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vergari</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>De Sandi</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Naci</LastName><ForeName>Anisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Aglieco</LastName><ForeName>Giada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Albizzati</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Guidetti</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ferrara</LastName><ForeName>Rosanna</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bocci</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASST Santi Paolo e Carlo, University Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Barbieri</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ferrucci</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0001-5109-9483</Identifier><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology and Emato-Oncology, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Priori</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-1549-3851</Identifier><AffiliationInfo><Affiliation>Aldo Ravelli Research Centre, Department of Health Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASST Santi Paolo e Carlo, University Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>Grant Number: 01</GrantID><Agency>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">boxing concussion</Keyword><Keyword MajorTopicYN=\"N\">chronic traumatic encephalopathy</Keyword><Keyword MajorTopicYN=\"N\">dementia</Keyword><Keyword MajorTopicYN=\"N\">nonlinear EEG</Keyword><Keyword MajorTopicYN=\"N\">sub&#x2010;concussion</Keyword><Keyword MajorTopicYN=\"N\">traumatic brain injuries</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>5</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39275911</ArticleId><ArticleId IdType=\"doi\">10.1111/ene.16411</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Nagahiro S, Mizobuchi Y. Current topics in sports&#x2010;related head injuries: a review. Neurol Med Chir (Tokyo). 2014;54(11):878&#x2010;886. doi:10.2176/nmc.ra.2014-0224</Citation></Reference><Reference><Citation>Koh JO, Cassidy JD, Watkinson EJ. Incidence of concussion in contact sports: a systematic review of the evidence. Brain Inj. 2003;17(10):901&#x2010;917. doi:10.1080/0269905031000088869</Citation></Reference><Reference><Citation>Powell JW, Barber&#x2010;foss KD. Traumatic Brain Injury in High School Athletes. JAMA. Original Contribution. 1999;282(10):958&#x2010;963.</Citation></Reference><Reference><Citation>Rabadi MH, Jordan BD. The cumulative effect of repetitive concussion in sports. Clin J Sport Med. 2001;11(3):194&#x2010;198. doi:10.1097/00042752-200107000-00011</Citation></Reference><Reference><Citation>Finch CF, Clapperton AJ, McCrory P. Increasing incidence of hospitalisation for sport&#x2010;related concussion in Victoria, Australia. Med J Aust. 2013;198(8):427&#x2010;430. doi:10.5694/mja12.11217</Citation></Reference><Reference><Citation>Rosenthal JA, Foraker RE, Collins CL, Comstock RD. National high school athlete concussion rates from 2005&#x2013;2006 to 2011&#x2013;2012. Am J Sports Med. 2014;42(7):1710&#x2010;1715. doi:10.1177/0363546514530091</Citation></Reference><Reference><Citation>Ruff RM. 20th anniversary article mild traumatic brain injury and neural recovery: rethinking the debate. NeuroRehabilitation. 2011;28:167&#x2010;180. doi:10.3233/NRE-2011-0646</Citation></Reference><Reference><Citation>Schneider DK, Galloway R, Bazarian JJ, et&#xa0;al. Diffusion tensor imaging in athletes sustaining repetitive head impacts: a systematic review of prospective studies. J Neurotrauma. 2019;36(20):2831&#x2010;2849. doi:10.1089/neu.2019.6398</Citation></Reference><Reference><Citation>McAllister T, McCrea M. Long&#x2010;term cognitive and neuropsychiatric consequences of repetitive concussion and head&#x2010;impact exposure. J Athl Train. 2017;52(3):309&#x2010;317. doi:10.4085/1062-6050-52.1.14</Citation></Reference><Reference><Citation>Mainwaring L, Ferdinand Pennock KM, Mylabathula S, Alavie BZ. Subconcussive head impacts in sport: a systematic review of the evidence. Int J Psychophysiol. 2018;132:39&#x2010;54. doi:10.1016/j.ijpsycho.2018.01.007</Citation></Reference><Reference><Citation>Gardner A, Iverson GL, McCrory P. Chronic traumatic encephalopathy in sport: a systematic review. Br J Sports Med. 2014;48(2):84&#x2010;90. doi:10.1136/bjsports-2013-092646</Citation></Reference><Reference><Citation>Alosco ML, Stern RA. The Long&#x2010;Term Consequences of Repetitive Head Impacts: Chronic Traumatic Encephalopathy. Vol 167. 1st ed. Elsevier B.V; 2019. doi:10.1016/B978-0-12-804766-8.00018-2</Citation></Reference><Reference><Citation>Martland HS. Punch drunk. JAMA. 1928;91(15):1103&#x2010;1107.</Citation></Reference><Reference><Citation>Castellani RJ, Perry G. Dementia Pugilistica Revisited. J Alzheimers Dis. 2017;60(4):1209&#x2010;1221. doi:10.3233/JAD-170669</Citation></Reference><Reference><Citation>Tarazi A, Tator CH, Tartaglia MC. Chronic traumatic encephalopathy and movement disorders: update. Curr Neurol Neurosci Rep. 2016;16(5):1&#x2010;8. doi:10.1007/s11910-016-0648-3</Citation></Reference><Reference><Citation>Armstrong RA, Mckee AC, Stein TD, Alvarez VE, Cairns NJ. A quantitative study of tau pathology in 11 cases of chronic traumatic encephalopathy. Neuropathol Appl Neurobiol. 2017;43:154&#x2010;166. doi:10.1111/nan.12323</Citation></Reference><Reference><Citation>Mckee AC et&#xa0;al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2012;136(1):43&#x2010;64. doi:10.1093/brain/aws307</Citation></Reference><Reference><Citation>Mez J, Daneshvar DH, Kiernan PT, et&#xa0;al. Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA. 2017;02118(4):360&#x2010;370. doi:10.1001/jama.2017.8334</Citation></Reference><Reference><Citation>Kokjohn TA, Maarouf CL, Daugs ID, et&#xa0;al. Neurochemical profile of dementia pugilistica. J Neurotrauma. 2013;30(11):981&#x2010;997. doi:10.1089/neu.2012.2699</Citation></Reference><Reference><Citation>Asken BM, Sullan MJ, Snyder AR, et&#xa0;al. Factors influencing clinical correlates of chronic traumatic encephalopathy (CTE): a review. Neuropsychol Rev. 2016;26(4):340&#x2010;363. doi:10.1007/s11065-016-9327-z</Citation></Reference><Reference><Citation>Broglio SP, Eckner JT, Paulson HL, Kutcher JS. Cognitive decline and aging: the role of concussive and subconcussive impacts. Exerc Sport Sci Rev. 2012;40(3):138&#x2010;144. doi:10.1097/JES.0b013e3182524273</Citation></Reference><Reference><Citation>Steven P, DeKosky T, Milos D, Ikonomovic MD, Sam Gandy MD. Traumatic brain injury&#x2014;football, warfare, and long&#x2010;term effects. N Engl J Med. 2010;363(14):1293&#x2010;1296.</Citation></Reference><Reference><Citation>Lewine JD, Plis S, Ulloa A, et&#xa0;al. Quantitative EEG biomarkers for mild traumatic brain injury. J Clin Neurophysiol. 2019;36(4):298&#x2010;305. doi:10.1097/WNP.0000000000000588</Citation></Reference><Reference><Citation>Munia TTK, Haider A, Schneider C, Romanick M, Fazel&#x2010;Rezai R. A novel EEG based spectral analysis of persistent brain function alteration in athletes with concussion history. Sci Rep. 2017;7(1):1&#x2010;13. doi:10.1038/s41598-017-17414-x</Citation></Reference><Reference><Citation>Santangelo G, Siciliano M, Pedone R, et&#xa0;al. Normative data for the Montreal Cognitive Assessment in an Italian population sample. Neurol Sci. 2015;36(4):585&#x2010;591. doi:10.1007/s10072-014-1995-y</Citation></Reference><Reference><Citation>Appollonio I, Leone M, Isella V, et&#xa0;al. The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci. 2005;26(2):108&#x2010;116. doi:10.1007/s10072-005-0443-4</Citation></Reference><Reference><Citation>Welch PD. The use of fast Fourier transform for the estimation of power spectra: a method based on time averaging over short, modified periodograms. IEEE Trans Audio Electroacoust. 1967;2:70&#x2010;73.</Citation></Reference><Reference><Citation>Demuru M, La Cava SM, Pani SM, Fraschini M. A comparison between power spectral density and network metrics: an EEG study. Biomed Signal Process Control. 2020;57:101760. doi:10.1016/j.bspc.2019.101760</Citation></Reference><Reference><Citation>Colombo MA, Napolitani M, Boly M, et&#xa0;al. The spectral exponent of the resting EEG indexes the presence of consciousness during unresponsiveness induced by propofol, xenon, and ketamine. NeuroImage. 2019;189:631&#x2010;644. doi:10.1016/j.neuroimage.2019.01.024</Citation></Reference><Reference><Citation>Peng CK, Buldyrev SV, Goldberger AL, et&#xa0;al. Long&#x2010;range correlations in nucleotide sequences. Nature. 1992;359:710&#x2010;713. file:///C:/Users/ASUS/Desktop/Rujukan PhD/p21/xiong1993.pdf.</Citation></Reference><Reference><Citation>Shao YH, Gu GF, Jiang ZQ, Zhou WX, Sornette D. Comparing the performance of FA, DFA and DMA using different synthetic long&#x2010;range correlated time series. Sci Rep. 2012;2:1&#x2010;5. doi:10.1038/srep00835</Citation></Reference><Reference><Citation>Ferrara R. Nonlinear analysis of neurophysiological time series: methodological evaluation and clinical application in Parkinson's and Alzheimer's diseases. Master's Dissertation. Politecnico di Milano. Biomed Eng. 2021:1&#x2010;137.</Citation></Reference><Reference><Citation>Costa M, Goldberger AL, Peng CK. Multiscale entropy analysis of complex physiologic time series. Phys Rev Lett. 2002;89(6):6&#x2010;9. doi:10.1103/PhysRevLett.89.068102</Citation></Reference><Reference><Citation>Weintraub S, Carrillo MC, Farias ST, et&#xa0;al. Measuring cognition and function in the preclinical stage of Alzheimer's disease. Alzheimer's Dement Transl Res Clin Interv. 2018;4:64&#x2010;75. doi:10.1016/j.trci.2018.01.003</Citation></Reference><Reference><Citation>Takahashi RH, Nagao T, Gouras GK. Plaque formation and the intraneuronal accumulation of &#x3b2;&#x2010;amyloid in Alzheimer's disease. Pathol Int. 2017;67(4):185&#x2010;193. doi:10.1111/pin.12520</Citation></Reference><Reference><Citation>Thies W, Bleiler L. 2012 Alzheimer's disease facts and figures. Alzheimers Dement. 2012;8(2):131&#x2010;168. doi:10.1016/j.jalz.2012.02.001</Citation></Reference><Reference><Citation>Vy&#x161;ata O, Proch&#xe1;zka A, Mare&#x161; J, et&#xa0;al. Change in the characteristics of EEG color noise in Alzheimer's disease. Clin EEG Neurosci. 2014;45(3):147&#x2010;151. doi:10.1177/1550059413491558</Citation></Reference><Reference><Citation>Stam CJ, Montez T, Jones BF, et&#xa0;al. Disturbed fluctuations of resting state EEG synchronization in Alzheimer's disease. Clin Neurophysiol. 2005;116(3):708&#x2010;715. doi:10.1016/j.clinph.2004.09.022</Citation></Reference><Reference><Citation>Mizuno T, Takahashi T, Cho RY, et&#xa0;al. Assessment of EEG dynamical complexity in Alzheimer's disease using multiscale entropy. Clin Neurophysiol. 2010;121(9):1438&#x2010;1446. doi:10.1016/j.clinph.2010.03.025</Citation></Reference><Reference><Citation>Escudero J, Ab&#xe1;solo D, Hornero R, Espino P, L&#xf3;pez M. Analysis of electroencephalograms in Alzheimer's disease patients with multiscale entropy. Physiol Meas. 2006;27(11):1091&#x2010;1106. doi:10.1088/0967-3334/27/11/004</Citation></Reference><Reference><Citation>Yang AC, Huang CC, Yeh HL, et&#xa0;al. Complexity of spontaneous BOLD activity in default mode network is correlated with cognitive function in normal male elderly: a multiscale entropy analysis. Neurobiol Aging. 2013;34(2):428&#x2010;438. doi:10.1016/j.neurobiolaging.2012.05.004</Citation></Reference><Reference><Citation>Sharma A, Rai JK, Tewari RP. Relative measures to characterize EEG signals for early detection of Alzheimer. 5th Int Conf Signal Process Integr Networks. 2018;43&#x2010;48. doi:10.1109/SPIN.2018.8474288</Citation></Reference><Reference><Citation>Nimmy John T, Subha Dharmapalan P, Ramshekhar Menon N. Exploration of time&#x2010;frequency reassignment and homologous inter&#x2010;hemispheric asymmetry analysis of MCI&#x2010;AD brain activity. BMC Neurosci. 2019;20(1):1&#x2010;14. doi:10.1186/s12868-019-0519-3</Citation></Reference><Reference><Citation>Reyes&#x2010;Coronel C, Waser M, Garn H, et&#xa0;al. Predicting rapid cognitive decline in Alzheimer's disease patients using quantitative EEG markers and neuropsychological test scores. Proc Annu Int Conf IEEE Eng Med Biol Soc EMBS. 2016;2016:6078&#x2010;6081. doi:10.1109/EMBC.2016.7592115</Citation></Reference><Reference><Citation>Saing T, Dick M, Nelson PT, Kim RC, Cribbs DH, Head E. Frontal cortex neuropathology in dementia pugilistica. J Neurotrauma. 2012;29(6):1054&#x2010;1070. doi:10.1089/neu.2011.1957</Citation></Reference><Reference><Citation>Falcon B, Zivanov J, Zhang W, et&#xa0;al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature. 2019;568(7752):420&#x2010;423. doi:10.1038/s41586-019-1026-5</Citation></Reference><Reference><Citation>Fickling SD, Poel DN, Dorman JC, D'Arcy RCN, Munce TA. Subconcussive changes in youth football players: objective evidence using brain vital signs and instrumented accelerometers. Brain Commun. 2022;4(2):1&#x2010;11. doi:10.1093/braincomms/fcab286</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39275263</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2072-6643</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>16</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Impact of Peptide Transport and Memory Function in the Brain.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">2947</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/nu16172947</ELocationID><Abstract><AbstractText>Recent studies have reported the benefits of food-derived peptides for memory dysfunction. Beyond the physiological effects of peptides, their bioavailability to the brain still remains unclear since the blood-brain barrier (BBB) strictly controls the transportation of compounds to the brain. Here, updated transportation studies on BBB transportable peptides are introduced and evaluated using in vitro BBB models, in situ perfusion, and in vivo mouse experiments. Additionally, the mechanisms of action of brain health peptides in relation to the pathogenesis of neurodegenerative diseases, particularly Alzheimer's disease, are discussed. This discussion follows a summary of bioactive peptides with neuroprotective effects that can improve cognitive decline through various mechanisms, including anti-inflammatory, antioxidative, anti-amyloid &#x3b2; aggregation, and neurotransmitter regulation.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Cheng</LastName><ForeName>Lihong</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0002-2522-4831</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shi</LastName><ForeName>Caiyue</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School of Kyushu University, Fukuoka 819-0395, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Xixi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School of Kyushu University, Fukuoka 819-0395, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Matsui</LastName><ForeName>Toshiro</ForeName><Initials>T</Initials><Identifier Source=\"ORCID\">0000-0002-9137-8417</Identifier><AffiliationInfo><Affiliation>Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School of Kyushu University, Fukuoka 819-0395, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>21H04863</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>21F21386</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D010455\">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018696\">Neuroprotective Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001812\" MajorTopicYN=\"Y\">Blood-Brain Barrier</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001921\" MajorTopicYN=\"Y\">Brain</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008568\" MajorTopicYN=\"Y\">Memory</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName><QualifierName UI=\"Q000502\" MajorTopicYN=\"N\">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D010455\" MajorTopicYN=\"Y\">Peptides</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001692\" MajorTopicYN=\"N\">Biological Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018696\" MajorTopicYN=\"N\">Neuroprotective Agents</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008569\" MajorTopicYN=\"N\">Memory Disorders</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">bioavailability</Keyword><Keyword MajorTopicYN=\"N\">blood-brain barrier</Keyword><Keyword MajorTopicYN=\"N\">cognitive impairment</Keyword><Keyword MajorTopicYN=\"N\">dementia</Keyword><Keyword MajorTopicYN=\"N\">peptide</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39275263</ArticleId><ArticleId IdType=\"doi\">10.3390/nu16172947</ArticleId><ArticleId IdType=\"pii\">nu16172947</ArticleId><ArticleId IdType=\"pmc\">PMC11396983</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kesidou E., Theotokis P., Damianidou O., Boziki M., Konstantinidou N., Taloumtzis C., Sintila S.-A., Grigoriadis P., Evangelopoulos M.E., Bakirtzis C., et al. CNS Ageing in Health and Neurodegenerative Disorders. J. Clin. Med. 2023;12:2255. doi: 10.3390/jcm12062255.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm12062255</ArticleId><ArticleId IdType=\"pmc\">PMC10054919</ArticleId><ArticleId IdType=\"pubmed\">36983254</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinmetz J.D., Seeher K.M., Schiess N., Nichols E., Cao B., Servili C., Cavallera V., Cousin E., Hagins H., Moberg M.E., et al. Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990&#x2013;2021: A Systematic Analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23:344&#x2013;381. doi: 10.1016/S1474-4422(24)00038-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(24)00038-3</ArticleId><ArticleId IdType=\"pmc\">PMC10949203</ArticleId><ArticleId IdType=\"pubmed\">38493795</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari D., Rafiq S., Gat Y., Gat P., Waghmare R., Kumar V. A Review on Bioactive Peptides: Physiological Functions, Bioavailability and Safety. Int. J. Pept. Res. Ther. 2020;26:139&#x2013;150. doi: 10.1007/s10989-019-09823-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10989-019-09823-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L., Wang L., Liu C., Liang Y., Lin Q. Bioactive Peptides from Foods: Production, Function, and Application. Food Funct. 2021;12:7108&#x2013;7125. doi: 10.1039/D1FO01265G.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D1FO01265G</ArticleId><ArticleId IdType=\"pubmed\">34223585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Sun-Waterhouse D., Neil Waterhouse G.I., Zheng L., Su G., Zhao M. Effects of Food-Derived Bioactive Peptides on Cognitive Deficits and Memory Decline in Neurodegenerative Diseases: A Review. Trends Food Sci. Technol. 2021;116:712&#x2013;732. doi: 10.1016/j.tifs.2021.04.056.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tifs.2021.04.056</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K., Gupta J.K., Kumar S., Soni U. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides. Curr. Protein Pept. Sci. 2024;25:507&#x2013;526. doi: 10.2174/0113892037275221240327042353.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/0113892037275221240327042353</ArticleId><ArticleId IdType=\"pubmed\">38561605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kita M., Obara K., Kondo S., Umeda S., Ano Y. Effect of Supplementation of a Whey Peptide Rich in Tryptophan-Tyrosine-Related Peptides on Cognitive Performance in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients. 2018;10:899. doi: 10.3390/nu10070899.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu10070899</ArticleId><ArticleId IdType=\"pmc\">PMC6073406</ArticleId><ArticleId IdType=\"pubmed\">30011836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kita M., Kobayashi K., Obara K., Koikeda T., Umeda S., Ano Y. Supplementation with Whey Peptide Rich in &#x3b2;-Lactolin Improves Cognitive Performance in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Study. Front. Neurosci. 2019;13:399. doi: 10.3389/fnins.2019.00399.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2019.00399</ArticleId><ArticleId IdType=\"pmc\">PMC6491855</ArticleId><ArticleId IdType=\"pubmed\">31068787</ArticleId></ArticleIdList></Reference><Reference><Citation>Markus C.R., Olivier B., Panhuysen G.E.M., Van der Gugten J., Alles M.S., Tuiten A., Westenberg H.G.M., Fekkes D., Koppeschaar H.F., de Haan E.E. The Bovine Protein &#x3b1;-Lactalbumin Increases the Plasma Ratio of Tryptophan to the Other Large Neutral Amino Acids, and in Vulnerable Subjects Raises Brain Serotonin Activity, Reduces Cortisol Concentration, and Improves Mood under Stress. Am. J. Clin. Nutr. 2000;71:1536&#x2013;1544. doi: 10.1093/ajcn/71.6.1536.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/71.6.1536</ArticleId><ArticleId IdType=\"pubmed\">10837296</ArticleId></ArticleIdList></Reference><Reference><Citation>Loveday S.M. Protein Digestion and Absorption: The Influence of Food Processing. Nutr. Res. Rev. 2023;36:544&#x2013;559. doi: 10.1017/S0954422422000245.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S0954422422000245</ArticleId><ArticleId IdType=\"pubmed\">36522674</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadry H., Noorani B., Cucullo L. A Blood-Brain Barrier Overview on Structure, Function, Impairment, and Biomarkers of Integrity. Fluids Barriers CNS. 2020;17:69. doi: 10.1186/s12987-020-00230-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12987-020-00230-3</ArticleId><ArticleId IdType=\"pmc\">PMC7672931</ArticleId><ArticleId IdType=\"pubmed\">33208141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronaldson P.T., Davis T.P. Regulation of Blood-Brain Barrier Integrity by Microglia in Health and Disease: A Therapeutic Opportunity. J. Cereb. Blood Flow Metab. 2020;40:S6&#x2013;S24. doi: 10.1177/0271678X20951995.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0271678X20951995</ArticleId><ArticleId IdType=\"pmc\">PMC7687032</ArticleId><ArticleId IdType=\"pubmed\">32928017</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardridge W.M. Why Is the Global CNS Pharmaceutical Market so Under-Penetrated? Drug Discov. Today. 2002;7:5&#x2013;7. doi: 10.1016/S1359-6446(01)02082-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1359-6446(01)02082-7</ArticleId><ArticleId IdType=\"pubmed\">11790589</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardridge W.M. The Blood-Brain Barrier: Bottleneck in Brain Drug Development. Neurotherapeutics. 2005;2:3&#x2013;14. doi: 10.1602/neurorx.2.1.3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1602/neurorx.2.1.3</ArticleId><ArticleId IdType=\"pmc\">PMC539316</ArticleId><ArticleId IdType=\"pubmed\">15717053</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks W.A. Characteristics of Compounds That Cross the Blood-Brain Barrier. BMC Neurol. 2009;9((Suppl. S1)):S3. doi: 10.1186/1471-2377-9-S1-S3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2377-9-S1-S3</ArticleId><ArticleId IdType=\"pmc\">PMC2697631</ArticleId><ArticleId IdType=\"pubmed\">19534732</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastin A.J., Nissen C., Nikolics K., Medzihradszky K., Coy D.H., Teplan I., Schally A.V. Distribution of 3H-&#x3b1;-MSH in Rat Brain. Brain Res. Bull. 1976;1:19&#x2013;26. doi: 10.1016/0361-9230(76)90045-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0361-9230(76)90045-9</ArticleId><ArticleId IdType=\"pubmed\">974794</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui T., Yoshino A., Tanaka M. A Trip of Peptides to the Brain. Food Prod. Process. Nutr. 2020;2:30. doi: 10.1186/s43014-020-00044-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s43014-020-00044-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott N.J., R&#xf6;nnb&#xe4;ck L., Hansson E. Astrocyte-Endothelial Interactions at the Blood-Brain Barrier. Nat. Rev. Neurosci. 2006;7:41&#x2013;53. doi: 10.1038/nrn1824.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrn1824</ArticleId><ArticleId IdType=\"pubmed\">16371949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolburg H., Lippoldt A. Tight Junctions of the Blood-Brain Barrier: Development, Composition and Regulation. Vascul. Pharmacol. 2002;38:323&#x2013;337. doi: 10.1016/S1537-1891(02)00200-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1537-1891(02)00200-8</ArticleId><ArticleId IdType=\"pubmed\">12529927</ArticleId></ArticleIdList></Reference><Reference><Citation>Curley S.M., Cady N.C. Biologically-Derived Nanomaterials for Targeted Therapeutic Delivery to the Brain. Sci. Prog. 2018;101:273&#x2013;292. doi: 10.3184/003685018X15306123582346.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3184/003685018X15306123582346</ArticleId><ArticleId IdType=\"pmc\">PMC10365220</ArticleId><ArticleId IdType=\"pubmed\">30071918</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixid&#xf3; M., Zurita E., Malakoutikhah M., Tarrag&#xf3; T., Giralt E. Diketopiperazines as a Tool for the Study of Transport across the Blood&#x2212;Brain Barrier (BBB) and Their Potential Use as BBB-Shuttles. J. Am. Chem. Soc. 2007;129:11802&#x2013;11813. doi: 10.1021/ja073522o.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/ja073522o</ArticleId><ArticleId IdType=\"pubmed\">17764181</ArticleId></ArticleIdList></Reference><Reference><Citation>Malakoutikhah M., Guixer B., Arranz-Gibert P., Teixid&#xf3; M., Giralt E. &#x2018;&#xc0; La Carte&#x2019; Peptide Shuttles: Tools to Increase Their Passage across the Blood&#x2013;Brain Barrier. ChemMedChem. 2014;9:1594&#x2013;1601. doi: 10.1002/cmdc.201300575.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cmdc.201300575</ArticleId><ArticleId IdType=\"pubmed\">24665021</ArticleId></ArticleIdList></Reference><Reference><Citation>Arranz-Gibert P., Guixer B., Malakoutikhah M., Muttenthaler M., Guzm&#xe1;n F., Teixid&#xf3; M., Giralt E. Lipid Bilayer Crossing&#x2014;The Gate of Symmetry. Water-Soluble Phenylproline-Based Blood-Brain Barrier Shuttles. J. Am. Chem. Soc. 2015;137:7357&#x2013;7364. doi: 10.1021/jacs.5b02050.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jacs.5b02050</ArticleId><ArticleId IdType=\"pubmed\">25992679</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Gonzalez B., Sanchez-Alegria K., Velazquez-Moctezuma J. From Blood-to-Brain: Regulating the Permeability of the Blood-Brain Barrier. Curr. Psychopharmacol. 2012;1:214&#x2013;227. doi: 10.2174/2211556011201030214.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/2211556011201030214</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Bedolla P., Walter F.R., Veszelka S., Deli M.A. Role of the Blood&#x2013;Brain Barrier in the Nutrition of the Central Nervous System. Arch. Med. Res. 2014;45:610&#x2013;638. doi: 10.1016/j.arcmed.2014.11.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arcmed.2014.11.018</ArticleId><ArticleId IdType=\"pubmed\">25481827</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris M.E., Rodriguez-Cruz V., Felmlee M.A. SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers. AAPS J. 2017;19:1317&#x2013;1331. doi: 10.1208/s12248-017-0110-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1208/s12248-017-0110-8</ArticleId><ArticleId IdType=\"pmc\">PMC6467070</ArticleId><ArticleId IdType=\"pubmed\">28664465</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieger B., Gao B. Drug Transporters in the Central Nervous System. Clin. Pharmacokinet. 2015;54:225&#x2013;242. doi: 10.1007/s40262-015-0241-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40262-015-0241-y</ArticleId><ArticleId IdType=\"pubmed\">25647629</ArticleId></ArticleIdList></Reference><Reference><Citation>Shawahna R., Uchida Y., Decl&#xe8;ves X., Ohtsuki S., Yousif S., Dauchy S., Jacob A., Chassoux F., Daumas-Duport C., Couraud P.-O., et al. Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels. Mol. Pharm. 2011;8:1332&#x2013;1341. doi: 10.1021/mp200129p.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/mp200129p</ArticleId><ArticleId IdType=\"pubmed\">21707071</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtsuki S., Terasaki T. Contribution of Carrier-Mediated Transport Systems to the Blood&#x2013;Brain Barrier as a Supporting and Protecting Interface for the Brain; Importance for CNS Drug Discovery and Development. Pharm. Res. 2007;24:1745&#x2013;1758. doi: 10.1007/s11095-007-9374-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11095-007-9374-5</ArticleId><ArticleId IdType=\"pubmed\">17619998</ArticleId></ArticleIdList></Reference><Reference><Citation>Puris E., Gynther M., Auriola S., Huttunen K.M. L-Type Amino Acid Transporter 1 as a Target for Drug Delivery. Pharm. Res. 2020;37:88. doi: 10.1007/s11095-020-02826-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11095-020-02826-8</ArticleId><ArticleId IdType=\"pmc\">PMC7203094</ArticleId><ArticleId IdType=\"pubmed\">32377929</ArticleId></ArticleIdList></Reference><Reference><Citation>Benz F., Liebner S. Structure and Function of the Blood-Brain Barrier (BBB) Handb. Exp. Pharmacol. 2022;273:3&#x2013;31.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33249527</ArticleId></ArticleIdList></Reference><Reference><Citation>Chafai A., Fromm M.F., K&#xf6;nig J., Maas R. The Prognostic Biomarker L-Homoarginine Is a Substrate of the Cationic Amino Acid Transporters CAT1, CAT2A and CAT2B. Sci. Rep. 2017;7:4767. doi: 10.1038/s41598-017-04965-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-017-04965-2</ArticleId><ArticleId IdType=\"pmc\">PMC5500509</ArticleId><ArticleId IdType=\"pubmed\">28684763</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith D.E., Cl&#xe9;men&#xe7;on B., Hediger M.A. Proton-Coupled Oligopeptide Transporter Family SLC15: Physiological, Pharmacological and Pathological Implications. Mol. Aspects Med. 2013;34:323&#x2013;336. doi: 10.1016/j.mam.2012.11.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mam.2012.11.003</ArticleId><ArticleId IdType=\"pmc\">PMC3602806</ArticleId><ArticleId IdType=\"pubmed\">23506874</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer K. Carnosine and Homocarnosine, the Forgotten, Enigmatic Peptides of the Brain. Neurochem. Res. 2005;30:1339&#x2013;1345. doi: 10.1007/s11064-005-8806-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11064-005-8806-z</ArticleId><ArticleId IdType=\"pubmed\">16341596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Xie Y., Keep R.F., Smith D.E. Divergent Developmental Expression and Function of the Proton-Coupled Oligopeptide Transporters PepT2 and PhT1 in Regional Brain Slices of Mouse and Rat. J. Neurochem. 2014;129:955&#x2013;965. doi: 10.1111/jnc.12687.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jnc.12687</ArticleId><ArticleId IdType=\"pmc\">PMC4181614</ArticleId><ArticleId IdType=\"pubmed\">24548120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C., Tao L., Cao X., Chen L. The Solute Carrier Transporters and the Brain: Physiological and Pharmacological Implications. Asian J. Pharm. Sci. 2020;15:131&#x2013;144. doi: 10.1016/j.ajps.2019.09.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajps.2019.09.002</ArticleId><ArticleId IdType=\"pmc\">PMC7193445</ArticleId><ArticleId IdType=\"pubmed\">32373195</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones A.R., Shusta E.V. Blood-Brain Barrier Transport of Therapeutics via Receptor-Mediation. Pharm. Res. 2007;24:1759&#x2013;1771. doi: 10.1007/s11095-007-9379-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11095-007-9379-0</ArticleId><ArticleId IdType=\"pmc\">PMC2685177</ArticleId><ArticleId IdType=\"pubmed\">17619996</ArticleId></ArticleIdList></Reference><Reference><Citation>Haqqani A.S., Stanimirovic D.B. Drug Delivery to the Brain. Springer International Publishing; Cham, Switzerland: 2022. Brain Delivery of Therapeutics via Transcytosis: Types and Mechanisms of Vesicle-Mediated Transport across the BBB; pp. 71&#x2013;91. AAPS Advances in the Pharmaceutical Sciences Series.</Citation></Reference><Reference><Citation>Bickel U., Yoshikawa T., Pardridge W.M. Delivery of Peptides and Proteins through the Blood-Brain Barrier. Adv. Drug Deliv. Rev. 2001;46:247&#x2013;279. doi: 10.1016/S0169-409X(00)00139-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0169-409X(00)00139-3</ArticleId><ArticleId IdType=\"pubmed\">11259843</ArticleId></ArticleIdList></Reference><Reference><Citation>Guixer B., Arroyo X., Belda I., Sabid&#xf3; E., Teixid&#xf3; M., Giralt E. Chemically Synthesized Peptide Libraries as a New Source of BBB Shuttles. Use of Mass Spectrometry for Peptide Identification. J. Pept. Sci. 2016;22:577&#x2013;591. doi: 10.1002/psc.2900.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/psc.2900</ArticleId><ArticleId IdType=\"pubmed\">27440580</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto K., Shinohara T., Adachi Y., Asami T., Ohtaki T. A Novel LRP1-Binding Peptide L57 That Crosses the Blood Brain Barrier. Biochem. Biophys. Rep. 2017;12:135&#x2013;139. doi: 10.1016/j.bbrep.2017.07.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrep.2017.07.003</ArticleId><ArticleId IdType=\"pmc\">PMC5645116</ArticleId><ArticleId IdType=\"pubmed\">29090274</ArticleId></ArticleIdList></Reference><Reference><Citation>Herv&#xe9; F., Ghinea N., Scherrmann J.-M. CNS Delivery via Adsorptive Transcytosis. AAPS J. 2008;10:455&#x2013;472. doi: 10.1208/s12248-008-9055-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1208/s12248-008-9055-2</ArticleId><ArticleId IdType=\"pmc\">PMC2761699</ArticleId><ArticleId IdType=\"pubmed\">18726697</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardridge W.M., Boado R.J. Enhanced Cellular Uptake of Biotinylated Antisense Oligonucleotide or Peptide Mediated by Avidin, a Cationic Protein. FEBS Lett. 1991;288:30&#x2013;32. doi: 10.1016/0014-5793(91)80996-G.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0014-5793(91)80996-G</ArticleId><ArticleId IdType=\"pubmed\">1879560</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardridge W.M., Triguero D., Buciak J. Transport of Histone through the Blood-Brain Barrier. J. Pharmacol. Exp. Ther. 1989;251:821&#x2013;826.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2600816</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardridge W.M., Buciak J.L., Kang Y.S., Boado R.J. Protamine-Mediated Transport of Albumin into Brain and Other Organs of the Rat. Binding and Endocytosis of Protamine-Albumin Complex by Microvascular Endothelium. J. Clin. Investig. 1993;92:2224&#x2013;2229. doi: 10.1172/JCI116825.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI116825</ArticleId><ArticleId IdType=\"pmc\">PMC288402</ArticleId><ArticleId IdType=\"pubmed\">8227337</ArticleId></ArticleIdList></Reference><Reference><Citation>Villegas J.C., Broadwell R.D. Transcytosis of Protein through the Mammalian Cerebral Epithelium and Endothelium. II. Adsorptive Transcytosis of WGA-HRP and the Blood-Brain and Brain-Blood Barriers. J. Neurocytol. 1993;22:67&#x2013;80. doi: 10.1007/BF01181571.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/BF01181571</ArticleId><ArticleId IdType=\"pubmed\">7680372</ArticleId></ArticleIdList></Reference><Reference><Citation>Azarmi M., Maleki H., Nikkam N., Malekinejad H. Transcellular Brain Drug Delivery: A Review on Recent Advancements. Int. J. Pharm. 2020;586:119582. doi: 10.1016/j.ijpharm.2020.119582.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijpharm.2020.119582</ArticleId><ArticleId IdType=\"pubmed\">32599130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma G., Modgil A., Zhong T., Sun C., Singh J. Influence of Short-Chain Cell-Penetrating Peptides on Transport of Doxorubicin Encapsulating Receptor-Targeted Liposomes across Brain Endothelial Barrier. Pharm. Res. 2014;31:1194&#x2013;1209. doi: 10.1007/s11095-013-1242-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11095-013-1242-x</ArticleId><ArticleId IdType=\"pubmed\">24242938</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Zheng X., Gong M., Zhang J. Delivery of a Peptide-Drug Conjugate Targeting the Blood Brain Barrier Improved the Efficacy of Paclitaxel against Glioma. Oncotarget. 2016;7:79401&#x2013;79407. doi: 10.18632/oncotarget.12708.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.12708</ArticleId><ArticleId IdType=\"pmc\">PMC5346723</ArticleId><ArticleId IdType=\"pubmed\">27765902</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Zhang W., Ma L., Fan L., Gao F., Ni J., Wang R. The Improved Blood-Brain Barrier Permeability of Endomorphin-1 Using the Cell-Penetrating Peptide SynB3 with Three Different Linkages. Int. J. Pharm. 2014;476:1&#x2013;8. doi: 10.1016/j.ijpharm.2014.08.045.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijpharm.2014.08.045</ArticleId><ArticleId IdType=\"pubmed\">25245547</ArticleId></ArticleIdList></Reference><Reference><Citation>Temsamani J., Bonnafous C., Rousselle C., Fraisse Y., Clair P., Granier L.-A., Rees A.R., Kaczorek M., Scherrmann J.-M. Improved Brain Uptake and Pharmacological Activity Profile of Morphine-6-Glucuronide Using a Peptide Vector-Mediated Strategy. J. Pharmacol. Exp. Ther. 2005;313:712&#x2013;719. doi: 10.1124/jpet.104.081000.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1124/jpet.104.081000</ArticleId><ArticleId IdType=\"pubmed\">15647327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruczy&#x144;ski J., Rusiecka I., Turecka K., Koz&#x142;owska A., Alenowicz M., G&#x105;ga&#x142;o I., Kawiak A., Rekowski P., Waleron K., Koci&#x107; I. Transportan 10 Improves the Pharmacokinetics and Pharmacodynamics of Vancomycin. Sci. Rep. 2019;9:3247. doi: 10.1038/s41598-019-40103-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-40103-w</ArticleId><ArticleId IdType=\"pmc\">PMC6397271</ArticleId><ArticleId IdType=\"pubmed\">30824786</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanafy A.S., Dietrich D., Fricker G., Lamprecht A. Blood-Brain Barrier Models: Rationale for Selection. Adv. Drug Deliv. Rev. 2021;176:113859. doi: 10.1016/j.addr.2021.113859.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.addr.2021.113859</ArticleId><ArticleId IdType=\"pubmed\">34246710</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa S., Deli M.A., Kawaguchi H., Shimizudani T., Shimono T., Kittel A., Tanaka K., Niwa M. A New Blood-Brain Barrier Model Using Primary Rat Brain Endothelial Cells, Pericytes and Astrocytes. Neurochem. Int. 2009;54:253&#x2013;263. doi: 10.1016/j.neuint.2008.12.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuint.2008.12.002</ArticleId><ArticleId IdType=\"pubmed\">19111869</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Qi Y., Liu X., Fang L., Gao Y., Liu C., Wu D., Wang X., Zhao F., Wang J., et al. Neuroprotective Effects of Fermented Yak Milk-Derived Peptide LYLKPR on H2O2-Injured HT-22 Cells. Food Funct. 2022;13:12021&#x2013;12038. doi: 10.1039/D2FO02131E.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D2FO02131E</ArticleId><ArticleId IdType=\"pubmed\">36300510</ArticleId></ArticleIdList></Reference><Reference><Citation>Oller-Salvia B., Teixid&#xf3; M., Giralt E. From Venoms to BBB Shuttles: Synthesis and Blood-Brain Barrier Transport Assessment of Apamin and a Nontoxic Analog. Biopolymers. 2013;100:675&#x2013;686. doi: 10.1002/bip.22257.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/bip.22257</ArticleId><ArticleId IdType=\"pubmed\">24281722</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuruoka N., Beppu Y., Koda H., Doe N., Watanabe H., Abe K. A DKP Cyclo(L-Phe-L-Phe) Found in Chicken Essence Is a Dual Inhibitor of the Serotonin Transporter and Acetylcholinesterase. PLoS ONE. 2012;7:e50824. doi: 10.1371/journal.pone.0050824.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0050824</ArticleId><ArticleId IdType=\"pmc\">PMC3509069</ArticleId><ArticleId IdType=\"pubmed\">23209830</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes M., Moen L.F., Auty M.A.E., Lea T.E. Transport of a Prolyl Endopeptidase Inhibitory Peptide across the Blood-Brain Barrier Demonstrated Using the HCMEC/D3 Cell Line Transcytosis Assay. J. Agric. Food Chem. 2016;64:146&#x2013;150. doi: 10.1021/acs.jafc.5b04696.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.5b04696</ArticleId><ArticleId IdType=\"pubmed\">26716467</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen B., Toth A.E., Nielsen S.S.E., Scavenius C., Petersen S.V., Enghild J.J., Rasmussen J.T., Nielsen M.S., S&#xf8;rensen E.S. Transport of a Peptide from Bovine As1-Casein across Models of the Intestinal and Blood-Brain Barriers. Nutrients. 2020;12:3157. doi: 10.3390/nu12103157.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu12103157</ArticleId><ArticleId IdType=\"pmc\">PMC7602804</ArticleId><ArticleId IdType=\"pubmed\">33081105</ArticleId></ArticleIdList></Reference><Reference><Citation>Domenger D., Cudennec B., Kouach M., Touche V., Landry C., Lesage J., Gosselet F., Lestavel S., Goossens J.-F., Dhulster P., et al. Food-Derived Hemorphins Cross Intestinal and Blood&#x2013;Brain Barriers in Vitro. Front. Endocrinol. 2018;9:159. doi: 10.3389/fendo.2018.00159.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2018.00159</ArticleId><ArticleId IdType=\"pmc\">PMC5903475</ArticleId><ArticleId IdType=\"pubmed\">29692758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Chen Q., Chen X., Han F., Chen Z., Wang Y. The Blood-Brain Barrier: Structure, Regulation, and Drug Delivery. Signal Transduct. Target. Ther. 2023;8:217. doi: 10.1038/s41392-023-01481-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-023-01481-w</ArticleId><ArticleId IdType=\"pmc\">PMC10212980</ArticleId><ArticleId IdType=\"pubmed\">37231000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Zhang Z., Wang X., Cade R., Elmir Z., Fregly M. Relation of &#x3b2;-Casomorphin to Apnea in Sudden Infant Death Syndrome. Peptides. 2003;24:937&#x2013;943. doi: 10.1016/S0196-9781(03)00156-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0196-9781(03)00156-6</ArticleId><ArticleId IdType=\"pubmed\">12948848</ArticleId></ArticleIdList></Reference><Reference><Citation>Ano Y., Ayabe T., Kutsukake T., Ohya R., Takaichi Y., Uchida S., Yamada K., Uchida K., Takashima A., Nakayama H. Novel Lactopeptides in Fermented Dairy Products Improve Memory Function and Cognitive Decline. Neurobiol. Aging. 2018;72:23&#x2013;31. doi: 10.1016/j.neurobiolaging.2018.07.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2018.07.016</ArticleId><ArticleId IdType=\"pubmed\">30176402</ArticleId></ArticleIdList></Reference><Reference><Citation>Ano Y., Kita M., Kitaoka S., Furuyashiki T. Leucine-Histidine Dipeptide Attenuates Microglial Activation and Emotional Disturbances Induced by Brain Inflammation and Repeated Social Defeat Stress. Nutrients. 2019;11:2161. doi: 10.3390/nu11092161.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu11092161</ArticleId><ArticleId IdType=\"pmc\">PMC6770249</ArticleId><ArticleId IdType=\"pubmed\">31505850</ArticleId></ArticleIdList></Reference><Reference><Citation>Ano Y., Yoshino Y., Kutsukake T., Ohya R., Fukuda T., Uchida K., Takashima A., Nakayama H. Tryptophan-Related Dipeptides in Fermented Dairy Products Suppress Microglial Activation and Prevent Cognitive Decline. Aging. 2019;11:2949&#x2013;2967. doi: 10.18632/aging.101909.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/aging.101909</ArticleId><ArticleId IdType=\"pmc\">PMC6555451</ArticleId><ArticleId IdType=\"pubmed\">31121563</ArticleId></ArticleIdList></Reference><Reference><Citation>Min L.-J., Kobayashi Y., Mogi M., Tsukuda K., Yamada A., Yamauchi K., Abe F., Iwanami J., Xiao J.-Z., Horiuchi M. Administration of Bovine Casein-Derived Peptide Prevents Cognitive Decline in Alzheimer Disease Model Mice. PLoS ONE. 2017;12:e0171515. doi: 10.1371/journal.pone.0171515.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0171515</ArticleId><ArticleId IdType=\"pmc\">PMC5291428</ArticleId><ArticleId IdType=\"pubmed\">28158298</ArticleId></ArticleIdList></Reference><Reference><Citation>Newcomb R., Abbruscato T.J., Singh T., Nadasdi L., Davis T.P., Miljanich G. Bioavailability of Ziconotide in Brain: Influx from Blood, Stability, and Diffusion. Peptides. 2000;21:491&#x2013;501. doi: 10.1016/S0196-9781(00)00175-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0196-9781(00)00175-3</ArticleId><ArticleId IdType=\"pubmed\">10822104</ArticleId></ArticleIdList></Reference><Reference><Citation>Demeule M., Beaudet N., R&#xe9;gina A., Besserer-Offroy &#xc9;., Murza A., T&#xe9;treault P., Belleville K., Ch&#xe9; C., Larocque A., Thiot C., et al. Conjugation of a Brain-Penetrant Peptide with Neurotensin Provides Antinociceptive Properties. J. Clin. Investig. 2014;124:1199&#x2013;1213. doi: 10.1172/JCI70647.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI70647</ArticleId><ArticleId IdType=\"pmc\">PMC3934173</ArticleId><ArticleId IdType=\"pubmed\">24531547</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Dohgu S., Komabayashi G., Kiyohara H., Takata F., Kataoka Y., Nirasawa T., Maebuchi M., Matsui T. Brain-Transportable Dipeptides across the Blood-Brain Barrier in Mice. Sci. Rep. 2019;9:5769. doi: 10.1038/s41598-019-42099-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-42099-9</ArticleId><ArticleId IdType=\"pmc\">PMC6453885</ArticleId><ArticleId IdType=\"pubmed\">30962462</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L., Tanaka M., Yoshino A., Nagasato Y., Takata F., Dohgu S., Matsui T. A Memory-Improving Dipeptide, Tyr-Pro, Can Reach the Mouse Brain after Oral Administration. Sci. Rep. 2023;13:16908. doi: 10.1038/s41598-023-44161-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-023-44161-z</ArticleId><ArticleId IdType=\"pmc\">PMC10560274</ArticleId><ArticleId IdType=\"pubmed\">37805661</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogimura D., Mizushige T., Taga Y., Nagai A., Shoji S., Azuma N., Kusubata M., Adachi S.-I., Yoshizawa F., Kabuyama Y. Prolyl-Hydroxyproline, a Collagen-Derived Dipeptide, Enhances Hippocampal Cell Proliferation, Which Leads to Antidepressant-like Effects in Mice. FASEB J. 2020;34:5715&#x2013;5723. doi: 10.1096/fj.201902871R.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.201902871R</ArticleId><ArticleId IdType=\"pubmed\">32115749</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Kiyohara H., Yoshino A., Nakano A., Takata F., Dohgu S., Kataoka Y., Matsui T. Brain-Transportable Soy Dipeptide, Tyr-Pro, Attenuates Amyloid &#x3b2; Peptide25-35-Induced Memory Impairment in Mice. Npj Sci. Food. 2020;4:7. doi: 10.1038/s41538-020-0067-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41538-020-0067-3</ArticleId><ArticleId IdType=\"pmc\">PMC7195433</ArticleId><ArticleId IdType=\"pubmed\">32377566</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris W.J., Asselin M.-C., Hinz R., Parkes L.M., Allan S., Schiessl I., Boutin H., Dickie B.R. In Vivo Methods for Imaging Blood-Brain Barrier Function and Dysfunction. Eur. J. Nucl. Med. Mol. Imaging. 2023;50:1051&#x2013;1083. doi: 10.1007/s00259-022-05997-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00259-022-05997-1</ArticleId><ArticleId IdType=\"pmc\">PMC9931809</ArticleId><ArticleId IdType=\"pubmed\">36437425</ArticleId></ArticleIdList></Reference><Reference><Citation>Raja R., Rosenberg G.A., Caprihan A. MRI Measurements of Blood-Brain Barrier Function in Dementia: A Review of Recent Studies. Neuropharmacology. 2018;134:259&#x2013;271. doi: 10.1016/j.neuropharm.2017.10.034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuropharm.2017.10.034</ArticleId><ArticleId IdType=\"pmc\">PMC6044415</ArticleId><ArticleId IdType=\"pubmed\">29107626</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9; S., Ansciaux E., Saidi E., Larbanoix L., Stanicki D., Nonclercq D., Vander Elst L., Laurent S., Muller R.N., Burtea C. Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-&#x3b2; and Able to Cross the Blood-Brain Barrier. J. Alzheimers Dis. 2017;60:1547&#x2013;1565. doi: 10.3233/JAD-170563.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-170563</ArticleId><ArticleId IdType=\"pubmed\">29036827</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyaert P., Padrela B.E., Morgan C.A., Petr J., Versijpt J., Barkhof F., Jurkiewicz M.T., Shao X., Oyeniran O., Manson T., et al. Imaging Blood-Brain Barrier Dysfunction: A State-of-the-Art Review from a Clinical Perspective. Front. Aging Neurosci. 2023;15:1132077. doi: 10.3389/fnagi.2023.1132077.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1132077</ArticleId><ArticleId IdType=\"pmc\">PMC10150073</ArticleId><ArticleId IdType=\"pubmed\">37139088</ArticleId></ArticleIdList></Reference><Reference><Citation>Breuer H., Meier M., Schneefeld S., H&#xe4;rtig W., Wittneben A., M&#xe4;rkel M., Ross T.L., Bengel F.M., Bankstahl M., Bankstahl J.P. Multimodality Imaging of Blood-Brain Barrier Impairment during Epileptogenesis. J. Cereb. Blood Flow Metab. 2017;37:2049&#x2013;2061. doi: 10.1177/0271678X16659672.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0271678X16659672</ArticleId><ArticleId IdType=\"pmc\">PMC5464700</ArticleId><ArticleId IdType=\"pubmed\">27435624</ArticleId></ArticleIdList></Reference><Reference><Citation>la Foug&#xe8;re C., Rominger A., F&#xf6;rster S., Geisler J., Bartenstein P. PET and SPECT in Epilepsy: A Critical Review. Epilepsy Behav. 2009;15:50&#x2013;55. doi: 10.1016/j.yebeh.2009.02.025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yebeh.2009.02.025</ArticleId><ArticleId IdType=\"pubmed\">19236949</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagni B., Feggi L.M., Carraro P.L., Candini G. Determination of cerebral blood flow using non-diffusible tracers. Radiol. Med. 1983;69:788&#x2013;791.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6377402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson D.M., 3rd, Cookson M.R., Van Den Bosch L., Zetterberg H., Holtzman D.M., Dewachter I. Hallmarks of Neurodegenerative Diseases. Cell. 2023;186:693&#x2013;714. doi: 10.1016/j.cell.2022.12.032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2022.12.032</ArticleId><ArticleId IdType=\"pubmed\">36803602</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari S., Atluri V., Kaushik A., Yndart A., Nair M. Alzheimer&#x2019;s Disease: Pathogenesis, Diagnostics, and Therapeutics. Int. J. Nanomed. 2019;14:5541&#x2013;5554. doi: 10.2147/IJN.S200490.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/IJN.S200490</ArticleId><ArticleId IdType=\"pmc\">PMC6650620</ArticleId><ArticleId IdType=\"pubmed\">31410002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandimalla R., Reddy P.H. Therapeutics of Neurotransmitters in Alzheimer&#x2019;s Disease. J. Alzheimers Dis. 2017;57:1049&#x2013;1069. doi: 10.3233/JAD-161118.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-161118</ArticleId><ArticleId IdType=\"pmc\">PMC5793221</ArticleId><ArticleId IdType=\"pubmed\">28211810</ArticleId></ArticleIdList></Reference><Reference><Citation>Querfurth H.W., LaFerla F.M. Alzheimer&#x2019;s Disease. N. Engl. J. Med. 2010;362:329&#x2013;344. doi: 10.1056/NEJMra0909142.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMra0909142</ArticleId><ArticleId IdType=\"pubmed\">20107219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H., Hardy J., Blennow K., Chen C., Perry G., Kim S.H., Villemagne V.L., Aisen P., Vendruscolo M., Iwatsubo T., et al. The Amyloid-&#x3b2; Pathway in Alzheimer&#x2019;s Disease. Mol. Psychiatry. 2021;26:5481&#x2013;5503. doi: 10.1038/s41380-021-01249-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41380-021-01249-0</ArticleId><ArticleId IdType=\"pmc\">PMC8758495</ArticleId><ArticleId IdType=\"pubmed\">34456336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W., Wu F., Zhang Y., Gong C.-X., Iqbal K., Liu F. Expression of Tau Pathology-Related Proteins in Different Brain Regions: A Molecular Basis of Tau Pathogenesis. Front. Aging Neurosci. 2017;9:311. doi: 10.3389/fnagi.2017.00311.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2017.00311</ArticleId><ArticleId IdType=\"pmc\">PMC5623682</ArticleId><ArticleId IdType=\"pubmed\">29021756</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Wei W., Zhao M., Ma L., Jiang X., Pei H., Cao Y., Li H. Interaction between A&#x3b2; and Tau in the Pathogenesis of Alzheimer&#x2019;s Disease. Int. J. Biol. Sci. 2021;17:2181&#x2013;2192. doi: 10.7150/ijbs.57078.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7150/ijbs.57078</ArticleId><ArticleId IdType=\"pmc\">PMC8241728</ArticleId><ArticleId IdType=\"pubmed\">34239348</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L.-K., Kuan Y.-C., Lin H.-W., Hu C.-J. Clinical Trials of New Drugs for Alzheimer Disease: A 2020&#x2013;2023 Update. J. Biomed. Sci. 2023;30:83. doi: 10.1186/s12929-023-00976-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12929-023-00976-6</ArticleId><ArticleId IdType=\"pmc\">PMC10544555</ArticleId><ArticleId IdType=\"pubmed\">37784171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin E., Jaqua E., Safaeipour M., Ladue T. Conventional versus New Treatment: Comparing the Effects of Acetylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonist with Aducanumab. Cureus. 2022;14:e31065. doi: 10.7759/cureus.31065.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7759/cureus.31065</ArticleId><ArticleId IdType=\"pmc\">PMC9719396</ArticleId><ArticleId IdType=\"pubmed\">36475205</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratic&#xf2; D. Oxidative Stress Hypothesis in Alzheimer&#x2019;s Disease: A Reappraisal. Trends Pharmacol. Sci. 2008;29:609&#x2013;615. doi: 10.1016/j.tips.2008.09.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tips.2008.09.001</ArticleId><ArticleId IdType=\"pubmed\">18838179</ArticleId></ArticleIdList></Reference><Reference><Citation>Grune T. Oxidized Protein Aggregates: Formation and Biological Effects. Free Radic. Biol. Med. 2020;150:120&#x2013;124. doi: 10.1016/j.freeradbiomed.2020.02.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.freeradbiomed.2020.02.014</ArticleId><ArticleId IdType=\"pubmed\">32097679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney J.W., Bemiller S.M., Murtishaw A.S., Leisgang A.M., Salazar A.M., Lamb B.T. Inflammation as a Central Mechanism in Alzheimer&#x2019;s Disease. Alzheimer&#x2019;s Dement. 2018;4:575&#x2013;590. doi: 10.1016/j.trci.2018.06.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.trci.2018.06.014</ArticleId><ArticleId IdType=\"pmc\">PMC6214864</ArticleId><ArticleId IdType=\"pubmed\">30406177</ArticleId></ArticleIdList></Reference><Reference><Citation>Picca A., Calvani R., Coelho-Junior H.J., Landi F., Bernabei R., Marzetti E. Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration. Antioxidants. 2020;9:647. doi: 10.3390/antiox9080647.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox9080647</ArticleId><ArticleId IdType=\"pmc\">PMC7466131</ArticleId><ArticleId IdType=\"pubmed\">32707949</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Zhao T., Zhang J., Wu C., Zhao M., Su G. Comparison of Neuroprotective and Cognition-Enhancing Properties of Hydrolysates from Soybean, Walnut, and Peanut Protein. J. Chem. 2016;2016:1&#x2013;8. doi: 10.1155/2016/9358285.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2016/9358285</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju D.-T., Kumar K.A., Kuo W.-W., Ho T.-J., Chang R.-L., Lin W.-T., Day C.H., Viswanadha V.V.P., Liao P.-H., Huang C.-Y. Bioactive Peptide VHVV Upregulates the Long-Term Memory-Related Biomarkers in Adult Spontaneously Hypertensive Rats. Int. J. Mol. Sci. 2019;20:3069. doi: 10.3390/ijms20123069.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms20123069</ArticleId><ArticleId IdType=\"pmc\">PMC6627188</ArticleId><ArticleId IdType=\"pubmed\">31234585</ArticleId></ArticleIdList></Reference><Reference><Citation>Amakye W.K., Hou C., Xie L., Lin X., Gou N., Yuan E., Ren J. Bioactive Anti-Aging Agents and the Identification of New Anti-Oxidant Soybean Peptides. Food Biosci. 2021;42:101194. doi: 10.1016/j.fbio.2021.101194.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.fbio.2021.101194</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L., Shi C., Nakamura S., Esaki N., Ichiba Y., Tanaka M., Sakai K., Matsui T. Adiponectin-Receptor Agonistic Dipeptide Tyr-Pro Stimulates the Acetylcholine Nervous System in NE-4C Cells. J. Agric. Food Chem. 2024;72:7121&#x2013;7129. doi: 10.1021/acs.jafc.3c07821.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.3c07821</ArticleId><ArticleId IdType=\"pubmed\">38511275</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Su G., Zhang Q., Zhao T., Liu Y., Zheng L., Zhao M. Walnut (Juglans regia) Peptides Reverse Sleep Deprivation-Induced Memory Impairment in Rat via Alleviating Oxidative Stress. J. Agric. Food Chem. 2018;66:10617&#x2013;10627. doi: 10.1021/acs.jafc.8b03884.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.8b03884</ArticleId><ArticleId IdType=\"pubmed\">30226056</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Guo Y., Zhao F., Qin H., Lu H., Fang L., Wang J., Min W. Potential Mechanisms Mediating the Protective Effects of a Peptide from Walnut (Juglans mandshurica Maxim.) against Hydrogen Peroxide Induced Neurotoxicity in PC12 Cells. Food Funct. 2019;10:3491&#x2013;3501. doi: 10.1039/C8FO02557F.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C8FO02557F</ArticleId><ArticleId IdType=\"pubmed\">31143910</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Amakye W.K., Guo L., Gong C., Zhao Y., Yao M., Ren J. Walnut-Derived Peptide PW5 Ameliorates Cognitive Impairments and Alters Gut Microbiota in APP/PS1 Transgenic Mice. Mol. Nutr. Food Res. 2019;63:e1900326. doi: 10.1002/mnfr.201900326.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mnfr.201900326</ArticleId><ArticleId IdType=\"pubmed\">31237989</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Zheng L., Zhao T., Zhang Q., Liu Y., Sun B., Su G., Zhao M. Inhibitory Effects of Walnut (Juglans regia) Peptides on Neuroinflammation and Oxidative Stress in Lipopolysaccharide-Induced Cognitive Impairment Mice. J. Agric. Food Chem. 2020;68:2381&#x2013;2392. doi: 10.1021/acs.jafc.9b07670.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.9b07670</ArticleId><ArticleId IdType=\"pubmed\">32037817</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao F., Wang J., Lu H., Fang L., Qin H., Liu C., Min W. Neuroprotection by Walnut-Derived Peptides through Autophagy Promotion via Akt/MTOR Signaling Pathway against Oxidative Stress in PC12 Cells. J. Agric. Food Chem. 2020;68:3638&#x2013;3648. doi: 10.1021/acs.jafc.9b08252.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.9b08252</ArticleId><ArticleId IdType=\"pubmed\">32090563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Su G., Zhang X., Song G., Zhang L., Zheng L., Zhao M. Characterization and Exploration of Potential Neuroprotective Peptides in Walnut (Juglans regia) Protein Hydrolysate against Cholinergic System Damage and Oxidative Stress in Scopolamine-Induced Cognitive and Memory Impairment Mice and Zebrafish. J. Agric. Food Chem. 2021;69:2773&#x2013;2783. doi: 10.1021/acs.jafc.0c07798.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.0c07798</ArticleId><ArticleId IdType=\"pubmed\">33645974</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y., Qin H., Wu D., Liu C., Fang L., Wang J., Liu X., Min W. Walnut Peptide WEKPPVSH in Alleviating Oxidative Stress and Inflammation in Lipopolysaccharide-Activated BV-2 Microglia via the Nrf2/HO-1 and NF-&#x39a;B/P38 MAPK Pathways. J. Biosci. Bioeng. 2021;132:496&#x2013;504. doi: 10.1016/j.jbiosc.2021.07.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jbiosc.2021.07.009</ArticleId><ArticleId IdType=\"pubmed\">34509368</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Zheng L., Zhao T., Zhang Q., Su G., Zhao M. The Neuroprotective Effect of Walnut-Derived Peptides against Glutamate-Induced Damage in PC12 Cells: Mechanism and Bioavailability. Food Sci. Hum. Wellness. 2022;11:933&#x2013;942. doi: 10.1016/j.fshw.2022.03.021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.fshw.2022.03.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Fang L., Wang J., Zhao F., Liu C., Gao Y., Liu J., Min W. Pine Nut Antioxidant Peptides Ameliorate the Memory Impairment in a Scopolamine-Induced Mouse Model via SIRT3-Induced Synaptic Plasticity. Food Funct. 2021;12:8026&#x2013;8036. doi: 10.1039/D1FO01817E.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D1FO01817E</ArticleId><ArticleId IdType=\"pubmed\">34269783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.K., Li-Chan E.C.Y., Cheung I.W.Y., Jeon Y.-J., Ko J.-Y., Byun H.-G. Neuroprotective Effect of &#x3b2;-Secretase Inhibitory Peptide from Pacific Hake (Merluccius productus) Fish Protein Hydrolysate. Curr. Alzheimer Res. 2019;16:1028&#x2013;1038. doi: 10.2174/1567205016666191113122046.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567205016666191113122046</ArticleId><ArticleId IdType=\"pubmed\">31724512</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai H.-J., Wu C.-J., Yang S.-H., Li T.-L., Sun Pan B. Peptides from Hydrolysate of Lantern Fish (Benthosema pterotum) Proved Neuroprotective in Vitro and in Vivo. J. Funct. Foods. 2016;24:438&#x2013;449. doi: 10.1016/j.jff.2016.04.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jff.2016.04.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao R., Shu W., Shen Y., Sun Q., Bai F., Wang J., Li D., Li Y., Jin W., Yuan L. Sturgeon Protein-Derived Peptides Exert Anti-Inflammatory Effects in LPS-Stimulated RAW264.7 Macrophages via the MAPK Pathway. J. Funct. Foods. 2020;72:104044. doi: 10.1016/j.jff.2020.104044.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jff.2020.104044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Dong Y., Ge Q., Cui P., Sun N., Lin S. Neuroprotective Effects of NDEELNK from Sea Cucumber Ovum against Scopolamine-Induced PC12 Cell Damage through Enhancing Energy Metabolism and Upregulation of the PKA/BDNF/NGF Signaling Pathway. Food Funct. 2021;12:7676&#x2013;7687. doi: 10.1039/D1FO00631B.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D1FO00631B</ArticleId><ArticleId IdType=\"pubmed\">34259275</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu M., Mishra A., Boschetti C., Lin J., Liu Y., Huang H., Kaminski C.F., Huang Z., Tunnacliffe A., Kaminski Schierle G.S. Sea Cucumber-Derived Peptides Alleviate Oxidative Stress in Neuroblastoma Cells and Improve Survival in C. elegans Exposed to Neurotoxic Paraquat. Oxid. Med. Cell. Longev. 2021;2021:8842926. doi: 10.1155/2021/8842926.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2021/8842926</ArticleId><ArticleId IdType=\"pmc\">PMC8075690</ArticleId><ArticleId IdType=\"pubmed\">33959216</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Zhang S., Sun N., Zhu B., Lin S. Neuroprotective Function of a Novel Hexapeptide QMDDQ from Shrimp via Activation of the PKA/CREB/BNDF Signaling Pathway and Its Structure-Activity Relationship. J. Agric. Food Chem. 2020;68:6759&#x2013;6769. doi: 10.1021/acs.jafc.0c02689.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.0c02689</ArticleId><ArticleId IdType=\"pubmed\">32452680</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T., Su G., Wang S., Zhang Q., Zhang J., Zheng L., Sun B., Zhao M. Neuroprotective Effects of Acetylcholinesterase Inhibitory Peptides from Anchovy (Coilia mystus) against Glutamate-Induced Toxicity in PC12 Cells. J. Agric. Food Chem. 2017;65:11192&#x2013;11201. doi: 10.1021/acs.jafc.7b03945.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.7b03945</ArticleId><ArticleId IdType=\"pubmed\">29190426</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Ding J., Lu Z., Zhu B., Lin S. Digestive and Absorptive Properties of the Antarctic Krill Tripeptide Phe-pro-Phe (FPF) and Its Auxiliary Memory-Enhancing Effect. J. Agric. Food Chem. 2024;72:8491&#x2013;8505. doi: 10.1021/acs.jafc.3c08158.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.3c08158</ArticleId><ArticleId IdType=\"pubmed\">38587859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ano Y., Kutsukake T., Sasaki T., Uchida S., Yamada K., Kondo K. Identification of a Novel Peptide from &#x3b2;-Casein That Enhances Spatial and Object Recognition Memory in Mice. J. Agric. Food Chem. 2019;67:8160&#x2013;8167. doi: 10.1021/acs.jafc.9b02495.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.9b02495</ArticleId><ArticleId IdType=\"pubmed\">31241932</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafique H., Hu X., Ren T., Dong R., Aadil R.M., Zou L., Sharif M.K., Li L. Characterization and Exploration of the Neuroprotective Potential of Oat-Protein-Derived Peptides in PC12 Cells and Scopolamine-Treated Zebrafish. Nutrients. 2023;16:117. doi: 10.3390/nu16010117.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu16010117</ArticleId><ArticleId IdType=\"pmc\">PMC10780882</ArticleId><ArticleId IdType=\"pubmed\">38201947</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z., Li Y. Review and Perspective on Bioactive Peptides: A Roadmap for Research, Development, and Future Opportunities. J. Agric. Food Res. 2022;9:100353. doi: 10.1016/j.jafr.2022.100353.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jafr.2022.100353</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39275195</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2072-6643</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>16</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Causal Association between Circulating Metabolites and Dementia: A Mendelian Randomization Study.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">2879</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/nu16172879</ELocationID><Abstract><AbstractText>The causal association of circulating metabolites with dementia remains uncertain. We assessed the causal association of circulating metabolites with dementia utilizing Mendelian randomization (MR) methods. We performed univariable MR analysis to evaluate the associations of 486 metabolites with dementia, Alzheimer's disease (AD), and vascular dementia (VaD) risk. For secondary validation, we replicated the analyses using an additional dataset with 123 metabolites. We observed 118 metabolites relevant to the risk of dementia, 59 of which were lipids, supporting the crucial role of lipids in dementia pathogenesis. After Bonferroni adjustment, we identified nine traits of HDL particles as potential causal mediators of dementia. Regarding dementia subtypes, protective effects were observed for epiandrosterone sulfate on AD (OR = 0.60, 95% CI: 0.48-0.75) and glycoproteins on VaD (OR = 0.89, 95% CI: 0.83-0.95). Bayesian model averaging MR (MR-BMA) analysis was further conducted to prioritize the predominant metabolites for dementia risk, which highlighted the mean diameter of HDL particles and the concentration of very large HDL particles as the predominant protective factors against dementia. Moreover, pathway analysis identified 17 significant and 2 shared metabolic pathways. These findings provide support for the identification of promising predictive biomarkers and therapeutic targets for dementia.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Hong-Min</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qiu</LastName><ForeName>Cheng-Shen</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Du</LastName><ForeName>Li-Ying</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tang</LastName><ForeName>Xu-Lian</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liao</LastName><ForeName>Dan-Qing</ForeName><Initials>DQ</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xiong</LastName><ForeName>Zhi-Yuan</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lai</LastName><ForeName>Shu-Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Huang</LastName><ForeName>Hong-Xuan</ForeName><Initials>HX</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kuang</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Bing-Yun</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Zhi-Hao</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>82204115</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2021A1515110230</GrantID><Agency>Guangdong Basic and Applied Basic Research Foundation</Agency><Country/></Grant><Grant><GrantID>2024A04J4571</GrantID><Agency>Science and Technology Program of Guangzhou</Agency><Country/></Grant><Grant><GrantID>SKXRC202408</GrantID><Agency>Youth S&amp;T Talent Support Programme of Guangdong Provincial Association for Science and Technology</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D057182\" MajorTopicYN=\"Y\">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003704\" MajorTopicYN=\"Y\">Dementia</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015415\" MajorTopicYN=\"Y\">Biomarkers</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012307\" MajorTopicYN=\"N\">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001499\" MajorTopicYN=\"N\">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015140\" MajorTopicYN=\"N\">Dementia, Vascular</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Mendelian randomization</Keyword><Keyword MajorTopicYN=\"N\">dementia</Keyword><Keyword MajorTopicYN=\"N\">metabolites</Keyword><Keyword MajorTopicYN=\"N\">vascular dementia</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39275195</ArticleId><ArticleId IdType=\"doi\">10.3390/nu16172879</ArticleId><ArticleId IdType=\"pii\">nu16172879</ArticleId><ArticleId IdType=\"pmc\">PMC11397200</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grande G., Qiu C., Fratiglioni L. Prevention of dementia in an ageing world: Evidence and biological rationale. Ageing Res. Rev. 2020;64:101045. doi: 10.1016/j.arr.2020.101045.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2020.101045</ArticleId><ArticleId IdType=\"pubmed\">32171784</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2019 Dementia Forecasting Collaborators Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105&#x2013;e125. doi: 10.1016/S2468-2667(21)00249-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S2468-2667(21)00249-8</ArticleId><ArticleId IdType=\"pmc\">PMC8810394</ArticleId><ArticleId IdType=\"pubmed\">34998485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefevre-Arbogast S., Wagner M., Proust-Lima C., Samieri C. Nutrition and Metabolic Profiles in the Natural History of Dementia: Recent Insights from Systems Biology and Life Course Epidemiology. Curr. Nutr. Rep. 2019;8:256&#x2013;269. doi: 10.1007/s13668-019-00285-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13668-019-00285-1</ArticleId><ArticleId IdType=\"pubmed\">31313074</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z., Lin Y., Li X., Driver J.A., Liang L. Shared genetic architecture between metabolic traits and Alzheimer&#x2019;s disease: A large-scale genome-wide cross-trait analysis. Hum. Genet. 2019;138:271&#x2013;285. doi: 10.1007/s00439-019-01988-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00439-019-01988-9</ArticleId><ArticleId IdType=\"pmc\">PMC7193309</ArticleId><ArticleId IdType=\"pubmed\">30805717</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Monte S.M., Tong M. Brain metabolic dysfunction at the core of Alzheimer&#x2019;s disease. Biochem. Pharmacol. 2014;88:548&#x2013;559. doi: 10.1016/j.bcp.2013.12.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bcp.2013.12.012</ArticleId><ArticleId IdType=\"pmc\">PMC4550323</ArticleId><ArticleId IdType=\"pubmed\">24380887</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Hu W., Wang Y., Wang W., Liao H., Zhang X., Kiburg K.V., Shang X., Bulloch G., Huang Y., et al. Plasma metabolomic profiles of dementia: A prospective study of 110,655 participants in the UK Biobank. BMC Med. 2022;20:252. doi: 10.1186/s12916-022-02449-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12916-022-02449-3</ArticleId><ArticleId IdType=\"pmc\">PMC9377110</ArticleId><ArticleId IdType=\"pubmed\">35965319</ArticleId></ArticleIdList></Reference><Reference><Citation>Proitsi P., Kuh D., Wong A., Maddock J., Bendayan R., Wulaningsih W., Hardy R., Richards M. Lifetime cognition and late midlife blood metabolites: Findings from a British birth cohort. Transl. Psychiatry. 2018;8:203. doi: 10.1038/s41398-018-0253-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41398-018-0253-0</ArticleId><ArticleId IdType=\"pmc\">PMC6158182</ArticleId><ArticleId IdType=\"pubmed\">30258059</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Lee S.J., Teunissen C.E., Pool R., Shipley M.J., Teumer A., Chouraki V., Melo van Lent D., Tynkkynen J., Fischer K., Hernesniemi J., et al. Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies. Alzheimer&#x2019;s Dement. J. Alzheimer&#x2019;s Assoc. 2018;14:707&#x2013;722. doi: 10.1016/j.jalz.2017.11.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2017.11.012</ArticleId><ArticleId IdType=\"pubmed\">29316447</ArticleId></ArticleIdList></Reference><Reference><Citation>Tynkkynen J., Chouraki V., van der Lee S.J., Hernesniemi J., Yang Q., Li S., Beiser A., Larson M.G., S&#xe4;&#xe4;ksj&#xe4;rvi K., Shipley M.J., et al. Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer&#x2019;s disease: A prospective study in eight cohorts. Alzheimer&#x2019;s Dement. J. Alzheimer&#x2019;s Assoc. 2018;14:723&#x2013;733. doi: 10.1016/j.jalz.2018.01.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2018.01.003</ArticleId><ArticleId IdType=\"pmc\">PMC6082422</ArticleId><ArticleId IdType=\"pubmed\">29519576</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson E., Richardson T.G., Morris T.T., Tilling K., Davey Smith G. Estimation of causal effects of a time-varying exposure at multiple time points through multivariable mendelian randomization. PLoS Genet. 2022;18:e1010290. doi: 10.1371/journal.pgen.1010290.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pgen.1010290</ArticleId><ArticleId IdType=\"pmc\">PMC9348730</ArticleId><ArticleId IdType=\"pubmed\">35849575</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S.Y., Fauman E.B., Petersen A.K., Krumsiek J., Santos R., Huang J., Arnold M., Erte I., Forgetta V., Yang T.P., et al. An atlas of genetic influences on human blood metabolites. Nat. Genet. 2014;46:543&#x2013;550. doi: 10.1038/ng.2982.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ng.2982</ArticleId><ArticleId IdType=\"pmc\">PMC4064254</ArticleId><ArticleId IdType=\"pubmed\">24816252</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrivankova V.W., Richmond R.C., Woolf B.A.R., Yarmolinsky J., Davies N.M., Swanson S.A., VanderWeele T.J., Higgins J.P.T., Timpson N.J., Dimou N., et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. Jama. 2021;326:1614&#x2013;1621. doi: 10.1001/jama.2021.18236.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2021.18236</ArticleId><ArticleId IdType=\"pubmed\">34698778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettunen J., Demirkan A., Wurtz P., Draisma H.H., Haller T., Rawal R., Vaarhorst A., Kangas A.J., Lyytikainen L.P., Pirinen M., et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat. Commun. 2016;7:11122. doi: 10.1038/ncomms11122.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncomms11122</ArticleId><ArticleId IdType=\"pmc\">PMC4814583</ArticleId><ArticleId IdType=\"pubmed\">27005778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki M.I., Karjalainen J., Palta P., Sipil&#xe4; T.P., Kristiansson K., Donner K.M., Reeve M.P., Laivuori H., Aavikko M., Kaunisto M.A., et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508&#x2013;518. doi: 10.1038/s41586-022-05473-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-022-05473-8</ArticleId><ArticleId IdType=\"pmc\">PMC9849126</ArticleId><ArticleId IdType=\"pubmed\">36653562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle B.W., Grenier-Boley B., Sims R., Bis J.C., Damotte V., Naj A.C., Boland A., Vronskaya M., van der Lee S.J., Amlie-Wolf A., et al. Genetic meta-analysis of diagnosed Alzheimer&#x2019;s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat. Genet. 2019;51:414&#x2013;430. doi: 10.1038/s41588-019-0358-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41588-019-0358-2</ArticleId><ArticleId IdType=\"pmc\">PMC6463297</ArticleId><ArticleId IdType=\"pubmed\">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S., Davies N.M., Thompson S.G. Bias due to participant overlap in two-sample Mendelian randomization. Genet. Epidemiol. 2016;40:597&#x2013;608. doi: 10.1002/gepi.21998.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/gepi.21998</ArticleId><ArticleId IdType=\"pmc\">PMC5082560</ArticleId><ArticleId IdType=\"pubmed\">27625185</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna S., van Zuydam N.R., Mahajan A., Kurilshikov A., Vich Vila A., Vosa U., Mujagic Z., Masclee A.A.M., Jonkers D., Oosting M., et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat. Genet. 2019;51:600&#x2013;605. doi: 10.1038/s41588-019-0350-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41588-019-0350-x</ArticleId><ArticleId IdType=\"pmc\">PMC6441384</ArticleId><ArticleId IdType=\"pubmed\">30778224</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Yan B., Zhao B., Fan Y., He X., Yang L., Ma Q., Zheng J., Wang W., Bai L., et al. Assessing the Causal Effects of Human Serum Metabolites on 5 Major Psychiatric Disorders. Schizophr. Bull. 2020;46:804&#x2013;813. doi: 10.1093/schbul/sbz138.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/schbul/sbz138</ArticleId><ArticleId IdType=\"pmc\">PMC7342080</ArticleId><ArticleId IdType=\"pubmed\">31919502</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G., Tilling K., Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13:e1007081.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5711033</ArticleId><ArticleId IdType=\"pubmed\">29149188</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce B.L., Ahsan H., Vanderweele T.J. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int. J. Epidemiol. 2011;40:740&#x2013;752. doi: 10.1093/ije/dyq151.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ije/dyq151</ArticleId><ArticleId IdType=\"pmc\">PMC3147064</ArticleId><ArticleId IdType=\"pubmed\">20813862</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S., Thompson S.G. Avoiding bias from weak instruments in Mendelian randomization studies. Int. J. Epidemiol. 2011;40:755&#x2013;764. doi: 10.1093/ije/dyr036.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ije/dyr036</ArticleId><ArticleId IdType=\"pubmed\">21414999</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J., Li X., Wu S., Tian Y., Zhang Y., Wei Z., Jin Z., Li X., Chen X., Chen W.X. Assessing the causal association between human blood metabolites and the risk of epilepsy. J. Transl. Med. 2022;20:437. doi: 10.1186/s12967-022-03648-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-022-03648-5</ArticleId><ArticleId IdType=\"pmc\">PMC9524049</ArticleId><ArticleId IdType=\"pubmed\">36180952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Huang Y., Hu J., Shao Z. Mendelian randomization study of inflammatory bowel disease and bone mineral density. BMC Med. 2020;18:312. doi: 10.1186/s12916-020-01778-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12916-020-01778-5</ArticleId><ArticleId IdType=\"pmc\">PMC7654011</ArticleId><ArticleId IdType=\"pubmed\">33167994</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue H., Shen X., Pan W. Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects. Am. J. Hum. Genet. 2021;108:1251&#x2013;1269. doi: 10.1016/j.ajhg.2021.05.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajhg.2021.05.014</ArticleId><ArticleId IdType=\"pmc\">PMC8322939</ArticleId><ArticleId IdType=\"pubmed\">34214446</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung C.H.C., Au Yeung S.L., Kwok M.K., Zhao J.V., Schooling C.M. The influence of growth and sex hormones on risk of alzheimer&#x2019;s disease: A mendelian randomization study. Eur. J. Epidemiol. 2023;38:745&#x2013;755. doi: 10.1007/s10654-023-01015-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10654-023-01015-2</ArticleId><ArticleId IdType=\"pubmed\">37253999</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuber V., Colijn J.M., Klaver C., Burgess S. Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization. Nat. Commun. 2020;11:29. doi: 10.1038/s41467-019-13870-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-019-13870-3</ArticleId><ArticleId IdType=\"pmc\">PMC6946691</ArticleId><ArticleId IdType=\"pubmed\">31911605</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin M.G., Zuber V., Walker V.M., Klarin D., Lynch J., Malik R., Aday A.W., Bottolo L., Pradhan A.D., Dichgans M., et al. Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease. Circulation. 2021;144:353&#x2013;364. doi: 10.1161/CIRCULATIONAHA.121.053797.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/CIRCULATIONAHA.121.053797</ArticleId><ArticleId IdType=\"pmc\">PMC8323712</ArticleId><ArticleId IdType=\"pubmed\">34139859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottman D.A., Chernick D., Cheng S., Wang Z., Li L. HDL and cognition in neurodegenerative disorders. Neurobiol. Dis. 2014;72 Pt A:22&#x2013;36. doi: 10.1016/j.nbd.2014.07.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2014.07.015</ArticleId><ArticleId IdType=\"pmc\">PMC4252583</ArticleId><ArticleId IdType=\"pubmed\">25131449</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjeldsen E.W., Thomassen J.Q., Juul Rasmussen I., Nordestgaard B.G., Tybj&#xe6;rg-Hansen A., Frikke-Schmidt R. Plasma high-density lipoprotein cholesterol and risk of dementia: Observational and genetic studies. Cardiovasc. Res. 2022;118:1330&#x2013;1343. doi: 10.1093/cvr/cvab164.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cvr/cvab164</ArticleId><ArticleId IdType=\"pubmed\">33964140</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;iz-Vazquez O., Puente-Mart&#xed;nez A., Ubillos-Landa S., Pacheco-Bonrostro J., Santab&#xe1;rbara J. Cholesterol and Alzheimer&#x2019;s Disease Risk: A Meta-Meta-Analysis. Brain Sci. 2020;10:386. doi: 10.3390/brainsci10060386.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/brainsci10060386</ArticleId><ArticleId IdType=\"pmc\">PMC7349210</ArticleId><ArticleId IdType=\"pubmed\">32570800</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Chen J.X., Lu Q., Geng T.T., Xia P.F., Wang Y., Chen L.K., Shan Z.L., Pan A., Liu G. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study. Diabetes Obes. Metab. 2023;25:3259&#x2013;3267. doi: 10.1111/dom.15224.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/dom.15224</ArticleId><ArticleId IdType=\"pubmed\">37492984</ArticleId></ArticleIdList></Reference><Reference><Citation>Proitsi P., Lupton M.K., Velayudhan L., Newhouse S., Fogh I., Tsolaki M., Daniilidou M., Pritchard M., Kloszewska I., Soininen H., et al. Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: A Mendelian randomization analysis. PLoS Med. 2014;11:e1001713. doi: 10.1371/journal.pmed.1001713.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pmed.1001713</ArticleId><ArticleId IdType=\"pmc\">PMC4165594</ArticleId><ArticleId IdType=\"pubmed\">25226301</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard S.D., Mukherjee S., Sharp S.J., Proitsi P., Lotta L.A., Day F., Perry J.R., Boehme K.L., Walter S., Kauwe J.S., et al. Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study. PLoS Med. 2015;12:e1001841. doi: 10.1371/journal.pmed.1001841.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pmed.1001841</ArticleId><ArticleId IdType=\"pmc\">PMC4469461</ArticleId><ArticleId IdType=\"pubmed\">26079503</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazio S., Pamir N. HDL Particle Size and Functional Heterogeneity. Circ. Res. 2016;119:704&#x2013;707. doi: 10.1161/CIRCRESAHA.116.309506.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/CIRCRESAHA.116.309506</ArticleId><ArticleId IdType=\"pmc\">PMC5971193</ArticleId><ArticleId IdType=\"pubmed\">27587407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontush A., Lhomme M., Chapman M.J. Unraveling the complexities of the HDL lipidome. J. Lipid Res. 2013;54:2950&#x2013;2963. doi: 10.1194/jlr.R036095.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1194/jlr.R036095</ArticleId><ArticleId IdType=\"pmc\">PMC3793600</ArticleId><ArticleId IdType=\"pubmed\">23543772</ArticleId></ArticleIdList></Reference><Reference><Citation>Turri M., Marchi C., Adorni M.P., Calabresi L., Zimetti F. Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2022;1867:159123. doi: 10.1016/j.bbalip.2022.159123.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbalip.2022.159123</ArticleId><ArticleId IdType=\"pubmed\">35151900</ArticleId></ArticleIdList></Reference><Reference><Citation>Moayyeri A., Cheung C.L., Tan K.C., Morris J.A., Cerani A., Mohney R.P., Richards J.B., Hammond C., Spector T.D., Menni C. Metabolomic Pathways to Osteoporosis in Middle-Aged Women: A Genome-Metabolome-Wide Mendelian Randomization Study. J. Bone Min. Res. 2018;33:643&#x2013;650. doi: 10.1002/jbmr.3358.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jbmr.3358</ArticleId><ArticleId IdType=\"pmc\">PMC5972819</ArticleId><ArticleId IdType=\"pubmed\">29232479</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Guo D., Jia Y., Shi M., Yang P., Wang Y., Liu F., Chen G.C., Zhang Y., Zhu Z. Association between Human Blood Metabolome and the Risk of Alzheimer&#x2019;s Disease. Ann. Neurol. 2022;92:756&#x2013;767. doi: 10.1002/ana.26464.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.26464</ArticleId><ArticleId IdType=\"pubmed\">35899678</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Jim&#xe9;nez M.M., Monje-Moreno J.M., Brokate-Llanos A.M., Venegas-Caler&#xf3;n M., S&#xe1;nchez-Garc&#xed;a A., Sansigre P., Valladares A., Esteban-Garc&#xed;a S., Su&#xe1;rez-Pereira I., Vitorica J., et al. Steroid hormones sulfatase inactivation extends lifespan and ameliorates age-related diseases. Nat. Commun. 2021;12:49. doi: 10.1038/s41467-020-20269-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-020-20269-y</ArticleId><ArticleId IdType=\"pmc\">PMC7782729</ArticleId><ArticleId IdType=\"pubmed\">33397961</ArticleId></ArticleIdList></Reference><Reference><Citation>Reily C., Stewart T.J., Renfrow M.B., Novak J. Glycosylation in health and disease. Nat. Rev. Nephrol. 2019;15:346&#x2013;366. doi: 10.1038/s41581-019-0129-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41581-019-0129-4</ArticleId><ArticleId IdType=\"pmc\">PMC6590709</ArticleId><ArticleId IdType=\"pubmed\">30858582</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran J.P., Bhattarai S.K., Foley S.E., Dutta P., Ward D.V., Bucci V., McCormick B.A. Alzheimer&#x2019;s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway. mBio. 2019;10:e00632-19. doi: 10.1128/mBio.00632-19.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/mBio.00632-19</ArticleId><ArticleId IdType=\"pmc\">PMC6509190</ArticleId><ArticleId IdType=\"pubmed\">31064831</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorens F., Hermann P., Villar-Piqu&#xe9; A., Diaz-Lucena D., N&#xe4;gga K., Hansson O., Santana I., Schmitz M., Schmidt C., Varges D., et al. Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia. Nat. Commun. 2020;11:619. doi: 10.1038/s41467-020-14373-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-020-14373-2</ArticleId><ArticleId IdType=\"pmc\">PMC6992814</ArticleId><ArticleId IdType=\"pubmed\">32001681</ArticleId></ArticleIdList></Reference><Reference><Citation>Horgusluoglu E., Neff R., Song W.M., Wang M., Wang Q., Arnold M., Krumsiek J., Galindo-Prieto B., Ming C., Nho K., et al. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. J. Alzheimer&#x2019;s Assoc. 2022;18:1260&#x2013;1278. doi: 10.1002/alz.12468.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.12468</ArticleId><ArticleId IdType=\"pmc\">PMC9085975</ArticleId><ArticleId IdType=\"pubmed\">34757660</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenn J.M., Madero E.N., Bott N.T. Dietary Protein and Amino Acid Intake: Links to the Maintenance of Cognitive Health. Nutrients. 2019;11:1315. doi: 10.3390/nu11061315.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu11061315</ArticleId><ArticleId IdType=\"pmc\">PMC6627761</ArticleId><ArticleId IdType=\"pubmed\">31212755</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter S.E., Evans A.M. Carnitine and acylcarnitines: Pharmacokinetic, pharmacological and clinical aspects. Clin. Pharmacokinet. 2012;51:553&#x2013;572. doi: 10.1007/BF03261931.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/BF03261931</ArticleId><ArticleId IdType=\"pubmed\">22804748</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie A., Sun B., Fu Z., Yu D. Roles of aminoacyl-tRNA synthetases in immune regulation and immune diseases. Cell Death Dis. 2019;10:901. doi: 10.1038/s41419-019-2145-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41419-019-2145-5</ArticleId><ArticleId IdType=\"pmc\">PMC6883034</ArticleId><ArticleId IdType=\"pubmed\">31780718</ArticleId></ArticleIdList></Reference><Reference><Citation>Polis B., Samson A.O. Role of the metabolism of branched-chain amino acids in the development of Alzheimer&#x2019;s disease and other metabolic disorders. Neural Regen. Res. 2020;15:1460&#x2013;1470. doi: 10.4103/1673-5374.274328.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/1673-5374.274328</ArticleId><ArticleId IdType=\"pmc\">PMC7059578</ArticleId><ArticleId IdType=\"pubmed\">31997805</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Dom&#xed;nguez R., Castellano-Escuder P., Lef&#xe8;vre-Arbogast S., Low D.Y., Du Preez A., Ruigrok S.R., Lee H., Helmer C., Pall&#xe0;s M., Urpi-Sarda M., et al. Apolipoprotein E and sex modulate fatty acid metabolism in a prospective observational study of cognitive decline. Alzheimers Res. Ther. 2022;14:1. doi: 10.1186/s13195-021-00948-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-021-00948-8</ArticleId><ArticleId IdType=\"pmc\">PMC8725342</ArticleId><ArticleId IdType=\"pubmed\">34980257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39275189</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2072-6643</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>16</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>27</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Body Size Measurements Grouped Independently of Common Clinical Measures of Metabolic Health: An Exploratory Factor Analysis.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">2874</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/nu16172874</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Obesity is commonly aggregated with indices of metabolic health. Proponents of body positivity approaches question whether body size is a determinant of health and well-being. Our objective was to conduct an exploratory factor analysis (EFA) to determine if body size measurements factor load with or independent of metabolic health measures.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">The EFA was conducted on <i>n</i>= 249 adults using baseline data from four weight loss trials (Sample 1: <i>n</i> = 40; Sample 2: <i>n</i> = 52; Sample 3: <i>n</i> = 53; Sample 4: <i>n</i> = 104). An EFA of nine items (systolic blood pressure [SBP], diastolic blood pressure [DBP], hemoglobin A1c [HbA1c], HDL-cholesterol [HDL], LDL-cholesterol [LDL], total cholesterol [TC], body mass index [BMI], body fat percent BF%], and waist circumference [WC]) was conducted with oblique rotation.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Three factors were retained, which produced a model explaining 87.5% of the variance. Six items loaded strongly (&gt;0.8) under three components and were selected for retention (Factor 1: LDL and TC; Factor 2: BMI and WC; Factor 3: SBP and DBP).</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">Body size measures loaded separately from measures of metabolic health and metabolic health were further split into lipid- and blood pressure-focused factors. These results support weight-neutral interventions to improve overall health and well-being.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ellison</LastName><ForeName>Katie M</ForeName><Initials>KM</Initials><Identifier Source=\"ORCID\">0000-0003-2141-2592</Identifier><AffiliationInfo><Affiliation>Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35233, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family and Community Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>El Zein</LastName><ForeName>Aseel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Family and Community Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Reynolds</LastName><ForeName>Chelsi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Family and Community Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ehrlicher</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35233, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Clina</LastName><ForeName>Julianne G</ForeName><Initials>JG</Initials><Identifier Source=\"ORCID\">0000-0002-3655-5644</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas City, MO 66103, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chui</LastName><ForeName>Tsz-Kiu</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35233, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Smith</LastName><ForeName>Kimberly A</ForeName><Initials>KA</Initials><Identifier Source=\"ORCID\">0000-0002-6519-1704</Identifier><AffiliationInfo><Affiliation>Department of Family and Community Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hill</LastName><ForeName>James O</ForeName><Initials>JO</Initials><Identifier Source=\"ORCID\">0000-0003-4690-2264</Identifier><AffiliationInfo><Affiliation>Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35233, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wyatt</LastName><ForeName>Holly R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35233, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sayer</LastName><ForeName>R Drew</ForeName><Initials>RD</Initials><Identifier Source=\"ORCID\">0000-0002-9488-7030</Identifier><AffiliationInfo><Affiliation>Department of Family and Community Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>K01DK124244</GrantID><Agency>National Institutes of Health (NIH), National Institute for Diabetes, and Digestive, and Kidney Diseases</Agency><Country/></Grant><Grant><GrantID>P30DK056336</GrantID><Agency>University of Alabama at Birmingham (UAB) Nutrition Obesity Research Center</Agency><Country/></Grant><Grant><GrantID>3P30DK056336-18S1</GrantID><Agency>UAB Nutrition Obesity Research Center - Chronic Disease and Health Disparities Revision</Agency><Country/></Grant><Grant><GrantID>P50MD017338-03S1</GrantID><Agency>National Institutes of Minority Health and Health Disparities as part of a competitive revision to the Forge AHEAD Center</Agency><Country/></Grant><Grant><GrantID>UL1TR002535</GrantID><Agency>Beef Checkoff/National Cattlemen's Beef Association and the National Institutes of Health/National Center for Advancing Translational Sciences (NCATS) Colorado Clinical and Translational Science Award</Agency><Country/></Grant><Grant><GrantID>P30 AG072973 and T32 AG078114</GrantID><Agency>Alzheimer's Disease Research Center</Agency><Country/></Grant><Grant><GrantID>N/A</GrantID><Agency>General Mills Inc.</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D006442\">Glycated Hemoglobin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D008078\">Cholesterol, LDL</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005163\" MajorTopicYN=\"N\">Factor Analysis, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D055105\" MajorTopicYN=\"Y\">Waist Circumference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001794\" MajorTopicYN=\"Y\">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015992\" MajorTopicYN=\"Y\">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D049628\" MajorTopicYN=\"N\">Body Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009765\" MajorTopicYN=\"N\">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006442\" MajorTopicYN=\"N\">Glycated Hemoglobin</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000032\" MajorTopicYN=\"N\">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008078\" MajorTopicYN=\"N\">Cholesterol, LDL</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">body positivity</Keyword><Keyword MajorTopicYN=\"N\">cardiometabolic disease</Keyword><Keyword MajorTopicYN=\"N\">exploratory factor analysis</Keyword><Keyword MajorTopicYN=\"N\">obesity</Keyword></KeywordList><CoiStatement>J.O.H. is a member of the General Mills Health and Wellness Advisory Committee, for which he receives an honorarium. H.R.W. and J.O.H. are co-owners of the <i>State of Slim</i> weight management program, which was the intervention in the affiliated study, NCT04014296. H.R.W. and R.D.S. report speaking fees from the National Cattlemen&#x2019;s Beef Association. The other authors declared no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39275189</ArticleId><ArticleId IdType=\"doi\">10.3390/nu16172874</ArticleId><ArticleId IdType=\"pii\">nu16172874</ArticleId><ArticleId IdType=\"pmc\">PMC11396867</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Academies of Sciences, Engineering, and Medicine. Division of Behavioral and Social Sciences and Education. Committee on National Statistics. Committee on Population. Committee on Rising Midlife Mortality Rates and Socioeconomic Disparities . Cardiometabolic Diseases. In: Harris K.M., Majmundar M.K., Becker T., editors. High and Rising Mortality Rates among Working-Age Adults. National Academies Press (US); Washington, DC, USA: 2021.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33656826</ArticleId></ArticleIdList></Reference><Reference><Citation>Wing R.R., Lang W., Wadden T.A., Safford M., Knowler W.C., Bertoni A.G., Hill J.O., Brancati F.L., Peters A., Wagenknecht L. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34:1481&#x2013;1486. doi: 10.2337/dc10-2415.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/dc10-2415</ArticleId><ArticleId IdType=\"pmc\">PMC3120182</ArticleId><ArticleId IdType=\"pubmed\">21593294</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvey W.T., Mechanick J.I., Brett E.M., Garber A.J., Hurley D.L., Jastreboff A.M., Nadolsky K., Pessah-Pollack R., Plodkowski R. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr. Pract. 2016;22:1&#x2013;203.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27219496</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan D.H., Yockey S.R. Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. Curr. Obes. Rep. 2017;6:187&#x2013;194. doi: 10.1007/s13679-017-0262-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13679-017-0262-y</ArticleId><ArticleId IdType=\"pmc\">PMC5497590</ArticleId><ArticleId IdType=\"pubmed\">28455679</ArticleId></ArticleIdList></Reference><Reference><Citation>The Association for Size Diversity and Health (ASDAH)  Health at Every Size&#xae;.  [(accessed on 23 May 2024)].  Available online:  https://asdah.org/haes/</Citation></Reference><Reference><Citation>Ulian M.D., Benatti F.B., de Campos-Ferraz P.L., Roble O.J., Unsain R.F., de Morais Sato P., Brito B.C., Murakawa K.A., Modesto B.T., Aburad L., et al. The Effects of a &#x201c;Health at Every Size&#xae;&#x201d;-Based Approach in Obese Women: A Pilot-Trial of the &#x201c;Health and Wellness in Obesity&#x201d; Study. Front. Nutr. 2015;2:34. doi: 10.3389/fnut.2015.00034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnut.2015.00034</ArticleId><ArticleId IdType=\"pmc\">PMC4621435</ArticleId><ArticleId IdType=\"pubmed\">26579524</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacon L., Aphramor L. Weight science: Evaluating the evidence for a paradigm shift. Nutr. J. 2011;10:9. doi: 10.1186/1475-2891-10-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1475-2891-10-9</ArticleId><ArticleId IdType=\"pmc\">PMC3041737</ArticleId><ArticleId IdType=\"pubmed\">21261939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagen S.J., Henningfield M.F. Health at Every Size Principles: Clinician Perspectives to Limit Weight Stigma in Medical Care. WMJ. 2023;122:277&#x2013;279.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37768769</ArticleId></ArticleIdList></Reference><Reference><Citation>Penney T.L., Kirk S.F. The Health at Every Size paradigm and obesity: Missing empirical evidence may help push the reframing obesity debate forward. Am. J. Public Health. 2015;105:e38&#x2013;e42. doi: 10.2105/AJPH.2015.302552.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2105/AJPH.2015.302552</ArticleId><ArticleId IdType=\"pmc\">PMC4386524</ArticleId><ArticleId IdType=\"pubmed\">25790393</ArticleId></ArticleIdList></Reference><Reference><Citation>Morsali M., Poorolajal J., Shahbazi F., Vahidinia A., Doosti-Irani A. Diet Therapeutics Interventions for Obesity: A Systematic Review and Network Meta-Analysis. J. Res. Health Sci. 2021;21:e00521. doi: 10.34172/jrhs.2021.63.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.34172/jrhs.2021.63</ArticleId><ArticleId IdType=\"pmc\">PMC8957686</ArticleId><ArticleId IdType=\"pubmed\">34698655</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall K.D. Metabolic Adaptations to Weight Loss. Obesity. 2018;26:790&#x2013;791. doi: 10.1002/oby.22189.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/oby.22189</ArticleId><ArticleId IdType=\"pmc\">PMC6086582</ArticleId><ArticleId IdType=\"pubmed\">29637734</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins C., Roekenes J., Gower B.A., Hunter G.R. Metabolic adaptation is associated with less weight and fat mass loss in response to low-energy diets. Nutr. Metab. 2021;18:60. doi: 10.1186/s12986-021-00587-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12986-021-00587-8</ArticleId><ArticleId IdType=\"pmc\">PMC8196522</ArticleId><ArticleId IdType=\"pubmed\">34116675</ArticleId></ArticleIdList></Reference><Reference><Citation>Hales C.M., Fryar C.D., Ogden C.L. Prevalence of Obesity and Severe Obesity among Adults: United States, 2017&#x2013;2018. National Center for Health Statistics; Hyattsville, MD, USA: 2020.</Citation></Reference><Reference><Citation>Clina J.G., Sayer R.D., Pan Z., Cohen C.W., McDermott M.T., Catenacci V.A., Wyatt H.R., Hill J.O. High- and normal-protein diets improve body composition and glucose control in adults with type 2 diabetes: A randomized trial. Obesity. 2023;31:2021&#x2013;2030. doi: 10.1002/oby.23815.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/oby.23815</ArticleId><ArticleId IdType=\"pmc\">PMC10421635</ArticleId><ArticleId IdType=\"pubmed\">37475689</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehead S.J., Ford C., Gama R. A combined laboratory and field evaluation of the Cholestech LDX and CardioChek PA point-of-care testing lipid and glucose analysers. Ann. Clin. Biochem. 2014;51:54&#x2013;67. doi: 10.1177/0004563213482890.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0004563213482890</ArticleId><ArticleId IdType=\"pubmed\">23880620</ArticleId></ArticleIdList></Reference><Reference><Citation>Shephard M.D., Mazzachi B.C., Shephard A.K. Comparative performance of two point-of-care analysers for lipid testing. Clin. Lab. 2007;53:561&#x2013;566.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18257461</ArticleId></ArticleIdList></Reference><Reference><Citation>Panz V.R., Raal F.J., Paiker J., Immelman R., Miles H. Performance of the CardioChek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids. Cardiovasc. J. S. Afr. 2005;16:112&#x2013;117.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15915279</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold W.D., Kupfer K., Little R.R., Amar M., Horowitz B., Godbole N., Hvidsten Swensen M., Li Y., San George R.C. Accuracy and Precision of a Point-of-Care HbA1c Test. J. Diabetes Sci. Technol. 2020;14:883&#x2013;889. doi: 10.1177/1932296819831292.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1932296819831292</ArticleId><ArticleId IdType=\"pmc\">PMC7753859</ArticleId><ArticleId IdType=\"pubmed\">30854894</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Hondt J., Waterplas J., Chapelle L., Clarys P., D&#x2019;Hondt E. A Comparative and Sex-Specific Study of Bio-Electrical Impedance Analysis and Dual Energy X-ray Absorptiometry for Estimating Whole-Body and Segmental Body Composition in Healthy Young Adults. Appl. Sci. 2022;12:7686. doi: 10.3390/app12157686.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/app12157686</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng B.K., Liu Y.E., Wang W., Kelly T.L., Wilson K.E., Schoeller D.A., Heymsfield S.B., Shepherd J.A. Validation of rapid 4-component body composition assessment with the use of dual-energy X-ray absorptiometry and bioelectrical impedance analysis. Am. J. Clin. Nutr. 2018;108:708&#x2013;715. doi: 10.1093/ajcn/nqy158.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/nqy158</ArticleId><ArticleId IdType=\"pmc\">PMC7263310</ArticleId><ArticleId IdType=\"pubmed\">30099474</ArticleId></ArticleIdList></Reference><Reference><Citation>Suida A., Chomentowski P.J., III, Salacinski A.J., Broeder C. Validity of Whole and Regional Body Composition Testing Devices: 986 Board #165 May 31 3: 30 PM&#x2013;5: 00 PM. Med. Sci. Sports Exerc. 2017;49:264&#x2013;265.</Citation></Reference><Reference><Citation>Ellison K.M., Ehrlicher S.E., El Zein A., Sayer R.D. Fat and fat-free mass measurement agreement by dual-energy X-ray absorptiometry versus bioelectrical impedance analysis: Effects of posture and waist circumference. Obes. Sci. Pract. 2024;10:e744. doi: 10.1002/osp4.744.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/osp4.744</ArticleId><ArticleId IdType=\"pmc\">PMC10928253</ArticleId><ArticleId IdType=\"pubmed\">38476295</ArticleId></ArticleIdList></Reference><Reference><Citation>Office of Public Health and Science, Health and Human Services Department . The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Office of Public Health and Science, Health and Human Services Department; Washington, DC, USA: 2000.</Citation></Reference><Reference><Citation>Taber K.S. The Use of Cronbach&#x2019;s Alpha When Developing and Reporting Research Instruments in Science Education. Res. Sci. Educ. 2018;48:1273&#x2013;1296. doi: 10.1007/s11165-016-9602-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11165-016-9602-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Zijlmans E.A.O., Tijmstra J., van der Ark L.A., Sijtsma K. Item-Score Reliability in Empirical-Data Sets and Its Relationship With Other Item Indices. Educ. Psychol. Meas. 2018;78:998&#x2013;1020. doi: 10.1177/0013164417728358.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0013164417728358</ArticleId><ArticleId IdType=\"pmc\">PMC6236637</ArticleId><ArticleId IdType=\"pubmed\">30542214</ArticleId></ArticleIdList></Reference><Reference><Citation>Bays H.E., Chapman R.H., Grandy S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: Comparison of data from two national surveys. Int. J. Clin. Pract. 2007;61:737&#x2013;747. doi: 10.1111/j.1742-1241.2007.01336.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1742-1241.2007.01336.x</ArticleId><ArticleId IdType=\"pmc\">PMC1890993</ArticleId><ArticleId IdType=\"pubmed\">17493087</ArticleId></ArticleIdList></Reference><Reference><Citation>Bl&#xfc;her M. Metabolically Healthy Obesity. Endocr. Rev. 2020;41:bnaa004. doi: 10.1210/endrev/bnaa004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/endrev/bnaa004</ArticleId><ArticleId IdType=\"pmc\">PMC7098708</ArticleId><ArticleId IdType=\"pubmed\">32128581</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor R., Holman R.R. Normal weight individuals who develop type 2 diabetes: The personal fat threshold. Clin. Sci. 2015;128:405&#x2013;410. doi: 10.1042/CS20140553.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/CS20140553</ArticleId><ArticleId IdType=\"pubmed\">25515001</ArticleId></ArticleIdList></Reference><Reference><Citation>Batsis J.A., Sahakyan K.R., Rodriguez-Escudero J.P., Bartels S.J., Somers V.K., Lopez-Jimenez F. Normal weight obesity and mortality in United States subjects &#x2265; 60 years of age (from the Third National Health and Nutrition Examination Survey) Am. J. Cardiol. 2013;112:1592&#x2013;1598. doi: 10.1016/j.amjcard.2013.07.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.amjcard.2013.07.014</ArticleId><ArticleId IdType=\"pubmed\">23993123</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Corral A., Somers V.K., Sierra-Johnson J., Korenfeld Y., Boarin S., Korinek J., Jensen M.D., Parati G., Lopez-Jimenez F. Normal weight obesity: A risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur. Heart J. 2010;31:737&#x2013;746. doi: 10.1093/eurheartj/ehp487.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/eurheartj/ehp487</ArticleId><ArticleId IdType=\"pmc\">PMC2838679</ArticleId><ArticleId IdType=\"pubmed\">19933515</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan N., Schick F., H&#xe4;ring H.-U. Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. Cell Metab. 2017;26:292&#x2013;300. doi: 10.1016/j.cmet.2017.07.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2017.07.008</ArticleId><ArticleId IdType=\"pubmed\">28768170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekelund U., Besson H., Luan J.A., May A.M., Sharp S.J., Brage S., Travier N., Agudo A., Slimani N., Rinaldi S., et al. Physical activity and gain in abdominal adiposity and body weight: Prospective cohort study in 288,498 men and women. Am. J. Clin. Nutr. 2011;93:826&#x2013;835. doi: 10.3945/ajcn.110.006593.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3945/ajcn.110.006593</ArticleId><ArticleId IdType=\"pubmed\">21346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Strasser B. Physical activity in obesity and metabolic syndrome. Ann. N. Y. Acad. Sci. 2013;1281:141&#x2013;159. doi: 10.1111/j.1749-6632.2012.06785.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1749-6632.2012.06785.x</ArticleId><ArticleId IdType=\"pmc\">PMC3715111</ArticleId><ArticleId IdType=\"pubmed\">23167451</ArticleId></ArticleIdList></Reference><Reference><Citation>Diels S., Vanden Berghe W., Van Hul W. Insights into the multifactorial causation of obesity by integrated genetic and epigenetic analysis. Obes. Rev. 2020;21:e13019. doi: 10.1111/obr.13019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/obr.13019</ArticleId><ArticleId IdType=\"pubmed\">32170999</ArticleId></ArticleIdList></Reference><Reference><Citation>Anna B., Costello J.O. Best practices in explor actices in exploratory factor analysis: Four or analysis: Four recommendations for getting the most from your analysis. Pract. Assess. Res. Eval. 2005;10:1&#x2013;9.</Citation></Reference><Reference><Citation>Ellison K., Smith K., Hill J., Wyatt H., Sayer D. PTFS04-06-23 An Exploratory Factor Analysis of Common Cardiometabolic Measures in People With Obesity for Building a Parsimonious Health Assessment. Curr. Dev. Nutr. 2023;7:101649. doi: 10.1016/j.cdnut.2023.101649.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cdnut.2023.101649</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39275108</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1420-3049</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>29</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>08</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Radiolabeled Probes from Derivatives of Natural Compounds Used in Nuclear Medicine.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">4260</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/molecules29174260</ELocationID><Abstract><AbstractText>Natural compounds are important precursors for the synthesis of new drugs. The development of novel molecules that are useful for various diseases is the main goal of researchers, especially for the diagnosis and treatment of many diseases. Some pathologies need to be treated with radiopharmaceuticals, and, for this reason, radiopharmaceuticals that use the radiolabeling of natural derivates molecules are arousing more and more interest. Radiopharmaceuticals can be used for both diagnostic and therapeutic purposes depending on the radionuclide. &#x3b2;<sup>+</sup>- and gamma-emitting radionuclides are used for diagnostic use for PET or SPECT imaging techniques, while &#x3b1;- and &#x3b2;<sup>-</sup>-emitting radionuclides are used for in metabolic radiotherapy. Based on these assumptions, the purpose of this review is to highlight the studies carried out in the last ten years, to search for potentially useful radiopharmaceuticals for nuclear medicine that use molecules of natural origin as lead structures. In this context, the main radiolabeled compounds containing natural products as scaffolds are analyzed, in particular curcumin, stilbene, chalcone, and benzofuran. Studies on structural and chemical modifications are emphasized in order to obtain a collection of potential radiopharmaceuticals that exploit the biological properties of molecules of natural origin. The radionuclides used to label these compounds are <sup>68</sup>Ga, <sup>44</sup>Sc, <sup>18</sup>F, <sup>64</sup>Cu, <sup>99m</sup>Tc, and <sup>125</sup>I for diagnostic imaging.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Tesse</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Radiopharma Division, ITEL Telecomunicazioni s.r.l., 70037 Ruvo di Puglia, BA, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tolomeo</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Radiopharma Division, ITEL Telecomunicazioni s.r.l., 70037 Ruvo di Puglia, BA, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>De Filippis</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source=\"ORCID\">0000-0001-7718-5814</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, Universit&#xe0; degli Studi G. d'Annunzio, 66100 Chieti, CH, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Giampietro</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0002-8483-1885</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, Universit&#xe0; degli Studi G. d'Annunzio, 66100 Chieti, CH, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>FAR</GrantID><Agency>Italian Ministry for Instruction</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D019275\">Radiopharmaceuticals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D001688\">Biological Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011868\">Radioisotopes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D019275\" MajorTopicYN=\"Y\">Radiopharmaceuticals</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001688\" MajorTopicYN=\"Y\">Biological Products</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009683\" MajorTopicYN=\"Y\">Nuclear Medicine</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D049268\" MajorTopicYN=\"N\">Positron-Emission Tomography</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011868\" MajorTopicYN=\"N\">Radioisotopes</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007553\" MajorTopicYN=\"N\">Isotope Labeling</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015899\" MajorTopicYN=\"N\">Tomography, Emission-Computed, Single-Photon</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">benzofuran</Keyword><Keyword MajorTopicYN=\"N\">cancer</Keyword><Keyword MajorTopicYN=\"N\">chalcone</Keyword><Keyword MajorTopicYN=\"N\">curcumin</Keyword><Keyword MajorTopicYN=\"N\">natural compounds</Keyword><Keyword MajorTopicYN=\"N\">nuclear medicine</Keyword><Keyword MajorTopicYN=\"N\">radiopharmaceutical</Keyword><Keyword MajorTopicYN=\"N\">stilbene</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39275108</ArticleId><ArticleId IdType=\"doi\">10.3390/molecules29174260</ArticleId><ArticleId IdType=\"pii\">molecules29174260</ArticleId><ArticleId IdType=\"pmc\">PMC11396893</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Frey K.A., Royal H.D., Di Carli M.F., Dillehay G.L., Gordon L., Mankoff D.A., O&#x2019;Malley J., Ramanna L., Rohren E., Segall G.M., et al. ABNM position statement: Nuclear medicine professional competency and scope of practice. J. Nucl. Med. 2011;52:994&#x2013;997. doi: 10.2967/jnumed.111.089979.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2967/jnumed.111.089979</ArticleId><ArticleId IdType=\"pubmed\">21571802</ArticleId></ArticleIdList></Reference><Reference><Citation>Cri&#x219;an G., Moldovean-Cioroianu N.S., Timaru D.G., Andrie&#x219; G., C&#x103;inap C., Chi&#x219; V. Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade. Int. J. Mol. Sci. 2022;23:5023. doi: 10.3390/ijms23095023.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23095023</ArticleId><ArticleId IdType=\"pmc\">PMC9103893</ArticleId><ArticleId IdType=\"pubmed\">35563414</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankoff D.A. A definition of molecular imaging. J. Nucl. Med. 2007;48:18N&#x2013;21N.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17536102</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R., Aboagye E. Development of radiotracers for oncology--the interface with pharmacology. Br. J. Pharmacol. 2011;163:1565&#x2013;1585. doi: 10.1111/j.1476-5381.2010.01160.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1476-5381.2010.01160.x</ArticleId><ArticleId IdType=\"pmc\">PMC3166688</ArticleId><ArticleId IdType=\"pubmed\">21175573</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner R.A., Bundschuh R.A., Bundschuh L., Fanti S., Javadi M.S., Higuchi T., Weich A., Pienta K.J., Buck A.K., Pomper M.G., et al. Novel Structured Reporting Systems for Theranostic Radiotracers. J. Nucl. Med. 2019;60:577&#x2013;584. doi: 10.2967/jnumed.118.223537.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2967/jnumed.118.223537</ArticleId><ArticleId IdType=\"pmc\">PMC6495242</ArticleId><ArticleId IdType=\"pubmed\">30796171</ArticleId></ArticleIdList></Reference><Reference><Citation>Witney T.H., Blower P.J. The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy. Cancer Imaging. 2021;21:18. doi: 10.1186/s40644-021-00385-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40644-021-00385-8</ArticleId><ArticleId IdType=\"pmc\">PMC7847158</ArticleId><ArticleId IdType=\"pubmed\">33516256</ArticleId></ArticleIdList></Reference><Reference><Citation>Fay R., Holland J.P. The Impact of Emerging Bioconjugation Chemistries on Radiopharmaceuticals. J. Nucl. Med. 2019;60:587&#x2013;591. doi: 10.2967/jnumed.118.220806.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2967/jnumed.118.220806</ArticleId><ArticleId IdType=\"pubmed\">30902878</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhanwar Y.S., Divgi C. Current status of therapy of solid tumors. J. Nucl. Med. 2005;46((Suppl. S1)):141S&#x2013;150S.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15653662</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker C., Nilsson S., Heinrich D., Helle S.I., O&#x2019;Sullivan J.M., Foss&#xe5; S.D., Chodacki A., Wiechno P., Logue J., Seke M., et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N. Engl. J. Med. 2013;369:213&#x2013;223. doi: 10.1056/NEJMoa1213755.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa1213755</ArticleId><ArticleId IdType=\"pubmed\">23863050</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M., Baum R.P., Simon T., Howman-Giles R. Therapeutic nuclear medicine in pediatric malignancy. Q. J. Nucl. Med. Mol. Imaging. 2010;54:411&#x2013;428.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20823809</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeong C.H., Cheng M.H., Ng K.H. Therapeutic radionuclides in nuclear medicine: Current and future prospects. J. Zhejiang Univ. Sci. B. 2014;15:845&#x2013;863. doi: 10.1631/jzus.B1400131.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1631/jzus.B1400131</ArticleId><ArticleId IdType=\"pmc\">PMC4201313</ArticleId><ArticleId IdType=\"pubmed\">25294374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar C., Shetake N., Desai S., Kumar A., Samuel G., Pandey B.N. Relevance of radiobiological concepts in radionuclide therapy of cancer. Int. J. Radiat. Biol. 2016;92:173&#x2013;186. doi: 10.3109/09553002.2016.1144944.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/09553002.2016.1144944</ArticleId><ArticleId IdType=\"pubmed\">26917443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrier M.G., Radchenko V. An Appendix of Radionuclides Used in Targeted Alpha Therapy. J. Med. Imaging Radiat. Sci. 2019;50((Suppl. S1)):S58&#x2013;S65. doi: 10.1016/j.jmir.2019.06.051.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jmir.2019.06.051</ArticleId><ArticleId IdType=\"pubmed\">31427258</ArticleId></ArticleIdList></Reference><Reference><Citation>Widel M., Przybyszewski W.M., Cieslar-Pobuda A., Saenko Y.V., Rzeszowska-Wolny J. Bystander normal human fibroblasts reduce damage response in radiation targeted cancer cells through intercellular ROS level modulation. Mutat. Res. 2012;731:117&#x2013;124. doi: 10.1016/j.mrfmmm.2011.12.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mrfmmm.2011.12.007</ArticleId><ArticleId IdType=\"pubmed\">22210495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgouros G., Bodei L., McDevitt M.R., Nedrow J.R. Radiopharmaceutical therapy in cancer: Clinical advances and challenges. Nat. Rev. Drug Discov. 2020;19:589&#x2013;608. doi: 10.1038/s41573-020-0073-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41573-020-0073-9</ArticleId><ArticleId IdType=\"pmc\">PMC7390460</ArticleId><ArticleId IdType=\"pubmed\">32728208</ArticleId></ArticleIdList></Reference><Reference><Citation>Salih S., Alkatheeri A., Alomaim W., Elliyanti A. Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges. Molecules. 2022;27:5231. doi: 10.3390/molecules27165231.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules27165231</ArticleId><ArticleId IdType=\"pmc\">PMC9415873</ArticleId><ArticleId IdType=\"pubmed\">36014472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahenkorah S., Cassells I., Deroose C.M., Cardinaels T., Burgoyne A.R., Bormans G., Ooms M., Cleeren F. Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside. Pharmaceutics. 2021;13:599. doi: 10.3390/pharmaceutics13050599.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics13050599</ArticleId><ArticleId IdType=\"pmc\">PMC8143329</ArticleId><ArticleId IdType=\"pubmed\">33919391</ArticleId></ArticleIdList></Reference><Reference><Citation>Gidaro M.C., Alcaro S., Secci D., Rivanera D., Mollica A., Agamennone M., Giampietro L., Carradori S. Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening. J. Enzyme Inhib. Med. Chem. 2016;31:1703&#x2013;1706. doi: 10.3109/14756366.2016.1156103.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/14756366.2016.1156103</ArticleId><ArticleId IdType=\"pubmed\">26985772</ArticleId></ArticleIdList></Reference><Reference><Citation>Baier A., Szyszka R. Compounds from Natural Sources as Protein Kinase Inhibitors. Biomolecules. 2020;10:1546. doi: 10.3390/biom10111546.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom10111546</ArticleId><ArticleId IdType=\"pmc\">PMC7698043</ArticleId><ArticleId IdType=\"pubmed\">33198400</ArticleId></ArticleIdList></Reference><Reference><Citation>Paoli P. Enzymatic Inhibitors from Natural Sources: A Huge Collection of New Potential Drugs. Biomolecules. 2021;11:133. doi: 10.3390/biom11020133.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom11020133</ArticleId><ArticleId IdType=\"pmc\">PMC7909571</ArticleId><ArticleId IdType=\"pubmed\">33498517</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani A.S., Hidayathulla S., Rehman M.T., ElGamal A.A., Al-Massarani S., Razmovski-Naumovski V., Alqahtani M.S., El Dib R.A., AlAjmi M.F. Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from Nuxia oppositifolia. Biomolecules. 2019;10:61. doi: 10.3390/biom10010061.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom10010061</ArticleId><ArticleId IdType=\"pmc\">PMC7022278</ArticleId><ArticleId IdType=\"pubmed\">31905962</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudoit A., Benbouguerra N., Richard T., Hornedo-Ortega R., Valls-Fonayet J., Coussot G., Saucier C. &#x3b1;-Glucosidase Inhibitory Activity of Tannat Grape Phenolic Extracts in Relation to Their Ripening Stages. Biomolecules. 2020;10:1088. doi: 10.3390/biom10081088.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom10081088</ArticleId><ArticleId IdType=\"pmc\">PMC7464188</ArticleId><ArticleId IdType=\"pubmed\">32707893</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalhotra P., Chittepu V.C.S.R., Osorio-Revilla G., Gallardo-Velazquez T. Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus. Biomolecules. 2020;10:305. doi: 10.3390/biom10020305.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom10020305</ArticleId><ArticleId IdType=\"pmc\">PMC7072494</ArticleId><ArticleId IdType=\"pubmed\">32075130</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisi R., Gaponenko V., Vanoni M., Sacco E. Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives. Biomolecules. 2020;10:1535. doi: 10.3390/biom10111535.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom10111535</ArticleId><ArticleId IdType=\"pmc\">PMC7698260</ArticleId><ArticleId IdType=\"pubmed\">33182807</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwar S., Ahmed N., Giampietro L. Editorial: Targeting tumor EMT-related signaling by natural products. Front. Pharmacol. 2023;14:1152328. doi: 10.3389/fphar.2023.1152328.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2023.1152328</ArticleId><ArticleId IdType=\"pmc\">PMC9986585</ArticleId><ArticleId IdType=\"pubmed\">36891267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24:981&#x2013;990. doi: 10.1016/j.cellsig.2012.01.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cellsig.2012.01.008</ArticleId><ArticleId IdType=\"pmc\">PMC3454471</ArticleId><ArticleId IdType=\"pubmed\">22286106</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor E., Kim Y., Zhang K., Chau L., Nguyen B.C., Rayalam S., Wang X. Antiaging Mechanism of Natural Compounds: Effects on Autophagy and Oxidative Stress. Molecules. 2022;27:4396. doi: 10.3390/molecules27144396.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules27144396</ArticleId><ArticleId IdType=\"pmc\">PMC9322024</ArticleId><ArticleId IdType=\"pubmed\">35889266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wongso H. Natural product-based radiopharmaceuticals: Focus on curcumin and its analogs, flavonoids, and marine peptides. J. Pharm. Anal. 2022;12:380&#x2013;393. doi: 10.1016/j.jpha.2021.07.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jpha.2021.07.006</ArticleId><ArticleId IdType=\"pmc\">PMC9257450</ArticleId><ArticleId IdType=\"pubmed\">35811617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mari M., Carrozza D., Ferrari E., Asti M. Applications of Radiolabelled Curcumin and Its Derivatives in Medicinal Chemistry. Int. J. Mol. Sci. 2021;22:7410. doi: 10.3390/ijms22147410.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22147410</ArticleId><ArticleId IdType=\"pmc\">PMC8306375</ArticleId><ArticleId IdType=\"pubmed\">34299029</ArticleId></ArticleIdList></Reference><Reference><Citation>Orteca G., Sinnes J.P., Rubagotti S., Iori M., Capponi P.C., Piel M., R&#xf6;sch F., Ferrari E., Asti M. Gallium-68 and scandium-44 labelled radiotracers based on curcumin structure linked to bifunctional chelators: Synthesis and characterization of potential PET radiotracers. J. Inorg. Biochem. 2020;204:110954. doi: 10.1016/j.jinorgbio.2019.110954.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jinorgbio.2019.110954</ArticleId><ArticleId IdType=\"pubmed\">31838188</ArticleId></ArticleIdList></Reference><Reference><Citation>Rokka J., Snellman A., Zona C., La Ferla B., Nicotra F., Salmona M., Forloni G., Haaparanta-Solin M., Rinne J.O., Solin O. Synthesis and evaluation of a (18)F-curcumin derivate for &#x3b2;-amyloid plaque imaging. Bioorg. Med. Chem. 2014;22:2753&#x2013;2762. doi: 10.1016/j.bmc.2014.03.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bmc.2014.03.010</ArticleId><ArticleId IdType=\"pubmed\">24702859</ArticleId></ArticleIdList></Reference><Reference><Citation>Asti M., Ferrari E., Croci S., Atti G., Rubagotti S., Iori M., Capponi P.C., Zerbini A., Saladini M., Versari A. Synthesis and characterization of (68)Ga-labeled curcumin and curcuminoid complexes as potential radiotracers for imaging of cancer and Alzheimer&#x2019;s disease. Inorg. Chem. 2014;53:4922&#x2013;4933. doi: 10.1021/ic403113z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/ic403113z</ArticleId><ArticleId IdType=\"pubmed\">24766626</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartik L., Whitfield G.K., Kaczmarska M., Lowmiller C.L., Moffet E.W., Furmick J.K., Hernandez Z., Haussler C.A., Haussler M.R., Jurutka P.W. Curcumin: A novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J. Nutr. Biochem. 2010;21:1153&#x2013;1161. doi: 10.1016/j.jnutbio.2009.09.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jnutbio.2009.09.012</ArticleId><ArticleId IdType=\"pmc\">PMC2891903</ArticleId><ArticleId IdType=\"pubmed\">20153625</ArticleId></ArticleIdList></Reference><Reference><Citation>Orteca G., Pisaneschi F., Rubagotti S., Liu T.W., Biagiotti G., Piwnica-Worms D., Iori M., Capponi P.C., Ferrari E., Asti M. Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies. Molecules. 2019;24:644. doi: 10.3390/molecules24030644.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules24030644</ArticleId><ArticleId IdType=\"pmc\">PMC6384893</ArticleId><ArticleId IdType=\"pubmed\">30759785</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu E.K., Choe Y.S., Lee K.H., Choi Y., Kim B.T. Curcumin and dehydrozingerone derivatives: Synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. J. Med. Chem. 2006;49:6111&#x2013;6119. doi: 10.1021/jm0607193.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jm0607193</ArticleId><ArticleId IdType=\"pubmed\">17004725</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007;4:807&#x2013;818. doi: 10.1021/mp700113r.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/mp700113r</ArticleId><ArticleId IdType=\"pubmed\">17999464</ArticleId></ArticleIdList></Reference><Reference><Citation>Elder G.A., Gama Sosa M.A., De Gasperi R. Transgenic mouse models of Alzheimer&#x2019;s disease. Mt. Sinai J. Med. 2010;77:69&#x2013;81. doi: 10.1002/msj.20159.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/msj.20159</ArticleId><ArticleId IdType=\"pmc\">PMC2925685</ArticleId><ArticleId IdType=\"pubmed\">20101721</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S., Koo H.-J., Lee I., Choe Y.S., Choi J.Y., Lee K.-H., Kim B.-T. Synthesis and characterization of 18F-labeled hydrazinocurcumin derivatives for tumor imaging. RSC Adv. 2015;5:96733&#x2013;96745. doi: 10.1039/C5RA15380H.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C5RA15380H</ArticleId></ArticleIdList></Reference><Reference><Citation>Leporini L., Giampietro L., Amoroso R., Ammazzalorso A., Fantacuzzi M., Menghini L., Maccallini C., Ferrante C., Brunetti L., Orlando G., et al. In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on C2C12 and MCF7 cells. J. Biol. Regul. Homeost. Agents. 2017;31:589&#x2013;601.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28889799</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T.H., Lee J., Harmalkar D.S., Kang H., Jin G., Park M.K., Kim M., Yang H.A., Kim J., Kwon S.J., et al. Stilbenoid derivatives as potent inhibitors of HIF-1&#x3b1;-centric cancer metabolism under hypoxia. Biomed. Pharmacother. 2024;176:116838. doi: 10.1016/j.biopha.2024.116838.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2024.116838</ArticleId><ArticleId IdType=\"pubmed\">38820970</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo E.S., Giampietro L., De Filippis B., Balaha M., Ferrone V., Locatelli M., Pietrangelo T., Tartaglia A., Amoroso R., Fulle S. Synthesis and Biological Evaluation of Halogenated E-Stilbenols as Promising Antiaging Agents. Molecules. 2020;25:5770. doi: 10.3390/molecules25235770.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules25235770</ArticleId><ArticleId IdType=\"pmc\">PMC7731283</ArticleId><ArticleId IdType=\"pubmed\">33297520</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoroso R., Leporini L., Cacciatore I., Marinelli L., Ammazzalorso A., Bruno I., De Filippis B., Fantacuzzi M., Maccallini C., Menghini L., et al. Synthesis, Characterization and Evaluation of Gemfibrozil-stilbene Hybrid as Antioxidant Agent. Lett. Drug. Des. Discov. 2018;15:1230&#x2013;1238. doi: 10.2174/1570180815666180321163246.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1570180815666180321163246</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Shang C., Sun C., Wang L. Simultaneously regulating absorption capacities and antioxidant activities of four stilbene derivatives utilizing substitution effect: A theoretical and experimental study against UVB radiation. Spectrochim. Acta A. Mol. Biomol. Spectrosc. 2024;304:123325. doi: 10.1016/j.saa.2023.123325.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.saa.2023.123325</ArticleId><ArticleId IdType=\"pubmed\">37678043</ArticleId></ArticleIdList></Reference><Reference><Citation>Naz R., Saqib F., Awadallah S., Wahid M., Latif M.F., Iqbal I., Mubarak M.S. Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms. Molecules. 2023;28:3996. doi: 10.3390/molecules28103996.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules28103996</ArticleId><ArticleId IdType=\"pmc\">PMC10222362</ArticleId><ArticleId IdType=\"pubmed\">37241737</ArticleId></ArticleIdList></Reference><Reference><Citation>Giampietro L., D&#x2019;Angelo A., Giancristofaro A., Ammazzalorso A., De Filippis B., Di Matteo M., Fantacuzzi M., Linciano P., Maccallini C., Amoroso R. Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPAR&#x3b1; agonistic activity. Med. Chem. 2014;10:59&#x2013;65. doi: 10.2174/157340641001131226123613.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/157340641001131226123613</ArticleId><ArticleId IdType=\"pubmed\">23432317</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S.S., Zheng J.N., Ma X.W., Shen S.Y., Liu X.S., Ma Y.Y., Li Y.K., Miao D., Wang W.G., Gong D.P., et al. Stilbene Derivatives from Bletilla striata and Their Antiviral Activity. Chem. Nat. Compd. 2023;59:621&#x2013;624. doi: 10.1007/s10600-023-04073-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10600-023-04073-w</ArticleId></ArticleIdList></Reference><Reference><Citation>De Angelis M., De Filippis B., Balaha M., Giampietro L., Miteva M.T., De Chiara G., Palamara A.T., Nencioni L., Mollica A. Nitrostilbenes: Synthesis and Biological Evaluation as Potential Anti-Influenza Virus Agents. Pharmaceuticals. 2022;15:1061. doi: 10.3390/ph15091061.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ph15091061</ArticleId><ArticleId IdType=\"pmc\">PMC9505218</ArticleId><ArticleId IdType=\"pubmed\">36145282</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khayri J.M., Mascarenhas R., Harish H.M., Gowda Y., Lakshmaiah V.V., Nagella P., Al-Mssallem M.Q., Alessa F.M., Almaghasla M.I., Rezk A.A. Stilbenes, a Versatile Class of Natural Metabolites for Inflammation-An Overview. Molecules. 2023;28:3786. doi: 10.3390/molecules28093786.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules28093786</ArticleId><ArticleId IdType=\"pmc\">PMC10180133</ArticleId><ArticleId IdType=\"pubmed\">37175197</ArticleId></ArticleIdList></Reference><Reference><Citation>De Filippis B., Ammazzalorso A., Fantacuzzi M., Giampietro L., Maccallini C., Amoroso R. Anticancer Activity of Stilbene-Based Derivatives. Chem. Med. Chem. 2017;12:558&#x2013;570. doi: 10.1002/cmdc.201700045.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cmdc.201700045</ArticleId><ArticleId IdType=\"pubmed\">28266812</ArticleId></ArticleIdList></Reference><Reference><Citation>Giampietro L., Laghezza A., Cerchia C., Florio R., Recinella L., Capone F., Ammazzalorso A., Bruno I., De Filippis B., Fantacuzzi M., et al. Novel Phenyldiazenyl Fibrate Analogues as PPAR &#x3b1;/&#x3b3;/&#x3b4; Pan-Agonists for the Amelioration of Metabolic Syndrome. ACS Med. Chem Lett. 2019;10:545&#x2013;551. doi: 10.1021/acsmedchemlett.8b00574.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsmedchemlett.8b00574</ArticleId><ArticleId IdType=\"pmc\">PMC6466826</ArticleId><ArticleId IdType=\"pubmed\">30996794</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi A., Seyyed Ebrahimi S.S., Golestani A., Meshkani R. Resveratrol Ameliorates Palmitate-Induced Inflammation in Skeletal Muscle Cells by Attenuating Oxidative Stress and JNK/NF-&#x3ba;B Pathway in a SIRT1-Independent Mechanism. J. Cell Biochem. 2017;118:2654&#x2013;2663. doi: 10.1002/jcb.25868.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcb.25868</ArticleId><ArticleId IdType=\"pubmed\">28059488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: Implications for the prevention and therapeutics of Alzheimer&#x2019;s disease. J. Neurochem. 2003;87:172&#x2013;181. doi: 10.1046/j.1471-4159.2003.01976.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1046/j.1471-4159.2003.01976.x</ArticleId><ArticleId IdType=\"pubmed\">12969264</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Lastra C.A., Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: Mechanisms and clinical implications. Pt 5Biochem. Soc. Trans. 2007;35:1156&#x2013;1160. doi: 10.1042/BST0351156.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/BST0351156</ArticleId><ArticleId IdType=\"pubmed\">17956300</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton R.G., Kovoor C., Brown K. Direct molecular targets of resveratrol: Identifying key interactions to unlock complex mechanisms. Ann. N. Y. Acad Sci. 2015;1348:124&#x2013;133. doi: 10.1111/nyas.12796.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/nyas.12796</ArticleId><ArticleId IdType=\"pubmed\">26099829</ArticleId></ArticleIdList></Reference><Reference><Citation>De Filippis B., De Lellis L., Florio R., Ammazzalorso A., Amoia P., Fantacuzzi M., Giampietro L., Maccallini C., Amoroso R., Veschi S., et al. Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs. Med. Chem. Res. 2019;28:984&#x2013;991. doi: 10.1007/s00044-019-02351-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00044-019-02351-3</ArticleId></ArticleIdList></Reference><Reference><Citation>de Medina P., Casper R., Savouret J.F., Poirot M. Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators. J. Med. Chem. 2005;48:287&#x2013;291. doi: 10.1021/jm0498194.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jm0498194</ArticleId><ArticleId IdType=\"pubmed\">15634023</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M., Wang M., Miller K.D., Sledge G.W., Hutchins G.D., Zheng Q.H. Synthesis of radiolabeled stilbene derivatives as new potential PET probes for aryl hydrocarbon receptor in cancers. Bioorg. Med. Chem. Lett. 2006;16:5767&#x2013;5772. doi: 10.1016/j.bmcl.2006.08.088.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bmcl.2006.08.088</ArticleId><ArticleId IdType=\"pubmed\">16950622</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Oya S., Kung M.P., Hou C., Maier D.L., Kung H.F. F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain. Nucl. Med. Biol. 2005;32:799&#x2013;809. doi: 10.1016/j.nucmedbio.2005.06.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nucmedbio.2005.06.001</ArticleId><ArticleId IdType=\"pubmed\">16253804</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabri O., Seibyl J., Rowe C., Barthel H. Beta-amyloid imaging with florbetaben. Clin Transl Imaging. 2015;3:13&#x2013;26. doi: 10.1007/s40336-015-0102-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40336-015-0102-6</ArticleId><ArticleId IdType=\"pmc\">PMC4339690</ArticleId><ArticleId IdType=\"pubmed\">25741488</ArticleId></ArticleIdList></Reference><Reference><Citation>Syed Y.Y., Deeks E. [(18)F]Florbetaben: A review in &#x3b2;-amyloid PET imaging in cognitive impairment. CNS Drugs. 2015;29:605&#x2013;613. doi: 10.1007/s40263-015-0258-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40263-015-0258-7</ArticleId><ArticleId IdType=\"pubmed\">26175116</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto L., Park S.Y., Hatami N., Gulaka P., Vasanawala S., Yohannan T.K., Herfkens R., Witteles R., Iagaru A. 18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition. EJNMMI Res. 2018;8:66. doi: 10.1186/s13550-018-0425-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13550-018-0425-1</ArticleId><ArticleId IdType=\"pmc\">PMC6057864</ArticleId><ArticleId IdType=\"pubmed\">30043115</ArticleId></ArticleIdList></Reference><Reference><Citation>Auvity S., Tonietto M., Caill&#xe9; F., Bodini B., Bottlaender M., Tournier N., Kuhnast B., Stankoff B. Repurposing radiotracers for myelin imaging: A study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB. Eur. J. Nucl. Med. Mol. Imaging. 2020;47:490&#x2013;501. doi: 10.1007/s00259-019-04516-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00259-019-04516-z</ArticleId><ArticleId IdType=\"pubmed\">31686177</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassano Cassano R., Genovesi D., Vergaro G., Giorgetti A., Aimo A., Del Giudice M.L., Galimberti S., Emdin M., Buda G. [18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis. Eur. J. Clin. Investig. 2024:e14270. doi: 10.1111/eci.14270. advance online publication .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/eci.14270</ArticleId><ArticleId IdType=\"pubmed\">39021058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason N.S., Mathis C.A., Klunk W.E. Positron emission tomography radioligands for in vivo imaging of A&#x3b2; plaques. J. Labelled Comp. Radiopharm. 2013;56:89&#x2013;95. doi: 10.1002/jlcr.2989.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jlcr.2989</ArticleId><ArticleId IdType=\"pmc\">PMC4089898</ArticleId><ArticleId IdType=\"pubmed\">24285314</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi L., Chiaravalloti A., Bagni O., Schillaci O. 18F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer&#x2019;s disease. Am. J. Nucl. Med. Mol. Imaging. 2018;8:268&#x2013;281.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6146162</ArticleId><ArticleId IdType=\"pubmed\">30245918</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal P., Singh N., Chaturvedi S., Jyoti A., Mishra A.K., Hazari P.P. Comprehensive review on design perspective of PET ligands based on &#x3b2;-amyloids, tau and neuroinflammation for diagnostic intervention of Alzheimer&#x2019;s disease. Clin. Transl. Imaging. 2021;9:153&#x2013;175. doi: 10.1007/s40336-021-00410-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40336-021-00410-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Datar Y., Clerc O.F., Cuddy S.A.M., Kim S., Taylor A., Neri J.C., Benz D.C., Bianchi G., Yee A.J., Sanchorawala V., et al. Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis. Eur. Heart J. Cardiovasc. Imaging. 2024;25:687&#x2013;697. doi: 10.1093/ehjci/jead350.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ehjci/jead350</ArticleId><ArticleId IdType=\"pmc\">PMC11057921</ArticleId><ArticleId IdType=\"pubmed\">38193678</ArticleId></ArticleIdList></Reference><Reference><Citation>Tago T., Toyohara J., Fujimaki R., Tatsuta M., Song R., Hirano K., Iwai K., Tanaka H. Effects of 18F-fluorinated neopentyl glycol side-chain on the biological characteristics of stilbene amyloid-&#x3b2; PET ligands. Nucl. Med. Biol. 2021;94&#x2013;95:38&#x2013;45. doi: 10.1016/j.nucmedbio.2020.12.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nucmedbio.2020.12.008</ArticleId><ArticleId IdType=\"pubmed\">33493787</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I., Choe Y.S., Choi J.Y., Lee K.H., Kim B.T. Synthesis and evaluation of &#xb9;&#x2078;F-labeled styryltriazole and resveratrol derivatives for &#x3b2;-amyloid plaque imaging. J. Med. Chem. 2012;55:883&#x2013;892. doi: 10.1021/jm201400q.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jm201400q</ArticleId><ArticleId IdType=\"pubmed\">22236086</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor A., Hayne D.J., Lim S., Van Zuylekom J.K., Cullinane C., Roselt P.D., McLean C.A., White J.M., Donnelly P.S. Copper Bis(thiosemicarbazonato)-stilbenyl Complexes That Bind to Amyloid-&#x3b2; Plaques. Inorg. Chem. 2020;59:11658&#x2013;11669. doi: 10.1021/acs.inorgchem.0c01520.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.inorgchem.0c01520</ArticleId><ArticleId IdType=\"pubmed\">32799487</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann B., Bohnenstengel F., Siegmund D., Wajant H., Weber C., Herr I., Debatin K.M., Proksch P., Wirth T. Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells. J. Biol. Chem. 2002;277:44791&#x2013;44800. doi: 10.1074/jbc.M208003200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M208003200</ArticleId><ArticleId IdType=\"pubmed\">12237314</ArticleId></ArticleIdList></Reference><Reference><Citation>Proksch P., Giaisi M., Treiber M.K., Palfi K., Merling A., Spring H., Krammer P.H., Li-Weber M. Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells. J. Immunol. 2005;174:7075&#x2013;7084. doi: 10.4049/jimmunol.174.11.7075.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.174.11.7075</ArticleId><ArticleId IdType=\"pubmed\">15905551</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa G.C., Montagnoli T.L., Da Silva J.S., de Alencar A.K.N., Reina Gamba L.E., Alves B.E.O., da Silva M.M.C., Trachez M.M., do Nascimento J.H.M., Pimentel-Coelho P.M., et al. New Benzofuran N-Acylhydrazone Reduces Cardiovascular Dysfunction in Obese Rats by Blocking TNF-Alpha Synthesis. Drug. Des. Devel. Ther. 2020;14:3337&#x2013;3350. doi: 10.2147/DDDT.S258459.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/DDDT.S258459</ArticleId><ArticleId IdType=\"pmc\">PMC7443037</ArticleId><ArticleId IdType=\"pubmed\">32884238</ArticleId></ArticleIdList></Reference><Reference><Citation>Radadiya A., Shah A. Bioactive benzofuran derivatives: An insight on lead developments, radioligands and advances of the last decade. Eur. J. Med. Chem. 2015;97:356&#x2013;376. doi: 10.1016/j.ejmech.2015.01.021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejmech.2015.01.021</ArticleId><ArticleId IdType=\"pubmed\">25703339</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Ono M., Kimura H., Ueda M., Saji H. Technetium-99m labeled pyridyl benzofuran derivatives as single photon emission computed tomography imaging probes for &#x3b2;-amyloid plaques in Alzheimer&#x2019;s brains. J. Med. Chem. 2012;55:2279&#x2013;2286. doi: 10.1021/jm201513c.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jm201513c</ArticleId><ArticleId IdType=\"pubmed\">22364445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang Y., Li J., Chen X., Fu X., Sun S., Wu Q. Chalcone Derivatives: Role in Anticancer Therapy. Biomolecules. 2021;11:894. doi: 10.3390/biom11060894.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom11060894</ArticleId><ArticleId IdType=\"pmc\">PMC8234180</ArticleId><ArticleId IdType=\"pubmed\">34208562</ArticleId></ArticleIdList></Reference><Reference><Citation>Capponi P.C., Mari M., Ferrari E., Asti M. Radiolabeled Chalcone Derivatives as Potential Radiotracers for &#x3b2;-Amyloid Plaques Imaging. Molecules. 2023;28:3233. doi: 10.3390/molecules28073233.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules28073233</ArticleId><ArticleId IdType=\"pmc\">PMC10096019</ArticleId><ArticleId IdType=\"pubmed\">37049995</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F., Huang G., Xiao J. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship. Med. Res. Rev. 2020;40:2049&#x2013;2084. doi: 10.1002/med.21698.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/med.21698</ArticleId><ArticleId IdType=\"pubmed\">32525247</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahapatra D.K., Bharti S.K., Asati V. Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives. Curr. Top. Med. Chem. 2017;17:3146&#x2013;3169. doi: 10.2174/1568026617666170914160446.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1568026617666170914160446</ArticleId><ArticleId IdType=\"pubmed\">28914193</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha S., Ribeiro D., Fernandes E., Freitas M. A Systematic Review on Anti-diabetic Properties of Chalcones. Curr. Med. Chem. 2020;27:2257&#x2013;2321. doi: 10.2174/0929867325666181001112226.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/0929867325666181001112226</ArticleId><ArticleId IdType=\"pubmed\">30277140</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Chen M., Chen W., Hui J., Ji J., Hu S., Zhou J., Wang Y., Liang G. Chemopreventive effect of chalcone derivative, L2H17, in colon cancer development. BMC Cancer. 2015;15:870. doi: 10.1186/s12885-015-1901-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12885-015-1901-x</ArticleId><ArticleId IdType=\"pmc\">PMC4638100</ArticleId><ArticleId IdType=\"pubmed\">26552551</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Zhang M., Lu Q., Xie J., Wu J., Chen C. A novel chalcone derivative exerts anti-inflammatory and anti-oxidant effects after acute lung injury. Aging. 2019;11:7805&#x2013;7816. doi: 10.18632/aging.102288.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/aging.102288</ArticleId><ArticleId IdType=\"pmc\">PMC6781971</ArticleId><ArticleId IdType=\"pubmed\">31553308</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry E.J., Bird S.J., Gowland P., Collins M., Cassella J.P. Ferrocenyl chalcone derivatives as possible antimicrobial agents. J. Antibiot. 2020;73:299&#x2013;308. doi: 10.1038/s41429-020-0280-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41429-020-0280-y</ArticleId><ArticleId IdType=\"pubmed\">31988484</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mello M.V.P., Abrahim-Vieira B.A., Domingos T.F.S., de Jesus J.B., de Sousa A.C.C., Rodrigues C.R., Souza A.M.T. A comprehensive review of chalcone derivatives as antileishmanial agents. Eur. J. Med. Chem. 2018;150:920&#x2013;929. doi: 10.1016/j.ejmech.2018.03.047.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejmech.2018.03.047</ArticleId><ArticleId IdType=\"pubmed\">29602038</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng P., Yang L., Huang X., Wang X., Gong M. Chalcone hybrids and their antimalarial activity. Arch. Pharm. 2020;353:e1900350. doi: 10.1002/ardp.201900350.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ardp.201900350</ArticleId><ArticleId IdType=\"pubmed\">32003489</ArticleId></ArticleIdList></Reference><Reference><Citation>Giampietro L., D&#x2019;Angelo A., Giancristofaro A., Ammazzalorso A., De Filippis B., Fantacuzzi M., Linciano P., Maccallini C., Amoroso R. Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs. Bioorg. Med. Chem. Lett. 2012;22:7662&#x2013;7666. doi: 10.1016/j.bmcl.2012.09.111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bmcl.2012.09.111</ArticleId><ArticleId IdType=\"pubmed\">23102891</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazumder R., Ichudaule Ghosh A., Deb S., Ghosh R. Significance of Chalcone Scaffolds in Medicinal Chemistry. Top. Curr. Chem. 2024;382:22. doi: 10.1007/s41061-024-00468-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s41061-024-00468-7</ArticleId><ArticleId IdType=\"pubmed\">38937401</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapa P., Upadhyay S.P., Suo W.Z., Singh V., Gurung P., Lee E.S., Sharma R., Sharma M. Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer&#x2019;s disease. Bioorg. Chem. 2021;108:104681. doi: 10.1016/j.bioorg.2021.104681.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bioorg.2021.104681</ArticleId><ArticleId IdType=\"pmc\">PMC7928223</ArticleId><ArticleId IdType=\"pubmed\">33571811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono M., Ikeoka R., Watanabe H., Kimura H., Fuchigami T., Haratake M., Saji H., Nakayama M. Synthesis and evaluation of novel chalcone derivatives with (99m)Tc/Re complexes as potential probes for detection of &#x3b2;-amyloid plaques. ACS Chem. Neurosci. 2010;1:598&#x2013;607. doi: 10.1021/cn100042d.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/cn100042d</ArticleId><ArticleId IdType=\"pmc\">PMC3368688</ArticleId><ArticleId IdType=\"pubmed\">22778849</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Cui M., Dai J., Wang X., Yu P., Yang Y., Jia J., Fu H., Ono M., Jia H., et al. Novel cyclopentadienyl tricarbonyl complexes of (99m)Tc mimicking chalcone as potential single-photon emission computed tomography imaging probes for &#x3b2;-amyloid plaques in brain. J. Med. Chem. 2013;56:471&#x2013;482. doi: 10.1021/jm3014184.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jm3014184</ArticleId><ArticleId IdType=\"pubmed\">23240831</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Gui Y., Chen L., Yuan G., Lu H.Z., Xu X. Use of natural products as chemical library for drug discovery and network pharmacology. PLoS ONE. 2013;8:e62839. doi: 10.1371/journal.pone.0062839.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0062839</ArticleId><ArticleId IdType=\"pmc\">PMC3636197</ArticleId><ArticleId IdType=\"pubmed\">23638153</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39275022</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1420-3049</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>29</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Pomegranate (<i>Punica granatum</i> L.) Extract Effects on Inflammaging.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">4174</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/molecules29174174</ELocationID><Abstract><AbstractText>Pomegranate is a notable source of nutrients, containing a considerable proportion of organic acids, polysaccharides, vitamins, fatty acids, and polyphenols such as flavonoids, phenolic acids, and tannins. It is also rich in nutritionally important minerals and chemical elements such as K, P, Na, Ca, Mg, and N. The presence of several bioactive compounds and metabolites in pomegranate has led to its incorporation into the functional food category, where it is used for its numerous therapeutic properties. Pomegranate's bioactive compounds have shown antioxidant, anti-inflammatory, and anticancer effects. Aging is a process characterized by the chronic accumulation of damages, progressively compromising cells, tissues, and organs over time. Inflammaging is a chronic, subclinical, low-grade inflammation that occurs during the aging process and is linked to many age-related diseases. This review aims to summarize and discuss the evidence of the benefits of pomegranate extract and its compounds to slow the aging processes by intervening in the mechanisms underlying inflammaging. These studies mainly concern neurodegenerative and skin diseases, while studies in other fields of application need to be more practical. Furthermore, no human studies have demonstrated the anti-inflammaging effects of pomegranate. In the future, supplementation with pomegranate extracts, polyphenols, or urolithins could represent a valuable low-risk complementary therapy for patients with difficult-to-manage diseases, as well as a valid therapeutic alternative for the topical or systemic treatment of skin pathologies.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Cordiano</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0002-1061-6883</Identifier><AffiliationInfo><Affiliation>Unit and School of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gammeri</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit and School of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Di Salvo</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Dental Science and Morphofunctional Imaging, University of Messina, 98125 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gangemi</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit and School of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Minciullo</LastName><ForeName>Paola Lucia</ForeName><Initials>PL</Initials><Identifier Source=\"ORCID\">0000-0002-3010-3815</Identifier><AffiliationInfo><Affiliation>Unit and School of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D010936\">Plant Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000893\">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000975\">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D059808\">Polyphenols</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000079702\" MajorTopicYN=\"Y\">Pomegranate</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010936\" MajorTopicYN=\"Y\">Plant Extracts</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000893\" MajorTopicYN=\"Y\">Anti-Inflammatory Agents</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007249\" MajorTopicYN=\"Y\">Inflammation</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000375\" MajorTopicYN=\"N\">Aging</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000975\" MajorTopicYN=\"N\">Antioxidants</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D059808\" MajorTopicYN=\"N\">Polyphenols</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D029561\" MajorTopicYN=\"N\">Lythraceae</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">aging</Keyword><Keyword MajorTopicYN=\"N\">central nervous system</Keyword><Keyword MajorTopicYN=\"N\">inflammaging</Keyword><Keyword MajorTopicYN=\"N\">inflammation</Keyword><Keyword MajorTopicYN=\"N\">nutraceutical</Keyword><Keyword MajorTopicYN=\"N\">oxidative stress</Keyword><Keyword MajorTopicYN=\"N\">pomegranate</Keyword><Keyword MajorTopicYN=\"N\">skin</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39275022</ArticleId><ArticleId IdType=\"doi\">10.3390/molecules29174174</ArticleId><ArticleId IdType=\"pii\">molecules29174174</ArticleId><ArticleId IdType=\"pmc\">PMC11396831</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Viuda-Martos M., Fern&#xe1;ndez-L&#xf3;pez J., P&#xe9;rez-&#xc1;lvarez J.A. Pomegranate and Its Many Functional Components as Related to Human Health: A Review. Compr. Rev. Food Sci. Food Saf. 2010;9:635&#x2013;654. doi: 10.1111/j.1541-4337.2010.00131.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1541-4337.2010.00131.x</ArticleId><ArticleId IdType=\"pubmed\">33467822</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sadi A.M., AL-Fahdi A.R., Al-Yahyai R.A., Al-Ghaithi A.G., Al-Said F.A., Soleiman M.J. Genetic Analysis Suggests a Shared Origin of Punica granatum Cultivars in Oman with Cultivars from the Center of Origin, Iran. Genet. Resour. Crop Evol. 2015;62:815&#x2013;821. doi: 10.1007/s10722-015-0256-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10722-015-0256-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo Y., Ma J., Gao W., Zhang L., Li J., Li J., Zang J. Pomegranate Peel as a Source of Bioactive Compounds: A Mini Review on Their Physiological Functions. Front. Nutr. 2022;9:887113. doi: 10.3389/fnut.2022.887113.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnut.2022.887113</ArticleId><ArticleId IdType=\"pmc\">PMC9218663</ArticleId><ArticleId IdType=\"pubmed\">35757262</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhumal S.S., Karale A., Jadhav S.B., Kad V.P. Recent Advances and the Developments in the Pomegranate Processing and Utilization: A Review. J. Agric. Crop Sci. 2012;1:1&#x2013;17.</Citation></Reference><Reference><Citation>Singh B., Singh J.P., Kaur A., Singh N. Phenolic Compounds as Beneficial Phytochemicals in Pomegranate (Punica granatum L.) Peel: A Review. Food Chem. 2018;261:75&#x2013;86. doi: 10.1016/j.foodchem.2018.04.039.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.foodchem.2018.04.039</ArticleId><ArticleId IdType=\"pubmed\">29739608</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Hadary A.E., Ramadan M.F. Phenolic Profiles, Antihyperglycemic, Antihyperlipidemic, and Antioxidant Properties of Pomegranate (Punica granatum) Peel Extract. J. Food Biochem. 2019;43:e12803. doi: 10.1111/jfbc.12803.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jfbc.12803</ArticleId><ArticleId IdType=\"pubmed\">31353600</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfalleh W., Tlili N., Nasri N., Yahia Y., Hannachi H., Chaira N., Ying M., Ferchichi A. Antioxidant Capacities of Phenolic Compounds and Tocopherols from Tunisian Pomegranate (Punica granatum) Fruits. J. Food Sci. 2011;76:C707&#x2013;C713. doi: 10.1111/j.1750-3841.2011.02179.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1750-3841.2011.02179.x</ArticleId><ArticleId IdType=\"pubmed\">22417416</ArticleId></ArticleIdList></Reference><Reference><Citation>Valero-Mendoza A.G., Mel&#xe9;ndez-Renter&#xed;a N.P., Ch&#xe1;vez-Gonz&#xe1;lez M.L., Flores-Gallegos A.C., Wong-Paz J.E., Govea-Salas M., Zugasti-Cruz A., Ascacio-Vald&#xe9;s J.A. The Whole Pomegranate (Punica granatum. L), Biological Properties and Important Findings: A Review. Food Chem. Adv. 2023;2:100153. doi: 10.1016/j.focha.2022.100153.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.focha.2022.100153</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Tian L. Diverse Phytochemicals and Bioactivities in the Ancient Fruit and Modern Functional Food Pomegranate (Punica granatum) Molecules. 2017;22:1606. doi: 10.3390/molecules22101606.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules22101606</ArticleId><ArticleId IdType=\"pmc\">PMC6151597</ArticleId><ArticleId IdType=\"pubmed\">28946708</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain T., Tan B., Yin Y., Blachier F., Tossou M.C.B., Rahu N. Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? Oxid. Med. Cell Longev. 2016;2016:7432797. doi: 10.1155/2016/7432797.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2016/7432797</ArticleId><ArticleId IdType=\"pmc\">PMC5055983</ArticleId><ArticleId IdType=\"pubmed\">27738491</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Cao K., Liu X., Zhao L., Feng Z., Liu J. Punicalagin Regulates Signaling Pathways in Inflammation-Associated Chronic Diseases. Antioxidants. 2021;11:29. doi: 10.3390/antiox11010029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox11010029</ArticleId><ArticleId IdType=\"pmc\">PMC8773334</ArticleId><ArticleId IdType=\"pubmed\">35052533</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Ding K., Qiao Y., Zhang L., Zheng L., Pan T., Zhang L. Flavonoids Regulate Inflammation and Oxidative Stress in Cancer. Molecules. 2020;25:5628. doi: 10.3390/molecules25235628.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules25235628</ArticleId><ArticleId IdType=\"pmc\">PMC7729519</ArticleId><ArticleId IdType=\"pubmed\">33265939</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu&#x10d;i&#x107; V., Grabe&#x17e; M., Trchounian A., Arsi&#x107; A. Composition and Potential Health Benefits of Pomegranate: A Review. Curr. Pharm. Des. 2019;25:1817&#x2013;1827. doi: 10.2174/1381612825666190708183941.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1381612825666190708183941</ArticleId><ArticleId IdType=\"pubmed\">31298147</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin D.J. Introduction to Skin Aging. J. Tissue Viability. 2017;26:37&#x2013;46. doi: 10.1016/j.jtv.2016.03.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jtv.2016.03.002</ArticleId><ArticleId IdType=\"pubmed\">27020864</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert L., Labat-Robert J., Robert A.-M. Physiology of Skin Aging. Pathol. Biol. 2009;57:336&#x2013;341. doi: 10.1016/j.patbio.2008.09.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.patbio.2008.09.007</ArticleId><ArticleId IdType=\"pubmed\">19046830</ArticleId></ArticleIdList></Reference><Reference><Citation>Farage M.A., Miller K.W., Elsner P., Maibach H.I. Intrinsic and Extrinsic Factors in Skin Ageing: A Review. Int. J. Cosmet. Sci. 2008;30:87&#x2013;95. doi: 10.1111/j.1468-2494.2007.00415.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1468-2494.2007.00415.x</ArticleId><ArticleId IdType=\"pubmed\">18377617</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C. Cell Proliferation, Cell Death and Aging. Aging Clin. Exp. Res. 1989;1:3&#x2013;15. doi: 10.1007/BF03323871.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/BF03323871</ArticleId><ArticleId IdType=\"pubmed\">2488297</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., et al. Inflammaging and Anti-Inflammaging: A Systemic Perspective on Aging and Longevity Emerged from Studies in Humans. Mech. Ageing Dev. 2007;128:92&#x2013;105. doi: 10.1016/j.mad.2006.11.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mad.2006.11.016</ArticleId><ArticleId IdType=\"pubmed\">17116321</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Bonaf&#xe8; M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-Aging. An Evolutionary Perspective on Immunosenescence. Ann. N. Y. Acad. Sci. 2000;908:244&#x2013;254. doi: 10.1111/j.1749-6632.2000.tb06651.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1749-6632.2000.tb06651.x</ArticleId><ArticleId IdType=\"pubmed\">10911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Salminen A., Huuskonen J., Ojala J., Kauppinen A., Kaarniranta K., Suuronen T. Activation of Innate Immunity System during Aging: NF-KB Signaling Is the Molecular Culprit of Inflamm-Aging. Ageing Res. Rev. 2008;7:83&#x2013;105. doi: 10.1016/j.arr.2007.09.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2007.09.002</ArticleId><ArticleId IdType=\"pubmed\">17964225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo L., Prather E.R., Stetskiv M., Garrison D.E., Meade J.R., Peace T.I., Zhou T. Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments. Int. J. Mol. Sci. 2019;20:4472. doi: 10.3390/ijms20184472.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms20184472</ArticleId><ArticleId IdType=\"pmc\">PMC6769561</ArticleId><ArticleId IdType=\"pubmed\">31510091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang Y., Lyga J. Inflammaging in Skin and Other Tissues&#x2014;The Roles of Complement System and Macrophage. Inflamm. Allergy Drug Targets. 2014;13:153&#x2013;161. doi: 10.2174/1871528113666140522112003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1871528113666140522112003</ArticleId><ArticleId IdType=\"pmc\">PMC4082166</ArticleId><ArticleId IdType=\"pubmed\">24853681</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque A., Woolery-Lloyd H. Inflammaging in Dermatology: A New Frontier for Research. J. Drugs Dermatol. 2021;20:144&#x2013;149. doi: 10.36849/JDD.5481.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.36849/JDD.5481</ArticleId><ArticleId IdType=\"pubmed\">33538570</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevenini E., Monti D., Franceschi C. Inflamm-Ageing. Curr. Opin. Clin. Nutr. Metab. Care. 2013;16:14&#x2013;20. doi: 10.1097/MCO.0b013e32835ada13.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MCO.0b013e32835ada13</ArticleId><ArticleId IdType=\"pubmed\">23132168</ArticleId></ArticleIdList></Reference><Reference><Citation>Maphetu N., Unuofin J.O., Masuku N.P., Olisah C., Lebelo S.L. Medicinal Uses, Pharmacological Activities, Phytochemistry, and the Molecular Mechanisms of Punica granatum L. (Pomegranate) Plant Extracts: A Review. Biomed. Pharmacother. [Biomed. Pharmacother.] 2022;153:113256. doi: 10.1016/j.biopha.2022.113256.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2022.113256</ArticleId><ArticleId IdType=\"pubmed\">36076615</ArticleId></ArticleIdList></Reference><Reference><Citation>Akaberi M., Boghrati Z., Sahebkar A., Emami S.A. Natural Products and Human Diseases. Springer International Publishing; Cham, Switzerland: 2021. Therapeutic Potential of Pomegranate in Metabolic Disorders; pp. 421&#x2013;440. (Advances in experimental medicine and biology).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34981494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaemi F., Emadzadeh M., Atkin S.L., Jamialahmadi T., Zengin G., Sahebkar A. Impact of Pomegranate Juice on Blood Pressure: A Systematic Review and Meta-Analysis. Phytother. Res. 2023;37:4429&#x2013;4441. doi: 10.1002/ptr.7952.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ptr.7952</ArticleId><ArticleId IdType=\"pubmed\">37461211</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dujaili E.A.S., Casey C., Stockton A. Antioxidant Properties and Beneficial Cardiovascular Effects of a Natural Extract of Pomegranate in Healthy Volunteers: A Randomized Preliminary Single-Blind Controlled Study. Antioxidants. 2022;11:2124. doi: 10.3390/antiox11112124.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox11112124</ArticleId><ArticleId IdType=\"pmc\">PMC9686489</ArticleId><ArticleId IdType=\"pubmed\">36358496</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P., McClees S., Afaq F. Pomegranate for Prevention and Treatment of Cancer: An Update. Molecules. 2017;22:177. doi: 10.3390/molecules22010177.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules22010177</ArticleId><ArticleId IdType=\"pmc\">PMC5560105</ArticleId><ArticleId IdType=\"pubmed\">28125044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Martins-Green M. Pomegranate and Its Components as Alternative Treatment for Prostate Cancer. Int. J. Mol. Sci. 2014;15:14949&#x2013;14966. doi: 10.3390/ijms150914949.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms150914949</ArticleId><ArticleId IdType=\"pmc\">PMC4200766</ArticleId><ArticleId IdType=\"pubmed\">25158234</ArticleId></ArticleIdList></Reference><Reference><Citation>Eghbali S., Askari S.F., Avan R., Sahebkar A. Therapeutic Effects of Punica granatum (Pomegranate): An Updated Review of Clinical Trials. J. Nutr. Metab. 2021;2021:5297162. doi: 10.1155/2021/5297162.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2021/5297162</ArticleId><ArticleId IdType=\"pmc\">PMC8595036</ArticleId><ArticleId IdType=\"pubmed\">34796029</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudrapal M., Khairnar S.J., Khan J., Dukhyil A.B., Ansari M.A., Alomary M.N., Alshabrmi F.M., Palai S., Deb P.K., Devi R. Dietary Polyphenols and Their Role in Oxidative Stress-Induced Human Diseases: Insights into Protective Effects, Antioxidant Potentials and Mechanism(s) of Action. Front. Pharmacol. 2022;13:806470. doi: 10.3389/fphar.2022.806470.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2022.806470</ArticleId><ArticleId IdType=\"pmc\">PMC8882865</ArticleId><ArticleId IdType=\"pubmed\">35237163</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana A., Samtiya M., Dhewa T., Mishra V., Aluko R.E. Health Benefits of Polyphenols: A Concise Review. J. Food Biochem. 2022;46:e14264. doi: 10.1111/jfbc.14264.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jfbc.14264</ArticleId><ArticleId IdType=\"pubmed\">35694805</ArticleId></ArticleIdList></Reference><Reference><Citation>Cory H., Passarelli S., Szeto J., Tamez M., Mattei J. The Role of Polyphenols in Human Health and Food Systems: A Mini-Review. Front. Nutr. 2018;5:87. doi: 10.3389/fnut.2018.00087.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnut.2018.00087</ArticleId><ArticleId IdType=\"pmc\">PMC6160559</ArticleId><ArticleId IdType=\"pubmed\">30298133</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez R., Ballester I., L&#xf3;pez-Posadas R., Su&#xe1;rez M.D., Zarzuelo A., Mart&#xed;nez-Augustin O., S&#xe1;nchez de Medina F. Effects of Flavonoids and Other Polyphenols on Inflammation. Crit. Rev. Food Sci. Nutr. 2011;51:331&#x2013;362. doi: 10.1080/10408390903584094.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10408390903584094</ArticleId><ArticleId IdType=\"pubmed\">21432698</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M., Luo Q., Nie R., Yang X., Tang Z., Chen H. Potential Implications of Polyphenols on Aging Considering Oxidative Stress, Inflammation, Autophagy, and Gut Microbiota. Crit. Rev. Food Sci. Nutr. 2021;61:2175&#x2013;2193. doi: 10.1080/10408398.2020.1773390.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10408398.2020.1773390</ArticleId><ArticleId IdType=\"pubmed\">32496818</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronado-Reyes J.A., Cort&#xe9;s-Penagos C.d.J., Gonz&#xe1;lez-Hern&#xe1;ndez J.C. Chemical Composition and Great Applications to the Fruit of the Pomegranate (Punica granatum): A Review. Food Sci. Technol. 2021;42:e29420. doi: 10.1590/fst.29420.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1590/fst.29420</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini E., D&#x2019;Angelo C., Reale M. The Role of Immunosenescence in Neurodegenerative Diseases. Mediators Inflamm. 2018;2018:6039171. doi: 10.1155/2018/6039171.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2018/6039171</ArticleId><ArticleId IdType=\"pmc\">PMC5863336</ArticleId><ArticleId IdType=\"pubmed\">29706800</ArticleId></ArticleIdList></Reference><Reference><Citation>Richartz E., Stransky E., Batra A., Simon P., Lewczuk P., Buchkremer G., Bartels M., Schott K. Decline of Immune Responsiveness: A Pathogenetic Factor in Alzheimer&#x2019;s Disease? J. Psychiatr. Res. 2005;39:535&#x2013;543. doi: 10.1016/j.jpsychires.2004.12.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jpsychires.2004.12.005</ArticleId><ArticleId IdType=\"pubmed\">15992563</ArticleId></ArticleIdList></Reference><Reference><Citation>Emami Kazemabad M.J., Asgari Toni S., Tizro N., Dadkhah P.A., Amani H., Akhavan Rezayat S., Sheikh Z., Mohammadi M., Alijanzadeh D., Alimohammadi F., et al. Pharmacotherapeutic Potential of Pomegranate in Age-Related Neurological Disorders. Front. Aging Neurosci. 2022;14:955735. doi: 10.3389/fnagi.2022.955735.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.955735</ArticleId><ArticleId IdType=\"pmc\">PMC9476556</ArticleId><ArticleId IdType=\"pubmed\">36118710</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehdi A., Lamiae B., Samira B., Ramchoun M., Abdelouahed K., Tamas F., Hicham B. Pomegranate (Punica granatum L.) Attenuates Neuroinflammation Involved in Neurodegenerative Diseases. Foods. 2022;11:2570. doi: 10.3390/foods11172570.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/foods11172570</ArticleId><ArticleId IdType=\"pmc\">PMC9455244</ArticleId><ArticleId IdType=\"pubmed\">36076756</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S., Barve K.H., Kumar M.S. Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer&#x2019;s Disease. Curr. Neuropharmacol. 2020;18:1106&#x2013;1125. doi: 10.2174/1570159X18666200528142429.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1570159X18666200528142429</ArticleId><ArticleId IdType=\"pmc\">PMC7709159</ArticleId><ArticleId IdType=\"pubmed\">32484110</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari S., Atluri V., Kaushik A., Yndart A., Nair M. Alzheimer&#x2019;s Disease: Pathogenesis, Diagnostics, and Therapeutics. Int. J. Nanomedicine. 2019;14:5541&#x2013;5554. doi: 10.2147/IJN.S200490.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/IJN.S200490</ArticleId><ArticleId IdType=\"pmc\">PMC6650620</ArticleId><ArticleId IdType=\"pubmed\">31410002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney J.W., Bemiller S.M., Murtishaw A.S., Leisgang A.M., Salazar A.M., Lamb B.T. Inflammation as a Central Mechanism in Alzheimer&#x2019;s Disease. Alzheimer&#x2019;s Dement. 2018;4:575&#x2013;590. doi: 10.1016/j.trci.2018.06.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.trci.2018.06.014</ArticleId><ArticleId IdType=\"pmc\">PMC6214864</ArticleId><ArticleId IdType=\"pubmed\">30406177</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss D.E. Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer&#x2019;s Disease: Are Irreversible Inhibitors the Future? Int. J. Mol. Sci. 2020;21:3438. doi: 10.3390/ijms21103438.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21103438</ArticleId><ArticleId IdType=\"pmc\">PMC7279429</ArticleId><ArticleId IdType=\"pubmed\">32414155</ArticleId></ArticleIdList></Reference><Reference><Citation>Cioffi F., Adam R.H.I., Broersen K. Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2019;72:981&#x2013;1017. doi: 10.3233/JAD-190863.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-190863</ArticleId><ArticleId IdType=\"pmc\">PMC6971833</ArticleId><ArticleId IdType=\"pubmed\">31744008</ArticleId></ArticleIdList></Reference><Reference><Citation>George N., AbuKhader M., Al Balushi K., Al Sabahi B., Khan S.A. An Insight into the Neuroprotective Effects and Molecular Targets of Pomegranate (Punica granatum) against Alzheimer&#x2019;s Disease. Nutr. Neurosci. 2023;26:975&#x2013;996. doi: 10.1080/1028415X.2022.2121092.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/1028415X.2022.2121092</ArticleId><ArticleId IdType=\"pubmed\">36125072</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.J., Lee J.-H., Heo H.J., Cho H.Y., Kim H.K., Kim C.-J., Kim M.O., Suh S.H., Shin D.-H. Punica granatum Protects against Oxidative Stress in PC12 Cells and Oxidative Stress-Induced Alzheimer&#x2019;s Symptoms in Mice. J. Med. Food. 2011;14:695&#x2013;701. doi: 10.1089/jmf.2010.1452.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/jmf.2010.1452</ArticleId><ArticleId IdType=\"pubmed\">21631359</ArticleId></ArticleIdList></Reference><Reference><Citation>Velagapudi R., Baco G., Khela S., Okorji U., Olajide O. Pomegranate Inhibits Neuroinflammation and Amyloidogenesis in IL-1&#x3b2;-stimulated SK-N-SH cells. Eur. J. Nutr. 2016;55:1653&#x2013;1660. doi: 10.1007/s00394-015-0984-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00394-015-0984-0</ArticleId><ArticleId IdType=\"pubmed\">26155780</ArticleId></ArticleIdList></Reference><Reference><Citation>Essa M.M., Subash S., Akbar M., Al-Adawi S., Guillemin G.J. Long-Term Dietary Supplementation of Pomegranates, Figs and Dates Alleviate Neuroinflammation in a Transgenic Mouse Model of Alzheimer&#x2019;s Disease. PLoS ONE. 2015;10:e0120964. doi: 10.1371/journal.pone.0120964.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0120964</ArticleId><ArticleId IdType=\"pmc\">PMC4373715</ArticleId><ArticleId IdType=\"pubmed\">25807081</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Maheshwari K., Singh V. Protective Effects of Punica granatum Seeds Extract against Aging and Scopolamine Induced Cognitive Impairments in Mice. Afr. J. Tradit. Complement. Altern. Med. 2010;6:49&#x2013;56. doi: 10.4314/ajtcam.v6i1.57073.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4314/ajtcam.v6i1.57073</ArticleId><ArticleId IdType=\"pmc\">PMC2816527</ArticleId><ArticleId IdType=\"pubmed\">20162041</ArticleId></ArticleIdList></Reference><Reference><Citation>Subash S., Essa M.M., Al-Asmi A., Al-Adawi S., Vaishnav R., Braidy N., Manivasagam T., Guillemin G.J. Pomegranate from Oman Alleviates the Brain Oxidative Damage in Transgenic Mouse Model of Alzheimer&#x2019;s Disease. J. Tradit. Complement. Med. 2014;4:232&#x2013;238. doi: 10.4103/2225-4110.139107.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/2225-4110.139107</ArticleId><ArticleId IdType=\"pmc\">PMC4220500</ArticleId><ArticleId IdType=\"pubmed\">25379464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A.H., Subaiea G.M., Eid A., Li L., Seeram N.P., Zawia N.H. Pomegranate Extract Modulates Processing of Amyloid-&#x3b2; Precursor Protein in an Aged Alzheimer&#x2019;s Disease Animal Model. Curr. Alzheimer Res. 2014;11:834&#x2013;843. doi: 10.2174/1567205011666141001115348.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567205011666141001115348</ArticleId><ArticleId IdType=\"pubmed\">25274111</ArticleId></ArticleIdList></Reference><Reference><Citation>Braidy N., Essa M.M., Poljak A., Selvaraju S., Al-Adawi S., Manivasagm T., Thenmozhi A.J., Ooi L., Sachdev P., Guillemin G.J. Consumption of Pomegranates Improves Synaptic Function in a Transgenic Mice Model of Alzheimer&#x2019;s Disease. Oncotarget. 2016;7:64589&#x2013;64604. doi: 10.18632/oncotarget.10905.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.10905</ArticleId><ArticleId IdType=\"pmc\">PMC5323101</ArticleId><ArticleId IdType=\"pubmed\">27486879</ArticleId></ArticleIdList></Reference><Reference><Citation>Morzelle M.C., Salgado J.M., Telles M., Mourelle D., Bachiega P., Buck H.S., Viel T.A. Neuroprotective Effects of Pomegranate Peel Extract after Chronic Infusion with Amyloid-&#x3b2; Peptide in Mice. PLoS ONE. 2016;11:e0166123. doi: 10.1371/journal.pone.0166123.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0166123</ArticleId><ArticleId IdType=\"pmc\">PMC5102433</ArticleId><ArticleId IdType=\"pubmed\">27829013</ArticleId></ArticleIdList></Reference><Reference><Citation>Almuhayawi M.S., Ramadan W.S., Harakeh S., Al Jaouni S.K., Bharali D.J., Mousa S.A., Almuhayawi S.M. The Potential Role of Pomegranate and Its Nano-Formulations on Cerebral Neurons in Aluminum Chloride Induced Alzheimer Rat Model. Saudi J. Biol. Sci. 2020;27:1710&#x2013;1716. doi: 10.1016/j.sjbs.2020.04.045.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.sjbs.2020.04.045</ArticleId><ArticleId IdType=\"pmc\">PMC7296487</ArticleId><ArticleId IdType=\"pubmed\">32565686</ArticleId></ArticleIdList></Reference><Reference><Citation>Khokar R., Hachani K., Hasan M., Othmani F., Essam M., Al Mamari A., Um D., Khan S.A. Anti-Alzheimer Potential of a Waste by-Product (Peel) of Omani Pomegranate Fruits: Quantification of Phenolic Compounds, in-Vitro Antioxidant, Anti-Cholinesterase and in-Silico Studies. Biocatal. Agric. Biotechnol. 2021;38:102223. doi: 10.1016/j.bcab.2021.102223.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bcab.2021.102223</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagecili H., &#x130;zol E., Kirecci E., Gulcin &#x130;. Determination of Antioxidant, Anti-Alzheimer, Antidiabetic, Antiglaucoma and Antimicrobial Effects of Zivzik Pomegranate (Punica granatum)-A Chemical Profiling by LC-MS/MS. Life. 2023;13:735. doi: 10.3390/life13030735.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/life13030735</ArticleId><ArticleId IdType=\"pmc\">PMC10058309</ArticleId><ArticleId IdType=\"pubmed\">36983890</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousof Ali M., Zaib S., Jannat S., Khan I. Discovery of Potent and Selective Dual Cholinesterases and &#x3b2;-Secretase Inhibitors in Pomegranate as a Treatment for Alzheimer&#x2019;s Disease. Bioorg. Chem. 2022;129:106137. doi: 10.1016/j.bioorg.2022.106137.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bioorg.2022.106137</ArticleId><ArticleId IdType=\"pubmed\">36108590</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojanathammanee L., Puig K.L., Combs C.K. Pomegranate Polyphenols and Extract Inhibit Nuclear Factor of Activated. J. Nutr. 2013;143:597&#x2013;605. doi: 10.3945/jn.112.169516.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3945/jn.112.169516</ArticleId><ArticleId IdType=\"pmc\">PMC3738232</ArticleId><ArticleId IdType=\"pubmed\">23468550</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.W., Lee Y.K., Yuk D.Y., Choi D.Y., Ban S.B., Oh K.W., Hong J.T. Neuro-Inflammation Induced by Lipopolysaccharide Causes Cognitive Impairment through Enhancement of Beta-Amyloid Generation. J. Neuroinflamm. 2008;5:37. doi: 10.1186/1742-2094-5-37.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1742-2094-5-37</ArticleId><ArticleId IdType=\"pmc\">PMC2556656</ArticleId><ArticleId IdType=\"pubmed\">18759972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.E., Hwang C.J., Lee H.P., Kim C.S., Son D.J., Ham Y.W., Hellstr&#xf6;m M., Han S.-B., Kim H.S., Park E.K., et al. Inhibitory Effect of Punicalagin on Lipopolysaccharide-Induced Neuroinflammation, Oxidative Stress and Memory Impairment via Inhibition of Nuclear Factor-KappaB. Neuropharmacology. 2017;117:21&#x2013;32. doi: 10.1016/j.neuropharm.2017.01.025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuropharm.2017.01.025</ArticleId><ArticleId IdType=\"pubmed\">28132781</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Chen F., Lei J., Zhou B. Pomegranate Polyphenol Punicalagin Improves Learning Memory Deficits, Redox Homeostasis, and Neuroinflammation in Aging Mice. Phytother. Res. 2023;37:3655&#x2013;3674. doi: 10.1002/ptr.7848.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ptr.7848</ArticleId><ArticleId IdType=\"pubmed\">37092799</ArticleId></ArticleIdList></Reference><Reference><Citation>Clementi M.E., Sampaolese B., Lazzarino G., Giardina B. Effect of Punicalagin and Resveratrol on Methionine Sulfoxide Reductase: A Possible Protective Contribution against Alzheimer&#x2019;s Disease. J. Prev. Alzheimer&#x2019;s Dis. 2015;2:33&#x2013;37. doi: 10.14283/jpad.2015.40.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14283/jpad.2015.40</ArticleId><ArticleId IdType=\"pubmed\">29234773</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskovitz J., Du F., Bowman C.F., Yan S.S. Methionine Sulfoxide Reductase A Affects &#x3b2;-Amyloid Solubility and Mitochondrial Function in a Mouse Model of Alzheimer&#x2019;s Disease. Am. J. Physiol. Endocrinol. Metab. 2016;310:E388&#x2013;E393. doi: 10.1152/ajpendo.00453.2015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpendo.00453.2015</ArticleId><ArticleId IdType=\"pmc\">PMC4796266</ArticleId><ArticleId IdType=\"pubmed\">26786779</ArticleId></ArticleIdList></Reference><Reference><Citation>Gates E.J., Bernath A.K., Klegeris A. Modifying the Diet and Gut Microbiota to Prevent and Manage Neurodegenerative Diseases. Rev. Neurosci. 2022;33:767&#x2013;787. doi: 10.1515/revneuro-2021-0146.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1515/revneuro-2021-0146</ArticleId><ArticleId IdType=\"pmc\">PMC9514114</ArticleId><ArticleId IdType=\"pubmed\">35304983</ArticleId></ArticleIdList></Reference><Reference><Citation>Farag M.A., Abdelwareth A., Sallam I.E., El Shorbagi M., Jehmlich N., Fritz-Wallace K., Serena Sch&#xe4;pe S., Rolle-Kampczyk U., Ehrlich A., Wessjohann L.A., et al. Metabolomics Reveals Impact of Seven Functional Foods on Metabolic Pathways in a Gut Microbiota Model. J. Adv. Res. 2020;23:47&#x2013;59. doi: 10.1016/j.jare.2020.01.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jare.2020.01.001</ArticleId><ArticleId IdType=\"pmc\">PMC7016031</ArticleId><ArticleId IdType=\"pubmed\">32071791</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeloni C., Malaguti M., Prata C., Freschi M., Barbalace M.C., Hrelia S. Mechanisms Underlying Neurodegenerative Disorders and Potential Neuroprotective Activity of Agrifood By-Products. Antioxidants. 2022;12:94. doi: 10.3390/antiox12010094.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox12010094</ArticleId><ArticleId IdType=\"pmc\">PMC9854890</ArticleId><ArticleId IdType=\"pubmed\">36670956</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy V.P., Aryal P., Robinson S., Rafiu R., Obrenovich M., Perry G. Polyphenols in Alzheimer&#x2019;s Disease and in the Gut-Brain Axis. Microorganisms. 2020;8:199. doi: 10.3390/microorganisms8020199.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/microorganisms8020199</ArticleId><ArticleId IdType=\"pmc\">PMC7074796</ArticleId><ArticleId IdType=\"pubmed\">32023969</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n J.C., Gonz&#xe1;lez-Barrio R., Cerd&#xe1; B., L&#xf3;pez-Bote C., Rey A.I., Tom&#xe1;s-Barber&#xe1;n F.A. Iberian Pig as a Model to Clarify Obscure Points in the Bioavailability and Metabolism of Ellagitannins in Humans. J. Agric. Food Chem. 2007;55:10476&#x2013;10485. doi: 10.1021/jf0723864.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jf0723864</ArticleId><ArticleId IdType=\"pubmed\">17990850</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan T., Ma H., Liu W., Niesen D.B., Shah N., Crews R., Rose K.N., Vattem D.A., Seeram N.P. Pomegranate&#x2019;s Neuroprotective Effects against Alzheimer&#x2019;s Disease Are Mediated by Urolithins, Its Ellagitannin-Gut Microbial Derived Metabolites. ACS Chem. Neurosci. 2016;7:26&#x2013;33. doi: 10.1021/acschemneuro.5b00260.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acschemneuro.5b00260</ArticleId><ArticleId IdType=\"pubmed\">26559394</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayatunga D.P.W., Hone E., Khaira H., Lunelli T., Singh H., Guillemin G.J., Fernando B., Garg M.L., Verdile G., Martins R.N. Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer&#x2019;s Disease. Nutrients. 2021;13:3744. doi: 10.3390/nu13113744.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu13113744</ArticleId><ArticleId IdType=\"pmc\">PMC8617978</ArticleId><ArticleId IdType=\"pubmed\">34836000</ArticleId></ArticleIdList></Reference><Reference><Citation>DaSilva N.A., Nahar P.P., Ma H., Eid A., Wei Z., Meschwitz S., Zawia N.H., Slitt A.L., Seeram N.P. Pomegranate Ellagitannin-Gut Microbial-Derived Metabolites, Urolithins, Inhibit Neuroinflammation in Vitro. Nutr. Neurosci. 2019;22:185&#x2013;195. doi: 10.1080/1028415X.2017.1360558.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/1028415X.2017.1360558</ArticleId><ArticleId IdType=\"pubmed\">28784051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu D., Mouchiroud L., Andreux P.A., Katsyuba E., Moullan N., Nicolet-dit-F&#xe9;lix A.A., Williams E.G., Jha P., Lo Sasso G., Huzard D., et al. Urolithin A Induces Mitophagy and Prolongs Lifespan in C. Elegans and Increases Muscle Function in Rodents. Nat. Med. 2016;22:879&#x2013;888. doi: 10.1038/nm.4132.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nm.4132</ArticleId><ArticleId IdType=\"pubmed\">27400265</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Ortiz J.M., Swerdlow R.H. Mitochondrial Dysfunction in Alzheimer&#x2019;s Disease: Role in Pathogenesis and Novel Therapeutic Opportunities. Br. J. Pharmacol. 2019;176:3489&#x2013;3507. doi: 10.1111/bph.14585.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/bph.14585</ArticleId><ArticleId IdType=\"pmc\">PMC6715612</ArticleId><ArticleId IdType=\"pubmed\">30675901</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayatunga D.P.W., Hone E., Bharadwaj P., Garg M., Verdile G., Guillemin G.J., Martins R.N. Targeting Mitophagy in Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2020;78:1273&#x2013;1297. doi: 10.3233/JAD-191258.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-191258</ArticleId><ArticleId IdType=\"pubmed\">33285629</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon D.K., Tanner C.M., Brundin P. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin. Geriatr. Med. 2020;36:1&#x2013;12. doi: 10.1016/j.cger.2019.08.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cger.2019.08.002</ArticleId><ArticleId IdType=\"pmc\">PMC6905381</ArticleId><ArticleId IdType=\"pubmed\">31733690</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino B.L.B., de Souza L.R., Sousa K.P.A., Ferreira J.V., Padilha E.C., da Silva C.H.T.P., Taft C.A., Hage-Melim L.I.S. Parkinson&#x2019;s Disease: A Review from Pathophysiology to Treatment. Mini Rev. Med. Chem. 2020;20:754&#x2013;767. doi: 10.2174/1389557519666191104110908.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1389557519666191104110908</ArticleId><ArticleId IdType=\"pubmed\">31686637</ArticleId></ArticleIdList></Reference><Reference><Citation>Beitz J.M. Parkinson s Disease a Review. Front. Biosci. (Schol. Ed.) 2014;6:65&#x2013;74. doi: 10.2741/S415.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2741/S415</ArticleId><ArticleId IdType=\"pubmed\">24389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Braidy N., Selvaraju S., Essa M.M., Vaishnav R., Al-Adawi S., Al-Asmi A., Al-Senawi H., Abd Alrahman Alobaidy A., Lakhtakia R., Guillemin G.J. Neuroprotective Effects of a Variety of Pomegranate Juice Extracts against MPTP-Induced Cytotoxicity and Oxidative Stress in Human Primary Neurons. Oxid. Med. Cell Longev. 2013;2013:685909. doi: 10.1155/2013/685909.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2013/685909</ArticleId><ArticleId IdType=\"pmc\">PMC3816068</ArticleId><ArticleId IdType=\"pubmed\">24223235</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapias V., Cannon J.R., Greenamyre J.T. Pomegranate Juice Exacerbates Oxidative Stress and Nigrostriatal Degeneration in Parkinson&#x2019;s Disease. Neurobiol. Aging. 2014;35:1162&#x2013;1176. doi: 10.1016/j.neurobiolaging.2013.10.077.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2013.10.077</ArticleId><ArticleId IdType=\"pmc\">PMC3946191</ArticleId><ArticleId IdType=\"pubmed\">24315037</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawska M., Jourdes M., Kurpik M., Szulc M., Szaefer H., Chmielarz P., Kreiner G., Krajka-Ku&#x17a;niak V., Miko&#x142;ajczak P.&#x141;., Teissedre P.-L., et al. Neuroprotective Effects of Pomegranate Juice against Parkinson&#x2019;s Disease and Presence of Ellagitannins-Derived Metabolite-Urolithin A-in the Brain. Int. J. Mol. Sci. 2019;21:202. doi: 10.3390/ijms21010202.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21010202</ArticleId><ArticleId IdType=\"pmc\">PMC6981883</ArticleId><ArticleId IdType=\"pubmed\">31892167</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawska M., Jourdes M., Witucki &#x141;., Kara&#x17a;niewicz-&#x141;ada M., Szulc M., G&#xf3;rska A., Miko&#x142;ajczak P.&#x141;., Teissedre P.-L., Jodynis-Liebert J. Pomegranate Juice Ameliorates Dopamine Release and Behavioral Deficits in a Rat Model of Parkinson&#x2019;s Disease. Brain Sci. 2021;11:1127. doi: 10.3390/brainsci11091127.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/brainsci11091127</ArticleId><ArticleId IdType=\"pmc\">PMC8467386</ArticleId><ArticleId IdType=\"pubmed\">34573149</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathy S.M., El-Dash H.A., Said N.I. Neuroprotective Effects of Pomegranate (Punica granatum L.) Juice and Seed Extract in Paraquat-Induced Mouse Model of Parkinson&#x2019;s Disease. BMC Complement. Med. Ther. 2021;21:130. doi: 10.1186/s12906-021-03298-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12906-021-03298-y</ArticleId><ArticleId IdType=\"pmc\">PMC8074500</ArticleId><ArticleId IdType=\"pubmed\">33902532</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkaki A., Farbood Y., Dolatshahi M., Mansouri S.M.T., Khodadadi A. Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinson&#x2019;s Disease. Acta Med. Iran. 2016;54:494&#x2013;502.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27701719</ArticleId></ArticleIdList></Reference><Reference><Citation>Baluchnejadmojarad T., Rabiee N., Zabihnejad S., Roghani M. Ellagic Acid Exerts Protective Effect in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson&#x2019;s Disease: Possible Involvement of ER&#x3b2;/Nrf2/HO-1 Signaling. Brain Res. 2017;1662:23&#x2013;30. doi: 10.1016/j.brainres.2017.02.021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainres.2017.02.021</ArticleId><ArticleId IdType=\"pubmed\">28238669</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Jiang J., Qiu J., Wang L., Zhuo J., Wang B., Sun D., Yu S., Lou H. Urolithin A Protects Dopaminergic Neurons in Experimental Models of Parkinson&#x2019;s Disease by Promoting Mitochondrial Biogenesis through the SIRT1/PGC-1&#x3b1; Signaling Pathway. Food Funct. 2022;13:375&#x2013;385. doi: 10.1039/D1FO02534A.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D1FO02534A</ArticleId><ArticleId IdType=\"pubmed\">34905594</ArticleId></ArticleIdList></Reference><Reference><Citation>Koohgoli R., Hudson L., Naidoo K., Wilkinson S., Chavan B., Birch-Machin M.A. Bad Air Gets under Your Skin. Exp. Dermatol. 2017;26:384&#x2013;387. doi: 10.1111/exd.13257.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/exd.13257</ArticleId><ArticleId IdType=\"pubmed\">27892609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritti&#xe9; L., Fisher G.J. Natural and Sun-Induced Aging of Human Skin. Cold Spring Harb. Perspect. Med. 2015;5:a015370. doi: 10.1101/cshperspect.a015370.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/cshperspect.a015370</ArticleId><ArticleId IdType=\"pmc\">PMC4292080</ArticleId><ArticleId IdType=\"pubmed\">25561721</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan T. Molecular Insights of Human Skin Epidermal and Dermal Aging. J. Dermatol. Sci. 2023;112:48&#x2013;53. doi: 10.1016/j.jdermsci.2023.08.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jdermsci.2023.08.006</ArticleId><ArticleId IdType=\"pubmed\">37661473</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu L., Mauro T.M., Dang E., Man G., Zhang J., Lee D., Wang G., Feingold K.R., Elias P.M., Man M.-Q. Epidermal Dysfunction Leads to an Age-Associated Increase in Levels of Serum Inflammatory Cytokines. J. Investig. Dermatol. 2017;137:1277&#x2013;1285. doi: 10.1016/j.jid.2017.01.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jid.2017.01.007</ArticleId><ArticleId IdType=\"pmc\">PMC5441930</ArticleId><ArticleId IdType=\"pubmed\">28115059</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P.-Y., Shen M., Cai S.-Q., Tang Z.-W. Association between Atopic Dermatitis and Aging: Clinical Observations and Underlying Mechanisms. J. Inflamm. Res. 2024;17:3433&#x2013;3448. doi: 10.2147/JIR.S467099.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/JIR.S467099</ArticleId><ArticleId IdType=\"pmc\">PMC11144009</ArticleId><ArticleId IdType=\"pubmed\">38828054</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal R., Hu A., Bollag W.B. The Skin and Inflamm-Aging. Biology. 2023;12:1396. doi: 10.3390/biology12111396.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biology12111396</ArticleId><ArticleId IdType=\"pmc\">PMC10669244</ArticleId><ArticleId IdType=\"pubmed\">37997995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf J., Weinberger B., Arnold C.R., Maier A.B., Westendorp R.G.J., Grubeck-Loebenstein B. The Effect of Chronological Age on the Inflammatory Response of Human Fibroblasts. Exp. Gerontol. 2012;47:749&#x2013;753. doi: 10.1016/j.exger.2012.07.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.exger.2012.07.001</ArticleId><ArticleId IdType=\"pmc\">PMC3427851</ArticleId><ArticleId IdType=\"pubmed\">22790019</ArticleId></ArticleIdList></Reference><Reference><Citation>Papp N., Cz&#xe9;g&#xe9;nyi D., T&#xf3;th M., D&#xe9;nes T., Bartha S.G., Csepregi R., Gyergy&#xe1;k K., Bukovics P., Stranczinger S., Varga E., et al. Ethnomedicine Survey on Folk Dermatology in Transylvania, Romania. Clin. Dermatol. 2022;40:651&#x2013;664. doi: 10.1016/j.clindermatol.2022.07.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clindermatol.2022.07.013</ArticleId><ArticleId IdType=\"pubmed\">35914644</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf8;rklund G., Shanaida M., Lysiuk R., Butnariu M., Peana M., Sarac I., Strus O., Smetanina K., Chirumbolo S. Natural Compounds and Products from an Anti-Aging Perspective. Molecules. 2022;27:7084. doi: 10.3390/molecules27207084.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules27207084</ArticleId><ArticleId IdType=\"pmc\">PMC9610014</ArticleId><ArticleId IdType=\"pubmed\">36296673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt K.J., Hung S.K., Ernst E. Botanical Extracts as Anti-Aging Preparations for the Skin: A Systematic Review. Drugs Aging. 2010;27:973&#x2013;985. doi: 10.2165/11584420-000000000-00000.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2165/11584420-000000000-00000</ArticleId><ArticleId IdType=\"pubmed\">21087067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitarek P., Kowalczyk T., Wieczfinska J., Merecz-Sadowska A., G&#xf3;rski K., &#x15a;liwi&#x144;ski T., Ska&#x142;a E. Plant Extracts as a Natural Source of Bioactive Compounds and Potential Remedy for the Treatment of Certain Skin Diseases. Curr. Pharm. Des. 2020;26:2859&#x2013;2875. doi: 10.2174/1381612826666200417160049.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1381612826666200417160049</ArticleId><ArticleId IdType=\"pubmed\">32303169</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.-K., Zhong L., Santiago J.L. Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils. Int. J. Mol. Sci. 2017;19:70. doi: 10.3390/ijms19010070.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms19010070</ArticleId><ArticleId IdType=\"pmc\">PMC5796020</ArticleId><ArticleId IdType=\"pubmed\">29280987</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., Natsuga K., Nishie W., Kobayashi Y., Donati G., Suzuki S., Fujimura Y., Tsukiyama T., Ujiie H., Shinkuma S., et al. Type XVII Collagen Coordinates Proliferation in the Interfollicular Epidermis. Elife. 2017;6:e26635. doi: 10.7554/eLife.26635.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7554/eLife.26635</ArticleId><ArticleId IdType=\"pmc\">PMC5505703</ArticleId><ArticleId IdType=\"pubmed\">28693719</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Y., Liu Y., Yang Y., Yan Y., Kim A.J., Guo C., Fisher G.J., Quan T. Reduced Expression of Collagen 17A1 in Naturally Aged, Photoaged, And. J. Cell Commun. Signal. 2022;16:421&#x2013;432. doi: 10.1007/s12079-021-00654-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12079-021-00654-y</ArticleId><ArticleId IdType=\"pmc\">PMC9411357</ArticleId><ArticleId IdType=\"pubmed\">35060094</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., Matsumura H., Kato T., Ichinose S., Takada A., Namiki T., Asakawa K., Morinaga H., Mohri Y., De Arcangelis A., et al. Stem Cell Competition Orchestrates Skin Homeostasis and Ageing. Nature. 2019;568:344&#x2013;350. doi: 10.1038/s41586-019-1085-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-019-1085-7</ArticleId><ArticleId IdType=\"pubmed\">30944469</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumura H., Mohri Y., Binh N.T., Morinaga H., Fukuda M., Ito M., Kurata S., Hoeijmakers J., Nishimura E.K. Hair Follicle Aging Is Driven by Transepidermal Elimination of Stem Cells via COL17A1 Proteolysis. Science. 2016;351:aad4395. doi: 10.1126/science.aad4395.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.aad4395</ArticleId><ArticleId IdType=\"pubmed\">26912707</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanimura S., Tadokoro Y., Inomata K., Binh N.T., Nishie W., Yamazaki S., Nakauchi H., Tanaka Y., McMillan J.R., Sawamura D., et al. Hair Follicle Stem Cells Provide a Functional Niche for Melanocyte Stem Cells. Cell Stem Cell. 2011;8:177&#x2013;187. doi: 10.1016/j.stem.2010.11.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.stem.2010.11.029</ArticleId><ArticleId IdType=\"pubmed\">21295274</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Chen D., Jiang K., Song L., Qian N., Du Y., Yang Y., Wang F., Chen T. Hair Shaft Miniaturization Causes Stem Cell Depletion through Mechanosensory Signals Mediated by a Piezo1-Calcium-TNF-&#x3b1; Axis. Cell Stem Cell. 2022;29:70&#x2013;85.e6. doi: 10.1016/j.stem.2021.09.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.stem.2021.09.009</ArticleId><ArticleId IdType=\"pubmed\">34624205</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher G.J., Kang S., Varani J., Bata-Csorgo Z., Wan Y., Datta S., Voorhees J.J. Mechanisms of Photoaging and Chronological Skin Aging. Arch. Dermatol. 2002;138:1462&#x2013;1470. doi: 10.1001/archderm.138.11.1462.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archderm.138.11.1462</ArticleId><ArticleId IdType=\"pubmed\">12437452</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher G.J., Wang Z.Q., Datta S.C., Varani J., Kang S., Voorhees J.J. Pathophysiology of Premature Skin Aging Induced by Ultraviolet Light. N. Engl. J. Med. 1997;337:1419&#x2013;1428. doi: 10.1056/NEJM199711133372003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJM199711133372003</ArticleId><ArticleId IdType=\"pubmed\">9358139</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan T., Fisher G.J. Role of Age-Associated Alterations of the Dermal Extracellular Matrix Microenvironment in Human Skin Aging: A Mini-Review. Gerontology. 2015;61:427&#x2013;434. doi: 10.1159/000371708.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000371708</ArticleId><ArticleId IdType=\"pmc\">PMC4524793</ArticleId><ArticleId IdType=\"pubmed\">25660807</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan T., He T., Shao Y., Lin L., Kang S., Voorhees J.J., Fisher G.J. Elevated Cysteine-Rich 61 Mediates Aberrant Collagen Homeostasis in Chronologically Aged and Photoaged Human Skin. Am. J. Pathol. 2006;169:482&#x2013;490. doi: 10.2353/ajpath.2006.060128.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2353/ajpath.2006.060128</ArticleId><ArticleId IdType=\"pmc\">PMC1698795</ArticleId><ArticleId IdType=\"pubmed\">16877350</ArticleId></ArticleIdList></Reference><Reference><Citation>Polj&#x161;ak B., Dahmane R. Free Radicals and Extrinsic Skin Aging. Dermatol. Res. Pract. 2012;2012:135206. doi: 10.1155/2012/135206.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2012/135206</ArticleId><ArticleId IdType=\"pmc\">PMC3299230</ArticleId><ArticleId IdType=\"pubmed\">22505880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorzadeh E., Heidary Z., Mohammadi M., Nadjarzadeh A., Ramezani-Jolfaie N., Salehi-Abargouei A. Does Pomegranate Consumption Improve Oxidative Stress? A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. Clin. Nutr. ESPEN. 2022;47:117&#x2013;127. doi: 10.1016/j.clnesp.2021.11.017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clnesp.2021.11.017</ArticleId><ArticleId IdType=\"pubmed\">35063191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence J.N., Dickson F.M., Benford D.J. Skin Irritant-Induced Cytotoxicity and Prostaglandin E2 Release in Human Skin Keratinocyte Cultures. Toxicol In Vitro. 1997;11:627&#x2013;631. doi: 10.1016/S0887-2333(97)00044-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0887-2333(97)00044-1</ArticleId><ArticleId IdType=\"pubmed\">20654361</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaar M., Gilchrest B.A. Skin Aging. Clin. Geriatr. Med. 2001;17:617&#x2013;630. doi: 10.1016/S0749-0690(05)70089-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0749-0690(05)70089-6</ArticleId><ArticleId IdType=\"pubmed\">11535419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimeswenger S., Schwarz A., F&#xf6;dinger D., M&#xfc;ller S., Pehamberger H., Schwarz T., Jantschitsch C. Infrared A Radiation Promotes Survival of Human Melanocytes Carrying Ultraviolet Radiation-Induced DNA Damage. Exp. Dermatol. 2016;25:447&#x2013;452. doi: 10.1111/exd.12968.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/exd.12968</ArticleId><ArticleId IdType=\"pmc\">PMC5737833</ArticleId><ArticleId IdType=\"pubmed\">26844814</ArticleId></ArticleIdList></Reference><Reference><Citation>Bickers D.R., Athar M. Oxidative Stress in the Pathogenesis of Skin Disease. J. Investig. Dermatol. 2006;126:2565&#x2013;2575. doi: 10.1038/sj.jid.5700340.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.jid.5700340</ArticleId><ArticleId IdType=\"pubmed\">17108903</ArticleId></ArticleIdList></Reference><Reference><Citation>Krutmann J., Schroeder P. Role of Mitochondria in Photoaging of Human Skin: The Defective Powerhouse Model. J. Investig. Dermatol. Symp. Proc. 2009;14:44&#x2013;49. doi: 10.1038/jidsymp.2009.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/jidsymp.2009.1</ArticleId><ArticleId IdType=\"pubmed\">19675552</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim A.L., Labasi J.M., Zhu Y., Tang X., McClure K., Gabel C.A., Athar M., Bickers D.R. Role of P38 MAPK in UVB-Induced Inflammatory Responses in the Skin of SKH-1 Hairless Mice. J. Investig. Dermatol. 2005;124:1318&#x2013;1325. doi: 10.1111/j.0022-202X.2005.23747.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.0022-202X.2005.23747.x</ArticleId><ArticleId IdType=\"pubmed\">15955110</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachelor M.A., Bowden G.T. UVA-Mediated Activation of Signaling Pathways Involved in Skin Tumor Promotion and Progression. Semin. Cancer Biol. 2004;14:131&#x2013;138. doi: 10.1016/j.semcancer.2003.09.017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.semcancer.2003.09.017</ArticleId><ArticleId IdType=\"pubmed\">15018897</ArticleId></ArticleIdList></Reference><Reference><Citation>Reelfs O., Tyrrell R.M., Pourzand C. Ultraviolet a Radiation-Induced Immediate Iron Release Is a Key Modulator of the Activation of NF-KappaB in Human Skin Fibroblasts. J. Investig. Dermatol. 2004;122:1440&#x2013;1447. doi: 10.1111/j.0022-202X.2004.22620.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.0022-202X.2004.22620.x</ArticleId><ArticleId IdType=\"pubmed\">15175035</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens M.C., Seebode C., Lehmann J., Emmert S. Photocarcinogenesis and Skin Cancer Prevention Strategies: An Update. Anticancer. Res. 2018;38:1153&#x2013;1158. doi: 10.21873/anticanres.12334.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.21873/anticanres.12334</ArticleId><ArticleId IdType=\"pubmed\">29374752</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsatsou F., Trakatelli M., Patsatsi A., Kalokasidis K., Sotiriadis D. Extrinsic Aging: UV-Mediated Skin Carcinogenesis. Dermatoendocrinol. 2012;4:285&#x2013;297. doi: 10.4161/derm.22519.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4161/derm.22519</ArticleId><ArticleId IdType=\"pmc\">PMC3583890</ArticleId><ArticleId IdType=\"pubmed\">23467430</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilkington S.M., Bulfone-Paus S., Griffiths C.E.M., Watson R.E.B. Inflammaging and the Skin. J. Investig. Dermatol. 2021;141:1087&#x2013;1095. doi: 10.1016/j.jid.2020.11.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jid.2020.11.006</ArticleId><ArticleId IdType=\"pubmed\">33358020</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinnerthaler M., Bischof J., Streubel M.K., Trost A., Richter K. Oxidative Stress in Aging Human Skin. Biomolecules. 2015;5:545&#x2013;589. doi: 10.3390/biom5020545.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom5020545</ArticleId><ArticleId IdType=\"pmc\">PMC4496685</ArticleId><ArticleId IdType=\"pubmed\">25906193</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi J. Aging, Cellular Senescence, and Cancer. Annu. Rev. Physiol. 2013;75:685&#x2013;705. doi: 10.1146/annurev-physiol-030212-183653.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-physiol-030212-183653</ArticleId><ArticleId IdType=\"pmc\">PMC4166529</ArticleId><ArticleId IdType=\"pubmed\">23140366</ArticleId></ArticleIdList></Reference><Reference><Citation>Csekes E., Ra&#x10d;kov&#xe1; L. Skin Aging, Cellular Senescence and Natural Polyphenols. Int. J. Mol. Sci. 2021;22:12641. doi: 10.3390/ijms222312641.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms222312641</ArticleId><ArticleId IdType=\"pmc\">PMC8657738</ArticleId><ArticleId IdType=\"pubmed\">34884444</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrab G., Nasrollahzadeh J., Zand H., Amiri Z., Tohidi M., Kimiagar M. Effects of Pomegranate Juice Consumption on Inflammatory Markers in Patients with Type 2 Diabetes: A Randomized, Placebo-Controlled Trial. J. Res. Med. Sci. 2014;19:215&#x2013;220.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4061642</ArticleId><ArticleId IdType=\"pubmed\">24949028</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W.-C., Liou C.-J., Shen S.-C., Hu S., Chao J.C.-J., Huang C.-H., Wu S.-J. Punicalagin from Pomegranate Ameliorates TNF-&#x3b1;/IFN-&#x3b3;-Induced Inflammatory Responses in HaCaT Cells via Regulation of SIRT1/STAT3 Axis and Nrf2/HO-1 Signaling Pathway. Int. Immunopharmacol. 2024;130:111665. doi: 10.1016/j.intimp.2024.111665.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.intimp.2024.111665</ArticleId><ArticleId IdType=\"pubmed\">38367463</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapa S.F., Magliocca G., Pepe G., Amodio G., Autore G., Campiglia P., Marzocco S. Protective Effect of Pomegranate on Oxidative Stress and Inflammatory Response Induced by 5-Fluorouracil in Human Keratinocytes. Antioxidants. 2021;10:203. doi: 10.3390/antiox10020203.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox10020203</ArticleId><ArticleId IdType=\"pmc\">PMC7911112</ArticleId><ArticleId IdType=\"pubmed\">33573363</ArticleId></ArticleIdList></Reference><Reference><Citation>Afaq F., Malik A., Syed D., Maes D., Matsui M.S., Mukhtar H. Pomegranate Fruit Extract Modulates UV-B-Mediated Phosphorylation of Mitogen-Activated Protein Kinases and Activation of Nuclear Factor Kappa B in Normal Human Epidermal Keratinocytes Paragraph Sign. Photochem. Photobiol. 2005;81:38&#x2013;45. doi: 10.1562/2004-08-06-RA-264.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1562/2004-08-06-RA-264</ArticleId><ArticleId IdType=\"pubmed\">15493960</ArticleId></ArticleIdList></Reference><Reference><Citation>Houston D.M.J., Bugert J., Denyer S.P., Heard C.M. Anti-Inflammatory Activity of Punica granatum L. (Pomegranate) Rind Extracts Applied Topically to Ex Vivo Skin. Eur. J. Pharm. Biopharm. 2017;112:30&#x2013;37. doi: 10.1016/j.ejpb.2016.11.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejpb.2016.11.014</ArticleId><ArticleId IdType=\"pubmed\">27867111</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamouda A.F., Felemban S. Biochemical Pilot Study on Effects of Pomegranate Seed Oil Extract and Cosmetic Cream on Neurologically Mediated Skin Inflammation in Animals and Humans: A Comparative Observational Study. Molecules. 2023;28:903. doi: 10.3390/molecules28020903.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules28020903</ArticleId><ArticleId IdType=\"pmc\">PMC9865066</ArticleId><ArticleId IdType=\"pubmed\">36677961</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N., Syed D.N., Pal H.C., Mukhtar H., Afaq F. Pomegranate Fruit Extract Inhibits UVB-Induced Inflammation and Proliferation by Modulating NF-&#x39a;B and MAPK Signaling Pathways in Mouse Skin. Photochem. Photobiol. 2012;88:1126&#x2013;1134. doi: 10.1111/j.1751-1097.2011.01063.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1751-1097.2011.01063.x</ArticleId><ArticleId IdType=\"pmc\">PMC3435465</ArticleId><ArticleId IdType=\"pubmed\">22181855</ArticleId></ArticleIdList></Reference><Reference><Citation>BenSaad L.A., Kim K.H., Quah C.C., Kim W.R., Shahimi M. Anti-Inflammatory Potential of Ellagic Acid, Gallic Acid and Punicalagin A&amp;B Isolated from Punica granatum. BMC Complement. Altern. Med. 2017;17:47. doi: 10.1186/s12906-017-1555-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12906-017-1555-0</ArticleId><ArticleId IdType=\"pmc\">PMC5237561</ArticleId><ArticleId IdType=\"pubmed\">28088220</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae J.-Y., Choi J.-S., Kang S.-W., Lee Y.-J., Park J., Kang Y.-H. Dietary Compound Ellagic Acid Alleviates Skin Wrinkle and Inflammation Induced by UV-B Irradiation. Exp. Dermatol. 2010;19:e182&#x2013;e190. doi: 10.1111/j.1600-0625.2009.01044.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1600-0625.2009.01044.x</ArticleId><ArticleId IdType=\"pubmed\">20113347</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Guo H., DaSilva N.A., Li D., Zhang K., Wan Y., Gao X.-H., Chen H.-D., Seeram N.P., Ma H. Pomegranate (Punica granatum) Phenolics Ameliorate Hydrogen Peroxide-Induced Oxidative Stress and Cytotoxicity in Human Keratinocytes. J. Funct. Foods. 2019;54:559&#x2013;567. doi: 10.1016/j.jff.2019.02.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jff.2019.02.015</ArticleId><ArticleId IdType=\"pmc\">PMC8168454</ArticleId><ArticleId IdType=\"pubmed\">34079588</ArticleId></ArticleIdList></Reference><Reference><Citation>Seok J.K., Lee J.-W., Kim Y.M., Boo Y.C. Punicalagin and (-)-Epigallocatechin-3-Gallate Rescue Cell Viability and Attenuate Inflammatory Responses of Human Epidermal Keratinocytes Exposed to Airborne Particulate Matter PM10. Skin. Pharmacol. Physiol. 2018;31:134&#x2013;143. doi: 10.1159/000487400.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000487400</ArticleId><ArticleId IdType=\"pubmed\">29566388</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiles J., Cabrera M., Jones J., Tsapekos M., Caturla N. In Vitro Determination of the Skin Anti-Aging Potential of Four-Component Plant-Based Ingredient. Molecules. 2022;27:8101. doi: 10.3390/molecules27228101.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules27228101</ArticleId><ArticleId IdType=\"pmc\">PMC9697998</ArticleId><ArticleId IdType=\"pubmed\">36432202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghimeray A.K., Jung U.S., Lee H.Y., Kim Y.H., Ryu E.K., Chang M.S. In Vitro Antioxidant, Collagenase Inhibition, and in Vivo Anti-Wrinkle Effects of Combined Formulation Containing Punica granatum, Ginkgo Biloba, Ficus Carica, and Morus Alba Fruits Extract. Clin. Cosmet. Investig. Dermatol. 2015;8:389&#x2013;396. doi: 10.2147/CCID.S80906.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/CCID.S80906</ArticleId><ArticleId IdType=\"pmc\">PMC4507742</ArticleId><ArticleId IdType=\"pubmed\">26203268</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L.-P., Tseng Y.-P., Liu C., Liang C.-H. Fermented Pomegranate Extracts Protect against Oxidative Stress and Aging of Skin. J. Cosmet. Dermatol. 2022;21:2236&#x2013;2245. doi: 10.1111/jocd.14379.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jocd.14379</ArticleId><ArticleId IdType=\"pubmed\">34416060</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdellatif A.A.H., Alawadh S.H., Bouazzaoui A., Alhowail A.H., Mohammed H.A. Anthocyanins Rich Pomegranate Cream as a Topical Formulation with Anti-Aging Activity. J. Dermatolog Treat. 2021;32:983&#x2013;990. doi: 10.1080/09546634.2020.1721418.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/09546634.2020.1721418</ArticleId><ArticleId IdType=\"pubmed\">32022625</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin&#xe9;-Casad&#xf3; R., Teichenn&#xe9; J., Tobajas Y., Caimari A., Villar A., Zangara A., Mul&#xe0; A., Del Bas J.M. Pomegranate Natural Extract Pomanox&#xae; Positively Modulates Skin Health-Related Parameters in Normal and UV-Induced Photoaging Conditions in Hs68 Human Fibroblast Cells. Int. J. Food Sci. Nutr. 2023;74:51&#x2013;63. doi: 10.1080/09637486.2022.2152189.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/09637486.2022.2152189</ArticleId><ArticleId IdType=\"pubmed\">36457282</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H.M., Moon E., Kim A.-J., Kim M.H., Lee S., Lee J.B., Park Y.K., Jung H.-S., Kim Y.-B., Kim S.Y. Extract of Punica granatum Inhibits Skin Photoaging Induced by UVB Irradiation. Int. J. Dermatol. 2010;49:276&#x2013;282. doi: 10.1111/j.1365-4632.2009.04269.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-4632.2009.04269.x</ArticleId><ArticleId IdType=\"pubmed\">20465664</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd-Elghany A.A., Mohamad E.A. Chitosan-Coated Niosomes Loaded with Ellagic Acid Present Antiaging Activity in a Skin Cell Line. ACS Omega. 2023;8:16620&#x2013;16629. doi: 10.1021/acsomega.2c07254.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsomega.2c07254</ArticleId><ArticleId IdType=\"pmc\">PMC10193557</ArticleId><ArticleId IdType=\"pubmed\">37214686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco-Palencia L.A., Noratto G., Hingorani L., Talcott S.T., Mertens-Talcott S.U. Protective Effects of Standardized Pomegranate (Punica granatum L.) Polyphenolic Extract in Ultraviolet-Irradiated Human Skin Fibroblasts. J. Agric. Food Chem. 2008;56:8434&#x2013;8441. doi: 10.1021/jf8005307.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jf8005307</ArticleId><ArticleId IdType=\"pubmed\">18717570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid M.A., Afaq F., Syed D.N., Dreher M., Mukhtar H. Inhibition of UVB-Mediated Oxidative Stress and Markers of Photoaging in Immortalized HaCaT Keratinocytes by Pomegranate Polyphenol Extract POMx. Photochem. Photobiol. 2007;83:882&#x2013;888. doi: 10.1111/j.1751-1097.2007.00157.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1751-1097.2007.00157.x</ArticleId><ArticleId IdType=\"pubmed\">17645659</ArticleId></ArticleIdList></Reference><Reference><Citation>Baccarin T., Mitjans M., Ramos D., Lemos-Senna E., Vinardell M.P. Photoprotection by Punica granatum Seed Oil Nanoemulsion Entrapping Polyphenol-Rich Ethyl Acetate Fraction against UVB-Induced DNA Damage in Human Keratinocyte (HaCaT) Cell Line. J. Photochem. Photobiol. B. 2015;153:127&#x2013;136. doi: 10.1016/j.jphotobiol.2015.09.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jphotobiol.2015.09.005</ArticleId><ArticleId IdType=\"pubmed\">26406978</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.-J., Choi B.-R., Kim S.-H., Yi H.-Y., Park H.-R., Song C.-H., Ku S.-K., Lee Y.-J. Beneficial Effects of Dried Pomegranate Juice Concentrated Powder on Ultraviolet B-Induced Skin Photoaging in Hairless Mice. Exp. Ther. Med. 2017;14:1023&#x2013;1036. doi: 10.3892/etm.2017.4626.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/etm.2017.4626</ArticleId><ArticleId IdType=\"pmc\">PMC5525583</ArticleId><ArticleId IdType=\"pubmed\">28810554</ArticleId></ArticleIdList></Reference><Reference><Citation>Henning S.M., Yang J., Lee R.-P., Huang J., Hsu M., Thames G., Gilbuena I., Long J., Xu Y., Park E.H., et al. Pomegranate Juice and Extract Consumption Increases the Resistance to UVB-Induced Erythema and Changes the Skin Microbiome in Healthy Women: A Randomized Controlled Trial. Sci. Rep. 2019;9:14528. doi: 10.1038/s41598-019-50926-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-50926-2</ArticleId><ArticleId IdType=\"pmc\">PMC6787198</ArticleId><ArticleId IdType=\"pubmed\">31601842</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy K.N.C., Reddy V.K., Veigas J.M., Murthy U.D. Study on Wound Healing Activity of Punica granatum Peel. J. Med. Food. 2004;7:256&#x2013;259. doi: 10.1089/1096620041224111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/1096620041224111</ArticleId><ArticleId IdType=\"pubmed\">15298776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayouni E.A., Miled K., Boubaker S., Bellasfar Z., Abedrabba M., Iwaski H., Oku H., Matsui T., Limam F., Hamdi M. Hydroalcoholic Extract Based-Ointment from Punica granatum L. Peels with Enhanced in Vivo Healing Potential on Dermal Wounds. Phytomedicine. 2011;18:976&#x2013;984. doi: 10.1016/j.phymed.2011.02.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.phymed.2011.02.011</ArticleId><ArticleId IdType=\"pubmed\">21466954</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayak S.B., Rodrigues V., Maharaj S., Bhogadi V.S. Wound Healing Activity of the Fruit Skin of Punica granatum. J. Med. Food. 2013;16:857&#x2013;861. doi: 10.1089/jmf.2012.0229.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/jmf.2012.0229</ArticleId><ArticleId IdType=\"pubmed\">24044494</ArticleId></ArticleIdList></Reference><Reference><Citation>Zekavat O., Amanat A., Karami M., Paydar S., Gramizadeh B., Zareian-Jahromi M. Wound Healing Studies Using Punica granatum Peel. Adv. Skin Wound Care. 2016;29:217&#x2013;225. doi: 10.1097/01.ASW.0000481116.16998.55.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/01.ASW.0000481116.16998.55</ArticleId><ArticleId IdType=\"pubmed\">27089150</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasiri E., Hosseinimehr S.J., Akbari J., Azadbakht M., Azizi S. The Effects of Punica granatum Flower Extract on Skin Injuries Induced by Burn in Rats. Adv. Pharmacol. Sci. 2017;2017:3059745. doi: 10.1155/2017/3059745.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2017/3059745</ArticleId><ArticleId IdType=\"pmc\">PMC5288512</ArticleId><ArticleId IdType=\"pubmed\">28203250</ArticleId></ArticleIdList></Reference><Reference><Citation>Elzayat E.M., Auda S.H., Alanazi F.K., Al-Agamy M.H. Evaluation of Wound Healing Activity of Henna, Pomegranate and Myrrh Herbal Ointment Blend. Saudi Pharm. J. 2018;26:733&#x2013;738. doi: 10.1016/j.jsps.2018.02.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jsps.2018.02.016</ArticleId><ArticleId IdType=\"pmc\">PMC6035320</ArticleId><ArticleId IdType=\"pubmed\">29991918</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiswanto B.S., Miranti A., Sudjarwo S.A., Primarizky H., Yuniarti W.M. Evaluation of Wound Healing Potential of Pomegranate (Punica granatum) Whole Fruit Extract on Skin Burn Wound in Rats (Rattus norvegicus) J. Adv. Vet. Anim. Res. 2019;6:202&#x2013;207. doi: 10.5455/javar.2019.f333.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5455/javar.2019.f333</ArticleId><ArticleId IdType=\"pmc\">PMC6702873</ArticleId><ArticleId IdType=\"pubmed\">31453192</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuniarti W.M., Primarizky H., Lukiswanto B.S. The Activity of Pomegranate Extract Standardized 40% Ellagic Acid during the Healing Process of Incision Wounds in Albino Rats (Rattus norvegicus) Vet. World. 2018;11:321&#x2013;326. doi: 10.14202/vetworld.2018.321-326.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14202/vetworld.2018.321-326</ArticleId><ArticleId IdType=\"pmc\">PMC5891847</ArticleId><ArticleId IdType=\"pubmed\">29657424</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslam M.N., Lansky E.P., Varani J. Pomegranate as a Cosmeceutical Source: Pomegranate Fractions Promote Proliferation and Procollagen Synthesis and Inhibit Matrix Metalloproteinase-1 Production in Human Skin Cells. J. Ethnopharmacol. 2006;103:311&#x2013;318. doi: 10.1016/j.jep.2005.07.027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jep.2005.07.027</ArticleId><ArticleId IdType=\"pubmed\">16221534</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Yang R., Hu Y., Yang Y., Zhang X., He B., Shen Z., Yang J., Chen P. Promoting Effect of Pomegranate Peel Extract on Second-Degree Burn Wound-Healing through VEGF-A and TGF-&#x392;1 Regulation. Burns. 2022;48:639&#x2013;648. doi: 10.1016/j.burns.2021.06.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.burns.2021.06.004</ArticleId><ArticleId IdType=\"pubmed\">34716043</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti G., Flori L., Spezzini J., Miragliotta V., Lazzarini G., Pirone A., Meneguzzo C., Tagliavento L., Martelli A., Antonelli M., et al. Improved Cardiovascular Effects of a Novel Pomegranate Byproduct Extract Obtained through Hydrodynamic Cavitation. Nutrients. 2024;16:506. doi: 10.3390/nu16040506.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu16040506</ArticleId><ArticleId IdType=\"pmc\">PMC10893178</ArticleId><ArticleId IdType=\"pubmed\">38398831</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos R.L., Dellacqua L.O., Delgado N.T.B., Rouver W.N., Podratz P.L., Lima L.C.F., Piccin M.P.C., Meyrelles S.S., Mauad H., Graceli J.B., et al. Pomegranate Peel Extract Attenuates Oxidative Stress by Decreasing Coronary Angiotensin-Converting Enzyme (ACE) Activity in Hypertensive Female Rats. J. Toxicol. Environ. Health A. 2016;79:998&#x2013;1007. doi: 10.1080/15287394.2016.1213690.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/15287394.2016.1213690</ArticleId><ArticleId IdType=\"pubmed\">27710705</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Rong X., Um I.S.I., Yamahara J., Li Y. 55-Week Treatment of Mice with the Unani and Ayurvedic Medicine Pomegranate Flower Ameliorates Ageing-Associated Insulin Resistance and Skin Abnormalities. Evid. Based Complement. Alternat Med. 2012;2012:350125. doi: 10.1155/2012/350125.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2012/350125</ArticleId><ArticleId IdType=\"pmc\">PMC3255288</ArticleId><ArticleId IdType=\"pubmed\">22253646</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshinnawy A.S., El-Sayed W.M., Sayed A.A., Salem A.M., Taha A.M. Telomerase Activator-65 and Pomegranate Peel Improved the Health Status of the Liver in Aged Rats; Multi-Targets Involved. Iran. J. Basic Med. Sci. 2021;24:842&#x2013;850. doi: 10.22038/ijbms.2021.56670.12655.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.22038/ijbms.2021.56670.12655</ArticleId><ArticleId IdType=\"pmc\">PMC8487600</ArticleId><ArticleId IdType=\"pubmed\">34630962</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshinnawy A.S., El-Sayed W.M., Taha A.M., Sayed A.A., Salem A.M. Astragalus Membranaceus and Punica granatum Alleviate Infertility and Kidney Dysfunction Induced by Aging in Male Rats. Turk Biyol. Derg. [Turk. J. Biol.] 2020;44:166&#x2013;175. doi: 10.3906/biy-2001-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3906/biy-2001-5</ArticleId><ArticleId IdType=\"pmc\">PMC7478130</ArticleId><ArticleId IdType=\"pubmed\">32922124</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazumder M.K., Choudhury S., Borah A. An in Silico Investigation on the Inhibitory Potential of the Constituents of Pomegranate Juice on Antioxidant Defense Mechanism: Relevance to Neurodegenerative Diseases. IBRO Rep. 2019;6:153&#x2013;159. doi: 10.1016/j.ibror.2019.05.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ibror.2019.05.003</ArticleId><ArticleId IdType=\"pmc\">PMC6527820</ArticleId><ArticleId IdType=\"pubmed\">31193374</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39274904</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1420-3049</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>29</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>27</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">4056</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/molecules29174056</ELocationID><Abstract><AbstractText>There has been a growing interest recently in exploring the role of the blood-brain barrier (BBB) in the treatment of Alzheimer's disease (AD), a neurodegenerative disorder characterized by cognitive decline and memory loss that affects millions of people worldwide. Research has shown that the BBB plays a crucial role in regulating the entry of therapeutics into the brain. Also, the potential benefits of using antioxidant molecules for drug delivery were highlighted in Alzheimer's treatment to enhance the therapeutic efficacy and reduce oxidative stress in affected patients. Antioxidant-based nanomedicine shows promise for treating AD by effectively crossing the BBB and targeting neuroinflammation, potentially slowing disease progression and improving cognitive function. Therefore, new drug delivery systems are being developed to overcome the BBB and improve the delivery of therapeutics to the brain, ultimately improving treatment outcomes for AD patients. In this context, the present review provides an in-depth analysis of recent advancements in AD treatment strategies, such as silica nanoparticles loaded with curcumin, selenium nanoparticles loaded with resveratrol, and many others, focusing on the critical role of the BBB and the use of antioxidant-based drug delivery systems.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Daraban</LastName><ForeName>Bianca S&#xe2;nziana</ForeName><Initials>BS</Initials><Identifier Source=\"ORCID\">0009-0002-5855-4973</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Bucharest, 91-95 Splaiul Independentei, 050095 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Popa</LastName><ForeName>Andrei Sabin</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Bucharest, 91-95 Splaiul Independentei, 050095 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stan</LastName><ForeName>Miruna S</ForeName><Initials>MS</Initials><Identifier Source=\"ORCID\">0000-0002-6273-8540</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Bucharest, 91-95 Splaiul Independentei, 050095 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute of the University of Bucharest-ICUB, University of Bucharest, 050095 Bucharest, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000975\">Antioxidants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001812\" MajorTopicYN=\"Y\">Blood-Brain Barrier</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000975\" MajorTopicYN=\"Y\">Antioxidants</DescriptorName><QualifierName UI=\"Q000008\" MajorTopicYN=\"N\">administration &amp; dosage</QualifierName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000493\" MajorTopicYN=\"N\">pharmacokinetics</QualifierName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016503\" MajorTopicYN=\"Y\">Drug Delivery Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D053758\" MajorTopicYN=\"N\">Nanoparticles</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018384\" MajorTopicYN=\"N\">Oxidative Stress</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">antioxidant molecules</Keyword><Keyword MajorTopicYN=\"N\">blood-brain barrier</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39274904</ArticleId><ArticleId IdType=\"doi\">10.3390/molecules29174056</ArticleId><ArticleId IdType=\"pii\">molecules29174056</ArticleId><ArticleId IdType=\"pmc\">PMC11397357</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Association 2023 Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s Dement. 2023;19:1598&#x2013;1695. doi: 10.1002/alz.13016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13016</ArticleId><ArticleId IdType=\"pubmed\">36918389</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira S.T., Clarke J.R., Bomfim T.R., De Felice F.G. Inflammation, Defective Insulin Signaling, and Neuronal Dysfunction in Alzheimer&#x2019;s Disease. Alzheimer&#x2019;s Dement. 2014;10:S76&#x2013;S83. doi: 10.1016/j.jalz.2013.12.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2013.12.010</ArticleId><ArticleId IdType=\"pubmed\">24529528</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Broek S.L., Shalgunov V., Herth M.M. Transport of Nanomedicines across the Blood-Brain Barrier: Challenges and Opportunities for Imaging and Therapy. Biomater. Adv. 2022;141:213125. doi: 10.1016/j.bioadv.2022.213125.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bioadv.2022.213125</ArticleId><ArticleId IdType=\"pubmed\">36182833</ArticleId></ArticleIdList></Reference><Reference><Citation>Halevas E., Mavroidi B., Nday C.M., Tang J., Smith G.C., Boukos N., Litsardakis G., Pelecanou M., Salifoglou A. Modified Magnetic Core-Shell Mesoporous Silica Nano-Formulations with Encapsulated Quercetin Exhibit Anti-Amyloid and Antioxidant Activity. J. Inorg. Biochem. 2020;213:111271. doi: 10.1016/j.jinorgbio.2020.111271.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jinorgbio.2020.111271</ArticleId><ArticleId IdType=\"pubmed\">33069945</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P., De Strooper B., Kivipelto M., Holstege H., Ch&#xe9;telat G., Teunissen C.E., Cummings J., van der Flier W.M. Alzheimer&#x2019;s Disease. Lancet. 2021;397:1577&#x2013;1590. doi: 10.1016/S0140-6736(20)32205-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)32205-4</ArticleId><ArticleId IdType=\"pmc\">PMC8354300</ArticleId><ArticleId IdType=\"pubmed\">33667416</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T., Zhang D., Zeng Y., Huang T.Y., Xu H., Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer&#x2019;s disease. Mol. Neurodegener. 2020;15:40. doi: 10.1186/s13024-020-00391-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-020-00391-7</ArticleId><ArticleId IdType=\"pmc\">PMC7364557</ArticleId><ArticleId IdType=\"pubmed\">32677986</ArticleId></ArticleIdList></Reference><Reference><Citation>d&#x2019;Errico P., Meyer-Luehmann M. Mechanisms of Pathogenic Tau and A&#x3b2; Protein Spreading in Alzheimer&#x2019;s Disease. Front. Aging Neurosci. 2020;12:265. doi: 10.3389/fnagi.2020.00265.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2020.00265</ArticleId><ArticleId IdType=\"pmc\">PMC7481386</ArticleId><ArticleId IdType=\"pubmed\">33061903</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller M.C., Baranowski B.J., Hayward G.C. New Insights on the Role of Residue 673 of APP in Alzheimer&#x2019;s Disease. J. Neurosci. 2018;38:515&#x2013;517. doi: 10.1523/JNEUROSCI.2710-17.2017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.2710-17.2017</ArticleId><ArticleId IdType=\"pmc\">PMC6596190</ArticleId><ArticleId IdType=\"pubmed\">29343592</ArticleId></ArticleIdList></Reference><Reference><Citation>Tackenberg C., Nitsch R.M. The secreted APP ectodomain sAPP&#x3b1;, but not sAPP&#x3b2;, protects neurons against A&#x3b2; oligomer-induced dendritic spine loss and increased tau phosphorylation. Mol. Brain. 2019;12:27. doi: 10.1186/s13041-019-0447-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13041-019-0447-2</ArticleId><ArticleId IdType=\"pmc\">PMC6440141</ArticleId><ArticleId IdType=\"pubmed\">30922360</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C., Kaether C., Thinakaran G., Sisodia S. Trafficking and Proteolytic Processing of APP. Cold Spring Harb. Perspect. Med. 2012;2:a006270. doi: 10.1101/cshperspect.a006270.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/cshperspect.a006270</ArticleId><ArticleId IdType=\"pmc\">PMC3331683</ArticleId><ArticleId IdType=\"pubmed\">22553493</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleksis R., Oleskovs F., Jaudzems K., Pahnke J., Biverst&#xe5;l H. Structural Studies of Amyloid-&#x3b2; Peptides: Unlocking the Mechanism of Aggregation and the Associated Toxicity. Biochimie. 2017;140:176&#x2013;192. doi: 10.1016/j.biochi.2017.07.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biochi.2017.07.011</ArticleId><ArticleId IdType=\"pubmed\">28751216</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabr&#xf2; M., Rinaldi C., Santoro G., Crisafulli C. The Biological Pathways of Alzheimer Disease: A Review. AIMS Neurosci. 2020;8:86&#x2013;132. doi: 10.3934/Neuroscience.2021005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3934/Neuroscience.2021005</ArticleId><ArticleId IdType=\"pmc\">PMC7815481</ArticleId><ArticleId IdType=\"pubmed\">33490374</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen K., Sloan S.A., Bennett M.L., Scholze A.R., O&#x2019;Keeffe S., Phatnani H.P., Guarnieri P., Caneda C., Ruderisch N., et al. An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex. J. Neurosci. 2014;34:11929&#x2013;11947. doi: 10.1523/JNEUROSCI.1860-14.2014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1860-14.2014</ArticleId><ArticleId IdType=\"pmc\">PMC4152602</ArticleId><ArticleId IdType=\"pubmed\">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Marciniak E., Leboucher A., Caron E., Ahmed T., Tailleux A., Dumont J., Issad T., Gerhardt E., Pagesy P., Vileno M., et al. Tau Deletion Promotes Brain Insulin Resistance. J. Exp. Med. 2017;214:2257&#x2013;2269. doi: 10.1084/jem.20161731.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20161731</ArticleId><ArticleId IdType=\"pmc\">PMC5551570</ArticleId><ArticleId IdType=\"pubmed\">28652303</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini M.G., Goedert M. Tau Pathology and Neurodegeneration. Lancet Neurol. 2013;12:609&#x2013;622. doi: 10.1016/S1474-4422(13)70090-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(13)70090-5</ArticleId><ArticleId IdType=\"pubmed\">23684085</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M., Walker L.C. Self-Propagation of Pathogenic Protein Aggregates in Neurodegenerative Diseases. Nature. 2013;501:45&#x2013;51. doi: 10.1038/nature12481.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature12481</ArticleId><ArticleId IdType=\"pmc\">PMC3963807</ArticleId><ArticleId IdType=\"pubmed\">24005412</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J.L., Narasimhan S., Changolkar L., He Z., Stieber A., Zhang B., Gathagan R.J., Iba M., McBride J.D., Trojanowski J.Q., et al. Unique Pathological Tau Conformers from Alzheimer&#x2019;s Brains Transmit Tau Pathology in Nontransgenic Mice. J. Exp. Med. 2016;213:2635&#x2013;2654. doi: 10.1084/jem.20160833.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20160833</ArticleId><ArticleId IdType=\"pmc\">PMC5110027</ArticleId><ArticleId IdType=\"pubmed\">27810929</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed Z., Cooper J., Murray T.K., Garn K., McNaughton E., Clarke H., Parhizkar S., Ward M.A., Cavallini A., Jackson S., et al. A Novel in Vivo Model of Tau Propagation with Rapid and Progressive Neurofibrillary Tangle Pathology: The Pattern of Spread Is Determined by Connectivity, Not Proximity. Acta Neuropathol. 2014;127:667&#x2013;683. doi: 10.1007/s00401-014-1254-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-014-1254-6</ArticleId><ArticleId IdType=\"pmc\">PMC4252866</ArticleId><ArticleId IdType=\"pubmed\">24531916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W.-H., Bastianetto S., Mennicken F., Ma W., Kar S. Amyloid &#x3b2; Peptide Induces Tau Phosphorylation and Loss of Cholinergic Neurons in Rat Primary Septal Cultures. Neuroscience. 2002;115:201&#x2013;211. doi: 10.1016/S0306-4522(02)00404-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0306-4522(02)00404-9</ArticleId><ArticleId IdType=\"pubmed\">12401334</ArticleId></ArticleIdList></Reference><Reference><Citation>Iijima K., Gatt A., Iijima-Ando K. Tau Ser262 Phosphorylation Is Critical for A&#x3b2;42-Induced Tau Toxicity in a Transgenic Drosophila Model of Alzheimer&#x2019;s Disease. Hum. Mol. Genet. 2010;19:2947&#x2013;2957. doi: 10.1093/hmg/ddq200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddq200</ArticleId><ArticleId IdType=\"pmc\">PMC2901137</ArticleId><ArticleId IdType=\"pubmed\">20466736</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiei S.S., Guerrero-Mu&#xf1;oz M.J., Castillo-Carranza D.L. Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage. Front. Aging Neurosci. 2017;9:83. doi: 10.3389/fnagi.2017.00083.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2017.00083</ArticleId><ArticleId IdType=\"pmc\">PMC5378766</ArticleId><ArticleId IdType=\"pubmed\">28420982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson G.R., Wiedau-Pazos M., Sang T.-K., Wagle N., Brown C.A., Massachi S., Geschwind D.H. Human Wild-Type Tau Interacts with Wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila. Neuron. 2002;34:509&#x2013;519. doi: 10.1016/S0896-6273(02)00706-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0896-6273(02)00706-7</ArticleId><ArticleId IdType=\"pubmed\">12062036</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitnis T., Weiner H.L. CNS Inflammation and Neurodegeneration. J. Clin. Investig. 2017;127:3577&#x2013;3587. doi: 10.1172/JCI90609.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI90609</ArticleId><ArticleId IdType=\"pmc\">PMC5617655</ArticleId><ArticleId IdType=\"pubmed\">28872464</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng F., Edison P. Neuroinflammation and Microglial Activation in Alzheimer Disease: Where Do We Go from Here? Nat. Rev. Neurol. 2021;17:157&#x2013;172. doi: 10.1038/s41582-020-00435-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41582-020-00435-y</ArticleId><ArticleId IdType=\"pubmed\">33318676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojala J.O., Sutinen E.M., Salminen A., Pirttil&#xe4; T. Interleukin-18 Increases Expression of Kinases Involved in Tau Phosphorylation in SH-SY5Y Neuroblastoma Cells. J. Neuroimmunol. 2008;205:86&#x2013;93. doi: 10.1016/j.jneuroim.2008.09.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jneuroim.2008.09.012</ArticleId><ArticleId IdType=\"pubmed\">18947885</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo J., Kritskiy O., Watson L.A., Barker S.J., Dey D., Raja W.K., Lin Y.-T., Ko T., Cho S., Penney J., et al. Inhibition of P25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia. J. Neurosci. 2017;37:9917&#x2013;9924. doi: 10.1523/JNEUROSCI.0621-17.2017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.0621-17.2017</ArticleId><ArticleId IdType=\"pmc\">PMC5637118</ArticleId><ArticleId IdType=\"pubmed\">28912154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhao Y., Zhang J., Yang G. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer&#x2019;s Disease. Neurochem. Res. 2020;45:2560&#x2013;2572. doi: 10.1007/s11064-020-03121-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11064-020-03121-z</ArticleId><ArticleId IdType=\"pubmed\">32929691</ArticleId></ArticleIdList></Reference><Reference><Citation>Masters S.L., O&#x2019;Neill L.A.J. Disease-Associated Amyloid and Misfolded Protein Aggregates Activate the Inflammasome. Trends Mol. Med. 2011;17:276&#x2013;282. doi: 10.1016/j.molmed.2011.01.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.molmed.2011.01.005</ArticleId><ArticleId IdType=\"pubmed\">21376667</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Kummer M.P., Stutz A., Delekate A., Schwartz S., Vieira-Saecker A., Griep A., Axt D., Remus A., Tzeng T.-C., et al. NLRP3 Is Activated in Alzheimer&#x2019;s Disease and Contributes to Pathology in APP/PS1 Mice. Nature. 2013;493:674&#x2013;678. doi: 10.1038/nature11729.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature11729</ArticleId><ArticleId IdType=\"pmc\">PMC3812809</ArticleId><ArticleId IdType=\"pubmed\">23254930</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofighi N., Asle-Rousta M., Rahnema M., Amini R. Protective Effect of Alpha-Linoleic Acid on A&#x3b2;-Induced Oxidative Stress, Neuroinflammation, and Memory Impairment by Alteration of A7 nAChR and NMDAR Gene Expression in the Hippocampus of Rats. Neurotoxicology. 2021;85:245&#x2013;253. doi: 10.1016/j.neuro.2021.06.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuro.2021.06.002</ArticleId><ArticleId IdType=\"pubmed\">34111468</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller V., Lawrence D., Mondal T., Seegal R. Reduced Glutathione Is Highly Expressed in White Matter and Neurons in the Unperturbed Mouse Brain&#x2014;Implications for Oxidative Stress Associated with Neurodegeneration. Brain Res. 2009;1276:22&#x2013;30. doi: 10.1016/j.brainres.2009.04.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainres.2009.04.029</ArticleId><ArticleId IdType=\"pmc\">PMC2744579</ArticleId><ArticleId IdType=\"pubmed\">19393633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia V., Sharma S. Role of Mitochondrial Dysfunction, Oxidative Stress and Autophagy in Progression of Alzheimer&#x2019;s Disease. J. Neurol. Sci. 2021;421:117253. doi: 10.1016/j.jns.2020.117253.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jns.2020.117253</ArticleId><ArticleId IdType=\"pubmed\">33476985</ArticleId></ArticleIdList></Reference><Reference><Citation>Desler C., Lillenes M.S., T&#xf8;njum T., Rasmussen L.J. The Role of Mitochondrial Dysfunction in the Progression of Alzheimer&#x2019;s Disease. Curr. Med. Chem. 2018;25:5578&#x2013;5587. doi: 10.2174/0929867324666170616110111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/0929867324666170616110111</ArticleId><ArticleId IdType=\"pmc\">PMC6446443</ArticleId><ArticleId IdType=\"pubmed\">28618998</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A., Nelson T.J., Alkon D.L., Hongpaisan J. Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer&#x2019;s Disease Hippocampus. J. Alzheimer&#x2019;s Dis. 2018;63:1173&#x2013;1189. doi: 10.3233/JAD-171008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-171008</ArticleId><ArticleId IdType=\"pubmed\">29710707</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow R.H., Khan S.M.A. &#x201c;Mitochondrial Cascade Hypothesis&#x201d; for Sporadic Alzheimer&#x2019;s Disease. Med. Hypotheses. 2004;63:8&#x2013;20. doi: 10.1016/j.mehy.2003.12.045.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2003.12.045</ArticleId><ArticleId IdType=\"pubmed\">15193340</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Monte S.M. Insulin Resistance and Alzheimer&#x2019;s Disease. BMB Rep. 2009;42:475&#x2013;481. doi: 10.5483/BMBRep.2009.42.8.475.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5483/BMBRep.2009.42.8.475</ArticleId><ArticleId IdType=\"pmc\">PMC4600067</ArticleId><ArticleId IdType=\"pubmed\">19712582</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L., Helmerhorst E., Taddei K., Plewright B., Van Bronswijk W., Martins R. Alzheimer&#x2019;s &#x3b2;-Amyloid Peptides Compete for Insulin Binding to the Insulin Receptor. J. Neurosci. 2002;22:RC221. doi: 10.1523/JNEUROSCI.22-10-j0001.2002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.22-10-j0001.2002</ArticleId><ArticleId IdType=\"pmc\">PMC6757630</ArticleId><ArticleId IdType=\"pubmed\">12006603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng R.C.-L., Chan K.-H. Potential Neuroprotective Effects of Adiponectin in Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2017;18:592. doi: 10.3390/ijms18030592.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms18030592</ArticleId><ArticleId IdType=\"pmc\">PMC5372608</ArticleId><ArticleId IdType=\"pubmed\">28282917</ArticleId></ArticleIdList></Reference><Reference><Citation>Morais L.H., Schreiber H.L., Mazmanian S.K. The Gut Microbiota-Brain Axis in Behaviour and Brain Disorders. Nat. Rev. Microbiol. 2021;19:241&#x2013;255. doi: 10.1038/s41579-020-00460-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41579-020-00460-0</ArticleId><ArticleId IdType=\"pubmed\">33093662</ArticleId></ArticleIdList></Reference><Reference><Citation>Yano J.M., Yu K., Donaldson G.P., Shastri G.G., Ann P., Ma L., Nagler C.R., Ismagilov R.F., Mazmanian S.K., Hsiao E.Y. Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis. Cell. 2015;161:264&#x2013;276. doi: 10.1016/j.cell.2015.02.047.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2015.02.047</ArticleId><ArticleId IdType=\"pmc\">PMC4393509</ArticleId><ArticleId IdType=\"pubmed\">25860609</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirrito J.R., Disabato B.M., Restivo J.L., Verges D.K., Goebel W.D., Sathyan A., Hayreh D., D&#x2019;Angelo G., Benzinger T., Yoon H., et al. Serotonin Signaling Is Associated with Lower Amyloid-&#x3b2; Levels and Plaques in Transgenic Mice and Humans. Proc. Natl. Acad. Sci. USA. 2011;108:14968&#x2013;14973. doi: 10.1073/pnas.1107411108.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1107411108</ArticleId><ArticleId IdType=\"pmc\">PMC3169155</ArticleId><ArticleId IdType=\"pubmed\">21873225</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Chen Q., Chen X., Han F., Chen Z., Wang Y. The blood&#x2013;brain barrier: Structure, regulation, and drug delivery. Sig. Transduct. Target Thr. 2023;8:217. doi: 10.1038/s41392-023-01481-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-023-01481-w</ArticleId><ArticleId IdType=\"pmc\">PMC10212980</ArticleId><ArticleId IdType=\"pubmed\">37231000</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermeier B., Verma A., Ransohoff R.M. The Blood-Brain Barrier. Handb. Clin. Neurol. 2016;133:39&#x2013;59. doi: 10.1016/B978-0-444-63432-0.00003-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/B978-0-444-63432-0.00003-7</ArticleId><ArticleId IdType=\"pubmed\">27112670</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz A.L., Firth J.A., Goldstein G.W. Polarity of the Blood-Brain Barrier: Distribution of Enzymes between the Luminal and Antiluminal Membranes of Brain Capillary Endothelial Cells. Brain Res. 1980;192:17&#x2013;28. doi: 10.1016/0006-8993(80)91004-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0006-8993(80)91004-5</ArticleId><ArticleId IdType=\"pubmed\">6103738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadry H., Noorani B., Cucullo L. A blood&#x2013;brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17:69. doi: 10.1186/s12987-020-00230-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12987-020-00230-3</ArticleId><ArticleId IdType=\"pmc\">PMC7672931</ArticleId><ArticleId IdType=\"pubmed\">33208141</ArticleId></ArticleIdList></Reference><Reference><Citation>Armulik A., M&#xe4;e M., Betsholtz C. Pericytes and the Blood-Brain Barrier: Recent Advances and Implications for the Delivery of CNS Therapy. Ther. Deliv. 2011;2:419&#x2013;422. doi: 10.4155/tde.11.23.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4155/tde.11.23</ArticleId><ArticleId IdType=\"pubmed\">22826851</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall C.N., Reynell C., Gesslein B., Hamilton N.B., Mishra A., Sutherland B.A., O&#x2019;Farrell F.M., Buchan A.M., Lauritzen M., Attwell D. Capillary Pericytes Regulate Cerebral Blood Flow in Health and Disease. Nature. 2014;508:55&#x2013;60. doi: 10.1038/nature13165.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature13165</ArticleId><ArticleId IdType=\"pmc\">PMC3976267</ArticleId><ArticleId IdType=\"pubmed\">24670647</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A., Barnes S.R., Sweeney M.D., Halliday M.R., Sagare A.P., Zhao Z., Toga A.W., Jacobs R.E., Liu C.Y., Amezcua L., et al. Blood-Brain Barrier Breakdown in the Aging Human Hippocampus. Neuron. 2015;85:296&#x2013;302. doi: 10.1016/j.neuron.2014.12.032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2014.12.032</ArticleId><ArticleId IdType=\"pmc\">PMC4350773</ArticleId><ArticleId IdType=\"pubmed\">25611508</ArticleId></ArticleIdList></Reference><Reference><Citation>Hladky S.B., Barrand M.A. Elimination of substances from the brain parenchyma: Efflux via perivascular pathways and via the blood-brain barrier. Fluids Barriers CNS. 2018;15:30. doi: 10.1186/s12987-018-0113-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12987-018-0113-6</ArticleId><ArticleId IdType=\"pmc\">PMC6194691</ArticleId><ArticleId IdType=\"pubmed\">30340614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlokovic B.V. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders. Neuron. 2008;57:178&#x2013;201. doi: 10.1016/j.neuron.2008.01.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2008.01.003</ArticleId><ArticleId IdType=\"pubmed\">18215617</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson I., Carruthers A., Vannucci S., Simpson I.A., Carruthers A., Vannucci S.J. Supply and Demand in Cerebral Energy Metabolism: The Role of Nutrient Transporters. J. Cereb. Blood Flow Metab. 2007;27:1766&#x2013;1791. doi: 10.1038/sj.jcbfm.9600521.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.jcbfm.9600521</ArticleId><ArticleId IdType=\"pmc\">PMC2094104</ArticleId><ArticleId IdType=\"pubmed\">17579656</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins R.A., O&#x2019;Kane R.L., Simpson I.A., Vi&#xf1;a J.R. Structure of the Blood-Brain Barrier and Its Role in the Transport of Amino Acids. J. Nutr. 2006;136:218S&#x2013;226S. doi: 10.1093/jn/136.1.218S.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jn/136.1.218S</ArticleId><ArticleId IdType=\"pubmed\">16365086</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan C.M., Raymond L.A. Selective Neuronal Degeneration in Huntington&#x2019;s Disease. Curr. Top Dev. Biol. 2006;75:25&#x2013;71. doi: 10.1016/S0070-2153(06)75002-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0070-2153(06)75002-5</ArticleId><ArticleId IdType=\"pubmed\">16984809</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott N.J., Patabendige A.A.K., Dolman D.E.M., Yusof S.R., Begley D.J. Structure and Function of the Blood&#x2013;Brain Barrier. Neurobiol. Dis. 2010;37:13&#x2013;25. doi: 10.1016/j.nbd.2009.07.030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2009.07.030</ArticleId><ArticleId IdType=\"pubmed\">19664713</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardridge W.M. Blood-Brain Barrier Delivery. Drug Discov. Today. 2007;12:54&#x2013;61. doi: 10.1016/j.drudis.2006.10.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.drudis.2006.10.013</ArticleId><ArticleId IdType=\"pubmed\">17198973</ArticleId></ArticleIdList></Reference><Reference><Citation>Barar J., Rafi M.A., Pourseif M.M., Omidi Y. Blood-Brain Barrier Transport Machineries and Targeted Therapy of Brain Diseases. Bioimpacts. 2016;6:225&#x2013;248. doi: 10.15171/bi.2016.30.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15171/bi.2016.30</ArticleId><ArticleId IdType=\"pmc\">PMC5326671</ArticleId><ArticleId IdType=\"pubmed\">28265539</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong C.W. Permeability of the Blood-Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds. J. Membr. Biol. 2015;248:651&#x2013;669. doi: 10.1007/s00232-015-9778-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00232-015-9778-9</ArticleId><ArticleId IdType=\"pubmed\">25675910</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., He Y., Han J., Wei W., Chen F. Blood-Brain Barrier Dysfunction and Alzheimer&#x2019;s Disease: Associations, Pathogenic Mechanisms, and Therapeutic Potential. Front. Aging Neurosci. 2023;15:1258640. doi: 10.3389/fnagi.2023.1258640.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1258640</ArticleId><ArticleId IdType=\"pmc\">PMC10679748</ArticleId><ArticleId IdType=\"pubmed\">38020775</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhalifa A.E., Al-Ghraiybah N.F., Odum J., Shunnarah J.G., Austin N., Kaddoumi A. Blood&#x2013;Brain Barrier Breakdown in Alzheimer&#x2019;s Disease: Mechanisms and Targeted Strategies. Int. J. Mol. Sci. 2023;24:16288. doi: 10.3390/ijms242216288.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms242216288</ArticleId><ArticleId IdType=\"pmc\">PMC10671257</ArticleId><ArticleId IdType=\"pubmed\">38003477</ArticleId></ArticleIdList></Reference><Reference><Citation>Epelbaum S., Burgos N., Canney M., Matthews D., Houot M., Santin M.D., Desseaux C., Bouchoux G., Stroer S., Martin C., et al. Pilot Study of Repeated Blood-Brain Barrier Disruption in Patients with Mild Alzheimer&#x2019;s Disease with an Implantable Ultrasound Device. Alzheimer&#x2019;s Res. Ther. 2022;14:40. doi: 10.1186/s13195-022-00981-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-022-00981-1</ArticleId><ArticleId IdType=\"pmc\">PMC8905724</ArticleId><ArticleId IdType=\"pubmed\">35260178</ArticleId></ArticleIdList></Reference><Reference><Citation>Archie S.R., Al Shoyaib A., Cucullo L. Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview. Pharmaceutics. 2021;13:1779. doi: 10.3390/pharmaceutics13111779.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics13111779</ArticleId><ArticleId IdType=\"pmc\">PMC8622070</ArticleId><ArticleId IdType=\"pubmed\">34834200</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue A., Komine O., Yamanaka K. Neuroinflammation in Alzheimer&#x2019;s Disease: Microglial Signature and Their Relevance to Disease. Inflamm. Regen. 2023;43:26. doi: 10.1186/s41232-023-00277-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s41232-023-00277-3</ArticleId><ArticleId IdType=\"pmc\">PMC10170691</ArticleId><ArticleId IdType=\"pubmed\">37165437</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Guo D., Zhu Y., Xiao S., Xie J., Zhang Z., Hu Y., Huang J., Ma X., Ning Z., et al. Amyloid &#x3b2; Oligomer Induces Cerebral Vasculopathy via Pericyte-Mediated Endothelial Dysfunction. Alzheimer&#x2019;s Res. Ther. 2024;16:56. doi: 10.1186/s13195-024-01423-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-024-01423-w</ArticleId><ArticleId IdType=\"pmc\">PMC10935813</ArticleId><ArticleId IdType=\"pubmed\">38475929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kook S.-Y., Hong H.S., Moon M., Ha C.M., Chang S., Mook-Jung I. A&#x3b2;1&#x2013;42-RAGE Interaction Disrupts Tight Junctions of the Blood&#x2013;Brain Barrier Via Ca2+-Calcineurin Signaling. J. Neurosci. 2012;32:8845&#x2013;8854. doi: 10.1523/JNEUROSCI.6102-11.2012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.6102-11.2012</ArticleId><ArticleId IdType=\"pmc\">PMC6622350</ArticleId><ArticleId IdType=\"pubmed\">22745485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ege D. Action Mechanisms of Curcumin in Alzheimer&#x2019;s Disease and Its Brain Targeted Delivery. Materials. 2021;14:3332. doi: 10.3390/ma14123332.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ma14123332</ArticleId><ArticleId IdType=\"pmc\">PMC8234049</ArticleId><ArticleId IdType=\"pubmed\">34208692</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S., Zheng Y., Liu X., Fang W., Chen X., Liao W., Jing X., Lei M., Tao E., Ma Q., et al. Curcumin-Loaded PLGA-PEG Nanoparticles Conjugated with B6 Peptide for Potential Use in Alzheimer&#x2019;s Disease. Drug Deliv. 2018;25:1091&#x2013;1102. doi: 10.1080/10717544.2018.1461955.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10717544.2018.1461955</ArticleId><ArticleId IdType=\"pmc\">PMC6116673</ArticleId><ArticleId IdType=\"pubmed\">30107760</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew A., Fukuda T., Nagaoka Y., Hasumura T., Morimoto H., Yoshida Y., Maekawa T., Venugopal K., Kumar D.S. Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer&#x2019;s Disease. PLoS ONE. 2012;7:e32616. doi: 10.1371/journal.pone.0032616.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0032616</ArticleId><ArticleId IdType=\"pmc\">PMC3293842</ArticleId><ArticleId IdType=\"pubmed\">22403681</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo X., Zhang Y., Jin X., Li Y., Zhang L.A. Novel Synthesis of Selenium Nanoparticles Encapsulated PLGA Nanospheres with Curcumin Molecules for the Inhibition of Amyloid &#x3b2; Aggregation in Alzheimer&#x2019;s Disease. J. Photochem. Photobiol. B. 2019;190:98&#x2013;102. doi: 10.1016/j.jphotobiol.2018.11.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jphotobiol.2018.11.008</ArticleId><ArticleId IdType=\"pubmed\">30504054</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng K.K., Yeung C.F., Ho S.W., Chow S.F., Chow A.H.L., Baum L. Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood&#x2013;Brain Barrier Model and in Alzheimer&#x2019;s Disease Tg2576 Mice. AAPS J. 2013;15:324&#x2013;336. doi: 10.1208/s12248-012-9444-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1208/s12248-012-9444-4</ArticleId><ArticleId IdType=\"pmc\">PMC3675736</ArticleId><ArticleId IdType=\"pubmed\">23229335</ArticleId></ArticleIdList></Reference><Reference><Citation>Voulgaropoulou S.D., van Amelsvoort T.A.M.J., Prickaerts J., Vingerhoets C. The effect of curcumin on cognition in Alzheimer&#x2019;s disease and healthy aging: A systematic review of pre-clinical and clinical studies. Brain Res. 2019;1725:146476. doi: 10.1016/j.brainres.2019.146476.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainres.2019.146476</ArticleId><ArticleId IdType=\"pubmed\">31560864</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan H., Ullah H., Aschner M., Cheang W.S., Akkol E.K. Neuroprotective Effects of Quercetin in Alzheimer&#x2019;s Disease. Biomolecules. 2020;10:59. doi: 10.3390/biom10010059.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom10010059</ArticleId><ArticleId IdType=\"pmc\">PMC7023116</ArticleId><ArticleId IdType=\"pubmed\">31905923</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D., Li N., Zhang W., Zhao Z., Mou Z., Huang D., Liu J., Wang W. Design of PLGA-Functionalized Quercetin Nanoparticles for Potential Use in Alzheimer&#x2019;s Disease. Colloids Surf. B Biointerfaces. 2016;148:116&#x2013;129. doi: 10.1016/j.colsurfb.2016.08.052.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.colsurfb.2016.08.052</ArticleId><ArticleId IdType=\"pubmed\">27591943</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhou H., Yin T., Gong Y., Yuan G., Chen L., Liu J. Quercetin-Modified Gold-Palladium Nanoparticles as a Potential Autophagy Inducer for the Treatment of Alzheimer&#x2019;s Disease. J. Colloid Interface Sci. 2019;552:388&#x2013;400. doi: 10.1016/j.jcis.2019.05.066.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jcis.2019.05.066</ArticleId><ArticleId IdType=\"pubmed\">31151017</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzales M.M., Garbarino V.R., Kautz T.F., Palavicini J.P., Lopez-Cruzan M., Dehkordi S.K., Mathews J.J., Zare H., Xu P., Zhang B., et al. Senolytic therapy in mild Alzheimer&#x2019;s disease: A phase 1 feasibility trial. Nat. Med. 2023;29:2481&#x2013;2488. doi: 10.1038/s41591-023-02543-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-023-02543-w</ArticleId><ArticleId IdType=\"pmc\">PMC10875739</ArticleId><ArticleId IdType=\"pubmed\">37679434</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathya S., Shanmuganathan B., Balasubramaniam B., Balamurugan K., Devi K.P. Phytol Loaded PLGA Nanoparticles Regulate the Expression of Alzheimer&#x2019;s Related Genes and Neuronal Apoptosis against Amyloid-&#x3b2; Induced Toxicity in Neuro-2a Cells and Transgenic Caenorhabditis Elegans. Food Chem. Toxicol. 2019;136:110962. doi: 10.1016/j.fct.2019.110962.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.fct.2019.110962</ArticleId><ArticleId IdType=\"pubmed\">31734340</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathya S., Shanmuganathan B., Saranya S., Vaidevi S., Ruckmani K., Pandima Devi K. Phytol-loaded PLGA nanoparticle as a modulator of Alzheimer&#x2019;s toxic A&#x3b2; peptide aggregation and fibrillation associated with impaired neuronal cell function. Artif. Cells Nanomed. Biotechnol. 2017;46:1719&#x2013;1730. doi: 10.1080/21691401.2017.1391822.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21691401.2017.1391822</ArticleId><ArticleId IdType=\"pubmed\">29069924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A.-H., Hong S.-C., Park I., Yoon S., Kim Y., Kim J., Yang S.-H. Validation of Fucoxanthin from Microalgae Phaeodactylum tricornutum for the Detection of Amyloid Burden in Transgenic Mouse Models of Alzheimer&#x2019;s Disease. Appl. Sci. 2021;11:5878. doi: 10.3390/app11135878.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/app11135878</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.N., Heo S.J., Yoon W.J., Kang S.M., Ahn G., Yi T.H., Jeon Y.J. Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-&#x3ba;B and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages. Eur. J. Pharmacol. 2010;649:369&#x2013;375. doi: 10.1016/j.ejphar.2010.09.032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejphar.2010.09.032</ArticleId><ArticleId IdType=\"pubmed\">20868674</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M., Jin L., Wu Z., Xie Y., Zhang P., Wang Q., Yan S., Chen B., Liang H., Naman C.B., et al. PLGA-PEG Nanoparticles Facilitate In Vivo Anti-Alzheimer&#x2019;s Effects of Fucoxanthin, a Marine Carotenoid Derived from Edible Brown Algae. J. Agric. Food Chem. 2021;69:9764&#x2013;9777. doi: 10.1021/acs.jafc.1c00569.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.1c00569</ArticleId><ArticleId IdType=\"pubmed\">34404210</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z., Zhao H., Song Y., Kou Y., Yang W., Li Y., Li X., Ding L., Sun Z., Lin J., et al. PEGylated-Liposomal Astaxanthin Ameliorates A&#x3b2; Neurotoxicity and Alzheimer-Related Phenotypes by Scavenging Formaldehyde. J. Control. Release. 2024;366:783&#x2013;797. doi: 10.1016/j.jconrel.2024.01.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jconrel.2024.01.019</ArticleId><ArticleId IdType=\"pubmed\">38242211</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhas N., Mehta T. Cationic Biopolymer Functionalized Nanoparticles Encapsulating Lutein to Attenuate Oxidative Stress in Effective Treatment of Alzheimer&#x2019;s Disease: A Non-Invasive Approach. Int. J. Pharm. 2020;586:119553. doi: 10.1016/j.ijpharm.2020.119553.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijpharm.2020.119553</ArticleId><ArticleId IdType=\"pubmed\">32561306</ArticleId></ArticleIdList></Reference><Reference><Citation>Wici&#x144;ski M., Domanowska A., W&#xf3;dkiewicz E., Malinowski B. Neuroprotective Properties of Resveratrol and Its Derivatives&#x2014;Influence on Potential Mechanisms Leading to the Development of Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2020;21:2749. doi: 10.3390/ijms21082749.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21082749</ArticleId><ArticleId IdType=\"pmc\">PMC7215333</ArticleId><ArticleId IdType=\"pubmed\">32326620</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Wang W., Chen J., Wang N., Zheng G. A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid &#x3b2; aggregation and reactive oxygen species formation properties. J. Biomed. Mater. Res. A. 2018;106:3034&#x2013;3041. doi: 10.1002/jbm.a.36493.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jbm.a.36493</ArticleId><ArticleId IdType=\"pubmed\">30295993</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput A., Bariya A., Allam A., Othman S., Butani S.B. In Situ Nanostructured Hydrogel of Resveratrol for Brain Targeting: In Vitro-in Vivo Characterization. Drug Deliv. Transl. Res. 2018;8:1460&#x2013;1470. doi: 10.1007/s13346-018-0540-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13346-018-0540-6</ArticleId><ArticleId IdType=\"pubmed\">29785574</ArticleId></ArticleIdList></Reference><Reference><Citation>Salem H.F., Kharshoum R.M., Abou-Taleb H.A., Naguib D.M. Brain Targeting of Resveratrol through Intranasal Lipid Vesicles Labelled with Gold Nanoparticles: In Vivo Evaluation and Bioaccumulation Investigation Using Computed Tomography and Histopathological Examination. J. Drug Target. 2019;27:1127&#x2013;1134. doi: 10.1080/1061186X.2019.1608553.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/1061186X.2019.1608553</ArticleId><ArticleId IdType=\"pubmed\">31094230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C.W., Grossman H., Neugroschl J., Parker S., Burden A., Luo X., Sano M. A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer&#x2019;s disease: A pilot study. Alzheimer&#x2019;s Dement. Transl. Res. Clin. Interv. 2018;4:609&#x2013;616. doi: 10.1016/j.trci.2018.09.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.trci.2018.09.009</ArticleId><ArticleId IdType=\"pmc\">PMC6240843</ArticleId><ArticleId IdType=\"pubmed\">30480082</ArticleId></ArticleIdList></Reference><Reference><Citation>Moussa C., Hebron M., Huang X., Ahn J., Rissman R.A., Aisen P.S., Turner R.S. Resveratrol Regulates Neuro-Inflammation and Induces Adaptive Immunity in Alzheimer&#x2019;s Disease. J. Neuroinflamm. 2017;14:1. doi: 10.1186/s12974-016-0779-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-016-0779-0</ArticleId><ArticleId IdType=\"pmc\">PMC5234138</ArticleId><ArticleId IdType=\"pubmed\">28086917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikram M., Muhammad T., Rehman S.U., Khan A., Jo M.G., Ali T., Kim M.O. Hesperetin Confers Neuroprotection by Regulating Nrf2/TLR4/NF-&#x3ba;B Signaling in an A&#x3b2; Mouse Model. Mol. Neurobiol. 2019;56:6293&#x2013;6309. doi: 10.1007/s12035-019-1512-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-019-1512-7</ArticleId><ArticleId IdType=\"pubmed\">30756299</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahr P.L., Grewal R., Eckert G.P., Keck C.M. Investigating Hesperetin Nanocrystals with Tailor-Made Sizes for the Prevention and Treatment of Alzheimer&#x2019;s Disease. Drug Deliv. Transl. Res. 2021;11:659&#x2013;674. doi: 10.1007/s13346-020-00888-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13346-020-00888-0</ArticleId><ArticleId IdType=\"pmc\">PMC7987607</ArticleId><ArticleId IdType=\"pubmed\">33433841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Yang Y., Wan Y., Xia J., Xu J.-F., Zhang L., Liu D., Chen L., Tang F., Ao H., et al. New Insights into the Role and Mechanisms of Ginsenoside Rg1 in the Management of Alzheimer&#x2019;s Disease. Biomed. Pharmacother. 2022;152:113207. doi: 10.1016/j.biopha.2022.113207.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2022.113207</ArticleId><ArticleId IdType=\"pubmed\">35667236</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Torre C., Ce&#xf1;a V. The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer&#x2019;s Disease Therapeutics and Diagnostics. Pharmaceutics. 2018;10:190. doi: 10.3390/pharmaceutics10040190.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics10040190</ArticleId><ArticleId IdType=\"pmc\">PMC6321229</ArticleId><ArticleId IdType=\"pubmed\">30336640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro T.d.C., S&#xe1;bio R.M., Luiz M.T., de Souza L.C., Fonseca-Santos B., Cides da Silva L.C., Fantini M.C.d.A., Planeta C.d.S., Chorilli M. Curcumin-Loaded Mesoporous Silica Nanoparticles Dispersed in Thermo-Responsive Hydrogel as Potential Alzheimer Disease Therapy. Pharmaceutics. 2022;14:1976. doi: 10.3390/pharmaceutics14091976.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics14091976</ArticleId><ArticleId IdType=\"pmc\">PMC9504573</ArticleId><ArticleId IdType=\"pubmed\">36145723</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro R.G.R., Granja A., Loureiro J.A., Pereira M.C., Pinheiro M., Neves A.R., Reis S. Quercetin Lipid Nanoparticles Functionalized with Transferrin for Alzheimer&#x2019;s Disease. Eur. J. Pharm. Sci. 2020;148:105314. doi: 10.1016/j.ejps.2020.105314.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejps.2020.105314</ArticleId><ArticleId IdType=\"pubmed\">32200044</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro R.G.R., Granja A., Loureiro J.A., Pereira M.C., Pinheiro M., Neves A.R., Reis S. RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer&#x2019;s Disease. Pharm. Res. 2020;37:139. doi: 10.1007/s11095-020-02865-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11095-020-02865-1</ArticleId><ArticleId IdType=\"pubmed\">32661727</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y., Yi P., He T., Song X., Liu Y., Li Q., Zheng J., Song R., Liu C., Zhang Z., et al. Quercetin-Loaded Selenium Nanoparticles Inhibit Amyloid-&#x3b2; Aggregation and Exhibit Antioxidant Activity. Colloids Surf. A Physicochem. Eng. Asp. 2020;602:125058. doi: 10.1016/j.colsurfa.2020.125058.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.colsurfa.2020.125058</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Gong Y., Xie W., Huang A., Yuan X., Zhou H., Zhu X., Chen X., Liu J., Liu J., et al. Microbubbles in Combination with Focused Ultrasound for the Delivery of Quercetin-Modified Sulfur Nanoparticles through the Blood Brain Barrier into the Brain Parenchyma and Relief of Endoplasmic Reticulum Stress to Treat Alzheimer&#x2019;s Disease. Nanoscale. 2020;12:6498&#x2013;6511. doi: 10.1039/C9NR09713A.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C9NR09713A</ArticleId><ArticleId IdType=\"pubmed\">32154811</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y., Guo L., Jiang Y., Shi Y., Sui H., Zhao L. Brain Delivery of Quercetin-Loaded Exosomes Improved Cognitive Function in AD Mice by Inhibiting Phosphorylated Tau-Mediated Neurofibrillary Tangles. Drug Deliv. 2020;27:745. doi: 10.1080/10717544.2020.1762262.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10717544.2020.1762262</ArticleId><ArticleId IdType=\"pmc\">PMC7269046</ArticleId><ArticleId IdType=\"pubmed\">32397764</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanzadeh Jajin E., Esmaeili A., Rahgozar S., Noorbakhshnia M. Quercetin-Conjugated Superparamagnetic Iron Oxide Nanoparticles Protect AlCl3-Induced Neurotoxicity in a Rat Model of Alzheimer&#x2019;s Disease via Antioxidant Genes, APP Gene, and miRNA-101. Front. Neurosci. 2021;14:598617. doi: 10.3389/fnins.2020.598617.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2020.598617</ArticleId><ArticleId IdType=\"pmc\">PMC7947204</ArticleId><ArticleId IdType=\"pubmed\">33716639</ArticleId></ArticleIdList></Reference><Reference><Citation>Loureiro J.A., Andrade S., Duarte A., Neves A.R., Queiroz J.F., Nunes C., Sevin E., Fenart L., Gosselet F., Coelho M.A.N., et al. Resveratrol and Grape Extract-Loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer&#x2019;s Disease. Molecules. 2017;22:277. doi: 10.3390/molecules22020277.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules22020277</ArticleId><ArticleId IdType=\"pmc\">PMC6155722</ArticleId><ArticleId IdType=\"pubmed\">28208831</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y., Chu X., Cui L., Fu S., Gao C., Li Y., Sun B. Neuronal Mitochondria-Targeted Therapy for Alzheimer&#x2019;s Disease by Systemic Delivery of Resveratrol Using Dual-Modified Novel Biomimetic Nanosystems. Drug Deliv. 2020;27:502&#x2013;518. doi: 10.1080/10717544.2020.1745328.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10717544.2020.1745328</ArticleId><ArticleId IdType=\"pmc\">PMC7170363</ArticleId><ArticleId IdType=\"pubmed\">32228100</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Wang Y., Zheng G., Li Z., Mei J. Resveratrol-loaded selenium/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer&#x2019;s disease. Int. J. Biol. Macromol. 2023;239:124316. doi: 10.1016/j.ijbiomac.2023.124316.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijbiomac.2023.124316</ArticleId><ArticleId IdType=\"pubmed\">37004937</ArticleId></ArticleIdList></Reference><Reference><Citation>Santonocito D., Raciti G., Campisi A., Sposito G., Panico A., Siciliano E.A., Sarpietro M.G., Damiani E., Puglia C. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer&#x2019;s Disease: Formulation Development and Optimization. Nanomaterials. 2021;11:391. doi: 10.3390/nano11020391.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nano11020391</ArticleId><ArticleId IdType=\"pmc\">PMC7913486</ArticleId><ArticleId IdType=\"pubmed\">33546352</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail N., Ismail M., Azmi N.H., Bakar M.F.A., Yida Z., Abdullah M.A., Basri H. Thymoquinone-Rich Fraction Nanoemulsion (TQRFNE) Decreases A&#x3b2;40 and A&#x3b2;42 Levels by Modulating APP Processing, up-Regulating IDE and LRP1, and down-Regulating BACE1 and RAGE in Response to High Fat/Cholesterol Diet-Induced Rats. Biomed. Pharmacother. 2017;95:780&#x2013;788. doi: 10.1016/j.biopha.2017.08.074.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2017.08.074</ArticleId><ArticleId IdType=\"pubmed\">28892789</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf M., Khan M., Alrobaian M.M., Alghamdi S.A., Warsi M.H., Sultana S., Khan R.A. Brain Targeted Polysorbate-80 Coated PLGA Thymoquinone Nanoparticles for the Treatment of Alzheimer&#x2019;s Disease, with Biomechanistic Insights. J. Drug Deliv. Sci. Technol. 2021;61:102214. doi: 10.1016/j.jddst.2020.102214.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jddst.2020.102214</ArticleId></ArticleIdList></Reference><Reference><Citation>Aalinkeel R., Kutscher H.L., Singh A., Cwiklinski K., Khechen N., Schwartz S.A., Prasad P.N., Mahajan S.D. Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: A potential nanotherapy for Alzheimer&#x2019;s disease? J. Drug Target. 2017;26:182&#x2013;193. doi: 10.1080/1061186X.2017.1354002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/1061186X.2017.1354002</ArticleId><ArticleId IdType=\"pubmed\">28697660</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajizadeh Moghaddam A., Ahmadnia H., Jelodar S.K., Ranjbar M. Hesperetin Nanoparticles Attenuate Anxiogenic-like Behavior and Cerebral Oxidative Stress through the Upregulation of Antioxidant Enzyme Expression in Experimental Dementia of Alzheimer&#x2019;s Type. Neurol. Res. 2020;42:477&#x2013;486. doi: 10.1080/01616412.2020.1747716.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/01616412.2020.1747716</ArticleId><ArticleId IdType=\"pubmed\">32252616</ArticleId></ArticleIdList></Reference><Reference><Citation>Babylon L., Grewal R., Stahr P.-L., Eckert R.W., Keck C.M., Eckert G.P. Hesperetin Nanocrystals Improve Mitochondrial Function in a Cell Model of Early Alzheimer Disease. Antioxidants. 2021;10:1003. doi: 10.3390/antiox10071003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox10071003</ArticleId><ArticleId IdType=\"pmc\">PMC8300699</ArticleId><ArticleId IdType=\"pubmed\">34201544</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Q., Wang A., Hua H., Jiang Y., Wang Y., Mu H., Wu Z., Sun K. Intranasal Delivery of Huperzine A to the Brain Using Lactoferrin-Conjugated N-Trimethylated Chitosan Surface-Modified PLGA Nanoparticles for Treatment of Alzheimer&#x2019;s Disease. Int. J. Nanomed. 2018;13:705&#x2013;718. doi: 10.2147/IJN.S151474.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/IJN.S151474</ArticleId><ArticleId IdType=\"pmc\">PMC5798568</ArticleId><ArticleId IdType=\"pubmed\">29440896</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca-Santos B., Gremi&#xe3;o M.P.D., Chorilli M. Nanotechnology-Based Drug Delivery Systems for the Treatment of Alzheimer&#x2019;s Disease. Int. J. Nanomed. 2015;10:4981&#x2013;5003. doi: 10.2147/IJN.S87148.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/IJN.S87148</ArticleId><ArticleId IdType=\"pmc\">PMC4531021</ArticleId><ArticleId IdType=\"pubmed\">26345528</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson B., Samanta M.K., Santhi K., Kumar K.P., Paramakrishnan N., Suresh B. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer&#x2019;s disease. Brain Res. 2008;1200:159&#x2013;168. doi: 10.1016/j.brainres.2008.01.039.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainres.2008.01.039</ArticleId><ArticleId IdType=\"pubmed\">18291351</ArticleId></ArticleIdList></Reference><Reference><Citation>Manek E., Darvas F., Petroianu G.A. Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer&#x2019;s Disease. Molecules. 2020;25:4866. doi: 10.3390/molecules25204866.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules25204866</ArticleId><ArticleId IdType=\"pmc\">PMC7587961</ArticleId><ArticleId IdType=\"pubmed\">33096898</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbez-Gindre C., Steele B.R., Micha-Screttas M. Dendrimers in Alzheimer&#x2019;s Disease: Recent Approaches in Multi-Targeting Strategies. Pharmaceutics. 2023;15:898. doi: 10.3390/pharmaceutics15030898.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics15030898</ArticleId><ArticleId IdType=\"pmc\">PMC10059864</ArticleId><ArticleId IdType=\"pubmed\">36986759</ArticleId></ArticleIdList></Reference><Reference><Citation>Igart&#xfa;a D.E., Martinez C.S., Alonso S.d.V., Prieto M.J. Combined Therapy for Alzheimer&#x2019;s Disease: Tacrine and PAMAM Dendrimers Co-Administration Reduces the Side Effects of the Drug without Modifying its Activity. AAPS PharmSciTech. 2020;21:110. doi: 10.1208/s12249-020-01652-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1208/s12249-020-01652-w</ArticleId><ArticleId IdType=\"pubmed\">32215751</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler M.E., Vela Ramirez J.E., Peppas N.A. 110th Anniversary: Nanoparticle Mediated Drug Delivery for the Treatment of Alzheimer&#x2019;s Disease: Crossing the Blood&#x2013;Brain Barrier. Ind. Eng. Chem. Res. 2019;58:15079&#x2013;15087. doi: 10.1021/acs.iecr.9b02196.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.iecr.9b02196</ArticleId><ArticleId IdType=\"pmc\">PMC7518412</ArticleId><ArticleId IdType=\"pubmed\">32982041</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao N., Sun H., Dong K., Ren J., Qu X. Gold-nanoparticle-based multifunctional amyloid-&#x3b2; inhibitor against Alzheimer&#x2019;s disease. Chemistry. 2015;21:829&#x2013;835. doi: 10.1002/chem.201404562.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/chem.201404562</ArticleId><ArticleId IdType=\"pubmed\">25376633</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirale P., Paul A., Yadav K.S. Nanoemulsions for Targeting the Neurodegenerative Diseases: Alzheimer&#x2019;s, Parkinson&#x2019;s and Prion&#x2019;s. Life Sci. 2020;245:117394. doi: 10.1016/j.lfs.2020.117394.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lfs.2020.117394</ArticleId><ArticleId IdType=\"pubmed\">32017870</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L.K., Kuan Y.C., Lin H.W., Hu C.-J. Clinical trials of new drugs for Alzheimer disease: A 2020&#x2013;2023 update. J. Biomed. Sci. 2023;30:83. doi: 10.1186/s12929-023-00976-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12929-023-00976-6</ArticleId><ArticleId IdType=\"pmc\">PMC10544555</ArticleId><ArticleId IdType=\"pubmed\">37784171</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini S., Hao B., Yang J., Karjadi C., Kolachalama B.B., Au R., Paschalidis I.C. Prediction of Alzheimer&#x2019;s disease progression within 6 years using speech: A novel approach leveraging language models. Alzheimer&#x2019;s Dement. 2024 doi: 10.1002/alz.13886. in press .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13886</ArticleId><ArticleId IdType=\"pmc\">PMC11350035</ArticleId><ArticleId IdType=\"pubmed\">38924662</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">39274441</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Print\">2077-0383</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>13</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Differences in Grey Matter Concentrations and Functional Connectivity between Young Carriers and Non-Carriers of the APOE &#x3b5;4 Genotype.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">5228</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/jcm13175228</ELocationID><Abstract><AbstractText><b>Background</b>: The pathophysiology of Alzheimer's disease (AD) may begin developing years or even decades prior to the manifestation of its first symptoms. The APOE &#x3b5;4 genotype is a prominent genetic risk for AD that has been found to be associated with brain changes across the lifespan since early adulthood. Thus, studying brain changes that may occur in young adults with an APOE &#x3b5;4 status is highly relevant. <b>Objective</b>: Examine potential differences in grey matter (GM) and functional connectivity (FC) in brains of cognitively healthy young APOE &#x3b5;4 carriers and non-carriers, denoted here as &#x3b5;4(+) and &#x3b5;4(-), respectively. <b>Methods</b>: Three Tesla magnetic resonance imaging (MRI) brain scans were acquired from cognitively healthy young participants aged approximately 20 years (n = 151). Voxel-based morphometry (VBM) analysis was employed to identify potential structural differences in GM between &#x3b5;4(+) and &#x3b5;4(-). In a subsequent seed-based connectivity (SBC) analysis, brain regions that structurally differed in the VBM analysis were considered as seeds and correlated with all the remaining voxels across the brains to then measure the differences in FC between groups. <b>Results</b>: The VBM analysis suggested that &#x3b5;4(+) (n = 28) had greater GM densities relative to &#x3b5;4(-) (n = 123) in the left hippocampus and the left posterior insula (p<sub>uncorr</sub> &lt; 0.001). However, the effect did not survive the correction for multiple comparisons, suggesting minimal structural differences in this age range. In contrast, the SBC analysis indicated that &#x3b5;4(+) exhibited significantly decreased FC between the left hippocampus and areas of the left middle temporal gyrus (n = 27) compared to &#x3b5;4(-) (n = 102). These results remained significant after multiple comparisons (p<sub>FDR</sub> &lt; 0.05). Lastly, no statistically significant differences in FC between groups were observed for the left insular seed (p<sub>FDR</sub> &gt; 0.05). <b>Discussion</b>: These results suggest early structural and functional brain changes associated with the APOE &#x3b5;4 genotype on young adults. Yet, they must be cautiously interpreted and contrasted with both older adults with genetic risk for AD and patients diagnosed with AD.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Mu&#xf1;oz-Neira</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source=\"ORCID\">0000-0002-4160-7875</Identifier><AffiliationInfo><Affiliation>Artificial Intelligence &amp; Computational Neuroscience Group (AICN Group), Sheffield Institute for Translational Neuroscience (SITraN), Division of Neuroscience, School of Medicine and Population Health, Faculty of Health, University of Sheffield, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Old Age Psychiatry Research Group (OAP Group), Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zeng</LastName><ForeName>Jianmin</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0003-0440-6684</Identifier><AffiliationInfo><Affiliation>Sino-Britain Centre for Cognition and Ageing Research, Faculty of Psychology, Southwest University, Chongqing 400715, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kucikova</LastName><ForeName>Ludmila</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0002-0769-9542</Identifier><AffiliationInfo><Affiliation>Artificial Intelligence &amp; Computational Neuroscience Group (AICN Group), Sheffield Institute for Translational Neuroscience (SITraN), Division of Neuroscience, School of Medicine and Population Health, Faculty of Health, University of Sheffield, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield S1 3JD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Huang</LastName><ForeName>Weijie</ForeName><Initials>W</Initials><Identifier Source=\"ORCID\">0000-0002-2481-1188</Identifier><AffiliationInfo><Affiliation>Artificial Intelligence &amp; Computational Neuroscience Group (AICN Group), Sheffield Institute for Translational Neuroscience (SITraN), Division of Neuroscience, School of Medicine and Population Health, Faculty of Health, University of Sheffield, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Old Age Psychiatry Research Group (OAP Group), Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0SZ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Systems Science, Beijing Normal University, Beijing 100875, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xiong</LastName><ForeName>Xiong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Artificial Intelligence &amp; Computational Neuroscience Group (AICN Group), Sheffield Institute for Translational Neuroscience (SITraN), Division of Neuroscience, School of Medicine and Population Health, Faculty of Health, University of Sheffield, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Information and Communication Engineering, Beijing University of Posts and Telecommunications, Beijing 100876, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Muniz-Terrera</LastName><ForeName>Graciela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Edinburgh Dementia Prevention, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH4 2XU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ohio University Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ritchie</LastName><ForeName>Craig</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Edinburgh Dementia Prevention, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH4 2XU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scottish Brain Sciences, Edinburgh EH12 9DQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>O'Brien</LastName><ForeName>John T</ForeName><Initials>JT</Initials><Identifier Source=\"ORCID\">0000-0002-0837-5080</Identifier><AffiliationInfo><Affiliation>Old Age Psychiatry Research Group (OAP Group), Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Su</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Artificial Intelligence &amp; Computational Neuroscience Group (AICN Group), Sheffield Institute for Translational Neuroscience (SITraN), Division of Neuroscience, School of Medicine and Population Health, Faculty of Health, University of Sheffield, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Old Age Psychiatry Research Group (OAP Group), Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0SZ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield S1 3JD, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>23YJA190001</GrantID><Agency>China Ministry of Education's Humanity and Social Sciences Project</Agency><Country/></Grant><Grant><GrantID>ARUK-SRF2017B-1</GrantID><Agency>Alzheimer's Research UK Senior Research Fellowship</Agency><Country/></Grant><Grant><GrantID>NIHR203321</GrantID><Agency>National Institute for Health and Care Research (NIHR) Sheffield Biomedical Research Centre</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">APOE &#x3b5;4</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">functional brain imaging</Keyword><Keyword MajorTopicYN=\"N\">magnetic resonance imaging</Keyword><Keyword MajorTopicYN=\"N\">resting state functional magnetic resonance imaging</Keyword><Keyword MajorTopicYN=\"N\">seed-based connectivity</Keyword><Keyword MajorTopicYN=\"N\">structural brain imaging</Keyword><Keyword MajorTopicYN=\"N\">voxel-based morphometry</Keyword><Keyword MajorTopicYN=\"N\">young adults</Keyword></KeywordList><CoiStatement>The authors have no conflict of interests to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39274441</ArticleId><ArticleId IdType=\"doi\">10.3390/jcm13175228</ArticleId><ArticleId IdType=\"pii\">jcm13175228</ArticleId><ArticleId IdType=\"pmc\">PMC11396314</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prince M., Wimo A., Guerchet M., Ali G., Wu Y., Prina M. The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends; World Alzheimer Report. 2015.  [(accessed on 17 July 2024)].  Available online:  https://www.alzint.org/u/WorldAlzheimerReport2015.pdf.</Citation></Reference><Reference><Citation>United Nations . World Population Prospects 2019: Highlights. Statistical Papers&#x2014;United Nations (Ser. A), Population and Vital Statistics Report. United Nations; New York, NY, USA: 2019. p. 43.</Citation></Reference><Reference><Citation>World Health Organization and Alzheimer&#x2019;s Disease International  . Dementia: A Public Health Priority. World Health Organization; Geneva, Switzerland: 2012.  [(accessed on 17 July 2024)].  1 Online Resource (112) Available online:  https://www.who.int/publications/i/item/dementia-a-public-health-priority.</Citation></Reference><Reference><Citation>Fiest K.M., Roberts J.I., Maxwell C.J., Hogan D.B., Smith E.E., Frolkis A., Cohen A., Kirk A., Pearson D., Pringsheim T., et al. The Prevalence and Incidence of Dementia Due to Alzheimer&#x2019;s Disease: A Systematic Review and Meta-Analysis. Can. J. Neurol. Sci. 2016;43((Suppl 1)):S51&#x2013;S82. doi: 10.1017/cjn.2016.36.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/cjn.2016.36</ArticleId><ArticleId IdType=\"pubmed\">27307128</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurtray A., Clark D.G., Christine D., Mendez M.F. Early-onset dementia: Frequency and causes compared to late-onset dementia. Dement. Geriatr. Cogn. Disord. 2006;21:59&#x2013;64. doi: 10.1159/000089546.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000089546</ArticleId><ArticleId IdType=\"pubmed\">16276111</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes J., Dickerson B.C., Frost C., Jiskoot L.C., Wolk D., van der Flier W.M. Alzheimer&#x2019;s disease first symptoms are age dependent: Evidence from the NACC dataset. Alzheimers Dement. 2015;11:1349&#x2013;1357. doi: 10.1016/j.jalz.2014.12.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2014.12.007</ArticleId><ArticleId IdType=\"pmc\">PMC4619185</ArticleId><ArticleId IdType=\"pubmed\">25916562</ArticleId></ArticleIdList></Reference><Reference><Citation>Bature F., Guinn B.-A., Pang D., Pappas Y. Signs and symptoms preceding the diagnosis of Alzheimer&#x2019;s disease: A systematic scoping review of literature from 1937 to 2016. BMJ Open. 2017;7:e015746. doi: 10.1136/bmjopen-2016-015746.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmjopen-2016-015746</ArticleId><ArticleId IdType=\"pmc\">PMC5724073</ArticleId><ArticleId IdType=\"pubmed\">28851777</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen P.S., Cummings J., Jack C.R., Jr., Morris J.C., Sperling R., Fr&#xf6;lich L., Jones R.W., Dowsett S.A., Matthews B.R., Raskin J., et al. On the path to 2025: Understanding the Alzheimer&#x2019;s disease continuum. Alzheimers Res. Ther. 2017;9:60. doi: 10.1186/s13195-017-0283-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-017-0283-5</ArticleId><ArticleId IdType=\"pmc\">PMC5549378</ArticleId><ArticleId IdType=\"pubmed\">28793924</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolova L.G. Alzheimer Disease. Contin. Lifelong Learn. Neurol. 2016;22:419&#x2013;434. doi: 10.1212/CON.0000000000000307.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/CON.0000000000000307</ArticleId><ArticleId IdType=\"pmc\">PMC5390933</ArticleId><ArticleId IdType=\"pubmed\">27042902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie K., Carriere I., Su L., O&#x2019;Brien J.T., Lovestone S., Wells K., Ritchie C.W. The midlife cognitive profiles of adults at high risk of late-onset Alzheimer&#x2019;s disease: The PREVENT study. Alzheimers Dement. 2017;13:1089&#x2013;1097. doi: 10.1016/j.jalz.2017.02.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2017.02.008</ArticleId><ArticleId IdType=\"pubmed\">28365321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie K., Ritchie C.W., Yaffe K., Skoog I., Scarmeas N. Is late-onset Alzheimer&#x2019;s disease really a disease of midlife? Alzheimers Dement. 2015;1:122&#x2013;130. doi: 10.1016/j.trci.2015.06.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.trci.2015.06.004</ArticleId><ArticleId IdType=\"pmc\">PMC5975058</ArticleId><ArticleId IdType=\"pubmed\">29854932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward A., Crean S., Mercaldi C.J., Collins J.M., Boyd D., Cook M.N., Arrighi H.M. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer&#x2019;s disease: A systematic review and meta-analysis. Neuroepidemiology. 2012;38:1&#x2013;17. doi: 10.1159/000334607.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000334607</ArticleId><ArticleId IdType=\"pubmed\">22179327</ArticleId></ArticleIdList></Reference><Reference><Citation>Crean S., Ward A., Mercaldi C.J., Collins J.M., Cook M.N., Baker N.L., Arrighi H.M. Apolipoprotein E epsilon4 prevalence in Alzheimer&#x2019;s disease patients varies across global populations: A systematic literature review and meta-analysis. Dement. Geriatr. Cogn. Disord. 2011;31:20&#x2013;30. doi: 10.1159/000321984.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000321984</ArticleId><ArticleId IdType=\"pubmed\">21124030</ArticleId></ArticleIdList></Reference><Reference><Citation>Suri S., Heise V., Trachtenberg A.J., Mackay C.E. The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE &#x25b;2. Pt 2Neurosci. Biobehav. Rev. 2013;37:2878&#x2013;2886. doi: 10.1016/j.neubiorev.2013.10.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2013.10.010</ArticleId><ArticleId IdType=\"pubmed\">24183852</ArticleId></ArticleIdList></Reference><Reference><Citation>De-Almada B., De-Almeida L., Camporez D., De-Moraes M., Morelato R., Perrone A., Belcavello L., Louro I., De-Paula F. Protective effect of the APOE-e3 allele in Alzheimer&#x2018;s&#x2019; disease. Braz. J. Med. Biol. Res. 2012;45:8&#x2013;12. doi: 10.1590/S0100-879X2011007500151.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1590/S0100-879X2011007500151</ArticleId><ArticleId IdType=\"pmc\">PMC3854133</ArticleId><ArticleId IdType=\"pubmed\">22068907</ArticleId></ArticleIdList></Reference><Reference><Citation>Piers R.J. Structural brain volume differences between cognitively intact ApoE4 carriers and non-carriers across the lifespan. Neural Regen. Res. 2018;13:1309&#x2013;1312. doi: 10.4103/1673-5374.235408.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/1673-5374.235408</ArticleId><ArticleId IdType=\"pmc\">PMC6108197</ArticleId><ArticleId IdType=\"pubmed\">30106031</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Dawyer L., Lamberton F., Matura S., Tanner C., Scheibe M., Miller J., Rujescu D., Prvulovic D., Hampel H. Reduced hippocampal volume in healthy young ApoE4 carriers: An MRI study. PLoS ONE. 2012;7:e48895. doi: 10.1371/journal.pone.0048895.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0048895</ArticleId><ArticleId IdType=\"pmc\">PMC3494711</ArticleId><ArticleId IdType=\"pubmed\">23152815</ArticleId></ArticleIdList></Reference><Reference><Citation>Stening E., Persson J., Eriksson E., Wahlund L.-O., Zetterberg H., S&#xf6;derlund H. Apolipoprotein E &#x3f5;4 is positively related to spatial performance but unrelated to hippocampal volume in healthy young adults. Behav. Brain Res. 2016;299:11&#x2013;18. doi: 10.1016/j.bbr.2015.11.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbr.2015.11.006</ArticleId><ArticleId IdType=\"pubmed\">26581118</ArticleId></ArticleIdList></Reference><Reference><Citation>Dounavi M.-E., Mak E., Wells K., Ritchie K., Ritchie C.W., Su L., Brien J.T.O. Volumetric alterations in the hippocampal subfields of subjects at increased risk of dementia. Neurobiol. Aging. 2020;91:36&#x2013;44. doi: 10.1016/j.neurobiolaging.2020.03.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2020.03.006</ArticleId><ArticleId IdType=\"pubmed\">32311609</ArticleId></ArticleIdList></Reference><Reference><Citation>Burggren A., Zeineh M., Ekstrom A., Braskie M., Thompson P., Small G., Bookheimer S. Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage. 2008;41:1177&#x2013;1183. doi: 10.1016/j.neuroimage.2008.03.039.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2008.03.039</ArticleId><ArticleId IdType=\"pmc\">PMC2601686</ArticleId><ArticleId IdType=\"pubmed\">18486492</ArticleId></ArticleIdList></Reference><Reference><Citation>Risacher S.L., Apostolova L.G. Neuroimaging in Dementia. Contin. Lifelong Learn. Neurol. 2023;29:219&#x2013;254. doi: 10.1212/CON.0000000000001248.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/CON.0000000000001248</ArticleId><ArticleId IdType=\"pubmed\">36795879</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J., Qin W., Xu Q., Xu L., Xu J., Zhang P., Liu H., Liu B., Jiang T., Yu C. Modulation of APOE and SORL1 genes on hippocampal functional connectivity in healthy young adults. Brain Struct. Funct. 2017;222:2877&#x2013;2889. doi: 10.1007/s00429-017-1377-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00429-017-1377-3</ArticleId><ArticleId IdType=\"pmc\">PMC5541082</ArticleId><ArticleId IdType=\"pubmed\">28229235</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Antuono P.G., Xie C., Chen G., Jones J.L., Ward B.D., Singh S.P., Franczak M.B., Goveas J.S., Li S.J. Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriers. Cortex. 2014;57:167&#x2013;176. doi: 10.1016/j.cortex.2014.04.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cortex.2014.04.006</ArticleId><ArticleId IdType=\"pmc\">PMC4448757</ArticleId><ArticleId IdType=\"pubmed\">24905971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheline Y.I., Morris J.C., Snyder A.Z., Price J.L., Yan Z., D&#x2019;Angelo G., Liu C., Dixit S., Benzinger T., Fagan A., et al. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF A&#x3b2;42. J. Neurosci. 2010;30:17035&#x2013;17040. doi: 10.1523/JNEUROSCI.3987-10.2010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.3987-10.2010</ArticleId><ArticleId IdType=\"pmc\">PMC3023180</ArticleId><ArticleId IdType=\"pubmed\">21159973</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Seeley W.W. Network dysfunction in Alzheimer&#x2019;s disease and frontotemporal dementia: Implications for psychiatry. Biol. Psychiatry. 2014;75:565&#x2013;573. doi: 10.1016/j.biopsych.2014.01.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopsych.2014.01.020</ArticleId><ArticleId IdType=\"pubmed\">24629669</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucikova L., Goerdten J., Dounavi M.E., Mak E., Su L., Waldman A.D., Danso S., Muniz-Terrera G., Ritchie C.W. Resting-state brain connectivity in healthy young and middle-aged adults at risk of progressive Alzheimer&#x2019;s disease. Neurosci. Biobehav. Rev. 2021;129:142&#x2013;153. doi: 10.1016/j.neubiorev.2021.07.024.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2021.07.024</ArticleId><ArticleId IdType=\"pubmed\">34310975</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo H., Mather K.A., Jiang J., Thalamuthu A., Wen W., Sachdev P.S. Genetic influence on ageing-related changes in resting-state brain functional networks in healthy adults: A systematic review. Neurosci. Biobehav. Rev. 2020;113:98&#x2013;110. doi: 10.1016/j.neubiorev.2020.03.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2020.03.011</ArticleId><ArticleId IdType=\"pubmed\">32169413</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y.Y., Liang X., Schoepf U.J., Varga-Szemes A., West H.C., Qi R., Kong X., Chen H.J., Lu G.M., Zhang L.J. APOE Polymorphism Affects Brain Default Mode Network in Healthy Young Adults: A STROBE Article. Medicine. 2015;94:e1734. doi: 10.1097/MD.0000000000001734.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MD.0000000000001734</ArticleId><ArticleId IdType=\"pmc\">PMC5291594</ArticleId><ArticleId IdType=\"pubmed\">26717353</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y.Y., Zhang X.D., Schoepf U.J., Varga-Szemes A., Stubenrauch A., Liang X., Zheng L.J., Zheng G., Kong X., Xu Q., et al. Lower functional connectivity of default mode network in cognitively normal young adults with mutation of APP, presenilins and APOE &#x3b5;4. Brain Imaging Behav. 2017;11:818&#x2013;828. doi: 10.1007/s11682-016-9556-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11682-016-9556-z</ArticleId><ArticleId IdType=\"pubmed\">27189159</ArticleId></ArticleIdList></Reference><Reference><Citation>Trachtenberg A.J., Filippini N., Ebmeier K.P., Smith S.M., Karpe F., Mackay C.E. The effects of APOE on the functional architecture of the resting brain. Neuroimage. 2012;59:565&#x2013;572. doi: 10.1016/j.neuroimage.2011.07.059.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2011.07.059</ArticleId><ArticleId IdType=\"pubmed\">21851856</ArticleId></ArticleIdList></Reference><Reference><Citation>JASP Team . JASP. Windows; Redmond, WA, USA: 2024. (Version 0.18.3)</Citation></Reference><Reference><Citation>Friston K.J., Ashburner J., Kiebel S., Nichols T., Penny W. Statistical Parametric Mapping: The Analysis of Funtional Brain Images. Elsevier; Amsterdam The Netherland: Academic Press; Boston, MA, USA: 2007.</Citation></Reference><Reference><Citation>Ashburner J., Friston K.J. Voxel-based morphometry&#x2014;The methods. Pt 1Neuroimage. 2000;11:805&#x2013;821. doi: 10.1006/nimg.2000.0582.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/nimg.2000.0582</ArticleId><ArticleId IdType=\"pubmed\">10860804</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaser C., Dahnke R. CAT&#x2014;A Computational Anatomy Toolbox for the Analysis of Structural MRI Data, in HBM. 2016.  [(accessed on 17 July 2024)].  Available online:  https://neuro-jena.github.io/cat12-help/</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC11299546</ArticleId><ArticleId IdType=\"pubmed\">39102518</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaser C., Dahnke R., Thompson P.M., Kurth F., Luders E., the Alzheimer&#x2019;s Disease Neuroimaging Initiative  CAT: A computational anatomy toolbox for the analysis of structural MRI data.  [(accessed on 17 July 2024)];GigaScience. 2024 13:1&#x2013;13. doi: 10.1093/gigascience/giae049. Available online:  https://jasp-stats.org/</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gigascience/giae049</ArticleId><ArticleId IdType=\"pmc\">PMC11299546</ArticleId><ArticleId IdType=\"pubmed\">39102518</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitfield-Gabrieli S., Nieto-Castanon A. Conn: A functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2:125&#x2013;141. doi: 10.1089/brain.2012.0073.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/brain.2012.0073</ArticleId><ArticleId IdType=\"pubmed\">22642651</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Castanon A.  Handbook of Functional Connectivity Magnetic Resonance Imaging Methods in CONN. Hilbert Press; Boston, MA, USA: 2020.  [(accessed on 17 July 2024)].  Available online:  https://www.hilbertpress.org/link-nieto-castanon2020.</Citation></Reference><Reference><Citation>Nieto-Castanon A. Citing CONN.  [(accessed on 8 January 2024)].  Available online:  https://web.conn-toolbox.org/resources/citing-conn.</Citation></Reference><Reference><Citation>DiBattista A.M., Stevens B.W., Rebeck G.W., Green A.E. Two Alzheimer&#x2019;s disease risk genes increase entorhinal cortex volume in young adults. Front. Hum. Neurosci. 2014;8:779. doi: 10.3389/fnhum.2014.00779.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnhum.2014.00779</ArticleId><ArticleId IdType=\"pmc\">PMC4186290</ArticleId><ArticleId IdType=\"pubmed\">25339884</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhovd K.B., Fjell A.M., S&#xf8;rensen &#xd8;., Mowinckel A.M., Reinbold C.S., Idland A.-V., Watne L.O., Franke A., Dobricic V., Kilpert F., et al. Genetic risk for Alzheimer disease predicts hippocampal volume through the human lifespan. Neurol. Genet. 2020;6:e506. doi: 10.1212/NXG.0000000000000506.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/NXG.0000000000000506</ArticleId><ArticleId IdType=\"pmc\">PMC7577559</ArticleId><ArticleId IdType=\"pubmed\">33134508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramusino M.C., Altomare D., Bacchin R., Ingala S., Bn&#xe0; C., Bonetti M., Costa A., Barkhof F., Nicolosi V., Festari C., et al. Medial temporal lobe atrophy and posterior atrophy scales normative values. Neuroimage Clin. 2019;24:101936. doi: 10.1016/j.nicl.2019.101936.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nicl.2019.101936</ArticleId><ArticleId IdType=\"pmc\">PMC6690662</ArticleId><ArticleId IdType=\"pubmed\">31382240</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi K., Bhat V., Banner H., Poirier J., Joober R., Bohbot V.D. APOE2 Is Associated with Spatial Navigational Strategies and Increased Gray Matter in the Hippocampus. Front. Hum. Neurosci. 2016;10:349. doi: 10.3389/fnhum.2016.00349.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnhum.2016.00349</ArticleId><ArticleId IdType=\"pmc\">PMC4942687</ArticleId><ArticleId IdType=\"pubmed\">27468260</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeever A., Paris A.F., Cullen J., Hayes L., Ritchie C.W., Ritchie K., Waldman A.D., Wells K., Busza A., Carriere I., et al. Hippocampal Subfield Volumes in Middle-Aged Adults at Risk of Dementia. J. Alzheimers Dis. 2020;75:1211&#x2013;1218. doi: 10.3233/JAD-200238.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-200238</ArticleId><ArticleId IdType=\"pubmed\">32417786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira L.K., Diniz B.S., Forlenza O.V., Busatto G.F., Zanetti M.V. Neurostructural predictors of Alzheimer&#x2019;s disease: A meta-analysis of VBM studies. Neurobiol. Aging. 2011;32:1733&#x2013;1741. doi: 10.1016/j.neurobiolaging.2009.11.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2009.11.008</ArticleId><ArticleId IdType=\"pubmed\">20005012</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H.Y., Park C.R., Suh C.H., Shim W.H., Kim S.J. Diagnostic performance of the medial temporal lobe atrophy scale in patients with Alzheimer&#x2019;s disease: A systematic review and meta-analysis. Eur. Radiol. 2021;31:9060&#x2013;9072. doi: 10.1007/s00330-021-08227-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00330-021-08227-8</ArticleId><ArticleId IdType=\"pubmed\">34510246</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak E., Gabel S., Mirette H., Su L., Williams G.B., Waldman A., Wells K., Ritchie K., Ritchie C., O&#x2019;Brien J.T. Structural neuroimaging in preclinical dementia: From microstructural deficits and grey matter atrophy to macroscale connectomic changes. Ageing Res. Rev. 2017;35:250&#x2013;264. doi: 10.1016/j.arr.2016.10.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2016.10.001</ArticleId><ArticleId IdType=\"pubmed\">27777039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucikova L., Zeng J., Mu&#xf1;oz-Neira C., Muniz-Terrera G., Huang W., Gregory S., Ritchie C., O&#x2019;Brien J.T., Su L. Genetic risk factors of Alzheimer&#x2019;s Disease disrupt resting-state functional connectivity in cognitively intact young individuals. J. Neurol. 2023;270:4949&#x2013;4958. doi: 10.1007/s00415-023-11809-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00415-023-11809-9</ArticleId><ArticleId IdType=\"pmc\">PMC10511575</ArticleId><ArticleId IdType=\"pubmed\">37358635</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng L.J., Su Y.Y., Wang Y.F., Schoepf U.J., Varga-Szemes A., Pannell J., Liang X., Zheng G., Lu G.M., Yang G.F., et al. Different Hippocampus Functional Connectivity Patterns in Healthy Young Adults with Mutations of APP/Presenilin-1/2 and APOEepsilon4. Mol. Neurobiol. 2018;55:3439&#x2013;3450. doi: 10.1007/s12035-017-0540-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-017-0540-4</ArticleId><ArticleId IdType=\"pubmed\">28502043</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng L.J., Lin L., Schoepf U.J., Varga-Szemes A., Savage R.H., Zhang H., Wang Y.F., Zhang X.Y., Luo S., Liu Y., et al. Different posterior hippocampus and default mode network modulation in young APOE epsilon4 carriers: A functional connectome-informed phenotype longitudinal study. Mol. Neurobiol. 2021;58:2757&#x2013;2769. doi: 10.1007/s12035-021-02292-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-021-02292-2</ArticleId><ArticleId IdType=\"pubmed\">33496907</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Huang C.C., Liu M.E., Liou Y.J., Hong C.J., Lo M.T., Huang N.E., Peng C.K., Lin C.P., Tsai S.J. The APOE epsilon4 allele affects complexity and functional connectivity of resting brain activity in healthy adults. Hum. Brain Mapp. 2014;35:3238&#x2013;3248. doi: 10.1002/hbm.22398.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/hbm.22398</ArticleId><ArticleId IdType=\"pmc\">PMC6869578</ArticleId><ArticleId IdType=\"pubmed\">24193893</ArticleId></ArticleIdList></Reference><Reference><Citation>Korthauer L.E., Zhan L., Ajilore O., Leow A., Driscoll I. Disrupted topology of the resting state structural connectome in middle-aged APOE epsilon4 carriers. Neuroimage. 2018;178:295&#x2013;305. doi: 10.1016/j.neuroimage.2018.05.052.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2018.05.052</ArticleId><ArticleId IdType=\"pmc\">PMC6249680</ArticleId><ArticleId IdType=\"pubmed\">29803958</ArticleId></ArticleIdList></Reference><Reference><Citation>Berron D., van Westen D., Ossenkoppele R., Strandberg O., Hansson O. Medial temporal lobe connectivity and its associations with cognition in early Alzheimer&#x2019;s disease. Brain. 2020;143:1233&#x2013;1248. doi: 10.1093/brain/awaa068.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awaa068</ArticleId><ArticleId IdType=\"pmc\">PMC7174043</ArticleId><ArticleId IdType=\"pubmed\">32252068</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny E.R., Blamire A.M., Firbank M.J., O&#x2019;Brien J.T. Functional connectivity in cortical regions in dementia with Lewy bodies and Alzheimer&#x2019;s disease. Pt 2Brain. 2012;135:569&#x2013;581. doi: 10.1093/brain/awr327.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awr327</ArticleId><ArticleId IdType=\"pmc\">PMC3708629</ArticleId><ArticleId IdType=\"pubmed\">22189566</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Li R., Fleisher A.S., Reiman E.M., Guan X., Zhang Y., Chen K., Yao L. Altered default mode network connectivity in Alzheimer&#x2019;s disease&#x2014;A resting functional MRI and Bayesian network study. Hum. Brain Mapp. 2011;32:1868&#x2013;1881. doi: 10.1002/hbm.21153.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/hbm.21153</ArticleId><ArticleId IdType=\"pmc\">PMC3208821</ArticleId><ArticleId IdType=\"pubmed\">21259382</ArticleId></ArticleIdList></Reference><Reference><Citation>Regy M., Dugravot A., Sabia S., Fayosse A., Mangin J.F., Chupin M., Fischer C., Bouteloup V., Dufouil C., Chene G., et al. Association of APOE epsilon4 with cerebral gray matter volumes in non-demented older adults: The MEMENTO cohort study. Neuroimage. 2022;250:118966. doi: 10.1016/j.neuroimage.2022.118966.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2022.118966</ArticleId><ArticleId IdType=\"pubmed\">35122970</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X., Holland D., Dale A.M., Miller M.I., Alzheimer&#x2019;s Disease Neuroimaging Initiative APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer&#x2019;s Disease: Age Matters. J. Alzheimers Dis. 2015;47:645&#x2013;660. doi: 10.3233/JAD-150262.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-150262</ArticleId><ArticleId IdType=\"pmc\">PMC5479937</ArticleId><ArticleId IdType=\"pubmed\">26401700</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Yu J.T., Wang H.F., Han P.R., Tan C.C., Wang C., Meng X.F., Risacher S.L., Saykin A.J., Tan L. APOE genotype and neuroimaging markers of Alzheimer&#x2019;s disease: Systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2015;86:127&#x2013;134. doi: 10.1136/jnnp-2014-307719.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jnnp-2014-307719</ArticleId><ArticleId IdType=\"pmc\">PMC4331076</ArticleId><ArticleId IdType=\"pubmed\">24838911</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuff N., Woerner N., Boreta L., Kornfield T., Shaw L.M., Trojanowski J.Q., Thompson P.M., Jack C.R., Jr., Weiner M.W., Alzheimer&#x2019;s Disease Neuroimaging Initiative MRI of hippocampal volume loss in early Alzheimer&#x2019;s disease in relation to APOE genotype and biomarkers. Pt 4Brain. 2009;132:1067&#x2013;1077. doi: 10.1093/brain/awp007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awp007</ArticleId><ArticleId IdType=\"pmc\">PMC2668943</ArticleId><ArticleId IdType=\"pubmed\">19251758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Stirnberg R., Wu S., Wang X., St&#xf6;cker T., Jung S., Montag C., Axmacher N. Genetic Alzheimer&#x2019;s Disease Risk Affects the Neural Mechanisms of Pattern Separation in Hippocampal Subfields. Curr. Biol. 2020;30:4201&#x2013;4212 e3. doi: 10.1016/j.cub.2020.08.042.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cub.2020.08.042</ArticleId><ArticleId IdType=\"pubmed\">32916120</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C.C., Kanekiyo T., Xu H., Bu G. Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nat. Rev. Neurol. 2013;9:106&#x2013;118. doi: 10.1038/nrneurol.2012.263.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrneurol.2012.263</ArticleId><ArticleId IdType=\"pmc\">PMC3726719</ArticleId><ArticleId IdType=\"pubmed\">23296339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley R.W., Weisgraber K.H., Huang Y. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2006;103:5644&#x2013;5651. doi: 10.1073/pnas.0600549103.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0600549103</ArticleId><ArticleId IdType=\"pmc\">PMC1414631</ArticleId><ArticleId IdType=\"pubmed\">16567625</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S.D., Bondi M.W. Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement. 2008;4:251&#x2013;254. doi: 10.1016/j.jalz.2008.02.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2008.02.006</ArticleId><ArticleId IdType=\"pubmed\">18631975</ArticleId></ArticleIdList></Reference><Reference><Citation>Bondi M.W., Houston W.S., Eyler L.T., Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology. 2005;64:501&#x2013;508. doi: 10.1212/01.WNL.0000150885.00929.7E.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/01.WNL.0000150885.00929.7E</ArticleId><ArticleId IdType=\"pmc\">PMC1761695</ArticleId><ArticleId IdType=\"pubmed\">15699382</ArticleId></ArticleIdList></Reference><Reference><Citation>Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer&#x2019;s disease. N. Engl. J. Med. 2000;343:450&#x2013;456. doi: 10.1056/NEJM200008173430701.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJM200008173430701</ArticleId><ArticleId IdType=\"pmc\">PMC2831477</ArticleId><ArticleId IdType=\"pubmed\">10944562</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuminello E.R., Han S.D. The apolipoprotein e antagonistic pleiotropy hypothesis: Review and recommendations. Int. J. Alzheimers Dis. 2011;2011:1. doi: 10.4061/2011/726197.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4061/2011/726197</ArticleId><ArticleId IdType=\"pmc\">PMC3056453</ArticleId><ArticleId IdType=\"pubmed\">21423560</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini N., Ebmeier K., MacIntosh B., Trachtenberg A., Frisoni G., Wilcock G., Beckmann C., Smith S., Matthews P., Mackay C.E. Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage. 2011;54:602&#x2013;610. doi: 10.1016/j.neuroimage.2010.08.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2010.08.009</ArticleId><ArticleId IdType=\"pubmed\">20705142</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitzman B.A., Snyder A.Z., Leuthardt E.C., Shimony J.S. The State of Resting State Networks. Top. Magn. Reson. Imaging. 2019;28:189&#x2013;196. doi: 10.1097/RMR.0000000000000214.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/RMR.0000000000000214</ArticleId><ArticleId IdType=\"pmc\">PMC6686880</ArticleId><ArticleId IdType=\"pubmed\">31385898</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">39274269</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Print\">2077-0383</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>13</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Metabolic and Immune System Dysregulation: Unraveling the Connections between Alzheimer's Disease, Diabetes, Inflammatory Bowel Diseases, and Rheumatoid Arthritis.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">5057</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/jcm13175057</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD), diabetes mellitus (DM), inflammatory bowel diseases (IBD), and rheumatoid arthritis (RA) are chronic conditions affecting millions globally. Despite differing clinical symptoms, these diseases share pathophysiological mechanisms involving metabolic and immune system dysregulation. This paper examines the intricate connections between these disorders, focusing on shared pathways such as insulin resistance, lipid metabolism dysregulation, oxidative stress, and chronic inflammation. An important aspect is the role of amyloid-beta plaques and tau protein tangles, which are hallmark features of AD. These protein aggregates are influenced by metabolic dysfunction and inflammatory processes similar to those seen in DM, RA, and IBD. This manuscript explores how amyloid and tau pathologies may be exacerbated by shared metabolic and immune dysfunction. Additionally, this work discusses the gut-brain axis and the influence of gut microbiota in mediating disease interactions. Understanding these commonalities opens new avenues for multi-targeted therapeutic approaches that address the root causes rather than merely the symptoms of these conditions. This integrative perspective could lead to more effective interventions and improved patient outcomes, emphasizing the importance of a unified approach in managing these interconnected diseases.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Doroszkiewicz</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mroczko</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Winkel</LastName><ForeName>Izabela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Dementia Disorders Centre, Medical University of Wroclaw, 50-425 Scinawa, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mroczko</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source=\"ORCID\">0000-0002-4075-8479</Identifier><AffiliationInfo><Affiliation>Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemical Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>B.SUB.24.166 and B.SUB.24.503</GrantID><Agency>Medical University of Bialystok</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">diabetes mellitus</Keyword><Keyword MajorTopicYN=\"N\">inflammatory bowel diseases</Keyword><Keyword MajorTopicYN=\"N\">rheumatoid arthritis</Keyword></KeywordList><CoiStatement>B.M. has received consultation and/or lecture honoraria from Abbott, Wiener, Roche, Cormay, Biameditek, and TK Biotech. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39274269</ArticleId><ArticleId IdType=\"doi\">10.3390/jcm13175057</ArticleId><ArticleId IdType=\"pii\">jcm13175057</ArticleId><ArticleId IdType=\"pmc\">PMC11396443</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heneka M.T., Carson M.J., Khoury J.E., Landreth G.E., Brosseron F., Feinstein D.L., Jacobs A.H., Wyss-Coray T., Vitorica J., Ransohoff R.M., et al. Neuroinflammation in Alzheimer&#x2019;s Disease. Lancet Neurol. 2015;14:388&#x2013;405. doi: 10.1016/S1474-4422(15)70016-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(15)70016-5</ArticleId><ArticleId IdType=\"pmc\">PMC5909703</ArticleId><ArticleId IdType=\"pubmed\">25792098</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanashiro A., Hiroki C.H., da Fonseca D.M., Birbrair A., Ferreira R.G., Bassi G.S., Fonseca M.D., Kusuda R., Cebinelli G.C.M., da Silva K.P., et al. The Role of Neutrophils in Neuro-Immune Modulation. Pharmacol. Res. 2020;151:104580. doi: 10.1016/j.phrs.2019.104580.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.phrs.2019.104580</ArticleId><ArticleId IdType=\"pmc\">PMC7023896</ArticleId><ArticleId IdType=\"pubmed\">31786317</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Xiao D., Mao Q., Xia H. Role of Neuroinflammation in Neurodegeneration Development. Signal Transduct. Target. Ther. 2023;8:267. doi: 10.1038/s41392-023-01486-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-023-01486-5</ArticleId><ArticleId IdType=\"pmc\">PMC10336149</ArticleId><ArticleId IdType=\"pubmed\">37433768</ArticleId></ArticleIdList></Reference><Reference><Citation>Garwood C.J., Pooler A.M., Atherton J., Hanger D.P., Noble W. Astrocytes Are Important Mediators of A&#x3b2;-Induced Neurotoxicity and Tau Phosphorylation in Primary Culture. Cell Death Dis. 2011;2:e167. doi: 10.1038/cddis.2011.50.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/cddis.2011.50</ArticleId><ArticleId IdType=\"pmc\">PMC3168992</ArticleId><ArticleId IdType=\"pubmed\">21633390</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrero I., Gonzalo M.R., Martin B., Sanz-Anquela J.M., Ar&#xe9;valo-Serrano J., Gonzalo-Ruiz A. Oligomers of &#x3b2;-Amyloid Protein (A&#x3b2;1-42) Induce the Activation of Cyclooxygenase-2 in Astrocytes via an Interaction with Interleukin-1&#x3b2;, Tumour Necrosis Factor-&#x3b1;, and a Nuclear Factor &#x3ba;-B Mechanism in the Rat Brain. Exp. Neurol. 2012;236:215&#x2013;227. doi: 10.1016/j.expneurol.2012.05.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.expneurol.2012.05.004</ArticleId><ArticleId IdType=\"pubmed\">22617488</ArticleId></ArticleIdList></Reference><Reference><Citation>Venegas C., Kumar S., Franklin B.S., Dierkes T., Brinkschulte R., Tejera D., Vieira-Saecker A., Schwartz S., Santarelli F., Kummer M.P., et al. Microglia-Derived ASC Specks Cross-Seed Amyloid-&#x3b2; in Alzheimer&#x2019;s Disease. Nature. 2017;552:355&#x2013;361. doi: 10.1038/nature25158.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature25158</ArticleId><ArticleId IdType=\"pubmed\">29293211</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank-Cannon T.C., Alto L.T., McAlpine F.E., Tansey M.G. Does Neuroinflammation Fan the Flame in Neurodegenerative Diseases? Mol. Neurodegener. 2009;4:47. doi: 10.1186/1750-1326-4-47.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1750-1326-4-47</ArticleId><ArticleId IdType=\"pmc\">PMC2784760</ArticleId><ArticleId IdType=\"pubmed\">19917131</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff J.J., Wang M., Liao Y., Plogg B.A., Peng W., Gundersen G.A., Benveniste H., Vates G.E., Deane R., Goldman S.A., et al. A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid &#x3b2;. Sci. Transl. Med. 2012;4:147ra111. doi: 10.1126/scitranslmed.3003748.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/scitranslmed.3003748</ArticleId><ArticleId IdType=\"pmc\">PMC3551275</ArticleId><ArticleId IdType=\"pubmed\">22896675</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Mesquita S., Louveau A., Vaccari A., Smirnov I., Cornelison R.C., Kingsmore K.M., Contarino C., Onengut-Gumuscu S., Farber E., Raper D., et al. Functional Aspects of Meningeal Lymphatics in Aging and Alzheimer&#x2019;s Disease. Nature. 2018;560:185. doi: 10.1038/s41586-018-0368-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-018-0368-8</ArticleId><ArticleId IdType=\"pmc\">PMC6085146</ArticleId><ArticleId IdType=\"pubmed\">30046111</ArticleId></ArticleIdList></Reference><Reference><Citation>He X.F., Liu D.X., Zhang Q., Liang F.Y., Dai G.Y., Zeng J.S., Pei Z., Xu G.Q., Lan Y. Voluntary Exercise Promotes Glymphatic Clearance of Amyloid Beta and Reduces the Activation of Astrocytes and Microglia in Aged Mice. Front. Mol. Neurosci. 2017;10:144. doi: 10.3389/fnmol.2017.00144.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnmol.2017.00144</ArticleId><ArticleId IdType=\"pmc\">PMC5437122</ArticleId><ArticleId IdType=\"pubmed\">28579942</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison I.F., Ismail O., Machhada A., Colgan N., Ohene Y., Nahavandi P., Ahmed Z., Fisher A., Meftah S., Murray T.K., et al. Impaired Glymphatic Function and Clearance of Tau in an Alzheimer&#x2019;s Disease Model. Brain. 2020;143:2576. doi: 10.1093/brain/awaa179.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awaa179</ArticleId><ArticleId IdType=\"pmc\">PMC7447521</ArticleId><ArticleId IdType=\"pubmed\">32705145</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff J.J., Chen M.J., Plog B.A., Zeppenfeld D.M., Soltero M., Yang L., Singh I., Deane R., Nedergaard M. Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury. J. Neurosci. 2014;34:16180. doi: 10.1523/JNEUROSCI.3020-14.2014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.3020-14.2014</ArticleId><ArticleId IdType=\"pmc\">PMC4252540</ArticleId><ArticleId IdType=\"pubmed\">25471560</ArticleId></ArticleIdList></Reference><Reference><Citation>He X.F., Li L.L., Xian W.B., Li M.Y., Zhang L.Y., Xu J.H., Pei Z., Zheng H.Q., Hu X. Quan Chronic Colitis Exacerbates NLRP3-Dependent Neuroinflammation and Cognitive Impairment in Middle-Aged Brain. J. Neuroinflammation. 2021;18:153. doi: 10.1186/s12974-021-02199-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-021-02199-8</ArticleId><ArticleId IdType=\"pmc\">PMC8262017</ArticleId><ArticleId IdType=\"pubmed\">34229722</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke L.E., Liddelow S.A., Chakraborty C., M&#xfc;nch A.E., Heiman M., Barres B.A. Normal Aging Induces A1-like Astrocyte Reactivity. Proc. Natl. Acad. Sci. USA. 2018;115:E1896&#x2013;E1905. doi: 10.1073/pnas.1800165115.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1800165115</ArticleId><ArticleId IdType=\"pmc\">PMC5828643</ArticleId><ArticleId IdType=\"pubmed\">29437957</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., M&#xfc;nch A.E., Chung W.S., Peterson T.C., et al. Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia. Nature. 2017;541:481. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature21029</ArticleId><ArticleId IdType=\"pmc\">PMC5404890</ArticleId><ArticleId IdType=\"pubmed\">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Facts and Figures|International Diabetes Federation.  [(accessed on 15 July 2024)].  Available online:  https://idf.org/about-diabetes/diabetes-facts-figures/</Citation></Reference><Reference><Citation>Chen Y., Yu Q., Gong C.X. Molecular Connection Between Diabetes and Dementia. Adv. Exp. Med. Biol. 2019;1128:103&#x2013;131. doi: 10.1007/978-981-13-3540-2_6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-981-13-3540-2_6</ArticleId><ArticleId IdType=\"pubmed\">31062327</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubis-Kubiak A.M., Rorbach-Dolata A., Piwowar A. Crucial Players in Alzheimer&#x2019;s Disease and Diabetes Mellitus: Friends or Foes? Mech. Ageing Dev. 2019;181:7&#x2013;21. doi: 10.1016/j.mad.2019.03.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mad.2019.03.008</ArticleId><ArticleId IdType=\"pubmed\">31085195</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudala K., Bansal D., Schifano F., Bhansali A. Diabetes Mellitus and Risk of Dementia: A Meta-Analysis of Prospective Observational Studies. J. Diabetes Investig. 2013;4:640&#x2013;650. doi: 10.1111/jdi.12087.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jdi.12087</ArticleId><ArticleId IdType=\"pmc\">PMC4020261</ArticleId><ArticleId IdType=\"pubmed\">24843720</ArticleId></ArticleIdList></Reference><Reference><Citation>Rorbach-Dolata A., Piwowar A. Neurometabolic Evidence Supporting the Hypothesis of Increased Incidence of Type 3 Diabetes Mellitus in the 21st Century. Biomed. Res. Int. 2019;2019:1435276. doi: 10.1155/2019/1435276.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2019/1435276</ArticleId><ArticleId IdType=\"pmc\">PMC6679855</ArticleId><ArticleId IdType=\"pubmed\">31428627</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.C., Chung C.M., Leu H.B., Lin L.Y., Chiu C.C., Hsu C.Y., Chiang C.H., Huang P.H., Chen T.J., Lin S.J., et al. Diabetes Mellitus and the Risk of Alzheimer&#x2019;s Disease: A Nationwide Population-Based Study. PLoS ONE. 2014;9:e87095. doi: 10.1371/journal.pone.0087095.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0087095</ArticleId><ArticleId IdType=\"pmc\">PMC3906115</ArticleId><ArticleId IdType=\"pubmed\">24489845</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Rodriguez J.J., Molina-Gil S., Ortiz-Barajas O., Jimenez-Palomares M., Perdomo G., Cozar-Castellano I., Lechuga-Sancho A.M., Garcia-Alloza M. Central Proliferation and Neurogenesis Is Impaired in Type 2 Diabetes and Prediabetes Animal Models. PLoS ONE. 2014;9:e89229. doi: 10.1371/journal.pone.0089229.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0089229</ArticleId><ArticleId IdType=\"pmc\">PMC3930705</ArticleId><ArticleId IdType=\"pubmed\">24586614</ArticleId></ArticleIdList></Reference><Reference><Citation>Gage F.H. Mammalian Neural Stem Cells. Science. 2000;287:1433&#x2013;1438. doi: 10.1126/science.287.5457.1433.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.287.5457.1433</ArticleId><ArticleId IdType=\"pubmed\">10688783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang B.T., Yan Y., Dempsey R.J., Vemuganti R. Impaired Neurogenesis in Adult Type-2 Diabetic Rats. Brain Res. 2009;1258:25&#x2013;33. doi: 10.1016/j.brainres.2008.12.026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainres.2008.12.026</ArticleId><ArticleId IdType=\"pmc\">PMC2649982</ArticleId><ArticleId IdType=\"pubmed\">19138677</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauquis J., Saravia F., Coulaud J., Roig P., Dardenne M., Homo-Delarche F., De Nicola A. Prominently Decreased Hippocampal Neurogenesis in a Spontaneous Model of Type 1 Diabetes, the Nonobese Diabetic Mouse. Exp. Neurol. 2008;210:359&#x2013;367. doi: 10.1016/j.expneurol.2007.11.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.expneurol.2007.11.009</ArticleId><ArticleId IdType=\"pubmed\">18190910</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J., Yu C., Li H., Liu F., Feng R., Wang H., Meng Y., Li Z., Ju G., Wang J. Impaired Neural Stem/Progenitor Cell Proliferation in Streptozotocin-Induced and Spontaneous Diabetic Mice. Neurosci. Res. 2010;68:329&#x2013;336. doi: 10.1016/j.neures.2010.08.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neures.2010.08.012</ArticleId><ArticleId IdType=\"pubmed\">20832431</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Tang Y., Cai D. IKK&#x3b2;/NF-&#x39a;B Disrupts Adult Hypothalamic Neural Stem Cells to Mediate Neurodegenerative Mechanism of Dietary Obesity and Pre-Diabetes. Nat. Cell Biol. 2012;14:999. doi: 10.1038/ncb2562.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncb2562</ArticleId><ArticleId IdType=\"pmc\">PMC3463771</ArticleId><ArticleId IdType=\"pubmed\">22940906</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin L.M., Bouchard R., Pugazhenthi S. Regulation of Cyclic AMP Response Element-Binding Protein during Neuroglial Interactions. J. Neurochem. 2016;136:918&#x2013;930. doi: 10.1111/jnc.13497.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jnc.13497</ArticleId><ArticleId IdType=\"pubmed\">26677139</ArticleId></ArticleIdList></Reference><Reference><Citation>Cukierman-Yaffe T., Gerstein H.C., Williamson J.D., Lazar R.M., Lovato L., Miller M.E., Coker L.H., Murray A., Sullivan M.D., Marcovina S.M., et al. Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Trial. Diabetes Care. 2009;32:221. doi: 10.2337/dc08-1153.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/dc08-1153</ArticleId><ArticleId IdType=\"pmc\">PMC2628683</ArticleId><ArticleId IdType=\"pubmed\">19171735</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaffe K., Blackwell T., Whitmer R.A., Krueger K., Barrett-Connor E. Glycosylated Hemoglobin Level and Development of Mild Cognitive Impairment or Dementia in Older Women. J. Nutr. Health Aging. 2006;10:293&#x2013;295.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16886099</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohara T., Doi Y., Ninomiya T., Hirakawa Y., Hata J., Iwaki T., Kanba S., Kiyohara Y. Glucose Tolerance Status and Risk of Dementia in the Community: The Hisayama Study. Neurology. 2011;77:1126&#x2013;1134. doi: 10.1212/WNL.0b013e31822f0435.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0b013e31822f0435</ArticleId><ArticleId IdType=\"pubmed\">21931106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding J., Strachan M.W.J., Reynolds R.M., Frier B.M., Deary I.J., Fowkes F.G.R., Lee A.J., McKnight J., Halpin P., Swa K., et al. Diabetic Retinopathy and Cognitive Decline in Older People with Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study. Diabetes. 2010;59:2883&#x2013;2889. doi: 10.2337/db10-0752.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/db10-0752</ArticleId><ArticleId IdType=\"pmc\">PMC2963547</ArticleId><ArticleId IdType=\"pubmed\">20798334</ArticleId></ArticleIdList></Reference><Reference><Citation>Crane P.K., Walker R., Hubbard R.A., Li G., Nathan D.M., Zheng H., Haneuse S., Craft S., Montine T.J., Kahn S.E., et al. Glucose Levels and Risk of Dementia. N. Engl. J. Med. 2013;369:540. doi: 10.1056/NEJMoa1215740.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa1215740</ArticleId><ArticleId IdType=\"pmc\">PMC3955123</ArticleId><ArticleId IdType=\"pubmed\">23924004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerfield A.J., Deary I.J., Frier B.M. Acute Hyperglycemia Alters Mood State and Impairs Cognitive Performance in People with Type 2 Diabetes. Diabetes Care. 2004;27:2335&#x2013;2340. doi: 10.2337/diacare.27.10.2335.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/diacare.27.10.2335</ArticleId><ArticleId IdType=\"pubmed\">15451897</ArticleId></ArticleIdList></Reference><Reference><Citation>Spauwen P.J.J., K&#xf6;hler S., Verhey F.R.J., Stehouwer C.D.A., Van Boxtel M.P.J. Effects of Type 2 Diabetes on 12-Year Cognitive Change: Results from the Maastricht Aging Study. Diabetes Care. 2013;36:1554&#x2013;1561. doi: 10.2337/dc12-0746.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/dc12-0746</ArticleId><ArticleId IdType=\"pmc\">PMC3661848</ArticleId><ArticleId IdType=\"pubmed\">23275366</ArticleId></ArticleIdList></Reference><Reference><Citation>Cukierman T., Gerstein H.C., Williamson J.D. Cognitive Decline and Dementia in Diabetes--Systematic Overview of Prospective Observational Studies. Diabetologia. 2005;48:2460&#x2013;2469. doi: 10.1007/s00125-005-0023-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00125-005-0023-4</ArticleId><ArticleId IdType=\"pubmed\">16283246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravona-Springer R., Moshier E., Schmeidler J., Godbold J., Akrivos J., Rapp M., Grossman H.T., Wysocki M., Silverman J.M., Haroutunian V., et al. Changes in Glycemic Control Are Associated with Changes in Cognition in Non-Diabetic Elderly. J. Alzheimers Dis. 2012;30:299. doi: 10.3233/JAD-2012-120106.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-2012-120106</ArticleId><ArticleId IdType=\"pmc\">PMC3586408</ArticleId><ArticleId IdType=\"pubmed\">22426020</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravona-Springer R., Heymann A., Schmeidler J., Moshier E., Godbold J., Sano M., Leroith D., Johnson S., Preiss R., Koifman K., et al. Trajectories in Glycemic Control over Time Are Associated with Cognitive Performance in Elderly Subjects with Type 2 Diabetes. PLoS ONE. 2014;9:e97384. doi: 10.1371/journal.pone.0097384.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0097384</ArticleId><ArticleId IdType=\"pmc\">PMC4041655</ArticleId><ArticleId IdType=\"pubmed\">24887092</ArticleId></ArticleIdList></Reference><Reference><Citation>Sue Kirkman M., Briscoe V.J., Clark N., Florez H., Haas L.B., Halter J.B., Huang E.S., Korytkowski M.T., Munshi M.N., Odegard P.S., et al. Diabetes in Older Adults: Consensus Report. J. Am. Geriatr. Soc. 2012;60:2342. doi: 10.1111/jgs.12035.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jgs.12035</ArticleId><ArticleId IdType=\"pmc\">PMC4525769</ArticleId><ArticleId IdType=\"pubmed\">23106132</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugazhenthi S., Qin L., Reddy P.H. Common Neurodegenerative Pathways in Obesity, Diabetes, and Alzheimer&#x2019;s Disease. Biochim. Biophys. Acta. 2017;1863:1037. doi: 10.1016/j.bbadis.2016.04.017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2016.04.017</ArticleId><ArticleId IdType=\"pmc\">PMC5344771</ArticleId><ArticleId IdType=\"pubmed\">27156888</ArticleId></ArticleIdList></Reference><Reference><Citation>Karmi A., Iozzo P., Viljanen A., Hirvonen J., Fielding B.A., Virtanen K., Oikonen V., Kemppainen J., Viljanen T., Guiducci L., et al. Increased Brain Fatty Acid Uptake in Metabolic Syndrome. Diabetes. 2010;59:2171. doi: 10.2337/db09-0138.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/db09-0138</ArticleId><ArticleId IdType=\"pmc\">PMC2927939</ArticleId><ArticleId IdType=\"pubmed\">20566663</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker L.D., Cross D.J., Minoshima S., Belongia D., Stennis Watson G., Craft S. Insulin resistance is associated with alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with pre-diabetes or early type 2 diabetes. Arch. Neurol. 2011;68:51. doi: 10.1001/archneurol.2010.225.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archneurol.2010.225</ArticleId><ArticleId IdType=\"pmc\">PMC3023149</ArticleId><ArticleId IdType=\"pubmed\">20837822</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#x229;dzikowska A., Szablewski L. Insulin and Insulin Resistance in Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2021;22:9987. doi: 10.3390/ijms22189987.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22189987</ArticleId><ArticleId IdType=\"pmc\">PMC8472298</ArticleId><ArticleId IdType=\"pubmed\">34576151</ArticleId></ArticleIdList></Reference><Reference><Citation>Neth B.J., Craft S. Insulin Resistance and Alzheimer&#x2019;s Disease: Bioenergetic Linkages. Front. Aging Neurosci. 2017;9:345. doi: 10.3389/fnagi.2017.00345.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2017.00345</ArticleId><ArticleId IdType=\"pmc\">PMC5671587</ArticleId><ArticleId IdType=\"pubmed\">29163128</ArticleId></ArticleIdList></Reference><Reference><Citation>Moult P.R., Harvey J. Hormonal Regulation of Hippocampal Dendritic Morphology and Synaptic Plasticity. Cell Adhes. Migr. 2008;2:269. doi: 10.4161/cam.2.4.6354.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4161/cam.2.4.6354</ArticleId><ArticleId IdType=\"pmc\">PMC2633690</ArticleId><ArticleId IdType=\"pubmed\">19262152</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Heide L.P., Kamal A., Artola A., Gispen W.H., Ramakers G.M.J. Insulin Modulates Hippocampal Activity-Dependent Synaptic Plasticity in a N-Methyl-d-Aspartate Receptor and Phosphatidyl-Inositol-3-Kinase-Dependent Manner. J. Neurochem. 2005;94:1158&#x2013;1166. doi: 10.1111/j.1471-4159.2005.03269.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1471-4159.2005.03269.x</ArticleId><ArticleId IdType=\"pubmed\">16092951</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M., Joly-Amado A., Vieau D., Bu&#xe9;e L., Blum D. Mutual Relationship between Tau and Central Insulin Signalling: Consequences for AD and Tauopathies? Neuroendocrinology. 2018;107:181&#x2013;195. doi: 10.1159/000487641.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000487641</ArticleId><ArticleId IdType=\"pubmed\">29439247</ArticleId></ArticleIdList></Reference><Reference><Citation>Skeberdis V.A., Lan J.Y., Zheng X., Zukin R.S., Bennett M.V.L. Insulin Promotes Rapid Delivery of N-Methyl-d- Aspartate Receptors to the Cell Surface by Exocytosis. Proc. Natl. Acad. Sci. USA. 2001;98:3561. doi: 10.1073/pnas.051634698.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.051634698</ArticleId><ArticleId IdType=\"pmc\">PMC30692</ArticleId><ArticleId IdType=\"pubmed\">11248117</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S.P., Lu K.T., Chang W.C., Gean P.W. Involvement of Mitogen-Activated Protein Kinase in Hippocampal Long-Term Potentiation. J. Biomed. Sci. 1999;6:409&#x2013;417. doi: 10.1007/BF02253672.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/BF02253672</ArticleId><ArticleId IdType=\"pubmed\">10545776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna P.P., Cammalleri M., Berton F., Simpson C., Lutjens R., Bloom F.E., Francesconi W. Phosphatidylinositol 3-Kinase Is Required for the Expression But Not for the Induction or the Maintenance of Long-Term Potentiation in the Hippocampal CA1 Region. J. Neurosci. 2002;22:3359. doi: 10.1523/JNEUROSCI.22-09-03359.2002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.22-09-03359.2002</ArticleId><ArticleId IdType=\"pmc\">PMC6758361</ArticleId><ArticleId IdType=\"pubmed\">11978812</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott M.A., Wells D.G., Fallon J.R. The Insulin Receptor Tyrosine Kinase Substrate P58/53 and the Insulin Receptor Are Components of CNS Synapses. J. Neurosci. 1999;19:7300. doi: 10.1523/JNEUROSCI.19-17-07300.1999.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.19-17-07300.1999</ArticleId><ArticleId IdType=\"pmc\">PMC6782521</ArticleId><ArticleId IdType=\"pubmed\">10460236</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli M., Fusco S., Mainardi M., Scala F., Natale F., Lapenta R., Mattera A., Rinaudo M., Li Puma D.D., Ripoli C., et al. Brain Insulin Resistance Impairs Hippocampal Synaptic Plasticity and Memory by Increasing GluA1 Palmitoylation through FoxO3a. Nat. Commun. 2017;8:2009. doi: 10.1038/s41467-017-02221-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-017-02221-9</ArticleId><ArticleId IdType=\"pmc\">PMC5722929</ArticleId><ArticleId IdType=\"pubmed\">29222408</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson T.J., Sun M.K., Hongpaisan J., Alkon D.L. Insulin, PKC Signaling Pathways and Synaptic Remodeling during Memory Storage and Neuronal Repair. Eur. J. Pharmacol. 2008;585:76&#x2013;87. doi: 10.1016/j.ejphar.2008.01.051.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejphar.2008.01.051</ArticleId><ArticleId IdType=\"pubmed\">18402935</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heide L.P., Ramakers G.M.J., Smidt M.P. Insulin Signaling in the Central Nervous System: Learning to Survive. Prog. Neurobiol. 2006;79:205&#x2013;221. doi: 10.1016/j.pneurobio.2006.06.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pneurobio.2006.06.003</ArticleId><ArticleId IdType=\"pubmed\">16916571</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S., Singh S., Arora A., Ram P., Kumar S., Kumar P., Abed S.N. Frontiers in Pharmacology of Neurotransmitters. Springer; Singapore: 2020. Pharmacology of GABA and Its Receptors; pp. 241&#x2013;292.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-981-15-3556-7_8</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval-Salazar C., Ram&#xed;rez-Emiliano J., Trejo-Bahena A., Oviedo-Sol&#xed;s C.I., Sol&#xed;s-Ortiz M.S. A High-Fat Diet Decreases GABA Concentration in the Frontal Cortex and Hippocampus of Rats. Biol. Res. 2016;49:15. doi: 10.1186/s40659-016-0075-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40659-016-0075-6</ArticleId><ArticleId IdType=\"pmc\">PMC4772645</ArticleId><ArticleId IdType=\"pubmed\">26927389</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold S.E., Arvanitakis Z., Macauley-Rambach S.L., Koenig A.M., Wang H.Y., Ahima R.S., Craft S., Gandy S., Buettner C., Stoeckel L.E., et al. Brain Insulin Resistance in Type 2 Diabetes and Alzheimer Disease: Concepts and Conundrums. Nat. Rev. Neurol. 2018;14:168. doi: 10.1038/nrneurol.2017.185.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrneurol.2017.185</ArticleId><ArticleId IdType=\"pmc\">PMC6098968</ArticleId><ArticleId IdType=\"pubmed\">29377010</ArticleId></ArticleIdList></Reference><Reference><Citation>Strachan M.W.J., Reynolds R.M., Marioni R.E., Price J.F. Cognitive Function, Dementia and Type 2 Diabetes Mellitus in the Elderly. Nat. Rev. Endocrinol. 2011;7:108&#x2013;114. doi: 10.1038/nrendo.2010.228.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrendo.2010.228</ArticleId><ArticleId IdType=\"pubmed\">21263438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Gong B., Zhao W., Tang C., Varghese M., Nguyen T., Bi W., Bilski A., Begum S., Vempati P., et al. Epigenetic Mechanisms Linking Diabetes and Synaptic Impairments. Diabetes. 2014;63:645&#x2013;654. doi: 10.2337/db13-1063.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/db13-1063</ArticleId><ArticleId IdType=\"pubmed\">24154559</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu W.Q., Folstein M.F. Insulin, Insulin-Degrading Enzyme and Amyloid-Beta Peptide in Alzheimer&#x2019;s Disease: Review and Hypothesis. Neurobiol. Aging. 2006;27:190&#x2013;198. doi: 10.1016/j.neurobiolaging.2005.01.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2005.01.004</ArticleId><ArticleId IdType=\"pubmed\">16399206</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque R., Nazir A. Insulin-Degrading Enzyme: A Link between Alzheimer&#x2019;s and Type 2 Diabetes Mellitus. CNS Neurol. Disord. Drug Targets. 2014;13:259&#x2013;264. doi: 10.2174/18715273113126660139.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/18715273113126660139</ArticleId><ArticleId IdType=\"pubmed\">24059320</ArticleId></ArticleIdList></Reference><Reference><Citation>Akter K., Lanza E.A., Martin S.A., Myronyuk N., Rua M., Raffa R.B. Diabetes Mellitus and Alzheimer&#x2019;s Disease: Shared Pathology and Treatment? Br. J. Clin. Pharmacol. 2011;71:365. doi: 10.1111/j.1365-2125.2010.03830.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2125.2010.03830.x</ArticleId><ArticleId IdType=\"pmc\">PMC3045545</ArticleId><ArticleId IdType=\"pubmed\">21284695</ArticleId></ArticleIdList></Reference><Reference><Citation>Janson J., Laedtke T., Parisi J.E., O&#x2019;Brien P., Petersen R.C., Butler P.C. Increased Risk of Type 2 Diabetes in Alzheimer Disease. Diabetes. 2004;53:474&#x2013;481. doi: 10.2337/diabetes.53.2.474.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/diabetes.53.2.474</ArticleId><ArticleId IdType=\"pubmed\">14747300</ArticleId></ArticleIdList></Reference><Reference><Citation>Maj M., Hoermann G., Rasul S., Base W., Wagner L., Attems J. The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells. J. Diabetes Res. 2016;2016:1964634. doi: 10.1155/2016/1964634.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2016/1964634</ArticleId><ArticleId IdType=\"pmc\">PMC4707345</ArticleId><ArticleId IdType=\"pubmed\">26824039</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Valbuena I., Valenti-Azcarate R., Amat-Villegas I., Riverol M., Marcilla I., de Andrea C.E., S&#xe1;nchez-Arias J.A., del Mar Carmona-Abellan M., Marti G., Erro M.E., et al. Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease. Ann. Neurol. 2019;86:539&#x2013;551. doi: 10.1002/ana.25570.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.25570</ArticleId><ArticleId IdType=\"pubmed\">31376172</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo J.B., Arnold M., Kastenm&#xfc;ller G., Chang R., Baillie R.A., Han X., Thambisetty M., Tenenbaum J.D., Suhre K., Thompson J.W., et al. Metabolic Network Failures in Alzheimer&#x2019;s Disease: A Biochemical Road Map. Alzheimers Dement. 2017;13:965&#x2013;984. doi: 10.1016/j.jalz.2017.01.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2017.01.020</ArticleId><ArticleId IdType=\"pmc\">PMC5866045</ArticleId><ArticleId IdType=\"pubmed\">28341160</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Zhong C. Decoding Alzheimer&#x2019;s Disease from Perturbed Cerebral Glucose Metabolism: Implications for Diagnostic and Therapeutic Strategies. Prog. Neurobiol. 2013;108:21&#x2013;43. doi: 10.1016/j.pneurobio.2013.06.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pneurobio.2013.06.004</ArticleId><ArticleId IdType=\"pubmed\">23850509</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Monte S.M., Tong M. Brain Metabolic Dysfunction at the Core of Alzheimer&#x2019;s Disease. Biochem. Pharmacol. 2014;88:548&#x2013;559. doi: 10.1016/j.bcp.2013.12.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bcp.2013.12.012</ArticleId><ArticleId IdType=\"pmc\">PMC4550323</ArticleId><ArticleId IdType=\"pubmed\">24380887</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz Pereira J., Gomes Fraga V., Morais Santos A.L., Carvalho M.D.G., Caramelli P., Braga Gomes K. Alzheimer&#x2019;s Disease and Type 2 Diabetes Mellitus: A Systematic Review of Proteomic Studies. J. Neurochem. 2021;156:753&#x2013;776. doi: 10.1111/jnc.15166.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jnc.15166</ArticleId><ArticleId IdType=\"pubmed\">32909269</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino S., Fujimoto K., Takada T., Kawamura S., Ogawa J., Kamata Y., Kodera Y., Shichiri M. Molecular Form and Concentration of Serum A2-Macroglobulin in Diabetes. Sci. Rep. 2019;9:12927. doi: 10.1038/s41598-019-49144-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-49144-7</ArticleId><ArticleId IdType=\"pmc\">PMC6736885</ArticleId><ArticleId IdType=\"pubmed\">31506491</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung T.J., Hsu K.Y., Chen J.H., Liu J.S., Chang H.W., Li P.F., Huang C.L., Shieh Y.S., Lee C.H. Association of Salivary Alpha 2-Macroglobulin Levels and Clinical Characteristics in Type 2 Diabetes. J. Diabetes Investig. 2016;7:190&#x2013;196. doi: 10.1111/jdi.12382.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jdi.12382</ArticleId><ArticleId IdType=\"pmc\">PMC4773666</ArticleId><ArticleId IdType=\"pubmed\">27042270</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravina A., Panarese I., Trotta M., Pellegrino R., Ferraraccio F., Galdiero M., Alfano R., Loguercio C., Romano M., Grieco P., et al. Relationship between Salivary Alpha-2 Macroglobulin and HbA1c among Patients with Type-2 Diabetes Mellitus: A Cross-Sectional Study. Indian. J. Endocrinol. Metab. 2019;23:184&#x2013;187. doi: 10.4103/IJEM.IJEM_40_19.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/IJEM.IJEM_40_19</ArticleId><ArticleId IdType=\"pmc\">PMC6540883</ArticleId><ArticleId IdType=\"pubmed\">31161100</ArticleId></ArticleIdList></Reference><Reference><Citation>James K., Merriman J., Gray R.S., Duncan L.J., Herd R. Serum Alpha 2-Macroglobulin Levels in Diabetes. J. Clin. Pathol. 1980;33:163&#x2013;166. doi: 10.1136/jcp.33.2.163.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jcp.33.2.163</ArticleId><ArticleId IdType=\"pmc\">PMC1146013</ArticleId><ArticleId IdType=\"pubmed\">6154066</ArticleId></ArticleIdList></Reference><Reference><Citation>Seddighi S., Varma V., Thambisetty M. A2-Macroglobulin in Alzheimer&#x2019;s Disease: New Roles for an Old Chaperone. Biomark. Med. 2018;12:311&#x2013;314. doi: 10.2217/bmm-2018-0027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2217/bmm-2018-0027</ArticleId><ArticleId IdType=\"pmc\">PMC5967355</ArticleId><ArticleId IdType=\"pubmed\">29537301</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma V.R., Varma S., An Y., Hohman T.J., Seddighi S., Casanova R., Beri A., Dammer E.B., Seyfried N.T., Pletnikova O., et al. Alpha-2 Macroglobulin in Alzheimer&#x2019;s Disease: A Marker of Neuronal Injury through the RCAN1 Pathway. Mol. Psychiatry. 2017;22:13&#x2013;23. doi: 10.1038/mp.2016.206.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/mp.2016.206</ArticleId><ArticleId IdType=\"pmc\">PMC5726508</ArticleId><ArticleId IdType=\"pubmed\">27872486</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms Underlying Inflammation in Neurodegeneration. Cell. 2010;140:918. doi: 10.1016/j.cell.2010.02.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2010.02.016</ArticleId><ArticleId IdType=\"pmc\">PMC2873093</ArticleId><ArticleId IdType=\"pubmed\">20303880</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanzel C.E., Pichet-Binette A., Pimentel L.S.B., Iulita M.F., Allard S., Ducatenzeiler A., Do Carmo S., Cuello A.C. Neuronal Driven Pre-Plaque Inflammation in a Transgenic Rat Model of Alzheimer&#x2019;s Disease. Neurobiol. Aging. 2014;35:2249&#x2013;2262. doi: 10.1016/j.neurobiolaging.2014.03.026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2014.03.026</ArticleId><ArticleId IdType=\"pubmed\">24831823</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo M., Chiasserini D., Gardoni F., Viviani B., Tozzi A., Giamp&#xe0; C., Costa C., Tantucci M., Zianni E., Boraso M., et al. Effects of Central and Peripheral Inflammation on Hippocampal Synaptic Plasticity. Neurobiol. Dis. 2013;52:229&#x2013;236. doi: 10.1016/j.nbd.2012.12.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2012.12.009</ArticleId><ArticleId IdType=\"pubmed\">23295855</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C. Inflammaging as a Major Characteristic of Old People: Can It Be Prevented or Cured? Nutr. Rev. 2007;65:S173&#x2013;S176. doi: 10.1301/nr.2007.dec.S173-S176.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1301/nr.2007.dec.S173-S176</ArticleId><ArticleId IdType=\"pubmed\">18240544</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoelson S.E., Lee J., Goldfine A.B. Inflammation and Insulin Resistance. J. Clin. Investig. 2006;116:1793. doi: 10.1172/JCI29069.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI29069</ArticleId><ArticleId IdType=\"pmc\">PMC1483173</ArticleId><ArticleId IdType=\"pubmed\">16823477</ArticleId></ArticleIdList></Reference><Reference><Citation>Skelly D.T., Hennessy E., Dansereau M.A., Cunningham C. A Systematic Analysis of the Peripheral and CNS Effects of Systemic LPS, IL-1&#x392;, TNF-&#x3b1; and IL-6 Challenges in C57BL/6 Mice. PLoS ONE. 2013;8:e69123. doi: 10.1371/annotation/90c76048-2edd-4315-8404-4d9d8cbd411e.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/annotation/90c76048-2edd-4315-8404-4d9d8cbd411e</ArticleId><ArticleId IdType=\"pmc\">PMC3698075</ArticleId><ArticleId IdType=\"pubmed\">23840908</ArticleId></ArticleIdList></Reference><Reference><Citation>Krstic D., Madhusudan A., Doehner J., Vogel P., Notter T., Imhof C., Manalastas A., Hilfiker M., Pfister S., Schwerdel C., et al. Systemic Immune Challenges Trigger and Drive Alzheimer-like Neuropathology in Mice. J. Neuroinflammation. 2012;9:151. doi: 10.1186/1742-2094-9-151.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1742-2094-9-151</ArticleId><ArticleId IdType=\"pmc\">PMC3483167</ArticleId><ArticleId IdType=\"pubmed\">22747753</ArticleId></ArticleIdList></Reference><Reference><Citation>Swardfager W., Lanctt K., Rothenburg L., Wong A., Cappell J., Herrmann N. A Meta-Analysis of Cytokines in Alzheimer&#x2019;s Disease. Biol. Psychiatry. 2010;68:930&#x2013;941. doi: 10.1016/j.biopsych.2010.06.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopsych.2010.06.012</ArticleId><ArticleId IdType=\"pubmed\">20692646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Miller R.G., Madison C., Jin X., Honrada R., Harris W., Katz J., Forshew D.A., McGrath M.S. Systemic Immune System Alterations in Early Stages of Alzheimer&#x2019;s Disease. J. Neuroimmunol. 2013;256:38. doi: 10.1016/j.jneuroim.2013.01.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jneuroim.2013.01.002</ArticleId><ArticleId IdType=\"pmc\">PMC3641776</ArticleId><ArticleId IdType=\"pubmed\">23380586</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo P., Mart&#xed;n-Arag&#xf3;n S., Bened&#xed; J., Sus&#xed;n C., Felici E., Gil P., Ribera J.M., Villar &#xc1;.M. Differences of Peripheral Inflammatory Markers between Mild Cognitive Impairment and Alzheimer&#x2019;s Disease. Immunol. Lett. 2008;117:198&#x2013;202. doi: 10.1016/j.imlet.2008.02.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.imlet.2008.02.002</ArticleId><ArticleId IdType=\"pubmed\">18367253</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama A., O&#x2019;Brien J., Weuve J., Blacker D., Metti A.L., Yaffe K. The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer&#x2019;s Disease: A Meta-Analysis. J. Gerontol. A Biol. Sci. Med. Sci. 2013;68:433. doi: 10.1093/gerona/gls187.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gerona/gls187</ArticleId><ArticleId IdType=\"pmc\">PMC3693673</ArticleId><ArticleId IdType=\"pubmed\">22982688</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Z.S., Beiser A.S., Vasan R.S., Roubenoff R., Dinarello C.A., Harris T.B., Benjamin E.J., Au R., Kiel D.P., Wolf P.A., et al. Inflammatory Markers and the Risk of Alzheimer Disease: The Framingham Study. Neurology. 2007;68:1902&#x2013;1908. doi: 10.1212/01.wnl.0000263217.36439.da.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/01.wnl.0000263217.36439.da</ArticleId><ArticleId IdType=\"pubmed\">17536046</ArticleId></ArticleIdList></Reference><Reference><Citation>Magaki S., Mueller C., Dickson C., Kirsch W. Increased Production of Inflammatory Cytokines in Mild Cognitive Impairment. Exp. Gerontol. 2007;42:233&#x2013;240. doi: 10.1016/j.exger.2006.09.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.exger.2006.09.015</ArticleId><ArticleId IdType=\"pmc\">PMC1868444</ArticleId><ArticleId IdType=\"pubmed\">17085001</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng L., Xu L., Ouyang W. Role of Peripheral Inflammatory Markers in Postoperative Cognitive Dysfunction (POCD): A Meta-Analysis. PLoS ONE. 2013;8:e79624. doi: 10.1371/journal.pone.0079624.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0079624</ArticleId><ArticleId IdType=\"pmc\">PMC3827367</ArticleId><ArticleId IdType=\"pubmed\">24236147</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks W.A., Kastin A.J. Blood to Brain Transport of Interleukin Links the Immune and Central Nervous Systems. Life Sci. 1991;48:PL117&#x2013;PL121. doi: 10.1016/0024-3205(91)90385-O.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0024-3205(91)90385-O</ArticleId><ArticleId IdType=\"pubmed\">2046463</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez E.G., Banks W.A., Kastin A.J. Murine Tumor Necrosis Factor Alpha Is Transported from Blood to Brain in the Mouse. J. Neuroimmunol. 1993;47:169&#x2013;176. doi: 10.1016/0165-5728(93)90027-V.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0165-5728(93)90027-V</ArticleId><ArticleId IdType=\"pubmed\">8370768</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilger R.N., Johnson R.W. Aging, Microglial Cell Priming, and the Discordant Central Inflammatory Response to Signals from the Peripheral Immune System. J. Leukoc. Biol. 2008;84:932&#x2013;939. doi: 10.1189/jlb.0208108.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1189/jlb.0208108</ArticleId><ArticleId IdType=\"pmc\">PMC2538600</ArticleId><ArticleId IdType=\"pubmed\">18495785</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson C.A., McColl A., Cavanagh J., Graham G.J. Peripheral Inflammation Is Associated with Remote Global Gene Expression Changes in the Brain. J. Neuroinflammation. 2014;11:73. doi: 10.1186/1742-2094-11-73.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1742-2094-11-73</ArticleId><ArticleId IdType=\"pmc\">PMC4022192</ArticleId><ArticleId IdType=\"pubmed\">24708794</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuschillo G., Celentano V., Rottoli M., Sciaudone G., Gravina A.G., Pellegrino R., Marfella R., Romano M., Selvaggi F., Pellino G. Influence of Diabetes Mellitus on Inflammatory Bowel Disease Course and Treatment Outcomes. A Systematic Review with Meta-Analysis. Dig. Liver Dis. 2023;55:580&#x2013;586. doi: 10.1016/j.dld.2022.08.017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.dld.2022.08.017</ArticleId><ArticleId IdType=\"pubmed\">36058820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ord&#xe1;s I., Eckmann L., Talamini M., Baumgart D.C., Sandborn W.J. Ulcerative Colitis. Lancet. 2012;380:1606&#x2013;1619. doi: 10.1016/S0140-6736(12)60150-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(12)60150-0</ArticleId><ArticleId IdType=\"pubmed\">22914296</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham C., Cho J.H. Inflammatory Bowel Disease. N. Engl. J. Med. 2009;361:2066&#x2013;2078. doi: 10.1056/NEJMra0804647.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMra0804647</ArticleId><ArticleId IdType=\"pmc\">PMC3491806</ArticleId><ArticleId IdType=\"pubmed\">19923578</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D.R., Bernstein C.N., Brant S.R., Caprilli R., Colombel J.F., Gasche C., Geboes K., et al. Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. Hepatol. 2005;19:5A&#x2013;36A. doi: 10.1155/2005/269076.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2005/269076</ArticleId><ArticleId IdType=\"pubmed\">16151544</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres J., Mehandru S., Colombel J.F., Peyrin-Biroulet L. Crohn&#x2019;s Disease. Lancet. 2017;389:1741&#x2013;1755. doi: 10.1016/S0140-6736(16)31711-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(16)31711-1</ArticleId><ArticleId IdType=\"pubmed\">27914655</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Wang H.E., Bai Y.M., Tsai S.J., Su T.P., Chen T.J., Wang Y.P., Chen M.H. Inflammatory Bowel Disease Is Associated with Higher Dementia Risk: A Nationwide Longitudinal Study. Gut. 2021;70:85&#x2013;91. doi: 10.1136/gutjnl-2020-320789.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gutjnl-2020-320789</ArticleId><ArticleId IdType=\"pubmed\">32576641</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingel R., Bohlken J., Kostev K. Association Between Inflammatory Bowel Disease and Dementia: A Retrospective Cohort Study. J. Alzheimers Dis. 2021;80:1471&#x2013;1478. doi: 10.3233/JAD-210103.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-210103</ArticleId><ArticleId IdType=\"pubmed\">33720902</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf8;nnow Sand J., Troelsen F.S., Horv&#xe1;th-Puh&#xf3; E., Henderson V.W., S&#xf8;rensen H.T., Erichsen R. Risk of Dementia in Patients with Inflammatory Bowel Disease: A Danish Population-Based Study. Aliment. Pharmacol. Ther. 2022;56:831&#x2013;843. doi: 10.1111/apt.17119.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/apt.17119</ArticleId><ArticleId IdType=\"pmc\">PMC9545113</ArticleId><ArticleId IdType=\"pubmed\">35781292</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Su B., Karhunen V., Gill D., Zuber V., Ahola-Olli A., Palaniswamy S., Auvinen J., Herzig K.H., Kein&#xe4;nen-Kiukaanniemi S., et al. Inflammatory Diseases, Inflammatory Biomarkers, and Alzheimer Disease: An Observational Analysis and Mendelian Randomization. Neurology. 2023;100:568&#x2013;581. doi: 10.1212/WNL.0000000000201489.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000201489</ArticleId><ArticleId IdType=\"pmc\">PMC9946179</ArticleId><ArticleId IdType=\"pubmed\">36384659</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoroso C., Perillo F., Strati F., Fantini M.C., Caprioli F., Facciotti F. The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation. Cells. 2020;9:1234. doi: 10.3390/cells9051234.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells9051234</ArticleId><ArticleId IdType=\"pmc\">PMC7291275</ArticleId><ArticleId IdType=\"pubmed\">32429359</ArticleId></ArticleIdList></Reference><Reference><Citation>Szandruk-Bender M., Wiatrak B., Szel&#x105;g A. The Risk of Developing Alzheimer&#x2019;s Disease and Parkinson&#x2019;s Disease in Patients with Inflammatory Bowel Disease: A Meta-Analysis. J. Clin. Med. 2022;11:3704. doi: 10.3390/jcm11133704.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm11133704</ArticleId><ArticleId IdType=\"pmc\">PMC9267426</ArticleId><ArticleId IdType=\"pubmed\">35806985</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartor R.B., Wu G.D. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. Gastroenterology. 2017;152:327. doi: 10.1053/j.gastro.2016.10.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2016.10.012</ArticleId><ArticleId IdType=\"pmc\">PMC5511756</ArticleId><ArticleId IdType=\"pubmed\">27769810</ArticleId></ArticleIdList></Reference><Reference><Citation>Szandruk-Bender M., Rutkowska M., Merwid-L&#x105;d A., Wiatrak B., Szel&#x105;g A., Dzimira S., Sobieszcza&#x144;ska B., Krzystek-Korpacka M., Kucharska A.Z., Matuszewska A., et al. Cornelian Cherry Iridoid-Polyphenolic Extract Improves Mucosal Epithelial Barrier Integrity in Rat Experimental Colitis and Exerts Antimicrobial and Antiadhesive Activities In Vitro. Oxid. Med. Cell Longev. 2020;2020:7697851. doi: 10.1155/2020/7697851.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2020/7697851</ArticleId><ArticleId IdType=\"pmc\">PMC7707999</ArticleId><ArticleId IdType=\"pubmed\">33299531</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirmer M., Garner A., Vlamakis H., Xavier R.J. Microbial Genes and Pathways in Inflammatory Bowel Disease. Nat. Rev. Microbiol. 2019;17:497. doi: 10.1038/s41579-019-0213-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41579-019-0213-6</ArticleId><ArticleId IdType=\"pmc\">PMC6759048</ArticleId><ArticleId IdType=\"pubmed\">31249397</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinan T.G., Cryan J.F. Gut Instincts: Microbiota as a Key Regulator of Brain Development, Ageing and Neurodegeneration. J. Physiol. 2017;595:489. doi: 10.1113/JP273106.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1113/JP273106</ArticleId><ArticleId IdType=\"pmc\">PMC5233671</ArticleId><ArticleId IdType=\"pubmed\">27641441</ArticleId></ArticleIdList></Reference><Reference><Citation>Burokas A., Moloney R.D., Dinan T.G., Cryan J.F. Microbiota Regulation of the Mammalian Gut-Brain Axis. Adv. Appl. Microbiol. 2015;91:1&#x2013;62. doi: 10.1016/BS.AAMBS.2015.02.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/BS.AAMBS.2015.02.001</ArticleId><ArticleId IdType=\"pubmed\">25911232</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiatrak B., Balon K., Jawie&#x144; P., Bednarz D., J&#x119;&#x15b;kowiak I., Szel&#x105;g A. The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2022;23:4862. doi: 10.3390/ijms23094862.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23094862</ArticleId><ArticleId IdType=\"pmc\">PMC9104401</ArticleId><ArticleId IdType=\"pubmed\">35563253</ArticleId></ArticleIdList></Reference><Reference><Citation>Villain N., Dubois B. Alzheimer&#x2019;s Disease Including Focal Presentations. Semin. Neurol. 2019;39:213&#x2013;226. doi: 10.1055/s-0039-1681041.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1055/s-0039-1681041</ArticleId><ArticleId IdType=\"pubmed\">30925614</ArticleId></ArticleIdList></Reference><Reference><Citation>Doroszkiewicz J., Groblewska M., Mroczko B. The Role of Gut Microbiota and Gut&#x2013;Brain Interplay in Selected Diseases of the Central Nervous System. Int. J. Mol. Sci. 2021;22:10028. doi: 10.3390/ijms221810028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms221810028</ArticleId><ArticleId IdType=\"pmc\">PMC8471822</ArticleId><ArticleId IdType=\"pubmed\">34576191</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandalise F., Roda E., Ratto D., Goppa L., Gargano M.L., Cirlincione F., Priori E.C., Venuti M.T., Pastorelli E., Savino E., et al. Hericium Erinaceus in Neurodegenerative Diseases: From Bench to Bedside and Beyond, How Far from the Shoreline? J. Fungi. 2023;9:551. doi: 10.3390/jof9050551.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jof9050551</ArticleId><ArticleId IdType=\"pmc\">PMC10218917</ArticleId><ArticleId IdType=\"pubmed\">37233262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S.M., Yoon D.H., Lee M.K., Lee J.K., Kim S.Y. A Mixture of Ginkgo Biloba L. Leaf and Hericium Erinaceus (Bull.) Pers. Fruit Extract Attenuates Scopolamine-Induced Memory Impairments in Mice. Oxid. Med. Cell Longev. 2022;2022:9973678. doi: 10.1155/2022/9973678.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2022/9973678</ArticleId><ArticleId IdType=\"pmc\">PMC8813274</ArticleId><ArticleId IdType=\"pubmed\">35126824</ArticleId></ArticleIdList></Reference><Reference><Citation>Roda E., Priori E.C., Ratto D., De Luca F., Di Iorio C., Angelone P., Locatelli C.A., Desiderio A., Goppa L., Savino E., et al. Neuroprotective Metabolites of Hericium Erinaceus Promote Neuro-Healthy Aging. Int. J. Mol. Sci. 2021;22:6379. doi: 10.3390/ijms22126379.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22126379</ArticleId><ArticleId IdType=\"pmc\">PMC8232141</ArticleId><ArticleId IdType=\"pubmed\">34203691</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirvani M., Nouri F., Sarihi A., Habibi P., Mohammadi M. Neuroprotective Effects of Dehydroepiandrosterone and Hericium Erinaceus in Scopolamine-Induced Alzheimer&#x2019;s Diseases-like Symptoms in Male Rats. Cell Biochem. Biophys. 2024:1&#x2013;12. doi: 10.1007/s12013-024-01400-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12013-024-01400-y</ArticleId><ArticleId IdType=\"pubmed\">38990419</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutthibutpong T., Posansee K., Liangruksa M., Termsaithong T., Piyayotai S., Phitsuwan P., Saparpakorn P., Hannongbua S., Laomettachit T. Combining Deep Learning and Structural Modeling to Identify Potential Acetylcholinesterase Inhibitors from Hericium Erinaceus. ACS Omega. 2024;9:16311&#x2013;16321. doi: 10.1021/acsomega.3c10459.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsomega.3c10459</ArticleId><ArticleId IdType=\"pmc\">PMC11007777</ArticleId><ArticleId IdType=\"pubmed\">38617639</ArticleId></ArticleIdList></Reference><Reference><Citation>Diling C., Xin Y., Chaoqun Z., Jian Y., Xiaocui T., Jun C., Ou S., Yizhen X. Extracts from Hericium Erinaceus Relieve Inflammatory Bowel Disease by Regulating Immunity and Gut Microbiota. Oncotarget. 2017;8:85838. doi: 10.18632/oncotarget.20689.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.20689</ArticleId><ArticleId IdType=\"pmc\">PMC5689651</ArticleId><ArticleId IdType=\"pubmed\">29156761</ArticleId></ArticleIdList></Reference><Reference><Citation>Westfall S., Lomis N., Kahouli I., Dia S.Y., Singh S.P., Prakash S. Microbiome, Probiotics and Neurodegenerative Diseases: Deciphering the Gut Brain Axis. Cell Mol. Life Sci. 2017;74:3769. doi: 10.1007/s00018-017-2550-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00018-017-2550-9</ArticleId><ArticleId IdType=\"pmc\">PMC11107790</ArticleId><ArticleId IdType=\"pubmed\">28643167</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistollato F., Cano S.S., Elio I., Vergara M.M., Giampieri F., Battino M. Role of Gut Microbiota and Nutrients in Amyloid Formation and Pathogenesis of Alzheimer Disease. Nutr. Rev. 2016;74:624&#x2013;634. doi: 10.1093/nutrit/nuw023.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nutrit/nuw023</ArticleId><ArticleId IdType=\"pubmed\">27634977</ArticleId></ArticleIdList></Reference><Reference><Citation>Erny D., De Angelis A.L.H., Jaitin D., Wieghofer P., Staszewski O., David E., Keren-Shaul H., Mahlakoiv T., Jakobshagen K., Buch T., et al. Host Microbiota Constantly Control Maturation and Function of Microglia in the CNS. Nat. Neurosci. 2015;18:965. doi: 10.1038/nn.4030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nn.4030</ArticleId><ArticleId IdType=\"pmc\">PMC5528863</ArticleId><ArticleId IdType=\"pubmed\">26030851</ArticleId></ArticleIdList></Reference><Reference><Citation>Braniste V., Al-Asmakh M., Kowal C., Anuar F., Abbaspour A., T&#xf3;th M., Korecka A., Bakocevic N., Guan N.L., Kundu P., et al. The Gut Microbiota Influences Blood-Brain Barrier Permeability in Mice. Sci. Transl. Med. 2014;6:263ra158. doi: 10.1126/scitranslmed.3009759.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/scitranslmed.3009759</ArticleId><ArticleId IdType=\"pmc\">PMC4396848</ArticleId><ArticleId IdType=\"pubmed\">25411471</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S., Kim J., Chun J., Han K., Soh H., Kang E.A., Lee H.J., Im J.P., Kim J.S. Patients with Inflammatory Bowel Disease Are at an Increased Risk of Parkinson&#x2019;s Disease: A South Korean Nationwide Population-Based Study. J. Clin. Med. 2019;8:1191. doi: 10.3390/jcm8081191.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm8081191</ArticleId><ArticleId IdType=\"pmc\">PMC6723604</ArticleId><ArticleId IdType=\"pubmed\">31398905</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C., Li G., Huang P., Liu Z., Zhao B. The Gut Microbiota and Alzheimer&#x2019;s Disease. J. Alzheimers Dis. 2017;58:1&#x2013;15. doi: 10.3233/JAD-161141.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-161141</ArticleId><ArticleId IdType=\"pubmed\">28372330</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Smith D., Leong B.J., Br&#xe4;nnstr&#xf6;m K., Almqvist F., Chapman M.R. Promiscuous Cross-Seeding between Bacterial Amyloids Promotes Interspecies Biofilms. J. Biol. Chem. 2012;287:35092. doi: 10.1074/jbc.M112.383737.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M112.383737</ArticleId><ArticleId IdType=\"pmc\">PMC3471717</ArticleId><ArticleId IdType=\"pubmed\">22891247</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedland R.P. Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration. J. Alzheimers Dis. 2015;45:349&#x2013;362. doi: 10.3233/JAD-142841.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-142841</ArticleId><ArticleId IdType=\"pubmed\">25589730</ArticleId></ArticleIdList></Reference><Reference><Citation>Neish A.S. Microbes in Gastrointestinal Health and Disease. Gastroenterology. 2009;136:65. doi: 10.1053/j.gastro.2008.10.080.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2008.10.080</ArticleId><ArticleId IdType=\"pmc\">PMC2892787</ArticleId><ArticleId IdType=\"pubmed\">19026645</ArticleId></ArticleIdList></Reference><Reference><Citation>Leylabadlo H.E., Ghotaslou R., Feizabadi M.M., Farajnia S., Moaddab S.Y., Ganbarov K., Khodadadi E., Tanomand A., Sheykhsaran E., Yousefi B., et al. The Critical Role of Faecalibacterium Prausnitzii in Human Health: An Overview. Microb. Pathog. 2020;149:104344. doi: 10.1016/j.micpath.2020.104344.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.micpath.2020.104344</ArticleId><ArticleId IdType=\"pubmed\">32534182</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo A., Cattane N., Galluzzi S., Provasi S., Lopizzo N., Festari C., Ferrari C., Guerra U.P., Paghera B., Muscio C., et al. Association of Brain Amyloidosis with Pro-Inflammatory Gut Bacterial Taxa and Peripheral Inflammation Markers in Cognitively Impaired Elderly. Neurobiol. Aging. 2017;49:60&#x2013;68. doi: 10.1016/j.neurobiolaging.2016.08.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2016.08.019</ArticleId><ArticleId IdType=\"pubmed\">27776263</ArticleId></ArticleIdList></Reference><Reference><Citation>Brierley S.M., Linden D.R. Neuroplasticity and Dysfunction after Gastrointestinal Inflammation. Nat. Rev. Gastroenterol. Hepatol. 2014;11:611&#x2013;627. doi: 10.1038/nrgastro.2014.103.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrgastro.2014.103</ArticleId><ArticleId IdType=\"pubmed\">25001973</ArticleId></ArticleIdList></Reference><Reference><Citation>Prigent A., Chapelet G., De Guilhem de Lataillade A., Oullier T., Durieu E., Bourreille A., Duchalais E., Hardonni&#xe8;re K., Neunlist M., Noble W., et al. Tau Accumulates in Crohn&#x2019;s Disease Gut. FASEB J. 2020;34:9285&#x2013;9296. doi: 10.1096/fj.202000414R.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.202000414R</ArticleId><ArticleId IdType=\"pubmed\">32436623</ArticleId></ArticleIdList></Reference><Reference><Citation>Lionnet A., Wade M.A., Corbill&#xe9; A.G., Prigent A., Paillusson S., Tasselli M., Gonzales J., Durieu E., Rolli-Derkinderen M., Coron E., et al. Characterisation of Tau in the Human and Rodent Enteric Nervous System under Physiological Conditions and in Tauopathy. Acta Neuropathol. Commun. 2018;6:65. doi: 10.1186/s40478-018-0568-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-018-0568-3</ArticleId><ArticleId IdType=\"pmc\">PMC6055332</ArticleId><ArticleId IdType=\"pubmed\">30037345</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugger B.N., Hoffman B.R., Scroggins A., Serrano G.E., Adler C.H., Shill H.A., Belden C.M., Sabbagh M.N., Caviness J.N., Driver Dunckley E., et al. Tau Immunoreactivity in Peripheral Tissues of Human Aging and Select Tauopathies. Neurosci. Lett. 2019;696:132. doi: 10.1016/j.neulet.2018.12.031.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2018.12.031</ArticleId><ArticleId IdType=\"pmc\">PMC7357994</ArticleId><ArticleId IdType=\"pubmed\">30579993</ArticleId></ArticleIdList></Reference><Reference><Citation>Prigent A., Lionnet A., Durieu E., Chapelet G., Bourreille A., Neunlist M., Rolli-Derkinderen M., Derkinderen P. Enteric Alpha-Synuclein Expression Is Increased in Crohn&#x2019;s Disease. Acta Neuropathol. 2019;137:359&#x2013;361. doi: 10.1007/s00401-018-1943-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-018-1943-7</ArticleId><ArticleId IdType=\"pubmed\">30506319</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenyi A., Leclair-Visonneau L., Clairembault T., Coron E., Neunlist M., Melki R., Derkinderen P., Bousset L. Detection of Alpha-Synuclein Aggregates in Gastrointestinal Biopsies by Protein Misfolding Cyclic Amplification. Neurobiol. Dis. 2019;129:38&#x2013;43. doi: 10.1016/j.nbd.2019.05.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2019.05.002</ArticleId><ArticleId IdType=\"pubmed\">31078683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong L., Shen Y., Li H., Zhang R., Yu S., Wu Q. Shared Genes of PPARG and NOS2 in Alzheimer&#x2019;s Disease and Ulcerative Colitis Drive Macrophages and Microglia Polarization: Evidence from Bioinformatics Analysis and Following Validation. Int. J. Mol. Sci. 2023;24:5651. doi: 10.3390/ijms24065651.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24065651</ArticleId><ArticleId IdType=\"pmc\">PMC10058634</ArticleId><ArticleId IdType=\"pubmed\">36982725</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravina A.G., Pellegrino R., Durante T., Palladino G., Imperio G., D&#x2019;Amico G., Trotta M.C., Dallio M., Romeo M., D&#x2019;Amico M., et al. The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials. Cells. 2023;12:1889. doi: 10.3390/cells12141889.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells12141889</ArticleId><ArticleId IdType=\"pmc\">PMC10378568</ArticleId><ArticleId IdType=\"pubmed\">37508552</ArticleId></ArticleIdList></Reference><Reference><Citation>Catania A. The Melanocortin System in Leukocyte Biology. J. Leukoc. Biol. 2007;81:383&#x2013;392. doi: 10.1189/jlb.0706426.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1189/jlb.0706426</ArticleId><ArticleId IdType=\"pubmed\">17041004</ArticleId></ArticleIdList></Reference><Reference><Citation>Catania A. Neuroprotective Actions of Melanocortins: A Therapeutic Opportunity. Trends Neurosci. 2008;31:353&#x2013;360. doi: 10.1016/j.tins.2008.04.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tins.2008.04.002</ArticleId><ArticleId IdType=\"pubmed\">18550183</ArticleId></ArticleIdList></Reference><Reference><Citation>Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the Melanocortin-4 Receptor (MC4-R) in Neuroendocrine and Autonomic Control Circuits in the Brain. Mol. Endocrinol. 1994;8:1298&#x2013;1308. doi: 10.1210/MEND.8.10.7854347.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/MEND.8.10.7854347</ArticleId><ArticleId IdType=\"pubmed\">7854347</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey K.J. Physiology and Immunology of the Cholinergic Antiinflammatory Pathway. J. Clin. Investig. 2007;117:289. doi: 10.1172/JCI30555.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI30555</ArticleId><ArticleId IdType=\"pmc\">PMC1783813</ArticleId><ArticleId IdType=\"pubmed\">17273548</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliani D., Ottani A., Altavilla D., Bazzani C., Squadrito F., Guarini S. Melanocortins and the Cholinergic Anti-Inflammatory Pathway. Adv. Exp. Med. Biol. 2010;681:71&#x2013;87. doi: 10.1007/978-1-4419-6354-3_6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-1-4419-6354-3_6</ArticleId><ArticleId IdType=\"pubmed\">21222261</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravina A.G., Pellegrino R., Durante T., Palladino G., Imperio G., D&#x2019;Amico G., Trotta M.C., Dallio M., Romeo M., D&#x2019;Amico M., et al. P072 Melanocortin MC3 and MC5 Receptors Expression Is Different According to Colonic Disease Activity in Crohn&#x2019;s Disease and Ulcerative Colitis Biopsies: Results from an Immunohistochemical Observational Study. J. Crohns Colitis. 2022;16:i176&#x2013;i177. doi: 10.1093/ecco-jcc/jjab232.201.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ecco-jcc/jjab232.201</ArticleId></ArticleIdList></Reference><Reference><Citation>Panaro B.L., Tough I.R., Engelstoft M.S., Matthews R.T., Digby G.J., M&#xf8;ller C.L., Svendsen B., Gribble F., Reimann F., Holst J.J., et al. The Melanocortin-4 Receptor Is Expressed in Enteroendocrine L Cells and Regulates the Release of Peptide YY and Glucagon-Like Peptide 1 In Vivo. Cell Metab. 2014;20:1018. doi: 10.1016/j.cmet.2014.10.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2014.10.004</ArticleId><ArticleId IdType=\"pmc\">PMC4255280</ArticleId><ArticleId IdType=\"pubmed\">25453189</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y., Fu W.Y., Cheng E.Y.L., Fu A.K.Y., Ip N.Y. Melanocortin-4 Receptor Regulates Hippocampal Synaptic Plasticity through a Protein Kinase A-Dependent Mechanism. J. Neurosci. 2013;33:464. doi: 10.1523/JNEUROSCI.3282-12.2013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.3282-12.2013</ArticleId><ArticleId IdType=\"pmc\">PMC6704894</ArticleId><ArticleId IdType=\"pubmed\">23303927</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y., Tian M., Zheng Y., Gong F., Fu A.K.Y., Ip N.Y. Stimulation of the Hippocampal POMC/MC4R Circuit Alleviates Synaptic Plasticity Impairment in an Alzheimer&#x2019;s Disease Model. Cell Rep. 2016;17:1819&#x2013;1831. doi: 10.1016/j.celrep.2016.10.043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2016.10.043</ArticleId><ArticleId IdType=\"pubmed\">27829153</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliani D., Bitto A., Galantucci M., Zaffe D., Ottani A., Irrera N., Neri L., Cavallini G.M., Altavilla D., Botticelli A.R., et al. Melanocortins Protect against Progression of Alzheimer&#x2019;s Disease in Triple-Transgenic Mice by Targeting Multiple Pathophysiological Pathways. Neurobiol. Aging. 2014;35:537&#x2013;547. doi: 10.1016/j.neurobiolaging.2013.08.030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2013.08.030</ArticleId><ArticleId IdType=\"pubmed\">24094579</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliani D., Galantucci M., Neri L., Canalini F., Calevro A., Bitto A., Ottani A., Vandini E., Sena P., Sandrini M., et al. Melanocortins Protect against Brain Damage and Counteract Cognitive Decline in a Transgenic Mouse Model of Moderate Alzheimer&#x2019;s Disease. Eur. J. Pharmacol. 2014;740:144&#x2013;150. doi: 10.1016/j.ejphar.2014.06.063.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejphar.2014.06.063</ArticleId><ArticleId IdType=\"pubmed\">25034807</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Chawla M.K., Rios-Monterrosa J.L., Wang L., Zempare M.A., Hruby V.J., Barnes C.A., Cai M. Aged Brains Express Less Melanocortin Receptors, Which Correlates with Age-Related Decline of Cognitive Functions. Molecules. 2021;26:6266. doi: 10.3390/molecules26206266.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules26206266</ArticleId><ArticleId IdType=\"pmc\">PMC8541441</ArticleId><ArticleId IdType=\"pubmed\">34684847</ArticleId></ArticleIdList></Reference><Reference><Citation>Doan T., Massarotti E. Rheumatoid Arthritis: An Overview of New and Emerging Therapies. J. Clin. Pharmacol. 2005;45:751&#x2013;762. doi: 10.1177/0091270005277938.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0091270005277938</ArticleId><ArticleId IdType=\"pubmed\">15951465</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy E.H.S., Panayi G.S. Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis. N. Engl. J. Med. 2001;344:907&#x2013;916. doi: 10.1056/NEJM200103223441207.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJM200103223441207</ArticleId><ArticleId IdType=\"pubmed\">11259725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoryani M., Shariati-Sarabi Z., Tavakkol-Afshari J., Ghasemi A., Poursamimi J., Mohammadi M. Amelioration of Clinical Symptoms of Patients with Refractory Rheumatoid Arthritis Following Treatment with Autologous Bone Marrow-Derived Mesenchymal Stem Cells: A Successful Clinical Trial in Iran. Biomed. Pharmacother. 2019;109:1834&#x2013;1840. doi: 10.1016/j.biopha.2018.11.056.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2018.11.056</ArticleId><ArticleId IdType=\"pubmed\">30551438</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldmann M., Maini R.N. The Role of Cytokines in the Pathogenesis of Rheumatoid Arthritis. Rheumatology (Oxford) 1999;38 Suppl 2:3&#x2013;7. doi: 10.2174/1573397054023100.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1573397054023100</ArticleId><ArticleId IdType=\"pubmed\">10646481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X., Wu S.L., Hincapie M., Hancock W.S. Study of the Human Plasma Proteome of Rheumatoid Arthritis. J. Chromatogr. A. 2009;1216:3538&#x2013;3545. doi: 10.1016/j.chroma.2009.01.063.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.chroma.2009.01.063</ArticleId><ArticleId IdType=\"pubmed\">19215933</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodi K., Prokaeva T., Spencer B., Eberhard M., Connors L.H., Seldin D.C. AL-Base: A Visual Platform Analysis Tool for the Study of Amyloidogenic Immunoglobulin Light Chain Sequences. Amyloid. 2009;16:1. doi: 10.1080/13506120802676781.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/13506120802676781</ArticleId><ArticleId IdType=\"pmc\">PMC4123194</ArticleId><ArticleId IdType=\"pubmed\">19291508</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J., Meloni B.P., Shi T., Bonser A., Papadimitriou J.M., Mastaglia F.L., Zhang C., Zheng M., Gao J. The Potential Influence of Bone-Derived Modulators on the Progression of Alzheimer&#x2019;s Disease. J. Alzheimers Dis. 2019;69:59&#x2013;70. doi: 10.3233/JAD-181249.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-181249</ArticleId><ArticleId IdType=\"pubmed\">30932886</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly J.P., Hanna M., Sperry B.W., Seitz W.H. Carpal Tunnel Syndrome: A Potential Early, Red-Flag Sign of Amyloidosis. J. Hand Surg. Am. 2019;44:868&#x2013;876. doi: 10.1016/j.jhsa.2019.06.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jhsa.2019.06.016</ArticleId><ArticleId IdType=\"pubmed\">31400950</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunger A.F., Nienhuis H.L.A., Bijzet J., Hazenberg B.P.C. Causes of AA Amyloidosis: A Systematic Review. Amyloid. 2020;27:1&#x2013;12. doi: 10.1080/13506129.2019.1693359.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/13506129.2019.1693359</ArticleId><ArticleId IdType=\"pubmed\">31766892</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart P.H., Hunt E.K., Bonder C.S., Watson C.J., Finlay-Jones J.J. Regulation of Surface and Soluble TNF Receptor Expression on Human Monocytes and Synovial Fluid Macrophages by IL-4 and IL-10. J. Immunol. 1996;157:3672&#x2013;3680. doi: 10.4049/jimmunol.157.8.3672.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.157.8.3672</ArticleId><ArticleId IdType=\"pubmed\">8871669</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker K.A., Gottesman R.F., Wu A., Knopman D.S., Gross A.L., Mosley T.H., Selvin E., Windham B.G. Systemic Inflammation during Midlife and Cognitive Change over 20 Years: The ARIC Study. Neurology. 2019;92:e1256. doi: 10.1212/WNL.0000000000007094.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000007094</ArticleId><ArticleId IdType=\"pmc\">PMC6511107</ArticleId><ArticleId IdType=\"pubmed\">30760633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.M., Chen W.S., Sheu J.J., Chen Y.H., Chen J.H., Chang C.C. Autoimmune Rheumatic Diseases Increase Dementia Risk in Middle-Aged Patients: A Nationwide Cohort Study. PLoS ONE. 2018;13:e0186475. doi: 10.1371/journal.pone.0186475.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0186475</ArticleId><ArticleId IdType=\"pmc\">PMC5755737</ArticleId><ArticleId IdType=\"pubmed\">29304089</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallin K., Solomon A., Kreholt I., Tuomilehto J., Soininen H., Walin K. Midlife Rheumatoid Arthritis Increases the Risk of Cognitive Impairment Two Decades Later: A Population-Based Study. J. Alzheimers Dis. 2012;31:669&#x2013;676. doi: 10.3233/JAD-2012-111736.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-2012-111736</ArticleId><ArticleId IdType=\"pubmed\">22647255</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Santos M.T., Garriga C., Judge A., Batra R.N., Price A.J., Liddle A.D., Javaid M.K., Cooper C., Murray D.W., Arden N.K. Development and Validation of a Clinical Prediction Model for Patient-Reported Pain and Function after Primary Total Knee Replacement Surgery. Sci. Rep. 2018;8:3381. doi: 10.1038/s41598-018-21714-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-21714-1</ArticleId><ArticleId IdType=\"pmc\">PMC5821875</ArticleId><ArticleId IdType=\"pubmed\">29467465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi P.P., Breitner J.C.S. Do NSAIDs Prevent Alzheimer&#x2019;s Disease? And, If so, Why? The Epidemiological Evidence. Neurobiol. Aging. 2001;22:811&#x2013;817. doi: 10.1016/S0197-4580(01)00297-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0197-4580(01)00297-4</ArticleId><ArticleId IdType=\"pubmed\">11754987</ArticleId></ArticleIdList></Reference><Reference><Citation>Policicchio S., Ahmad A.N., Powell J.F., Proitsi P. Rheumatoid Arthritis and Risk for Alzheimer&#x2019;s Disease: A Systematic Review and Meta-Analysis and a Mendelian Randomization Study. Sci. Rep. 2017;7:12861. doi: 10.1038/s41598-017-13168-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-017-13168-8</ArticleId><ArticleId IdType=\"pmc\">PMC5634412</ArticleId><ArticleId IdType=\"pubmed\">28993680</ArticleId></ArticleIdList></Reference><Reference><Citation>The Alzheimer&#x2019;s Disease Anti-inflammatory Prevention Trial Research Group Results of a Follow-up Study to the Randomized Alzheimer&#x2019;s Disease Anti-Inflammatory Prevention Trial (ADAPT) Alzheimers Dement. 2013;9:714&#x2013;723. doi: 10.1016/J.JALZ.2012.11.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/J.JALZ.2012.11.012</ArticleId><ArticleId IdType=\"pmc\">PMC3823756</ArticleId><ArticleId IdType=\"pubmed\">23562431</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebrasseur N.K., Tchkonia T., Kirkland J.L. Cellular Senescence and the Biology of Aging, Disease, and Frailty. Nestle Nutr. Inst. Workshop Ser. 2015;83:11. doi: 10.1159/000382054.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000382054</ArticleId><ArticleId IdType=\"pmc\">PMC4780350</ArticleId><ArticleId IdType=\"pubmed\">26485647</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou R.C., Kane M., Ghimire S., Gautam S., Gui J. Treatment for Rheumatoid Arthritis and Risk of Alzheimer&#x2019;s Disease: A Nested Case-Control Analysis. CNS Drugs. 2016;30:1111. doi: 10.1007/s40263-016-0374-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40263-016-0374-z</ArticleId><ArticleId IdType=\"pmc\">PMC5585782</ArticleId><ArticleId IdType=\"pubmed\">27470609</ArticleId></ArticleIdList></Reference><Reference><Citation>Judge A., Garriga C., Arden N.K., Lovestone S., Prieto-Alhambra D., Cooper C., Edwards C.J. Protective Effect of Antirheumatic Drugs on Dementia in Rheumatoid Arthritis Patients. Alzheimer&#x2019;s Dementia Transl. Res. Clin. Interv. 2017;3:612. doi: 10.1016/j.trci.2017.10.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.trci.2017.10.002</ArticleId><ArticleId IdType=\"pmc\">PMC5700830</ArticleId><ArticleId IdType=\"pubmed\">29201995</ArticleId></ArticleIdList></Reference><Reference><Citation>Trzeciak P., Herbet M., Dudka J. Common Factors of Alzheimer&#x2019;s Disease and Rheumatoid Arthritis&#x2014;Pathomechanism and Treatment. Molecules. 2021;26:6038. doi: 10.3390/molecules26196038.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules26196038</ArticleId><ArticleId IdType=\"pmc\">PMC8512006</ArticleId><ArticleId IdType=\"pubmed\">34641582</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273694</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Experimental Cell Models for Investigating Neurodegenerative Diseases.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9747</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179747</ELocationID><Abstract><AbstractText>Experimental models play a pivotal role in biomedical research, facilitating the understanding of disease mechanisms and the development of novel therapeutics. This is particularly true for neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and motor neuron disease, which present complex challenges for research and therapy development. In this work, we review the recent literature about experimental models and motor neuron disease. We identified three main categories of models that are highly studied by scientists. In fact, experimental models for investigating these diseases encompass a variety of approaches, including modeling the patient's cell culture, patient-derived induced pluripotent stem cells, and organoids. Each model offers unique advantages and limitations, providing researchers with a range of tools to address complex biological questions. Here, we discuss the characteristics, applications, and recent advancements in terms of each model system, highlighting their contributions to advancing biomedical knowledge and translational research.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Evangelisti</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><Identifier Source=\"ORCID\">0000-0002-0877-7696</Identifier><AffiliationInfo><Affiliation>Medical Genetics Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ramadan</LastName><ForeName>Sherin</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0009-0003-1129-2010</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Orlacchio</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-2602-3281</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Perugia, 06123 Perugia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurogenetics, European Center for Brain Research (CERC), IRCCS Santa Lucia Foundation, 00143 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Panza</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source=\"ORCID\">0000-0002-2338-1139</Identifier><AffiliationInfo><Affiliation>Medical Genetics Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D019636\" MajorTopicYN=\"Y\">Neurodegenerative Diseases</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D057026\" MajorTopicYN=\"Y\">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI=\"Q000166\" MajorTopicYN=\"N\">cytology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D009940\" MajorTopicYN=\"Y\">Organoids</DescriptorName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008954\" MajorTopicYN=\"N\">Models, Biological</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">gene editing</Keyword><Keyword MajorTopicYN=\"N\">iPSCs</Keyword><Keyword MajorTopicYN=\"N\">model organisms</Keyword><Keyword MajorTopicYN=\"N\">organoid</Keyword><Keyword MajorTopicYN=\"N\">primary cells</Keyword></KeywordList><CoiStatement>The authors declare that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273694</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179747</ArticleId><ArticleId IdType=\"pii\">ijms25179747</ArticleId><ArticleId IdType=\"pmc\">PMC11396244</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Antony P.M., Diederich N.J., Kr&#xfc;ger R., Balling R. The hallmarks of Parkinson&#x2019;s disease. FEBS J. 2013;23:5981&#x2013;5993. doi: 10.1111/febs.12335.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/febs.12335</ArticleId><ArticleId IdType=\"pubmed\">23663200</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi K., Tanji K., Odagiri S., Miki Y., Mori F., Takahashi H. The Lewy body in Parkinson&#x2019;s disease and related neurodegenerative disorders. Mol. Neurobiol. 2013;2:495&#x2013;508. doi: 10.1007/s12035-012-8280-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-012-8280-y</ArticleId><ArticleId IdType=\"pubmed\">22622968</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauwendraat C., Nalls M.A., Singleton A.B. The genetic architecture of Parkinson&#x2019;s disease. Lancet Neurol. 2020;2:170&#x2013;178. doi: 10.1016/S1474-4422(19)30287-X.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(19)30287-X</ArticleId><ArticleId IdType=\"pmc\">PMC8972299</ArticleId><ArticleId IdType=\"pubmed\">31521533</ArticleId></ArticleIdList></Reference><Reference><Citation>Funayama M., Nishioka K., Li Y., Hattori N. Molecular genetics of Parkinson&#x2019;s disease: Contributions and global trends. J. Hum. Genet. 2023;3:125&#x2013;130. doi: 10.1038/s10038-022-01058-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s10038-022-01058-5</ArticleId><ArticleId IdType=\"pmc\">PMC9968657</ArticleId><ArticleId IdType=\"pubmed\">35821405</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams E.T., Chen X., Moore D.J. VPS35, the Retromer Complex and Parkinson&#x2019;s Disease. J. Park. Dis. 2017;2:219&#x2013;233. doi: 10.3233/JPD-161020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JPD-161020</ArticleId><ArticleId IdType=\"pmc\">PMC5438477</ArticleId><ArticleId IdType=\"pubmed\">28222538</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumenfeld J., Yip O., Kim M.J., Huang Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat. Rev. Neurosci. 2024;2:91&#x2013;110. doi: 10.1038/s41583-023-00776-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41583-023-00776-9</ArticleId><ArticleId IdType=\"pmc\">PMC11073858</ArticleId><ArticleId IdType=\"pubmed\">38191720</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Kant R., Goldstein L.S.B., Ossenkoppele R. Amyloid-&#x3b2;-independent regulators of tau pathology in Alzheimer disease. Nat. Rev. Neurosci. 2020;1:21&#x2013;35. doi: 10.1038/s41583-019-0240-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41583-019-0240-3</ArticleId><ArticleId IdType=\"pubmed\">31780819</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott E.O., Malek A.M., Lacomis D. Handbook of Clinical Neurology. Volume 138. Elsevier; Amsterdam, The Netherlands: 2016. The epidemiology of amyotrophic lateral sclerosis; pp. 225&#x2013;238.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/B978-0-12-802973-2.00013-6</ArticleId><ArticleId IdType=\"pubmed\">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinello C., Panza E., Orlacchio A. Hereditary spastic paraplegias proteome: Common pathways and pathogenetic mechanisms. Expert Rev. Proteom. 2023;20:171&#x2013;188. doi: 10.1080/14789450.2023.2260952.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/14789450.2023.2260952</ArticleId><ArticleId IdType=\"pubmed\">37788157</ArticleId></ArticleIdList></Reference><Reference><Citation>Panza E., Meyyazhagan A., Orlacchio A. Hereditary spastic paraplegia: Genetic heterogeneity and common pathways. Exp. Neurol. 2022;357:114203. doi: 10.1016/j.expneurol.2022.114203.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.expneurol.2022.114203</ArticleId><ArticleId IdType=\"pubmed\">35970204</ArticleId></ArticleIdList></Reference><Reference><Citation>Aversano S., Caiazza C., Caiazzo M. Induced pluripotent stem cell-derived and directly reprogrammed neurons to study neurodegenerative diseases: The impact of aging signatures. Front. Aging Neurosci. 2022;14:1069482. doi: 10.3389/fnagi.2022.1069482.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.1069482</ArticleId><ArticleId IdType=\"pmc\">PMC9810544</ArticleId><ArticleId IdType=\"pubmed\">36620769</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., La Cognata V., Guarnaccia M., La Bella V., Conforti F.L., Cavallaro S. A Diagnostic Gene-Expression Signature in Fibroblasts of Amyotrophic Lateral Sclerosis. Cells. 2023;14:1884. doi: 10.3390/cells12141884.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells12141884</ArticleId><ArticleId IdType=\"pmc\">PMC10378077</ArticleId><ArticleId IdType=\"pubmed\">37508548</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter J.C., Messer A., Peterson A. The motor neuron degeneration (mnd) gene acts intrinsically in motor neurons and peripheral fibroblasts. Mol. Cell. Neurosci. 1997;3:185&#x2013;193. doi: 10.1006/mcne.1997.0617.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/mcne.1997.0617</ArticleId><ArticleId IdType=\"pubmed\">9245501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremerm L.S., Baderm D.M., Mertes C., Kopajtich R., Pichler G., Iuso A., Haack T.B., Graf E., Schwarzmayr T., Terrile C., et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat. Commun. 2017;8:15824. doi: 10.1038/ncomms15824.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncomms15824</ArticleId><ArticleId IdType=\"pmc\">PMC5499207</ArticleId><ArticleId IdType=\"pubmed\">28604674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser S., Schuster S., Heuten E., H&#xf6;flinger P., Admard J., Schelling Y., Velic A., Macek B., Ossowski S., Sch&#xf6;ls L. Comparative Transcriptional Profiling of Motor Neuron Disorder-Associated Genes in Various Human Cell Culture Models. Front. Cell Dev. Biol. 2020;8:544043. doi: 10.3389/fcell.2020.544043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2020.544043</ArticleId><ArticleId IdType=\"pmc\">PMC7543453</ArticleId><ArticleId IdType=\"pubmed\">33072739</ArticleId></ArticleIdList></Reference><Reference><Citation>Corenblum M.J., McRobbie-Johnson A., Carruth E., Bernard K., Luo M., Mandarino L.J., Peterson S., Sans-Fuentes M.A., Billheimer D., Maley T., et al. Parallel neurodegenerative phenotypes in sporadic Parkinson&#x2019;s disease fibroblasts and midbrain dopamine neurons. Prog. Neurobiol. 2023;229:102501. doi: 10.1016/j.pneurobio.2023.102501.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pneurobio.2023.102501</ArticleId><ArticleId IdType=\"pmc\">PMC11249208</ArticleId><ArticleId IdType=\"pubmed\">37451330</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannello G., Patel A., Sirabella D., Diaz A.G., Hoover B.N., Sarmah H., Corneo B. Simple, Fast, and Efficient Method for Derivation of Dermal Fibroblasts From Skin Biopsies. Curr. Protoc. 2023;3:e714. doi: 10.1002/cpz1.714.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cpz1.714</ArticleId><ArticleId IdType=\"pubmed\">36912580</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L., Yu X. Fibroblasts: New players in the central nervous system? Fundam. Res. 2023;4:262&#x2013;266. doi: 10.1016/j.fmre.2023.01.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.fmre.2023.01.014</ArticleId><ArticleId IdType=\"pmc\">PMC11197739</ArticleId><ArticleId IdType=\"pubmed\">38933505</ArticleId></ArticleIdList></Reference><Reference><Citation>Olesen M.A., Villavicencio-Tejo F., Quintanilla R.A. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders. Transl. Neurodegener. 2022;1:36. doi: 10.1186/s40035-022-00308-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40035-022-00308-y</ArticleId><ArticleId IdType=\"pmc\">PMC9251940</ArticleId><ArticleId IdType=\"pubmed\">35787292</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Gumina V., Lenzi P., Bossolasco P., Fulceri F., Volpe C., Bardelli D., Pregnolato F., Maraschi A., Fornai F., et al. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Neurobiol. Dis. 2020;145:105051. doi: 10.1016/j.nbd.2020.105051.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2020.105051</ArticleId><ArticleId IdType=\"pubmed\">32827688</ArticleId></ArticleIdList></Reference><Reference><Citation>Eysert F., Kinoshita P.F., Lagarde J., Lacas-Gervais S., Xicota L., Doroth&#xe9;e G., Bottlaender M., Checler F., Potier M.C., Sarazin M., et al. Mitochondrial alterations in fibroblasts from sporadic Alzheimer&#x2019;s disease (AD) patients correlate with AD-related clinical hallmarks. Acta Neuropathol. Commun. 2024;1:90. doi: 10.1186/s40478-024-01807-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-024-01807-x</ArticleId><ArticleId IdType=\"pmc\">PMC11161956</ArticleId><ArticleId IdType=\"pubmed\">38851733</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvagnion C., Marlet F.R., Cerri S., Schapira A.H.V., Blandini F., Di Monte D.A. Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote &#x3b1;-synuclein aggregation. Brain. 2022;3:1038&#x2013;1051. doi: 10.1093/brain/awab371.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awab371</ArticleId><ArticleId IdType=\"pmc\">PMC9050548</ArticleId><ArticleId IdType=\"pubmed\">35362022</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J., Castanedo-V&#xe1;zquez D., Gil-Bea F., Tapia O., Arozamena J., Dur&#xe1;n-V&#xed;an C., Sedano M.J., Berciano M.T., Lopez de Munain A., Lafarga M. ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage. J. Neurol. 2020;267:1291&#x2013;1299. doi: 10.1007/s00415-020-09704-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00415-020-09704-8</ArticleId><ArticleId IdType=\"pubmed\">31938860</ArticleId></ArticleIdList></Reference><Reference><Citation>Imberechts D., Kinnart I., Wauters F., Terbeek J., Manders L., Wierda K., Eggermont K., Madeiro R.F., Sue C., Verfaillie C., et al. DJ-1 is an essential downstream mediator in PINK1/parkin-dependent mitophagy. Brain. 2022;12:4368&#x2013;4384. doi: 10.1093/brain/awac313.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awac313</ArticleId><ArticleId IdType=\"pmc\">PMC9762950</ArticleId><ArticleId IdType=\"pubmed\">36039535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Toledo G., Silva-Lucero M.D., Herrera-D&#xed;az J., Garc&#xed;a D.E., Arias-Monta&#xf1;o J.A., Cardenas-Aguayo M.D. Patient-Derived Fibroblasts with Presenilin-1 Mutations, That Model Aspects of Alzheimer&#x2019;s Disease Pathology, Constitute a Potential Object for Early Diagnosis. Front. Aging Neurosci. 2022;14:921573. doi: 10.3389/fnagi.2022.921573.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.921573</ArticleId><ArticleId IdType=\"pmc\">PMC9283986</ArticleId><ArticleId IdType=\"pubmed\">35847683</ArticleId></ArticleIdList></Reference><Reference><Citation>Ib&#xe1;&#xf1;ez-Salazar A., Ba&#xf1;uelos-Hern&#xe1;ndez B., Rodr&#xed;guez-Leyva I., Chi-Ahumada E., Monreal-Escalante E., Jim&#xe9;nez-Capdeville M.E., Rosales-Mendoza S. Oxidative Stress Modifies the Levels and Phosphorylation State of Tau Protein in Human Fibroblasts. Front. Neurosci. 2017;11:495. doi: 10.3389/fnins.2017.00495.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2017.00495</ArticleId><ArticleId IdType=\"pmc\">PMC5594088</ArticleId><ArticleId IdType=\"pubmed\">28936161</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan A., Nesslany F., Violet M., B&#xe9;gard S., Loyens A., Talahari S., Mansuroglu Z., Marzin D., Sergeant N., Humez S., et al. Nuclear tau, a key player in neuronal DNA protection. J. Biol. Chem. 2011;6:4566&#x2013;4575. doi: 10.1074/jbc.M110.199976.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M110.199976</ArticleId><ArticleId IdType=\"pmc\">PMC3039398</ArticleId><ArticleId IdType=\"pubmed\">21131359</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C.L., Maiuri T., Bowie L.E., Gotesman R., Son S., Falcone M., Giordano J.V., Gillis T., Mattis V., Lau T., et al. A patient-derived cellular model for Huntington&#x2019;s disease reveals phenotypes at clinically relevant CAG lengths. Mol. Biol. Cell. 2018;23:2809&#x2013;2820. doi: 10.1091/mbc.E18-09-0590.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1091/mbc.E18-09-0590</ArticleId><ArticleId IdType=\"pmc\">PMC6249865</ArticleId><ArticleId IdType=\"pubmed\">30256717</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;nberg A., Skene N., Sanders F., Trusohamn M., Remnest&#xe5;l J., Szczepi&#x144;ska A., Aksoylu I.S., L&#xf6;nnerberg P., Ebarasi L., Wouters S., et al. Altered perivascular fibroblast activity precedes ALS disease onset. Nat. Med. 2021;4:640&#x2013;646. doi: 10.1038/s41591-021-01295-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-021-01295-9</ArticleId><ArticleId IdType=\"pmc\">PMC7613336</ArticleId><ArticleId IdType=\"pubmed\">33859435</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano N., Catalani A., Lattante S., Belardo A., Proietti S., Bertini L., Silvestri F., Catalani E., Cervia D., Zolla L., et al. ALS skin fibroblasts reveal oxidative stress and ERK1/2-mediated cytoplasmic localization of TDP-43. Cell. Signal. 2020;70:109591. doi: 10.1016/j.cellsig.2020.109591.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cellsig.2020.109591</ArticleId><ArticleId IdType=\"pubmed\">32126264</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng R., Medico-Salsench E., Nikoncuk A., Ramakrishnan R., Lanko K., K&#xfc;hn N.A., van der Linde H.C., Lor-Zade S., Albuainain F., Shi Y., et al. AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model. Acta Neuropathol. 2023;2:353&#x2013;368. doi: 10.1007/s00401-023-02579-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-023-02579-9</ArticleId><ArticleId IdType=\"pmc\">PMC10328903</ArticleId><ArticleId IdType=\"pubmed\">37119330</ArticleId></ArticleIdList></Reference><Reference><Citation>Online Mendelian Inheritance in Man, OMIM&#xae;. Johns Hopkins University; Baltimore, MD, USA: 2020.</Citation></Reference><Reference><Citation>Schlotawa L., Tyka K., Kettwig M., Ahrens-Nicklas R.C., Baud M., Berulava T., Brunetti-Pierri N., Gagne A., Herbst Z.M., Maguire J.A., et al. Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO Mol. Med. 2023;3:e14837. doi: 10.15252/emmm.202114837.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.202114837</ArticleId><ArticleId IdType=\"pmc\">PMC9994482</ArticleId><ArticleId IdType=\"pubmed\">36789546</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehman A., Fatima I., Noor F., Qasim M., Wang P., Jia J., Alshabrmim F.M., Liao M. Role of small molecules as drug candidates for reprogramming somatic cells into induced pluripotent stem cells: A comprehensive review. Comput. Biol. Med. 2024;177:108661. doi: 10.1016/j.compbiomed.2024.108661.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.compbiomed.2024.108661</ArticleId><ArticleId IdType=\"pubmed\">38810477</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;5858:1917&#x2013;1920. doi: 10.1126/science.1151526.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1151526</ArticleId><ArticleId IdType=\"pubmed\">18029452</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;5:861&#x2013;872. doi: 10.1016/j.cell.2007.11.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2007.11.019</ArticleId><ArticleId IdType=\"pubmed\">18035408</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazzin D.B., Previato T.T.R., Gon&#xe7;alves J.I.B., Zanirati G., Xavier F.A.C., da Costa J.C., Marinowic D.R. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies. Cells. 2024;9:745. doi: 10.3390/cells13090745.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells13090745</ArticleId><ArticleId IdType=\"pmc\">PMC11083827</ArticleId><ArticleId IdType=\"pubmed\">38727281</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Lee S.J., Wolters F.J., Ikram M.K., Hofman A., Ikram M.A., Amin N., van Duijn C.M. The effect of APOE and other common genetic variants on the onset of Alzheimer&#x2019;s disease and dementia: A community-based cohort study. Lancet Neurol. 2018;5:434&#x2013;444. doi: 10.1016/S1474-4422(18)30053-X.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(18)30053-X</ArticleId><ArticleId IdType=\"pubmed\">29555425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayeni E.A., Aldossary A.M., Ayejoto D.A., Gbadegesin L.A., Alshehri A.A., Alfassam H.A., Afewerky H.K., Almughem F.A., Bello S.M., Tawfik E.A. Neurodegenerative Diseases: Implications of Environmental and Climatic Influences on Neurotransmitters and Neuronal Hormones Activities. Int. J. Environ. Res. Public Health. 2022;19:12495. doi: 10.3390/ijerph191912495.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijerph191912495</ArticleId><ArticleId IdType=\"pmc\">PMC9564880</ArticleId><ArticleId IdType=\"pubmed\">36231792</ArticleId></ArticleIdList></Reference><Reference><Citation>Abud E.M., Ramirez R.N., Martinez E.S., Healy L.M., Nguyen C.H.H., Newman S.A., Yeromin A.V., Scarfone V.M., Marsh S.E., Fimbres C., et al. iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases. Neuron. 2017;2:278&#x2013;293.e9. doi: 10.1016/j.neuron.2017.03.042.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2017.03.042</ArticleId><ArticleId IdType=\"pmc\">PMC5482419</ArticleId><ArticleId IdType=\"pubmed\">28426964</ArticleId></ArticleIdList></Reference><Reference><Citation>Matilla-Due&#xf1;as A., Corral-Juan M., Rodr&#xed;guez-Palmero Seuma A., Vilas D., Ispierto L., Morais S., Sequeiros J., Alonso I., Volpini V., Serrano-Munuera C., et al. Rare Neurodegenerative Diseases: Clinical and Genetic Update. Adv. Exp. Med. Biol. 2017;1031:443&#x2013;496. doi: 10.1007/978-3-319-67144-4_25.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-3-319-67144-4_25</ArticleId><ArticleId IdType=\"pubmed\">29214587</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Waltz S., Woodruff G., Ouyang J., Israel M.A., Herrera C., Sarsoza F., Tanzi R.E., Koo E.H., Ringman J.M., et al. Effect of potent &#x3b3;-secretase modulator in human neurons derived from multiple presenilin 1-induced pluripotent stem cell mutant carriers. JAMA Neurol. 2014;12:1481&#x2013;1489. doi: 10.1001/jamaneurol.2014.2482.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaneurol.2014.2482</ArticleId><ArticleId IdType=\"pmc\">PMC4374637</ArticleId><ArticleId IdType=\"pubmed\">25285942</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Maestro P., Gargini R.A., Sproul A., Garc&#xed;a E., Ant&#xf3;n L.C., Noggle S., Arancio O., Avila J., Garc&#xed;a-Escudero V. Mitophagy Failure in Fibroblasts and iPSC-Derived Neurons of Alzheimer&#x2019;s Disease-Associated Presenilin 1 Mutation. Front. Mol. Neurosci. 2017;10:291. doi: 10.3389/fnmol.2017.00291.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnmol.2017.00291</ArticleId><ArticleId IdType=\"pmc\">PMC5603661</ArticleId><ArticleId IdType=\"pubmed\">28959184</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproul A.A., Jacob S., Pre D., Kim S.H., Nestor M.W., Navarro-Sobrino M., Santa-Maria I., Zimmer M., Aubry S., Steele J.W., et al. Characterization and molecular profiling of PSEN1 familial Alzheimer&#x2019;s disease iPSC-derived neural progenitors. PLoS ONE. 2014;1:e84547. doi: 10.1371/journal.pone.0084547.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0084547</ArticleId><ArticleId IdType=\"pmc\">PMC3885572</ArticleId><ArticleId IdType=\"pubmed\">24416243</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Zhao H., Ma Y., Shi G., Song J., Tang Y., Li S., Li T., Liu N., Tang F., et al. Early pathogenic event of Alzheimer&#x2019;s disease documented in iPSCs from patients with PSEN1 mutations. Oncotarget. 2017;5:7900&#x2013;7913. doi: 10.18632/oncotarget.13776.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.13776</ArticleId><ArticleId IdType=\"pmc\">PMC5352369</ArticleId><ArticleId IdType=\"pubmed\">27926491</ArticleId></ArticleIdList></Reference><Reference><Citation>Budny V., Kn&#xf6;pfli Y., Meier D., Z&#xfc;rcher K., Bodenmann C., Peter S.L., M&#xfc;ller T., Tardy M., Cortijo C., Tackenberg C. APOE4 Increases Energy Metabolism in APOE-Isogenic iPSC-Derived Neurons. Cells. 2024;14:1207. doi: 10.3390/cells13141207.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells13141207</ArticleId><ArticleId IdType=\"pmc\">PMC11274733</ArticleId><ArticleId IdType=\"pubmed\">39056789</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Najm R., Xu Q., Jeong D.E., Walker D., Balestra M.E., Yoon S.Y., Yuan H., Li G., Miller Z.A., et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med. 2018;5:647&#x2013;657. doi: 10.1038/s41591-018-0004-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-018-0004-z</ArticleId><ArticleId IdType=\"pmc\">PMC5948154</ArticleId><ArticleId IdType=\"pubmed\">29632371</ArticleId></ArticleIdList></Reference><Reference><Citation>Byers B., Cord B., Nguyen H.N., Sch&#xfc;le B., Fenno L., Lee P.C., Deisseroth K., Langston J.W., Pera R.R., Palmer T.D. SNCA triplication Parkinson&#x2019;s patient&#x2019;s iPSC-derived DA neurons accumulate &#x3b1;-synuclein and are susceptible to oxidative stress. PLoS ONE. 2011;11:e26159. doi: 10.1371/journal.pone.0026159.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0026159</ArticleId><ArticleId IdType=\"pmc\">PMC3217921</ArticleId><ArticleId IdType=\"pubmed\">22110584</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine M.J., Ryten M., Vodicka P., Thomson A.J., Burdon T., Houlden H., Cavaleri F., Nagano M., Drummond N.J., Taanman J.W., et al. Parkinson&#x2019;s disease induced pluripotent stem cells with triplication of the &#x3b1;-synuclein locus. Nat. Commun. 2011;2:440. doi: 10.1038/ncomms1453.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncomms1453</ArticleId><ArticleId IdType=\"pmc\">PMC3265381</ArticleId><ArticleId IdType=\"pubmed\">21863007</ArticleId></ArticleIdList></Reference><Reference><Citation>Online Mendelian Inheritance in Man, OMIM&#xae;. Johns Hopkins University; Baltimore, MD, USA: 2024.</Citation></Reference><Reference><Citation>Bono K., Hara-Miyauchi C., Sumi S., Oka H., Iguchi Y., Okano H.J. Endosomal dysfunction in iPSC-derived neural cells from Parkinson&#x2019;s disease patients with VPS35 D620N. Mol. Brain. 2020;1:137. doi: 10.1186/s13041-020-00675-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13041-020-00675-5</ArticleId><ArticleId IdType=\"pmc\">PMC7542911</ArticleId><ArticleId IdType=\"pubmed\">33032646</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarkova E.S., Grigor&#x2019;eva E.V., Medvedev S.P., Pavlova S.V., Zakian S.M., Malakhova A.A. IPSC-Derived Astrocytes Contribute to In Vitro Modeling of Parkinson&#x2019;s Disease Caused by the GBA1 N370S Mutation. Int. J. Mol. Sci. 2023;1:327. doi: 10.3390/ijms25010327.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms25010327</ArticleId><ArticleId IdType=\"pmc\">PMC10779194</ArticleId><ArticleId IdType=\"pubmed\">38203497</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshkolova A.A., Grekhnev D.A., Kruchinina A.A., Belikova L.D., Volovikov E.A., Lebedeva O.S., Bogomazova A.N., Vigont V.A., Lagarkova M.A., Kaznacheyeva E.V. Comparison of the calcium signaling alterations in GABA-ergic medium spiny neurons produced from iPSCs of different origins. Biochimie. 2024;222:63&#x2013;71. doi: 10.1016/j.biochi.2023.12.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biochi.2023.12.011</ArticleId><ArticleId IdType=\"pubmed\">38163516</ArticleId></ArticleIdList></Reference><Reference><Citation>Workman M.J., Lim R.G., Wu J., Frank A., Ornelas L., Panther L., Galvez E., Perez D., Meepe I., Lei S., et al. Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects. Neuron. 2023;8:1191&#x2013;1204.e5. doi: 10.1016/j.neuron.2023.01.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2023.01.010</ArticleId><ArticleId IdType=\"pmc\">PMC10557526</ArticleId><ArticleId IdType=\"pubmed\">36764301</ArticleId></ArticleIdList></Reference><Reference><Citation>Jothi D., Kulka L.A.M. Strategies for modeling aging and age-related diseases. NPJ Aging. 2024;1:32. doi: 10.1038/s41514-024-00161-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41514-024-00161-5</ArticleId><ArticleId IdType=\"pmc\">PMC11237002</ArticleId><ArticleId IdType=\"pubmed\">38987252</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang R., Xia C., Close J.L., Zhang M., He J., Huang Z., Halpern A.R., Long B., Miller J.A., Lein E.S., et al. Conservation and divergence of cortical cell organization in human and mouse revealed by MERFISH. Science. 2022;6601:56&#x2013;62. doi: 10.1126/science.abm1741.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abm1741</ArticleId><ArticleId IdType=\"pmc\">PMC9262715</ArticleId><ArticleId IdType=\"pubmed\">35771910</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang Y., Lyu Y., Tan Y., Hu Z. Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy. Front. Immunol. 2023;14:1195194. doi: 10.3389/fimmu.2023.1195194.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2023.1195194</ArticleId><ArticleId IdType=\"pmc\">PMC10461088</ArticleId><ArticleId IdType=\"pubmed\">37646021</ArticleId></ArticleIdList></Reference><Reference><Citation>Song H.W., Foreman K.L., Gastfriend B.D., Kuo J.S., Palecek S.P., Shusta E.V. Transcriptomic comparison of human and mouse brain microvessels. Sci. Rep. 2020;1:12358. doi: 10.1038/s41598-020-69096-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-020-69096-7</ArticleId><ArticleId IdType=\"pmc\">PMC7378255</ArticleId><ArticleId IdType=\"pubmed\">32704093</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornson-Hooper Z.B., Fragiadakis G.K., Spitzer M.H., Chen H., Madhireddy D., Hu K., Lundsten K., McIlwain D.R., Nolan G.P. A Comprehensive Atlas of Immunological Differences Between Humans, Mice, and Non-Human Primates. Front. Immunol. 2022;13:867015. doi: 10.3389/fimmu.2022.867015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2022.867015</ArticleId><ArticleId IdType=\"pmc\">PMC8962947</ArticleId><ArticleId IdType=\"pubmed\">35359965</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Xiao D., Mao Q., Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct. Target. Ther. 2023;1:267. doi: 10.1038/s41392-023-01486-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-023-01486-5</ArticleId><ArticleId IdType=\"pmc\">PMC10336149</ArticleId><ArticleId IdType=\"pubmed\">37433768</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamu A., Li S., Gao F., Xue G. The role of neuroinflammation in neurodegenerative diseases: Current understanding and future therapeutic targets. Front. Aging Neurosci. 2024;16:1347987. doi: 10.3389/fnagi.2024.1347987.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2024.1347987</ArticleId><ArticleId IdType=\"pmc\">PMC11045904</ArticleId><ArticleId IdType=\"pubmed\">38681666</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulse J., Bachstetter A., Paul S., Bhaskar K. Editorial: Innate immunity and neurodegenerative diseases&#x2014;Triggers from self and non-self. Front. Mol. Neurosci. 2023;16:1227896. doi: 10.3389/fnmol.2023.1227896.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnmol.2023.1227896</ArticleId><ArticleId IdType=\"pmc\">PMC10282936</ArticleId><ArticleId IdType=\"pubmed\">37351198</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken T.E., Jorstad N.L., Hu Q., Lake B.B., Tian W., Kalmbach B.E., Crow M., Hodge R.D., Krienen F.M., Sorensen S.A., et al. Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature. 2021;7879:111&#x2013;119. doi: 10.1038/s41586-021-03465-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-021-03465-8</ArticleId><ArticleId IdType=\"pmc\">PMC8494640</ArticleId><ArticleId IdType=\"pubmed\">34616062</ArticleId></ArticleIdList></Reference><Reference><Citation>Pippucci T., Panza E., Pompilii E., Donadio V., Borreca A., Babalini C., Patrono C., Zuntini R., Kawarai T., Bernardi G., et al. Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: A novel mutation in the SPG11 gene and further evidence for genetic heterogeneity. Eur. J. Neurol. 2009;1:121&#x2013;126. doi: 10.1111/j.1468-1331.2008.02367.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1468-1331.2008.02367.x</ArticleId><ArticleId IdType=\"pubmed\">19087158</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Brangul&#xed; F., Buchsbaum I.Y., Pozner T., Regensburger M., Fan W., Schray A., B&#xf6;rstler T., Mishra H., Gr&#xe4;f D., Kohl Z., et al. Human SPG11 cerebral organoids reveal cortical neurogenesis impairment. Hum. Mol. Genet. 2019;6:961&#x2013;971. doi: 10.1093/hmg/ddy397.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddy397</ArticleId><ArticleId IdType=\"pmc\">PMC6400051</ArticleId><ArticleId IdType=\"pubmed\">30476097</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;2:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMra1603471</ArticleId><ArticleId IdType=\"pubmed\">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira J.D., DuBreuil D.M., Devlin A.C., Held A., Sapir Y., Berezovski E., Hawrot J., Dorfman K., Chander V., Wainger B.J. Human sensorimotor organoids derived from healthy and amyotrophic lateral sclerosis stem cells form neuromuscular junctions. Nat. Commun. 2021;1:4744. doi: 10.1038/s41467-021-24776-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-021-24776-4</ArticleId><ArticleId IdType=\"pmc\">PMC8346474</ArticleId><ArticleId IdType=\"pubmed\">34362895</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C., Shi Q., Pan X., Chen J., Zhang Y., Lang J., Wen S., Liu X., Cheng T.L., Lei K. Neuromuscular organoids model spinal neuromuscular pathologies in C9orf72 amyotrophic lateral sclerosis. Cell Rep. 2024;3:113892. doi: 10.1016/j.celrep.2024.113892.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2024.113892</ArticleId><ArticleId IdType=\"pubmed\">38431841</ArticleId></ArticleIdList></Reference><Reference><Citation>Szeb&#xe9;nyi K., Wenger L.M.D., Sun Y., Dunn A.W.E., Limegrover C.A., Gibbons G.M., Conci E., Paulsen O., Mierau S.B., Balmus G., et al. Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology. Nat. Neurosci. 2021;11:1542&#x2013;1554. doi: 10.1038/s41593-021-00923-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41593-021-00923-4</ArticleId><ArticleId IdType=\"pmc\">PMC8553627</ArticleId><ArticleId IdType=\"pubmed\">34675437</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahmoradian S.H., Lewis A.J., Genoud C., Hench J., Moors T.E., Navarro P.P., Casta&#xf1;o-D&#xed;ez D., Schweighauser G., Graff-Meyer A., Goldie K.N., et al. Lewy pathology in Parkinson&#x2019;s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 2019;7:1099&#x2013;1109. doi: 10.1038/s41593-019-0423-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41593-019-0423-2</ArticleId><ArticleId IdType=\"pubmed\">31235907</ArticleId></ArticleIdList></Reference><Reference><Citation>Becerra-Calixto A., Mukherjee A., Ramirez S., Sepulveda S., Sinha T., Al-Lahham R., De Gregorio N., Gherardelli C., Soto C. Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson&#x2019;s Disease Patient. Cells. 2023;4:625. doi: 10.3390/cells12040625.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells12040625</ArticleId><ArticleId IdType=\"pmc\">PMC9954141</ArticleId><ArticleId IdType=\"pubmed\">36831291</ArticleId></ArticleIdList></Reference><Reference><Citation>Muwanigwa M.N., Modamio-Chamarro J., Antony P.M.A., Gomez-Giro G., Kr&#xfc;ger R., Bolognin S., Schwamborn J.C. Alpha-synuclein pathology is associated with astrocyte senescence in a midbrain organoid model of familial Parkinson&#x2019;s disease. Mol. Cell. Neurosci. 2024;128:103919. doi: 10.1016/j.mcn.2024.103919.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mcn.2024.103919</ArticleId><ArticleId IdType=\"pubmed\">38307302</ArticleId></ArticleIdList></Reference><Reference><Citation>Su C.J., Feng Y., Liu T.T., Liu X., Bao J.J., Shi A.M., Hu D.M., Liu T., Yu Y.L. Thioredoxin-interacting protein induced &#x3b1;-synuclein accumulation via inhibition of autophagic flux: Implications for Parkinson&#x2019;s disease. CNS Neurosci. Ther. 2017;9:717&#x2013;723. doi: 10.1111/cns.12721.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cns.12721</ArticleId><ArticleId IdType=\"pmc\">PMC6492710</ArticleId><ArticleId IdType=\"pubmed\">28755477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Park H.J., Choi H., Chang Y., Park H., Shin J., Kim J., Lengner C.J., Lee Y.K., Kim J. Modeling G2019S-LRRK2 Sporadic Parkinson&#x2019;s Disease in 3D Midbrain Organoids. Stem Cell Rep. 2019;3:518&#x2013;531. doi: 10.1016/j.stemcr.2019.01.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.stemcr.2019.01.020</ArticleId><ArticleId IdType=\"pmc\">PMC6410341</ArticleId><ArticleId IdType=\"pubmed\">30799274</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter J., Bolognin S., Poovathingal S.K., Magni S., G&#xe9;rard D., Antony P.M., Nickels S.L., Salamanca L., Berger E., Smits L.M., et al. The Parkinson&#x2019;s-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1. Cell Rep. 2021;3:109864. doi: 10.1016/j.celrep.2021.109864.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2021.109864</ArticleId><ArticleId IdType=\"pubmed\">34686322</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrone Parfitt G., Coccia E., Goldman C., Whitney K., Reyes R., Sarrafha L., Nam K.H., Sohail S., Jones D.R., Crary J.F., et al. Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson&#x2019;s disease model. Nat. Commun. 2024;10:447. doi: 10.1038/s41467-024-44732-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-024-44732-2</ArticleId><ArticleId IdType=\"pmc\">PMC10781970</ArticleId><ArticleId IdType=\"pubmed\">38200091</ArticleId></ArticleIdList></Reference><Reference><Citation>Online Mendelian Inheritance in Man, OMIM&#xae;. Johns Hopkins University; Baltimore, MD, USA: 2016.</Citation></Reference><Reference><Citation>Wulansari N., Darsono W.H.W., Woo H.J., Chang M.Y., Kim J., Bae E.J., Sun W., Lee J.H., Cho I.J., Shin H., et al. Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson&#x2019;s disease-linked DNAJC6 mutations. Sci. Adv. 2021;8:1540. doi: 10.1126/sciadv.abb1540.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/sciadv.abb1540</ArticleId><ArticleId IdType=\"pmc\">PMC7888924</ArticleId><ArticleId IdType=\"pubmed\">33597231</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura Y., Li M.Y., Revah O., Yoon S.J., Narazaki G., Pa&#x219;ca S.P. Engineering brain assembloids to interrogate human neural circuits. Nat. Protoc. 2022;1:15&#x2013;35. doi: 10.1038/s41596-021-00632-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41596-021-00632-z</ArticleId><ArticleId IdType=\"pubmed\">34992269</ArticleId></ArticleIdList></Reference><Reference><Citation>Reumann D., Krauditsch C., Novatchkova M., Sozzi E., Wong S.N., Zabolocki M., Priouret M., Doleschall B., Ritzau-Reid K.I., Piber M., et al. In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain-striatum-cortex assembloids. Nat. Methods. 2023;12:2034&#x2013;2047. doi: 10.1038/s41592-023-02080-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41592-023-02080-x</ArticleId><ArticleId IdType=\"pmc\">PMC10703680</ArticleId><ArticleId IdType=\"pubmed\">38052989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozgun A., Lomboni D.J., Aylsworth A., Macdonald A., Staines W.A., Martina M., Schlossmacher M.G., Tauskela J.S., Woulfe J., Variola F. Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions. Mater. Today Bio. 2024;25:100992. doi: 10.1016/j.mtbio.2024.100992.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mtbio.2024.100992</ArticleId><ArticleId IdType=\"pmc\">PMC10873721</ArticleId><ArticleId IdType=\"pubmed\">38371467</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez C., Armijo E., Bravo-Alegria J., Becerra-Calixto A., Mays C.E., Soto C. Modeling amyloid beta and tau pathology in human cerebral organoids. Mol. Psychiatry. 2018;12:2363&#x2013;2374. doi: 10.1038/s41380-018-0229-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41380-018-0229-8</ArticleId><ArticleId IdType=\"pmc\">PMC6594704</ArticleId><ArticleId IdType=\"pubmed\">30171212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Fu Y., Yamazaki Y., Ren Y., Davis M.D., Liu C.C., Lu W., Wang X., Chen K., Cherukuri Y., et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer&#x2019;s disease patient iPSC-derived cerebral organoids. Nat. Commun. 2020;11:5540. doi: 10.1038/s41467-020-19264-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-020-19264-0</ArticleId><ArticleId IdType=\"pmc\">PMC7608683</ArticleId><ArticleId IdType=\"pubmed\">33139712</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanova T., Sedmik J., Raska J., Amruz Cerna K., Taus P., Pospisilova V., Nezvedova M., Fedorova V., Kadakova S., Klimova H., et al. Cerebral organoids derived from patients with Alzheimer&#x2019;s disease with PSEN1/2 mutations have defective tissue patterning and altered development. Cell Rep. 2023;28:113310. doi: 10.1016/j.celrep.2023.113310.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2023.113310</ArticleId><ArticleId IdType=\"pubmed\">37864790</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.C., Jang S.Y., Lee D., Lee J., Kang U., Chang H., Kim H.J., Han S.H., Seo J., Choi M., et al. A logical network-based drug-screening platform for Alzheimer&#x2019;s disease representing pathological features of human brain organoids. Nat. Commun. 2021;12:280. doi: 10.1038/s41467-020-20440-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-020-20440-5</ArticleId><ArticleId IdType=\"pmc\">PMC7804132</ArticleId><ArticleId IdType=\"pubmed\">33436582</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlacchio A., Bernardi G., Orlacchio A., Martino S. Stem cells: An overview of the current status of therapies for central and peripheral nervous system diseases. Curr. Med. Chem. 2010;17:595&#x2013;608. doi: 10.2174/092986710790416272.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/092986710790416272</ArticleId><ArticleId IdType=\"pubmed\">20088765</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews M.G., Kriegstein A.R. Challenges of Organoid Research. Annu. Rev. Neurosci. 2022;45:23&#x2013;39. doi: 10.1146/annurev-neuro-111020-090812.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-neuro-111020-090812</ArticleId><ArticleId IdType=\"pmc\">PMC10559943</ArticleId><ArticleId IdType=\"pubmed\">34985918</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273645</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Alzheimer's Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9690</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179690</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) still prevails and continues to increase indiscriminately throughout the 21st century, and is thus responsible for the depreciating quality of health and associated sectors. AD is a progressive neurodegenerative disorder marked by a significant amassment of beta-amyloid plaques and neurofibrillary tangles near the hippocampus, leading to the consequent loss of cognitive abilities. Conventionally, amyloid and tau hypotheses have been established as the most prominent in providing detailed insight into the disease pathogenesis and revealing the associative biomarkers intricately involved in AD progression. Nanotheranostic deliberates rational thought toward designing efficacious nanosystems and strategic endeavors for AD diagnosis and therapeutic implications. The exceeding advancements in this field enable the scientific community to envisage and conceptualize pharmacokinetic monitoring of the drug, sustained and targeted drug delivery responses, fabrication of anti-amyloid therapeutics, and enhanced accumulation of the targeted drug across the blood-brain barrier (BBB), thus giving an optimistic approach towards personalized and precision medicine. Current methods idealized on the design and bioengineering of an array of nanoparticulate systems offer higher affinity towards neurocapillary endothelial cells and the BBB. They have recently attracted intriguing attention to the early diagnostic and therapeutic measures taken to manage the progression of the disease. In this article, we tend to furnish a comprehensive outlook, the detailed mechanism of conventional AD pathogenesis, and new findings. We also summarize the shortcomings in diagnostic, prognostic, and therapeutic approaches undertaken to alleviate AD, thus providing a unique window towards nanotheranostic advancements without disregarding potential drawbacks, side effects, and safety concerns.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Dey</LastName><ForeName>Anuvab</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-8098-7372</Identifier><AffiliationInfo><Affiliation>Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, North Guwahati 781039, Assam, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ghosh</LastName><ForeName>Subhrojyoti</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0003-1528-423X</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rajendran</LastName><ForeName>Ramya Lakshmi</ForeName><Initials>RL</Initials><Identifier Source=\"ORCID\">0000-0001-6987-0854</Identifier><AffiliationInfo><Affiliation>Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bhuniya</LastName><ForeName>Tiyasa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, National Institute of Technology Durgapur, Durgapur 713209, West Bengal, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Das</LastName><ForeName>Purbasha</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, Presidency University, Kolkata 700073, West Bengal, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bhattacharjee</LastName><ForeName>Bidyabati</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, Jain (Deemed-to-be) University, Bangalore 560078, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Das</LastName><ForeName>Sagnik</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, St Xavier's College (Autonomous), Kolkata 700016, West Bengal, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mahajan</LastName><ForeName>Atharva Anand</ForeName><Initials>AA</Initials><Identifier Source=\"ORCID\">0000-0002-8099-8127</Identifier><AffiliationInfo><Affiliation>Advance Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai 410210, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Samant</LastName><ForeName>Anushka</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0009-0008-7285-2428</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela, Rourkela 769008, Orissa, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Krishnan</LastName><ForeName>Anand</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-8886-8482</Identifier><AffiliationInfo><Affiliation>Department of Chemical Pathology, School of Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ahn</LastName><ForeName>Byeong-Cheol</ForeName><Initials>BC</Initials><Identifier Source=\"ORCID\">0000-0001-7700-3929</Identifier><AffiliationInfo><Affiliation>Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Sciences, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gangadaran</LastName><ForeName>Prakash</ForeName><Initials>P</Initials><Identifier Source=\"ORCID\">0000-0002-0658-4604</Identifier><AffiliationInfo><Affiliation>Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Sciences, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>NRF-2021R1I1A1A01040732</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant><Grant><GrantID>NRF-2022R1I1A1A01068652</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016229\">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000068936\" MajorTopicYN=\"Y\">Theranostic Nanomedicine</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001812\" MajorTopicYN=\"Y\">Blood-Brain Barrier</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016503\" MajorTopicYN=\"N\">Drug Delivery Systems</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D053758\" MajorTopicYN=\"N\">Nanoparticles</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016229\" MajorTopicYN=\"N\">Amyloid beta-Peptides</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">nanomedicine</Keyword><Keyword MajorTopicYN=\"N\">nanotheranostic</Keyword><Keyword MajorTopicYN=\"N\">neurodegeneration</Keyword><Keyword MajorTopicYN=\"N\">personalized therapy</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273645</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179690</ArticleId><ArticleId IdType=\"pii\">ijms25179690</ArticleId><ArticleId IdType=\"pmc\">PMC11395116</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bagga S., Kumar M. Current Status of Alzheimer&#x2019;s Disease and Pathological Mechanisms Investigating the Therapeutic Molecular Targets. Curr. Mol. Med. 2022;23:492&#x2013;508. doi: 10.2174/1566524022666220404112843.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1566524022666220404112843</ArticleId><ArticleId IdType=\"pubmed\">35379149</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeyaraman M., Rajendran R.L., Muthu S., Jeyaraman N., Sharma S., Jha S.K., Muthukanagaraj P., Hong C.M., da Fonseca L.F., Lana J.F.S.D., et al. An update on stem cell and stem cell-derived extracellular vesicle-based therapy in the management of Alzheimer&#x2019;s disease. Heliyon. 2023;9:e17808. doi: 10.1016/j.heliyon.2023.e17808.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.heliyon.2023.e17808</ArticleId><ArticleId IdType=\"pmc\">PMC10336689</ArticleId><ArticleId IdType=\"pubmed\">37449130</ArticleId></ArticleIdList></Reference><Reference><Citation>Onkar A., Khan F., Goenka A., Rajendran R.L., Dmello C., Hong C.M., Mubin N., Gangadaran P., Ahn B.C. Smart Nanoscale Extracellular Vesicles in the Brain: Unveiling their Biology, Diagnostic Potential, and Therapeutic Applications. ACS Appl. Mater. Interfaces. 2024;16:6709&#x2013;6742. doi: 10.1021/acsami.3c16839.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsami.3c16839</ArticleId><ArticleId IdType=\"pubmed\">38315446</ArticleId></ArticleIdList></Reference><Reference><Citation>Petralla S., Colavitta M.F., Barrantes F.J. Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease. Pharmaceutics. 2023;15:2052. doi: 10.3390/pharmaceutics15082052.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics15082052</ArticleId><ArticleId IdType=\"pmc\">PMC10459958</ArticleId><ArticleId IdType=\"pubmed\">37631266</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W., Luo H., Ruan Y., Mai Y., Liu C., Chen J., Yang S., Xuan A., Liu J. Identification of candidate genes associated with clinical onset of Alzheimer&#x2019;s disease. Front. Neurosci. 2022;16:1060111. doi: 10.3389/fnins.2022.1060111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2022.1060111</ArticleId><ArticleId IdType=\"pmc\">PMC9808086</ArticleId><ArticleId IdType=\"pubmed\">36605552</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohd Murshid N., Aminullah Lubis F., Makpol S. Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases. Cell Mol. Neurobiol. 2022;42:577&#x2013;595. doi: 10.1007/s10571-020-00979-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10571-020-00979-z</ArticleId><ArticleId IdType=\"pubmed\">33074454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozben T., Ozben S. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer&#x2019;s disease. Clin. Biochem. 2019;72:87&#x2013;89. doi: 10.1016/j.clinbiochem.2019.04.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clinbiochem.2019.04.001</ArticleId><ArticleId IdType=\"pubmed\">30954437</ArticleId></ArticleIdList></Reference><Reference><Citation>Som Chaudhury S., Nandi M., Kumar K., Ruidas B., Sur T.K., Prasad P., Chakrabarti S., De P., Sil J., Das Mukhopadhyay C., et al. Rodent Model Preclinical Assessment of PEGylated Block Copolymer Targeting Cognition and Oxidative Stress Insults of Alzheimer&#x2019;s Disease. Mol. Neurobiol. 2023;60:2036&#x2013;2050. doi: 10.1007/s12035-022-03194-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-022-03194-7</ArticleId><ArticleId IdType=\"pubmed\">36598649</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Bai F. The association of tau with mitochondrial dysfunction in Alzheimer&#x2019;s disease. Front. Neurosci. 2018;12:320523. doi: 10.3389/fnins.2018.00163.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2018.00163</ArticleId><ArticleId IdType=\"pmc\">PMC5874499</ArticleId><ArticleId IdType=\"pubmed\">29623026</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbu E., Moln&#xe0;r &#xc9;., Tsibouklis J., G&#xf3;recki D.C. The potential for nanoparticle-based drug delivery to the brain: Overcoming the blood&#x2013;brain barrier. Expert Opin. Drug Deliv. 2009;6:553&#x2013;565. doi: 10.1517/17425240902939143.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1517/17425240902939143</ArticleId><ArticleId IdType=\"pubmed\">19435406</ArticleId></ArticleIdList></Reference><Reference><Citation>Karthivashan G., Ganesan P., Park S.Y., Kim J.S., Choi D.K. Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer&#x2019;s disease. Drug Deliv. 2018;25:307&#x2013;320. doi: 10.1080/10717544.2018.1428243.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10717544.2018.1428243</ArticleId><ArticleId IdType=\"pmc\">PMC6058502</ArticleId><ArticleId IdType=\"pubmed\">29350055</ArticleId></ArticleIdList></Reference><Reference><Citation>Harilal S., Jose J., Parambi D.G.T., Kumar R., Mathew G.E., Uddin M.S., Kim H., Mathew B. Advancements in nanotherapeutics for Alzheimer&#x2019;s disease: Current perspectives. J. Pharm. Pharmacol. 2019;71:1370&#x2013;1383. doi: 10.1111/jphp.13132.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jphp.13132</ArticleId><ArticleId IdType=\"pubmed\">31304982</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Luo C., Pang Z., Zhang J., Ruan S., Wu M., Wang L., Sun T., Li N., Han L., et al. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chin. Chem. Lett. 2023;34:107518. doi: 10.1016/j.cclet.2022.05.032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cclet.2022.05.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrakala V., Aruna V., Angajala G. Review on metal nanoparticles as nanocarriers: Current challenges and perspectives in drug delivery systems. Emergent Mater. 2022;5:1593&#x2013;1615. doi: 10.1007/s42247-021-00335-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s42247-021-00335-x</ArticleId><ArticleId IdType=\"pmc\">PMC8724657</ArticleId><ArticleId IdType=\"pubmed\">35005431</ArticleId></ArticleIdList></Reference><Reference><Citation>Binda A., Murano C., Rivolta I. Innovative therapies and nanomedicine applications for the treatment of alzheimer&#x2019;s disease: A. state-of-the-art (2017&#x2013;2020) Int. J. Nanomed. 2020;15:6113&#x2013;6135. doi: 10.2147/IJN.S231480.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/IJN.S231480</ArticleId><ArticleId IdType=\"pmc\">PMC7434571</ArticleId><ArticleId IdType=\"pubmed\">32884267</ArticleId></ArticleIdList></Reference><Reference><Citation>Naz&#x131;ro&#x11f;lu M., Muhamad S., Pecze L. Nanoparticles as potential clinical therapeutic agents in Alzheimer&#x2019;s disease: Focus on selenium nanoparticles. Expert Rev. Clin. Pharmacol. 2017;10:773&#x2013;782. doi: 10.1080/17512433.2017.1324781.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/17512433.2017.1324781</ArticleId><ArticleId IdType=\"pubmed\">28463572</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedse G., Di Domenico F., Serviddio G., Cassano T. Aberrant insulin signaling in Alzheimer&#x2019;s disease: Current knowledge. Front. Neurosci. 2015;9:140046. doi: 10.3389/fnins.2015.00204.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2015.00204</ArticleId><ArticleId IdType=\"pmc\">PMC4468388</ArticleId><ArticleId IdType=\"pubmed\">26136647</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark W.J., Stoessel P.R., Wohlleben W., Hafner A. Industrial applications of nanoparticles. Chem. Soc. Rev. 2015;44:5793&#x2013;5805. doi: 10.1039/C4CS00362D.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C4CS00362D</ArticleId><ArticleId IdType=\"pubmed\">25669838</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberd&#xf6;rster G., Sharp Z., Atudorei V., Elder A., Gelein R., Kreyling W., Cox C. Translocation of Inhaled Ultrafine Particles to the Brain. Inhal. Toxicol. 2008;16:437&#x2013;445. doi: 10.1080/08958370490439597.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/08958370490439597</ArticleId><ArticleId IdType=\"pubmed\">15204759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zolnik B.S., Gonz&#xe1;lez-Fern&#xe1;ndez &#xc1;., Sadrieh N., Dobrovolskaia M.A. Minireview: Nanoparticles and the Immune System. Endocrinology. 2010;151:458&#x2013;465. doi: 10.1210/en.2009-1082.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/en.2009-1082</ArticleId><ArticleId IdType=\"pmc\">PMC2817614</ArticleId><ArticleId IdType=\"pubmed\">20016026</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Rapun R., De Matteis L., Ambrosone A., Garcia-Embid S., Gutierrez L., M de la Fuente J. Targeted Nanoparticles for the Treatment of Alzheimer&#x2019;s Disease. Curr. Pharm. Des. 2017;23:1927&#x2013;1952. doi: 10.2174/1381612822666161226151011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1381612822666161226151011</ArticleId><ArticleId IdType=\"pubmed\">28025949</ArticleId></ArticleIdList></Reference><Reference><Citation>Kononenko V., Narat M., Drobne D. Nanoparticle interaction with the immune system. Arch. Ind. Hyg. Toxicol. 2015;66:97&#x2013;108. doi: 10.1515/aiht-2015-66-2582.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1515/aiht-2015-66-2582</ArticleId><ArticleId IdType=\"pubmed\">26110471</ArticleId></ArticleIdList></Reference><Reference><Citation>Amor S., Peferoen L.A.N., Vogel D.Y.S., Breur M., van der Valk P., Baker D., van Noort J.M. Inflammation in neurodegenerative diseases&#x2014;An update. Immunology. 2014;142:151&#x2013;166. doi: 10.1111/imm.12233.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/imm.12233</ArticleId><ArticleId IdType=\"pmc\">PMC4008224</ArticleId><ArticleId IdType=\"pubmed\">24329535</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Hardie J., Zhang X., Rotello V.M. Effects of engineered nanoparticles on the innate immune system. Semin. Immunol. 2017;34:25&#x2013;32. doi: 10.1016/j.smim.2017.09.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.smim.2017.09.011</ArticleId><ArticleId IdType=\"pmc\">PMC5705289</ArticleId><ArticleId IdType=\"pubmed\">28985993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Xie W., Zhu X., Xu M., Liu J. Sulfur Nanoparticles with Novel Morphologies Coupled with Brain-Targeting Peptides RVG as a New Type of Inhibitor against Metal-Induced A&#x3b2; Aggregation. ACS Chem. Neurosci. 2018;9:749&#x2013;761. doi: 10.1021/acschemneuro.7b00312.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acschemneuro.7b00312</ArticleId><ArticleId IdType=\"pubmed\">29192759</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy P.H. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer&#x2019;s disease. Brain Res. 2011;1415:136&#x2013;148. doi: 10.1016/j.brainres.2011.07.052.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainres.2011.07.052</ArticleId><ArticleId IdType=\"pmc\">PMC3176990</ArticleId><ArticleId IdType=\"pubmed\">21872849</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengul A.B., Asmatulu E. Toxicity of metal and metal oxide nanoparticles: A review. Environ. Chem. Lett. 2020;18:1659&#x2013;1683. doi: 10.1007/s10311-020-01033-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10311-020-01033-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Annangi B., Bach J., Vales G., Rubio L., Marcos R., Hern&#xe1;ndez A. Long-term exposures to low doses of cobalt nanoparticles induce cell transformation enhanced by oxidative damage. Nanotoxicology. 2015;9:138&#x2013;147. doi: 10.3109/17435390.2014.900582.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/17435390.2014.900582</ArticleId><ArticleId IdType=\"pubmed\">24713074</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouras G.K., Olsson T.T., Hansson O. &#x3b2;-amyloid Peptides and Amyloid Plaques in Alzheimer&#x2019;s Disease. Neurotherapeutics. 2015;12:3&#x2013;11. doi: 10.1007/s13311-014-0313-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13311-014-0313-y</ArticleId><ArticleId IdType=\"pmc\">PMC4322079</ArticleId><ArticleId IdType=\"pubmed\">25371168</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy P.H., Oliver D.M.A. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer&#x2019;s Disease. Cells. 2019;8:488. doi: 10.3390/cells8050488.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells8050488</ArticleId><ArticleId IdType=\"pmc\">PMC6562604</ArticleId><ArticleId IdType=\"pubmed\">31121890</ArticleId></ArticleIdList></Reference><Reference><Citation>Mufson E.J., Ikonomovic M.D., Counts S.E., Perez S.E., Malek-Ahmadi M., Scheff S.W., Ginsberg S.D. Molecular and cellular pathophysiology of preclinical Alzheimer&#x2019;s disease. Behav. Brain Res. 2016;311:54&#x2013;69. doi: 10.1016/j.bbr.2016.05.030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbr.2016.05.030</ArticleId><ArticleId IdType=\"pmc\">PMC4931948</ArticleId><ArticleId IdType=\"pubmed\">27185734</ArticleId></ArticleIdList></Reference><Reference><Citation>Deture M.A., Dickson D.W. The neuropathological diagnosis of Alzheimer&#x2019;s disease. Mol. Neurodegener. 2019;14:32. doi: 10.1186/s13024-019-0333-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-019-0333-5</ArticleId><ArticleId IdType=\"pmc\">PMC6679484</ArticleId><ArticleId IdType=\"pubmed\">31375134</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Day D.H. Calmodulin and Amyloid Beta as Coregulators of Critical Events during the Onset and Progression of Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2023;24:1393. doi: 10.3390/ijms24021393.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24021393</ArticleId><ArticleId IdType=\"pmc\">PMC9863087</ArticleId><ArticleId IdType=\"pubmed\">36674908</ArticleId></ArticleIdList></Reference><Reference><Citation>Roda A., Serra-Mir G., Montoliu-Gaya L., Tiessler L., Villegas S. Amyloid-beta peptide and tau protein crosstalk in Alzheimer&#x2019;s disease. Neural Regen. Res. 2022;17:1666. doi: 10.4103/1673-5374.332127.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/1673-5374.332127</ArticleId><ArticleId IdType=\"pmc\">PMC8820696</ArticleId><ArticleId IdType=\"pubmed\">35017413</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotkin S.S., Cashman N.R. Passive immunotherapies targeting A&#x3b2; and tau in Alzheimer&#x2019;s disease. Neurobiol. Dis. 2020;144:105010. doi: 10.1016/j.nbd.2020.105010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2020.105010</ArticleId><ArticleId IdType=\"pmc\">PMC7365083</ArticleId><ArticleId IdType=\"pubmed\">32682954</ArticleId></ArticleIdList></Reference><Reference><Citation>Budvytyte R., Valincius G. The interactions of amyloid &#x3b2; aggregates with phospholipid membranes and the implications for neurodegeneration. Biochem. Soc. Trans. 2023;51:147&#x2013;159. doi: 10.1042/BST20220434.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/BST20220434</ArticleId><ArticleId IdType=\"pubmed\">36629697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ch&#xe9;vez-Guti&#xe9;rrez L., Bammens L., Benilova I., Vandersteen A., Benurwar M., Borgers M., Lismont S., Zhou L., Van Cleynenbreugel S., Esselmann H., et al. The mechanism of &#x3b3;-Secretase dysfunction in familial Alzheimer disease. EMBO J. 2012;31:2261&#x2013;2274. doi: 10.1038/emboj.2012.79.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/emboj.2012.79</ArticleId><ArticleId IdType=\"pmc\">PMC3364747</ArticleId><ArticleId IdType=\"pubmed\">22505025</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C., Kaether C., Thinakaran G., Sisodia S. Trafficking and Proteolytic Processing of APP. Cold Spring Harb. Perspect. Med. 2012;2:a006270. doi: 10.1101/cshperspect.a006270.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/cshperspect.a006270</ArticleId><ArticleId IdType=\"pmc\">PMC3331683</ArticleId><ArticleId IdType=\"pubmed\">22553493</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K., Saito Y., Saito H., Toyoda M., Abe R., Saito T., Saido T.C., Michikawa M., Taru H., Sobu Y., et al. Accumulation of amyloid-&#x3b2; in the brain of mouse models of Alzheimer&#x2019;s disease is modified by altered gene expression in the presence of human apoE isoforms during aging. Neurobiol. Aging. 2023;123:63&#x2013;74. doi: 10.1016/j.neurobiolaging.2022.12.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2022.12.003</ArticleId><ArticleId IdType=\"pubmed\">36638682</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchhave P., Minthon L., Zetterberg H., Wallin &#xc5;.K., Blennow K., Hansson O. Cerebrospinal Fluid Levels of&#x3b2;-Amyloid 1-2012, 42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia. Arch. Gen. Psychiatry. 2012;69:98&#x2013;106. doi: 10.1001/archgenpsychiatry.2011.155.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archgenpsychiatry.2011.155</ArticleId><ArticleId IdType=\"pubmed\">22213792</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman R.J., Xiong C., Benzinger T.L.S., Fagan A.M., Goate A., Fox N.C., Marcus D.S., Cairns N.J., Xie X., Blazey T.M., et al. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer&#x2019;s Disease. N. Engl. J. Med. 2012;367:795&#x2013;804. doi: 10.1056/NEJMoa1202753.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa1202753</ArticleId><ArticleId IdType=\"pmc\">PMC3474597</ArticleId><ArticleId IdType=\"pubmed\">22784036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira A., Busciglio J., C&#xe1;ceres A. Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: Evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and Tau. Dev. Brain Res. 1989;49:215&#x2013;228. doi: 10.1016/0165-3806(89)90023-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0165-3806(89)90023-0</ArticleId><ArticleId IdType=\"pubmed\">2509111</ArticleId></ArticleIdList></Reference><Reference><Citation>Takei Y., Teng J., Harada A., Hirokawa N. Defects in Axonal Elongation and Neuronal Migration in Mice with Disrupted tau and map1b Genes. J. Cell Biol. 2000;150:989&#x2013;1000. doi: 10.1083/jcb.150.5.989.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.150.5.989</ArticleId><ArticleId IdType=\"pmc\">PMC2175245</ArticleId><ArticleId IdType=\"pubmed\">10973990</ArticleId></ArticleIdList></Reference><Reference><Citation>Perea J.R., L&#xf3;pez E., Di&#xe9;z-Ballesteros J.C. Extracellular monomeric tau is internalized by astrocytes. Front. Neurosci. 2019;13:444353. doi: 10.3389/fnins.2019.00442.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2019.00442</ArticleId><ArticleId IdType=\"pmc\">PMC6504834</ArticleId><ArticleId IdType=\"pubmed\">31118883</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyko S., Surewicz W.K. Tau liquid&#x2013;liquid phase separation in neurodegenerative diseases. Trends Cell Biol. 2022;32:611&#x2013;623. doi: 10.1016/j.tcb.2022.01.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tcb.2022.01.011</ArticleId><ArticleId IdType=\"pmc\">PMC9189016</ArticleId><ArticleId IdType=\"pubmed\">35181198</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinsky J., Pichlerova K., Hanes J. Tau Protein Interaction Partners and Their Roles in Alzheimer&#x2019;s Disease and Other Tauopathies. Int. J. Mol. Sci. 2021;22:9207. doi: 10.3390/ijms22179207.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22179207</ArticleId><ArticleId IdType=\"pmc\">PMC8431036</ArticleId><ArticleId IdType=\"pubmed\">34502116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanseeuw B.J., Betensky R.A., Jacobs H.I.L., Schultz A.P., Sepulcre J., Becker J.A., Cosio D.M.O., Farrell M., Quiroz Y.T., Mormino E.C., et al. Association of Amyloid and Tau with Cognition in Preclinical Alzheimer Disease: A. Longitudinal Study. JAMA Neurol. 2019;76:915&#x2013;924. doi: 10.1001/jamaneurol.2019.1424.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaneurol.2019.1424</ArticleId><ArticleId IdType=\"pmc\">PMC6547132</ArticleId><ArticleId IdType=\"pubmed\">31157827</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris M.C., Tangney C.C., Wang Y. MIND diet associated with reduced incidence of Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2015;11:1007&#x2013;1014. doi: 10.1016/j.jalz.2014.11.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2014.11.009</ArticleId><ArticleId IdType=\"pmc\">PMC4532650</ArticleId><ArticleId IdType=\"pubmed\">25681666</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;imi&#x107; G., Babi&#x107; Leko M., Wray S., Harrington C., Delalle I., Jovanov-Milo&#x161;evi&#x107; N., Ba&#x17e;adona D., Bu&#xe9;e L., De Silva R., Di Giovanni G., et al. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer&#x2019;s Disease and Other Tauopathies, and Possible Neuroprotective Strategies. Biomolecules. 2016;6:6. doi: 10.3390/biom6010006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom6010006</ArticleId><ArticleId IdType=\"pmc\">PMC4808800</ArticleId><ArticleId IdType=\"pubmed\">26751493</ArticleId></ArticleIdList></Reference><Reference><Citation>Manczak M., Reddy P.H. Abnormal Interaction of Oligomeric Amyloid-&#x3b2; with Phosphorylated Tau: Implications to Synaptic Dysfunction and Neuronal Damage. J. Alzheimer&#x2019;s Dis. 2013;36:285&#x2013;295. doi: 10.3233/JAD-130275.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-130275</ArticleId><ArticleId IdType=\"pmc\">PMC3943249</ArticleId><ArticleId IdType=\"pubmed\">23594602</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascoal T.A., Mathotaarachchi S., Shin M., Benedet A.L., Mohades S., Wang S., Beaudry T., Kang M.S., Soucy J.P., Labbe A., et al. Synergistic interaction between amyloid and tau predicts the progression to dementia. Alzheimer&#x2019;s Dement. 2017;13:644&#x2013;653. doi: 10.1016/j.jalz.2016.11.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2016.11.005</ArticleId><ArticleId IdType=\"pubmed\">28024995</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry R.D., Masliah E., Salmon D.P. Physical basis of cognitive alterations in alzheimer&#x2019;s disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991;30:572&#x2013;580. doi: 10.1002/ana.410300410.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.410300410</ArticleId><ArticleId IdType=\"pubmed\">1789684</ArticleId></ArticleIdList></Reference><Reference><Citation>DeKosky S.T., Scheff S.W., Styren S.D. Structural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change. Neurodegeneration. 1996;5:417&#x2013;421. doi: 10.1006/neur.1996.0056.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/neur.1996.0056</ArticleId><ArticleId IdType=\"pubmed\">9117556</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida C.G., Tampellini D., Takahashi R.H., Greengard P., Lin M.T., Snyder E.M., Gouras G.K. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 2005;20:187&#x2013;198. doi: 10.1016/j.nbd.2005.02.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2005.02.008</ArticleId><ArticleId IdType=\"pubmed\">16242627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Perry G., Smith M.A., Zhu X. Amyloid-&#x3b2;-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in Neurons. Neurodegener. Dis. 2010;7:56&#x2013;59. doi: 10.1159/000283484.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000283484</ArticleId><ArticleId IdType=\"pmc\">PMC2859232</ArticleId><ArticleId IdType=\"pubmed\">20160460</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M.J., Pekkurnaz G. Powerhouse of the mind: Mitochondrial plasticity at the synapse. Curr. Opin. Neurobiol. 2019;57:149&#x2013;155. doi: 10.1016/j.conb.2019.02.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.conb.2019.02.001</ArticleId><ArticleId IdType=\"pmc\">PMC6629504</ArticleId><ArticleId IdType=\"pubmed\">30875521</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam M.M. Neuroplasticity Failure in Alzheimer&#x2019;s Disease: Bridging the Gap between Plaques and Tangles. Neuron. 1999;24:521&#x2013;529. doi: 10.1016/S0896-6273(00)81109-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0896-6273(00)81109-5</ArticleId><ArticleId IdType=\"pubmed\">10595506</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamenetz F., Tomita T., Hsieh H. APP Processing and Synaptic Function. Neuron. 2003;37:925&#x2013;937. doi: 10.1016/S0896-6273(03)00124-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0896-6273(03)00124-7</ArticleId><ArticleId IdType=\"pubmed\">12670422</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheff S.W., Scott S.A., DeKosky S.T. Quantitation of synaptic density in the septal nuclei of young and aged Fischer 344 rats. Neurobiol. Aging. 1991;12:3&#x2013;12. doi: 10.1016/0197-4580(91)90032-F.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0197-4580(91)90032-F</ArticleId><ArticleId IdType=\"pubmed\">2002880</ArticleId></ArticleIdList></Reference><Reference><Citation>Gylys K.H., Fein J.A., Yang F., Wiley D.J., Miller C.A., Cole G.M. Synaptic Changes in Alzheimer&#x2019;s Disease: Increased Amyloid-&#x3b2; and Gliosis in Surviving Terminals Is Accompanied by Decreased PSD-95 Fluorescence. Am. J. Pathol. 2004;165:1809&#x2013;1817. doi: 10.1016/S0002-9440(10)63436-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0002-9440(10)63436-0</ArticleId><ArticleId IdType=\"pmc\">PMC1618663</ArticleId><ArticleId IdType=\"pubmed\">15509549</ArticleId></ArticleIdList></Reference><Reference><Citation>Tampellini D., Gouras G.K. Synapses, synaptic activity and intraneuronal A&#x3b2; in Alzheimer&#x2019;s disease. Front. Aging Neurosci. 2010;2:1330. doi: 10.3389/fnagi.2010.00013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2010.00013</ArticleId><ArticleId IdType=\"pmc\">PMC2912028</ArticleId><ArticleId IdType=\"pubmed\">20725518</ArticleId></ArticleIdList></Reference><Reference><Citation>Calkins M.J., Reddy P.H. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer&#x2019;s disease neurons. Biochim. Biophys. Acta Mol. Basis Dis. 2011;1812:507&#x2013;513. doi: 10.1016/j.bbadis.2011.01.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2011.01.007</ArticleId><ArticleId IdType=\"pmc\">PMC3042500</ArticleId><ArticleId IdType=\"pubmed\">21241801</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy P.H., Beal M.F. Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer&#x2019;s disease. Trends Mol. Med. 2008;14:45&#x2013;53. doi: 10.1016/j.molmed.2007.12.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.molmed.2007.12.002</ArticleId><ArticleId IdType=\"pmc\">PMC3107703</ArticleId><ArticleId IdType=\"pubmed\">18218341</ArticleId></ArticleIdList></Reference><Reference><Citation>Calkins M.J., Manczak M., Mao P. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer&#x2019;s disease. Hum. Mol. Genet. 2011;20:4515&#x2013;4529. doi: 10.1093/hmg/ddr381.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddr381</ArticleId><ArticleId IdType=\"pmc\">PMC3209824</ArticleId><ArticleId IdType=\"pubmed\">21873260</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangaraju V., Lewis T.L., Hirabayashi Y. Pleiotropic Mitochondria: The Influence of Mitochondria on Neuronal Development and Disease. J. Neurosci. 2019;39:8200&#x2013;8208. doi: 10.1523/JNEUROSCI.1157-19.2019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1157-19.2019</ArticleId><ArticleId IdType=\"pmc\">PMC6794931</ArticleId><ArticleId IdType=\"pubmed\">31619488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray N. Many makes of mitochondria. Nat. Rev. Neurosci. 2019;20:645. doi: 10.1038/s41583-019-0229-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41583-019-0229-y</ArticleId><ArticleId IdType=\"pubmed\">31554939</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal A., Drerup C.M. Axonal Transport and Mitochondrial Function in Neurons. Front. Cell Neurosci. 2019;13:475553. doi: 10.3389/fncel.2019.00373.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2019.00373</ArticleId><ArticleId IdType=\"pmc\">PMC6696875</ArticleId><ArticleId IdType=\"pubmed\">31447650</ArticleId></ArticleIdList></Reference><Reference><Citation>Son G., Han J. Roles of mitochondria in neuronal development. BMB Rep. 2018;51:549. doi: 10.5483/BMBRep.2018.51.11.226.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5483/BMBRep.2018.51.11.226</ArticleId><ArticleId IdType=\"pmc\">PMC6283025</ArticleId><ArticleId IdType=\"pubmed\">30269744</ArticleId></ArticleIdList></Reference><Reference><Citation>Misrani A., Tabassum S., Yang L. Mitochondrial Dysfunction and Oxidative Stress in Alzheimer&#x2019;s Disease. Front. Aging Neurosci. 2021;13:617588. doi: 10.3389/fnagi.2021.617588.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2021.617588</ArticleId><ArticleId IdType=\"pmc\">PMC7930231</ArticleId><ArticleId IdType=\"pubmed\">33679375</ArticleId></ArticleIdList></Reference><Reference><Citation>Brillo V., Chieregato L., Leanza L., Muccioli S., Costa R. Mitochondrial Dynamics, ROS, and Cell Signaling: A Blended Overview. Life. 2021;11:332. doi: 10.3390/life11040332.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/life11040332</ArticleId><ArticleId IdType=\"pmc\">PMC8070048</ArticleId><ArticleId IdType=\"pubmed\">33920160</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi R., Zhang W., Zhang D.F. Genetic association of the cytochrome c oxidase-related genes with Alzheimer&#x2019;s disease in Han Chinese. Neuropsychopharmacology. 2018;43:2264&#x2013;2276. doi: 10.1038/s41386-018-0144-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41386-018-0144-3</ArticleId><ArticleId IdType=\"pmc\">PMC6135758</ArticleId><ArticleId IdType=\"pubmed\">30054583</ArticleId></ArticleIdList></Reference><Reference><Citation>Quntanilla R.A., Tapia-Monsalves C. The Role of Mitochondrial Impairment in Alzheimer&#x2019;s Disease Neurodegeneration: The Tau Connection. Curr. Neuropharmacol. 2020;18:1076&#x2013;1091. doi: 10.2174/1570159X18666200525020259.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1570159X18666200525020259</ArticleId><ArticleId IdType=\"pmc\">PMC7709157</ArticleId><ArticleId IdType=\"pubmed\">32448104</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow R.H. Mitochondria and Mitochondrial Cascades in Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2018;62:1403&#x2013;1416. doi: 10.3233/JAD-170585.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-170585</ArticleId><ArticleId IdType=\"pmc\">PMC5869994</ArticleId><ArticleId IdType=\"pubmed\">29036828</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto S., Ishii A., Kamano N., Watamura N., Saito T., Ohshima T., Yokosuka M., Saido T.C. Endoplasmic reticulum stress responses in mouse models of Alzheimer&#x2019;s disease: Overexpression paradigm versus knockin paradigm. J. Biol. Chem. 2018;293:3118&#x2013;3125. doi: 10.1074/jbc.M117.811315.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M117.811315</ArticleId><ArticleId IdType=\"pmc\">PMC5836140</ArticleId><ArticleId IdType=\"pubmed\">29298895</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y., Gao P., Shi L. Central and peripheral metabolic defects contribute to the pathogenesis of Alzheimer&#x2019;s disease: Targeting mitochondria for diagnosis and prevention. Antioxid. Redox Signal. 2020;32:1188&#x2013;1236. doi: 10.1089/ars.2019.7763.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/ars.2019.7763</ArticleId><ArticleId IdType=\"pmc\">PMC7196371</ArticleId><ArticleId IdType=\"pubmed\">32050773</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao Y.L., Ganaraja B., Murlimanju B.V., Joy T., Krishnamurthy A., Agrawal A. Hippocampus and its involvement in Alzheimer&#x2019;s disease: A review. 3 Biotech. 2022;12:55. doi: 10.1007/s13205-022-03123-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13205-022-03123-4</ArticleId><ArticleId IdType=\"pmc\">PMC8807768</ArticleId><ArticleId IdType=\"pubmed\">35116217</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkov A., Popova I., Ivanov A., Jang S.S., Yoon S.Y., Osypov A., Huang Y., Zilberter Y., Zilberter M. A&#x3b2; initiates brain hypometabolism, network dysfunction and behavioral abnormalities via NOX2-induced oxidative stress in mice. Commun. Biol. 2021;4:1054. doi: 10.1038/s42003-021-02551-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s42003-021-02551-x</ArticleId><ArticleId IdType=\"pmc\">PMC8429759</ArticleId><ArticleId IdType=\"pubmed\">34504272</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma C., Kim S., Nam Y. Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2021;22:4850. doi: 10.3390/ijms22094850.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22094850</ArticleId><ArticleId IdType=\"pmc\">PMC8125007</ArticleId><ArticleId IdType=\"pubmed\">34063708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra R.S., Kandimalla R., Binukumar K.B. Editorial: Apoptosis, autophagy, and mitophagy dysfunction in Alzheimer&#x2019;s disease: Evolving emergence and mechanisms. Front. Mol. Neurosci. 2022;15:1049914. doi: 10.3389/fnmol.2022.1049914.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnmol.2022.1049914</ArticleId><ArticleId IdType=\"pmc\">PMC9594543</ArticleId><ArticleId IdType=\"pubmed\">36304998</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao N., Zhang X., Li B., Wang J., Zhang C., Xu B. Treadmill Exercise Improves PINK1/Parkin-Mediated Mitophagy Activity Against Alzheimer&#x2019;s Disease Pathologies by Upregulated SIRT1-FOXO1/3 Axis in APP/PS1 Mice. Mol. Neurobiol. 2023;60:277&#x2013;291. doi: 10.1007/s12035-022-03035-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-022-03035-7</ArticleId><ArticleId IdType=\"pubmed\">36261693</ArticleId></ArticleIdList></Reference><Reference><Citation>Travaglio M., Michopoulos F., Yu Y. Increased cysteine metabolism in PINK1 models of Parkinson&#x2019;s disease. DMM Dis. Models Mech. 2023;16:dmm049727. doi: 10.1242/dmm.049727.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1242/dmm.049727</ArticleId><ArticleId IdType=\"pmc\">PMC9903142</ArticleId><ArticleId IdType=\"pubmed\">36695500</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas S., Bagchi A. Study of the Effects of Nicotine and Caffeine for the Treatment of Parkinson&#x2019;s Disease. Appl. Biochem. Biotechnol. 2023;195:639&#x2013;654. doi: 10.1007/s12010-022-04155-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12010-022-04155-5</ArticleId><ArticleId IdType=\"pubmed\">36121634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr J.S., Adriaanse B.A., Greig N.H., Mattson M.P., Cader M.Z., Bohr V.A., Fang E.F. Mitophagy and Alzheimer&#x2019;s Disease: Cellular and Molecular Mechanisms. Trends Neurosci. 2017;40:151&#x2013;166. doi: 10.1016/j.tins.2017.01.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tins.2017.01.002</ArticleId><ArticleId IdType=\"pmc\">PMC5341618</ArticleId><ArticleId IdType=\"pubmed\">28190529</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterky F.H., Lee S., Wibom R. Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc. Natl. Acad. Sci. USA. 2011;108:12937&#x2013;12942. doi: 10.1073/pnas.1103295108.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1103295108</ArticleId><ArticleId IdType=\"pmc\">PMC3150929</ArticleId><ArticleId IdType=\"pubmed\">21768369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q., Jeong Y.Y. Mitophagy in Alzheimer&#x2019;s Disease and Other Age-Related Neurodegenerative Diseases. Cells. 2020;9:150. doi: 10.3390/cells9010150.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells9010150</ArticleId><ArticleId IdType=\"pmc\">PMC7017092</ArticleId><ArticleId IdType=\"pubmed\">31936292</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradeepkiran J.A., Hemachandra Reddy P. Defective mitophagy in Alzheimer&#x2019;s disease. Ageing Res. Rev. 2020;64:101191. doi: 10.1016/j.arr.2020.101191.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2020.101191</ArticleId><ArticleId IdType=\"pmc\">PMC7710581</ArticleId><ArticleId IdType=\"pubmed\">33022416</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-L&#xf3;pez E., Schuhmacher A.J. Transportation of Single-Domain Antibodies through the Blood&#x2013;Brain Barrier. Biomolecules. 2021;11:1131. doi: 10.3390/biom11081131.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom11081131</ArticleId><ArticleId IdType=\"pmc\">PMC8394617</ArticleId><ArticleId IdType=\"pubmed\">34439797</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra H., Bibi S., Singh I., Kamal M.A., Islam F., Alhumaydhi F.A., Emran T.B., Cavalu S. Nanomedicines in the Management of Alzheimer&#x2019;s Disease: Current View and Future Prospects. Front. Aging Neurosci. 2022;14:879114. doi: 10.3389/fnagi.2022.879114.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.879114</ArticleId><ArticleId IdType=\"pmc\">PMC9304964</ArticleId><ArticleId IdType=\"pubmed\">35875806</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalu S., Fritea L., Brocks M. Novel Hybrid Composites Based on PVA/SeTiO2 Nanoparticles and Natural Hydroxyapatite for Orthopedic Applications: Correlations between Structural, Morphological and Biocompatibility Properties. Materials. 2020;13:2077. doi: 10.3390/ma13092077.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ma13092077</ArticleId><ArticleId IdType=\"pmc\">PMC7254265</ArticleId><ArticleId IdType=\"pubmed\">32369898</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Bharti, Kumar R., Pavlov P.F., Winblad B. Small molecule therapeutics for tauopathy in Alzheimer&#x2019;s disease: Walking on the path of most resistance. Eur. J. Med. Chem. 2021;209:112915. doi: 10.1016/j.ejmech.2020.112915.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejmech.2020.112915</ArticleId><ArticleId IdType=\"pubmed\">33139110</ArticleId></ArticleIdList></Reference><Reference><Citation>Harini K., Koyeli G., Vijaya A.A. Nano-mediated Strategies for Metal Ion&#x2013;Induced Neurodegenerative Disorders: Focus on Alzheimer&#x2019;s and Parkinson&#x2019;s Diseases. Curr. Pharmacol. Rep. 2022;8:450&#x2013;463. doi: 10.1007/s40495-022-00307-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40495-022-00307-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan S., Sharma D., Rastogi K. Therapeutic and Diagnostic Applications of Nanocomposites in the Treatment Alzheimer&#x2019;s Disease Studies. Review. 2022;12:940&#x2013;960. doi: 10.33263/BRIAC121.940960.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.33263/BRIAC121.940960</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Zhu X.Y., Zhang X.M., Xiong H. Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer&#x2019;s Disease Treatment. Int. J. Mol. Sci. 2022;23:9703. doi: 10.3390/ijms23179703.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23179703</ArticleId><ArticleId IdType=\"pmc\">PMC9456144</ArticleId><ArticleId IdType=\"pubmed\">36077101</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.U., Kim S., Sim S.J. SERS-based Nanoplasmonic Exosome Analysis: Enabling Liquid Biopsy for Cancer Diagnosis and Monitoring Progression. Biochip J. 2020;14:231&#x2013;241. doi: 10.1007/s13206-020-4301-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13206-020-4301-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Iranifar E., Seresht B.M., Momeni F. Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy. J. Cell Physiol. 2019;234:2296&#x2013;2305. doi: 10.1002/jcp.27214.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcp.27214</ArticleId><ArticleId IdType=\"pubmed\">30191975</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Q., Ji X., Lv R. Targetting exosomes as a new biomarker and therapeutic approach for Alzheimer&#x2019;s disease. Clin. Interv. Aging. 2020;15:195&#x2013;205. doi: 10.2147/CIA.S240400.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/CIA.S240400</ArticleId><ArticleId IdType=\"pmc\">PMC7025655</ArticleId><ArticleId IdType=\"pubmed\">32103922</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S., Lee J.U., Jeon M.J., Kim S., Sim S.J. Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer&#x2019;s disease using label-free plasmonic biosensor based on DNA-Assembled advanced plasmonic architecture. Biosens. Bioelectron. 2022;199:113864. doi: 10.1016/j.bios.2021.113864.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bios.2021.113864</ArticleId><ArticleId IdType=\"pubmed\">34890883</ArticleId></ArticleIdList></Reference><Reference><Citation>Derakhshankhah H., Sajadimajd S., Jafari S., Izadi Z., Sarvari S., Sharifi M., Falahati M., Moakedi F., Muganda W.C.A., M&#xfc;ller M., et al. Novel therapeutic strategies for Alzheimer&#x2019;s disease: Implications from cell-based therapy and nanotherapy. Nanomedicine. 2020;24:102149. doi: 10.1016/j.nano.2020.102149.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nano.2020.102149</ArticleId><ArticleId IdType=\"pubmed\">31927133</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyuklieva R., Pilicheva B. Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders. Biomedicines. 2022;10:1706. doi: 10.3390/biomedicines10071706.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines10071706</ArticleId><ArticleId IdType=\"pmc\">PMC9313014</ArticleId><ArticleId IdType=\"pubmed\">35885011</ArticleId></ArticleIdList></Reference><Reference><Citation>Neganova M.E., Aleksandrova Y.R., Sukocheva O.A., Klochkov S.G. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Semin. Cancer Biol. 2022;86:805&#x2013;833. doi: 10.1016/j.semcancer.2022.06.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.semcancer.2022.06.011</ArticleId><ArticleId IdType=\"pubmed\">35779712</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui N., Lu H., Li M. Magnetic nanoparticles associated PEG/PLGA block copolymer targeted with anti-transferrin receptor antibodies for Alzheimer&#x2019;s disease. J. Biomed. Nanotechnol. 2018;14:1017&#x2013;1024. doi: 10.1166/jbn.2018.2512.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1166/jbn.2018.2512</ArticleId><ArticleId IdType=\"pubmed\">29883571</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Raina D., Rishipathak D., Babu K.R., Khurana R., Gupta Y., Garg K., Rehan F., Gupta S.M. Quantum dots in the biomedical world: A smart advanced nanocarrier for multiple venues application. Arch. Pharm. 2022;355:2200299. doi: 10.1002/ardp.202200299.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ardp.202200299</ArticleId><ArticleId IdType=\"pubmed\">36058643</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.T., Nguyen T.D., Nguyen T.K.O. Advances in developing therapeutic strategies for Alzheimer&#x2019;s disease. Biomed. Pharmacother. 2021;139:111623. doi: 10.1016/j.biopha.2021.111623.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2021.111623</ArticleId><ArticleId IdType=\"pubmed\">33915504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S., Sachdeva B., Sachdeva P., Chaudhary V., Rani G.M., Sinha J.K. Graphene quantum dots as a potential diagnostic and therapeutic tool for the management of Alzheimer&#x2019;s disease. Carbon Lett. 2022;32:1381&#x2013;1394. doi: 10.1007/s42823-022-00397-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s42823-022-00397-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro T.d.C., S&#xe1;bio R.M., Luiz M.T. Curcumin-Loaded Mesoporous Silica Nanoparticles Dispersed in Thermo-Responsive Hydrogel as Potential Alzheimer Disease Therapy. Pharmaceutics. 2022;14:1976. doi: 10.3390/pharmaceutics14091976.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics14091976</ArticleId><ArticleId IdType=\"pmc\">PMC9504573</ArticleId><ArticleId IdType=\"pubmed\">36145723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohail I., Bhatti I.A., Ashar A., Sarim F.M., Mohsin M., Naveed R., Yasir M., Iqbal M., Nazir A. Polyamidoamine (PAMAM) dendrimers synthesis, characterization and adsorptive removal of nickel ions from aqueous solution. J. Mater. Res. Technol. 2020;9:498&#x2013;506. doi: 10.1016/j.jmrt.2019.10.079.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jmrt.2019.10.079</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo M.W., Park T.E. Recent advances with liposomes as drug carriers for treatment of neurodegenerative diseases. Biomed. Eng. Lett. 2021;11:211&#x2013;216. doi: 10.1007/s13534-021-00198-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13534-021-00198-5</ArticleId><ArticleId IdType=\"pmc\">PMC8316512</ArticleId><ArticleId IdType=\"pubmed\">34350048</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabiee N., Ahmadi S., Afshari R. Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer&#x2019;s Disease. Adv. Ther. 2021;4:2000076. doi: 10.1002/adtp.202000076.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/adtp.202000076</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel P., Park S. Recent Advances in the Treatment of Alzheimer&#x2019;s Disease Using Nanoparticle-Based Drug Delivery Systems. Pharmaceutics. 2022;14:835. doi: 10.3390/pharmaceutics14040835.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics14040835</ArticleId><ArticleId IdType=\"pmc\">PMC9026997</ArticleId><ArticleId IdType=\"pubmed\">35456671</ArticleId></ArticleIdList></Reference><Reference><Citation>Agraharam G., Saravanan N., Girigoswami A., Girigoswami K. Future of Alzheimer&#x2019;s Disease: Nanotechnology-Based Diagnostics and Therapeutic Approach. BioNanoScience. 2022;12:1002&#x2013;1017. doi: 10.1007/s12668-022-00998-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12668-022-00998-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazaca L.C., Sampaio I., Zucolotto V., Janegitz B.C. Applications of biosensors in Alzheimer&#x2019;s disease diagnosis. Talanta. 2020;210:120644. doi: 10.1016/j.talanta.2019.120644.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.talanta.2019.120644</ArticleId><ArticleId IdType=\"pubmed\">31987214</ArticleId></ArticleIdList></Reference><Reference><Citation>Carneiro P., Morais S., Pereira M.C. Nanomaterials towards Biosensing of Alzheimer&#x2019;s Disease Biomarkers. Nanomaterials. 2019;9:1663. doi: 10.3390/nano9121663.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nano9121663</ArticleId><ArticleId IdType=\"pmc\">PMC6956238</ArticleId><ArticleId IdType=\"pubmed\">31766693</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin J., Jo D.G., Cho M., Lee Y. Monitoring of early diagnosis of Alzheimer&#x2019;s disease using the cellular prion protein and poly(pyrrole-2-carboxylic acid) modified electrode. Biosens. Bioelectron. 2018;113:82&#x2013;87. doi: 10.1016/j.bios.2018.04.061.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bios.2018.04.061</ArticleId><ArticleId IdType=\"pubmed\">29734034</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Xu N., Yang X., Ling G., Zhang P. The roles of gold nanoparticles in the detection of amyloid-&#x3b2; peptide for Alzheimer&#x2019;s disease. Colloid Interface Sci. Commun. 2022;46:100579. doi: 10.1016/j.colcom.2021.100579.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.colcom.2021.100579</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilal M., Barani M., Sabir F. Nanomaterials for the treatment and diagnosis of Alzheimer&#x2019;s disease: An overview. NanoImpact. 2020;20:100251. doi: 10.1016/j.impact.2020.100251.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.impact.2020.100251</ArticleId></ArticleIdList></Reference><Reference><Citation>Trino L.D., Albano L.G.S., Granato D.C. ZIF-8 Metal-Organic Framework Electrochemical Biosensor for the Detection of Protein-Protein Interaction. Chem. Mater. 2021;33:1293&#x2013;1306. doi: 10.1021/acs.chemmater.0c04201.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.chemmater.0c04201</ArticleId></ArticleIdList></Reference><Reference><Citation>Shui B., Tao D., Cheng J. A novel electrochemical aptamer&#x2013;antibody sandwich assay for the detection of tau-381 in human serum. Analyst. 2018;143:3549&#x2013;3554. doi: 10.1039/C8AN00527C.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C8AN00527C</ArticleId><ArticleId IdType=\"pubmed\">30004544</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;pringer T., Hemmerov&#xe1; E., Finocchiaro G., Kri&#x161;tofikov&#xe1; Z., Vyhn&#xe1;lek M., Homola J. Surface plasmon resonance biosensor for the detection of tau-amyloid &#x3b2; complex. Sens. Actuator B Chem. 2020;316:128146. doi: 10.1016/j.snb.2020.128146.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.snb.2020.128146</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan Z.A., Park S. AuNPs- A&#x3b2;-Ni-HRP sandwich assay: A new sensitive colorimetric method for the detection of A&#x3b2; 1-40. Talanta. 2022;237:122946. doi: 10.1016/j.talanta.2021.122946.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.talanta.2021.122946</ArticleId><ArticleId IdType=\"pubmed\">34736673</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., He R., Yan H. Nanotechnology for the diagnosis and treatment of Alzheimer&#x2019;s disease: A bibliometric analysis. Nano Today. 2022;47:101654. doi: 10.1016/j.nantod.2022.101654.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nantod.2022.101654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K., Lee C.H., Park C.B. Chemical sensing platforms for detecting trace-level Alzheimer&#x2019;s core biomarkers. Chem. Soc. Rev. 2020;49:5446&#x2013;5472. doi: 10.1039/D0CS00107D.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D0CS00107D</ArticleId><ArticleId IdType=\"pubmed\">32627779</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitvoranund N., Jiemsirilers S., Kashima D.P. Effects of Surface Treatment on Adhesion of Silver Film on Glass Substrate Fabricated by Electroless Plating. Adv. Mat. Res. 2013;664:566&#x2013;573. doi: 10.4028/www.scientific.net/AMR.664.566.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4028/www.scientific.net/AMR.664.566</ArticleId></ArticleIdList></Reference><Reference><Citation>Khun K., Ibupoto Z.H., AlSalhi M.S. Fabrication of Well-Aligned ZnO Nanorods Using a Composite Seed Layer of ZnO Nanoparticles and Chitosan Polymer. Materials. 2013;6:4361&#x2013;4374. doi: 10.3390/ma6104361.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ma6104361</ArticleId><ArticleId IdType=\"pmc\">PMC5452860</ArticleId><ArticleId IdType=\"pubmed\">28788336</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar N., Metkar S.K., Girigoswami A., Girigoswami K. ZnO nanoflower based sensitive nano-biosensor for amyloid detection. Mater. Sci. Eng. C. 2017;78:960&#x2013;968. doi: 10.1016/j.msec.2017.04.118.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.msec.2017.04.118</ArticleId><ArticleId IdType=\"pubmed\">28576073</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancalana M., Koide S. Molecular Mechanism of Thioflavin-T Binding to Amyloid Fibrils. Biochim. Biophys. Acta. 2010;1804:1405. doi: 10.1016/j.bbapap.2010.04.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbapap.2010.04.001</ArticleId><ArticleId IdType=\"pmc\">PMC2880406</ArticleId><ArticleId IdType=\"pubmed\">20399286</ArticleId></ArticleIdList></Reference><Reference><Citation>Porsteinsson A.P., Isaacson R.S., Knox S. Diagnosis of Early Alzheimer&#x2019;s Disease: Clinical Practice in 2021. J. Prev. Alzheimer&#x2019;s Dis. 2021;8:371&#x2013;386. doi: 10.14283/jpad.2021.23.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14283/jpad.2021.23</ArticleId><ArticleId IdType=\"pubmed\">34101796</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirisala A., Uchida S., Toh K., Li J., Osawa S., Tockary T.A., Liu X., Abbasi S., Hayashi K., Mochida Y., et al. Transient stealth coating of liver sinusoidal wall by anchoring two-armed PEG for retargeting nanomedicines. Sci. Adv. 2020;6:eabb8133. doi: 10.1126/sciadv.abb8133.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/sciadv.abb8133</ArticleId><ArticleId IdType=\"pmc\">PMC7319729</ArticleId><ArticleId IdType=\"pubmed\">32637625</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Lv H., Duan X., Du Y., Tang Y., Xu W. Advancements in Macrophage-Targeted Drug Delivery for Effective Disease Management. Int. J. Nanomed. 2023;18:6915&#x2013;6940. doi: 10.2147/IJN.S430877.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/IJN.S430877</ArticleId><ArticleId IdType=\"pmc\">PMC10680479</ArticleId><ArticleId IdType=\"pubmed\">38026516</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N.H., Mir M., Ngowi E.E., Zafar U., Khakwani M.M.A.K., Khattak S., Zhai Y.-K., Jiang E.-S., Zheng M., Duan S.-F., et al. Nanomedicine: A Promising Way to Manage Alzheimer&#x2019;s Disease. Front. Bioeng. Biotechnol. 2021;9:630055. doi: 10.3389/fbioe.2021.630055.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fbioe.2021.630055</ArticleId><ArticleId IdType=\"pmc\">PMC8120897</ArticleId><ArticleId IdType=\"pubmed\">33996777</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil S., Chandrasekaran R. Biogenic nanoparticles: A comprehensive perspective in synthesis, characterization, application and its challenges. J. Genet. Eng. Biotechnol. 2020;18:67. doi: 10.1186/s43141-020-00081-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s43141-020-00081-3</ArticleId><ArticleId IdType=\"pmc\">PMC7588575</ArticleId><ArticleId IdType=\"pubmed\">33104931</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke W., Afonin K.A. Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs) Adv. Drug. Deliv. Rev. 2021;176:113835. doi: 10.1016/j.addr.2021.113835.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.addr.2021.113835</ArticleId><ArticleId IdType=\"pmc\">PMC8440450</ArticleId><ArticleId IdType=\"pubmed\">34144087</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z.Z., Zhang Y.Q., Wang Z.Z. Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration. Int. J. Pharm. 2013;452:344&#x2013;354. doi: 10.1016/j.ijpharm.2013.05.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijpharm.2013.05.009</ArticleId><ArticleId IdType=\"pubmed\">23680731</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Dong H., Cao H., Ji X., Luan S., Liu J. Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer&#x2019;s Disease. Med. Sci. Monit. 2019;25:3329&#x2013;3335. doi: 10.12659/MSM.914027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.12659/MSM.914027</ArticleId><ArticleId IdType=\"pmc\">PMC6515980</ArticleId><ArticleId IdType=\"pubmed\">31056537</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Q., Wu P., Zhou X. Extracellular Vesicles: Novel Roles in Neurological Disorders. Stem Cells Int. 2021;2021:6640836. doi: 10.1155/2021/6640836.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2021/6640836</ArticleId><ArticleId IdType=\"pmc\">PMC7904361</ArticleId><ArticleId IdType=\"pubmed\">33679989</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y., Guo L., Jiang Y. Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles. Drug Deliv. 2020;27:745&#x2013;755. doi: 10.1080/10717544.2020.1762262.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10717544.2020.1762262</ArticleId><ArticleId IdType=\"pmc\">PMC7269046</ArticleId><ArticleId IdType=\"pubmed\">32397764</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltr&#xe1;n-Gracia E., L&#xf3;pez-Camacho A., Higuera-Ciapara I. Nanomedicine review: Clinical developments in liposomal applications. Cancer Nanotechnol. 2019;10:11. doi: 10.1186/s12645-019-0055-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12645-019-0055-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal M., Ajazuddin, Tripathi D.K. Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer&#x2019;s disease. J. Control. Release. 2017;260:61&#x2013;77. doi: 10.1016/j.jconrel.2017.05.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jconrel.2017.05.019</ArticleId><ArticleId IdType=\"pubmed\">28549949</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong L., Li X.T., Ni Y.N. Transferrin-modified osthole PEGylated liposomes travel the blood-brain barrier and mitigate alzheimer&#x2019;s disease-related pathology in APP/PS-1 mice. Int. J. Nanomed. 2020;15:2841&#x2013;2858. doi: 10.2147/IJN.S239608.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/IJN.S239608</ArticleId><ArticleId IdType=\"pmc\">PMC7186891</ArticleId><ArticleId IdType=\"pubmed\">32425521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji B., Wang M., Gao D. Combining nanoscale magnetic nimodipine liposomes with magnetic resonance image for Parkinson&#x2019;s disease targeting therapy. Nanomedicine. 2017;12:237&#x2013;253. doi: 10.2217/nnm-2016-0267.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2217/nnm-2016-0267</ArticleId><ArticleId IdType=\"pubmed\">28093036</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadia K., Markoutsa E., Mourtas S. Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept. Eur. J. Pharm. Sci. 2017;101:140&#x2013;148. doi: 10.1016/j.ejps.2017.02.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejps.2017.02.019</ArticleId><ArticleId IdType=\"pubmed\">28193538</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Zhou B.Q., Li Y.H., Jiang Q.Q., Cong W.H., Chen K.J., Wen X.M., Wu Z.Z. Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer&#x2019;s disease. Neural Regen. Res. 2023;18:226. doi: 10.4103/1673-5374.344841.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/1673-5374.344841</ArticleId><ArticleId IdType=\"pmc\">PMC9241388</ArticleId><ArticleId IdType=\"pubmed\">35799547</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav H.K.S., Almokdad A.A., Shaluf S.I.M., Debe M.S. Polymer-Based Nanomaterials for Drug-Delivery Carriers. Nanocarriers Drug Deliv. 2018:531&#x2013;556. doi: 10.1016/B978-0-12-814033-8.00017-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/B978-0-12-814033-8.00017-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Montegiove N., Calzoni E., Emiliani C., Cesaretti A. Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases. J. Funct. Biomater. 2022;13:125. doi: 10.3390/jfb13030125.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jfb13030125</ArticleId><ArticleId IdType=\"pmc\">PMC9504125</ArticleId><ArticleId IdType=\"pubmed\">36135560</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazahir F., Yadav A.K. Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer&#x2019;s Disease. CNS Neurol. Disord. Drug Targets. 2022;22:477&#x2013;499. doi: 10.2174/1871527321666220420133059.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1871527321666220420133059</ArticleId><ArticleId IdType=\"pubmed\">35450536</ArticleId></ArticleIdList></Reference><Reference><Citation>Ailioaie L.M., Ailioaie C., Litscher G. Photobiomodulation in Alzheimer&#x2019;s Disease-A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine? Pharmaceutics. 2023;15:916. doi: 10.3390/pharmaceutics15030916.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics15030916</ArticleId><ArticleId IdType=\"pmc\">PMC10054386</ArticleId><ArticleId IdType=\"pubmed\">36986776</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., Gonzalez-Carter D., Tockary T.A., Nakamura N., Xue Y., Nakakido M., Akiba H., Dirisala A., Liu X., Toh K., et al. Dual-sensitive nanomicelles enhancing systemic delivery of therapeutically active antibodies specifically into the brain. ACS Nano. 2020;14:6729&#x2013;6742. doi: 10.1021/acsnano.9b09991.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsnano.9b09991</ArticleId><ArticleId IdType=\"pubmed\">32431145</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi S., Uchida S., Toh K., Tockary T.A., Dirisala A., Hayashi K., Fukushima S., Kataoka K. Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain. J. Control. Release. 2021;332:260&#x2013;268. doi: 10.1016/j.jconrel.2021.02.026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jconrel.2021.02.026</ArticleId><ArticleId IdType=\"pubmed\">33647431</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller B.L., Lohmann C.A., Kyeremateng S.O., Fricker G. Synthesis and Characterization of Biodegradable Poly(butyl cyanoacrylate) for Drug Delivery Applications. Polymers. 2022;14:998. doi: 10.3390/polym14050998.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/polym14050998</ArticleId><ArticleId IdType=\"pmc\">PMC8912508</ArticleId><ArticleId IdType=\"pubmed\">35267821</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew A., Fukuda T., Nagaoka Y. Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer&#x2019;s Disease. PLoS ONE. 2012;7:e32616. doi: 10.1371/journal.pone.0032616.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0032616</ArticleId><ArticleId IdType=\"pmc\">PMC3293842</ArticleId><ArticleId IdType=\"pubmed\">22403681</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukhari S.N.A., Yogesh R. An Overview of Tetramethylpyrazine (Ligustrazine) and its Derivatives as Potent Anti-Alzheimer&#x2019;s Disease Agents. Lett. Drug. Des. Discov. 2022;19:565&#x2013;578. doi: 10.2174/1570180819666220405232333.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1570180819666220405232333</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez C., Shukla S. Liposome based drug delivery as a potential treatment option for Alzheimer&#x2019;s disease. Neural Regen. Res. 2022;17:1190. doi: 10.4103/1673-5374.327328.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/1673-5374.327328</ArticleId><ArticleId IdType=\"pmc\">PMC8643057</ArticleId><ArticleId IdType=\"pubmed\">34782553</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanojia N., Thapa K., Kaur G. Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer&#x2019;s and Parkinson&#x2019;s disease. J. Drug. Deliv. Sci. Technol. 2023;79:104074. doi: 10.1016/j.jddst.2022.104074.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jddst.2022.104074</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasae K.D., Abolaji A.O., Faloye T.R. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer&#x2019;s disease: Limitations, and current and future perspectives. J. Trace Elem. Med. Biol. 2021;67:126779. doi: 10.1016/j.jtemb.2021.126779.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jtemb.2021.126779</ArticleId><ArticleId IdType=\"pubmed\">34034029</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra J., Kumar B., Pandey M. Carbon Nano Tubes: Novel Drug Delivery System in Amelioration of Alzheimer&#x2019;s Disease. Comb. Chem. High Throughput Screen. 2020;24:1528&#x2013;1543. doi: 10.2174/1386207323999200918112538.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1386207323999200918112538</ArticleId><ArticleId IdType=\"pubmed\">32957874</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Zhang Y., Yang Y. Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease. Nanomedicine. 2010;6:427&#x2013;441. doi: 10.1016/j.nano.2009.11.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nano.2009.11.007</ArticleId><ArticleId IdType=\"pubmed\">20056170</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu Z., Ding L., Huang A.Y.T., Kao C.L., Peng L. Poly(amidoamine) dendrimers: Covalent and supramolecular synthesis. Mater. Today Chem. 2019;13:34&#x2013;48. doi: 10.1016/j.mtchem.2019.04.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mtchem.2019.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Aurelia Chis A., Dobrea C., Morgovan C., Arseniu A.M., Rus L.L., Butuca A., Juncan A.M., Totan M., Vonica-Tincu A.L., Cormos G., et al. Applications and Limitations of Dendrimers in Biomedicine. Molecules. 2020;25:3982. doi: 10.3390/molecules25173982.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules25173982</ArticleId><ArticleId IdType=\"pmc\">PMC7504821</ArticleId><ArticleId IdType=\"pubmed\">32882920</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P., Zhang T., Chen Q. Biomimetic Dendrimer&#x2013;Peptide Conjugates for Early Multi-Target Therapy of Alzheimer&#x2019;s Disease by Inflammatory Microenvironment Modulation. Adv. Mater. 2021;33:2100746. doi: 10.1002/adma.202100746.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/adma.202100746</ArticleId><ArticleId IdType=\"pubmed\">33998706</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Liu C., Pang Z. Dendrimer-Based Drug Delivery Systems for Brain Targeting. Biomolecules. 2019;9:790. doi: 10.3390/biom9120790.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom9120790</ArticleId><ArticleId IdType=\"pmc\">PMC6995517</ArticleId><ArticleId IdType=\"pubmed\">31783573</ArticleId></ArticleIdList></Reference><Reference><Citation>Arotiba O., Owino J., Songa E., Hendricks N., Waryo T., Jahed N., Baker P., Iwuoha E. An Electrochemical DNA Biosensor Developed on a Nanocomposite Platform of Gold and Poly(propyleneimine) Dendrimer. Sensors. 2008;8:6791&#x2013;6809. doi: 10.3390/s8116791.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/s8116791</ArticleId><ArticleId IdType=\"pmc\">PMC3787416</ArticleId><ArticleId IdType=\"pubmed\">27873900</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel D.A., Henry J.E., Good T.A. Attenuation of &#x3b2;-amyloid-induced toxicity by sialic-acid-conjugated dendrimers: Role of sialic acid attachment. Brain Res. 2007;1161:95&#x2013;105. doi: 10.1016/j.brainres.2007.05.055.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainres.2007.05.055</ArticleId><ArticleId IdType=\"pmc\">PMC2031224</ArticleId><ArticleId IdType=\"pubmed\">17604005</ArticleId></ArticleIdList></Reference><Reference><Citation>Palan F., Chatterjee B. Dendrimers in the context of targeting central nervous system disorders. J. Drug. Deliv. Sci. Technol. 2022;73:103474. doi: 10.1016/j.jddst.2022.103474.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jddst.2022.103474</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini I., Mattoli V., Ciofani G. Mitochondria and neurodegenerative diseases: The promising role of nanotechnology in targeted drug delivery. Expert Opin. Drug Deliv. 461. 2016;14:513&#x2013;523. doi: 10.1080/17425247.2016.1218461.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/17425247.2016.1218461</ArticleId><ArticleId IdType=\"pubmed\">27467010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren C., Li D., Zhou Q., Hu X. Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1/M2 microglial polarization in an Alzheimer&#x2019;s disease model. Biomaterials. 2020;232:119752. doi: 10.1016/j.biomaterials.2019.119752.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biomaterials.2019.119752</ArticleId><ArticleId IdType=\"pubmed\">31923845</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J., Li F., Li X. An amplification label of core&#x2013;shell CdSe@CdS QD sensitized GO for a signal-on photoelectrochemical immunosensor for amyloid &#x3b2;-protein. J. Mater. Chem. B. 2019;7:1142&#x2013;1148. doi: 10.1039/C8TB03164A.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C8TB03164A</ArticleId><ArticleId IdType=\"pubmed\">32254782</ArticleId></ArticleIdList></Reference><Reference><Citation>Villalva M.D., Agarwal V., Ulanova M. Quantum dots as a theranostic approach in Alzheimer&#x2019;s disease: A systematic review. Nanomedicine. 2021;16:1595&#x2013;1611. doi: 10.2217/nnm-2021-0104.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2217/nnm-2021-0104</ArticleId><ArticleId IdType=\"pubmed\">34180261</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Liu R., Zhang D. Neuroprotective effects of maize tetrapeptide-anchored gold nanoparticles in Alzheimer&#x2019;s disease. Colloids Surf. B Biointerfaces. 2021;200:111584. doi: 10.1016/j.colsurfb.2021.111584.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.colsurfb.2021.111584</ArticleId><ArticleId IdType=\"pubmed\">33508658</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes A., Camosseto V., N&#x2019;Guessan P. BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells. Nat. Commun. 2017;8:913. doi: 10.1038/s41467-017-00695-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-017-00695-1</ArticleId><ArticleId IdType=\"pmc\">PMC5640662</ArticleId><ArticleId IdType=\"pubmed\">29030552</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Lie Q., Liu Y. Multifunctional Selenium Quantum Dots for the Treatment of Alzheimer&#x2019;s Disease by Reducing A&#x3b2;-Neurotoxicity and Oxidative Stress and Alleviate Neuroinflammation. ACS Appl. Mater. Interfaces. 2021;13:30261&#x2013;30273. doi: 10.1021/acsami.1c00690.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsami.1c00690</ArticleId><ArticleId IdType=\"pubmed\">34169710</ArticleId></ArticleIdList></Reference><Reference><Citation>Birla H., Minocha T., Kumar G. Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer&#x2019;s Disease. Curr. Neuropharmacol. 2020;18:552. doi: 10.2174/1570159X18666200122122512.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1570159X18666200122122512</ArticleId><ArticleId IdType=\"pmc\">PMC7457422</ArticleId><ArticleId IdType=\"pubmed\">31969104</ArticleId></ArticleIdList></Reference><Reference><Citation>Fakhri S., Abdian S., Zarneshan S.N. Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs against Neurodegenerative Diseases. Int. J. Nanomed. 2022;17:299. doi: 10.2147/IJN.S347187.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/IJN.S347187</ArticleId><ArticleId IdType=\"pmc\">PMC8791303</ArticleId><ArticleId IdType=\"pubmed\">35095273</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin T., Yang L., Liu Y. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer&#x2019;s disease. Acta Biomater. 2015;25:172&#x2013;183. doi: 10.1016/j.actbio.2015.06.035.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.actbio.2015.06.035</ArticleId><ArticleId IdType=\"pubmed\">26143603</ArticleId></ArticleIdList></Reference><Reference><Citation>Suganthy N., Sri Ramkumar V., Pugazhendhi A. Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: Assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects. Environ. Sci. Pollut. Res. Int. 2018;25:10418&#x2013;10433. doi: 10.1007/s11356-017-9789-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11356-017-9789-4</ArticleId><ArticleId IdType=\"pubmed\">28762049</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta D., Boora A., Thakur A., Gupta T.K. Green and sustainable synthesis of nanomaterials: Recent advancements and limitations. Environ. Res. 2023;231:116316. doi: 10.1016/j.envres.2023.116316.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.envres.2023.116316</ArticleId><ArticleId IdType=\"pubmed\">37270084</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayaz M., Ovais M., Ahmad I. Biosynthesized metal nanoparticles as potential Alzheimer&#x2019;s disease therapeutics. Metal Nanoparticles Drug Deliv. Diagn. Appl. 2020:31&#x2013;42. doi: 10.1016/B978-0-12-816960-5.00003-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/B978-0-12-816960-5.00003-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X., Vo C., Taylor M., Smith B.R. Non-spherical micro- and nanoparticles in nanomedicine. Mater. Horiz. 2019;6:1094&#x2013;1121. doi: 10.1039/C8MH01527A.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C8MH01527A</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Wang H., He M. Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells. Ecotoxicol. Environ. Saf. 2019;171:337&#x2013;346. doi: 10.1016/j.ecoenv.2018.12.096.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ecoenv.2018.12.096</ArticleId><ArticleId IdType=\"pubmed\">30616150</ArticleId></ArticleIdList></Reference><Reference><Citation>Farah F.H. Nanocarriers AS Delivery Systems FOR Therapeutics Agents. Int. J. Pharm. Sci. Res. 2019;10:3487. doi: 10.13040/IJPSR.0975-8232.10(8).3487-07.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.13040/IJPSR.0975-8232.10(8).3487-07</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaicherd S., Killingsworth M.C., Pissuwan D. Toxicity of gold nanoparticles in a commercial dietary supplement drink on connective tissue fibroblast cells. SN Appl. Sci. 2019;1:336. doi: 10.1007/s42452-019-0354-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s42452-019-0354-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Carro C.E., Pilozzi A.R., Huang X. Nanoneurotoxicity and Potential Nanotheranostics for Alzheimer&#x2019;s Disease. EC Pharmacol. Toxicol. 2019;7:1.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6905634</ArticleId><ArticleId IdType=\"pubmed\">31828253</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Pilozzi A.R., Huang X. Exposure of CuO Nanoparticles Contributes to Cellular Apoptosis, Redox Stress, and Alzheimer&#x2019;s A&#x3b2; Amyloidosis. Int. J. Environ. Res. Public Health. 2020;17:1005. doi: 10.3390/ijerph17031005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijerph17031005</ArticleId><ArticleId IdType=\"pmc\">PMC7038189</ArticleId><ArticleId IdType=\"pubmed\">32033400</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbuna C., Parmar V.K., Jeevanandam J., Ezzat S.M., Patrick-Iwuanyanwu K.C., Adetunji C.O., Khan J., Onyeike E.N., Uche C.Z., Akram M., et al. Toxicity of Nanoparticles in Biomedical Application: Nanotoxicology. J. Toxicol. 2021;2021:9954443. doi: 10.1155/2021/9954443.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2021/9954443</ArticleId><ArticleId IdType=\"pmc\">PMC8376461</ArticleId><ArticleId IdType=\"pubmed\">34422042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou J., Liu H., Zhang S., Liu X., Hayat T., Alsaedi A., Wang X. Mechanism of toxic effects of Nano-ZnO on cell cycle of zebrafish (Danio rerio) Chemosphere. 2019;229:206&#x2013;213. doi: 10.1016/j.chemosphere.2019.04.217.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.chemosphere.2019.04.217</ArticleId><ArticleId IdType=\"pubmed\">31078877</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.W., Cambre M., Lee H.J. The Toxicity of Nanoparticles Depends on Multiple Molecular and Physicochemical Mechanisms. Int. J. Mol. Sci. 2017;18:2702. doi: 10.3390/ijms18122702.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms18122702</ArticleId><ArticleId IdType=\"pmc\">PMC5751303</ArticleId><ArticleId IdType=\"pubmed\">29236059</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F., Ma N.J., Zhou H., Wang Q., Zhang H., Wang P., Hou H., Wen H., Li L. Zinc oxide nanoparticles-induced epigenetic change and G2/M arrest are associated with apoptosis in human epidermal keratinocytes. Int. J. Nanomed. 2016;11:3859&#x2013;3874. doi: 10.2147/IJN.S107021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/IJN.S107021</ArticleId><ArticleId IdType=\"pmc\">PMC4986971</ArticleId><ArticleId IdType=\"pubmed\">27570453</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaragh-Alhadad L.A., Falahati M. Copper oxide nanoparticles promote amyloid-&#x3b2;-triggered neurotoxicity through formation of oligomeric species as a prelude to Alzheimer&#x2019;s diseases. Int. J. Biol. Macromol. 2022;207:121&#x2013;129. doi: 10.1016/j.ijbiomac.2022.03.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijbiomac.2022.03.006</ArticleId><ArticleId IdType=\"pubmed\">35259430</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimmer I., Tietz S., Nishihara H., Deutsch U., Sallusto F., Gosselet F., Lyck R., Muller W.A., Lassmann H., Engelhardt B. PECAM-1 stabilizes blood-brain barrier integrity and favors paracellular T-cell diapedesis across the blood-brain barrier during neuroinflammation. Front. Immunol. 2019;10:711. doi: 10.3389/fimmu.2019.00711.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2019.00711</ArticleId><ArticleId IdType=\"pmc\">PMC6460670</ArticleId><ArticleId IdType=\"pubmed\">31024547</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares S., Sousa J., Pais A., Vitorino C. Nanomedicine: Principles, properties, and regulatory issues. Front. Chem. 2018;6:356901. doi: 10.3389/fchem.2018.00360.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fchem.2018.00360</ArticleId><ArticleId IdType=\"pmc\">PMC6109690</ArticleId><ArticleId IdType=\"pubmed\">30177965</ArticleId></ArticleIdList></Reference><Reference><Citation>Min H.S., Kim H.J., Naito M., Ogura S., Toh K., Hayashi K., Kim B.S., Fukushima S., Anraku Y., Miyata K., et al. Systemic Brain Delivery of Antisense Oligonucleotides across the Blood&#x2013;Brain Barrier with a Glucose-Coated Polymeric Nanocarrier. Angew. Chem. 2020;59:8173&#x2013;8180. doi: 10.1002/anie.201914751.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/anie.201914751</ArticleId><ArticleId IdType=\"pmc\">PMC7317551</ArticleId><ArticleId IdType=\"pubmed\">31995252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling T.S., Chandrasegaran S., Xuan L.Z., Suan T.L., Elaine E., Nathan D.V., Chai Y.H., Gunasekaran B., Salvamani S. The Potential Benefits of Nanotechnology in Treating Alzheimer&#x2019;s Disease. Biomed. Res. Int. 2021;2021:5550938. doi: 10.1155/2021/5550938.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2021/5550938</ArticleId><ArticleId IdType=\"pmc\">PMC8275379</ArticleId><ArticleId IdType=\"pubmed\">34285915</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabrizio C., Termine A., Caltagirone C., Sancesario G. Artificial Intelligence for Alzheimer&#x2019;s Disease: Promise or Challenge? Diagnostics. 2021;11:1473. doi: 10.3390/diagnostics11081473.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diagnostics11081473</ArticleId><ArticleId IdType=\"pmc\">PMC8391160</ArticleId><ArticleId IdType=\"pubmed\">34441407</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Sp&#xed;nola A., Baldeiras I., Arrais J.P., Santana I. The Road to Personalized Medicine in Alzheimer&#x2019;s Disease: The Use of Artificial Intelligence. Biomedicines. 2022;10:315. doi: 10.3390/biomedicines10020315.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines10020315</ArticleId><ArticleId IdType=\"pmc\">PMC8869403</ArticleId><ArticleId IdType=\"pubmed\">35203524</ArticleId></ArticleIdList></Reference><Reference><Citation>Olaniyan O.T., Adetunji C.O., Adeyomoye O., Dare A., Adeniyi M.J., Enoch A. Cognitive therapy for brain diseases using deep learning models. Artif. Intell. Neurol. Disord. 2023:171&#x2013;184. doi: 10.1016/B978-0-323-90277-9.00017-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/B978-0-323-90277-9.00017-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav A., Pandey D., Ashraf G.M. Rachana Peptide Based Therapy for Neurological Disorders. Curr. Protein. Pept. Sci. 2021;22:656&#x2013;665. doi: 10.2174/1389203722666210920151810.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1389203722666210920151810</ArticleId><ArticleId IdType=\"pubmed\">34544337</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassilakopoulou V., Karachaliou C.E., Evangelou A., Zikos C., Livaniou E. Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives. Vaccines. 2021;9:1278. doi: 10.3390/vaccines9111278.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/vaccines9111278</ArticleId><ArticleId IdType=\"pmc\">PMC8622585</ArticleId><ArticleId IdType=\"pubmed\">34835209</ArticleId></ArticleIdList></Reference><Reference><Citation>Malonis R.J., Lai J.R., Vergnolle O. Peptide-Based Vaccines: Current Progress and Future Challenges. Chem. Rev. 2020;120:3210&#x2013;3229. doi: 10.1021/acs.chemrev.9b00472.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.chemrev.9b00472</ArticleId><ArticleId IdType=\"pmc\">PMC7094793</ArticleId><ArticleId IdType=\"pubmed\">31804810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopade P., Chopade N., Zhao Z., Mitragotri S., Liao R., Chandran Suja V. Alzheimer&#x2019;s and Parkinson&#x2019;s disease therapies in the clinic. Bioeng. Transl. Med. 2023;8:e10367. doi: 10.1002/btm2.10367.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/btm2.10367</ArticleId><ArticleId IdType=\"pmc\">PMC9842041</ArticleId><ArticleId IdType=\"pubmed\">36684083</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Zhang R. The application of nanotechnology in treatment of Alzheimer&#x2019;s disease. Front. Bioeng. Biotechnol. 2022;10:1042986. doi: 10.3389/fbioe.2022.1042986.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fbioe.2022.1042986</ArticleId><ArticleId IdType=\"pmc\">PMC9713307</ArticleId><ArticleId IdType=\"pubmed\">36466349</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273636</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Alzheimer's Disease as a Membrane Dysfunction Tauopathy? New Insights into the Amyloid Cascade Hypothesis.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9689</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179689</ELocationID><Abstract><AbstractText>The amyloid cascade hypothesis postulates that extracellular deposits of amyloid &#x3b2; (A&#x3b2;) are the primary and initial cause leading to the full development of Alzheimer's disease (AD) with intracellular neurofibrillary tangles; however, the details of this mechanism have not been fully described until now. Our preliminary data, coming from our day-to-day neuropathology practice, show that the primary location of the hyperphosphorylated tau protein is in the vicinity of the cell membrane of dystrophic neurites. This observation inspired us to formulate a hypothesis that presumes an interaction between low-density lipoprotein receptor-related protein 1 (LRP1) and fibrillar aggregates of, particularly, A&#x3b2;<sub>42</sub> anchored at the periphery of neuritic plaques, making internalization of the LRP1-A&#x3b2;<sub>42</sub> complex infeasible and, thus, causing membrane dysfunction, leading to the tauopathy characterized by intracellular accumulation and hyperphosphorylation of the tau protein. Understanding AD as a membrane dysfunction tauopathy may draw attention to new treatment approaches not only targeting A&#x3b2;<sub>42</sub> production but also, perhaps paradoxically, preventing the formation of LRP1-A&#x3b2;<sub>42</sub>.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Olejar</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><Identifier Source=\"ORCID\">0000-0002-0786-5029</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer Faculty Hospital, 140 59 Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jankovska</LastName><ForeName>Nikol</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">0000-0001-8422-2628</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer Faculty Hospital, 140 59 Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Matej</LastName><ForeName>Radoslav</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0002-6152-6343</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer Faculty Hospital, 140 59 Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, 128 00 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>00064165</GrantID><Agency>Ministry of Health, Czech Reoublic (Conceptual development of research organization)</Agency><Country/></Grant><Grant><GrantID>00064190</GrantID><Agency>Ministry of Health, Czech Reoublic (Conceptual development of research organization)</Agency><Country/></Grant><Grant><GrantID>NU23-04-00173</GrantID><Agency>Grants Agency of the Ministry of Health</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016229\">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016875\">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D026503\">Low Density Lipoprotein Receptor-Related Protein-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C475476\">LRP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D010446\">Peptide Fragments</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016229\" MajorTopicYN=\"Y\">Amyloid beta-Peptides</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016875\" MajorTopicYN=\"Y\">tau Proteins</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D026503\" MajorTopicYN=\"Y\">Low Density Lipoprotein Receptor-Related Protein-1</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D024801\" MajorTopicYN=\"Y\">Tauopathies</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002462\" MajorTopicYN=\"N\">Cell Membrane</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D010766\" MajorTopicYN=\"N\">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010446\" MajorTopicYN=\"N\">Peptide Fragments</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">amyloid &#x3b2;</Keyword><Keyword MajorTopicYN=\"N\">membrane dysfunction</Keyword><Keyword MajorTopicYN=\"N\">tauopathy</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273636</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179689</ArticleId><ArticleId IdType=\"pii\">ijms25179689</ArticleId><ArticleId IdType=\"pmc\">PMC11396199</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jankovska N., Olejar T., Matej R. Extracellular Amyloid Deposits in Alzheimer&#x2019;s and Creutzfeldt-Jakob Disease: Similar Behavior of Different Proteins? Int. J. Mol. Sci. 2020;22:7. doi: 10.3390/ijms22010007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22010007</ArticleId><ArticleId IdType=\"pmc\">PMC7792617</ArticleId><ArticleId IdType=\"pubmed\">33374972</ArticleId></ArticleIdList></Reference><Reference><Citation>DeTure M.A., Dickson D.W. The neuropathological diagnosis of Alzheimer&#x2019;s disease. Mol. Neurodegener. 2019;14:32. doi: 10.1186/s13024-019-0333-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-019-0333-5</ArticleId><ArticleId IdType=\"pmc\">PMC6679484</ArticleId><ArticleId IdType=\"pubmed\">31375134</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman B.T., Phelps C.H., Beach T.G., Bigio E.H., Cairns N.J., Carrillo M.C., Dickson D.W., Duyckaerts C., Frosch M.P., Masliah E., et al. National Institute on Aging-Alzheimer&#x2019;s Association guidelines for the neuropathologic assessment of Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2012;8:1&#x2013;13. doi: 10.1016/j.jalz.2011.10.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2011.10.007</ArticleId><ArticleId IdType=\"pmc\">PMC3266529</ArticleId><ArticleId IdType=\"pubmed\">22265587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy J.A., Higgins G.A. Alzheimer&#x2019;s disease: The amyloid cascade hypothesis. Science. 1992;256:184&#x2013;185. doi: 10.1126/science.1566067.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1566067</ArticleId><ArticleId IdType=\"pubmed\">1566067</ArticleId></ArticleIdList></Reference><Reference><Citation>Barage S.H., Sonawane K.D. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer&#x2019;s disease. Neuropeptides. 2015;52:1&#x2013;18. doi: 10.1016/j.npep.2015.06.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.npep.2015.06.008</ArticleId><ArticleId IdType=\"pubmed\">26149638</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovska N., Olejar T., Kukal J., Matej R. Different Morphology of Neuritic Plaques in the Archicortex of Alzheimer&#x2019;s Disease with Comorbid Synucleinopathy: A Pilot Study. Curr. Alzheimer&#x2019;s Res. 2020;17:948&#x2013;958. doi: 10.2174/1875692117999201215162043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1875692117999201215162043</ArticleId><ArticleId IdType=\"pubmed\">33327912</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239&#x2013;259. doi: 10.1007/BF00308809.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/BF00308809</ArticleId><ArticleId IdType=\"pubmed\">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett D.A., Schneider J.A., Arvanitakis Z., Kelly J.F., Aggarwal N.T., Shah R.C., Wilson R.S. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66:1837&#x2013;1844. doi: 10.1212/01.wnl.0000219668.47116.e6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/01.wnl.0000219668.47116.e6</ArticleId><ArticleId IdType=\"pubmed\">16801647</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett D.A., Schneider J.A., Aggarwal N.T., Arvanitakis Z., Shah R.C., Kelly J.F., Fox J.H., Cochran E.J., Arends D., Treinkman A.D., et al. Decision rules guiding the clinical diagnosis of Alzheimer&#x2019;s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006;27:169&#x2013;176. doi: 10.1159/000096129.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000096129</ArticleId><ArticleId IdType=\"pubmed\">17035694</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones S.L., Svitkina T.M. Axon Initial Segment Cytoskeleton: Architecture, Development, and Role in Neuron Polarity. Neural Plast. 2016;2016:6808293. doi: 10.1155/2016/6808293.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2016/6808293</ArticleId><ArticleId IdType=\"pmc\">PMC4967436</ArticleId><ArticleId IdType=\"pubmed\">27493806</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada R., Kuba H. Structural and Functional Plasticity at the Axon Initial Segment. Front. Cell Neurosci. 2016;10:250. doi: 10.3389/fncel.2016.00250.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2016.00250</ArticleId><ArticleId IdType=\"pmc\">PMC5078684</ArticleId><ArticleId IdType=\"pubmed\">27826229</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer&#x2019;s disease mutations: Potential factors in amyloid plaque formation. J. Neurosci. 2006;26:10129&#x2013;10140. doi: 10.1523/JNEUROSCI.1202-06.2006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1202-06.2006</ArticleId><ArticleId IdType=\"pmc\">PMC6674618</ArticleId><ArticleId IdType=\"pubmed\">17021169</ArticleId></ArticleIdList></Reference><Reference><Citation>Claeysen S., Giannoni P., Ismeurt C. Diagnosis and Management in Dementia. Academic Press; Cambridge, MA, USA: 2020. The 5xFAD Mouse Model of Alzheimer&#x2019;s Disease. The Neuroscience of Dementia 1; pp. 207&#x2013;221. Chapter 13.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/B978-0-12-815854-8.00013-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Youmans K.L., Tai L.M., Kanekiyo T., Stine W.B., Jr., Michon S.-C., Nwabuisi-Heath E., Manelli A.M., Fu Y., Riordan S., Roher A.E., et al. Intraneuronal A&#x3b2; detection in 5xFAD mice by a new A&#x3b2;-specific antibody. Mol. Neurodegener. 2012;7:8. doi: 10.1186/1750-1326-7-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1750-1326-7-8</ArticleId><ArticleId IdType=\"pmc\">PMC3355009</ArticleId><ArticleId IdType=\"pubmed\">22423893</ArticleId></ArticleIdList></Reference><Reference><Citation>Maarouf C.L., Kokjohn T.A., Whiteside C.M., Macias M.P., Kalback W.M., Sabbagh M.N., Beach T.G., Vassar R., Roher A.E. Molecular Differences and Similarities Between Alzheimer&#x2019;s Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis. Biochem. Insights. 2013;6:BCI-S13025. doi: 10.4137/BCI.S13025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4137/BCI.S13025</ArticleId><ArticleId IdType=\"pmc\">PMC4154482</ArticleId><ArticleId IdType=\"pubmed\">25210460</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J., Park S., Lee H., Kim Y. Thioflavin-positive tau aggregates complicating quantification of amyloid plaques in the brain of 5XFAD transgenic mouse model. Sci. Rep. 2021;11:1617. doi: 10.1038/s41598-021-81304-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-021-81304-6</ArticleId><ArticleId IdType=\"pmc\">PMC7810901</ArticleId><ArticleId IdType=\"pubmed\">33452414</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohda C., Urano T., Umezaki M., Nemere I., Kuboyama T. Diosgenin is an exogenous activator of 1,25D3-MARRS/Pdia3/ERp57 and improves Alzheimer&#x2019;s disease pathologies in 5XFAD mice. Sci. Rep. 2012;2:535. doi: 10.1038/srep00535.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/srep00535</ArticleId><ArticleId IdType=\"pmc\">PMC3405293</ArticleId><ArticleId IdType=\"pubmed\">22837815</ArticleId></ArticleIdList></Reference><Reference><Citation>Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer&#x2019;s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409&#x2013;421. doi: 10.1016/S0896-6273(03)00434-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0896-6273(03)00434-3</ArticleId><ArticleId IdType=\"pubmed\">12895417</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings L.M., Oddo S., Green K.N., McGaugh J.L., LaFerla F.M. Intraneuronal Abeta causes the onset of early Alzheimer&#x2019;s disease-related cognitive deficits in transgenic mice. Neuron. 2005;45:675&#x2013;688. doi: 10.1016/j.neuron.2005.01.040.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2005.01.040</ArticleId><ArticleId IdType=\"pubmed\">15748844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekiyo T., Cirrito J.R., Liu C.C., Shinohara M., Li J., Schuler D.R., Shinohara M., Holtzman D.M., Bu G. Neuronal clearance of amyloid-&#x3b2; by endocytic receptor LRP1. J. Neurosci. 2013;33:19276&#x2013;19283. doi: 10.1523/JNEUROSCI.3487-13.2013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.3487-13.2013</ArticleId><ArticleId IdType=\"pmc\">PMC3850043</ArticleId><ArticleId IdType=\"pubmed\">24305823</ArticleId></ArticleIdList></Reference><Reference><Citation>Citron M., Diehl T.S., Gordon G., Biere A.L., Seubert P., Selkoe D.J. Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA. 1996;93:13170&#x2013;13175. doi: 10.1073/pnas.93.23.13170.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.93.23.13170</ArticleId><ArticleId IdType=\"pmc\">PMC24065</ArticleId><ArticleId IdType=\"pubmed\">8917563</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer T.A. N-Truncated A&#x3b2; Starting at Position Four-Biochemical Features, Preclinical Models, and Potential as Drug Target in Alzheimer&#x2019;s Disease. Front. Aging Neurosci. 2021;13:710579. doi: 10.3389/fnagi.2021.710579.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2021.710579</ArticleId><ArticleId IdType=\"pmc\">PMC8417877</ArticleId><ArticleId IdType=\"pubmed\">34489680</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirths O., Zampar S., Weggen S. N-Terminally Truncated A&#x3b2; Peptide Variants in Alzheimer&#x2019;s Disease. In: Wisniewski T., editor. Alzheimer&#x2019;s Disease [Internet] Codon Publications; Brisbane, Australia: 2019. Chapter 7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15586/alzheimersdisease.2019.ch7</ArticleId><ArticleId IdType=\"pubmed\">31895514</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyckaerts C., Dickson D.W. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. 2nd ed. Wiley-Blackwell; Hoboken, NJ, USA: 2011. pp. 62&#x2013;68.</Citation></Reference><Reference><Citation>Bernstein S.L., Dupuis N.F., Lazo N.D., Wyttenbach T., Condron M.M., Bitan G., Teplow D.B., Shea J.-E., Ruotolo T., Robinson C.V., et al. Amyloid-&#x3b2; protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer&#x2019;s disease. Nat. Chem. 2009;1:326&#x2013;331. doi: 10.1038/nchem.247.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nchem.247</ArticleId><ArticleId IdType=\"pmc\">PMC2918915</ArticleId><ArticleId IdType=\"pubmed\">20703363</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunther E.C., Strittmatter S.M. Beta-amyloid oligomers and cellular prion protein in Alzheimer&#x2019;s disease. J. Mol. Med. 2009;88:331&#x2013;338. doi: 10.1007/s00109-009-0568-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00109-009-0568-7</ArticleId><ArticleId IdType=\"pmc\">PMC2846635</ArticleId><ArticleId IdType=\"pubmed\">19960174</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokota O., Terada S., Ishizu H., Ujike H., Ishihara T., Nakashima H., Yasuda M., Kitamura Y., U&#xe9;da K., Checler F., et al. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer&#x2019;s disease with the E184D presenilin-1 mutation: A clinicopathological study of two autopsy cases. Acta Neuropathol. 2002;104:637&#x2013;648. doi: 10.1007/s00401-002-0596-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-002-0596-7</ArticleId><ArticleId IdType=\"pubmed\">12410385</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer&#x2019;s amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 2007;8:101&#x2013;112. doi: 10.1038/nrm2101.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrm2101</ArticleId><ArticleId IdType=\"pubmed\">17245412</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535&#x2013;539. doi: 10.1038/416535a.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/416535a</ArticleId><ArticleId IdType=\"pubmed\">11932745</ArticleId></ArticleIdList></Reference><Reference><Citation>Candelise N., Scaricamazza S., Salvatori I., Ferri A., Valle C., Manganelli V., Garofalo T., Sorice M., Misasi R. Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications. Int. J. Mol. Sci. 2021;22:6016. doi: 10.3390/ijms22116016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22116016</ArticleId><ArticleId IdType=\"pmc\">PMC8199687</ArticleId><ArticleId IdType=\"pubmed\">34199513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallaberry C.A., Voss B.J., Majewski J., Biernat J., Mandelkow E., Chi E.Y., Vander Zanden C.M. Tau and Membranes: Interactions That Promote Folding and Condensation. Front. Cell Dev. Biol. 2021;9:725241. doi: 10.3389/fcell.2021.725241.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2021.725241</ArticleId><ArticleId IdType=\"pmc\">PMC8491580</ArticleId><ArticleId IdType=\"pubmed\">34621743</ArticleId></ArticleIdList></Reference><Reference><Citation>Narita M., Holtzman D.M., Schwartz A.L., Bu G. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 1997;69:1904&#x2013;1911. doi: 10.1046/j.1471-4159.1997.69051904.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1046/j.1471-4159.1997.69051904.x</ArticleId><ArticleId IdType=\"pubmed\">9349534</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinohara M., Tachibana M., Kanekiyo T., Bu G. Role of LRP1 in the pathogenesis of Alzheimer&#x2019;s disease: Evidence from clinical and preclinical studies. J. Lipid Res. 2017;58:1267&#x2013;1281. doi: 10.1194/jlr.R075796.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1194/jlr.R075796</ArticleId><ArticleId IdType=\"pmc\">PMC5496044</ArticleId><ArticleId IdType=\"pubmed\">28381441</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer&#x2019;s disease: Allelic variation and receptor interactions. Neuron. 1993;11:575&#x2013;580. doi: 10.1016/0896-6273(93)90070-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0896-6273(93)90070-8</ArticleId><ArticleId IdType=\"pubmed\">8398148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ar&#xe9;lin K., Kinoshita A., Whelan C.M., Irizarry M.C., Rebeck G.W., Strickland D.K., Hyman B.T. LRP and senile plaques in Alzheimer&#x2019;s disease: Colocalization with apolipoprotein E and with activated astrocytes. Brain Res. Mol. Brain Res. 2002;15:38&#x2013;46. doi: 10.1016/S0169-328X(02)00203-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0169-328X(02)00203-6</ArticleId><ArticleId IdType=\"pubmed\">12117549</ArticleId></ArticleIdList></Reference><Reference><Citation>Akram A., Schmeidler J., Katsel P., Hof P.R., Haroutunian V. Association of ApoE and LRP mRNA levels with dementia and AD neuropathology. Neurobiol. Aging. 2012;33:628.e1&#x2013;628.e14. doi: 10.1016/j.neurobiolaging.2011.04.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2011.04.010</ArticleId><ArticleId IdType=\"pmc\">PMC3234309</ArticleId><ArticleId IdType=\"pubmed\">21676498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D.E., Pietrzik C.U., Baum L., Chevallier N., Merriam D.E., Kounnas M.Z., Wagner S.L., Troncoso J.C., Kawas C.H., Katzman R., et al. Modulation of amyloid beta-protein clearance and Alzheimer&#x2019;s disease susceptibility by the LDL receptor-related protein pathway. J. Clin. Investig. 2000;106:1159&#x2013;1166. doi: 10.1172/JCI11013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI11013</ArticleId><ArticleId IdType=\"pmc\">PMC301422</ArticleId><ArticleId IdType=\"pubmed\">11067868</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva M.C., Haggarty S.J. Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies. Int. J. Mol. Sci. 2020;21:8948. doi: 10.3390/ijms21238948.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21238948</ArticleId><ArticleId IdType=\"pmc\">PMC7728099</ArticleId><ArticleId IdType=\"pubmed\">33255694</ArticleId></ArticleIdList></Reference><Reference><Citation>Hori T., Eguchi K., Wang H.Y., Miyasaka T., Guillaud L., Taoufiq Z., Mahapatra S., Yamada H., Takei K., Takahashi T. Microtubule assembly by tau impairs endocytosis and neurotransmission via dynamin sequestration in Alzheimer&#x2019;s disease synapse model. eLife. 2022;11:e73542. doi: 10.7554/eLife.73542.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7554/eLife.73542</ArticleId><ArticleId IdType=\"pmc\">PMC9071263</ArticleId><ArticleId IdType=\"pubmed\">35471147</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T., Noble W., Hanger D.P. Roles of tau protein in health and disease. Acta Neuropathol. 2017;133:665&#x2013;704. doi: 10.1007/s00401-017-1707-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-017-1707-9</ArticleId><ArticleId IdType=\"pmc\">PMC5390006</ArticleId><ArticleId IdType=\"pubmed\">28386764</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovska N., Matej R., Olejar T. Extracellular Prion Protein Aggregates in Nine Gerstmann-Str&#xe4;ussler-Scheinker Syndrome Subjects with Mutation P102L: A Micromorphological Study and Comparison with Literature Data. Int. J. Mol Sci. 2021;22:13303. doi: 10.3390/ijms222413303.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms222413303</ArticleId><ArticleId IdType=\"pmc\">PMC8704598</ArticleId><ArticleId IdType=\"pubmed\">34948096</ArticleId></ArticleIdList></Reference><Reference><Citation>Risacher S.L., Farlow M.R., Bateman D.R., Epperson F., Tallman E.F., Richardson R., Murrell J.R., Unverzagt F.W., Apostolova L.G., Bonnin J.M., et al. Detection of tau in Gerstmann-Str&#xe4;ussler-Scheinker disease (PRNP F198S) by [18F]Flortaucipir PET. Acta Neuropathol. Commun. 2018;6:114. doi: 10.1186/s40478-018-0608-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-018-0608-z</ArticleId><ArticleId IdType=\"pmc\">PMC6205777</ArticleId><ArticleId IdType=\"pubmed\">30373672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mabrouk R., Gotkiewicz M., Rauramaa T., Tanila H. DAPI (4&#x2019;.;6-diamidino-2-phenylindole) Stains Compact Amyloid Plaques. J. Alzheimer&#x2019;s Dis. 2022;88:949&#x2013;955. doi: 10.3233/JAD-220072.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-220072</ArticleId><ArticleId IdType=\"pubmed\">35754268</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273625</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>A Novel Rare PSEN2 Val226Ala in PSEN2 in a Korean Patient with Atypical Alzheimer's Disease, and the Importance of PSEN2 5th Transmembrane Domain (TM5) in AD Pathogenesis.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9678</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179678</ELocationID><Abstract><AbstractText>In this manuscript, a novel presenilin-2 (PSEN2) mutation, Val226Ala, was found in a 59-year-old Korean patient who exhibited rapid progressive memory dysfunction and hallucinations six months prior to her first visit to the hospital. Her Magnetic Resonance Imaging (MRI) showed brain atrophy, and both amyloid positron emission tomography (PET) and multimer detection system-oligomeric amyloid-beta (A&#x3b2;) results were positive. The patient was diagnosed with early onset Alzheimer's disease. The whole-exome analysis revealed a new PSEN2 Val226Ala mutation with heterozygosity in the 5th transmembrane domain of the PSEN2 protein near the lumen region. Analyses of the structural prediction suggested structural changes in the helix, specifically a loss of a hydrogen bond between Val226 and Gln229, which may lead to elevated helix motion. Multiple PSEN2 mutations were reported in PSEN2 transmembrane-5 (TM5), such as Tyr231Cys, Ile235Phe, Ala237Val, Leu238Phe, Leu238Pro, and Met239Thr, highlighting the dynamic importance of the 5th transmembrane domain of PSEN2. Mutations in TM5 may alter the access tunnel of the A&#x3b2; substrate in the membrane to the gamma-secretase active site, indicating a possible influence on enzyme function that increases A&#x3b2; production. Interestingly, the current patient with the Val226Ala mutation presented with a combination of hallucinations and memory dysfunction. Although the causal mechanisms of hallucinations in AD remain unclear, it is possible that PSEN2 interacts with other disease risk factors, including Notch Receptor 3 (NOTCH3) or Glucosylceramidase Beta-1 (GBA) variants, enhancing the occurrence of hallucinations. In conclusion, the direct or indirect role of PSEN2 Val226Ala in AD onset cannot be ruled out.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>YoungSoon</ForeName><Initials>Y</Initials><Identifier Source=\"ORCID\">0000-0002-2448-2599</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan 31151, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bagyinszky</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Industrial and Environmental Engineering, Gachon University Graduate School of Environment, Gachon University, Seongnam-si 13120, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>An</LastName><ForeName>Seong Soo A</ForeName><Initials>SSA</Initials><Identifier Source=\"ORCID\">0000-0002-8123-6183</Identifier><AffiliationInfo><Affiliation>Department of Bionano Technology, Gachon Medical Research Institute, College of Bionano Technology, Gachon University, Seongnam-si 13120, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D002363\">Case Reports</PublicationType><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D053766\">Presenilin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C508861\">PSEN2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D053766\" MajorTopicYN=\"Y\">Presenilin-2</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D056910\" MajorTopicYN=\"N\" Type=\"Geographic\">Republic of Korea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000072417\" MajorTopicYN=\"N\">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009154\" MajorTopicYN=\"N\">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008279\" MajorTopicYN=\"N\">Magnetic Resonance Imaging</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">PSEN2 TM5</Keyword><Keyword MajorTopicYN=\"N\">hallucination</Keyword><Keyword MajorTopicYN=\"N\">mutation</Keyword><Keyword MajorTopicYN=\"N\">presenilin-2</Keyword><Keyword MajorTopicYN=\"N\">structure prediction</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273625</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179678</ArticleId><ArticleId IdType=\"pii\">ijms25179678</ArticleId><ArticleId IdType=\"pmc\">PMC11395454</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>De Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., Moechars D., Bollen M., Fraser P., George-Hyslop P.S., et al. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer&#x2019;s disease-associated presenilins. J. Biol. Chem. 1997;272:3590&#x2013;3598. doi: 10.1074/jbc.272.6.3590.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.272.6.3590</ArticleId><ArticleId IdType=\"pubmed\">9013610</ArticleId></ArticleIdList></Reference><Reference><Citation>Rademakers R., Cruts M., Van Broeckhoven C. Genetics of early-onset Alzheimer dementia. Sci. World J. 2003;3:497&#x2013;519. doi: 10.1100/tsw.2003.39.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1100/tsw.2003.39</ArticleId><ArticleId IdType=\"pmc\">PMC5974891</ArticleId><ArticleId IdType=\"pubmed\">12847300</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y., An S.S., Kim S. Mutations in presenilin 2 and its implications in Alzheimer&#x2019;s disease and other dementia-associated disorders. Clin. Interv. Aging. 2015;10:1163&#x2013;1172. doi: 10.2147/CIA.S85808.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/CIA.S85808</ArticleId><ArticleId IdType=\"pmc\">PMC4507455</ArticleId><ArticleId IdType=\"pubmed\">26203236</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjhussein H., Gardner L.A., Fujii N., Anderson N.M., Bahouth S.W. The hydrophobic amino acid cluster at the cytoplasmic end of transmembrane helix III modulates the coupling of the &#x3b2;(1)-adrenergic receptor to G(s) J. Recept. Signal Transduct. 2013;33:79&#x2013;88. doi: 10.3109/10799893.2012.759590.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/10799893.2012.759590</ArticleId><ArticleId IdType=\"pubmed\">23351074</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marothy M.T., Elofsson A. Marginally hydrophobic transmembrane &#x3b1;-helices shaping membrane protein folding. Protein Sci. 2015;24:1057&#x2013;1074. doi: 10.1002/pro.2698.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/pro.2698</ArticleId><ArticleId IdType=\"pmc\">PMC4500307</ArticleId><ArticleId IdType=\"pubmed\">25970811</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyden M., Freites J.A., Ulmschneider M.B., White S.H., Tobias D.J. Assembly and Stability of &#x3b1;-Helical Membrane Proteins. Soft Matter. 2012;8:7742&#x2013;7752. doi: 10.1039/c2sm25402f.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/c2sm25402f</ArticleId><ArticleId IdType=\"pmc\">PMC3500387</ArticleId><ArticleId IdType=\"pubmed\">23166562</ArticleId></ArticleIdList></Reference><Reference><Citation>Finckh U., Alberici A., Antoniazzi M., Benussi L., Fedi V., Giannini C., Gal A., Nitsch R.M., Binetti G. Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I. Neurology. 2000;54:2006&#x2013;2008. doi: 10.1212/WNL.54.10.2006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.54.10.2006</ArticleId><ArticleId IdType=\"pubmed\">10822446</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong L., Liu C., Sha L., Mao C., Li J., Huang X., Wang J., Chu S., Peng B., Cui L., et al. PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer&#x2019;s Disease: Data from PUMCH Dementia Cohort. J. Alzheimers Dis. 2022;87:1549&#x2013;1556. doi: 10.3233/JAD-220194.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-220194</ArticleId><ArticleId IdType=\"pmc\">PMC9277672</ArticleId><ArticleId IdType=\"pubmed\">35491795</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone F., Bjerke M., Hens E., Sieben A., Timmers M., De Roeck A., Vandenberghe R., Sleegers K., Martin J.J., De Deyn P.P., et al. Amyloid-&#x3b2;1-43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations. Alzheimers Res. Ther. 2020;12:108. doi: 10.1186/s13195-020-00676-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-020-00676-5</ArticleId><ArticleId IdType=\"pmc\">PMC7488767</ArticleId><ArticleId IdType=\"pubmed\">32917274</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertekin-Taner N., Younkin L.H., Yager D.M., Parfitt F., Baker M.C., Asthana S., Hutton M.L., Younkin S.G., Graff-Radford N.R. Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families. Neurology. 2008;70:596&#x2013;606. doi: 10.1212/01.wnl.0000278386.00035.21.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/01.wnl.0000278386.00035.21</ArticleId><ArticleId IdType=\"pubmed\">17914065</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., et al. Candidate gene for the chromosome 1 familial Alzheimer&#x2019;s disease locus. Science. 1995;269:973&#x2013;977. doi: 10.1126/science.7638622.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.7638622</ArticleId><ArticleId IdType=\"pubmed\">7638622</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu F., Yu S., Zhang Z., Yi X., Ye L., Tang W., Qiu C., Wen H., Sun Y., Gao J., et al. Novel mutation in the PSEN2 gene (N141Y) associated with early-onset autosomal dominant Alzheimer&#x2019;s disease in a Chinese Han family. Neurobiol. Aging. 2014;35:2420-e1. doi: 10.1016/j.neurobiolaging.2014.04.011. Erratum in: Neurobiol. Aging 2014, 35, 2885.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2014.04.011</ArticleId><ArticleId IdType=\"pubmed\">24838186</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., et al. Familial Alzheimer&#x2019;s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer&#x2019;s disease type 3 gene. Nature. 1995;376:775&#x2013;778. doi: 10.1038/376775a0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/376775a0</ArticleId><ArticleId IdType=\"pubmed\">7651536</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Xiao X., Wang J., Shen L., Jiao B. Early-onset familial Alzheimer&#x2019;s disease in a family with mutation of presenilin 2 gene. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46:189&#x2013;194. doi: 10.11817/j.issn.1672-7347.2021.190616. (In English, Chinese)</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.11817/j.issn.1672-7347.2021.190616</ArticleId><ArticleId IdType=\"pmc\">PMC10929775</ArticleId><ArticleId IdType=\"pubmed\">33678657</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruchaga C., Haller G., Chakraverty S., Mayo K., Vallania F.L., Mitra R.D., Faber K., Williamson J., Bird T., Diaz-Arrastia R., et al. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer&#x2019;s disease families. PLoS ONE. 2012;7:e31039. doi: 10.1371/annotation/c92e16da-7733-421d-b063-1db19488daa6. Erratum in PLoS ONE 2012, 7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/annotation/c92e16da-7733-421d-b063-1db19488daa6</ArticleId><ArticleId IdType=\"pmc\">PMC3270040</ArticleId><ArticleId IdType=\"pubmed\">22312439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauwe J.S., Jacquart S., Chakraverty S., Wang J., Mayo K., Fagan A.M., Holtzman D.M., Morris J.C., Goate A.M. Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer&#x2019;s disease presenilin 1 mutation. Ann. Neurol. 2007;61:446&#x2013;453. doi: 10.1002/ana.21099.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.21099</ArticleId><ArticleId IdType=\"pubmed\">17366635</ArticleId></ArticleIdList></Reference><Reference><Citation>Koriath C., Kenny J., Adamson G., Druyeh R., Taylor W., Beck J., Quinn L., Mok T.H., Dimitriadis A., Norsworthy P., et al. Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series. Mol. Psychiatry. 2020;25:3399&#x2013;3412. doi: 10.1038/s41380-018-0224-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41380-018-0224-0</ArticleId><ArticleId IdType=\"pmc\">PMC6330090</ArticleId><ArticleId IdType=\"pubmed\">30279455</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcon G., Di Fede G., Giaccone G., Rossi G., Giovagnoli A.R., Maccagnano E., Tagliavini F. A novel Italian presenilin 2 gene mutation with prevalent behavioral phenotype. J. Alzheimers Dis. 2009;16:3&#x2013;11. doi: 10.3233/JAD-2009-0986.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-2009-0986</ArticleId><ArticleId IdType=\"pubmed\">19276543</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeus B., Verstraeten A., Crosiers D., Engelborghs S., Van den Broeck M., Mattheijssens M., Peeters K., Corsmit E., Elinck E., Pickut B., et al. DLB and PDD: A role for mutations in dementia and Parkinson disease genes? Neurobiol. Aging. 2012;33:629.e5&#x2013;629.e18. doi: 10.1016/j.neurobiolaging.2011.10.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2011.10.014</ArticleId><ArticleId IdType=\"pubmed\">22118943</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Parks S.B., Kushner J.D., Nauman D., Burgess D., Ludwigsen S., Partain J., Nixon R.R., Allen C.N., Irwin R.P., et al. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am. J. Hum. Genet. 2006;79:1030&#x2013;1039. doi: 10.1086/509900.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1086/509900</ArticleId><ArticleId IdType=\"pmc\">PMC1698711</ArticleId><ArticleId IdType=\"pubmed\">17186461</ArticleId></ArticleIdList></Reference><Reference><Citation>To M.D., Gokgoz N., Doyle T.G., Donoviel D.B., Knight J.A., Hyslop P.S., Bernstein A., Andrulis I.L. Functional characterization of novel presenilin-2 variants identified in human breast cancers. Oncogene. 2006;25:3557&#x2013;3564. doi: 10.1038/sj.onc.1209397.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.onc.1209397</ArticleId><ArticleId IdType=\"pubmed\">16474849</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedeli C., Filadi R., Rossi A., Mammucari C., Pizzo P. PSEN2 (presenilin 2) mutants linked to familial Alzheimer disease impair autophagy by altering Ca2+ homeostasis. Autophagy. 2019;15:2044&#x2013;2062. doi: 10.1080/15548627.2019.1596489.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/15548627.2019.1596489</ArticleId><ArticleId IdType=\"pmc\">PMC6844518</ArticleId><ArticleId IdType=\"pubmed\">30892128</ArticleId></ArticleIdList></Reference><Reference><Citation>Azimi M., Le T.T., Brown N.L. Presenilin gene function and Notch signaling feedback regulation in the developing mouse lens. Differentiation. 2018;102:40&#x2013;52. doi: 10.1016/j.diff.2018.07.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.diff.2018.07.003</ArticleId><ArticleId IdType=\"pmc\">PMC6089524</ArticleId><ArticleId IdType=\"pubmed\">30059908</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.N., Lee M.S., Hwang D.Y., Kim Y.K., Yoon D.Y., Lee J.W., Yun Y.P., Lee M.K., Oh K.W., Hong J.T. Mutant presenilin 2 increased oxidative stress and p53 expression in neuronal cells. Biochem. Biophys. Res. Commun. 2007;357:174&#x2013;180. doi: 10.1016/j.bbrc.2007.03.119.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2007.03.119</ArticleId><ArticleId IdType=\"pubmed\">17418105</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker E.S., Martinez M., Brunkan A.L., Goate A. Presenilin 2 familial Alzheimer&#x2019;s disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios. J. Neurochem. 2005;92:294&#x2013;301. doi: 10.1111/j.1471-4159.2004.02858.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1471-4159.2004.02858.x</ArticleId><ArticleId IdType=\"pubmed\">15663477</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.M., Kang D.W., Um Y.H., Kim S., Lee C.U., Scheltens P., Lim H.K. Plasma Oligomer &#x3b2;-Amyloid and White Matter Microstructural Integrity in Cognitively Normal Older Adults According to Cerebral Amyloid Deposition. J. Prev. Alzheimers Dis. 2023;10:837&#x2013;846. doi: 10.14283/jpad.2023.87.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14283/jpad.2023.87</ArticleId><ArticleId IdType=\"pubmed\">37874106</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez J.C., Yu J.R.T., De Guzman M.F., Ampil E., Guevarra A.C., Joson M.L., Reandelar M., Jr., Martinez M.S., Ligsay A., Ocampo F., et al. Multimer Detection System-Oligomerized Amyloid Beta (MDS-OA&#x3b2;): A Plasma-Based Biomarker Differentiates Alzheimer&#x2019;s Disease from Other Etiologies of Dementia. Int. J. Alzheimers Dis. 2022;2022:9960832. doi: 10.1155/2022/9960832.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2022/9960832</ArticleId><ArticleId IdType=\"pmc\">PMC9085320</ArticleId><ArticleId IdType=\"pubmed\">35547155</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyun J.M., Ryu J.S., Lee R., Shim K.H., Youn Y.C., Ryoo N., Han S.W., Park Y.H., Kang S., An S.S.A., et al. Plasma Amyloid-&#x3b2; Oligomerization Tendency Predicts Amyloid PET Positivity. Clin. Interv. Aging. 2021;16:749&#x2013;755. doi: 10.2147/CIA.S312473.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/CIA.S312473</ArticleId><ArticleId IdType=\"pmc\">PMC8096417</ArticleId><ArticleId IdType=\"pubmed\">33958861</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim K.H., Kim D., Kang M.J., Pyun J.M., Park Y.H., Youn Y.C., Park K.W., Suk K., Lee H.W., Gomes B.F., et al. Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer&#x2019;s disease. Alzheimers Dement. 2024;20:2731&#x2013;2741. doi: 10.1002/alz.13734.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13734</ArticleId><ArticleId IdType=\"pmc\">PMC11032549</ArticleId><ArticleId IdType=\"pubmed\">38411315</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirdita M., Sch&#xfc;tze K., Moriwaki Y., Heo L., Ovchinnikov S., Steinegger M. ColabFold: Making protein folding accessible to all. Nat. Methods. 2022;19:679&#x2013;682. doi: 10.1038/s41592-022-01488-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41592-022-01488-1</ArticleId><ArticleId IdType=\"pmc\">PMC9184281</ArticleId><ArticleId IdType=\"pubmed\">35637307</ArticleId></ArticleIdList></Reference><Reference><Citation>Zekanowski C., Styczy&#x144;ska M., Pep&#x142;o&#x144;ska B., Gabryelewicz T., Religa D., Ilkowski J., Kijanowska-Ha&#x142;adyna B., Kotapka-Minc S., Mikkelsen S., Pfeffer A., et al. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer&#x2019;s disease in Poland. Exp. Neurol. 2003;184:991&#x2013;996. doi: 10.1016/S0014-4886(03)00384-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0014-4886(03)00384-4</ArticleId><ArticleId IdType=\"pubmed\">14769392</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.H., Kahn A., Cheng R., Reitz C., Vardarajan B., Lantigua R., Medrano M., Jim&#xe9;nez-Vel&#xe1;zquez I.Z., Williamson J., Nagy P., et al. Disease-related mutations among Caribbean Hispanics with familial dementia. Mol. Genet. Genom. Med. 2014;2:430&#x2013;437. doi: 10.1002/mgg3.85.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mgg3.85</ArticleId><ArticleId IdType=\"pmc\">PMC4190878</ArticleId><ArticleId IdType=\"pubmed\">25333068</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu S., Pimenova A.A., Hayes K., Villa J.A., Rosene M.J., Jere M., Goate A.M., Karch C.M. Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2. Neurobiol. Dis. 2020;139:104817. doi: 10.1016/j.nbd.2020.104817.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2020.104817</ArticleId><ArticleId IdType=\"pmc\">PMC7236786</ArticleId><ArticleId IdType=\"pubmed\">32087291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sassi C., Guerreiro R., Gibbs R., Ding J., Lupton M.K., Troakes C., Al-Sarraj S., Niblock M., Gallo J.M., Adnan J., et al. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer&#x2019;s disease. Neurobiol. Aging. 2014;35:2881.e1&#x2013;2881.e6. doi: 10.1016/j.neurobiolaging.2014.06.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2014.06.002</ArticleId><ArticleId IdType=\"pmc\">PMC4236585</ArticleId><ArticleId IdType=\"pubmed\">25104557</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala Frigerio C., Lau P., Troakes C., Deramecourt V., Gele P., Van Loo P., Voet T., De Strooper B. On the identification of low allele frequency mosaic mutations in the brains of Alzheimer&#x2019;s disease patients. Alzheimers Dement. 2015;11:1265&#x2013;1276. doi: 10.1016/j.jalz.2015.02.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2015.02.007</ArticleId><ArticleId IdType=\"pubmed\">25937274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright C.A., Taylor J.W., Cochran M., Lawlor J.M.J., Moyers B.A., Amaral M.D., Bonnstetter Z.T., Carter P., Solomon V., Myers R.M., et al. Contributions of rare and common variation to early-onset and atypical dementia risk. Mol. Case Stud. 2023;9:a006271. doi: 10.1101/mcs.a006271.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/mcs.a006271</ArticleId><ArticleId IdType=\"pmc\">PMC10393188</ArticleId><ArticleId IdType=\"pubmed\">37308299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Scalici A., Wang Y., Lin H., Pitsillides A., Heard-Costa N., Cruchaga C., Ziegemeier E., Bis J.C., Fornage M., et al. Frequency of Variants in Mendelian Alzheimer&#x2019;s Disease Genes within the Alzheimer&#x2019;s Disease Sequencing Project (ADSP) medRxiv. 2024. preprint .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2023.10.24.23297227</ArticleId><ArticleId IdType=\"pmc\">PMC10635182</ArticleId><ArticleId IdType=\"pubmed\">37961373</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu S., Gordon B.A., Hornbeck R., Norton J.B., Levitch D., Louden A., Ziegemeier E., Laforce R., Jr., Chhatwal J., Day G.S., et al. Karch CM. Discovery and validation of autosomal dominant Alzheimer&#x2019;s disease mutations. Alzheimers Res. Ther. 2018;10:67. doi: 10.1186/s13195-018-0392-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-018-0392-9</ArticleId><ArticleId IdType=\"pmc\">PMC6052673</ArticleId><ArticleId IdType=\"pubmed\">30021643</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauwendraat C., Wilke C., Jansen I.E., Schulte C., Sim&#xf3;n-S&#xe1;nchez J., Metzger F.G., Bender B., Gasser T., Maetzler W., Rizzu P., et al. Pilot whole-exome sequencing of a German early-onset Alzheimer&#x2019;s disease cohort reveals a substantial frequency of PSEN2 variants. Neurobiol. Aging. 2016;37:208.e11&#x2013;208.e17. doi: 10.1016/j.neurobiolaging.2015.09.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2015.09.016</ArticleId><ArticleId IdType=\"pubmed\">26522186</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez M.V., Kim J.H., Budde J.P., Black K., Medvedeva A., Saef B., Deming Y., Del-Aguila J., Iba&#xf1;ez L., Dube U., et al. Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease. PLoS Genet. 2017;13:e1007045. doi: 10.1371/journal.pgen.1007045.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pgen.1007045</ArticleId><ArticleId IdType=\"pmc\">PMC5683650</ArticleId><ArticleId IdType=\"pubmed\">29091718</ArticleId></ArticleIdList></Reference><Reference><Citation>Testi S., Fabrizi G.M., Pompanin S., Cagnin A. Autosomal dominant Alzheimer&#x2019;s disease with early frontal lobe involvement associated with the Met239Ile mutation of Presenilin 2 gene. J. Alzheimers Dis. 2012;31:1&#x2013;11. doi: 10.3233/JAD-2012-120280.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-2012-120280</ArticleId><ArticleId IdType=\"pubmed\">22531416</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremolizzo L., Susani E., Mapelli C., Isella V., Bertola F., Ferrarese C., Appollonio I. First report of PSEN2 mutation presenting as posterior cortical atrophy. Alzheimer Dis. Assoc. Disord. 2015;29:249&#x2013;251. doi: 10.1097/WAD.0000000000000052.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/WAD.0000000000000052</ArticleId><ArticleId IdType=\"pubmed\">25010293</ArticleId></ArticleIdList></Reference><Reference><Citation>Llibre-Guerra J.J., Li Y., Allegri R.F., Mendez P.C., Surace E.I., Llibre-Rodriguez J.J., Sosa A.L., Al&#xe1;ez-Verson C., Longoria E.M., Tellez A., et al. Dominantly inherited Alzheimer&#x2019;s disease in Latin America: Genetic heterogeneity and clinical phenotypes. Alzheimers Dement. 2021;17:653&#x2013;664. doi: 10.1002/alz.12227.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.12227</ArticleId><ArticleId IdType=\"pmc\">PMC8140610</ArticleId><ArticleId IdType=\"pubmed\">33226734</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao B., Liu H., Guo L., Xiao X., Liao X., Zhou Y., Weng L., Zhou L., Wang X., Jiang Y., et al. The role of genetics in neurodegenerative dementia: A large cohort study in South China. npj Genom. Med. 2021;6:69. doi: 10.1038/s41525-021-00235-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41525-021-00235-3</ArticleId><ArticleId IdType=\"pmc\">PMC8363644</ArticleId><ArticleId IdType=\"pubmed\">34389718</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X.Y., Cui Y., Jing D., Xie K., Zhong X., Kong Y., Wang Y., Chu M., Wang C., Wu L. Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy. Alzheimer Dis. Assoc. Disord. 2021;35:208&#x2013;213. doi: 10.1097/WAD.0000000000000438.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/WAD.0000000000000438</ArticleId><ArticleId IdType=\"pmc\">PMC8386585</ArticleId><ArticleId IdType=\"pubmed\">33973882</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao C., Li J., Dong L., Huang X., Lei D., Wang J., Chu S., Liu C., Peng B., Rom&#xe1;n G.C., et al. Clinical Phenotype and Mutation Spectrum of Alzheimer&#x2019;s Disease with Causative Genetic Mutation in a Chinese Cohort. Curr. Alzheimer Res. 2021;18:265&#x2013;272. doi: 10.2174/1567205018666210608120339.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567205018666210608120339</ArticleId><ArticleId IdType=\"pmc\">PMC8506917</ArticleId><ArticleId IdType=\"pubmed\">34102969</ArticleId></ArticleIdList></Reference><Reference><Citation>Zatti G., Burgo A., Giacomello M., Barbiero L., Ghidoni R., Sinigaglia G., Florean C., Bagnoli S., Binetti G., Sorbi S., et al. Presenilin mutations linked to familial Alzheimer&#x2019;s disease reduce endoplasmic reticulum and Golgi apparatus calcium levels. Cell Calcium. 2006;39:539&#x2013;550. doi: 10.1016/j.ceca.2006.03.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ceca.2006.03.002</ArticleId><ArticleId IdType=\"pubmed\">16620965</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallon D., Rousseau S., Rovelet-Lecrux A., Quillard-Muraine M., Guyant-Mar&#xe9;chal L., Martinaud O., Pariente J., Puel M., Rollin-Sillaire A., Pasquier F., et al. The French series of autosomal dominant early onset Alzheimer&#x2019;s disease cases: Mutation spectrum and cerebrospinal fluid biomarkers. J. Alzheimers Dis. 2012;30:847&#x2013;856. doi: 10.3233/JAD-2012-120172.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-2012-120172</ArticleId><ArticleId IdType=\"pubmed\">22475797</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas G., Wallon D., Charbonnier C., Quenez O., Rousseau S., Richard A.C., Rovelet-Lecrux A., Coutant S., Le Guennec K., Bacq D., et al. Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: Input and lessons. Eur. J. Hum. Genet. 2016;24:710&#x2013;716. doi: 10.1038/ejhg.2015.173.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ejhg.2015.173</ArticleId><ArticleId IdType=\"pmc\">PMC4930083</ArticleId><ArticleId IdType=\"pubmed\">26242991</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe N., Tomita T., Sato C., Kitamura T., Morohashi Y., Iwatsubo T. Pen-2 is incorporated into the gamma-secretase complex through binding to transmembrane domain 4 of presenilin 1. J. Biol. Chem. 2005;280:41967&#x2013;41975. doi: 10.1074/jbc.M509066200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M509066200</ArticleId><ArticleId IdType=\"pubmed\">16234244</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoltowska K.M., Berezovska O. Dynamic Nature of presenilin1/&#x3b3;-Secretase: Implication for Alzheimer&#x2019;s Disease Pathogenesis. Mol. Neurobiol. 2018;55:2275&#x2013;2284. doi: 10.1007/s12035-017-0487-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-017-0487-5</ArticleId><ArticleId IdType=\"pmc\">PMC5610083</ArticleId><ArticleId IdType=\"pubmed\">28332150</ArticleId></ArticleIdList></Reference><Reference><Citation>Colijn M.A., Ismail Z. Presenilin Gene Mutation-associated Psychosis: Phenotypic Characteristics and Clinical Implications. Alzheimer Dis. Assoc. Disord. 2024;38:101&#x2013;106. doi: 10.1097/WAD.0000000000000599.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/WAD.0000000000000599</ArticleId><ArticleId IdType=\"pubmed\">38227890</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayadev S., Leverenz J.B., Steinbart E., Stahl J., Klunk W., Yu C.E., Bird T.D. Alzheimer&#x2019;s disease phenotypes and genotypes associated with mutations in presenilin 2. Pt 4Brain. 2010;133:1143&#x2013;1154. doi: 10.1093/brain/awq033.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awq033</ArticleId><ArticleId IdType=\"pmc\">PMC2850581</ArticleId><ArticleId IdType=\"pubmed\">20375137</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaino C., Bernardi L., Anfossi M., Costanzo A., Ferrise F., Gallo M., Geracitano S., Maletta R., Curcio S.A., Mirabelli M., et al. Presenilin 2 Ser130Leu mutation in a case of late-onset &#x201c;sporadic&#x201d; Alzheimer&#x2019;s disease. J. Neurol. 2007;254:391&#x2013;393. doi: 10.1007/s00415-006-0373-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00415-006-0373-y</ArticleId><ArticleId IdType=\"pubmed\">17345043</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.H., Seelaar H., Melhem S., Rozemuller A.J.M., van Swieten J.C. Genetic screening in early-onset Alzheimer&#x2019;s disease identified three novel presenilin mutations. Neurobiol. Aging. 2020;86:201.e9&#x2013;201.e14. doi: 10.1016/j.neurobiolaging.2019.01.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2019.01.015</ArticleId><ArticleId IdType=\"pubmed\">30797548</ArticleId></ArticleIdList></Reference><Reference><Citation>Avramopoulos D., Fallin M.D., Bassett S.S. Linkage to chromosome 14q in Alzheimer&#x2019;s disease (AD) patients without psychotic symptoms. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005;132:9&#x2013;13. doi: 10.1002/ajmg.b.30074.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ajmg.b.30074</ArticleId><ArticleId IdType=\"pubmed\">15389761</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair L.I., Kumar A., Darreh-Shori T., Love S. Visual hallucinations in Alzheimer&#x2019;s disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas. Alzheimers Res. Ther. 2019;11:80. doi: 10.1186/s13195-019-0519-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-019-0519-7</ArticleId><ArticleId IdType=\"pmc\">PMC6740037</ArticleId><ArticleId IdType=\"pubmed\">31511061</ArticleId></ArticleIdList></Reference><Reference><Citation>DeChellis-Marks M.R., Wei Y., Ding Y., Wolfe C.M., Krivinko J.M., MacDonald M.L., Lopez O.L., Sweet R.A., Kofler J. Psychosis in Alzheimer&#x2019;s Disease Is Associated with Increased Excitatory Neuron Vulnerability and Post-transcriptional Mechanisms Altering Synaptic Protein Levels. Front. Neurol. 2022;13:778419. doi: 10.3389/fneur.2022.778419.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2022.778419</ArticleId><ArticleId IdType=\"pmc\">PMC8925864</ArticleId><ArticleId IdType=\"pubmed\">35309563</ArticleId></ArticleIdList></Reference><Reference><Citation>El Haj M., Roche J., Jardri R., Kapogiannis D., Gallouj K., Antoine P. Clinical and neurocognitive aspects of hallucinations in Alzheimer&#x2019;s disease. Neurosci. Biobehav. Rev. 2017;83:713&#x2013;720. doi: 10.1016/j.neubiorev.2017.02.021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2017.02.021</ArticleId><ArticleId IdType=\"pmc\">PMC5565710</ArticleId><ArticleId IdType=\"pubmed\">28235545</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe D.J. Presenilin, Notch, and the genesis and treatment of Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2001;98:11039&#x2013;11041. doi: 10.1073/pnas.211352598.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.211352598</ArticleId><ArticleId IdType=\"pmc\">PMC58679</ArticleId><ArticleId IdType=\"pubmed\">11572965</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida S., Kido J., Matsumoto S., Momosaki K., Mitsubuchi H., Shimazu T., Sugawara K., Endo F., Nakamura K. Prenatal diagnosis of Gaucher disease using next-generation sequencing. Pediatr. Int. 2016;58:946&#x2013;949. doi: 10.1111/ped.13069.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ped.13069</ArticleId><ArticleId IdType=\"pubmed\">27682613</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick B.S., Magalhaes J., Beavan M.S., McNeill A., Gegg M.E., Cleeter M.W., Bloor-Young D., Churchill G.C., Duchen M.R., Schapira A.H., et al. Endoplasmic reticulum and lysosomal Ca2+ stores are remodelled in GBA1-linked Parkinson disease patient fibroblasts. Cell Calcium. 2016;59:12&#x2013;20. doi: 10.1016/j.ceca.2015.11.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ceca.2015.11.002</ArticleId><ArticleId IdType=\"pmc\">PMC4751977</ArticleId><ArticleId IdType=\"pubmed\">26691915</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti B. Wnt/&#x3b2;-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson&#x2019;s Disease. Int. J. Mol. Sci. 2018;19:3743. doi: 10.3390/ijms19123743.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms19123743</ArticleId><ArticleId IdType=\"pmc\">PMC6321180</ArticleId><ArticleId IdType=\"pubmed\">30477246</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonen R.A., van Tijn P., Zivkovic D. Wnt signaling in Alzheimer&#x2019;s disease: Up or down, that is the question. Ageing Res. Rev. 2009;8:71&#x2013;82. doi: 10.1016/j.arr.2008.11.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2008.11.003</ArticleId><ArticleId IdType=\"pubmed\">19101658</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostes W.W., Brafman D.A. The Multifaceted Role of WNT Signaling in Alzheimer&#x2019;s Disease Onset and Age-Related Progression. Cells. 2023;12:1204. doi: 10.3390/cells12081204.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells12081204</ArticleId><ArticleId IdType=\"pmc\">PMC10136584</ArticleId><ArticleId IdType=\"pubmed\">37190113</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzo P., Basso E., Filadi R., Greotti E., Leparulo A., Pendin D., Redolfi N., Rossini M., Vajente N., Pozzan T., et al. Presenilin-2 and Calcium Handling: Molecules, Organelles, Cells and Brain Networks. Cells. 2020;9:2166. doi: 10.3390/cells9102166.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells9102166</ArticleId><ArticleId IdType=\"pmc\">PMC7601421</ArticleId><ArticleId IdType=\"pubmed\">32992716</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi A., Galla L., Gomiero C., Zentilin L., Giacca M., Giorgio V., Cal&#xec; T., Pozzan T., Greotti E., Pizzo P. Calcium Signaling and Mitochondrial Function in Presenilin 2 Knock-Out Mice: Looking for Any Loss-of-Function Phenotype Related to Alzheimer&#x2019;s Disease. Cells. 2021;10:204. doi: 10.3390/cells10020204.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells10020204</ArticleId><ArticleId IdType=\"pmc\">PMC7909802</ArticleId><ArticleId IdType=\"pubmed\">33494218</ArticleId></ArticleIdList></Reference><Reference><Citation>Gegg M.E., Schapira A.H.V. The role of glucocerebrosidase in Parkinson disease pathogenesis. FEBS J. 2018;285:3591&#x2013;3603. doi: 10.1111/febs.14393.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/febs.14393</ArticleId><ArticleId IdType=\"pubmed\">29385658</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohl C.A., Fiori W., Baldwin R.L. Alanine is helix-stabilizing in both template-nucleated and standard peptide helices. Proc. Natl. Acad. Sci. USA. 1999;96:3682&#x2013;3687. doi: 10.1073/pnas.96.7.3682.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.96.7.3682</ArticleId><ArticleId IdType=\"pmc\">PMC22354</ArticleId><ArticleId IdType=\"pubmed\">10097097</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu P.C., Sherman J.C., Chen A., Kallenbach N.R. Alpha-helix stabilization by natural and unnatural amino acids with alkyl side chains. Proc. Natl. Acad. Sci. USA. 1991;88:5317&#x2013;5320. doi: 10.1073/pnas.88.12.5317.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.88.12.5317</ArticleId><ArticleId IdType=\"pmc\">PMC51863</ArticleId><ArticleId IdType=\"pubmed\">2052608</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Bagyinszky E., An S.S.A. Patient with PSEN1 Glu318Gly and Other Possible Disease Risk Mutations, Diagnosed with Early Onset Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2023;24:15461. doi: 10.3390/ijms242015461.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms242015461</ArticleId><ArticleId IdType=\"pmc\">PMC10607718</ArticleId><ArticleId IdType=\"pubmed\">37895139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagyinszky E., Kim M., Park Y.H., An S.S.A., Kim S. PSEN1 His214Asn Mutation in a Korean Patient with Familial EOAD and the Importance of Histidine-Tryptophan Interactions in TM-4 Stability. Int. J. Mol. Sci. 2023;25:116. doi: 10.3390/ijms25010116.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms25010116</ArticleId><ArticleId IdType=\"pmc\">PMC10778985</ArticleId><ArticleId IdType=\"pubmed\">38203287</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273614</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>A Computational Approach in the Systematic Search of the Interaction Partners of Alternatively Spliced TREM2 Isoforms.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9667</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179667</ELocationID><Abstract><AbstractText>Alzheimer's disease is the most common form of dementia, characterized by the pathological accumulation of amyloid-beta (A&#x3b2;) plaques and tau neurofibrillary tangles. Triggering receptor expressed on myeloid cells 2 (TREM2) is increasingly recognized as playing a central role in A&#x3b2; clearance and microglia activation in AD. The <i>TREM2</i> gene transcriptional product is alternatively spliced to produce three different protein isoforms. The canonical TREM2 isoform binds to DAP12 to activate downstream pathways. However, little is known about the function or interaction partners of the alternative TREM2 isoforms. The present study utilized a computational approach in a systematic search for new interaction partners of the TREM2 isoforms by integrating several state-of-the-art structural bioinformatics tools from initial large-scale screening to one-on-one corroborative modeling and eventual all-atom visualization. CD9, a cell surface glycoprotein involved in cell-cell adhesion and migration, was identified as a new interaction partner for two TREM2 isoforms, and CALM, a calcium-binding protein involved in calcium signaling, was identified as an interaction partner for a third TREM2 isoform, highlighting the potential role of cell adhesion and calcium regulation in AD.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Liang</LastName><ForeName>Junyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Menon</LastName><ForeName>Aditya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tomco</LastName><ForeName>Taylor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bhattarai</LastName><ForeName>Nisha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Smith</LastName><ForeName>Iris Nira</ForeName><Initials>IN</Initials><Identifier Source=\"ORCID\">0000-0001-5560-8871</Identifier><AffiliationInfo><Affiliation>Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Khrestian</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Formica</LastName><ForeName>Shane V</ForeName><Initials>SV</Initials><Identifier Source=\"ORCID\">0000-0003-2303-2331</Identifier><AffiliationInfo><Affiliation>Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Eng</LastName><ForeName>Charis</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Buck</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0002-2958-0403</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bekris</LastName><ForeName>Lynn M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>roughly 300k</GrantID><Agency>Aging Mind Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D008562\">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C498715\">TREM2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011971\">Receptors, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D020033\">Protein Isoforms</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D008562\" MajorTopicYN=\"Y\">Membrane Glycoproteins</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011971\" MajorTopicYN=\"Y\">Receptors, Immunologic</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017398\" MajorTopicYN=\"Y\">Alternative Splicing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020033\" MajorTopicYN=\"Y\">Protein Isoforms</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011485\" MajorTopicYN=\"Y\">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D019295\" MajorTopicYN=\"N\">Computational Biology</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">TREM2 isoforms</Keyword><Keyword MajorTopicYN=\"N\">binder</Keyword><Keyword MajorTopicYN=\"N\">structural bioinformatics</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273614</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179667</ArticleId><ArticleId IdType=\"pii\">ijms25179667</ArticleId><ArticleId IdType=\"pmc\">PMC11395018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Long J.M., Holtzman D.M. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 2019;179:312&#x2013;339. doi: 10.1016/j.cell.2019.09.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2019.09.001</ArticleId><ArticleId IdType=\"pmc\">PMC6778042</ArticleId><ArticleId IdType=\"pubmed\">31564456</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman D.S., Amieva H., Petersen R.C., Ch&#xe9;telat G., Holtzman D.M., Hyman B.T., Nixon R.A., Jones D.T. Alzheimer disease. Nat. Rev. Dis. Primer. 2021;7:33. doi: 10.1038/s41572-021-00269-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41572-021-00269-y</ArticleId><ArticleId IdType=\"pmc\">PMC8574196</ArticleId><ArticleId IdType=\"pubmed\">33986301</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Feng X., Sun X., Hou N., Han F., Liu Y. Global, regional, and national burden of Alzheimer&#x2019;s disease and other dementias, 1990&#x2013;2019. Front. Aging Neurosci. 2022;14:937486. doi: 10.3389/fnagi.2022.937486.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.937486</ArticleId><ArticleId IdType=\"pmc\">PMC9588915</ArticleId><ArticleId IdType=\"pubmed\">36299608</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandi A., Counts N., Chen S., Seligman B., Tortorice D., Vigo D., Bloom D.E. Global and regional projections of the economic burden of Alzheimer&#x2019;s disease and related dementias from 2019 to 2050: A value of statistical life approach. eClinicalMedicine. 2022;51:101580. doi: 10.1016/j.eclinm.2022.101580.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eclinm.2022.101580</ArticleId><ArticleId IdType=\"pmc\">PMC9310134</ArticleId><ArticleId IdType=\"pubmed\">35898316</ArticleId></ArticleIdList></Reference><Reference><Citation>Jay T.R., von Saucken V.E., Landreth G.E. TREM2 in Neurodegenerative Diseases. Mol. Neurodegener. 2017;12:56. doi: 10.1186/s13024-017-0197-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-017-0197-5</ArticleId><ArticleId IdType=\"pmc\">PMC5541421</ArticleId><ArticleId IdType=\"pubmed\">28768545</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M., Leyns C.E.G., Holtzman D.M. New insights into the role of TREM2 in Alzheimer&#x2019;s disease. Mol. Neurodegener. 2018;13:66. doi: 10.1186/s13024-018-0298-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-018-0298-9</ArticleId><ArticleId IdType=\"pmc\">PMC6302500</ArticleId><ArticleId IdType=\"pubmed\">30572908</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipello F., Goldsbury C., You S.F., Locca A., Karch C.M., Piccio L. Soluble TREM2: Innocent bystander or active player in neurological diseases? Neurobiol. Dis. 2022;165:105630. doi: 10.1016/j.nbd.2022.105630.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2022.105630</ArticleId><ArticleId IdType=\"pmc\">PMC10108835</ArticleId><ArticleId IdType=\"pubmed\">35041990</ArticleId></ArticleIdList></Reference><Reference><Citation>Deczkowska A., Weiner A., Amit I. The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway. Cell. 2020;181:1207&#x2013;1217. doi: 10.1016/j.cell.2020.05.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2020.05.003</ArticleId><ArticleId IdType=\"pubmed\">32531244</ArticleId></ArticleIdList></Reference><Reference><Citation>George J. TREM2 as an evolving therapeutic target in Alzheimer&#x2019;s disease. Neural Regen. Res. 2023;18:2680&#x2013;2681. doi: 10.4103/1673-5374.371360.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/1673-5374.371360</ArticleId><ArticleId IdType=\"pmc\">PMC10358665</ArticleId><ArticleId IdType=\"pubmed\">37449620</ArticleId></ArticleIdList></Reference><Reference><Citation>Moutinho M., Coronel I., Tsai A.P., Di Prisco G.V., Pennington T., Atwood B.K., Puntambekar S.S., Smith D.C., Martinez P., Han S., et al. TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation. Genome Med. 2023;15:11. doi: 10.1186/s13073-023-01160-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13073-023-01160-z</ArticleId><ArticleId IdType=\"pmc\">PMC9940368</ArticleId><ArticleId IdType=\"pubmed\">36805764</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey C.C., DeVaux L.B., Farzan M. The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E. J. Biol. Chem. 2015;290:26033&#x2013;26042. doi: 10.1074/jbc.M115.677286.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M115.677286</ArticleId><ArticleId IdType=\"pmc\">PMC4646256</ArticleId><ArticleId IdType=\"pubmed\">26374897</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z., Zhang X., Dong W., Wang X., He S., Zhang H., Wang X., Wei R., Chen Y., Liu X., et al. TREM2 suppresses the proinflammatory response to facilitate PRRSV infection via PI3K/NF-&#x3ba;B signaling. PLoS Pathog. 2020;16:e1008543. doi: 10.1371/journal.ppat.1008543.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.ppat.1008543</ArticleId><ArticleId IdType=\"pmc\">PMC7250469</ArticleId><ArticleId IdType=\"pubmed\">32401783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessard C.B., Malnik S.L., Zhou Y., Ladd T.B., Cruz P.E., Ran Y., Mahan T.E., Chakrabaty P., Holtzman D.M., Ulrich J.D., et al. High-affinity interactions and signal transduction between A&#x3b2; oligomers and TREM 2. EMBO Mol. Med. 2018;10:e9027. doi: 10.15252/emmm.201809027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.201809027</ArticleId><ArticleId IdType=\"pmc\">PMC6220267</ArticleId><ArticleId IdType=\"pubmed\">30341064</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H., Coppola K., Schweig J.E., Crawford F., Mullan M., Paris D. Distinct Signaling Pathways Regulate TREM2 Phagocytic and NF&#x3ba;B Antagonistic Activities. Front. Cell. Neurosci. 2019;13:457. doi: 10.3389/fncel.2019.00457.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2019.00457</ArticleId><ArticleId IdType=\"pmc\">PMC6795686</ArticleId><ArticleId IdType=\"pubmed\">31649511</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiianitsa K., Kurtz I., Beeman N., Matsushita M., Chien W.-M., Raskind W.H., Korvatska O. Novel TREM2 splicing isoform that lacks the V-set immunoglobulin domain is abundant in the human brain. J. Leukoc. Biol. 2021;110:829&#x2013;837. doi: 10.1002/JLB.2HI0720-463RR.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/JLB.2HI0720-463RR</ArticleId><ArticleId IdType=\"pmc\">PMC10433532</ArticleId><ArticleId IdType=\"pubmed\">34061398</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw B.C., Snider H.C., Turner A.K., Zajac D.J., Simpson J.F., Estus S. An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain. J. Alzheimers Dis. 2022;87:1647&#x2013;1657. doi: 10.3233/JAD-215602.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-215602</ArticleId><ArticleId IdType=\"pmc\">PMC9335121</ArticleId><ArticleId IdType=\"pubmed\">35527547</ArticleId></ArticleIdList></Reference><Reference><Citation>Del-Aguila J.L., Benitez B.A., Li Z., Dube U., Mihindukulasuriya K.A., Budde J.P., Farias F.H.G., Fern&#xe1;ndez M.V., Ibanez L., Jiang S., et al. TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers. Mol. Neurodegener. 2019;14:18. doi: 10.1186/s13024-019-0319-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-019-0319-3</ArticleId><ArticleId IdType=\"pmc\">PMC6505298</ArticleId><ArticleId IdType=\"pubmed\">31068200</ArticleId></ArticleIdList></Reference><Reference><Citation>Olufunmilayo E.O., Holsinger R.M.D. Variant TREM2 Signaling in Alzheimer&#x2019;s Disease. J. Mol. Biol. 2022;434:167470. doi: 10.1016/j.jmb.2022.167470.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jmb.2022.167470</ArticleId><ArticleId IdType=\"pubmed\">35120968</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M. The biology of TREM receptors. Nat. Rev. Immunol. 2023;23:580&#x2013;594. doi: 10.1038/s41577-023-00837-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41577-023-00837-1</ArticleId><ArticleId IdType=\"pmc\">PMC9904274</ArticleId><ArticleId IdType=\"pubmed\">36750615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulland T.K., Colonna M. TREM2&#x2014;A key player in microglial biology and Alzheimer disease. Nat. Rev. Neurol. 2018;14:667&#x2013;675. doi: 10.1038/s41582-018-0072-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41582-018-0072-1</ArticleId><ArticleId IdType=\"pubmed\">30266932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Cella M., Mallinson K., Ulrich J.D., Young K.L., Robinette M.L., Gilfillan S., Krishnan G.M., Sudhakar S., Zinselmeyer B.H., et al. TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer&#x2019;s Disease Model. Cell. 2015;160:1061&#x2013;1071. doi: 10.1016/j.cell.2015.01.049.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2015.01.049</ArticleId><ArticleId IdType=\"pmc\">PMC4477963</ArticleId><ArticleId IdType=\"pubmed\">25728668</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W., Hooli B., Mullin K., Jin S.C., Cella M., Ulland T.K., Wang Y., Tanzi R.E., Colonna M. Alzheimer&#x2019;s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. Alzheimers Dement. 2017;13:381&#x2013;387. doi: 10.1016/j.jalz.2016.07.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2016.07.004</ArticleId><ArticleId IdType=\"pmc\">PMC5299056</ArticleId><ArticleId IdType=\"pubmed\">27520774</ArticleId></ArticleIdList></Reference><Reference><Citation>Atagi Y., Liu C.-C., Painter M.M., Chen X.-F., Verbeeck C., Zheng H., Li X., Rademakers R., Kang S.S., Xu H., et al. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) J. Biol. Chem. 2015;290:26043&#x2013;26050. doi: 10.1074/jbc.M115.679043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M115.679043</ArticleId><ArticleId IdType=\"pmc\">PMC4646257</ArticleId><ArticleId IdType=\"pubmed\">26374899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai Z., Wei W., Yu H., Chen Y., Wang Y., Ding Y. Molecular recognition of the interaction between ApoE and the TREM2 protein. Transl. Neurosci. 2022;13:93&#x2013;103. doi: 10.1515/tnsci-2022-0218.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1515/tnsci-2022-0218</ArticleId><ArticleId IdType=\"pmc\">PMC9055258</ArticleId><ArticleId IdType=\"pubmed\">35582645</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh F.L., Wang Y., Tom I., Gonzalez L.C., Sheng M. TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia. Neuron. 2016;91:328&#x2013;340. doi: 10.1016/j.neuron.2016.06.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2016.06.015</ArticleId><ArticleId IdType=\"pubmed\">27477018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Wu X., Li X., Jiang L.-L., Gui X., Liu Y., Sun Y., Zhu B., Pi&#xf1;a-Crespo J.C., Zhang M., et al. TREM2 Is a Receptor for &#x3b2;-Amyloid that Mediates Microglial Function. Neuron. 2018;97:1023&#x2013;1031.e7. doi: 10.1016/j.neuron.2018.01.031.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2018.01.031</ArticleId><ArticleId IdType=\"pmc\">PMC5889092</ArticleId><ArticleId IdType=\"pubmed\">29518356</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi H., Kiyama H. Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases. Front. Cell. Neurosci. 2018;12:206. doi: 10.3389/fncel.2018.00206.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2018.00206</ArticleId><ArticleId IdType=\"pmc\">PMC6087757</ArticleId><ArticleId IdType=\"pubmed\">30127720</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X., Qiao J., Liu S., Wu M., Gu W. Mechanism of TREM2/DAP12 complex affecting &#x3b2;-amyloid plaque deposition in Alzheimer&#x2019;s disease modeled mice through mediating inflammatory response. Brain Res. Bull. 2021;166:21&#x2013;28. doi: 10.1016/j.brainresbull.2020.10.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainresbull.2020.10.006</ArticleId><ArticleId IdType=\"pubmed\">33053435</ArticleId></ArticleIdList></Reference><Reference><Citation>Haure-Mirande J.-V., Audrain M., Ehrlich M.E., Gandy S. Microglial TYROBP/DAP12 in Alzheimer&#x2019;s disease: Transduction of physiological and pathological signals across TREM2. Mol. Neurodegener. 2022;17:55. doi: 10.1186/s13024-022-00552-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-022-00552-w</ArticleId><ArticleId IdType=\"pmc\">PMC9404585</ArticleId><ArticleId IdType=\"pubmed\">36002854</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo C., Manzo E., Barra G., Fioretto L., Ziaco M., Nuzzo G., d&#x2019;Ippolito G., Ferrera F., Contini P., Castiglia D., et al. Sulfavant A as the first synthetic TREM2 ligand discloses a homeostatic response of dendritic cells after receptor engagement. Cell. Mol. Life Sci. 2022;79:369. doi: 10.1007/s00018-022-04297-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00018-022-04297-z</ArticleId><ArticleId IdType=\"pmc\">PMC9207826</ArticleId><ArticleId IdType=\"pubmed\">35723745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekris L.M., Khrestian M., Dyne E., Shao Y., Pillai J.A., Rao S.M., Bemiller S.M., Lamb B., Fernandez H.H., Leverenz J.B. Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease. J. Neuroimmunol. 2018;319:19&#x2013;27. doi: 10.1016/j.jneuroim.2018.03.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jneuroim.2018.03.003</ArticleId><ArticleId IdType=\"pmc\">PMC6036902</ArticleId><ArticleId IdType=\"pubmed\">29685286</ArticleId></ArticleIdList></Reference><Reference><Citation>Heslegrave A., Heywood W., Paterson R., Magdalinou N., Svensson J., Johansson P., &#xd6;hrfelt A., Blennow K., Hardy J., Schott J., et al. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer&#x2019;s disease. Mol. Neurodegener. 2016;11:3. doi: 10.1186/s13024-016-0071-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-016-0071-x</ArticleId><ArticleId IdType=\"pmc\">PMC4709982</ArticleId><ArticleId IdType=\"pubmed\">26754172</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccio L., Buonsanti C., Cella M., Tassi I., Schmidt R.E., Fenoglio C., Rinker J., Naismith R.T., Panina-Bordignon P., Passini N., et al. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain. 2008;131:3081&#x2013;3091. doi: 10.1093/brain/awn217.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awn217</ArticleId><ArticleId IdType=\"pmc\">PMC2577803</ArticleId><ArticleId IdType=\"pubmed\">18790823</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlepckow K., Kleinberger G., Fukumori A., Feederle R., Lichtenthaler S.F., Steiner H., Haass C. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function. EMBO Mol. Med. 2017;9:1356&#x2013;1365. doi: 10.15252/emmm.201707672.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.201707672</ArticleId><ArticleId IdType=\"pmc\">PMC5623859</ArticleId><ArticleId IdType=\"pubmed\">28855300</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuerbach D., Schindler P., Barske C., Joller S., Beng-Louka E., Worringer K.A., Kommineni S., Kaykas A., Ho D.J., Ye C., et al. ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157. Neurosci. Lett. 2017;660:109&#x2013;114. doi: 10.1016/j.neulet.2017.09.034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2017.09.034</ArticleId><ArticleId IdType=\"pubmed\">28923481</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Lucena D., Kruse N., Th&#xfc;ne K., Schmitz M., Villar-Piqu&#xe9; A., Da Cunha J.E.G., Hermann P., L&#xf3;pez-P&#xe9;rez &#xd3;., Andr&#xe9;s-Benito P., Ladogana A., et al. TREM2 expression in the brain and biological fluids in prion diseases. Acta Neuropathol. 2021;141:841&#x2013;859. doi: 10.1007/s00401-021-02296-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-021-02296-1</ArticleId><ArticleId IdType=\"pmc\">PMC8113222</ArticleId><ArticleId IdType=\"pubmed\">33881612</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonomi C.G., Assogna M., Di Donna M.G., Bernocchi F., De Lucia V., Nuccetelli M., Fiorelli D., Loizzo S., Mercuri N.B., Koch G., et al. Cerebrospinal Fluid sTREM-2, GFAP, and &#x3b2;-S100 in Symptomatic Sporadic Alzheimer&#x2019;s Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer&#x2019;s Disease Continuum. J. Alzheimers Dis. JAD. 2023;92:1385&#x2013;1397. doi: 10.3233/JAD-221010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-221010</ArticleId><ArticleId IdType=\"pubmed\">36911936</ArticleId></ArticleIdList></Reference><Reference><Citation>Hok-A-Hin Y.S., Del Campo M., Boiten W.A., Stoops E., Vanhooren M., Lemstra A.W., Van Der Flier W.M., Teunissen C.E. Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer&#x2019;s disease. J. Neuroinflammation. 2023;20:107. doi: 10.1186/s12974-023-02796-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-023-02796-9</ArticleId><ArticleId IdType=\"pmc\">PMC10163795</ArticleId><ArticleId IdType=\"pubmed\">37147668</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Cao B., Zhao Y., Huang H., McIntyre R.S., Rosenblat J.D., Zhou H. Soluble TREM2 changes during the clinical course of Alzheimer&#x2019;s disease: A meta-analysis. Neurosci. Lett. 2018;686:10&#x2013;16. doi: 10.1016/j.neulet.2018.08.038.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2018.08.038</ArticleId><ArticleId IdType=\"pubmed\">30171911</ArticleId></ArticleIdList></Reference><Reference><Citation>Morenas-Rodr&#xed;guez E., Li Y., Nuscher B., Franzmeier N., Xiong C., Su&#xe1;rez-Calvet M., Fagan A.M., Schultz S., Gordon B.A., Benzinger T.L.S., et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer&#x2019;s disease: A longitudinal observational study. Lancet Neurol. 2022;21:329&#x2013;341. doi: 10.1016/S1474-4422(22)00027-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(22)00027-8</ArticleId><ArticleId IdType=\"pmc\">PMC8926925</ArticleId><ArticleId IdType=\"pubmed\">35305339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hur J.-Y. &#x3b3;-Secretase in Alzheimer&#x2019;s disease. Exp. Mol. Med. 2022;54:433&#x2013;446. doi: 10.1038/s12276-022-00754-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s12276-022-00754-8</ArticleId><ArticleId IdType=\"pmc\">PMC9076685</ArticleId><ArticleId IdType=\"pubmed\">35396575</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong L., Xu Y., Zhuo R., Wang T., Wang K., Huang R., Wang D., Gao Y., Zhu Y., Sheng X., et al. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer&#x2019;s disease model. Nat. Commun. 2019;10:1365. doi: 10.1038/s41467-019-09118-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-019-09118-9</ArticleId><ArticleId IdType=\"pmc\">PMC6433910</ArticleId><ArticleId IdType=\"pubmed\">30911003</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown G.C., St George-Hyslop P. Does Soluble TREM2 Protect Against Alzheimer&#x2019;s Disease? Front. Aging Neurosci. 2022;13:834697. doi: 10.3389/fnagi.2021.834697.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2021.834697</ArticleId><ArticleId IdType=\"pmc\">PMC8831327</ArticleId><ArticleId IdType=\"pubmed\">35153729</ArticleId></ArticleIdList></Reference><Reference><Citation>Canzler S., Fischer M., Ulbricht D., Ristic N., Hildebrand P.W., Staritzbichler R. ProteinPrompt: A webserver for predicting protein&#x2013;protein interactions. Bioinform. Adv. 2022;2:vbac059. doi: 10.1093/bioadv/vbac059.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/bioadv/vbac059</ArticleId><ArticleId IdType=\"pmc\">PMC9710678</ArticleId><ArticleId IdType=\"pubmed\">36699419</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W., Shenoy A., Kundrotas P., Elofsson A. Evaluation of AlphaFold-Multimer prediction on multi-chain protein complexes. Bioinformatics. 2023;39:btad424. doi: 10.1093/bioinformatics/btad424.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/bioinformatics/btad424</ArticleId><ArticleId IdType=\"pmc\">PMC10348836</ArticleId><ArticleId IdType=\"pubmed\">37405868</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen E.F., Goddard T.D., Huang C.C., Meng E.C., Couch G.S., Croll T.I., Morris J.H., Ferrin T.E. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70&#x2013;82. doi: 10.1002/pro.3943.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/pro.3943</ArticleId><ArticleId IdType=\"pmc\">PMC7737788</ArticleId><ArticleId IdType=\"pubmed\">32881101</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirdita M., Sch&#xfc;tze K., Moriwaki Y., Heo L., Ovchinnikov S., Steinegger M. ColabFold: Making protein folding accessible to all. Nat. Methods. 2022;19:679&#x2013;682. doi: 10.1038/s41592-022-01488-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41592-022-01488-1</ArticleId><ArticleId IdType=\"pmc\">PMC9184281</ArticleId><ArticleId IdType=\"pubmed\">35637307</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami Y., Kawakami K., Steelant W.F.A., Ono M., Baek R.C., Handa K., Withers D.A., Hakomori S. Tetraspanin CD9 Is a &#x201c;Proteolipid&#x201d;, and Its Interaction with &#x3b1;3 Integrin in Microdomain Is Promoted by GM3 Ganglioside, Leading to Inhibition of Laminin-5-dependent Cell Motility. J. Biol. Chem. 2002;277:34349&#x2013;34358. doi: 10.1074/jbc.M200771200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M200771200</ArticleId><ArticleId IdType=\"pubmed\">12068006</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes R., Carde&#xf1;es B., Machado-Pineda Y., Caba&#xf1;as C. Tetraspanin CD9: A Key Regulator of Cell Adhesion in the Immune System. Front. Immunol. 2018;9:863. doi: 10.3389/fimmu.2018.00863.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2018.00863</ArticleId><ArticleId IdType=\"pmc\">PMC5936783</ArticleId><ArticleId IdType=\"pubmed\">29760699</ArticleId></ArticleIdList></Reference><Reference><Citation>Powner D., Kopp P.M., Monkley S.J., Critchley D.R., Berditchevski F. Tetraspanin CD9 in cell migration. Biochem. Soc. Trans. 2011;39:563&#x2013;567. doi: 10.1042/BST0390563.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/BST0390563</ArticleId><ArticleId IdType=\"pubmed\">21428940</ArticleId></ArticleIdList></Reference><Reference><Citation>Suwatthanarak T., Tanaka M., Miyamoto Y., Miyado K., Okochi M. Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide. Chem. Commun. 2021;57:4906&#x2013;4909. doi: 10.1039/D1CC01295A.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D1CC01295A</ArticleId><ArticleId IdType=\"pubmed\">33870995</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazaheri F., Snaidero N., Kleinberger G., Madore C., Daria A., Werner G., Krasemann S., Capell A., Tr&#xfc;mbach D., Wurst W., et al. TREM 2 deficiency impairs chemotaxis and microglial responses to neuronal injury. EMBO Rep. 2017;18:1186&#x2013;1198. doi: 10.15252/embr.201743922.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/embr.201743922</ArticleId><ArticleId IdType=\"pmc\">PMC5494532</ArticleId><ArticleId IdType=\"pubmed\">28483841</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaitin D.A., Adlung L., Thaiss C.A., Weiner A., Li B., Descamps H., Lundgren P., Bleriot C., Liu Z., Deczkowska A., et al. Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner. Cell. 2019;178:686&#x2013;698.e14. doi: 10.1016/j.cell.2019.05.054.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2019.05.054</ArticleId><ArticleId IdType=\"pmc\">PMC7068689</ArticleId><ArticleId IdType=\"pubmed\">31257031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge M., Zhang J., Chen S., Huang Y., Chen W., He L., Zhang Y. Role of Calcium Homeostasis in Alzheimer&#x2019;s Disease. Neuropsychiatr. Dis. Treat. 2022;18:487&#x2013;498. doi: 10.2147/NDT.S350939.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/NDT.S350939</ArticleId><ArticleId IdType=\"pmc\">PMC8901263</ArticleId><ArticleId IdType=\"pubmed\">35264851</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLorenzo R.J. Calmodulin in neurotransmitter release and synaptic function. Fed. Proc. 1982;41:2265&#x2013;2272. doi: 10.1111/j.1749-6632.1980.tb29603.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1749-6632.1980.tb29603.x</ArticleId><ArticleId IdType=\"pubmed\">6122609</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Day D.H. Calmodulin Binding Proteins and Alzheimer&#x2019;s Disease: Biomarkers, Regulatory Enzymes and Receptors That Are Regulated by Calmodulin. Int. J. Mol. Sci. 2020;21:7344. doi: 10.3390/ijms21197344.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21197344</ArticleId><ArticleId IdType=\"pmc\">PMC7582761</ArticleId><ArticleId IdType=\"pubmed\">33027906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng M., Sabatini B.L., Sudhof T.C. Synapses and Alzheimer&#x2019;s Disease. Cold Spring Harb. Perspect. Biol. 2012;4:a005777. doi: 10.1101/cshperspect.a005777.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/cshperspect.a005777</ArticleId><ArticleId IdType=\"pmc\">PMC3331702</ArticleId><ArticleId IdType=\"pubmed\">22491782</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh J., Alifragis P. Synaptic dysfunction in Alzheimer&#x2019;s disease: The effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention. Neural Regen. Res. 2018;13:616.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5950662</ArticleId><ArticleId IdType=\"pubmed\">29722304</ArticleId></ArticleIdList></Reference><Reference><Citation>Meftah S., Gan J. Alzheimer&#x2019;s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression. Front. Synaptic Neurosci. 2023;15:1129036. doi: 10.3389/fnsyn.2023.1129036.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnsyn.2023.1129036</ArticleId><ArticleId IdType=\"pmc\">PMC10033629</ArticleId><ArticleId IdType=\"pubmed\">36970154</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Q., Wang M., Yin Y., Tang Y. The Specific Mechanism of TREM2 Regulation of Synaptic Clearance in Alzheimer&#x2019;s Disease. Front. Immunol. 2022;13:845897. doi: 10.3389/fimmu.2022.845897.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2022.845897</ArticleId><ArticleId IdType=\"pmc\">PMC9160359</ArticleId><ArticleId IdType=\"pubmed\">35663962</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Day D.H., Huber R.J. Calmodulin binding proteins and neuroinflammation in multiple neurodegenerative diseases. BMC Neurosci. 2022;23:10. doi: 10.1186/s12868-022-00695-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12868-022-00695-y</ArticleId><ArticleId IdType=\"pmc\">PMC8896083</ArticleId><ArticleId IdType=\"pubmed\">35246032</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo A.R., Souza P.C.T., Meng Z., Buck M. Transmembrane dimers of type 1 receptors sample alternate configurations: MD simulations using coarse grain Martini 3 versus AlphaFold2 Multimer. Structure. 2023;31:735&#x2013;745.e2. doi: 10.1016/j.str.2023.03.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.str.2023.03.014</ArticleId><ArticleId IdType=\"pmc\">PMC10833135</ArticleId><ArticleId IdType=\"pubmed\">37075749</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell E.W., Schwartz J.H., Freddolino P.L., Zhang Y. PEPPI: Whole-proteome Protein-protein Interaction Prediction through Structure and Sequence Similarity, Functional Association, and Machine Learning. J. Mol. Biol. 2022;434:167530. doi: 10.1016/j.jmb.2022.167530.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jmb.2022.167530</ArticleId><ArticleId IdType=\"pmc\">PMC8897833</ArticleId><ArticleId IdType=\"pubmed\">35662463</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R., O&#x2019;Neill M., Pritzel A., Antropova N., Senior A., Green T., &#x17d;&#xed;dek A., Bates R., Blackwell S., Yim J., et al. Protein complex prediction with AlphaFold-Multimer. bioRxiv. 2021</Citation></Reference><Reference><Citation>Liang J., Qin M., Xu R., Gao X., Shen Y., Xu Q., Cao Y., Wang W. A genetically encoded copper(i) sensor based on engineered structural distortion of EGFP. Chem. Commun. 2012;48:3890. doi: 10.1039/c2cc30531c.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/c2cc30531c</ArticleId><ArticleId IdType=\"pubmed\">22415114</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J., Yang Y., Yin P., Ding Y., Shen Y., Qin M., Wang J., Xu Q., Cao Y., Wang W. A Yellow Fluorescent Protein with Reduced Chloride Sensitivity Engineered by Loop-Insertion. ChemBioChem. 2013;14:1423&#x2013;1426. doi: 10.1002/cbic.201300199.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cbic.201300199</ArticleId><ArticleId IdType=\"pubmed\">23868849</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J., Guo L., Ding Y., Xia L., Shen Y., Qin M., Xu Q., Cao Y., Wang W. Genetically encoded red fluorescent copper(I) sensors for cellular copper(I) imaging. Biochem. Biophys. Res. Commun. 2014;443:894&#x2013;898. doi: 10.1016/j.bbrc.2013.12.101.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2013.12.101</ArticleId><ArticleId IdType=\"pubmed\">24380863</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J., Seghiri M., Singh P.K., Seo H.G., Lee J.Y., Jo Y., Song Y.B., Park C., Zalicki P., Jeong J.-Y., et al. The &#x3b2;2-adrenergic receptor associates with CXCR4 multimers in human cancer cells. Proc. Natl. Acad. Sci. USA. 2024;121:e2304897121. doi: 10.1073/pnas.2304897121.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2304897121</ArticleId><ArticleId IdType=\"pmc\">PMC10998613</ArticleId><ArticleId IdType=\"pubmed\">38547061</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J., Smith A.W. The Oligomeric State of Vasorin in the Plasma Membrane Measured Non-Invasively by Quantitative Fluorescence Fluctuation Spectroscopy. Int. J. Mol. Sci. 2024;25:4115. doi: 10.3390/ijms25074115.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms25074115</ArticleId><ArticleId IdType=\"pmc\">PMC11012933</ArticleId><ArticleId IdType=\"pubmed\">38612924</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273571</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Protein Kinase C-Delta Mediates Cell Cycle Reentry and Apoptosis Induced by Amyloid-Beta Peptide in Post-Mitotic Cortical Neurons.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9626</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179626</ELocationID><Abstract><AbstractText>Amyloid-beta peptide (A&#x3b2;) is a neurotoxic constituent of senile plaques in the brains of Alzheimer's disease (AD) patients. The detailed mechanisms by which protein kinase C-delta (PKC&#x3b4;) contributes to A&#x3b2; toxicity is not yet entirely understood. Using fully differentiated primary rat cortical neurons, we found that inhibition of A&#x3b2;25-35-induced PKC&#x3b4; increased cell viability with restoration of neuronal morphology. Using cyclin D1, proliferating cell nuclear antigen (PCNA), and histone H3 phosphorylated at Ser-10 (p-Histone H3) as the respective markers for the G1-, S-, and G2/M-phases, PKC&#x3b4; inhibition mitigated cell cycle reentry (CCR) and subsequent caspase-3 cleavage induced by both A&#x3b2;25-35 and A&#x3b2;1-42 in the post-mitotic cortical neurons. Upstream of PKC&#x3b4;, signal transducers and activators of transcription (STAT)-3 mediated PKC&#x3b4; induction, CCR, and caspase-3 cleavage upon A&#x3b2; exposure. Downstream of PKC&#x3b4;, aberrant neuronal CCR was triggered by overactivating cyclin-dependent kinase-5 (CDK5) via calpain2-dependent p35 cleavage into p25. Finally, PKC&#x3b4; and CDK5 also contributed to A&#x3b2;25-35 induction of p53-upregulated modulator of apoptosis (PUMA) in cortical neurons. Together, we demonstrated that, in the post-mitotic neurons exposed to A&#x3b2;s, STAT3-dependent PKC&#x3b4; expression triggers calpain2-mediated p35 cleavage into p25 to overactivate CDK5, thus leading to aberrant CCR, PUMA induction, caspase-3 cleavage, and ultimately apoptosis.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wu</LastName><ForeName>Ming-Hsuan</ForeName><Initials>MH</Initials><Identifier Source=\"ORCID\">0009-0007-0981-1335</Identifier><AffiliationInfo><Affiliation>Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chao</LastName><ForeName>A-Ching</ForeName><Initials>AC</Initials><Identifier Source=\"ORCID\">0000-0003-1230-9622</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung 807377, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, College of Medicine, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sports Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hsieh</LastName><ForeName>Yi-Heng</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lien</LastName><ForeName>You</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lin</LastName><ForeName>Yi-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Taipei City Hospital Renai Branch, Taipei 106243, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Ding-I</ForeName><Initials>DI</Initials><Identifier Source=\"ORCID\">0000-0001-5544-7561</Identifier><AffiliationInfo><Affiliation>Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Research Center, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>NSTC 111-2314-B-A49-068-MY3; NSTC 112-2320-B-A49-029-MY3; NSTC 112-2314-B-037-061-MY3</GrantID><Agency>National Science and Technology Council in Taiwan</Agency><Country/></Grant><Grant><GrantID>11101-62-006; 11201-62-043</GrantID><Agency>Department of Health in Taipei City Government, Taiwan</Agency><Country/></Grant><Grant><GrantID>NSTC 112-2811-B-A49A-033; NSTC 113-2811-B-A49A-021</GrantID><Agency>National Science and Technology Council in Taiwan</Agency><Country/></Grant><Grant><GrantID>KMUH112-2R65</GrantID><Agency>Kaohsiung Medical University Hospital, Taiwan</Agency><Country/></Grant><Grant><GrantID>112W032101; 113W032101</GrantID><Agency>Ministry of Education in Taiwan</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016229\">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.13</RegistryNumber><NameOfSubstance UI=\"D051745\">Protein Kinase C-delta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI=\"D051360\">Cyclin-Dependent Kinase 5</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D010446\">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI=\"D053148\">Caspase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C074636\">amyloid beta-protein (25-35)</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI=\"C495907\">Cdk5 protein, rat</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D016229\" MajorTopicYN=\"Y\">Amyloid beta-Peptides</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009474\" MajorTopicYN=\"Y\">Neurons</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017209\" MajorTopicYN=\"Y\">Apoptosis</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051381\" MajorTopicYN=\"N\">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D051745\" MajorTopicYN=\"Y\">Protein Kinase C-delta</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002540\" MajorTopicYN=\"Y\">Cerebral Cortex</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000166\" MajorTopicYN=\"N\">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002453\" MajorTopicYN=\"Y\">Cell Cycle</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051360\" MajorTopicYN=\"N\">Cyclin-Dependent Kinase 5</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D010446\" MajorTopicYN=\"N\">Peptide Fragments</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D053148\" MajorTopicYN=\"N\">Caspase 3</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017207\" MajorTopicYN=\"N\">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002478\" MajorTopicYN=\"N\">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015398\" MajorTopicYN=\"N\">Signal Transduction</DescriptorName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">calpain</Keyword><Keyword MajorTopicYN=\"N\">caspase-3</Keyword><Keyword MajorTopicYN=\"N\">cyclin-dependent kinase-5 (CDK5)</Keyword><Keyword MajorTopicYN=\"N\">p53-upregulated modulator of apoptosis (PUMA)</Keyword><Keyword MajorTopicYN=\"N\">signal transducers and activators of transcription-3 (STAT3)</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273571</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179626</ArticleId><ArticleId IdType=\"pii\">ijms25179626</ArticleId><ArticleId IdType=\"pmc\">PMC11395613</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Knopman D.S., Amieva H., Petersen R.C., Chetelat G., Holtzman D.M., Hyman B.T., Nixon R.A., Jones D.T. Alzheimer disease. Nat. Rev. Dis. Primers. 2021;7:33. doi: 10.1038/s41572-021-00269-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41572-021-00269-y</ArticleId><ArticleId IdType=\"pmc\">PMC8574196</ArticleId><ArticleId IdType=\"pubmed\">33986301</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao C.V., Asch A.S., Carr D.J.J., Yamada H.Y. &#x201c;Amyloid-beta accumulation cycle&#x201d; as a prevention and/or therapy target for Alzheimer&#x2019;s disease. Aging Cell. 2020;19:e13109. doi: 10.1111/acel.13109.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/acel.13109</ArticleId><ArticleId IdType=\"pmc\">PMC7059149</ArticleId><ArticleId IdType=\"pubmed\">31981470</ArticleId></ArticleIdList></Reference><Reference><Citation>Hradek A.C., Lee H.P., Siedlak S.L., Torres S.L., Jung W., Han A.H., Lee H.G. Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer&#x2019;s disease patients. J. Alzheimers Dis. 2015;43:57&#x2013;65. doi: 10.3233/JAD-141083.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-141083</ArticleId><ArticleId IdType=\"pmc\">PMC5944600</ArticleId><ArticleId IdType=\"pubmed\">25061053</ArticleId></ArticleIdList></Reference><Reference><Citation>van Leeuwen L.A., Hoozemans J.J. Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: Implications for Alzheimer&#x2019;s disease. Acta Neuropathol. 2015;129:511&#x2013;525. doi: 10.1007/s00401-015-1382-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-015-1382-7</ArticleId><ArticleId IdType=\"pmc\">PMC4366542</ArticleId><ArticleId IdType=\"pubmed\">25618528</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik B., Currais A., Andres A., Towlson C., Pitsi D., Nunes A., Niblock M., Cooper J., Hortobagyi T., Soriano S. Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer&#x2019;s disease brain. Cell Cycle. 2008;7:637&#x2013;646. doi: 10.4161/cc.7.5.5427.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4161/cc.7.5.5427</ArticleId><ArticleId IdType=\"pubmed\">18239458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Bu B., Xie M., Zhang M., Yu Z., Tao D. Neural cell cycle dysregulation and central nervous system diseases. Prog. Neurobiol. 2009;89:1&#x2013;17. doi: 10.1016/j.pneurobio.2009.01.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pneurobio.2009.01.007</ArticleId><ArticleId IdType=\"pubmed\">19619927</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N., Nandy S.K., Jyoti A., Saxena J., Sharma A., Siddiqui A.J., Sharma L. Protein kinase C (PKC) in neurological health: Implications for Alzheimer&#x2019;s disease and chronic alcohol consumption. Brain Sci. 2024;14:554. doi: 10.3390/brainsci14060554.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/brainsci14060554</ArticleId><ArticleId IdType=\"pmc\">PMC11201589</ArticleId><ArticleId IdType=\"pubmed\">38928554</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucke-Wold B.P., Turner R.C., Logsdon A.F., Simpkins J.W., Alkon D.L., Smith K.E., Chen Y.W., Tan Z., Huber J.D., Rosen C.L. Common mechanisms of Alzheimer&#x2019;s disease and ischemic stroke: The role of protein kinase C in the progression of age-related neurodegeneration. J. Alzheimers Dis. 2015;43:711&#x2013;724. doi: 10.3233/JAD-141422.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-141422</ArticleId><ArticleId IdType=\"pmc\">PMC4446718</ArticleId><ArticleId IdType=\"pubmed\">25114088</ArticleId></ArticleIdList></Reference><Reference><Citation>Conboy L., Foley A.G., O&#x2019;Boyle N.M., Lawlor M., Gallagher H.C., Murphy K.J., Regan C.M. Curcumin-induced degradation of PKC delta is associated with enhanced dentate NCAM PSA expression and spatial learning in adult and aged Wistar rats. Biochem. Pharmacol. 2009;77:1254&#x2013;1265. doi: 10.1016/j.bcp.2008.12.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bcp.2008.12.011</ArticleId><ArticleId IdType=\"pubmed\">19161989</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Zhao Y., Li C., Zheng Q., Tian J., Li Z., Huang T.Y., Zhang W., Xu H. Inhibition of PKCdelta reduces amyloid-beta levels and reverses Alzheimer disease phenotypes. J. Exp. Med. 2018;215:1665&#x2013;1677. doi: 10.1084/jem.20171193.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20171193</ArticleId><ArticleId IdType=\"pmc\">PMC5987914</ArticleId><ArticleId IdType=\"pubmed\">29739836</ArticleId></ArticleIdList></Reference><Reference><Citation>Shupp A., Casimiro M.C., Pestell R.G. Biological functions of CDK5 and potential CDK5 targeted clinical treatments. Oncotarget. 2017;8:17373&#x2013;17382. doi: 10.18632/oncotarget.14538.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.14538</ArticleId><ArticleId IdType=\"pmc\">PMC5370047</ArticleId><ArticleId IdType=\"pubmed\">28077789</ArticleId></ArticleIdList></Reference><Reference><Citation>Malumbres M. Cyclin-dependent kinases. Genome Biol. 2014;15:122. doi: 10.1186/gb4184.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/gb4184</ArticleId><ArticleId IdType=\"pmc\">PMC4097832</ArticleId><ArticleId IdType=\"pubmed\">25180339</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Allen M.E., Rui Y., Ku L., Liu G., Bankston A.N., Zheng J.Q., Feng Y. p39 is responsible for increasing Cdk5 activity during postnatal neuron differentiation and governs neuronal network formation and epileptic responses. J. Neurosci. 2016;36:11283&#x2013;11294. doi: 10.1523/JNEUROSCI.1155-16.2016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1155-16.2016</ArticleId><ArticleId IdType=\"pmc\">PMC5148244</ArticleId><ArticleId IdType=\"pubmed\">27807169</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai L.H., Delalle I., Caviness V.S., Jr., Chae T., Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature. 1994;371:419&#x2013;423. doi: 10.1038/371419a0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/371419a0</ArticleId><ArticleId IdType=\"pubmed\">8090221</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature. 2000;405:360&#x2013;364. doi: 10.1038/35012636.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/35012636</ArticleId><ArticleId IdType=\"pubmed\">10830966</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M.Y., Shang L., Hu Y.Y., Jiang L.P., Wan Y.Y., Zhou Q.Q., Zhang K., Liao H.F., Yi J.L., Han X.J. The role of Cdk5-mediated Drp1 phosphorylation in Abeta(1-42) induced mitochondrial fission and neuronal apoptosis. J. Cell. Biochem. 2018;119:4815&#x2013;4825. doi: 10.1002/jcb.26680.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcb.26680</ArticleId><ArticleId IdType=\"pubmed\">29345339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mushtaq G., Greig N.H., Anwar F., Al-Abbasi F.A., Zamzami M.A., Al-Talhi H.A., Kamal M.A. Neuroprotective mechanisms mediated by CDK5 inhibition. Curr. Pharm. Des. 2016;22:527&#x2013;534. doi: 10.2174/1381612822666151124235028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1381612822666151124235028</ArticleId><ArticleId IdType=\"pmc\">PMC5002348</ArticleId><ArticleId IdType=\"pubmed\">26601962</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhounsule A.S., Bhatt L.K., Prabhavalkar K.S., Oza M. Cyclin dependent kinase 5: A novel avenue for Alzheimer&#x2019;s disease. Brain Res. Bull. 2017;132:28&#x2013;38. doi: 10.1016/j.brainresbull.2017.05.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainresbull.2017.05.006</ArticleId><ArticleId IdType=\"pubmed\">28526617</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.L., Wang C., Jiang T., Tan L., Xing A., Yu J.T. The role of Cdk5 in Alzheimer&#x2019;s disease. Mol. Neurobiol. 2016;53:4328&#x2013;4342. doi: 10.1007/s12035-015-9369-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-015-9369-x</ArticleId><ArticleId IdType=\"pubmed\">26227906</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S., Saito T., Hisanaga S., Pant H.C., Kulkarni A.B. Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules. J. Biol. Chem. 2003;278:10506&#x2013;10515. doi: 10.1074/jbc.M211964200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M211964200</ArticleId><ArticleId IdType=\"pubmed\">12536148</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapresa R., Agulla J., Sanchez-Moran I., Zamarreno R., Prieto E., Bolanos J.P., Almeida A. Amyloid-&#x3b2; promotes neurotoxicity by Cdk5-induced p53 stabilization. Neuropharmacology. 2019;146:19&#x2013;27. doi: 10.1016/j.neuropharm.2018.11.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuropharm.2018.11.019</ArticleId><ArticleId IdType=\"pubmed\">30452955</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J., Meng C., Xing D. Abeta induces PUMA activation: A new mechanism for Abeta-mediated neuronal apoptosis. Neurobiol. Aging. 2015;36:789&#x2013;800. doi: 10.1016/j.neurobiolaging.2014.10.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2014.10.007</ArticleId><ArticleId IdType=\"pubmed\">25457551</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu X., Ma S., Zhang N., Yang D., Wang L., Ye S., Zhang Q., Ruan J., Ma J., et al. ChK1 activation induces reactive astrogliosis through CIP2A/PP2A/STAT3 pathway in Alzheimer&#x2019;s disease. FASEB J. 2022;36:e22209. doi: 10.1096/fj.202101625R.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.202101625R</ArticleId><ArticleId IdType=\"pubmed\">35195302</ArticleId></ArticleIdList></Reference><Reference><Citation>Toral-Rios D., Patino-Lopez G., Gomez-Lira G., Gutierrez R., Becerril-Perez F., Rosales-Cordova A., Leon-Contreras J.C., Hernandez-Pando R., Leon-Rivera I., Soto-Cruz I., et al. Activation of STAT3 regulates reactive astrogliosis and neuronal death induced by AbetaO neurotoxicity. Int. J. Mol. Sci. 2020;21:7458. doi: 10.3390/ijms21207458.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21207458</ArticleId><ArticleId IdType=\"pmc\">PMC7590075</ArticleId><ArticleId IdType=\"pubmed\">33050466</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi M., Kim H., Yang E.J., Kim H.S. Inhibition of STAT3 phosphorylation attenuates impairments in learning and memory in 5XFAD mice, an animal model of Alzheimer&#x2019;s disease. J. Pharmacol. Sci. 2020;143:290&#x2013;299. doi: 10.1016/j.jphs.2020.05.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jphs.2020.05.009</ArticleId><ArticleId IdType=\"pubmed\">32507685</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehla J., Singh I., Diwan D., Nelson J.W., Lawrence M., Lee E., Bauer A.Q., Holtzman D.M., Zipfel G.J. STAT3 inhibitor mitigates cerebral amyloid angiopathy and parenchymal amyloid plaques while improving cognitive functions and brain networks. Acta Neuropathol. Commun. 2021;9:193. doi: 10.1186/s40478-021-01293-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-021-01293-5</ArticleId><ArticleId IdType=\"pmc\">PMC8672532</ArticleId><ArticleId IdType=\"pubmed\">34911575</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G., Tong Y., Wang X., Zhao C., Ba Z., Ahelijiang R., Liu X., Gao W., Zhao Y., Gu Y., et al. Guizhi Fuling capsule relieves memory deficits by inhibition of microglial neuroinflammation through blocking JAK2/STAT3 pathway in presenilin1/2 conditional double knockout mice. Front. Immunol. 2023;14:1185570. doi: 10.3389/fimmu.2023.1185570.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2023.1185570</ArticleId><ArticleId IdType=\"pmc\">PMC10350565</ArticleId><ArticleId IdType=\"pubmed\">37465679</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Huang Q., Wang S., Liao Z., Jin H., Huang S., Hong X., Liu Y., Pang J., Shen Q., et al. The food additive beta-caryophyllene exerts its neuroprotective effects through the JAK2-STAT3-BACE1 pathway. Front. Aging Neurosci. 2022;14:814432.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8919047</ArticleId><ArticleId IdType=\"pubmed\">35296033</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan H.L., Hong X.Y., Zhao Z.H., Li T., Zhang B.G., Liu Q., Wang Q., Zhao S., Wang J.Z., Shen X.F., et al. STAT3 ameliorates cognitive deficits via regulation of NMDAR expression in an Alzheimer&#x2019;s disease animal model. Theranostics. 2021;11:5511&#x2013;5524. doi: 10.7150/thno.56541.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7150/thno.56541</ArticleId><ArticleId IdType=\"pmc\">PMC8039956</ArticleId><ArticleId IdType=\"pubmed\">33859760</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao A.C., Chen C.H., Wu M.H., Hou B.Y., Yang D.I. Roles of Id1/HIF-1 and CDK5/HIF-1 in cell cycle reentry induced by amyloid-beta peptide in post-mitotic cortical neuron. Biochim. Biophys. Acta Mol. Cell Res. 2020;1867:118628. doi: 10.1016/j.bbamcr.2019.118628.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamcr.2019.118628</ArticleId><ArticleId IdType=\"pubmed\">31884068</ArticleId></ArticleIdList></Reference><Reference><Citation>Prigent C., Dimitrov S. Phosphorylation of serine 10 in histone H3, what for? J. Cell Sci. 2003;116:3677&#x2013;3685. doi: 10.1242/jcs.00735.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1242/jcs.00735</ArticleId><ArticleId IdType=\"pubmed\">12917355</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao A.C., Chen C.H., Chang S.H., Huang C.T., Hwang W.C., Yang D.I. Id1 and sonic hedgehog mediate cell cycle reentry and apoptosis induced by amyloid beta-peptide in post-mitotic cortical neurons. Mol. Neurobiol. 2019;56:465&#x2013;489. doi: 10.1007/s12035-018-1098-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-018-1098-5</ArticleId><ArticleId IdType=\"pubmed\">29721855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen H.C., Huo Y.N., Chou C.M., Lee W.S. PMA inhibits endothelial cell migration through activating the PKC-delta/Syk/NF-kappaB-mediated up-regulation of Thy-1. Sci. Rep. 2018;8:16247. doi: 10.1038/s41598-018-34548-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-34548-8</ArticleId><ArticleId IdType=\"pmc\">PMC6214930</ArticleId><ArticleId IdType=\"pubmed\">30389973</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain N., Zhang T., Kee W.H., Li W., Cao X. Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J. Biol. Chem. 1999;274:24392&#x2013;24400. doi: 10.1074/jbc.274.34.24392.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.274.34.24392</ArticleId><ArticleId IdType=\"pubmed\">10446219</ArticleId></ArticleIdList></Reference><Reference><Citation>Vosler P.S., Brennan C.S., Chen J. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol. Neurobiol. 2008;38:78&#x2013;100. doi: 10.1007/s12035-008-8036-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-008-8036-x</ArticleId><ArticleId IdType=\"pmc\">PMC2726710</ArticleId><ArticleId IdType=\"pubmed\">18686046</ArticleId></ArticleIdList></Reference><Reference><Citation>Pao P.C., Tsai L.H. Three decades of Cdk5. J. Biomed. Sci. 2021;28:79. doi: 10.1186/s12929-021-00774-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12929-021-00774-y</ArticleId><ArticleId IdType=\"pmc\">PMC8609871</ArticleId><ArticleId IdType=\"pubmed\">34814918</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Guo T., Hao Y., Li C., Tang L., Li X., Zhang X., Li L., Yao D., Xu X., et al. PKCdelta serves as a potential biomarker and therapeutic target for microglia-mediated neuroinflammation in Alzheimer&#x2019;s disease. Alzheimers Dement. 2024;20:5511&#x2013;5527. doi: 10.1002/alz.14047.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.14047</ArticleId><ArticleId IdType=\"pmc\">PMC11350009</ArticleId><ArticleId IdType=\"pubmed\">38938161</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu W., Tang S., Li A., Huang Q., Dou M., Zhang Y., Hu X., Chang R.C.C., Wong G.T.C., Huang C. The role of PKC/PKR in aging, Alzheimer&#x2019;s disease, and perioperative neurocognitive disorders. Front. Aging Neurosci. 2022;14:973068. doi: 10.3389/fnagi.2022.973068.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.973068</ArticleId><ArticleId IdType=\"pmc\">PMC9510619</ArticleId><ArticleId IdType=\"pubmed\">36172481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.K., Jee H.J., Jung Y.S. Abeta(1-40)-induced platelet adhesion is ameliorated by rosmarinic acid through inhibition of NADPH oxidase/PKC-delta/integrin alpha(IIb)beta(3) signaling. Antioxidants (Basel) 2021;10:1671. doi: 10.3390/antiox10111671.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox10111671</ArticleId><ArticleId IdType=\"pmc\">PMC8615194</ArticleId><ArticleId IdType=\"pubmed\">34829541</ArticleId></ArticleIdList></Reference><Reference><Citation>Gschwendt M., Muller H.J., Kielbassa K., Zang R., Kittstein W., Rincke G., Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 1994;199:93&#x2013;98. doi: 10.1006/bbrc.1994.1199.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/bbrc.1994.1199</ArticleId><ArticleId IdType=\"pubmed\">8123051</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhavanasi D., Kostyak J.C., Swindle J., Kilpatrick L.E., Kunapuli S.P. CGX1037 is a novel PKC isoform delta selective inhibitor in platelets. Platelets. 2015;26:2&#x2013;9. doi: 10.3109/09537104.2013.868877.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/09537104.2013.868877</ArticleId><ArticleId IdType=\"pmc\">PMC4101062</ArticleId><ArticleId IdType=\"pubmed\">24433221</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou B.Y., Wu M.H., Hsu H.Y., Lin Y.C., Yang D.I. Polysaccharides from Basella alba protect post-mitotic neurons against cell cycle re-entry and apoptosis induced by the amyloid-beta peptide by blocking sonic hedgehog expression. Int. J. Mol. Sci. 2024;25:7316. doi: 10.3390/ijms25137316.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms25137316</ArticleId><ArticleId IdType=\"pmc\">PMC11242684</ArticleId><ArticleId IdType=\"pubmed\">39000427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul S., Kanthasamy A., Kitazawa M., Anantharam V., Kanthasamy A.G. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: Relevance to oxidative stress in dopaminergic degeneration. Eur. J. Neurosci. 2003;18:1387&#x2013;1401. doi: 10.1046/j.1460-9568.2003.02864.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1046/j.1460-9568.2003.02864.x</ArticleId><ArticleId IdType=\"pubmed\">14511319</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul S., Anantharam V., Yang Y., Choi C.J., Kanthasamy A., Kanthasamy A.G. Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells. J. Biol. Chem. 2005;280:28721&#x2013;28730. doi: 10.1074/jbc.M501092200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M501092200</ArticleId><ArticleId IdType=\"pubmed\">15961393</ArticleId></ArticleIdList></Reference><Reference><Citation>Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 1994;77:817&#x2013;827. doi: 10.1016/0092-8674(94)90131-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0092-8674(94)90131-7</ArticleId><ArticleId IdType=\"pubmed\">8004671</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray R.D., Lucas C.D., MacKellar A., Li F., Hiersemenzel K., Haslett C., Davidson D.J., Rossi A.G. Activation of conventional protein kinase C (PKC) is critical in the generation of human neutrophil extracellular traps. J. Inflamm. (Lond) 2013;10:12. doi: 10.1186/1476-9255-10-12.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1476-9255-10-12</ArticleId><ArticleId IdType=\"pmc\">PMC3643828</ArticleId><ArticleId IdType=\"pubmed\">23514610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C.T., Li K., Li J.T., Zheng W., Liang X.J., Geng A.Q., Li N., Yuan X.B. PKCdelta regulates cortical radial migration by stabilizing the Cdk5 activator p35. Proc. Natl. Acad. Sci. U S A. 2009;106:21353&#x2013;21358. doi: 10.1073/pnas.0812872106.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0812872106</ArticleId><ArticleId IdType=\"pmc\">PMC2781735</ArticleId><ArticleId IdType=\"pubmed\">19965374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin B., Hawasli A.H., Greene R.W., Molkentin J.D., Bibb J.A. Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C. Eur. J. Pharmacol. 2008;581:270&#x2013;275. doi: 10.1016/j.ejphar.2007.11.061.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejphar.2007.11.061</ArticleId><ArticleId IdType=\"pmc\">PMC2268033</ArticleId><ArticleId IdType=\"pubmed\">18190909</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Chang L., Zhang H., Nie J., Zhang Z., Yang X., Vuong A.M., Wang Z., Chen A., Niu Q. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153. Toxicol. Lett. 2017;277:41&#x2013;53. doi: 10.1016/j.toxlet.2017.05.027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.toxlet.2017.05.027</ArticleId><ArticleId IdType=\"pubmed\">28559121</ArticleId></ArticleIdList></Reference><Reference><Citation>Requejo-Aguilar R. Cdk5 and aberrant cell cycle activation at the core of neurodegeneration. Neural Regen. Res. 2023;18:1186&#x2013;1190. doi: 10.4103/1673-5374.360165.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/1673-5374.360165</ArticleId><ArticleId IdType=\"pmc\">PMC9838168</ArticleId><ArticleId IdType=\"pubmed\">36453392</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian B., Yang Q., Mao Z. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat. Cell Biol. 2009;11:211&#x2013;218. doi: 10.1038/ncb1829.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncb1829</ArticleId><ArticleId IdType=\"pmc\">PMC2760486</ArticleId><ArticleId IdType=\"pubmed\">19151707</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin B.N., Kim D.W., Kim I.H., Park J.H., Ahn J.H., Kang I.J., Lee Y.L., Lee C.H., Hwang I.K., Kim Y.M., et al. Down-regulation of cyclin-dependent kinase 5 attenuates p53-dependent apoptosis of hippocampal CA1 pyramidal neurons following transient cerebral ischemia. Sci. Rep. 2019;9:13032. doi: 10.1038/s41598-019-49623-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-49623-x</ArticleId><ArticleId IdType=\"pmc\">PMC6737192</ArticleId><ArticleId IdType=\"pubmed\">31506563</ArticleId></ArticleIdList></Reference><Reference><Citation>Samidurai M., Tarale P., Janarthanam C., Estrada C.G., Gordon R., Zenitsky G., Jin H., Anantharam V., Kanthasamy A.G., Kanthasamy A. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances activation of STAT3/NLRC4 inflammasome signaling axis through PKCdelta in astrocytes: Implications for Parkinson&#x2019;s disease. Cells. 2020;9:1831. doi: 10.3390/cells9081831.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells9081831</ArticleId><ArticleId IdType=\"pmc\">PMC7464730</ArticleId><ArticleId IdType=\"pubmed\">32759670</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan J., Fu A.K., Ip F.C., Ng H.K., Hugon J., Page G., Wang J.H., Lai K.O., Wu Z., Ip N.Y. Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: Implications in Alzheimer&#x2019;s disease. J. Neurosci. 2010;30:6873&#x2013;6881. doi: 10.1523/JNEUROSCI.0519-10.2010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.0519-10.2010</ArticleId><ArticleId IdType=\"pmc\">PMC6632652</ArticleId><ArticleId IdType=\"pubmed\">20484629</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Ding M., Yan F., Yin J., Shi W., Yang N., Zhao H., Fang Y., Huang Y., Zheng Y., et al. Inhibition of the JAK2/STAT3 pathway and cell cycle re-entry contribute to the protective effect of remote ischemic pre-conditioning of rat hindlimbs on cerebral ischemia/reperfusion injury. CNS Neurosci. Ther. 2023;29:866&#x2013;877. doi: 10.1111/cns.14023.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cns.14023</ArticleId><ArticleId IdType=\"pmc\">PMC9928551</ArticleId><ArticleId IdType=\"pubmed\">36419252</ArticleId></ArticleIdList></Reference><Reference><Citation>Olah Z., Kalman J., Toth M.E., Zvara A., Santha M., Ivitz E., Janka Z., Pakaski M. Proteomic analysis of cerebrospinal fluid in Alzheimer&#x2019;s disease: Wanted dead or alive. J. Alzheimers Dis. 2015;44:1303&#x2013;1312. doi: 10.3233/JAD-140141.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-140141</ArticleId><ArticleId IdType=\"pubmed\">25428253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang J., Cai P., Chen Z., Yang Q., Chen X., Wang X., Zhuang X. Long noncoding RNA MALAT1 and its target microRNA-125b are potential biomarkers for Alzheimer&#x2019;s disease management via interactions with FOXQ1, PTGS2 and CDK5. Am. J. Transl. Res. 2020;12:5940&#x2013;5954.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7540111</ArticleId><ArticleId IdType=\"pubmed\">33042470</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Jiao L., Zhong X., Yao W., Du K., Lu S., Wu Y., Ma T., Tong J., Xu M., et al. Platelet activating factor receptor exaggerates microglia-mediated microenvironment by IL10-STAT3 signaling: A novel potential biomarker and target for diagnosis and treatment of Alzheimer&#x2019;s disease. Front. Aging Neurosci. 2022;14:856628. doi: 10.3389/fnagi.2022.856628.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.856628</ArticleId><ArticleId IdType=\"pmc\">PMC9096237</ArticleId><ArticleId IdType=\"pubmed\">35572136</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias-Vasquez A., Aulchenko Y.S., Isaacs A., van Oosterhout A., Sleegers K., Hofman A., van Broeckhoven C., Oostra B.A., Breteler M., van Duijn C.M. Cyclin-dependent kinase 5 is associated with risk for Alzheimer&#x2019;s disease in a Dutch population-based study. J. Neurol. 2008;255:655&#x2013;662. doi: 10.1007/s00415-008-0770-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00415-008-0770-5</ArticleId><ArticleId IdType=\"pubmed\">18350355</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez-Higuera J.L., Mateo I., Sanchez-Juan P., Rodriguez-Rodriguez E., Infante J., Berciano J., Combarros O. No association of CDK5 genetic variants with Alzheimer&#x2019;s disease risk. BMC Med. Genet. 2009;10:68. doi: 10.1186/1471-2350-10-68.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2350-10-68</ArticleId><ArticleId IdType=\"pmc\">PMC2716333</ArticleId><ArticleId IdType=\"pubmed\">19615060</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjolander A., Andersson M.E., Zetterberg H., Minthon L., Bogdanovic N., Blennow K. Alzheimer&#x2019;s disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk. Mol Med Rep. 2009;2:989&#x2013;992. doi: 10.3892/mmr_00000203.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/mmr_00000203</ArticleId><ArticleId IdType=\"pubmed\">21475932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju T.C., Yang Y.T., Yang D.I. Protective effects of S-nitrosoglutathione against neurotoxicity of 3-nitropropionic acid in rat. Neurosci. Lett. 2004;362:226&#x2013;231. doi: 10.1016/j.neulet.2004.03.028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2004.03.028</ArticleId><ArticleId IdType=\"pubmed\">15158020</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.L., Hwang C.S., Yang D.I. Protective effects of brain-derived neurotrophic factor against neurotoxicity of 3-nitropropionic acid in rat cortical neurons. Neurotoxicology. 2009;30:718&#x2013;726. doi: 10.1016/j.neuro.2009.03.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuro.2009.03.008</ArticleId><ArticleId IdType=\"pubmed\">19428112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju T.C., Chen S.D., Liu C.C., Yang D.I. Protective effects of S-nitrosoglutathione against amyloid beta-peptide neurotoxicity. Free Radic. Biol. Med. 2005;38:938&#x2013;949. doi: 10.1016/j.freeradbiomed.2004.12.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.freeradbiomed.2004.12.019</ArticleId><ArticleId IdType=\"pubmed\">15749390</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273520</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Body Composition and Alzheimer's Disease: A Holistic Review.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9573</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179573</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) represents a significant global health challenge and affects approximately 50 million people worldwide. This overview of published reviews provides a comprehensive understanding of the intricate correlations between AD and body composition, focusing particularly on obesity. We used a systematic approach to collect and analyze relevant reviews on the topic of obesity and Alzheimer's disease. A comprehensive search of electronic databases, including PubMed, MEDLINE, and Google Scholar, was conducted. We searched keywords such as \"Alzheimer's disease\", \"body composition\", \"lean mass\", \"bone mass\", and \"fat mass\". We considered only reviews written within the past 5 years and in English. Fifty-six relevant reviews were identified that shed light on the multiple connections between AD and body composition. The review involves several aspects, including the impact of lean mass, bone mass, and endocrinological factors related to obesity, as well as inflammation, neuroinflammation, and molecular/genetic factors. The findings highlight the complex interplay of these elements in the development of AD, underscoring the need for holistic approaches to reduce the risk of AD and to explore innovative strategies for diagnosis, prevention, and treatment.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Frank</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0003-4515-548X</Identifier><AffiliationInfo><Affiliation>PhD School of Applied Medical-Surgical Sciences, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Specialization in Food Science, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gualtieri</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source=\"ORCID\">0000-0003-1533-4276</Identifier><AffiliationInfo><Affiliation>Section of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cianci</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0001-5378-8442</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Caldarelli</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0001-5308-7072</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Palma</LastName><ForeName>Roselisa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>PhD School of Applied Medical-Surgical Sciences, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Specialization in Food Science, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>De Santis</LastName><ForeName>Gemma Lou</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Section of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Porfilio</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Specialization in Food Science, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nicoletti</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Section of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bigioni</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Section of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Di Renzo</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0001-8875-6723</Identifier><AffiliationInfo><Affiliation>Section of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>PNRR-MAD-2022-12376383, CIMA</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001823\" MajorTopicYN=\"Y\">Body Composition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009765\" MajorTopicYN=\"Y\">Obesity</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">body composition</Keyword><Keyword MajorTopicYN=\"N\">obesity</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273520</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179573</ArticleId><ArticleId IdType=\"pii\">ijms25179573</ArticleId><ArticleId IdType=\"pmc\">PMC11395597</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brayne C., Miller B. Dementia and Aging Populations-A Global Priority for Contextualized Research and Health Policy. PLoS Med. 2017;14:e1002275. doi: 10.1371/journal.pmed.1002275.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pmed.1002275</ArticleId><ArticleId IdType=\"pmc\">PMC5370112</ArticleId><ArticleId IdType=\"pubmed\">28350794</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P., Strooper B.D., Kivipelto M., Holstege H., Ch&#xe9;telat G., Teunissen C.E., Cummings J., van der Flier W.M. Alzheimer&#x2019;s Disease. Lancet. 2021;397:1577&#x2013;1590. doi: 10.1016/S0140-6736(20)32205-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)32205-4</ArticleId><ArticleId IdType=\"pmc\">PMC8354300</ArticleId><ArticleId IdType=\"pubmed\">33667416</ArticleId></ArticleIdList></Reference><Reference><Citation>Therriault J., Pascoal T.A., Benedet A.L., Tissot C., Savard M., Chamoun M., Lussier F., Kang M.S., Berzgin G., Wang T., et al. Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE &#x395;4, and Cognitive Impairment. Neurology. 2021;96:e975&#x2013;e985. doi: 10.1212/WNL.0000000000011416.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000011416</ArticleId><ArticleId IdType=\"pmc\">PMC8055338</ArticleId><ArticleId IdType=\"pubmed\">33443136</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisam M., Khan M.T., Lodhi M.S., Mou K., Liu Z., Wei D. Alzheimer&#x2019;s Disease; Mechanism, Mutations, and Applications of Nano-Medicine. Front. Biosci. 2023;28:258. doi: 10.31083/j.fbl2810258.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.31083/j.fbl2810258</ArticleId><ArticleId IdType=\"pubmed\">37919079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Sun M., Li W., Liu X., Zhu M., Qin H. Biomarkers Associated with the Pathogenesis of Alzheimer&#x2019;s Disease. Front. Cell. Neurosci. 2023;17:1279046. doi: 10.3389/fncel.2023.1279046.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2023.1279046</ArticleId><ArticleId IdType=\"pmc\">PMC10733517</ArticleId><ArticleId IdType=\"pubmed\">38130871</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazan J., Liu K.Y., Fox N.C., Howard R. Online Clinical Tools to Support the Use of New Plasma Biomarker Diagnostic Technology in the Assessment of Alzheimer&#x2019;s Disease: A Narrative Review. Brain Commun. 2023;5:fcad322. doi: 10.1093/braincomms/fcad322.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/braincomms/fcad322</ArticleId><ArticleId IdType=\"pmc\">PMC10715781</ArticleId><ArticleId IdType=\"pubmed\">38090277</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh S., Singh S A., Rushendran R., Vellapandian C., Prajapati B. Alzheimer&#x2019;s Disease: The Role of Extrinsic Factors in Its Development, an Investigation of the Environmental Enigma. Front. Neurol. 2023;14:1303111. doi: 10.3389/fneur.2023.1303111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2023.1303111</ArticleId><ArticleId IdType=\"pmc\">PMC10730937</ArticleId><ArticleId IdType=\"pubmed\">38125832</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao C., Fu G., Xu R., Li N. Coupling of Alzheimer&#x2019;s Disease Genetic Risk Factors with Viral Susceptibility and Inflammation. Aging Dis. 2023;15:2028&#x2013;2050. doi: 10.14336/AD.2023.1017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14336/AD.2023.1017</ArticleId><ArticleId IdType=\"pmc\">PMC11346407</ArticleId><ArticleId IdType=\"pubmed\">37962454</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozupone M., Dibello V., Sardone R., Castellana F., Zupo R., Lampignano L., Bortone I., Daniele A., Bellomo A., Solfrizzi V., et al. The Impact of Apolipoprotein E (APOE) Epigenetics on Aging and Sporadic Alzheimer&#x2019;s Disease. Biology. 2023;12:1529. doi: 10.3390/biology12121529.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biology12121529</ArticleId><ArticleId IdType=\"pmc\">PMC10740847</ArticleId><ArticleId IdType=\"pubmed\">38132357</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W., Huang J., Huang N., Luo Y. The Role of TREM2 in Alzheimer&#x2019;s Disease: From the Perspective of Tau. Front. Cell Dev. Biol. 2023;11:1280257. doi: 10.3389/fcell.2023.1280257.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2023.1280257</ArticleId><ArticleId IdType=\"pmc\">PMC10663217</ArticleId><ArticleId IdType=\"pubmed\">38020891</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen L., Bi D., Shen Y. Complement-Mediated Synapse Loss in Alzheimer&#x2019;s Disease: Mechanisms and Involvement of Risk Factors. Trends Neurosci. 2023;47:135&#x2013;149. doi: 10.1016/j.tins.2023.11.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tins.2023.11.010</ArticleId><ArticleId IdType=\"pubmed\">38129195</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui W., Qiu C., Shao Q., Li J. Associations of Vascular Risk Factors, APOE and TOMM40 Polymorphisms with Cognitive Function in Dementia-Free Chinese Older Adults: A Community-Based Study. Front. Psychiatry. 2021;12:617773. doi: 10.3389/fpsyt.2021.617773.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpsyt.2021.617773</ArticleId><ArticleId IdType=\"pmc\">PMC8005534</ArticleId><ArticleId IdType=\"pubmed\">33790814</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies G., Armstrong N., Bis J.C., Bressler J., Chouraki V., Giddaluru S., Hofer E., Ibrahim-Verbaas C.A., Kirin M., Lahti J., et al. Genetic Contributions to Variation in General Cognitive Function: A Meta-Analysis of Genome-Wide Association Studies in the CHARGE Consortium (N=53949) Mol. Psychiatry. 2015;20:183&#x2013;192. doi: 10.1038/mp.2014.188.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/mp.2014.188</ArticleId><ArticleId IdType=\"pmc\">PMC4356746</ArticleId><ArticleId IdType=\"pubmed\">25644384</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Zhao J., Xu B., Ma X., Dai Q., Li T., Xue F., Chen B. The TOMM40 Gene Rs2075650 Polymorphism Contributes to Alzheimer&#x2019;s Disease in Caucasian, and Asian Populations. Neurosci. Lett. 2016;628:142&#x2013;146. doi: 10.1016/j.neulet.2016.05.050.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2016.05.050</ArticleId><ArticleId IdType=\"pubmed\">27328316</ArticleId></ArticleIdList></Reference><Reference><Citation>Nianogo R.A., Rosenwohl-Mack A., Yaffe K., Carrasco A., Hoffmann C.M., Barnes D.E. Risk Factors Associated with Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US. JAMA Neurol. 2022;79:584&#x2013;591. doi: 10.1001/jamaneurol.2022.0976.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaneurol.2022.0976</ArticleId><ArticleId IdType=\"pmc\">PMC9086930</ArticleId><ArticleId IdType=\"pubmed\">35532912</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmaksoud N.M., Sallam A.-A.M., Abulsoud A.I., El-Dakroury W.A., Abdel Mageed S.S., AL-Noshokaty T.M., Elrebehy M.A., Elshaer S.S., Mahmoud N.A., Fathi D., et al. Unraveling the Role of miRNAs in the Diagnosis, Progression, and Therapeutic Intervention of Alzheimer&#x2019;s Disease. Pathol. Res. Pract. 2024;253:155007. doi: 10.1016/j.prp.2023.155007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.prp.2023.155007</ArticleId><ArticleId IdType=\"pubmed\">38061270</ArticleId></ArticleIdList></Reference><Reference><Citation>Planche V., Bouteloup V., Pellegrin I., Mangin J.-F., Dubois B., Ousset P.-J., Pasquier F., Blanc F., Paquet C., Hanon O., et al. Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort. Neurology. 2023;100:e473&#x2013;e484. doi: 10.1212/WNL.0000000000201479.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000201479</ArticleId><ArticleId IdType=\"pmc\">PMC9931079</ArticleId><ArticleId IdType=\"pubmed\">36261295</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperling R.A., Donohue M.C., Raman R., Rafii M.S., Johnson K., Masters C.L., van Dyck C.H., Iwatsubo T., Marshall G.A., Yaari R., et al. Trial of Solanezumab in Preclinical Alzheimer&#x2019;s Disease. N. Engl. J. Med. 2023;389:1096&#x2013;1107. doi: 10.1056/NEJMoa2305032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa2305032</ArticleId><ArticleId IdType=\"pmc\">PMC10559996</ArticleId><ArticleId IdType=\"pubmed\">37458272</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L.X., Tan E.K., Zhou Z.D. Passive Immunotherapy for Alzheimer&#x2019;s Disease: Challenges &amp; Future Directions. J. Transl. Med. 2024;22:430. doi: 10.1186/s12967-024-05248-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12967-024-05248-x</ArticleId><ArticleId IdType=\"pmc\">PMC11075320</ArticleId><ArticleId IdType=\"pubmed\">38715084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosyreva A., Sentyabreva A., Tsvetkov I., Makarova O. Alzheimer&#x2019;s Disease and Inflammaging. Brain Sci. 2022;12:1237. doi: 10.3390/brainsci12091237.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/brainsci12091237</ArticleId><ArticleId IdType=\"pmc\">PMC9496782</ArticleId><ArticleId IdType=\"pubmed\">36138973</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang Q.-S., Meng L., Wang Z., Shen L., Ji H.-F. Associations Between Obesity and Alzheimer&#x2019;s Disease: Multiple Bioinformatic Analyses. J. Alzheimer&#x2019;s Dis. 2021;80:271&#x2013;281. doi: 10.3233/JAD-201235.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-201235</ArticleId><ArticleId IdType=\"pubmed\">33523009</ArticleId></ArticleIdList></Reference><Reference><Citation>Borda M.G., Castellanos-Perilla N., Tovar-Rios D.A., Ferreira D., Duque G., Aarsland D. Tongue Muscle Mass Is Associated with Total Grey Matter and Hippocampal Volumes in Dementia with Lewy Bodies. Arch. Gerontol. Geriatr. 2022;100:104647. doi: 10.1016/j.archger.2022.104647.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.archger.2022.104647</ArticleId><ArticleId IdType=\"pubmed\">35134612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wi&#x119;ckowska-Gacek A., Mietelska-Porowska A., Wydrych M., Wojda U. Western Diet as a Trigger of Alzheimer&#x2019;s Disease: From Metabolic Syndrome and Systemic Inflammation to Neuroinflammation and Neurodegeneration. Ageing Res. Rev. 2021;70:101397. doi: 10.1016/j.arr.2021.101397.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2021.101397</ArticleId><ArticleId IdType=\"pubmed\">34214643</ArticleId></ArticleIdList></Reference><Reference><Citation>Birkic V., Celeste T., Cochrane L. Which Review Is That? A Guide to Review Types. The University of Melbourne; Melbourne, Australia: 2020.</Citation></Reference><Reference><Citation>Wu M.-Y., Zou W.-J., Lee D., Mei L., Xiong W.-C. APP in the Neuromuscular Junction for the Development of Sarcopenia and Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2023;24:7809. doi: 10.3390/ijms24097809.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24097809</ArticleId><ArticleId IdType=\"pmc\">PMC10178513</ArticleId><ArticleId IdType=\"pubmed\">37175515</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa-de-Araujo R., Addison O., Miljkovic I., Goodpaster B.H., Bergman B.C., Clark R.V., Elena J.W., Esser K.A., Ferrucci L., Harris-Love M.O., et al. Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging. Front. Physiol. 2020;11:963. doi: 10.3389/fphys.2020.00963.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2020.00963</ArticleId><ArticleId IdType=\"pmc\">PMC7438777</ArticleId><ArticleId IdType=\"pubmed\">32903666</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingenbleek Y. Implications of Protein Malnutrition and Inflammatory Disorders in the Pathophysiology of Alzheimer&#x2019;s Disease. Asia Pac. J. Clin. Nutr. 2020;29:450&#x2013;461. doi: 10.6133/apjcn.202009_29(3).0002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.6133/apjcn.202009_29(3).0002</ArticleId><ArticleId IdType=\"pubmed\">32990603</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryadevara V., Kl&#xfc;ppel M., Monte F.D., Willis M.S. The Unraveling. Am. J. Pathol. 2020;190:1609&#x2013;1621. doi: 10.1016/j.ajpath.2020.04.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajpath.2020.04.013</ArticleId><ArticleId IdType=\"pubmed\">32407731</ArticleId></ArticleIdList></Reference><Reference><Citation>Halon-Golabek M., Borkowska A., Herman-Antosiewicz A., Antosiewicz J. Iron Metabolism of the Skeletal Muscle and Neurodegeneration. Front. Neurosci. 2019;13:165. doi: 10.3389/fnins.2019.00165.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2019.00165</ArticleId><ArticleId IdType=\"pmc\">PMC6436082</ArticleId><ArticleId IdType=\"pubmed\">30949015</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Ashraf M., Tipparaju S.M., Xuan W. Muscle-Brain Crosstalk in Cognitive Impairment. Front. Aging Neurosci. 2023;15:1221653. doi: 10.3389/fnagi.2023.1221653.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1221653</ArticleId><ArticleId IdType=\"pmc\">PMC10413125</ArticleId><ArticleId IdType=\"pubmed\">37577356</ArticleId></ArticleIdList></Reference><Reference><Citation>Brisendine M.H., Drake J.C. Early-Stage Alzheimer&#x2019;s Disease: Are Skeletal Muscle and Exercise the Key? J. Appl. Physiol. 2023;134:515&#x2013;520. doi: 10.1152/japplphysiol.00659.2022.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/japplphysiol.00659.2022</ArticleId><ArticleId IdType=\"pmc\">PMC9970658</ArticleId><ArticleId IdType=\"pubmed\">36656981</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Llorente A.M., Casimiro-And&#xfa;jar A.J., Linhares D.G., De Souza Vale R.G., Marcos-Pardo P.J. Multidomain Interventions for Sarcopenia and Cognitive Flexibility in Older Adults for Promoting Healthy Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Aging Clin. Exp. Res. 2024;36:47. doi: 10.1007/s40520-024-02700-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40520-024-02700-2</ArticleId><ArticleId IdType=\"pmc\">PMC10884056</ArticleId><ArticleId IdType=\"pubmed\">38386173</ArticleId></ArticleIdList></Reference><Reference><Citation>Jodeiri Farshbaf M., Alvi&#xf1;a K. Multiple Roles in Neuroprotection for the Exercise Derived Myokine Irisin. Front. Aging Neurosci. 2021;13:649929. doi: 10.3389/fnagi.2021.649929.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2021.649929</ArticleId><ArticleId IdType=\"pmc\">PMC8086837</ArticleId><ArticleId IdType=\"pubmed\">33935687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K., Wang K., Wang T. Protective Effect of Irisin against Alzheimer&#x2019;s Disease. Front. Psychiatry. 2022;13:967683. doi: 10.3389/fpsyt.2022.967683.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpsyt.2022.967683</ArticleId><ArticleId IdType=\"pmc\">PMC9530446</ArticleId><ArticleId IdType=\"pubmed\">36203845</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X., Thyfault J.P. Exercise Drives Metabolic Integration between Muscle, Adipose and Liver Metabolism and Protects against Aging-Related Diseases. Exp. Gerontol. 2023;176:112178. doi: 10.1016/j.exger.2023.112178.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.exger.2023.112178</ArticleId><ArticleId IdType=\"pubmed\">37085127</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnik S.J., Margetts T.J., Wang H.S., Movila A., Oblak A.L., Fehrenbacher J.C., Kacena M.A., Plotkin L.I. Mind the Gap: Unraveling the Intricate Dance Between Alzheimer&#x2019;s Disease and Related Dementias and Bone Health. Curr. Osteoporos. Rep. 2024;22:165&#x2013;176. doi: 10.1007/s11914-023-00847-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11914-023-00847-x</ArticleId><ArticleId IdType=\"pmc\">PMC10912190</ArticleId><ArticleId IdType=\"pubmed\">38285083</ArticleId></ArticleIdList></Reference><Reference><Citation>Frame G., Bretland K.A., Dengler-Crish C.M. Mechanistic Complexities of Bone Loss in Alzheimer&#x2019;s Disease: A Review. Connect. Tissue Res. 2020;61:4&#x2013;18. doi: 10.1080/03008207.2019.1624734.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/03008207.2019.1624734</ArticleId><ArticleId IdType=\"pubmed\">31184223</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B.-N., Zhang Q., Li M. Alzheimer&#x2019;s Disease and Its Associated Risk of Bone Fractures: A Narrative Review. Front. Endocrinol. 2023;14:1190762. doi: 10.3389/fendo.2023.1190762.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2023.1190762</ArticleId><ArticleId IdType=\"pmc\">PMC10450034</ArticleId><ArticleId IdType=\"pubmed\">37635980</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggiero C., Baroni M., Xenos D., Parretti L., Macchione I.G., Bubba V., Laudisio A., Pedone C., Ferracci M., Magierski R., et al. Dementia, Osteoporosis and Fragility Fractures: Intricate Epidemiological Relationships, Plausible Biological Connections, and Twisted Clinical Practices. Ageing Res. Rev. 2024;93:102130. doi: 10.1016/j.arr.2023.102130.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2023.102130</ArticleId><ArticleId IdType=\"pubmed\">38030092</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Chen H., Qiu F., He J., Chen J. Cognitive Impairment and Risks of Osteoporosis: A Systematic Review and Meta-Analysis. Arch. Gerontol. Geriatr. 2023;106:104879. doi: 10.1016/j.archger.2022.104879.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.archger.2022.104879</ArticleId><ArticleId IdType=\"pubmed\">36462246</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindzingre L., Bouaziz-Amar E., Mouton-Liger F., Cognat E., Dumurgier J., Vrillon A., Paquet C., Lilamand M. The Role of Adiponectin in Alzheimer&#x2019;s Disease: A Translational Review. J. Nutr. Health Aging. 2024;28:100166. doi: 10.1016/j.jnha.2024.100166.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jnha.2024.100166</ArticleId><ArticleId IdType=\"pubmed\">38280832</ArticleId></ArticleIdList></Reference><Reference><Citation>Casado M.E., Collado-P&#xe9;rez R., Frago L.M., Barrios V. Recent Advances in the Knowledge of the Mechanisms of Leptin Physiology and Actions in Neurological and Metabolic Pathologies. Int. J. Mol. Sci. 2023;24:1422. doi: 10.3390/ijms24021422.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24021422</ArticleId><ArticleId IdType=\"pmc\">PMC9860943</ArticleId><ArticleId IdType=\"pubmed\">36674935</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade L.J.D.O., Oliveira L.M.D., Bittencourt A.M.V., Louren&#xe7;o L.G.D.C., Oliveira G.C.M.D. Brain Insulin Resistance and Alzheimer&#x2019;s Disease: A Systematic Review. Dement. Neuropsychol. 2024;18:e20230032. doi: 10.1590/1980-5764-dn-2023-0032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1590/1980-5764-dn-2023-0032</ArticleId><ArticleId IdType=\"pmc\">PMC10901561</ArticleId><ArticleId IdType=\"pubmed\">38425702</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber K., Szerenos E., Lewandowski D., Toczylowski K., Sulik A. The Role of Adipokines in the Pathologies of the Central Nervous System. Int. J. Mol. Sci. 2023;24:14684. doi: 10.3390/ijms241914684.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms241914684</ArticleId><ArticleId IdType=\"pmc\">PMC10572192</ArticleId><ArticleId IdType=\"pubmed\">37834128</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto A., Fernandes A., Barateiro A. The Complex Relationship between Obesity and Neurodegenerative Diseases: An Updated Review. Front. Cell. Neurosci. 2023;17:1294420. doi: 10.3389/fncel.2023.1294420.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2023.1294420</ArticleId><ArticleId IdType=\"pmc\">PMC10665538</ArticleId><ArticleId IdType=\"pubmed\">38026693</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdalla M.M.I. Insulin Resistance as the Molecular Link between Diabetes and Alzheimer&#x2019;s Disease. World J. Diabetes. 2024;15:1430&#x2013;1447. doi: 10.4239/wjd.v15.i7.1430.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4239/wjd.v15.i7.1430</ArticleId><ArticleId IdType=\"pmc\">PMC11292327</ArticleId><ArticleId IdType=\"pubmed\">39099819</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjunan A., Sah D.K., Woo M., Song J. Identification of the Molecular Mechanism of Insulin-like Growth Factor-1 (IGF-1): A Promising Therapeutic Target for Neurodegenerative Diseases Associated with Metabolic Syndrome. Cell. Biosci. 2023;13:16. doi: 10.1186/s13578-023-00966-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13578-023-00966-z</ArticleId><ArticleId IdType=\"pmc\">PMC9872444</ArticleId><ArticleId IdType=\"pubmed\">36691085</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasnim N., Khan N., Gupta A., Neupane P., Mehta A., Shah S.A., Dey R.C. Exploring the Effects of Adiponectin and Leptin in Correlating Obesity with Cognitive Decline: A Systematic Review. Ann. Med. Surg. 2023;85:2906&#x2013;2915. doi: 10.1097/MS9.0000000000000766.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MS9.0000000000000766</ArticleId><ArticleId IdType=\"pmc\">PMC10289712</ArticleId><ArticleId IdType=\"pubmed\">37363537</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimini F.A., Perluigi M., Barchetta I., Cavallo M.G., Barone E. Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update. Int. J. Mol. Sci. 2022;23:5574. doi: 10.3390/ijms23105574.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23105574</ArticleId><ArticleId IdType=\"pmc\">PMC9141761</ArticleId><ArticleId IdType=\"pubmed\">35628384</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Cordero J.A., P&#xe9;rez-P&#xe9;rez A., Jim&#xe9;nez-Cortegana C., Alba G., Flores-Barrag&#xe1;n A., S&#xe1;nchez-Margalet V. Obesity as a Risk Factor for Dementia and Alzheimer&#x2019;s Disease: The Role of Leptin. Int. J. Mol. Sci. 2022;23:5202. doi: 10.3390/ijms23095202.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23095202</ArticleId><ArticleId IdType=\"pmc\">PMC9099768</ArticleId><ArticleId IdType=\"pubmed\">35563589</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung K.W. Advances in Understanding of the Role of Lipid Metabolism in Aging. Cells. 2021;10:880. doi: 10.3390/cells10040880.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells10040880</ArticleId><ArticleId IdType=\"pmc\">PMC8068994</ArticleId><ArticleId IdType=\"pubmed\">33924316</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoramipour K., Chamari K., Hekmatikar A.A., Ziyaiyan A., Taherkhani S., Elguindy N.M., Bragazzi N.L. Adiponectin: Structure, Physiological Functions, Role in Diseases, and Effects of Nutrition. Nutrients. 2021;13:1180. doi: 10.3390/nu13041180.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu13041180</ArticleId><ArticleId IdType=\"pmc\">PMC8066826</ArticleId><ArticleId IdType=\"pubmed\">33918360</ArticleId></ArticleIdList></Reference><Reference><Citation>Komleva Y., Chernykh A., Lopatina O., Gorina Y., Lokteva I., Salmina A., Gollasch M. Inflamm-Aging and Brain Insulin Resistance: New Insights and Role of Life-Style Strategies on Cognitive and Social Determinants in Aging and Neurodegeneration. Front. Neurosci. 2021;14:618395. doi: 10.3389/fnins.2020.618395.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2020.618395</ArticleId><ArticleId IdType=\"pmc\">PMC7841337</ArticleId><ArticleId IdType=\"pubmed\">33519369</ArticleId></ArticleIdList></Reference><Reference><Citation>Polito R., Di Meo I., Barbieri M., Daniele A., Paolisso G., Rizzo M.R. Adiponectin Role in Neurodegenerative Diseases: Focus on Nutrition Review. Int. J. Mol. Sci. 2020;21:9255. doi: 10.3390/ijms21239255.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21239255</ArticleId><ArticleId IdType=\"pmc\">PMC7729837</ArticleId><ArticleId IdType=\"pubmed\">33291597</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.Y., Barua S., Jeong Y.J., Lee J.E. Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2020;21:6419. doi: 10.3390/ijms21176419.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21176419</ArticleId><ArticleId IdType=\"pmc\">PMC7504582</ArticleId><ArticleId IdType=\"pubmed\">32899357</ArticleId></ArticleIdList></Reference><Reference><Citation>Forny-Germano L., De Felice F.G., do Nascimento Vieira M.N. The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer&#x2019;s Disease. Front. Neurosci. 2018;12:1027. doi: 10.3389/fnins.2018.01027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2018.01027</ArticleId><ArticleId IdType=\"pmc\">PMC6340072</ArticleId><ArticleId IdType=\"pubmed\">30692905</ArticleId></ArticleIdList></Reference><Reference><Citation>Uddin M.S., Rahman M.M., Sufian M.A., Jeandet P., Ashraf G.M., Bin-Jumah M.N., Mousa S.A., Abdel-Daim M.M., Akhtar M.F., Saleem A., et al. Exploring the New Horizon of AdipoQ in Obesity-Related Alzheimer&#x2019;s Dementia. Front. Physiol. 2020;11:567678. doi: 10.3389/fphys.2020.567678.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2020.567678</ArticleId><ArticleId IdType=\"pmc\">PMC7873563</ArticleId><ArticleId IdType=\"pubmed\">33584324</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Wang Y.-J., Xiang Y. Bidirectional Communication between Brain and Visceral White Adipose Tissue: Its Potential Impact on Alzheimer&#x2019;s Disease. eBioMedicine. 2022;84:104263. doi: 10.1016/j.ebiom.2022.104263.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ebiom.2022.104263</ArticleId><ArticleId IdType=\"pmc\">PMC9490488</ArticleId><ArticleId IdType=\"pubmed\">36122553</ArticleId></ArticleIdList></Reference><Reference><Citation>Farruggia M.C., Small D.M. Effects of Adiposity and Metabolic Dysfunction on Cognition: A Review. Physiol. Behav. 2019;208:112578. doi: 10.1016/j.physbeh.2019.112578.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.physbeh.2019.112578</ArticleId><ArticleId IdType=\"pmc\">PMC6625347</ArticleId><ArticleId IdType=\"pubmed\">31194997</ArticleId></ArticleIdList></Reference><Reference><Citation>Kueck P.J., Morris J.K., Stanford J.A. Current Perspectives: Obesity and Neurodegeneration&#x2014;Links and Risks. Degener. Neurol. Neuromuscul. Dis. 2023;13:111&#x2013;129. doi: 10.2147/DNND.S388579.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/DNND.S388579</ArticleId><ArticleId IdType=\"pmc\">PMC10774290</ArticleId><ArticleId IdType=\"pubmed\">38196559</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo A., Botta A., Shi S.S.W., Paus T., Pausova Z. Obesity-Related Neuroinflammation: Magnetic Resonance and Microscopy Imaging of the Brain. Int. J. Mol. Sci. 2022;23:8790. doi: 10.3390/ijms23158790.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23158790</ArticleId><ArticleId IdType=\"pmc\">PMC9368789</ArticleId><ArticleId IdType=\"pubmed\">35955925</ArticleId></ArticleIdList></Reference><Reference><Citation>Litwiniuk A., Bik W., Kalisz M., Baranowska-Bik A. Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2021;22:5603. doi: 10.3390/ijms22115603.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22115603</ArticleId><ArticleId IdType=\"pmc\">PMC8198882</ArticleId><ArticleId IdType=\"pubmed\">34070553</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichiah P.B.T., Sankarganesh D., Arunachalam S., Achiraman S. Adipose-Derived Molecules-Untouched Horizons in Alzheimer&#x2019;s Disease Biology. Front. Aging Neurosci. 2020;12:17. doi: 10.3389/fnagi.2020.00017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2020.00017</ArticleId><ArticleId IdType=\"pmc\">PMC7032035</ArticleId><ArticleId IdType=\"pubmed\">32116650</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J.W., Zivkovic A.M. The Potential Utility of Prebiotics to Modulate Alzheimer&#x2019;s Disease: A Review of the Evidence. Microorganisms. 2021;9:2310. doi: 10.3390/microorganisms9112310.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/microorganisms9112310</ArticleId><ArticleId IdType=\"pmc\">PMC8625457</ArticleId><ArticleId IdType=\"pubmed\">34835436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Zhang P., Xu F., Zheng Y., Zhao H. Advances in the Study of IL-17 in Neurological Diseases and Mental Disorders. Front. Neurol. 2023;14:1284304. doi: 10.3389/fneur.2023.1284304.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2023.1284304</ArticleId><ArticleId IdType=\"pmc\">PMC10690603</ArticleId><ArticleId IdType=\"pubmed\">38046578</ArticleId></ArticleIdList></Reference><Reference><Citation>Natale G., Zhang Y., Hanes D.W., Clouston S.A. Obesity in Late-Life as a Protective Factor Against Dementia and Dementia-Related Mortality. Am. J. Alzheimers Dis. Other Demen. 2023;38:15333175221111658. doi: 10.1177/15333175221111658.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/15333175221111658</ArticleId><ArticleId IdType=\"pmc\">PMC10580725</ArticleId><ArticleId IdType=\"pubmed\">37391890</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Dorantes M.T., D&#xed;az-L&#xf3;pez Y.E., Guti&#xe9;rrez-Aguilar R. Environment and Gene Association with Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases. Front. Neurosci. 2020;14:863. doi: 10.3389/fnins.2020.00863.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2020.00863</ArticleId><ArticleId IdType=\"pmc\">PMC7483585</ArticleId><ArticleId IdType=\"pubmed\">32982666</ArticleId></ArticleIdList></Reference><Reference><Citation>Cianci R., Franza L., Massaro M.G., Borriello R., Tota A., Pallozzi M., De Vito F., Gambassi G. The Crosstalk between Gut Microbiota, Intestinal Immunological Niche and Visceral Adipose Tissue as a New Model for the Pathogenesis of Metabolic and Inflammatory Diseases: The Paradigm of Type 2 Diabetes Mellitus. Curr. Med. Chem. 2022;29:3189&#x2013;3201. doi: 10.2174/0929867329666220105121124.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/0929867329666220105121124</ArticleId><ArticleId IdType=\"pubmed\">34986766</ArticleId></ArticleIdList></Reference><Reference><Citation>Kune&#x161; J., Hojn&#xe1; S., Mr&#xe1;zikov&#xe1; L., Montezano A., Touyz R., Malet&#xed;nsk&#xe1; L. Obesity, Cardiovascular and Neurodegenerative Diseases: Potential Common Mechanisms. Physiol. Res. 2023;72:S73&#x2013;S90. doi: 10.33549/physiolres.935109.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.33549/physiolres.935109</ArticleId><ArticleId IdType=\"pmc\">PMC10660578</ArticleId><ArticleId IdType=\"pubmed\">37565414</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy H.M., Al-Gareeb A.I., Alsayegh A.A., Hakami Z.H., Khamjan N.A., Saad H.M., Batiha G.E.-S., De Waard M. A Potential Link Between Visceral Obesity and Risk of Alzheimer&#x2019;s Disease. Neurochem. Res. 2023;48:745&#x2013;766. doi: 10.1007/s11064-022-03817-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11064-022-03817-4</ArticleId><ArticleId IdType=\"pubmed\">36409447</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingenbleek Y. Plasma Transthyretin as A Biomarker of Sarcopenia in Elderly Subjects. Nutrients. 2019;11:895. doi: 10.3390/nu11040895.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu11040895</ArticleId><ArticleId IdType=\"pmc\">PMC6521094</ArticleId><ArticleId IdType=\"pubmed\">31010086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou A., Fontana M., Gillmore J.D. Patisiran for the Treatment of Transthyretin-Mediated Amyloidosis with Cardiomyopathy. Heart Int. 2023;17:27&#x2013;35. doi: 10.17925/HI.2023.17.1.27.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17925/HI.2023.17.1.27</ArticleId><ArticleId IdType=\"pmc\">PMC10339464</ArticleId><ArticleId IdType=\"pubmed\">37456349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingenbleek Y. Revisiting PINI Scoring in Light of Recent Biological Advances. Nutrients. 2023;15:1846. doi: 10.3390/nu15081846.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu15081846</ArticleId><ArticleId IdType=\"pmc\">PMC10146499</ArticleId><ArticleId IdType=\"pubmed\">37111065</ArticleId></ArticleIdList></Reference><Reference><Citation>Obradovic M., Sudar-Milovanovic E., Soskic S., Essack M., Arya S., Stewart A.J., Gojobori T., Isenovic E.R. Leptin and Obesity: Role and Clinical Implication. Front. Endocrinol. 2021;12:585887. doi: 10.3389/fendo.2021.585887.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2021.585887</ArticleId><ArticleId IdType=\"pmc\">PMC8167040</ArticleId><ArticleId IdType=\"pubmed\">34084149</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarapultsev A., Gusev E., Komelkova M., Utepova I., Luo S., Hu D. JAK-STAT Signaling in Inflammation and Stress-Related Diseases: Implications for Therapeutic Interventions. Mol. Biomed. 2023;4:40. doi: 10.1186/s43556-023-00151-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s43556-023-00151-1</ArticleId><ArticleId IdType=\"pmc\">PMC10632324</ArticleId><ArticleId IdType=\"pubmed\">37938494</ArticleId></ArticleIdList></Reference><Reference><Citation>Amontree M., Deasy S., Turner R.S., Conant K. Matrix Disequilibrium in Alzheimer&#x2019;s Disease and Conditions That Increase Alzheimer&#x2019;s Disease Risk. Front. Neurosci. 2023;17:1188065. doi: 10.3389/fnins.2023.1188065.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2023.1188065</ArticleId><ArticleId IdType=\"pmc\">PMC10250680</ArticleId><ArticleId IdType=\"pubmed\">37304012</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyna N.C., Clark B.J., Hamilton D.A., Pentkowski N.S. Anxiety and Alzheimer&#x2019;s Disease Pathogenesis: Focus on 5-HT and CRF Systems in 3xTg-AD and TgF344-AD Animal Models. Front. Aging Neurosci. 2023;15:1251075. doi: 10.3389/fnagi.2023.1251075.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1251075</ArticleId><ArticleId IdType=\"pmc\">PMC10699143</ArticleId><ArticleId IdType=\"pubmed\">38076543</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Apo E., Mondrag&#xf3;n-Maya A., Ferrari-D&#xed;az M., Silva-Pereyra J. Structural Brain Changes Associated with Overweight and Obesity. J. Obes. 2021;2021:6613385. doi: 10.1155/2021/6613385.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2021/6613385</ArticleId><ArticleId IdType=\"pmc\">PMC8302366</ArticleId><ArticleId IdType=\"pubmed\">34327017</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt L.O., Gaspar J.M. Obesity-Induced Brain Neuroinflammatory and Mitochondrial Changes. Metabolites. 2023;13:86. doi: 10.3390/metabo13010086.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo13010086</ArticleId><ArticleId IdType=\"pmc\">PMC9865135</ArticleId><ArticleId IdType=\"pubmed\">36677011</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann M.J., Tesar A., Beier J., Berg M., Warrings B. Grey Matter Alterations in Obesity: A Meta-analysis of Whole-brain Studies. Obes. Rev. 2019;20:464&#x2013;471. doi: 10.1111/obr.12799.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/obr.12799</ArticleId><ArticleId IdType=\"pubmed\">30537231</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccara E., Golan S., Beeri M.S. The Association between Regional Adiposity, Cognitive Function, and Dementia-Related Brain Changes: A Systematic Review. Front. Med. 2023;10:1160426. doi: 10.3389/fmed.2023.1160426.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmed.2023.1160426</ArticleId><ArticleId IdType=\"pmc\">PMC10349176</ArticleId><ArticleId IdType=\"pubmed\">37457589</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson S.C., Burgess S. Causal Role of High Body Mass Index in Multiple Chronic Diseases: A Systematic Review and Meta-Analysis of Mendelian Randomization Studies. BMC Med. 2021;19:320. doi: 10.1186/s12916-021-02188-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12916-021-02188-x</ArticleId><ArticleId IdType=\"pmc\">PMC8672504</ArticleId><ArticleId IdType=\"pubmed\">34906131</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T., Zhong T., Zhang M., Xu Y., Zhang M., Chen L. Alzheimer&#x2019;s Disease: Causal Effect between Obesity and APOE Gene Polymorphisms. Int. J. Mol. Sci. 2023;24:13531. doi: 10.3390/ijms241713531.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms241713531</ArticleId><ArticleId IdType=\"pmc\">PMC10487910</ArticleId><ArticleId IdType=\"pubmed\">37686334</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C.-C., Liu C.-C., Kanekiyo T., Xu H., Bu G. Apolipoprotein E and Alzheimer Disease: Risk, Mechanisms and Therapy. Nat. Rev. Neurol. 2013;9:106&#x2013;118. doi: 10.1038/nrneurol.2012.263.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrneurol.2012.263</ArticleId><ArticleId IdType=\"pmc\">PMC3726719</ArticleId><ArticleId IdType=\"pubmed\">23296339</ArticleId></ArticleIdList></Reference><Reference><Citation>Linton M.F., Gish R., Hubl S.T., B&#xfc;tler E., Esquivel C., Bry W.I., Boyles J.K., Wardell M.R., Young S.G. Phenotypes of Apolipoprotein B and Apolipoprotein E after Liver Transplantation. J. Clin. Invest. 1991;88:270&#x2013;281. doi: 10.1172/JCI115288.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI115288</ArticleId><ArticleId IdType=\"pmc\">PMC296029</ArticleId><ArticleId IdType=\"pubmed\">2056122</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies N.M., Holmes M.V., Davey Smith G. Reading Mendelian Randomisation Studies: A Guide, Glossary, and Checklist for Clinicians. BMJ. 2018;362:k601. doi: 10.1136/bmj.k601.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.k601</ArticleId><ArticleId IdType=\"pmc\">PMC6041728</ArticleId><ArticleId IdType=\"pubmed\">30002074</ArticleId></ArticleIdList></Reference><Reference><Citation>Charisis S., Lin H., Ray R., Joehanes R., Beiser A.S., Levy D., Seshadri S., Sargurupremraj M., Satizabal C.L. Obesity Impacts the Expression of Alzheimer&#x2019;s Disease-Related Genes: The Framingham Heart Study. Alzheimers Dement. 2023;19:3496&#x2013;3505. doi: 10.1002/alz.12954.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.12954</ArticleId><ArticleId IdType=\"pmc\">PMC10435662</ArticleId><ArticleId IdType=\"pubmed\">36811231</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Bank H., Kirsh C., Simcox J. Aging Adipose: Depot Location Dictates Age-Associated Expansion and Dysfunction. Ageing Res. Rev. 2021;67:101259. doi: 10.1016/j.arr.2021.101259.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2021.101259</ArticleId><ArticleId IdType=\"pmc\">PMC8379680</ArticleId><ArticleId IdType=\"pubmed\">33515751</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavaliere G., Trinchese G., Penna E., Cimmino F., Pirozzi C., Lama A., Annunziata C., Catapano A., Mattace Raso G., Meli R., et al. High-Fat Diet Induces Neuroinflammation and Mitochondrial Impairment in Mice Cerebral Cortex and Synaptic Fraction. Front. Cell. Neurosci. 2019;13:509. doi: 10.3389/fncel.2019.00509.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2019.00509</ArticleId><ArticleId IdType=\"pmc\">PMC6861522</ArticleId><ArticleId IdType=\"pubmed\">31798417</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldarelli M., Rio P., Marrone A., Ocarino F., Chiantore M., Candelli M., Gasbarrini A., Gambassi G., Cianci R. Gut&#x2013;Brain Axis: Focus on Sex Differences in Neuroinflammation. Int. J. Mol. Sci. 2024;25:5377. doi: 10.3390/ijms25105377.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms25105377</ArticleId><ArticleId IdType=\"pmc\">PMC11120930</ArticleId><ArticleId IdType=\"pubmed\">38791415</ArticleId></ArticleIdList></Reference><Reference><Citation>Solanki R., Karande A., Ranganathan P. Emerging Role of Gut Microbiota Dysbiosis in Neuroinflammation and Neurodegeneration. Front. Neurol. 2023;14:1149618. doi: 10.3389/fneur.2023.1149618.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2023.1149618</ArticleId><ArticleId IdType=\"pmc\">PMC10225576</ArticleId><ArticleId IdType=\"pubmed\">37255721</ArticleId></ArticleIdList></Reference><Reference><Citation>Grey A., Bolland M.J., Avenell A., Klein A.A., Gunsalus C.K. Check for Publication Integrity before Misconduct. Nature. 2020;577:167&#x2013;169. doi: 10.1038/d41586-019-03959-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/d41586-019-03959-6</ArticleId><ArticleId IdType=\"pubmed\">31911697</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273436</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>A New Strategy for Ultrasensitive Detection Based on Target microRNA-Triggered Rolling Circle Amplification in the Early Diagnosis of Alzheimer's Disease.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9490</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179490</ELocationID><Abstract><AbstractText>There is an urgent need to accurately quantify microRNA (miRNA)-based Alzheimer's disease (AD) biomarkers, which have emerged as promising diagnostic biomarkers. In this study, we present a rapid and universal approach to establishing a target miRNA-triggered rolling circle amplification (RCA) detection strategy, which achieves ultrasensitive detection of several targets, including miR-let7a-5p, miR-34a-5p, miR-206-3p, miR-9-5p, miR-132-3p, miR-146a-5p, and miR-21-5p. Herein, the padlock probe contains three repeated signal strand binding regions and a target miRNA-specific region. The target miRNA-specific region captures miRNA, and then the padlock probe is circularized with the addition of T4 DNA ligase. Subsequently, an RCA reaction is triggered, and RCA products containing multiple signal strand binding regions are generated to trap abundant fluorescein-labeled signal strands. The addition of exonuclease III (Exo III) causes signal strand digestion and leads to RCA product recycling and liberation of fluorescein. Ultimately, graphene oxide (GO) does not absorb the liberated fluorescein because of poor mutual interaction. This method exhibited high specificity, sensitivity, repeatability, and stability toward let-7a, with a detection limit of 19.35 fM and a linear range of 50 fM to 5 nM. Moreover, it showed excellent applicability for recovering miRNAs in normal human serum. Our strategy was applied to detect miRNAs in the plasma of APP/PS1 mice, demonstrating its potential in the diagnosis of miRNA-associated disease and biochemical research.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Zhao</LastName><ForeName>Fei</ForeName><Initials>F</Initials><Identifier Source=\"ORCID\">0000-0003-3521-9072</Identifier><AffiliationInfo><Affiliation>Academy of Medical Engineering and Translational Medicine, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Brain Science and Neural Engineering, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Academy of Medical Engineering and Translational Medicine, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Academy of Medical Engineering and Translational Medicine, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>21904096</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D035683\">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>7782-42-5</RegistryNumber><NameOfSubstance UI=\"D006108\">Graphite</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C000628730\">graphene oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D035683\" MajorTopicYN=\"Y\">MicroRNAs</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D021141\" MajorTopicYN=\"Y\">Nucleic Acid Amplification Techniques</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D042241\" MajorTopicYN=\"Y\">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006108\" MajorTopicYN=\"N\">Graphite</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015415\" MajorTopicYN=\"N\">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D057230\" MajorTopicYN=\"N\">Limit of Detection</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">biomarkers</Keyword><Keyword MajorTopicYN=\"N\">early diagnosis</Keyword><Keyword MajorTopicYN=\"N\">plasma miRNAs</Keyword><Keyword MajorTopicYN=\"N\">rolling circle amplification</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273436</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179490</ArticleId><ArticleId IdType=\"pii\">ijms25179490</ArticleId><ArticleId IdType=\"pmc\">PMC11394956</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Scheltens P., De Strooper B., Kivipelto M., Holstege H., Ch&#xe9;telat G., Teunissen C.E., Cummings J., van der Flier W.M. Alzheimer&#x2019;s disease. Lancet. 2021;397:1577&#x2013;1590. doi: 10.1016/S0140-6736(20)32205-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)32205-4</ArticleId><ArticleId IdType=\"pmc\">PMC8354300</ArticleId><ArticleId IdType=\"pubmed\">33667416</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y., Jin H., Xue Y.-H., Chen Q., Yao S.-Y., Du M.-Q., Liu S. Current and future therapeutic strategies for Alzheimer&#x2019;s disease: An overview of drug development bottlenecks. Front. Aging Neurosci. 2023;15:1206572. doi: 10.3389/fnagi.2023.1206572.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1206572</ArticleId><ArticleId IdType=\"pmc\">PMC10438465</ArticleId><ArticleId IdType=\"pubmed\">37600514</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Chen J., Sen S. MicroRNA as Biomarkers and Diagnostics. J. Cell. Physiol. 2016;231:25&#x2013;30. doi: 10.1002/jcp.25056.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcp.25056</ArticleId><ArticleId IdType=\"pmc\">PMC8776330</ArticleId><ArticleId IdType=\"pubmed\">26031493</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgos K., Malenica I., Metpally R., Courtright A., Rakela B., Beach T., Shill H., Adler C., Sabbagh M., Villa S., et al. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer&#x2019;s and Parkinson&#x2019;s diseases correlate with disease status and features of pathology. PLoS ONE. 2014;9:e94839. doi: 10.1371/journal.pone.0094839.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0094839</ArticleId><ArticleId IdType=\"pmc\">PMC4010405</ArticleId><ArticleId IdType=\"pubmed\">24797360</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W.J., Vergallo A., Lista S., Hampel H., Zhao Y. Biomarkers for Alzheimer&#x2019;s Disease (AD) and the Application of Precision Medicine. J. Pers. Med. 2020;10:138. doi: 10.3390/jpm10030138.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jpm10030138</ArticleId><ArticleId IdType=\"pmc\">PMC7565758</ArticleId><ArticleId IdType=\"pubmed\">32967128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou L., Li Q., Jiang L., Qiu H., Geng C., Hong J.-S., Li H., Wang Q. Hypertension and Diagnosis of Parkinson&#x2019;s Disease: A Meta-Analysis of Cohort Studies. Front. Neurol. 2018;9:162. doi: 10.3389/fneur.2018.00162.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2018.00162</ArticleId><ArticleId IdType=\"pmc\">PMC5867351</ArticleId><ArticleId IdType=\"pubmed\">29615961</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobricic V., Schilling M., Schulz J., Zhu L.-S., Zhou C.-W., Fu&#xdf; J., Franzenburg S., Zhu L.-Q., Parkkinen L., Lill C.M., et al. Differential microRNA expression analyses across two brain regions in Alzheimer&#x2019;s disease. Transl. Psychiatry. 2022;12:352. doi: 10.1038/s41398-022-02108-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41398-022-02108-4</ArticleId><ArticleId IdType=\"pmc\">PMC9424308</ArticleId><ArticleId IdType=\"pubmed\">36038535</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon S., Kim S.E., Ko Y., Jeong G.H., Lee K.H., Lee J., Solmi M., Jacob L., Smith L., Stickley A., et al. Differential expression of MicroRNAs in Alzheimer&#x2019;s disease: A systematic review and meta-analysis. Mol. Psychiatry. 2022;27:2405&#x2013;2413. doi: 10.1038/s41380-022-01476-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41380-022-01476-z</ArticleId><ArticleId IdType=\"pubmed\">35264731</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain G., Stuendl A., Rao P., Berulava T., Pena Centeno T., Kaurani L., Burkhardt S., Delalle I., Kornhuber J., H&#xfc;ll M., et al. A combined miRNA-piRNA signature to detect Alzheimer&#x2019;s disease. Transl. Psychiatry. 2019;9:250. doi: 10.1038/s41398-019-0579-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41398-019-0579-2</ArticleId><ArticleId IdType=\"pmc\">PMC6779890</ArticleId><ArticleId IdType=\"pubmed\">31591382</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Z., Gu H., Guo Q., Liang S., Xue J., Yao F., Liu X., Li F., Liu H., Sun L., et al. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer&#x2019;s Disease. Mol. Neurobiol. 2021;58:3084&#x2013;3094. doi: 10.1007/s12035-021-02323-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-021-02323-y</ArticleId><ArticleId IdType=\"pubmed\">33629272</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza V.C., Morais G.S., Henriques A.D., Machado-Silva W., Perez D.I.V., Brito C.J., Camargos E.F., Moraes C.F., N&#xf3;brega O.T. Whole-Blood Levels of MicroRNA-9 Are Decreased in Patients With Late-Onset Alzheimer Disease. Am. J. Alzheimer&#x2019;s Dis. Other Demen. 2020;35:1533317520911573. doi: 10.1177/1533317520911573.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1533317520911573</ArticleId><ArticleId IdType=\"pmc\">PMC10623914</ArticleId><ArticleId IdType=\"pubmed\">32301334</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarbrick S., Wragg N., Ghosh S., Stolzing A. Systematic Review of miRNA as Biomarkers in Alzheimer&#x2019;s Disease. Mol. Neurobiol. 2019;56:6156&#x2013;6167. doi: 10.1007/s12035-019-1500-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-019-1500-y</ArticleId><ArticleId IdType=\"pmc\">PMC6682547</ArticleId><ArticleId IdType=\"pubmed\">30734227</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallick B., Ghosh Z. A complex crosstalk between polymorphic microRNA target sites and AD prognosis. RNA Biol. 2011;8:665&#x2013;673. doi: 10.4161/rna.8.4.15584.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4161/rna.8.4.15584</ArticleId><ArticleId IdType=\"pubmed\">21659796</ArticleId></ArticleIdList></Reference><Reference><Citation>Leidinger P., Backes C., Deutscher S., Schmitt K., Mueller S.C., Frese K., Haas J., Ruprecht K., Paul F., St&#xe4;hler C., et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 2013;14:R78. doi: 10.1186/gb-2013-14-7-r78.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/gb-2013-14-7-r78</ArticleId><ArticleId IdType=\"pmc\">PMC4053778</ArticleId><ArticleId IdType=\"pubmed\">23895045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan D.-Y., Jian J.-M., Huang S., Li W.-W., Shen Y.-Y., Wang Z., Zeng G.-H., Yi X., Jin W.-S., Liu Y.-H., et al. Establishment of combined diagnostic models of Alzheimer&#x2019;s disease in a Chinese cohort: The Chongqing Ageing &amp; Dementia Study (CADS) Transl. Psychiatry. 2022;12:252. doi: 10.1038/s41398-022-02016-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41398-022-02016-7</ArticleId><ArticleId IdType=\"pmc\">PMC9203516</ArticleId><ArticleId IdType=\"pubmed\">35710549</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Tong H., Li T., Wang X., Chen Y. Research progress in molecular biology related quantitative methods of MicroRNA. Am. J. Transl. Res. 2020;12:3198&#x2013;3211.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7407681</ArticleId><ArticleId IdType=\"pubmed\">32774694</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H., Lei J., Ding L., Wen Y., Ju H., Zhang X. MicroRNA: Function, detection, and bioanalysis. Chem. Rev. 2013;113:6207&#x2013;6233. doi: 10.1021/cr300362f.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/cr300362f</ArticleId><ArticleId IdType=\"pubmed\">23697835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt E.A., Broyles D., Head T., Deo S.K. MicroRNA Detection: Current Technology and Research Strategies. Annu. Rev. Anal. Chem. 2015;8:217&#x2013;237. doi: 10.1146/annurev-anchem-071114-040343.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-anchem-071114-040343</ArticleId><ArticleId IdType=\"pubmed\">25973944</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrasekaran A.R., MacIsaac M., Dey P., Levchenko O., Zhou L., Andres M., Dey B.K., Halvorsen K. Cellular microRNA detection with miRacles: microRNA-activated conditional looping of engineered switches. Sci. Adv. 2019;5:eaau9443. doi: 10.1126/sciadv.aau9443.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/sciadv.aau9443</ArticleId><ArticleId IdType=\"pmc\">PMC6415953</ArticleId><ArticleId IdType=\"pubmed\">30891499</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitikultham P., Putnin T., Pimalai D., Sathirapongsasuti N., Kitiyakara C., Jiang Q., Ding B., Japrung D. Ultrasensitive Detection of MicroRNA in Human Saliva via Rolling Circle Amplification Using a DNA-Decorated Graphene Oxide Sensor. ACS Omega. 2023;8:15266&#x2013;15275. doi: 10.1021/acsomega.3c00411.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsomega.3c00411</ArticleId><ArticleId IdType=\"pmc\">PMC10157686</ArticleId><ArticleId IdType=\"pubmed\">37151566</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W., Chen Z., Lu J., Ren X., Ma Y. Ultrasensitive visual detection of miRNA-143 using a CRISPR/Cas12a-based platform coupled with hyperbranched rolling circle amplification. Talanta. 2022;251:123784. doi: 10.1016/j.talanta.2022.123784.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.talanta.2022.123784</ArticleId><ArticleId IdType=\"pubmed\">35988346</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge J., Hu Y., Deng R., Li Z., Zhang K., Shi M., Yang D., Cai R., Tan W. Highly Sensitive MicroRNA Detection by Coupling Nicking-Enhanced Rolling Circle Amplification with MoS Quantum Dots. Anal. Chem. 2020;92:13588&#x2013;13594. doi: 10.1021/acs.analchem.0c03405.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.analchem.0c03405</ArticleId><ArticleId IdType=\"pubmed\">32894943</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali M.M., Li F., Zhang Z., Zhang K., Kang D.-K., Ankrum J.A., Le X.C., Zhao W. Rolling circle amplification: A versatile tool for chemical biology, materials science and medicine. Chem. Soc. Rev. 2014;43:3324&#x2013;3341. doi: 10.1039/c3cs60439j.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/c3cs60439j</ArticleId><ArticleId IdType=\"pubmed\">24643375</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Wang Y., Zhang L., Liu S., Zhang M., Wang J., Ning B., Peng Y., He J., Hu Y., et al. CRISPR-Cas9 Triggered Two-Step Isothermal Amplification Method for E. coli O157:H7 Detection Based on a Metal-Organic Framework Platform. Anal. Chem. 2020;92:3032&#x2013;3041. doi: 10.1021/acs.analchem.9b04162.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.analchem.9b04162</ArticleId><ArticleId IdType=\"pubmed\">31994379</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan T., Mao Y., Sun Q., Liu F., Lin J.-S., Liu Y., Cui J., Jiang Y. Branched rolling circle amplification method for measuring serum circulating microRNA levels for early breast cancer detection. Cancer Sci. 2018;109:2897&#x2013;2906. doi: 10.1111/cas.13725.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cas.13725</ArticleId><ArticleId IdType=\"pmc\">PMC6125458</ArticleId><ArticleId IdType=\"pubmed\">29981251</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian B., Fock J., Minero G.A.S., Garbarino F., Hansen M.F. Ultrasensitive Real-Time Rolling Circle Amplification Detection Enhanced by Nicking-Induced Tandem-Acting Polymerases. Anal. Chem. 2019;91:10102&#x2013;10109. doi: 10.1021/acs.analchem.9b02073.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.analchem.9b02073</ArticleId><ArticleId IdType=\"pubmed\">31246001</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung S.-Y., Su Y.-L., Cheng W., Hu P.-F., Chiang C.-S., Chen W.-T., Hu S.-H. Graphene Quantum Dots-Mediated Theranostic Penetrative Delivery of Drug and Photolytics in Deep Tumors by Targeted Biomimetic Nanosponges. Nano. Lett. 2019;19:69&#x2013;81. doi: 10.1021/acs.nanolett.8b03249.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.nanolett.8b03249</ArticleId><ArticleId IdType=\"pubmed\">30521346</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Sun Z., Zhang X., Liu J. Mechanisms of DNA sensing on graphene oxide. Anal. Chem. 2013;85:7987&#x2013;7993. doi: 10.1021/ac401845p.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/ac401845p</ArticleId><ArticleId IdType=\"pubmed\">23875867</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Wu Y., Wu X., Zhao J.X. A graphene oxide-based fluorescence assay for the sensitive detection of DNA exonuclease enzymatic activity. Analyst. 2019;144:6231&#x2013;6239. doi: 10.1039/C9AN01283D.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C9AN01283D</ArticleId><ArticleId IdType=\"pubmed\">31552930</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwe I., Li Z., Huang J. Graphene oxide and enzyme-assisted dual-cycling amplification method for sensitive fluorometric determination of DNA. Mikrochim. Acta. 2019;186:716. doi: 10.1007/s00604-019-3825-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00604-019-3825-7</ArticleId><ArticleId IdType=\"pubmed\">31654133</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Xu X., Cai Q., Luo X., Zhou Z., Xu G., Xie Y. Graphene oxide-based fluorometric determination of microRNA-141 using rolling circle amplification and exonuclease III-aided recycling amplification. Microchim. Acta. 2019;186:531. doi: 10.1007/s00604-019-3676-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00604-019-3676-2</ArticleId><ArticleId IdType=\"pubmed\">31302786</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Lou Z. Ultrasensitive Detection of Nasopharyngeal Carcinoma-Related MiRNA through Garland Rolling Circle Amplification Integrated Catalytic Hairpin Assembly. ACS Omega. 2021;6:6460&#x2013;6465. doi: 10.1021/acsomega.1c00154.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsomega.1c00154</ArticleId><ArticleId IdType=\"pmc\">PMC7948431</ArticleId><ArticleId IdType=\"pubmed\">33718736</ArticleId></ArticleIdList></Reference><Reference><Citation>Apiwat C., Luksirikul P., Kankla P., Pongprayoon P., Treerattrakoon K., Paiboonsukwong K., Fucharoen S., Dharakul T., Japrung D. Graphene based aptasensor for glycated albumin in diabetes mellitus diagnosis and monitoring. Biosens. Bioelectron. 2016;82:140&#x2013;145. doi: 10.1016/j.bios.2016.04.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bios.2016.04.015</ArticleId><ArticleId IdType=\"pubmed\">27084987</ArticleId></ArticleIdList></Reference><Reference><Citation>Putnin T., Waiwinya W., Pimalai D., Chawjiraphan W., Sathirapongsasuti N., Japrung D. Dual sensitive and rapid detection of glycated human serum albumin using a versatile lead/graphene nanocomposite probe as a fluorescence-electrochemical aptasensor. Analyst. 2021;146:4357&#x2013;4364. doi: 10.1039/D1AN00556A.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D1AN00556A</ArticleId><ArticleId IdType=\"pubmed\">34128007</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Q., Zhou D.-M., Kan Y.-Y., Ge J., Wu Z.-K., Yu R.-Q., Jiang J.-H. Highly sensitive and selective strategy for microRNA detection based on WS2 nanosheet mediated fluorescence quenching and duplex-specific nuclease signal amplification. Anal. Chem. 2014;86:1361&#x2013;1365. doi: 10.1021/ac403944c.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/ac403944c</ArticleId><ArticleId IdType=\"pubmed\">24446758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao S., Wu J., Yan J., Zhang W., Zhu F. Dysregulation of miR-146a: A causative factor in epilepsy pathogenesis, diagnosis, and prognosis. Front. Neurol. 2023;14:1094709. doi: 10.3389/fneur.2023.1094709.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2023.1094709</ArticleId><ArticleId IdType=\"pmc\">PMC10196196</ArticleId><ArticleId IdType=\"pubmed\">37213914</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccardi V., Poli G., Cecchetti R., Bastiani P., Scamosci M., Febo M., Mazzon E., Bruscoli S., Brancorsini S., Mecocci P. miRNAs and Alzheimer&#x2019;s Disease: Exploring the Role of Inflammation and Vitamin E in an Old-Age Population. Nutrients. 2023;15:634. doi: 10.3390/nu15030634.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu15030634</ArticleId><ArticleId IdType=\"pmc\">PMC9919026</ArticleId><ArticleId IdType=\"pubmed\">36771341</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos F., Cabreira V., Rocha S., Massano J. Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review. J. Geriatr. Psychiatry Neurol. 2022;36:267&#x2013;281. doi: 10.1177/08919887221141651.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/08919887221141651</ArticleId><ArticleId IdType=\"pubmed\">36423207</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.-X., Huang Q., Hu Y., Stromberg A.J., Nelson P.T. Patterns of microRNA expression in normal and early Alzheimer&#x2019;s disease human temporal cortex: White matter versus gray matter. Acta Neuropathol. 2011;121:193&#x2013;205. doi: 10.1007/s00401-010-0756-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-010-0756-0</ArticleId><ArticleId IdType=\"pmc\">PMC3073518</ArticleId><ArticleId IdType=\"pubmed\">20936480</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliani A., Gaetani S., Sorgentoni G., Agarbati S., Laggetta M., Matacchione G., Gobbi M., Rossi T., Galeazzi R., Piccinini G., et al. Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer&#x2019;s Disease. Front. Aging Neurosci. 2021;13:647015. doi: 10.3389/fnagi.2021.647015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2021.647015</ArticleId><ArticleId IdType=\"pmc\">PMC7990771</ArticleId><ArticleId IdType=\"pubmed\">33776746</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie B., Liu Z., Jiang L., Liu W., Song M., Zhang Q., Zhang R., Cui D., Wang X., Xu S. Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer&#x2019;s Disease: A 5-Year Follow-up Study. J. Alzheimer&#x2019;s Dis. 2017;55:509&#x2013;520. doi: 10.3233/JAD-160468.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-160468</ArticleId><ArticleId IdType=\"pubmed\">27662297</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z., Zhang K., Zhou H., Jiang L., Xie B., Wang R., Xia W., Yin Y., Gao Z., Cui D., et al. Increased miR-34c mediates synaptic deficits by targeting synaptotagmin 1 through ROS-JNK-p53 pathway in Alzheimer&#x2019;s Disease. Aging Cell. 2020;19:e13125. doi: 10.1111/acel.13125.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/acel.13125</ArticleId><ArticleId IdType=\"pmc\">PMC7059146</ArticleId><ArticleId IdType=\"pubmed\">32092796</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiey M., Nosrati R., Babaei P. Protective effect of miR-34c antagomir against STZ-induced memory impairment by targeting mTOR and PSD-95 in the hippocampus of rats. Neurosci. Lett. 2022;789:136881. doi: 10.1016/j.neulet.2022.136881.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2022.136881</ArticleId><ArticleId IdType=\"pubmed\">36152745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatnagar S., Chertkow H., Schipper H.M., Yuan Z., Shetty V., Jenkins S., Jones T., Wang E. Increased microRNA-34c abundance in Alzheimer&#x2019;s disease circulating blood plasma. Front. Mol. Neurosci. 2014;7:2. doi: 10.3389/fnmol.2014.00002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnmol.2014.00002</ArticleId><ArticleId IdType=\"pmc\">PMC3912349</ArticleId><ArticleId IdType=\"pubmed\">24550773</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha D.J., Mengel D., Mustapic M., Liu W., Selkoe D.J., Kapogiannis D., Galasko D., Rissman R.A., Bennett D.A., Walsh D.M. miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer&#x2019;s Patients. Front. Neurosci. 2019;13:1208. doi: 10.3389/fnins.2019.01208.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2019.01208</ArticleId><ArticleId IdType=\"pmc\">PMC6902042</ArticleId><ArticleId IdType=\"pubmed\">31849573</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie B., Zhou H., Zhang R., Song M., Yu L., Wang L., Liu Z., Zhang Q., Cui D., Wang X., et al. Serum miR-206 and miR-132 as Potential Circulating Biomarkers for Mild Cognitive Impairment. J. Alzheimer&#x2019;s Dis. 2015;45:721&#x2013;731. doi: 10.3233/JAD-142847.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-142847</ArticleId><ArticleId IdType=\"pubmed\">25589731</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Jiang G., Wang S. Neuroprotective Role of MiRNA-9 in Neurological Diseases: A Mini Review. Curr. Mol. Med. 2023;23:1007&#x2013;1011. doi: 10.2174/1566524023666221025123132.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1566524023666221025123132</ArticleId><ArticleId IdType=\"pubmed\">36284391</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rensen S.S., Nygaard A.-B., Christensen T. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer&#x2019;s disease and other types of dementia&#x2014;An exploratory study. Transl. Neurodegener. 2016;5:6. doi: 10.1186/s40035-016-0053-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40035-016-0053-5</ArticleId><ArticleId IdType=\"pmc\">PMC4791887</ArticleId><ArticleId IdType=\"pubmed\">26981236</ArticleId></ArticleIdList></Reference><Reference><Citation>Karuppagounder S.S., Pinto J.T., Xu H., Chen H.-L., Beal M.F., Gibson G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer&#x2019;s disease. Neurochem. Int. 2009;54:111&#x2013;118. doi: 10.1016/j.neuint.2008.10.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuint.2008.10.008</ArticleId><ArticleId IdType=\"pmc\">PMC2892907</ArticleId><ArticleId IdType=\"pubmed\">19041676</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;bert S.S., Horr&#xe9; K., Nicola&#xef; L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer&#x2019;s disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. USA. 2008;105:6415&#x2013;6420. doi: 10.1073/pnas.0710263105.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0710263105</ArticleId><ArticleId IdType=\"pmc\">PMC2359789</ArticleId><ArticleId IdType=\"pubmed\">18434550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zia A., Sahebdel F., Farkhondeh T., Ashrafizadeh M., Zarrabi A., Hushmandi K., Samarghandian S. A review study on the modulation of SIRT1 expression by miRNAs in aging and age-associated diseases. Int. J. Biol. Macromol. 2021;188:52&#x2013;61. doi: 10.1016/j.ijbiomac.2021.08.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijbiomac.2021.08.013</ArticleId><ArticleId IdType=\"pubmed\">34364937</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng C., Meng X., Mai D., Xu K., Qu S. Overexpression of miR-132-3p contributes to neuronal protection in in vitro and in vivo models of Alzheimer&#x2019;s disease. Behav. Brain Res. 2022;417:113584. doi: 10.1016/j.bbr.2021.113584.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbr.2021.113584</ArticleId><ArticleId IdType=\"pubmed\">34536429</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Rapp J., Rainone S., Goupil C., Dorval V., Smith P.Y., Saint-Pierre M., Vall&#xe9;e M., Planel E., Droit A., Calon F., et al. microRNA-132/212 deficiency enhances A&#x3b2; production and senile plaque deposition in Alzheimer&#x2019;s disease triple transgenic mice. Sci. Rep. 2016;6:30953. doi: 10.1038/srep30953.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/srep30953</ArticleId><ArticleId IdType=\"pmc\">PMC4971468</ArticleId><ArticleId IdType=\"pubmed\">27484949</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierksma A., Lu A., Salta E., Vanden Eynden E., Callaerts-Vegh Z., D&#x2019;Hooge R., Blum D., Bu&#xe9;e L., Fiers M., De Strooper B. Deregulation of neuronal miRNAs induced by amyloid-&#x3b2; or TAU pathology. Mol. Neurodegener. 2018;13:54. doi: 10.1186/s13024-018-0285-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-018-0285-1</ArticleId><ArticleId IdType=\"pmc\">PMC6186090</ArticleId><ArticleId IdType=\"pubmed\">30314521</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoyni F., Giudice L., V&#xe4;&#xe4;n&#xe4;nen M.-A., Downes N., Korhonen P., Choo X.Y., V&#xe4;lim&#xe4;ki N.-N., M&#xe4;kinen P., Korvenlaita N., Rozemuller A.J., et al. Alzheimer&#x2019;s disease-induced phagocytic microglia express a specific profile of coding and non-coding RNAs. Alzheimer&#x2019;s Dement. 2024;20:954&#x2013;974. doi: 10.1002/alz.13502.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13502</ArticleId><ArticleId IdType=\"pmc\">PMC10916983</ArticleId><ArticleId IdType=\"pubmed\">37828821</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W., Li Z., Jia Y., Zhu Y., Cai W., Wan P., Zhang Y., Zheng S.G., Zhuo Y. microRNA-21a-5p/PDCD4 axis regulates mesenchymal stem cell-induced neuroprotection in acute glaucoma. J. Mol. Cell Biol. 2017;9:289&#x2013;301. doi: 10.1093/jmcb/mjx022.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jmcb/mjx022</ArticleId><ArticleId IdType=\"pubmed\">28655163</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Salt T.E., Luong V., Wood N., Cheung W., Maass A., Ferrari G., Russo-Marie F., Sillito A.M., Cheetham M.E., et al. Targeting amyloid-beta in glaucoma treatment. Proc. Natl. Acad. Sci. USA. 2007;104:13444&#x2013;13449. doi: 10.1073/pnas.0703707104.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0703707104</ArticleId><ArticleId IdType=\"pmc\">PMC1940230</ArticleId><ArticleId IdType=\"pubmed\">17684098</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Z., Geng X., Zhang Z., Wang Y., Gao X. Rhein Relieves Oxidative Stress in an A&#x3b2;1-42 Oligomer-Burdened Neuron Model by Activating the SIRT1/PGC-1&#x3b1;-Regulated Mitochondrial Biogenesis. Front. Pharmacol. 2021;12:746711. doi: 10.3389/fphar.2021.746711.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2021.746711</ArticleId><ArticleId IdType=\"pmc\">PMC8461019</ArticleId><ArticleId IdType=\"pubmed\">34566664</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X., Zhou Z., Qiu Y., Fan X., Zhao C., Bao J., Liu C., Liu F., Qian W. SIRT1 Regulates Tau Expression and Tau Synaptic Pathology. J. Alzheimer&#x2019;s Dis. 2021;84:895&#x2013;904. doi: 10.3233/JAD-215118.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-215118</ArticleId><ArticleId IdType=\"pubmed\">34602486</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R., Chaterjee P., Sharma P.K., Singh A.K., Gupta A., Gill K., Tripathi M., Dey A.B., Dey S. Sirtuin1: A promising serum protein marker for early detection of Alzheimer&#x2019;s disease. PLoS ONE. 2013;8:e61560. doi: 10.1371/journal.pone.0061560.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0061560</ArticleId><ArticleId IdType=\"pmc\">PMC3628714</ArticleId><ArticleId IdType=\"pubmed\">23613875</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273435</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Psychobiotic Properties of <i>Lactiplantibacillus plantarum</i> in Neurodegenerative Diseases.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9489</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179489</ELocationID><Abstract><AbstractText>Neurodegenerative disorders are the main cause of cognitive and physical disabilities, affect millions of people worldwide, and their incidence is on the rise. Emerging evidence pinpoints a disturbance of the communication of the gut-brain axis, and in particular to gut microbial dysbiosis, as one of the contributors to the pathogenesis of these diseases. In fact, dysbiosis has been associated with neuro-inflammatory processes, hyperactivation of the neuronal immune system, impaired cognitive functions, aging, depression, sleeping disorders, and anxiety. With the rapid advance in metagenomics, metabolomics, and big data analysis, together with a multidisciplinary approach, a new horizon has just emerged in the fields of translational neurodegenerative disease. In fact, recent studies focusing on taxonomic profiling and leaky gut in the pathogenesis of neurodegenerative disorders are not only shedding light on an overlooked field but are also creating opportunities for biomarker discovery and development of new therapeutic and adjuvant strategies to treat these disorders. <i>Lactiplantibacillus plantarum</i> (LBP) strains are emerging as promising psychobiotics for the treatment of these diseases. In fact, LBP strains are able to promote eubiosis, increase the enrichment of bacteria producing beneficial metabolites such as short-chain fatty acids, boost the production of neurotransmitters, and support the homeostasis of the gut-brain axis. In this review, we summarize the current knowledge on the role of the gut microbiota in the pathogenesis of neurodegenerative disorders with a particular focus on the benefits of LBP strains in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, autism, anxiety, and depression.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Di Chiano</LastName><ForeName>Mariagiovanna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Piazza Giulio Cesare n. 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sallustio</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><Identifier Source=\"ORCID\">0000-0002-5132-6532</Identifier><AffiliationInfo><Affiliation>Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Piazza Giulio Cesare n. 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fiocco</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><Identifier Source=\"ORCID\">0000-0002-3654-0362</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rocchetti</LastName><ForeName>Maria Teresa</ForeName><Initials>MT</Initials><Identifier Source=\"ORCID\">0000-0002-2397-6474</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Spano</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0003-1507-9869</Identifier><AffiliationInfo><Affiliation>Department of Agriculture Food Natural Science Engineering (DAFNE), University of Foggia, 71122 Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pontrelli</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source=\"ORCID\">0000-0002-7654-8318</Identifier><AffiliationInfo><Affiliation>Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Piazza Giulio Cesare n. 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Moschetta</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0003-2123-6074</Identifier><AffiliationInfo><Affiliation>Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Piazza Giulio Cesare n. 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Biostructure and Biosystems (INBB), Viale delle Medaglie d'Oro n. 305, 00136 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gesualdo</LastName><ForeName>Loreto</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0002-4861-0911</Identifier><AffiliationInfo><Affiliation>Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Piazza Giulio Cesare n. 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gadaleta</LastName><ForeName>Raffaella Maria</ForeName><Initials>RM</Initials><Identifier Source=\"ORCID\">0000-0003-4951-9543</Identifier><AffiliationInfo><Affiliation>Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Piazza Giulio Cesare n. 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Biostructure and Biosystems (INBB), Viale delle Medaglie d'Oro n. 305, 00136 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gallone</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-2252-9584</Identifier><AffiliationInfo><Affiliation>Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Piazza Giulio Cesare n. 11, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>1062</GrantID><Agency>PON \"RICERCA E INNOVAZIONE\" 2014-2020-Innovazione</Agency><Country/></Grant><Grant><GrantID>Call for tender No. 341 of 15 March 2022 of Italian Ministry of University and Research funded by the European Union - Next Generation EU</GrantID><Agency>National Recovery and Resilience Plan (NRRP)</Agency><Country/></Grant><Grant><GrantID>Concession Decree No. 1550 of 11 October 2022 adopted by the Italian Ministry of University and Research, CUP D93C22000890001</GrantID><Agency>Italian Ministry of University and Research, CUP D93C22000890001</Agency><Country/></Grant><Grant><GrantID>Codice progetto n. 2022H9MPZ5</GrantID><Agency>MIUR- PRIN Progetti di Ricerca di Rilevante Interesse Nazionale 2022</Agency><Country/></Grant><Grant><GrantID>Id. 23239</GrantID><Agency>AIRC IG 2019</Agency><Country/></Grant><Grant><GrantID>Call for tender No. 3138 of 16/12/2021 of Italian Ministry of University and Research funded by the European Union</GrantID><Agency>National Recovery and Resilience Plan (NRRP)</Agency><Country/></Grant><Grant><GrantID>Project code: CN00000041, CUP H93C22000430007</GrantID><Agency>NextGenerationEU</Agency><Country/></Grant><Grant><GrantID>PNRR-MR1-2022-12376395</GrantID><Agency>European Union - Next Generation EU - PNRR M6C2</Agency><Country/></Grant><Grant><GrantID>\"POFACS\" - ARS01_00640 -\", D.D. 1211/2020 and 1104/2021</GrantID><Agency>Italian Ministry of University and Research (MIUR)</Agency><Country/></Grant><Grant><GrantID>PRA-HE 2021</GrantID><Agency>University of Foggia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D019636\" MajorTopicYN=\"Y\">Neurodegenerative Diseases</DescriptorName><QualifierName UI=\"Q000382\" MajorTopicYN=\"N\">microbiology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000069196\" MajorTopicYN=\"Y\">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D019936\" MajorTopicYN=\"Y\">Probiotics</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D064806\" MajorTopicYN=\"N\">Dysbiosis</DescriptorName><QualifierName UI=\"Q000382\" MajorTopicYN=\"N\">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000087502\" MajorTopicYN=\"N\">Brain-Gut Axis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Lactiplantibacillus plantarum</Keyword><Keyword MajorTopicYN=\"N\">gut&#x2013;brain axis</Keyword><Keyword MajorTopicYN=\"N\">microbiome</Keyword><Keyword MajorTopicYN=\"N\">microbiota</Keyword><Keyword MajorTopicYN=\"N\">neurological disorders</Keyword></KeywordList><CoiStatement>The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273435</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179489</ArticleId><ArticleId IdType=\"pii\">ijms25179489</ArticleId><ArticleId IdType=\"pmc\">PMC11394828</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ding C., Wu Y., Chen X., Chen Y., Kang D., Fang W., Chen F. Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990&#x2013;2019. Front. Public Health. 2022;10:952161. doi: 10.3389/fpubh.2022.952161.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpubh.2022.952161</ArticleId><ArticleId IdType=\"pmc\">PMC9745318</ArticleId><ArticleId IdType=\"pubmed\">36523572</ArticleId></ArticleIdList></Reference><Reference><Citation>Carloni S., Bertocchi A., Mancinelli S., Bellini M., Erreni M., Borreca A., Braga D., Giugliano S., Mozzarelli A.M., Manganaro D., et al. Identification of a choroid plexus vascular barrier closing during intestinal inflammation. Science. 2021;374:439&#x2013;448. doi: 10.1126/science.abc6108.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abc6108</ArticleId><ArticleId IdType=\"pubmed\">34672740</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlokovic B.V. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders. Neuron. 2008;57:178&#x2013;201. doi: 10.1016/j.neuron.2008.01.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2008.01.003</ArticleId><ArticleId IdType=\"pubmed\">18215617</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeckxstaens G., Camilleri M., Sifrim D., Houghton L.A., Elsenbruch S., Lindberg G., Azpiroz F., Parkman H.P. Fundamentals of Neurogastroenterology: Physiology/Motility&#x2014;Sensation. Gastroenterology. 2016;150:1292&#x2013;1304.e2. doi: 10.1053/j.gastro.2016.02.030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2016.02.030</ArticleId><ArticleId IdType=\"pubmed\">27144619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998;42:2&#x2013;7. doi: 10.1136/gut.42.1.2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gut.42.1.2</ArticleId><ArticleId IdType=\"pmc\">PMC1726957</ArticleId><ArticleId IdType=\"pubmed\">9505873</ArticleId></ArticleIdList></Reference><Reference><Citation>Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., Vyas J.M., Boes M., Ploegh H.L., Fox J.G., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science. 2005;307:254&#x2013;258. doi: 10.1126/science.1102901.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1102901</ArticleId><ArticleId IdType=\"pubmed\">15653504</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowat A.M., Maloy K.J., Donachie A.M. Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens. Immunology. 1993;80:527&#x2013;534.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC1422256</ArticleId><ArticleId IdType=\"pubmed\">7508416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sender R., Fuchs S., Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14:e1002533. doi: 10.1371/journal.pbio.1002533.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pbio.1002533</ArticleId><ArticleId IdType=\"pmc\">PMC4991899</ArticleId><ArticleId IdType=\"pubmed\">27541692</ArticleId></ArticleIdList></Reference><Reference><Citation>Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., Magris M., Hidalgo G., Baldassano R.N., Anokhin A.P., et al. Human gut microbiome viewed across age and geography. Nature. 2012;486:222&#x2013;227. doi: 10.1038/nature11053.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature11053</ArticleId><ArticleId IdType=\"pmc\">PMC3376388</ArticleId><ArticleId IdType=\"pubmed\">22699611</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrieta M.-C., Stiemsma L.T., Amenyogbe N., Brown E.M., Finlay B. The Intestinal Microbiome in Early Life: Health and Disease. Front. Immunol. 2014;5:427. doi: 10.3389/fimmu.2014.00427.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2014.00427</ArticleId><ArticleId IdType=\"pmc\">PMC4155789</ArticleId><ArticleId IdType=\"pubmed\">25250028</ArticleId></ArticleIdList></Reference><Reference><Citation>Laursen M.F., Bahl M.I., Michaelsen K.F., Licht T.R. First Foods and Gut Microbes. Front. Microbiol. 2017;8:356. doi: 10.3389/fmicb.2017.00356.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2017.00356</ArticleId><ArticleId IdType=\"pmc\">PMC5337510</ArticleId><ArticleId IdType=\"pubmed\">28321211</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollister E.B., Riehle K., Luna R.A., Weidler E.M., Rubio-Gonzales M., Mistretta T.-A., Raza S., Doddapaneni H.V., Metcalf G.A., Muzny D.M., et al. Structure and function of the healthy pre-adolescent pediatric gut microbiome. Microbiome. 2015;3:36. doi: 10.1186/s40168-015-0101-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40168-015-0101-x</ArticleId><ArticleId IdType=\"pmc\">PMC4550057</ArticleId><ArticleId IdType=\"pubmed\">26306392</ArticleId></ArticleIdList></Reference><Reference><Citation>Bien J., Palagani V., Bozko P. The intestinal microbiota dysbiosis and Clostridium difficile infection: Is there a relationship with inflammatory bowel disease? Ther. Adv. Gastroenterol. 2013;6:53&#x2013;68. doi: 10.1177/1756283X12454590.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1756283X12454590</ArticleId><ArticleId IdType=\"pmc\">PMC3539291</ArticleId><ArticleId IdType=\"pubmed\">23320050</ArticleId></ArticleIdList></Reference><Reference><Citation>Knights D., Lassen K.G., Xavier R.J. Advances in inflammatory bowel disease pathogenesis: Linking host genetics and the microbiome. Gut. 2013;62:1505&#x2013;1510. doi: 10.1136/gutjnl-2012-303954.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gutjnl-2012-303954</ArticleId><ArticleId IdType=\"pmc\">PMC3822528</ArticleId><ArticleId IdType=\"pubmed\">24037875</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold J.W., Roach J., Azcarate-Peril M.A. Emerging Technologies for Gut Microbiome Research. Trends Microbiol. 2016;24:887&#x2013;901. doi: 10.1016/j.tim.2016.06.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tim.2016.06.008</ArticleId><ArticleId IdType=\"pmc\">PMC5074899</ArticleId><ArticleId IdType=\"pubmed\">27426971</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull M.J., Plummer N.T. Part 1: The Human Gut Microbiome in Health and Disease. Integr. Med. Clin. J. 2014;13:17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4566439</ArticleId><ArticleId IdType=\"pubmed\">26770121</ArticleId></ArticleIdList></Reference><Reference><Citation>Rath C.M., Dorrestein P.C. The bacterial chemical repertoire mediates metabolic exchange within gut microbiomes. Curr. Opin. Microbiol. 2012;15:147&#x2013;154. doi: 10.1016/j.mib.2011.12.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mib.2011.12.009</ArticleId><ArticleId IdType=\"pmc\">PMC4112563</ArticleId><ArticleId IdType=\"pubmed\">22209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hvas C.L., Dahl J&#xf8;rgensen S.M., J&#xf8;rgensen S.P., Storgaard M., Lemming L., Hansen M.M., Erikstrup C., Dahlerup J.F. Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection. Gastroenterology. 2019;156:1324&#x2013;1332.e3. doi: 10.1053/j.gastro.2018.12.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2018.12.019</ArticleId><ArticleId IdType=\"pubmed\">30610862</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson J.K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., Pettersson S. Host-Gut Microbiota Metabolic Interactions. Science. 2012;336:1262&#x2013;1267. doi: 10.1126/science.1223813.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1223813</ArticleId><ArticleId IdType=\"pubmed\">22674330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange K., Buerger M., Stallmach A., Bruns T. Effects of Antibiotics on Gut Microbiota. Dig. Dis. 2016;34:260&#x2013;268. doi: 10.1159/000443360.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000443360</ArticleId><ArticleId IdType=\"pubmed\">27028893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-J., Li S., Gan R.-Y., Zhou T., Xu D.-P., Li H.-B. Impacts of Gut Bacteria on Human Health and Diseases. Int. J. Mol. Sci. 2015;16:7493&#x2013;7519. doi: 10.3390/ijms16047493.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms16047493</ArticleId><ArticleId IdType=\"pmc\">PMC4425030</ArticleId><ArticleId IdType=\"pubmed\">25849657</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyte M. Microbial endocrinology: Host-microbiota neuroendocrine interactions influencing brain and behavior. Gut Microbes. 2014;5:381&#x2013;389. doi: 10.4161/gmic.28682.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4161/gmic.28682</ArticleId><ArticleId IdType=\"pmc\">PMC4153777</ArticleId><ArticleId IdType=\"pubmed\">24690573</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu G., Gao Y., Tuo Y., Li H., Zhang Y., Qian F., Jiang S. Assessing and comparing antioxidant activities of lactobacilli strains by using different chemical and cellular antioxidant methods. J. Dairy Sci. 2018;101:10792&#x2013;10806. doi: 10.3168/jds.2018-14989.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3168/jds.2018-14989</ArticleId><ArticleId IdType=\"pubmed\">30268622</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao M., Xiao Z.J., Yang B., Lan Z., Fang F. Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders. Front. Neurosci. 2020;14:764. doi: 10.3389/fnins.2020.00764.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2020.00764</ArticleId><ArticleId IdType=\"pmc\">PMC7438939</ArticleId><ArticleId IdType=\"pubmed\">32903669</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryan J.F., O&#x2019;Riordan K.J., Sandhu K., Peterson V., Dinan T.G. The gut microbiome in neurological disorders. Lancet Neurol. 2020;19:179&#x2013;194. doi: 10.1016/S1474-4422(19)30356-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(19)30356-4</ArticleId><ArticleId IdType=\"pubmed\">31753762</ArticleId></ArticleIdList></Reference><Reference><Citation>Yano J.M., Yu K., Donaldson G.P., Shastri G.G., Ann P., Ma L., Nagler C.R., Ismagilov R.F., Mazmanian S.K., Hsiao E.Y. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161:264&#x2013;276. doi: 10.1016/j.cell.2015.02.047.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2015.02.047</ArticleId><ArticleId IdType=\"pmc\">PMC4393509</ArticleId><ArticleId IdType=\"pubmed\">25860609</ArticleId></ArticleIdList></Reference><Reference><Citation>Roager H.M., Licht T.R. Microbial tryptophan catabolites in health and disease. Nat. Commun. 2018;9:3294. doi: 10.1038/s41467-018-05470-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-018-05470-4</ArticleId><ArticleId IdType=\"pmc\">PMC6098093</ArticleId><ArticleId IdType=\"pubmed\">30120222</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett E., Ross R.P., O&#x2019;Toole P.W., Fitzgerald G.F., Stanton C. &#x3b3;-Aminobutyric acid production by culturable bacteria from the human intestine. J. Appl. Microbiol. 2012;113:411&#x2013;417. doi: 10.1111/j.1365-2672.2012.05344.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2672.2012.05344.x</ArticleId><ArticleId IdType=\"pubmed\">22612585</ArticleId></ArticleIdList></Reference><Reference><Citation>Kali A. Psychobiotics: An emerging probiotic in psychiatric practice. Biomed. J. 2016;39:223&#x2013;224. doi: 10.1016/j.bj.2015.11.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bj.2015.11.004</ArticleId><ArticleId IdType=\"pmc\">PMC6140288</ArticleId><ArticleId IdType=\"pubmed\">27621125</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Qiu T., Huang G., Cao Y. Production of gamma-aminobutyric acid by Lactobacillus brevis NCL912 using fed-batch fermentation. Microb. Cell Factories. 2010;9:85. doi: 10.1186/1475-2859-9-85.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1475-2859-9-85</ArticleId><ArticleId IdType=\"pmc\">PMC2996345</ArticleId><ArticleId IdType=\"pubmed\">21070676</ArticleId></ArticleIdList></Reference><Reference><Citation>Mombereau C., Kaupmann K., Froestl W., Sansig G., van der Putten H., Cryan J.F. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. . 2004;29:1050&#x2013;1062. doi: 10.1038/sj.npp.1300413.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.npp.1300413</ArticleId><ArticleId IdType=\"pubmed\">15039762</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang S., Wang T., Hu X., Luo J., Li W., Wu X., Duan Y., Jin F. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience. 2015;310:561&#x2013;577. doi: 10.1016/j.neuroscience.2015.09.033.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroscience.2015.09.033</ArticleId><ArticleId IdType=\"pubmed\">26408987</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L.-H., Liu Y.-W., Wu C.-C., Wang S., Tsai Y.-C. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders. J. Food Drug Anal. 2019;27:632&#x2013;648. doi: 10.1016/j.jfda.2019.01.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jfda.2019.01.002</ArticleId><ArticleId IdType=\"pmc\">PMC9307042</ArticleId><ArticleId IdType=\"pubmed\">31324280</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W.-H., Chuang H.-L., Huang Y.-T., Wu C.-C., Chou G.-T., Wang S., Tsai Y.-C. Alteration of behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free mice. Behav. Brain Res. 2016;298:202&#x2013;209. doi: 10.1016/j.bbr.2015.10.046.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbr.2015.10.046</ArticleId><ArticleId IdType=\"pubmed\">26522841</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.-W., Liu W.-H., Wu C.-C., Juan Y.-C., Wu Y.-C., Tsai H.-P., Wang S., Tsai Y.-C. Psychotropic effects of Lactobacillus plantarum PS128 in early life-stressed and na&#xef;ve adult mice. Brain Res. 2016;1631:1&#x2013;12. doi: 10.1016/j.brainres.2015.11.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainres.2015.11.018</ArticleId><ArticleId IdType=\"pubmed\">26620542</ArticleId></ArticleIdList></Reference><Reference><Citation>Braniste V., Al-Asmakh M., Kowal C., Anuar F., Abbaspour A., T&#xf3;th M., Korecka A., Bakocevic N., Ng L.G., Kundu P., et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 2014;6:263ra158. doi: 10.1126/scitranslmed.3009759.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/scitranslmed.3009759</ArticleId><ArticleId IdType=\"pmc\">PMC4396848</ArticleId><ArticleId IdType=\"pubmed\">25411471</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman M.P., Bennett S.H., Hwang F.F.Y., Yu C. Neonatal small bowel epithelia: Enhancing anti-bacterial defense with lactoferrin and Lactobacillus GG. Biometals Int. J. Role Met. Ions Biol. Biochem. Med. 2004;17:285&#x2013;289. doi: 10.1023/B:BIOM.0000027706.51112.62.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1023/B:BIOM.0000027706.51112.62</ArticleId><ArticleId IdType=\"pubmed\">15222479</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee S., Lukiw W.J. Alzheimer&#x2019;s disease and the microbiome. Front. Cell. Neurosci. 2013;7:153. doi: 10.3389/fncel.2013.00153.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2013.00153</ArticleId><ArticleId IdType=\"pmc\">PMC3775450</ArticleId><ArticleId IdType=\"pubmed\">24062644</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59&#x2013;65. doi: 10.1038/nature08821.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature08821</ArticleId><ArticleId IdType=\"pmc\">PMC3779803</ArticleId><ArticleId IdType=\"pubmed\">20203603</ArticleId></ArticleIdList></Reference><Reference><Citation>Brydges C.R., Fiehn O., Mayberg H.S., Schreiber H., Dehkordi S.M., Bhattacharyya S., Cha J., Choi K.S., Craighead W.E., Krishnan R.R., et al. Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature. Sci. Rep. 2021;11:21011. doi: 10.1038/s41598-021-99845-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-021-99845-1</ArticleId><ArticleId IdType=\"pmc\">PMC8546034</ArticleId><ArticleId IdType=\"pubmed\">34697401</ArticleId></ArticleIdList></Reference><Reference><Citation>Salminen A. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer&#x2019;s disease: Role of tryptophan metabolites generated by gut host-microbiota. J. Mol. Med. 2023;101:201&#x2013;222. doi: 10.1007/s00109-023-02289-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00109-023-02289-5</ArticleId><ArticleId IdType=\"pmc\">PMC10036442</ArticleId><ArticleId IdType=\"pubmed\">36757399</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobot M., Thomas L., Moyon A., Fernandez S., McKay N., Balasse L., Garrigue P., Brige P., Chopinet S., Poitevin S., et al. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction. J. Am. Soc. Nephrol. JASN. 2020;31:1509&#x2013;1521. doi: 10.1681/ASN.2019070728.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1681/ASN.2019070728</ArticleId><ArticleId IdType=\"pmc\">PMC7350986</ArticleId><ArticleId IdType=\"pubmed\">32527975</ArticleId></ArticleIdList></Reference><Reference><Citation>Burokas A., Arboleya S., Moloney R.D., Peterson V.L., Murphy K., Clarke G., Stanton C., Dinan T.G., Cryan J.F. Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice. Biol. Psychiatry. 2017;82:472&#x2013;487. doi: 10.1016/j.biopsych.2016.12.031.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopsych.2016.12.031</ArticleId><ArticleId IdType=\"pubmed\">28242013</ArticleId></ArticleIdList></Reference><Reference><Citation>Valvassori S.S., Resende W.R., Budni J., Dal-Pont G.C., Bavaresco D.V., R&#xe9;us G.Z., Carvalho A.F., Gon&#xe7;alves C.L., Furlanetto C.B., Streck E.L., et al. Sodium Butyrate, a Histone Deacetylase Inhibitor, Reverses Behavioral and Mitochondrial Alterations in Animal Models of Depression Induced by Early- or Late-life Stress. Curr. Neurovasc. Res. 2015;12:312&#x2013;320. doi: 10.2174/1567202612666150728121121.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567202612666150728121121</ArticleId><ArticleId IdType=\"pubmed\">26216027</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y., Melas P.A., Wegener G., Math&#xe9; A.A., Lavebratt C. Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene. Int. J. Neuropsychopharmacol. 2014;18:pyu032. doi: 10.1093/ijnp/pyu032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ijnp/pyu032</ArticleId><ArticleId IdType=\"pmc\">PMC4368891</ArticleId><ArticleId IdType=\"pubmed\">25618518</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabouridis P.S., Lasrado R., McCallum S., Chng S.H., Snippert H.J., Clevers H., Pettersson S., Pachnis V. Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron. 2015;85:289&#x2013;295. doi: 10.1016/j.neuron.2014.12.037.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2014.12.037</ArticleId><ArticleId IdType=\"pmc\">PMC4306542</ArticleId><ArticleId IdType=\"pubmed\">25578362</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J.H., Pomare E.W., Branch W.J., Naylor C.P., Macfarlane G.T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28:1221&#x2013;1227. doi: 10.1136/gut.28.10.1221.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gut.28.10.1221</ArticleId><ArticleId IdType=\"pmc\">PMC1433442</ArticleId><ArticleId IdType=\"pubmed\">3678950</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vadder F., Kovatcheva-Datchary P., Goncalves D., Vinera J., Zitoun C., Duchampt A., B&#xe4;ckhed F., Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell. 2014;156:84&#x2013;96. doi: 10.1016/j.cell.2013.12.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2013.12.016</ArticleId><ArticleId IdType=\"pubmed\">24412651</ArticleId></ArticleIdList></Reference><Reference><Citation>Erny D., Hrab&#x11b; de Angelis A.L., Jaitin D., Wieghofer P., Staszewski O., David E., Keren-Shaul H., Mahlakoiv T., Jakobshagen K., Buch T., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 2015;18:965&#x2013;977. doi: 10.1038/nn.4030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nn.4030</ArticleId><ArticleId IdType=\"pmc\">PMC5528863</ArticleId><ArticleId IdType=\"pubmed\">26030851</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvani R., Picca A., Lo Monaco M.R., Landi F., Bernabei R., Marzetti E. Of Microbes and Minds: A Narrative Review on the Second Brain Aging. Front. Med. 2018;5:53. doi: 10.3389/fmed.2018.00053.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmed.2018.00053</ArticleId><ArticleId IdType=\"pmc\">PMC5840854</ArticleId><ArticleId IdType=\"pubmed\">29552561</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N., Singh V., Rai S.N., Mishra V., Vamanu E., Singh M.P. Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes. Biomed. Pharmacother. 2022;156:113958. doi: 10.1016/j.biopha.2022.113958.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2022.113958</ArticleId><ArticleId IdType=\"pubmed\">36411639</ArticleId></ArticleIdList></Reference><Reference><Citation>Askarova S., Umbayev B., Masoud A.-R., Kaiyrlykyzy A., Safarova Y., Tsoy A., Olzhayev F., Kushugulova A. The Links Between the Gut Microbiome, Aging, Modern Lifestyle and Alzheimer&#x2019;s Disease. Front. Cell. Infect. Microbiol. 2020;10:104. doi: 10.3389/fcimb.2020.00104.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcimb.2020.00104</ArticleId><ArticleId IdType=\"pmc\">PMC7093326</ArticleId><ArticleId IdType=\"pubmed\">32257964</ArticleId></ArticleIdList></Reference><Reference><Citation>Molinero N., Ant&#xf3;n-Fern&#xe1;ndez A., Hern&#xe1;ndez F., &#xc1;vila J., Bartolom&#xe9; B., Moreno-Arribas M.V. Gut Microbiota, an Additional Hallmark of Human Aging and Neurodegeneration. Neuroscience. 2023;518:141&#x2013;161. doi: 10.1016/j.neuroscience.2023.02.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroscience.2023.02.014</ArticleId><ArticleId IdType=\"pubmed\">36893982</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xf6;hlich E.E., Farzi A., Mayerhofer R., Reichmann F., Ja&#x10d;an A., Wagner B., Zinser E., Bordag N., Magnes C., Fr&#xf6;hlich E., et al. Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication. Brain. Behav. Immun. 2016;56:140&#x2013;155. doi: 10.1016/j.bbi.2016.02.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2016.02.020</ArticleId><ArticleId IdType=\"pmc\">PMC5014122</ArticleId><ArticleId IdType=\"pubmed\">26923630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim N., Yun M., Oh Y.J., Choi H.-J. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics. J. Microbiol. 2018;56:172&#x2013;182. doi: 10.1007/s12275-018-8032-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12275-018-8032-4</ArticleId><ArticleId IdType=\"pubmed\">29492874</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;rkl S., Butler M.I., Holl A., Cryan J.F., Dinan T.G. Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry. Curr. Nutr. Rep. 2020;9:171&#x2013;182. doi: 10.1007/s13668-020-00313-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13668-020-00313-5</ArticleId><ArticleId IdType=\"pmc\">PMC7398953</ArticleId><ArticleId IdType=\"pubmed\">32406013</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M.P., Arumugam T.V. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. Cell Metab. 2018;27:1176&#x2013;1199. doi: 10.1016/j.cmet.2018.05.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2018.05.011</ArticleId><ArticleId IdType=\"pmc\">PMC6039826</ArticleId><ArticleId IdType=\"pubmed\">29874566</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N., Yadav V.K., Gacem A., Al-Dossari M., Yadav K.K., Abd El-Gawaad N.S., Ben Khedher N., Choudhary N., Kumar P., Cavalu S. Deleterious Effect of Air Pollution on Human Microbial Community and Bacterial Flora: A Short Review. Int. J. Environ. Res. Public Health. 2022;19:15494. doi: 10.3390/ijerph192315494.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijerph192315494</ArticleId><ArticleId IdType=\"pmc\">PMC9738139</ArticleId><ArticleId IdType=\"pubmed\">36497569</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zhao F., Wang Y., Chen J., Tao J., Tian G., Wu S., Liu W., Cui Q., Geng B., et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5:14. doi: 10.1186/s40168-016-0222-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40168-016-0222-x</ArticleId><ArticleId IdType=\"pmc\">PMC5286796</ArticleId><ArticleId IdType=\"pubmed\">28143587</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao J.-F., Cheng Y.-F., You S.-T., Kuo W.-C., Huang C.-W., Chiou J.-J., Hsu C.-C., Hsieh-Li H.-M., Wang S., Tsai Y.-C. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson&#x2019;s disease. Brain Behav. Immun. 2020;90:26&#x2013;46. doi: 10.1016/j.bbi.2020.07.036.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2020.07.036</ArticleId><ArticleId IdType=\"pubmed\">32739365</ArticleId></ArticleIdList></Reference><Reference><Citation>Food and Agriculture Organization of the United Nations (FAO)  Publication Preview Page. FAO Documents.  [(accessed on 15 February 2024)].  Available online:  https://www.fao.org/documents/card/en?details=7c102d95-2fd5-5b22-8faf-f0b2e68dfbb6/</Citation></Reference><Reference><Citation>Bosco N., Noti M. The aging gut microbiome and its impact on host immunity. Genes Immun. 2021;22:289&#x2013;303. doi: 10.1038/s41435-021-00126-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41435-021-00126-8</ArticleId><ArticleId IdType=\"pmc\">PMC8054695</ArticleId><ArticleId IdType=\"pubmed\">33875817</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogal A., Valdes A.M., Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes. 2021;13:1897212. doi: 10.1080/19490976.2021.1897212.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/19490976.2021.1897212</ArticleId><ArticleId IdType=\"pmc\">PMC8007165</ArticleId><ArticleId IdType=\"pubmed\">33764858</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.M., Islam M.R., Shohag S., Ahasan M.T., Sarkar N., Khan H., Hasan A.M., Cavalu S., Rauf A. Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies. Biomed. Pharmacother. 2022;149:112898. doi: 10.1016/j.biopha.2022.112898.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2022.112898</ArticleId><ArticleId IdType=\"pubmed\">35381448</ArticleId></ArticleIdList></Reference><Reference><Citation>Foglietta F., Serpe L., Canaparo R. The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems. Cells. 2021;10:3295. doi: 10.3390/cells10123295.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells10123295</ArticleId><ArticleId IdType=\"pmc\">PMC8699241</ArticleId><ArticleId IdType=\"pubmed\">34943803</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong S., Kim Y., Park S., Lee D., Lee J., Hlaing S.P., Yoo J.-W., Rhee S.H., Im E. Lactobacillus plantarum Metabolites Elicit Anticancer Effects by Inhibiting Autophagy-Related Responses. Molecules. 2023;28:1890. doi: 10.3390/molecules28041890.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules28041890</ArticleId><ArticleId IdType=\"pmc\">PMC9966080</ArticleId><ArticleId IdType=\"pubmed\">36838877</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Xiao H., Su Y., Cheng D., Jia Y., Li Y., Yin Q., Gao J., Tang Y., Bai Q. Synergistic Inhibitory Effect of Honey and Lactobacillus plantarum on Pathogenic Bacteria and Their Promotion of Healing in Infected Wounds. Pathogens. 2023;12:501. doi: 10.3390/pathogens12030501.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pathogens12030501</ArticleId><ArticleId IdType=\"pmc\">PMC10053434</ArticleId><ArticleId IdType=\"pubmed\">36986423</ArticleId></ArticleIdList></Reference><Reference><Citation>OjiNjideka Hemphill N., Pezley L., Steffen A., Elam G., Kominiarek M.A., Odoms-Young A., Kessee N., Hamm A., Tussing-Humphreys L., Koenig M.D. Feasibility Study of Lactobacillus plantarum 299v Probiotic Supplementation in an Urban Academic Facility among Diverse Pregnant Individuals. Nutrients. 2023;15:875. doi: 10.3390/nu15040875.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu15040875</ArticleId><ArticleId IdType=\"pmc\">PMC9966742</ArticleId><ArticleId IdType=\"pubmed\">36839232</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Ke Y., Zhan R., Liu C., Zhao M., Zeng A., Shi X., Ji L., Cheng S., Pan B., et al. Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice. Aging Cell. 2018;17:e12768. doi: 10.1111/acel.12768.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/acel.12768</ArticleId><ArticleId IdType=\"pmc\">PMC6052480</ArticleId><ArticleId IdType=\"pubmed\">29749694</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy Sarkar S., Banerjee S. Gut microbiota in neurodegenerative disorders. J. Neuroimmunol. 2019;328:98&#x2013;104. doi: 10.1016/j.jneuroim.2019.01.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jneuroim.2019.01.004</ArticleId><ArticleId IdType=\"pubmed\">30658292</ArticleId></ArticleIdList></Reference><Reference><Citation>Seddik H.A., Bendali F., Gancel F., Fliss I., Spano G., Drider D. Lactobacillus plantarum and Its Probiotic and Food Potentialities. Probiotics Antimicrob. Proteins. 2017;9:111&#x2013;122. doi: 10.1007/s12602-017-9264-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12602-017-9264-z</ArticleId><ArticleId IdType=\"pubmed\">28271469</ArticleId></ArticleIdList></Reference><Reference><Citation>Cammarota G., Ianiro G., Bibb&#xf2; S., Gasbarrini A. Gut microbiota modulation: Probiotics, antibiotics or fecal microbiota transplantation? Intern. Emerg. Med. 2014;9:365&#x2013;373. doi: 10.1007/s11739-014-1069-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11739-014-1069-4</ArticleId><ArticleId IdType=\"pubmed\">24664520</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho S.-T., Hsieh Y.-T., Wang S.-Y., Chen M.-J. Improving effect of a probiotic mixture on memory and learning abilities in d-galactose&#x2013;treated aging mice. J. Dairy Sci. 2019;102:1901&#x2013;1909. doi: 10.3168/jds.2018-15811.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3168/jds.2018-15811</ArticleId><ArticleId IdType=\"pubmed\">30639021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S.-W., Tsai Y.-S., Chen Y.-L., Wang M.-F., Chen C.-C., Lin W.-H., Fang T.J. Lactobacillus plantarum GKM3 Promotes Longevity, Memory Retention, and Reduces Brain Oxidation Stress in SAMP8 Mice. Nutrients. 2021;13:2860. doi: 10.3390/nu13082860.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu13082860</ArticleId><ArticleId IdType=\"pmc\">PMC8401498</ArticleId><ArticleId IdType=\"pubmed\">34445020</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Y., Zhang J., Zhou X., Yi R., Mu J., Long X., Pan Y., Zhao X., Liu W. Lactobacillus plantarum CQPC11 Isolated from Sichuan Pickled Cabbages Antagonizes d-galactose-Induced Oxidation and Aging in Mice. Molecules. 2018;23:3026. doi: 10.3390/molecules23113026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules23113026</ArticleId><ArticleId IdType=\"pmc\">PMC6278364</ArticleId><ArticleId IdType=\"pubmed\">30463304</ArticleId></ArticleIdList></Reference><Reference><Citation>Samtiya M., Puniya A.K., Puniya M., Shah N.P., Dhewa T., Vemuri R. Probiotic Regulation to Modulate Aging Gut and Brain Health: A Concise Review. Bacteria. 2022;1:250&#x2013;265. doi: 10.3390/bacteria1040019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/bacteria1040019</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Zhou H., Deng L., Wang L., Chen J., Zhou X. Serine Deficiency Exacerbates Inflammation and Oxidative Stress via Microbiota-Gut-Brain Axis in D-Galactose-Induced Aging Mice. Mediat. Inflamm. 2020;2020:e5821428. doi: 10.1155/2020/5821428.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2020/5821428</ArticleId><ArticleId IdType=\"pmc\">PMC7071807</ArticleId><ArticleId IdType=\"pubmed\">32189994</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Yu D., Xue L., Li H., Du J. Probiotics modulate the microbiota&#x2013;gut&#x2013;brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm. Sin. B. 2020;10:475&#x2013;487. doi: 10.1016/j.apsb.2019.07.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.apsb.2019.07.001</ArticleId><ArticleId IdType=\"pmc\">PMC7049608</ArticleId><ArticleId IdType=\"pubmed\">32140393</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaydi A.I., Lew L.-C., Hor Y.-Y., Jaafar M.H., Chuah L.-O., Yap K.-P., Azlan A., Azzam G., Liong M.-T. Lactobacillus plantarum DR7 improved brain health in aging rats via the serotonin, inflammatory and apoptosis pathways. Benef. Microbes. 2020;11:753&#x2013;766. doi: 10.3920/BM2019.0200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3920/BM2019.0200</ArticleId><ArticleId IdType=\"pubmed\">33245015</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Zhao X., Jiang Y., Zhao W., Guo T., Cao Y., Teng J., Hao X., Zhao J., Yang Z. Antioxidant status and gut microbiota change in an aging mouse model as influenced by exopolysaccharide produced by Lactobacillus plantarum YW11 isolated from Tibetan kefir. J. Dairy Sci. 2017;100:6025&#x2013;6041. doi: 10.3168/jds.2016-12480.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3168/jds.2016-12480</ArticleId><ArticleId IdType=\"pubmed\">28551178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Sun H., Tan F., Yi R., Zhou C., Deng Y., Mu J., Zhao X. Anti-aging effect of Lactobacillus plantarum HFY09-fermented soymilk on D-galactose-induced oxidative aging in mice through modulation of the Nrf2 signaling pathway. J. Funct. Foods. 2021;78:104386. doi: 10.1016/j.jff.2021.104386.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jff.2021.104386</ArticleId></ArticleIdList></Reference><Reference><Citation>Moqri M., Herzog C., Poganik J.R., Justice J., Belsky D.W., Higgins-Chen A., Moskalev A., Fuellen G., Cohen A.A., Bautmans I., et al. Biomarkers of aging for the identification and evaluation of longevity interventions. Cell. 2023;186:3758&#x2013;3775. doi: 10.1016/j.cell.2023.08.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2023.08.003</ArticleId><ArticleId IdType=\"pmc\">PMC11088934</ArticleId><ArticleId IdType=\"pubmed\">37657418</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzievski&#x12d; S.A., Kapel&#x2019;ko V.I. The strength and rate of contraction of the myocardium of the cardiac ventricles. Biull. Eksp. Biol. Med. 1969;67:3&#x2013;5.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">5821428</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedin M.M., Chourasia R., Phukon L.C., Sarkar P., Ray R.C., Singh S.P., Rai A.K. Lactic acid bacteria in the functional food industry: Biotechnological properties and potential applications. Crit. Rev. Food Sci. Nutr. 2023;5:1&#x2013;19. doi: 10.1080/10408398.2023.2227896.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10408398.2023.2227896</ArticleId><ArticleId IdType=\"pubmed\">37405373</ArticleId></ArticleIdList></Reference><Reference><Citation>Axelsson L. Lactic Acid Bacteria: Classification and Physiology. In: Salminen S., Von Wright A., Ouwehand A., editors. Lactic Acid Bacteria. CRC Press; Boca Raton, FL, USA: 2004.</Citation></Reference><Reference><Citation>Guarner F., Malagelada J.-R. Gut flora in health and disease. Lancet Lond. Engl. 2003;361:512&#x2013;519. doi: 10.1016/S0140-6736(03)12489-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(03)12489-0</ArticleId><ArticleId IdType=\"pubmed\">12583961</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves J.L., Lemos L., Rodrigues N.M., Pereira V.B., Barros P.A.V., Canesso M.C.C., Guimar&#xe3;es M.A.F., Cara D.C., Miyoshi A., Azevedo V.A., et al. Immunomodulatory effects of different strains of Lactococcus lactis in DSS-induced colitis. Braz. J. Microbiol. 2023;54:1203&#x2013;1215. doi: 10.1007/s42770-023-00928-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s42770-023-00928-0</ArticleId><ArticleId IdType=\"pmc\">PMC10234881</ArticleId><ArticleId IdType=\"pubmed\">36821043</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis. Cell. 2004;118:229&#x2013;241. doi: 10.1016/j.cell.2004.07.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2004.07.002</ArticleId><ArticleId IdType=\"pubmed\">15260992</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaretti A., di Nunzio M., Pompei A., Raimondi S., Rossi M., Bordoni A. Antioxidant properties of potentially probiotic bacteria: In vitro and in vivo activities. Appl. Microbiol. Biotechnol. 2013;97:809&#x2013;817. doi: 10.1007/s00253-012-4241-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00253-012-4241-7</ArticleId><ArticleId IdType=\"pubmed\">22790540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianniello R.G., Ricciardi A., Parente E., Tramutola A., Reale A., Zotta T. Aeration and supplementation with heme and menaquinone affect survival to stresses and antioxidant capability of Lactobacillus casei strains. LWT&#x2014;Food Sci. Technol. 2015;60:817&#x2013;824. doi: 10.1016/j.lwt.2014.10.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lwt.2014.10.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wu Y., Wang Y., Xu H., Mei X., Yu D., Wang Y., Li W. Antioxidant Properties of Probiotic Bacteria. Nutrients. 2017;9:521. doi: 10.3390/nu9050521.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu9050521</ArticleId><ArticleId IdType=\"pmc\">PMC5452251</ArticleId><ArticleId IdType=\"pubmed\">28534820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J., Wittouck S., Salvetti E., Franz C.M.A.P., Harris H.M.B., Mattarelli P., O&#x2019;Toole P.W., Pot B., Vandamme P., Walter J., et al. A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int. J. Syst. Evol. Microbiol. 2020;70:2782&#x2013;2858. doi: 10.1099/ijsem.0.004107.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1099/ijsem.0.004107</ArticleId><ArticleId IdType=\"pubmed\">32293557</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino M.E., Bayjanov J.R., Caffrey B.E., Wels M., Joncour P., Hughes S., Gillet B., Kleerebezem M., van Hijum S.A.F.T., Leulier F. Nomadic lifestyle of Lactobacillus plantarum revealed by comparative genomics of 54 strains isolated from different habitats. Environ. Microbiol. 2016;18:4974&#x2013;4989. doi: 10.1111/1462-2920.13455.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/1462-2920.13455</ArticleId><ArticleId IdType=\"pubmed\">27422487</ArticleId></ArticleIdList></Reference><Reference><Citation>Fidanza M., Panigrahi P., Kollmann T.R. Lactiplantibacillus plantarum-Nomad and Ideal Probiotic. Front. Microbiol. 2021;12:712236. doi: 10.3389/fmicb.2021.712236.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2021.712236</ArticleId><ArticleId IdType=\"pmc\">PMC8527090</ArticleId><ArticleId IdType=\"pubmed\">34690957</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordstr&#xf6;m E.A., Teixeira C., Montelius C., Jeppsson B., Larsson N. Lactiplantibacillus plantarum 299v (LP299V&#xae;): Three decades of research. Benef. Microbes. 2021;12:441&#x2013;465. doi: 10.3920/BM2020.0191.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3920/BM2020.0191</ArticleId><ArticleId IdType=\"pubmed\">34365915</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;tt P., Songisepp E., R&#xe4;tsep M., Mahlapuu R., Kilk K., Mikelsaar M. Impact of probiotic Lactobacillus plantarum TENSIA in different dairy products on anthropometric and blood biochemical indices of healthy adults. Benef. Microbes. 2015;6:233&#x2013;243. doi: 10.3920/BM2014.0035.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3920/BM2014.0035</ArticleId><ArticleId IdType=\"pubmed\">25524863</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawa-Szewieczek A., Adamczak M., Kwiecie&#x144; K., Dudzicz S., Gazda M., Wi&#x119;cek A. The Effect of Lactobacillus plantarum 299v on the Incidence of Clostridium difficile Infection in High Risk Patients Treated with Antibiotics. Nutrients. 2015;7:10179&#x2013;10188. doi: 10.3390/nu7125526.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu7125526</ArticleId><ArticleId IdType=\"pmc\">PMC4690078</ArticleId><ArticleId IdType=\"pubmed\">26690209</ArticleId></ArticleIdList></Reference><Reference><Citation>McNicholl A.G., Molina-Infante J., Lucendo A.J., Calleja J.L., P&#xe9;rez-Aisa &#xc1;., Modolell I., Aldeguer X., Calafat M., Comino L., Ramas M., et al. Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial. Helicobacter. 2018;23:e12529. doi: 10.1111/hel.12529.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/hel.12529</ArticleId><ArticleId IdType=\"pubmed\">30141228</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicariotto F., Mogna L., Del Piano M. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: A pilot study. J. Clin. Gastroenterol. 2014;48((Suppl. S1)):S106&#x2013;S112. doi: 10.1097/MCG.0000000000000226.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MCG.0000000000000226</ArticleId><ArticleId IdType=\"pubmed\">25291116</ArticleId></ArticleIdList></Reference><Reference><Citation>Barraza-Ortiz D.A., P&#xe9;rez-L&#xf3;pez N., Medina-L&#xf3;pez V.M., Minero-Alfaro J.I., Zamarripa-Dorsey F., Fern&#xe1;ndez-Mart&#xed;nez N.d.C., Llorente-Ram&#xf3;n A., Ramos-Aguilar G.A. Combination of a Probiotic and an Antispasmodic Increases Quality of Life and Reduces Symptoms in Patients with Irritable Bowel Syndrome: A Pilot Study. Dig. Dis. 2020;39:294&#x2013;300. doi: 10.1159/000510950.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000510950</ArticleId><ArticleId IdType=\"pubmed\">32810850</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorak R.N., Feagan B.G., Hotte N., Leddin D., Dieleman L.A., Petrunia D.M., Enns R., Bitton A., Chiba N., Par&#xe9; P., et al. The Probiotic VSL#3 Has Anti-inflammatory Effects and Could Reduce Endoscopic Recurrence After Surgery for Crohn&#x2019;s Disease. Clin. Gastroenterol. Hepatol. 2015;13:928&#x2013;935.e2. doi: 10.1016/j.cgh.2014.10.031.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cgh.2014.10.031</ArticleId><ArticleId IdType=\"pubmed\">25460016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ka&#x17a;mierczak-Siedlecka K., Folwarski M., Skonieczna-&#x17b;ydecka K., Ruszkowski J., Makarewicz W. The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition-study protocol for a randomized, double-blind, and placebo-controlled trial. Nutr. J. 2020;19:98. doi: 10.1186/s12937-020-00598-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12937-020-00598-w</ArticleId><ArticleId IdType=\"pmc\">PMC7488741</ArticleId><ArticleId IdType=\"pubmed\">32917221</ArticleId></ArticleIdList></Reference><Reference><Citation>Alisi A., Bedogni G., Baviera G., Giorgio V., Porro E., Paris C., Giammaria P., Reali L., Anania F., Nobili V. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 2014;39:1276&#x2013;1285. doi: 10.1111/apt.12758.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/apt.12758</ArticleId><ArticleId IdType=\"pmc\">PMC4046270</ArticleId><ArticleId IdType=\"pubmed\">24738701</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch M., Fuentes M.C., Audivert S., Bonachera M.A., Peir&#xf3; S., Cu&#xf1;&#xe9; J. Lactobacillus plantarum CECT 7527, 7528 and 7529: Probiotic candidates to reduce cholesterol levels. J. Sci. Food Agric. 2014;94:803&#x2013;809. doi: 10.1002/jsfa.6467.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jsfa.6467</ArticleId><ArticleId IdType=\"pubmed\">24186773</ArticleId></ArticleIdList></Reference><Reference><Citation>Miraghajani M., Dehsoukhteh S.S., Rafie N., Hamedani S.G., Sabihi S., Ghiasvand R. Potential mechanisms linking probiotics to diabetes: A narrative review of the literature. Sao Paulo Med. J. 2017;135:169&#x2013;178. doi: 10.1590/1516-3180.2016.0311271216.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1590/1516-3180.2016.0311271216</ArticleId><ArticleId IdType=\"pmc\">PMC9977330</ArticleId><ArticleId IdType=\"pubmed\">28538869</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira S.T., Lourenco M.V., Oliveira M.M., De Felice F.G. Soluble amyloid-b oligomers as synaptotoxins leading to cognitive impairment in Alzheimer&#x2019;s disease. Front. Cell. Neurosci. 2015;9:191. doi: 10.3389/fncel.2015.00191.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2015.00191</ArticleId><ArticleId IdType=\"pmc\">PMC4443025</ArticleId><ArticleId IdType=\"pubmed\">26074767</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudzki L., Ostrowska L., Pawlak D., Ma&#x142;us A., Pawlak K., Waszkiewicz N., Szulc A. Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study. Psychoneuroendocrinology. 2019;100:213&#x2013;222. doi: 10.1016/j.psyneuen.2018.10.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.psyneuen.2018.10.010</ArticleId><ArticleId IdType=\"pubmed\">30388595</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H.-J., Chen J.-L., Liao J.-F., Chen Y.-H., Chieu M.-W., Ke Y.-Y., Hsu C.-C., Tsai Y.-C., Hsieh-Li H.M. Lactobacillus plantarum PS128 prevents cognitive dysfunction in Alzheimer&#x2019;s disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis. BMC Complement. Med. Ther. 2021;21:259. doi: 10.1186/s12906-021-03426-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12906-021-03426-8</ArticleId><ArticleId IdType=\"pmc\">PMC8502419</ArticleId><ArticleId IdType=\"pubmed\">34627204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.Z., Cheng S.-H., Chang M.-Y., Lin Y.-F., Wu C.-C., Tsai Y.-C. Neuroprotective Effects of Lactobacillus plantarum PS128 in a Mouse Model of Parkinson&#x2019;s Disease: The Role of Gut Microbiota and MicroRNAs. Int. J. Mol. Sci. 2023;24:6794. doi: 10.3390/ijms24076794.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24076794</ArticleId><ArticleId IdType=\"pmc\">PMC10095543</ArticleId><ArticleId IdType=\"pubmed\">37047769</ArticleId></ArticleIdList></Reference><Reference><Citation>Tankou S.K., Regev K., Healy B.C., Tjon E., Laghi L., Cox L.M., Kivis&#xe4;kk P., Pierre I.V., Hrishikesh L., Gandhi R., et al. A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann. Neurol. 2018;83:1147&#x2013;1161. doi: 10.1002/ana.25244.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.25244</ArticleId><ArticleId IdType=\"pmc\">PMC6181139</ArticleId><ArticleId IdType=\"pubmed\">29679417</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin Z., Xin C., Huo J., Liu Q., Dong H., Li R., Liu Y. Neuroprotective Effect of a Multistrain Probiotic Mixture in SOD1G93A Mice by Reducing SOD1 Aggregation and Targeting the Microbiota-Gut-Brain Axis. Mol. Neurobiol. 2024 doi: 10.1007/s12035-024-03988-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-024-03988-x</ArticleId><ArticleId IdType=\"pubmed\">38349516</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M., Li R., Wang Y., Ma S., Zhang Y., Li S., Zhang H., Liu Z., You C., Zheng H. Lactobacillus plantarum ST-III modulates abnormal behavior and gut microbiota in a mouse model of autism spectrum disorder. Physiol. Behav. 2022;257:113965. doi: 10.1016/j.physbeh.2022.113965.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.physbeh.2022.113965</ArticleId><ArticleId IdType=\"pubmed\">36126693</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.-M., Kuo P.-H., Hsu C.-Y., Chiu Y.-H., Liu Y.-W., Lu M.-L., Chen C.-H. Psychophysiological Effects of Lactobacillus plantarum PS128 in Patients with Major Depressive Disorder: A Preliminary 8-Week Open Trial. Nutrients. 2021;13:3731. doi: 10.3390/nu13113731.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu13113731</ArticleId><ArticleId IdType=\"pmc\">PMC8618644</ArticleId><ArticleId IdType=\"pubmed\">34835987</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultana O.F., Hia R.A., Reddy P.H. A Combinational Therapy for Preventing and Delaying the Onset of Alzheimer&#x2019;s Disease: A Focus on Probiotic and Vitamin Co-Supplementation. Antioxidants. 2024;13:202. doi: 10.3390/antiox13020202.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox13020202</ArticleId><ArticleId IdType=\"pmc\">PMC10886126</ArticleId><ArticleId IdType=\"pubmed\">38397800</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Yang G., Zhao Z., Wang C., Duan C., Gao L., Li S. Antidepressant-like effects of Lactobacillus plantarum DP189 in a corticosterone-induced rat model of chronic stress. Behav. Brain Res. 2020;395:112853. doi: 10.1016/j.bbr.2020.112853.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbr.2020.112853</ArticleId><ArticleId IdType=\"pubmed\">32771396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L., Mogna L., De Marchi F., Amoruso A., Pane M., Aloisio I., Cionci N.B., Gagg&#xec;a F., Lucenti A., Bersano E., et al. Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies. J. Clin. Gastroenterol. 2018;52((Suppl. S1)):S68&#x2013;S70. doi: 10.1097/MCG.0000000000001042.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MCG.0000000000001042</ArticleId><ArticleId IdType=\"pubmed\">29782468</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.-W., Liong M.T., Chung Y.-C.E., Huang H.-Y., Peng W.-S., Cheng Y.-F., Lin Y.-S., Wu Y.-Y., Tsai Y.-C. Effects of Lactobacillus plantarum PS128 on Children with Autism Spectrum Disorder in Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2019;11:820. doi: 10.3390/nu11040820.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu11040820</ArticleId><ArticleId IdType=\"pmc\">PMC6521002</ArticleId><ArticleId IdType=\"pubmed\">30979038</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Yeo S., Kim B., Holzapfel W.H., Kang H.-J. Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) attenuates depressive-like behavior and physiology via association with gut microbiota in BALB/c mice. J. Funct. Foods. 2023;107:105692. doi: 10.1016/j.jff.2023.105692.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jff.2023.105692</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung Y.-C., Jin H.-M., Cui Y., Kim D.S., Jung J.M., Park J.-I., Jung E.-S., Choi E.-K., Chae S.-W. Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. J. Funct. Foods. 2014;10:465&#x2013;474. doi: 10.1016/j.jff.2014.07.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jff.2014.07.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghyselinck J., Verstrepen L., Moens F., Van Den Abbeele P., Bruggeman A., Said J., Smith B., Barker L.A., Jordan C., Leta V., et al. Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson&#x2019;s disease. Int. J. Pharm. X. 2021;3:100087. doi: 10.1016/j.ijpx.2021.100087.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijpx.2021.100087</ArticleId><ArticleId IdType=\"pmc\">PMC8683682</ArticleId><ArticleId IdType=\"pubmed\">34977556</ArticleId></ArticleIdList></Reference><Reference><Citation>Parracho H.M.R.T., Gibson G.R., Knott F., Bosscher D., Kleerebezem M., McCartney A.L. A double-blind, placebo-controlled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorders. Int. J. Probiotics Prebiotics. 2010;5:69&#x2013;74.</Citation></Reference><Reference><Citation>Mallikarjuna N., Praveen K., Yellamma K. Role of Lactobacillus plantarum MTCC1325 in membrane-bound transport ATPases system in Alzheimer&#x2019;s disease-induced rat brain. BioImpacts BI. 2016;6:203&#x2013;209. doi: 10.15171/bi.2016.27.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15171/bi.2016.27</ArticleId><ArticleId IdType=\"pmc\">PMC5326668</ArticleId><ArticleId IdType=\"pubmed\">28265536</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehipour Z., Haghmorad D., Sankian M., Rastin M., Nosratabadi R., Soltan Dallal M.M., Tabasi N., Khazaee M., Nasiraii L.R., Mahmoudi M. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. Biomed. Pharmacother. 2017;95:1535&#x2013;1548. doi: 10.1016/j.biopha.2017.08.117.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2017.08.117</ArticleId><ArticleId IdType=\"pubmed\">28946394</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao Z., Chen L., Zhang Y., Zhang J., Zhang H. Bifidobacterium animalis subsp. lactis Probio-M8 alleviates abnormal behavior and regulates gut microbiota in a mouse model suffering from autism. mSystems. 2024;9:e0101323. doi: 10.1128/msystems.01013-23.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/msystems.01013-23</ArticleId><ArticleId IdType=\"pmc\">PMC10804959</ArticleId><ArticleId IdType=\"pubmed\">38108654</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu R., Fang Y., Li H., Liu Y., Wei J., Zhang S., Wang L., Fan R., Wang L., Li S., et al. Psychobiotic Lactobacillus plantarum JYLP-326 relieves anxiety, depression, and insomnia symptoms in test anxious college via modulating the gut microbiota and its metabolism. Front. Immunol. 2023;14:1158137. doi: 10.3389/fimmu.2023.1158137.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2023.1158137</ArticleId><ArticleId IdType=\"pmc\">PMC10077425</ArticleId><ArticleId IdType=\"pubmed\">37033942</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonfili L., Cecarini V., Gogoi O., Berardi S., Scarpona S., Angeletti M., Rossi G., Eleuteri A.M. Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer&#x2019;s disease. Neurobiol. Aging. 2020;87:35&#x2013;43. doi: 10.1016/j.neurobiolaging.2019.11.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2019.11.004</ArticleId><ArticleId IdType=\"pubmed\">31813629</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajedi D., Shabani R., Elmieh A. Effects of exercise training with Lactobacillus plantarum intake on ionized calcium-binding adaptor molecule 1, glial fibrillary acidic protein, interleukin-6 and interleukin-1&#x3b2; in cuprizone-induced demyelination mouse model of multiple sclerosis. Clin. Exp. Neuroimmunol. 2022;13:42&#x2013;53. doi: 10.1111/cen3.12673.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cen3.12673</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdellatif B., McVeigh C., Bendriss G., Chaari A. The Promising Role of Probiotics in Managing the Altered Gut in Autism Spectrum Disorders. Int. J. Mol. Sci. 2020;21:4159. doi: 10.3390/ijms21114159.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21114159</ArticleId><ArticleId IdType=\"pmc\">PMC7312735</ArticleId><ArticleId IdType=\"pubmed\">32532137</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong H.X., Yusoff N.a.A., Hor Y.-Y., Lew L.-C., Jaafar M.H., Choi S.-B., Yusoff M.S.B., Wahid N., Abdullah M.F.I.L., Zakaria N., et al. Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: A randomised, double-blind, placebo-controlled study. Benef. Microbes. 2019;10:355&#x2013;373. doi: 10.3920/BM2018.0135.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3920/BM2018.0135</ArticleId><ArticleId IdType=\"pubmed\">30882244</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar A., Lehto S.M., Harty S., Dinan T.G., Cryan J.F., Burnet P.W.J. Psychobiotics and the Manipulation of Bacteria&#x2013;Gut&#x2013;Brain Signals. Trends Neurosci. 2016;39:763&#x2013;781. doi: 10.1016/j.tins.2016.09.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tins.2016.09.002</ArticleId><ArticleId IdType=\"pmc\">PMC5102282</ArticleId><ArticleId IdType=\"pubmed\">27793434</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N., Agarwal A.K., Al-Dossari M., Abd EL-Gawaad N.S. Psychobiotic potential of Lactiplantibacillus plantarum: Current perspective in neurodegeneration and geriatric therapies. Brain Behav. Immun. Integr. 2024;5:100038. doi: 10.1016/j.bbii.2023.100038.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbii.2023.100038</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Liu F., Xu C., Liu Z., Ma J., Gu L., Jiang Z., Hou J. Lactobacillus plantarum 69-2 Combined with Galacto-Oligosaccharides Alleviates d-Galactose-Induced Aging by Regulating the AMPK/SIRT1 Signaling Pathway and Gut Microbiota in Mice. J. Agric. Food Chem. 2021;69:2745&#x2013;2757. doi: 10.1021/acs.jafc.0c06730.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.0c06730</ArticleId><ArticleId IdType=\"pubmed\">33565862</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunes R.A., Poluektova E.U., Vasileva E.V., Odorskaya M.V., Marsova M.V., Kovalev G.I., Danilenko V.N. A Multi-strain Potential Probiotic Formulation of GABA-Producing Lactobacillus plantarum 90sk and Bifidobacterium adolescentis 150 with Antidepressant Effects. Probiotics Antimicrob. Proteins. 2020;12:973&#x2013;979. doi: 10.1007/s12602-019-09601-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12602-019-09601-1</ArticleId><ArticleId IdType=\"pubmed\">31677091</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Bosch C., Boorman E., Zunszain P.A., Mann G.E. Short-chain fatty acids as modulators of redox signaling in health and disease. Redox Biol. 2021;47:102165. doi: 10.1016/j.redox.2021.102165.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.redox.2021.102165</ArticleId><ArticleId IdType=\"pmc\">PMC8577496</ArticleId><ArticleId IdType=\"pubmed\">34662811</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M., Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu. Rev. Immunol. 2017;35:441&#x2013;468. doi: 10.1146/annurev-immunol-051116-052358.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-immunol-051116-052358</ArticleId><ArticleId IdType=\"pmc\">PMC8167938</ArticleId><ArticleId IdType=\"pubmed\">28226226</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiihonen K., Ouwehand A.C., Rautonen N. Human intestinal microbiota and healthy ageing. Ageing Res. Rev. 2010;9:107&#x2013;116. doi: 10.1016/j.arr.2009.10.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2009.10.004</ArticleId><ArticleId IdType=\"pubmed\">19874918</ArticleId></ArticleIdList></Reference><Reference><Citation>2023 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement. J. Alzheimers Assoc. 2023;19:1598&#x2013;1695. doi: 10.1002/alz.13016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13016</ArticleId><ArticleId IdType=\"pubmed\">36918389</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P., De Strooper B., Kivipelto M., Holstege H., Ch&#xe9;telat G., Teunissen C.E., Cummings J., van der Flier W.M. Alzheimer&#x2019;s disease. Lancet. 2021;397:1577&#x2013;1590. doi: 10.1016/S0140-6736(20)32205-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)32205-4</ArticleId><ArticleId IdType=\"pmc\">PMC8354300</ArticleId><ArticleId IdType=\"pubmed\">33667416</ArticleId></ArticleIdList></Reference><Reference><Citation>Asti A., Gioglio L. Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation? J. Alzheimers Dis. JAD. 2014;39:169&#x2013;179. doi: 10.3233/JAD-131394.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-131394</ArticleId><ArticleId IdType=\"pubmed\">24150108</ArticleId></ArticleIdList></Reference><Reference><Citation>Vom Berg J., Prokop S., Miller K.R., Obst J., K&#xe4;lin R.E., Lopategui-Cabezas I., Wegner A., Mair F., Schipke C.G., Peters O., et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer&#x2019;s disease-like pathology and cognitive decline. Nat. Med. 2012;18:1812&#x2013;1819. doi: 10.1038/nm.2965.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nm.2965</ArticleId><ArticleId IdType=\"pubmed\">23178247</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz A. What&#x2019;s next for Alzheimer treatment?: While A&#x3b2; isn&#x2019;t out of the picture yet, several other therapeutic routes are being explored. Ann. Neurol. 2013;73:A7&#x2013;A9. doi: 10.1002/ana.23900.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.23900</ArticleId><ArticleId IdType=\"pubmed\">24643982</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo A., Cattane N., Galluzzi S., Provasi S., Lopizzo N., Festari C., Ferrari C., Guerra U.P., Paghera B., Muscio C., et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging. 2017;49:60&#x2013;68. doi: 10.1016/j.neurobiolaging.2016.08.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2016.08.019</ArticleId><ArticleId IdType=\"pubmed\">27776263</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Z., Zhu M., Liu X., Shao L., Cheng Y., Yan X., Jiang R., Wu S. Fecal Fungal Dysbiosis in Chinese Patients with Alzheimer&#x2019;s Disease. Front. Cell Dev. Biol. 2020;8:631460. doi: 10.3389/fcell.2020.631460.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2020.631460</ArticleId><ArticleId IdType=\"pmc\">PMC7876328</ArticleId><ArticleId IdType=\"pubmed\">33585471</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Wang Y., Xiayu X., Shi C., Chen W., Song N., Fu X., Zhou R., Xu Y.-F., Huang L., et al. Altered Gut Microbiota in a Mouse Model of Alzheimer&#x2019;s Disease. J. Alzheimers Dis. JAD. 2017;60:1241&#x2013;1257. doi: 10.3233/JAD-170020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-170020</ArticleId><ArticleId IdType=\"pubmed\">29036812</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho L., Ono K., Tsuji M., Mazzola P., Singh R., Pasinetti G.M. Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer&#x2019;s disease-type beta-amyloid neuropathological mechanisms. Expert Rev. Neurother. 2018;18:83&#x2013;90. doi: 10.1080/14737175.2018.1400909.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/14737175.2018.1400909</ArticleId><ArticleId IdType=\"pmc\">PMC5958896</ArticleId><ArticleId IdType=\"pubmed\">29095058</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rijke T.J., Doting M.H.E., van Hemert S., De Deyn P.P., Harmsen H.J.M., Sommer I.E.C. A Systematic Review on the Effects of Different Types of Probiotics in Animal Alzheimer&#x2019;s Disease Studies. Front. Psychiatry. 2022;13:879491. doi: 10.3389/fpsyt.2022.879491.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpsyt.2022.879491</ArticleId><ArticleId IdType=\"pmc\">PMC9094066</ArticleId><ArticleId IdType=\"pubmed\">35573324</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimgampalle M., Kuna Y. Anti-Alzheimer Properties of Probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer&#x2019;s Disease induced Albino Rats. J. Clin. Diagn. Res. JCDR. 2017;11:KC01&#x2013;KC05. doi: 10.7860/JCDR/2017/26106.10428.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7860/JCDR/2017/26106.10428</ArticleId><ArticleId IdType=\"pmc\">PMC5620801</ArticleId><ArticleId IdType=\"pubmed\">28969160</ArticleId></ArticleIdList></Reference><Reference><Citation>Minkova L., Habich A., Peter J., Kaller C.P., Eickhoff S.B., Kl&#xf6;ppel S. Gray matter asymmetries in aging and neurodegeneration: A review and meta-analysis. Hum. Brain Mapp. 2017;38:5890&#x2013;5904. doi: 10.1002/hbm.23772.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/hbm.23772</ArticleId><ArticleId IdType=\"pmc\">PMC6866813</ArticleId><ArticleId IdType=\"pubmed\">28856766</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaub A.-C., Schneider E., Vazquez-Castellanos J.F., Schweinfurth N., Kettelhack C., Doll J.P.K., Yamanbaeva G., M&#xe4;hlmann L., Brand S., Beglinger C., et al. Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: A randomized controlled trial. Transl. Psychiatry. 2022;12:227. doi: 10.1038/s41398-022-01977-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41398-022-01977-z</ArticleId><ArticleId IdType=\"pmc\">PMC9163095</ArticleId><ArticleId IdType=\"pubmed\">35654766</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., Nelson L.M. Incidence of Parkinson&#x2019;s disease: Variation by age, gender, and race/ethnicity. Am. J. Epidemiol. 2003;157:1015&#x2013;1022. doi: 10.1093/aje/kwg068.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/kwg068</ArticleId><ArticleId IdType=\"pubmed\">12777365</ArticleId></ArticleIdList></Reference><Reference><Citation>Tysnes O.-B., Storstein A. Epidemiology of Parkinson&#x2019;s disease. J. Neural Transm. 2017;124:901&#x2013;905. doi: 10.1007/s00702-017-1686-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00702-017-1686-y</ArticleId><ArticleId IdType=\"pubmed\">28150045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampropoulos I.C., Malli F., Sinani O., Gourgoulianis K.I., Xiromerisiou G. Worldwide trends in mortality related to Parkinson&#x2019;s disease in the period of 1994&#x2013;2019: Analysis of vital registration data from the WHO Mortality Database. Front. Neurol. 2022;13:956440. doi: 10.3389/fneur.2022.956440.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2022.956440</ArticleId><ArticleId IdType=\"pmc\">PMC9576872</ArticleId><ArticleId IdType=\"pubmed\">36267881</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrag A., Horsfall L., Walters K., Noyce A., Petersen I. Prediagnostic presentations of Parkinson&#x2019;s disease in primary care: A case-control study. Lancet Neurol. 2015;14:57&#x2013;64. doi: 10.1016/S1474-4422(14)70287-X.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(14)70287-X</ArticleId><ArticleId IdType=\"pubmed\">25435387</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestrino R., Schapira A.h.v. Parkinson disease. Eur. J. Neurol. 2020;27:27&#x2013;42. doi: 10.1111/ene.14108.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ene.14108</ArticleId><ArticleId IdType=\"pubmed\">31631455</ArticleId></ArticleIdList></Reference><Reference><Citation>Poewe W., Seppi K., Tanner C.M., Halliday G.M., Brundin P., Volkmann J., Schrag A.-E., Lang A.E. Parkinson disease. Nat. Rev. Dis. Primer. 2017;3:17013. doi: 10.1038/nrdp.2017.13.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrdp.2017.13</ArticleId><ArticleId IdType=\"pubmed\">28332488</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheperjans F., Aho V., Pereira P.A.B., Koskinen K., Paulin L., Pekkonen E., Haapaniemi E., Kaakkola S., Eerola-Rautio J., Pohja M., et al. Gut microbiota are related to Parkinson&#x2019;s disease and clinical phenotype. Mov. Disord. Off. J. Mov. Disord. Soc. 2015;30:350&#x2013;358. doi: 10.1002/mds.26069.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mds.26069</ArticleId><ArticleId IdType=\"pubmed\">25476529</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsyth C.B., Shannon K.M., Kordower J.H., Voigt R.M., Shaikh M., Jaglin J.A., Estes J.D., Dodiya H.B., Keshavarzian A. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson&#x2019;s disease. PLoS ONE. 2011;6:e28032. doi: 10.1371/journal.pone.0028032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0028032</ArticleId><ArticleId IdType=\"pmc\">PMC3228722</ArticleId><ArticleId IdType=\"pubmed\">22145021</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan A.H., Chong C.W., Lim S.-Y., Yap I.K.S., Teh C.S.J., Loke M.F., Song S.-L., Tan J.Y., Ang B.H., Tan Y.Q., et al. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics. Ann. Neurol. 2021;89:546&#x2013;559. doi: 10.1002/ana.25982.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.25982</ArticleId><ArticleId IdType=\"pubmed\">33274480</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger M.M., Spiegel J., Dillmann K.-U., Grundmann D., Philippeit H., B&#xfc;rmann J., Fa&#xdf;bender K., Schwiertz A., Sch&#xe4;fer K.-H. Short chain fatty acids and gut microbiota differ between patients with Parkinson&#x2019;s disease and age-matched controls. Park. Relat. Disord. 2016;32:66&#x2013;72. doi: 10.1016/j.parkreldis.2016.08.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.parkreldis.2016.08.019</ArticleId><ArticleId IdType=\"pubmed\">27591074</ArticleId></ArticleIdList></Reference><Reference><Citation>Aho V.T.E., Houser M.C., Pereira P.A.B., Chang J., Rudi K., Paulin L., Hertzberg V., Auvinen P., Tansey M.G., Scheperjans F. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson&#x2019;s disease. Mol. Neurodegener. 2021;16:6. doi: 10.1186/s13024-021-00427-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-021-00427-6</ArticleId><ArticleId IdType=\"pmc\">PMC7869249</ArticleId><ArticleId IdType=\"pubmed\">33557896</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang F., Liu S., Du J., Hu X., Xiong J., Fang R., Chen W., Sun J. Sodium butyrate exerts protective effect against Parkinson&#x2019;s disease in mice via stimulation of glucagon like peptide-1. J. Neurol. Sci. 2017;381:176&#x2013;181. doi: 10.1016/j.jns.2017.08.3235.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jns.2017.08.3235</ArticleId><ArticleId IdType=\"pubmed\">28991675</ArticleId></ArticleIdList></Reference><Reference><Citation>Paiva I., Pinho R., Pavlou M.A., Hennion M., Wales P., Sch&#xfc;tz A.-L., Rajput A., Szego &#xc9;.M., Kerimoglu C., Gerhardt E., et al. Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Hum. Mol. Genet. 2017;26:2231&#x2013;2246. doi: 10.1093/hmg/ddx114.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddx114</ArticleId><ArticleId IdType=\"pubmed\">28369321</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Vis&#xf1;uk D., del Milagro Teran M., Savoy de Giori G., LeBlanc J.G., de Moreno de LeBlanc A. Neuroprotective Effect of Riboflavin Producing Lactic Acid Bacteria in Parkinsonian Models. Neurochem. Res. 2022;47:1269&#x2013;1279. doi: 10.1007/s11064-021-03520-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11064-021-03520-w</ArticleId><ArticleId IdType=\"pubmed\">35113305</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan A.H., Hor J.W., Chong C.W., Lim S.-Y. Probiotics for Parkinson&#x2019;s disease: Current evidence and future directions. JGH Open. 2021;5:414&#x2013;419. doi: 10.1002/jgh3.12450.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jgh3.12450</ArticleId><ArticleId IdType=\"pmc\">PMC8035463</ArticleId><ArticleId IdType=\"pubmed\">33860090</ArticleId></ArticleIdList></Reference><Reference><Citation>Noto D., Miyake S. Gut dysbiosis and multiple sclerosis. Clin. Immunol. 2022;235:108380. doi: 10.1016/j.clim.2020.108380.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clim.2020.108380</ArticleId><ArticleId IdType=\"pubmed\">32169440</ArticleId></ArticleIdList></Reference><Reference><Citation>Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., Nishikawa H., Fukuda S., Saito T., Narushima S., Hase K., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500:232&#x2013;236. doi: 10.1038/nature12331.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature12331</ArticleId><ArticleId IdType=\"pubmed\">23842501</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangi S., Gandhi R., Cox L.M., Li N., von Glehn F., Yan R., Patel B., Mazzola M.A., Liu S., Glanz B.L., et al. Alterations of the human gut microbiome in multiple sclerosis. Nat. Commun. 2016;7:12015. doi: 10.1038/ncomms12015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncomms12015</ArticleId><ArticleId IdType=\"pmc\">PMC4931233</ArticleId><ArticleId IdType=\"pubmed\">27352007</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake S., Kim S., Suda W., Oshima K., Nakamura M., Matsuoka T., Chihara N., Tomita A., Sato W., Kim S.-W., et al. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS ONE. 2015;10:e0137429. doi: 10.1371/journal.pone.0137429.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0137429</ArticleId><ArticleId IdType=\"pmc\">PMC4569432</ArticleId><ArticleId IdType=\"pubmed\">26367776</ArticleId></ArticleIdList></Reference><Reference><Citation>Berer K., Mues M., Koutrolos M., Rasbi Z.A., Boziki M., Johner C., Wekerle H., Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479:538&#x2013;541. doi: 10.1038/nature10554.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature10554</ArticleId><ArticleId IdType=\"pubmed\">22031325</ArticleId></ArticleIdList></Reference><Reference><Citation>Goverman J., Woods A., Larson L., Weiner L.P., Hood L., Zaller D.M. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 1993;72:551&#x2013;560. doi: 10.1016/0092-8674(93)90074-Z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0092-8674(93)90074-Z</ArticleId><ArticleId IdType=\"pubmed\">7679952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA. 2011;108((Suppl. S1)):4615&#x2013;4622. doi: 10.1073/pnas.1000082107.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1000082107</ArticleId><ArticleId IdType=\"pmc\">PMC3063590</ArticleId><ArticleId IdType=\"pubmed\">20660719</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa-Rep&#xe1;raz J., Mielcarz D.W., Haque-Begum S., Kasper L.H. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes. 2010;1:103&#x2013;108. doi: 10.4161/gmic.1.2.11515.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4161/gmic.1.2.11515</ArticleId><ArticleId IdType=\"pmc\">PMC3023588</ArticleId><ArticleId IdType=\"pubmed\">21326918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa-Rep&#xe1;raz J., Mielcarz D.W., Ditrio L.E., Burroughs A.R., Foureau D.M., Haque-Begum S., Kasper L.H. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2009;183:6041&#x2013;6050. doi: 10.4049/jimmunol.0900747.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.0900747</ArticleId><ArticleId IdType=\"pubmed\">19841183</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokote H., Miyake S., Croxford J.L., Oki S., Mizusawa H., Yamamura T. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am. J. Pathol. 2008;173:1714&#x2013;1723. doi: 10.2353/ajpath.2008.080622.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2353/ajpath.2008.080622</ArticleId><ArticleId IdType=\"pmc\">PMC2626383</ArticleId><ArticleId IdType=\"pubmed\">18974295</ArticleId></ArticleIdList></Reference><Reference><Citation>Frohman E.M., Racke M.K., Raine C.S. Multiple sclerosis&#x2014;The plaque and its pathogenesis. N. Engl. J. Med. 2006;354:942&#x2013;955. doi: 10.1056/NEJMra052130.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMra052130</ArticleId><ArticleId IdType=\"pubmed\">16510748</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Noto D., Hoshino Y., Mizuno M., Miyake S. Butyrate suppresses demyelination and enhances remyelination. J. Neuroinflammation. 2019;16:165. doi: 10.1186/s12974-019-1552-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-019-1552-y</ArticleId><ArticleId IdType=\"pmc\">PMC6688239</ArticleId><ArticleId IdType=\"pubmed\">31399117</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghikia A., J&#xf6;rg S., Duscha A., Berg J., Manzel A., Waschbisch A., Hammer A., Lee D.-H., May C., Wilck N., et al. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. Immunity. 2015;43:817&#x2013;829. doi: 10.1016/j.immuni.2015.09.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.immuni.2015.09.007</ArticleId><ArticleId IdType=\"pubmed\">26488817</ArticleId></ArticleIdList></Reference><Reference><Citation>Saresella M., Mendozzi L., Rossi V., Mazzali F., Piancone F., LaRosa F., Marventano I., Caputo D., Felis G.E., Clerici M. Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study. Front. Immunol. 2017;8:1391. doi: 10.3389/fimmu.2017.01391.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2017.01391</ArticleId><ArticleId IdType=\"pmc\">PMC5661395</ArticleId><ArticleId IdType=\"pubmed\">29118761</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestre L., Carrillo-Salinas F.J., Feli&#xfa; A., Mecha M., Alonso G., Espejo C., Calvo-Barreiro L., Luque-Garc&#xed;a J.L., Estevez H., Villar L.M., et al. How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process. Gut Microbes. 2020;12:1813532. doi: 10.1080/19490976.2020.1813532.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/19490976.2020.1813532</ArticleId><ArticleId IdType=\"pmc\">PMC7524398</ArticleId><ArticleId IdType=\"pubmed\">32900255</ArticleId></ArticleIdList></Reference><Reference><Citation>Achtert K., Kerkemeyer L. The economic burden of amyotrophic lateral sclerosis: A systematic review. Eur. J. Health Econ. 2021;22:1151&#x2013;1166. doi: 10.1007/s10198-021-01328-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10198-021-01328-7</ArticleId><ArticleId IdType=\"pubmed\">34143346</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry J.D., Blanchard M., Bonar K., Drane E., Murton M., Ploug U., Ricchetti-Masterson K., Savic N., Worthington E., Heiman-Patterson T. Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: A literature review. Amyotroph. Lateral Scler. Front. Degener. 2023;24:436&#x2013;448. doi: 10.1080/21678421.2023.2165947.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/21678421.2023.2165947</ArticleId><ArticleId IdType=\"pubmed\">36748473</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfc;bling G.S., Mie E., Bauer R.M., Hensler M., Lorenzl S., Hapfelmeier A., Irwin D.E., Borasio G.D., Winkler A.S. Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2014;15:174&#x2013;179. doi: 10.3109/21678421.2013.868001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/21678421.2013.868001</ArticleId><ArticleId IdType=\"pubmed\">24479577</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Yi J., Zhang Y.-G., Zhou J., Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol. Rep. 2015;3:e12356. doi: 10.14814/phy2.12356.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14814/phy2.12356</ArticleId><ArticleId IdType=\"pmc\">PMC4425962</ArticleId><ArticleId IdType=\"pubmed\">25847918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-G., Wu S., Yi J., Xia Y., Jin D., Zhou J., Sun J. Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis. Clin. Ther. 2017;39:322&#x2013;336. doi: 10.1016/j.clinthera.2016.12.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clinthera.2016.12.014</ArticleId><ArticleId IdType=\"pmc\">PMC5344195</ArticleId><ArticleId IdType=\"pubmed\">28129947</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin J., Xia Y., Jung B., Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol. Rep. 2017;5:e13443. doi: 10.14814/phy2.13443.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14814/phy2.13443</ArticleId><ArticleId IdType=\"pmc\">PMC5617930</ArticleId><ArticleId IdType=\"pubmed\">28947596</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Miller R.G., Gascon R., Champion S., Katz J., Lancero M., Narvaez A., Honrada R., Ruvalcaba D., McGrath M.S. Circulating endotoxin and systemic immune activation in sporadic Amyotrophic Lateral Sclerosis (sALS) J. Neuroimmunol. 2009;206:121&#x2013;124. doi: 10.1016/j.jneuroim.2008.09.017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jneuroim.2008.09.017</ArticleId><ArticleId IdType=\"pmc\">PMC2995297</ArticleId><ArticleId IdType=\"pubmed\">19013651</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter A.J., Brugha T.S., Erskine H.E., Scheurer R.W., Vos T., Scott J.G. The epidemiology and global burden of autism spectrum disorders. Psychol. Med. 2015;45:601&#x2013;613. doi: 10.1017/S003329171400172X.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S003329171400172X</ArticleId><ArticleId IdType=\"pubmed\">25108395</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord C., Brugha T.S., Charman T., Cusack J., Dumas G., Frazier T., Jones E.J.H., Jones R.M., Pickles A., State M.W., et al. Autism spectrum disorder. Nat. Rev. Dis. Primer. 2020;6:5. doi: 10.1038/s41572-019-0138-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41572-019-0138-4</ArticleId><ArticleId IdType=\"pmc\">PMC8900942</ArticleId><ArticleId IdType=\"pubmed\">31949163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord C., Elsabbagh M., Baird G., Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392:508&#x2013;520. doi: 10.1016/S0140-6736(18)31129-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(18)31129-2</ArticleId><ArticleId IdType=\"pmc\">PMC7398158</ArticleId><ArticleId IdType=\"pubmed\">30078460</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelis M.D., Piccolo M., Vannini L., Siragusa S., Giacomo A.D., Serrazzanetti D.I., Cristofori F., Guerzoni M.E., Gobbetti M., Francavilla R. Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified. PLoS ONE. 2013;8:e76993. doi: 10.1371/journal.pone.0076993.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0076993</ArticleId><ArticleId IdType=\"pmc\">PMC3793965</ArticleId><ArticleId IdType=\"pubmed\">24130822</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomova A., Husarova V., Lakatosova S., Bakos J., Vlkova B., Babinska K., Ostatnikova D. Gastrointestinal microbiota in children with autism in Slovakia. Physiol. Behav. 2015;138:179&#x2013;187. doi: 10.1016/j.physbeh.2014.10.033.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.physbeh.2014.10.033</ArticleId><ArticleId IdType=\"pubmed\">25446201</ArticleId></ArticleIdList></Reference><Reference><Citation>Strati F., Cavalieri D., Albanese D., De Felice C., Donati C., Hayek J., Jousson O., Leoncini S., Renzi D., Calabr&#xf2; A., et al. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome. 2017;5:24. doi: 10.1186/s40168-017-0242-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40168-017-0242-1</ArticleId><ArticleId IdType=\"pmc\">PMC5320696</ArticleId><ArticleId IdType=\"pubmed\">28222761</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamtouri M., Merghni A., Gaddour N., Mastouri M., Arboleya S., de los Reyes-Gavil&#xe1;n C.G. Lactobacilli Profile in Faecal Samples of Tunisian Children Diagnosed with Autism Spectrum Disorder. Microbiol. Res. 2023;14:1225&#x2013;1237. doi: 10.3390/microbiolres14030082.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/microbiolres14030082</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaaban S.Y., El Gendy Y.G., Mehanna N.S., El-Senousy W.M., El-Feki H.S.A., Saad K., El-Asheer O.M. The role of probiotics in children with autism spectrum disorder: A prospective, open-label study. Nutr. Neurosci. 2018;21:676&#x2013;681. doi: 10.1080/1028415X.2017.1347746.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/1028415X.2017.1347746</ArticleId><ArticleId IdType=\"pubmed\">28686541</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossi E., Melli S., Dunca D., Terruzzi V. Unexpected improvement in core autism spectrum disorder symptoms after long-term treatment with probiotics. SAGE Open Med. Case Rep. 2016;4:2050313X16666231. doi: 10.1177/2050313X16666231.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/2050313X16666231</ArticleId><ArticleId IdType=\"pmc\">PMC5006292</ArticleId><ArticleId IdType=\"pubmed\">27621806</ArticleId></ArticleIdList></Reference><Reference><Citation>Foss-Feig J.H., Adkinson B.D., Ji J.L., Yang G., Srihari V.H., McPartland J.C., Krystal J.H., Murray J.D., Anticevic A. Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders. Biol. Psychiatry. 2017;81:848&#x2013;861. doi: 10.1016/j.biopsych.2017.03.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopsych.2017.03.005</ArticleId><ArticleId IdType=\"pmc\">PMC5436134</ArticleId><ArticleId IdType=\"pubmed\">28434615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong Q., Chen Q., Mao X., Wang G., Zhao J., Zhang H., Chen W. Bifidobacterium longum CCFM1077 Ameliorated Neurotransmitter Disorder and Neuroinflammation Closely Linked to Regulation in the Kynurenine Pathway of Autistic-like Rats. Nutrients. 2022;14:1615. doi: 10.3390/nu14081615.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu14081615</ArticleId><ArticleId IdType=\"pmc\">PMC9031594</ArticleId><ArticleId IdType=\"pubmed\">35458177</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Guo M., Zhang H., Wang Y., Li R., Liu Z., Zheng H., You C. Lactiplantibacillus plantarum ST-III-fermented milk improves autistic-like behaviors in valproic acid-induced autism spectrum disorder mice by altering gut microbiota. Front. Nutr. 2022;9:1005308. doi: 10.3389/fnut.2022.1005308.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnut.2022.1005308</ArticleId><ArticleId IdType=\"pmc\">PMC9729765</ArticleId><ArticleId IdType=\"pubmed\">36505260</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra A., Arora G., Sahni G., Kaur M., Singh H., Singh B., Kaur S. Gut microbiota and Autism Spectrum Disorder: From pathogenesis to potential therapeutic perspectives. J. Tradit. Complement. Med. 2023;13:135&#x2013;149. doi: 10.1016/j.jtcme.2022.03.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jtcme.2022.03.001</ArticleId><ArticleId IdType=\"pmc\">PMC10037072</ArticleId><ArticleId IdType=\"pubmed\">36970459</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong X.-J., Kang J., Liu K. Probiotic and intra-nasal oxytocin combination therapy on autonomic function and gut-brain axis signaling in young children and teens with autism spectrum disorder. J. Psychiatr. Res. 2023;166:1&#x2013;9. doi: 10.1016/j.jpsychires.2023.08.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jpsychires.2023.08.006</ArticleId><ArticleId IdType=\"pubmed\">37639877</ArticleId></ArticleIdList></Reference><Reference><Citation>Soca&#x142;a K., Doboszewska U., Szopa A., Serefko A., W&#x142;odarczyk M., Zieli&#x144;ska A., Poleszak E., Fichna J., Wla&#x17a; P. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol. Res. 2021;172:105840. doi: 10.1016/j.phrs.2021.105840.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.phrs.2021.105840</ArticleId><ArticleId IdType=\"pubmed\">34450312</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier L., Pruteanu M., Kuhn M., Zeller G., Telzerow A., Anderson E.E., Brochado A.R., Fernandez K.C., Dose H., Mori H., et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555:623&#x2013;628. doi: 10.1038/nature25979.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature25979</ArticleId><ArticleId IdType=\"pmc\">PMC6108420</ArticleId><ArticleId IdType=\"pubmed\">29555994</ArticleId></ArticleIdList></Reference><Reference><Citation>Vich Vila A., Collij V., Sanna S., Sinha T., Imhann F., Bourgonje A.R., Mujagic Z., Jonkers D.M.A.E., Masclee A.A.M., Fu J., et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat. Commun. 2020;11:362. doi: 10.1038/s41467-019-14177-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-019-14177-z</ArticleId><ArticleId IdType=\"pmc\">PMC6969170</ArticleId><ArticleId IdType=\"pubmed\">31953381</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng C., Yang P., Cao T., Gu Y., Li N., Zhang B., Xu P., Liu Y., Luo Z., Cai H. Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2021;106:110097. doi: 10.1016/j.pnpbp.2020.110097.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pnpbp.2020.110097</ArticleId><ArticleId IdType=\"pubmed\">32916223</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang R., Wang K., Hu J. Effect of Probiotics on Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2016;8:483. doi: 10.3390/nu8080483.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu8080483</ArticleId><ArticleId IdType=\"pmc\">PMC4997396</ArticleId><ArticleId IdType=\"pubmed\">27509521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.J., Hong J.K., Kim J.-K., Kim D.-H., Jang S.W., Han S.-W., Yoon I.-Y. Effects of Probiotic NVP-1704 on Mental Health and Sleep in Healthy Adults: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021;13:2660. doi: 10.3390/nu13082660.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu13082660</ArticleId><ArticleId IdType=\"pmc\">PMC8398773</ArticleId><ArticleId IdType=\"pubmed\">34444820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayichew T., Belete A., Alebachew T., Tsehaye H., Berhanu H., Minwuyelet A. Bacterial Probiotics their Importances and Limitations: A Review. J. Nutr. Health Sci. 2017;4:202. doi: 10.15744/2393-9060.4.202.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15744/2393-9060.4.202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferstl R., Frei R., Schiavi E., Konieczna P., Barcik W., Ziegler M., Lauener R.P., Chassard C., Lacroix C., Akdis C.A., et al. Histamine receptor 2 is a key influence in immune responses to intestinal histamine-secreting microbes. J. Allergy Clin. Immunol. 2014;134:744&#x2013;746.e3. doi: 10.1016/j.jaci.2014.04.034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaci.2014.04.034</ArticleId><ArticleId IdType=\"pubmed\">24954261</ArticleId></ArticleIdList></Reference><Reference><Citation>Zmora N., Zilberman-Schapira G., Suez J., Mor U., Dori-Bachash M., Bashiardes S., Kotler E., Zur M., Regev-Lehavi D., Brik R.B.-Z., et al. Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features. Cell. 2018;174:1388&#x2013;1405.e21. doi: 10.1016/j.cell.2018.08.041.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2018.08.041</ArticleId><ArticleId IdType=\"pubmed\">30193112</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora K., Green M., Prakash S. The Microbiome and Alzheimer&#x2019;s Disease: Potential and Limitations of Prebiotic, Synbiotic, and Probiotic Formulations. Front. Bioeng. Biotechnol. 2020;8:537847. doi: 10.3389/fbioe.2020.537847.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fbioe.2020.537847</ArticleId><ArticleId IdType=\"pmc\">PMC7771210</ArticleId><ArticleId IdType=\"pubmed\">33384986</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273422</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Spatiotemporal Dysregulation of Neuron-Glia Related Genes and Pro-/Anti-Inflammatory miRNAs in the <i>5xFAD</i> Mouse Model of Alzheimer's Disease.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9475</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179475</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD), the leading cause of dementia, is a multifactorial disease influenced by aging, genetics, and environmental factors. miRNAs are crucial regulators of gene expression and play significant roles in AD onset and progression. This exploratory study analyzed the expression levels of 28 genes and 5 miRNAs (miR-124-3p, miR-125b-5p, miR-21-5p, miR-146a-5p, and miR-155-5p) related to AD pathology and neuroimmune responses using RT-qPCR. Analyses were conducted in the prefrontal cortex (PFC) and the hippocampus (HPC) of the <i>5xFAD</i> mouse AD model at 6 and 9 months old. Data highlighted upregulated genes encoding for glial fibrillary acidic protein (<i>Gfap</i>), triggering receptor expressed on myeloid cells (<i>Trem2</i>) and cystatin F (<i>Cst7</i>), in the <i>5xFAD</i> mice at both regions and ages highlighting their roles as critical disease players and potential biomarkers. Overexpression of genes encoding for CCAAT enhancer-binding protein alpha (<i>Cebpa</i>) and myelin proteolipid protein (<i>Plp</i>) in the PFC, as well as for BCL2 apoptosis regulator (<i>Bcl2</i>) and purinergic receptor P2Y12 (<i>P2yr12</i>) in the HPC, together with upregulated microRNA(miR)-146a-5p in the PFC, prevailed in 9-month-old animals. miR-155 positively correlated with miR-146a and miR-21 in the PFC, and miR-125b positively correlated with miR-155, miR-21, while miR-146a in the HPC. Correlations between genes and miRNAs were dynamic, varying by genotype, region, and age, suggesting an intricate, disease-modulated interaction between miRNAs and target pathways. These findings contribute to our understanding of miRNAs as therapeutic targets for AD, given their multifaceted effects on neurons and glial cells.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ianni</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0009-0008-0241-967X</Identifier><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o do Medicamento (iMed.ULisboa), Faculdade de Farm&#xe1;cia da Universidade de Lisboa, 1649-003 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze della Vita, Universit&#xe0; degli Studi di Trieste, 34127 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Corraliza-Gomez</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0002-1417-2757</Identifier><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o do Medicamento (iMed.ULisboa), Faculdade de Farm&#xe1;cia da Universidade de Lisboa, 1649-003 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Physiology, School of Medicine, Universidad de Cadiz, 11003 Cadiz, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n e Innovaci&#xf3;n Biom&#xe9;dica de Cadiz (INIBICA), 11003 Cadiz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Costa-Coelho</LastName><ForeName>Tiago</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o do Medicamento (iMed.ULisboa), Faculdade de Farm&#xe1;cia da Universidade de Lisboa, 1649-003 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Farmacologia e Neuroci&#xea;ncias, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Medicina Molecular Jo&#xe3;o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ferreira-Manso</LastName><ForeName>Mafalda</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0001-5074-8154</Identifier><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o do Medicamento (iMed.ULisboa), Faculdade de Farm&#xe1;cia da Universidade de Lisboa, 1649-003 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Farmacologia e Neuroci&#xea;ncias, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Medicina Molecular Jo&#xe3;o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Inteiro-Oliveira</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Instituto de Farmacologia e Neuroci&#xea;ncias, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Medicina Molecular Jo&#xe3;o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Alem&#xe3;n-Serrano</LastName><ForeName>Nuno</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">0000-0003-2100-1240</Identifier><AffiliationInfo><Affiliation>Instituto de Farmacologia e Neuroci&#xea;ncias, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Medicina Molecular Jo&#xe3;o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ULS Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, Centro Acad&#xe9;mico de Medicina de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sebasti&#xe3;o</LastName><ForeName>Ana M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Instituto de Farmacologia e Neuroci&#xea;ncias, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Medicina Molecular Jo&#xe3;o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Garcia</LastName><ForeName>Gon&#xe7;alo</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0001-5526-5362</Identifier><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o do Medicamento (iMed.ULisboa), Faculdade de Farm&#xe1;cia da Universidade de Lisboa, 1649-003 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences and Medicines, Faculdade de Farm&#xe1;cia da Universidade de Lisboa, 1649-003 Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Di&#xf3;genes</LastName><ForeName>Maria Jos&#xe9;</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Instituto de Farmacologia e Neuroci&#xea;ncias, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Medicina Molecular Jo&#xe3;o Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brites</LastName><ForeName>Dora</ForeName><Initials>D</Initials><Identifier Source=\"ORCID\">0000-0002-3024-9777</Identifier><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o do Medicamento (iMed.ULisboa), Faculdade de Farm&#xe1;cia da Universidade de Lisboa, 1649-003 Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences and Medicines, Faculdade de Farm&#xe1;cia da Universidade de Lisboa, 1649-003 Lisboa, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>FCT-PTDC/MED-NEU/2382/2021</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e Tecnologia</Agency><Country/></Grant><Grant><GrantID>LISBOA-01-0145-FEDER-031395</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e Tecnologia</Agency><Country/></Grant><Grant><GrantID>HR21-00931</GrantID><Agency>La Caixa Foundation-Luz&#xf3;n Foundation</Agency><Country/></Grant><Grant><GrantID>UIDB/04138/2020</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e Tecnologia</Agency><Country/></Grant><Grant><GrantID>UIDP/04138/2020</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e Tecnologia</Agency><Country/></Grant><Grant><GrantID>MB35-2021</GrantID><Agency>SCML</Agency><Country/></Grant><Grant><GrantID>PRR-02/C05-i01/2022</GrantID><Agency>NextGenerationEU</Agency><Country/></Grant><Grant><GrantID>2023.01388.BD</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e Tecnologia</Agency><Country/></Grant><Grant><GrantID>2022/23</GrantID><Agency>Fundaci&#xf3;n \"Margarita Salas\"</Agency><Country/></Grant><Grant><GrantID>2022/23</GrantID><Agency>European Union, Erasmus+</Agency><Country/></Grant><Grant><GrantID>5/2022/PTDC/MED-NEU/2382/2021</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e Tecnologia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D035683\">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C527468\">Mirn125 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C532623\">Mirn155 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C498716\">Trem2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C534190\">Mirn146 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011971\">Receptors, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D008562\">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D005904\">Glial Fibrillary Acidic Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C531950\">MIRN21 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C528900\">glial fibrillary astrocytic protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D035683\" MajorTopicYN=\"Y\">MicroRNAs</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004195\" MajorTopicYN=\"Y\">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009474\" MajorTopicYN=\"Y\">Neurons</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D009457\" MajorTopicYN=\"Y\">Neuroglia</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006624\" MajorTopicYN=\"Y\">Hippocampus</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008822\" MajorTopicYN=\"N\">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011971\" MajorTopicYN=\"N\">Receptors, Immunologic</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005786\" MajorTopicYN=\"N\">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008562\" MajorTopicYN=\"N\">Membrane Glycoproteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017397\" MajorTopicYN=\"N\">Prefrontal Cortex</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005904\" MajorTopicYN=\"N\">Glial Fibrillary Acidic Protein</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">5xFAD mouse model</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">hippocampus</Keyword><Keyword MajorTopicYN=\"N\">microRNAs</Keyword><Keyword MajorTopicYN=\"N\">neurodegeneration</Keyword><Keyword MajorTopicYN=\"N\">neuroimmune genes</Keyword><Keyword MajorTopicYN=\"N\">neuroinflammation</Keyword><Keyword MajorTopicYN=\"N\">prefrontal cortex</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The founders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273422</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179475</ArticleId><ArticleId IdType=\"pii\">ijms25179475</ArticleId><ArticleId IdType=\"pmc\">PMC11394861</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McKeever P.M., Schneider R., Taghdiri F., Weichert A., Multani N., Brown R.A., Boxer A.L., Karydas A., Miller B., Robertson J., et al. MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer&#x2019;s Disease. Mol. Neurobiol. 2018;55:8826&#x2013;8841. doi: 10.1007/s12035-018-1032-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-018-1032-x</ArticleId><ArticleId IdType=\"pmc\">PMC6208843</ArticleId><ArticleId IdType=\"pubmed\">29603092</ArticleId></ArticleIdList></Reference><Reference><Citation>Korczyn A.D., Grinberg L.T. Is Alzheimer disease a disease? Nat. Rev. Neurol. 2024;20:245&#x2013;251. doi: 10.1038/s41582-024-00940-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41582-024-00940-4</ArticleId><ArticleId IdType=\"pubmed\">38424454</ArticleId></ArticleIdList></Reference><Reference><Citation>Pittock R.R., Aakre J.A., Castillo A.M., Ramanan V.K., Kremers W.K., Jack C.R., Jr., Vemuri P., Lowe V.J., Knopman D.S., Petersen R.C., et al. Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging. Neurology. 2023;101:e1837&#x2013;e1849. doi: 10.1212/WNL.0000000000207770.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000207770</ArticleId><ArticleId IdType=\"pmc\">PMC10663008</ArticleId><ArticleId IdType=\"pubmed\">37586881</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman D.S., Amieva H., Petersen R.C., Chetelat G., Holtzman D.M., Hyman B.T., Nixon R.A., Jones D.T. Alzheimer disease. Nat. Rev. Dis. Primers. 2021;7:33. doi: 10.1038/s41572-021-00269-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41572-021-00269-y</ArticleId><ArticleId IdType=\"pmc\">PMC8574196</ArticleId><ArticleId IdType=\"pubmed\">33986301</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia X., Jiang Q., McDermott J., Han J.J. Aging and Alzheimer&#x2019;s disease: Comparison and associations from molecular to system level. Aging Cell. 2018;17:e12802. doi: 10.1111/acel.12802.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/acel.12802</ArticleId><ArticleId IdType=\"pmc\">PMC6156542</ArticleId><ArticleId IdType=\"pubmed\">29963744</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Lee C., Torres E.R.S., Carling G., Gan L. Mechanisms of sex differences in Alzheimer&#x2019;s disease. Neuron. 2024;112:1208&#x2013;1221. doi: 10.1016/j.neuron.2024.01.024.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2024.01.024</ArticleId><ArticleId IdType=\"pmc\">PMC11076015</ArticleId><ArticleId IdType=\"pubmed\">38402606</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobler C., van Tongeren M., Gettemans J., Kell D.B., Pretorius E. Alzheimer&#x2019;s Disease: A Systems View Provides a Unifying Explanation of Its Development. J. Alzheimers Dis. 2023;91:43&#x2013;70. doi: 10.3233/JAD-220720.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-220720</ArticleId><ArticleId IdType=\"pubmed\">36442193</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Huai J. Role of primary aging hallmarks in Alzheimer&#x2019;s disease. Theranostics. 2023;13:197&#x2013;230. doi: 10.7150/thno.79535.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7150/thno.79535</ArticleId><ArticleId IdType=\"pmc\">PMC9800733</ArticleId><ArticleId IdType=\"pubmed\">36593969</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorszewska J., Prendecki M., Oczkowska A., Dezor M., Kozubski W. Molecular Basis of Familial and Sporadic Alzheimer&#x2019;s Disease. Curr. Alzheimer Res. 2016;13:952&#x2013;963. doi: 10.2174/1567205013666160314150501.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567205013666160314150501</ArticleId><ArticleId IdType=\"pubmed\">26971934</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B., Iwatsubo T., Wolfe M.S. Presenilins and gamma-secretase: Structure, function, and role in Alzheimer Disease. Cold Spring Harb. Perspect. Med. 2012;2:a006304. doi: 10.1101/cshperspect.a006304.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/cshperspect.a006304</ArticleId><ArticleId IdType=\"pmc\">PMC3253024</ArticleId><ArticleId IdType=\"pubmed\">22315713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson D.M., 3rd, Cookson M.R., Van Den Bosch L., Zetterberg H., Holtzman D.M., Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186:693&#x2013;714. doi: 10.1016/j.cell.2022.12.032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2022.12.032</ArticleId><ArticleId IdType=\"pubmed\">36803602</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchanan H., Mackay M., Palmer K., Tothova K., Katsur M., Platt B., Koss D.J. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer&#x2019;s Disease. Mol. Neurobiol. 2020;57:3258&#x2013;3272. doi: 10.1007/s12035-020-01950-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-020-01950-1</ArticleId><ArticleId IdType=\"pmc\">PMC7340653</ArticleId><ArticleId IdType=\"pubmed\">32514860</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Zhang X., Zhang R., Wang Z., Gan J., Gao Q., Yang L., Xu P., Jiang X. Inflammatory signaling pathways in the treatment of Alzheimer&#x2019;s disease with inhibitors, natural products and metabolites (Review) Int. J. Mol. Med. 2023;52:111. doi: 10.3892/ijmm.2023.5314.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/ijmm.2023.5314</ArticleId><ArticleId IdType=\"pmc\">PMC10558228</ArticleId><ArticleId IdType=\"pubmed\">37800614</ArticleId></ArticleIdList></Reference><Reference><Citation>Henstridge C.M., Hyman B.T., Spires-Jones T.L. Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis. Nat. Rev. Neurosci. 2019;20:94&#x2013;108. doi: 10.1038/s41583-018-0113-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41583-018-0113-1</ArticleId><ArticleId IdType=\"pmc\">PMC6545070</ArticleId><ArticleId IdType=\"pubmed\">30643230</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney J.W., Bemiller S.M., Murtishaw A.S., Leisgang A.M., Salazar A.M., Lamb B.T. Inflammation as a central mechanism in Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;4:575&#x2013;590. doi: 10.1016/j.trci.2018.06.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.trci.2018.06.014</ArticleId><ArticleId IdType=\"pmc\">PMC6214864</ArticleId><ArticleId IdType=\"pubmed\">30406177</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Qin L., Tang B. MicroRNAs in Alzheimer&#x2019;s Disease. Front. Genet. 2019;10:153. doi: 10.3389/fgene.2019.00153.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fgene.2019.00153</ArticleId><ArticleId IdType=\"pmc\">PMC6405631</ArticleId><ArticleId IdType=\"pubmed\">30881384</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan G.P., Henshall D.C. MicroRNAs as regulators of brain function and targets for treatment of epilepsy. Nat. Rev. Neurol. 2020;16:506&#x2013;519. doi: 10.1038/s41582-020-0369-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41582-020-0369-8</ArticleId><ArticleId IdType=\"pubmed\">32546757</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Benedetto G., Burgaletto C., Bellanca C.M., Munafo A., Bernardini R., Cantarella G. Role of Microglia and Astrocytes in Alzheimer&#x2019;s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation. Cells. 2022;11:2728. doi: 10.3390/cells11172728.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells11172728</ArticleId><ArticleId IdType=\"pmc\">PMC9454513</ArticleId><ArticleId IdType=\"pubmed\">36078138</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer&#x2019;s disease mutations: Potential factors in amyloid plaque formation. J. Neurosci. 2006;26:10129&#x2013;10140. doi: 10.1523/JNEUROSCI.1202-06.2006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1202-06.2006</ArticleId><ArticleId IdType=\"pmc\">PMC6674618</ArticleId><ArticleId IdType=\"pubmed\">17021169</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowsky J.L., Zheng H. Practical considerations for choosing a mouse model of Alzheimer&#x2019;s disease. Mol. Neurodegener. 2017;12:89. doi: 10.1186/s13024-017-0231-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-017-0231-7</ArticleId><ArticleId IdType=\"pmc\">PMC5741956</ArticleId><ArticleId IdType=\"pubmed\">29273078</ArticleId></ArticleIdList></Reference><Reference><Citation>Forner S., Kawauchi S., Balderrama-Gutierrez G., Kramar E.A., Matheos D.P., Phan J., Javonillo D.I., Tran K.M., Hingco E., da Cunha C., et al. Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer&#x2019;s disease. Sci. Data. 2021;8:270. doi: 10.1038/s41597-021-01054-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41597-021-01054-y</ArticleId><ArticleId IdType=\"pmc\">PMC8519958</ArticleId><ArticleId IdType=\"pubmed\">34654824</ArticleId></ArticleIdList></Reference><Reference><Citation>Brites D. Regulatory function of microRNAs in microglia. Glia. 2020;68:1631&#x2013;1642. doi: 10.1002/glia.23846.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/glia.23846</ArticleId><ArticleId IdType=\"pubmed\">32463968</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia G., Pinto S., Ferreira S., Lopes D., Serrador M.J., Fernandes A., Vaz A.R., Mendon&#xe7;a A., Edenhofer F., Malm T., et al. Emerging Role of miR-21-5p in Neuron-Glia Dysregulation and Exosome Transfer Using Multiple Models of Alzheimer&#x2019;s Disease. Cells. 2022;11:3377. doi: 10.3390/cells11213377.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells11213377</ArticleId><ArticleId IdType=\"pmc\">PMC9655962</ArticleId><ArticleId IdType=\"pubmed\">36359774</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasheed Z., Rasheed N., Abdulmonem W.A., Khan M.I. MicroRNA-125b-5p regulates IL-1beta induced inflammatory genes via targeting TRAF6-mediated MAPKs and NF-kappaB signaling in human osteoarthritic chondrocytes. Sci. Rep. 2019;9:6882. doi: 10.1038/s41598-019-42601-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-42601-3</ArticleId><ArticleId IdType=\"pmc\">PMC6499837</ArticleId><ArticleId IdType=\"pubmed\">31053727</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Li Q., Gui H., Xu D.P., Yang Y.L., Su D.F., Liu X. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Res. 2013;23:1270&#x2013;1283. doi: 10.1038/cr.2013.116.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/cr.2013.116</ArticleId><ArticleId IdType=\"pmc\">PMC3817544</ArticleId><ArticleId IdType=\"pubmed\">23979021</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes A., Ribeiro A.R., Monteiro M., Garcia G., Vaz A.R., Brites D. Secretome from SH-SY5Y APP(Swe) cells trigger time-dependent CHME3 microglia activation phenotypes, ultimately leading to miR-21 exosome shuttling. Biochimie. 2018;155:67&#x2013;82. doi: 10.1016/j.biochi.2018.05.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biochi.2018.05.015</ArticleId><ArticleId IdType=\"pubmed\">29857185</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark A., Brennecke J., Bushati N., Russell R.B., Cohen S.M. Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3&#x2019;UTR evolution. Cell. 2005;123:1133&#x2013;1146. doi: 10.1016/j.cell.2005.11.023.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2005.11.023</ArticleId><ArticleId IdType=\"pubmed\">16337999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Zhang H., Li M., Frid M.G., Flockton A.R., McKeon B.A., Yeager M.E., Fini M.A., Morrell N.W., Pullamsetti S.S., et al. MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ. Res. 2014;114:67&#x2013;78. doi: 10.1161/CIRCRESAHA.114.301633.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/CIRCRESAHA.114.301633</ArticleId><ArticleId IdType=\"pmc\">PMC4117588</ArticleId><ArticleId IdType=\"pubmed\">24122720</ArticleId></ArticleIdList></Reference><Reference><Citation>Soreq H., Wolf Y. NeurimmiRs: microRNAs in the neuroimmune interface. Trends Mol. Med. 2011;17:548&#x2013;555. doi: 10.1016/j.molmed.2011.06.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.molmed.2011.06.009</ArticleId><ArticleId IdType=\"pubmed\">21813326</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia G., Pinto S., Cunha M., Fernandes A., Koistinaho J., Brites D. Neuronal Dynamics and miRNA Signaling Differ between SH-SY5Y APPSwe and PSEN1 Mutant iPSC-Derived AD Models upon Modulation with miR-124 Mimic and Inhibitor. Cells. 2021;10:2424. doi: 10.3390/cells10092424.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells10092424</ArticleId><ArticleId IdType=\"pmc\">PMC8465877</ArticleId><ArticleId IdType=\"pubmed\">34572073</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M., Wang J., Zhang X., Geng Y., Hu Z., Rudd J.A., Ling S., Chen W., Han S. The miR-124 regulates the expression of BACE1/beta-secretase correlated with cell death in Alzheimer&#x2019;s disease. Toxicol. Lett. 2012;209:94&#x2013;105. doi: 10.1016/j.toxlet.2011.11.032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.toxlet.2011.11.032</ArticleId><ArticleId IdType=\"pubmed\">22178568</ArticleId></ArticleIdList></Reference><Reference><Citation>An F., Gong G., Wang Y., Bian M., Yu L., Wei C. MiR-124 acts as a target for Alzheimer&#x2019;s disease by regulating BACE1. Oncotarget. 2017;8:114065&#x2013;114071. doi: 10.18632/oncotarget.23119.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.23119</ArticleId><ArticleId IdType=\"pmc\">PMC5768386</ArticleId><ArticleId IdType=\"pubmed\">29371969</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Du J., Zhou J., Zhong B., Ba L., Zhang J., Liu Y., Liu S. Elevated microRNA-21 Is a Brake of Inflammation Involved in the Development of Nasal Polyps. Front. Immunol. 2021;12:530488. doi: 10.3389/fimmu.2021.530488.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2021.530488</ArticleId><ArticleId IdType=\"pmc\">PMC8082185</ArticleId><ArticleId IdType=\"pubmed\">33936025</ArticleId></ArticleIdList></Reference><Reference><Citation>Amakiri N., Kubosumi A., Tran J., Reddy P.H. Amyloid Beta and MicroRNAs in Alzheimer&#x2019;s Disease. Front. Neurosci. 2019;13:430. doi: 10.3389/fnins.2019.00430.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2019.00430</ArticleId><ArticleId IdType=\"pmc\">PMC6510214</ArticleId><ArticleId IdType=\"pubmed\">31130840</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliani A., Gaetani S., Sorgentoni G., Agarbati S., Laggetta M., Matacchione G., Gobbi M., Rossi T., Galeazzi R., Piccinini G., et al. Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer&#x2019;s Disease. Front. Aging Neurosci. 2021;13:647015. doi: 10.3389/fnagi.2021.647015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2021.647015</ArticleId><ArticleId IdType=\"pmc\">PMC7990771</ArticleId><ArticleId IdType=\"pubmed\">33776746</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudet A.D., Fonken L.K., Watkins L.R., Nelson R.J., Popovich P.G. MicroRNAs: Roles in Regulating Neuroinflammation. Neuroscientist. 2018;24:221&#x2013;245. doi: 10.1177/1073858417721150.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1073858417721150</ArticleId><ArticleId IdType=\"pmc\">PMC8377730</ArticleId><ArticleId IdType=\"pubmed\">28737113</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Huang Y., Wang L.L., Zhang Y.F., Xu J., Zhou Y., Lourenco G.F., Zhang B., Wang Y., Ren R.J., et al. MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer&#x2019;s disease. Sci. Rep. 2016;6:26697. doi: 10.1038/srep26697.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/srep26697</ArticleId><ArticleId IdType=\"pmc\">PMC4879631</ArticleId><ArticleId IdType=\"pubmed\">27221467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansari A., Maffioletti E., Milanesi E., Marizzoni M., Frisoni G.B., Blin O., Richardson J.C., Bordet R., Forloni G., Gennarelli M., et al. miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer&#x2019;s disease. Neurobiol. Aging. 2019;82:102&#x2013;109. doi: 10.1016/j.neurobiolaging.2019.06.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2019.06.005</ArticleId><ArticleId IdType=\"pubmed\">31437718</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloi M.S., Prater K.E., Sanchez R.E.A., Beck A., Pathan J.L., Davidson S., Wilson A., Keene C.D., de la Iglesia H., Jayadev S., et al. Microglia specific deletion of miR-155 in Alzheimer&#x2019;s disease mouse models reduces amyloid-beta pathology but causes hyperexcitability and seizures. J. Neuroinflamm. 2023;20:60. doi: 10.1186/s12974-023-02745-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-023-02745-6</ArticleId><ArticleId IdType=\"pmc\">PMC9990295</ArticleId><ArticleId IdType=\"pubmed\">36879321</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedes J.R., Custodia C.M., Silva R.J., de Almeida L.P., Pedroso de Lima M.C., Cardoso A.L. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer&#x2019;s disease triple transgenic mouse model. Hum. Mol. Genet. 2014;23:6286&#x2013;6301. doi: 10.1093/hmg/ddu348.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddu348</ArticleId><ArticleId IdType=\"pubmed\">24990149</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingale V.D., Gugliandolo A., Mazzon E. MiR-155: An Important Regulator of Neuroinflammation. Int. J. Mol. Sci. 2021;23:90. doi: 10.3390/ijms23010090.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23010090</ArticleId><ArticleId IdType=\"pmc\">PMC8745074</ArticleId><ArticleId IdType=\"pubmed\">35008513</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster T.M., Hill M.J., Sims R., Williams J. Microglia-mediated immunity partly contributes to the genetic association between Alzheimer&#x2019;s disease and hippocampal volume. Brain Behav. Immun. 2019;79:267&#x2013;273. doi: 10.1016/j.bbi.2019.02.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2019.02.011</ArticleId><ArticleId IdType=\"pmc\">PMC6605284</ArticleId><ArticleId IdType=\"pubmed\">30776473</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Liu Z., Ji B., Liu L., Wu S., Liu X., Wang S., Wang L. Metabolite Profile of Alzheimer&#x2019;s Disease in the Frontal Cortex as Analyzed by HRMAS (1)H NMR. Front. Aging Neurosci. 2018;10:424. doi: 10.3389/fnagi.2018.00424.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2018.00424</ArticleId><ArticleId IdType=\"pmc\">PMC6333733</ArticleId><ArticleId IdType=\"pubmed\">30687076</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Li J., Li L., Zhang Y., Yang M., Liang S., Li L., Dai Y., Chen L., Jia W., et al. Enhanced Medial Prefrontal Cortex and Hippocampal Activity Improves Memory Generalization in APP/PS1 Mice: A Multimodal Animal MRI Study. Front. Cell. Neurosci. 2022;16:848967. doi: 10.3389/fncel.2022.848967.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2022.848967</ArticleId><ArticleId IdType=\"pmc\">PMC8977524</ArticleId><ArticleId IdType=\"pubmed\">35386301</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z.H., Wang H., Wang D.M., Zhao X.Y., Liu W.W., Zhong X., He D.M., Mu B.R., Lu M.H. Identification of core genes in prefrontal cortex and hippocampus of Alzheimer&#x2019;s disease based on mRNA-miRNA network. J. Cell. Mol. Med. 2022;26:5779&#x2013;5793. doi: 10.1111/jcmm.17593.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jcmm.17593</ArticleId><ArticleId IdType=\"pmc\">PMC9716226</ArticleId><ArticleId IdType=\"pubmed\">36401602</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst C.D., Dunn A.R., Dammer E.B., Duong D.M., Shapley S.M., Seyfried N.T., Kaczorowski C.C., Johnson E.C.B. Genetic background influences the 5XFAD Alzheimer&#x2019;s disease mouse model brain proteome. Front. Aging Neurosci. 2023;15:1239116. doi: 10.3389/fnagi.2023.1239116.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1239116</ArticleId><ArticleId IdType=\"pmc\">PMC10602695</ArticleId><ArticleId IdType=\"pubmed\">37901791</ArticleId></ArticleIdList></Reference><Reference><Citation>Landel V., Baranger K., Virard I., Loriod B., Khrestchatisky M., Rivera S., Benech P., Feron F. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer&#x2019;s disease. Mol. Neurodegener. 2014;9:33. doi: 10.1186/1750-1326-9-33.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1750-1326-9-33</ArticleId><ArticleId IdType=\"pmc\">PMC4237952</ArticleId><ArticleId IdType=\"pubmed\">25213090</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao N.A., Zhang J., Zhou M., Wei Z., Wu X.L., Dai X.M., Zhu Y.G., Chen X.C. Reduction of Glucose Metabolism in Olfactory Bulb is an Earlier Alzheimer&#x2019;s Disease-related Biomarker in 5XFAD Mice. Chin. Med. J. 2015;128:2220&#x2013;2227. doi: 10.4103/0366-6999.162507.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/0366-6999.162507</ArticleId><ArticleId IdType=\"pmc\">PMC4717990</ArticleId><ArticleId IdType=\"pubmed\">26265617</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanigan T.J., Xue Y., Kishan Rao S., Dhanushkodi A., McDonald M.P. Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics. Genes. Brain Behav. 2014;13:488&#x2013;500. doi: 10.1111/gbb.12133.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/gbb.12133</ArticleId><ArticleId IdType=\"pmc\">PMC4170055</ArticleId><ArticleId IdType=\"pubmed\">24655396</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C., Galea E., Lakatos A., O&#x2019;Callaghan J.P., Petzold G.C., Serrano-Pozo A., Steinhauser C., Volterra A., Carmignoto G., Agarwal A., et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 2021;24:312&#x2013;325. doi: 10.1038/s41593-020-00783-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41593-020-00783-4</ArticleId><ArticleId IdType=\"pmc\">PMC8007081</ArticleId><ArticleId IdType=\"pubmed\">33589835</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R.C., Sierra A., Stevens B., Tremblay M.E., Aguzzi A., Ajami B., Amit I., Audinat E., Bechmann I., Bennett M., et al. Microglia states and nomenclature: A field at its crossroads. Neuron. 2022;110:3458&#x2013;3483. doi: 10.1016/j.neuron.2022.10.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2022.10.020</ArticleId><ArticleId IdType=\"pmc\">PMC9999291</ArticleId><ArticleId IdType=\"pubmed\">36327895</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomeshchik Y., Klementieva O., Gil J., Martinsson I., Hansen M.G., de Vries T., Sancho-Balsells A., Russ K., Savchenko E., Collin A., et al. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies. Stem Cell Rep. 2020;15:256&#x2013;273. doi: 10.1016/j.stemcr.2020.06.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.stemcr.2020.06.001</ArticleId><ArticleId IdType=\"pmc\">PMC7363942</ArticleId><ArticleId IdType=\"pubmed\">32589876</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz A.R., Vizinha D., Morais H., Colaco A.R., Loch-Neckel G., Barbosa M., Brites D. Overexpression of miR-124 in Motor Neurons Plays a Key Role in ALS Pathological Processes. Int. J. Mol. Sci. 2021;22:6128. doi: 10.3390/ijms22116128.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22116128</ArticleId><ArticleId IdType=\"pmc\">PMC8201298</ArticleId><ArticleId IdType=\"pubmed\">34200161</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitre M., Jeltsch-David H., Okechukwu N.G., Klein C., Patte-Mensah C., Mensah-Nyagan A.G. Myelin in Alzheimer&#x2019;s disease: Culprit or bystander? Acta Neuropathol. Commun. 2023;11:56. doi: 10.1186/s40478-023-01554-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-023-01554-5</ArticleId><ArticleId IdType=\"pmc\">PMC10067200</ArticleId><ArticleId IdType=\"pubmed\">37004127</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha C., Santos C., Gomes C., Fernandes A., Correia A.M., Sebastiao A.M., Vaz A.R., Brites D. Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage. Mol. Neurobiol. 2018;55:4207&#x2013;4224. doi: 10.1007/s12035-017-0631-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-017-0631-2</ArticleId><ArticleId IdType=\"pubmed\">28612258</ArticleId></ArticleIdList></Reference><Reference><Citation>Dainichi T., Matsumoto R., Mostafa A., Kabashima K. Immune Control by TRAF6-Mediated Pathways of Epithelial Cells in the EIME (Epithelial Immune Microenvironment) Front. Immunol. 2019;10:1107. doi: 10.3389/fimmu.2019.01107.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2019.01107</ArticleId><ArticleId IdType=\"pmc\">PMC6532024</ArticleId><ArticleId IdType=\"pubmed\">31156649</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao X.Y., Wang Y., Zhang W., Li Q., Liu C., Dao J.J., Qiao C.M., Cui C., Shen Y.Q., Zhao W.J. Involvement of CXCL10 in Neuronal Damage under the Condition of Spinal Cord Injury and the Potential Therapeutic Effect of Nrg1. J. Integr. Neurosci. 2023;22:96. doi: 10.31083/j.jin2204096.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.31083/j.jin2204096</ArticleId><ArticleId IdType=\"pubmed\">37519170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C., Huang Y., Li L. Drp1-Dependent Mitochondrial Fission Plays Critical Roles in Physiological and Pathological Progresses in Mammals. Int. J. Mol. Sci. 2017;18:144. doi: 10.3390/ijms18010144.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms18010144</ArticleId><ArticleId IdType=\"pmc\">PMC5297777</ArticleId><ArticleId IdType=\"pubmed\">28098754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.J., Cao Y.L., Feng J.X., Qi Y., Meng S., Yang J.F., Zhong Y.T., Kang S., Chen X., Lan L., et al. Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset. Nat. Commun. 2019;10:4914. doi: 10.1038/s41467-019-12912-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-019-12912-0</ArticleId><ArticleId IdType=\"pmc\">PMC6820788</ArticleId><ArticleId IdType=\"pubmed\">31664033</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn S.R., O&#x2019;Neill L.A. A trio of microRNAs that control Toll-like receptor signalling. Int. Immunol. 2011;23:421&#x2013;425. doi: 10.1093/intimm/dxr034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/intimm/dxr034</ArticleId><ArticleId IdType=\"pubmed\">21652514</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y., Wang L. Inflamma-MicroRNAs in Alzheimer&#x2019;s Disease: From Disease Pathogenesis to Therapeutic Potentials. Front. Cell. Neurosci. 2021;15:785433. doi: 10.3389/fncel.2021.785433.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2021.785433</ArticleId><ArticleId IdType=\"pmc\">PMC8581643</ArticleId><ArticleId IdType=\"pubmed\">34776873</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Fan M., Zheng Q., Hao S., Yang L., Xia Q., Qi C., Ge J. MicroRNAs in Alzheimer&#x2019;s disease: Potential diagnostic markers and therapeutic targets. Biomed. Pharmacother. 2022;148:112681. doi: 10.1016/j.biopha.2022.112681.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2022.112681</ArticleId><ArticleId IdType=\"pubmed\">35177290</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn O., Foltz A.G., Atkins M., Kedir B., Moran-Losada P., Guldner I.H., Munson C., Kern F., Palovics R., Lu N., et al. Atlas of the aging mouse brain reveals white matter as vulnerable foci. Cell. 2023;186:4117&#x2013;4133.e22. doi: 10.1016/j.cell.2023.07.027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2023.07.027</ArticleId><ArticleId IdType=\"pmc\">PMC10528304</ArticleId><ArticleId IdType=\"pubmed\">37591239</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijms B.M., Gobom J., Reus L., Jansen I., Hong S., Dobricic V., Kilpert F., Ten Kate M., Barkhof F., Tsolaki M., et al. Pathophysiological subtypes of Alzheimer&#x2019;s disease based on cerebrospinal fluid proteomics. Brain. 2020;143:3776&#x2013;3792. doi: 10.1093/brain/awaa325.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awaa325</ArticleId><ArticleId IdType=\"pmc\">PMC7805814</ArticleId><ArticleId IdType=\"pubmed\">33439986</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T., Lin D., Cheng Y., Jiang S., Riaz M.W., Fu N., Mou C., Ye M., Zheng Y. Amyloid Cascade Hypothesis for the Treatment of Alzheimer&#x2019;s Disease: Progress and Challenges. Aging Dis. 2022;13:1745&#x2013;1758. doi: 10.14336/AD.2022.0412.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14336/AD.2022.0412</ArticleId><ArticleId IdType=\"pmc\">PMC9662281</ArticleId><ArticleId IdType=\"pubmed\">36465173</ArticleId></ArticleIdList></Reference><Reference><Citation>Avelar-Pereira B., Belloy M.E., O&#x2019;Hara R., Hosseini S.M.H., Alzheimer&#x2019;s Disease Neuroimaging I. Decoding the heterogeneity of Alzheimer&#x2019;s disease diagnosis and progression using multilayer networks. Mol. Psychiatry. 2023;28:2423&#x2013;2432. doi: 10.1038/s41380-022-01886-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41380-022-01886-z</ArticleId><ArticleId IdType=\"pmc\">PMC10279806</ArticleId><ArticleId IdType=\"pubmed\">36539525</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidin S.Z., Mat Pauzi N.A., Mansor N.I., Mohd Isa N.I., Hamid A.A. A new perspective on Alzheimer&#x2019;s disease: microRNAs and circular RNAs. Front. Genet. 2023;14:1231486. doi: 10.3389/fgene.2023.1231486.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fgene.2023.1231486</ArticleId><ArticleId IdType=\"pmc\">PMC10542399</ArticleId><ArticleId IdType=\"pubmed\">37790702</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuelezz N.Z., Nasr F.E., AbdulKader M.A., Bassiouny A.R., Zaky A. MicroRNAs as Potential Orchestrators of Alzheimer&#x2019;s Disease-Related Pathologies: Insights on Current Status and Future Possibilities. Front. Aging Neurosci. 2021;13:743573. doi: 10.3389/fnagi.2021.743573.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2021.743573</ArticleId><ArticleId IdType=\"pmc\">PMC8546247</ArticleId><ArticleId IdType=\"pubmed\">34712129</ArticleId></ArticleIdList></Reference><Reference><Citation>Walgrave H., Zhou L., De Strooper B., Salta E. The promise of microRNA-based therapies in Alzheimer&#x2019;s disease: Challenges and perspectives. Mol. Neurodegener. 2021;16:76. doi: 10.1186/s13024-021-00496-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-021-00496-7</ArticleId><ArticleId IdType=\"pmc\">PMC8572071</ArticleId><ArticleId IdType=\"pubmed\">34742333</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon S., Kim S.E., Ko Y., Jeong G.H., Lee K.H., Lee J., Solmi M., Jacob L., Smith L., Stickley A., et al. Differential expression of MicroRNAs in Alzheimer&#x2019;s disease: A systematic review and meta-analysis. Mol. Psychiatry. 2022;27:2405&#x2013;2413. doi: 10.1038/s41380-022-01476-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41380-022-01476-z</ArticleId><ArticleId IdType=\"pubmed\">35264731</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Qin Y., Jian C. Screening for Core Genes Related to Pathogenesis of Alzheimer&#x2019;s Disease. Front. Cell Dev. Biol. 2021;9:668738. doi: 10.3389/fcell.2021.668738.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2021.668738</ArticleId><ArticleId IdType=\"pmc\">PMC8101499</ArticleId><ArticleId IdType=\"pubmed\">33968940</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill M.A., Gammie S.C. Alzheimer&#x2019;s disease large-scale gene expression portrait identifies exercise as the top theoretical treatment. Sci. Rep. 2022;12:17189. doi: 10.1038/s41598-022-22179-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-022-22179-z</ArticleId><ArticleId IdType=\"pmc\">PMC9561721</ArticleId><ArticleId IdType=\"pubmed\">36229643</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile G., Morello G., La Cognata V., Guarnaccia M., Conforti F.L., Cavallaro S. Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases. J. Pers. Med. 2022;12:770. doi: 10.3390/jpm12050770.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jpm12050770</ArticleId><ArticleId IdType=\"pmc\">PMC9143965</ArticleId><ArticleId IdType=\"pubmed\">35629192</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldeira C., Cunha C., Vaz A.R., Falcao A.S., Barateiro A., Seixas E., Fernandes A., Brites D. Key Aging-Associated Alterations in Primary Microglia Response to Beta-Amyloid Stimulation. Front. Aging Neurosci. 2017;9:277. doi: 10.3389/fnagi.2017.00277.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2017.00277</ArticleId><ArticleId IdType=\"pmc\">PMC5583148</ArticleId><ArticleId IdType=\"pubmed\">28912710</ArticleId></ArticleIdList></Reference><Reference><Citation>Nativio R., Donahue G., Berson A., Lan Y., Amlie-Wolf A., Tuzer F., Toledo J.B., Gosai S.J., Gregory B.D., Torres C., et al. Dysregulation of the epigenetic landscape of normal aging in Alzheimer&#x2019;s disease. Nat. Neurosci. 2018;21:497&#x2013;505. doi: 10.1038/s41593-018-0101-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41593-018-0101-9</ArticleId><ArticleId IdType=\"pmc\">PMC6124498</ArticleId><ArticleId IdType=\"pubmed\">29507413</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong-Guerra M., Calfio C., Maccioni R.B., Rojo L.E. Revisiting the neuroinflammation hypothesis in Alzheimer&#x2019;s disease: A focus on the druggability of current targets. Front. Pharmacol. 2023;14:1161850. doi: 10.3389/fphar.2023.1161850.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2023.1161850</ArticleId><ArticleId IdType=\"pmc\">PMC10288808</ArticleId><ArticleId IdType=\"pubmed\">37361208</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Xiao D., Mao Q., Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct. Target. Ther. 2023;8:267. doi: 10.1038/s41392-023-01486-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-023-01486-5</ArticleId><ArticleId IdType=\"pmc\">PMC10336149</ArticleId><ArticleId IdType=\"pubmed\">37433768</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng F., Edison P. Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here? Nat. Rev. Neurol. 2021;17:157&#x2013;172. doi: 10.1038/s41582-020-00435-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41582-020-00435-y</ArticleId><ArticleId IdType=\"pubmed\">33318676</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallach A., Zielonka M., van Lieshout V., An Y., Khoo J.H., Vanheusden M., Chen W.T., Moechars D., Arancibia-Carcamo I.L., Fiers M., et al. Microglia-astrocyte crosstalk in the amyloid plaque niche of an Alzheimer&#x2019;s disease mouse model, as revealed by spatial transcriptomics. Cell Rep. 2024;43:114216. doi: 10.1016/j.celrep.2024.114216.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2024.114216</ArticleId><ArticleId IdType=\"pubmed\">38819990</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarland K.N., Chakrabarty P. Microglia in Alzheimer&#x2019;s Disease: A Key Player in the Transition between Homeostasis and Pathogenesis. Neurotherapeutics. 2022;19:186&#x2013;208. doi: 10.1007/s13311-021-01179-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13311-021-01179-3</ArticleId><ArticleId IdType=\"pmc\">PMC9130399</ArticleId><ArticleId IdType=\"pubmed\">35286658</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinser H.E., Pincus Z. MicroRNAs as modulators of longevity and the aging process. Hum. Genet. 2020;139:291&#x2013;308. doi: 10.1007/s00439-019-02046-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00439-019-02046-0</ArticleId><ArticleId IdType=\"pmc\">PMC6954352</ArticleId><ArticleId IdType=\"pubmed\">31297598</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivieri F., Prattichizzo F., Giuliani A., Matacchione G., Rippo M.R., Sabbatinelli J., Bonafe M. miR-21 and miR-146a: The microRNAs of inflammaging and age-related diseases. Ageing Res. Rev. 2021;70:101374. doi: 10.1016/j.arr.2021.101374.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2021.101374</ArticleId><ArticleId IdType=\"pubmed\">34082077</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa M., Santos M., de Sousa N., Duarte-Silva S., Vaz A.R., Salgado A.J., Brites D. Intrathecal Injection of the Secretome from ALS Motor Neurons Regulated for miR-124 Expression Prevents Disease Outcomes in SOD1-G93A Mice. Biomedicines. 2022;10:2120. doi: 10.3390/biomedicines10092120.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines10092120</ArticleId><ArticleId IdType=\"pmc\">PMC9496075</ArticleId><ArticleId IdType=\"pubmed\">36140218</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa M., Gomes C., Sequeira C., Goncalves-Ribeiro J., Pina C.C., Carvalho L.A., Moreira R., Vaz S.H., Vaz A.R., Brites D. Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons. Front. Cell Dev. Biol. 2021;9:634355. doi: 10.3389/fcell.2021.634355.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2021.634355</ArticleId><ArticleId IdType=\"pmc\">PMC8103001</ArticleId><ArticleId IdType=\"pubmed\">33968923</ArticleId></ArticleIdList></Reference><Reference><Citation>Han D., Dong X., Zheng D., Nao J. MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders. Front. Pharmacol. 2019;10:1555. doi: 10.3389/fphar.2019.01555.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2019.01555</ArticleId><ArticleId IdType=\"pmc\">PMC6978711</ArticleId><ArticleId IdType=\"pubmed\">32009959</ArticleId></ArticleIdList></Reference><Reference><Citation>Banzhaf-Strathmann J., Benito E., May S., Arzberger T., Tahirovic S., Kretzschmar H., Fischer A., Edbauer D. MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer&#x2019;s disease. EMBO J. 2014;33:1667&#x2013;1680. doi: 10.15252/embj.201387576.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/embj.201387576</ArticleId><ArticleId IdType=\"pmc\">PMC4194100</ArticleId><ArticleId IdType=\"pubmed\">25001178</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Zhao D., Zhao Y., Wang Y., Zhao Y., Wen C. Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer&#x2019;s Disease and Involvement of Neuroinflammation. Curr. Alzheimer Res. 2019;16:473&#x2013;482. doi: 10.2174/1567205016666190503145207.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567205016666190503145207</ArticleId><ArticleId IdType=\"pubmed\">31456514</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H., Lee E.J., Shin J.S., Kim H., Bae S., Choi Y., Lee D.S. Spatiotemporal characterization of glial cell activation in an Alzheimer&#x2019;s disease model by spatially resolved transcriptomics. Exp. Mol. Med. 2023;55:2564&#x2013;2575. doi: 10.1038/s12276-023-01123-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s12276-023-01123-9</ArticleId><ArticleId IdType=\"pmc\">PMC10767047</ArticleId><ArticleId IdType=\"pubmed\">38036733</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Yu T., Liu Z., Ye X., Liao X., Wang X., Han C., Zhu G., Qin W., Peng T. Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early-stage pancreatic ductal adenocarcinoma. Oncol. Rep. 2019;42:79&#x2013;90. doi: 10.3892/or.2019.7135.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/or.2019.7135</ArticleId><ArticleId IdType=\"pmc\">PMC6549077</ArticleId><ArticleId IdType=\"pubmed\">31059105</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharpure M., Vyavahare S., Ahluwalia P., Gupta S.K., Lee T.J., Lohakare J., Kolhe R., Lei Y., Deak F., Lu X.Y., et al. Alterations in Alzheimer&#x2019;s disease microglia transcriptome might be involved in bone pathophysiology. Neurobiol. Dis. 2024;191:106404. doi: 10.1016/j.nbd.2024.106404.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2024.106404</ArticleId><ArticleId IdType=\"pubmed\">38184014</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemonnot-Girard A.L., Meersseman C., Pastore M., Garcia V., Linck N., Rey C., Chebbi A., Jeanneteau F., Ginsberg S.D., Lachuer J., et al. Comparative analysis of transcriptome remodeling in plaque-associated and plaque-distant microglia during amyloid-beta pathology progression in mice. J. Neuroinflamm. 2022;19:234. doi: 10.1186/s12974-022-02581-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-022-02581-0</ArticleId><ArticleId IdType=\"pmc\">PMC9508749</ArticleId><ArticleId IdType=\"pubmed\">36153535</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H., Spinrad A., Weiner A., Matcovitch-Natan O., Dvir-Szternfeld R., Ulland T.K., David E., Baruch K., Lara-Astaiso D., Toth B., et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer&#x2019;s Disease. Cell. 2017;169:1276&#x2013;1290.e17. doi: 10.1016/j.cell.2017.05.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType=\"pubmed\">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Baleviciute A., Keane L. Sex-specific role for microglial CST7 in Alzheimer&#x2019;s disease. Nat. Rev. Immunol. 2023;23:73. doi: 10.1038/s41577-022-00830-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41577-022-00830-0</ArticleId><ArticleId IdType=\"pubmed\">36596847</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen M.K., Mahns D.A., Coorssen J.R., Shortland P.J. The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis. Glia. 2022;70:1215&#x2013;1250. doi: 10.1002/glia.24148.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/glia.24148</ArticleId><ArticleId IdType=\"pmc\">PMC9302634</ArticleId><ArticleId IdType=\"pubmed\">35107839</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnerbauer M., Wheeler M.A., Quintana F.J. Astrocyte Crosstalk in CNS Inflammation. Neuron. 2020;108:608&#x2013;622. doi: 10.1016/j.neuron.2020.08.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2020.08.012</ArticleId><ArticleId IdType=\"pmc\">PMC7704785</ArticleId><ArticleId IdType=\"pubmed\">32898475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.Y., Shin K.Y., Chang K.A. GFAP as a Potential Biomarker for Alzheimer&#x2019;s Disease: A Systematic Review and Meta-Analysis. Cells. 2023;12:1309. doi: 10.3390/cells12091309.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells12091309</ArticleId><ArticleId IdType=\"pmc\">PMC10177296</ArticleId><ArticleId IdType=\"pubmed\">37174709</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Shi Z., Qiu Y., Sun D., Zhou H. Peripheral GFAP and NfL as early biomarkers for dementia: Longitudinal insights from the UK Biobank. BMC Med. 2024;22:192. doi: 10.1186/s12916-024-03418-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12916-024-03418-8</ArticleId><ArticleId IdType=\"pmc\">PMC11089788</ArticleId><ArticleId IdType=\"pubmed\">38735950</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S., Younkin S., et al. TREM2 variants in Alzheimer&#x2019;s disease. N. Engl. J. Med. 2013;368:117&#x2013;127. doi: 10.1056/NEJMoa1211851.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa1211851</ArticleId><ArticleId IdType=\"pmc\">PMC3631573</ArticleId><ArticleId IdType=\"pubmed\">23150934</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank S., Burbach G.J., Bonin M., Walter M., Streit W., Bechmann I., Deller T. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia. 2008;56:1438&#x2013;1447. doi: 10.1002/glia.20710.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/glia.20710</ArticleId><ArticleId IdType=\"pubmed\">18551625</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Song W.M., Andhey P.S., Swain A., Levy T., Miller K.R., Poliani P.L., Cominelli M., Grover S., Gilfillan S., et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer&#x2019;s disease. Nat. Med. 2020;26:131&#x2013;142. doi: 10.1038/s41591-019-0695-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-019-0695-9</ArticleId><ArticleId IdType=\"pmc\">PMC6980793</ArticleId><ArticleId IdType=\"pubmed\">31932797</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R.Y., Qin Q., Yang H.C., Wang Y.Y., Mi Y.X., Yin Y.S., Wang M., Yu C.J., Tang Y. TREM2 in the pathogenesis of AD: A lipid metabolism regulator and potential metabolic therapeutic target. Mol. Neurodegener. 2022;17:40. doi: 10.1186/s13024-022-00542-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-022-00542-y</ArticleId><ArticleId IdType=\"pmc\">PMC9166437</ArticleId><ArticleId IdType=\"pubmed\">35658903</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M., Leyns C.E.G., Holtzman D.M. New insights into the role of TREM2 in Alzheimer&#x2019;s disease. Mol. Neurodegener. 2018;13:66. doi: 10.1186/s13024-018-0298-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-018-0298-9</ArticleId><ArticleId IdType=\"pmc\">PMC6302500</ArticleId><ArticleId IdType=\"pubmed\">30572908</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain N., Lewis C.A., Ulrich J.D., Holtzman D.M. Chronic TREM2 activation exacerbates Abeta-associated tau seeding and spreading. J. Exp. Med. 2023;220:e20220654. doi: 10.1084/jem.20220654.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20220654</ArticleId><ArticleId IdType=\"pmc\">PMC9559604</ArticleId><ArticleId IdType=\"pubmed\">36219197</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M., Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu. Rev. Immunol. 2017;35:441&#x2013;468. doi: 10.1146/annurev-immunol-051116-052358.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-immunol-051116-052358</ArticleId><ArticleId IdType=\"pmc\">PMC8167938</ArticleId><ArticleId IdType=\"pubmed\">28226226</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachiller S., Jimenez-Ferrer I., Paulus A., Yang Y., Swanberg M., Deierborg T., Boza-Serrano A. Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response. Front. Cell. Neurosci. 2018;12:488. doi: 10.3389/fncel.2018.00488.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2018.00488</ArticleId><ArticleId IdType=\"pmc\">PMC6305407</ArticleId><ArticleId IdType=\"pubmed\">30618635</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee S., Zhao Y., Dua P., Rogaev E.I., Lukiw W.J. microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration. PLoS ONE. 2016;11:e0150211. doi: 10.1371/journal.pone.0150211.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0150211</ArticleId><ArticleId IdType=\"pmc\">PMC4780721</ArticleId><ArticleId IdType=\"pubmed\">26949937</ArticleId></ArticleIdList></Reference><Reference><Citation>Podlesny-Drabiniok A., Novikova G., Liu Y., Dunst J., Temizer R., Giannarelli C., Marro S., Kreslavsky T., Marcora E., Goate A.M. BHLHE40/41 regulate microglia and peripheral macrophage responses associated with Alzheimer&#x2019;s disease and other disorders of lipid-rich tissues. Nat. Commun. 2024;15:2058. doi: 10.1038/s41467-024-46315-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-024-46315-7</ArticleId><ArticleId IdType=\"pmc\">PMC10917780</ArticleId><ArticleId IdType=\"pubmed\">38448474</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasrabady S.E., Rizvi B., Goldman J.E., Brickman A.M. White matter changes in Alzheimer&#x2019;s disease: A focus on myelin and oligodendrocytes. Acta Neuropathol. Commun. 2018;6:22. doi: 10.1186/s40478-018-0515-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-018-0515-3</ArticleId><ArticleId IdType=\"pmc\">PMC5834839</ArticleId><ArticleId IdType=\"pubmed\">29499767</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu X., Wang N., Cheng W., Xue Y., Chen W., Qi M. MicroRNA-146a protects against intracerebral hemorrhage by inhibiting inflammation and oxidative stress. Exp. Ther. Med. 2019;18:3920&#x2013;3928. doi: 10.3892/etm.2019.8060.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/etm.2019.8060</ArticleId><ArticleId IdType=\"pmc\">PMC6812313</ArticleId><ArticleId IdType=\"pubmed\">31656540</ArticleId></ArticleIdList></Reference><Reference><Citation>Magilnick N., Reyes E.Y., Wang W.L., Vonderfecht S.L., Gohda J., Inoue J.I., Boldin M.P. miR-146a-Traf6 regulatory axis controls autoimmunity and myelopoiesis, but is dispensable for hematopoietic stem cell homeostasis and tumor suppression. Proc. Natl. Acad. Sci. USA. 2017;114:E7140&#x2013;E7149. doi: 10.1073/pnas.1706833114.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1706833114</ArticleId><ArticleId IdType=\"pmc\">PMC5576818</ArticleId><ArticleId IdType=\"pubmed\">28784800</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu M., Fan Y., Wu L., Ma X., Sao J., Yao Y., Zhuang W., Zhang C. Knockdown of lncRNA BDNF-AS inhibited the progression of multiple myeloma by targeting the miR-125a/b-5p-BCL2 axis. Immun. Ageing. 2022;19:3. doi: 10.1186/s12979-021-00258-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12979-021-00258-5</ArticleId><ArticleId IdType=\"pmc\">PMC8722203</ArticleId><ArticleId IdType=\"pubmed\">34980181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernyuk D., Callens M., Polozova M., Gordeev A., Chigriai M., Rakovskaya A., Ilina A., Pchitskaya E., Van den Haute C., Vervliet T., et al. Neuroprotective properties of anti-apoptotic BCL-2 proteins in 5xFAD mouse model of Alzheimer&#x2019;s disease. IBRO Neurosci. Rep. 2023;14:273&#x2013;283. doi: 10.1016/j.ibneur.2023.02.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ibneur.2023.02.005</ArticleId><ArticleId IdType=\"pmc\">PMC10011438</ArticleId><ArticleId IdType=\"pubmed\">36926591</ArticleId></ArticleIdList></Reference><Reference><Citation>Callens M., Kraskovskaya N., Derevtsova K., Annaert W., Bultynck G., Bezprozvanny I., Vervliet T. The role of Bcl-2 proteins in modulating neuronal Ca2+ signaling in health and in Alzheimer&#x2019;s disease. Biochim. Biophys. Acta Mol. Cell Res. 2021;1868:118997. doi: 10.1016/j.bbamcr.2021.118997.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamcr.2021.118997</ArticleId><ArticleId IdType=\"pmc\">PMC8041352</ArticleId><ArticleId IdType=\"pubmed\">33711363</ArticleId></ArticleIdList></Reference><Reference><Citation>Oblak A.L., Lin P.B., Kotredes K.P., Pandey R.S., Garceau D., Williams H.M., Uyar A., O&#x2019;Rourke R., O&#x2019;Rourke S., Ingraham C., et al. Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study. Front. Aging Neurosci. 2021;13:713726. doi: 10.3389/fnagi.2021.713726.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2021.713726</ArticleId><ArticleId IdType=\"pmc\">PMC8346252</ArticleId><ArticleId IdType=\"pubmed\">34366832</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda J., Minamihisamatsu T., Shimojo M., Zhou X., Ono M., Matsuba Y., Ji B., Ishii H., Ogawa M., Akatsu H., et al. Distinct microglial response against Alzheimer&#x2019;s amyloid and tau pathologies characterized by P2Y12 receptor. Brain Commun. 2021;3:fcab011. doi: 10.1093/braincomms/fcab011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/braincomms/fcab011</ArticleId><ArticleId IdType=\"pmc\">PMC7901060</ArticleId><ArticleId IdType=\"pubmed\">33644757</ArticleId></ArticleIdList></Reference><Reference><Citation>Zech A., Ayata C.K., Pankratz F., Meyer A., Baudiss K., Cicko S., Yegutkin G.G., Grundmann S., Idzko M. MicroRNA-155 modulates P2R signaling and Th2 priming of dendritic cells during allergic airway inflammation in mice. Allergy. 2015;70:1121&#x2013;1129. doi: 10.1111/all.12643.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/all.12643</ArticleId><ArticleId IdType=\"pubmed\">25944053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim H., Lee J.H., Hwangbo C. Toll-like receptor 4 (TLR4): New insight immune and aging. Immun. Ageing. 2023;20:67. doi: 10.1186/s12979-023-00383-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12979-023-00383-3</ArticleId><ArticleId IdType=\"pmc\">PMC10668412</ArticleId><ArticleId IdType=\"pubmed\">38001481</ArticleId></ArticleIdList></Reference><Reference><Citation>Quave C.B., Nieto S.J., Haile C.N., Kosten T.A. Immune receptor toll-like receptor 4 contributes to stress-induced affective responses in a sex-specific manner. Brain Behav. Immun. Health. 2021;14:100248. doi: 10.1016/j.bbih.2021.100248.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbih.2021.100248</ArticleId><ArticleId IdType=\"pmc\">PMC8474610</ArticleId><ArticleId IdType=\"pubmed\">34589759</ArticleId></ArticleIdList></Reference><Reference><Citation>Okun E., Barak B., Saada-Madar R., Rothman S.M., Griffioen K.J., Roberts N., Castro K., Mughal M.R., Pita M.A., Stranahan A.M., et al. Evidence for a developmental role for TLR4 in learning and memory. PLoS ONE. 2012;7:e47522. doi: 10.1371/journal.pone.0047522.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0047522</ArticleId><ArticleId IdType=\"pmc\">PMC3469493</ArticleId><ArticleId IdType=\"pubmed\">23071817</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly M.G., Yost O.L., Potter O.V., Giedraitis M.E., Kohman R.A. Toll-like receptor 4 differentially regulates adult hippocampal neurogenesis in an age- and sex-dependent manner. Hippocampus. 2020;30:958&#x2013;969. doi: 10.1002/hipo.23209.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/hipo.23209</ArticleId><ArticleId IdType=\"pmc\">PMC8162993</ArticleId><ArticleId IdType=\"pubmed\">32343455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.K., Jang S.W., Suk K., Lee W.H. Fascin regulates TLR4/PKC-mediated translational activation through miR-155 and miR-125b, which targets the 3&#x2019; untranslated region of TNF-alpha mRNA. Immunol. Investig. 2015;44:309&#x2013;320. doi: 10.3109/08820139.2014.914533.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/08820139.2014.914533</ArticleId><ArticleId IdType=\"pubmed\">25831081</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wu Z., Yuan B., Dong Y., Zhang L., Zeng Z. MicroRNA-146a-5p attenuates irradiation-induced and LPS-induced hepatic stellate cell activation and hepatocyte apoptosis through inhibition of TLR4 pathway. Cell Death Dis. 2018;9:22. doi: 10.1038/s41419-017-0038-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41419-017-0038-z</ArticleId><ArticleId IdType=\"pmc\">PMC5833436</ArticleId><ArticleId IdType=\"pubmed\">29348414</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G.J., Zhang Q.R., Gao X., Wang H., Tao T., Gao Y.Y., Zhou Y., Chen X.X., Li W., Hang C.H. MiR-146a Ameliorates Hemoglobin-Induced Microglial Inflammatory Response via TLR4/IRAK1/TRAF6 Associated Pathways. Front. Neurosci. 2020;14:311. doi: 10.3389/fnins.2020.00311.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2020.00311</ArticleId><ArticleId IdType=\"pmc\">PMC7147172</ArticleId><ArticleId IdType=\"pubmed\">32317924</ArticleId></ArticleIdList></Reference><Reference><Citation>Eimer W.A., Vassar R. Neuron loss in the 5XFAD mouse model of Alzheimer&#x2019;s disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation. Mol. Neurodegener. 2013;8:2. doi: 10.1186/1750-1326-8-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1750-1326-8-2</ArticleId><ArticleId IdType=\"pmc\">PMC3552866</ArticleId><ArticleId IdType=\"pubmed\">23316765</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Tu Q., Liu M. MicroRNA-125b regulates Alzheimer&#x2019;s disease through SphK1 regulation. Mol. Med. Rep. 2018;18:2373&#x2013;2380. doi: 10.3892/mmr.2018.9156.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/mmr.2018.9156</ArticleId><ArticleId IdType=\"pubmed\">29901156</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W., Liang C., Ou M., Zou T., Sun F., Zhou H., Cui L. MicroRNA-146a Is a Wide-Reaching Neuroinflammatory Regulator and Potential Treatment Target in Neurological Diseases. Front. Mol. Neurosci. 2020;13:90. doi: 10.3389/fnmol.2020.00090.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnmol.2020.00090</ArticleId><ArticleId IdType=\"pmc\">PMC7291868</ArticleId><ArticleId IdType=\"pubmed\">32581706</ArticleId></ArticleIdList></Reference><Reference><Citation>Hares K., Miners J.S., Cook A.J., Rice C., Scolding N., Love S., Wilkins A. Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer&#x2019;s Disease. J. Alzheimers Dis. 2017;60:1511&#x2013;1524. doi: 10.3233/JAD-170094.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-170094</ArticleId><ArticleId IdType=\"pubmed\">29060936</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvarasu K., Singh A.K., Iyaswamy A., Gopalkrishnashetty Sreenivasmurthy S., Krishnamoorthi S., Bera A.K., Huang J.D., Durairajan S.S.K. Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer&#x2019;s disease and tauopathy models. Front. Mol. Biosci. 2022;9:1050768. doi: 10.3389/fmolb.2022.1050768.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmolb.2022.1050768</ArticleId><ArticleId IdType=\"pmc\">PMC9641281</ArticleId><ArticleId IdType=\"pubmed\">36387285</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorfi M., Park J., Hall C.K., Lin C.J., Chen M., von Maydell D., Kruskop J.M., Kang B., Choi Y., Prokopenko D., et al. Infiltrating CD8(+) T cells exacerbate Alzheimer&#x2019;s disease pathology in a 3D human neuroimmune axis model. Nat. Neurosci. 2023;26:1489&#x2013;1504. doi: 10.1038/s41593-023-01415-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41593-023-01415-3</ArticleId><ArticleId IdType=\"pmc\">PMC11184920</ArticleId><ArticleId IdType=\"pubmed\">37620442</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.M., Kim T.S., Jo E.K. MiR-146 and miR-125 in the regulation of innate immunity and inflammation. BMB Rep. 2016;49:311&#x2013;318. doi: 10.5483/BMBRep.2016.49.6.056.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5483/BMBRep.2016.49.6.056</ArticleId><ArticleId IdType=\"pmc\">PMC5070718</ArticleId><ArticleId IdType=\"pubmed\">26996343</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovcanin Dragovic I., Popovic N., Zdralevic M., Radulovic L., Vukovic T., Marzano F., Tullo A., Radunovic M. Inflammation-Related microRNAs-146a and -155 Are Upregulated in Mild Cognitive Impairment Subjects Among Older Age Population in Montenegro. J. Alzheimers Dis. 2022;90:625&#x2013;638. doi: 10.3233/JAD-220676.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-220676</ArticleId><ArticleId IdType=\"pubmed\">36155522</ArticleId></ArticleIdList></Reference><Reference><Citation>Yashooa R.K., Nabi A.Q. The miR-146a-5p and miR-125b-5p levels as biomarkers for early prediction of Alzheimer&#x2019;s disease. Hum. Gene. 2022;34:201129. doi: 10.1016/j.humgen.2022.201129.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.humgen.2022.201129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J., Guo R., Shi Y., Qi F., Guo C., Yang L. miR-155 Regulated Inflammation Response by the SOCS1-STAT3-PDCD4 Axis in Atherogenesis. Mediat. Inflamm. 2016;2016:8060182. doi: 10.1155/2016/8060182.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2016/8060182</ArticleId><ArticleId IdType=\"pmc\">PMC5098093</ArticleId><ArticleId IdType=\"pubmed\">27843203</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Liu D., Huang H.Z., Wang Z.H., Hou T.Y., Yang X., Pang P., Wei N., Zhou Y.F., Dupras M.J., et al. A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer&#x2019;s Disease. Biol. Psychiatry. 2018;83:395&#x2013;405. doi: 10.1016/j.biopsych.2017.07.023.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopsych.2017.07.023</ArticleId><ArticleId IdType=\"pubmed\">28965984</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W.J. Micro-RNA speciation in fetal, adult and Alzheimer&#x2019;s disease hippocampus. Neuroreport. 2007;18:297&#x2013;300. doi: 10.1097/WNR.0b013e3280148e8b.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/WNR.0b013e3280148e8b</ArticleId><ArticleId IdType=\"pubmed\">17314675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabekkodu S.P., Shukla V., Varghese V.K., D&#x2019; Souza J., Chakrabarty S., Satyamoorthy K. Clustered miRNAs and their role in biological functions and diseases. Biol. Rev. Camb. Philos. Soc. 2018;93:1955&#x2013;1986. doi: 10.1111/brv.12428.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/brv.12428</ArticleId><ArticleId IdType=\"pubmed\">29797774</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H., Boix C.A., Akay L.A., Xia Z., Davila-Velderrain J., Ng A.P., Jiang X., Abdelhady G., Galani K., Mantero J., et al. Single-cell multiregion dissection of Alzheimer&#x2019;s disease. Nature. 2024;632:858&#x2013;868. doi: 10.1038/s41586-024-07606-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-024-07606-7</ArticleId><ArticleId IdType=\"pmc\">PMC11338834</ArticleId><ArticleId IdType=\"pubmed\">39048816</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S., Hopp S.C. The 5XFAD mouse model of Alzheimer&#x2019;s disease displays age-dependent deficits in habituation to a novel environment. Aging Brain. 2023;3:100078. doi: 10.1016/j.nbas.2023.100078.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbas.2023.100078</ArticleId><ArticleId IdType=\"pmc\">PMC10275951</ArticleId><ArticleId IdType=\"pubmed\">37333676</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon C.H., Wong S.T.N., Roy J., Wang Y., Chan H.W.H., Steinbusch H., Blokland A., Temel Y., Aquili L., Lim L.W. Sex Differences between Neuronal Loss and the Early Onset of Amyloid Deposits and Behavioral Consequences in 5xFAD Transgenic Mouse as a Model for Alzheimer&#x2019;s Disease. Cells. 2023;12:780. doi: 10.3390/cells12050780.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells12050780</ArticleId><ArticleId IdType=\"pmc\">PMC10000751</ArticleId><ArticleId IdType=\"pubmed\">36899916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zernov N., Veselovsky A.V., Poroikov V.V., Melentieva D., Bolshakova A., Popugaeva E. New Positive TRPC6 Modulator Penetrates Blood-Brain Barrier, Eliminates Synaptic Deficiency and Restores Memory Deficit in 5xFAD Mice. Int. J. Mol. Sci. 2022;23:13552. doi: 10.3390/ijms232113552.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms232113552</ArticleId><ArticleId IdType=\"pmc\">PMC9653995</ArticleId><ArticleId IdType=\"pubmed\">36362339</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Zhong L., Han X., Xiong G., Xu D., Zhang S., Cheng H., Chiu K., Xu Y. Brain and Retinal Abnormalities in the 5xFAD Mouse Model of Alzheimer&#x2019;s Disease at Early Stages. Front. Neurosci. 2021;15:681831. doi: 10.3389/fnins.2021.681831.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2021.681831</ArticleId><ArticleId IdType=\"pmc\">PMC8343228</ArticleId><ArticleId IdType=\"pubmed\">34366774</ArticleId></ArticleIdList></Reference><Reference><Citation>Manji Z., Rojas A., Wang W., Dingledine R., Varvel N.H., Ganesh T. 5xFAD Mice Display Sex-Dependent Inflammatory Gene Induction During the Prodromal Stage of Alzheimer&#x2019;s Disease. J. Alzheimers Dis. 2019;70:1259&#x2013;1274. doi: 10.3233/JAD-180678.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-180678</ArticleId><ArticleId IdType=\"pmc\">PMC7379326</ArticleId><ArticleId IdType=\"pubmed\">31322556</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x2212;&#x394;&#x394;C(T) Method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/meth.2001.1262</ArticleId><ArticleId IdType=\"pubmed\">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ru Y., Kechris K.J., Tabakoff B., Hoffman P., Radcliffe R.A., Bowler R., Mahaffey S., Rossi S., Calin G.A., Bemis L., et al. The multiMiR R package and database: Integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res. 2014;42:e133. doi: 10.1093/nar/gku631.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/gku631</ArticleId><ArticleId IdType=\"pmc\">PMC4176155</ArticleId><ArticleId IdType=\"pubmed\">25063298</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T., Hu E., Xu S., Chen M., Guo P., Dai Z., Feng T., Zhou L., Tang W., Zhan L., et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141. doi: 10.1016/j.xinn.2021.100141.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.xinn.2021.100141</ArticleId><ArticleId IdType=\"pmc\">PMC8454663</ArticleId><ArticleId IdType=\"pubmed\">34557778</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D., Chen M., Huang X., Zhang G., Zeng L., Zhang G., Wu S., Wang Y. SRplot: A free online platform for data visualization and graphing. PLoS ONE. 2023;18:e0294236. doi: 10.1371/journal.pone.0294236.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0294236</ArticleId><ArticleId IdType=\"pmc\">PMC10635526</ArticleId><ArticleId IdType=\"pubmed\">37943830</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273347</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Impact of High-Dose Fish Oil Supplementation on Mfsd2a, Aqp4, and Amyloid-&#x3b2; Expression in Retinal Blood Vessels of 5xFAD Alzheimer's Mouse Model.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9400</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179400</ELocationID><Abstract><AbstractText>In patients with Alzheimer's disease (AD) and in animal models, the increased accumulation of amyloid &#x3b2; (A&#x3b2;) in retinal blood vessels strongly correlates with brain amyloid deposits and cognitive decline. The accumulation of A&#x3b2; in blood vessels may result from impaired transcytosis and a dysfunctional ocular glymphatic system in AD. High-dose fish oil (FO) supplementation has been shown to significantly change the expression of major facilitator superfamily domain-containing protein 2a (Mfsd2a), a key regulator of transcytosis, and Aquaporin 4 (Aqp4), an essential component of the glymphatic system in the retinas of WT mice. We examined the expression of Mfsd2a and Aqp4 in the retinas of 4-month-old 5xFAD female mice supplemented with high-dose FO for three weeks. There was a significant increase in Mfsd2a expression in 5xFAD retinas supplemented with FO compared to control 5xFAD mice. Additionally, the increase in Aqp4 expression observed in 4-month-old 5xFAD retinas, indicative of an impaired glymphatic system, was significantly decreased. Simultaneously, A&#x3b2; accumulation in 5xFAD retinal blood vessels was reduced following FO supplementation. These findings suggest that high-dose FO supplementation could serve as an adjunct in developing new treatments aimed at improving the regulation of transcytosis or the function of the glymphatic system in the AD retina.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Jovanovic Macura</LastName><ForeName>Irena</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute for Biological Research \"Sinisa Stankovic\", National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Milanovic</LastName><ForeName>Desanka</ForeName><Initials>D</Initials><Identifier Source=\"ORCID\">0000-0001-9799-0335</Identifier><AffiliationInfo><Affiliation>Institute for Biological Research \"Sinisa Stankovic\", National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tesic</LastName><ForeName>Vesna</ForeName><Initials>V</Initials><Identifier Source=\"ORCID\">0000-0002-7247-1034</Identifier><AffiliationInfo><Affiliation>Institute for Biological Research \"Sinisa Stankovic\", National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Major</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Perovic</LastName><ForeName>Milka</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0003-0941-6988</Identifier><AffiliationInfo><Affiliation>Institute for Biological Research \"Sinisa Stankovic\", National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Adzic</LastName><ForeName>Miroslav</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0003-4234-7275</Identifier><AffiliationInfo><Affiliation>Vinca-Institute for Nuclear Sciences, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ivkovic</LastName><ForeName>Sanja</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0002-7977-3166</Identifier><AffiliationInfo><Affiliation>Vinca-Institute for Nuclear Sciences, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>451-03-66/2024-03/200007 and 451-03-66/2024-03/ 200017</GrantID><Agency>Ministry of Science, Technological Development and Innovation of the Republic of Serbia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D051401\">Aquaporin 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016229\">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D005395\">Fish Oils</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C534136\">Mfsd2a protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C496031\">Aqp4 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D027981\">Symporters</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051401\" MajorTopicYN=\"Y\">Aquaporin 4</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016229\" MajorTopicYN=\"Y\">Amyloid beta-Peptides</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004195\" MajorTopicYN=\"Y\">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D019587\" MajorTopicYN=\"Y\">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012171\" MajorTopicYN=\"Y\">Retinal Vessels</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008822\" MajorTopicYN=\"Y\">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005395\" MajorTopicYN=\"Y\">Fish Oils</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000008\" MajorTopicYN=\"N\">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D027981\" MajorTopicYN=\"N\">Symporters</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Aqp4</Keyword><Keyword MajorTopicYN=\"N\">BRB</Keyword><Keyword MajorTopicYN=\"N\">Mfsd2a</Keyword><Keyword MajorTopicYN=\"N\">amyloid beta</Keyword><Keyword MajorTopicYN=\"N\">retina</Keyword><Keyword MajorTopicYN=\"N\">transcytosis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273347</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179400</ArticleId><ArticleId IdType=\"pii\">ijms25179400</ArticleId><ArticleId IdType=\"pmc\">PMC11394872</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Breteler M.M. Vascular risk factors for Alzheimer&#x2019;s disease: An epidemiologic perspective. Neurobiol. Aging. 2000;21:153&#x2013;160. doi: 10.1016/S0197-4580(99)00110-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0197-4580(99)00110-4</ArticleId><ArticleId IdType=\"pubmed\">10867200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer&#x2019;s disease. Acta Neuropathol. 2009;118:103&#x2013;113. doi: 10.1007/s00401-009-0522-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-009-0522-3</ArticleId><ArticleId IdType=\"pmc\">PMC2853006</ArticleId><ArticleId IdType=\"pubmed\">19319544</ArticleId></ArticleIdList></Reference><Reference><Citation>Weller R.O., Preston S.D., Subash M., Carare R.O. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimer&#x2019;s Res. Ther. 2009;1:6. doi: 10.1186/alzrt6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/alzrt6</ArticleId><ArticleId IdType=\"pmc\">PMC2874258</ArticleId><ArticleId IdType=\"pubmed\">19822028</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipser B.D., Johanson C.E., Gonzalez L., Berzin T.M., Tavares R., Hulette C.M., Vitek M.P., Hovanesian V., Stopa E.G. Microvascular injury and blood-brain barrier leakage in Alzheimer&#x2019;s disease. Neurobiol. Aging. 2007;28:977&#x2013;986. doi: 10.1016/j.neurobiolaging.2006.05.016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2006.05.016</ArticleId><ArticleId IdType=\"pubmed\">16782234</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Haar H.J., Jansen J.F.A., van Osch M.J.P., van Buchem M.A., Muller M., Wong S.M., Hofman P.A.M., Burgmans S., Verhey F.R.J., Backes W.H. Neurovascular unit impairment in early Alzheimer&#x2019;s disease measured with magnetic resonance imaging. Neurobiol. Aging. 2016;45:190&#x2013;196. doi: 10.1016/j.neurobiolaging.2016.06.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2016.06.006</ArticleId><ArticleId IdType=\"pubmed\">27459939</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchesi V.T. Alzheimer&#x2019;s dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: Implications for early detection and therapy. FASEB. 2011;25:5&#x2013;13. doi: 10.1096/fj.11-0102ufm.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.11-0102ufm</ArticleId><ArticleId IdType=\"pubmed\">21205781</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown W.R., Thore C.R. Review: Cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol. Appl. Neurobiol. 2011;37:56&#x2013;74. doi: 10.1111/j.1365-2990.2010.01139.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2990.2010.01139.x</ArticleId><ArticleId IdType=\"pmc\">PMC3020267</ArticleId><ArticleId IdType=\"pubmed\">20946471</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Koronyo Y., Fuchs D.T., Sheyn J., Wawrowsky K., Lahiri S., Back K.L., Koronyo-Hamaoui M. Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 2020;8:202. doi: 10.1186/s40478-020-01076-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-020-01076-4</ArticleId><ArticleId IdType=\"pmc\">PMC7686701</ArticleId><ArticleId IdType=\"pubmed\">33228786</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Koronyo Y., Rentsendorj A., Regis G.C., Sheyn J., Fuchs D.T., Kramerov A.A., Ljubimov A.V., Dumitrascu O.M., Rodriguez A.R., et al. Identification of early pericyte loss and vascular amyloidosis in Alzheimer&#x2019;s disease retina. Acta Neuropathol. 2020;139:813&#x2013;836. doi: 10.1007/s00401-020-02134-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-020-02134-w</ArticleId><ArticleId IdType=\"pmc\">PMC7181564</ArticleId><ArticleId IdType=\"pubmed\">32043162</ArticleId></ArticleIdList></Reference><Reference><Citation>Koronyo Y., Biggs D., Barron E., Boyer D.S., Pearlman J.A., Au W.J., Kile S.J., Blanco A., Fuchs D.-T., Ashfaq A., et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer&#x2019;s disease. JCI Insight. 2017;2:e93621. doi: 10.1172/jci.insight.93621.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/jci.insight.93621</ArticleId><ArticleId IdType=\"pmc\">PMC5621887</ArticleId><ArticleId IdType=\"pubmed\">28814675</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Koronyo Y., Fuchs D.-T., Sheyn J., Jallow O., Mandalia K., Graham S.L., Gupta V.K., Mirzaei M., Kramerov A.A., et al. Retinal arterial A&#x3b2;40 deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients. Alzheimer&#x2019;s Dement. 2023;19:5185&#x2013;5197. doi: 10.1002/alz.13086.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13086</ArticleId><ArticleId IdType=\"pmc\">PMC10638467</ArticleId><ArticleId IdType=\"pubmed\">37166032</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C., Zeng R., Wu G., Hu Y., Yu H. Beyond Vision: A View from Eye to Alzheimer&#x2019;s Disease and Dementia. J. Prev. Alzheimers Dis. 2024;11:469&#x2013;483. doi: 10.14283/jpad.2023.118.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14283/jpad.2023.118</ArticleId><ArticleId IdType=\"pubmed\">38374754</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreone B.J., Chow B.W., Tata A., Lacoste B., Ben-Zvi A., Bullock K., Deik A.A., Ginty D.D., Clish C.B., Gu C. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis. Neuron. 2017;94:581&#x2013;594. doi: 10.1016/j.neuron.2017.03.043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2017.03.043</ArticleId><ArticleId IdType=\"pmc\">PMC5474951</ArticleId><ArticleId IdType=\"pubmed\">28416077</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow B.W., Gu C. Gradual Suppression of Transcytosis Governs Functional Blood-Retinal Barrier Formation. Neuron. 2017;93:1325&#x2013;1333. doi: 10.1016/j.neuron.2017.02.043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2017.02.043</ArticleId><ArticleId IdType=\"pmc\">PMC5480403</ArticleId><ArticleId IdType=\"pubmed\">28334606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Zvi A., Lacoste B., Kur E., Andreone B.J., Mayshar Y., Yan H., Gu C. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature. 2014;509:507&#x2013;511. doi: 10.1038/nature13324.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature13324</ArticleId><ArticleId IdType=\"pmc\">PMC4134871</ArticleId><ArticleId IdType=\"pubmed\">24828040</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.-R., Xiong X.-Y., Liu J., Wu L.-R., Zhong Q., Zhou K., Meng Z.-Y., Liu L., Wang F.-X., Gong Q.-W., et al. Mfsd2a (Major Facilitator Superfamily Domain Containing 2a) Attenuates Intracerebral Hemorrhage-Induced Blood-Brain Barrier Disruption by Inhibiting Vesicular Transcytosis. J. Am. Heart Ass. 2017;6:e005811. doi: 10.1161/JAHA.117.005811.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/JAHA.117.005811</ArticleId><ArticleId IdType=\"pmc\">PMC5586300</ArticleId><ArticleId IdType=\"pubmed\">28724654</ArticleId></ArticleIdList></Reference><Reference><Citation>Macura J.I., Zivanovic A., Perovic M., Ciric J., Major T., Kanazir S., Ivkovic S. The Expression of Major Facilitator Superfamily Domain-Containing Protein2a (Mfsd2a) and Aquaporin 4 Is Altered in the Retinas of a 5xFAD Mouse Model of Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2023;24:14092. doi: 10.3390/ijms241814092.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms241814092</ArticleId><ArticleId IdType=\"pmc\">PMC10531902</ArticleId><ArticleId IdType=\"pubmed\">37762391</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen N.A., Munk A.S., Lundgaard I., Nedergaard M. The glymphatic system: A beginner&#x2019;s guide. Neurochem. Res. 2015;40:2583&#x2013;2599. doi: 10.1007/s11064-015-1581-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11064-015-1581-6</ArticleId><ArticleId IdType=\"pmc\">PMC4636982</ArticleId><ArticleId IdType=\"pubmed\">25947369</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff J.J., Wang M., Liao Y., Plogg B.A., Peng W., Gundersen G.A., Benveniste H., Vates G.E., Deane R., Goldman S.A., et al. Paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid &#x3b2;. Sci. Transl. Med. 2012;4:147ra111. doi: 10.1126/scitranslmed.3003748.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/scitranslmed.3003748</ArticleId><ArticleId IdType=\"pmc\">PMC3551275</ArticleId><ArticleId IdType=\"pubmed\">22896675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Lou N., Eberhardt A., Yang Y., Kusk P., Xu Q., Forstera B., Peng S., Shi M., Ladron-de-Guevara A., et al. An ocular glymphatic clearance system removes &#x3b2;-amyloid from the rodent eye. Sci. Transl. Med. 2020;12:eaaw3210. doi: 10.1126/scitranslmed.aaw3210.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/scitranslmed.aaw3210</ArticleId><ArticleId IdType=\"pmc\">PMC7356596</ArticleId><ArticleId IdType=\"pubmed\">32213628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitchen P., Salman M.M., Halsey A.M., Clarke-Bland C., MacDonald J.A., Ishida H., Vogel H.J., Almutri S., Logan A., Kreida S., et al. Targeting aquaporin-4 subcellular localization to treat central nervous system edema. Cell. 2020;181:784&#x2013;799.e719. doi: 10.1016/j.cell.2020.03.037.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2020.03.037</ArticleId><ArticleId IdType=\"pmc\">PMC7242911</ArticleId><ArticleId IdType=\"pubmed\">32413299</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeppenfeld D.M., Simon M., Haswell J.D., D&#x2019;Abreo D., Murchison C., Quinn J.F., Grafe M.R., Woltjer R.L., Kaye J., Iliff J.J. Association of Perivascular Localization of Aquaporin-4 with Cognition and Alzheimer Disease in Aging Brains. JAMA Neurol. 2017;74:91. doi: 10.1001/jamaneurol.2016.4370.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaneurol.2016.4370</ArticleId><ArticleId IdType=\"pubmed\">27893874</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshi A., Yamamoto T., Shimizu K., Yoshikazu U., Nishizawa M., Takahashi H., Kakita A. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2012;71:750&#x2013;759. doi: 10.1097/NEN.0b013e3182632566.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/NEN.0b013e3182632566</ArticleId><ArticleId IdType=\"pubmed\">22805778</ArticleId></ArticleIdList></Reference><Reference><Citation>Moftakhar P., Lynch M.D., Pomakian J.L., Vinters H.V. Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol. 2010;69:1201&#x2013;1209. doi: 10.1097/NEN.0b013e3181fd252c.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/NEN.0b013e3181fd252c</ArticleId><ArticleId IdType=\"pmc\">PMC3155418</ArticleId><ArticleId IdType=\"pubmed\">21107133</ArticleId></ArticleIdList></Reference><Reference><Citation>SanGiovanni J.P., Chew E.Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res. 2005;24:87&#x2013;138. doi: 10.1016/j.preteyeres.2004.06.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.preteyeres.2004.06.002</ArticleId><ArticleId IdType=\"pubmed\">15555528</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair A.J. Docosahexaenoic acid and the brain- what is its role? Asia Pac. J. Clin. Nutr. 2019;28:675&#x2013;688. doi: 10.6133/apjcn.201912_28(4).0002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.6133/apjcn.201912_28(4).0002</ArticleId><ArticleId IdType=\"pubmed\">31826363</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott B.L., Bazan N.G. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc. Natl. Acad. Sci. USA. 1989;86:2903&#x2013;2907. doi: 10.1073/pnas.86.8.2903.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.86.8.2903</ArticleId><ArticleId IdType=\"pmc\">PMC287028</ArticleId><ArticleId IdType=\"pubmed\">2523075</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L.N., Ma D., Shui G., Wong P., Cazenave-Gassiot A., Zhang X., Wenk M.R., Goh E.L., Silver D.L. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 2014;509:503&#x2013;506. doi: 10.1038/nature13241.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature13241</ArticleId><ArticleId IdType=\"pubmed\">24828044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Zlokovic B.V. Blood-brain barrier: A dual life of MFSD2A? Neuron. 2014;82:728&#x2013;730. doi: 10.1016/j.neuron.2014.05.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2014.05.012</ArticleId><ArticleId IdType=\"pmc\">PMC4114515</ArticleId><ArticleId IdType=\"pubmed\">24853933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H., Luo C., Feng Y., Yao X., Shi Z., Liang F., Kang J.X., Wan J.B., Pei Z., Su H. Omega-3 polyunsaturated fatty acids promote amyloid-&#x3b2; clearance from the brain through mediating the function of the glymphatic system. FASEB J. 2017;31:282&#x2013;293. doi: 10.1096/fj.201600896.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.201600896</ArticleId><ArticleId IdType=\"pubmed\">27789520</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang E., Wan X., Yang L., Wang D., Chen Z., Chen Y., Liu M., Zhang G., Wu J., Han H., et al. Omega-3 Polyunsaturated Fatty Acids Alleviate Traumatic Brain Injury by Regulating the Glymphatic Pathway in Mice. Front. Neurol. 2020;11:707. doi: 10.3389/fneur.2020.00707.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2020.00707</ArticleId><ArticleId IdType=\"pmc\">PMC7380115</ArticleId><ArticleId IdType=\"pubmed\">32765412</ArticleId></ArticleIdList></Reference><Reference><Citation>Arellanes I.C., Choe N., Solomon V., He X., Kavin B., Martinez A.E., Kono N., Buennagel D.P., Hazra N., Kim G., et al. Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial. EBioMedicine. 2020;59:102883. doi: 10.1016/j.ebiom.2020.102883.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ebiom.2020.102883</ArticleId><ArticleId IdType=\"pmc\">PMC7502665</ArticleId><ArticleId IdType=\"pubmed\">32690472</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooperton K.E., Tr&#xe9;panier M.O., James N.C.E., Chouinard-Watkins R., Bazinet R.P. Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer&#x2019;s disease. Brain Behav. Immunol. 2018;69:74&#x2013;90. doi: 10.1016/j.bbi.2017.11.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2017.11.002</ArticleId><ArticleId IdType=\"pubmed\">29109025</ArticleId></ArticleIdList></Reference><Reference><Citation>Macura Jovanovic I., Djuricic I., Major T., Milanovic D., Brkic B., Sobajic S., Kanazir S., Ivkovic S. The high-dose fish oil supplementation increased Mfsd2a expression without altering DHA levels in the healthy retina. J. Funct. Foods. 2022;99:105302. doi: 10.1016/j.jff.2022.105302.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jff.2022.105302</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanovic D., Petrovic S., Brkic M., Avramovic V., Perovic M., Ivkovic S., Glibetic M., Kanazir S. Short-Term Fish Oil Treatment Changes the Composition of Phospholipids While Not Affecting the Expression of Mfsd2a Omega-3 Transporter in the Brain and Liver of the 5xFAD Mouse Model of Alzheimer&#x2019;s Disease. Nutrients. 2018;10:1250. doi: 10.3390/nu10091250.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu10091250</ArticleId><ArticleId IdType=\"pmc\">PMC6165196</ArticleId><ArticleId IdType=\"pubmed\">30200627</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovic M., Lon&#x10d;arevi&#x107;-Vasiljkovi&#x107; N., Ivkovi&#x107; S., Dini&#x107; J., Milanovi&#x107; D., Zlokovic B., Kanazir S. Short-term fish oil supplementation applied in presymptomatic stage of Alzheimer&#x2019;s disease enhances microglial/macrophage barrier and prevents neuritic dystrophy in parietal cortex of 5xFAD mouse model. PLoS ONE. 2019;14:e0216726. doi: 10.1371/journal.pone.0216726.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0216726</ArticleId><ArticleId IdType=\"pmc\">PMC6522015</ArticleId><ArticleId IdType=\"pubmed\">31095617</ArticleId></ArticleIdList></Reference><Reference><Citation>Casali B.T., Corona A.W., Mariani M.M., Karlo J.C., Ghosal K., Landreth G.E. Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer&#x2019;s Disease. J. Neurosci. 2015;35:9173&#x2013;9181. doi: 10.1523/JNEUROSCI.1000-15.2015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1000-15.2015</ArticleId><ArticleId IdType=\"pmc\">PMC4469742</ArticleId><ArticleId IdType=\"pubmed\">26085639</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannoni P., Arango-Lievano M., Neves I.D., Rousset M.C., Baranger K., Rivera S., Jeanneteau F., Claeysen S., Marchi N. Cerebrovascular pathology during the progression of experimental Alzheimer&#x2019;s disease. Neurobiol. Dis. 2016;88:107&#x2013;117. doi: 10.1016/j.nbd.2016.01.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2016.01.001</ArticleId><ArticleId IdType=\"pubmed\">26774030</ArticleId></ArticleIdList></Reference><Reference><Citation>Parthasarathy R., Chow K.M., Derafshi Z., Fautsch M.P., Hetling J.R., Rodgers D.W., Hersh L.B., Pepperberg D.R. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin. Exp. Eye Res. 2015;138:134&#x2013;144. doi: 10.1016/j.exer.2015.06.027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.exer.2015.06.027</ArticleId><ArticleId IdType=\"pmc\">PMC4659645</ArticleId><ArticleId IdType=\"pubmed\">26142956</ArticleId></ArticleIdList></Reference><Reference><Citation>Matei N., Leahy S., Blair N.P., Burford J., Rahimi M., Shahidi M. Retinal Vascular Physiology Biomarkers in a 5XFAD Mouse Model of Alzheimer&#x2019;s Disease. Cells. 2022;11:2413. doi: 10.3390/cells11152413.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells11152413</ArticleId><ArticleId IdType=\"pmc\">PMC9368483</ArticleId><ArticleId IdType=\"pubmed\">35954257</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., et al. Intraneuronal &#x3b2;-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer&#x2019;s Disease Mutations: Potential Factors in Amyloid Plaque Formation. J. Neurosci. 2006;26:10129&#x2013;10140. doi: 10.1523/JNEUROSCI.1202-06.2006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1202-06.2006</ArticleId><ArticleId IdType=\"pmc\">PMC6674618</ArticleId><ArticleId IdType=\"pubmed\">17021169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugasini D., Park J.C., McAnany J.J., Kim T.H., Ma G., Yao X., Antharavally B., Oroskar A., Oroskar A.A., Layden B.T., et al. Improvement of retinal function in Alzheimer disease-associated retinopathy by dietary lysophosphatidylcholine-EPA/DHA. Sci. Rep. 2023;13:9179. doi: 10.1038/s41598-023-36268-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-023-36268-0</ArticleId><ArticleId IdType=\"pmc\">PMC10244360</ArticleId><ArticleId IdType=\"pubmed\">37280266</ArticleId></ArticleIdList></Reference><Reference><Citation>Devi L., Alldred M.J., Ginsberg S.D., Ohno M. Sex- and brain region-specific acceleration of &#x3b2;-amyloidogenesis following behavioral stress in a mouse model of Alzheimer&#x2019;s disease. Mol. Brain. 2010;3:34. doi: 10.1186/1756-6606-3-34.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1756-6606-3-34</ArticleId><ArticleId IdType=\"pmc\">PMC2988063</ArticleId><ArticleId IdType=\"pubmed\">21059265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong B.H., Chan J.P., Cazenave-Gassiot A., Poh R.W., Foo J.C., Galam D.L., Ghosh S., Nguyen L.N., Barathi V.A., Yeo S.W., et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid (DHA) in eye and is important for photoreceptor cell development. J. Biol. Chem. 2016;291:10501&#x2013;10514. doi: 10.1074/jbc.M116.721340.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M116.721340</ArticleId><ArticleId IdType=\"pmc\">PMC4865901</ArticleId><ArticleId IdType=\"pubmed\">27008858</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice D.S., Calandria J.M., Gordon W.C., Jun B., Zhou Y., Gelfman C.M., Li S., Jin M., Knott E.J., Chang B., et al. Adiponectin receptor 1 conserves docosahexaenoic acid and promotes photoreceptor cell survival. Nat. Commun. 2015;6:6228. doi: 10.1038/ncomms7228. Erratum in Nat. Commun. 2015, 6, 7225.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncomms7228</ArticleId><ArticleId IdType=\"pmc\">PMC4351799</ArticleId><ArticleId IdType=\"pubmed\">25736573</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C.-L., Wang H.-L., Li P.-C., Hong C.-D., Chen A.-Q., Qiu Y.-M., Zeng A.-P., Zhou Y.-F., Hu B., Li Y.-N. Mfsd2a overexpression alleviates vascular dysfunction in diabetic retinopathy. Pharm. Res. 2021;171:105755. doi: 10.1016/j.phrs.2021.105755.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.phrs.2021.105755</ArticleId><ArticleId IdType=\"pubmed\">34229049</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton J.D. Sterol regulatory element-binding proteins: Transcriptional activators of lipid synthesis. Biochem. Soc. Trans. 2002;30:1091&#x2013;1095. doi: 10.1042/bst0301091.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/bst0301091</ArticleId><ArticleId IdType=\"pubmed\">12440980</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J., Briggs M.M., McIntosh T.J. Water permeability of aquaporin-4 channel depends on bilayer composition, thickness, and elasticity. Biophys. J. 2012;103:1899&#x2013;1908. doi: 10.1016/j.bpj.2012.09.025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bpj.2012.09.025</ArticleId><ArticleId IdType=\"pmc\">PMC3491688</ArticleId><ArticleId IdType=\"pubmed\">23199918</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalaany N.Y., Mangelsdorf D.J. LXRs and FXR: The yin and yang of cholesterol and fat metabolism. Ann. Rev. Physiol. 2006;68:159&#x2013;191. doi: 10.1146/annurev.physiol.68.033104.152158.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev.physiol.68.033104.152158</ArticleId><ArticleId IdType=\"pubmed\">16460270</ArticleId></ArticleIdList></Reference><Reference><Citation>Siperstein M.D., Fagan V.M. Feedback control of mevalonate synthesis by dietary cholesterol. JBC. 1966;241:602&#x2013;609. doi: 10.1016/S0021-9258(18)96879-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0021-9258(18)96879-1</ArticleId><ArticleId IdType=\"pubmed\">5908125</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 2001;294:1354&#x2013;1357. doi: 10.1126/science.294.5545.1354.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.294.5545.1354</ArticleId><ArticleId IdType=\"pubmed\">11701931</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobanova E.S., Schuhmann K., Finkelstein S., Lewis T.R., Cady M.A., Hao Y., Keuthan C., Ash J.D., Burns M.E., Shevchenko A., et al. Disrupted Blood-Retina Lysophosphatidylcholine Transport Impairs Photoreceptor Health But Not Visual Signal Transduction. J. Neurosci. 2019;39:9689&#x2013;9701. doi: 10.1523/JNEUROSCI.1142-19.2019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1142-19.2019</ArticleId><ArticleId IdType=\"pmc\">PMC6891062</ArticleId><ArticleId IdType=\"pubmed\">31676603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kress B.T., Iliff J.J., Xia M., Wang M., Wei H.S., Zeppenfeld D., Xie L., Kang H., Xu Q., Liew J.A., et al. Impairment of paravascular clearance pathways in the aging brain. Ann. Neurol. 2014;76:845&#x2013;861. doi: 10.1002/ana.24271.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.24271</ArticleId><ArticleId IdType=\"pmc\">PMC4245362</ArticleId><ArticleId IdType=\"pubmed\">25204284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Sagare A.P., Ma Q., Halliday M.R., Kong P., Kisler K., Winkler E.A., Ramanathan A., Kanekiyo T., Bu G., et al. Central role for PICALM in amyloid-&#x3b2; blood-brain barrier transcytosis and clearance. Nat. Neurosci. 2015;18:978&#x2013;987. doi: 10.1038/nn.4025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nn.4025</ArticleId><ArticleId IdType=\"pmc\">PMC4482781</ArticleId><ArticleId IdType=\"pubmed\">26005850</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney M.D., Sagare A.P., Zlokovic B.V. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 2018;14:133&#x2013;150. doi: 10.1038/nrneurol.2017.188.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrneurol.2017.188</ArticleId><ArticleId IdType=\"pmc\">PMC5829048</ArticleId><ArticleId IdType=\"pubmed\">29377008</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannice G., Rasmussen H. Position of the Academy of Nutrition and Dietetics: Dietary Fatty Acids for Healthy Adults. J. Acad. Nutr. Diet. 2014;114:136&#x2013;153. doi: 10.1016/j.jand.2013.11.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jand.2013.11.001</ArticleId><ArticleId IdType=\"pubmed\">24342605</ArticleId></ArticleIdList></Reference><Reference><Citation>European Food Safety Authority (EFSA) EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA); Parma, Italy. EFSA J. 2012;10:2815.</Citation></Reference><Reference><Citation>Patch C.S., Hill-Yardin E.L., Lewis M., Ryan L., Daly E., Pearce A.J. The More, the Better: High-Dose Omega-3 Fatty Acids Improve Behavioural and Molecular Outcomes in Preclinical Models in Mild Brain Injury. Curr. Neurol. Neurosci. Rep. 2021;21:45. doi: 10.1007/s11910-021-01132-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11910-021-01132-z</ArticleId><ArticleId IdType=\"pubmed\">34227043</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X.-D., Feng J.-S., Yang Z., Huang Q.-T., Lin J.-D., Yang B., Su K.-P., Pan J.-Y. High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: A network meta-analysis. BMC Psychiatry. 2020;20:248. doi: 10.1186/s12888-020-02656-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12888-020-02656-3</ArticleId><ArticleId IdType=\"pmc\">PMC7238659</ArticleId><ArticleId IdType=\"pubmed\">32434488</ArticleId></ArticleIdList></Reference><Reference><Citation>Connor K.M., SanGiovanni J.P., Lofqvist C., Aderman C.M., Chen J., Higuchi A., Hong S., A Pravda E., Majchrzak S., Carper D., et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 2007;13:868&#x2013;873. doi: 10.1038/nm1591.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nm1591</ArticleId><ArticleId IdType=\"pmc\">PMC4491412</ArticleId><ArticleId IdType=\"pubmed\">17589522</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapieha P., Chen J., Stahl A., Seaward M.R., Favazza T.L., Juan A.M., Hatton C.J., Joyal J.-S., Krah N.M., Dennison R.J., et al. Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutr. Diabetes. 2012;2:e36. doi: 10.1038/nutd.2012.10.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nutd.2012.10</ArticleId><ArticleId IdType=\"pmc\">PMC3408641</ArticleId><ArticleId IdType=\"pubmed\">23448719</ArticleId></ArticleIdList></Reference><Reference><Citation>Carare R.O., Hawkes C.A., Jeffrey M., Kalaria R.N., Weller R.O. Review: Cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropat. Appl. Neurobiol. 2013;39:593&#x2013;611. doi: 10.1111/nan.12042.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/nan.12042</ArticleId><ArticleId IdType=\"pubmed\">23489283</ArticleId></ArticleIdList></Reference><Reference><Citation>Deane R., Bell R.D., Sagare A., Zlokovic B.V. Clearance of amyloid-beta peptide across the blood-brain barrier: Implication for therapies in Alzheimer&#x2019;s disease. CNS Neurol. Dis. Drug Targets. 2009;8:16&#x2013;30. doi: 10.2174/187152709787601867.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/187152709787601867</ArticleId><ArticleId IdType=\"pmc\">PMC2872930</ArticleId><ArticleId IdType=\"pubmed\">19275634</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlokovic B.V., Deane R., Sagare A.P., Bell R.D., Winkler E.A. Low-density lipoprotein receptor-related protein-1: A serial clearance homeostatic mechanism controlling Alzheimer&#x2019;s amyloid beta-peptide elimination from the brain. J. Neurochem. 2010;115:1077&#x2013;1089. doi: 10.1111/j.1471-4159.2010.07002.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1471-4159.2010.07002.x</ArticleId><ArticleId IdType=\"pmc\">PMC2972355</ArticleId><ArticleId IdType=\"pubmed\">20854368</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Rasool S., Yang Z., Glabe C.G., Schreiber S.S., Ge J., Tan Z. Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer&#x2019;s transgenic mice. Am. J. Pathol. 2009;175:2099&#x2013;2110. doi: 10.2353/ajpath.2009.090159.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2353/ajpath.2009.090159</ArticleId><ArticleId IdType=\"pmc\">PMC2774073</ArticleId><ArticleId IdType=\"pubmed\">19834067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T.H., Son T., Klatt D., Yao X. Concurrent OCT and OCT angiography of retinal neurovascular degeneration in the 5XFAD Alzheimer&#x2019;s disease mice. Neurophot. 2021;8:035002. doi: 10.1117/1.NPh.8.3.035002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1117/1.NPh.8.3.035002</ArticleId><ArticleId IdType=\"pmc\">PMC8271351</ArticleId><ArticleId IdType=\"pubmed\">34277888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J.K.H., Li Q.X., He Z., Vingrys A.J., Chinnery H.R., Mullen J., Bui B.V., Nguyen C.T.O. Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer&#x2019;s Disease. Front. Neurosci. 2020;14:862. doi: 10.3389/fnins.2020.00862.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2020.00862</ArticleId><ArticleId IdType=\"pmc\">PMC7438734</ArticleId><ArticleId IdType=\"pubmed\">32903645</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhukov O., He C., Soylu-Kucharz R., Cai C., Lauritzen A.D., Aldana B.I., Bj&#xf6;rkqvist M., Lauritzen M., Kucharz K. Preserved blood-brain barrier and neurovascular coupling in female 5xFAD model of Alzheimer&#x2019;s disease. Front. Aging Neurosci. 2023;15:1089005. doi: 10.3389/fnagi.2023.1089005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1089005</ArticleId><ArticleId IdType=\"pmc\">PMC10228387</ArticleId><ArticleId IdType=\"pubmed\">37261266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.P., Wong B.H., Chin C.F., Galam D.L.A., Foo J.C., Wong L.C., Ghosh S., Wenk M.R., Cazenave-Gassiot A., Silver D.L. The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain. PLoS Biol. 2018;16:e2006443. doi: 10.1371/journal.pbio.2006443.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pbio.2006443</ArticleId><ArticleId IdType=\"pmc\">PMC6093704</ArticleId><ArticleId IdType=\"pubmed\">30074985</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Jump D.B., Esselman W.J., Busik J.V. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Investig. Ophthal. Vis. Sci. 2007;48:18&#x2013;26. doi: 10.1167/iovs.06-0619.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1167/iovs.06-0619</ArticleId><ArticleId IdType=\"pmc\">PMC1975816</ArticleId><ArticleId IdType=\"pubmed\">17197511</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou J., Tu H., Shan B., Luk A., DeBose-Boyd R.A., Bashmakov Y., Goldstein J.L., Brown M.S. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. USA. 2001;98:6027&#x2013;6032. doi: 10.1073/pnas.111138698.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.111138698</ArticleId><ArticleId IdType=\"pmc\">PMC33416</ArticleId><ArticleId IdType=\"pubmed\">11371634</ArticleId></ArticleIdList></Reference><Reference><Citation>Boergesen M., Pedersen T.A., Gross B., van Heeringen S.J., Hagenbeek D., Bindesboll C., Caron S., Lalloyer F., Steffensen K.R., Nebb H.I., et al. Genome- wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor alpha in mouse liver reveals extensive sharing of binding sites. Mol. Cell. Biol. 2012;32:852&#x2013;867. doi: 10.1128/MCB.06175-11.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/MCB.06175-11</ArticleId><ArticleId IdType=\"pmc\">PMC3272984</ArticleId><ArticleId IdType=\"pubmed\">22158963</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W.B., Huang Y., Guo X.R., Zhang M.Q., Yuan X.S., Zu H.B. DHCR24 reverses Alzheimer&#x2019;s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xFAD mice. Acta Neuropathol. Commun. 2023;11:102. doi: 10.1186/s40478-023-01593-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-023-01593-y</ArticleId><ArticleId IdType=\"pmc\">PMC10286507</ArticleId><ArticleId IdType=\"pubmed\">37344916</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.Z., Xiao N., Zhang Y.Z., Zhao C.X., Guo X.H., Lu L.M. Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier. Pharmacol. Res. 2016;104:124&#x2013;131. doi: 10.1016/j.phrs.2015.12.024.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.phrs.2015.12.024</ArticleId><ArticleId IdType=\"pubmed\">26747400</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Li D., Shen Q., Gao L., Zhuang P., Zhang Y., Guo H. Storax Inhibits Caveolae-Mediated Transcytosis at Blood-Brain Barrier After Ischemic Stroke in Rats. Front. Pharmacol. 2022;13:876235. doi: 10.3389/fphar.2022.876235.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2022.876235</ArticleId><ArticleId IdType=\"pmc\">PMC9304983</ArticleId><ArticleId IdType=\"pubmed\">35873558</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon M., Wang M.X., Ismail O., Braun M., Schindler A.G., Reemmer J., Wang Z., Haveliwala M.A., O&#x2019;Boyle R.P., Han W.Y., et al. Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid &#x3b2; plaque formation in mice. Alzheimer&#x2019;s Res. Ther. 2022;14:59. doi: 10.1186/s13195-022-00999-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-022-00999-5</ArticleId><ArticleId IdType=\"pmc\">PMC9040291</ArticleId><ArticleId IdType=\"pubmed\">35473943</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoozi S., Rao S.B., Skauli N., Froehner S.C., Ottersen O.P., Adams M.E., Amiry-Moghaddam M. Functional specialization of retinal M&#xfc;ller cell endfeet depends on an interplay between two syntrophin isoforms. Mol. Brain. 2020;13:40. doi: 10.1186/s13041-020-00581-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13041-020-00581-w</ArticleId><ArticleId IdType=\"pmc\">PMC7074989</ArticleId><ArticleId IdType=\"pubmed\">32178707</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Xiao N., Chen Y., Huang H., Marshall C., Gao J., Cai Z., Wu T., HU G., Xiao M. Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain A&#x3b2; accumulation and memory deficits. Mol. Neurodegener. 2015;10:58. doi: 10.1186/s13024-015-0056-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-015-0056-1</ArticleId><ArticleId IdType=\"pmc\">PMC4631089</ArticleId><ArticleId IdType=\"pubmed\">26526066</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosu G.C., Catalin B., Balseanu T.A., Laurentiu M., Claudiu M., Kumar-Singh S., Daniel P. Inhibition of Aquaporin 4 Decreases Amyloid A&#x3b2;40 Drainage Around Cerebral Vessels. Mol. Neurobiol. 2020;57:4720&#x2013;4734. doi: 10.1007/s12035-020-02044-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-020-02044-8</ArticleId><ArticleId IdType=\"pmc\">PMC7515968</ArticleId><ArticleId IdType=\"pubmed\">32783141</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Mao X. Role of Retinal Amyloid-&#x3b2; in Neurodegenerative Diseases: Overlapping Mechanisms and Emerging Clinical Applications. Int. J. Mol. Sci. 2021;22:2360. doi: 10.3390/ijms22052360.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22052360</ArticleId><ArticleId IdType=\"pmc\">PMC7956232</ArticleId><ArticleId IdType=\"pubmed\">33653000</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/meth.2001.1262</ArticleId><ArticleId IdType=\"pubmed\">11846609</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273325</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Cognitive Effects of Simulated Galactic Cosmic Radiation Are Mediated by ApoE Status, Sex, and Environment in APP Knock-In Mice.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9379</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179379</ELocationID><Abstract><AbstractText>Cosmic radiation experienced during space travel may increase the risk of cognitive impairment. While simulated galactic cosmic radiation (GCRsim) has led to memory deficits in wildtype (WT) mice, it has not been investigated whether GCRsim in combination with genetic risk factors for Alzheimer's disease (AD) worsens memory further in aging mice. Here, we investigated the central nervous system (CNS) effects of 0 Gy (sham) or 0.75 Gy five-ion GCRsim or 2 Gy gamma radiation (IRR) in 14-month-old female and male APP<sup>NL-F/NL-F</sup> knock-in (KI) mice bearing humanized ApoE3 or ApoE4 (APP;E3F and APP;E4F). As travel to a specialized facility was required for irradiation, both traveled sham-irradiated C57BL/6J WT and KI mice and non-traveled (NT) KI mice acted as controls for potential effects of travel. Mice underwent four behavioral tests at 20 months of age and were euthanized for pathological and biochemical analyses 1 month later. Fecal samples were collected pre- and post-irradiation at four different time points. GCRsim seemed to impair memory in male APP;E3F mice compared to their sham counterparts. Travel tended to improve cognition in male APP;E3F mice and lowered total A&#x3b2; in female and male APP;E3F mice compared to their non-traveled counterparts. Sham-irradiated male APP;E4F mice accumulated more fibrillar amyloid than their APP;E3F counterparts. Radiation exposure had only modest effects on behavior and brain changes, but travel-, sex-, and genotype-specific effects were seen. Irradiated mice had immediate and long-term differences in their gut bacterial composition that correlated to Alzheimer's disease phenotypes.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wieg</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0009-0000-0735-4299</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ciola</LastName><ForeName>Jason C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Was&#xe9;n</LastName><ForeName>Caroline C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gaba</LastName><ForeName>Fidelia</ForeName><Initials>F</Initials><Identifier Source=\"ORCID\">0009-0007-7247-671X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Colletti</LastName><ForeName>Brianna R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schroeder</LastName><ForeName>Maren K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hinshaw</LastName><ForeName>Robert G</ForeName><Initials>RG</Initials><Identifier Source=\"ORCID\">0000-0003-0060-7753</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ekwudo</LastName><ForeName>Millicent N</ForeName><Initials>MN</Initials><Identifier Source=\"ORCID\">0000-0002-6270-6573</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Saito</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><Identifier Source=\"ORCID\">0000-0002-9659-9251</Identifier><AffiliationInfo><Affiliation>Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Science, Nagoya 467-8601, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sasaguri</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Wako City 351-0198, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Saido</LastName><ForeName>Takaomi C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Wako City 351-0198, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cox</LastName><ForeName>Laura M</ForeName><Initials>LM</Initials><Identifier Source=\"ORCID\">0000-0002-9564-9894</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lemere</LastName><ForeName>Cynthia A</ForeName><Initials>CA</Initials><Identifier Source=\"ORCID\">0000-0002-2983-7870</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>80NSSC18K0810</GrantID><Acronym>NASA</Acronym><Agency>NASA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016564\">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D001057\">Apolipoproteins E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003359\" MajorTopicYN=\"Y\">Cosmic Radiation</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003071\" MajorTopicYN=\"Y\">Cognition</DescriptorName><QualifierName UI=\"Q000528\" MajorTopicYN=\"N\">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016564\" MajorTopicYN=\"Y\">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008822\" MajorTopicYN=\"Y\">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D055879\" MajorTopicYN=\"N\">Gene Knock-In Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008810\" MajorTopicYN=\"N\">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001057\" MajorTopicYN=\"N\">Apolipoproteins E</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D004195\" MajorTopicYN=\"N\">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012737\" MajorTopicYN=\"N\">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D060825\" MajorTopicYN=\"N\">Cognitive Dysfunction</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">APP mouse models</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">apolipoprotein E</Keyword><Keyword MajorTopicYN=\"N\">galactic cosmic radiation</Keyword><Keyword MajorTopicYN=\"N\">gamma radiation</Keyword><Keyword MajorTopicYN=\"N\">gut microbiome</Keyword><Keyword MajorTopicYN=\"N\">sex differences</Keyword></KeywordList><CoiStatement>D.M.H. is a co-founder with equity of C2N Diagnostics and is on the scientific advisory board of Genentech, C2N Diagnostics, Denali, Cajal Neurosciences, and Asteroid. C.A.L. serves as a paid scientific advisor for Acumen Pharmaceuticals, ADvantage Therapeutics, Alnylam Pharmaceuticals, Apellis Pharmaceuticals, Cyclo Therapeutics, Merck, Novo Nordisk, and Sanofi-Genzyme and receives research funding from the National Institutes of Health (NIH), NASA, and the Cure Alzheimer&#x2019;s Fund. All the other authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273325</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179379</ArticleId><ArticleId IdType=\"pii\">ijms25179379</ArticleId><ArticleId IdType=\"pmc\">PMC11394682</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cucinotta F.A., Kim M.-H.Y., Ren L. Evaluating shielding effectiveness for reducing space radiation cancer risks. Radiat. Meas. 2006;41:1173&#x2013;1185. doi: 10.1016/j.radmeas.2006.03.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.radmeas.2006.03.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Cucinotta F.A., Nikjoo H., Goodhead D.T. The Effects of Delta Rays on the Number of Particle-Track Traversals per Cell in Laboratory and Space Exposures. Radiat. Res. 1998;150:115. doi: 10.2307/3579651.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2307/3579651</ArticleId><ArticleId IdType=\"pubmed\">9650608</ArticleId></ArticleIdList></Reference><Reference><Citation>Cucinotta F.A., Durante M. Cancer risk from exposure to galactic cosmic rays: Implications for space exploration by human beings. Lancet Oncol. 2006;7:431&#x2013;435. doi: 10.1016/S1470-2045(06)70695-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1470-2045(06)70695-7</ArticleId><ArticleId IdType=\"pubmed\">16648048</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations Scientific Committee on the Effects of Atomic Radiation . Sources and Effects of Ionizing Radiation: United Nations Committee of the Effects of Atomic Radiation UNSCEAR 2000 Report to the General Assembly, with Scientific Annexes. U.N.; New York, NY, USA: 2000.</Citation></Reference><Reference><Citation>Hassler D.M., Zeitlin C., Wimmer-Schweingruber R.F., Ehresmann B., Rafkin S., Eigenbrode J.L., Brinza D.E., Weigle G., B&#xf6;ttcher S., B&#xf6;hm E., et al. Mars&#x2019; surface radiation environment measured with the Mars Science Laboratory&#x2019;s Curiosity rover. Science. 2014;343:1244797. doi: 10.1126/science.1244797.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1244797</ArticleId><ArticleId IdType=\"pubmed\">24324275</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeitlin C., Hassler D.M., Cucinotta F.A., Ehresmann B., Wimmer-Schweingruber R.F., Brinza D.E., Kang S., Weigle G., B&#xf6;ttcher S., B&#xf6;hm E., et al. Measurements of energetic particle radiation in transit to Mars on the Mars Science Laboratory. Science. 2013;340:1080&#x2013;1084. doi: 10.1126/science.1235989.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1235989</ArticleId><ArticleId IdType=\"pubmed\">23723233</ArticleId></ArticleIdList></Reference><Reference><Citation>Toprani S.M., Scheibler C., Mordukhovich I., McNeely E., Nagel Z.D. Cosmic Ionizing Radiation: A DNA Damaging Agent That May Underly Excess Cancer in Flight Crews. Int. J. Mol. Sci. 2024;25:7670. doi: 10.3390/ijms25147670.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms25147670</ArticleId><ArticleId IdType=\"pmc\">PMC11277465</ArticleId><ArticleId IdType=\"pubmed\">39062911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiffer F., Boerma M., Allen A. Behavioral effects of space radiation: A comprehensive review of animal studies. Life Sci. Space Res. 2019;21:1&#x2013;21. doi: 10.1016/j.lssr.2019.02.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lssr.2019.02.004</ArticleId><ArticleId IdType=\"pmc\">PMC7150604</ArticleId><ArticleId IdType=\"pubmed\">31101151</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein P.M., Parihar V.K., Szabo G.G., Z&#xf6;ldi M., Angulo M.C., Allen B.D., Amin A.N., Nguyen Q.-A., Katona I., Baulch J.E., et al. Detrimental impacts of mixed-ion radiation on nervous system function. Neurobiol. Dis. 2021;151:105252. doi: 10.1016/j.nbd.2021.105252.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2021.105252</ArticleId><ArticleId IdType=\"pubmed\">33418069</ArticleId></ArticleIdList></Reference><Reference><Citation>Keiser A.A., Kram&#xe1;r E.A., Dong T., Shanur S., Pirodan M., Ru N., Acharya M.M., Baulch J.E., Limoli C.L., Wood M.A. Systemic HDAC3 inhibition ameliorates impairments in synaptic plasticity caused by simulated galactic cosmic radiation exposure in male mice. Neurobiol. Learn. Mem. 2021;178:107367. doi: 10.1016/j.nlm.2020.107367.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nlm.2020.107367</ArticleId><ArticleId IdType=\"pmc\">PMC8456980</ArticleId><ArticleId IdType=\"pubmed\">33359392</ArticleId></ArticleIdList></Reference><Reference><Citation>Krukowski K., Grue K., Frias E.S., Pietrykowski J., Jones T., Nelson G., Rosi S. Female mice are protected from space radiation-induced maladaptive responses. Brain Behav. Immun. 2018;74:106&#x2013;120. doi: 10.1016/j.bbi.2018.08.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2018.08.008</ArticleId><ArticleId IdType=\"pmc\">PMC8715721</ArticleId><ArticleId IdType=\"pubmed\">30107198</ArticleId></ArticleIdList></Reference><Reference><Citation>Krukowski K., Grue K., Becker M., Elizarraras E., Frias E.S., Halvorsen A., Koenig-Zanoff M., Frattini V., Nimmagadda H., Feng X., et al. The impact of deep space radiation on cognitive performance: From biological sex to biomarkers to countermeasures. Sci. Adv. 2021;7:eabg6702. doi: 10.1126/sciadv.abg6702.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/sciadv.abg6702</ArticleId><ArticleId IdType=\"pmc\">PMC8519563</ArticleId><ArticleId IdType=\"pubmed\">34652936</ArticleId></ArticleIdList></Reference><Reference><Citation>Alaghband Y., Klein P.M., Kram&#xe1;r E.A., Cranston M.N., Perry B.C., Shelerud L.M., Kane A.E., Doan N.-L., Ru N., Acharya M.M., et al. Galactic cosmic radiation exposure causes multifaceted neurocognitive impairments. Cell. Mol. Life Sci. 2023;80:29. doi: 10.1007/s00018-022-04666-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00018-022-04666-8</ArticleId><ArticleId IdType=\"pmc\">PMC9823026</ArticleId><ArticleId IdType=\"pubmed\">36607431</ArticleId></ArticleIdList></Reference><Reference><Citation>Britten R.A., Fesshaye A., Ihle P., Wheeler A., Baulch J.E., Limoli C.L., Stark C.E. Dissecting Differential Complex Behavioral Responses to Simulated Space Radiation Exposures. Radiat. Res. 2022;197:289&#x2013;297. doi: 10.1667/RADE-21-00068.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RADE-21-00068.1</ArticleId><ArticleId IdType=\"pubmed\">34905619</ArticleId></ArticleIdList></Reference><Reference><Citation>Britten R.A., Fesshaye A., Tidmore A., Blackwell A.A. Similar Loss of Executive Function Performance after Exposure to Low (10 cGy) Doses of Single (4He) Ions and the Multi-Ion GCRSim Beam. Radiat. Res. 2022;198:375&#x2013;383. doi: 10.1667/RADE-22-00022.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RADE-22-00022.1</ArticleId><ArticleId IdType=\"pubmed\">36223207</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackwell A.A., Fesshaye A., Tidmore A., I Lake R., Wallace D.G., Britten R.A. Rapid loss of fine motor skills after low dose space radiation exposure. Behav. Brain Res. 2022;430:113907. doi: 10.1016/j.bbr.2022.113907.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbr.2022.113907</ArticleId><ArticleId IdType=\"pubmed\">35500721</ArticleId></ArticleIdList></Reference><Reference><Citation>Overbey E.G., Paul A.M., Da Silveira W.A., Tahimic C.G.T., Reinsch S.S., Szewczyk N., Stanbouly S., Wang C., Galazka J.M., Mao X.W. Mice Exposed to Combined Chronic Low-Dose Irradiation and Modeled Microgravity Develop Long-Term Neurological Sequelae. Int. J. Mol. Sci. 2019;20:4094. doi: 10.3390/ijms20174094.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms20174094</ArticleId><ArticleId IdType=\"pmc\">PMC6747492</ArticleId><ArticleId IdType=\"pubmed\">31443374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweet T.B., Hurley S.D., Wu M.D., Olschowka J.A., Williams J.P., O&#x2019;Banion M.K. Neurogenic Effects of Low-Dose Whole-Body HZE (Fe) Ion and Gamma Irradiation. Radiat. Res. 2016;186:614&#x2013;623. doi: 10.1667/RR14530.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR14530.1</ArticleId><ArticleId IdType=\"pmc\">PMC5240657</ArticleId><ArticleId IdType=\"pubmed\">27905869</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M.-K., Kim S., Jung U., Kim I., Kim J.K., Roh C. Effect of acute and fractionated irradiation on hippocampal neurogenesis. Molecules. 2012;17:9462&#x2013;9468. doi: 10.3390/molecules17089462.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules17089462</ArticleId><ArticleId IdType=\"pmc\">PMC6268856</ArticleId><ArticleId IdType=\"pubmed\">22874790</ArticleId></ArticleIdList></Reference><Reference><Citation>Suman S., Rodriguez O.C., Winters T.A., Fornace A.J., Albanese C., Datta K. Therapeutic and space radiation exposure of mouse brain causes impaired DNA repair response and premature senescence by chronic oxidant production. Aging. 2013;5:607&#x2013;622. doi: 10.18632/aging.100587.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/aging.100587</ArticleId><ArticleId IdType=\"pmc\">PMC3796214</ArticleId><ArticleId IdType=\"pubmed\">23928451</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel R., Arakawa H., Radivoyevitch T., Gerson S.L., Welford S.M. Long-Term Deficits in Behavior Performances Caused by Low- and High-Linear Energy Transfer Radiation. Radiat. Res. 2017;188:672&#x2013;680. doi: 10.1667/RR14795.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR14795.1</ArticleId><ArticleId IdType=\"pubmed\">28961076</ArticleId></ArticleIdList></Reference><Reference><Citation>Durante M., Cucinotta F.A. Heavy ion carcinogenesis and human space exploration. Nat. Rev. Cancer. 2008;8:465&#x2013;472. doi: 10.1038/nrc2391.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrc2391</ArticleId><ArticleId IdType=\"pubmed\">18451812</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlkolinsky R., Titova E., Krucker T., Chi B.B., Staufenbiel M., Nelson G.A., Obenaus A. Exposure to 56Fe-particle radiation accelerates electrophysiological alterations in the hippocampus of APP23 transgenic mice. Radiat. Res. 2010;173:342&#x2013;352. doi: 10.1667/RR1825.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR1825.1</ArticleId><ArticleId IdType=\"pubmed\">20199219</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherry J.D., Liu B., Frost J.L., Lemere C.A., Williams J.P., Olschowka J.A., O&#x2019;Banion M.K. Galactic cosmic radiation leads to cognitive impairment and increased a&#x3b2; plaque accumulation in a mouse model of Alzheimer&#x2019;s disease. PLoS ONE. 2012;7:e53275. doi: 10.1371/journal.pone.0053275.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0053275</ArticleId><ArticleId IdType=\"pmc\">PMC3534034</ArticleId><ArticleId IdType=\"pubmed\">23300905</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Hinshaw R.G., Le K.X., Park M.-A., Wang S., Belanger A.P., Dubey S., Frost J.L., Shi Q., Holton P., et al. Space-like 56Fe irradiation manifests mild, early sex-specific behavioral and neuropathological changes in wildtype and Alzheimer&#x2019;s-like transgenic mice. Sci. Rep. 2019;9:12118. doi: 10.1038/s41598-019-48615-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-48615-1</ArticleId><ArticleId IdType=\"pmc\">PMC6702228</ArticleId><ArticleId IdType=\"pubmed\">31431669</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder M.K., Liu B., Hinshaw R.G., Park M.-A., Wang S., Dubey S., Liu G.G., Shi Q., Holton P., Reiser V., et al. Long-Term Sex- and Genotype-Specific Effects of 56Fe Irradiation on Wild-Type and APPswe/PS1dE9 Transgenic Mice. Int. J. Mol. Sci. 2021;22:13305. doi: 10.3390/ijms222413305.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms222413305</ArticleId><ArticleId IdType=\"pmc\">PMC8703695</ArticleId><ArticleId IdType=\"pubmed\">34948098</ArticleId></ArticleIdList></Reference><Reference><Citation>Owlett L., Belcher E.K., Dionisio-Santos D.A., Williams J.P., Olschowka J.A., O&#x2019;Banion M.K. Space radiation does not alter amyloid or tau pathology in the 3xTg mouse model of Alzheimer&#x2019;s disease. Life Sci. Space Res. 2020;27:89&#x2013;98. doi: 10.1016/j.lssr.2020.08.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lssr.2020.08.001</ArticleId><ArticleId IdType=\"pubmed\">34756235</ArticleId></ArticleIdList></Reference><Reference><Citation>Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer&#x2019;s disease in late onset families. Science. 1993;261:921&#x2013;923. doi: 10.1126/science.8346443.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.8346443</ArticleId><ArticleId IdType=\"pubmed\">8346443</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349&#x2013;1356. doi: 10.1001/jama.1997.03550160069041.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.1997.03550160069041</ArticleId><ArticleId IdType=\"pubmed\">9343467</ArticleId></ArticleIdList></Reference><Reference><Citation>Safieh M., Korczyn A.D., Michaelson D.M. ApoE4: An emerging therapeutic target for Alzheimer&#x2019;s disease. BMC Med. 2019;17:64. doi: 10.1186/s12916-019-1299-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12916-019-1299-4</ArticleId><ArticleId IdType=\"pmc\">PMC6425600</ArticleId><ArticleId IdType=\"pubmed\">30890171</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward A., Crean S., Mercaldi C.J., Collins J.M., Boyd D., Cook M.N., Arrighi H.M. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer&#x2019;s disease: A systematic review and meta-analysis. Neuroepidemiology. 2012;38:1&#x2013;17. doi: 10.1159/000334607.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000334607</ArticleId><ArticleId IdType=\"pubmed\">22179327</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch C.M., Goate A.M. Alzheimer&#x2019;s disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry. 2015;77:43&#x2013;51. doi: 10.1016/j.biopsych.2014.05.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopsych.2014.05.006</ArticleId><ArticleId IdType=\"pmc\">PMC4234692</ArticleId><ArticleId IdType=\"pubmed\">24951455</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeux R., Stern Y., Ottman R., Tatemichi T.K., Tang M.X., Maestre G., Ngai C., Tycko B., Ginsberg H. The apolipoprotein epsilon 4 allele in patients with Alzheimer&#x2019;s disease. Ann. Neurol. 1993;34:752&#x2013;754. doi: 10.1002/ana.410340527.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.410340527</ArticleId><ArticleId IdType=\"pubmed\">8239575</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin E., Hannequin D., Wallon D., Sleegers K., Hiltunen M., Combarros O., Bullido M.J., Engelborghs S., de Deyn P., Berr C., et al. APOE and Alzheimer disease: A major gene with semi-dominant inheritance. Mol. Psychiatry. 2011;16:903&#x2013;907. doi: 10.1038/mp.2011.52.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/mp.2011.52</ArticleId><ArticleId IdType=\"pmc\">PMC3162068</ArticleId><ArticleId IdType=\"pubmed\">21556001</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang M.X., Stern Y., Marder K., Bell K., Gurland B., Lantigua R., Andrews H., Feng L., Tycko B., Mayeux R. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998;279:751&#x2013;755. doi: 10.1001/jama.279.10.751.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.279.10.751</ArticleId><ArticleId IdType=\"pubmed\">9508150</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre G., Ottman R., Stern Y., Gurland B., Chun M., Tang M.X., Shelanski M., Tycko B., Mayeux R. Apolipoprotein E and Alzheimer&#x2019;s disease: Ethnic variation in genotypic risks. Ann. Neurol. 1995;37:254&#x2013;259. doi: 10.1002/ana.410370217.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.410370217</ArticleId><ArticleId IdType=\"pubmed\">7847867</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M., Bian C., Zhang J., Wen F. Apolipoprotein E gene polymorphism and Alzheimer&#x2019;s disease in Chinese population: A meta-analysis. Sci. Rep. 2014;4:4383. doi: 10.1038/srep04383.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/srep04383</ArticleId><ArticleId IdType=\"pmc\">PMC3955907</ArticleId><ArticleId IdType=\"pubmed\">24632849</ArticleId></ArticleIdList></Reference><Reference><Citation>Villasana L.E., Weber S., Akinyeke T., Raber J. Genotype differences in anxiety and fear learning and memory of WT and ApoE4 mice associated with enhanced generation of hippocampal reactive oxygen species. J. Neurochem. 2016;138:896&#x2013;908. doi: 10.1111/jnc.13737.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jnc.13737</ArticleId><ArticleId IdType=\"pmc\">PMC5017911</ArticleId><ArticleId IdType=\"pubmed\">27412623</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley G.E., Villasana L., Dayger C., Davis M.J., Raber J. Apolipoprotein e genotype-dependent paradoxical short-term effects of (56)Fe irradiation on the brain. Int. J. Radiat. Oncol. Biol. Phys. 2012;84:793&#x2013;799. doi: 10.1016/j.ijrobp.2011.12.049.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijrobp.2011.12.049</ArticleId><ArticleId IdType=\"pmc\">PMC3742074</ArticleId><ArticleId IdType=\"pubmed\">22401921</ArticleId></ArticleIdList></Reference><Reference><Citation>Bairamian D., Sha S., Rolhion N., Sokol H., Doroth&#xe9;e G., Lemere C.A., Krantic S. Microbiota in neuroinflammation and synaptic dysfunction: A focus on Alzheimer&#x2019;s disease. Mol. Neurodegener. 2022;17:19. doi: 10.1186/s13024-022-00522-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-022-00522-2</ArticleId><ArticleId IdType=\"pmc\">PMC8898063</ArticleId><ArticleId IdType=\"pubmed\">35248147</ArticleId></ArticleIdList></Reference><Reference><Citation>Harach T., Marungruang N., Duthilleul N., Cheatham V., Mc Coy K.D., Frisoni G., Neher J.J., F&#xe5;k F., Jucker M., Lasser T., et al. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci. Rep. 2017;7:41802. doi: 10.1038/srep41802.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/srep41802</ArticleId><ArticleId IdType=\"pmc\">PMC5297247</ArticleId><ArticleId IdType=\"pubmed\">28176819</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox L.M., Schafer M.J., Sohn J., Vincentini J., Weiner H.L., Ginsberg S.D., Blaser M.J. Calorie restriction slows age-related microbiota changes in an Alzheimer&#x2019;s disease model in female mice. Sci. Rep. 2019;9:17904. doi: 10.1038/s41598-019-54187-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-54187-x</ArticleId><ArticleId IdType=\"pmc\">PMC6884494</ArticleId><ArticleId IdType=\"pubmed\">31784610</ArticleId></ArticleIdList></Reference><Reference><Citation>Honarpisheh P., Reynolds C.R., Blasco Conesa M.P., Moruno Manchon J.F., Putluri N., Bhattacharjee M.B., Urayama A., McCullough L.D., Ganesh B.P. Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-&#x3b2; in Tg2576 Mice. Int. J. Mol. Sci. 2020;21:1711. doi: 10.3390/ijms21051711.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21051711</ArticleId><ArticleId IdType=\"pmc\">PMC7084806</ArticleId><ArticleId IdType=\"pubmed\">32138161</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Fang L., Chen S., Zhou H., Fan Y., Lin L., Li J., Xu J., Chen Y., Ma Y., et al. Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer&#x2019;s Disease. Biomed. Res. Int. 2020;2020:8456596. doi: 10.1155/2020/8456596.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2020/8456596</ArticleId><ArticleId IdType=\"pmc\">PMC7273394</ArticleId><ArticleId IdType=\"pubmed\">32596386</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Medina P.C., Hern&#xe1;ndez-Quiroz F., P&#xe9;rez-Morales M., Gonz&#xe1;lez-Franco D.A., Cruz-Pauseno G., Garc&#xed;a-Mena J., D&#xed;az-Cintra S., Pacheco-L&#xf3;pez G. Spatial Memory and Gut Microbiota Alterations Are Already Present in Early Adulthood in a Pre-clinical Transgenic Model of Alzheimer&#x2019;s Disease. Front. Neurosci. 2021;15:595583. doi: 10.3389/fnins.2021.595583.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2021.595583</ArticleId><ArticleId IdType=\"pmc\">PMC8116633</ArticleId><ArticleId IdType=\"pubmed\">33994914</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla P.K., Delotterie D.F., Xiao J., Pierre J.F., Rao R., McDonald M.P., Khan M.M. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer&#x2019;s Disease. Cells. 2021;10:779. doi: 10.3390/cells10040779.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells10040779</ArticleId><ArticleId IdType=\"pmc\">PMC8067249</ArticleId><ArticleId IdType=\"pubmed\">33916001</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt N.M., Kerby R.L., Dill-McFarland K.A., Harding S.J., Merluzzi A.P., Johnson S.C., Carlsson C.M., Asthana S., Zetterberg H., Blennow K., et al. Gut microbiome alterations in Alzheimer&#x2019;s disease. Sci. Rep. 2017;7:13537. doi: 10.1038/s41598-017-13601-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-017-13601-y</ArticleId><ArticleId IdType=\"pmc\">PMC5648830</ArticleId><ArticleId IdType=\"pubmed\">29051531</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran J.P., Bhattarai S.K., Foley S.E., Dutta P., Ward D.V., Bucci V., McCormick B.A. Alzheimer&#x2019;s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway. mBio. 2019;10:10&#x2013;1128. doi: 10.1128/mBio.00632-19.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/mBio.00632-19</ArticleId><ArticleId IdType=\"pmc\">PMC6509190</ArticleId><ArticleId IdType=\"pubmed\">31064831</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., He Y., Ma J., Huang P., Du J., Cao L., Wang Y., Xiao Q., Tang H., Chen S. Mild cognitive impairment has similar alterations as Alzheimer&#x2019;s disease in gut microbiota. Alzheimers Dement. 2019;15:1357&#x2013;1366. doi: 10.1016/j.jalz.2019.07.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2019.07.002</ArticleId><ArticleId IdType=\"pubmed\">31434623</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang Z.-Q., Shen L.-L., Li W.-W., Fu X., Zeng F., Gui L., L&#xfc; Y., Cai M., Zhu C., Tan Y.-L., et al. Gut Microbiota is Altered in Patients with Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2018;63:1337&#x2013;1346. doi: 10.3233/JAD-180176.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-180176</ArticleId><ArticleId IdType=\"pubmed\">29758946</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Z., Zhu M., Yan X., Cheng Y., Shao L., Liu X., Jiang R., Wu S. Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients with Alzheimer&#x2019;s Disease. Front. Cell Dev. Biol. 2020;8:634069. doi: 10.3389/fcell.2020.634069.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2020.634069</ArticleId><ArticleId IdType=\"pmc\">PMC7889981</ArticleId><ArticleId IdType=\"pubmed\">33614635</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo A., Cattane N., Galluzzi S., Provasi S., Lopizzo N., Festari C., Ferrari C., Guerra U.P., Paghera B., Muscio C., et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging. 2017;49:60&#x2013;68. doi: 10.1016/j.neurobiolaging.2016.08.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2016.08.019</ArticleId><ArticleId IdType=\"pubmed\">27776263</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran T.T.T., Corsini S., Kellingray L., Hegarty C., Le Gall G., Narbad A., M&#xfc;ller M., Tejera N., O&#x2019;Toole P.W., Minihane A.-M., et al. APOE genotype influences the gut microbiome structure and function in humans and mice: Relevance for Alzheimer&#x2019;s disease pathophysiology. FASEB. 2019;33:8221&#x2013;8231. doi: 10.1096/fj.201900071R.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.201900071R</ArticleId><ArticleId IdType=\"pmc\">PMC6593891</ArticleId><ArticleId IdType=\"pubmed\">30958695</ArticleId></ArticleIdList></Reference><Reference><Citation>Villasana L., Acevedo S., Poage C., Raber J. Sex- and APOE isoform-dependent effects of radiation on cognitive function. Radiat. Res. 2006;166:883&#x2013;891. doi: 10.1667/RR0642.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR0642.1</ArticleId><ArticleId IdType=\"pubmed\">17149978</ArticleId></ArticleIdList></Reference><Reference><Citation>Villasana L.E., Rosenthal R.A., Doctrow S.R., Pfankuch T., Zuloaga D.G., Garfinkel A.M., Raber J. Effects of alpha-lipoic acid on associative and spatial memory of sham-irradiated and 56Fe-irradiated C57BL/6J male mice. Pharmacol. Biochem. Behav. 2013;103:487&#x2013;493. doi: 10.1016/j.pbb.2012.09.021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pbb.2012.09.021</ArticleId><ArticleId IdType=\"pmc\">PMC5930007</ArticleId><ArticleId IdType=\"pubmed\">23051895</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeiser L.A., Villasana L.E., Raber J. ApoE isoform modulates effects of cranial &#x2075;&#x2076;Fe irradiation on spatial learning and memory in the water maze. Behav. Brain Res. 2013;237:207&#x2013;214. doi: 10.1016/j.bbr.2012.09.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbr.2012.09.029</ArticleId><ArticleId IdType=\"pubmed\">23018124</ArticleId></ArticleIdList></Reference><Reference><Citation>Villasana L.E., Benice T.S., Raber J. Long-term effects of 56Fe irradiation on spatial memory of mice: Role of sex and apolipoprotein E isoform. Int. J. Radiat. Oncol. Biol. Phys. 2011;80:567&#x2013;573. doi: 10.1016/j.ijrobp.2010.12.034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijrobp.2010.12.034</ArticleId><ArticleId IdType=\"pubmed\">21549250</ArticleId></ArticleIdList></Reference><Reference><Citation>Novo N., Romero-Tamayo S., Marcuello C., Boneta S., Blasco-Machin I., Vel&#xe1;zquez-Campoy A., Villanueva R., Moreno-Loshuertos R., Lostao A., Medina M., et al. Beyond a platform protein for the degradosome assembly: The Apoptosis-Inducing Factor as an efficient nuclease involved in chromatinolysis. PNAS Nexus. 2022;2:pgac312. doi: 10.1093/pnasnexus/pgac312.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/pnasnexus/pgac312</ArticleId><ArticleId IdType=\"pmc\">PMC9944232</ArticleId><ArticleId IdType=\"pubmed\">36845352</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks A.L., Bao S., Rithidech K., Couch L.A., Braby L.A. Relative Effectiveness of HZE Iron-56 Particles for the Induction of Cytogenetic Damage In Vivo. Radiat. Res. 2001;155:353&#x2013;359. doi: 10.1667/0033-7587(2001)155[0353:REOHIP]2.0.CO;2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/0033-7587(2001)155[0353:REOHIP]2.0.CO;2</ArticleId><ArticleId IdType=\"pubmed\">11175671</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin B.M., Carrihill-Knoll K.L., Shukitt-Hale B. Comparison of the Effectiveness of Exposure to Low-LET Helium Particles ((4)He) and Gamma Rays ((137)Cs) on the Disruption of Cognitive Performance. Radiat. Res. 2015;184:266&#x2013;272. doi: 10.1667/RR14001.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR14001.1</ArticleId><ArticleId IdType=\"pubmed\">26284421</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.D., Nedjai B., Hurst T., Pennington D.J. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim. Biophys. Acta. 2014;1843:2563&#x2013;2582. doi: 10.1016/j.bbamcr.2014.05.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamcr.2014.05.014</ArticleId><ArticleId IdType=\"pubmed\">24892271</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong F., Du Y.R., Xie W., Strong J.A., He X.J., Zhang J.M. Increased function of the TRPV1 channel in small sensory neurons after local inflammation or in vitro exposure to the pro-inflammatory cytokine GRO/KC. Neurosci. Bull. 2012;28:155&#x2013;164. doi: 10.1007/s12264-012-1208-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12264-012-1208-8</ArticleId><ArticleId IdType=\"pmc\">PMC3324197</ArticleId><ArticleId IdType=\"pubmed\">22466126</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta. 2011;1813:878&#x2013;888. doi: 10.1016/j.bbamcr.2011.01.034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamcr.2011.01.034</ArticleId><ArticleId IdType=\"pubmed\">21296109</ArticleId></ArticleIdList></Reference><Reference><Citation>Decourt B., Lahiri D.K., Sabbagh M.N. Targeting Tumor Necrosis Factor Alpha for Alzheimer&#x2019;s Disease. Curr. Alzheimer Res. 2017;14:412&#x2013;425. doi: 10.2174/1567205013666160930110551.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567205013666160930110551</ArticleId><ArticleId IdType=\"pmc\">PMC5328927</ArticleId><ArticleId IdType=\"pubmed\">27697064</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark I.A., Alleva L.M., Vissel B. The roles of TNF in brain dysfunction and disease. Pharmacol. Ther. 2010;128:519&#x2013;548. doi: 10.1016/j.pharmthera.2010.08.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pharmthera.2010.08.007</ArticleId><ArticleId IdType=\"pubmed\">20813131</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss S., Bauer J., Ganter U., Jonas U., Berger M., Volk B. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer&#x2019;s disease patients. Lab. Investig. 1992;66:223&#x2013;230.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1370967</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang C.S., Hong J.H., Stalder A., Sun J.R., Withers H.R., McBride W.H. Delayed molecular responses to brain irradiation. Int. J. Radiat. Biol. 1997;72:45&#x2013;53. doi: 10.1080/095530097143527.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/095530097143527</ArticleId><ArticleId IdType=\"pubmed\">9246193</ArticleId></ArticleIdList></Reference><Reference><Citation>Moravan M.J., Olschowka J.A., Williams J.P., O&#x2019;Banion M.K. Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain. Radiat. Res. 2011;176:459&#x2013;473. doi: 10.1667/RR2587.1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1667/RR2587.1</ArticleId><ArticleId IdType=\"pmc\">PMC3191189</ArticleId><ArticleId IdType=\"pubmed\">21787181</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnuolo R., Scipione C.A., Boffa M.B., Marcovina S.M., Seidah N.G., Koschinsky M.L. Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor. J. Biol. Chem. 2015;290:11649&#x2013;11662. doi: 10.1074/jbc.M114.611988.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M114.611988</ArticleId><ArticleId IdType=\"pmc\">PMC4416867</ArticleId><ArticleId IdType=\"pubmed\">25778403</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitz N.F., Cronican A.A., Saleem M., Fauq A.H., Chapman R., Lefterov I., Koldamova R. Abca1 deficiency affects Alzheimer&#x2019;s disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. J. Neurosci. 2012;32:13125&#x2013;13136. doi: 10.1523/JNEUROSCI.1937-12.2012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1937-12.2012</ArticleId><ArticleId IdType=\"pmc\">PMC3646580</ArticleId><ArticleId IdType=\"pubmed\">22993429</ArticleId></ArticleIdList></Reference><Reference><Citation>Grenon M.B., Papavergi M.-Z., Bathini P., Sadowski M., Lemere C.A. Temporal characterization of the amyloidogenic APP/PS1dE9;hAPOE4 mouse model of Alzheimer&#x2019;s disease. Int. J. Mol. Sci. 2024 submitted .</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC11172317</ArticleId><ArticleId IdType=\"pubmed\">38891941</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankiewicz J.E., Baquero-Buitrago J., Sanchez S., Lopez-Contreras J., Kim J., Sullivan P.M., Holtzman D.M., Sadowski M.J. APOE Genotype Differentially Modulates Effects of Anti-A&#x3b2;, Passive Immunization in APP Transgenic Mice. Mol. Neurodegener. 2017;12:12. doi: 10.1186/s13024-017-0156-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-017-0156-1</ArticleId><ArticleId IdType=\"pmc\">PMC5282859</ArticleId><ArticleId IdType=\"pubmed\">28143566</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H., Goico B., Martin M., Csernansky C.A., Bertchume A., Csernansky J.G. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience. 2004;127:601&#x2013;609. doi: 10.1016/j.neuroscience.2004.05.040.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroscience.2004.05.040</ArticleId><ArticleId IdType=\"pubmed\">15283960</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong Y.H., Park C.H., Yoo J., Shin K.Y., Ahn S.-M., Kim H.-S., Lee S.H., Emson P.C., Suh Y.-H. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer&#x2019;s disease model. FASEB. 2006;20:729&#x2013;731. doi: 10.1096/fj.05-4265fje.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.05-4265fje</ArticleId><ArticleId IdType=\"pubmed\">16467370</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J.-E., Cirrito J.R., Dong H., Csernansky J.G., Holtzman D.M. Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc. Natl. Acad. Sci. USA. 2007;104:10673&#x2013;10678. doi: 10.1073/pnas.0700148104.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0700148104</ArticleId><ArticleId IdType=\"pmc\">PMC1965571</ArticleId><ArticleId IdType=\"pubmed\">17551018</ArticleId></ArticleIdList></Reference><Reference><Citation>Devi L., Alldred M.J., Ginsberg S.D., Ohno M. Sex- and brain region-specific acceleration of &#x3b2;-amyloidogenesis following behavioral stress in a mouse model of Alzheimer&#x2019;s disease. Mol. Brain. 2010;3:34. doi: 10.1186/1756-6606-3-34.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1756-6606-3-34</ArticleId><ArticleId IdType=\"pmc\">PMC2988063</ArticleId><ArticleId IdType=\"pubmed\">21059265</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuadrado-Tejedor M., Ricobaraza A., Frechilla D., Franco R., P&#xe9;rez-Mediavilla A., Garcia-Osta A. Chronic mild stress accelerates the onset and progression of the Alzheimer&#x2019;s disease phenotype in Tg2576 mice. J. Alzheimer&#x2019;s Dis. 2012;28:567&#x2013;578. doi: 10.3233/JAD-2011-110572.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-2011-110572</ArticleId><ArticleId IdType=\"pubmed\">22045482</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman S.M., Herdener N., Camandola S., Texel S.J., Mughal M.R., Cong W.-N., Martin B., Mattson M.P. 3xTgAD mice exhibit altered behavior and elevated A&#x3b2; after chronic mild social stress. Front. Cell Dev. Biol. 2012;33:830.e1-12. doi: 10.1016/j.neurobiolaging.2011.07.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2011.07.005</ArticleId><ArticleId IdType=\"pmc\">PMC4074356</ArticleId><ArticleId IdType=\"pubmed\">21855175</ArticleId></ArticleIdList></Reference><Reference><Citation>Baglietto-Vargas D., Chen Y., Suh D., Ager R.R., Rodriguez-Ortiz C.J., Medeiros R., Myczek K., Green K.N., Baram T.Z., LaFerla F.M. Short-term modern life-like stress exacerbates A&#x3b2;-pathology and synapse loss in 3xTg-AD mice. J. Neurochem. 2015;134:915&#x2013;926. doi: 10.1111/jnc.13195.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jnc.13195</ArticleId><ArticleId IdType=\"pmc\">PMC4792118</ArticleId><ArticleId IdType=\"pubmed\">26077803</ArticleId></ArticleIdList></Reference><Reference><Citation>Justice N.J., Huang L., Tian J.-B., Cole A., Pruski M., Hunt A.J., Flores R., Zhu M.X., Arenkiel B.R., Zheng H. Posttraumatic stress disorder-like induction elevates &#x3b2;-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses. J. Neurosci. 2015;35:2612&#x2013;2623. doi: 10.1523/JNEUROSCI.3333-14.2015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.3333-14.2015</ArticleId><ArticleId IdType=\"pmc\">PMC4323535</ArticleId><ArticleId IdType=\"pubmed\">25673853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesuis S.L., Maurin H., Borghgraef P., Lucassen P.J., van Leuven F., Krugers H.J. Positive and negative early life experiences differentially modulate long term survival and amyloid protein levels in a mouse model of Alzheimer&#x2019;s disease. Oncotarget. 2016;7:39118&#x2013;39135. doi: 10.18632/oncotarget.9776.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.9776</ArticleId><ArticleId IdType=\"pmc\">PMC5129918</ArticleId><ArticleId IdType=\"pubmed\">27259247</ArticleId></ArticleIdList></Reference><Reference><Citation>Han B., Yu L., Geng Y., Shen L., Wang H., Wang Y., Wang J., Wang M. Chronic Stress Aggravates Cognitive Impairment and Suppresses Insulin Associated Signaling Pathway in APP/PS1 Mice. J. Alzheimer&#x2019;s Dis. 2016;53:1539&#x2013;1552. doi: 10.3233/JAD-160189.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-160189</ArticleId><ArticleId IdType=\"pubmed\">27392857</ArticleId></ArticleIdList></Reference><Reference><Citation>Han B., Wang J.-H., Geng Y., Shen L., Wang H.-L., Wang Y.-Y., Wang M.-W. Chronic Stress Contributes to Cognitive Dysfunction and Hippocampal Metabolic Abnormalities in APP/PS1 Mice. Cell. Physiol. Biochem. 2017;41:1766&#x2013;1776. doi: 10.1159/000471869.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000471869</ArticleId><ArticleId IdType=\"pubmed\">28365686</ArticleId></ArticleIdList></Reference><Reference><Citation>Justice N.J. The relationship between stress and Alzheimer&#x2019;s disease. Neurobiol. Stress. 2018;8:127&#x2013;133. doi: 10.1016/j.ynstr.2018.04.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ynstr.2018.04.002</ArticleId><ArticleId IdType=\"pmc\">PMC5991350</ArticleId><ArticleId IdType=\"pubmed\">29888308</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo E.P., Konno T., Farace I., Awadelkareem M.A., Skov L.R., Teodoro F., Sancho T.P., Paton A.W., Paton J.C., Fares M., et al. Stress-induced protein disaggregation in the endoplasmic reticulum catalysed by BiP. Nat. Commun. 2022;13:2501. doi: 10.1038/s41467-022-30238-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-30238-2</ArticleId><ArticleId IdType=\"pmc\">PMC9076838</ArticleId><ArticleId IdType=\"pubmed\">35523806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby E.D., Muroy S.E., Sun W.G., Covarrubias D., Leong M.J., Barchas L.A., Kaufer D. Acute stress enhances adult rat hippocampal neurogenesis and activation of newborn neurons via secreted astrocytic FGF2. eLife. 2013;2:e00362. doi: 10.7554/eLife.00362.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7554/eLife.00362</ArticleId><ArticleId IdType=\"pmc\">PMC3628086</ArticleId><ArticleId IdType=\"pubmed\">23599891</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Ramasamy V.S., Samidurai M., Jo J. Acute restraint stress reverses impaired LTP in the hippocampal CA1 region in mouse models of Alzheimer&#x2019;s disease. Sci. Rep. 2019;9:10955. doi: 10.1038/s41598-019-47452-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-47452-6</ArticleId><ArticleId IdType=\"pmc\">PMC6662902</ArticleId><ArticleId IdType=\"pubmed\">31358853</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka J., Fujita H., Matsuda S., Toku K., Sakanaka M., Maeda N. Glucocorticoid- and mineralocorticoid receptors in microglial cells: The two receptors mediate differential effects of corticosteroids. Glia. 1997;20:23&#x2013;37. doi: 10.1002/(SICI)1098-1136(199705)20:1&lt;23::AID-GLIA3&gt;3.0.CO;2-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/(SICI)1098-1136(199705)20:1&lt;23::AID-GLIA3&gt;3.0.CO;2-6</ArticleId><ArticleId IdType=\"pubmed\">9145302</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierra A., Gottfried-Blackmore A., Milner T.A., McEwen B.S., Bulloch K. Steroid hormone receptor expression and function in microglia. Glia. 2008;56:659&#x2013;674. doi: 10.1002/glia.20644.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/glia.20644</ArticleId><ArticleId IdType=\"pubmed\">18286612</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugama S., Fujita M., Hashimoto M., Conti B. Stress induced morphological microglial activation in the rodent brain: Involvement of interleukin-18. Neuroscience. 2007;146:1388&#x2013;1399. doi: 10.1016/j.neuroscience.2007.02.043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroscience.2007.02.043</ArticleId><ArticleId IdType=\"pubmed\">17433555</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrazzoli M., Losurdo M., Paolone G., Medelin M., Jaupaj L., Cisterna B., Slanzi A., Malatesta M., Coco S., Buffelli M. Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer&#x2019;s disease. Neurobiol. 2019;132:104568. doi: 10.1016/j.nbd.2019.104568.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2019.104568</ArticleId><ArticleId IdType=\"pubmed\">31394203</ArticleId></ArticleIdList></Reference><Reference><Citation>Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 2000;6:916&#x2013;919. doi: 10.1038/78682.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/78682</ArticleId><ArticleId IdType=\"pubmed\">10932230</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolmont T., Haiss F., Eicke D., Radde R., Mathis C.A., Klunk W.E., Kohsaka S., Jucker M., Calhoun M.E. Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J. Neurosci. 2008;28:4283&#x2013;4292. doi: 10.1523/JNEUROSCI.4814-07.2008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.4814-07.2008</ArticleId><ArticleId IdType=\"pmc\">PMC3844768</ArticleId><ArticleId IdType=\"pubmed\">18417708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ries M., Sastre M. Mechanisms of A&#x3b2; Clearance and Degradation by Glial Cells. Front. Aging Neurosci. 2016;8:160. doi: 10.3389/fnagi.2016.00160.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2016.00160</ArticleId><ArticleId IdType=\"pmc\">PMC4932097</ArticleId><ArticleId IdType=\"pubmed\">27458370</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenigsknecht J., Landreth G. Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J. Neurosci. 2004;24:9838&#x2013;9846. doi: 10.1523/JNEUROSCI.2557-04.2004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.2557-04.2004</ArticleId><ArticleId IdType=\"pmc\">PMC6730228</ArticleId><ArticleId IdType=\"pubmed\">15525768</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Andrea M.R., Cole G.M., Ard M.D. The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol. Aging. 2004;25:675&#x2013;683. doi: 10.1016/j.neurobiolaging.2003.12.026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2003.12.026</ArticleId><ArticleId IdType=\"pubmed\">15172747</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumdar A., Cruz D., Asamoah N., Buxbaum A., Sohar I., Lobel P., Maxfield F.R. Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol. Biol. Cell. 2007;18:1490&#x2013;1496. doi: 10.1091/mbc.e06-10-0975.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1091/mbc.e06-10-0975</ArticleId><ArticleId IdType=\"pmc\">PMC1838985</ArticleId><ArticleId IdType=\"pubmed\">17314396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrekar S., Jiang Q., Lee C.Y.D., Koenigsknecht-Talboo J., Holtzman D.M., Landreth G.E. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J. Neurosci. 2009;29:4252&#x2013;4262. doi: 10.1523/JNEUROSCI.5572-08.2009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.5572-08.2009</ArticleId><ArticleId IdType=\"pmc\">PMC3034143</ArticleId><ArticleId IdType=\"pubmed\">19339619</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan X.-D., Zhu Y.-G., Lin N., Zhang J., Ye Q.-Y., Huang H.-P., Chen X.-C. Microglial phagocytosis induced by fibrillar &#x3b2;-amyloid is attenuated by oligomeric &#x3b2;-amyloid: Implications for Alzheimer&#x2019;s disease. Mol. Neurodegener. 2011;6:45. doi: 10.1186/1750-1326-6-45.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1750-1326-6-45</ArticleId><ArticleId IdType=\"pmc\">PMC3149591</ArticleId><ArticleId IdType=\"pubmed\">21718498</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Q., Lee C.Y.D., Mandrekar S., Wilkinson B., Cramer P., Zelcer N., Mann K., Lamb B., Willson T.M., Collins J.L., et al. ApoE promotes the proteolytic degradation of Abeta. Neuron. 2008;58:681&#x2013;693. doi: 10.1016/j.neuron.2008.04.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2008.04.010</ArticleId><ArticleId IdType=\"pmc\">PMC2493297</ArticleId><ArticleId IdType=\"pubmed\">18549781</ArticleId></ArticleIdList></Reference><Reference><Citation>Minter M.R., Zhang C., Leone V., Ringus D.L., Zhang X., Oyler-Castrillo P., Musch M.W., Liao F., Ward J.F., Holtzman D.M., et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer&#x2019;s disease. Sci. Rep. 2016;6:30028. doi: 10.1038/srep30028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/srep30028</ArticleId><ArticleId IdType=\"pmc\">PMC4956742</ArticleId><ArticleId IdType=\"pubmed\">27443609</ArticleId></ArticleIdList></Reference><Reference><Citation>Mez&#xf6; C., Dokalis N., Mossad O., Staszewski O., Neuber J., Yilmaz B., Schnepf D., de Ag&#xfc;ero M.G., Ganal-Vonarburg S.C., Macpherson A.J., et al. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 2020;8:119. doi: 10.1186/s40478-020-00988-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-020-00988-5</ArticleId><ArticleId IdType=\"pmc\">PMC7389451</ArticleId><ArticleId IdType=\"pubmed\">32727612</ArticleId></ArticleIdList></Reference><Reference><Citation>Was&#xe9;n C., Beauchamp L.C., Vincentini J., Li S., LeServe D.S., Gauthier C., Lopes J.R., Moreira T.G., Ekwudo M.N., Yin Z., et al. Bacteroidota inhibit microglia clearance of amyloid-beta and promote plaque deposition in Alzheimer&#x2019;s disease mouse models. Nat. Commun. 2024;15:3872. doi: 10.1038/s41467-024-47683-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-024-47683-w</ArticleId><ArticleId IdType=\"pmc\">PMC11078963</ArticleId><ArticleId IdType=\"pubmed\">38719797</ArticleId></ArticleIdList></Reference><Reference><Citation>Odamaki T., Kato K., Sugahara H., Hashikura N., Takahashi S., Xiao J.Z., Abe F., Osawa R. Age-related changes in gut microbiota composition from newborn to centenarian: A cross-sectional study. BMC Microbiol. 2016;16:90. doi: 10.1186/s12866-016-0708-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12866-016-0708-5</ArticleId><ArticleId IdType=\"pmc\">PMC4879732</ArticleId><ArticleId IdType=\"pubmed\">27220822</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T., Matsuba Y., Mihira N., Takano J., Nilsson P., Itohara S., Iwata N., Saido T.C. Single App knock-in mouse models of Alzheimer&#x2019;s disease. Nat. Neurosci. 2014;17:661&#x2013;663. doi: 10.1038/nn.3697.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nn.3697</ArticleId><ArticleId IdType=\"pubmed\">24728269</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh T.-P.V., Wang C., Tran A.C., Tabor G.T., Mahan T.E., Francis C.M., Finn M.B., Spellman R., Manis M., Tanzi R.E., et al. Lack of hepatic apoE does not influence early A&#x3b2; deposition: Observations from a new APOE knock-in model. Mol. Neurodegener. 2019;14:37. doi: 10.1186/s13024-019-0337-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-019-0337-1</ArticleId><ArticleId IdType=\"pmc\">PMC6796484</ArticleId><ArticleId IdType=\"pubmed\">31623648</ArticleId></ArticleIdList></Reference><Reference><Citation>Quast C., Pruesse E., Yilmaz P., Gerken J., Schweer T., Yarza P., Peplies J., Gl&#xf6;ckner F.O. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590&#x2013;D596. doi: 10.1093/nar/gks1219.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/gks1219</ArticleId><ArticleId IdType=\"pmc\">PMC3531112</ArticleId><ArticleId IdType=\"pubmed\">23193283</ArticleId></ArticleIdList></Reference><Reference><Citation>Segata N., Izard J., Waldron L., Gevers D., Miropolsky L., Garrett W.S., Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60. doi: 10.1186/gb-2011-12-6-r60.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/gb-2011-12-6-r60</ArticleId><ArticleId IdType=\"pmc\">PMC3218848</ArticleId><ArticleId IdType=\"pubmed\">21702898</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273288</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Unveiling the Therapeutic Potential of Folate-Dependent One-Carbon Metabolism in Cancer and Neurodegeneration.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9339</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179339</ELocationID><Abstract><AbstractText>Cellular metabolism is crucial for various physiological processes, with folate-dependent one-carbon (1C) metabolism playing a pivotal role. Folate, a B vitamin, is a key cofactor in this pathway, supporting DNA synthesis, methylation processes, and antioxidant defenses. In dividing cells, folate facilitates nucleotide biosynthesis, ensuring genomic stability and preventing carcinogenesis. Additionally, in neurodevelopment, folate is essential for neural tube closure and central nervous system formation. Thus, dysregulation of folate metabolism can contribute to pathologies such as cancer, severe birth defects, and neurodegenerative diseases. Epidemiological evidence highlights folate's impact on disease risk and its potential as a therapeutic target. In cancer, antifolate drugs that inhibit key enzymes of folate-dependent 1C metabolism and strategies targeting folate receptors are current therapeutic options. However, folate's impact on cancer risk is complex, varying among cancer types and dietary contexts. In neurodegenerative conditions, including Alzheimer's and Parkinson's diseases, folate deficiency exacerbates cognitive decline through elevated homocysteine levels, contributing to neuronal damage. Clinical trials of folic acid supplementation show mixed outcomes, underscoring the complexities of its neuroprotective effects. This review integrates current knowledge on folate metabolism in cancer and neurodegeneration, exploring molecular mechanisms, clinical implications, and therapeutic strategies, which can provide crucial information for advancing treatments.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Sobral</LastName><ForeName>Ana Filipa</ForeName><Initials>AF</Initials><Identifier Source=\"ORCID\">0000-0003-3674-3116</Identifier><AffiliationInfo><Affiliation>Associate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCIBIO-Applied Molecular Biosciences Unit, Toxicologic Pathology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cunha</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-3012-1079</Identifier><AffiliationInfo><Affiliation>UNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Silva</LastName><ForeName>Vera</ForeName><Initials>V</Initials><Identifier Source=\"ORCID\">0000-0003-3099-8433</Identifier><AffiliationInfo><Affiliation>Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIQUP-IMS/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gil-Martins</LastName><ForeName>Eva</ForeName><Initials>E</Initials><Identifier Source=\"ORCID\">0000-0002-8142-562X</Identifier><AffiliationInfo><Affiliation>Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIQUP-IMS/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Silva</LastName><ForeName>Renata</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0001-9962-7548</Identifier><AffiliationInfo><Affiliation>Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Barbosa</LastName><ForeName>Daniel Jos&#xe9;</ForeName><Initials>DJ</Initials><Identifier Source=\"ORCID\">0000-0002-1726-6011</Identifier><AffiliationInfo><Affiliation>Associate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCIBIO-Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>935E97BOY8</RegistryNumber><NameOfSubstance UI=\"D005492\">Folic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>7440-44-0</RegistryNumber><NameOfSubstance UI=\"D002244\">Carbon</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D005493\">Folic Acid Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005492\" MajorTopicYN=\"Y\">Folic Acid</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D009369\" MajorTopicYN=\"Y\">Neoplasms</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D019636\" MajorTopicYN=\"Y\">Neurodegenerative Diseases</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002244\" MajorTopicYN=\"N\">Carbon</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005493\" MajorTopicYN=\"N\">Folic Acid Antagonists</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">cancer</Keyword><Keyword MajorTopicYN=\"N\">folate</Keyword><Keyword MajorTopicYN=\"N\">folate cycle</Keyword><Keyword MajorTopicYN=\"N\">folate-dependent one-carbon metabolism</Keyword><Keyword MajorTopicYN=\"N\">folate-targeted therapies</Keyword><Keyword MajorTopicYN=\"N\">methionine cycle</Keyword><Keyword MajorTopicYN=\"N\">neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273288</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179339</ArticleId><ArticleId IdType=\"pii\">ijms25179339</ArticleId><ArticleId IdType=\"pmc\">PMC11395277</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Judge A., Dodd M.S. Metabolism. Essays Biochem. 2020;64:607&#x2013;647. doi: 10.1042/EBC20190041.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/EBC20190041</ArticleId><ArticleId IdType=\"pmc\">PMC7545035</ArticleId><ArticleId IdType=\"pubmed\">32830223</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrova B., Maynard A.G., Wang P., Kanarek N. Regulatory mechanisms of one-carbon metabolism enzymes. J. Biol. Chem. 2023;299:105457. doi: 10.1016/j.jbc.2023.105457.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jbc.2023.105457</ArticleId><ArticleId IdType=\"pmc\">PMC10758965</ArticleId><ArticleId IdType=\"pubmed\">37949226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lionaki E., Ploumi C., Tavernarakis N. One-carbon metabolism: Pulling the strings behind aging and neurodegeneration. Cells. 2022;11:214. doi: 10.3390/cells11020214.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells11020214</ArticleId><ArticleId IdType=\"pmc\">PMC8773781</ArticleId><ArticleId IdType=\"pubmed\">35053330</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisato V., Silva J.A., Scarpellini F., Capucci R., Marci R., Gallo I., Salvatori F., D&#x2019;Aversa E., Secchiero P., Serino M.L., et al. Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance. Sci. Rep. 2024;14:3275. doi: 10.1038/s41598-024-53737-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-024-53737-2</ArticleId><ArticleId IdType=\"pmc\">PMC10853191</ArticleId><ArticleId IdType=\"pubmed\">38332006</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore L.D., Le T., Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38:23&#x2013;38. doi: 10.1038/npp.2012.112.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/npp.2012.112</ArticleId><ArticleId IdType=\"pmc\">PMC3521964</ArticleId><ArticleId IdType=\"pubmed\">22781841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson A.L., Menelaou K., Rakoczy J., Tan X.S., Watson E.D. Disruption of folate metabolism causes poor alignment and spacing of mouse conceptuses for multiple generations. Front. Cell Dev. Biol. 2021;9:723978. doi: 10.3389/fcell.2021.723978.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2021.723978</ArticleId><ArticleId IdType=\"pmc\">PMC8703036</ArticleId><ArticleId IdType=\"pubmed\">34957089</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Pei P., Shen J., Yu J., Wang F., Wang L., Liu C., Wang S. Folate deficiency reduced aberrant level of DOT1L-mediated histone H3K79 methylation causes disruptive SHH gene expression involved in neural tube defects. Epigenet. Chromatin. 2023;16:50. doi: 10.1186/s13072-023-00517-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13072-023-00517-3</ArticleId><ArticleId IdType=\"pmc\">PMC10720071</ArticleId><ArticleId IdType=\"pubmed\">38093377</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu M., Ren B., Fang Y., Ren J., Liu X., Wang X., Zhou F., Xiao R., Luo X., You L., et al. Epigenetic regulation in cancer. MedComm. 2024;5:e495. doi: 10.1002/mco2.495.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mco2.495</ArticleId><ArticleId IdType=\"pmc\">PMC10876210</ArticleId><ArticleId IdType=\"pubmed\">38374872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A., Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37:1012&#x2013;1027. doi: 10.1016/j.tig.2021.05.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tig.2021.05.002</ArticleId><ArticleId IdType=\"pubmed\">34120771</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Peng Q., Jiang X., Tan S., Yang Y., Yang W., Han Y., Chen Y., Oyang L., Lin J., et al. Metabolic reprogramming and epigenetic modifications in cancer: From the impacts and mechanisms to the treatment potential. Exp. Mol. Med. 2023;55:1357&#x2013;1370. doi: 10.1038/s12276-023-01020-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s12276-023-01020-1</ArticleId><ArticleId IdType=\"pmc\">PMC10394076</ArticleId><ArticleId IdType=\"pubmed\">37394582</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijerathne C.U.B., Au-Yeung K.K.W., Siow Y.L., O K. 5-Methyltetrahydrofolate attenuates oxidative stress and improves kidney function in acute kidney injury through activation of Nrf2 and antioxidant defense. Antioxidants. 2022;11:1046. doi: 10.3390/antiox11061046.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox11061046</ArticleId><ArticleId IdType=\"pmc\">PMC9219715</ArticleId><ArticleId IdType=\"pubmed\">35739943</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmani F., Karamali M., Shakeri H., Asemi Z. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial. Clin. Endocrinol. 2014;81:582&#x2013;587. doi: 10.1111/cen.12451.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cen.12451</ArticleId><ArticleId IdType=\"pubmed\">24628390</ArticleId></ArticleIdList></Reference><Reference><Citation>Asemi Z., Vahedpoor Z., Jamilian M., Bahmani F., Esmaillzadeh A. Effects of long-term folate supplementation on metabolic status and regression of cervical intraepithelial neoplasia: A randomized, double-blind, placebo-controlled trial. Nutrition. 2016;32:681&#x2013;686. doi: 10.1016/j.nut.2015.12.028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nut.2015.12.028</ArticleId><ArticleId IdType=\"pubmed\">26853484</ArticleId></ArticleIdList></Reference><Reference><Citation>Quevedo-Ocampo J., Escobedo-Calvario A., Souza-Arroyo V., Miranda-Labra R.U., Bucio-Ortiz L., Guti&#xe9;rrez-Ruiz M.C., Ch&#xe1;vez-Rodr&#xed;guez L., Gomez-Quiroz L.E. Folate metabolism in hepatocellular carcinoma. What do we know so far? Technol. Cancer Res. Treat. 2022;21:15330338221144446. doi: 10.1177/15330338221144446.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/15330338221144446</ArticleId><ArticleId IdType=\"pmc\">PMC9749048</ArticleId><ArticleId IdType=\"pubmed\">36503290</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Gao M., Tang H., Cao Y., Liu S., Tao Y. Metabolic intermediates in tumorigenesis and progression. Int. J. Biol. Sci. 2019;15:1187&#x2013;1199. doi: 10.7150/ijbs.33496.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7150/ijbs.33496</ArticleId><ArticleId IdType=\"pmc\">PMC6567815</ArticleId><ArticleId IdType=\"pubmed\">31223279</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarrag&#xf3;-Celada J., Foguet C., Tarrado-Castellarnau M., Marin S., Hern&#xe1;ndez-Alias X., Perarnau J., Morrish F., Hockenbery D., Gomis R.R., Ruppin E., et al. Cysteine and folate metabolism are targetable vulnerabilities of metastatic colorectal cancer. Cancers. 2021;13:725. doi: 10.3390/cancers13030425.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cancers13030425</ArticleId><ArticleId IdType=\"pmc\">PMC7866204</ArticleId><ArticleId IdType=\"pubmed\">33498690</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmood K., Emadi A. 1-C metabolism-serine, glycine, folates-in acute myeloid leukemia. Pharmaceuticals. 2021;14:190. doi: 10.3390/ph14030190.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ph14030190</ArticleId><ArticleId IdType=\"pmc\">PMC7996867</ArticleId><ArticleId IdType=\"pubmed\">33652666</ArticleId></ArticleIdList></Reference><Reference><Citation>Delhey L.M., Nur Kilinc E., Yin L., Slattery J.C., Tippett M.L., Rose S., Bennuri S.C., Kahler S.G., Damle S., Legido A., et al. The Effect of mitochondrial supplements on mitochondrial activity in children with autism spectrum disorder. J. Clin. Med. 2017;6:18. doi: 10.3390/jcm6020018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm6020018</ArticleId><ArticleId IdType=\"pmc\">PMC5332922</ArticleId><ArticleId IdType=\"pubmed\">28208802</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh Y.C., Chou L.S., Lin C.H., Wu H.C., Li D.J., Tseng P.T. Serum folate levels in bipolar disorder: A systematic review and meta-analysis. BMC Psychiatry. 2019;19:305. doi: 10.1186/s12888-019-2269-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12888-019-2269-2</ArticleId><ArticleId IdType=\"pmc\">PMC6805488</ArticleId><ArticleId IdType=\"pubmed\">31640634</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W., Li W., Qi H., Xiao L., Sim K., Ungvari G.S., Lu X.B., Huang X., Ning Y.P., Xiang Y.T. Adjunctive folate for major mental disorders: A systematic review. J. Affect. Disord. 2020;267:123&#x2013;130. doi: 10.1016/j.jad.2020.01.096.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jad.2020.01.096</ArticleId><ArticleId IdType=\"pubmed\">32063563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Wu K., Li Y., Song R., Wu Y., Zhang X., Song M., Liang L., Smith-Warner S.A., Giovannucci E.L., et al. Association of folate intake and colorectal cancer risk in the postfortification era in US women. Am. J. Clin. Nutr. 2021;114:49&#x2013;58. doi: 10.1093/ajcn/nqab035.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/nqab035</ArticleId><ArticleId IdType=\"pmc\">PMC8246607</ArticleId><ArticleId IdType=\"pubmed\">33742202</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Li C., Li X., Li J., Chu R., Wang H. Higher dietary folate intake reduces the breast cancer risk: A systematic review and meta-analysis. Br. J. Cancer. 2014;110:2327&#x2013;2338. doi: 10.1038/bjc.2014.155.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/bjc.2014.155</ArticleId><ArticleId IdType=\"pmc\">PMC4007237</ArticleId><ArticleId IdType=\"pubmed\">24667649</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Hebert L.E., Scherr P.A., Schneider J.A. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch. Neurol. 2005;62:641&#x2013;645. doi: 10.1001/archneur.62.4.641.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archneur.62.4.641</ArticleId><ArticleId IdType=\"pubmed\">15824266</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronenberg G., Harms C., Sobol R.W., Cardozo-Pelaez F., Linhart H., Winter B., Balkaya M., Gertz K., Gay S.B., Cox D., et al. Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase. J. Neurosci. 2008;28:7219&#x2013;7230. doi: 10.1523/JNEUROSCI.0940-08.2008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.0940-08.2008</ArticleId><ArticleId IdType=\"pmc\">PMC3844834</ArticleId><ArticleId IdType=\"pubmed\">18614692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma F., Zhou X., Li Q., Zhao J., Song A., An P., Du Y., Xu W., Huang G. Effects of folic acid and vitamin B12, alone and in combination on cognitive function and inflammatory factors in the elderly with mild cognitive impairment: A single-blind experimental design. Curr. Alzheimer Res. 2019;16:622&#x2013;632. doi: 10.2174/1567205016666190725144629.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567205016666190725144629</ArticleId><ArticleId IdType=\"pubmed\">31345146</ArticleId></ArticleIdList></Reference><Reference><Citation>Bou Ghanem A., Hussayni Y., Kadbey R., Ratel Y., Yehya S., Khouzami L., Ghadieh H.E., Kanaan A., Azar S., Harb F. Exploring the complexities of 1C metabolism: Implications in aging and neurodegenerative diseases. Front. Aging Neurosci. 2023;15:1322419. doi: 10.3389/fnagi.2023.1322419.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1322419</ArticleId><ArticleId IdType=\"pmc\">PMC10794399</ArticleId><ArticleId IdType=\"pubmed\">38239489</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung A., Bax H.J., Josephs D.H., Ilieva K.M., Pellizzari G., Opzoomer J., Bloomfield J., Fittall M., Grigoriadis A., Figini M., et al. Targeting folate receptor alpha for cancer treatment. Oncotarget. 2016;7:52553&#x2013;52574. doi: 10.18632/oncotarget.9651.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.9651</ArticleId><ArticleId IdType=\"pmc\">PMC5239573</ArticleId><ArticleId IdType=\"pubmed\">27248175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarou M.M., Vazquez A., Vignir Helgason G. Folate metabolism: A re-emerging therapeutic target in haematological cancers. Leukemia. 2021;35:1539&#x2013;1551. doi: 10.1038/s41375-021-01189-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41375-021-01189-2</ArticleId><ArticleId IdType=\"pmc\">PMC8179844</ArticleId><ArticleId IdType=\"pubmed\">33707653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurniawan H., Kobayashi T., Brenner D. The emerging role of one-carbon metabolism in T cells. Curr. Opin. Biotechnol. 2021;68:193&#x2013;201. doi: 10.1016/j.copbio.2020.12.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.copbio.2020.12.001</ArticleId><ArticleId IdType=\"pubmed\">33422815</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh E., Choi S.-W., Friso S. Chapter 36&#x2014;One-Carbon Metabolism: An Unsung Hero for Healthy Aging. In: Malavolta M., Mocchegiani E., editors. Molecular Basis of Nutrition and Aging. Academic Press; San Diego, CA, USA: 2016. pp. 513&#x2013;522.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/B978-0-12-801816-3.00036-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon P., Strippoli V., Fang B., Cimmino L. B vitamins and one-carbon metabolism: Implications in human health and disease. Nutrients. 2020;12:2867. doi: 10.3390/nu12092867.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu12092867</ArticleId><ArticleId IdType=\"pmc\">PMC7551072</ArticleId><ArticleId IdType=\"pubmed\">32961717</ArticleId></ArticleIdList></Reference><Reference><Citation>ChemSketch, Version 2023.2.4, Advanced Chemistry Development, Inc. (ACD/Labs), Toronto, ON, Canada.  [(accessed on 16 August 2024)].  Available online:  www.acdlabs.com.</Citation></Reference><Reference><Citation>Ducker G.S., Rabinowitz J.D. One-Carbon Metabolism in Health and Disease. Cell Metab. 2017;25:27&#x2013;42. doi: 10.1016/j.cmet.2016.08.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2016.08.009</ArticleId><ArticleId IdType=\"pmc\">PMC5353360</ArticleId><ArticleId IdType=\"pubmed\">27641100</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Zhang X., Liu Y., Liu L., Li J., Du G., Chen J. Synthetic biology-driven microbial production of folates: Advances and perspectives. Bioresour. Technol. 2021;324:124624. doi: 10.1016/j.biortech.2020.124624.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biortech.2020.124624</ArticleId><ArticleId IdType=\"pubmed\">33434873</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Araujo D. Folic acid advisories: A public health challenge? Health Econ. 2016;25:1104&#x2013;1122. doi: 10.1002/hec.3362.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/hec.3362</ArticleId><ArticleId IdType=\"pubmed\">27270606</ArticleId></ArticleIdList></Reference><Reference><Citation>Saubade F., Hemery Y.M., Guyot J.-P., Humblot C. Lactic acid fermentation as a tool for increasing the folate content of foods. Crit. Rev. Food Sci. Nutr. 2017;57:3894&#x2013;3910. doi: 10.1080/10408398.2016.1192986.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10408398.2016.1192986</ArticleId><ArticleId IdType=\"pubmed\">27351520</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail S., Eljazzar S., Ganji V. Intended and unintended benefits of folic acid fortification&#x2014;A narrative review. Foods. 2023;12:1612. doi: 10.3390/foods12081612.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/foods12081612</ArticleId><ArticleId IdType=\"pmc\">PMC10137700</ArticleId><ArticleId IdType=\"pubmed\">37107407</ArticleId></ArticleIdList></Reference><Reference><Citation>Pravst I., Lavri&#x161;a &#x17d;., Hribar M., Hristov H., Kvarantan N., Seljak B.K., Gregori&#x10d; M., Blaznik U., Gregori&#x10d; N., Zaletel K., et al. Dietary intake of folate and assessment of the folate deficiency prevalence in slovenia using serum biomarkers. Nutrients. 2021;13:3860. doi: 10.3390/nu13113860.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu13113860</ArticleId><ArticleId IdType=\"pmc\">PMC8620305</ArticleId><ArticleId IdType=\"pubmed\">34836112</ArticleId></ArticleIdList></Reference><Reference><Citation>Castenmiller J.J., van de Poll C.J., West C.E., Brouwer I.A., Thomas C.M., van Dusseldorp M. Bioavailability of folate from processed spinach in humans. Effect of food matrix and interaction with carotenoids. Ann. Nutr. Metab. 2000;44:163&#x2013;169. doi: 10.1159/000012840.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000012840</ArticleId><ArticleId IdType=\"pubmed\">11111131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesan K., Xu B. Polyphenol-rich lentils and their health promoting effects. Int. J. Mol. Sci. 2017;18:2390. doi: 10.3390/ijms18112390.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms18112390</ArticleId><ArticleId IdType=\"pmc\">PMC5713359</ArticleId><ArticleId IdType=\"pubmed\">29125587</ArticleId></ArticleIdList></Reference><Reference><Citation>The United States Department of Agriculture  Spinach, Raw.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/168462/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Collards, Raw.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/170406/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Kale, Raw.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/323505/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Chard, Swiss, Raw.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/169991/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Lentils, Mature Seeds, Cooked, Boiled, without Salt.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/172421/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Chickpeas (Garbanzo Beans, Bengal Gram), Mature Seeds, Cooked, Boiled, with Salt.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/173799/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Beans, Black, Mature Seeds, Cooked, Boiled, without Salt.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/173735/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Peas, Green, Raw.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/170419/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Avocado, Raw.  [(accessed on 15 August 2024)];2020  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/1102652/nutrients.</Citation></Reference><Reference><Citation>Str&#xe5;lsj&#xf6; L.M., Witth&#xf6;ft C.M., Sj&#xf6;holm I.M., J&#xe4;gerstad M.I. Folate content in strawberries (Fragaria x ananassa): Effects of cultivar, ripeness, year of harvest, storage, and commercial processing. J. Agric. Food Chem. 2003;51:128&#x2013;133. doi: 10.1021/jf020699n.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jf020699n</ArticleId><ArticleId IdType=\"pubmed\">12502396</ArticleId></ArticleIdList></Reference><Reference><Citation>Striegel L., Weber N., Dumler C., Chebib S., Netzel M.E., Sultanbawa Y., Rychlik M. Promising tropical fruits high in folates. Foods. 2019;8:363. doi: 10.3390/foods8090363.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/foods8090363</ArticleId><ArticleId IdType=\"pmc\">PMC6770070</ArticleId><ArticleId IdType=\"pubmed\">31454879</ArticleId></ArticleIdList></Reference><Reference><Citation>The United States Department of Agriculture  Oranges, Raw, All Commercial Varieties.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/169097/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Quinoa, Cooked.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/168917/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Oats, Raw.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/1101825/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Barley, Hulled.  [(accessed on 15 August 2024)];2019  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/170283/nutrients.</Citation></Reference><Reference><Citation>The United States Department of Agriculture  Rice, Brown, Cooked, No Added Fat.  [(accessed on 15 August 2024)];2020  Available online:  https://fdc.nal.usda.gov/fdc-app.html#/food-details/1101631/nutrients.</Citation></Reference><Reference><Citation>Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes . Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. The National Academies Press; Washington, DC, USA: 1998. p. 592.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17226/6015</ArticleId><ArticleId IdType=\"pubmed\">23193625</ArticleId></ArticleIdList></Reference><Reference><Citation>Netzel M.E., Dumler C., Weber N., Striegel L., Rychlik M., Hong H.T., O&#x2019;Hare T. The inside and out of folate in strawberries and avocados. Proceedings. 2019;36:86.</Citation></Reference><Reference><Citation>Jones J.M., Engleson J. Whole grains: Benefits and challenges. Annu. Rev. Food Sci. Technol. 2010;1:19&#x2013;40. doi: 10.1146/annurev.food.112408.132746.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev.food.112408.132746</ArticleId><ArticleId IdType=\"pubmed\">22129328</ArticleId></ArticleIdList></Reference><Reference><Citation>Crider K.S., Bailey L.B., Berry R.J. Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients. 2011;3:370&#x2013;384. doi: 10.3390/nu3030370.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu3030370</ArticleId><ArticleId IdType=\"pmc\">PMC3257747</ArticleId><ArticleId IdType=\"pubmed\">22254102</ArticleId></ArticleIdList></Reference><Reference><Citation>Czeizel A.E., Dud&#xe1;s I., Vereczkey A., B&#xe1;nhidy F. Folate deficiency and folic acid supplementation: The prevention of neural-tube defects and congenital heart defects. Nutrients. 2013;5:4760&#x2013;4775. doi: 10.3390/nu5114760.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu5114760</ArticleId><ArticleId IdType=\"pmc\">PMC3847759</ArticleId><ArticleId IdType=\"pubmed\">24284617</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez H., Pach&#xf3;n H., Kancherla V., Oakley G.P. Food fortification with folic acid for prevention of spina bifida and anencephaly: The need for a paradigm shift in evidence evaluation for policy-making. Am. J. Epidemiol. 2021;190:1972&#x2013;1976. doi: 10.1093/aje/kwab061.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/kwab061</ArticleId><ArticleId IdType=\"pmc\">PMC8485149</ArticleId><ArticleId IdType=\"pubmed\">33728445</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulpekova Y., Nechaev V., Kardasheva S., Sedova A., Kurbatova A., Bueverova E., Kopylov A., Malsagova K., Dlamini J.C., Ivashkin V. The concept of folic acid in health and disease. Molecules. 2021;26:3731. doi: 10.3390/molecules26123731.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules26123731</ArticleId><ArticleId IdType=\"pmc\">PMC8235569</ArticleId><ArticleId IdType=\"pubmed\">34207319</ArticleId></ArticleIdList></Reference><Reference><Citation>van het Hof K.H., Tijburg L.B., Pietrzik K., Weststrate J.A. Influence of feeding different vegetables on plasma levels of carotenoids, folate and vitamin C. Effect of disruption of the vegetable matrix. Br. J. Nutr. 1999;82:203&#x2013;212. doi: 10.1017/S0007114599001385.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S0007114599001385</ArticleId><ArticleId IdType=\"pubmed\">10655967</ArticleId></ArticleIdList></Reference><Reference><Citation>Czarnowska-Kujawska M., Draszanowska A., Starowicz M. Effect of different cooking methods on the folate content, organoleptic and functional properties of broccoli and spinach. LWT. 2022;167:113825. doi: 10.1016/j.lwt.2022.113825.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lwt.2022.113825</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin A.M., Ling E.H., Peerson J.M., Fernando S., Clarke R., Smith A.D., Halsted C.H. Glutamate carboxypeptidase II: A polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum. Mol. Genet. 2000;9:2837&#x2013;2844. doi: 10.1093/hmg/9.19.2837.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/9.19.2837</ArticleId><ArticleId IdType=\"pubmed\">11092759</ArticleId></ArticleIdList></Reference><Reference><Citation>Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995;10:111&#x2013;113. doi: 10.1038/ng0595-111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ng0595-111</ArticleId><ArticleId IdType=\"pubmed\">7647779</ArticleId></ArticleIdList></Reference><Reference><Citation>Afman L.A., Trijbels F.J., Blom H.J. The H475Y polymorphism in the glutamate carboxypeptidase II gene increases plasma folate without affecting the risk for neural tube defects in humans. J. Nutr. 2003;133:75&#x2013;77. doi: 10.1093/jn/133.1.75.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jn/133.1.75</ArticleId><ArticleId IdType=\"pubmed\">12514270</ArticleId></ArticleIdList></Reference><Reference><Citation>Halczuk K., Ka&#x17a;mierczak-Bara&#x144;ska J., Karwowski B.T., Karma&#x144;ska A., Cie&#x15b;lak M. Vitamin B12&#x2014;Multifaceted in vivo functions and in vitro applications. Nutrients. 2023;15:2734. doi: 10.3390/nu15122734.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu15122734</ArticleId><ArticleId IdType=\"pmc\">PMC10305463</ArticleId><ArticleId IdType=\"pubmed\">37375638</ArticleId></ArticleIdList></Reference><Reference><Citation>Shere M., Bapat P., Nickel C., Kapur B., Koren G. Association between use of oral contraceptives and folate status: A systematic review and Meta-Analysis. J. Obstet. Gynaecol. Can. 2015;37:430&#x2013;438. doi: 10.1016/S1701-2163(15)30258-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1701-2163(15)30258-9</ArticleId><ArticleId IdType=\"pubmed\">26168104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiilesmaa V.K., Teramo K., Granstr&#xf6;m M.L., Bardy A.H. Serum folate concentrations during pregnancy in women with epilepsy: Relation to antiepileptic drug concentrations, number of seizures, and fetal outcome. Br. Med. J. 1983;287:577&#x2013;579. doi: 10.1136/bmj.287.6392.577.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.287.6392.577</ArticleId><ArticleId IdType=\"pmc\">PMC1549018</ArticleId><ArticleId IdType=\"pubmed\">6411231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis D.P., Van Dyke D.C., Willhite L.A., Stumbo P.J., Berg M.J. Phenytoin-folic acid interaction. Ann. Pharmacother. 1995;29:726&#x2013;735. doi: 10.1177/106002809502907-816.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/106002809502907-816</ArticleId><ArticleId IdType=\"pubmed\">8520091</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnebank M., Moskau S., Semmler A., Widman G., Stoffel-Wagner B., Weller M., Elger C.E. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann. Neurol. 2011;69:352&#x2013;359. doi: 10.1002/ana.22229.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.22229</ArticleId><ArticleId IdType=\"pubmed\">21246600</ArticleId></ArticleIdList></Reference><Reference><Citation>Dansky L.V., Andermann E., Rosenblatt D., Sherwin A.L., Andermann F. Anticonvulsants, folate levels, and pregnancy outcome: A prospective study. Ann. Neurol. 1987;21:176&#x2013;182. doi: 10.1002/ana.410210210.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.410210210</ArticleId><ArticleId IdType=\"pubmed\">3827226</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre R.L., Molenaars M., Schomakers B.V., Gao A.W., Kamble R., Jongejan A., van Weeghel M., van Kuilenburg A.B.P., Possemato R., Houtkooper R.H., et al. Anti-retroviral treatment with zidovudine alters pyrimidine metabolism, reduces translation, and extends healthy longevity via ATF-4. Cell Rep. 2023;42:111928. doi: 10.1016/j.celrep.2022.111928.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2022.111928</ArticleId><ArticleId IdType=\"pubmed\">36640360</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R.K., van Haandel L., Kiptoo P., Becker M.L., Siahaan T.J., Funk R.S. Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse model. Eur. J. Pharmacol. 2019;853:264&#x2013;274. doi: 10.1016/j.ejphar.2019.03.052.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejphar.2019.03.052</ArticleId><ArticleId IdType=\"pmc\">PMC6500488</ArticleId><ArticleId IdType=\"pubmed\">30951714</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin J.L., Rosenberg H.H. Impaired folic acid absorption in inflammatory bowel disease: Effects of salicylazosulfapyridine (Azulfidine) Gastroenterology. 1973;64:517&#x2013;525. doi: 10.1016/S0016-5085(73)80120-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0016-5085(73)80120-9</ArticleId><ArticleId IdType=\"pubmed\">4144775</ArticleId></ArticleIdList></Reference><Reference><Citation>Selhub J., Dhar G.J., Rosenberg I.H. Inhibition of folate enzymes by sulfasalazine. J. Clin. Investig. 1978;61:221&#x2013;224. doi: 10.1172/JCI108921.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI108921</ArticleId><ArticleId IdType=\"pmc\">PMC372530</ArticleId><ArticleId IdType=\"pubmed\">22555</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonawane K., Zhu Y., Chan W., Aguilar D., Deshmukh A.A., Suarez-Almazor M.E. Association of serum folate levels with cardiovascular mortality among adults with rheumatoid arthritis. JAMA Netw. Open. 2020;3:e200100. doi: 10.1001/jamanetworkopen.2020.0100.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2020.0100</ArticleId><ArticleId IdType=\"pmc\">PMC7137687</ArticleId><ArticleId IdType=\"pubmed\">32101310</ArticleId></ArticleIdList></Reference><Reference><Citation>Meidahl Petersen K., Eplov K., Kj&#xe6;r Nielsen T., Jimenez-Solem E., Petersen M., Broedbaek K., Daugaard Popik S., Kallehave Hansen L., Enghusen Poulsen H., Tr&#xe6;rup Andersen J. The effect of trimethoprim on serum folate levels in humans: A randomized, double-blind, llacebo-controlled trial. Am. J. Ther. 2016;23:e382&#x2013;e387. doi: 10.1097/MJT.0000000000000372.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MJT.0000000000000372</ArticleId><ArticleId IdType=\"pubmed\">26566149</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosario F.J., Powell T.L., Jansson T. mTOR folate sensing links folate availability to trophoblast cell function. J. Physiol. 2017;595:4189&#x2013;4206. doi: 10.1113/JP272424.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1113/JP272424</ArticleId><ArticleId IdType=\"pmc\">PMC5491891</ArticleId><ArticleId IdType=\"pubmed\">28374905</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Sahra I., Hoxhaj G., Ricoult S.J.H., Asara J.M., Manning B.D. mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science. 2016;351:728&#x2013;733. doi: 10.1126/science.aad0489.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.aad0489</ArticleId><ArticleId IdType=\"pmc\">PMC4786372</ArticleId><ArticleId IdType=\"pubmed\">26912861</ArticleId></ArticleIdList></Reference><Reference><Citation>Higa R., Rosario F.J., Powell T.L., Jansson T., Jawerbaum A. Inhibition of mTOR signaling impairs rat embryo organogenesis by affecting folate availability. Reproduction. 2021;161:365&#x2013;373. doi: 10.1530/REP-20-0603.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1530/REP-20-0603</ArticleId><ArticleId IdType=\"pubmed\">33528379</ArticleId></ArticleIdList></Reference><Reference><Citation>Good L., Dimri G.P., Campisi J., Chen K.Y. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence. J. Cell Physiol. 1996;168:580&#x2013;588. doi: 10.1002/(SICI)1097-4652(199609)168:3&lt;580::AID-JCP10&gt;3.0.CO;2-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/(SICI)1097-4652(199609)168:3&lt;580::AID-JCP10&gt;3.0.CO;2-3</ArticleId><ArticleId IdType=\"pubmed\">8816912</ArticleId></ArticleIdList></Reference><Reference><Citation>Slansky J.E., Farnham P.J. Transcriptional regulation of the dihydrofolate reductase gene. Bioessays. 1996;18:55&#x2013;62. doi: 10.1002/bies.950180111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/bies.950180111</ArticleId><ArticleId IdType=\"pubmed\">8593164</ArticleId></ArticleIdList></Reference><Reference><Citation>DeGregori J., Kowalik T., Nevins J.R. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell Biol. 1995;15:4215&#x2013;4224. doi: 10.1128/MCB.15.8.4215.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/MCB.15.8.4215</ArticleId><ArticleId IdType=\"pmc\">PMC230660</ArticleId><ArticleId IdType=\"pubmed\">7623816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J., Fan J., Venneti S., Wan Y.W., Pawel B.R., Zhang J., Finley L.W., Lu C., Lindsten T., Cross J.R., et al. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov. 2014;4:1406&#x2013;1417. doi: 10.1158/2159-8290.CD-14-0250.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1158/2159-8290.CD-14-0250</ArticleId><ArticleId IdType=\"pmc\">PMC4258153</ArticleId><ArticleId IdType=\"pubmed\">25186948</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippone M.G., Gaglio D., Bonfanti R., Tucci F.A., Ceccacci E., Pennisi R., Bonanomi M., Jodice G., Tillhon M., Montani F., et al. CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer. Nat. Commun. 2022;13:2642. doi: 10.1038/s41467-022-30375-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-30375-8</ArticleId><ArticleId IdType=\"pmc\">PMC9098894</ArticleId><ArticleId IdType=\"pubmed\">35550508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovatcheva M., Melendez E., Chondronasiou D., Pietrocola F., Bernad R., Caballe A., Junza A., Capellades J., Holgu&#xed;n-Horcajo A., Prats N., et al. Vitamin B(12) is a limiting factor for induced cellular plasticity and tissue repair. Nat. Metab. 2023;5:1911&#x2013;1930. doi: 10.1038/s42255-023-00916-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s42255-023-00916-6</ArticleId><ArticleId IdType=\"pmc\">PMC10663163</ArticleId><ArticleId IdType=\"pubmed\">37973897</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan X., Field M.S., Stover P.J. Cell cycle regulation of folate-mediated one-carbon metabolism. Wiley Interdiscip. Rev. Syst. Biol. Med. 2018;10:e1426. doi: 10.1002/wsbm.1426.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/wsbm.1426</ArticleId><ArticleId IdType=\"pubmed\">29889360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ercikan-Abali E.A., Banerjee D., Waltham M.C., Skacel N., Scotto K.W., Bertino J.R. Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region. Biochemistry. 1997;36:12317&#x2013;12322. doi: 10.1021/bi971026e.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/bi971026e</ArticleId><ArticleId IdType=\"pubmed\">9315871</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu E., Allegra C.J. The role of thymidylate synthase as an RNA binding protein. Bioessays. 1996;18:191&#x2013;198. doi: 10.1002/bies.950180306.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/bies.950180306</ArticleId><ArticleId IdType=\"pubmed\">8867733</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati S., Brody L.C., Banerjee R. Posttranscriptional regulation of mammalian methionine synthase by B12. Biochem. Biophys. Res. Commun. 1999;259:436&#x2013;442. doi: 10.1006/bbrc.1999.0696.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/bbrc.1999.0696</ArticleId><ArticleId IdType=\"pubmed\">10362526</ArticleId></ArticleIdList></Reference><Reference><Citation>Oltean S., Banerjee R. Nutritional modulation of gene expression and homocysteine utilization by vitamin B12. J. Biol. Chem. 2003;278:20778&#x2013;20784. doi: 10.1074/jbc.M300845200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M300845200</ArticleId><ArticleId IdType=\"pubmed\">12670934</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada K., Strahler J.R., Andrews P.C., Matthews R.G. Regulation of human methylenetetrahydrofolate reductase by phosphorylation. Proc. Natl. Acad. Sci. USA. 2005;102:10454&#x2013;10459. doi: 10.1073/pnas.0504786102.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0504786102</ArticleId><ArticleId IdType=\"pmc\">PMC1180802</ArticleId><ArticleId IdType=\"pubmed\">16024724</ArticleId></ArticleIdList></Reference><Reference><Citation>Froese D.S., Kopec J., Rembeza E., Bezerra G.A., Oberholzer A.E., Suormala T., Lutz S., Chalk R., Borkowska O., Baumgartner M.R., et al. Structural basis for the regulation of human 5,10-methylenetetrahydrofolate reductase by phosphorylation and S-adenosylmethionine inhibition. Nat. Commun. 2018;9:2261. doi: 10.1038/s41467-018-04735-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-018-04735-2</ArticleId><ArticleId IdType=\"pmc\">PMC5995969</ArticleId><ArticleId IdType=\"pubmed\">29891918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu B., Xiahou Z., Zhao H., Peng B., Zhao H., Xu X. MTHFR promotes heterochromatin maintenance. Biochem. Biophys. Res. Commun. 2014;447:702&#x2013;706. doi: 10.1016/j.bbrc.2014.04.082.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2014.04.082</ArticleId><ArticleId IdType=\"pubmed\">24769206</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Ramsamooj S., Li Q., Johnson J.L., Yaron T.M., Sharra K., Cantley L.C. Regulation of folate and methionine metabolism by multisite phosphorylation of human methylenetetrahydrofolate reductase. Sci. Rep. 2019;9:4190. doi: 10.1038/s41598-019-40950-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-40950-7</ArticleId><ArticleId IdType=\"pmc\">PMC6414673</ArticleId><ArticleId IdType=\"pubmed\">30862944</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker W., Sippl W. Activation, regulation, and inhibition of DYRK1A. FEBS J. 2011;278:246&#x2013;256. doi: 10.1111/j.1742-4658.2010.07956.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1742-4658.2010.07956.x</ArticleId><ArticleId IdType=\"pubmed\">21126318</ArticleId></ArticleIdList></Reference><Reference><Citation>Foukas L.C., Berenjeno I.M., Gray A., Khwaja A., Vanhaesebroeck B. Activity of any class IA PI3K isoform can sustain cell proliferation and survival. Proc. Natl. Acad. Sci. USA. 2010;107:11381&#x2013;11386. doi: 10.1073/pnas.0906461107.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0906461107</ArticleId><ArticleId IdType=\"pmc\">PMC2895061</ArticleId><ArticleId IdType=\"pubmed\">20534549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutzbach C., Stokstad E.L. Mammalian methylenetetrahydrofolate reductase. Partial purification, properties, and inhibition by S-adenosylmethionine. Biochim. Biophys. Acta. 1971;250:459&#x2013;477. doi: 10.1016/0005-2744(71)90247-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0005-2744(71)90247-6</ArticleId><ArticleId IdType=\"pubmed\">4399897</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumner J., Jencks D.A., Khani S., Matthews R.G. Photoaffinity labeling of methylenetetrahydrofolate reductase with 8-azido-S-adenosylmethionine. J. Biol. Chem. 1986;261:7697&#x2013;7700. doi: 10.1016/S0021-9258(19)57456-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0021-9258(19)57456-7</ArticleId><ArticleId IdType=\"pubmed\">3754872</ArticleId></ArticleIdList></Reference><Reference><Citation>Field M.S., Szebenyi D.M., Stover P.J. Regulation of de novo purine biosynthesis by methenyltetrahydrofolate synthetase in neuroblastoma. J. Biol. Chem. 2006;281:4215&#x2013;4221. doi: 10.1074/jbc.M510624200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M510624200</ArticleId><ArticleId IdType=\"pubmed\">16365037</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson D.D., Eom J.Y., Stover P.J. Competition between sumoylation and ubiquitination of serine hydroxymethyltransferase 1 determines its nuclear localization and its accumulation in the nucleus. J. Biol. Chem. 2012;287:4790&#x2013;4799. doi: 10.1074/jbc.M111.302174.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M111.302174</ArticleId><ArticleId IdType=\"pmc\">PMC3281627</ArticleId><ArticleId IdType=\"pubmed\">22194612</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a M.M., Xing Y.Y., Koli S., Berger F.G. Role of N-terminal residues in the ubiquitin-independent degradation of human thymidylate synthase. Biochem. J. 2006;394:355&#x2013;363. doi: 10.1042/BJ20051479.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/BJ20051479</ArticleId><ArticleId IdType=\"pmc\">PMC1386034</ArticleId><ArticleId IdType=\"pubmed\">16259621</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider J.A., Rees D.C., Liu Y.T., Clegg J.B. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am. J. Hum. Genet. 1998;62:1258&#x2013;1260. doi: 10.1086/301836.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1086/301836</ArticleId><ArticleId IdType=\"pmc\">PMC1377093</ArticleId><ArticleId IdType=\"pubmed\">9545406</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepe G., Camacho Vanegas O., Giusti B., Brunelli T., Marcucci R., Attanasio M., Rickards O., De Stefano G.F., Prisco D., Gensini G.F., et al. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am. J. Hum. Genet. 1998;63:917&#x2013;920. doi: 10.1086/302015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1086/302015</ArticleId><ArticleId IdType=\"pmc\">PMC1377403</ArticleId><ArticleId IdType=\"pubmed\">9718345</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada K., Chen Z., Rozen R., Matthews R.G. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc. Natl. Acad. Sci. USA. 2001;98:14853&#x2013;14858. doi: 10.1073/pnas.261469998.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.261469998</ArticleId><ArticleId IdType=\"pmc\">PMC64948</ArticleId><ArticleId IdType=\"pubmed\">11742092</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.S., Passen E.L., Ruggie N., Wong P.W., Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 1993;88:1463&#x2013;1469. doi: 10.1161/01.CIR.88.4.1463.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/01.CIR.88.4.1463</ArticleId><ArticleId IdType=\"pubmed\">8403293</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., Porcellini E., Licastro F. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr. 2005;82:636&#x2013;643. doi: 10.1093/ajcn/82.3.636.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/82.3.636</ArticleId><ArticleId IdType=\"pubmed\">16155278</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazki F.H., Sameer A.S., Ganaie B.A. Folate: Metabolism, genes, polymorphisms and the associated diseases. Gene. 2014;533:11&#x2013;20. doi: 10.1016/j.gene.2013.09.063.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.gene.2013.09.063</ArticleId><ArticleId IdType=\"pubmed\">24091066</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang B.L., Devine O.J., Cordero A.M., Marchetta C.M., Mulinare J., Mersereau P., Guo J., Qi Y.P., Berry R.J., Rosenthal J., et al. Assessing the association between the methylenetetrahydrofolate reductase (MTHFR) 677C&gt;T polymorphism and blood folate concentrations: A systematic review and meta-analysis of trials and observational studies. Am. J. Clin. Nutr. 2015;101:1286&#x2013;1294. doi: 10.3945/ajcn.114.099994.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3945/ajcn.114.099994</ArticleId><ArticleId IdType=\"pubmed\">25788000</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabo R., Hernes S., Slettan A., Haugen M., Ye S., Blomhoff R., Mansoor M.A. Effect of genetic polymorphisms involved in folate metabolism on the concentration of serum folate and plasma total homocysteine (p-tHcy) in healthy subjects after short-term folic acid supplementation: A randomized, double blind, crossover study. Genes Nutr. 2015;10:456. doi: 10.1007/s12263-015-0456-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12263-015-0456-4</ArticleId><ArticleId IdType=\"pmc\">PMC4353892</ArticleId><ArticleId IdType=\"pubmed\">25758536</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q.H., Botto L.D., Gallagher M., Friedman J.M., Sanders C.L., Koontz D., Nikolova S., Erickson J.D., Steinberg K. Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: Findings from the third National Health and Nutrition Examination Survey DNA Bank. Am. J. Clin. Nutr. 2008;88:232&#x2013;246. doi: 10.1093/ajcn/88.1.232.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn/88.1.232</ArticleId><ArticleId IdType=\"pubmed\">18614746</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappacosta B., Graziano M., Persichilli S., Di Castelnuovo A., Mastroiacovo P., Iacoviello L. 5,10-Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms: Genotype frequency and association with homocysteine and folate levels in middle-southern Italian adults. Cell Biochem. Funct. 2014;32:1&#x2013;4. doi: 10.1002/cbf.3019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cbf.3019</ArticleId><ArticleId IdType=\"pubmed\">24277487</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin A.M., Clarke R., Birks J., Evans J.G., Halsted C.H. Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population. Am. J. Clin. Nutr. 2006;83:708&#x2013;713. doi: 10.1093/ajcn.83.3.708.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajcn.83.3.708</ArticleId><ArticleId IdType=\"pubmed\">16522921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraoka M., Kagawa Y. Genetic polymorphisms and folate status. Congenit. Anom. 2017;57:142&#x2013;149. doi: 10.1111/cga.12232.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cga.12232</ArticleId><ArticleId IdType=\"pmc\">PMC5601299</ArticleId><ArticleId IdType=\"pubmed\">28598562</ArticleId></ArticleIdList></Reference><Reference><Citation>Pangilinan F., Molloy A.M., Mills J.L., Troendle J.F., Parle-McDermott A., Signore C., O&#x2019;Leary V.B., Chines P., Seay J.M., Geiler-Samerotte K., et al. Evaluation of common genetic variants in 82 candidate genes as risk factors for neural tube defects. BMC Med. Genet. 2012;13:62. doi: 10.1186/1471-2350-13-62.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2350-13-62</ArticleId><ArticleId IdType=\"pmc\">PMC3458983</ArticleId><ArticleId IdType=\"pubmed\">22856873</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinelli M., Scapoli L., Palmieri A., Pezzetti F., Baciliero U., Padula E., Carinci P., Morselli P.G., Carinci F. Study of four genes belonging to the folate pathway: Transcobalamin 2 is involved in the onset of non-syndromic cleft lip with or without cleft palate. Hum. Mutat. 2006;27:294. doi: 10.1002/humu.9411.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/humu.9411</ArticleId><ArticleId IdType=\"pubmed\">16470748</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva L.M., Silva J.N., Galbiatti A.L., Succi M., Ruiz M.T., Raposo L.S., Maniglia J.V., Pavarino-Bertelli E.C., Goloni-Bertollo E.M. Head and neck carconogenesis: Impact of MTHFD1 G1958A polymorphism. Rev. Assoc. Med. Bras. 2011;57:194&#x2013;199. doi: 10.1590/S0104-42302011000200018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1590/S0104-42302011000200018</ArticleId><ArticleId IdType=\"pubmed\">21537707</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones P.A., Takai D. The role of DNA methylation in mammalian epigenetics. Science. 2001;293:1068&#x2013;1070. doi: 10.1126/science.1063852.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1063852</ArticleId><ArticleId IdType=\"pubmed\">11498573</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693&#x2013;705. doi: 10.1016/j.cell.2007.02.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2007.02.005</ArticleId><ArticleId IdType=\"pubmed\">17320507</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattick J.S., Amaral P.P., Dinger M.E., Mercer T.R., Mehler M.F. RNA regulation of epigenetic processes. Bioessays. 2009;31:51&#x2013;59. doi: 10.1002/bies.080099.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/bies.080099</ArticleId><ArticleId IdType=\"pubmed\">19154003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitz-James M.H., Cavalli G. Molecular mechanisms of transgenerational epigenetic inheritance. Nat. Rev. Genet. 2022;23:325&#x2013;341. doi: 10.1038/s41576-021-00438-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41576-021-00438-5</ArticleId><ArticleId IdType=\"pubmed\">34983971</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaenisch R., Bird A. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat. Genet. 2003;33:245&#x2013;254. doi: 10.1038/ng1089.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ng1089</ArticleId><ArticleId IdType=\"pubmed\">12610534</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Zhang H., Huang S., Yin L., Wang F., Luo P., Huang H. Epigenetic regulation in cardiovascular disease: Mechanisms and advances in clinical trials. Signal Transduct. Target. Ther. 2022;7:200. doi: 10.1038/s41392-022-01055-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-022-01055-2</ArticleId><ArticleId IdType=\"pmc\">PMC9233709</ArticleId><ArticleId IdType=\"pubmed\">35752619</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliore L., Copped&#xe8; F. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat. Res. 2009;667:82&#x2013;97. doi: 10.1016/j.mrfmmm.2008.10.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mrfmmm.2008.10.011</ArticleId><ArticleId IdType=\"pubmed\">19026668</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok J.B. Role of epigenetics in Alzheimer&#x2019;s and Parkinson&#x2019;s disease. Epigenomics. 2010;2:671&#x2013;682. doi: 10.2217/epi.10.43.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2217/epi.10.43</ArticleId><ArticleId IdType=\"pubmed\">22122050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogg S.J., Beavis P.A., Dawson M.A., Johnstone R.W. Targeting the epigenetic regulation of antitumour immunity. Nat. Rev. Drug Discov. 2020;19:776&#x2013;800. doi: 10.1038/s41573-020-0077-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41573-020-0077-5</ArticleId><ArticleId IdType=\"pubmed\">32929243</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Chan Y.T., Tan H.Y., Li S., Wang N., Feng Y. Epigenetic regulation in human cancer: The potential role of epi-drug in cancer therapy. Mol. Cancer. 2020;19:79. doi: 10.1186/s12943-020-01197-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12943-020-01197-3</ArticleId><ArticleId IdType=\"pmc\">PMC7184703</ArticleId><ArticleId IdType=\"pubmed\">32340605</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurugubelli K.R., Ballambattu V.B. Perspectives on folate with special reference to epigenetics and neural tube defects. Reprod. Toxicol. 2024;125:108576. doi: 10.1016/j.reprotox.2024.108576.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.reprotox.2024.108576</ArticleId><ArticleId IdType=\"pubmed\">38479591</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuso A., Nicolia V., Cavallaro R.A., Ricceri L., D&#x2019;Anselmi F., Coluccia P., Calamandrei G., Scarpa S. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol. Cell Neurosci. 2008;37:731&#x2013;746. doi: 10.1016/j.mcn.2007.12.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mcn.2007.12.018</ArticleId><ArticleId IdType=\"pubmed\">18243734</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H.Y., Liu S.M., Zhang Y.Z. Maternal folic acid supplementation mediates offspring health via DNA methylation. Reprod. Sci. 2020;27:963&#x2013;976. doi: 10.1007/s43032-020-00161-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s43032-020-00161-2</ArticleId><ArticleId IdType=\"pubmed\">32124397</ArticleId></ArticleIdList></Reference><Reference><Citation>Alata Jimenez N., Strobl-Mazzulla P.H. Folate carrier deficiency drives differential methylation and enhanced cellular potency in the neural plate border. Front. Cell Dev. Biol. 2022;10:834625. doi: 10.3389/fcell.2022.834625.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2022.834625</ArticleId><ArticleId IdType=\"pmc\">PMC9326018</ArticleId><ArticleId IdType=\"pubmed\">35912103</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng Y., Gao R., Liu X., Chen X., Liu S., Ding Y., Mu X., Wang Y., He J. Folate deficiency inhibits the PCP pathway and alters genomic methylation levels during embryonic development. J. Cell. Physiol. 2018;233:7333&#x2013;7342. doi: 10.1002/jcp.26564.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcp.26564</ArticleId><ArticleId IdType=\"pubmed\">29574721</ArticleId></ArticleIdList></Reference><Reference><Citation>Friso S., Choi S.W., Girelli D., Mason J.B., Dolnikowski G.G., Bagley P.J., Olivieri O., Jacques P.F., Rosenberg I.H., Corrocher R., et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. USA. 2002;99:5606&#x2013;5611. doi: 10.1073/pnas.062066299.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.062066299</ArticleId><ArticleId IdType=\"pmc\">PMC122817</ArticleId><ArticleId IdType=\"pubmed\">11929966</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooney C.A., Dave A.A., Wolff G.L. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J. Nutr. 2002;132:2393s&#x2013;2400s. doi: 10.1093/jn/132.8.2393S.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jn/132.8.2393S</ArticleId><ArticleId IdType=\"pubmed\">12163699</ArticleId></ArticleIdList></Reference><Reference><Citation>Socha M.W., Flis W., Wart&#x119;ga M. Epigenetic genome modifications during pregnancy: The impact of essential nutritional supplements on DNA methylation. Nutrients. 2024;16:678. doi: 10.3390/nu16050678.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu16050678</ArticleId><ArticleId IdType=\"pmc\">PMC10934520</ArticleId><ArticleId IdType=\"pubmed\">38474806</ArticleId></ArticleIdList></Reference><Reference><Citation>Joubert B.R., den Dekker H.T., Felix J.F., Bohlin J., Ligthart S., Beckett E., Tiemeier H., van Meurs J.B., Uitterlinden A.G., Hofman A., et al. Maternal plasma folate impacts differential DNA methylation in an epigenome-wide meta-analysis of newborns. Nat. Commun. 2016;7:10577. doi: 10.1038/ncomms10577.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncomms10577</ArticleId><ArticleId IdType=\"pmc\">PMC4749955</ArticleId><ArticleId IdType=\"pubmed\">26861414</ArticleId></ArticleIdList></Reference><Reference><Citation>Kok D.E., Richmond R.C., Adriaens M., Evelo C.T., Ford D., Mathers J.C., Robinson N., McKay J.A. Impact of in utero folate exposure on DNA methylation and its potential relevance for later-life health-evidence from mouse models translated to human cohorts. Mol. Nutr. Food Res. 2022;66:e2100789. doi: 10.1002/mnfr.202100789.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mnfr.202100789</ArticleId><ArticleId IdType=\"pmc\">PMC7614326</ArticleId><ArticleId IdType=\"pubmed\">34850562</ArticleId></ArticleIdList></Reference><Reference><Citation>Michels K.B., Binder A.M. Impact of folic acid supplementation on the epigenetic profile in healthy unfortified individuals&#x2014;A randomized intervention trial. Epigenetics. 2024;19:2293410. doi: 10.1080/15592294.2023.2293410.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/15592294.2023.2293410</ArticleId><ArticleId IdType=\"pmc\">PMC10730197</ArticleId><ArticleId IdType=\"pubmed\">38096372</ArticleId></ArticleIdList></Reference><Reference><Citation>Pufulete M., Al-Ghnaniem R., Khushal A., Appleby P., Harris N., Gout S., Emery P.W., Sanders T.A. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut. 2005;54:648&#x2013;653. doi: 10.1136/gut.2004.054718.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/gut.2004.054718</ArticleId><ArticleId IdType=\"pmc\">PMC1774481</ArticleId><ArticleId IdType=\"pubmed\">15831910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kok D.E., Dhonukshe-Rutten R.A., Lute C., Heil S.G., Uitterlinden A.G., van der Velde N., van Meurs J.B., van Schoor N.M., Hooiveld G.J., de Groot L.C., et al. The effects of long-term daily folic acid and vitamin B12 supplementation on genome-wide DNA methylation in elderly subjects. Clin. Epigenet. 2015;7:121. doi: 10.1186/s13148-015-0154-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13148-015-0154-5</ArticleId><ArticleId IdType=\"pmc\">PMC4644301</ArticleId><ArticleId IdType=\"pubmed\">26568774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingrosso D., Cimmino A., Perna A.F., Masella L., De Santo N.G., De Bonis M.L., Vacca M., D&#x2019;Esposito M., D&#x2019;Urso M., Galletti P., et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet. 2003;361:1693&#x2013;1699. doi: 10.1016/S0140-6736(03)13372-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(03)13372-7</ArticleId><ArticleId IdType=\"pubmed\">12767735</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi&#xf1;u&#xf1;uri R., Casta&#xf1;o-Moreno E., Llanos M.N., Ronco A.M. Epigenetic regulation of folate receptor-&#x3b1; (FOLR1) in human placenta of preterm newborns. Placenta. 2020;94:20&#x2013;25. doi: 10.1016/j.placenta.2020.03.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.placenta.2020.03.009</ArticleId><ArticleId IdType=\"pubmed\">32421530</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz T.G., Silva A.S., Dos Santos Nunes M.K., Ribeiro M.D., Filho J.M., do Nascimento R.A.F., Gomes C., Evangelista I.W.Q., de Oliveira N.F.P., Persuhn D.C. Physical activity level influences MTHFR gene methylation profile in diabetic patients. Front. Physiol. 2020;11:618672. doi: 10.3389/fphys.2020.618672.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2020.618672</ArticleId><ArticleId IdType=\"pmc\">PMC7835660</ArticleId><ArticleId IdType=\"pubmed\">33510650</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos Nunes M.K., Silva A.S., de Queiroga Evangelista I.W., Filho J.M., Gomes C., do Nascimento R.A.F., Luna R.C.P., de Carvalho Costa M.J., de Oliveira N.F.P., Persuhn D.C. Hypermethylation in the promoter of the MTHFR gene is associated with diabetic complications and biochemical indicators. Diabetol. Metab. Syndr. 2017;9:84. doi: 10.1186/s13098-017-0284-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13098-017-0284-3</ArticleId><ArticleId IdType=\"pmc\">PMC5648437</ArticleId><ArticleId IdType=\"pubmed\">29075332</ArticleId></ArticleIdList></Reference><Reference><Citation>Osunkalu V.O., Taiwo I.A., Makwe C.C., Abiola A.A., Quao R.A., Anorlu R.I. Epigenetic modification in methylene tetrahydrofolate reductase (MTHFR) gene of women with pre-eclampsia. J. Obstet. Gynaecol. India. 2021;71:52&#x2013;57. doi: 10.1007/s13224-020-01374-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13224-020-01374-w</ArticleId><ArticleId IdType=\"pmc\">PMC7960825</ArticleId><ArticleId IdType=\"pubmed\">33814799</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.C., Oelze B., Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer&#x2019;s disease. PLoS ONE. 2008;3:e2698. doi: 10.1371/journal.pone.0002698.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0002698</ArticleId><ArticleId IdType=\"pmc\">PMC2444024</ArticleId><ArticleId IdType=\"pubmed\">18628954</ArticleId></ArticleIdList></Reference><Reference><Citation>Serefidou M., Venkatasubramani A.V., Imhof A. The impact of one carbon metabolism on histone methylation. Front. Genet. 2019;10:764. doi: 10.3389/fgene.2019.00764.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fgene.2019.00764</ArticleId><ArticleId IdType=\"pmc\">PMC6722216</ArticleId><ArticleId IdType=\"pubmed\">31555321</ArticleId></ArticleIdList></Reference><Reference><Citation>Luka Z., Moss F., Loukachevitch L.V., Bornhop D.J., Wagner C. Histone demethylase LSD1 is a folate-binding protein. Biochemistry. 2011;50:4750&#x2013;4756. doi: 10.1021/bi200247b.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/bi200247b</ArticleId><ArticleId IdType=\"pmc\">PMC3111596</ArticleId><ArticleId IdType=\"pubmed\">21510664</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia B.A., Luka Z., Loukachevitch L.V., Bhanu N.V., Wagner C. Folate deficiency affects histone methylation. Med. Hypotheses. 2016;88:63&#x2013;67. doi: 10.1016/j.mehy.2015.12.027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2015.12.027</ArticleId><ArticleId IdType=\"pmc\">PMC4769866</ArticleId><ArticleId IdType=\"pubmed\">26880641</ArticleId></ArticleIdList></Reference><Reference><Citation>Abali E.E., Skacel N.E., Celikkaya H., Hsieh Y.C. Regulation of human dihydrofolate reductase activity and expression. Vitam. Horm. 2008;79:267&#x2013;292. doi: 10.1016/s0083-6729(08)00409-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s0083-6729(08)00409-3</ArticleId><ArticleId IdType=\"pubmed\">18804698</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas E., Roumillac C., Trouche D. Balance between acetylation and methylation of histone H3 lysine 9 on the E2F-responsive dihydrofolate reductase promoter. Mol. Cell. Biol. 2003;23:1614&#x2013;1622. doi: 10.1128/MCB.23.5.1614-1622.2003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/MCB.23.5.1614-1622.2003</ArticleId><ArticleId IdType=\"pmc\">PMC151719</ArticleId><ArticleId IdType=\"pubmed\">12588981</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmo-Smith R.H. Ciba Foundation Symposium-Chemistry and Biology of Pteridines. John Wiley &amp; Sons, Ltd.; Chichester, UK: 1954. The Function of Folic Acid in the Biosynthesis of Purine and Pyrimidine Derivatives; pp. 237&#x2013;252.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/9780470718919.ch19</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb M. Ciba Foundation Symposium-Chemistry and Biology of Pteridines. John Wiley &amp; Sons, Ltd.; Chichester, UK: 1954. The effects of folic acid analogues on the growth and cell division of micro-organisms; pp. 253&#x2013;271.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/9780470718919.ch20</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner C. Biochemical role of folate in cellular metabolism. Clin. Res. Regul. Aff. 2001;18:161&#x2013;180. doi: 10.1081/CRP-100108171.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1081/CRP-100108171</ArticleId></ArticleIdList></Reference><Reference><Citation>Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., Ames B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. USA. 1997;94:3290&#x2013;3295. doi: 10.1073/pnas.94.7.3290.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.94.7.3290</ArticleId><ArticleId IdType=\"pmc\">PMC20362</ArticleId><ArticleId IdType=\"pubmed\">9096386</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.W., Mason J.B. Folate and carcinogenesis: An integrated scheme. J. Nutr. 2000;130:129&#x2013;132. doi: 10.1093/jn/130.2.129.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jn/130.2.129</ArticleId><ArticleId IdType=\"pubmed\">10720158</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickremasinghe R.G., Hoffbrand A.V. Reduced rate of DNA replication fork movement in megaloblastic anemia. J. Clin. Investig. 1980;65:26&#x2013;36. doi: 10.1172/JCI109656.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI109656</ArticleId><ArticleId IdType=\"pmc\">PMC371336</ArticleId><ArticleId IdType=\"pubmed\">7350200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bills N.D., Koury M.J., Clifford A.J., Dessypris E.N. Ineffective hematopoiesis in folate-deficient mice. Blood. 1992;79:2273&#x2013;2280. doi: 10.1182/blood.V79.9.2273.2273.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.V79.9.2273.2273</ArticleId><ArticleId IdType=\"pubmed\">1571542</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordero A.M., Crider K.S., Rogers L.M., Cannon M.J., Berry R.J. Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines. MMWR Morb. Mortal. Wkly. Rep. 2015;64:421&#x2013;423.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5779552</ArticleId><ArticleId IdType=\"pubmed\">25905896</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  . Serum and Red Blood Cell Folate Concentrations for Assessing Folate Status in Populations. World Health Organization; Geneva, Switzerland: 2012.  [(accessed on 8 July 2024)].  Available online:  https://iris.who.int/bitstream/handle/10665/75584/WHO_NMH_NHD_EPG_12.1_eng.pdf?sequence=1.</Citation></Reference><Reference><Citation>Stanislawska-Sachadyn A., Borzyszkowska J., Krzeminski M., Janowicz A., Dziadziuszko R., Jassem J., Rzyman W., Limon J. Folate/homocysteine metabolism and lung cancer risk among smokers. PLoS ONE. 2019;14:e0214462. doi: 10.1371/journal.pone.0214462.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0214462</ArticleId><ArticleId IdType=\"pmc\">PMC6445430</ArticleId><ArticleId IdType=\"pubmed\">30939165</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason J.B., Dickstein A., Jacques P.F., Haggarty P., Selhub J., Dallal G., Rosenberg I.H. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: A hypothesis. Cancer Epidemiol. Biomark. Prev. 2007;16:1325&#x2013;1329. doi: 10.1158/1055-9965.EPI-07-0329.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1158/1055-9965.EPI-07-0329</ArticleId><ArticleId IdType=\"pubmed\">17626997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartman T.J., Woodson K., Stolzenberg-Solomon R., Virtamo J., Selhub J., Barrett M.J., Albanes D. Association of the B-vitamins pyridoxal 5&#x2032;-phosphate (B(6)), B(12), and folate with lung cancer risk in older men. Am. J. Epidemiol. 2001;153:688&#x2013;694. doi: 10.1093/aje/153.7.688.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/153.7.688</ArticleId><ArticleId IdType=\"pubmed\">11282797</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan C., Yu S., Zhang S., Ding X., Su J., Cheng Z. Association between folate intake and risk of head and neck squamous cell carcinoma: An overall and dose-response PRISMA meta-analysis. Medicine. 2017;96:e8182. doi: 10.1097/MD.0000000000008182.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MD.0000000000008182</ArticleId><ArticleId IdType=\"pmc\">PMC5662367</ArticleId><ArticleId IdType=\"pubmed\">29049201</ArticleId></ArticleIdList></Reference><Reference><Citation>Tio M., Andrici J., Cox M.R., Eslick G.D. Folate intake and the risk of upper gastrointestinal cancers: A systematic review and meta-analysis. J. Gastroenterol. Hepatol. 2014;29:250&#x2013;258. doi: 10.1111/jgh.12446.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jgh.12446</ArticleId><ArticleId IdType=\"pubmed\">24224911</ArticleId></ArticleIdList></Reference><Reference><Citation>Farber S., Diamond L.K. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N. Engl. J. Med. 1948;238:787&#x2013;793. doi: 10.1056/NEJM194806032382301.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJM194806032382301</ArticleId><ArticleId IdType=\"pubmed\">18860765</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.I. Does a high folate intake increase the risk of breast cancer? Nutr. Rev. 2006;64:468&#x2013;475. doi: 10.1111/j.1753-4887.2006.tb00178.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1753-4887.2006.tb00178.x</ArticleId><ArticleId IdType=\"pubmed\">17063929</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole B.F., Baron J.A., Sandler R.S., Haile R.W., Ahnen D.J., Bresalier R.S., McKeown-Eyssen G., Summers R.W., Rothstein R.I., Burke C.A., et al. Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. JAMA. 2007;297:2351&#x2013;2359. doi: 10.1001/jama.297.21.2351.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.297.21.2351</ArticleId><ArticleId IdType=\"pubmed\">17551129</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliai Araghi S., Kiefte-de Jong J.C., van Dijk S.C., Swart K.M.A., van Laarhoven H.W., van Schoor N.M., de Groot L., Lemmens V., Stricker B.H., Uitterlinden A.G., et al. Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial. Cancer Epidemiol. Biomark. Prev. 2019;28:275&#x2013;282. doi: 10.1158/1055-9965.EPI-17-1198.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1158/1055-9965.EPI-17-1198</ArticleId><ArticleId IdType=\"pubmed\">30341095</ArticleId></ArticleIdList></Reference><Reference><Citation>Bo Y., Zhu Y., Tao Y., Li X., Zhai D., Bu Y., Wan Z., Wang L., Wang Y., Yu Z. Association between Folate and Health Outcomes: An Umbrella Review of Meta-Analyses. Front. Public Health. 2020;8:550753. doi: 10.3389/fpubh.2020.550753.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpubh.2020.550753</ArticleId><ArticleId IdType=\"pmc\">PMC7770110</ArticleId><ArticleId IdType=\"pubmed\">33384976</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R., Ali T., Kaur J. Folic acid depletion as well as oversupplementation helps in the progression of hepatocarcinogenesis in HepG2 cells. Sci. Rep. 2022;12:16617. doi: 10.1038/s41598-022-21084-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-022-21084-9</ArticleId><ArticleId IdType=\"pmc\">PMC9534894</ArticleId><ArticleId IdType=\"pubmed\">36198749</ArticleId></ArticleIdList></Reference><Reference><Citation>Bistulfi G., Vandette E., Matsui S., Smiraglia D.J. Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells. BMC Biol. 2010;8:6. doi: 10.1186/1741-7007-8-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1741-7007-8-6</ArticleId><ArticleId IdType=\"pmc\">PMC2845099</ArticleId><ArticleId IdType=\"pubmed\">20092614</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitstick L., Goral J., Ciancio M.J., Meyer A., Pytynia M., Bychek S., Zidan S., Shuey J., Jham B.C., Green J.M. Effects of folate deficiency and sex on carcinogenesis in a mouse model of oral cancer. Oral Dis. 2024;30:1989&#x2013;2003. doi: 10.1111/odi.14728.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/odi.14728</ArticleId><ArticleId IdType=\"pubmed\">37731277</ArticleId></ArticleIdList></Reference><Reference><Citation>Duthie S.J., Narayanan S., Blum S., Pirie L., Brand G.M. Folate deficiency in vitro induces uracil misincorporation and DNA hypomethylation and inhibits DNA excision repair in immortalized normal human colon epithelial cells. Nutr. Cancer. 2000;37:245&#x2013;251. doi: 10.1207/S15327914NC372_18.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1207/S15327914NC372_18</ArticleId><ArticleId IdType=\"pubmed\">11142099</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.M., Yu C.C., Lu H.T., Chou Y.F., Huang R.F. Folate deprivation promotes mitochondrial oxidative decay: DNA large deletions, cytochrome c oxidase dysfunction, membrane depolarization and superoxide overproduction in rat liver. Br. J. Nutr. 2007;97:855&#x2013;863. doi: 10.1017/S0007114507666410.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S0007114507666410</ArticleId><ArticleId IdType=\"pubmed\">17381984</ArticleId></ArticleIdList></Reference><Reference><Citation>Latteri S., Malaguarnera G., Catania V.E., La Greca G., Bertino G., Borzi A.M., Drago F., Malaguarnera M. Homocysteine serum levels as prognostic marker of hepatocellular carcinoma with portal vein thrombosis. Curr. Mol. Med. 2019;19:532&#x2013;538. doi: 10.2174/1566524019666190610120416.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1566524019666190610120416</ArticleId><ArticleId IdType=\"pubmed\">31187711</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L.H., Song Y., Si H., Shen F., Shin M.H., Kim H.N., Choi J.S. Folate metabolism-related gene polymorphisms and susceptibility to primary liver cancer in North China. Med. Oncol. 2012;29:1837&#x2013;1842. doi: 10.1007/s12032-011-0066-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12032-011-0066-y</ArticleId><ArticleId IdType=\"pubmed\">21956592</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaguarnera G., Gagliano C., Giordano M., Salomone S., Vacante M., Bucolo C., Caraci F., Reibaldi M., Drago F., Avitabile T., et al. Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy. Biomed. Res. Int. 2014;2014:191497. doi: 10.1155/2014/191497.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2014/191497</ArticleId><ArticleId IdType=\"pmc\">PMC4022262</ArticleId><ArticleId IdType=\"pubmed\">24877066</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahed M.M., Bahramian A., Katebi K., Salehnia F. The relationship between serum folate and homocysteine with head and neck cancer: A systematic review and meta-analysis. Shiraz E-Med. J. 2024;25:e140961.</Citation></Reference><Reference><Citation>Kim Y.I. Folate and DNA methylation: A mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol. Biomark. Prev. 2004;13:511&#x2013;519. doi: 10.1158/1055-9965.511.13.4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1158/1055-9965.511.13.4</ArticleId><ArticleId IdType=\"pubmed\">15066913</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson R., Nicolaidou V., Koufaris C. Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer. Gene. 2019;716:144032. doi: 10.1016/j.gene.2019.144032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.gene.2019.144032</ArticleId><ArticleId IdType=\"pubmed\">31377316</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan M.R., Darnell A.M., Reilly M.F., Kunchok T., Joesch-Cohen L., Rosenberg D., Ali A., Rees M.G., Roth J.A., Lewis C.A., et al. Methionine synthase is essential for cancer cell proliferation in physiological folate environments. Nat. Metab. 2021;3:1500&#x2013;1511. doi: 10.1038/s42255-021-00486-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s42255-021-00486-5</ArticleId><ArticleId IdType=\"pmc\">PMC8608285</ArticleId><ArticleId IdType=\"pubmed\">34799701</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Braun A., Bauman Z., Olteanu H., Madzelan P., Banerjee R. Expression profiling of homocysteine junction enzymes in the NCI60 panel of human cancer cell lines. Cancer Res. 2005;65:1554&#x2013;1560. doi: 10.1158/0008-5472.CAN-04-1554.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1158/0008-5472.CAN-04-1554</ArticleId><ArticleId IdType=\"pubmed\">15735045</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlen M., Zhang C., Lee S., Sjostedt E., Fagerberg L., Bidkhori G., Benfeitas R., Arif M., Liu Z., Edfors F., et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357:eaan2507. doi: 10.1126/science.aan2507.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.aan2507</ArticleId><ArticleId IdType=\"pubmed\">28818916</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghergurovich J.M., Xu X., Wang J.Z., Yang L., Ryseck R.P., Wang L., Rabinowitz J.D. Methionine synthase supports tumour tetrahydrofolate pools. Nat. Metab. 2021;3:1512&#x2013;1520. doi: 10.1038/s42255-021-00465-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s42255-021-00465-w</ArticleId><ArticleId IdType=\"pmc\">PMC9284419</ArticleId><ArticleId IdType=\"pubmed\">34799699</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupenko S.A., Krupenko N.I. Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression. Chem. Biol. Interact. 2019;302:149&#x2013;155. doi: 10.1016/j.cbi.2019.02.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cbi.2019.02.013</ArticleId><ArticleId IdType=\"pmc\">PMC6433412</ArticleId><ArticleId IdType=\"pubmed\">30794800</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupenko N.I., Sharma J., Fogle H.M., Pediaditakis P., Strickland K.C., Du X., Helke K.L., Sumner S., Krupenko S.A. Knockout of putative tumor suppressor Aldh1l1 in mice reprograms metabolism to accelerate growth of tumors in a diethylnitrosamine (DEN) model of liver carcinogenesis. Cancers. 2021;13:3219. doi: 10.3390/cancers13133219.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cancers13133219</ArticleId><ArticleId IdType=\"pmc\">PMC8268287</ArticleId><ArticleId IdType=\"pubmed\">34203215</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki M., Yamamoto K., Ueda T., Irokawa H., Takeda K., Sekine R., Itoh F., Tanaka Y., Kuge S., Shibata N. One-carbon metabolizing enzyme ALDH1L1 influences mitochondrial metabolism through 5-aminoimidazole-4-carboxamide ribonucleotide accumulation and serine depletion, contributing to tumor suppression. Sci. Rep. 2023;13:13486. doi: 10.1038/s41598-023-38142-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-023-38142-5</ArticleId><ArticleId IdType=\"pmc\">PMC10439146</ArticleId><ArticleId IdType=\"pubmed\">37596270</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleinik N.V., Krupenko N.I., Krupenko S.A. Epigenetic silencing of ALDH1L1, a metabolic regulator of cellular proliferation, in cancers. Genes Cancer. 2011;2:130&#x2013;139. doi: 10.1177/1947601911405841.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1947601911405841</ArticleId><ArticleId IdType=\"pmc\">PMC3111244</ArticleId><ArticleId IdType=\"pubmed\">21779486</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y., He Y., Ruan H., Qin L., Han Z. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway. Cancer Med. 2023;12:5781&#x2013;5797. doi: 10.1002/cam4.5327.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cam4.5327</ArticleId><ArticleId IdType=\"pmc\">PMC10028165</ArticleId><ArticleId IdType=\"pubmed\">36336972</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Li G. Mechanisms of methotrexate resistance in osteosarcoma cell lines and strategies for overcoming this resistance. Oncol. Lett. 2015;9:940&#x2013;944. doi: 10.3892/ol.2014.2773.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/ol.2014.2773</ArticleId><ArticleId IdType=\"pmc\">PMC4301490</ArticleId><ArticleId IdType=\"pubmed\">25621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Broccoli A., Argnani L., Zinzani P.L. Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease. Cancer Treat. Rev. 2017;60:120&#x2013;129. doi: 10.1016/j.ctrv.2017.09.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ctrv.2017.09.002</ArticleId><ArticleId IdType=\"pubmed\">28946015</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui J., Przespo E., Elefante A. Pralatrexate: A novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses. J. Oncol. Pharm. Pract. 2012;18:275&#x2013;283. doi: 10.1177/1078155211420605.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1078155211420605</ArticleId><ArticleId IdType=\"pubmed\">21956523</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Wei S., Chen J. Critical appraisal of pemetrexed in the treatment of NSCLC and metastatic pulmonary nodules. OncoTargets Ther. 2014;7:937&#x2013;945. doi: 10.2147/OTT.S45148.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/OTT.S45148</ArticleId><ArticleId IdType=\"pmc\">PMC4057332</ArticleId><ArticleId IdType=\"pubmed\">24944517</ArticleId></ArticleIdList></Reference><Reference><Citation>Barni S., Ghidini A., Coinu A., Borgonovo K., Petrelli F. A systematic review of raltitrexed-based first-line chemotherapy in advanced colorectal cancer. Anticancer Drugs. 2014;25:1122&#x2013;1128. doi: 10.1097/CAD.0000000000000133.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/CAD.0000000000000133</ArticleId><ArticleId IdType=\"pubmed\">24869761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ser Z., Gao X., Johnson C., Mehrmohamadi M., Liu X., Li S., Locasale J.W. Targeting one carbon metabolism with an antimetabolite disrupts pyrimidine homeostasis and induces nucleotide overflow. Cell Rep. 2016;15:2367&#x2013;2376. doi: 10.1016/j.celrep.2016.05.035.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2016.05.035</ArticleId><ArticleId IdType=\"pmc\">PMC4909568</ArticleId><ArticleId IdType=\"pubmed\">27264180</ArticleId></ArticleIdList></Reference><Reference><Citation>Douillard J.Y., Siena S., Cassidy J., Tabernero J., Burkes R., Barugel M., Humblet Y., Bodoky G., Cunningham D., Jassem J., et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The PRIME study. J. Clin. Oncol. 2010;28:4697&#x2013;4705. doi: 10.1200/JCO.2009.27.4860.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1200/JCO.2009.27.4860</ArticleId><ArticleId IdType=\"pubmed\">20921465</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmiegelow K., Nielsen S.N., Frandsen T.L., Nersting J. Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: Clinical facts and fiction. J. Pediatr. Hematol. Oncol. 2014;36:503&#x2013;517. doi: 10.1097/MPH.0000000000000206.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MPH.0000000000000206</ArticleId><ArticleId IdType=\"pmc\">PMC4222610</ArticleId><ArticleId IdType=\"pubmed\">24936744</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaranti M., Cojocaru E., Banerjee S., Banerji U. Exploiting the folate receptor alpha in oncology. Nat. Rev. Clin. Oncol. 2020;17:349&#x2013;359. doi: 10.1038/s41571-020-0339-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41571-020-0339-5</ArticleId><ArticleId IdType=\"pubmed\">32152484</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalli K.R., Oberg A.L., Keeney G.L., Christianson T.J., Low P.S., Knutson K.L., Hartmann L.C. Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol. Oncol. 2008;108:619&#x2013;626. doi: 10.1016/j.ygyno.2007.11.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ygyno.2007.11.020</ArticleId><ArticleId IdType=\"pmc\">PMC2707764</ArticleId><ArticleId IdType=\"pubmed\">18222534</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy J.A., Nelson M., Dircksen C., Vetzel M., Johnson T., Cross V., Westrick E., Qi L., Hahn S., Santhapuram H.K., et al. Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent. Sci. Rep. 2020;10:12772. doi: 10.1038/s41598-020-69682-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-020-69682-9</ArticleId><ArticleId IdType=\"pmc\">PMC7391724</ArticleId><ArticleId IdType=\"pubmed\">32728172</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim M.A.I., Othman R., Chee C.F., Ahmad Fisol F. Evaluation of folate-functionalized nanoparticle drug delivery systems-effectiveness and concerns. Biomedicines. 2023;11:2080. doi: 10.3390/biomedicines11072080.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines11072080</ArticleId><ArticleId IdType=\"pmc\">PMC10376941</ArticleId><ArticleId IdType=\"pubmed\">37509719</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelemen L.E. The role of folate receptor alpha in cancer development, progression and treatment: Cause, consequence or innocent bystander? Int. J. Cancer. 2006;119:243&#x2013;250. doi: 10.1002/ijc.21712.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ijc.21712</ArticleId><ArticleId IdType=\"pubmed\">16453285</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudkov S.V., Shilyagina N.Y., Vodeneev V.A., Zvyagin A.V. Targeted radionuclide therapy of human tumors. Int. J. Mol. Sci. 2015;17:33. doi: 10.3390/ijms17010033.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms17010033</ArticleId><ArticleId IdType=\"pmc\">PMC4730279</ArticleId><ArticleId IdType=\"pubmed\">26729091</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitipir C., Niculae D., Orlov C., Barbu M.A., Popescu B., Popa A.M., Pantea A.M.S., Stanciu A.E., Galateanu B., Ginghina O., et al. Update on radionuclide therapy in oncology. Oncol. Lett. 2017;14:7011&#x2013;7015. doi: 10.3892/ol.2017.7141.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/ol.2017.7141</ArticleId><ArticleId IdType=\"pmc\">PMC5754838</ArticleId><ArticleId IdType=\"pubmed\">29344129</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel B.A., Dehdashti F., Mutch D.G., Podoloff D.A., Wendt R., Sutton G.P., Burt R.W., Ellis P.R., Mathias C.J., Green M.A., et al. Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: Initial clinical results. J. Nucl. Med. 2003;44:700&#x2013;707.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12732670</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher R.E., Siegel B.A., Edell S.L., Oyesiku N.M., Morgenstern D.E., Messmann R.A., Amato R.J. Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors. J. Nucl. Med. 2008;49:899&#x2013;906. doi: 10.2967/jnumed.107.049478.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2967/jnumed.107.049478</ArticleId><ArticleId IdType=\"pubmed\">18483093</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller C., Reddy J.A., Leamon C.P., Schibli R. Effects of the antifolates pemetrexed and CB3717 on the tissue distribution of (99m)Tc-EC20 in xenografted and syngeneic tumor-bearing mice. Mol. Pharm. 2010;7:597&#x2013;604. doi: 10.1021/mp900296k.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/mp900296k</ArticleId><ArticleId IdType=\"pubmed\">20199053</ArticleId></ArticleIdList></Reference><Reference><Citation>Reber J., Haller S., Leamon C.P., Muller C. 177Lu-EC0800 combined with the antifolate pemetrexed: Preclinical pilot study of folate receptor targeted radionuclide tumor therapy. Mol. Cancer Ther. 2013;12:2436&#x2013;2445. doi: 10.1158/1535-7163.MCT-13-0422-T.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1158/1535-7163.MCT-13-0422-T</ArticleId><ArticleId IdType=\"pubmed\">24030631</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller C., Struthers H., Winiger C., Zhernosekov K., Schibli R. DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice. J. Nucl. Med. 2013;54:124&#x2013;131. doi: 10.2967/jnumed.112.107235.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2967/jnumed.112.107235</ArticleId><ArticleId IdType=\"pubmed\">23236020</ArticleId></ArticleIdList></Reference><Reference><Citation>Siwowska K., Haller S., Bortoli F., Benesova M., Groehn V., Bernhardt P., Schibli R., Muller C. Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the In Vitro and In Vivo Properties. Mol. Pharm. 2017;14:523&#x2013;532. doi: 10.1021/acs.molpharmaceut.6b01010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.molpharmaceut.6b01010</ArticleId><ArticleId IdType=\"pubmed\">28094532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladak I., Preti B., Dias B., Breadner D.A. Raltitrexed as a substitute for capecitabine in metastatic gastric cancer: A case report and literature review. Ann. Transl. Med. 2022;10:1285. doi: 10.21037/atm-2022-69.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.21037/atm-2022-69</ArticleId><ArticleId IdType=\"pmc\">PMC9816848</ArticleId><ArticleId IdType=\"pubmed\">36618781</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Sanderson S.M., Dai Z., Reid M.A., Cooper D.E., Lu M., Richie J.P., Jr., Ciccarella A., Calcagnotto A., Mikhael P.G., et al. Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature. 2019;572:397&#x2013;401. doi: 10.1038/s41586-019-1437-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-019-1437-3</ArticleId><ArticleId IdType=\"pmc\">PMC6951023</ArticleId><ArticleId IdType=\"pubmed\">31367041</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Guo J., Li C., Wang Z. A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer. Drug Des. Devel. Ther. 2015;9:4989&#x2013;4996. doi: 10.2147/DDDT.S90670.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/DDDT.S90670</ArticleId><ArticleId IdType=\"pmc\">PMC4560517</ArticleId><ArticleId IdType=\"pubmed\">26357465</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergote I., Leamon C.P. Vintafolide: A novel targeted therapy for the treatment of folate receptor expressing tumors. Ther. Adv. Med. Oncol. 2015;7:206&#x2013;218. doi: 10.1177/1758834015584763.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1758834015584763</ArticleId><ArticleId IdType=\"pmc\">PMC4480526</ArticleId><ArticleId IdType=\"pubmed\">26136852</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana A., Bhatnagar S. Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach. Bioorg. Chem. 2021;112:104946. doi: 10.1016/j.bioorg.2021.104946.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bioorg.2021.104946</ArticleId><ArticleId IdType=\"pubmed\">33989916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G.T., Azari F.S., Chang A., Nadeem B., Bernstein E., Segil A., Din A., Marfatia I., Desphande C., Okusanya O., et al. Comparative experience of short-wavelength versus long-wavelength fluorophores for intraoperative molecular imaging of lung cancer. Ann. Surg. 2022;276:711&#x2013;719. doi: 10.1097/SLA.0000000000005596.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/SLA.0000000000005596</ArticleId><ArticleId IdType=\"pmc\">PMC9463092</ArticleId><ArticleId IdType=\"pubmed\">35837887</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato S., Itamochi H. Profile of farletuzumab and its potential in the treatment of solid tumors. Onco Targets Ther. 2016;9:1181&#x2013;1188. doi: 10.2147/OTT.S98242.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/OTT.S98242</ArticleId><ArticleId IdType=\"pmc\">PMC4789847</ArticleId><ArticleId IdType=\"pubmed\">27022278</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Fujiwara Y., Yonemori K., Koyama T., Sato J., Tamura K., Shimomura A., Ikezawa H., Nomoto M., Furuuchi K., et al. First-in-human phase 1 study of MORAb-202, an antibody-drug conjugate comprising farletuzumab linked to eribulin mesylate, in patients with folate receptor-&#x3b1;-positive advanced solid tumors. Clin. Cancer Res. 2021;27:3905&#x2013;3915. doi: 10.1158/1078-0432.CCR-20-4740.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1158/1078-0432.CCR-20-4740</ArticleId><ArticleId IdType=\"pubmed\">33926914</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo Y.A. Mirvetuximab soravtansine: First approval. Drugs. 2023;83:265&#x2013;273. doi: 10.1007/s40265-023-01834-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40265-023-01834-3</ArticleId><ArticleId IdType=\"pubmed\">36656533</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart D., Cristea M. Antibody-drug conjugates for ovarian cancer: Current clinical development. Curr. Opin. Obstet. Gynecol. 2019;31:18&#x2013;23. doi: 10.1097/GCO.0000000000000515.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/GCO.0000000000000515</ArticleId><ArticleId IdType=\"pubmed\">30531606</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigre J., Martinez-Osuna M., Bethke M., Steiner L., Dittmer V., Krischer K., Bleilevens C., Brauner J., Kopatz J., Grundmann M.D., et al. Preclinical evaluation of novel folate receptor 1-directed CAR T cells for ovarian cancer. Cancers. 2024;16:333. doi: 10.3390/cancers16020333.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cancers16020333</ArticleId><ArticleId IdType=\"pmc\">PMC10813853</ArticleId><ArticleId IdType=\"pubmed\">38254822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S., Li X., Wang X., Cheng L., Li Z., Zhang C., Ye Z., Qian Q. Current progress in CAR-T cell therapy for solid tumors. Int. J. Biol. Sci. 2019;15:2548&#x2013;2560. doi: 10.7150/ijbs.34213.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7150/ijbs.34213</ArticleId><ArticleId IdType=\"pmc\">PMC6854376</ArticleId><ArticleId IdType=\"pubmed\">31754328</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand S., Devanaboyina M., Staats H., Stanbery L., Nemunaitis J. Ovarian cancer immunotherapy and personalized medicine. Int. J. Mol. Sci. 2021;22:6532. doi: 10.3390/ijms22126532.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22126532</ArticleId><ArticleId IdType=\"pmc\">PMC8234871</ArticleId><ArticleId IdType=\"pubmed\">34207103</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik P., Benesova M., Ratz M., Monne Rodriguez J.M., Deberle L.M., Schibli R., Muller C. Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates-new perspectives for folate receptor-targeted radionuclide therapy. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:972&#x2013;983. doi: 10.1007/s00259-020-04980-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00259-020-04980-y</ArticleId><ArticleId IdType=\"pmc\">PMC8041685</ArticleId><ArticleId IdType=\"pubmed\">33063250</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann R.W., Coleman R.L., Burger R.A., Sausville E.A., Kutarska E., Ghamande S.A., Gabrail N.Y., Depasquale S.E., Nowara E., Gilbert L., et al. PRECEDENT: A randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer. J. Clin. Oncol. 2013;31:4400&#x2013;4406. doi: 10.1200/JCO.2013.49.7685.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1200/JCO.2013.49.7685</ArticleId><ArticleId IdType=\"pubmed\">24127448</ArticleId></ArticleIdList></Reference><Reference><Citation>Oza A.M., Vergote I.B., Gilbert L.G., Ghatage P., Lisyankaya A., Ghamande S., Chambers S.K., Arranz J.A., Provencher D.M., Bessette P., et al. A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil&#xae;/Caelyx&#xae;) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650) Gynecol. Oncol. 2015;137:5&#x2013;6. doi: 10.1016/j.ygyno.2015.01.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ygyno.2015.01.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelman M.J., Harb W.A., Pal S.E., Boccia R.V., Kraut M.J., Bonomi P., Conley B.A., Rogers J.S., Messmann R.A., Garon E.B. Multicenter trial of EC145 in advanced, folate-receptor positive adenocarcinoma of the lung. J. Thorac. Oncol. 2012;7:1618&#x2013;1621. doi: 10.1097/JTO.0b013e318267d051.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/JTO.0b013e318267d051</ArticleId><ArticleId IdType=\"pubmed\">22982661</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelman M.J., Ma H., Perez W., Adjei A.A., Hanna N. A randomized, open-label phase II study of single-agent vintafolide versus vintafolide plus docetaxel versus docetaxel alone in second-line NSCLC patients with all target lesions expressing folate-receptor (TARGET) J. Clin. Oncol. 2013;31:TPS8125. doi: 10.1200/jco.2013.31.15_suppl.tps8125.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1200/jco.2013.31.15_suppl.tps8125</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergote I., Armstrong D., Scambia G., Teneriello M., Sehouli J., Schweizer C., Weil S.C., Bamias A., Fujiwara K., Ochiai K., et al. A randomized, double-blind, placebo-controlled, phase III study to assess efficacy and safety of weekly farletuzumab in combination with carboplatin and taxane in patients with ovarian cancer in first platinum-sensitive relapse. J. Clin. Oncol. 2016;34:2271&#x2013;2278. doi: 10.1200/JCO.2015.63.2596.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1200/JCO.2015.63.2596</ArticleId><ArticleId IdType=\"pubmed\">27001568</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT01218516. A Safety and Efficacy Study of Farletuzumab in Participants with Adenocarcinoma of the Lung.  [(accessed on 20 August 2024)];2013  Available online:  https://clinicaltrials.gov/study/NCT01218516.</Citation></Reference><Reference><Citation>Matulonis U.A., Lorusso D., Oaknin A., Pignata S., Dean A., Denys H., Colombo N., Van Gorp T., Konner J.A., Marin M.R., et al. Efficacy and safety of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer with high folate receptor alpha expression: Results from the SORAYA study. J. Clin. Oncol. 2023;41:2436&#x2013;2445. doi: 10.1200/JCO.22.01900.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1200/JCO.22.01900</ArticleId><ArticleId IdType=\"pmc\">PMC10150846</ArticleId><ArticleId IdType=\"pubmed\">36716407</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore K.N., Oza A.M., Colombo N., Oaknin A., Scambia G., Lorusso D., Konecny G.E., Banerjee S., Murphy C.G., Tanyi J.L., et al. Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: Primary analysis of FORWARD I. Ann. Oncol. 2021;32:757&#x2013;765. doi: 10.1016/j.annonc.2021.02.017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.annonc.2021.02.017</ArticleId><ArticleId IdType=\"pubmed\">33667670</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantor J.R., Abu-Remaileh M., Kanarek N., Freinkman E., Gao X., Louissaint A., Jr., Lewis C.A., Sabatini D.M. Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase. Cell. 2017;169:258&#x2013;272.e17. doi: 10.1016/j.cell.2017.03.023.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2017.03.023</ArticleId><ArticleId IdType=\"pmc\">PMC5421364</ArticleId><ArticleId IdType=\"pubmed\">28388410</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardito S., Oudin A., Ahmed S.U., Fack F., Keunen O., Zheng L., Miletic H., Sakariassen P.O., Weinstock A., Wagner A., et al. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nat. Cell Biol. 2015;17:1556&#x2013;1568. doi: 10.1038/ncb3272.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncb3272</ArticleId><ArticleId IdType=\"pmc\">PMC4663685</ArticleId><ArticleId IdType=\"pubmed\">26595383</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha A., Rocha A.C., Barbosa F., Baiao A., Silva P., Sarmento B., Queiros O. Glycolytic inhibitors potentiated the activity of paclitaxel and their nanoencapsulation increased their delivery in a lung cancer model. Pharmaceutics. 2022;14:2021. doi: 10.3390/pharmaceutics14102021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics14102021</ArticleId><ArticleId IdType=\"pmc\">PMC9611291</ArticleId><ArticleId IdType=\"pubmed\">36297455</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddocks O.D.K., Athineos D., Cheung E.C., Lee P., Zhang T., van den Broek N.J.F., Mackay G.M., Labuschagne C.F., Gay D., Kruiswijk F., et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature. 2017;544:372&#x2013;376. doi: 10.1038/nature22056.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature22056</ArticleId><ArticleId IdType=\"pubmed\">28425994</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel S.P., Hulea L., Toban N., Birman E., Blouin M.J., Zakikhani M., Zhao Y., Topisirovic I., St-Pierre J., Pollak M. Serine deprivation enhances antineoplastic activity of biguanides. Cancer Res. 2014;74:7521&#x2013;7533. doi: 10.1158/0008-5472.CAN-14-2643-T.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1158/0008-5472.CAN-14-2643-T</ArticleId><ArticleId IdType=\"pubmed\">25377470</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi S., Hoffman R.M., Bertino J.R. Exploiting methionine restriction for cancer treatment. Biochem. Pharmacol. 2018;154:170&#x2013;173. doi: 10.1016/j.bcp.2018.05.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bcp.2018.05.003</ArticleId><ArticleId IdType=\"pubmed\">29733806</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibbard B.M. The role of folic acid in pregnancy. BJOG. 1964;71:529&#x2013;542. doi: 10.1111/j.1471-0528.1964.tb04317.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1471-0528.1964.tb04317.x</ArticleId><ArticleId IdType=\"pubmed\">14194440</ArticleId></ArticleIdList></Reference><Reference><Citation>Blom H.J., Shaw G.M., den Heijer M., Finnell R.H. Neural tube defects and folate: Case far from closed. Nat. Rev. Neurosci. 2006;7:724&#x2013;731. doi: 10.1038/nrn1986.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrn1986</ArticleId><ArticleId IdType=\"pmc\">PMC2970514</ArticleId><ArticleId IdType=\"pubmed\">16924261</ArticleId></ArticleIdList></Reference><Reference><Citation>Kancherla V. Neural tube defects: A review of global prevalence, causes, and primary prevention. Childs Nerv. Syst. 2023;39:1703&#x2013;1710. doi: 10.1007/s00381-023-05910-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00381-023-05910-7</ArticleId><ArticleId IdType=\"pubmed\">36882610</ArticleId></ArticleIdList></Reference><Reference><Citation>Rofail D., Maguire L., Kissner M., Colligs A., Abetz-Webb L. A review of the social, psychological, and economic burdens experienced by people with spina bifida and their caregivers. Neurol. Ther. 2013;2:1&#x2013;12. doi: 10.1007/s40120-013-0007-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40120-013-0007-0</ArticleId><ArticleId IdType=\"pmc\">PMC4389032</ArticleId><ArticleId IdType=\"pubmed\">26000212</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang K.F., Li Y.L., Wang H.Y. Quantitative assessment of maternal biomarkers related to one-carbon metabolism and neural tube defects. Sci. Rep. 2015;5:8510. doi: 10.1038/srep08510.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/srep08510</ArticleId><ArticleId IdType=\"pmc\">PMC4345334</ArticleId><ArticleId IdType=\"pubmed\">25728980</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav U., Kumar P., Rai V. Maternal biomarkers for early prediction of the neural tube defects pregnancies. Birth Defects Res. 2021;113:589&#x2013;600. doi: 10.1002/bdr2.1842.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/bdr2.1842</ArticleId><ArticleId IdType=\"pubmed\">33188559</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul S., Sadhukhan S., Munian D., Bankura B., Das M. Association of FOLH1, DHFR, and MTHFR gene polymorphisms with susceptibility of neural tube defects: A case control study from Eastern India. Birth Defects Res. 2018;110:1129&#x2013;1138. doi: 10.1002/bdr2.1365.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/bdr2.1365</ArticleId><ArticleId IdType=\"pubmed\">30120883</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247&#x2013;257. doi: 10.1016/S0092-8674(00)81656-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0092-8674(00)81656-6</ArticleId><ArticleId IdType=\"pubmed\">10555141</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudin A.E., Stover P.J. Insights into metabolic mechanisms underlying folate-responsive neural tube defects: A minireview. Birth Defects Res. A Clin. Mol. Teratol. 2009;85:274&#x2013;284. doi: 10.1002/bdra.20553.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/bdra.20553</ArticleId><ArticleId IdType=\"pmc\">PMC4435943</ArticleId><ArticleId IdType=\"pubmed\">19180567</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei P., Cheng X., Yu J., Shen J., Li X., Wu J., Wang S., Zhang T. Folate deficiency induced H2A ubiquitination to lead to downregulated expression of genes involved in neural tube defects. Epigenet. Chromatin. 2019;12:69. doi: 10.1186/s13072-019-0312-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13072-019-0312-7</ArticleId><ArticleId IdType=\"pmc\">PMC6852770</ArticleId><ArticleId IdType=\"pubmed\">31722724</ArticleId></ArticleIdList></Reference><Reference><Citation>Alata Jimenez N., Torres P&#xe9;rez S.A., S&#xe1;nchez-V&#xe1;squez E., Fernandino J.I., Strobl-Mazzulla P.H. Folate deficiency prevents neural crest fate by disturbing the epigenetic Sox2 repression on the dorsal neural tube. Dev. Biol. 2018;444((Suppl. S1)):S193&#x2013;S201. doi: 10.1016/j.ydbio.2018.08.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ydbio.2018.08.001</ArticleId><ArticleId IdType=\"pubmed\">30098999</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Byrne M.R., Au K.S., Morrison A.C., Lin J.I., Fletcher J.M., Ostermaier K.K., Tyerman G.H., Doebel S., Northrup H. Association of folate receptor (FOLR1, FOLR2, FOLR3) and reduced folate carrier (SLC19A1) genes with meningomyelocele. Birth Defects Res. A Clin. Mol. Teratol. 2010;88:689&#x2013;694. doi: 10.1002/bdra.20706.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/bdra.20706</ArticleId><ArticleId IdType=\"pmc\">PMC3046546</ArticleId><ArticleId IdType=\"pubmed\">20683905</ArticleId></ArticleIdList></Reference><Reference><Citation>Piedrahita J.A., Oetama B., Bennett G.D., van Waes J., Kamen B.A., Richardson J., Lacey S.W., Anderson R.G., Finnell R.H. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat. Genet. 1999;23:228&#x2013;232. doi: 10.1038/13861.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/13861</ArticleId><ArticleId IdType=\"pubmed\">10508523</ArticleId></ArticleIdList></Reference><Reference><Citation>Toriyama M., Toriyama M., Wallingford J.B., Finnell R.H. Folate-dependent methylation of septins governs ciliogenesis during neural tube closure. FASEB J. 2017;31:3622&#x2013;3635. doi: 10.1096/fj.201700092R.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.201700092R</ArticleId><ArticleId IdType=\"pmc\">PMC5503710</ArticleId><ArticleId IdType=\"pubmed\">28432198</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue Y., Ren L., Zhang C., Miao K., Tan K., Yang Q., Hu Y., Xi G., Luo G., Yang M., et al. Mitochondrial genome undergoes de novo DNA methylation that protects mtDNA against oxidative damage during the peri-implantation window. Proc. Natl. Acad. Sci. USA. 2022;119:e2201168119. doi: 10.1073/pnas.2201168119.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2201168119</ArticleId><ArticleId IdType=\"pmc\">PMC9335330</ArticleId><ArticleId IdType=\"pubmed\">35858425</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Wang X., Zhao H., Wang F., Bao Y., Guo J., Chang S., Wu L., Cheng H., Chen S., et al. Low folate concentration impacts mismatch repair deficiency in neural tube defects. Epigenomics. 2020;12:5&#x2013;18. doi: 10.2217/epi-2019-0279.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2217/epi-2019-0279</ArticleId><ArticleId IdType=\"pubmed\">31769301</ArticleId></ArticleIdList></Reference><Reference><Citation>De-Regil L.M., Pe&#xf1;a-Rosas J.P., Fern&#xe1;ndez-Gaxiola A.C., Rayco-Solon P. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database Syst. Rev. 2015;2015:Cd007950. doi: 10.1002/14651858.CD007950.pub3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/14651858.CD007950.pub3</ArticleId><ArticleId IdType=\"pmc\">PMC8783750</ArticleId><ArticleId IdType=\"pubmed\">26662928</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo-Lancellotti C., Tur J.A., Uauy R. Impact of folic acid fortification of flour on neural tube defects: A systematic review. Public Health Nutr. 2013;16:901&#x2013;911. doi: 10.1017/S1368980012003576.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S1368980012003576</ArticleId><ArticleId IdType=\"pmc\">PMC10271422</ArticleId><ArticleId IdType=\"pubmed\">22850218</ArticleId></ArticleIdList></Reference><Reference><Citation>Shlobin N.A., LoPresti M.A., Du R.Y., Lam S. Folate fortification and supplementation in prevention of folate-sensitive neural tube defects: A systematic review of policy. J. Neurosurg. Pediatr. 2020;27:294&#x2013;310. doi: 10.3171/2020.7.PEDS20442.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3171/2020.7.PEDS20442</ArticleId><ArticleId IdType=\"pubmed\">33338998</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez H., Benavides-Lara A., Arynchyna-Smith A., Ghotme K.A., Arabi M., Arynchyn A. Global strategies for the prevention of neural tube defects through the improvement of folate status in women of reproductive age. Childs Nerv. Syst. 2023;39:1719&#x2013;1736. doi: 10.1007/s00381-023-05913-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00381-023-05913-4</ArticleId><ArticleId IdType=\"pubmed\">37103517</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan M., Urrutia R.P. Preventive Services Task Force. Evidence Synthesis No. 230. Agency for Healthcare Research and Quality; Rockville, MD, USA: 2023. Folic acid supplementation to prevent neural tube defects: A limited systematic review update for the U.S. AHRQ Publication No. 22-05302-EF-1.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37552787</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl S.M. L-methylfolate: A vitamin for your monoamines. J. Clin. Psychiatry. 2008;69:1352&#x2013;1353. doi: 10.4088/JCP.v69n0901.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4088/JCP.v69n0901</ArticleId><ArticleId IdType=\"pubmed\">19193337</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Zou D., Li Y., Gu S., Dong J., Ma X., Xu S., Wang F., Huang J.H. Monoamine neurotransmitters control basic emotions and affect major depressive disorders. Pharmaceuticals. 2022;15:1203. doi: 10.3390/ph15101203.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ph15101203</ArticleId><ArticleId IdType=\"pmc\">PMC9611768</ArticleId><ArticleId IdType=\"pubmed\">36297314</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottiglieri T., Hyland K., Laundy M., Godfrey P., Carney M.W., Toone B.K., Reynolds E.H. Folate deficiency, biopterin and monoamine metabolism in depression. Psychol. Med. 1992;22:871&#x2013;876. doi: 10.1017/S0033291700038447.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S0033291700038447</ArticleId><ArticleId IdType=\"pubmed\">1283223</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottiglieri T., Laundy M., Crellin R., Toone B.K., Carney M.W., Reynolds E.H. Homocysteine, folate, methylation, and monoamine metabolism in depression. J. Neurol. Neurosurg. Psychiatry. 2000;69:228&#x2013;232. doi: 10.1136/jnnp.69.2.228.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jnnp.69.2.228</ArticleId><ArticleId IdType=\"pmc\">PMC1737050</ArticleId><ArticleId IdType=\"pubmed\">10896698</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L., Li S., Wang S., Wu X., Liu Y., Yu W., Wang Y., Tang Y., Xia M., Li B. Major depressive disorder: Hypothesis, mechanism, prevention and treatment. Signal Transduct. Target. Ther. 2024;9:30. doi: 10.1038/s41392-024-01738-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-024-01738-y</ArticleId><ArticleId IdType=\"pmc\">PMC10853571</ArticleId><ArticleId IdType=\"pubmed\">38331979</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender A., Hagan K.E., Kingston N. The association of folate and depression: A meta-analysis. J. Psychiatry Res. 2017;95:9&#x2013;18. doi: 10.1016/j.jpsychires.2017.07.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jpsychires.2017.07.019</ArticleId><ArticleId IdType=\"pubmed\">28759846</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi M., Sotoudeh G., Amini M., Raisi F., Mansoori A., Hosseinzadeh M. The relationship between dietary patterns and depression mediated by serum levels of folate and vitamin B12. BMC Psychiatry. 2020;20:63. doi: 10.1186/s12888-020-2455-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12888-020-2455-2</ArticleId><ArticleId IdType=\"pmc\">PMC7020545</ArticleId><ArticleId IdType=\"pubmed\">32054533</ArticleId></ArticleIdList></Reference><Reference><Citation>Liwinski T., Lang U.E. Folate and its significance in depressive disorders and suicidality: A comprehensive narrative review. Nutrients. 2023;15:3859. doi: 10.3390/nu15173859.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu15173859</ArticleId><ArticleId IdType=\"pmc\">PMC10490031</ArticleId><ArticleId IdType=\"pubmed\">37686891</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarris J., Murphy J., Mischoulon D., Papakostas G.I., Fava M., Berk M., Ng C.H. Adjunctive nutraceuticals for depression: A systematic review and meta-analyses. Am. J. Psychiatry. 2016;173:575&#x2013;587. doi: 10.1176/appi.ajp.2016.15091228.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1176/appi.ajp.2016.15091228</ArticleId><ArticleId IdType=\"pubmed\">27113121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarris J., Ravindran A., Yatham L.N., Marx W., Rucklidge J.J., McIntyre R.S., Akhondzadeh S., Benedetti F., Caneo C., Cramer H., et al. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. World J. Biol. Psychiatry. 2022;23:424&#x2013;455. doi: 10.1080/15622975.2021.2013041.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/15622975.2021.2013041</ArticleId><ArticleId IdType=\"pubmed\">35311615</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruf A.A., Poweleit E.A., Brown L.C., Strawn J.R., Bousman C.A. Systematic review and meta-analysis of L-methylfolate augmentation in depressive disorders. Pharmacopsychiatry. 2022;55:139&#x2013;147. doi: 10.1055/a-1681-2047.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1055/a-1681-2047</ArticleId><ArticleId IdType=\"pubmed\">34794190</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts E., Carter B., Young A.H. Caveat emptor: Folate in unipolar depressive illness, a systematic review and meta-analysis. J. Psychopharmacol. 2018;32:377&#x2013;384. doi: 10.1177/0269881118756060.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0269881118756060</ArticleId><ArticleId IdType=\"pubmed\">29442609</ArticleId></ArticleIdList></Reference><Reference><Citation>Schefft C., Kilarski L.L., Bschor T., K&#xf6;hler S. Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis. Eur. Neuropsychopharmacol. 2017;27:1090&#x2013;1109. doi: 10.1016/j.euroneuro.2017.07.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.euroneuro.2017.07.004</ArticleId><ArticleId IdType=\"pubmed\">28988944</ArticleId></ArticleIdList></Reference><Reference><Citation>Frye R.E., Sequeira J.M., Quadros E.V., James S.J., Rossignol D.A. Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol. Psychiatry. 2013;18:369&#x2013;381. doi: 10.1038/mp.2011.175.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/mp.2011.175</ArticleId><ArticleId IdType=\"pmc\">PMC3578948</ArticleId><ArticleId IdType=\"pubmed\">22230883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaekers V.T., Th&#xf6;ny B., Sequeira J.M., Ansseau M., Philippe P., Boemer F., Bours V., Quadros E.V. Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies. Mol. Genet. Metab. 2014;113:307&#x2013;314. doi: 10.1016/j.ymgme.2014.10.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ymgme.2014.10.002</ArticleId><ArticleId IdType=\"pubmed\">25456743</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossignol D.A., Frye R.E. Cerebral folate deficiency, folate receptor alpha autoantibodies and leucovorin (folinic acid) treatment in autism spectrum disorders: A systematic review and meta-analysis. J. Pers. Med. 2021;11:1141. doi: 10.3390/jpm11111141.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jpm11111141</ArticleId><ArticleId IdType=\"pmc\">PMC8622150</ArticleId><ArticleId IdType=\"pubmed\">34834493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis S.J., Lawlor D.A., Davey Smith G., Araya R., Timpson N., Day I.N., Ebrahim S. The thermolabile variant of MTHFR is associated with depression in the British Women&#x2019;s Heart and Health Study and a meta-analysis. Mol. Psychiatry. 2006;11:352&#x2013;360. doi: 10.1038/sj.mp.4001790.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.mp.4001790</ArticleId><ArticleId IdType=\"pubmed\">16402130</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbody S., Lewis S., Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: A HuGE review. Am. J. Epidemiol. 2007;165:1&#x2013;13. doi: 10.1093/aje/kwj347.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/kwj347</ArticleId><ArticleId IdType=\"pubmed\">17074966</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashayekhi F., Hadipour E., Shabani S., Salehi Z. Folate receptor alpha autoantibodies in the serum of patients with relapsing-remitting multiple sclerosis (RRMS) Clin. Neurol. Neurosurg. 2024;237:108161. doi: 10.1016/j.clineuro.2024.108161.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clineuro.2024.108161</ArticleId><ArticleId IdType=\"pubmed\">38325038</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton S.A., Kim W.K., Choi Y.B., Kumar S., D&#x2019;Emilia D.M., Rayudu P.V., Arnelle D.R., Stamler J.S. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA. 1997;94:5923&#x2013;5928. doi: 10.1073/pnas.94.11.5923.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.94.11.5923</ArticleId><ArticleId IdType=\"pmc\">PMC20882</ArticleId><ArticleId IdType=\"pubmed\">9159176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruman I.I., Culmsee C., Chan S.L., Kruman Y., Guo Z., Penix L., Mattson M.P. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 2000;20:6920&#x2013;6926. doi: 10.1523/JNEUROSCI.20-18-06920.2000.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.20-18-06920.2000</ArticleId><ArticleId IdType=\"pmc\">PMC6772815</ArticleId><ArticleId IdType=\"pubmed\">10995836</ArticleId></ArticleIdList></Reference><Reference><Citation>White A.R., Huang X., Jobling M.F., Barrow C.J., Beyreuther K., Masters C.L., Bush A.I., Cappai R. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: Possible risk factors in the Alzheimer&#x2019;s-type neurodegenerative pathways. J. Neurochem. 2001;76:1509&#x2013;1520. doi: 10.1046/j.1471-4159.2001.00178.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1046/j.1471-4159.2001.00178.x</ArticleId><ArticleId IdType=\"pubmed\">11238735</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho P.I., Ashline D., Dhitavat S., Ortiz D., Collins S.C., Shea T.B., Rogers E. Folate deprivation induces neurodegeneration: Roles of oxidative stress and increased homocysteine. Neurobiol. Dis. 2003;14:32&#x2013;42. doi: 10.1016/S0969-9961(03)00070-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0969-9961(03)00070-6</ArticleId><ArticleId IdType=\"pubmed\">13678664</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayal S., Arning E., Bottiglieri T., B&#xf6;ger R.H., Sigmund C.D., Faraci F.M., Lentz S.R. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke. 2004;35:1957&#x2013;1962. doi: 10.1161/01.STR.0000131749.81508.18.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/01.STR.0000131749.81508.18</ArticleId><ArticleId IdType=\"pubmed\">15178827</ArticleId></ArticleIdList></Reference><Reference><Citation>Elens I., Dekeyster E., Moons L., D&#x2019;Hooge R. Methotrexate affects cerebrospinal fluid folate and tau levels and induces late cognitive deficits in mice. Neuroscience. 2019;404:62&#x2013;70. doi: 10.1016/j.neuroscience.2019.01.024.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroscience.2019.01.024</ArticleId><ArticleId IdType=\"pubmed\">30703509</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaikh A., Roy H. Folate deprivation induced neuroinflammation impairs cognition. Neurosci. Lett. 2023;807:137264. doi: 10.1016/j.neulet.2023.137264.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2023.137264</ArticleId><ArticleId IdType=\"pubmed\">37086862</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantone M., Sacco L. Editorial: Highlights in Alzheimer&#x2019;s and Parkinson&#x2019;s disease. Front. Hum. Neurosci. 2023;17:1238525. doi: 10.3389/fnhum.2023.1238525.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnhum.2023.1238525</ArticleId><ArticleId IdType=\"pmc\">PMC10443213</ArticleId><ArticleId IdType=\"pubmed\">37614569</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Yang F., Zhang S., Xin R., Sun Y. Genetic and environmental factors in Alzheimer&#x2019;s and Parkinson&#x2019;s diseases and promising therapeutic intervention via fecal microbiota transplantation. NPJ Parkinsons. Dis. 2021;7:70. doi: 10.1038/s41531-021-00213-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41531-021-00213-7</ArticleId><ArticleId IdType=\"pmc\">PMC8357954</ArticleId><ArticleId IdType=\"pubmed\">34381040</ArticleId></ArticleIdList></Reference><Reference><Citation>Charbit J., Vidal J.S., Hanon O. The role of nutrition in the prevention of cognitive decline. Curr. Opin. Clin. Nutr. Metab. Care. 2024;27:9&#x2013;16. doi: 10.1097/MCO.0000000000001002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MCO.0000000000001002</ArticleId><ArticleId IdType=\"pubmed\">38001066</ArticleId></ArticleIdList></Reference><Reference><Citation>Puri S., Shaheen M., Grover B. Nutrition and cognitive health: A life course approach. Front. Public Health. 2023;11:1023907. doi: 10.3389/fpubh.2023.1023907.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpubh.2023.1023907</ArticleId><ArticleId IdType=\"pmc\">PMC10083484</ArticleId><ArticleId IdType=\"pubmed\">37050953</ArticleId></ArticleIdList></Reference><Reference><Citation>Waly M.I. Nutritional Management and Metabolic Aspects of Hyperhomocysteinemia. Springer; Berlin/Heidelberg, Germany: 2021.</Citation></Reference><Reference><Citation>Wang Z., Zhu W., Xing Y., Jia J., Tang Y. B vitamins and prevention of cognitive decline and incident dementia: A systematic review and meta-analysis. Nutr. Rev. 2022;80:931&#x2013;949. doi: 10.1093/nutrit/nuab057.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nutrit/nuab057</ArticleId><ArticleId IdType=\"pubmed\">34432056</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Liu S., Ji L., Wu T., Ma F., Ji Y., Zhou Y., Zheng M., Zhang M., Huang G. Associations between Alzheimer&#x2019;s disease and blood homocysteine, vitamin B12, and folate: A case-control study. Curr. Alzheimer Res. 2015;12:88&#x2013;94. doi: 10.2174/1567205012666141218144035.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567205012666141218144035</ArticleId><ArticleId IdType=\"pubmed\">25523421</ArticleId></ArticleIdList></Reference><Reference><Citation>Postiglione A., Milan G., Ruocco A., Gallotta G., Guiotto G., Di Minno G. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer&#x2019;s dementia. A case-control study. Gerontology. 2001;47:324&#x2013;329. doi: 10.1159/000052822.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000052822</ArticleId><ArticleId IdType=\"pubmed\">11721146</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida C.C., Brentani H.P., Forlenza O.V., Diniz B.S. Serum folic acid is reduced in patients with Alzheimer&#x2019;s disease. Arch. Clin. 2012;39:90&#x2013;93.</Citation></Reference><Reference><Citation>Yukawa M., Naka H., Murata Y., Katayama S., Kohriyama T., Mimori Y., Nakamura S. Folic acid-responsive neurological diseases in Japan. J. Nutr. Sci. Vitaminol. 2001;47:181&#x2013;187. doi: 10.3177/jnsv.47.181.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3177/jnsv.47.181</ArticleId><ArticleId IdType=\"pubmed\">11575572</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos E.F., Busanello E.N., Miglioranza A., Zanatta A., Barchak A.G., Vargas C.R., Saute J., Rosa C., Carrion M.J., Camargo D., et al. Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson&#x2019;s disease. Metab. Brain Dis. 2009;24:257&#x2013;269. doi: 10.1007/s11011-009-9139-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11011-009-9139-4</ArticleId><ArticleId IdType=\"pubmed\">19294496</ArticleId></ArticleIdList></Reference><Reference><Citation>Peri&#xf1;&#xe1;n M.T., Mac&#xed;as-Garc&#xed;a D., Jes&#xfa;s S., Mart&#xed;n-Rodr&#xed;guez J.F., Mu&#xf1;oz-Delgado L., Jimenez-Jaraba M.V., Buiza-Rueda D., Bonilla-Toribio M., Adarmes-G&#xf3;mez A.D., G&#xf3;mez-Garre P., et al. Homocysteine levels, genetic background, and cognitive impairment in Parkinson&#x2019;s disease. J. Neurol. 2023;270:477&#x2013;485. doi: 10.1007/s00415-022-11361-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00415-022-11361-y</ArticleId><ArticleId IdType=\"pmc\">PMC9813118</ArticleId><ArticleId IdType=\"pubmed\">36169739</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomic S., Pekic V., Popijac Z., Pucic T., Vinkovic M.P., Kuric T.G., Popovic Z. Hyperhomocysteinemia influenced malnutrition in Parkinson&#x2019;s disease patients. Neurol. Sci. 2018;39:1691&#x2013;1695. doi: 10.1007/s10072-018-3480-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10072-018-3480-5</ArticleId><ArticleId IdType=\"pubmed\">29961201</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma F., Li Q., Zhou X., Zhao J., Song A., Li W., Liu H., Xu W., Huang G. Effects of folic acid supplementation on cognitive function and Abeta-related biomarkers in mild cognitive impairment: A randomized controlled trial. Eur. J. Nutr. 2019;58:345&#x2013;356. doi: 10.1007/s00394-017-1598-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00394-017-1598-5</ArticleId><ArticleId IdType=\"pubmed\">29255930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma F., Wu T., Zhao J., Han F., Marseglia A., Liu H., Huang G. Effects of 6-Month Folic Acid Supplementation on Cognitive Function and Blood Biomarkers in Mild Cognitive Impairment: A Randomized Controlled Trial in China. J. Gerontol. A Biol. Sci. Med. Sci. 2016;71:1376&#x2013;1383. doi: 10.1093/gerona/glv183.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gerona/glv183</ArticleId><ArticleId IdType=\"pubmed\">26508298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma F., Wu T., Zhao J., Song A., Liu H., Xu W., Huang G. Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI. Sci. Rep. 2016;6:37486. doi: 10.1038/srep37486.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/srep37486</ArticleId><ArticleId IdType=\"pmc\">PMC5120319</ArticleId><ArticleId IdType=\"pubmed\">27876835</ArticleId></ArticleIdList></Reference><Reference><Citation>Durga J., van Boxtel M.P., Schouten E.G., Kok F.J., Jolles J., Katan M.B., Verhoef P. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: A randomised, double blind, controlled trial. Lancet. 2007;369:208&#x2013;216. doi: 10.1016/S0140-6736(07)60109-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(07)60109-3</ArticleId><ArticleId IdType=\"pubmed\">17240287</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv X., Wang X., Wang Y., Zhou D., Li W., Wilson J.X., Chang H., Huang G. Folic acid delays age-related cognitive decline in senescence-accelerated mouse prone 8: Alleviating telomere attrition as a potential mechanism. Aging. 2019;11:10356&#x2013;10373. doi: 10.18632/aging.102461.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/aging.102461</ArticleId><ArticleId IdType=\"pmc\">PMC6914419</ArticleId><ArticleId IdType=\"pubmed\">31757935</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer B.R., Hoff A.L., Costa M. Folic acid supplementation in dementia: A preliminary report. J. Geriatr. Psychiatry Neurol. 2003;16:156&#x2013;159. doi: 10.1177/0891988703256052.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0891988703256052</ArticleId><ArticleId IdType=\"pubmed\">12967058</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Liu S., Ji L., Wu T., Ji Y., Zhou Y., Zheng M., Zhang M., Xu W., Huang G. Folic acid supplementation mitigates Alzheimer&#x2019;s disease by reducing inflammation: A randomized controlled trial. Mediators Inflamm. 2016;2016:5912146. doi: 10.1155/2016/5912146.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2016/5912146</ArticleId><ArticleId IdType=\"pmc\">PMC4909909</ArticleId><ArticleId IdType=\"pubmed\">27340344</ArticleId></ArticleIdList></Reference><Reference><Citation>Connelly P.J., Prentice N.P., Cousland G., Bonham J. A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer&#x2019;s disease. Int. J. Geriatr. Psychiatry. 2008;23:155&#x2013;160. doi: 10.1002/gps.1856.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/gps.1856</ArticleId><ArticleId IdType=\"pubmed\">17600848</ArticleId></ArticleIdList></Reference><Reference><Citation>Hama Y., Hamano T., Shirafuji N., Hayashi K., Ueno A., Enomoto S., Nagata M., Kimura H., Matsunaga A., Ikawa M., et al. Influences of folate supplementation on homocysteine and cognition in patients with folate deficiency and cognitive impairment. Nutrients. 2020;12:3138. doi: 10.3390/nu12103138.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu12103138</ArticleId><ArticleId IdType=\"pmc\">PMC7602498</ArticleId><ArticleId IdType=\"pubmed\">33066591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahimagic O.C., Smajlovic D., Dostovic Z., Pasic Z., Kunic S., Iljazovic A., Hajdarevic D.S. Hyperhomocysteinemia and Its Treatment in Patients with Parkinson&#x2019;s Disease. Mater. Sociomed. 2016;28:303&#x2013;306. doi: 10.5455/msm.2016.28.303-306.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5455/msm.2016.28.303-306</ArticleId><ArticleId IdType=\"pmc\">PMC5034996</ArticleId><ArticleId IdType=\"pubmed\">27698607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Y., Yuan S., Huang X., Tan S., Cheng H., Xu A., Lyu J. Associations of folate/folic acid supplementation alone and in combination with other B vitamins on dementia risk and brain structure: Evidence from 466 224 UK Biobank participants. J. Gerontol. A Biol. Sci. Med. Sci. 2024;79:glad266. doi: 10.1093/gerona/glad266.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gerona/glad266</ArticleId><ArticleId IdType=\"pmc\">PMC10957129</ArticleId><ArticleId IdType=\"pubmed\">38029284</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller T., Woitalla D., Kuhn W. Benefit of folic acid supplementation in parkinsonian patients treated with levodopa. J. Neurol. Neurosurg. Psychiatry. 2003;74:549. doi: 10.1136/jnnp.74.4.549.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jnnp.74.4.549</ArticleId><ArticleId IdType=\"pmc\">PMC1738372</ArticleId><ArticleId IdType=\"pubmed\">12640094</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X.W., Qin S.M., Li D., Hu L.F., Liu C.F. Elevated homocysteine levels in levodopa-treated idiopathic Parkinson&#x2019;s disease: A meta-analysis. Acta Neurol. Scand. 2013;128:73&#x2013;82. doi: 10.1111/ane.12106.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ane.12106</ArticleId><ArticleId IdType=\"pubmed\">23432663</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Y., Li J., Wang Y., Ma Y., Chen L., Zhang H., Xue M., Liang H. Folic acid rescues dopaminergic neurons in MPTP-induced mice by inhibiting the NLRP3 inflammasome and ameliorating mitochondrial impairment. J. Agric. Food Chem. 2024;72:5734&#x2013;5745. doi: 10.1021/acs.jafc.3c06337.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.3c06337</ArticleId><ArticleId IdType=\"pubmed\">38453725</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghdoost-Yazdi H., Fraidouni N., Faraji A., Jahanihashemi H., Sarookhani M. High intake of folic acid or complex of B vitamins provides anti-Parkinsonism effect: No role for serum level of homocysteine. Behav. Brain Res. 2012;233:375&#x2013;381. doi: 10.1016/j.bbr.2012.05.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbr.2012.05.011</ArticleId><ArticleId IdType=\"pubmed\">22610053</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastav S., Singh S.K., Yadav A.K., Srikrishna S. Folic Acid Supplementation Ameliorates Oxidative Stress, Metabolic Functions and Developmental Anomalies in a Novel Fly Model of Parkinson&#x2019;s Disease. Neurochem. Res. 2015;40:1350&#x2013;1359. doi: 10.1007/s11064-015-1598-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11064-015-1598-x</ArticleId><ArticleId IdType=\"pubmed\">25963948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu N., Wang X. The level of homocysteine in amyotrophic lateral sclerosis: A systematic review and meta-analysis. Neurol. Sci. 2023;44:1185&#x2013;1192. doi: 10.1007/s10072-022-06518-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10072-022-06518-6</ArticleId><ArticleId IdType=\"pubmed\">36422727</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Liu Z., Sun W., Yuan Y., Jiao B., Zhang X., Shen L., Jiang H., Xia K., Tang B., et al. Association between vitamins and amyotrophic lateral sclerosis: A center-based survey in Mainland China. Front. Neurol. 2020;11:488. doi: 10.3389/fneur.2020.00488.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2020.00488</ArticleId><ArticleId IdType=\"pmc\">PMC7314934</ArticleId><ArticleId IdType=\"pubmed\">32625160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Fan D. The relation between plasma homocysteine level and amyotrophic lateral sclerosis. Zhonghua Nei Ke Za Zhi. 2012;51:308&#x2013;310.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22781953</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S., Simone I.L., Lamberti P., Samarelli V., Tortelli R., Serlenga L., Logroscino G. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis. Neurology. 2008;70:222&#x2013;225. doi: 10.1212/01.wnl.0000297193.53986.6f.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/01.wnl.0000297193.53986.6f</ArticleId><ArticleId IdType=\"pubmed\">18195267</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Chen S., Li L., Wang Q., Le W. Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1 G93A transgenic mice. Neuropharmacology. 2008;54:1112&#x2013;1119. doi: 10.1016/j.neuropharm.2008.02.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuropharm.2008.02.020</ArticleId><ArticleId IdType=\"pubmed\">18436268</ArticleId></ArticleIdList></Reference><Reference><Citation>An Y., Feng L., Zhang X., Wang Y., Wang Y., Tao L., Qin Z., Xiao R. Dietary intakes and biomarker patterns of folate, vitamin B(6), and vitamin B(12) can be associated with cognitive impairment by hypermethylation of redox-related genes NUDT15 and TXNRD1. Clin. Epigenet. 2019;11:139. doi: 10.1186/s13148-019-0741-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13148-019-0741-y</ArticleId><ArticleId IdType=\"pmc\">PMC6787977</ArticleId><ArticleId IdType=\"pubmed\">31601260</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Liu S., Ge B., Zhou D., Li M., Li W., Ma F., Liu Z., Ji Y., Huang G. Effects of folic acid and vitamin B12 supplementation on cognitive impairment and inflammation in patients with Alzheimer&#x2019;s disease: A randomized, single-blinded, placebo-controlled trial. J. Prev. Alzheimers Dis. 2021;8:249&#x2013;256. doi: 10.14283/jpad.2021.22.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14283/jpad.2021.22</ArticleId><ArticleId IdType=\"pubmed\">34101780</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng D., Kong H., Pang W., Yang H., Lu H., Huang C., Jiang Y. B vitamin supplementation improves cognitive function in the middle aged and elderly with hyperhomocysteinemia. Nutr. Neurosci. 2016;19:461&#x2013;466. doi: 10.1179/1476830514Y.0000000136.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1179/1476830514Y.0000000136</ArticleId><ArticleId IdType=\"pubmed\">24938711</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Refsum H., de Jager C.A., Jacoby R., Nichols T.E., Smith S.M., Smith A.D. Preventing Alzheimer&#x2019;s disease-related gray matter atrophy by B-vitamin treatment. Proc. Natl. Acad. Sci. USA. 2013;110:9523&#x2013;9528. doi: 10.1073/pnas.1301816110.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1301816110</ArticleId><ArticleId IdType=\"pmc\">PMC3677457</ArticleId><ArticleId IdType=\"pubmed\">23690582</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A.D., Smith S.M., de Jager C.A., Whitbread P., Johnston C., Agacinski G., Oulhaj A., Bradley K.M., Jacoby R., Refsum H. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS ONE. 2010;5:e12244. doi: 10.1371/journal.pone.0012244.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0012244</ArticleId><ArticleId IdType=\"pmc\">PMC2935890</ArticleId><ArticleId IdType=\"pubmed\">20838622</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Lu C.J., Chien K.L., Chen S.T., Chen R.C. Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer&#x2019;s disease: A 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients. Clin. Ther. 2007;29:2204&#x2013;2214. doi: 10.1016/j.clinthera.2007.10.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.clinthera.2007.10.012</ArticleId><ArticleId IdType=\"pubmed\">18042476</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretzschmar G.C., Targa A.D.S., Soares-Lima S.C., Dos Santos P.I., Rodrigues L.S., Macedo D.A., Ribeiro Pinto L.F., Lima M.M.S., Boldt A.B.W. Folic acid and vitamin B12 prevent deleterious effects of rotenone on object novelty recognition memory and kynu expression in an animal model of Parkinson&#x2019;s disease. Genes. 2022;13:2397. doi: 10.3390/genes13122397.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/genes13122397</ArticleId><ArticleId IdType=\"pmc\">PMC9778036</ArticleId><ArticleId IdType=\"pubmed\">36553663</ArticleId></ArticleIdList></Reference><Reference><Citation>Boston P.F., McKirdy S.J., Al-Turki M.A., Barker M.E., Russell J.M. Vitamin B12 and folate levels in progression of Alzheimer&#x2019;s disease&#x2014;A short report. Int. J. Psychiatry Clin. Pract. 2020;24:68&#x2013;70. doi: 10.1080/13651501.2019.1681457.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/13651501.2019.1681457</ArticleId><ArticleId IdType=\"pubmed\">31661337</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen P.S., Schneider L.S., Sano M., Diaz-Arrastia R., van Dyck C.H., Weiner M.F., Bottiglieri T., Jin S., Stokes K.T., Thomas R.G., et al. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: A randomized controlled trial. JAMA. 2008;300:1774&#x2013;1783. doi: 10.1001/jama.300.15.1774.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.300.15.1774</ArticleId><ArticleId IdType=\"pmc\">PMC2684821</ArticleId><ArticleId IdType=\"pubmed\">18854539</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford A.H., Flicker L., Alfonso H., Thomas J., Clarnette R., Martins R., Almeida O.P. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology. 2010;75:1540&#x2013;1547. doi: 10.1212/WNL.0b013e3181f962c4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0b013e3181f962c4</ArticleId><ArticleId IdType=\"pubmed\">20861451</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F., Vignaroli F., Mazzini L., Comi C., Tondo G. New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer&#x2019;s Disease: Preventive and Therapeutic Perspectives. CNS Neurol. Disord. Drug Targets. 2024;23:614&#x2013;627. doi: 10.2174/1871527322666230608110201.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1871527322666230608110201</ArticleId><ArticleId IdType=\"pubmed\">37291780</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen J. The LipiDiDiet trial: What does it add to the current evidence for Fortasyn Connect in early Alzheimer&#x2019;s disease? Clin. Interv. Aging. 2019;14:1481&#x2013;1492. doi: 10.2147/CIA.S211739.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/CIA.S211739</ArticleId><ArticleId IdType=\"pmc\">PMC6699494</ArticleId><ArticleId IdType=\"pubmed\">31616139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurtman R.J., Cansev M., Sakamoto T., Ulus I.H. Use of phosphatide precursors to promote synaptogenesis. Annu. Rev. Nutr. 2009;29:59&#x2013;87. doi: 10.1146/annurev-nutr-080508-141059.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-nutr-080508-141059</ArticleId><ArticleId IdType=\"pubmed\">19400698</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J., Scheltens P., McKeith I., Blesa R., Harrison J.E., Bertolucci P.H., Rockwood K., Wilkinson D., Wijker W., Bennett D.A., et al. Effect size analyses of souvenaid in patients with Alzheimer&#x2019;s disease. J. Alzheimers Dis. 2017;55:1131&#x2013;1139. doi: 10.3233/JAD-160745.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-160745</ArticleId><ArticleId IdType=\"pmc\">PMC5147481</ArticleId><ArticleId IdType=\"pubmed\">27767993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sijben J.W.C., de Wilde M.C., Wieggers R., Groenendijk M., Kamphuis P.J.G.H. A multi nutrient concept to enhance synapse formation and function: Science behind a medical food for Alzheimer&#x2019;s disease. Ol&#xe9;agineux Corp. Gras Lipides. 2011;18:267&#x2013;270. doi: 10.1051/ocl.2011.0410.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1051/ocl.2011.0410</ArticleId></ArticleIdList></Reference><Reference><Citation>Olde Rikkert M.G., Verhey F.R., Blesa R., von Arnim C.A., Bongers A., Harrison J., Sijben J., Scarpini E., Vandewoude M.F., Vellas B., et al. Tolerability and safety of Souvenaid in patients with mild Alzheimer&#x2019;s disease: Results of multi-center, 24-week, open-label extension study. J. Alzheimers Dis. 2015;44:471&#x2013;480. doi: 10.3233/JAD-141305.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-141305</ArticleId><ArticleId IdType=\"pubmed\">25322923</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P., Kamphuis P.J., Verhey F.R., Olde Rikkert M.G., Wurtman R.J., Wilkinson D., Twisk J.W., Kurz A. Efficacy of a medical food in mild Alzheimer&#x2019;s disease: A randomized, controlled trial. Alzheimers Dement. 2010;6:1.e11&#x2013;10.e11. doi: 10.1016/j.jalz.2009.10.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2009.10.003</ArticleId><ArticleId IdType=\"pubmed\">20129316</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P., Twisk J.W., Blesa R., Scarpini E., von Arnim C.A., Bongers A., Harrison J., Swinkels S.H., Stam C.J., de Waal H., et al. Efficacy of Souvenaid in mild Alzheimer&#x2019;s disease: Results from a randomized, controlled trial. J. Alzheimers Dis. 2012;31:225&#x2013;236. doi: 10.3233/JAD-2012-121189.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-2012-121189</ArticleId><ArticleId IdType=\"pubmed\">22766770</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waal H., Stam C.J., Lansbergen M.M., Wieggers R.L., Kamphuis P.J., Scheltens P., Maestu F., van Straaten E.C. The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer&#x2019;s disease: A randomised controlled study. PLoS ONE. 2014;9:e86558. doi: 10.1371/journal.pone.0086558.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0086558</ArticleId><ArticleId IdType=\"pmc\">PMC3903587</ArticleId><ArticleId IdType=\"pubmed\">24475144</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah R.C., Kamphuis P.J., Leurgans S., Swinkels S.H., Sadowsky C.H., Bongers A., Rappaport S.A., Quinn J.F., Wieggers R.L., Scheltens P., et al. The S-Connect study: Results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer&#x2019;s disease. Alzheimers Res. Ther. 2013;5:59. doi: 10.1186/alzrt224.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/alzrt224</ArticleId><ArticleId IdType=\"pmc\">PMC3978853</ArticleId><ArticleId IdType=\"pubmed\">24280255</ArticleId></ArticleIdList></Reference><Reference><Citation>Remington R., Bechtel C., Larsen D., Samar A., Doshanjh L., Fishman P., Luo Y., Smyers K., Page R., Morrell C., et al. A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer&#x2019;s Disease. J. Alzheimers Dis. 2015;45:395&#x2013;405. doi: 10.3233/JAD-142499.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-142499</ArticleId><ArticleId IdType=\"pubmed\">25589719</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K.H., Chiu C.H., Kuo W.W., Ju D.T., Shen C.Y., Chen R.J., Lin C.C., Viswanadha V.P., Liu J.S., Huang R.S., et al. The preventive effects of edible folic acid on cardiomyocyte apoptosis and survival in early onset triple-transgenic Alzheimer&#x2019;s disease model mice. Environ. Toxicol. 2018;33:83&#x2013;92. doi: 10.1002/tox.22498.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/tox.22498</ArticleId><ArticleId IdType=\"pubmed\">29068127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju D.T., Huang R.S., Tsai B.C., Su Y.C., Chiu P.L., Chang Y.M., Padma V.V., Ho T.J., Yao C.H., Kuo W.W., et al. Folic Acid and Folinic Acid Protect Hearts of Aging Triple-transgenic Alzheimer&#x2019;s Disease mice via IGF1R/PI3K/AKT and SIRT1/AMPK Pathways. Neurotox. Res. 2023;41:648&#x2013;659. doi: 10.1007/s12640-023-00666-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12640-023-00666-z</ArticleId><ArticleId IdType=\"pubmed\">37707697</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M.P., Haberman F. Folate and homocysteine metabolism: Therapeutic targets in cardiovascular and neurodegenerative disorders. Curr. Med. Chem. 2003;10:1923&#x2013;1929. doi: 10.2174/0929867033456864.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/0929867033456864</ArticleId><ArticleId IdType=\"pubmed\">12871094</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao H.M., Song Z.F., Xu H.D. Association between MTHFR genetic polymorphism and Parkinson&#x2019;s disease susceptibility: A meta-analysis. Open Med. 2019;14:613&#x2013;624. doi: 10.1515/med-2019-0069.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1515/med-2019-0069</ArticleId><ArticleId IdType=\"pmc\">PMC6698055</ArticleId><ArticleId IdType=\"pubmed\">31428686</ArticleId></ArticleIdList></Reference><Reference><Citation>Matherly L.H., Hou Z. Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter. Vitam. Horm. 2008;79:145&#x2013;184. doi: 10.1016/s0083-6729(08)00405-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s0083-6729(08)00405-6</ArticleId><ArticleId IdType=\"pmc\">PMC3806226</ArticleId><ArticleId IdType=\"pubmed\">18804694</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao R., Diop-Bove N., Visentin M., Goldman I.D. Mechanisms of membrane transport of folates into cells and across epithelia. Annu. Rev. Nutr. 2011;31:177&#x2013;201. doi: 10.1146/annurev-nutr-072610-145133.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-nutr-072610-145133</ArticleId><ArticleId IdType=\"pmc\">PMC3885234</ArticleId><ArticleId IdType=\"pubmed\">21568705</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu A., Jansen M., Sakaris A., Min S.H., Chattopadhyay S., Tsai E., Sandoval C., Zhao R., Akabas M.H., Goldman I.D. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. 2006;127:917&#x2013;928. doi: 10.1016/j.cell.2006.09.041.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2006.09.041</ArticleId><ArticleId IdType=\"pubmed\">17129779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothem L., Aronheim A., Assaraf Y.G. Alterations in the expression of transcription factors and the reduced folate carrier as a novel mechanism of antifolate resistance in human lLeukemia cells. J. Biol. Chem. 2003;278:8935&#x2013;8941. doi: 10.1074/jbc.M209578200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M209578200</ArticleId><ArticleId IdType=\"pubmed\">12519783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreri A.J., Dell&#x2019;Oro S., Capello D., Ponzoni M., Iuzzolino P., Rossi D., Pasini F., Ambrosetti A., Orvieto E., Ferrarese F., et al. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. Br. J. Haematol. 2004;126:657&#x2013;664. doi: 10.1111/j.1365-2141.2004.05109.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2141.2004.05109.x</ArticleId><ArticleId IdType=\"pubmed\">15327516</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Singh R., Rios Z., Bhushan A., Li M., Sheridan P.P., Bearden S.E., Lai J.C.K., Agbenowu S., Cao S., et al. Tyrosine phosphorylation of HSC70 and its interaction with RFC mediates methotrexate resistance in murine L1210 leukemia cells. Cancer Lett. 2015;357:231&#x2013;241. doi: 10.1016/j.canlet.2014.11.036.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.canlet.2014.11.036</ArticleId><ArticleId IdType=\"pmc\">PMC4785865</ArticleId><ArticleId IdType=\"pubmed\">25444929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman Y., Ifergan I., Rothem L., Jansen G., Assaraf Y.G. Coexistence of multiple mechanisms of PT523 resistance in human leukemia cells harboring 3 reduced folate carrier alleles: Transcriptional silencing, inactivating mutations, and allele loss. Blood. 2006;107:3288&#x2013;3294. doi: 10.1182/blood-2005-10-4048.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood-2005-10-4048</ArticleId><ArticleId IdType=\"pubmed\">16368880</ArticleId></ArticleIdList></Reference><Reference><Citation>Matherly L.H., Hou Z., Gangjee A. The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer. Cancer Chemother. Pharmacol. 2018;81:1&#x2013;15. doi: 10.1007/s00280-017-3473-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00280-017-3473-8</ArticleId><ArticleId IdType=\"pmc\">PMC5756103</ArticleId><ArticleId IdType=\"pubmed\">29127457</ArticleId></ArticleIdList></Reference><Reference><Citation>Raz S., Stark M., Assaraf Y.G. Folylpoly-&#x3b3;-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer. Drug Resist. Updat. 2016;28:43&#x2013;64. doi: 10.1016/j.drup.2016.06.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.drup.2016.06.004</ArticleId><ArticleId IdType=\"pubmed\">27620954</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.C., Bernal S.D. Reversal of methotrexate resistance in human squamous carcinoma cells by SQM1-liposome. Anticancer Res. 1999;19:251&#x2013;254.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10226550</ArticleId></ArticleIdList></Reference><Reference><Citation>Scionti I., Michelacci F., Pasello M., Hattinger C.M., Alberghini M., Manara M.C., Bacci G., Ferrari S., Scotlandi K., Picci P., et al. Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma. Ann. Oncol. 2008;19:1500&#x2013;1508. doi: 10.1093/annonc/mdn148.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/annonc/mdn148</ArticleId><ArticleId IdType=\"pubmed\">18385200</ArticleId></ArticleIdList></Reference><Reference><Citation>Organista-Nava J., G&#xf3;mez-G&#xf3;mez Y., Illades-Aguiar B., Rivera-Ram&#xed;rez A.B., Saavedra-Herrera M.V., Leyva-V&#xe1;zquez M.A. Overexpression of dihydrofolate reductase is a factor of poor survival in acute lymphoblastic leukemia. Oncol. Lett. 2018;15:8405&#x2013;8411. doi: 10.3892/ol.2018.8429.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/ol.2018.8429</ArticleId><ArticleId IdType=\"pmc\">PMC5950508</ArticleId><ArticleId IdType=\"pubmed\">29805575</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;ker E., Waltham M., Kheradpour A., Trippett T., Mazumdar M., Elisseyeff Y., Schnieders B., Steinherz P., Tan C., Berman E., et al. Amplification of the dihydrofolate reductase gene Is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Blood. 1995;86:677&#x2013;684. doi: 10.1182/blood.V86.2.677.bloodjournal862677.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood.V86.2.677.bloodjournal862677</ArticleId><ArticleId IdType=\"pubmed\">7605998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamed K.M., Dighriri I.M., Baomar A.F., Alharthy B.T., Alenazi F.E., Alali G.H., Alenazy R.H., Alhumaidi N.T., Alhulayfi D.H., Alotaibi Y.B., et al. Overview of methotrexate toxicity: A comprehensive literature review. Cureus. 2022;14:e29518. doi: 10.7759/cureus.29518.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7759/cureus.29518</ArticleId><ArticleId IdType=\"pmc\">PMC9595261</ArticleId><ArticleId IdType=\"pubmed\">36312688</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Zhang D., Huang L., Li G., Chen L., Ma J., Li M., Wei M., Zhou W., Zhou C., et al. Discovery of novel biomarkers of therapeutic responses in Han Chinese pemetrexed-based treated advanced NSCLC patients. Front. Pharmacol. 2019;10:944. doi: 10.3389/fphar.2019.00944.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2019.00944</ArticleId><ArticleId IdType=\"pmc\">PMC6716463</ArticleId><ArticleId IdType=\"pubmed\">31507426</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda S. Functional characteristics and pharmacokinetic significance of kidney-specific organic anion transporters, OAT-K1 and OAT-K2, in the urinary excretion of anionic drugs. Drug Metab. Pharmacokinet. 2003;18:91&#x2013;103. doi: 10.2133/dmpk.18.91.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2133/dmpk.18.91</ArticleId><ArticleId IdType=\"pubmed\">15618723</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon D.H., Glynn R.J., Karlson E.W., Lu F., Corrigan C., Colls J., Xu C., MacFadyen J., Barbhaiya M., Berliner N., et al. Adverse effects of low-dose methotrexate: A randomized trial. Ann. Intern. Med. 2020;172:369&#x2013;380. doi: 10.7326/M19-3369.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7326/M19-3369</ArticleId><ArticleId IdType=\"pmc\">PMC7229518</ArticleId><ArticleId IdType=\"pubmed\">32066146</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdallah H.M., Al-Abd A.M., El-Dine R.S., El-Halawany A.M. P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review. J. Adv. Res. 2015;6:45&#x2013;62. doi: 10.1016/j.jare.2014.11.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jare.2014.11.008</ArticleId><ArticleId IdType=\"pmc\">PMC4293676</ArticleId><ArticleId IdType=\"pubmed\">25685543</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu X., Manautou J.E. Regulation of hepatic ABCC transporters by xenobiotics and in disease states. Drug Metab. Rev. 2010;42:482&#x2013;538. doi: 10.3109/03602531003654915.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/03602531003654915</ArticleId><ArticleId IdType=\"pmc\">PMC4458072</ArticleId><ArticleId IdType=\"pubmed\">20233023</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez M., Javaid F., Chudasama V. Advances in targeting the folate receptor in the treatment/imaging of cancers. Chem. Sci. 2018;9:790&#x2013;810. doi: 10.1039/C7SC04004K.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C7SC04004K</ArticleId><ArticleId IdType=\"pmc\">PMC5890329</ArticleId><ArticleId IdType=\"pubmed\">29675145</ArticleId></ArticleIdList></Reference><Reference><Citation>Alekseeva A.A., Moiseeva E.V., Onishchenko N.R., Boldyrev I.A., Singin A.S., Budko A.P., Shprakh Z.S., Molotkovsky J.G., Vodovozova E.L. Liposomal formulation of a methotrexate lipophilic prodrug: Assessment in tumor cells and mouse T-cell leukemic lymphoma. Int. J. Nanomed. 2017;12:3735&#x2013;3749. doi: 10.2147/IJN.S133034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/IJN.S133034</ArticleId><ArticleId IdType=\"pmc\">PMC5439940</ArticleId><ArticleId IdType=\"pubmed\">28553111</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodhi M.S., Khalid F., Khan M.T., Samra Z.Q., Muhammad S., Zhang Y.J., Mou K. A novel method of magnetic nanoparticles functionalized with anti-folate receptor antibody and methotrexate for antibody mediated targeted drug delivery. Molecules. 2022;27:261. doi: 10.3390/molecules27010261.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules27010261</ArticleId><ArticleId IdType=\"pmc\">PMC8747068</ArticleId><ArticleId IdType=\"pubmed\">35011493</ArticleId></ArticleIdList></Reference><Reference><Citation>Achar A., Myers R., Ghosh C. Drug delivery challenges in brain disorders across the blood-brain barrier: Novel methods and future considerations for improved therapy. Biomedicines. 2021;9:1834. doi: 10.3390/biomedicines9121834.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines9121834</ArticleId><ArticleId IdType=\"pmc\">PMC8698904</ArticleId><ArticleId IdType=\"pubmed\">34944650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A.M., Sonabend A.M., Bruce J.N. Convection-enhanced delivery. Neurotherapeutics. 2017;14:358&#x2013;371. doi: 10.1007/s13311-017-0520-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13311-017-0520-4</ArticleId><ArticleId IdType=\"pmc\">PMC5398992</ArticleId><ArticleId IdType=\"pubmed\">28299724</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng S., Guo Y., Yan F., Yan F., Qi R., Shen J. Chances and challenges in intranasal administration delivery for brain disease treatment. Clin. Transl. Discov. 2023;3:e253. doi: 10.1002/ctd2.253.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ctd2.253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeiadeh I., Najjar A., Karaman R. Strategies for enhancing the permeation of CNS-active drugs through the blood-brain barrier: A review. Molecules. 2018;23:1289. doi: 10.3390/molecules23061289.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules23061289</ArticleId><ArticleId IdType=\"pmc\">PMC6100436</ArticleId><ArticleId IdType=\"pubmed\">29843371</ArticleId></ArticleIdList></Reference><Reference><Citation>Niazi S.K. Non-invasive drug delivery across the blood-brain barrier: A prospective analysis. Pharmaceutics. 2023;15:2599. doi: 10.3390/pharmaceutics15112599.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics15112599</ArticleId><ArticleId IdType=\"pmc\">PMC10674293</ArticleId><ArticleId IdType=\"pubmed\">38004577</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier-Sawyer J.K., Deng Y., Seo Y.E., Cheng C.J., Zhang J., Quijano E., Saltzman W.M. Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue. J. Drug Target. 2015;23:736&#x2013;749. doi: 10.3109/1061186X.2015.1065833.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/1061186X.2015.1065833</ArticleId><ArticleId IdType=\"pmc\">PMC4860350</ArticleId><ArticleId IdType=\"pubmed\">26453169</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro R.G.R., Coutinho A.J., Pinheiro M., Neves A.R. Nanoparticles for targeted brain drug delivery: What do we know? Int. J. Mol. Sci. 2021;22:11654. doi: 10.3390/ijms222111654.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms222111654</ArticleId><ArticleId IdType=\"pmc\">PMC8584083</ArticleId><ArticleId IdType=\"pubmed\">34769082</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess A., Hynynen K. Drug delivery across the blood-brain barrier using focused ultrasound. Expert. Opin. Drug Deliv. 2014;11:711&#x2013;721. doi: 10.1517/17425247.2014.897693.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1517/17425247.2014.897693</ArticleId><ArticleId IdType=\"pmc\">PMC4388327</ArticleId><ArticleId IdType=\"pubmed\">24650132</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Chen Q., Chen X., Han F., Chen Z., Wang Y. The blood-brain barrier: Structure, regulation, and drug delivery. Signal Transduct. Target. Ther. 2023;8:217. doi: 10.1038/s41392-023-01481-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-023-01481-w</ArticleId><ArticleId IdType=\"pmc\">PMC10212980</ArticleId><ArticleId IdType=\"pubmed\">37231000</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273172</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Multi-Omics Integration Analysis Pinpoint Proteins Influencing Brain Structure and Function: Toward Drug Targets and Neuroimaging Biomarkers for Neuropsychiatric Disorders.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9223</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179223</ELocationID><Abstract><AbstractText>Integrating protein quantitative trait loci (pQTL) data and summary statistics from genome-wide association studies (GWAS) of brain image-derived phenotypes (IDPs) can benefit in identifying IDP-related proteins. Here, we developed a systematic omics-integration analytic framework by sequentially using proteome-wide association study (PWAS), Mendelian randomization (MR), and colocalization (COLOC) analyses to identify the potentially causal brain and plasma proteins for IDPs, followed by pleiotropy analysis, mediation analysis, and drug exploration analysis to investigate potential mediation pathways of pleiotropic proteins to neuropsychiatric disorders (NDs) as well as candidate drug targets. A total of 201 plasma proteins and 398 brain proteins were significantly associated with IDPs from PWAS analysis. Subsequent MR and COLOC analyses further identified 313 potentially causal IDP-related proteins, which were significantly enriched in neural-related phenotypes, among which 91 were further identified as pleiotropic proteins associated with both IDPs and NDs, including <i>EGFR</i>, <i>TMEM106B</i>, <i>GPT</i>, and <i>HLA-B</i>. Drug prioritization analysis showed that 6.33% of unique pleiotropic proteins had drug targets or interactions with medications for NDs. Nine potential mediation pathways were identified to illustrate the mediating roles of the IDPs in the causal effect of the pleiotropic proteins on NDs, including the indirect effect of <i>TMEM106B</i> on Alzheimer's disease (AD) risk via radial diffusivity (RD) of the posterior limb of the internal capsule (PLIC), with the mediation proportion being 11.18%, and the indirect effect of <i>EGFR</i> on AD through RD of PLIC, RD of splenium of corpus callosum (SCC), and fractional anisotropy (FA) of SCC, with the mediation proportion being 18.99%, 22.79%, and 19.91%, respectively. These findings provide novel insights into pathogenesis, drug targets, and neuroimaging biomarkers of NDs.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Yunzhuang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44, Wenhua West Road, Jinan 250012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Dataology, Shandong University, 12550, Erhuan East Road, Jinan 250003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Sunjie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44, Wenhua West Road, Jinan 250012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Dataology, Shandong University, 12550, Erhuan East Road, Jinan 250003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gong</LastName><ForeName>Weiming</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44, Wenhua West Road, Jinan 250012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Dataology, Shandong University, 12550, Erhuan East Road, Jinan 250003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Xinyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44, Wenhua West Road, Jinan 250012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Dataology, Shandong University, 12550, Erhuan East Road, Jinan 250003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mo</LastName><ForeName>Qinyou</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44, Wenhua West Road, Jinan 250012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Dataology, Shandong University, 12550, Erhuan East Road, Jinan 250003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shen</LastName><ForeName>Lujia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44, Wenhua West Road, Jinan 250012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Dataology, Shandong University, 12550, Erhuan East Road, Jinan 250003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhao</LastName><ForeName>Yansong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44, Wenhua West Road, Jinan 250012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Dataology, Shandong University, 12550, Erhuan East Road, Jinan 250003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Shukang</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0002-4156-9784</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44, Wenhua West Road, Jinan 250012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Dataology, Shandong University, 12550, Erhuan East Road, Jinan 250003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yuan</LastName><ForeName>Zhongshang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44, Wenhua West Road, Jinan 250012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Dataology, Shandong University, 12550, Erhuan East Road, Jinan 250003, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>82173624</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>82373686</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>ZR2019ZD02</GrantID><Agency>Natural Science Foundation of Shandong Province</Agency><Country/></Grant><Grant><GrantID>tsqn202211025</GrantID><Agency>Taishan Scholar Project of Shandong Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D020543\">Proteome</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015415\" MajorTopicYN=\"Y\">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001921\" MajorTopicYN=\"Y\">Brain</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000000981\" MajorTopicYN=\"N\">diagnostic imaging</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D059906\" MajorTopicYN=\"Y\">Neuroimaging</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D040641\" MajorTopicYN=\"Y\">Quantitative Trait Loci</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D055106\" MajorTopicYN=\"Y\">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001523\" MajorTopicYN=\"Y\">Mental Disorders</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000000981\" MajorTopicYN=\"N\">diagnostic imaging</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D057182\" MajorTopicYN=\"N\">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020543\" MajorTopicYN=\"N\">Proteome</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D040901\" MajorTopicYN=\"N\">Proteomics</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D058685\" MajorTopicYN=\"N\">Genetic Pleiotropy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010641\" MajorTopicYN=\"N\">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000095028\" MajorTopicYN=\"N\">Multiomics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">brain and plasma proteins</Keyword><Keyword MajorTopicYN=\"N\">drug targets</Keyword><Keyword MajorTopicYN=\"N\">image-derived phenotypes</Keyword><Keyword MajorTopicYN=\"N\">neuropsychiatric disorders</Keyword><Keyword MajorTopicYN=\"N\">omics-integration analyses</Keyword><Keyword MajorTopicYN=\"N\">pleiotropy analysis</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273172</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179223</ArticleId><ArticleId IdType=\"pii\">ijms25179223</ArticleId><ArticleId IdType=\"pmc\">PMC11395524</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fu J., Zhang Q., Wang J., Wang M., Zhang B., Zhu W., Qiu S., Geng Z., Cui G., Yu Y., et al. Cross-Ancestry Genome-Wide Association Studies of Brain Imaging Phenotypes. Nat. Genet. 2024;56:1110&#x2013;1120. doi: 10.1038/s41588-024-01766-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41588-024-01766-y</ArticleId><ArticleId IdType=\"pubmed\">38811844</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarraj J.P.J., Kitagawa R., Kim D.H., Choi H.A. White Matter Connectivity for Early Prediction of Alzheimer&#x2019;s Disease. Technol. Health Care Off. J. Eur. Soc. Eng. Med. 2022;30:17&#x2013;28. doi: 10.3233/THC-192012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/THC-192012</ArticleId><ArticleId IdType=\"pubmed\">33998562</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K., Wu Z., Long J., Li W., Wang X., Hu N., Zhao X., Sun T. White Matter Changes in Parkinson&#x2019;s Disease. NPJ Park. Dis. 2023;9:150. doi: 10.1038/s41531-023-00592-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41531-023-00592-z</ArticleId><ArticleId IdType=\"pmc\">PMC10618166</ArticleId><ArticleId IdType=\"pubmed\">37907554</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldiroli A., Buoli M., van Haren N.E.M., de Nijs J., Altamura A.C., Cahn W. The Relationship of IQ and Emotional Processing with Insula Volume in Schizophrenia. Schizophr. Res. 2018;202:141&#x2013;148. doi: 10.1016/j.schres.2018.06.048.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.schres.2018.06.048</ArticleId><ArticleId IdType=\"pubmed\">29954697</ArticleId></ArticleIdList></Reference><Reference><Citation>Jauhar S., Johnstone M., McKenna P.J. Schizophrenia. Lancet Lond. Engl. 2022;399:473&#x2013;486. doi: 10.1016/S0140-6736(21)01730-X.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(21)01730-X</ArticleId><ArticleId IdType=\"pubmed\">35093231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B., Li T., Yang Y., Wang X., Luo T., Shan Y., Zhu Z., Xiong D., Hauberg M.E., Bendl J., et al. Common Genetic Variation Influencing Human White Matter Microstructure. Science. 2021;372:eabf3736. doi: 10.1126/science.abf3736.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abf3736</ArticleId><ArticleId IdType=\"pmc\">PMC8370718</ArticleId><ArticleId IdType=\"pubmed\">34140357</ArticleId></ArticleIdList></Reference><Reference><Citation>Somasundaram K., Kalaiselvi T. Automatic Brain Extraction Methods for T1 Magnetic Resonance Images Using Region Labeling and Morphological Operations. Comput. Biol. Med. 2011;41:716&#x2013;725. doi: 10.1016/j.compbiomed.2011.06.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.compbiomed.2011.06.008</ArticleId><ArticleId IdType=\"pubmed\">21724183</ArticleId></ArticleIdList></Reference><Reference><Citation>Conole E.L.S., Stevenson A.J., Mu&#xf1;oz Maniega S., Harris S.E., Green C., Vald&#xe9;s Hern&#xe1;ndez M.D.C., Harris M.A., Bastin M.E., Wardlaw J.M., Deary I.J., et al. DNA Methylation and Protein Markers of Chronic Inflammation and Their Associations With Brain and Cognitive Aging. Neurology. 2021;97:e2340&#x2013;e2352. doi: 10.1212/WNL.0000000000012997.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000012997</ArticleId><ArticleId IdType=\"pmc\">PMC8665430</ArticleId><ArticleId IdType=\"pubmed\">34789543</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin J.M., Wang Y., Minn I., Bienko N., Ambinder E.B., Xu X., Peters M.E., Dougherty J.W., Vranesic M., Koo S.M., et al. Imaging of Glial Cell Activation and White Matter Integrity in Brains of Active and Recently Retired National Football League Players. JAMA Neurol. 2017;74:67&#x2013;74. doi: 10.1001/jamaneurol.2016.3764.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaneurol.2016.3764</ArticleId><ArticleId IdType=\"pmc\">PMC5504689</ArticleId><ArticleId IdType=\"pubmed\">27893897</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X., Dong S., Yang Y., Bao G., Ma H. Nominating Novel Proteins for Anxiety via Integrating Human Brain Proteomes and Genome-Wide Association Study. J. Affect. Disord. 2024;358:129&#x2013;137. doi: 10.1016/j.jad.2024.04.097.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jad.2024.04.097</ArticleId><ArticleId IdType=\"pubmed\">38697224</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingo T.S., Liu Y., Gerasimov E.S., Gockley J., Logsdon B.A., Duong D.M., Dammer E.B., Lori A., Kim P.J., Ressler K.J., et al. Brain Proteome-Wide Association Study Implicates Novel Proteins in Depression Pathogenesis. Nat. Neurosci. 2021;24:810&#x2013;817. doi: 10.1038/s41593-021-00832-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41593-021-00832-6</ArticleId><ArticleId IdType=\"pmc\">PMC8530461</ArticleId><ArticleId IdType=\"pubmed\">33846625</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain P.R., Yates M., de Celis C.R., Drineas P., Jahanshad N., Thompson P., Paschou P. Multiomic Approach and Mendelian Randomization Analysis Identify Causal Associations between Blood Biomarkers and Subcortical Brain Structure Volumes. NeuroImage. 2023;284:120466. doi: 10.1016/j.neuroimage.2023.120466.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2023.120466</ArticleId><ArticleId IdType=\"pubmed\">37995919</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Wang Z., Yi M., Xie S., Zhang X., Tao D., Liu Y., Yang Y. Evidence Based on Mendelian Randomization and Colocalization Analysis Strengthens Causal Relationships between Structural Changes in Specific Brain Regions and Risk of Amyotrophic Lateral Sclerosis. Front. Neurosci. 2024;18:1333782. doi: 10.3389/fnins.2024.1333782.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2024.1333782</ArticleId><ArticleId IdType=\"pmc\">PMC10948422</ArticleId><ArticleId IdType=\"pubmed\">38505770</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W., Qian W., Wang W., Yu S., Lin G.N. Mendelian Randomization Studies of Brain MRI Yield Insights into the Pathogenesis of Neuropsychiatric Disorders. BMC Genom. 2021;22:342. doi: 10.1186/s12864-021-07661-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12864-021-07661-8</ArticleId><ArticleId IdType=\"pmc\">PMC8171058</ArticleId><ArticleId IdType=\"pubmed\">34078268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji G.-J., Sun J., Hua Q., Zhang L., Zhang T., Bai T., Wei L., Wang X., Qiu B., Wang A., et al. White Matter Dysfunction in Psychiatric Disorders Is Associated with Neurotransmitter and Genetic Profiles. Nat. Ment. Health. 2023;1:655&#x2013;666. doi: 10.1038/s44220-023-00111-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s44220-023-00111-2</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien J.T. Clinical Significance of White Matter Changes. Am. J. Geriatr. Psychiatry Off. J. Am. Assoc. Geriatr. Psychiatry. 2014;22:133&#x2013;137. doi: 10.1016/j.jagp.2013.07.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jagp.2013.07.006</ArticleId><ArticleId IdType=\"pubmed\">24041523</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazi Sherbaf F., Rahmani F., Jooyandeh S.M., Aarabi M.H. Microstructural Changes in Patients with Parkinson Disease and REM Sleep Behavior Disorder: Depressive Symptoms versus Non-Depressed. Acta Neurol. Belg. 2018;118:415&#x2013;421. doi: 10.1007/s13760-018-0896-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13760-018-0896-x</ArticleId><ArticleId IdType=\"pubmed\">29442234</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y., Sun H., Shi S., Jiang D., Tao B., Zhao Y., Zhang W., Gong Q., Sweeney J.A., Lui S. White Matter Abnormalities in Never-Treated Patients With Long-Term Schizophrenia. Am. J. Psychiatry. 2018;175:1129&#x2013;1136. doi: 10.1176/appi.ajp.2018.17121402.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1176/appi.ajp.2018.17121402</ArticleId><ArticleId IdType=\"pubmed\">30068259</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao Y., Lin F., Wu J., Li H., Fu W., Huo R., Cao Y., Wang S., Zhao J. Plasticity in Language Cortex and White Matter Tracts after Resection of Dominant Inferior Parietal Lobule Arteriovenous Malformations: A Combined fMRI and DTI Study. J. Neurosurg. 2020;134:953&#x2013;960. doi: 10.3171/2019.12.JNS191987.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3171/2019.12.JNS191987</ArticleId><ArticleId IdType=\"pubmed\">32197246</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan C.C., Loughnan R., Makowski C., Pecheva D., Chen C.-H., Hagler D.J., Thompson W.K., Parker N., van der Meer D., Frei O., et al. Multivariate Genome-Wide Association Study on Tissue-Sensitive Diffusion Metrics Highlights Pathways That Shape the Human Brain. Nat. Commun. 2022;13:2423. doi: 10.1038/s41467-022-30110-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-30110-3</ArticleId><ArticleId IdType=\"pmc\">PMC9065144</ArticleId><ArticleId IdType=\"pubmed\">35505052</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., Zhang L., Tian T., Cheng J., Zhang B., Qiu S., Geng Z., Cui G., Zhang Q., Liao W., et al. Cross-Ancestry Genome-Wide Association Meta-Analyses of Hippocampal and Subfield Volumes. Nat. Genet. 2023;55:1126&#x2013;1137. doi: 10.1038/s41588-023-01425-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41588-023-01425-8</ArticleId><ArticleId IdType=\"pubmed\">37337106</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers T., Escott-Price V., Legge S., Baker E., Singh K.D., Walters J.T.R., Caseras X., Anney R.J.L. Genetic Common Variants Associated with Cerebellar Volume and Their Overlap with Mental Disorders: A Study on 33,265 Individuals from the UK-Biobank. Mol. Psychiatry. 2022;27:2282&#x2013;2290. doi: 10.1038/s41380-022-01443-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41380-022-01443-8</ArticleId><ArticleId IdType=\"pmc\">PMC9126806</ArticleId><ArticleId IdType=\"pubmed\">35079123</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B., Luo T., Li T., Li Y., Zhang J., Shan Y., Wang X., Yang L., Zhou F., Zhu Z., et al. Genome-Wide Association Analysis of 19,629 Individuals Identifies Variants Influencing Regional Brain Volumes and Refines Their Genetic Co-Architecture with Cognitive and Mental Health Traits. Nat. Genet. 2019;51:1637&#x2013;1644. doi: 10.1038/s41588-019-0516-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41588-019-0516-6</ArticleId><ArticleId IdType=\"pmc\">PMC6858580</ArticleId><ArticleId IdType=\"pubmed\">31676860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-R., Kim S.H., Ben-Mahmoud A., Kim O.-H., Choi T.-I., Lee K.-H., Ku B., Eum J., Kee Y., Lee S., et al. Eif2b3 Mutants Recapitulate Phenotypes of Vanishing White Matter Disease and Validate Novel Disease Alleles in Zebrafish. Hum. Mol. Genet. 2021;30:331&#x2013;342. doi: 10.1093/hmg/ddab033.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddab033</ArticleId><ArticleId IdType=\"pubmed\">33517449</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasca A., Scotton C., Zaharieva I., Neri M., Selvatici R., Magnusson O.T., Gal A., Weaver D., Rossi R., Armaroli A., et al. Recessive Mutations in MSTO1 Cause Mitochondrial Dynamics Impairment, Leading to Myopathy and Ataxia. Hum. Mutat. 2017;38:970&#x2013;977. doi: 10.1002/humu.23262.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/humu.23262</ArticleId><ArticleId IdType=\"pmc\">PMC5575512</ArticleId><ArticleId IdType=\"pubmed\">28544275</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Jin R., Wu X. Whole-Exome Sequencing Identifies Rare Compound Heterozygous Mutations in the MSTO1 Gene Associated with Cerebellar Ataxia and Myopathy. Eur. J. Med. Genet. 2020;63:103623. doi: 10.1016/j.ejmg.2019.01.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejmg.2019.01.013</ArticleId><ArticleId IdType=\"pubmed\">30684668</ArticleId></ArticleIdList></Reference><Reference><Citation>Musumeci O., Ferlazzo E., Rodolico C., Gambardella A., Gagliardi M., Aguglia U., Toscano A. A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies. Front. Neurol. 2020;11:514. doi: 10.3389/fneur.2020.00514.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2020.00514</ArticleId><ArticleId IdType=\"pmc\">PMC7324651</ArticleId><ArticleId IdType=\"pubmed\">32655480</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Chiang H.-C., Wu W., Liang B., Xie Z., Yao X., Ma W., Du S., Zhong Y. Epidermal Growth Factor Receptor Is a Preferred Target for Treating Amyloid-&#x3b2;-Induced Memory Loss. Proc. Natl. Acad. Sci. USA. 2012;109:16743&#x2013;16748. doi: 10.1073/pnas.1208011109.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1208011109</ArticleId><ArticleId IdType=\"pmc\">PMC3478595</ArticleId><ArticleId IdType=\"pubmed\">23019586</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H.-J., Jeong Y.J., Kim J., Hoe H.-S. EGFR Is a Potential Dual Molecular Target for Cancer and Alzheimer&#x2019;s Disease. Front. Pharmacol. 2023;14:1238639. doi: 10.3389/fphar.2023.1238639.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2023.1238639</ArticleId><ArticleId IdType=\"pmc\">PMC10433764</ArticleId><ArticleId IdType=\"pubmed\">37601068</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada K., Lee J.-Y., Hung H.-Y., Shi Q., Lin L., Zhao Y., Goto M., Yang P.-C., Kuo S.-C., Chen H.-W., et al. Novel Curcumin Analogs to Overcome EGFR-TKI Lung Adenocarcinoma Drug Resistance and Reduce EGFR-TKI-Induced GI Adverse Effects. Bioorg. Med. Chem. 2015;23:1507&#x2013;1514. doi: 10.1016/j.bmc.2015.02.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bmc.2015.02.003</ArticleId><ArticleId IdType=\"pmc\">PMC4782611</ArticleId><ArticleId IdType=\"pubmed\">25753330</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabira T., Kawamura N. A Study of a Supplement Containing Huperzine A and Curcumin in Dementia Patients and Individuals with Mild Cognitive Impairment. J. Alzheimers Dis. JAD. 2018;63:75&#x2013;78. doi: 10.3233/JAD-171154.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-171154</ArticleId><ArticleId IdType=\"pubmed\">29614668</ArticleId></ArticleIdList></Reference><Reference><Citation>Healy B.C., Liguori M., Tran D., Chitnis T., Glanz B., Wolfish C., Gauthier S., Buckle G., Houtchens M., Stazzone L., et al. HLA B*44: Protective Effects in MS Susceptibility and MRI Outcome Measures. Neurology. 2010;75:634&#x2013;640. doi: 10.1212/WNL.0b013e3181ed9c9c.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0b013e3181ed9c9c</ArticleId><ArticleId IdType=\"pmc\">PMC2931768</ArticleId><ArticleId IdType=\"pubmed\">20713950</ArticleId></ArticleIdList></Reference><Reference><Citation>Brucato N., Guadalupe T., Franke B., Fisher S.E., Francks C. A Schizophrenia-Associated HLA Locus Affects Thalamus Volume and Asymmetry. Brain. Behav. Immun. 2015;46:311&#x2013;318. doi: 10.1016/j.bbi.2015.02.021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2015.02.021</ArticleId><ArticleId IdType=\"pubmed\">25728236</ArticleId></ArticleIdList></Reference><Reference><Citation>Celis K., Shuldiner S., Haverfield E.V., Cappell J., Yang R., Gong D.-W., Chung W.K. Loss of Function Mutation in Glutamic Pyruvate Transaminase 2 (GPT2) Causes Developmental Encephalopathy. J. Inherit. Metab. Dis. 2015;38:941&#x2013;948. doi: 10.1007/s10545-015-9824-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10545-015-9824-x</ArticleId><ArticleId IdType=\"pmc\">PMC4919120</ArticleId><ArticleId IdType=\"pubmed\">25758935</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano R., Bucci C. Role of EGFR in the Nervous System. Cells. 2020;9:1887. doi: 10.3390/cells9081887.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells9081887</ArticleId><ArticleId IdType=\"pmc\">PMC7464966</ArticleId><ArticleId IdType=\"pubmed\">32806510</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S., Dobricic V., Ohlei O., Bos I., Vos S.J.B., Prokopenko D., Tijms B.M., Andreasson U., Blennow K., Vandenberghe R., et al. TMEM106B and CPOX Are Genetic Determinants of Cerebrospinal Fluid Alzheimer&#x2019;s Disease Biomarker Levels. Alzheimers Dement. J. Alzheimers Assoc. 2021;17:1628&#x2013;1640. doi: 10.1002/alz.12330.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.12330</ArticleId><ArticleId IdType=\"pubmed\">33991015</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann A., Ohlei O., K&#xfc;&#xe7;&#xfc;kali F., Bos I.J., Timsina J., Vos S., Prokopenko D., Tijms B.M., Andreasson U., Blennow K., et al. Multivariate GWAS of Alzheimer&#x2019;s Disease CSF Biomarker Profiles Implies GRIN2D in Synaptic Functioning. Genome Med. 2023;15:79. doi: 10.1186/s13073-023-01233-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13073-023-01233-z</ArticleId><ArticleId IdType=\"pmc\">PMC10548686</ArticleId><ArticleId IdType=\"pubmed\">37794492</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Wang H., Tian Y., Zhou S., Li X., Wang K., Yu Y. Impaired White Matter Connections of the Limbic System Networks Associated with Impaired Emotional Memory in Alzheimer&#x2019;s Disease. Front. Aging Neurosci. 2016;8:250. doi: 10.3389/fnagi.2016.00250.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2016.00250</ArticleId><ArticleId IdType=\"pmc\">PMC5081353</ArticleId><ArticleId IdType=\"pubmed\">27833549</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein A., Ghosh S.S., Bao F.S., Giard J., H&#xe4;me Y., Stavsky E., Lee N., Rossa B., Reuter M., Chaibub Neto E., et al. Mindboggling Morphometry of Human Brains. PLoS Comput. Biol. 2017;13:e1005350. doi: 10.1371/journal.pcbi.1005350.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pcbi.1005350</ArticleId><ArticleId IdType=\"pmc\">PMC5322885</ArticleId><ArticleId IdType=\"pubmed\">28231282</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahanshad N., Kochunov P.V., Sprooten E., Mandl R.C., Nichols T.E., Almasy L., Blangero J., Brouwer R.M., Curran J.E., de Zubicaray G.I., et al. Multi-Site Genetic Analysis of Diffusion Images and Voxelwise Heritability Analysis: A Pilot Project of the ENIGMA-DTI Working Group. NeuroImage. 2013;81:455&#x2013;469. doi: 10.1016/j.neuroimage.2013.04.061.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2013.04.061</ArticleId><ArticleId IdType=\"pmc\">PMC3729717</ArticleId><ArticleId IdType=\"pubmed\">23629049</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Beckmann N.D., Roussos P., Wang E., Zhou X., Wang Q., Ming C., Neff R., Ma W., Fullard J.F., et al. The Mount Sinai Cohort of Large-Scale Genomic, Transcriptomic and Proteomic Data in Alzheimer&#x2019;s Disease. Sci. Data. 2018;5:180185. doi: 10.1038/sdata.2018.185.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sdata.2018.185</ArticleId><ArticleId IdType=\"pmc\">PMC6132187</ArticleId><ArticleId IdType=\"pubmed\">30204156</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jager P.L., Ma Y., McCabe C., Xu J., Vardarajan B.N., Felsky D., Klein H.-U., White C.C., Peters M.A., Lodgson B., et al. A Multi-Omic Atlas of the Human Frontal Cortex for Aging and Alzheimer&#x2019;s Disease Research. Sci. Data. 2018;5:180142. doi: 10.1038/sdata.2018.142.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sdata.2018.142</ArticleId><ArticleId IdType=\"pmc\">PMC6080491</ArticleId><ArticleId IdType=\"pubmed\">30084846</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingo A.P., Liu Y., Gerasimov E.S., Gockley J., Logsdon B.A., Duong D.M., Dammer E.B., Robins C., Beach T.G., Reiman E.M., et al. Integrating Human Brain Proteomes with Genome-Wide Association Data Implicates New Proteins in Alzheimer&#x2019;s Disease Pathogenesis. Nat. Genet. 2021;53:143&#x2013;146. doi: 10.1038/s41588-020-00773-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41588-020-00773-z</ArticleId><ArticleId IdType=\"pmc\">PMC8130821</ArticleId><ArticleId IdType=\"pubmed\">33510477</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Tam W.W., Yu Y., Zhuo Z., Xue Z., Tsang C., Qiao X., Wang X., Wang W., Li Y., et al. The Application of Aptamer in Biomarker Discovery. Biomark. Res. 2023;11:70. doi: 10.1186/s40364-023-00510-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40364-023-00510-8</ArticleId><ArticleId IdType=\"pmc\">PMC10354955</ArticleId><ArticleId IdType=\"pubmed\">37468977</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Dutta D., K&#xf6;ttgen A., Tin A., Schlosser P., Grams M.E., Harvey B., CKDGen Consortium. Yu B., Boerwinkle E., et al. Plasma Proteome Analyses in Individuals of European and African Ancestry Identify Cis-pQTLs and Models for Proteome-Wide Association Studies. Nat. Genet. 2022;54:593&#x2013;602. doi: 10.1038/s41588-022-01051-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41588-022-01051-w</ArticleId><ArticleId IdType=\"pmc\">PMC9236177</ArticleId><ArticleId IdType=\"pubmed\">35501419</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev A., Ko A., Shi H., Bhatia G., Chung W., Penninx B.W.J.H., Jansen R., de Geus E.J.C., Boomsma D.I., Wright F.A., et al. Integrative Approaches for Large-Scale Transcriptome-Wide Association Studies. Nat. Genet. 2016;48:245&#x2013;252. doi: 10.1038/ng.3506.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ng.3506</ArticleId><ArticleId IdType=\"pmc\">PMC4767558</ArticleId><ArticleId IdType=\"pubmed\">26854917</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Liu S., Gong W., Guo P., Xue F., Zhou X., Wang S., Yuan Z. Protein-Centric Omics Integration Analysis Identifies Candidate Plasma Proteins for Multiple Autoimmune Diseases. Hum. Genet. :2023. doi: 10.1007/s00439-023-02627-0. in press.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00439-023-02627-0</ArticleId><ArticleId IdType=\"pubmed\">38143258</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong W., Guo P., Li Y., Liu L., Yan R., Liu S., Wang S., Xue F., Zhou X., Yuan Z. Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders: A Genome-Wide Pleiotropic Analysis. JAMA Psychiatry. 2023;80:360&#x2013;370. doi: 10.1001/jamapsychiatry.2022.4974.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamapsychiatry.2022.4974</ArticleId><ArticleId IdType=\"pmc\">PMC9909581</ArticleId><ArticleId IdType=\"pubmed\">36753304</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrivankova V.W., Richmond R.C., Woolf B.A.R., Davies N.M., Swanson S.A., VanderWeele T.J., Timpson N.J., Higgins J.P.T., Dimou N., Langenberg C., et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomisation (STROBE-MR): Explanation and Elaboration. BMJ. 2021;375:n2233. doi: 10.1136/bmj.n2233.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.n2233</ArticleId><ArticleId IdType=\"pmc\">PMC8546498</ArticleId><ArticleId IdType=\"pubmed\">34702754</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J., Davey Smith G., Burgess S. Mendelian Randomization with Invalid Instruments: Effect Estimation and Bias Detection through Egger Regression. Int. J. Epidemiol. 2015;44:512&#x2013;525. doi: 10.1093/ije/dyv080.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ije/dyv080</ArticleId><ArticleId IdType=\"pmc\">PMC4469799</ArticleId><ArticleId IdType=\"pubmed\">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J., Del Greco M.F., Minelli C., Davey Smith G., Sheehan N.A., Thompson J.R. Assessing the Suitability of Summary Data for Two-Sample Mendelian Randomization Analyses Using MR-Egger Regression: The Role of the I2 Statistic. Int. J. Epidemiol. 2016;45:1961&#x2013;1974. doi: 10.1093/ije/dyw220.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ije/dyw220</ArticleId><ArticleId IdType=\"pmc\">PMC5446088</ArticleId><ArticleId IdType=\"pubmed\">27616674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G., Tilling K., Davey Smith G. Orienting the Causal Relationship between Imprecisely Measured Traits Using GWAS Summary Data. PLoS Genet. 2017;13:e1007081. doi: 10.1371/journal.pgen.1007081.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pgen.1007081</ArticleId><ArticleId IdType=\"pmc\">PMC5711033</ArticleId><ArticleId IdType=\"pubmed\">29149188</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S., Butterworth A., Thompson S.G. Mendelian Randomization Analysis with Multiple Genetic Variants Using Summarized Data. Genet. Epidemiol. 2013;37:658&#x2013;665. doi: 10.1002/gepi.21758.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/gepi.21758</ArticleId><ArticleId IdType=\"pmc\">PMC4377079</ArticleId><ArticleId IdType=\"pubmed\">24114802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J., Del Greco M.F., Minelli C., Davey Smith G., Sheehan N., Thompson J. A Framework for the Investigation of Pleiotropy in Two-Sample Summary Data Mendelian Randomization. Stat. Med. 2017;36:1783&#x2013;1802. doi: 10.1002/sim.7221.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/sim.7221</ArticleId><ArticleId IdType=\"pmc\">PMC5434863</ArticleId><ArticleId IdType=\"pubmed\">28114746</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambartolomei C., Vukcevic D., Schadt E.E., Franke L., Hingorani A.D., Wallace C., Plagnol V. Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics. PLoS Genet. 2014;10:e1004383. doi: 10.1371/journal.pgen.1004383.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pgen.1004383</ArticleId><ArticleId IdType=\"pmc\">PMC4022491</ArticleId><ArticleId IdType=\"pubmed\">24830394</ArticleId></ArticleIdList></Reference><Reference><Citation>Blake J.A., Baldarelli R., Kadin J.A., Richardson J.E., Smith C.L., Bult C.J., Mouse Genome Database Group Mouse Genome Database (MGD): Knowledgebase for Mouse-Human Comparative Biology. Nucleic Acids Res. 2021;49:D981&#x2013;D987. doi: 10.1093/nar/gkaa1083.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/gkaa1083</ArticleId><ArticleId IdType=\"pmc\">PMC7779030</ArticleId><ArticleId IdType=\"pubmed\">33231642</ArticleId></ArticleIdList></Reference><Reference><Citation>Freshour S.L., Kiwala S., Cotto K.C., Coffman A.C., McMichael J.F., Song J.J., Griffith M., Griffith O.L., Wagner A.H. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with Open Crowdsource Efforts. Nucleic Acids Res. 2021;49:D1144&#x2013;D1151. doi: 10.1093/nar/gkaa1084.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/gkaa1084</ArticleId><ArticleId IdType=\"pmc\">PMC7778926</ArticleId><ArticleId IdType=\"pubmed\">33237278</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter A.R., Sanderson E., Hammerton G., Richmond R.C., Davey Smith G., Heron J., Taylor A.E., Davies N.M., Howe L.D. Mendelian Randomisation for Mediation Analysis: Current Methods and Challenges for Implementation. Eur. J. Epidemiol. 2021;36:465&#x2013;478. doi: 10.1007/s10654-021-00757-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10654-021-00757-1</ArticleId><ArticleId IdType=\"pmc\">PMC8159796</ArticleId><ArticleId IdType=\"pubmed\">33961203</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273160</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Elucidating the Functional Roles of Long Non-Coding RNAs in Alzheimer's Disease.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9211</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179211</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is a multifaceted neurodegenerative disorder characterized by cognitive decline and neuronal loss, representing a most challenging health issue. We present a computational analysis of transcriptomic data of AD tissues vs. healthy controls, focused on the elucidation of functional roles played by long non-coding RNAs (lncRNAs) throughout the AD progression. We first assembled our own lncRNA transcripts from the raw RNA-Seq data generated from 527 samples of the dorsolateral prefrontal cortex, resulting in the identification of 31,574 novel lncRNA genes. Based on co-expression analyses between mRNAs and lncRNAs, a co-expression network was constructed. Maximal subnetworks with dense connections were identified as functional clusters. Pathway enrichment analyses were conducted over mRNAs and lncRNAs in each cluster, which served as the basis for the inference of functional roles played by lncRNAs involved in each of the key steps in an AD development model that we have previously built based on transcriptomic data of protein-encoding genes. Detailed information is presented about the functional roles of lncRNAs in activities related to stress response, reprogrammed metabolism, cell polarity, and development. Our analyses also revealed that lncRNAs have the discerning power to distinguish between AD samples of each stage and healthy controls. This study represents the first of its kind.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Huang</LastName><ForeName>Zhenyu</ForeName><Initials>Z</Initials><Identifier Source=\"ORCID\">0009-0009-0029-1729</Identifier><AffiliationInfo><Affiliation>College of Computer Science and Technology, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systems Biology Lab for Metabolic Reprogramming, Department of Human Genetics and Cell Biology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chen</LastName><ForeName>Qiufen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Systems Biology Lab for Metabolic Reprogramming, Department of Human Genetics and Cell Biology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mu</LastName><ForeName>Xuechen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Systems Biology Lab for Metabolic Reprogramming, Department of Human Genetics and Cell Biology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Mathematics, Jilin University, Changchun 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>An</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Medicine, Indiana University, Indianapolis, IN 46202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Systems Biology Lab for Metabolic Reprogramming, Department of Human Genetics and Cell Biology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>2022KSYS007</GrantID><Agency>the Key Laboratory of Metabolism and Health of Guangdong Ordinary Colleges and Universities</Agency><Country/></Grant><Grant><GrantID>T2350010</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D062085\">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D012333\">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D062085\" MajorTopicYN=\"Y\">RNA, Long Noncoding</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D053263\" MajorTopicYN=\"Y\">Gene Regulatory Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D059467\" MajorTopicYN=\"N\">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020869\" MajorTopicYN=\"N\">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012333\" MajorTopicYN=\"N\">RNA, Messenger</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005786\" MajorTopicYN=\"N\">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D019295\" MajorTopicYN=\"N\">Computational Biology</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Fenton reaction</Keyword><Keyword MajorTopicYN=\"N\">long non-coding RNAs</Keyword><Keyword MajorTopicYN=\"N\">oxidative stress</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273160</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179211</ArticleId><ArticleId IdType=\"pii\">ijms25179211</ArticleId><ArticleId IdType=\"pmc\">PMC11394787</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schwartz L., Peres S., Jolicoeur M., da Veiga Moreira J. Cancer and Alzheimer&#x2019;s disease: Intracellular pH scales the metabolic disorders. Biogerontology. 2020;21:683&#x2013;694. doi: 10.1007/s10522-020-09888-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10522-020-09888-6</ArticleId><ArticleId IdType=\"pubmed\">32617766</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Z.-G., Pignataro G., Li M., Chang S., Simon R.P. Acid-Sensing Ion Channels (ASICs) as Pharmacological Targets for Neurodegenerative Diseases. Curr. Opin. Pharmacol. 2008;8:25&#x2013;32. doi: 10.1016/j.coph.2007.09.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.coph.2007.09.001</ArticleId><ArticleId IdType=\"pmc\">PMC2267925</ArticleId><ArticleId IdType=\"pubmed\">17945532</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan P.-P., Cao L.-L., Yang Y., Wang P. Calcium Ions Aggravate Alzheimer&#x2019;s Disease Through the Aberrant Activation of Neuronal Networks, Leading to Synaptic and Cognitive Deficits. Front. Mol. Neurosci. 2021;14:757515. doi: 10.3389/fnmol.2021.757515.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnmol.2021.757515</ArticleId><ArticleId IdType=\"pmc\">PMC8674839</ArticleId><ArticleId IdType=\"pubmed\">34924952</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitvitsky V.M., Garg S.K., Keep R.F., Albin R.L., Banerjee R. Na+ and K+ ion imbalances in Alzheimer&#x2019;s disease. Biochim. Biophys. Acta. 2012;1822:1671&#x2013;1681. doi: 10.1016/j.bbadis.2012.07.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2012.07.004</ArticleId><ArticleId IdType=\"pmc\">PMC3444663</ArticleId><ArticleId IdType=\"pubmed\">22820549</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdile G., Keane K.N., Cruzat V.F., Medic S., Sabale M., Rowles J., Wijesekara N., Martins R.N., Fraser P.E., Newsholme P. Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer&#x2019;s Disease. Mediators Inflamm. 2015;2015:105828. doi: 10.1155/2015/105828.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2015/105828</ArticleId><ArticleId IdType=\"pmc\">PMC4674598</ArticleId><ArticleId IdType=\"pubmed\">26693205</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo L., Prather E.R., Stetskiv M., Garrison D.E., Meade J.R., Peace T.I., Zhou T. Inflammaging and oxidative stress in human diseases: From molecular mechanisms to novel treatments. Int. J. Mol. Sci. 2019;20:4472. doi: 10.3390/ijms20184472.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms20184472</ArticleId><ArticleId IdType=\"pmc\">PMC6769561</ArticleId><ArticleId IdType=\"pubmed\">31510091</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson D.W. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: Cause or effect? J. Clin. Investig. 2004;114:23&#x2013;27. doi: 10.1172/JCI22317.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI22317</ArticleId><ArticleId IdType=\"pmc\">PMC437977</ArticleId><ArticleId IdType=\"pubmed\">15232608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi H., Chang H.-Y., Sang T.-K. Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases. Int. J. Mol. Sci. 2018;19:3082. doi: 10.3390/ijms19103082.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms19103082</ArticleId><ArticleId IdType=\"pmc\">PMC6213751</ArticleId><ArticleId IdType=\"pubmed\">30304824</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C., Selkoe D. If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline? PLoS Biol. 2022;20:e3001694. doi: 10.1371/journal.pbio.3001694.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pbio.3001694</ArticleId><ArticleId IdType=\"pmc\">PMC9302755</ArticleId><ArticleId IdType=\"pubmed\">35862308</ArticleId></ArticleIdList></Reference><Reference><Citation>Niikura T., Tajima H., Kita Y. Neuronal Cell Death in Alzheimer&#x2019;s Disease and a Neuroprotective Factor, Humanin. Curr. Neuropharmacol. 2006;4:139&#x2013;147. doi: 10.2174/157015906776359577.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/157015906776359577</ArticleId><ArticleId IdType=\"pmc\">PMC2430668</ArticleId><ArticleId IdType=\"pubmed\">18615127</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Wang W., Li L., Perry G., Lee H., Zhu X. Oxidative Stress and Mitochondrial Dysfunction in Alzheimer&#x2019;s Disease. Biochim. Biophys. Acta. 2014;1842:1240&#x2013;1247. doi: 10.1016/j.bbadis.2013.10.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2013.10.015</ArticleId><ArticleId IdType=\"pmc\">PMC4007397</ArticleId><ArticleId IdType=\"pubmed\">24189435</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohlkamp T., Xian X., Wong C.H., Durakoglugil M., Werthmann G.C., Saido T., Evers B.M., White C.L., Connor J., Hammer R.E., et al. Endosomal Acidification by NHE6-depletion Corrects ApoE4-mediated Synaptic Impairments and Reduces Amyloid Plaque Load. Elife. 2021;10:E72034. doi: 10.7554/eLife.72034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7554/eLife.72034</ArticleId><ArticleId IdType=\"pmc\">PMC8547963</ArticleId><ArticleId IdType=\"pubmed\">34617884</ArticleId></ArticleIdList></Reference><Reference><Citation>Im E., Jiang Y., Stavrides P.H., Darji S., Erdjument-Bromage H., Neubert T.A., Choi J.Y., Wegiel J., Lee J.-H., Nixon R.A. Lysosomal dysfunction in Down Syndrome and Alzheimer mouse models is caused by selective v-ATPase inhibition by Tyr682 phosphorylated APP &#x3b2;CTF. Sci. Adv. 2023;9:eadg1925. doi: 10.1126/sciadv.adg1925.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/sciadv.adg1925</ArticleId><ArticleId IdType=\"pmc\">PMC10371027</ArticleId><ArticleId IdType=\"pubmed\">37494443</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Pozo A., Frosch M.P., Masliah E., Hyman B.T. Neuropathological Alterations in Alzheimer Disease. Cold Spring Harb. Perspect. Med. 2011;1:a006189. doi: 10.1101/cshperspect.a006189.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/cshperspect.a006189</ArticleId><ArticleId IdType=\"pmc\">PMC3234452</ArticleId><ArticleId IdType=\"pubmed\">22229116</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond E., Wisniewski T. Alzheimer&#x2019;s Disease: Experimental Models and Reality. Acta Neuropathol. 2017;133:155&#x2013;175. doi: 10.1007/s00401-016-1662-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-016-1662-x</ArticleId><ArticleId IdType=\"pmc\">PMC5253109</ArticleId><ArticleId IdType=\"pubmed\">28025715</ArticleId></ArticleIdList></Reference><Reference><Citation>Olufunmilayo E.O., Holsinger R.M.D. Roles of Non-Coding RNA in Alzheimer&#x2019;s Disease Pathophysiology. Int. J. Mol. Sci. 2023;24:12498. doi: 10.3390/ijms241512498.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms241512498</ArticleId><ArticleId IdType=\"pmc\">PMC10420049</ArticleId><ArticleId IdType=\"pubmed\">37569871</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan Z., Chen Y., Jin J., Xu Y., Zhu X. Long Non-coding RNA: Insight Into Mechanisms of Alzheimer&#x2019;s Disease. Front. Mol. Neurosci. 2022;14:821002. doi: 10.3389/fnmol.2021.821002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnmol.2021.821002</ArticleId><ArticleId IdType=\"pmc\">PMC8795976</ArticleId><ArticleId IdType=\"pubmed\">35095418</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X., Tashiro H., Lin C.G. The Identification and Characterization of Oxidized RNAs in Alzheimer&#x2019;s Disease. J. Neurosci. 2003;23:4913&#x2013;4921. doi: 10.1523/JNEUROSCI.23-12-04913.2003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.23-12-04913.2003</ArticleId><ArticleId IdType=\"pmc\">PMC6741200</ArticleId><ArticleId IdType=\"pubmed\">12832513</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett D.A., Buchman A.S., Boyle P.A., Barnes L.L., Wilson R.S., Schneider J.A. Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers Dis. 2018;64:S161&#x2013;S189. doi: 10.3233/JAD-179939.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-179939</ArticleId><ArticleId IdType=\"pmc\">PMC6380522</ArticleId><ArticleId IdType=\"pubmed\">29865057</ArticleId></ArticleIdList></Reference><Reference><Citation>Rijpma A., van der Graaf M., Meulenbroek O., Rikkert M.G.M.O., Heerschap A. Altered brain high-energy phosphate metabolism in mild Alzheimer&#x2019;s disease: A 3-dimensional 31P MR spectroscopic imaging study. NeuroImage Clin. 2018;18:254&#x2013;261. doi: 10.1016/j.nicl.2018.01.031.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nicl.2018.01.031</ArticleId><ArticleId IdType=\"pmc\">PMC5987799</ArticleId><ArticleId IdType=\"pubmed\">29876246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyros E., Ragoschke-Schumm A., Kostopoulos P., Sehr A., Backens M., Kalampokini S., Decker Y., Lesmeister M., Liu Y., Reith W., et al. Normal brain aging and Alzheimer&#x2019;s disease are associated with lower cerebral pH: An in vivo histidine 1H-MR spectroscopy study. Neurobiol. Aging. 2020;87:60&#x2013;69. doi: 10.1016/j.neurobiolaging.2019.11.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2019.11.012</ArticleId><ArticleId IdType=\"pubmed\">31902521</ArticleId></ArticleIdList></Reference><Reference><Citation>Decker Y., N&#xe9;meth E., Schomburg R., Chemla A., F&#xfc;l&#xf6;p L., Menger M.D., Liu Y., Fassbender K. Decreased pH in the aging brain and Alzheimer&#x2019;s disease. Neurobiol. Aging. 2021;101:40&#x2013;49. doi: 10.1016/j.neurobiolaging.2020.12.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2020.12.007</ArticleId><ArticleId IdType=\"pubmed\">33578193</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene Ontology Annotations.  [(accessed on 31 July 2024)].  Available online:  https://www.informatics.jax.org/go/term/GO:0051454.</Citation></Reference><Reference><Citation>Gong C.-X., Grundke-Iqbal I., Iqbal K. Dephosphorylation of Alzheimer&#x2019;s disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience. 1994;61:765&#x2013;772. doi: 10.1016/0306-4522(94)90400-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0306-4522(94)90400-6</ArticleId><ArticleId IdType=\"pubmed\">7838376</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin E., Kim B., Kang H., Lee H., Park J., Kang J., Park E., Jo S., Kim H.Y., Lee J.S., et al. Mitochondrial glutamate transporter SLC25A22 uni-directionally export glutamate for metabolic rewiring in radioresistant glioblastoma. Int. J. Biol. Macromol. 2023;253:127511. doi: 10.1016/j.ijbiomac.2023.127511.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijbiomac.2023.127511</ArticleId><ArticleId IdType=\"pubmed\">37866557</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomierny B., Krzy&#x17c;anowska W., Sk&#xf3;rkowska A., Jurczyk J., Bystrowska B., Budziszewska B., Pera J. Inhibition of Vesicular Glutamate Transporters (VGLUTs) with Chicago Sky Blue 6B Before Focal Cerebral Ischemia Offers Neuroprotection. Mol. Neurobiol. 2023;60:3130&#x2013;3146. doi: 10.1007/s12035-023-03259-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-023-03259-1</ArticleId><ArticleId IdType=\"pmc\">PMC10122628</ArticleId><ArticleId IdType=\"pubmed\">36802054</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene Ontology Annotations.  [(accessed on 31 July 2024)].  Available online:  https://www.informatics.jax.org/go/term/GO:0099610.</Citation></Reference><Reference><Citation>Gene Ontology Annotations.  [(accessed on 31 July 2024)].  Available online:  https://www.informatics.jax.org/go/term/GO:0036465.</Citation></Reference><Reference><Citation>Drew L.J., Rohrer D.K., Price M.P., Blaver K.E., Cockayne D.A., Cesare P., Wood J.N. Acid-sensing ion channels ASIC2 and ASIC3 do not contribute to mechanically activated currents in mammalian sensory neurones. J. Physiol. 2004;556:691&#x2013;710. doi: 10.1113/jphysiol.2003.058693.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1113/jphysiol.2003.058693</ArticleId><ArticleId IdType=\"pmc\">PMC1664992</ArticleId><ArticleId IdType=\"pubmed\">14990679</ArticleId></ArticleIdList></Reference><Reference><Citation>Theparambil S.M., Hosford P.S., Ruminot I., Kopach O., Reynolds J.R., Sandoval P.Y., Rusakov D.A., Barros L.F., Gourine A.V. Astrocytes regulate brain extracellular pH via a neuronal activity-dependent bicarbonate shuttle. Nat. Commun. 2020;11:5073. doi: 10.1038/s41467-020-18756-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-020-18756-3</ArticleId><ArticleId IdType=\"pmc\">PMC7545092</ArticleId><ArticleId IdType=\"pubmed\">33033238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciudad S., Puig E., Botzanowski T., Meigooni M., Arango A.S., Do J., Mayzel M., Bayoumi M., Chaignepain S., Maglia G., et al. A&#x3b2;(1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage. Nat. Commun. 2020;11:3014. doi: 10.1038/s41467-020-16566-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-020-16566-1</ArticleId><ArticleId IdType=\"pmc\">PMC7296003</ArticleId><ArticleId IdType=\"pubmed\">32541820</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooqui A.A. Contribution of Dietary Carbohydrates in Induction of Oxidative Stress. In: Farooqui A.A., editor. Inflammation and Oxidative Stress in Neurological Disorders: Effect of Lifestyle, Genes, and Age. Springer International Publishing; Cham, Switzerland: 2014. pp. 237&#x2013;261.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-3-319-04111-7_8</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrow J., Frankish A., Gonzalez J.M., Tapanari E., Diekhans M., Kokocinski F., Aken B.L., Barrell D., Zadissa A., Searle S., et al. GENCODE: The reference human genome annotation for The ENCODE Project. Genome Res. 2012;22:1760&#x2013;1774. doi: 10.1101/gr.135350.111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/gr.135350.111</ArticleId><ArticleId IdType=\"pmc\">PMC3431492</ArticleId><ArticleId IdType=\"pubmed\">22955987</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C.-H., Lin T.-C., Chang Y.-H., Tsai H.-K., Huang J.-H. Identification and comparative analysis of long non-coding RNAs in the brain of fire ant queens in two different reproductive states. BMC Genom. 2022;22:917. doi: 10.1186/s12864-022-08539-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12864-022-08539-z</ArticleId><ArticleId IdType=\"pmc\">PMC9006410</ArticleId><ArticleId IdType=\"pubmed\">35418014</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcoxon Signed-Rank Test&#x2014;Handbook of Biological Statistic.  [(accessed on 13 March 2024)].  Available online:  https://www.biostathandbook.com/wilcoxonsignedrank.html.</Citation></Reference><Reference><Citation>Ju J.-Q., Zhang H.-L., Wang Y., Hu L.-L., Sun S.-C. Kinesin KIFC3 is essential for microtubule stability and cytokinesis in oocyte meiosis. Cell Commun. Signal. 2024;22:199. doi: 10.1186/s12964-024-01589-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12964-024-01589-8</ArticleId><ArticleId IdType=\"pmc\">PMC10979585</ArticleId><ArticleId IdType=\"pubmed\">38553728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozon S., Guichet A., Gavet O., Roth S., Sobel A. Drosophila Stathmin: A Microtubule-destabilizing Factor Involved in Nervous System Formation. Mol. Biol. Cell. 2002;13:698&#x2013;710. doi: 10.1091/mbc.01-07-0362.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1091/mbc.01-07-0362</ArticleId><ArticleId IdType=\"pmc\">PMC65660</ArticleId><ArticleId IdType=\"pubmed\">11854423</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckert T., Le D.T.-V., Link S., Friedmann L., Woehlke G. Spastin&#x2019;s Microtubule-Binding Properties and Comparison to Katanin. PLoS ONE. 2012;7:e50161. doi: 10.1371/journal.pone.0050161.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0050161</ArticleId><ArticleId IdType=\"pmc\">PMC3521757</ArticleId><ArticleId IdType=\"pubmed\">23272056</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan C.M., Mudher A. Are Tau Aggregates Toxic or Protective in Tauopathies? Front. Neurol. 2013;4:114. doi: 10.3389/fneur.2013.00114.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2013.00114</ArticleId><ArticleId IdType=\"pmc\">PMC3741634</ArticleId><ArticleId IdType=\"pubmed\">23964266</ArticleId></ArticleIdList></Reference><Reference><Citation>Introduction to Condensed Matter Chemistry&#x2014;1st Edition|Elsevier Shop.  [(accessed on 16 April 2024)].  Available online:  https://shop.elsevier.com/books/introduction-to-condensed-matter-chemistry/yu/978-0-443-16140-7.</Citation></Reference><Reference><Citation>Rival T., Page R.M., Chandraratna D.S., Sendall T.J., Ryder E., Liu B., Lewis H., Rosahl T., Hider R., Camargo L.M., et al. Fenton chemistry and oxidative stress mediate the toxicity of the &#x3b2;-amyloid peptide in a Drosophila model of Alzheimer&#x2019;s disease. Eur. J. Neurosci. 2009;29:1335&#x2013;1347. doi: 10.1111/j.1460-9568.2009.06701.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1460-9568.2009.06701.x</ArticleId><ArticleId IdType=\"pmc\">PMC2777252</ArticleId><ArticleId IdType=\"pubmed\">19519625</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer R., Br&#xfc;ne B., Schmid T. Cholesterol metabolism in the regulation of inflammatory responses. Front. Pharmacol. 2023;14:1121819. doi: 10.3389/fphar.2023.1121819.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2023.1121819</ArticleId><ArticleId IdType=\"pmc\">PMC9895399</ArticleId><ArticleId IdType=\"pubmed\">36744258</ArticleId></ArticleIdList></Reference><Reference><Citation>Trupp M., Altman T., Fulcher C.A., Caspi R., Krummenacker M., Paley S., Karp P.D. Beyond the genome (BTG) is a (PGDB) pathway genome database: HumanCyc. Genome Biol. 2010;11:O12. doi: 10.1186/gb-2010-11-s1-o12.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/gb-2010-11-s1-o12</ArticleId></ArticleIdList></Reference><Reference><Citation>Gencel-Augusto J., Wu W., Bivona T.G. Long Non-Coding RNAs as Emerging Targets in Lung Cancer. Cancers. 2023;15:3135. doi: 10.3390/cancers15123135.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cancers15123135</ArticleId><ArticleId IdType=\"pmc\">PMC10295998</ArticleId><ArticleId IdType=\"pubmed\">37370745</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Zhu H., Luo Y. Understanding the Functions of Long Non-Coding RNAs through Their Higher-Order Structures. Int. J. Mol. Sci. 2016;17:702. doi: 10.3390/ijms17050702.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms17050702</ArticleId><ArticleId IdType=\"pmc\">PMC4881525</ArticleId><ArticleId IdType=\"pubmed\">27196897</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J., Qu L., Gao F., Lin J., Liu J., Lin A. LncRNAs: Architectural Scaffolds or More Potential Roles in Phase Separation. Front. Genet. 2021;12:626234. doi: 10.3389/fgene.2021.626234.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fgene.2021.626234</ArticleId><ArticleId IdType=\"pmc\">PMC8044363</ArticleId><ArticleId IdType=\"pubmed\">33868368</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonikidis P.S., Kirichenko S.N., Tatjanenko L.V., Schwarz W., Vasilets L.A. Extracellular pH modulates kinetics of the Na+,K+-ATPase. Biochim. Biophys. Acta (BBA)-Biomembr. 2000;1509:496&#x2013;504. doi: 10.1016/S0005-2736(00)00356-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0005-2736(00)00356-4</ArticleId><ArticleId IdType=\"pubmed\">11118558</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S., Stomrud E., Palmqvist S., Zetterberg H., van Westen D., Jeromin A., Song L., Hanlon D., Hehir C.A.T., Baker D., et al. Plasma &#x3b2;-amyloid in Alzheimer&#x2019;s disease and vascular disease. Sci. Rep. 2016;6:26801. doi: 10.1038/srep26801.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/srep26801</ArticleId><ArticleId IdType=\"pmc\">PMC4886210</ArticleId><ArticleId IdType=\"pubmed\">27241045</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari T.K., Benedet A.L., Ashton N.J., Rodriguez J.L., Snellman A., Su&#xe1;rez-Calvet M., Saha-Chaudhuri P., Lussier F., Kvartsberg H., Rial A.M., et al. Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer&#x2019;s Disease Neuroimaging Initiative. Mol. Psychiatry. 2020;26:429&#x2013;442. doi: 10.1038/s41380-020-00923-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41380-020-00923-z</ArticleId><ArticleId IdType=\"pubmed\">33106600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett D.A., Schneider J.A., Arvanitakis Z., Wilson R.S. Overview and Findings from the Religious Orders Study. Curr. Alzheimer Res. 2012;9:628&#x2013;645. doi: 10.2174/156720512801322573.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/156720512801322573</ArticleId><ArticleId IdType=\"pmc\">PMC3409291</ArticleId><ArticleId IdType=\"pubmed\">22471860</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspi R., Altman T., Dreher K., Fulcher C.A., Subhraveti P., Keseler I.M., Kothari A., Krummenacker M., Latendresse M., Mueller L.A., et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res. 2011;40:D742&#x2013;D753. doi: 10.1093/nar/gkr1014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/gkr1014</ArticleId><ArticleId IdType=\"pmc\">PMC3245006</ArticleId><ArticleId IdType=\"pubmed\">22102576</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Chen Y., Shi C., Huang Z., Zhang Y., Li S., Li Y., Ye J., Yu C., Li Z., et al. SOAPnuke: A MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data. GigaScience. 2017;7:gix120. doi: 10.1093/gigascience/gix120.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gigascience/gix120</ArticleId><ArticleId IdType=\"pmc\">PMC5788068</ArticleId><ArticleId IdType=\"pubmed\">29220494</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Park C., Bennett C., Thornton M., Kim D. Rapid and accurate alignment of nucleotide conversion sequencing reads with HISAT-3N. Genome Res. 2021;31:1290&#x2013;1295. doi: 10.1101/gr.275193.120.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/gr.275193.120</ArticleId><ArticleId IdType=\"pmc\">PMC8256862</ArticleId><ArticleId IdType=\"pubmed\">34103331</ArticleId></ArticleIdList></Reference><Reference><Citation>Shumate A., Wong B., Pertea G., Pertea M. Improved transcriptome assembly using a hybrid of long and short reads with StringTie. PLoS Comput. Biol. 2022;18:e1009730. doi: 10.1371/journal.pcbi.1009730.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pcbi.1009730</ArticleId><ArticleId IdType=\"pmc\">PMC9191730</ArticleId><ArticleId IdType=\"pubmed\">35648784</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Tang H., Li C., Huang N., Miao J., Chen L., Luo K., Li F., Liu S., Liao S., et al. Long non-coding RNA and circular RNA and coding RNA profiling of plasma exosomes of osteosarcoma by RNA seq. Sci. Data. 2023;10:395. doi: 10.1038/s41597-023-02295-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41597-023-02295-9</ArticleId><ArticleId IdType=\"pmc\">PMC10287625</ArticleId><ArticleId IdType=\"pubmed\">37349312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y.-J., Yang D.-C., Kong L., Hou M., Meng Y.-Q., Wei L., Gao G. CPC2: A fast and accurate coding potential calculator based on sequence intrinsic features. Nucleic Acids Res. 2017;45:W12&#x2013;W16. doi: 10.1093/nar/gkx428.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/gkx428</ArticleId><ArticleId IdType=\"pmc\">PMC5793834</ArticleId><ArticleId IdType=\"pubmed\">28521017</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S., Liang Y., Li Y., Du W. Long Noncoding RNA Identification: Comparing Machine Learning Based Tools for Long Noncoding Transcripts Discrimination. BioMed Res. Int. 2016;2016:8496165. doi: 10.1155/2016/8496165.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2016/8496165</ArticleId><ArticleId IdType=\"pmc\">PMC5153550</ArticleId><ArticleId IdType=\"pubmed\">28042575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Park H.J., Dasari S., Wang S., Kocher J.-P., Li W. CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res. 2013;41:e74. doi: 10.1093/nar/gkt006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/gkt006</ArticleId><ArticleId IdType=\"pmc\">PMC3616698</ArticleId><ArticleId IdType=\"pubmed\">23335781</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A., Zhang J., Zhou Z. PLEK: A tool for predicting long non-coding RNAs and messenger RNAs based on an improved k-mer scheme. BMC Bioinform. 2014;15:311. doi: 10.1186/1471-2105-15-311.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2105-15-311</ArticleId><ArticleId IdType=\"pmc\">PMC4177586</ArticleId><ArticleId IdType=\"pubmed\">25239089</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong X., Liu S. CPPred: Coding potential prediction based on the global description of RNA sequence. Nucleic Acids Res. 2019;47:e43. doi: 10.1093/nar/gkz087.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/gkz087</ArticleId><ArticleId IdType=\"pmc\">PMC6486542</ArticleId><ArticleId IdType=\"pubmed\">30753596</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M.I., Huber W. Anders. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType=\"pmc\">PMC4302049</ArticleId><ArticleId IdType=\"pubmed\">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Frazee A.C., Pertea G., Jaffe A.E., Langmead B., Salzberg S.L., Leek J.T. Ballgown bridges the gap between transcriptome assembly and expression analysis. Nat. Biotechnol. 2015;33:243&#x2013;246. doi: 10.1038/nbt.3172.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nbt.3172</ArticleId><ArticleId IdType=\"pmc\">PMC4792117</ArticleId><ArticleId IdType=\"pubmed\">25748911</ArticleId></ArticleIdList></Reference><Reference><Citation>MGI-Mouse Vertebrate Homology.  [(accessed on 16 December 2019)].  Available online:  http://www.informatics.jax.org/homology.shtml.</Citation></Reference><Reference><Citation>Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 2005;102:15545&#x2013;15550. doi: 10.1073/pnas.0506580102.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0506580102</ArticleId><ArticleId IdType=\"pmc\">PMC1239896</ArticleId><ArticleId IdType=\"pubmed\">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629&#x2013;641. doi: 10.1016/j.cell.2009.02.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2009.02.006</ArticleId><ArticleId IdType=\"pubmed\">19239885</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornienko A.E., Guenzl P.M., Barlow D.P., Pauler F.M. Gene regulation by the act of long non-coding RNA transcription. BMC Biol. 2013;11:59. doi: 10.1186/1741-7007-11-59.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1741-7007-11-59</ArticleId><ArticleId IdType=\"pmc\">PMC3668284</ArticleId><ArticleId IdType=\"pubmed\">23721193</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Wu J., Zhang W., Jiang H., Zhou Y., Liu J., Mao H., Liu S., Chen B. Whole-Transcriptome RNA Sequencing Uncovers the Global Expression Changes and RNA Regulatory Networks in Duck Embryonic Myogenesis. Int. J. Mol. Sci. 2023;24:16387. doi: 10.3390/ijms242216387.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms242216387</ArticleId><ArticleId IdType=\"pmc\">PMC10671564</ArticleId><ArticleId IdType=\"pubmed\">38003577</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Shahid M.Q., Wen M., Chen S., Yu H., Jiao Y., Lu Z., Li Y., Liu X. Global identification and analysis revealed differentially expressed lncRNAs associated with meiosis and low fertility in autotetraploid rice. BMC Plant Biol. 2020;20:82. doi: 10.1186/s12870-020-2290-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12870-020-2290-0</ArticleId><ArticleId IdType=\"pmc\">PMC7032005</ArticleId><ArticleId IdType=\"pubmed\">32075588</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel A., Akba&#x15f;li E., Gorodkin J. RIsearch: Fast RNA&#x2013;RNA interaction search using a simplified nearest-neighbor energy model. Bioinformatics. 2012;28:2738&#x2013;2746. doi: 10.1093/bioinformatics/bts519.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/bioinformatics/bts519</ArticleId><ArticleId IdType=\"pmc\">PMC3476332</ArticleId><ArticleId IdType=\"pubmed\">22923300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Cao X., Sumayya, Ma Y., Li H., Han W., Qu L. Genome-wide transcriptional profiling and functional analysis of long noncoding RNAs and mRNAs in chicken macrophages associated with the infection of avian pathogenic E. coli. BMC Veter-Res. 2024;20:49. doi: 10.1186/s12917-024-03890-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12917-024-03890-7</ArticleId><ArticleId IdType=\"pmc\">PMC10848384</ArticleId><ArticleId IdType=\"pubmed\">38326918</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann A., Tolo&#x15f;i L., Sander O., Lengauer T. Permutation importance: A corrected feature importance measure. Bioinformatics. 2010;26:1340&#x2013;1347. doi: 10.1093/bioinformatics/btq134.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/bioinformatics/btq134</ArticleId><ArticleId IdType=\"pubmed\">20385727</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Gao L., Liao Q., Xiao H., Ma X., Yang X., Luo H., Zhao G., Bu D., Jiao F., et al. Long non-coding RNAs function annotation: A global prediction method based on bi-colored networks. Nucleic Acids Res. 2012;41:e35. doi: 10.1093/nar/gks967.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/gks967</ArticleId><ArticleId IdType=\"pmc\">PMC3554231</ArticleId><ArticleId IdType=\"pubmed\">23132350</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright A.J., Van Dongen S., Ouzounis C.A. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res. 2002;30:1575&#x2013;1584. doi: 10.1093/nar/30.7.1575.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/30.7.1575</ArticleId><ArticleId IdType=\"pmc\">PMC101833</ArticleId><ArticleId IdType=\"pubmed\">11917018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M., Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27&#x2013;30. doi: 10.1093/nar/28.1.27.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/nar/28.1.27</ArticleId><ArticleId IdType=\"pmc\">PMC102409</ArticleId><ArticleId IdType=\"pubmed\">10592173</ArticleId></ArticleIdList></Reference><Reference><Citation>Reactome.  [(accessed on 29 December 2019)].  Available online:  ftp.cbi.pku.edu.cn/pub/databases/Reactome/latest_release/</Citation></Reference><Reference><Citation>Wu T., Hu E., Xu S., Chen M., Guo P., Dai Z., Feng T., Zhou L., Tang W., Zhan L., et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141. doi: 10.1016/j.xinn.2021.100141.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.xinn.2021.100141</ArticleId><ArticleId IdType=\"pmc\">PMC8454663</ArticleId><ArticleId IdType=\"pubmed\">34557778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura S., Oda D., Tokuhisa M. Feature Selection using Modified Null Importance; Proceedings of the 2021 IEEE Symposium Series on Computational Intelligence (SSCI); Orlando, FL, USA. 5&#x2013;7 December 2021; pp. 1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/SSCI50451.2021.9659841</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39273099</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1422-0067</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>25</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Characterization of Stealth Liposome-Based Nanoparticles Encapsulating the ACAT1/SOAT1 Inhibitor F26: Efficacy and Toxicity Studies In Vitro and in Wild-Type Mice.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">9151</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/ijms25179151</ELocationID><Abstract><AbstractText>Cholesterol homeostasis is pivotal for cellular function. Acyl-coenzyme A:cholesterol acyltransferase 1 (ACAT1), also abbreviated as SOAT1, is an enzyme responsible for catalyzing the storage of excess cholesterol to cholesteryl esters. ACAT1 is an emerging target to treat diverse diseases including atherosclerosis, cancer, and neurodegenerative diseases. F12511 is a high-affinity ACAT1 inhibitor. Previously, we developed a stealth liposome-based nanoparticle to encapsulate F12511 to enhance its delivery to the brain and showed its efficacy in treating a mouse model for Alzheimer's disease (AD). In this study, we introduce F26, a close derivative of F12511 metabolite in rats. F26 was encapsulated in the same DSPE-PEG<sub>2000</sub>/phosphatidylcholine (PC) liposome-based nanoparticle system. We employed various in vitro and in vivo methodologies to assess F26's efficacy and toxicity compared to F12511. The results demonstrate that F26 is more effective and durable than F12511 in inhibiting ACAT1, in both mouse embryonic fibroblasts (MEFs), and in multiple mouse tissues including the brain tissues, without exhibiting any overt systemic or neurotoxic effects. This study demonstrates the superior pharmacokinetic and safety profile of F26 in wild-type mice, and suggests its therapeutic potential against various neurodegenerative diseases including AD.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Lee</LastName><ForeName>Junghoon</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0003-0013-6912</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>De La Torre</LastName><ForeName>Adrianna L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rawlinson</LastName><ForeName>Felix L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ness</LastName><ForeName>Dylan B</ForeName><Initials>DB</Initials><Identifier Source=\"ORCID\">0000-0003-2941-5050</Identifier><AffiliationInfo><Affiliation>Clinical Pharmacology Shared Resource, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lewis</LastName><ForeName>Lionel D</ForeName><Initials>LD</Initials><Identifier Source=\"ORCID\">0000-0003-1164-5157</Identifier><AffiliationInfo><Affiliation>Clinical Pharmacology Shared Resource, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hickey</LastName><ForeName>William F</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chang</LastName><ForeName>Catherine C Y</ForeName><Initials>CCY</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chang</LastName><ForeName>Ta Yuan</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>5R01AG063544-04</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D008081\">Liposomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.26</RegistryNumber><NameOfSubstance UI=\"D002785\">Sterol O-Acyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.26</RegistryNumber><NameOfSubstance UI=\"C493492\">sterol O-acyltransferase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.9</RegistryNumber><NameOfSubstance UI=\"D000101\">Acetyl-CoA C-Acetyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D004791\">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.9</RegistryNumber><NameOfSubstance UI=\"C506641\">Acat1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008081\" MajorTopicYN=\"Y\">Liposomes</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D053758\" MajorTopicYN=\"Y\">Nanoparticles</DescriptorName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002785\" MajorTopicYN=\"Y\">Sterol O-Acyltransferase</DescriptorName><QualifierName UI=\"Q000037\" MajorTopicYN=\"N\">antagonists &amp; inhibitors</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000101\" MajorTopicYN=\"N\">Acetyl-CoA C-Acetyltransferase</DescriptorName><QualifierName UI=\"Q000037\" MajorTopicYN=\"N\">antagonists &amp; inhibitors</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001921\" MajorTopicYN=\"N\">Brain</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000187\" MajorTopicYN=\"N\">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D004791\" MajorTopicYN=\"N\">Enzyme Inhibitors</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000737\" MajorTopicYN=\"N\">chemistry</QualifierName><QualifierName UI=\"Q000008\" MajorTopicYN=\"N\">administration &amp; dosage</QualifierName><QualifierName UI=\"Q000493\" MajorTopicYN=\"N\">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051381\" MajorTopicYN=\"N\">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"N\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">ACAT1/SOAT1</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">DSPE-PEG</Keyword><Keyword MajorTopicYN=\"N\">F1251</Keyword><Keyword MajorTopicYN=\"N\">F26</Keyword><Keyword MajorTopicYN=\"N\">cholesterol</Keyword><Keyword MajorTopicYN=\"N\">cholesteryl ester</Keyword><Keyword MajorTopicYN=\"N\">nanoparticle</Keyword><Keyword MajorTopicYN=\"N\">neurodegenerative diseases</Keyword><Keyword MajorTopicYN=\"N\">phosphatidylcholine</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39273099</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms25179151</ArticleId><ArticleId IdType=\"pii\">ijms25179151</ArticleId><ArticleId IdType=\"pmc\">PMC11394700</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Luo J., Yang H., Song B.L. Mechanisms and regulation of cholesterol homeostasis. Nat. Rev. Mol. Cell Biol. 2020;21:225&#x2013;245. doi: 10.1038/s41580-019-0190-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41580-019-0190-7</ArticleId><ArticleId IdType=\"pubmed\">31848472</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabas I. Consequences of cellular cholesterol accumulation: Basic concepts and physiological implications. J. Clin. Investig. 2002;110:905&#x2013;911. doi: 10.1172/JCI0216452.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI0216452</ArticleId><ArticleId IdType=\"pmc\">PMC151158</ArticleId><ArticleId IdType=\"pubmed\">12370266</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y., Gong K., Xu S., Zhang F., Meng X., Han J. Regulation of cholesterol homeostasis in health and diseases: From mechanisms to targeted therapeutics. Signal Transduct. Target. Ther. 2022;7:265. doi: 10.1038/s41392-022-01125-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-022-01125-5</ArticleId><ArticleId IdType=\"pmc\">PMC9344793</ArticleId><ArticleId IdType=\"pubmed\">35918332</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34&#x2013;47. doi: 10.1126/science.3513311.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.3513311</ArticleId><ArticleId IdType=\"pubmed\">3513311</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.C., Huh H.Y., Cadigan K.M., Chang T.Y. Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. 1993;268:20747&#x2013;20755. doi: 10.1016/S0021-9258(19)36846-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0021-9258(19)36846-2</ArticleId><ArticleId IdType=\"pubmed\">8407899</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang T.Y., Chang C.C., Lin S., Yu C., Li B.L., Miyazaki A. Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2. Curr. Opin. Lipidol. 2001;12:289&#x2013;296. doi: 10.1097/00041433-200106000-00008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00041433-200106000-00008</ArticleId><ArticleId IdType=\"pubmed\">11353332</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson R.A., Joyce C., Davis M., Reagan J.W., Clark M., Shelness G.S., Rudel L.L. Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J. Biol. Chem. 1998;273:26747&#x2013;26754. doi: 10.1074/jbc.273.41.26747.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.273.41.26747</ArticleId><ArticleId IdType=\"pubmed\">9756918</ArticleId></ArticleIdList></Reference><Reference><Citation>Cases S., Novak S., Zheng Y.W., Myers H.M., Lear S.R., Sande E., Welch C.B., Lusis A.J., Spencer T.A., Krause B.R., et al. ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization. J. Biol. Chem. 1998;273:26755&#x2013;26764. doi: 10.1074/jbc.273.41.26755.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.273.41.26755</ArticleId><ArticleId IdType=\"pubmed\">9756919</ArticleId></ArticleIdList></Reference><Reference><Citation>Oelkers P., Behari A., Cromley D., Billheimer J.T., Sturley S.L. Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes. J. Biol. Chem. 1998;273:26765&#x2013;26771. doi: 10.1074/jbc.273.41.26765.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.273.41.26765</ArticleId><ArticleId IdType=\"pubmed\">9756920</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Chang C.C., Westover E.J., Covey D.F., Chang T.Y. Investigating the allosterism of acyl-CoA:cholesterol acyltransferase (ACAT) by using various sterols: In vitro and intact cell studies. Biochem. J. 2005;391:389&#x2013;397. doi: 10.1042/BJ20050428.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/BJ20050428</ArticleId><ArticleId IdType=\"pmc\">PMC1276938</ArticleId><ArticleId IdType=\"pubmed\">15992359</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakashita N., Miyazaki A., Takeya M., Horiuchi S., Chang C.C., Chang T.Y., Takahashi K. Localization of human acyl-coenzyme A: Cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues. Am. J. Pathol. 2000;156:227&#x2013;236. doi: 10.1016/S0002-9440(10)64723-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0002-9440(10)64723-2</ArticleId><ArticleId IdType=\"pmc\">PMC1868616</ArticleId><ArticleId IdType=\"pubmed\">10623671</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.C., Sakashita N., Ornvold K., Lee O., Chang E.T., Dong R., Lin S., Lee C.Y., Strom S.C., Kashyap R., et al. Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J. Biol. Chem. 2000;275:28083&#x2013;28092. doi: 10.1074/jbc.M003927200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M003927200</ArticleId><ArticleId IdType=\"pubmed\">10846185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu M., Hu X.H., Li Q., Xiong Y., Hu G.J., Xu J.J., Zhao X.N., Wei X.X., Chang C.C., Liu Y.K., et al. A specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth. J. Mol. Cell Biol. 2013;5:404&#x2013;415. doi: 10.1093/jmcb/mjt039.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jmcb/mjt039</ArticleId><ArticleId IdType=\"pmc\">PMC3841111</ArticleId><ArticleId IdType=\"pubmed\">24163426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee R.G., Willingham M.C., Davis M.A., Skinner K.A., Rudel L.L. Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates. J. Lipid Res. 2000;41:1991&#x2013;2001. doi: 10.1016/S0022-2275(20)32360-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0022-2275(20)32360-9</ArticleId><ArticleId IdType=\"pubmed\">11108732</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Huynh T.N., Duong M.T., Gow J.G., Chang C.C.Y., Chang T.Y. ACAT1/SOAT1 Blockade Suppresses LPS-Mediated Neuroinflammation by Modulating the Fate of Toll-like Receptor 4 in Microglia. Int. J. Mol. Sci. 2023;24:5616. doi: 10.3390/ijms24065616.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24065616</ArticleId><ArticleId IdType=\"pmc\">PMC10053317</ArticleId><ArticleId IdType=\"pubmed\">36982689</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki A., Sakashita N., Lee O., Takahashi K., Horiuchi S., Hakamata H., Morganelli P.M., Chang C.C., Chang T.Y. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler.Thromb. Vasc. Biol. 1998;18:1568&#x2013;1574. doi: 10.1161/01.ATV.18.10.1568.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/01.ATV.18.10.1568</ArticleId><ArticleId IdType=\"pubmed\">9763528</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.J., Bian Y., Luo J., Lu M., Xiong Y., Guo S.Y., Yin H.Y., Lin X., Li Q., Chang C.C.Y., et al. Cholesterol and fatty acids regulate cysteine ubiquitylation of ACAT2 through competitive oxidation. Nat. Cell Biol. 2017;19:808&#x2013;819. doi: 10.1038/ncb3551.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncb3551</ArticleId><ArticleId IdType=\"pmc\">PMC5518634</ArticleId><ArticleId IdType=\"pubmed\">28604676</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J.L., Rangaraj K., Simpson R., Maclean D.J., Nathanson L.K., Stuart K.A., Scott S.P., Ramm G.A., de Jersey J. Quantitative analysis of the expression of ACAT genes in human tissues by real-time PCR. J. Lipid Res. 2004;45:686&#x2013;696. doi: 10.1194/jlr.M300365-JLR200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1194/jlr.M300365-JLR200</ArticleId><ArticleId IdType=\"pubmed\">14729857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutter-Paier B., Huttunen H.J., Puglielli L., Eckman C.B., Kim D.Y., Hofmeister A., Moir R.D., Domnitz S.B., Frosch M.P., Windisch M., et al. The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer&#x2019;s disease. Neuron. 2004;44:227&#x2013;238. doi: 10.1016/j.neuron.2004.08.043.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2004.08.043</ArticleId><ArticleId IdType=\"pubmed\">15473963</ArticleId></ArticleIdList></Reference><Reference><Citation>Farese R.V., Jr. The nine lives of ACAT inhibitors. Arterioscler. Thromb. Vasc. Biol. 2006;26:1684&#x2013;1686. doi: 10.1161/01.ATV.0000227511.35456.90.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/01.ATV.0000227511.35456.90</ArticleId><ArticleId IdType=\"pubmed\">16857957</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya Y., Chang C.C., Chang T.Y. ACAT1/SOAT1 as a therapeutic target for Alzheimer&#x2019;s disease. Future Med. Chem. 2015;7:2451&#x2013;2467. doi: 10.4155/fmc.15.161.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4155/fmc.15.161</ArticleId><ArticleId IdType=\"pmc\">PMC4976859</ArticleId><ArticleId IdType=\"pubmed\">26669800</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng F., Cheng X., Wu X., Yoo J.Y., Cheng C., Guo J.Y., Mo X., Ru P., Hurwitz B., Kim S.H., et al. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis. Clin. Cancer Res. 2016;22:5337&#x2013;5348. doi: 10.1158/1078-0432.CCR-15-2973.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1158/1078-0432.CCR-15-2973</ArticleId><ArticleId IdType=\"pmc\">PMC5093025</ArticleId><ArticleId IdType=\"pubmed\">27281560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayyagari V.N., Wang X., Diaz-Sylvester P.L., Groesch K., Brard L. Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression&#x2014;An in vitro study. PLoS ONE. 2020;15:e0228024. doi: 10.1371/journal.pone.0228024.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0228024</ArticleId><ArticleId IdType=\"pmc\">PMC6980601</ArticleId><ArticleId IdType=\"pubmed\">31978092</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith D.C., Kroiss M., Kebebew E., Habra M.A., Chugh R., Schneider B.J., Fassnacht M., Jafarinasabian P., Ijzerman M.M., Lin V.H., et al. A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma. Investig. New Drugs. 2020;38:1421&#x2013;1429. doi: 10.1007/s10637-020-00899-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10637-020-00899-1</ArticleId><ArticleId IdType=\"pubmed\">31984451</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent A.A., Lin K., van Lengerich B., Lianoglou S., Przybyla L., Davis S.S., Llapashtica C., Wang J., Kim D.J., Xia D., et al. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge. Neuron. 2020;105:837&#x2013;854.e839. doi: 10.1016/j.neuron.2019.12.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2019.12.007</ArticleId><ArticleId IdType=\"pubmed\">31902528</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers M.A., Chang C.C.Y., Maue R.A., Melton E.M., Peden A.A., Garver W.S., Lee J., Schroen P., Huang M., Chang T.Y. Acat1/Soat1 knockout extends the mutant Npc1 mouse lifespan and ameliorates functional deficiencies in multiple organelles of mutant cells. Proc. Natl. Acad. Sci. USA. 2022;119:e2201646119. doi: 10.1073/pnas.2201646119.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2201646119</ArticleId><ArticleId IdType=\"pmc\">PMC9170141</ArticleId><ArticleId IdType=\"pubmed\">35507892</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X.C., Luo L.M., Huang T.S., Feng L.F. SOAT1 is a new prognostic factor of colorectal cancer. Ir. J. Med. Sci. 2022;191:1549&#x2013;1554. doi: 10.1007/s11845-021-02746-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11845-021-02746-5</ArticleId><ArticleId IdType=\"pubmed\">34460058</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Torre A.L., Huynh T.N., Chang C.C.Y., Pooler D.B., Ness D.B., Lewis L.D., Pannem S., Feng Y., Samkoe K.S., Hickey W.F., et al. Stealth Liposomes Encapsulating a Potent ACAT1/SOAT1 Inhibitor F12511: Pharmacokinetic, Biodistribution, and Toxicity Studies in Wild-Type Mice and Efficacy Studies in Triple Transgenic Alzheimer&#x2019;s Disease Mice. Int. J. Mol. Sci. 2023;24:1013. doi: 10.3390/ijms241311013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms241311013</ArticleId><ArticleId IdType=\"pmc\">PMC10341764</ArticleId><ArticleId IdType=\"pubmed\">37446191</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia-Olvera A.C., Balu D., Faulk N., Amiridis A., Wang Y., Pham C., Avila-Munoz E., York J.M., Thatcher G.R.J., LaDu M.J. Inhibition of ACAT as a Therapeutic Target for Alzheimer&#x2019;s Disease Is Independent of ApoE4 Lipidation. Neurotherapeutics. 2023;20:1120&#x2013;1137. doi: 10.1007/s13311-023-01375-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13311-023-01375-3</ArticleId><ArticleId IdType=\"pmc\">PMC10457278</ArticleId><ArticleId IdType=\"pubmed\">37157042</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun T., Xiao X. Targeting ACAT1 in cancer: From threat to treatment. Front. Oncol. 2024;14:1395192. doi: 10.3389/fonc.2024.1395192.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fonc.2024.1395192</ArticleId><ArticleId IdType=\"pmc\">PMC11076747</ArticleId><ArticleId IdType=\"pubmed\">38720812</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhat N.Y., Alexander D., McKee K., Iben J., Rodriguez-Gil J.L., Wassif C.A., Cawley N.X., Balch W.E., Porter F.D. Sterol O-Acyltransferase 1 (SOAT1): A Genetic Modifier of Niemann-Pick Disease, Type C1. Int. J. Mol. Sci. 2024;25:4217. doi: 10.3390/ijms25084217.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms25084217</ArticleId><ArticleId IdType=\"pmc\">PMC11050712</ArticleId><ArticleId IdType=\"pubmed\">38673803</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardif J.C., Gregoire J., L&#x2019;Allier P.L., Anderson T.J., Bertrand O., Reeves F., Title L.M., Alfonso F., Schampaert E., Hassan A., et al. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation. 2004;110:3372&#x2013;3377. doi: 10.1161/01.CIR.0000147777.12010.EF.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/01.CIR.0000147777.12010.EF</ArticleId><ArticleId IdType=\"pubmed\">15533865</ArticleId></ArticleIdList></Reference><Reference><Citation>Nissen S.E., Tuzcu E.M., Brewer H.B., Sipahi I., Nicholls S.J., Ganz P., Schoenhagen P., Waters D.D., Pepine C.J., Crowe T.D., et al. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N. Engl. J. Med. 2006;354:1253&#x2013;1263. doi: 10.1056/NEJMoa054699.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa054699</ArticleId><ArticleId IdType=\"pubmed\">16554527</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenoya M., Yoshinaka Y., Kobayashi H., Kawamine K., Shibuya K., Sato F., Sawanobori K., Watanabe T., Miyazaki A. A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels. Atherosclerosis. 2007;191:290&#x2013;297. doi: 10.1016/j.atherosclerosis.2006.05.048.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.atherosclerosis.2006.05.048</ArticleId><ArticleId IdType=\"pubmed\">16820149</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Farre A.J., Sacristan D., Zamorano-Leon J.J., San-Martin N., Macaya C. Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): Could it be a new antiatherosclerotic therapeutic? Cardiovasc. Ther. 2008;26:65&#x2013;74. doi: 10.1111/j.1527-3466.2007.00030.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1527-3466.2007.00030.x</ArticleId><ArticleId IdType=\"pubmed\">18466422</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuwese M.C., de Groot E., Duivenvoorden R., Trip M.D., Ose L., Maritz F.J., Basart D.C., Kastelein J.J., Habib R., Davidson M.H., et al. ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: The CAPTIVATE randomized trial. JAMA. 2009;301:1131&#x2013;1139. doi: 10.1001/jama.301.11.1131.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.301.11.1131</ArticleId><ArticleId IdType=\"pubmed\">19293413</ArticleId></ArticleIdList></Reference><Reference><Citation>Hai Q., Smith J.D. Acyl-Coenzyme A: Cholesterol Acyltransferase (ACAT) in Cholesterol Metabolism: From Its Discovery to Clinical Trials and the Genomics Era. Metabolites. 2021;11:543. doi: 10.3390/metabo11080543.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo11080543</ArticleId><ArticleId IdType=\"pmc\">PMC8398989</ArticleId><ArticleId IdType=\"pubmed\">34436484</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttunen H.J., Puglielli L., Ellis B.C., MacKenzie Ingano L.A., Kovacs D.M. Novel N-terminal cleavage of APP precludes Abeta generation in ACAT-defective AC29 cells. J. Mol. Neurosci. 2009;37:6&#x2013;15. doi: 10.1007/s12031-008-9088-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12031-008-9088-0</ArticleId><ArticleId IdType=\"pmc\">PMC2721794</ArticleId><ArticleId IdType=\"pubmed\">18618086</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya R., Kovacs D.M. ACAT inhibition and amyloid beta reduction. Biochim. Biophys. Acta. 2010;1801:960&#x2013;965. doi: 10.1016/j.bbalip.2010.04.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbalip.2010.04.003</ArticleId><ArticleId IdType=\"pmc\">PMC2918257</ArticleId><ArticleId IdType=\"pubmed\">20398792</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryleva E.Y., Rogers M.A., Chang C.C., Buen F., Harris B.T., Rousselet E., Seidah N.G., Oddo S., LaFerla F.M., Spencer T.A., et al. ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD. Proc. Natl. Acad. Sci. USA. 2010;107:3081&#x2013;3086. doi: 10.1073/pnas.0913828107.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0913828107</ArticleId><ArticleId IdType=\"pmc\">PMC2840286</ArticleId><ArticleId IdType=\"pubmed\">20133765</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance J.E. Dysregulation of cholesterol balance in the brain: Contribution to neurodegenerative diseases. Dis. Model Mech. 2012;5:746&#x2013;755. doi: 10.1242/dmm.010124.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1242/dmm.010124</ArticleId><ArticleId IdType=\"pmc\">PMC3484857</ArticleId><ArticleId IdType=\"pubmed\">23065638</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya Y., Chang C.C., Huang L.H., Bryleva E.Y., Chang T.Y. Inhibiting ACAT1/SOAT1 in microglia stimulates autophagy-mediated lysosomal proteolysis and increases Abeta1-42 clearance. J. Neurosci. 2014;34:14484&#x2013;14501. doi: 10.1523/JNEUROSCI.2567-14.2014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.2567-14.2014</ArticleId><ArticleId IdType=\"pmc\">PMC4205563</ArticleId><ArticleId IdType=\"pubmed\">25339759</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin U., Park S.J., Park S.M. Cholesterol Metabolism in the Brain and Its Association with Parkinson&#x2019;s Disease. Exp. Neurobiol. 2019;28:554&#x2013;567. doi: 10.5607/en.2019.28.5.554.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5607/en.2019.28.5.554</ArticleId><ArticleId IdType=\"pmc\">PMC6844833</ArticleId><ArticleId IdType=\"pubmed\">31698548</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Kant R., Langness V.F., Herrera C.M., Williams D.A., Fong L.K., Leestemaker Y., Steenvoorden E., Rynearson K.D., Brouwers J.F., Helms J.B., et al. Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-beta in iPSC-Derived Alzheimer&#x2019;s Disease Neurons. Cell Stem Cell. 2019;24:363&#x2013;375.e369. doi: 10.1016/j.stem.2018.12.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.stem.2018.12.013</ArticleId><ArticleId IdType=\"pmc\">PMC6414424</ArticleId><ArticleId IdType=\"pubmed\">30686764</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Torre A.L., Smith C., Granger J., Anderson F.L., Harned T.C., Havrda M.C., Chang C.C.Y., Chang T.Y. Facile method to incorporate high-affinity ACAT/SOAT1 inhibitor F12511 into stealth liposome-based nanoparticle and demonstration of its efficacy in blocking cholesteryl ester biosynthesis without overt toxicity in neuronal cell culture. J. Neurosci. Methods. 2022;367:109437. doi: 10.1016/j.jneumeth.2021.109437.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jneumeth.2021.109437</ArticleId><ArticleId IdType=\"pmc\">PMC8775100</ArticleId><ArticleId IdType=\"pubmed\">34890698</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.C., Lee C.Y., Chang E.T., Cruz J.C., Levesque M.C., Chang T.Y. Recombinant acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) purified to essential homogeneity utilizes cholesterol in mixed micelles or in vesicles in a highly cooperative manner. J. Biol. Chem. 1998;273:35132&#x2013;35141. doi: 10.1074/jbc.273.52.35132.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.273.52.35132</ArticleId><ArticleId IdType=\"pubmed\">9857049</ArticleId></ArticleIdList></Reference><Reference><Citation>Junquero D., Oms P., Carilla-Durand E., Autin J., Tarayre J., Degryse A., Patoiseau J., Colpaert F.C., Delhon A. Pharmacological profile of F 12511, (S)-2&#x2032;,3&#x2032;, 5&#x2032;-trimethyl-4&#x2032;-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: Cholesterol acyltransferase inhibitor. Biochem. Pharmacol. 2001;61:97&#x2013;108. doi: 10.1016/S0006-2952(00)00523-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0006-2952(00)00523-2</ArticleId><ArticleId IdType=\"pubmed\">11137714</ArticleId></ArticleIdList></Reference><Reference><Citation>Junquero D., Bruniquel F., N&#x2019;Guyen X., Autin J.M., Patoiseau J.F., Degryse A.D., Colpaert F.C., Delhon A. F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet. Atherosclerosis. 2001;155:131&#x2013;142. doi: 10.1016/S0021-9150(00)00559-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0021-9150(00)00559-1</ArticleId><ArticleId IdType=\"pubmed\">11223434</ArticleId></ArticleIdList></Reference><Reference><Citation>Junquero D., Pilon A., Carilla-Durand E., Patoiseau J.F., Tarayre J.P., Torpier G., Staels B., Fruchart J.C., Colpaert F.C., Clavey V., et al. Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: Cholesterol O-acyltransferase, on human adrenocortical cells in culture. Biochem. Pharmacol. 2001;61:387&#x2013;398. doi: 10.1016/S0006-2952(00)00555-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0006-2952(00)00555-4</ArticleId><ArticleId IdType=\"pubmed\">11226372</ArticleId></ArticleIdList></Reference><Reference><Citation>Thi T.T.H., Suys E.J.A., Lee J.S., Nguyen D.H., Park K.D., Truong N.P. Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines. 2021;9:359. doi: 10.3390/vaccines9040359.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/vaccines9040359</ArticleId><ArticleId IdType=\"pmc\">PMC8069344</ArticleId><ArticleId IdType=\"pubmed\">33918072</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen T.M., Cullis P.R. Drug delivery systems: Entering the mainstream. Science. 2004;303:1818&#x2013;1822. doi: 10.1126/science.1095833.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1095833</ArticleId><ArticleId IdType=\"pubmed\">15031496</ArticleId></ArticleIdList></Reference><Reference><Citation>Immordino M.L., Dosio F., Cattel L. Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomed. 2006;1:297&#x2013;315.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2426795</ArticleId><ArticleId IdType=\"pubmed\">17717971</ArticleId></ArticleIdList></Reference><Reference><Citation>Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., Blunk T., Muller R.H. &#x2018;Stealth&#x2019; corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf. B Biointerfaces. 2000;18:301&#x2013;313. doi: 10.1016/S0927-7765(99)00156-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0927-7765(99)00156-3</ArticleId><ArticleId IdType=\"pubmed\">10915952</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk J.S., Xu Q., Kim N., Hanes J., Ensign L.M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 2016;99:28&#x2013;51. doi: 10.1016/j.addr.2015.09.012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.addr.2015.09.012</ArticleId><ArticleId IdType=\"pmc\">PMC4798869</ArticleId><ArticleId IdType=\"pubmed\">26456916</ArticleId></ArticleIdList></Reference><Reference><Citation>Miteva M., Kirkbride K.C., Kilchrist K.V., Werfel T.A., Li H., Nelson C.E., Gupta M.K., Giorgio T.D., Duvall C.L. Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers. Biomaterials. 2015;38:97&#x2013;107. doi: 10.1016/j.biomaterials.2014.10.036.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biomaterials.2014.10.036</ArticleId><ArticleId IdType=\"pmc\">PMC5477977</ArticleId><ArticleId IdType=\"pubmed\">25453977</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesplet N., Morin P., Ribet J.P. Development of a method for simultaneous determination of eflucimibe and its three major metabolites in rat plasma by liquid chromatography/electrospray tandem mass spectrometry: A preliminary study. Rapid Commun. Mass Spectrom. 2005;19:297&#x2013;302. doi: 10.1002/rcm.1784.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/rcm.1784</ArticleId><ArticleId IdType=\"pubmed\">15645487</ArticleId></ArticleIdList></Reference><Reference><Citation>Patoiseau J.F., Autin J.M., Delhon A., Junquero D. Alpha-Phenyl Acetanilide Derivatives Having an Acat Inhibiting Activity and the Therapeutic Application Thereof. US20060135785A1. 2006 June 22;</Citation></Reference><Reference><Citation>Hansen J.M., Piorczynski T.B. Use of Primary Mouse Embryonic Fibroblasts in Developmental Toxicity Assessments. Methods Mol. Biol. 2019;1965:7&#x2013;17. doi: 10.1007/978-1-4939-9182-2_2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-1-4939-9182-2_2</ArticleId><ArticleId IdType=\"pubmed\">31069665</ArticleId></ArticleIdList></Reference><Reference><Citation>Harned T.C., Stan R.V., Cao Z., Chakrabarti R., Higgs H.N., Chang C.C.Y., Chang T.Y. Acute ACAT1/SOAT1 Blockade Increases MAM Cholesterol and Strengthens ER-Mitochondria Connectivity. Int. J. Mol. Sci. 2023;24:5525. doi: 10.3390/ijms24065525.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24065525</ArticleId><ArticleId IdType=\"pmc\">PMC10059652</ArticleId><ArticleId IdType=\"pubmed\">36982602</ArticleId></ArticleIdList></Reference><Reference><Citation>Garman R.H. Histology of the central nervous system. Toxicol. Pathol. 2011;39:22&#x2013;35. doi: 10.1177/0192623310389621.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0192623310389621</ArticleId><ArticleId IdType=\"pubmed\">21119051</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey P.W., Everett D.J. The adrenal cortex and steroidogenesis as cellular and molecular targets for toxicity: Critical omissions from regulatory endocrine disrupter screening strategies for human health? J. Appl. Toxicol. 2003;23:81&#x2013;87. doi: 10.1002/jat.896.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jat.896</ArticleId><ArticleId IdType=\"pubmed\">12666151</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey P.W., Everett D.J., Springall C.J. Adrenal toxicology: A strategy for assessment of functional toxicity to the adrenal cortex and steroidogenesis. J. Appl. Toxicol. 2007;27:103&#x2013;115. doi: 10.1002/jat.1221.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jat.1221</ArticleId><ArticleId IdType=\"pubmed\">17265431</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliskovic D.R., Picard J.A., Krause B.R. ACAT inhibitors: The search for a novel and effective treatment of hypercholesterolemia and atherosclerosis. Prog. Med. Chem. 2002;39:121&#x2013;171. doi: 10.1016/s0079-6468(08)70070-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s0079-6468(08)70070-5</ArticleId><ArticleId IdType=\"pubmed\">12536672</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya K., Morikawa S., Miyamoto M., Ogawa S.I., Tsunenari Y., Urano Y., Noguchi N. Brain Targeting of Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor K-604 via the Intranasal Route Using a Hydroxycarboxylic Acid Solution. ACS Omega. 2019;4:16943&#x2013;16955. doi: 10.1021/acsomega.9b02307.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsomega.9b02307</ArticleId><ArticleId IdType=\"pmc\">PMC6796924</ArticleId><ArticleId IdType=\"pubmed\">31646241</ArticleId></ArticleIdList></Reference><Reference><Citation>Namiot E.D., Sokolov A.V., Chubarev V.N., Tarasov V.V., Schioth H.B. Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines. Int. J. Mol. Sci. 2023;24:787. doi: 10.3390/ijms24010787.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24010787</ArticleId><ArticleId IdType=\"pmc\">PMC9821409</ArticleId><ArticleId IdType=\"pubmed\">36614230</ArticleId></ArticleIdList></Reference><Reference><Citation>Safra T., Muggia F., Jeffers S., Tsao-Wei D.D., Groshen S., Lyass O., Henderson R., Berry G., Gabizon A. Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Ann. Oncol. 2000;11:1029&#x2013;1033. doi: 10.1023/A:1008365716693.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1023/A:1008365716693</ArticleId><ArticleId IdType=\"pubmed\">11038041</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida B., Nag O.K., Rogers K.E., Delehanty J.B. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery. Molecules. 2020;25:5672. doi: 10.3390/molecules25235672.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules25235672</ArticleId><ArticleId IdType=\"pmc\">PMC7730700</ArticleId><ArticleId IdType=\"pubmed\">33271886</ArticleId></ArticleIdList></Reference><Reference><Citation>Juhairiyah F., de Lange E.C.M. Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential. AAPS J. 2021;23:114. doi: 10.1208/s12248-021-00648-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1208/s12248-021-00648-z</ArticleId><ArticleId IdType=\"pmc\">PMC8553706</ArticleId><ArticleId IdType=\"pubmed\">34713363</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro R.G.R., Coutinho A.J., Pinheiro M., Neves A.R. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know? Int. J. Mol. Sci. 2021;22:11654. doi: 10.3390/ijms222111654.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms222111654</ArticleId><ArticleId IdType=\"pmc\">PMC8584083</ArticleId><ArticleId IdType=\"pubmed\">34769082</ArticleId></ArticleIdList></Reference><Reference><Citation>Senapati S., Tripathi K., Awad K., Rahimipour S. Multifunctional Liposomes Targeting Amyloid-beta Oligomers for Early Diagnosis and Therapy of Alzheimer&#x2019;s Disease. Small. 2024;20:e2311670. doi: 10.1002/smll.202311670.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/smll.202311670</ArticleId><ArticleId IdType=\"pubmed\">38461531</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Hu S., Sun M., Shi J., Zhang H., Yu H., Yang Z. Recent advances and clinical translation of liposomal delivery systems in cancer therapy. Eur. J. Pharm. Sci. 2024;193:106688. doi: 10.1016/j.ejps.2023.106688.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejps.2023.106688</ArticleId><ArticleId IdType=\"pubmed\">38171420</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulcur E., Thaqi M., Khaja F., Kuzmis A., Onyuksel H. Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: A novel therapeutic approach for breast cancer and breast cancer stem cells. Drug Deliv. Transl. Res. 2013;3:562&#x2013;574. doi: 10.1007/s13346-013-0167-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13346-013-0167-6</ArticleId><ArticleId IdType=\"pmc\">PMC3867017</ArticleId><ArticleId IdType=\"pubmed\">24363979</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhaveri A.M., Torchilin V.P. Multifunctional polymeric micelles for delivery of drugs and siRNA. Front. Pharmacol. 2014;5:77. doi: 10.3389/fphar.2014.00077.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2014.00077</ArticleId><ArticleId IdType=\"pmc\">PMC4007015</ArticleId><ArticleId IdType=\"pubmed\">24795633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashok B., Arleth L., Hjelm R.P., Rubinstein I., Onyuksel H. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: Effects of PEG chain length and PC incorporation. J. Pharm. Sci. 2004;93:2476&#x2013;2487. doi: 10.1002/jps.20150.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jps.20150</ArticleId><ArticleId IdType=\"pubmed\">15349957</ArticleId></ArticleIdList></Reference><Reference><Citation>Willnow T.E., Herz J. Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands. Pt 3J. Cell Sci. 1994;107:719&#x2013;726. doi: 10.1242/jcs.107.3.719.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1242/jcs.107.3.719</ArticleId><ArticleId IdType=\"pubmed\">8006085</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.C., Doolittle G.M., Chang T.Y. Cycloheximide sensitivity in regulation of acyl coenzyme A:cholesterol acyltransferase activity in Chinese hamster ovary cells. 1. Effect of exogenous sterols. Biochemistry. 1986;25:1693&#x2013;1699. doi: 10.1021/bi00355a038.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/bi00355a038</ArticleId><ArticleId IdType=\"pubmed\">3707902</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein J.L., Dana S.E., Brown M.S. Esterification of low density lipoprotein cholesterol in human fibroblasts and its absence in homozygous familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 1974;71:4288&#x2013;4292. doi: 10.1073/pnas.71.11.4288.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.71.11.4288</ArticleId><ArticleId IdType=\"pmc\">PMC433867</ArticleId><ArticleId IdType=\"pubmed\">4373706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39272998</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2073-4409</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>13</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1426</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/cells13171426</ELocationID><Abstract><AbstractText>There is an urgent need for effective disease-modifying therapeutic interventions for Alzheimer's disease (AD)-the most prevalent cause of dementia with a profound socioeconomic burden. Most clinical trials targeting the classical hallmarks of this disease-&#x3b2;-amyloid plaques and neurofibrillary tangles-failed, showed discrete clinical effects, or were accompanied by concerning side effects. There has been an ongoing search for novel therapeutic targets. Neuroinflammation, now widely recognized as a hallmark of all neurodegenerative diseases, has been proven to be a major contributor to AD pathology. Here, we summarize the role of neuroinflammation in the pathogenesis and progression of AD and discuss potential targets such as microglia, TREM2, the complement system, inflammasomes, and cytosolic DNA sensors. We also present an overview of ongoing studies targeting specific innate immune system components, highlighting the progress in this field of drug research while bringing attention to the delicate nature of innate immune modulations in AD.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Serradas</LastName><ForeName>Maria L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Institute of Physiology II, University Hospital Bonn, 53115 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ding</LastName><ForeName>Yingying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Physiology II, University Hospital Bonn, 53115 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Martorell</LastName><ForeName>Paula V</ForeName><Initials>PV</Initials><AffiliationInfo><Affiliation>Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kuli&#x144;ska</LastName><ForeName>Ida</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Physiology II, University Hospital Bonn, 53115 Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Castro-Gomez</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0002-1581-474X</Identifier><AffiliationInfo><Affiliation>Institute of Physiology II, University Hospital Bonn, 53115 Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neurology, Department of Parkinson, Sleep and Movement Disorders, University Hospital Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>21060</GrantID><Agency>Alzheimer Forschung Initiative e.V</Agency><Country/></Grant><Grant><GrantID>2021-1A-12</GrantID><Agency>Hertie Network of Excellence in Clinical Neuroscience</Agency><Country/></Grant><Grant><GrantID>2021-A1</GrantID><Agency>BONFOR-Forschungskommission der Medizinischen Fakult&#xe4;t Bonn</Agency><Country/></Grant><Grant><GrantID>EXC2151-390873048.</GrantID><Agency>Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under the Germany's Ex-cellence Strategy</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D058847\">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C498715\">TREM2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D008562\">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011971\">Receptors, Immunologic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007113\" MajorTopicYN=\"Y\">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017628\" MajorTopicYN=\"N\">Microglia</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D058847\" MajorTopicYN=\"N\">Inflammasomes</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D058990\" MajorTopicYN=\"N\">Molecular Targeted Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008562\" MajorTopicYN=\"N\">Membrane Glycoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011971\" MajorTopicYN=\"N\">Receptors, Immunologic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">innate immunity</Keyword><Keyword MajorTopicYN=\"N\">neuroinflammation</Keyword><Keyword MajorTopicYN=\"N\">therapeutic targets</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39272998</ArticleId><ArticleId IdType=\"doi\">10.3390/cells13171426</ArticleId><ArticleId IdType=\"pii\">cells13171426</ArticleId><ArticleId IdType=\"pmc\">PMC11394242</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li X., Feng X., Sun X., Hou N., Han F., Liu Y. Global, Regional, and National Burden of Alzheimer&#x2019;s Disease and Other Dementias, 1990&#x2013;2019. Front. Aging Neurosci. 2022;14:937486. doi: 10.3389/fnagi.2022.937486.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.937486</ArticleId><ArticleId IdType=\"pmc\">PMC9588915</ArticleId><ArticleId IdType=\"pubmed\">36299608</ArticleId></ArticleIdList></Reference><Reference><Citation>Trejo-Lopez J.A., Yachnis A.T., Prokop S. Neuropathology of Alzheimer&#x2019;s Disease. Neurotherapeutics. 2022;19:173&#x2013;185. doi: 10.1007/s13311-021-01146-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13311-021-01146-y</ArticleId><ArticleId IdType=\"pmc\">PMC9130398</ArticleId><ArticleId IdType=\"pubmed\">34729690</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical Model of Dynamic Biomarkers of the Alzheimer&#x2019;s Pathological Cascade. Lancet Neurol. 2010;9:119&#x2013;128. doi: 10.1016/S1474-4422(09)70299-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(09)70299-6</ArticleId><ArticleId IdType=\"pmc\">PMC2819840</ArticleId><ArticleId IdType=\"pubmed\">20083042</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Gomez S., Heneka M.T. Innate Immune Activation in Neurodegenerative Diseases. Immunity. 2024;57:790&#x2013;814. doi: 10.1016/j.immuni.2024.03.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.immuni.2024.03.010</ArticleId><ArticleId IdType=\"pubmed\">38599171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., He Y., Han J., Wei W., Chen F. Blood-Brain Barrier Dysfunction and Alzheimer&#x2019;s Disease: Associations, Pathogenic Mechanisms, and Therapeutic Potential. Front. Aging Neurosci. 2023;15:1258640. doi: 10.3389/fnagi.2023.1258640.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1258640</ArticleId><ArticleId IdType=\"pmc\">PMC10679748</ArticleId><ArticleId IdType=\"pubmed\">38020775</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Bhatt L.K. Targeting Cellular Senescence: A Potential Therapeutic Approach forAlzheimer&#x2019;s Disease. Curr. Mol. Pharmacol. 2023;17:e010623217543. doi: 10.2174/1874467217666230601113430.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1874467217666230601113430</ArticleId><ArticleId IdType=\"pubmed\">37264659</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada K., Iwatsubo T. Involvement of the Glymphatic/Meningeal Lymphatic System in Alzheimer&#x2019;s Disease: Insights into Proteostasis and Future Directions. Cell. Mol. Life Sci. 2024;81:192. doi: 10.1007/s00018-024-05225-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00018-024-05225-z</ArticleId><ArticleId IdType=\"pmc\">PMC11039514</ArticleId><ArticleId IdType=\"pubmed\">38652179</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom G.S. Amyloid-&#x3b2; and Tau: The Trigger and Bullet in Alzheimer Disease Pathogenesis. JAMA Neurol. 2014;71:505&#x2013;508. doi: 10.1001/jamaneurol.2013.5847.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaneurol.2013.5847</ArticleId><ArticleId IdType=\"pubmed\">24493463</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Gomez S., Binder J., Heneka M.T. [Neuroinflammation as motor of Alzheimer&#x2019;s disease] Nervenarzt. 2019;90:898&#x2013;906. doi: 10.1007/s00115-019-0778-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00115-019-0778-3</ArticleId><ArticleId IdType=\"pubmed\">31428829</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Z., Brooks D.J., Okello A., Edison P. An Early and Late Peak in Microglial Activation in Alzheimer&#x2019;s Disease Trajectory. Brain. 2017;140:792&#x2013;803. doi: 10.1093/brain/aww349.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/aww349</ArticleId><ArticleId IdType=\"pmc\">PMC5837520</ArticleId><ArticleId IdType=\"pubmed\">28122877</ArticleId></ArticleIdList></Reference><Reference><Citation>Boza-Serrano A., Yang Y., Paulus A., Deierborg T. Innate Immune Alterations Are Elicited in Microglial Cells before Plaque Deposition in the Alzheimer&#x2019;s Disease Mouse Model 5xFAD. Sci. Rep. 2018;8:1550. doi: 10.1038/s41598-018-19699-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-19699-y</ArticleId><ArticleId IdType=\"pmc\">PMC5784016</ArticleId><ArticleId IdType=\"pubmed\">29367720</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzirusso G., Preka E., Goikolea J., Aguilar-Ruiz C., Rodriguez-Rodriguez P., Vazquez-Cabrera G., Laterza S., Latorre-Leal M., Eroli F., Blomgren K., et al. Dynamic Microglia Alterations Associate with Hippocampal Network Impairments: A Turning Point in Amyloid Pathology Progression. Brain Behav. Immun. 2024;119:286&#x2013;300. doi: 10.1016/j.bbi.2024.04.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2024.04.009</ArticleId><ArticleId IdType=\"pubmed\">38608739</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez O.L., Becker J.T., Wahed A.S., Saxton J., Sweet R.A., Wolk D.A., Klunk W., Dekosky S.T. Long-Term Effects of the Concomitant Use of Memantine with Cholinesterase Inhibition in Alzheimer Disease. J. Neurol. Neurosurg. Psychiatry. 2009;80:600&#x2013;607. doi: 10.1136/jnnp.2008.158964.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jnnp.2008.158964</ArticleId><ArticleId IdType=\"pmc\">PMC2823571</ArticleId><ArticleId IdType=\"pubmed\">19204022</ArticleId></ArticleIdList></Reference><Reference><Citation>Coimbra J.R.M., Resende R., Cust&#xf3;dio J.B.A., Salvador J.A.R., Santos A.E. BACE1 Inhibitors for Alzheimer&#x2019;s Disease: Current Challenges and Future Perspectives. J. Alzheimer&#x2019;s Dis. 2024:1&#x2013;26. doi: 10.3233/JAD-240146. pre-press.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-240146</ArticleId><ArticleId IdType=\"pubmed\">38943390</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dyck C.H., Swanson C.J., Aisen P., Bateman R.J., Chen C., Gee M., Kanekiyo M., Li D., Reyderman L., Cohen S., et al. Lecanemab in Early Alzheimer&#x2019;s Disease. N. Engl. J. Med. 2023;388:9&#x2013;21. doi: 10.1056/NEJMoa2212948.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa2212948</ArticleId><ArticleId IdType=\"pubmed\">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims J.R., Zimmer J.A., Evans C.D., Lu M., Ardayfio P., Sparks J., Wessels A.M., Shcherbinin S., Wang H., Monkul Nery E.S., et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023;330:512. doi: 10.1001/jama.2023.13239.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2023.13239</ArticleId><ArticleId IdType=\"pmc\">PMC10352931</ArticleId><ArticleId IdType=\"pubmed\">37459141</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukmir R.B. Amyloid-related Imaging Abnormalities (ARIA): Diagnosis, Management, and Care in the Setting of Amyloid-modifying Therapy. Ann. Clin. Transl. Neurol. 2024;11:1669&#x2013;1680. doi: 10.1002/acn3.52042.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/acn3.52042</ArticleId><ArticleId IdType=\"pmc\">PMC11251480</ArticleId><ArticleId IdType=\"pubmed\">38939962</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.V., Mital S., Knopman D.S., Alexander G.C. Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease. Neurology. 2024;102:e209218. doi: 10.1212/WNL.0000000000209218.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000209218</ArticleId><ArticleId IdType=\"pubmed\">38484190</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney J.W., Bemiller S.M., Murtishaw A.S., Leisgang A.M., Salazar A.M., Lamb B.T. Inflammation as a Central Mechanism in Alzheimer&#x2019;s Disease. Alzheimer&#x2019;s Dement. Transl. Res. Clin. Interv. 2018;4:575&#x2013;590. doi: 10.1016/j.trci.2018.06.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.trci.2018.06.014</ArticleId><ArticleId IdType=\"pmc\">PMC6214864</ArticleId><ArticleId IdType=\"pubmed\">30406177</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Carson M.J., Khoury J.E., Landreth G.E., Brosseron F., Feinstein D.L., Jacobs A.H., Wyss-Coray T., Vitorica J., Ransohoff R.M., et al. Neuroinflammation in Alzheimer&#x2019;s Disease. Lancet Neurol. 2015;14:388&#x2013;405. doi: 10.1016/S1474-4422(15)70016-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(15)70016-5</ArticleId><ArticleId IdType=\"pmc\">PMC5909703</ArticleId><ArticleId IdType=\"pubmed\">25792098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., Zalinski J., Cofield M., Mansukhani L., Willson P., et al. Clinical Trial of Indomethacin in Alzheimer&#x2019;s Disease. Neurology. 1993;43:1609. doi: 10.1212/WNL.43.8.1609.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.43.8.1609</ArticleId><ArticleId IdType=\"pubmed\">8351023</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer P.L., Rogers J., McGeer E.G. Inflammation, Anti-Inflammatory Agents and Alzheimer Disease: The Last 12 Years. J. Alzheimer&#x2019;s Dis. 2006;9:271&#x2013;276. doi: 10.3233/JAD-2006-9S330.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-2006-9S330</ArticleId><ArticleId IdType=\"pubmed\">16914866</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama H. Inflammation and Alzheimer&#x2019;s Disease. Neurobiol. Aging. 2000;21:383&#x2013;421. doi: 10.1016/S0197-4580(00)00124-X.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0197-4580(00)00124-X</ArticleId><ArticleId IdType=\"pmc\">PMC3887148</ArticleId><ArticleId IdType=\"pubmed\">10858586</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews S.J., Renton A.E., Fulton-Howard B., Podlesny-Drabiniok A., Marcora E., Goate A.M. The Complex Genetic Architecture of Alzheimer&#x2019;s Disease: Novel Insights and Future Directions. EBioMedicine. 2023;90:104511. doi: 10.1016/j.ebiom.2023.104511.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ebiom.2023.104511</ArticleId><ArticleId IdType=\"pmc\">PMC10024184</ArticleId><ArticleId IdType=\"pubmed\">36907103</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohapatra L., Mishra D., Shiomurti Tripathi A., Kumar Parida S. Immunosenescence as a Convergence Pathway in Neurodegeneration. Int. Immunopharmacol. 2023;121:110521. doi: 10.1016/j.intimp.2023.110521.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.intimp.2023.110521</ArticleId><ArticleId IdType=\"pubmed\">37385122</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett B.L., Gardner R.C., Godbout J., Dams-O&#x2019;Connor K., Keene C.D. Traumatic Brain Injury and Risk of Neurodegenerative Disorder. Biol. Psychiatry. 2022;91:498&#x2013;507. doi: 10.1016/j.biopsych.2021.05.025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopsych.2021.05.025</ArticleId><ArticleId IdType=\"pmc\">PMC8636548</ArticleId><ArticleId IdType=\"pubmed\">34364650</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzambi R., Bhaskaran K., Brayne C., Davidson J.A., Smeeth L., Warren-Gash C. Common Bacterial Infections and Risk of Dementia or Cognitive Decline: A Systematic Review. J. Alzheimer&#x2019;s Dis. 2020;76:1609&#x2013;1626. doi: 10.3233/JAD-200303.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-200303</ArticleId><ArticleId IdType=\"pmc\">PMC7504996</ArticleId><ArticleId IdType=\"pubmed\">32651320</ArticleId></ArticleIdList></Reference><Reference><Citation>Asby D., Boche D., Allan S., Love S., Miners J.S. Systemic Infection Exacerbates Cerebrovascular Dysfunction in Alzheimer&#x2019;s Disease. Brain. 2021;144:1869&#x2013;1883. doi: 10.1093/brain/awab094.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awab094</ArticleId><ArticleId IdType=\"pmc\">PMC8320299</ArticleId><ArticleId IdType=\"pubmed\">33723589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang Q.-S., Meng L., Wang Z., Shen L., Ji H.-F. Associations Between Obesity and Alzheimer&#x2019;s Disease: Multiple Bioinformatic Analyses. J. Alzheimer&#x2019;s Dis. 2021;80:271&#x2013;281. doi: 10.3233/JAD-201235.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-201235</ArticleId><ArticleId IdType=\"pubmed\">33523009</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubman A., Choo X.Y., Chew G., Ouyang J.F., Sun G., Croft N.P., Rossello F.J., Simmons R., Buckberry S., Landin D.V., et al. Transcriptional Signature in Microglia Associated with A&#x3b2; Plaque Phagocytosis. Nat. Commun. 2021;12:3015. doi: 10.1038/s41467-021-23111-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-021-23111-1</ArticleId><ArticleId IdType=\"pmc\">PMC8140091</ArticleId><ArticleId IdType=\"pubmed\">34021136</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun N., Victor M.B., Park Y.P., Xiong X., Scannail A.N., Leary N., Prosper S., Viswanathan S., Luna X., Boix C.A., et al. Human Microglial State Dynamics in Alzheimer&#x2019;s Disease Progression. Cell. 2023;186:4386&#x2013;4403.e29. doi: 10.1016/j.cell.2023.08.037.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2023.08.037</ArticleId><ArticleId IdType=\"pmc\">PMC10644954</ArticleId><ArticleId IdType=\"pubmed\">37774678</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M., Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu. Rev. Immunol. 2017;35:441&#x2013;468. doi: 10.1146/annurev-immunol-051116-052358.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-immunol-051116-052358</ArticleId><ArticleId IdType=\"pmc\">PMC8167938</ArticleId><ArticleId IdType=\"pubmed\">28226226</ArticleId></ArticleIdList></Reference><Reference><Citation>Shmuel-Galia L., Klug Y., Porat Z., Charni M., Zarmi B., Shai Y. Intramembrane Attenuation of the TLR4-TLR6 Dimer Impairs Receptor Assembly and Reduces Microglia-Mediated Neurodegeneration. J. Biol. Chem. 2017;292:13415&#x2013;13427. doi: 10.1074/jbc.M117.784983.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M117.784983</ArticleId><ArticleId IdType=\"pmc\">PMC5555200</ArticleId><ArticleId IdType=\"pubmed\">28655763</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., Rayner K.J., Boyer L., Zhong R., Frazier W.A., et al. CD36 Ligands Promote Sterile Inflammation through Assembly of a Toll-like Receptor 4 and 6 Heterodimer. Nat. Immunol. 2010;11:155&#x2013;161. doi: 10.1038/ni.1836.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ni.1836</ArticleId><ArticleId IdType=\"pmc\">PMC2809046</ArticleId><ArticleId IdType=\"pubmed\">20037584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosher K.I., Wyss-Coray T. Microglial Dysfunction in Brain Aging and Alzheimer&#x2019;s Disease. Biochem. Pharmacol. 2014;88:594&#x2013;604. doi: 10.1016/j.bcp.2014.01.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bcp.2014.01.008</ArticleId><ArticleId IdType=\"pmc\">PMC3972294</ArticleId><ArticleId IdType=\"pubmed\">24445162</ArticleId></ArticleIdList></Reference><Reference><Citation>Spangenberg E., Severson P.L., Hohsfield L.A., Crapser J., Zhang J., Burton E.A., Zhang Y., Spevak W., Lin J., Phan N.Y., et al. Sustained Microglial Depletion with CSF1R Inhibitor Impairs Parenchymal Plaque Development in an Alzheimer&#x2019;s Disease Model. Nat. Commun. 2019;10:3758. doi: 10.1038/s41467-019-11674-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-019-11674-z</ArticleId><ArticleId IdType=\"pmc\">PMC6704256</ArticleId><ArticleId IdType=\"pubmed\">31434879</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiani Shabestari S., Morabito S., Danhash E.P., McQuade A., Sanchez J.R., Miyoshi E., Chadarevian J.P., Claes C., Coburn M.A., Hasselmann J., et al. Absence of Microglia Promotes Diverse Pathologies and Early Lethality in Alzheimer&#x2019;s Disease Mice. Cell Rep. 2022;39:110961. doi: 10.1016/j.celrep.2022.110961.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2022.110961</ArticleId><ArticleId IdType=\"pmc\">PMC9285116</ArticleId><ArticleId IdType=\"pubmed\">35705056</ArticleId></ArticleIdList></Reference><Reference><Citation>Munro D.A.D., Bestard-Cuche N., McQuaid C., Chagnot A., Shabestari S.K., Chadarevian J.P., Maheshwari U., Szymkowiak S., Morris K., Mohammad M., et al. Microglia Protect against Age-Associated Brain Pathologies. Neuron. 2024;112:2732&#x2013;2748.e8. doi: 10.1016/j.neuron.2024.05.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2024.05.018</ArticleId><ArticleId IdType=\"pubmed\">38897208</ArticleId></ArticleIdList></Reference><Reference><Citation>Coniglio S.J., Eugenin E., Dobrenis K., Stanley E.R., West B.L., Symons M.H., Segall J.E. Microglial Stimulation of Glioblastoma Invasion Involves Epidermal Growth Factor Receptor (EGFR) and Colony Stimulating Factor 1 Receptor (CSF-1R) Signaling. Mol. Med. 2012;18:519&#x2013;527. doi: 10.2119/molmed.2011.00217.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2119/molmed.2011.00217</ArticleId><ArticleId IdType=\"pmc\">PMC3356419</ArticleId><ArticleId IdType=\"pubmed\">22294205</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagher N.N., Najafi A.R., Kayala K.M.N., Elmore M.R.P., White T.E., Medeiros R., West B.L., Green K.N. Colony-Stimulating Factor 1 Receptor Inhibition Prevents Microglial Plaque Association and Improves Cognition in 3xTg-AD Mice. J. Neuroinflamm. 2015;12:139. doi: 10.1186/s12974-015-0366-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-015-0366-9</ArticleId><ArticleId IdType=\"pmc\">PMC4522109</ArticleId><ArticleId IdType=\"pubmed\">26232154</ArticleId></ArticleIdList></Reference><Reference><Citation>Krauser J.A., Jin Y., Walles M., Pfaar U., Sutton J., Wiesmann M., Graf D., Pflimlin-Fritschy V., Wolf T., Camenisch G., et al. Phenotypic and Metabolic Investigation of a CSF-1R Kinase Receptor Inhibitor (BLZ945) and Its Pharmacologically Active Metabolite. Xenobiotica. 2015;45:107&#x2013;123. doi: 10.3109/00498254.2014.945988.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/00498254.2014.945988</ArticleId><ArticleId IdType=\"pubmed\">25180976</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura Y., Ohno H., Ohzeki Y., Takanashi H., Murooka H., Kubo K., Serizawa I. The Selective M-CSF Receptor Tyrosine Kinase Inhibitor Ki20227 Suppresses Experimental Autoimmune Encephalomyelitis. J. Neuroimmunol. 2008;195:73&#x2013;80. doi: 10.1016/j.jneuroim.2008.01.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jneuroim.2008.01.015</ArticleId><ArticleId IdType=\"pubmed\">18378004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R., Fryatt G., Cleal M., Obst J., Pipi E., Monz&#xf3;n-Sandoval J., Ribe E., Winchester L., Webber C., Nevado A., et al. CSF1R Inhibitor JNJ-40346527 Attenuates Microglial Proliferation and Neurodegeneration in P301S Mice. Brain. 2019;142:3243&#x2013;3264. doi: 10.1093/brain/awz241.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awz241</ArticleId><ArticleId IdType=\"pmc\">PMC6794948</ArticleId><ArticleId IdType=\"pubmed\">31504240</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson M., Dudek A.Z., Sukari A., Call J., Kunk P.R., Lewis K., Gainor J.F., Sarantopoulos J., Lee P., Golden A., et al. ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study. Clin. Cancer Res. 2022;28:2517&#x2013;2526. doi: 10.1158/1078-0432.CCR-21-3009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1158/1078-0432.CCR-21-3009</ArticleId><ArticleId IdType=\"pmc\">PMC9359741</ArticleId><ArticleId IdType=\"pubmed\">35302585</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway J.G., McDonald B., Parham J., Keith B., Rusnak D.W., Shaw E., Jansen M., Lin P., Payne A., Crosby R.M., et al. Inhibition of Colony-Stimulating-Factor-1 Signaling in Vivo with the Orally Bioavailable cFMS Kinase Inhibitor GW2580. Proc. Natl. Acad. Sci. USA. 2005;102:16078&#x2013;16083. doi: 10.1073/pnas.0502000102.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0502000102</ArticleId><ArticleId IdType=\"pmc\">PMC1276040</ArticleId><ArticleId IdType=\"pubmed\">16249345</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosna J., Philipp S., Albay R., Reyes-Ruiz J.M., Baglietto-Vargas D., LaFerla F.M., Glabe C.G. Early Long-Term Administration of the CSF1R Inhibitor PLX3397 Ablates Microglia and Reduces Accumulation of Intraneuronal Amyloid, Neuritic Plaque Deposition and Pre-Fibrillar Oligomers in 5XFAD Mouse Model of Alzheimer&#x2019;s Disease. Mol. Neurodegener. 2018;13:11. doi: 10.1186/s13024-018-0244-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-018-0244-x</ArticleId><ArticleId IdType=\"pmc\">PMC5831225</ArticleId><ArticleId IdType=\"pubmed\">29490706</ArticleId></ArticleIdList></Reference><Reference><Citation>Son Y., Jeong Y.J., Shin N.-R., Oh S.J., Nam K.R., Choi H.-D., Choi J.Y., Lee H.-J. Inhibition of Colony-Stimulating Factor 1 Receptor by PLX3397 Prevents Amyloid Beta Pathology and Rescues Dopaminergic Signaling in Aging 5xFAD Mice. Int. J. Mol. Sci. 2020;21:5553. doi: 10.3390/ijms21155553.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21155553</ArticleId><ArticleId IdType=\"pmc\">PMC7432084</ArticleId><ArticleId IdType=\"pubmed\">32756440</ArticleId></ArticleIdList></Reference><Reference><Citation>Casali B.T., MacPherson K.P., Reed-Geaghan E.G., Landreth G.E. Microglia Depletion Rapidly and Reversibly Alters Amyloid Pathology by Modification of Plaque Compaction and Morphologies. Neurobiol. Dis. 2020;142:104956. doi: 10.1016/j.nbd.2020.104956.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2020.104956</ArticleId><ArticleId IdType=\"pmc\">PMC7526856</ArticleId><ArticleId IdType=\"pubmed\">32479996</ArticleId></ArticleIdList></Reference><Reference><Citation>Olmos-Alonso A., Schetters S.T.T., Sri S., Askew K., Mancuso R., Vargas-Caballero M., Holscher C., Perry V.H., Gomez-Nicola D. Pharmacological Targeting of CSF1R Inhibits Microglial Proliferation and Prevents the Progression of Alzheimer&#x2019;s-like Pathology. Brain. 2016;139:891&#x2013;907. doi: 10.1093/brain/awv379.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awv379</ArticleId><ArticleId IdType=\"pmc\">PMC4766375</ArticleId><ArticleId IdType=\"pubmed\">26747862</ArticleId></ArticleIdList></Reference><Reference><Citation>Boissonneault V., Filali M., Lessard M., Relton J., Wong G., Rivest S. Powerful Beneficial Effects of Macrophage Colony-Stimulating Factor on Beta-Amyloid Deposition and Cognitive Impairment in Alzheimer&#x2019;s Disease. Brain. 2009;132:1078&#x2013;1092. doi: 10.1093/brain/awn331.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awn331</ArticleId><ArticleId IdType=\"pubmed\">19151372</ArticleId></ArticleIdList></Reference><Reference><Citation>Umpierre A.D., Wu L.-J. How Microglia Sense and Regulate Neuronal Activity. Glia. 2021;69:1637&#x2013;1653. doi: 10.1002/glia.23961.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/glia.23961</ArticleId><ArticleId IdType=\"pmc\">PMC8113084</ArticleId><ArticleId IdType=\"pubmed\">33369790</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray P.J. Understanding and Exploiting the Endogenous Interleukin-10/STAT3-Mediated Anti-Inflammatory Response. Curr. Opin. Pharmacol. 2006;6:379&#x2013;386. doi: 10.1016/j.coph.2006.01.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.coph.2006.01.010</ArticleId><ArticleId IdType=\"pubmed\">16713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo-Silva D., Carriche G.M., Castro A.G., Roque S., Saraiva M. Balancing the Immune Response in the Brain: IL-10 and Its Regulation. J. Neuroinflamm. 2016;13:297. doi: 10.1186/s12974-016-0763-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-016-0763-8</ArticleId><ArticleId IdType=\"pmc\">PMC5121946</ArticleId><ArticleId IdType=\"pubmed\">27881137</ArticleId></ArticleIdList></Reference><Reference><Citation>Shemer A., Scheyltjens I., Frumer G.R., Kim J.-S., Grozovski J., Ayanaw S., Dassa B., Van Hove H., Chappell-Maor L., Boura-Halfon S., et al. Interleukin-10 Prevents Pathological Microglia Hyperactivation Following Peripheral Endotoxin Challenge. Immunity. 2020;53:1033&#x2013;1049.e7. doi: 10.1016/j.immuni.2020.09.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.immuni.2020.09.018</ArticleId><ArticleId IdType=\"pubmed\">33049219</ArticleId></ArticleIdList></Reference><Reference><Citation>Weston L.L., Jiang S., Chisholm D., Jantzie L.L., Bhaskar K. Interleukin-10 Deficiency Exacerbates Inflammation-Induced Tau Pathology. J. Neuroinflamm. 2021;18:161. doi: 10.1186/s12974-021-02211-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-021-02211-1</ArticleId><ArticleId IdType=\"pmc\">PMC8286621</ArticleId><ArticleId IdType=\"pubmed\">34275478</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillot-Sestier M.-V., Doty K.R., Gate D., Rodriguez J., Leung B.P., Rezai-Zadeh K., Town T. Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-like Pathology. Neuron. 2015;85:534&#x2013;548. doi: 10.1016/j.neuron.2014.12.068.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2014.12.068</ArticleId><ArticleId IdType=\"pmc\">PMC4352138</ArticleId><ArticleId IdType=\"pubmed\">25619654</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarty P., Li A., Ceballos-Diaz C., Eddy J.A., Funk C.C., Moore B., DiNunno N., Rosario A.M., Cruz P.E., Verbeeck C., et al. IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior. Neuron. 2015;85:519&#x2013;533. doi: 10.1016/j.neuron.2014.11.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2014.11.020</ArticleId><ArticleId IdType=\"pmc\">PMC4320003</ArticleId><ArticleId IdType=\"pubmed\">25619653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyota T., Ingraham K.L., Swan R.J., Jacobsen M.T., Andrews S.J., Ikezu T. AAV Serotype 2/1-Mediated Gene Delivery of Anti-Inflammatory Interleukin-10 Enhances Neurogenesis and Cognitive Function in APP+PS1 Mice. Gene Ther. 2012;19:724&#x2013;733. doi: 10.1038/gt.2011.126.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/gt.2011.126</ArticleId><ArticleId IdType=\"pmc\">PMC3241853</ArticleId><ArticleId IdType=\"pubmed\">21918553</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatherley D., Lea S.M., Johnson S., Barclay A.N. Structures of CD200/CD200 Receptor Family and Implications for Topology, Regulation, and Evolution. Structure. 2013;21:820&#x2013;832. doi: 10.1016/j.str.2013.03.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.str.2013.03.008</ArticleId><ArticleId IdType=\"pmc\">PMC3664923</ArticleId><ArticleId IdType=\"pubmed\">23602662</ArticleId></ArticleIdList></Reference><Reference><Citation>Manich G., Recasens M., Valente T., Almolda B., Gonz&#xe1;lez B., Castellano B. Role of the CD200-CD200R Axis During Homeostasis and Neuroinflammation. Neuroscience. 2019;405:118&#x2013;136. doi: 10.1016/j.neuroscience.2018.10.030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroscience.2018.10.030</ArticleId><ArticleId IdType=\"pubmed\">30367946</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., Blom B., Homola M.E., Streit W.J., Brown M.H., et al. Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200) Science. 2000;290:1768&#x2013;1771. doi: 10.1126/science.290.5497.1768.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.290.5497.1768</ArticleId><ArticleId IdType=\"pubmed\">11099416</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker D.G., Dalsing-Hernandez J.E., Campbell N.A., Lue L.-F. Decreased Expression of CD200 and CD200 Receptor in Alzheimer&#x2019;s Disease: A Potential Mechanism Leading to Chronic Inflammation. Exp. Neurol. 2009;215:5&#x2013;19. doi: 10.1016/j.expneurol.2008.09.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.expneurol.2008.09.003</ArticleId><ArticleId IdType=\"pmc\">PMC2765462</ArticleId><ArticleId IdType=\"pubmed\">18938162</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng D., Huang A., Yan W., Chen D. CD200 Dysfunction in Neuron Contributes to Synaptic Deficits and Cognitive Impairment. Biochem. Biophys. Res. Commun. 2019;516:1053&#x2013;1059. doi: 10.1016/j.bbrc.2019.06.134.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2019.06.134</ArticleId><ArticleId IdType=\"pubmed\">31277944</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., et al. Role for Neuronally Derived Fractalkine in Mediating Interactions between Neurons and CX3CR1-Expressing Microglia. Proc. Natl. Acad. Sci. USA. 1998;95:10896&#x2013;10901. doi: 10.1073/pnas.95.18.10896.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.95.18.10896</ArticleId><ArticleId IdType=\"pmc\">PMC27992</ArticleId><ArticleId IdType=\"pubmed\">9724801</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyori A., Minami M., Ohtani Y., Takami S., Yamamoto J., Kawaguchi N., Kume T., Akaike A., Satoh M. Localization of Fractalkine and CX 3 CR1 mRNAs in Rat Brain: Does Fractalkine Play a Role in Signaling from Neuron to Microglia? FEBS Lett. 1998;429:167&#x2013;172. doi: 10.1016/S0014-5793(98)00583-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0014-5793(98)00583-3</ArticleId><ArticleId IdType=\"pubmed\">9650583</ArticleId></ArticleIdList></Reference><Reference><Citation>Iemmolo M., Ghersi G., Bivona G. The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases. Int. J. Mol. Sci. 2023;24:8026. doi: 10.3390/ijms24098026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24098026</ArticleId><ArticleId IdType=\"pmc\">PMC10179166</ArticleId><ArticleId IdType=\"pubmed\">37175729</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R.C., Bolasco G., Pagani F., Maggi L., Scianni M., Panzanelli P., Giustetto M., Ferreira T.A., Guiducci E., Dumas L., et al. Synaptic Pruning by Microglia Is Necessary for Normal Brain Development. Science. 2011;333:1456&#x2013;1458. doi: 10.1126/science.1202529.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1202529</ArticleId><ArticleId IdType=\"pubmed\">21778362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno M., Fujita Y., Tanaka T., Nakamura Y., Kikuta J., Ishii M., Yamashita T. Layer V Cortical Neurons Require Microglial Support for Survival during Postnatal Development. Nat. Neurosci. 2013;16:543&#x2013;551. doi: 10.1038/nn.3358.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nn.3358</ArticleId><ArticleId IdType=\"pubmed\">23525041</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggi L. CX3CR1 Deficiency Alters Hippocampal-Dependent Plasticity Phenomena Blunting the Effects of Enriched Environment. Front. Cell. Neurosci. 2011;5:22. doi: 10.3389/fncel.2011.00022.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2011.00022</ArticleId><ArticleId IdType=\"pmc\">PMC3198035</ArticleId><ArticleId IdType=\"pubmed\">22025910</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.T., Morganti J.M., Bachstetter A.D., Hudson C.E., Peters M.M., Grimmig B.A., Weeber E.J., Bickford P.C., Gemma C. CX3CR1 Deficiency Leads to Impairment of Hippocampal Cognitive Function and Synaptic Plasticity. J. Neurosci. 2011;31:16241&#x2013;16250. doi: 10.1523/JNEUROSCI.3667-11.2011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.3667-11.2011</ArticleId><ArticleId IdType=\"pmc\">PMC3236509</ArticleId><ArticleId IdType=\"pubmed\">22072675</ArticleId></ArticleIdList></Reference><Reference><Citation>Zujovic V., Benavides J., Vig&#xe9; X., Carter C., Taupin V. Fractalkine Modulates TNF-Alpha Secretion and Neurotoxicity Induced by Microglial Activation. Glia. 2000;29:305&#x2013;315. doi: 10.1002/(SICI)1098-1136(20000215)29:4&lt;305::AID-GLIA2&gt;3.0.CO;2-V.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/(SICI)1098-1136(20000215)29:4&lt;305::AID-GLIA2&gt;3.0.CO;2-V</ArticleId><ArticleId IdType=\"pubmed\">10652441</ArticleId></ArticleIdList></Reference><Reference><Citation>Zujovic V., Schussler N., Jourdain D., Duverger D., Taupin V. In Vivo Neutralization of Endogenous Brain Fractalkine Increases Hippocampal TNFalpha and 8-Isoprostane Production Induced by Intracerebroventricular Injection of LPS. J. Neuroimmunol. 2001;115:135&#x2013;143. doi: 10.1016/S0165-5728(01)00259-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0165-5728(01)00259-4</ArticleId><ArticleId IdType=\"pubmed\">11282163</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., et al. Control of Microglial Neurotoxicity by the Fractalkine Receptor. Nat. Neurosci. 2006;9:917&#x2013;924. doi: 10.1038/nn1715.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nn1715</ArticleId><ArticleId IdType=\"pubmed\">16732273</ArticleId></ArticleIdList></Reference><Reference><Citation>Bol&#xf3;s M., Llorens-Mart&#xed;n M., Perea J.R., Jurado-Arjona J., R&#xe1;bano A., Hern&#xe1;ndez F., Avila J. Absence of CX3CR1 Impairs the Internalization of Tau by Microglia. Mol. Neurodegener. 2017;12:59. doi: 10.1186/s13024-017-0200-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-017-0200-1</ArticleId><ArticleId IdType=\"pmc\">PMC5558740</ArticleId><ArticleId IdType=\"pubmed\">28810892</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulczy&#x144;ska-Przybik A., S&#x142;owik A., Mroczko P., Borawski B., Groblewska M., Borawska R., Mroczko B. Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia. Curr. Alzheimer Res. 2020;17:709&#x2013;721. doi: 10.2174/1567205017666201109095657.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567205017666201109095657</ArticleId><ArticleId IdType=\"pubmed\">33167838</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Varvel N.H., Konerth M.E., Xu G., Cardona A.E., Ransohoff R.M., Lamb B.T. CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer&#x2019;s Disease Mouse Models. Am. J. Pathol. 2010;177:2549&#x2013;2562. doi: 10.2353/ajpath.2010.100265.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2353/ajpath.2010.100265</ArticleId><ArticleId IdType=\"pmc\">PMC2966811</ArticleId><ArticleId IdType=\"pubmed\">20864679</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman S.E., Allison E.K., Coleman U., Kingery-Gallagher N.D., El Khoury J. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal &#x3b2;-Amyloid Clearance Pathways and Slows Progression of Alzheimer&#x2019;s Like-Disease in PS1-APP Mice. Front. Immunol. 2019;10:2780. doi: 10.3389/fimmu.2019.02780.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2019.02780</ArticleId><ArticleId IdType=\"pmc\">PMC6900980</ArticleId><ArticleId IdType=\"pubmed\">31849963</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskar K., Konerth M., Kokiko-Cochran O.N., Cardona A., Ransohoff R.M., Lamb B.T. Regulation of Tau Pathology by the Microglial Fractalkine Receptor. Neuron. 2010;68:19&#x2013;31. doi: 10.1016/j.neuron.2010.08.023.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2010.08.023</ArticleId><ArticleId IdType=\"pmc\">PMC2950825</ArticleId><ArticleId IdType=\"pubmed\">20920788</ArticleId></ArticleIdList></Reference><Reference><Citation>Maphis N., Xu G., Kokiko-Cochran O.N., Jiang S., Cardona A., Ransohoff R.M., Lamb B.T., Bhaskar K. Reactive Microglia Drive Tau Pathology and Contribute to the Spreading of Pathological Tau in the Brain. Brain. 2015;138:1738&#x2013;1755. doi: 10.1093/brain/awv081.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awv081</ArticleId><ArticleId IdType=\"pmc\">PMC4542622</ArticleId><ArticleId IdType=\"pubmed\">25833819</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash K.R., Lee D.C., Hunt J.B., Morganti J.M., Selenica M.-L., Moran P., Reid P., Brownlow M., Guang-Yu Yang C., Savalia M., et al. Fractalkine Overexpression Suppresses Tau Pathology in a Mouse Model of Tauopathy. Neurobiol. Aging. 2013;34:1540&#x2013;1548. doi: 10.1016/j.neurobiolaging.2012.12.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2012.12.011</ArticleId><ArticleId IdType=\"pmc\">PMC8970215</ArticleId><ArticleId IdType=\"pubmed\">23332170</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuhrmann M., Bittner T., Jung C.K.E., Burgold S., Page R.M., Mitteregger G., Haass C., LaFerla F.M., Kretzschmar H., Herms J. Microglial Cx3cr1 Knockout Prevents Neuron Loss in a Mouse Model of Alzheimer&#x2019;s Disease. Nat. Neurosci. 2010;13:411&#x2013;413. doi: 10.1038/nn.2511.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nn.2511</ArticleId><ArticleId IdType=\"pmc\">PMC4072212</ArticleId><ArticleId IdType=\"pubmed\">20305648</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlstr&#xf6;m S., Nordvall G., Sohn D., Hettman A., Turek D., &#xc5;hlin K., Kers A., Claesson M., Slivo C., Lo-Alfredsson Y., et al. Substituted 7-Amino-5-Thio-Thiazolo[4,5-d ]Pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX 3 CR1) J. Med. Chem. 2013;56:3177&#x2013;3190. doi: 10.1021/jm3012273.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jm3012273</ArticleId><ArticleId IdType=\"pubmed\">23516963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridderstad Wollberg A., Ericsson-Dahlstrand A., Jur&#xe9;us A., Ekerot P., Simon S., Nilsson M., Wiklund S.-J., Berg A.-L., Ferm M., Sunnemark D., et al. Pharmacological Inhibition of the Chemokine Receptor CX3CR1 Attenuates Disease in a Chronic-Relapsing Rat Model for Multiple Sclerosis. Proc. Natl. Acad. Sci. USA. 2014;111:5409&#x2013;5414. doi: 10.1073/pnas.1316510111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1316510111</ArticleId><ArticleId IdType=\"pmc\">PMC3986185</ArticleId><ArticleId IdType=\"pubmed\">24706865</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Zhou Z., Sha W., Wang L., Yan F., Yang X., Qin X., Wu M., Li D., Tian S., et al. A Novel CX3CR1 Inhibitor AZD8797 Facilitates Early Recovery of Rat Acute Spinal Cord Injury by Inhibiting Inflammation and Apoptosis. Int. J. Mol. Med. 2020;45:1373&#x2013;1384. doi: 10.3892/ijmm.2020.4509.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/ijmm.2020.4509</ArticleId><ArticleId IdType=\"pmc\">PMC7138267</ArticleId><ArticleId IdType=\"pubmed\">32323731</ArticleId></ArticleIdList></Reference><Reference><Citation>Gayen M., Benoit M.R., Fan Q., Hudobenko J., Yan R. The CX3CL1 Intracellular Domain Exhibits Neuroprotection via Insulin Receptor/Insulin-like Growth Factor Receptor Signaling. J. Biol. Chem. 2022;298:102532. doi: 10.1016/j.jbc.2022.102532.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jbc.2022.102532</ArticleId><ArticleId IdType=\"pmc\">PMC9626938</ArticleId><ArticleId IdType=\"pubmed\">36162508</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y., Takeuchi T., Yamanaka H., Nanki T., Umehara H., Yasuda N., Tago F., Kitahara Y., Kawakubo M., Torii K., et al. Long-Term Safety and Efficacy of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients with Rheumatoid Arthritis Inadequately Responding to Methotrexate. Mod. Rheumatol. 2023;34:37&#x2013;44. doi: 10.1093/mr/road004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/mr/road004</ArticleId><ArticleId IdType=\"pubmed\">36680426</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M. The Biology of TREM Receptors. Nat. Rev. Immunol. 2023;23:580&#x2013;594. doi: 10.1038/s41577-023-00837-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41577-023-00837-1</ArticleId><ArticleId IdType=\"pmc\">PMC9904274</ArticleId><ArticleId IdType=\"pubmed\">36750615</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M., Leyns C.E.G., Holtzman D.M. New Insights into the Role of TREM2 in Alzheimer&#x2019;s Disease. Mol. Neurodegener. 2018;13:66. doi: 10.1186/s13024-018-0298-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-018-0298-9</ArticleId><ArticleId IdType=\"pmc\">PMC6302500</ArticleId><ArticleId IdType=\"pubmed\">30572908</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona S., Zahs K., Wu E., Dakin K., Bras J., Guerreiro R. The Role of TREM2 in Alzheimer&#x2019;s Disease and Other Neurodegenerative Disorders. Lancet Neurol. 2018;17:721&#x2013;730. doi: 10.1016/S1474-4422(18)30232-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(18)30232-1</ArticleId><ArticleId IdType=\"pubmed\">30033062</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirotani K., Hori Y., Yoshizaki R., Higuchi E., Colonna M., Saito T., Hashimoto S., Saito T., Saido T.C., Iwata N. Aminophospholipids Are Signal-Transducing TREM2 Ligands on Apoptotic Cells. Sci. Rep. 2019;9:7508. doi: 10.1038/s41598-019-43535-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-019-43535-6</ArticleId><ArticleId IdType=\"pmc\">PMC6525155</ArticleId><ArticleId IdType=\"pubmed\">31101881</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey C.C., DeVaux L.B., Farzan M. The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein, E. J. Biol. Chem. 2015;290:26033&#x2013;26042. doi: 10.1074/jbc.M115.677286.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M115.677286</ArticleId><ArticleId IdType=\"pmc\">PMC4646256</ArticleId><ArticleId IdType=\"pubmed\">26374897</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Wu X., Li X., Jiang L.-L., Gui X., Liu Y., Sun Y., Zhu B., Pi&#xf1;a-Crespo J.C., Zhang M., et al. TREM2 Is a Receptor for &#x3b2;-Amyloid That Mediates Microglial Function. Neuron. 2018;97:1023&#x2013;1031.e7. doi: 10.1016/j.neuron.2018.01.031.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2018.01.031</ArticleId><ArticleId IdType=\"pmc\">PMC5889092</ArticleId><ArticleId IdType=\"pubmed\">29518356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni B., Kumar D., Cruz-Martins N., Sellamuthu S. Role of TREM2 in Alzheimer&#x2019;s Disease: A Long Road Ahead. Mol. Neurobiol. 2021;58:5239&#x2013;5252. doi: 10.1007/s12035-021-02477-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-021-02477-9</ArticleId><ArticleId IdType=\"pubmed\">34275100</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S.K., Younkin S., et al. TREM2 Variants in Alzheimer&#x2019;s Disease. N. Engl. J. Med. 2013;368:117&#x2013;127. doi: 10.1056/NEJMoa1211851.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa1211851</ArticleId><ArticleId IdType=\"pmc\">PMC3631573</ArticleId><ArticleId IdType=\"pubmed\">23150934</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J., et al. Variant of TREM2 Associated with the Risk of Alzheimer&#x2019;s Disease. N. Engl. J. Med. 2013;368:107&#x2013;116. doi: 10.1056/NEJMoa1211103.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa1211103</ArticleId><ArticleId IdType=\"pmc\">PMC3677583</ArticleId><ArticleId IdType=\"pubmed\">23150908</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang X., Piers T.M., Wefers B., Zhu K., Mallach A., Brunner B., Kleinberger G., Song W., Colonna M., Herms J., et al. The Trem2 R47H Alzheimer&#x2019;s Risk Variant Impairs Splicing and Reduces Trem2 mRNA and Protein in Mice but Not in Humans. Mol. Neurodegener. 2018;13:49. doi: 10.1186/s13024-018-0280-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-018-0280-6</ArticleId><ArticleId IdType=\"pmc\">PMC6126019</ArticleId><ArticleId IdType=\"pubmed\">30185230</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Wang X., He P. The Most Prevalent Rare Coding Variants of TREM2 Conferring Risk of Alzheimer&#x2019;s Disease: A Systematic Review and Meta-analysis. Exp. Ther. Med. 2021;21:347. doi: 10.3892/etm.2021.9778.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/etm.2021.9778</ArticleId><ArticleId IdType=\"pmc\">PMC7903442</ArticleId><ArticleId IdType=\"pubmed\">33732320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Ulland T.K., Ulrich J.D., Song W., Tzaferis J.A., Hole J.T., Yuan P., Mahan T.E., Shi Y., Gilfillan S., et al. TREM2-Mediated Early Microglial Response Limits Diffusion and Toxicity of Amyloid Plaques. J. Exp. Med. 2016;213:667&#x2013;675. doi: 10.1084/jem.20151948.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20151948</ArticleId><ArticleId IdType=\"pmc\">PMC4854736</ArticleId><ArticleId IdType=\"pubmed\">27091843</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Cella M., Mallinson K., Ulrich J.D., Young K.L., Robinette M.L., Gilfillan S., Krishnan G.M., Sudhakar S., Zinselmeyer B.H., et al. TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer&#x2019;s Disease Model. Cell. 2015;160:1061&#x2013;1071. doi: 10.1016/j.cell.2015.01.049.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2015.01.049</ArticleId><ArticleId IdType=\"pmc\">PMC4477963</ArticleId><ArticleId IdType=\"pubmed\">25728668</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan P., Condello C., Keene C.D., Wang Y., Bird T.D., Paul S.M., Luo W., Colonna M., Baddeley D., Grutzendler J. TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron. 2016;90:724&#x2013;739. doi: 10.1016/j.neuron.2016.05.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2016.05.003</ArticleId><ArticleId IdType=\"pmc\">PMC4898967</ArticleId><ArticleId IdType=\"pubmed\">27196974</ArticleId></ArticleIdList></Reference><Reference><Citation>Jay T.R., Hirsch A.M., Broihier M.L., Miller C.M., Neilson L.E., Ransohoff R.M., Lamb B.T., Landreth G.E. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer&#x2019;s Disease. J. Neurosci. 2017;37:637&#x2013;647. doi: 10.1523/JNEUROSCI.2110-16.2016.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.2110-16.2016</ArticleId><ArticleId IdType=\"pmc\">PMC5242410</ArticleId><ArticleId IdType=\"pubmed\">28100745</ArticleId></ArticleIdList></Reference><Reference><Citation>Jay T.R., Miller C.M., Cheng P.J., Graham L.C., Bemiller S., Broihier M.L., Xu G., Margevicius D., Karlo J.C., Sousa G.L., et al. TREM2 Deficiency Eliminates TREM2+ Inflammatory Macrophages and Ameliorates Pathology in Alzheimer&#x2019;s Disease Mouse Models. J. Exp. Med. 2015;212:287&#x2013;295. doi: 10.1084/jem.20142322.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20142322</ArticleId><ArticleId IdType=\"pmc\">PMC4354365</ArticleId><ArticleId IdType=\"pubmed\">25732305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich J.D., Finn M.B., Wang Y., Shen A., Mahan T.E., Jiang H., Stewart F.R., Piccio L., Colonna M., Holtzman D.M. Altered Microglial Response to A&#x3b2; Plaques in APPPS1-21 Mice Heterozygous for TREM2. Mol. Neurodegener. 2014;9:20. doi: 10.1186/1750-1326-9-20.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1750-1326-9-20</ArticleId><ArticleId IdType=\"pmc\">PMC4049806</ArticleId><ArticleId IdType=\"pubmed\">24893973</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T., Tan L., Zhu X.-C., Zhang Q.-Q., Cao L., Tan M.-S., Gu L.-Z., Wang H.-F., Ding Z.-Z., Zhang Y.-D., et al. Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer&#x2019;s Disease. Neuropsychopharmacology. 2014;39:2949&#x2013;2962. doi: 10.1038/npp.2014.164.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/npp.2014.164</ArticleId><ArticleId IdType=\"pmc\">PMC4229581</ArticleId><ArticleId IdType=\"pubmed\">25047746</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K., Rochford C.D.P., Neumann H. Clearance of Apoptotic Neurons without Inflammation by Microglial Triggering Receptor Expressed on Myeloid Cells-2. J. Exp. Med. 2005;201:647&#x2013;657. doi: 10.1084/jem.20041611.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20041611</ArticleId><ArticleId IdType=\"pmc\">PMC2213053</ArticleId><ArticleId IdType=\"pubmed\">15728241</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlepckow K., Monroe K.M., Kleinberger G., Cantuti-Castelvetri L., Parhizkar S., Xia D., Willem M., Werner G., Pettkus N., Brunner B., et al. Enhancing Protective Microglial Activities with a Dual Function TREM2 Antibody to the Stalk Region. EMBO Mol. Med. 2020;12:e11227. doi: 10.15252/emmm.201911227.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.201911227</ArticleId><ArticleId IdType=\"pmc\">PMC7136959</ArticleId><ArticleId IdType=\"pubmed\">32154671</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlepckow K., Morenas-Rodr&#xed;guez E., Hong S., Haass C. Stimulation of TREM2 with Agonistic Antibodies-an Emerging Therapeutic Option for Alzheimer&#x2019;s Disease. Lancet Neurol. 2023;22:1048&#x2013;1060. doi: 10.1016/S1474-4422(23)00247-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(23)00247-8</ArticleId><ArticleId IdType=\"pubmed\">37863592</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Mustafa M., Yuede C.M., Salazar S.V., Kong P., Long H., Ward M., Siddiqui O., Paul R., Gilfillan S., et al. Anti-Human TREM2 Induces Microglia Proliferation and Reduces Pathology in an Alzheimer&#x2019;s Disease Model. J. Exp. Med. 2020;217:e20200785. doi: 10.1084/jem.20200785.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20200785</ArticleId><ArticleId IdType=\"pmc\">PMC7478730</ArticleId><ArticleId IdType=\"pubmed\">32579671</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassler M., Rappaport M.S., Cu&#xf1;o C.B., George J. Engagement of TREM2 by a Novel Monoclonal Antibody Induces Activation of Microglia and Improves Cognitive Function in Alzheimer&#x2019;s Disease Models. J. Neuroinflamm. 2021;18:19. doi: 10.1186/s12974-020-01980-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-020-01980-5</ArticleId><ArticleId IdType=\"pmc\">PMC7796541</ArticleId><ArticleId IdType=\"pubmed\">33422057</ArticleId></ArticleIdList></Reference><Reference><Citation>West E.E., Woodruff T., Fremeaux-Bacchi V., Kemper C. Complement in Human Disease: Approved and up-and-Coming Therapeutics. Lancet. 2024;403:392&#x2013;405. doi: 10.1016/S0140-6736(23)01524-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(23)01524-6</ArticleId><ArticleId IdType=\"pmc\">PMC10872502</ArticleId><ArticleId IdType=\"pubmed\">37979593</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavaillon J.-M., Sansonetti P., Goldman M. 100th Anniversary of Jules Bordet&#x2019;s Nobel Prize: Tribute to a Founding Father of Immunology. Front. Immunol. 2019;10:2114. doi: 10.3389/fimmu.2019.02114.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2019.02114</ArticleId><ArticleId IdType=\"pmc\">PMC6749103</ArticleId><ArticleId IdType=\"pubmed\">31572361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrlich P., Morgenroth J. Zur Theorie Der Lysinwirkung. Berl. Klin. Wochenschr. 1899;36:1&#x2013;9.</Citation></Reference><Reference><Citation>Buchner H. Zur Nomenklatur Der Sch&#xfc;tzenden Eiweissk&#xf6;rper. Centr. F Bakteriol. Parasitenk. 1891;10:699&#x2013;701.</Citation></Reference><Reference><Citation>Nomenclature of Complement. Bull. World Health Organ. 1968;39:935&#x2013;938.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2554587</ArticleId><ArticleId IdType=\"pubmed\">5306104</ArticleId></ArticleIdList></Reference><Reference><Citation>Garred P., Tenner A.J., Mollnes T.E. Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics. Pharmacol. Rev. 2021;73:792&#x2013;827. doi: 10.1124/pharmrev.120.000072.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1124/pharmrev.120.000072</ArticleId><ArticleId IdType=\"pmc\">PMC7956994</ArticleId><ArticleId IdType=\"pubmed\">33687995</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesargikar P., Spiller B., Chavez R. The Complement System: History, Pathways, Cascade and Inhibitors. Eur. J. Microbiol. Immunol. 2012;2:103&#x2013;111. doi: 10.1556/EuJMI.2.2012.2.2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1556/EuJMI.2.2012.2.2</ArticleId><ArticleId IdType=\"pmc\">PMC3956958</ArticleId><ArticleId IdType=\"pubmed\">24672678</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajishengallis G., Reis E.S., Mastellos D.C., Ricklin D., Lambris J.D. Novel Mechanisms and Functions of Complement. Nat. Immunol. 2017;18:1288&#x2013;1298. doi: 10.1038/ni.3858.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ni.3858</ArticleId><ArticleId IdType=\"pmc\">PMC5706779</ArticleId><ArticleId IdType=\"pubmed\">29144501</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeley S., Kemper C., Le Friec G. The &#x201c;Ins and Outs&#x201d; of Complement-Driven Immune Responses. Immunol. Rev. 2016;274:16&#x2013;32. doi: 10.1111/imr.12472.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/imr.12472</ArticleId><ArticleId IdType=\"pmc\">PMC5102160</ArticleId><ArticleId IdType=\"pubmed\">27782335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kareem S., Jacob A., Mathew J., Quigg R.J., Alexander J.J. Complement: Functions, Location and Implications. Immunology. 2023;170:180&#x2013;192. doi: 10.1111/imm.13663.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/imm.13663</ArticleId><ArticleId IdType=\"pmc\">PMC10524990</ArticleId><ArticleId IdType=\"pubmed\">37222083</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker S.E., Bellingham M.C., Woodruff T.M. Complement Drives Circuit Modulation in the Adult Brain. Prog. Neurobiol. 2022;214:102282. doi: 10.1016/j.pneurobio.2022.102282.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pneurobio.2022.102282</ArticleId><ArticleId IdType=\"pubmed\">35533811</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., Ransohoff R.M., Greenberg M.E., Barres B.A., Stevens B. Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron. 2012;74:691&#x2013;705. doi: 10.1016/j.neuron.2012.03.026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2012.03.026</ArticleId><ArticleId IdType=\"pmc\">PMC3528177</ArticleId><ArticleId IdType=\"pubmed\">22632727</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulthard L.G., Hawksworth O.A., Li R., Balachandran A., Lee J.D., Sepehrband F., Kurniawan N., Jeanes A., Simmons D.G., Wolvetang E., et al. Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKC&#x3b6;. J. Neurosci. 2017;37:5395&#x2013;5407. doi: 10.1523/JNEUROSCI.0525-17.2017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.0525-17.2017</ArticleId><ArticleId IdType=\"pmc\">PMC6596536</ArticleId><ArticleId IdType=\"pubmed\">28455369</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorelik A., Sapir T., Haffner-Krausz R., Olender T., Woodruff T.M., Reiner O. Developmental Activities of the Complement Pathway in Migrating Neurons. Nat. Commun. 2017;8:15096. doi: 10.1038/ncomms15096.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncomms15096</ArticleId><ArticleId IdType=\"pmc\">PMC5418580</ArticleId><ArticleId IdType=\"pubmed\">28462915</ArticleId></ArticleIdList></Reference><Reference><Citation>Warwick C.A., Keyes A.L., Woodruff T.M., Usachev Y.M. The Complement Cascade in the Regulation of Neuroinflammation, Nociceptive Sensitization, and Pain. J. Biol. Chem. 2021;297:101085. doi: 10.1016/j.jbc.2021.101085.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jbc.2021.101085</ArticleId><ArticleId IdType=\"pmc\">PMC8446806</ArticleId><ArticleId IdType=\"pubmed\">34411562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Yue H., Hu Z., Shen Y., Ma J., Li J., Wang X.-D., Wang L., Sun B., Shi P., et al. Microglia Mediate Forgetting via Complement-Dependent Synaptic Elimination. Science. 2020;367:688&#x2013;694. doi: 10.1126/science.aaz2288.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.aaz2288</ArticleId><ArticleId IdType=\"pubmed\">32029629</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelek W.M., Morgan B.P. Targeting Complement in Neurodegeneration: Challenges, Risks, and Strategies. Trends Pharmacol. Sci. 2022;43:615&#x2013;628. doi: 10.1016/j.tips.2022.02.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tips.2022.02.006</ArticleId><ArticleId IdType=\"pubmed\">35272861</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouw R.B., Ricklin D. Tipping the Balance: Intricate Roles of the Complement System in Disease and Therapy. Semin. Immunopathol. 2021;43:757&#x2013;771. doi: 10.1007/s00281-021-00892-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00281-021-00892-7</ArticleId><ArticleId IdType=\"pmc\">PMC8547127</ArticleId><ArticleId IdType=\"pubmed\">34698894</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohlson S.S., Tenner A.J. Complement in the Brain: Contributions to Neuroprotection, Neuronal Plasticity, and Neuroinflammation. Annu. Rev. Immunol. 2023;41:431&#x2013;452. doi: 10.1146/annurev-immunol-101921-035639.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-immunol-101921-035639</ArticleId><ArticleId IdType=\"pubmed\">36750318</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X.-C., Tang B.-F., Zhu M.-Z., Lu J., Lin H.-X., Tang J.-M., Li R., Ma T. Analysis of Complement System and Its Related Factors in Alzheimer&#x2019;s Disease. BMC Neurol. 2023;23:446. doi: 10.1186/s12883-023-03503-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12883-023-03503-0</ArticleId><ArticleId IdType=\"pmc\">PMC10729410</ArticleId><ArticleId IdType=\"pubmed\">38114984</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephan A.H., Barres B.A., Stevens B. The Complement System: An Unexpected Role in Synaptic Pruning during Development and Disease. Annu. Rev. Neurosci. 2012;35:369&#x2013;389. doi: 10.1146/annurev-neuro-061010-113810.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-neuro-061010-113810</ArticleId><ArticleId IdType=\"pubmed\">22715882</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen L., Bi D., Shen Y. Complement-Mediated Synapse Loss in Alzheimer&#x2019;s Disease: Mechanisms and Involvement of Risk Factors. Trends Neurosci. 2024;47:135&#x2013;149. doi: 10.1016/j.tins.2023.11.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tins.2023.11.010</ArticleId><ArticleId IdType=\"pubmed\">38129195</ArticleId></ArticleIdList></Reference><Reference><Citation>Winston C.N., Goetzl E.J., Schwartz J.B., Elahi F.M., Rissman R.A. Complement Protein Levels in Plasma Astrocyte-Derived Exosomes Are Abnormal in Conversion from Mild Cognitive Impairment to Alzheimer&#x2019;s Disease Dementia. Alzheimers Dement. (Amst.) 2019;11:61&#x2013;66. doi: 10.1016/j.dadm.2018.11.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.dadm.2018.11.002</ArticleId><ArticleId IdType=\"pmc\">PMC6477776</ArticleId><ArticleId IdType=\"pubmed\">31032394</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl E.J., Schwartz J.B., Abner E.L., Jicha G.A., Kapogiannis D. High Complement Levels in Astrocyte-Derived Exosomes of Alzheimer Disease. Ann. Neurol. 2018;83:544&#x2013;552. doi: 10.1002/ana.25172.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.25172</ArticleId><ArticleId IdType=\"pmc\">PMC5867263</ArticleId><ArticleId IdType=\"pubmed\">29406582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kov&#xe1;cs R.&#xc1;., Vad&#xe1;szi H., Buly&#xe1;ki &#xc9;., T&#xf6;r&#xf6;k G., T&#xf3;th V., M&#xe1;ty&#xe1;s D., Kun J., Hunyadi-Guly&#xe1;s &#xc9;., Fedor F.Z., Csincsi &#xc1;., et al. Identification of Neuronal Pentraxins as Synaptic Binding Partners of C1q and the Involvement of NP1 in Synaptic Pruning in Adult Mice. Front. Immunol. 2020;11:599771. doi: 10.3389/fimmu.2020.599771.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2020.599771</ArticleId><ArticleId IdType=\"pmc\">PMC7897678</ArticleId><ArticleId IdType=\"pubmed\">33628204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian H., Yang L., Cole A., Sun L., Chiang A.C.-A., Fowler S.W., Shim D.J., Rodriguez-Rivera J., Taglialatela G., Jankowsky J.L., et al. NF&#x3ba;B-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer&#x2019;s Disease. Neuron. 2015;85:101&#x2013;115. doi: 10.1016/j.neuron.2014.11.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2014.11.018</ArticleId><ArticleId IdType=\"pmc\">PMC4289109</ArticleId><ArticleId IdType=\"pubmed\">25533482</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Q., Colodner K.J., Matousek S.B., Merry K., Hong S., Kenison J.E., Frost J.L., Le K.X., Li S., Dodart J.-C., et al. Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline. J. Neurosci. 2015;35:13029&#x2013;13042. doi: 10.1523/JNEUROSCI.1698-15.2015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1698-15.2015</ArticleId><ArticleId IdType=\"pmc\">PMC6605437</ArticleId><ArticleId IdType=\"pubmed\">26400934</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas A., Gasque P., Vaudry D., Gonzalez B., Fontaine M. Expression of a Complete and Functional Complement System by Human Neuronal Cells in Vitro. Int. Immunol. 2000;12:1015&#x2013;1023. doi: 10.1093/intimm/12.7.1015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/intimm/12.7.1015</ArticleId><ArticleId IdType=\"pubmed\">10882413</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Z., Chen L., Chen P., Peng H., Rong Y., Hong W., Zhou Q., Li N., Li B., Paolicelli R.C., et al. Clearance of &#x3b2;-Amyloid and Synapses by the Optogenetic Depolarization of Microglia Is Complement Selective. Neuron. 2024;112:740&#x2013;754.e7. doi: 10.1016/j.neuron.2023.12.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2023.12.003</ArticleId><ArticleId IdType=\"pubmed\">38295790</ArticleId></ArticleIdList></Reference><Reference><Citation>Eikelenboom P., Stam F.C. Immunoglobulins and Complement Factors in Senile Plaques. An Immunoperoxidase Study. Acta Neuropathol. 1982;57:239&#x2013;242. doi: 10.1007/BF00685397.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/BF00685397</ArticleId><ArticleId IdType=\"pubmed\">6812382</ArticleId></ArticleIdList></Reference><Reference><Citation>Spurrier J., Nicholson L., Fang X.T., Stoner A.J., Toyonaga T., Holden D., Siegert T.R., Laird W., Allnutt M.A., Chiasseu M., et al. Reversal of Synapse Loss in Alzheimer Mouse Models by Targeting mGluR5 to Prevent Synaptic Tagging by C1Q. Sci. Transl. Med. 2022;14:eabi8593. doi: 10.1126/scitranslmed.abi8593.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/scitranslmed.abi8593</ArticleId><ArticleId IdType=\"pmc\">PMC9554345</ArticleId><ArticleId IdType=\"pubmed\">35648810</ArticleId></ArticleIdList></Reference><Reference><Citation>Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-Transgenic Model of Alzheimer&#x2019;s Disease with Plaques and Tangles: Intracellular Abeta and Synaptic Dysfunction. Neuron. 2003;39:409&#x2013;421. doi: 10.1016/S0896-6273(03)00434-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0896-6273(03)00434-3</ArticleId><ArticleId IdType=\"pubmed\">12895417</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen D.V., Hanson J.E., Sheng M. Microglia in Alzheimer&#x2019;s Disease. J. Cell Biol. 2018;217:459&#x2013;472. doi: 10.1083/jcb.201709069.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.201709069</ArticleId><ArticleId IdType=\"pmc\">PMC5800817</ArticleId><ArticleId IdType=\"pubmed\">29196460</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser D.A., Arora M., Bohlson S.S., Lozano E., Tenner A.J. Generation of Inhibitory NFkappaB Complexes and Phosphorylated cAMP Response Element-Binding Protein Correlates with the Anti-Inflammatory Activity of Complement Protein C1q in Human Monocytes. J. Biol. Chem. 2007;282:7360&#x2013;7367. doi: 10.1074/jbc.M605741200.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M605741200</ArticleId><ArticleId IdType=\"pubmed\">17209050</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoit M.E., Hernandez M.X., Dinh M.L., Benavente F., Vasquez O., Tenner A.J. C1q-Induced LRP1B and GPR6 Proteins Expressed Early in Alzheimer Disease Mouse Models, Are Essential for the C1q-Mediated Protection against Amyloid-&#x3b2; Neurotoxicity. J. Biol. Chem. 2013;288:654&#x2013;665. doi: 10.1074/jbc.M112.400168.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M112.400168</ArticleId><ArticleId IdType=\"pmc\">PMC3537064</ArticleId><ArticleId IdType=\"pubmed\">23150673</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser D.A., Pisalyaput K., Tenner A.J. C1q Enhances Microglial Clearance of Apoptotic Neurons and Neuronal Blebs, and Modulates Subsequent Inflammatory Cytokine Production. J. Neurochem. 2010;112:733&#x2013;743. doi: 10.1111/j.1471-4159.2009.06494.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1471-4159.2009.06494.x</ArticleId><ArticleId IdType=\"pmc\">PMC2809134</ArticleId><ArticleId IdType=\"pubmed\">19919576</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y., Lue L., Yang L., Roher A., Kuo Y., Strohmeyer R., Goux W.J., Lee V., Johnson G.V., Webster S.D., et al. Complement Activation by Neurofibrillary Tangles in Alzheimer&#x2019;s Disease. Neurosci. Lett. 2001;305:165&#x2013;168. doi: 10.1016/S0304-3940(01)01842-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0304-3940(01)01842-0</ArticleId><ArticleId IdType=\"pubmed\">11403931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T., Dejanovic B., Gandham V.D., Gogineni A., Edmonds R., Schauer S., Srinivasan K., Huntley M.A., Wang Y., Wang T.-M., et al. Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy. Cell Rep. 2019;28:2111&#x2013;2123.e6. doi: 10.1016/j.celrep.2019.07.060.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2019.07.060</ArticleId><ArticleId IdType=\"pubmed\">31433986</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokowska A., Atkins A.L., Mor&#xe1;n J., Pekny T., Bulmer L., Pascoe M.C., Barnum S.R., Wetsel R.A., Nilsson J.A., Dragunow M., et al. Complement Peptide C3a Stimulates Neural Plasticity after Experimental Brain Ischaemia. Brain. 2017;140:353&#x2013;369. doi: 10.1093/brain/aww314.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/aww314</ArticleId><ArticleId IdType=\"pubmed\">27956400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez M.X., Namiranian P., Nguyen E., Fonseca M.I., Tenner A.J. C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta. ASN Neuro. 2017;9:1759091416687871. doi: 10.1177/1759091416687871.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1759091416687871</ArticleId><ArticleId IdType=\"pmc\">PMC5298486</ArticleId><ArticleId IdType=\"pubmed\">28078911</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca M.I., Ager R.R., Chu S.-H., Yazan O., Sanderson S.D., LaFerla F.M., Taylor S.M., Woodruff T.M., Tenner A.J. Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer&#x2019;s Disease. J. Immunol. 2009;183:1375&#x2013;1383. doi: 10.4049/jimmunol.0901005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4049/jimmunol.0901005</ArticleId><ArticleId IdType=\"pmc\">PMC4067320</ArticleId><ArticleId IdType=\"pubmed\">19561098</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Arboledas A., Carvalho K., Balderrama-Gutierrez G., Chu S.-H., Liang H.Y., Schartz N.D., Selvan P., Petrisko T.J., Pan M.A., Mortazavi A., et al. C5aR1 Antagonism Alters Microglial Polarization and Mitigates Disease Progression in a Mouse Model of Alzheimer&#x2019;s Disease. Acta Neuropathol. Commun. 2022;10:116. doi: 10.1186/s40478-022-01416-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-022-01416-6</ArticleId><ArticleId IdType=\"pmc\">PMC9386996</ArticleId><ArticleId IdType=\"pubmed\">35978440</ArticleId></ArticleIdList></Reference><Reference><Citation>Panayiotou E., Fella E., Andreou S., Papacharalambous R., Gerasimou P., Costeas P., Angeli S., Kousiappa I., Papacostas S., Kyriakides T. C5aR Agonist Enhances Phagocytosis of Fibrillar and Non-Fibrillar A&#x3b2; Amyloid and Preserves Memory in a Mouse Model of Familial Alzheimer&#x2019;s Disease. PLoS ONE. 2019;14:e0225417. doi: 10.1371/journal.pone.0225417.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0225417</ArticleId><ArticleId IdType=\"pmc\">PMC6897413</ArticleId><ArticleId IdType=\"pubmed\">31809505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.-H., Afridi R., Han J., Jung H.-G., Kim S.-C., Hwang E.M., Shim H.S., Ryu H., Choe Y., Hoe H.-S., et al. Gamma Subunit of Complement Component 8 Is a Neuroinflammation Inhibitor. Brain. 2021;144:528&#x2013;552. doi: 10.1093/brain/awaa425.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awaa425</ArticleId><ArticleId IdType=\"pubmed\">33382892</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng D., Liwinski T., Elinav E. Inflammasome Activation and Regulation: Toward a Better Understanding of Complex Mechanisms. Cell Discov. 2020;6:36. doi: 10.1038/s41421-020-0167-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41421-020-0167-x</ArticleId><ArticleId IdType=\"pmc\">PMC7280307</ArticleId><ArticleId IdType=\"pubmed\">32550001</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H., Callaway J.B., Ting J.P.-Y. Inflammasomes: Mechanism of Action, Role in Disease, and Therapeutics. Nat. Med. 2015;21:677&#x2013;687. doi: 10.1038/nm.3893.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nm.3893</ArticleId><ArticleId IdType=\"pmc\">PMC4519035</ArticleId><ArticleId IdType=\"pubmed\">26121197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamkanfi M., Dixit V.M. Mechanisms and Functions of Inflammasomes. Cell. 2014;157:1013&#x2013;1022. doi: 10.1016/j.cell.2014.04.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2014.04.007</ArticleId><ArticleId IdType=\"pubmed\">24855941</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh J.G., Muruve D.A., Power C. Inflammasomes in the CNS. Nat. Rev. Neurosci. 2014;15:84&#x2013;97. doi: 10.1038/nrn3638.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrn3638</ArticleId><ArticleId IdType=\"pubmed\">24399084</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., McManus R.M., Latz E. Inflammasome Signalling in Brain Function and Neurodegenerative Disease. Nat. Rev. Neurosci. 2018;19:610&#x2013;621. doi: 10.1038/s41583-018-0055-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41583-018-0055-7</ArticleId><ArticleId IdType=\"pubmed\">30206330</ArticleId></ArticleIdList></Reference><Reference><Citation>Latz E., Duewell P. NLRP3 Inflammasome Activation in Inflammaging. Semin. Immunol. 2018;40:61&#x2013;73. doi: 10.1016/j.smim.2018.09.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.smim.2018.09.001</ArticleId><ArticleId IdType=\"pubmed\">30268598</ArticleId></ArticleIdList></Reference><Reference><Citation>Masumoto J., Taniguchi S., Ayukawa K., Sarvotham H., Kishino T., Niikawa N., Hidaka E., Katsuyama T., Higuchi T., Sagara J. ASC, a Novel 22-kDa Protein, Aggregates during Apoptosis of Human Promyelocytic Leukemia HL-60 Cells. J. Biol. Chem. 1999;274:33835&#x2013;33838. doi: 10.1074/jbc.274.48.33835.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.274.48.33835</ArticleId><ArticleId IdType=\"pubmed\">10567338</ArticleId></ArticleIdList></Reference><Reference><Citation>Stutz A., Horvath G.L., Monks B.G., Latz E. ASC Speck Formation as a Readout for Inflammasome Activation. In: De Nardo C.M., Latz E., editors. The Inflammasome. Volume 1040. Humana Press; Totowa, NJ, USA: 2013. pp. 91&#x2013;101. Methods in Molecular Biology.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23852599</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulse J., Bhaskar K. Crosstalk Between the NLRP3 Inflammasome/ASC Speck and Amyloid Protein Aggregates Drives Disease Progression in Alzheimer&#x2019;s and Parkinson&#x2019;s Disease. Front. Mol. Neurosci. 2022;15:805169. doi: 10.3389/fnmol.2022.805169.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnmol.2022.805169</ArticleId><ArticleId IdType=\"pmc\">PMC8850380</ArticleId><ArticleId IdType=\"pubmed\">35185469</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinon F., Burns K., Tschopp J. The Inflammasome. Mol. Cell. 2002;10:417&#x2013;426. doi: 10.1016/S1097-2765(02)00599-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1097-2765(02)00599-3</ArticleId><ArticleId IdType=\"pubmed\">12191486</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinon F., P&#xe9;trilli V., Mayor A., Tardivel A., Tschopp J. Gout-Associated Uric Acid Crystals Activate the NALP3 Inflammasome. Nature. 2006;440:237&#x2013;241. doi: 10.1038/nature04516.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature04516</ArticleId><ArticleId IdType=\"pubmed\">16407889</ArticleId></ArticleIdList></Reference><Reference><Citation>McManus R.M., Latz E. NLRP3 Inflammasome Signalling in Alzheimer&#x2019;s Disease. Neuropharmacology. 2024;252:109941. doi: 10.1016/j.neuropharm.2024.109941.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuropharm.2024.109941</ArticleId><ArticleId IdType=\"pubmed\">38565393</ArticleId></ArticleIdList></Reference><Reference><Citation>Halle A., Hornung V., Petzold G.C., Stewart C.R., Monks B.G., Reinheckel T., Fitzgerald K.A., Latz E., Moore K.J., Golenbock D.T. The NALP3 Inflammasome Is Involved in the Innate Immune Response to Amyloid-&#x3b2;. Nat. Immunol. 2008;9:857&#x2013;865. doi: 10.1038/ni.1636.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ni.1636</ArticleId><ArticleId IdType=\"pmc\">PMC3101478</ArticleId><ArticleId IdType=\"pubmed\">18604209</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Kummer M.P., Stutz A., Delekate A., Schwartz S., Vieira-Saecker A., Griep A., Axt D., Remus A., Tzeng T.-C., et al. NLRP3 Is Activated in Alzheimer&#x2019;s Disease and Contributes to Pathology in APP/PS1 Mice. Nature. 2013;493:674&#x2013;678. doi: 10.1038/nature11729.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature11729</ArticleId><ArticleId IdType=\"pmc\">PMC3812809</ArticleId><ArticleId IdType=\"pubmed\">23254930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ising C., Venegas C., Zhang S., Scheiblich H., Schmidt S.V., Vieira-Saecker A., Schwartz S., Albasset S., McManus R.M., Tejera D., et al. NLRP3 Inflammasome Activation Drives Tau Pathology. Nature. 2019;575:669&#x2013;673. doi: 10.1038/s41586-019-1769-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-019-1769-z</ArticleId><ArticleId IdType=\"pmc\">PMC7324015</ArticleId><ArticleId IdType=\"pubmed\">31748742</ArticleId></ArticleIdList></Reference><Reference><Citation>Stancu I.-C., Cremers N., Vanrusselt H., Couturier J., Vanoosthuyse A., Kessels S., Lodder C., Br&#xf4;ne B., Huaux F., Octave J.-N., et al. Aggregated Tau Activates NLRP3&#x2013;ASC Inflammasome Exacerbating Exogenously Seeded and Non-Exogenously Seeded Tau Pathology in Vivo. Acta Neuropathol. 2019;137:599&#x2013;617. doi: 10.1007/s00401-018-01957-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-018-01957-y</ArticleId><ArticleId IdType=\"pmc\">PMC6426830</ArticleId><ArticleId IdType=\"pubmed\">30721409</ArticleId></ArticleIdList></Reference><Reference><Citation>Venegas C., Kumar S., Franklin B.S., Dierkes T., Brinkschulte R., Tejera D., Vieira-Saecker A., Schwartz S., Santarelli F., Kummer M.P., et al. Microglia-Derived ASC Specks Cross-Seed Amyloid-&#x3b2; in Alzheimer&#x2019;s Disease. Nature. 2017;552:355&#x2013;361. doi: 10.1038/nature25158.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature25158</ArticleId><ArticleId IdType=\"pubmed\">29293211</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang T., Zhang Y., Wu S., Chen Q., Wang L. The Role of NLRP3 Inflammasome in Alzheimer&#x2019;s Disease and Potential Therapeutic Targets. Front. Pharmacol. 2022;13:845185. doi: 10.3389/fphar.2022.845185.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2022.845185</ArticleId><ArticleId IdType=\"pmc\">PMC8889079</ArticleId><ArticleId IdType=\"pubmed\">35250595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu&#x10d;i&#x16b;nait&#x117; A., McManus R.M., Jankunec M., R&#xe1;cz I., Dansokho C., Dalg&#x117;dien&#x117; I., Schwartz S., Brosseron F., Heneka M.T. Soluble A&#x3b2; Oligomers and Protofibrils Induce NLRP3 Inflammasome Activation in Microglia. J. Neurochem. 2020;155:650&#x2013;661. doi: 10.1111/jnc.14945.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jnc.14945</ArticleId><ArticleId IdType=\"pubmed\">31872431</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin B.S., Bossaller L., De Nardo D., Ratter J.M., Stutz A., Engels G., Brenker C., Nordhoff M., Mirandola S.R., Al-Amoudi A., et al. The Adaptor ASC Has Extracellular and &#x201c;prionoid&#x201d; Activities That Propagate Inflammation. Nat. Immunol. 2014;15:727&#x2013;737. doi: 10.1038/ni.2913.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ni.2913</ArticleId><ArticleId IdType=\"pmc\">PMC4116676</ArticleId><ArticleId IdType=\"pubmed\">24952505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahillio&#x11f;lu A.C., &#xd6;z&#xf6;ren N. Artificial Loading of ASC Specks with Cytosolic Antigens. PLoS ONE. 2015;10:e0134912. doi: 10.1371/journal.pone.0134912.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0134912</ArticleId><ArticleId IdType=\"pmc\">PMC4530869</ArticleId><ArticleId IdType=\"pubmed\">26258904</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan S., Kancheva D., De Ren S., Saito T., Jans M., Boone F., Vandendriessche C., Paesmans I., Maurin H., Vandenbroucke R.E., et al. Inflammasome Signaling Is Dispensable for SS-Amyloid-Induced Neuropathology in Preclinical Models of Alzheimer&#x2019;s Disease. Front. Immunol. 2024;15:1323409. doi: 10.3389/fimmu.2024.1323409.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2024.1323409</ArticleId><ArticleId IdType=\"pmc\">PMC10863058</ArticleId><ArticleId IdType=\"pubmed\">38352874</ArticleId></ArticleIdList></Reference><Reference><Citation>Coll R.C., Robertson A.A.B., Chae J.J., Higgins S.C., Mu&#xf1;oz-Planillo R., Inserra M.C., Vetter I., Dungan L.S., Monks B.G., Stutz A., et al. A Small-Molecule Inhibitor of the NLRP3 Inflammasome for the Treatment of Inflammatory Diseases. Nat. Med. 2015;21:248&#x2013;255. doi: 10.1038/nm.3806.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nm.3806</ArticleId><ArticleId IdType=\"pmc\">PMC4392179</ArticleId><ArticleId IdType=\"pubmed\">25686105</ArticleId></ArticleIdList></Reference><Reference><Citation>Dempsey C., Rubio Araiz A., Bryson K.J., Finucane O., Larkin C., Mills E.L., Robertson A.A.B., Cooper M.A., O&#x2019;Neill L.A.J., Lynch M.A. Inhibiting the NLRP3 Inflammasome with MCC950 Promotes Non-Phlogistic Clearance of Amyloid-&#x3b2; and Cognitive Function in APP/PS1 Mice. Brain Behav. Immun. 2017;61:306&#x2013;316. doi: 10.1016/j.bbi.2016.12.014.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2016.12.014</ArticleId><ArticleId IdType=\"pubmed\">28003153</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., He H., Chen Y., Huang W., Cheng J., Ye J., Wang A., Tao J., Wang C., Liu Q., et al. Identification of a Selective and Direct NLRP3 Inhibitor to Treat Inflammatory Disorders. J. Exp. Med. 2017;214:3219&#x2013;3238. doi: 10.1084/jem.20171419.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20171419</ArticleId><ArticleId IdType=\"pmc\">PMC5679172</ArticleId><ArticleId IdType=\"pubmed\">29021150</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti C., Swartzwelter B., Gamboni F., Neff C.P., Richter K., Azam T., Carta S., Tengesdal I., Nemkov T., D&#x2019;Alessandro A., et al. OLT1177, a &#x3b2;-Sulfonyl Nitrile Compound, Safe in Humans, Inhibits the NLRP3 Inflammasome and Reverses the Metabolic Cost of Inflammation. Proc. Natl. Acad. Sci. USA. 2018;115:E1530&#x2013;E1539. doi: 10.1073/pnas.1716095115.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1716095115</ArticleId><ArticleId IdType=\"pmc\">PMC5816172</ArticleId><ArticleId IdType=\"pubmed\">29378952</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia-Abell&#xe1;n A., Angosto-Bazarra D., Mart&#xed;nez-Banaclocha H., De Torre-Minguela C., Cer&#xf3;n-Carrasco J.P., P&#xe9;rez-S&#xe1;nchez H., Arostegui J.I., Pelegrin P. MCC950 Closes the Active Conformation of NLRP3 to an Inactive State. Nat. Chem. Biol. 2019;15:560&#x2013;564. doi: 10.1038/s41589-019-0278-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41589-019-0278-6</ArticleId><ArticleId IdType=\"pmc\">PMC7116292</ArticleId><ArticleId IdType=\"pubmed\">31086329</ArticleId></ArticleIdList></Reference><Reference><Citation>Fekete C., Vastagh C., D&#xe9;nes &#xc1;., Hrabovszky E., Nyiri G., Kall&#xf3; I., Liposits Z., S&#xe1;rv&#xe1;ri M. Chronic Amyloid &#x3b2; Oligomer Infusion Evokes Sustained Inflammation and Microglial Changes in the Rat Hippocampus via NLRP3. Neuroscience. 2019;405:35&#x2013;46. doi: 10.1016/j.neuroscience.2018.02.046.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroscience.2018.02.046</ArticleId><ArticleId IdType=\"pubmed\">29522854</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Sun K., Zhou Y., Wang H., Zhou Y., Liu S., Nie Y., Li Y. NLRP3 Inflammasome Inhibitor CY-09 Reduces Hepatic Steatosis in Experimental NAFLD Mice. Biochem. Biophys. Res. Commun. 2021;534:734&#x2013;739. doi: 10.1016/j.bbrc.2020.11.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2020.11.009</ArticleId><ArticleId IdType=\"pubmed\">33213837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonnemann N., Hosseini S., Marchetti C., Skouras D.B., Stefanoni D., D&#x2019;Alessandro A., Dinarello C.A., Korte M. The NLRP3 Inflammasome Inhibitor OLT1177 Rescues Cognitive Impairment in a Mouse Model of Alzheimer&#x2019;s Disease. Proc. Natl. Acad. Sci. USA. 2020;117:32145&#x2013;32154. doi: 10.1073/pnas.2009680117.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2009680117</ArticleId><ArticleId IdType=\"pmc\">PMC7749353</ArticleId><ArticleId IdType=\"pubmed\">33257576</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Jiang H., Chen Y., Wang X., Yang Y., Tao J., Deng X., Liang G., Zhang H., Jiang W., et al. Tranilast Directly Targets NLRP 3 to Treat Inflammasome-driven Diseases. EMBO Mol. Med. 2018;10:e8689. doi: 10.15252/emmm.201708689.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.201708689</ArticleId><ArticleId IdType=\"pmc\">PMC5887903</ArticleId><ArticleId IdType=\"pubmed\">29531021</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulp J., He L., Toldo S., Jiang Y., Boice A., Guo C., Li X., Rolfe A., Sun D., Abbate A., et al. Structural Insights of Benzenesulfonamide Analogues as NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization. J. Med. Chem. 2018;61:5412&#x2013;5423. doi: 10.1021/acs.jmedchem.8b00733.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jmedchem.8b00733</ArticleId><ArticleId IdType=\"pmc\">PMC6225534</ArticleId><ArticleId IdType=\"pubmed\">29877709</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J., Zhao F., Chojnacki J.E., Fulp J., Klein W.L., Zhang S., Zhu X. NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer&#x2019;s Disease. Mol. Neurobiol. 2018;55:1977&#x2013;1987. doi: 10.1007/s12035-017-0467-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-017-0467-9</ArticleId><ArticleId IdType=\"pmc\">PMC5585057</ArticleId><ArticleId IdType=\"pubmed\">28255908</ArticleId></ArticleIdList></Reference><Reference><Citation>He H., Jiang H., Chen Y., Ye J., Wang A., Wang C., Liu Q., Liang G., Deng X., Jiang W., et al. Oridonin Is a Covalent NLRP3 Inhibitor with Strong Anti-Inflammasome Activity. Nat. Commun. 2018;9:2550. doi: 10.1038/s41467-018-04947-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-018-04947-6</ArticleId><ArticleId IdType=\"pmc\">PMC6026158</ArticleId><ArticleId IdType=\"pubmed\">29959312</ArticleId></ArticleIdList></Reference><Reference><Citation>Juliana C., Fernandes-Alnemri T., Wu J., Datta P., Solorzano L., Yu J.-W., Meng R., Quong A.A., Latz E., Scott C.P., et al. Anti-Inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome. J. Biol. Chem. 2010;285:9792&#x2013;9802. doi: 10.1074/jbc.M109.082305.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M109.082305</ArticleId><ArticleId IdType=\"pmc\">PMC2843228</ArticleId><ArticleId IdType=\"pubmed\">20093358</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapak P., Bishnoi M., Sharma S.S. Tranilast, a Transient Receptor Potential Vanilloid 2 Channel (TRPV2) Inhibitor Attenuates Amyloid &#x3b2;-Induced Cognitive Impairment: Possible Mechanisms. Neuromol. Med. 2022;24:183&#x2013;194. doi: 10.1007/s12017-021-08675-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12017-021-08675-x</ArticleId><ArticleId IdType=\"pubmed\">34231190</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Yang H., Yu L., Jin J., Qian L., Zhao H., Xu Y., Zhu X. Oridonin Attenuates A&#x3b2;1&#x2013;42-Induced Neuroinflammation and Inhibits NF-&#x3ba;B Pathway. PLoS ONE. 2014;9:e104745. doi: 10.1371/journal.pone.0104745.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0104745</ArticleId><ArticleId IdType=\"pmc\">PMC4133239</ArticleId><ArticleId IdType=\"pubmed\">25121593</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Yu L., Yang H., Li C., Hui Z., Xu Y., Zhu X. Oridonin Attenuates Synaptic Loss and Cognitive Deficits in an A&#x3b2;1&#x2013;42-Induced Mouse Model of Alzheimer&#x2019;s Disease. PLoS ONE. 2016;11:e0151397. doi: 10.1371/journal.pone.0151397.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0151397</ArticleId><ArticleId IdType=\"pmc\">PMC4790895</ArticleId><ArticleId IdType=\"pubmed\">26974541</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano-Teruel P.M., Garc&#xed;a-La&#xed;nez G., Marco-Salvador M., Pardo J., Arias M., DeFord C., Merfort I., Vicent M.J., Pelegr&#xed;n P., Sancho M., et al. Identification of an ASC Oligomerization Inhibitor for the Treatment of Inflammatory Diseases. Cell Death Dis. 2021;12:1155. doi: 10.1038/s41419-021-04420-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41419-021-04420-1</ArticleId><ArticleId IdType=\"pmc\">PMC8667020</ArticleId><ArticleId IdType=\"pubmed\">34903717</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertheloot D., Wanderley C.W., Schneider A.H., Schiffelers L.D., Wuerth J.D., T&#xf6;dtmann J.M., Maasewerd S., Hawwari I., Duthie F., Rohland C., et al. Nanobodies Dismantle Post-pyroptotic ASC Specks and Counteract Inflammation in Vivo. EMBO Mol. Med. 2022;14:e15415. doi: 10.15252/emmm.202115415.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.202115415</ArticleId><ArticleId IdType=\"pmc\">PMC9174887</ArticleId><ArticleId IdType=\"pubmed\">35438238</ArticleId></ArticleIdList></Reference><Reference><Citation>Adriouch S., Pelegrin P. ASC Nanobodies to Counteract the Consequences of Inflammasome Activation. EMBO Mol. Med. 2022;14:e16087. doi: 10.15252/emmm.202216087.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.202216087</ArticleId><ArticleId IdType=\"pmc\">PMC9174878</ArticleId><ArticleId IdType=\"pubmed\">35574976</ArticleId></ArticleIdList></Reference><Reference><Citation>Desu H.L., Plastini M., Illiano P., Bramlett H.M., Dietrich W.D., De Rivero Vaccari J.P., Brambilla R., Keane R.W. IC100: A Novel Anti-ASC Monoclonal Antibody Improves Functional Outcomes in an Animal Model of Multiple Sclerosis. J. Neuroinflamm. 2020;17:143. doi: 10.1186/s12974-020-01826-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-020-01826-0</ArticleId><ArticleId IdType=\"pmc\">PMC7199312</ArticleId><ArticleId IdType=\"pubmed\">32366256</ArticleId></ArticleIdList></Reference><Reference><Citation>Youm Y.-H., Nguyen K.Y., Grant R.W., Goldberg E.L., Bodogai M., Kim D., D&#x2019;Agostino D., Planavsky N., Lupfer C., Kanneganti T.D., et al. The Ketone Metabolite &#x3b2;-Hydroxybutyrate Blocks NLRP3 Inflammasome&#x2013;Mediated Inflammatory Disease. Nat. Med. 2015;21:263&#x2013;269. doi: 10.1038/nm.3804.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nm.3804</ArticleId><ArticleId IdType=\"pmc\">PMC4352123</ArticleId><ArticleId IdType=\"pubmed\">25686106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota M., Matsuo J., Ishida I., Takano H., Yokoi Y., Hori H., Yoshida S., Ashida K., Nakamura K., Takahashi T., et al. Effects of a Medium-Chain Triglyceride-Based Ketogenic Formula on Cognitive Function in Patients with Mild-to-Moderate Alzheimer&#x2019;s Disease. Neurosci. Lett. 2019;690:232&#x2013;236. doi: 10.1016/j.neulet.2018.10.048.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2018.10.048</ArticleId><ArticleId IdType=\"pubmed\">30367958</ArticleId></ArticleIdList></Reference><Reference><Citation>Shippy D.C., Wilhelm C., Viharkumar P.A., Raife T.J., Ulland T.K. &#x3b2;-Hydroxybutyrate Inhibits Inflammasome Activation to Attenuate Alzheimer&#x2019;s Disease Pathology. J. Neuroinflamm. 2020;17:280. doi: 10.1186/s12974-020-01948-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-020-01948-5</ArticleId><ArticleId IdType=\"pmc\">PMC7507727</ArticleId><ArticleId IdType=\"pubmed\">32958021</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores J., No&#xeb;l A., Foveau B., Lynham J., Lecrux C., LeBlanc A.C. Caspase-1 Inhibition Alleviates Cognitive Impairment and Neuropathology in an Alzheimer&#x2019;s Disease Mouse Model. Nat. Commun. 2018;9:3916. doi: 10.1038/s41467-018-06449-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-018-06449-x</ArticleId><ArticleId IdType=\"pmc\">PMC6156230</ArticleId><ArticleId IdType=\"pubmed\">30254377</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie B.A., Mamik M.K., Saito L.B., Boghozian R., Monaco M.C., Major E.O., Lu J.-Q., Branton W.G., Power C. Caspase-1 Inhibition Prevents Glial Inflammasome Activation and Pyroptosis in Models of Multiple Sclerosis. Proc. Natl. Acad. Sci. USA. 2018;115:E6065&#x2013;E6074. doi: 10.1073/pnas.1722041115.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1722041115</ArticleId><ArticleId IdType=\"pmc\">PMC6042136</ArticleId><ArticleId IdType=\"pubmed\">29895691</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores J., No&#xeb;l A., Foveau B., Beauchet O., LeBlanc A.C. Pre-Symptomatic Caspase-1 Inhibitor Delays Cognitive Decline in a Mouse Model of Alzheimer Disease and Aging. Nat. Commun. 2020;11:4571. doi: 10.1038/s41467-020-18405-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-020-18405-9</ArticleId><ArticleId IdType=\"pmc\">PMC7486940</ArticleId><ArticleId IdType=\"pubmed\">32917871</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H., Sun Y., Gao A., Zhang N., Jia Y., Yang S., Na M., Liu H., Cheng X., Fang X., et al. Ac-YVAD-Cmk Improves Neurological Function by Inhibiting Caspase-1-Mediated Inflammatory Response in the Intracerebral Hemorrhage of Rats. Int. Immunopharmacol. 2019;75:105771. doi: 10.1016/j.intimp.2019.105771.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.intimp.2019.105771</ArticleId><ArticleId IdType=\"pubmed\">31352322</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X., Ye H., Siaw-Debrah F., Pan S., He Z., Ni H., Xu Z., Jin K., Zhuge Q., Huang L. AC-YVAD-CMK Inhibits Pyroptosis and Improves Functional Outcome after Intracerebral Hemorrhage. BioMed Res. Int. 2018;2018:3706047. doi: 10.1155/2018/3706047.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2018/3706047</ArticleId><ArticleId IdType=\"pmc\">PMC6206581</ArticleId><ArticleId IdType=\"pubmed\">30410928</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu X., Wu H., Xie Y., Xu L., Liu X., Wang W. Caspase-1/IL-1&#x3b2; Represses Membrane Transport of GluA1 by Inhibiting the Interaction between Stargazin and GluA1 in Alzheimer&#x2019;s Disease. Mol. Med. 2021;27:8. doi: 10.1186/s10020-021-00273-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s10020-021-00273-8</ArticleId><ArticleId IdType=\"pmc\">PMC7842056</ArticleId><ArticleId IdType=\"pubmed\">33509083</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKenzie S.H., Schipper J.L., Clark A.C. The Potential for Caspases in Drug Discovery. Curr. Opin. Drug Discov. Dev. 2010;13:568&#x2013;576.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3289102</ArticleId><ArticleId IdType=\"pubmed\">20812148</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotem Z., Cox R.A., Isaacs A. Inhibition of Virus Multiplication by Foreign Nucleic Acid. Nature. 1963;197:564&#x2013;566. doi: 10.1038/197564a0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/197564a0</ArticleId><ArticleId IdType=\"pubmed\">13975288</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark G.R., Kerr I.M., Williams B.R.G., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998;67:227&#x2013;264. doi: 10.1146/annurev.biochem.67.1.227.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev.biochem.67.1.227</ArticleId><ArticleId IdType=\"pubmed\">9759489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Sun L., Chen Z.J. Regulation and Function of the cGAS&#x2013;STING Pathway of Cytosolic DNA Sensing. Nat. Immunol. 2016;17:1142&#x2013;1149. doi: 10.1038/ni.3558.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ni.3558</ArticleId><ArticleId IdType=\"pubmed\">27648547</ArticleId></ArticleIdList></Reference><Reference><Citation>Decout A., Katz J.D., Venkatraman S., Ablasser A. The cGAS-STING Pathway as a Therapeutic Target in Inflammatory Diseases. Nat. Rev. Immunol. 2021;21:548&#x2013;569. doi: 10.1038/s41577-021-00524-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41577-021-00524-z</ArticleId><ArticleId IdType=\"pmc\">PMC8029610</ArticleId><ArticleId IdType=\"pubmed\">33833439</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz C.R.R., Maurmann R.M., Guma F.T., Bauer M.E., = Barbe-Tuana F.M. cGAS-STING Pathway as a Potential Trigger of Immunosenescence and Inflammaging. Front. Immunol. 2023;14:1132653. doi: 10.3389/fimmu.2023.1132653.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2023.1132653</ArticleId><ArticleId IdType=\"pmc\">PMC10011111</ArticleId><ArticleId IdType=\"pubmed\">36926349</ArticleId></ArticleIdList></Reference><Reference><Citation>Guey B., Ablasser A. Emerging Dimensions of Cellular cGAS-STING Signaling. Curr. Opin. Immunol. 2022;74:164&#x2013;171. doi: 10.1016/j.coi.2022.01.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.coi.2022.01.004</ArticleId><ArticleId IdType=\"pubmed\">35124516</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvorkin S., Cambier S., Volkman H.E., Stetson D.B. New Frontiers in the cGAS-STING Intracellular DNA-Sensing Pathway. Immunity. 2024;57:718&#x2013;730. doi: 10.1016/j.immuni.2024.02.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.immuni.2024.02.019</ArticleId><ArticleId IdType=\"pmc\">PMC11013568</ArticleId><ArticleId IdType=\"pubmed\">38599167</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablasser A., Chen Z.J. cGAS in Action: Expanding Roles in Immunity and Inflammation. Science. 2019;363:eaat8657. doi: 10.1126/science.aat8657.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.aat8657</ArticleId><ArticleId IdType=\"pubmed\">30846571</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., Cheng J., Ko H., Tang Y. Cytosolic DNA Sensors in Neurodegenerative Diseases: From Physiological Defenders to Pathological Culprits. EMBO Mol. Med. 2024;16:678&#x2013;699. doi: 10.1038/s44321-024-00046-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s44321-024-00046-w</ArticleId><ArticleId IdType=\"pmc\">PMC11018843</ArticleId><ArticleId IdType=\"pubmed\">38467840</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablasser A., Goldeck M., Cavlar T., Deimling T., Witte G., R&#xf6;hl I., Hopfner K.-P., Ludwig J., Hornung V. cGAS Produces a 2&#x2019;-5&#x2019;-Linked Cyclic Dinucleotide Second Messenger That Activates STING. Nature. 2013;498:380&#x2013;384. doi: 10.1038/nature12306.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature12306</ArticleId><ArticleId IdType=\"pmc\">PMC4143541</ArticleId><ArticleId IdType=\"pubmed\">23722158</ArticleId></ArticleIdList></Reference><Reference><Citation>Civril F., Deimling T., de Oliveira Mann C.C., Ablasser A., Moldt M., Witte G., Hornung V., Hopfner K.-P. Structural Mechanism of Cytosolic DNA Sensing by cGAS. Nature. 2013;498:332&#x2013;337. doi: 10.1038/nature12305.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature12305</ArticleId><ArticleId IdType=\"pmc\">PMC3768140</ArticleId><ArticleId IdType=\"pubmed\">23722159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa H., Ma Z., Barber G.N. STING Regulates Intracellular DNA-Mediated, Type I Interferon-Dependent Innate Immunity. Nature. 2009;461:788&#x2013;792. doi: 10.1038/nature08476.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature08476</ArticleId><ArticleId IdType=\"pmc\">PMC4664154</ArticleId><ArticleId IdType=\"pubmed\">19776740</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway. Science. 2013;339:786&#x2013;791. doi: 10.1126/science.1232458.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1232458</ArticleId><ArticleId IdType=\"pmc\">PMC3863629</ArticleId><ArticleId IdType=\"pubmed\">23258413</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Sun L., Chen X., Du F., Shi H., Chen C., Chen Z.J. Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA. Science. 2013;339:826&#x2013;830. doi: 10.1126/science.1229963.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1229963</ArticleId><ArticleId IdType=\"pmc\">PMC3855410</ArticleId><ArticleId IdType=\"pubmed\">23258412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wischnewski M., Ablasser A. Interplay of cGAS with Chromatin. Trends Biochem. Sci. 2021;46:822&#x2013;831. doi: 10.1016/j.tibs.2021.05.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tibs.2021.05.011</ArticleId><ArticleId IdType=\"pubmed\">34215510</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumann T., Ramon S.C., Schubert N., Mayo M.A., Hega M., Maser K.I., Ada S.-R., Sydow L., Hajikazemi M., Badst&#xfc;bner M., et al. Deficiency for SAMHD1 Activates MDA5 in a cGAS/STING-Dependent Manner. J. Exp. Med. 2022;220:e20220829. doi: 10.1084/jem.20220829.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20220829</ArticleId><ArticleId IdType=\"pmc\">PMC9648672</ArticleId><ArticleId IdType=\"pubmed\">36346347</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbs N., Burnaevskiy N., Chen D., Gonugunta V.K., Alto N.M., Yan N. STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease. Cell Host Microbe. 2015;18:157&#x2013;168. doi: 10.1016/j.chom.2015.07.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.chom.2015.07.001</ArticleId><ArticleId IdType=\"pmc\">PMC4537353</ArticleId><ArticleId IdType=\"pubmed\">26235147</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai K., Ogawa E., Uematsu R., Kuchitsu Y., Kiku F., Uemura T., Waguri S., Suzuki T., Dohmae N., Arai H., et al. Homeostatic Regulation of STING by Retrograde Membrane Traffic to the ER. Nat. Commun. 2021;12:61. doi: 10.1038/s41467-020-20234-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-020-20234-9</ArticleId><ArticleId IdType=\"pmc\">PMC7782846</ArticleId><ArticleId IdType=\"pubmed\">33397928</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeltema D., Abbott K., Yan N. STING Trafficking as a New Dimension of Immune Signaling. J. Exp. Med. 2023;220:e20220990. doi: 10.1084/jem.20220990.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20220990</ArticleId><ArticleId IdType=\"pmc\">PMC9930166</ArticleId><ArticleId IdType=\"pubmed\">36705629</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Chang L., Ji Y., Liang T. ER: A Critical Hub for STING Signaling Regulation. Trends Cell Biol. 2024 doi: 10.1016/j.tcb.2024.02.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tcb.2024.02.006</ArticleId><ArticleId IdType=\"pubmed\">38423853</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui X., Yang H., Li T., Tan X., Shi P., Li M., Du F., Chen Z.J. Autophagy Induction via STING Trafficking Is a Primordial Function of the cGAS Pathway. Nature. 2019;567:262&#x2013;266. doi: 10.1038/s41586-019-1006-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-019-1006-9</ArticleId><ArticleId IdType=\"pmc\">PMC9417302</ArticleId><ArticleId IdType=\"pubmed\">30842662</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira Mann C.C., Orzalli M.H., King D.S., Kagan J.C., Lee A.S.Y., Kranzusch P.J. Modular Architecture of the STING C-Terminal Tail Allows Interferon and NF-&#x3ba;B Signaling Adaptation. Cell Rep. 2019;27:1165&#x2013;1175.e5. doi: 10.1016/j.celrep.2019.03.098.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2019.03.098</ArticleId><ArticleId IdType=\"pmc\">PMC7733315</ArticleId><ArticleId IdType=\"pubmed\">31018131</ArticleId></ArticleIdList></Reference><Reference><Citation>Balka K.R., Louis C., Saunders T.L., Smith A.M., Calleja D.J., D&#x2019;Silva D.B., Moghaddas F., Tailler M., Lawlor K.E., Zhan Y., et al. TBK1 and IKK&#x3b5; Act Redundantly to Mediate STING-Induced NF-&#x3ba;B Responses in Myeloid Cells. Cell Rep. 2020;31:107492. doi: 10.1016/j.celrep.2020.03.056.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2020.03.056</ArticleId><ArticleId IdType=\"pubmed\">32268090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouchi M., Ouchi T. Role of IFI16 in DNA Damage and Checkpoint. Front. Biosci. Landmark. 2008;13:236&#x2013;239. doi: 10.2741/2673.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2741/2673</ArticleId><ArticleId IdType=\"pubmed\">17981541</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan X., Ponomareva L., Veeranki S., Panchanathan R., Dickerson E., Choubey D. Differential Roles for the Interferon-Inducible IFI16 and AIM2 Innate Immune Sensors for Cytosolic DNA in Cellular Senescence of Human Fibroblasts. Mol. Cancer Res. 2011;9:589&#x2013;602. doi: 10.1158/1541-7786.MCR-10-0565.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1158/1541-7786.MCR-10-0565</ArticleId><ArticleId IdType=\"pmc\">PMC3096691</ArticleId><ArticleId IdType=\"pubmed\">21471287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosso M., Kirchhoff F. Emerging Role of PYHIN Proteins as Antiviral Restriction Factors. Viruses. 2020;12:1464. doi: 10.3390/v12121464.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/v12121464</ArticleId><ArticleId IdType=\"pmc\">PMC7767131</ArticleId><ArticleId IdType=\"pubmed\">33353088</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xf8;nsson K.L., Laustsen A., Krapp C., Skipper K.A., Thavachelvam K., Hotter D., Egedal J.H., Kjolby M., Mohammadi P., Prabakaran T., et al. IFI16 Is Required for DNA Sensing in Human Macrophages by Promoting Production and Function of cGAMP. Nat. Commun. 2017;8:14391. doi: 10.1038/ncomms14391.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncomms14391</ArticleId><ArticleId IdType=\"pmc\">PMC5309897</ArticleId><ArticleId IdType=\"pubmed\">28186168</ArticleId></ArticleIdList></Reference><Reference><Citation>Almine J.F., O&#x2019;Hare C.A.J., Dunphy G., Haga I.R., Naik R.J., Atrih A., Connolly D.J., Taylor J., Kelsall I.R., Bowie A.G., et al. IFI16 and cGAS Cooperate in the Activation of STING during DNA Sensing in Human Keratinocytes. Nat. Commun. 2017;8:14392. doi: 10.1038/ncomms14392.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncomms14392</ArticleId><ArticleId IdType=\"pmc\">PMC5316833</ArticleId><ArticleId IdType=\"pubmed\">28194029</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W., Zhou R., Li S., He S., Luo J., Zhu M., Chen N., Chen H., Meurens F., Zhu J. Porcine IFI16 Negatively Regulates cGAS Signaling Through the Restriction of DNA Binding and Stimulation. Front. Immunol. 2020;11:1669. doi: 10.3389/fimmu.2020.01669.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2020.01669</ArticleId><ArticleId IdType=\"pmc\">PMC7456882</ArticleId><ArticleId IdType=\"pubmed\">32922386</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliter D.A., Martinez J., Hao L., Chen X., Sun N., Fischer T.D., Burman J.L., Li Y., Zhang Z., Narendra D.P., et al. Parkin and PINK1 Mitigate STING-Induced Inflammation. Nature. 2018;561:258&#x2013;262. doi: 10.1038/s41586-018-0448-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-018-0448-9</ArticleId><ArticleId IdType=\"pmc\">PMC7362342</ArticleId><ArticleId IdType=\"pubmed\">30135585</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Yuan B., Bao M., Lu N., Kim T., Liu Y.-J. The Helicase DDX41 Senses Intracellular DNA Mediated by the Adaptor STING in Dendritic Cells. Nat. Immunol. 2011;12:959&#x2013;965. doi: 10.1038/ni.2091.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ni.2091</ArticleId><ArticleId IdType=\"pmc\">PMC3671854</ArticleId><ArticleId IdType=\"pubmed\">21892174</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.-H., Davidson S., Harapas C.R., Hilton J.B., Mlodzianoski M.J., Laohamonthonkul P., Louis C., Low R.R.J., Moecking J., De Nardo D., et al. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. Cell. 2020;183:636&#x2013;649.e18. doi: 10.1016/j.cell.2020.09.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2020.09.020</ArticleId><ArticleId IdType=\"pmc\">PMC7599077</ArticleId><ArticleId IdType=\"pubmed\">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma M., Rajendrarao S., Shahani N., Ram&#xed;rez-Jarqu&#xed;n U.N., Subramaniam S. Cyclic GMP-AMP Synthase Promotes the Inflammatory and Autophagy Responses in Huntington Disease. Proc. Natl. Acad. Sci. USA. 2020;117:15989&#x2013;15999. doi: 10.1073/pnas.2002144117.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2002144117</ArticleId><ArticleId IdType=\"pmc\">PMC7354937</ArticleId><ArticleId IdType=\"pubmed\">32581130</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M., Shiwaku H., Tanaka H., Obita T., Ohuchi S., Yoshioka Y., Jin X., Kondo K., Fujita K., Homma H., et al. Tau Activates Microglia via the PQBP1-cGAS-STING Pathway to Promote Brain Inflammation. Nat. Commun. 2021;12:6565. doi: 10.1038/s41467-021-26851-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-021-26851-2</ArticleId><ArticleId IdType=\"pmc\">PMC8592984</ArticleId><ArticleId IdType=\"pubmed\">34782623</ArticleId></ArticleIdList></Reference><Reference><Citation>Udeochu J.C., Amin S., Huang Y., Fan L., Torres E.R.S., Carling G., Liu B., McGurran H., Coronas-Samano G., Kauwe G., et al. Tau Activation of Microglial cGAS&#x2013;IFN Reduces MEF2C-Mediated Cognitive Resilience. Nat. Neurosci. 2023;26:737&#x2013;750. doi: 10.1038/s41593-023-01315-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41593-023-01315-6</ArticleId><ArticleId IdType=\"pmc\">PMC10166855</ArticleId><ArticleId IdType=\"pubmed\">37095396</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., O&#x2019;Rourke J.G., Y&#xe1;&#xf1;ez A., Markman J.L., Ho R., Wang X., Chen S., Lall D., Jin M., Muhammad A.K.M.G., et al. C9orf72 in Myeloid Cells Suppresses STING-Induced Inflammation. Nature. 2020;585:96&#x2013;101. doi: 10.1038/s41586-020-2625-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-020-2625-x</ArticleId><ArticleId IdType=\"pmc\">PMC7484469</ArticleId><ArticleId IdType=\"pubmed\">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X., Ma G., Li X., Zhao J., Zhao Z., Zeng J. Activation of Innate Immune cGAS-STING Pathway Contributes to Alzheimer&#x2019;s Pathogenesis in 5&#xd7;FAD Mice. Nat. Aging. 2023;3:202&#x2013;212. doi: 10.1038/s43587-022-00337-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s43587-022-00337-2</ArticleId><ArticleId IdType=\"pubmed\">37118112</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett J.P., Knoblach S.M., Bhattacharya S., Gordish-Dressman H., Stoica B.A., Loane D.J. Traumatic Brain Injury Induces cGAS Activation and Type I Interferon Signaling in Aged Mice. Front. Immunol. 2021;12:710608. doi: 10.3389/fimmu.2021.710608.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2021.710608</ArticleId><ArticleId IdType=\"pmc\">PMC8423402</ArticleId><ArticleId IdType=\"pubmed\">34504493</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinkle J.T., Patel J., Panicker N., Karuppagounder S.S., Biswas D., Belingon B., Chen R., Brahmachari S., Pletnikova O., Troncoso J.C., et al. STING Mediates Neurodegeneration and Neuroinflammation in Nigrostriatal &#x3b1;-Synucleinopathy. Proc. Natl. Acad. Sci. USA. 2022;119:e2118819119. doi: 10.1073/pnas.2118819119.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2118819119</ArticleId><ArticleId IdType=\"pmc\">PMC9169780</ArticleId><ArticleId IdType=\"pubmed\">35394877</ArticleId></ArticleIdList></Reference><Reference><Citation>Jauhari A., Baranov S.V., Suofu Y., Kim J.-H., Singh T., Yablonska S., Li F., Wang X., Oberly P., Minnigh M.B., et al. Melatonin Inhibits Cytosolic Mitochondrial DNA&#x2013;Induced Neuroinflammatory Signaling in Accelerated Aging and Neurodegeneration. J. Clin. Investig. 2020;131:3124&#x2013;3136. doi: 10.1172/JCI135026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI135026</ArticleId><ArticleId IdType=\"pmc\">PMC7260019</ArticleId><ArticleId IdType=\"pubmed\">32182222</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Liu B., Sinha S.C., Amin S., Gan L. Mechanism and Therapeutic Potential of Targeting cGAS-STING Signaling in Neurological Disorders. Mol. Neurodegener. 2023;18:79. doi: 10.1186/s13024-023-00672-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-023-00672-x</ArticleId><ArticleId IdType=\"pmc\">PMC10634099</ArticleId><ArticleId IdType=\"pubmed\">37941028</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy E., Wang B., Wan Y.-W., Chiu G.S.-H., Cole A.L., Yin Z., Propson N.E., Xu Y., Jankowsky J.L., Liu Z., et al. Type I Interferon Response Drives Neuroinflammation and Synapse Loss in Alzheimer Disease. J. Clin. Investig. 2020;130:1912&#x2013;1930. doi: 10.1172/JCI133737.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI133737</ArticleId><ArticleId IdType=\"pmc\">PMC7108898</ArticleId><ArticleId IdType=\"pubmed\">31917687</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L., Chen J., Lo C.-Y.Z., Guo Q., Feng J., Zhao X.-M. Impaired Type I Interferon Signaling Activity Implicated in the Peripheral Blood Transcriptome of Preclinical Alzheimer&#x2019;s Disease. eBioMedicine. 2022;82:104175. doi: 10.1016/j.ebiom.2022.104175.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ebiom.2022.104175</ArticleId><ArticleId IdType=\"pmc\">PMC9304603</ArticleId><ArticleId IdType=\"pubmed\">35863293</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy E., Cao W. Glial Interference: Impact of Type I Interferon in Neurodegenerative Diseases. Mol. Neurodegener. 2022;17:78. doi: 10.1186/s13024-022-00583-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-022-00583-3</ArticleId><ArticleId IdType=\"pmc\">PMC9701358</ArticleId><ArticleId IdType=\"pubmed\">36435817</ArticleId></ArticleIdList></Reference><Reference><Citation>Govindarajulu M., Ramesh S., Beasley M., Lynn G., Wallace C., Labeau S., Pathak S., Nadar R., Moore T., Dhanasekaran M. Role of cGAS&#x2013;Sting Signaling in Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2023;24:8151. doi: 10.3390/ijms24098151.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24098151</ArticleId><ArticleId IdType=\"pmc\">PMC10179704</ArticleId><ArticleId IdType=\"pubmed\">37175853</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Wei Y., Lautrup S., Yang B., Wang Y., Cordonnier S., Mattson M.P., Croteau D.L., Bohr V.A. NAD+ Supplementation Reduces Neuroinflammation and Cell Senescence in a Transgenic Mouse Model of Alzheimer&#x2019;s Disease via cGAS-STING. Proc. Natl. Acad. Sci. USA. 2021;118:e2011226118. doi: 10.1073/pnas.2011226118.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2011226118</ArticleId><ArticleId IdType=\"pmc\">PMC8449423</ArticleId><ArticleId IdType=\"pubmed\">34497121</ArticleId></ArticleIdList></Reference><Reference><Citation>McWhirter S.M., Jefferies C.A. Nucleic Acid Sensors as Therapeutic Targets for Human Disease. Immunity. 2020;53:78&#x2013;97. doi: 10.1016/j.immuni.2020.04.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.immuni.2020.04.004</ArticleId><ArticleId IdType=\"pubmed\">32668230</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulen M.F., Samson N., Keller A., Schwabenland M., Liu C., Gl&#xfc;ck S., Thacker V.V., Favre L., Mangeat B., Kroese L.J., et al. cGAS&#x2013;STING Drives Ageing-Related Inflammation and Neurodegeneration. Nature. 2023;620:374&#x2013;380. doi: 10.1038/s41586-023-06373-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-023-06373-1</ArticleId><ArticleId IdType=\"pmc\">PMC10412454</ArticleId><ArticleId IdType=\"pubmed\">37532932</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39272986</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2073-4409</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>13</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1413</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/cells13171413</ELocationID><Abstract><AbstractText>The &#x3b1;-Klotho protein (hereafter Klotho) is an obligate coreceptor for fibroblast growth factor 23 (FGF23). It is produced in the kidneys, brain and other sites. Klotho insufficiency causes hyperphosphatemia and other anomalies. Importantly, it is associated with chronic pathologies (often age-related) that have an inflammatory component. This includes atherosclerosis, diabetes and Alzheimer's disease. Its mode of action in these diseases is not well understood, but it inhibits or regulates multiple major pathways. Klotho has a membrane form and a soluble form (s-Klotho). Cytosolic Klotho is postulated but not well characterized. s-Klotho has endocrine properties that are incompletely elucidated. It binds to the FGF receptor 1c (FGFR1c) that is widely expressed (including endothelial cells). It also attaches to soluble FGF23, and FGF23/Klotho binds to FGFRs. Thus, s-Klotho might be a roaming FGF23 coreceptor, but it has other functions. Notably, Klotho (cell-bound or soluble) counteracts inflammation and appears to mitigate related aging (inflammaging). It inhibits NF-&#x3ba;B and the NLRP3 inflammasome. This inflammasome requires priming by NF-&#x3ba;B and produces active IL-1&#x3b2;, membrane pores and cell death (pyroptosis). In accord, Klotho countered inflammation and cell injury induced by toxins, damage-associated molecular patterns (DAMPs), cytokines, and reactive oxygen species (ROS). s-Klotho also blocks the TGF-&#x3b2; receptor and Wnt ligands, which lessens fibrotic disease. Low Klotho is associated with loss of muscle mass (sarcopenia), as occurs in aging and chronic diseases. s-Klotho counters the inhibitory effects of myostatin and TGF-&#x3b2; on muscle, reduces inflammation, and improves muscle repair following injury. The inhibition of TGF-&#x3b2; and other factors may also be protective in diabetic retinopathy and age-related macular degeneration (AMD). This review examines Klotho functions especially as related to inflammation and potential applications.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Prud'homme</LastName><ForeName>G&#xe9;rald J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, 220 Walmer Rd, Toronto, ON M5R 3R7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, Unity Health Toronto, Toronto, ON M5B 1W8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Qinghua</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical School, Fudan University, Shanghai 200030, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Innogen Pharmaceutical Co., Ltd., Shanghai 201318, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>2-SRA-2018-497-A-B</GrantID><Agency>Juvenile Diabetes Research Foundation</Agency><Country/></Grant><Grant><GrantID>2-SRA-2015-64-Q-R</GrantID><Agency>Juvenile Diabetes Research Foundation</Agency><Country/></Grant><Grant><GrantID>OG-3-13-4066</GrantID><Agency>Diabetes Canada</Agency><Country/></Grant><Grant><GrantID>81570518, 81630020, 82370814</GrantID><Agency>National Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>N/A</GrantID><Agency>St. Michael's Hospital Foundation and Keenan Research Centre for Biomedical Science, Toronto</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.1.31</RegistryNumber><NameOfSubstance UI=\"D000090265\">Klotho Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>7Q7P4S7RRE</RegistryNumber><NameOfSubstance UI=\"D000089703\">Fibroblast Growth Factor-23</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.31</RegistryNumber><NameOfSubstance UI=\"D005966\">Glucuronidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C000717427\">FGF23 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000893\">Anti-Inflammatory Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000090265\" MajorTopicYN=\"Y\">Klotho Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000375\" MajorTopicYN=\"Y\">Aging</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000089703\" MajorTopicYN=\"Y\">Fibroblast Growth Factor-23</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005966\" MajorTopicYN=\"Y\">Glucuronidase</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000893\" MajorTopicYN=\"N\">Anti-Inflammatory Agents</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer</Keyword><Keyword MajorTopicYN=\"N\">FGF23</Keyword><Keyword MajorTopicYN=\"N\">Klotho</Keyword><Keyword MajorTopicYN=\"N\">NF-&#x3ba;B</Keyword><Keyword MajorTopicYN=\"N\">TGF-&#x3b2;</Keyword><Keyword MajorTopicYN=\"N\">aging</Keyword><Keyword MajorTopicYN=\"N\">atherosclerosis</Keyword><Keyword MajorTopicYN=\"N\">fibrosis</Keyword><Keyword MajorTopicYN=\"N\">inflammasome</Keyword><Keyword MajorTopicYN=\"N\">sarcopenia</Keyword></KeywordList><CoiStatement>G.J.P. reports no conflict of interest. Author Q.W. is employed by Shanghai Innogen Pharmaceutical Co., Ltd., Shanghai, China. Q.W. holds GLP-1 related patents.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39272986</ArticleId><ArticleId IdType=\"doi\">10.3390/cells13171413</ArticleId><ArticleId IdType=\"pii\">cells13171413</ArticleId><ArticleId IdType=\"pmc\">PMC11394293</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kuro-o M. The Klotho proteins in health and disease. Nat. Rev. Nephrol. 2019;15:27&#x2013;44. doi: 10.1038/s41581-018-0078-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41581-018-0078-3</ArticleId><ArticleId IdType=\"pubmed\">30455427</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim K., Halim A., Lu T.-S., Ashworth A., Chong I. Klotho: A Major Shareholder in Vascular Aging Enterprises. Int. J. Mol. Sci. 2019;20:4637. doi: 10.3390/ijms20184637.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms20184637</ArticleId><ArticleId IdType=\"pmc\">PMC6770519</ArticleId><ArticleId IdType=\"pubmed\">31546756</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchanan S., Combet E., Stenvinkel P., Shiels P.G. Klotho, Aging, and the Failing Kidney. Front. Endocrinol. 2020;11:560. doi: 10.3389/fendo.2020.00560.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2020.00560</ArticleId><ArticleId IdType=\"pmc\">PMC7481361</ArticleId><ArticleId IdType=\"pubmed\">32982966</ArticleId></ArticleIdList></Reference><Reference><Citation>Typiak M., Piwkowska A. Antiinflammatory Actions of Klotho: Implications for Therapy of Diabetic Nephropathy. Int. J. Mol. Sci. 2021;22:956. doi: 10.3390/ijms22020956.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22020956</ArticleId><ArticleId IdType=\"pmc\">PMC7835923</ArticleId><ArticleId IdType=\"pubmed\">33478014</ArticleId></ArticleIdList></Reference><Reference><Citation>Prud&#x2019;homme G.J., Kurt M., Wang Q. Pathobiology of the Klotho Antiaging Protein and Therapeutic Considerations. Front. Aging. 2022;3:931331. doi: 10.3389/fragi.2022.931331.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fragi.2022.931331</ArticleId><ArticleId IdType=\"pmc\">PMC9314780</ArticleId><ArticleId IdType=\"pubmed\">35903083</ArticleId></ArticleIdList></Reference><Reference><Citation>Edmonston D., Grabner A., Wolf M. FGF23 and klotho at the intersection of kidney and cardiovascular disease. Nat. Rev. Cardiol. 2023;21:11&#x2013;24. doi: 10.1038/s41569-023-00903-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41569-023-00903-0</ArticleId><ArticleId IdType=\"pubmed\">37443358</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanbay M., Copur S., Ozbek L., Mutlu A., Cejka D., Ciceri P., Cozzolino M., Haarhaus M.L. Klotho: A potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease-a comprehensive review from the ERA CKD-MBD working group. Clin. Kidney J. 2023;17:sfad276. doi: 10.1093/ckj/sfad276.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ckj/sfad276</ArticleId><ArticleId IdType=\"pmc\">PMC10783249</ArticleId><ArticleId IdType=\"pubmed\">38213484</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang A., Zhang Y., Wu L., Lin Y., Lv L., Zhao L., Xu B., Huang Y., Li M. Klotho&#x2019;s impact on diabetic nephropathy and its emerging connection to diabetic retinopathy. Front. Endocrinol. 2023;14:1180169. doi: 10.3389/fendo.2023.1180169.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2023.1180169</ArticleId><ArticleId IdType=\"pmc\">PMC10151763</ArticleId><ArticleId IdType=\"pubmed\">37143722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuro-O M., Matsumura Y., Aizawa H., Kawaguchi H., Suga T., Utsugi T., Ohyama Y., Kurabayashi M., Kaname T., Kume E., et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45&#x2013;51. doi: 10.1038/36285.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/36285</ArticleId><ArticleId IdType=\"pubmed\">9363890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurosu H., Yamamoto M., Clark J.D., Pastor J.V., Nandi A., Gurnani P., McGuinness O.P., Chikuda H., Yamaguchi M., Kawaguchi H., et al. Suppression of aging in mice by the hormone Klotho. Science. 2005;309:1829&#x2013;1833. doi: 10.1126/science.1112766.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1112766</ArticleId><ArticleId IdType=\"pmc\">PMC2536606</ArticleId><ArticleId IdType=\"pubmed\">16123266</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu M.C., Kuro-o M., Moe O.W. Klotho and chronic kidney disease. Contrib. Nephrol. 2013;180:47&#x2013;63. doi: 10.1159/000346778.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000346778</ArticleId><ArticleId IdType=\"pmc\">PMC3911771</ArticleId><ArticleId IdType=\"pubmed\">23652549</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu M.C., Shi M., Zhang J., Addo T., Cho H.J., Barker S.L., Ravikumar P., Gillings N., Bian A., Sidhu S.S., et al. Renal Production, Uptake, and Handling of Circulating alphaKlotho. J. Am. Soc. Nephrol. 2016;27:79&#x2013;90. doi: 10.1681/ASN.2014101030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1681/ASN.2014101030</ArticleId><ArticleId IdType=\"pmc\">PMC4696570</ArticleId><ArticleId IdType=\"pubmed\">25977312</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu M.C., Shi M., Gillings N., Flores B., Takahashi M., Kuro-O M., Moe O.W. Recombinant alpha-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. Kidney Int. 2017;91:1104&#x2013;1114. doi: 10.1016/j.kint.2016.10.034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.kint.2016.10.034</ArticleId><ArticleId IdType=\"pmc\">PMC5592833</ArticleId><ArticleId IdType=\"pubmed\">28131398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuro-o M. Klotho in health and disease. Curr. Opin. Nephrol. Hypertens. 2012;21:362&#x2013;368. doi: 10.1097/MNH.0b013e32835422ad.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MNH.0b013e32835422ad</ArticleId><ArticleId IdType=\"pubmed\">22660551</ArticleId></ArticleIdList></Reference><Reference><Citation>Erben R.G., Andrukhova O. FGF23-Klotho signaling axis in the kidney. Bone. 2017;100:62&#x2013;68. doi: 10.1016/j.bone.2016.09.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bone.2016.09.010</ArticleId><ArticleId IdType=\"pubmed\">27622885</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham C.R., Li A. Aging-suppressor Klotho: Prospects in diagnostics and therapeutics. Ageing Res. Rev. 2022;82:101766. doi: 10.1016/j.arr.2022.101766.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2022.101766</ArticleId><ArticleId IdType=\"pubmed\">36283617</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Z., Liu X., Zhang T. L-shaped association of systemic immune-inflammation index (SII) with serum soluble alpha-Klotho in the prospective cohort study from the NHANES database. Sci. Rep. 2024;14:13189. doi: 10.1038/s41598-024-64050-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-024-64050-3</ArticleId><ArticleId IdType=\"pmc\">PMC11162490</ArticleId><ArticleId IdType=\"pubmed\">38851827</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo K. Signaling Cross Talk between TGF-beta/Smad and Other Signaling Pathways. Cold Spring Harb. Perspect. Biol. 2017;9:a022137. doi: 10.1101/cshperspect.a022137.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/cshperspect.a022137</ArticleId><ArticleId IdType=\"pmc\">PMC5204325</ArticleId><ArticleId IdType=\"pubmed\">27836834</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullen A.C., Wrana J.L. TGF-beta Family Signaling in Embryonic and Somatic Stem-Cell Renewal and Differentiation. Cold Spring Harb. Perspect. Biol. 2017;9:a022186. doi: 10.1101/cshperspect.a022186.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/cshperspect.a022186</ArticleId><ArticleId IdType=\"pmc\">PMC5495062</ArticleId><ArticleId IdType=\"pubmed\">28108485</ArticleId></ArticleIdList></Reference><Reference><Citation>Derynck R., Budi E.H. Specificity, versatility, and control of TGF-&#x3b2; family signaling. Sci. Signal. 2019;12:eaav5183. doi: 10.1126/scisignal.aav5183.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/scisignal.aav5183</ArticleId><ArticleId IdType=\"pmc\">PMC6800142</ArticleId><ArticleId IdType=\"pubmed\">30808818</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q., Jin Y., Chen X., Ye X., Shen X., Lin M., Zeng C., Zhou T., Zhang J. NF-kB in biology and targeted therapy: New insights and translational implications. Signal Transduct. Target. Ther. 2024;9:53. doi: 10.1038/s41392-024-01757-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-024-01757-9</ArticleId><ArticleId IdType=\"pmc\">PMC10910037</ArticleId><ArticleId IdType=\"pubmed\">38433280</ArticleId></ArticleIdList></Reference><Reference><Citation>Sopjani M., Rinnerthaler M., Kruja J., Dermaku-Sopjani M. Intracellular signaling of the aging suppressor protein Klotho. Curr. Mol. Med. 2015;15:27&#x2013;37. doi: 10.2174/1566524015666150114111258.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1566524015666150114111258</ArticleId><ArticleId IdType=\"pubmed\">25601466</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinek T., Wolf I. The Role of Alpha-Klotho as a Universal Tumor Suppressor. Vitam. Horm. 2016;101:197&#x2013;214. doi: 10.1016/bs.vh.2016.03.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/bs.vh.2016.03.001</ArticleId><ArticleId IdType=\"pubmed\">27125743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewendt F., Feger M., F&#xf6;ller M. Role of Fibroblast Growth Factor 23 (FGF23) and &#x3b1;Klotho in Cancer. Front. Cell Dev. Biol. 2021;8:601006. doi: 10.3389/fcell.2020.601006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2020.601006</ArticleId><ArticleId IdType=\"pmc\">PMC7841205</ArticleId><ArticleId IdType=\"pubmed\">33520985</ArticleId></ArticleIdList></Reference><Reference><Citation>Erben R.G. Physiological Actions of Fibroblast Growth Factor-23. Front. Endocrinol. 2018;9:267. doi: 10.3389/fendo.2018.00267.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2018.00267</ArticleId><ArticleId IdType=\"pmc\">PMC5985418</ArticleId><ArticleId IdType=\"pubmed\">29892265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Liu Y., Goetz R., Fu L., Jayaraman S., Hu M.-C., Moe O.W., Liang G., Li X., Mohammadi M. &#x3b1;-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. Nature. 2018;553:461&#x2013;466. doi: 10.1038/nature25451.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature25451</ArticleId><ArticleId IdType=\"pmc\">PMC6007875</ArticleId><ArticleId IdType=\"pubmed\">29342138</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou D., Wu W., He Y., Ma S., Gao J. The role of klotho in chronic kidney disease. BMC Nephrol. 2018;19:285. doi: 10.1186/s12882-018-1094-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12882-018-1094-z</ArticleId><ArticleId IdType=\"pmc\">PMC6198535</ArticleId><ArticleId IdType=\"pubmed\">30348110</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki Y., Kuzina E., An S.J., Tome F., Mohanty J., Li W., Lee S., Liu Y., Lax I., Schlessinger J. FGF23 contains two distinct high-affinity binding sites enabling bivalent interactions with &#x3b1;-Klotho. Proc. Natl. Acad. Sci. USA. 2020;117:31800&#x2013;31807. doi: 10.1073/pnas.2018554117.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2018554117</ArticleId><ArticleId IdType=\"pmc\">PMC7749347</ArticleId><ArticleId IdType=\"pubmed\">33257569</ArticleId></ArticleIdList></Reference><Reference><Citation>Neyra J.A., Hu M.C., Moe O.W. Klotho in Clinical Nephrology: Diagnostic and Therapeutic Implications. Clin. J. Am. Soc. Nephrol. 2021;16:162&#x2013;176. doi: 10.2215/CJN.02840320.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2215/CJN.02840320</ArticleId><ArticleId IdType=\"pmc\">PMC7792642</ArticleId><ArticleId IdType=\"pubmed\">32699047</ArticleId></ArticleIdList></Reference><Reference><Citation>Saar-Kovrov V., Donners M.M.P.C., van der Vorst E.P.C. Shedding of Klotho: Functional Implications in Chronic Kidney Disease and Associated Vascular Disease. Front. Cardiovasc. Med. 2021;7:617842. doi: 10.3389/fcvm.2020.617842.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcvm.2020.617842</ArticleId><ArticleId IdType=\"pmc\">PMC7876272</ArticleId><ArticleId IdType=\"pubmed\">33585584</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun F., Liang P., Wang B., Liu W. The fibroblast growth factor-Klotho axis at molecular level. Open Life Sci. 2023;18:20220655. doi: 10.1515/biol-2022-0655.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1515/biol-2022-0655</ArticleId><ArticleId IdType=\"pmc\">PMC10628560</ArticleId><ArticleId IdType=\"pubmed\">37941788</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Sun Z. Molecular basis of Klotho: From gene to function in aging. Endocr. Rev. 2015;36:174&#x2013;193. doi: 10.1210/er.2013-1079.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/er.2013-1079</ArticleId><ArticleId IdType=\"pmc\">PMC4399270</ArticleId><ArticleId IdType=\"pubmed\">25695404</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalton G.D., Xie J., An S.W., Huang C.L. New Insights into the Mechanism of Action of Soluble Klotho. Front. Endocrinol. 2017;8:323. doi: 10.3389/fendo.2017.00323.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2017.00323</ArticleId><ArticleId IdType=\"pmc\">PMC5715364</ArticleId><ArticleId IdType=\"pubmed\">29250031</ArticleId></ArticleIdList></Reference><Reference><Citation>Mencke R., Harms G., Moser J., van Meurs M., Diepstra A., Leuvenink H.G., Hillebrands J.-L. Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease. JCI Insight. 2017;2:e94375. doi: 10.1172/jci.insight.94375.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/jci.insight.94375</ArticleId><ArticleId IdType=\"pmc\">PMC5846909</ArticleId><ArticleId IdType=\"pubmed\">29046474</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Fu L., Sun J., Huang Z., Fang M., Zinkle A., Liu X., Lu J., Pan Z., Wang Y., et al. Structural basis for FGF hormone signalling. Nature. 2023;618:862&#x2013;870. doi: 10.1038/s41586-023-06155-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-023-06155-9</ArticleId><ArticleId IdType=\"pmc\">PMC10284700</ArticleId><ArticleId IdType=\"pubmed\">37286607</ArticleId></ArticleIdList></Reference><Reference><Citation>Urakawa I., Yamazaki Y., Shimada T., Iijima K., Hasegawa H., Okawa K., Fujita T., Fukumoto S., Yamashita T. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444:770&#x2013;774. doi: 10.1038/nature05315.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature05315</ArticleId><ArticleId IdType=\"pubmed\">17086194</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.R., Holt S.G., Hewitson T.D. 76&#x3b1;Klotho-FGF23 interactions and their role in kidney disease: A molecular insight. Cell. Mol. Life Sci. 2019;76:4705&#x2013;4724. doi: 10.1007/s00018-019-03241-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00018-019-03241-y</ArticleId><ArticleId IdType=\"pmc\">PMC11105488</ArticleId><ArticleId IdType=\"pubmed\">31350618</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanucil C., Kentrup D., Campos I., Czaya B., Heitman K., Westbrook D., Osis G., Grabner A., Wende A.R., Vallejo J., et al. Soluble alpha-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease. Kidney Int. 2022;102:261&#x2013;279. doi: 10.1016/j.kint.2022.03.028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.kint.2022.03.028</ArticleId><ArticleId IdType=\"pmc\">PMC9329240</ArticleId><ArticleId IdType=\"pubmed\">35513125</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S.M., Li Q., Faul C. Fibroblast growth factor 23, klotho and heparin. Curr. Opin. Nephrol. Hypertens. 2023;32:313&#x2013;323. doi: 10.1097/MNH.0000000000000895.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MNH.0000000000000895</ArticleId><ArticleId IdType=\"pmc\">PMC10241433</ArticleId><ArticleId IdType=\"pubmed\">37195242</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho B.B., Bergwitz C. FGF23 signalling and physiology. J. Mol. Endocrinol. 2021;66:R23&#x2013;R32. doi: 10.1530/JME-20-0178.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1530/JME-20-0178</ArticleId><ArticleId IdType=\"pmc\">PMC8782161</ArticleId><ArticleId IdType=\"pubmed\">33338030</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano T., Kishimoto H., Tokumoto M. Direct and indirect effects of fibroblast growth factor 23 on the heart. Front. Endocrinol. 2023;14:1059179. doi: 10.3389/fendo.2023.1059179.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2023.1059179</ArticleId><ArticleId IdType=\"pmc\">PMC9999118</ArticleId><ArticleId IdType=\"pubmed\">36909314</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Wang Y., Gao W., Yuan C., Zhang S., Zhou H., Huang M., Yao X. Klotho Reduction in Alveolar Macrophages Contributes to Cigarette Smoke Extract-induced Inflammation in Chronic Obstructive Pulmonary Disease. J. Biol. Chem. 2015;290:27890&#x2013;27900. doi: 10.1074/jbc.M115.655431.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M115.655431</ArticleId><ArticleId IdType=\"pmc\">PMC4646031</ArticleId><ArticleId IdType=\"pubmed\">26385922</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Su B., Li X., Li Y., Zhao J. Klotho overexpression suppresses apoptosis by regulating the Hsp70/Akt/Bad pathway in H9c2(2-1) cells. Exp. Ther. Med. 2021;21:486. doi: 10.3892/etm.2021.9917.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/etm.2021.9917</ArticleId><ArticleId IdType=\"pmc\">PMC8005687</ArticleId><ArticleId IdType=\"pubmed\">33790995</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Wu S., Ren H., Gu J. Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat. Cell Biol. 2011;13:254&#x2013;262. doi: 10.1038/ncb2167.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncb2167</ArticleId><ArticleId IdType=\"pubmed\">21336305</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama S., Sun J., Horikoshi Y., Kamimura Y., Ike T., Fujino S., Kinugasa Y., Sasaki K., Nakashima A., Masaki T., et al. Klotho protects chromosomal DNA from radiation-induced damage. J. Biochem. 2023;173:375&#x2013;382. doi: 10.1093/jb/mvad001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/jb/mvad001</ArticleId><ArticleId IdType=\"pmc\">PMC10129345</ArticleId><ArticleId IdType=\"pubmed\">36634373</ArticleId></ArticleIdList></Reference><Reference><Citation>German D.C., Khobahy I., Pastor J., Kuro-O M., Liu X. Nuclear localization of Klotho in brain: An anti-aging protein. Neurobiol. Aging. 2012;33:1483.e25&#x2013;1483.e30. doi: 10.1016/j.neurobiolaging.2011.12.018.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2011.12.018</ArticleId><ArticleId IdType=\"pmc\">PMC3328593</ArticleId><ArticleId IdType=\"pubmed\">22245317</ArticleId></ArticleIdList></Reference><Reference><Citation>Prud&#x2019;homme G.J., Glinka Y., Kurt M., Liu W., Wang Q. The anti-aging protein Klotho is induced by GABA therapy and exerts protective and stimulatory effects on pancreatic &#x3b2; cells. Biochem. Biophys. Res. Commun. 2017;493:1542&#x2013;1547. doi: 10.1016/j.bbrc.2017.10.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2017.10.029</ArticleId><ArticleId IdType=\"pubmed\">28993191</ArticleId></ArticleIdList></Reference><Reference><Citation>Buend&#xed;a P., Carracedo J., Soriano S., Madue&#xf1;o J.A., Ortiz A., Mart&#xed;n-Malo A., Aljama P., Ram&#xed;rez R. &#x3b1;-Klotho Prevents NF&#x3ba;B Translocation and Protects Endothelial Cell from Senescence Induced by Uremia. J. Gerontol. A Biol. Sci. Med. Sci. 2015;70:1198&#x2013;1209. doi: 10.1093/gerona/glu170.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gerona/glu170</ArticleId><ArticleId IdType=\"pubmed\">25246106</ArticleId></ArticleIdList></Reference><Reference><Citation>Buend&#xed;a P., Ram&#xed;rez R., Aljama P., Carracedo J. &#x3b1;-Klotho Prevents Translocation of NF&#x3ba;B. Vitam. Horm. 2016;101:119&#x2013;150. doi: 10.1016/bs.vh.2016.02.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/bs.vh.2016.02.005</ArticleId><ArticleId IdType=\"pubmed\">27125740</ArticleId></ArticleIdList></Reference><Reference><Citation>He T., Xiong J., Huang Y., Zheng C., Liu Y., Bi X., Liu C., Han W., Yang K., Xiao T., et al. Klotho restrain RIG-1/NF-&#x3ba;B signaling activation and monocyte inflammatory factor release under uremic condition. Life Sci. 2019;231:116570. doi: 10.1016/j.lfs.2019.116570.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lfs.2019.116570</ArticleId><ArticleId IdType=\"pubmed\">31207307</ArticleId></ArticleIdList></Reference><Reference><Citation>Azubel M., Carter S.D., Weiszmann J., Zhang J., Jensen G.J., Li Y., Kornberg R.D. FGF21 trafficking in intact human cells revealed by cryo-electron tomography with gold nanoparticles. Elife. 2019;8:e43146. doi: 10.7554/eLife.43146.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7554/eLife.43146</ArticleId><ArticleId IdType=\"pmc\">PMC6349402</ArticleId><ArticleId IdType=\"pubmed\">30688648</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakrzewska M., S&#xf8;rensen V., Jin Y., Wiedlocha A., Olsnes S. Translocation of exogenous FGF1 into cytosol and nucleus is a periodic event independent of receptor kinase activity. Exp. Cell Res. 2011;317:1005&#x2013;1015. doi: 10.1016/j.yexcr.2011.01.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yexcr.2011.01.003</ArticleId><ArticleId IdType=\"pubmed\">21223966</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozniak M., Sokolowska-Wedzina A., Jastrzebski K., Szymczyk J., Porebska N., Krzyscik M.A., Zakrzewska M., Miaczynska M., Otlewski J., Opalinski L. FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization. Mol. Oncol. 2020;14:1998&#x2013;2021. doi: 10.1002/1878-0261.12740.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/1878-0261.12740</ArticleId><ArticleId IdType=\"pmc\">PMC7463352</ArticleId><ArticleId IdType=\"pubmed\">32511887</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim K., Groen A., Molostvov G., Lu T., Lilley K.S., Snead D., James S., Wilkinson I.B., Ting S., Hsiao L.-L., et al. alpha-Klotho Expression in Human Tissues. J. Clin. Endocrinol. Metab. 2015;100:E1308&#x2013;E1318. doi: 10.1210/jc.2015-1800.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/jc.2015-1800</ArticleId><ArticleId IdType=\"pmc\">PMC4596032</ArticleId><ArticleId IdType=\"pubmed\">26280509</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter B., Haller J., Haffner D., Leifheit-Nestler M. Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells. Pflug. Arch. 2016;468:1621&#x2013;1635. doi: 10.1007/s00424-016-1858-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00424-016-1858-x</ArticleId><ArticleId IdType=\"pubmed\">27448998</ArticleId></ArticleIdList></Reference><Reference><Citation>Mencke R., Hillebrands J.L., NIGRAM consortium The role of the anti-ageing protein Klotho in vascular physiology and pathophysiology. Ageing Res. Rev. 2017;35:124&#x2013;146. doi: 10.1016/j.arr.2016.09.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2016.09.001</ArticleId><ArticleId IdType=\"pubmed\">27693241</ArticleId></ArticleIdList></Reference><Reference><Citation>Donate-Correa J., Mart&#xed;n-N&#xfa;&#xf1;ez E., Martin-Olivera A., Mora-Fern&#xe1;ndez C., Tagua V.G., Ferri C.M., L&#xf3;pez-Castillo &#xc1;., Delgado-Molinos A., L&#xf3;pez-Tarruella V.C., Ar&#xe9;valo-G&#xf3;mez M.A., et al. Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR &#x2265;60 mL/min/1.73m2): A proof-of-concept study. Front. Endocrinol. 2023;14:1146012. doi: 10.3389/fendo.2023.1146012.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2023.1146012</ArticleId><ArticleId IdType=\"pmc\">PMC10235765</ArticleId><ArticleId IdType=\"pubmed\">37274332</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung C.-P., Chang Y.-C., Ding Y., Lim K., Liu Q., Zhu L., Zhang W., Lu T.-S., Molostvov G., Zehnder D., et al. &#x3b1;-Klotho expression determines nitric oxide synthesis in response to FGF-23 in human aortic endothelial cells. PLoS ONE. 2017;12:e0176817. doi: 10.1371/journal.pone.0176817.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0176817</ArticleId><ArticleId IdType=\"pmc\">PMC5413063</ArticleId><ArticleId IdType=\"pubmed\">28463984</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito Y., Yamagishi T., Nakamuraa T., Ohyamaa Y., Aizawaa H., Sugaa T., Matsumuraab Y., Masudaab H., Kurabayashia M., Kuro-Ob M., et al. Klotho protein protects against endothelial dysfunction. Biochem. Biophys. Res. Commun. 1998;248:324&#x2013;329. doi: 10.1006/bbrc.1998.8943.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/bbrc.1998.8943</ArticleId><ArticleId IdType=\"pubmed\">9675134</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai T., Yamada K., Kim H., Kim Y., Noda Y., Imura A., Nabeshima Y., Nabeshima T. Cognition impairment in the genetic model of aging klotho gene mutant mice: A role of oxidative stress. FASEB J. 2003;17:50&#x2013;52. doi: 10.1096/fj.02-0448fje.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.02-0448fje</ArticleId><ArticleId IdType=\"pubmed\">12475907</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurston R.D., Larmonier C.B., Majewski P.M., Ramalingam R., Midura-Kiela M., Laubitz D., Vandewalle A., Besselsen D.G., M&#xfc;hlbauer M., Jobin C., et al. Tumor necrosis factor and interferon-gamma down-regulate Klotho in mice with colitis. Gastroenterology. 2010;138:1384&#x2013;1394.e2. doi: 10.1053/j.gastro.2009.12.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1053/j.gastro.2009.12.002</ArticleId><ArticleId IdType=\"pmc\">PMC3454518</ArticleId><ArticleId IdType=\"pubmed\">20004202</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S.E., Chen W.L. Soluble klotho as an effective biomarker to characterize inflammatory states. Ann. Med. 2022;54:1520&#x2013;1529. doi: 10.1080/07853890.2022.2077428.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/07853890.2022.2077428</ArticleId><ArticleId IdType=\"pmc\">PMC9132391</ArticleId><ArticleId IdType=\"pubmed\">35603960</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q., Lin S., Tang R., Veeraragoo P., Peng W., Wu R. Role of Fosinopril and Valsartan on Klotho Gene Expression Induced by Angiotensin II in Rat Renal Tubular Epithelial Cells. Kidney Blood Press. Res. 2010;33:186&#x2013;192. doi: 10.1159/000316703.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000316703</ArticleId><ArticleId IdType=\"pubmed\">20571281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwahara N., Sasaki S., Kobara M., Nakata T., Tatsumi T., Irie H., Narumiya H., Hatta T., Takeda K., Matsubara H., et al. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis. Int. J. Cardiol. 2008;123:84&#x2013;90. doi: 10.1016/j.ijcard.2007.02.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijcard.2007.02.029</ArticleId><ArticleId IdType=\"pubmed\">17434618</ArticleId></ArticleIdList></Reference><Reference><Citation>Narumiya H., Sasaki S., Kuwahara N., Irie H., Kusaba T., Kameyama H., Tamagaki K., Hatta T., Takeda K., Matsubara H. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells. Cardiovasc. Res. 2004;64:331&#x2013;336. doi: 10.1016/j.cardiores.2004.07.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cardiores.2004.07.011</ArticleId><ArticleId IdType=\"pubmed\">15485693</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsell R., Krajisnik T., G&#xf6;ransson H., Ohlsson C., Ljunggren, Larsson T.E., Jonsson K.B. Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23. Nephrol. Dial. Transplant. 2008;23:827&#x2013;833. doi: 10.1093/ndt/gfm672.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ndt/gfm672</ArticleId><ArticleId IdType=\"pubmed\">17911089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuczera P., Adamczak M., Wiecek A. Fibroblast Growth Factor-23-A Potential Uremic Toxin. Toxins. 2016;8:369. doi: 10.3390/toxins8120369.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/toxins8120369</ArticleId><ArticleId IdType=\"pmc\">PMC5198563</ArticleId><ArticleId IdType=\"pubmed\">27941640</ArticleId></ArticleIdList></Reference><Reference><Citation>Rausch S., F&#xf6;ller M. The regulation of FGF23 under physiological and pathophysiological conditions. Pflug. Arch. 2022;474:281&#x2013;292. doi: 10.1007/s00424-022-02668-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00424-022-02668-w</ArticleId><ArticleId IdType=\"pmc\">PMC8837506</ArticleId><ArticleId IdType=\"pubmed\">35084563</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura H., Yoshida T., Shiohira S., Kohei J., Mitobe M., Kurosu H., Kuro-O M., Nitta K., Tsuchiya K. Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis. Am. J. Physiol. Renal Physiol. 2012;302:F1252&#x2013;F1264. doi: 10.1152/ajprenal.00294.2011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajprenal.00294.2011</ArticleId><ArticleId IdType=\"pubmed\">22338084</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S.-S., Sheng M.-J., Sun Z.-Y., Liang Y., Yu L.-X., Liu Q.-F. Upstream and downstream regulators of Klotho expression in chronic kidney disease. Metabolism. 2023;142:155530. doi: 10.1016/j.metabol.2023.155530.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.metabol.2023.155530</ArticleId><ArticleId IdType=\"pubmed\">36868370</ArticleId></ArticleIdList></Reference><Reference><Citation>de Almeida A.J.P.O., Rezende M.S.d.A., Dantas S.H., Silva S.d.L., de Oliveira J.C.P.L., Azevedo F.d.L.A.A.d., Alves R.M.F.R., de Menezes G.M.S., dos Santos P.F., Gon&#xe7;alves T.A.F., et al. Unveiling the Role of Inflammation and Oxidative Stress on Age-Related Cardiovascular Diseases. Oxid. Med. Cell. Longev. 2020;2020:1954398. doi: 10.1155/2020/1954398.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2020/1954398</ArticleId><ArticleId IdType=\"pmc\">PMC7232723</ArticleId><ArticleId IdType=\"pubmed\">32454933</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulop T., Larbi A., Pawelec G., Khalil A., Cohen A.A., Hirokawa K., Witkowski J.M., Franceschi C. Immunology of Aging: The Birth of Inflammaging. Clin. Rev. Allergy Immunol. 2021;64:109&#x2013;122. doi: 10.1007/s12016-021-08899-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12016-021-08899-6</ArticleId><ArticleId IdType=\"pmc\">PMC8449217</ArticleId><ArticleId IdType=\"pubmed\">34536213</ArticleId></ArticleIdList></Reference><Reference><Citation>Baechle J.J., Chen N., Makhijani P., Winer S., Furman D., Winer D.A. Chronic inflammation and the hallmarks of aging. Mol. Metab. 2023;74:101755. doi: 10.1016/j.molmet.2023.101755.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.molmet.2023.101755</ArticleId><ArticleId IdType=\"pmc\">PMC10359950</ArticleId><ArticleId IdType=\"pubmed\">37329949</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Li C., Zhang W., Wang Y., Qian P., Huang H. Inflammation and aging: Signaling pathways and intervention therapies. Signal Transduct. Target. Ther. 2023;8:239. doi: 10.1038/s41392-023-01502-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-023-01502-8</ArticleId><ArticleId IdType=\"pmc\">PMC10248351</ArticleId><ArticleId IdType=\"pubmed\">37291105</ArticleId></ArticleIdList></Reference><Reference><Citation>Haga M., Okada M. Systems approaches to investigate the role of NF-kappaB signaling in aging. Biochem. J. 2022;479:161&#x2013;183. doi: 10.1042/BCJ20210547.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/BCJ20210547</ArticleId><ArticleId IdType=\"pmc\">PMC8883486</ArticleId><ArticleId IdType=\"pubmed\">35098992</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalid M., Petroianu G., Adem A. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. Biomolecules. 2022;12:542. doi: 10.3390/biom12040542.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biom12040542</ArticleId><ArticleId IdType=\"pmc\">PMC9030615</ArticleId><ArticleId IdType=\"pubmed\">35454131</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberti A., Chaffey L.E., Greaves D.R. NF-&#x3ba;B Signaling and Inflammation-Drug Repurposing to Treat Inflammatory Disorders? Biology. 2022;11:372. doi: 10.3390/biology11030372.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biology11030372</ArticleId><ArticleId IdType=\"pmc\">PMC8945680</ArticleId><ArticleId IdType=\"pubmed\">35336746</ArticleId></ArticleIdList></Reference><Reference><Citation>Zindel J., Kubes P. DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation. Annu. Rev. Pathol. 2020;15:493&#x2013;518. doi: 10.1146/annurev-pathmechdis-012419-032847.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-pathmechdis-012419-032847</ArticleId><ArticleId IdType=\"pubmed\">31675482</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa Y., Ishikawa K., Yasuda O., Oguro R., Hanasaki H., Kida I., Takemura Y., Ohishi M., Katsuya T., Rakugi H. Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine. 2009;35:341&#x2013;346. doi: 10.1007/s12020-009-9181-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12020-009-9181-3</ArticleId><ArticleId IdType=\"pubmed\">19367378</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Zeng C., Li X., Yang T., Kuang X., Du J. Klotho overexpression improves amyloid-&#x3b2; clearance and cognition in the APP/PS1 mouse model of Alzheimer&#x2019;s disease. Aging Cell. 2020;19:e13239. doi: 10.1111/acel.13239.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/acel.13239</ArticleId><ArticleId IdType=\"pmc\">PMC7576297</ArticleId><ArticleId IdType=\"pubmed\">32964663</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K., Du C., Wang X., Li F., Xu Y., Wang S., Chen S., Chen F., Shen M., Chen M., et al. Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease-associated thrombosis in mice. Blood. 2017;129:2667&#x2013;2679. doi: 10.1182/blood-2016-10-744060.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood-2016-10-744060</ArticleId><ArticleId IdType=\"pubmed\">28264799</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Zhuang X., Huang Z., Zou J., Yang D., Hu X., Du Z., Wang L., Liao X. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-kappaB-mediated inflammation both in vitro and in vivo. Biochim. Biophys. Acta Mol. Basis Dis. 2018;1864:238&#x2013;251. doi: 10.1016/j.bbadis.2017.09.029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2017.09.029</ArticleId><ArticleId IdType=\"pubmed\">28982613</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi F., Liu W., Wu Z., Ji C., Chang C. Antiaging Factor Klotho Retards the Progress of Intervertebral Disc Degeneration through the Toll-Like Receptor 4-NF-&#x3ba;B Pathway. Int. J. Cell Biol. 2020;2020:8319516. doi: 10.1155/2020/8319516.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2020/8319516</ArticleId><ArticleId IdType=\"pmc\">PMC7106913</ArticleId><ArticleId IdType=\"pubmed\">32256598</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S., Yang H., Guo X., Sun Y. Klotho attenuates angiotensin II-induced cardiotoxicity through suppression of necroptosis and oxidative stress. Mol. Med. Rep. 2021;23:66. doi: 10.3892/mmr.2020.11705.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/mmr.2020.11705</ArticleId><ArticleId IdType=\"pmc\">PMC7716407</ArticleId><ArticleId IdType=\"pubmed\">33215215</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wang K., Bao Y., Zhang T., Ainiwaer D., Xiong X., Wang G., Sun Z. The serum soluble Klotho alleviates cardiac aging and regulates M2a/M2c macrophage polarization via inhibiting TLR4/Myd88/NF-&#x3ba;B pathway. Tissue Cell. 2022;76:101812. doi: 10.1016/j.tice.2022.101812.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tice.2022.101812</ArticleId><ArticleId IdType=\"pubmed\">35597178</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai K.-D., Lee Y.-C., Chen B.-Y., Wu L.-S., Liang S.-Y., Liu M.-Y., Hung Y.-W., Hsu H.-L., Chen P.-Q., Shieh J.-C., et al. Recombinant Klotho attenuates IFN&#x3b3; receptor signaling and SAMHD1 expression through blocking NF-&#x3ba;B translocation in glomerular mesangial cells. Int. J. Med. Sci. 2023;20:810&#x2013;817. doi: 10.7150/ijms.78279.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7150/ijms.78279</ArticleId><ArticleId IdType=\"pmc\">PMC10198147</ArticleId><ArticleId IdType=\"pubmed\">37213666</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno J.A., Izquierdo M.C., Sanchez-Ni&#xf1;o M.D., Su&#xe1;rez-Alvarez B., Lopez-Larrea C., Jakubowski A., Blanco J., Ramirez R., Selgas R., Ruiz-Ortega M., et al. The inflammatory cytokines TWEAK and TNF&#x3b1; reduce renal klotho expression through NF&#x3ba;B. J. Am. Soc. Nephrol. 2011;22:1315&#x2013;1325. doi: 10.1681/ASN.2010101073.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1681/ASN.2010101073</ArticleId><ArticleId IdType=\"pmc\">PMC3137579</ArticleId><ArticleId IdType=\"pubmed\">21719790</ArticleId></ArticleIdList></Reference><Reference><Citation>Paerewijck O., Lamkanfi M. The human inflammasomes. Mol. Asp. Med. 2022;88:101100. doi: 10.1016/j.mam.2022.101100.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mam.2022.101100</ArticleId><ArticleId IdType=\"pubmed\">35696786</ArticleId></ArticleIdList></Reference><Reference><Citation>Accogli T., Hibos C., Vegran F. Canonical and non-canonical functions of NLRP3. J. Adv. Res. 2023;53:137&#x2013;151. doi: 10.1016/j.jare.2023.01.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jare.2023.01.001</ArticleId><ArticleId IdType=\"pmc\">PMC10658328</ArticleId><ArticleId IdType=\"pubmed\">36610670</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Y., Zhou J., Shi C. Inflammasome: Structure, biological functions, and therapeutic targets. MedComm. 2023;4:e391. doi: 10.1002/mco2.391.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mco2.391</ArticleId><ArticleId IdType=\"pmc\">PMC10560975</ArticleId><ArticleId IdType=\"pubmed\">37817895</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Gao S., Chen Z., Zhao X., Gu J., Wu H., Liao Y., Wang J., Chen W. Pyroptosis in septic lung injury: Interactions with other types of cell death. Biomed. Pharmacother. 2023;169:115914. doi: 10.1016/j.biopha.2023.115914.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2023.115914</ArticleId><ArticleId IdType=\"pubmed\">38000360</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S., Lee J., Oh J., Yu G., Ryu H., Kim D., Lee S. Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis. Cell. Mol. Immunol. 2023;20:1513&#x2013;1526. doi: 10.1038/s41423-023-01107-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41423-023-01107-9</ArticleId><ArticleId IdType=\"pmc\">PMC10687226</ArticleId><ArticleId IdType=\"pubmed\">38008850</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Wu M. Pattern recognition receptors in health and diseases. Signal Transduct. Target. Ther. 2021;6:291. doi: 10.1038/s41392-021-00687-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-021-00687-0</ArticleId><ArticleId IdType=\"pmc\">PMC8333067</ArticleId><ArticleId IdType=\"pubmed\">34344870</ArticleId></ArticleIdList></Reference><Reference><Citation>Moltrasio C., Romagnuolo M., Marzano A.V. NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies. Front. Immunol. 2022;13:1007705. doi: 10.3389/fimmu.2022.1007705.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2022.1007705</ArticleId><ArticleId IdType=\"pmc\">PMC9583146</ArticleId><ArticleId IdType=\"pubmed\">36275641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Ye X., Escames G., Lei W., Zhang X., Li M., Jing T., Yao Y., Qiu Z., Wang Z., et al. The NLRP3 inflammasome: Contributions to inflammation-related diseases. Cell. Mol. Biol. Lett. 2023;28:51. doi: 10.1186/s11658-023-00462-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s11658-023-00462-9</ArticleId><ArticleId IdType=\"pmc\">PMC10303833</ArticleId><ArticleId IdType=\"pubmed\">37370025</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H., Chen L., Huang M., Hou J., Chen Z., Yang X. Hunting down NLRP3 inflammasome: An executioner of radiation-induced injury. Front. Immunol. 2022;13:967989. doi: 10.3389/fimmu.2022.967989.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2022.967989</ArticleId><ArticleId IdType=\"pmc\">PMC9637992</ArticleId><ArticleId IdType=\"pubmed\">36353625</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.K. The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout. J. Rheum. Dis. 2022;29:140&#x2013;153. doi: 10.4078/jrd.2022.29.3.140.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4078/jrd.2022.29.3.140</ArticleId><ArticleId IdType=\"pmc\">PMC10324924</ArticleId><ArticleId IdType=\"pubmed\">37475970</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Z., Yu D., Gou T., Tang G., Guo C., Shi J. Research progress of NLRP3 inflammasome and its inhibitors with aging diseases. Eur. J. Pharmacol. 2023;957:175931. doi: 10.1016/j.ejphar.2023.175931.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejphar.2023.175931</ArticleId><ArticleId IdType=\"pubmed\">37495038</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao N., Li C.C., Di B., Xu L.L. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors. J. Autoimmun. 2020;113:102515. doi: 10.1016/j.jaut.2020.102515.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaut.2020.102515</ArticleId><ArticleId IdType=\"pubmed\">32703754</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu J., Schroder K., Wu H. Mechanistic insights from inflammasome structures. Nat. Rev. Immunol. 2024;24:518&#x2013;535. doi: 10.1038/s41577-024-00995-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41577-024-00995-w</ArticleId><ArticleId IdType=\"pmc\">PMC11216901</ArticleId><ArticleId IdType=\"pubmed\">38374299</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Matico R.E., Miller R., Chauhan D., Van Schoubroeck B., Grauwen K., Suarez J., Pietrak B., Haloi N., Yin Y., et al. Structural basis for the oligomerization-facilitated NLRP3 activation. Nat. Commun. 2024;15:1164. doi: 10.1038/s41467-024-45396-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-024-45396-8</ArticleId><ArticleId IdType=\"pmc\">PMC10850481</ArticleId><ArticleId IdType=\"pubmed\">38326375</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson K.V., Deng M., Ting J.P. The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 2019;19:477&#x2013;489. doi: 10.1038/s41577-019-0165-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41577-019-0165-0</ArticleId><ArticleId IdType=\"pmc\">PMC7807242</ArticleId><ArticleId IdType=\"pubmed\">31036962</ArticleId></ArticleIdList></Reference><Reference><Citation>Groslambert M., Py B.F. Spotlight on the NLRP3 inflammasome pathway. J. Inflamm. Res. 2018;11:359&#x2013;374. doi: 10.2147/JIR.S141220.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/JIR.S141220</ArticleId><ArticleId IdType=\"pmc\">PMC6161739</ArticleId><ArticleId IdType=\"pubmed\">30288079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Chen S., Liu M., Zhang M., Jia X. NEK7: A new target for the treatment of multiple tumors and chronic inflammatory diseases. Inflammopharmacology. 2022;30:1179&#x2013;1187. doi: 10.1007/s10787-022-01026-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10787-022-01026-7</ArticleId><ArticleId IdType=\"pubmed\">35829941</ArticleId></ArticleIdList></Reference><Reference><Citation>Walle L.V., Lamkanfi M. Drugging the NLRP3 inflammasome: From signalling mechanisms to therapeutic targets. Nat. Rev. Drug Discov. 2023;23:43&#x2013;66. doi: 10.1038/s41573-023-00822-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41573-023-00822-2</ArticleId><ArticleId IdType=\"pubmed\">38030687</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Y., Xu G., Feng C., Cai D., Wu S., Liu Y., Chen Y., Ma W. Klotho inhibits the activation of NLRP3 inflammasome to alleviate lipopolysaccharide-induced inflammatory injury in A549 cells and restore mitochondrial function through SIRT1/Nrf2 signaling pathway. Chin. J. Physiol. 2023;66:335&#x2013;344. doi: 10.4103/cjop.CJOP-D-23-00029.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/cjop.CJOP-D-23-00029</ArticleId><ArticleId IdType=\"pubmed\">37929344</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero A., Dongil P., Valencia I., Vallejo S., Hip&#xf3;lito-Luengo &#xc1;.S., D&#xed;az-Araya G., Bartha J.L., Gonz&#xe1;lez-Arlanz&#xf3;n M.M., Rivilla F., de la Cuesta F., et al. Pharmacological Blockade of NLRP3 Inflammasome/IL-1&#x3b2;-Positive Loop Mitigates Endothelial Cell Senescence and Dysfunction. Aging Dis. 2022;13:84&#x2013;297. doi: 10.14336/AD.2021.0617.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14336/AD.2021.0617</ArticleId><ArticleId IdType=\"pmc\">PMC8782550</ArticleId><ArticleId IdType=\"pubmed\">35111374</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M., Lou J., Yu H., Miao M., Wang G., Ai H., Huang Y., Han S., Han D., Yu G. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin promotes inflammation in mouse testes: The critical role of Klotho in Sertoli cells. Toxicol. Lett. 2018;295:134&#x2013;143. doi: 10.1016/j.toxlet.2018.06.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.toxlet.2018.06.001</ArticleId><ArticleId IdType=\"pubmed\">29885354</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L., Stein L.R., Kim D., Ho K., Yu G.-Q., Zhan L., Larsson T.E., Mucke L. Klotho controls the brain-immune system interface in the choroid plexus. Proc. Natl. Acad. Sci. USA. 2018;115:E11388&#x2013;E11396. doi: 10.1073/pnas.1808609115.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1808609115</ArticleId><ArticleId IdType=\"pmc\">PMC6275534</ArticleId><ArticleId IdType=\"pubmed\">30413620</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y., Ren K., Jiang C., Wang L., Yao Q. Regulation of cartilage damage caused by lack of Klotho with thioredoxin/peroxiredoxin (Trx/Prx) system and succedent NLRP3 activation in osteoarthritis mice. Am. J. Transl. Res. 2019;11:7338&#x2013;7350.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6943451</ArticleId><ArticleId IdType=\"pubmed\">31934282</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Li Z., Li B., Zhu X., Lai X. Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway. Life Sci. 2019;234:116773. doi: 10.1016/j.lfs.2019.116773.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lfs.2019.116773</ArticleId><ArticleId IdType=\"pubmed\">31422095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Banerjee S., Dey N., LeJeune W.S., Sarkar P.S., Brobey R., Rosenblatt K.P., Tilton R.G., Choudhary S. Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation. Diabetes. 2011;60:1907&#x2013;1916. doi: 10.2337/db10-1262.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/db10-1262</ArticleId><ArticleId IdType=\"pmc\">PMC3121423</ArticleId><ArticleId IdType=\"pubmed\">21593200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismael S., Nasoohi S., Li L., Aslam K.S., Khan M.M., El-Remessy A.B., McDonald M.P., Liao F.-F., Ishrat T. Thioredoxin interacting protein regulates age-associated neuroinflammation. Neurobiol. Dis. 2021;156:105399. doi: 10.1016/j.nbd.2021.105399.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2021.105399</ArticleId><ArticleId IdType=\"pmc\">PMC8277763</ArticleId><ArticleId IdType=\"pubmed\">34029695</ArticleId></ArticleIdList></Reference><Reference><Citation>He J., Cui J., Shi Y., Wang T., Xin J., Li Y., Shan X., Zhu Z., Gao Y. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-&#x3ba;B/NLRP3 Axis. J. Diabetes Res. 2023;2023:7423661. doi: 10.1155/2023/7423661.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2023/7423661</ArticleId><ArticleId IdType=\"pmc\">PMC10228232</ArticleId><ArticleId IdType=\"pubmed\">37261217</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang T., Luo X., Ye L., Huang H., Wu Y. Klotho alleviates NLRP3 inflammasome-mediated neuroinflammation in a temporal lobe epilepsy rat model by activating the Nrf2 signaling pathway. Epilepsy Behav. 2022;128:108509. doi: 10.1016/j.yebeh.2021.108509.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yebeh.2021.108509</ArticleId><ArticleId IdType=\"pubmed\">35104732</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y., Cao J., Wei X., Ge Y., Su Z., Yu D. Klotho alleviates contrast-induced acute kidney injury by suppressing oxidative stress, inflammation, and NF-KappaB/NLRP3-mediated pyroptosis. Int. Immunopharmacol. 2023;118:110105. doi: 10.1016/j.intimp.2023.110105.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.intimp.2023.110105</ArticleId><ArticleId IdType=\"pubmed\">37018977</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X.-Y., Zhang L.-Y., Wang X.-Y., Li S.-C., Hu Y.-Y., Zhang J.-G., Xian X.-H., Li W.-B., Zhang M. STAT4-Mediated Klotho Up-Regulation Contributes to the Brain Ischemic Tolerance by Cerebral Ischemic Preconditioning via Inhibiting Neuronal Pyroptosis. Mol. Neurobiol. 2023;61:2336&#x2013;2356. doi: 10.1007/s12035-023-03703-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-023-03703-2</ArticleId><ArticleId IdType=\"pubmed\">37875707</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan M., Sun L., He X., Wang Z., Hou Y., Zhao Y. Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023. Eur. J. Med. Chem. 2023;260:115750. doi: 10.1016/j.ejmech.2023.115750.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejmech.2023.115750</ArticleId><ArticleId IdType=\"pubmed\">37639823</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang Z., Zheng Y., Yu Q., Zeng M., Bai L., Yang L., Guo M., Jiang X., Gan J. Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review) Int. J. Mol. Med. 2023;51:35. doi: 10.3892/ijmm.2023.5238.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3892/ijmm.2023.5238</ArticleId><ArticleId IdType=\"pmc\">PMC10049046</ArticleId><ArticleId IdType=\"pubmed\">36960868</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson P.C., Terkeltaub R., Pillinger M.H., Shah B., Karalis V., Karatza E., Liew D., Imazio M., Cornel J.H., Thompson P.L., et al. Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease. Am. J. Med. 2022;135:32&#x2013;38. doi: 10.1016/j.amjmed.2021.07.025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.amjmed.2021.07.025</ArticleId><ArticleId IdType=\"pmc\">PMC8688259</ArticleId><ArticleId IdType=\"pubmed\">34416165</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez L., Bulnes J.F., Orellana M.P., Venturelli P.M., Rodriguez G.M. The Role of Colchicine in Atherosclerosis: From Bench to Bedside. Pharmaceutics. 2022;14:1395. doi: 10.3390/pharmaceutics14071395.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics14071395</ArticleId><ArticleId IdType=\"pmc\">PMC9323936</ArticleId><ArticleId IdType=\"pubmed\">35890291</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang T., Li S., Yi X., Guo S., Wang Y., Chen J., Liu L., Jian Z., Gao T., Kang P., et al. Tranilast Directly Targets NLRP3 to Protect Melanocytes From Keratinocyte-Derived IL-1&#x3b2; Under Oxidative Stress. Front. Cell Dev. Biol. 2020;8:588. doi: 10.3389/fcell.2020.00588.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2020.00588</ArticleId><ArticleId IdType=\"pmc\">PMC7365842</ArticleId><ArticleId IdType=\"pubmed\">32754591</ArticleId></ArticleIdList></Reference><Reference><Citation>Prud&#x2019;homme G.J. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab. Investig. 2007;87:1077&#x2013;1091. doi: 10.1038/labinvest.3700669.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/labinvest.3700669</ArticleId><ArticleId IdType=\"pubmed\">17724448</ArticleId></ArticleIdList></Reference><Reference><Citation>Prud&#x2019;homme G.J. Cancer stem cells and novel targets for antitumor strategies. Curr. Pharm. Des. 2012;18:2838&#x2013;2849. doi: 10.2174/138161212800626120.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/138161212800626120</ArticleId><ArticleId IdType=\"pubmed\">22390767</ArticleId></ArticleIdList></Reference><Reference><Citation>Prud&#x2019;Homme G.J., Glinka Y., Toulina A., Ace O., Subramaniam V., Jothy S. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist. PLoS ONE. 2010;5:e13831. doi: 10.1371/journal.pone.0013831.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0013831</ArticleId><ArticleId IdType=\"pmc\">PMC2972222</ArticleId><ArticleId IdType=\"pubmed\">21072210</ArticleId></ArticleIdList></Reference><Reference><Citation>Darakhshan S., Pour A.B. Tranilast: A review of its therapeutic applications. Pharmacol. Res. 2015;91:15&#x2013;28. doi: 10.1016/j.phrs.2014.10.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.phrs.2014.10.009</ArticleId><ArticleId IdType=\"pubmed\">25447595</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Shi C., He M., Xiong S., Xia X. Endoplasmic reticulum stress: Molecular mechanism and therapeutic targets. Signal Transduct. Target. Ther. 2023;8:352. doi: 10.1038/s41392-023-01570-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-023-01570-w</ArticleId><ArticleId IdType=\"pmc\">PMC10502142</ArticleId><ArticleId IdType=\"pubmed\">37709773</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebert M., S&#x142;awski J., Kalinowski L., Collawn J.F., Bartoszewski R. The Unfolded Protein Response: A Double-Edged Sword for Brain Health. Antioxidants. 2023;12:1648. doi: 10.3390/antiox12081648.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox12081648</ArticleId><ArticleId IdType=\"pmc\">PMC10451475</ArticleId><ArticleId IdType=\"pubmed\">37627643</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee S., Zhao Y., Sarkar P.S., Rosenblatt K.P., Tilton R.G., Choudhary S. Klotho ameliorates chemically induced endoplasmic reticulum (ER) stress signaling. Cell. Physiol. Biochem. 2013;31:659&#x2013;672. doi: 10.1159/000350085.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000350085</ArticleId><ArticleId IdType=\"pubmed\">23711492</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S., Gao P., Xiao H., Xu Y., Si L.Y. Klotho suppresses cardiomyocyte apoptosis in mice with stress-induced cardiac injury via downregulation of endoplasmic reticulum stress. PLoS ONE. 2013;8:e82968. doi: 10.1371/annotation/d7fe4fdf-4be4-4aa5-b3f0-d98790fc0b11.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/annotation/d7fe4fdf-4be4-4aa5-b3f0-d98790fc0b11</ArticleId><ArticleId IdType=\"pmc\">PMC3858310</ArticleId><ArticleId IdType=\"pubmed\">24340070</ArticleId></ArticleIdList></Reference><Reference><Citation>Mytych J. Actions of Klotho on hippocampal neuronal cells. Vitam. Horm. 2022;118:223&#x2013;246. doi: 10.1016/bs.vh.2021.12.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/bs.vh.2021.12.001</ArticleId><ArticleId IdType=\"pubmed\">35180928</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J.S., Son S.S., Lee J.-H., Lee S.W., Jeong A.R., Lee E.S., Cha S.-K., Chung C.H. Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy. PLoS ONE. 2021;16:e0250666. doi: 10.1371/journal.pone.0250666.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0250666</ArticleId><ArticleId IdType=\"pmc\">PMC8064606</ArticleId><ArticleId IdType=\"pubmed\">33891667</ArticleId></ArticleIdList></Reference><Reference><Citation>Donate-Correa J., Mart&#xed;n-Carro B., Cannata-And&#xed;a J.B., Mora-Fern&#xe1;ndez C., Navarro-Gonz&#xe1;lez J.F. Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease. Antioxidants. 2023;12:239. doi: 10.3390/antiox12020239.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox12020239</ArticleId><ArticleId IdType=\"pmc\">PMC9952437</ArticleId><ArticleId IdType=\"pubmed\">36829798</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltese G., Psefteli P., Rizzo B., Srivastava S., Gnudi L., Mann G.E., Siow R.C. The anti-ageing hormone klotho induces Nrf2-mediated antioxidant defences in human aortic smooth muscle cells. J. Cell. Mol. Med. 2017;21:621&#x2013;627. doi: 10.1111/jcmm.12996.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jcmm.12996</ArticleId><ArticleId IdType=\"pmc\">PMC5323877</ArticleId><ArticleId IdType=\"pubmed\">27696667</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H., Gao Y., Zhu S., Cui Q., Du J. Klotho Improves Cardiac Function by Suppressing Reactive Oxygen Species (ROS) Mediated Apoptosis by Modulating Mapks/Nrf2 Signaling in Doxorubicin-Induced Cardiotoxicity. Med. Sci. Monit. 2017;23:5283&#x2013;5293. doi: 10.12659/MSM.907449.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.12659/MSM.907449</ArticleId><ArticleId IdType=\"pmc\">PMC5687120</ArticleId><ArticleId IdType=\"pubmed\">29107939</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing L., Guo H., Meng S., Zhu B., Fang J., Huang J., Chen J., Wang Y., Wang L., Yao X., et al. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes. Biochem. Biophys. Res. Commun. 2021;534:450&#x2013;456. doi: 10.1016/j.bbrc.2020.11.061.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2020.11.061</ArticleId><ArticleId IdType=\"pubmed\">33256980</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W., Guo L., Yang Y., Wang Y., Xia S., Gong H., Zhang B.-K., Yan M. Dissecting the Crosstalk Between Nrf2 and NF-kappaB Response Pathways in Drug-Induced Toxicity. Front. Cell. Dev. Biol. 2022;9:809952. doi: 10.3389/fcell.2021.809952.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcell.2021.809952</ArticleId><ArticleId IdType=\"pmc\">PMC8847224</ArticleId><ArticleId IdType=\"pubmed\">35186957</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Khor T.O., Xu C., Shen G., Jeong W.-S., Yu S., Kong A.-N. Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem. Pharmacol. 2008;76:1485&#x2013;1489. doi: 10.1016/j.bcp.2008.07.017.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bcp.2008.07.017</ArticleId><ArticleId IdType=\"pmc\">PMC2610259</ArticleId><ArticleId IdType=\"pubmed\">18694732</ArticleId></ArticleIdList></Reference><Reference><Citation>Minelli A., Grottelli S., Mierla A., Pinnen F., Cacciatore I., Bellezza I. Cyclo(His-Pro) exerts anti-inflammatory effects by modulating NF-&#x3ba;B and Nrf2 signalling. Int. J. Biochem. Cell. Biol. 2012;44:525&#x2013;535. doi: 10.1016/j.biocel.2011.12.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biocel.2011.12.006</ArticleId><ArticleId IdType=\"pubmed\">22185821</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.-W., Lee H.-K., Shin J.-H., Lee J.-K. Up-down regulation of HO-1 and iNOS gene expressions by ethyl pyruvate via recruiting p300 to Nrf2 and depriving It from p65. Free Radic. Biol. Med. 2013;65:468&#x2013;476. doi: 10.1016/j.freeradbiomed.2013.07.028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.freeradbiomed.2013.07.028</ArticleId><ArticleId IdType=\"pubmed\">23891677</ArticleId></ArticleIdList></Reference><Reference><Citation>Grottelli S., Ferrari I., Pietrini G., Peirce M.J., Minelli A., Bellezza I. The Role of Cyclo(His-Pro) in Neurodegeneration. Int. J. Mol. Sci. 2016;17:1332. doi: 10.3390/ijms17081332.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms17081332</ArticleId><ArticleId IdType=\"pmc\">PMC5000729</ArticleId><ArticleId IdType=\"pubmed\">27529240</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos B.F., Grenho I., Martel P.J., Ferreira B.I., Link W. FOXO family isoforms. Cell Death Dis. 2023;14:702. doi: 10.1038/s41419-023-06177-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41419-023-06177-1</ArticleId><ArticleId IdType=\"pmc\">PMC10611805</ArticleId><ArticleId IdType=\"pubmed\">37891184</ArticleId></ArticleIdList></Reference><Reference><Citation>Olejnik A., Radajewska A., Krzywonos-Zawadzka A., Bil-Lula I. Klotho inhibits IGF1R/PI3K/AKT signalling pathway and protects the heart from oxidative stress during ischemia/reperfusion injury. Sci. Rep. 2023;13:20312. doi: 10.1038/s41598-023-47686-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-023-47686-5</ArticleId><ArticleId IdType=\"pmc\">PMC10662387</ArticleId><ArticleId IdType=\"pubmed\">37985893</ArticleId></ArticleIdList></Reference><Reference><Citation>Wungu C.D.K., Susilo H., Alsagaff M.Y., Witarto B.S., Witarto A.P., Pakpahan C., Gusnanto A. Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: A meta-analysis of observational studies. Sci. Rep. 2024;14:5712. doi: 10.1038/s41598-024-56377-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-024-56377-8</ArticleId><ArticleId IdType=\"pmc\">PMC10923819</ArticleId><ArticleId IdType=\"pubmed\">38459119</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuro-o M. Klotho and calciprotein particles as therapeutic targets against accelerated ageing. Clin. Sci. 2021;135:1915&#x2013;1927. doi: 10.1042/CS20201453.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/CS20201453</ArticleId><ArticleId IdType=\"pmc\">PMC8355631</ArticleId><ArticleId IdType=\"pubmed\">34374422</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner L.E., Wagner U. Calcium-sensing receptor-mediated NLRP3 inflammasome activation in rheumatoid arthritis and autoinflammation. Front. Physiol. 2023;13:1078569. doi: 10.3389/fphys.2022.1078569.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2022.1078569</ArticleId><ArticleId IdType=\"pmc\">PMC9854345</ArticleId><ArticleId IdType=\"pubmed\">36685206</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha-Singh K.J., Zeller T., Jaff M.R. Peripheral arterial calcification: Prevalence, mechanism, detection, and clinical implications. Catheter. Cardiovasc. Interv. 2014;83:E212&#x2013;E220. doi: 10.1002/ccd.25387.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ccd.25387</ArticleId><ArticleId IdType=\"pmc\">PMC4262070</ArticleId><ArticleId IdType=\"pubmed\">24402839</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty T.M., Fitzpatrick L.A., Inoue D., Qiao J.-H., Fishbein M.C., Detrano R.C., Shah P.K., Rajavashisth T.B. Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr. Rev. 2004;25:629&#x2013;672. doi: 10.1210/er.2003-0015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/er.2003-0015</ArticleId><ArticleId IdType=\"pubmed\">15294885</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu D., Jiang H., Zou T., Jia Y., Zhao Y., Wang Z. Endothelial-to-mesenchymal transition: New insights into vascular calcification. Biochem. Pharmacol. 2023;213:115579. doi: 10.1016/j.bcp.2023.115579.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bcp.2023.115579</ArticleId><ArticleId IdType=\"pubmed\">37589048</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan A., Gotlieb A.I. The microenvironment of the atheroma expresses phenotypes of plaque instability. Cardiovas. Pathol. 2023;67:107572. doi: 10.1016/j.carpath.2023.107572.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.carpath.2023.107572</ArticleId><ArticleId IdType=\"pubmed\">37595697</ArticleId></ArticleIdList></Reference><Reference><Citation>Olejnik A., Franczak A., Krzywonos-Zawadzka A., Ka&#x142;u&#x17c;na-Oleksy M., Bil-Lula I. The Biological Role of Klotho Protein in the Development of Cardiovascular Diseases. Biomed. Res. Int. 2018;2018:5171945. doi: 10.1155/2018/5171945.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2018/5171945</ArticleId><ArticleId IdType=\"pmc\">PMC6323445</ArticleId><ArticleId IdType=\"pubmed\">30671457</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhiyat N., Ozcan I., Gulati R., Prasad A., Tchkonia T., Kirkland J.L., Lewis B., Lerman L.O., Lerman A. Patients with Coronary Microvascular Dysfunction Have Less Circulating &#x3b1;-Klotho. J. Am. Heart Assoc. 2024;13:e031972. doi: 10.1161/JAHA.123.031972.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/JAHA.123.031972</ArticleId><ArticleId IdType=\"pmc\">PMC11179916</ArticleId><ArticleId IdType=\"pubmed\">38639380</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Moro A., Valencia I., Shamoon L., S&#xe1;nchez-Ferrer C.F., Peir&#xf3; C., de la Cuesta F. NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically. Antioxidants. 2022;11:269. doi: 10.3390/antiox11020269.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox11020269</ArticleId><ArticleId IdType=\"pmc\">PMC8868353</ArticleId><ArticleId IdType=\"pubmed\">35204152</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X.-D., Chen J.-X., Zhu L., Xu S.-T., Jiang J., Ren K. The emerging role of pyroptosis-related inflammasome pathway in atherosclerosis. Mol. Med. 2022;28:160. doi: 10.1186/s10020-022-00594-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s10020-022-00594-2</ArticleId><ArticleId IdType=\"pmc\">PMC9773468</ArticleId><ArticleId IdType=\"pubmed\">36544112</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyurenkov I.N., Perfilova V.N., Nesterova A.A., Glinka Y. Klotho Protein and Cardio-Vascular System. Biochemistry. 2021;86:132&#x2013;145. doi: 10.1134/S0006297921020024.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1134/S0006297921020024</ArticleId><ArticleId IdType=\"pubmed\">33832412</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanriover C., Copur S., Mutlu A., Peltek I.B., Galassi A., Ciceri P., Cozzolino M., Kanbay M. Early aging and premature vascular aging in chronic kidney disease. Clin. Kidney J. 2023;16:1751&#x2013;1765. doi: 10.1093/ckj/sfad076.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ckj/sfad076</ArticleId><ArticleId IdType=\"pmc\">PMC10616490</ArticleId><ArticleId IdType=\"pubmed\">37915901</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi S., Zou Y., Togao O., Pastor J.V., John G.B., Wang L., Shiizaki K., Gotschall R., Schiavi S., Yorioka N., et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J. Biol. Chem. 2011;286:8655&#x2013;8665. doi: 10.1074/jbc.M110.174037.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M110.174037</ArticleId><ArticleId IdType=\"pmc\">PMC3048747</ArticleId><ArticleId IdType=\"pubmed\">21209102</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohsawa Y., Ohtsubo H., Munekane A., Ohkubo K., Murakami T., Fujino M., Nishimatsu S.-I., Hagiwara H., Nishimura H., Kaneko R., et al. Circulating &#x3b1;-Klotho Counteracts Transforming Growth Factor-&#x3b2;-Induced Sarcopenia. Am. J. Pathol. 2023;193:591&#x2013;607. doi: 10.1016/j.ajpath.2023.01.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajpath.2023.01.009</ArticleId><ArticleId IdType=\"pubmed\">36773783</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratsinis H., Mavrogonatou E., Kletsas D. TGF-beta in development and aging. In: Rattan S.I.S., editor. Hormones in Ageing and Longevity. Springer International Publishing AG; Cham, Switzerland: 2017. pp. 127&#x2013;148.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-3-319-63001-4_7</ArticleId></ArticleIdList></Reference><Reference><Citation>Prud&#x2019;homme G.J., Glinka Y., Matkar P.N., Leong-Poi H. The role of neuropilins in TGF-beta signaling and cancer biology. In: Neufeld G., Kessler O., editors. The Neuropilins: Role and Function in Health and Disease. Springer International Publishing AG; Cham, Switzerland: 2017. pp. 187&#x2013;212.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-3-319-48824-0_11</ArticleId></ArticleIdList></Reference><Reference><Citation>Miku&#x142;a-Pietrasik J., Rutecki S., Ksi&#x105;&#x17c;ek K. The functional multipotency of transforming growth factor beta signaling at the intersection of senescence and cancer. Cell. Mol. Life Sci. 2022;79:196. doi: 10.1007/s00018-022-04236-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00018-022-04236-y</ArticleId><ArticleId IdType=\"pmc\">PMC11073081</ArticleId><ArticleId IdType=\"pubmed\">35305149</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren L.-L., Miao H., Wang Y.-N., Liu F., Li P., Zhao Y.-Y. TGF-&#x3b2; as A Master Regulator of Aging-Associated Tissue Fibrosis. Aging Dis. 2023;14:1633&#x2013;1650. doi: 10.14336/AD.2023.0222.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14336/AD.2023.0222</ArticleId><ArticleId IdType=\"pmc\">PMC10529747</ArticleId><ArticleId IdType=\"pubmed\">37196129</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Hu F., Xue M., Jia Y.-J., Zheng Z.-J., Wang L., Guan M.-P., Xue Y.-M. Klotho down-regulates Egr-1 by inhibiting TGF-beta1/Smad3 signaling in high glucose treated human mesangial cells. Biochem. Biophys. Res. Commun. 2017;487:216&#x2013;222. doi: 10.1016/j.bbrc.2017.04.036.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2017.04.036</ArticleId><ArticleId IdType=\"pubmed\">28411025</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadpech S., Thongboonkerd V. Epithelial-mesenchymal plasticity in kidney fibrosis. Genesis. 2023;62:e23529. doi: 10.1002/dvg.23529.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/dvg.23529</ArticleId><ArticleId IdType=\"pubmed\">37345818</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Eichhorn P.J.A., Thiery J.P. TGF-&#x3b2;, EMT, and resistance to anti-cancer treatment. Semin. Cancer Biol. 2023;97:1&#x2013;11. doi: 10.1016/j.semcancer.2023.10.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.semcancer.2023.10.004</ArticleId><ArticleId IdType=\"pubmed\">37944215</ArticleId></ArticleIdList></Reference><Reference><Citation>Prud&#x2019;homme G.J., Glinka Y. Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity. Oncotarget. 2012;3:921&#x2013;939. doi: 10.18632/oncotarget.626.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.626</ArticleId><ArticleId IdType=\"pmc\">PMC3660061</ArticleId><ArticleId IdType=\"pubmed\">22948112</ArticleId></ArticleIdList></Reference><Reference><Citation>Varun B.R., Ramani P., Arya I., Palani J., Joseph A.P. Epithelial-mesenchymal transition in cancer stem cells: Therapeutic implications. J. Oral. Maxillofac. Pathol. 2023;27:359&#x2013;363.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10581319</ArticleId><ArticleId IdType=\"pubmed\">37854925</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Xue M., Hu F., Jia Y., Zheng Z., Yang Y., Liu X., Yang Y., Wang Y. Klotho prevents epithelial-mesenchymal transition through Egr-1 downregulation in diabetic kidney disease. BMJ Open Diabetes Res. Care. 2021;9:e002038. doi: 10.1136/bmjdrc-2020-002038.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmjdrc-2020-002038</ArticleId><ArticleId IdType=\"pmc\">PMC8186752</ArticleId><ArticleId IdType=\"pubmed\">34099438</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Lu P., Shao X.-F., Jiang T., Liu F., Li G. Klotho Regulates Epithelial-to-Mesenchymal Transition In Vitro via Wnt/beta-Catenin Pathway and Attenuates Chronic Allog-raft Dysfunction in a Rat Renal Transplant Model. Ann. Transplant. 2021;26:e930066. doi: 10.12659/AOT.930066.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.12659/AOT.930066</ArticleId><ArticleId IdType=\"pmc\">PMC7986726</ArticleId><ArticleId IdType=\"pubmed\">33737505</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H.Y., Kim S.J., Park K.S., Kim J.H. Klotho prevents transforming growth factor-&#x3b2;2-induced senescent-like morphological changes in the retinal pigment epithelium. Cell Death Dis. 2023;14:334. doi: 10.1038/s41419-023-05851-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41419-023-05851-8</ArticleId><ArticleId IdType=\"pmc\">PMC10199917</ArticleId><ArticleId IdType=\"pubmed\">37210384</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Q., Ren Q., Li L., Tan H., Lu M., Tian Y., Huang L., Zhao B., Fu H., Hou F.F., et al. A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-beta signaling. Nat. Commun. 2022;13:438. doi: 10.1038/s41467-022-28096-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-022-28096-z</ArticleId><ArticleId IdType=\"pmc\">PMC8782923</ArticleId><ArticleId IdType=\"pubmed\">35064106</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Tan H., Xu J., Tian Y., Yuan Q., Zuo Y., Chen Q., Hong X., Fu H., Hou F.F., et al. Klotho-derived peptide 6 ameliorates diabetic kidney disease by targeting Wnt/&#x3b2;-catenin signaling. Kidney Int. 2022;102:506&#x2013;520. doi: 10.1016/j.kint.2022.04.028.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.kint.2022.04.028</ArticleId><ArticleId IdType=\"pubmed\">35644285</ArticleId></ArticleIdList></Reference><Reference><Citation>Abboud M., Merenbakh-Lamin K., Volkov H., Ben-Neriah S., Ligumsky H., Bronfeld S., Keren-Khadmy N., Giladi M., Shomron N., Wolf I., et al. Oncogene Revealing the tumor suppressive sequence within KL1 domain of the hormone Klotho. Oncogene. 2023;43:354&#x2013;362. doi: 10.1038/s41388-023-02904-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41388-023-02904-2</ArticleId><ArticleId IdType=\"pubmed\">38040805</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P.Y., Schwartz M.A., Simons M. Endothelial-to-Mesenchymal Transition, Vascular Inflammation, and Atherosclerosis. Front. Cardiovasc. Med. 2020;7:53. doi: 10.3389/fcvm.2020.00053.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcvm.2020.00053</ArticleId><ArticleId IdType=\"pmc\">PMC7232582</ArticleId><ArticleId IdType=\"pubmed\">32478094</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Q., Shan D., Cui K., Li K., Zhu B., Wu H., Wang B., Wong S., Norton V., Dong Y., et al. The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease. Cells. 2022;11:1834. doi: 10.3390/cells11111834.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells11111834</ArticleId><ArticleId IdType=\"pmc\">PMC9180466</ArticleId><ArticleId IdType=\"pubmed\">35681530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P.-Y., Qin L., Baeyens N., Li G., Afolabi T., Budatha M., Tellides G., Schwartz M.A., Simons M. Endothelial-to-mesenchymal transition drives atherosclerosis progression. J. Clin. Investig. 2015;125:4514&#x2013;4528. doi: 10.1172/JCI82719.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI82719</ArticleId><ArticleId IdType=\"pmc\">PMC4665771</ArticleId><ArticleId IdType=\"pubmed\">26517696</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Yu L., He A., Liu Q. Klotho Inhibits Unilateral Ureteral Obstruction-Induced Endothelial-to-Mesenchymal Transition via TGF-&#x3b2;1/Smad2/Snail1 Signaling in Mice. Front. Pharmacol. 2019;10:348. doi: 10.3389/fphar.2019.00348.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2019.00348</ArticleId><ArticleId IdType=\"pmc\">PMC6460315</ArticleId><ArticleId IdType=\"pubmed\">31024315</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Q., The E., Zhai Y., Ao L., Fullerton D., Meng X. Klotho Suppresses Endothelial-to-Mesenchymal Transition in the Aorta of Mice With Chronic Kidney Disease by Inhibition of Endothelial Senescent Activity. Circulation. 2022;146:A13254. doi: 10.1161/circ.146.suppl_1.13254.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/circ.146.suppl_1.13254</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho M.R., Lee S., Song S.K. A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction. J. Korean Med. Sci. 2022;37:e146. doi: 10.3346/jkms.2022.37.e146.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3346/jkms.2022.37.e146</ArticleId><ArticleId IdType=\"pmc\">PMC9091430</ArticleId><ArticleId IdType=\"pubmed\">35535373</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.J. Myostatin: A Skeletal Muscle Chalone. Annu. Rev. Physiol. 2023;85:269&#x2013;291. doi: 10.1146/annurev-physiol-012422-112116.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-physiol-012422-112116</ArticleId><ArticleId IdType=\"pmc\">PMC10163667</ArticleId><ArticleId IdType=\"pubmed\">36266260</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers B.D., Ward C.W. Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs. Endocr. Rev. 2022;43:329&#x2013;365. doi: 10.1210/endrev/bnab030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/endrev/bnab030</ArticleId><ArticleId IdType=\"pmc\">PMC8905337</ArticleId><ArticleId IdType=\"pubmed\">34520530</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Huang K., Li H., Kong W., Ye J. High serum klotho levels are inversely associated with the risk of low muscle mass in middle-aged adults: Results from a cross-sectional study. Front. Nutr. 2024;11:1390517. doi: 10.3389/fnut.2024.1390517.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnut.2024.1390517</ArticleId><ArticleId IdType=\"pmc\">PMC11157077</ArticleId><ArticleId IdType=\"pubmed\">38854159</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu A., Mamiya H., Shinde S.N., Cheikhi A., Winter L.L., Vo N.V., Stolz D., Roginskaya V., Tang W.-Y., Croix C.S., et al. Age-related declines in &#x3b1;-Klotho drive progenitor cell mitochondrial dysfunction and impaired muscle regeneration. Nat. Commun. 2018;9:4859. doi: 10.1038/s41467-018-07253-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-018-07253-3</ArticleId><ArticleId IdType=\"pmc\">PMC6242898</ArticleId><ArticleId IdType=\"pubmed\">30451844</ArticleId></ArticleIdList></Reference><Reference><Citation>Afsar R.E., Afsar B., Ikizler T.A. Fibroblast Growth Factor 23 and Muscle Wasting: A Metabolic Point of View. Kidney Int. Rep. 2023;8:1301&#x2013;1314. doi: 10.1016/j.ekir.2023.04.027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ekir.2023.04.027</ArticleId><ArticleId IdType=\"pmc\">PMC10334408</ArticleId><ArticleId IdType=\"pubmed\">37441473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Sun Z. In vivo pancreatic &#x3b2;-cell-specific expression of antiaging gene &#x3b1;-Klotho: A novel approach for preserving &#x3b2;-cells in type 2 diabetes. Diabetes. 2015;64:1444&#x2013;1458. doi: 10.2337/db14-0632.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/db14-0632</ArticleId><ArticleId IdType=\"pmc\">PMC4375073</ArticleId><ArticleId IdType=\"pubmed\">25377875</ArticleId></ArticleIdList></Reference><Reference><Citation>Keles N., Dogan B., Kalcik M., Caliskan M., Keles N.N., Aksu F., Bulut M., Kostek O., Isbilen B., Yilmaz Y., et al. Is serum &#x3b1;-Klotho protective against atherosclerosis in patients with type 1 diabetes mellitus? J. Diabetes Complicat. 2016;30:126&#x2013;132. doi: 10.1016/j.jdiacomp.2015.09.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jdiacomp.2015.09.013</ArticleId><ArticleId IdType=\"pubmed\">26601789</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie F., Wu D., Du H., Yang X., Yang M., Pang X., Xu Y. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus. J. Diabetes Complicat. 2017;31:594&#x2013;598. doi: 10.1016/j.jdiacomp.2016.11.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jdiacomp.2016.11.008</ArticleId><ArticleId IdType=\"pubmed\">27916483</ArticleId></ArticleIdList></Reference><Reference><Citation>Fountoulakis N., Maltese G., Gnudi L., Karalliedde J. Reduced Levels of Anti-Ageing Hormone Klotho Predict Renal Function Decline in Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2018;103:2026&#x2013;2032. doi: 10.1210/jc.2018-00004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/jc.2018-00004</ArticleId><ArticleId IdType=\"pubmed\">29509906</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Liu T. Clinical implication of alterations in serum Klotho levels in patients with type 2 diabetes mellitus and its associated complications. J. Diabetes Complicat. 2018;32:922&#x2013;930. doi: 10.1016/j.jdiacomp.2018.06.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jdiacomp.2018.06.002</ArticleId><ArticleId IdType=\"pubmed\">30042059</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarhani F., Heidari G., Nezami A. Evaluation of &#x3b1;-klotho level in insulin dependent diabetes mellitus (IDDM) children. J. Pediatr. Endocrinol. Metab. 2020;33:761&#x2013;765. doi: 10.1515/jpem-2019-0591.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1515/jpem-2019-0591</ArticleId><ArticleId IdType=\"pubmed\">32469333</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubkiewicz-Kucharska A., Wikiera B., Noczy&#x144;ska A. Soluble Klotho Is Decreased in Children with Type 1 Diabetes and Correlated with Metabolic Control. Front. Endocrinol. 2021;12:709564. doi: 10.3389/fendo.2021.709564.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2021.709564</ArticleId><ArticleId IdType=\"pmc\">PMC8484787</ArticleId><ArticleId IdType=\"pubmed\">34603200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefta R.F., Hassan E.A. Serum soluble &#x3b1;-Klotho levels in patients with diabetic nephropathy. Ir. J. Med. Sci. 2023;193:725&#x2013;731. doi: 10.1007/s11845-023-03502-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11845-023-03502-7</ArticleId><ArticleId IdType=\"pubmed\">37626257</ArticleId></ArticleIdList></Reference><Reference><Citation>Takenaka T., Kobori H., Miyazaki T., Suzuki H., Nishiyama A., Ishii N., Yamashita M., Hayashi M. Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type 2 diabetes. Acta Physiol. 2019;225:e13190. doi: 10.1111/apha.13190.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/apha.13190</ArticleId><ArticleId IdType=\"pmc\">PMC6335176</ArticleId><ArticleId IdType=\"pubmed\">30251773</ArticleId></ArticleIdList></Reference><Reference><Citation>Prud&#x2019;homme G.J., Glinka Y., Kurt M., Liu W., Wang Q. Systemic Klotho therapy protects against insulitis and enhances beta-cell mass in NOD mice. Biochem. Biophys. Res. Commun. 2020;525:693&#x2013;698. doi: 10.1016/j.bbrc.2020.02.123.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2020.02.123</ArticleId><ArticleId IdType=\"pubmed\">32139120</ArticleId></ArticleIdList></Reference><Reference><Citation>Razzaque M.S. The role of Klotho in energy metabolism. Nat. Rev. Endocrinol. 2012;8:579&#x2013;587. doi: 10.1038/nrendo.2012.75.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrendo.2012.75</ArticleId><ArticleId IdType=\"pmc\">PMC3704949</ArticleId><ArticleId IdType=\"pubmed\">22641000</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Sun Z. Antiaging Gene &#x3b1;-Klotho Attenuates Pancreatic &#x3b2;-Cell Apoptosis in Type 1 Diabetes. Diabetes. 2015;64:4298&#x2013;4311. doi: 10.2337/db15-0066.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/db15-0066</ArticleId><ArticleId IdType=\"pmc\">PMC4657580</ArticleId><ArticleId IdType=\"pubmed\">26340932</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Son D.O., Lau H.K., Zhou Y., Prud&#x2019;homme G.J., Jin T., Wang Q. Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents &#x392; Cell Damage and Promotes &#x392; Cell Regeneration in Mice. Front. Pharmacol. 2017;8:362. doi: 10.3389/fphar.2017.00362.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2017.00362</ArticleId><ArticleId IdType=\"pmc\">PMC5476705</ArticleId><ArticleId IdType=\"pubmed\">28676760</ArticleId></ArticleIdList></Reference><Reference><Citation>Son D.O., Liu W., Li X., Prud&#x2019;homme G.J., Wang Q. Combined effect of GABA and glucagon-like peptide-1 receptor agonist on cytokine-induced apoptosis in pancreatic &#x3b2;-cell line and isolated human islets. J. Diabetes. 2019;11:563&#x2013;572. doi: 10.1111/1753-0407.12881.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/1753-0407.12881</ArticleId><ArticleId IdType=\"pubmed\">30520247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Ren L., Wan Y., Prud&#x2019;homme G.J. GABAergic regulation of pancreatic islet cells: Physiology and antidiabetic effects. J. Cell. Physiol. 2019;234:14432&#x2013;14444. doi: 10.1002/jcp.28214.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jcp.28214</ArticleId><ArticleId IdType=\"pubmed\">30693506</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Lau H.K., Son D.O., Jin T., Yang Y., Zhang Z., Li Y., Prud&#x2019;homme G.J., Wang Q. Combined use of GABA and sitagliptin promotes human &#x3b2;-cell proliferation and reduces apoptosis. J. Endocrinol. 2021;248:133&#x2013;143. doi: 10.1530/JOE-20-0315.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1530/JOE-20-0315</ArticleId><ArticleId IdType=\"pubmed\">33258801</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart A.W., Baeza N., Apelqvist A., Edlund H. Attenuation of FGF signalling in mouse &#x3b2;-cells leads to diabetes. Nature. 2000;408:864&#x2013;868. doi: 10.1038/35048589.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/35048589</ArticleId><ArticleId IdType=\"pubmed\">11130726</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad M.K., Mohandas S., Ramkumar K.M. Dysfunctions, molecular mechanisms, and therapeutic strategies of pancreatic &#x3b2;-cells in diabetes. Apoptosis. 2023;28:958&#x2013;976. doi: 10.1007/s10495-023-01854-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10495-023-01854-0</ArticleId><ArticleId IdType=\"pubmed\">37273039</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalle S., Abderrahmani A., Renard E. Pharmacological inhibitors of &#x3b2;-cell dysfunction and death as therapeutics for diabetes. Front. Endocrinol. 2023;14:1076343. doi: 10.3389/fendo.2023.1076343.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2023.1076343</ArticleId><ArticleId IdType=\"pmc\">PMC10050720</ArticleId><ArticleId IdType=\"pubmed\">37008937</ArticleId></ArticleIdList></Reference><Reference><Citation>Borowiec A.M., W&#x142;aszczuk A., Olakowska E., Lewin-Kowalik J. TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients. Med. Pharm. Rep. 2022;95:243&#x2013;250. doi: 10.15386/mpr-2187.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15386/mpr-2187</ArticleId><ArticleId IdType=\"pmc\">PMC9387585</ArticleId><ArticleId IdType=\"pubmed\">36060506</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E.H., Park S.J. TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target. Exp. Mol. Med. 2023;55:1348&#x2013;1356. doi: 10.1038/s12276-023-01019-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s12276-023-01019-8</ArticleId><ArticleId IdType=\"pmc\">PMC10393958</ArticleId><ArticleId IdType=\"pubmed\">37394581</ArticleId></ArticleIdList></Reference><Reference><Citation>Zgutka K., Tkacz M., Tomasiak P., Tarnowski M. A Role for Advanced Glycation End Products in Molecular Ageing. Int. J. Mol. Sci. 2023;24:9881. doi: 10.3390/ijms24129881.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24129881</ArticleId><ArticleId IdType=\"pmc\">PMC10298716</ArticleId><ArticleId IdType=\"pubmed\">37373042</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi K., Fukami K. RAGE signaling regulates the progression of diabetic complications. Front. Pharmacol. 2023;14:1128872. doi: 10.3389/fphar.2023.1128872.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2023.1128872</ArticleId><ArticleId IdType=\"pmc\">PMC10060566</ArticleId><ArticleId IdType=\"pubmed\">37007029</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M.I., Ashfaq F., A Alsayegh A., Hamouda A., Khatoon F., Altamimi T.N., Alhodieb F.S., Beg M.M.A. Advanced glycation end product signaling and metabolic complications: Dietary approach. World J. Diabetes. 2023;14:995&#x2013;1012. doi: 10.4239/wjd.v14.i7.995.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4239/wjd.v14.i7.995</ArticleId><ArticleId IdType=\"pmc\">PMC10401445</ArticleId><ArticleId IdType=\"pubmed\">37547584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W., Tao M., Zhao Y., Hu X., Wang M. 4&#x2032;-Methoxyresveratrol Alleviated AGE-Induced Inflammation via RAGE-Mediated NF-&#x3ba;B and NLRP3 Inflammasome Pathway. Molecules. 2018;23:1447. doi: 10.3390/molecules23061447.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules23061447</ArticleId><ArticleId IdType=\"pmc\">PMC6100160</ArticleId><ArticleId IdType=\"pubmed\">29903983</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng X., Huang W., Peng J., Zhu T.-T., Sun X.-L., Zhou X.-Y., Yang H., Xiong J.-F., He H.-Q., Xu Y.-H., et al. Irisin Alleviates Advanced Glycation End Products-Induced Inflammation and Endothelial Dysfunction via Inhibiting ROS-NLRP3 Inflammasome Signaling. Inflammation. 2018;41:260&#x2013;275. doi: 10.1007/s10753-017-0685-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10753-017-0685-3</ArticleId><ArticleId IdType=\"pubmed\">29098483</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Wang Y., Zhang Y., Geng W., Liu W., Gao Y., Li S., Wang K., Wu X., Kang L., et al. Advanced glycation end products regulate anabolic and catabolic activities via NLRP3-inflammasome activation in human nucleus pulposus cells. J. Cell. Mol. Med. 2017;21:1373&#x2013;1387. doi: 10.1111/jcmm.13067.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jcmm.13067</ArticleId><ArticleId IdType=\"pmc\">PMC5487914</ArticleId><ArticleId IdType=\"pubmed\">28224704</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L., Chen X., Lu M., Wu Q., Yuan Q., Hu C., Miao J., Zhang Y., Li H., Hou F.F., et al. Wnt/&#x3b2;-catenin links oxidative stress to podocyte injury and proteinuria. Kidney Int. 2019;95:830&#x2013;845. doi: 10.1016/j.kint.2018.10.032.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.kint.2018.10.032</ArticleId><ArticleId IdType=\"pmc\">PMC6431566</ArticleId><ArticleId IdType=\"pubmed\">30770219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kan W.-C., Hwang J.-Y., Chuang L.-Y., Guh J.-Y., Ye Y.-L., Yang Y.-L., Huang J.-S. Effect of osthole on advanced glycation end products-induced renal tubular hypertrophy and role of klotho in its mechanism of action. Phytomedicine. 2019;53:205&#x2013;212. doi: 10.1016/j.phymed.2018.09.030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.phymed.2018.09.030</ArticleId><ArticleId IdType=\"pubmed\">30668400</ArticleId></ArticleIdList></Reference><Reference><Citation>Puddu A., Maggi D.C. Klotho: A new therapeutic target in diabetic retinopathy? World J. Diabetes. 2023;14:1027&#x2013;1036. doi: 10.4239/wjd.v14.i7.1027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4239/wjd.v14.i7.1027</ArticleId><ArticleId IdType=\"pmc\">PMC10401458</ArticleId><ArticleId IdType=\"pubmed\">37547589</ArticleId></ArticleIdList></Reference><Reference><Citation>Reish N.J., Maltare A., McKeown A.S., Laszczyk A.M., Kraft T.W., Gross A.K., King G.D. The age-regulating protein klotho is vital to sustain retinal function. Investig. Ophthalmol. Vis. Sci. 2013;54:6675&#x2013;6685. doi: 10.1167/iovs.13-12550.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1167/iovs.13-12550</ArticleId><ArticleId IdType=\"pmc\">PMC3796940</ArticleId><ArticleId IdType=\"pubmed\">24045987</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham C.R., Mullen P.C., Tucker-Zhou T., Chen C., Zeldich E. Is a Neuroprotective and Cognition-Enhancing Protein. Vitam. Horm. 2016;101:215&#x2013;238. doi: 10.1016/bs.vh.2016.02.004.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/bs.vh.2016.02.004</ArticleId><ArticleId IdType=\"pubmed\">27125744</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo H., Chang Y., Ryu D.R., Song T.J. Plasma Klotho concentration is associated with the presence, burden and progression of cerebral small vessel disease in patients with acute ischaemic stroke. PLoS ONE. 2019;14:e0220796. doi: 10.1371/journal.pone.0220796.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0220796</ArticleId><ArticleId IdType=\"pmc\">PMC6688787</ArticleId><ArticleId IdType=\"pubmed\">31398214</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias G.P., Murphy T., Stangl D., Ahmet S., Morisse B., Nix A., Aimone L.J., Aimone J.B., Kuro-O M., Gage F.H., et al. Intermittent fasting enhances long-term memory consolidation, adult hippocampal neurogenesis, and expression of longevity gene Klotho. Mol. Psychiatry. 2021;26:6365&#x2013;6379. doi: 10.1038/s41380-021-01102-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41380-021-01102-4</ArticleId><ArticleId IdType=\"pmc\">PMC8760057</ArticleId><ArticleId IdType=\"pubmed\">34031536</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson K., Fisher K., Hooper N.M. Exploiting the neuroprotective effects of alpha-klotho to tackle ageing- and neurodegeneration-related cognitive dysfunction. Neuronal Signal. 2021;5:NS20200101. doi: 10.1042/NS20200101.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/NS20200101</ArticleId><ArticleId IdType=\"pmc\">PMC8204227</ArticleId><ArticleId IdType=\"pubmed\">34194816</ArticleId></ArticleIdList></Reference><Reference><Citation>Neitzel J., Franzmeier N., Rubinski A., Dichgans M., Brendel M., Malik R., Ewers M. KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer&#x2019;s disease. Nat. Commun. 2021;12:3825. doi: 10.1038/s41467-021-23755-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-021-23755-z</ArticleId><ArticleId IdType=\"pmc\">PMC8219708</ArticleId><ArticleId IdType=\"pubmed\">34158479</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaker M.R., Aguado J., Chaggar H.K., Wolvetang E.J. Klotho inhibits neuronal senescence in human brain organoids. NPJ Aging Mech. Dis. 2021;7:18. doi: 10.1038/s41514-021-00070-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41514-021-00070-x</ArticleId><ArticleId IdType=\"pmc\">PMC8329278</ArticleId><ArticleId IdType=\"pubmed\">34341344</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait&#xe1;n J.M., Asthana S., Carlsson C.M., Engelman C.D., Johnson S.C., Sager M.A., Wang D., Dubal D.B., Okonkwo O.C. Circulating Klotho Is Higher in Cerebrospinal Fluid than Serum and Elevated Among Klotho Heterozygotes in a Cohort with Risk for Alzheimer&#x2019;s Disease. J. Alzheimers Dis. 2022;90:1557&#x2013;1569. doi: 10.3233/JAD-220571.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-220571</ArticleId><ArticleId IdType=\"pmc\">PMC10139824</ArticleId><ArticleId IdType=\"pubmed\">36314202</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf8;ntvedt G.R., Sando S.B., Lauridsen C., Br&#xe5;then G., White L.R., Salvesen &#xd8;., Aarsland D., Hessen E., Fladby T., Waterloo K., et al. Association of Klotho Protein Levels and KL-VS Heterozygosity With Alzheimer Disease and Amyloid and Tau Burden. JAMA Netw. Open. 2022;5:e2243232. doi: 10.1001/jamanetworkopen.2022.43232.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2022.43232</ArticleId><ArticleId IdType=\"pmc\">PMC9682425</ArticleId><ArticleId IdType=\"pubmed\">36413367</ArticleId></ArticleIdList></Reference><Reference><Citation>PKundu P., Zimmerman B., Quinn J.F., Kaye J., Mattek N., Westaway S.K., Raber J. Serum Levels of alpha-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function. J. Alzheimers Dis. 2022;86:1471&#x2013;1481. doi: 10.3233/JAD-215719.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-215719</ArticleId><ArticleId IdType=\"pmc\">PMC9108571</ArticleId><ArticleId IdType=\"pubmed\">35213382</ArticleId></ArticleIdList></Reference><Reference><Citation>Castner S.A., Gupta S., Wang D., Moreno A.J., Park C., Chen C., Poon Y., Groen A., Greenberg K., David N., et al. Longevity factor klotho enhances cognition in aged nonhuman primates. Nat. Aging. 2023;3:931&#x2013;937. doi: 10.1038/s43587-023-00441-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s43587-023-00441-x</ArticleId><ArticleId IdType=\"pmc\">PMC10432271</ArticleId><ArticleId IdType=\"pubmed\">37400721</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L., Yu S., Zhang Z., Li Y., Qiu S., Dong B. The relationship between serum klotho and cognitive performance in a nationally representative sample of US adults. Front. Aging Neurosci. 2023;15:1053390. doi: 10.3389/fnagi.2023.1053390.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1053390</ArticleId><ArticleId IdType=\"pmc\">PMC9932504</ArticleId><ArticleId IdType=\"pubmed\">36819720</ArticleId></ArticleIdList></Reference><Reference><Citation>Panczyszyn-Trzewik P., Czechowska E., Stachowicz K., Sowa-Kucma M. The Importance of &#x3b1;-Klotho in Depression and Cognitive Impairment and Its Connection to Glutamate Neurotransmission-An Up-to-Date Review. Int. J. Mol. Sci. 2023;24:15268. doi: 10.3390/ijms242015268.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms242015268</ArticleId><ArticleId IdType=\"pmc\">PMC10607524</ArticleId><ArticleId IdType=\"pubmed\">37894946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrentino F., Fenoglio C., Sacchi L., Serpente M., Arighi A., Carandini T., Arosio B., Ferri E., Arcaro M., Visconte C., et al. Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer&#x2019;s Disease and Frontotemporal Dementia. J. Alzheimers Dis. 2023;94:1225&#x2013;1231. doi: 10.3233/JAD-230322.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-230322</ArticleId><ArticleId IdType=\"pubmed\">37393504</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinton S.M., Glover M.E., Maltare A., Laszczyk A.M., Mehi S.J., Simmons R.K., King G.D. Expression of klotho mRNA and protein in rat brain parenchyma from early postnatal development into adulthood. Brain Res. 2013;1527:1&#x2013;14. doi: 10.1016/j.brainres.2013.06.044.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainres.2013.06.044</ArticleId><ArticleId IdType=\"pmc\">PMC3756829</ArticleId><ArticleId IdType=\"pubmed\">23838326</ArticleId></ArticleIdList></Reference><Reference><Citation>Cararo-Lopes M.M., Mazucanti C.H.Y., Scavone C., Kawamoto E.M., Berwick D.C. The relevance of &#x3b1;-KLOTHO to the central nervous system: Some key questions. Ageing Res. Rev. 2017;36:137&#x2013;148. doi: 10.1016/j.arr.2017.03.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2017.03.003</ArticleId><ArticleId IdType=\"pubmed\">28323064</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung T.Y., Iyaswamy A., Sreenivasmurthy S.G., Krishnamoorthi S., Guan X.-J., Zhu Z., Su C.-F., Liu J., Kan Y., Zhang Y., et al. Klotho an Autophagy Stimulator as a Potential Therapeutic Target for Alzheimer&#x2019;s Disease: A Review. Biomedicines. 2022;10:705. doi: 10.3390/biomedicines10030705.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines10030705</ArticleId><ArticleId IdType=\"pmc\">PMC8945569</ArticleId><ArticleId IdType=\"pubmed\">35327507</ArticleId></ArticleIdList></Reference><Reference><Citation>Gholami A. Alzheimer&#x2019;s disease: The role of proteins in formation, mechanisms, and new therapeutic approaches. Neurosci. Lett. 2023;817:137532. doi: 10.1016/j.neulet.2023.137532.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2023.137532</ArticleId><ArticleId IdType=\"pubmed\">37866702</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury S., Chowdhury N.S. Novel anti-amyloid-beta (A&#x3b2;) monoclonal antibody lecanemab for Alzheimer&#x2019;s disease: A systematic review. Int. J. Immunopathol. Pharmacol. 2023;37:3946320231209839. doi: 10.1177/03946320231209839.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/03946320231209839</ArticleId><ArticleId IdType=\"pmc\">PMC10617290</ArticleId><ArticleId IdType=\"pubmed\">37902139</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadollahikhales G., Rojas J.C. Anti-Amyloid Immunotherapies for Alzheimer&#x2019;s Disease: A 2023 Clinical Update. Neurotherapeutics. 2023;20:914&#x2013;931. doi: 10.1007/s13311-023-01405-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13311-023-01405-0</ArticleId><ArticleId IdType=\"pmc\">PMC10457266</ArticleId><ArticleId IdType=\"pubmed\">37490245</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Li X., Luo G., Wang J., Li R., Zhou C., Wan T., Yang F. Pyroptosis as a candidate therapeutic target for Alzheimer&#x2019;s disease. Front. Aging Neurosci. 2022;14:996646. doi: 10.3389/fnagi.2022.996646.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.996646</ArticleId><ArticleId IdType=\"pmc\">PMC9520296</ArticleId><ArticleId IdType=\"pubmed\">36185484</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose S., Groves N.J., Roper K.E., Gordon R. Mechanisms of NLRP3 activation and pathology during neurodegeneration. Int. J. Biochem. Cell Biol. 2022;151:106273. doi: 10.1016/j.biocel.2022.106273.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biocel.2022.106273</ArticleId><ArticleId IdType=\"pubmed\">35926782</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y.-H., Liu X.-D., Jin M.-H., Sun H.-N., Kwon T. Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases. Inflamm. Res. 2023;72:1839&#x2013;1859. doi: 10.1007/s00011-023-01790-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00011-023-01790-4</ArticleId><ArticleId IdType=\"pubmed\">37725102</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang C.J., Choi D.-Y., Park M.H., Hong J.T. NF-&#x3ba;B as a Key Mediator of Brain Inflammation in Alzheimer&#x2019;s Disease. CNS Neurol. Disord. Drug Targets. 2019;18:3&#x2013;10. doi: 10.2174/1871527316666170807130011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1871527316666170807130011</ArticleId><ArticleId IdType=\"pubmed\">28782486</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonen S., Koper M.J., Van Schoor E., Schaeverbeke J.M., Vandenberghe R., von Arnim C.A.F., Tousseyn T., De Strooper B., Thal D.R. Pyroptosis in Alzheimer&#x2019;s disease: Cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol. 2023;145:175&#x2013;195. doi: 10.1007/s00401-022-02528-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-022-02528-y</ArticleId><ArticleId IdType=\"pubmed\">36481964</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh J., Habean M.L., Panicker N. Inflammasome assembly in neurodegenerative diseases. Trends Neurosci. 2023;46:814&#x2013;831. doi: 10.1016/j.tins.2023.07.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tins.2023.07.009</ArticleId><ArticleId IdType=\"pmc\">PMC10530301</ArticleId><ArticleId IdType=\"pubmed\">37633753</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao J., Wang Z., Song W., Zhang Y. Targeting NLRP3 inflammasome for neurodegenerative disorders. Mol. Psychiatry. 2023;28:4512&#x2013;4527. doi: 10.1038/s41380-023-02239-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41380-023-02239-0</ArticleId><ArticleId IdType=\"pubmed\">37670126</ArticleId></ArticleIdList></Reference><Reference><Citation>Ising C., Venegas C., Zhang S., Scheiblich H., Schmidt S.V., Vieira-Saecker A., Schwartz S., Albasset S., McManus R.M., Tejera D., et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575:669&#x2013;673. doi: 10.1038/s41586-019-1769-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-019-1769-z</ArticleId><ArticleId IdType=\"pmc\">PMC7324015</ArticleId><ArticleId IdType=\"pubmed\">31748742</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiarini A., Armato U., Hu P., Para I.D. Danger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2020;21:9036. doi: 10.3390/ijms21239036.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21239036</ArticleId><ArticleId IdType=\"pmc\">PMC7731137</ArticleId><ArticleId IdType=\"pubmed\">33261147</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiarini A., Gui L., Viviani C., Armato U., Pr&#xe0; I.D. NLRP3 Inflammasome&#x2019;s Activation in Acute and Chronic Brain Diseases-An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes. Biomedicines. 2023;11:999. doi: 10.3390/biomedicines11040999.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines11040999</ArticleId><ArticleId IdType=\"pmc\">PMC10135565</ArticleId><ArticleId IdType=\"pubmed\">37189617</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Dai Y., Li Q., Chen C., Chen H., Song Y., Hua F., Zhang Z. Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia. Neurosci. Lett. 2020;736:135279. doi: 10.1016/j.neulet.2020.135279.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2020.135279</ArticleId><ArticleId IdType=\"pubmed\">32726591</ArticleId></ArticleIdList></Reference><Reference><Citation>Koerich S., Parreira G.M., de Almeida D.L., Vieira R.P., de Oliveira A.C.P. Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions. Curr. Neuropharmacol. 2023;21:219&#x2013;234. doi: 10.2174/1570159X20666220922153903.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1570159X20666220922153903</ArticleId><ArticleId IdType=\"pmc\">PMC10190138</ArticleId><ArticleId IdType=\"pubmed\">36154605</ArticleId></ArticleIdList></Reference><Reference><Citation>Veselov I.M., Vinogradova D.V., Maltsev A.V., Shevtsov P.N., Spirkova E.A., Bachurin S.O., Shevtsova E.F. Mitochondria and Oxidative Stress as a Link between Alzheimer&#x2019;s Disease and Diabetes Mellitus. Int. J. Mol. Sci. 2023;24:14450. doi: 10.3390/ijms241914450.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms241914450</ArticleId><ArticleId IdType=\"pmc\">PMC10572926</ArticleId><ArticleId IdType=\"pubmed\">37833898</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.-D., Sloane J.A., Li H., Aytan N., Giannaris E.L., Zeldich E., Hinman J.D., Dedeoglu A., Rosene D.L., Bansal R., et al. The antiaging protein Klotho enhances oligodendrocyte maturation and myelination of the CNS. J. Neurosci. 2013;33:1927&#x2013;1939. doi: 10.1523/JNEUROSCI.2080-12.2013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.2080-12.2013</ArticleId><ArticleId IdType=\"pmc\">PMC3711388</ArticleId><ArticleId IdType=\"pubmed\">23365232</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubal D.B., Zhu L., Sanchez P.E., Worden K., Broestl L., Johnson E., Ho K., Yu G.-Q., Kim D., Betourne A., et al. Life extension factor klotho prevents mortality and enhances cognition in hAPP transgenic mice. J. Neurosci. 2015;35:2358&#x2013;2371. doi: 10.1523/JNEUROSCI.5791-12.2015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.5791-12.2015</ArticleId><ArticleId IdType=\"pmc\">PMC4323521</ArticleId><ArticleId IdType=\"pubmed\">25673831</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng C.Y., Yang T.T., Zhou H.J., Zhao Y., Kuang X., Duan W., Du J.R. Lentiviral vector-mediated overexpression of Klotho in the brain improves Alzheimer&#x2019;s disease-like pathology and cognitive deficits in mice. Neurobiol. Aging. 2019;78:18&#x2013;28. doi: 10.1016/j.neurobiolaging.2019.02.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2019.02.003</ArticleId><ArticleId IdType=\"pubmed\">30851437</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Moreno A.J., Wang D., Leon J., Chen C., Hahn O., Poon Y., Greenberg K., David N., Wyss-Coray T., et al. vKL1 domain of longevity factor klotho mimics the metabolome of cognitive stimulation and enhances cognition in young and aging mice. J. Neurosci. 2022;42:4016&#x2013;4025. doi: 10.1523/JNEUROSCI.2458-21.2022.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.2458-21.2022</ArticleId><ArticleId IdType=\"pmc\">PMC9097772</ArticleId><ArticleId IdType=\"pubmed\">35428698</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubnov S., Bennett E.R., Yayon N., Yakov O., Bennett D.A., Seshadri S., Mufson E., Tzur Y., Greenberg D., Kuro-O M., et al. Knockout of the longevity gene Klotho perturbs aging- and Alzheimer&#x2019;s disease-linked brain microRNAs and tRNA fragments. Commun. Biol. 2023;7:720. doi: 10.1038/s42003-024-06407-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s42003-024-06407-y</ArticleId><ArticleId IdType=\"pmc\">PMC11166644</ArticleId><ArticleId IdType=\"pubmed\">38862813</ArticleId></ArticleIdList></Reference><Reference><Citation>Orellana A.M., Mazucanti C.H., dos Anjos L.P., Lima L.d.S., Kawamoto E.M., Scavone C. Klotho increases antioxidant defenses in astrocytes and ubiquitin-proteasome activity in neurons. Sci. Rep. 2023;13:15080. doi: 10.1038/s41598-023-41166-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-023-41166-6</ArticleId><ArticleId IdType=\"pmc\">PMC10497516</ArticleId><ArticleId IdType=\"pubmed\">37699938</ArticleId></ArticleIdList></Reference><Reference><Citation>Driscoll I., Ma Y., Gallagher C.L., Johnson S.C., Asthana S., Hermann B.P., Sager M.A., Blennow K., Zetterberg H., Carlsson C.M., et al. Age-Related Tau Burden and Cognitive Deficits Are Attenuated in KLOTHO KL-VS Heterozygotes. J. Alzheimers Dis. 2021;82:1369&#x2013;1370. doi: 10.3233/JAD-219006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-219006</ArticleId><ArticleId IdType=\"pubmed\">34250957</ArticleId></ArticleIdList></Reference><Reference><Citation>Poursistany H., Azar S.T., Azar M.T., Raeisi S. The current and emerging Klotho-enhancement strategies. Biochem. Biophys. Res. Commun. 2023;693:149357. doi: 10.1016/j.bbrc.2023.149357.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2023.149357</ArticleId><ArticleId IdType=\"pubmed\">38091839</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora-Fern&#xe1;ndez C., S&#xe1;nchez-Ni&#xf1;o M.D., Donate-Correa J., Mart&#xed;n-N&#xfa;&#xf1;ez E., P&#xe9;rez-Delgado N., Vali&#xf1;o-Rivas L., Fern&#xe1;ndez-Fern&#xe1;ndez B., Ortiz A., Navarro-Gonz&#xe1;lez J.F. Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: A clinical and experimental study. Biomed. Pharmacother. 2022;154:113677. doi: 10.1016/j.biopha.2022.113677.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2022.113677</ArticleId><ArticleId IdType=\"pubmed\">36942605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Gonz&#xe1;lez C., G&#xf3;mez-Bernal F., Quevedo-Abeledo J.C., Ferrer-Moure C., Espelos&#xed;n-Ortega E., Gonz&#xe1;lez-Gay M., Ferraz-Amaro I. Alpha-Klotho protein in systemic lupus erythematosus. Clin. Exp. Rheumatol. 2023;41:41&#x2013;47. doi: 10.55563/clinexprheumatol/salqon.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.55563/clinexprheumatol/salqon</ArticleId><ArticleId IdType=\"pubmed\">35349421</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell D.L., Oates J.C., Markiewicz M. Association Between the Anti-Aging Gene Klotho and Selected Rheumatologic Autoimmune Diseases. Am. J. Med. Sci. 2021;361:169&#x2013;175. doi: 10.1016/j.amjms.2020.10.021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.amjms.2020.10.021</ArticleId><ArticleId IdType=\"pmc\">PMC9741923</ArticleId><ArticleId IdType=\"pubmed\">33349438</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaro-Gahete F.J., de-la-O A., Jurado-Fasoli L., Ruiz J.R., Castillo M.J., Guti&#xe9;rrez &#xc1;. Role of Exercise on S-Klotho Protein Regulation: A Systematic Review. Curr. Aging Sci. 2018;11:100&#x2013;107. doi: 10.2174/1874609811666180702101338.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1874609811666180702101338</ArticleId><ArticleId IdType=\"pubmed\">29962352</ArticleId></ArticleIdList></Reference><Reference><Citation>Arroyo E., Troutman A.D., Moorthi R.N., Avin K.G., Coggan A.R., Lim K. Klotho: An Emerging Factor with Ergogenic Potential. Front. Rehabil. Sci. 2022;2:807123. doi: 10.3389/fresc.2021.807123.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fresc.2021.807123</ArticleId><ArticleId IdType=\"pmc\">PMC9397700</ArticleId><ArticleId IdType=\"pubmed\">36188832</ArticleId></ArticleIdList></Reference><Reference><Citation>Corr&#xea;a H.d.L., Raab A.T.O., Ara&#xfa;jo T.M., Deus L.A., Reis A.L., Honorato F.S., Rodrigues-Silva P.L., Neves R.V.P., Brunetta H.S., Mori M.A.d.S., et al. A systematic review and meta-analysis demonstrating Klotho as an emerging exerkine. Sci. Rep. 2022;12:17587. doi: 10.1038/s41598-022-22123-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-022-22123-1</ArticleId><ArticleId IdType=\"pmc\">PMC9585050</ArticleId><ArticleId IdType=\"pubmed\">36266389</ArticleId></ArticleIdList></Reference><Reference><Citation>Avin K.G., Coen P.M., Huang W., Stolz D.B., Sowa G.A., Dub&#xe9; J.J., Goodpaster B.H., O&#x2019;Doherty R.M., Ambrosio F. Skeletal muscle as a regulator of the longevity protein, Klotho. Front. Physiol. 2014;5:189. doi: 10.3389/fphys.2014.00189.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2014.00189</ArticleId><ArticleId IdType=\"pmc\">PMC4060456</ArticleId><ArticleId IdType=\"pubmed\">24987372</ArticleId></ArticleIdList></Reference><Reference><Citation>Arroyo E., Leber C.A., Burney H.N., Narayanan G., Moorthi R., Avin K.G., Warden S.J., Moe S.M., Lim K. Relationship between klotho and physical function in healthy aging. Sci. Rep. 2023;13:21158. doi: 10.1038/s41598-023-47791-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-023-47791-5</ArticleId><ArticleId IdType=\"pmc\">PMC10689840</ArticleId><ArticleId IdType=\"pubmed\">38036596</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Mao Y., Lu M., Liu X., Sun Y., Li Z., Li Y., Ding Y., Zhang J., Hong J., et al. Association between serum Klotho levels and the prevalence of diabetes among adults in the United States. Front. Endocrinol. 2022;13:1005553. doi: 10.3389/fendo.2022.1005553.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2022.1005553</ArticleId><ArticleId IdType=\"pmc\">PMC9681912</ArticleId><ArticleId IdType=\"pubmed\">36440221</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan S., Luo W., Lei L., Zhang Q., Xiu J. Association between serum Klotho concentration and hyperlipidemia in adults: A cross-sectional study from NHANES 2007&#x2013;2016. Front. Endocrinol. 2023;14:1280873. doi: 10.3389/fendo.2023.1280873.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2023.1280873</ArticleId><ArticleId IdType=\"pmc\">PMC10668332</ArticleId><ArticleId IdType=\"pubmed\">38027194</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi J., Zheng M., Li K., Sun S., Zhang Z., Yan N., Li X. Relationships of serum FGF23 and alpha-klotho with atherosclerosis in patients with type 2 diabetes mellitus. Cardiovasc. Diabetol. 2024;23:128. doi: 10.1186/s12933-024-02205-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12933-024-02205-2</ArticleId><ArticleId IdType=\"pmc\">PMC11020347</ArticleId><ArticleId IdType=\"pubmed\">38622690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadier K., Liu P., Dilixiati D., Peng X., Ainiwaer A., Kadier D., Lu J., Liu X., Ainiwan M., Wang Q., et al. Maintaining ideal cardiovascular health is associated with higher serum anti-aging protein klotho in the middle-aged and older populations. J. Nutr. Health Aging. 2024;28:100224. doi: 10.1016/j.jnha.2024.100224.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jnha.2024.100224</ArticleId><ArticleId IdType=\"pubmed\">38582034</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang H., Liu Q., Long S., Wu Y., Wang N., Lin W., Chen G., Lin M., Wen J. Klotho exerts protection in chronic kidney disease associated with regulating inflammatory response and lipid metabolism. Cell Biosci. 2024;14:46. doi: 10.1186/s13578-024-01226-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13578-024-01226-4</ArticleId><ArticleId IdType=\"pmc\">PMC11000353</ArticleId><ArticleId IdType=\"pubmed\">38584258</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H., Zheng Z., Hu H., Sun C. Serum klotho levels and mortality patterns in frail individuals: Unraveling the u-shaped association. Aging Clin. Exp. Res. 2024;36:92. doi: 10.1007/s40520-024-02730-w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40520-024-02730-w</ArticleId><ArticleId IdType=\"pmc\">PMC11008069</ArticleId><ArticleId IdType=\"pubmed\">38602574</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Ma Y., Wang Y., Jin M., Bin J., Chen Z., Teng Z., Yang Z., Ma Y., Wang Y., et al. The prognostic value of serum alpha-klotho in age-related diseases among the US population: A prospective population-based cohort study. Prev. Med. Rep. 2024;42:102730. doi: 10.1016/j.pmedr.2024.102730.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pmedr.2024.102730</ArticleId><ArticleId IdType=\"pmc\">PMC11059319</ArticleId><ArticleId IdType=\"pubmed\">38689889</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Yin X., Zhao Y., Chen H., Tan T., Yao P., Tang Y. Biological ageing and the risks of all-cause and cause-specific mortality among people with diabetes: A prospective cohort study. J. Epidemiol. Community Health. 2022;76:771&#x2013;778. doi: 10.1136/jech-2022-219142.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jech-2022-219142</ArticleId><ArticleId IdType=\"pubmed\">35738895</ArticleId></ArticleIdList></Reference><Reference><Citation>Neyra J.A., Moe O.W., Pastor J., Gianella F., Sidhu S.S., Sarnak M.J., Ix J.H., Drew D.A. Performance of soluble Klotho assays in clinical samples of kidney disease. Clin. Kidney J. 2020;13:235&#x2013;244. doi: 10.1093/ckj/sfz085.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ckj/sfz085</ArticleId><ArticleId IdType=\"pmc\">PMC7147321</ArticleId><ArticleId IdType=\"pubmed\">32297879</ArticleId></ArticleIdList></Reference><Reference><Citation>Mencke R., Olauson H., Hillebrands J.L. Effects of Klotho on fibrosis and cancer: A renal focus on mechanisms and therapeutic strategies. Adv. Drug Deliv. Rev. 2017;121:85&#x2013;100. doi: 10.1016/j.addr.2017.07.009.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.addr.2017.07.009</ArticleId><ArticleId IdType=\"pubmed\">28709936</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownstein C.A., Adler F., Nelson-Williams C., Iijima J., Li P., Imura A., Nabeshima Y.-I., Reyes-Mugica M., Carpenter T.O., Lifton R.P. A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc. Natl. Acad. Sci. USA. 2008;105:3455&#x2013;3460. doi: 10.1073/pnas.0712361105.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0712361105</ArticleId><ArticleId IdType=\"pmc\">PMC2265125</ArticleId><ArticleId IdType=\"pubmed\">18308935</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquette J.-S., Rh&#xe9;aume C., Cordeau P., Moulin J.-A., Audet-Walsh E., Blanchette V., Drouin-Chartier J.-P., Toi A.-K., Tremblay A. The Longevity Protein Klotho: A Promising Tool to Monitor Lifestyle Improvements. Metabolites. 2023;13:1157. doi: 10.3390/metabo13111157.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/metabo13111157</ArticleId><ArticleId IdType=\"pmc\">PMC10673288</ArticleId><ArticleId IdType=\"pubmed\">37999253</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">39272160</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Print\">2045-3701</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Cell &amp; bioscience</Title><ISOAbbreviation>Cell Biosci</ISOAbbreviation></Journal><ArticleTitle>Sex-specific hypothalamic neuropathology and glucose metabolism in an amyloidosis transgenic mouse model of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>120</StartPage><MedlinePgn>120</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">120</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s13578-024-01295-5</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Amyloid toxicity and glucose metabolic disorders are key pathological features during the progression of Alzheimer's disease (AD). While the hypothalamus plays a crucial role in regulating systemic energy balance, the distribution of amyloid plaques in the preoptic, anterior, tuberal, and mammillary regions of the hypothalamus in AD mice, particularly across both sexes, remains largely unclear. Our ongoing research aims to explore hypothalamic neuropathology and glucose metabolic disturbances in a well-described APP/PS1 mouse model of AD.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Immunocytochemical staining revealed that Old-AD-Female mice exhibited a greater hypothalamic Amyloid &#x3b2; (A&#x3b2;) burden than their Old-AD-Male counterparts, with the mammillary bodies showing the most severe accumulation. Analysis of ionized calcium binding adaptor molecule 1 (IBA1) immunoreactivity and Iba1 mRNA indicated differential microgliosis based on sex, while tanycytic territory and ZO-1 tight junction protein expression remained stable in AD mice. Moreover, sex-specific peripheral glucose metabolic parameters (random and fasting blood glucose) seemed to be exacerbated by age. Old AD mice of both sexes exhibited limited hypothalamic activation (c-Fos&#x2009;+&#x2009;cells) in response to blood glucose fluctuations. Hypothalamic Glut 1 expression decreased in young but increased in old female AD mice compared with age-matched male AD mice. Pearson correlation analysis further supported a negative correlation between hypothalamic A&#x3b2; load and random blood glucose in old AD groups of both genders, shedding light on the mechanisms underlying this amyloidosis mouse model.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">Aged APP/PS1 mice exhibit sex-specific hypothalamic neuropathology and differential glucose metabolism, highlighting distinct pathological mechanisms within each gender.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Qi</LastName><ForeName>Guibo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Tang</LastName><ForeName>Han</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gong</LastName><ForeName>Pifang</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Yitong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>He</LastName><ForeName>Chenzhao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hu</LastName><ForeName>Jianian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kang</LastName><ForeName>Siying</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chen</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China. liangchen@fudan.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qin</LastName><ForeName>Song</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0002-5569-4324</Identifier><AffiliationInfo><Affiliation>Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China. sqin@fudan.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200032, China. sqin@fudan.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>31871477</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>32170971</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>81528006</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>18ZR1403800</GrantID><Agency>Natural Science Foundation of Shanghai</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Biosci</MedlineTA><NlmUniqueID>101561195</NlmUniqueID><ISSNLinking>2045-3701</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Amyloid plaque</Keyword><Keyword MajorTopicYN=\"N\">Gliosis</Keyword><Keyword MajorTopicYN=\"N\">Glucose metabolism</Keyword><Keyword MajorTopicYN=\"N\">Hypothalamus</Keyword><Keyword MajorTopicYN=\"N\">Neuropathology</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39272160</ArticleId><ArticleId IdType=\"doi\">10.1186/s13578-024-01295-5</ArticleId><ArticleId IdType=\"pii\">10.1186/s13578-024-01295-5</ArticleId><ArticleId IdType=\"pmc\">PMC11395863</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312&#x2013;39. 10.1016/j.cell.2019.09.001</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2019.09.001</ArticleId><ArticleId IdType=\"pmc\">PMC6778042</ArticleId><ArticleId IdType=\"pubmed\">31564456</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Amieva H, Petersen RC, Chetelat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT. Alzheimer disease. Nat Rev Dis Primers. 2021;7(1):33. 10.1038/s41572-021-00269-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41572-021-00269-y</ArticleId><ArticleId IdType=\"pmc\">PMC8574196</ArticleId><ArticleId IdType=\"pubmed\">33986301</ArticleId></ArticleIdList></Reference><Reference><Citation>Usenovic M, Niroomand S, Drolet RE, Yao L, Gaspar RC, Hatcher NG, Schachter J, Renger JJ, Parmentier-Batteur S. Internalized tau oligomers cause neurodegeneration by inducing accumulation of pathogenic tau in human neurons derived from induced pluripotent stem cells. J Neurosci. 2015;35(42):14234&#x2013;50. 10.1523/JNEUROSCI.1523-15.2015</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1523-15.2015</ArticleId><ArticleId IdType=\"pmc\">PMC6605424</ArticleId><ArticleId IdType=\"pubmed\">26490863</ArticleId></ArticleIdList></Reference><Reference><Citation>Finder VH, Glockshuber R. Amyloid-beta aggregation. Neurodegener Dis. 2007;4(1):13&#x2013;27. 10.1159/000100355</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000100355</ArticleId><ArticleId IdType=\"pubmed\">17429215</ArticleId></ArticleIdList></Reference><Reference><Citation>Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and down syndrome. Proc Natl Acad Sci U S A. 1985;82(12):4245&#x2013;9. 10.1073/pnas.82.12.4245</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.82.12.4245</ArticleId><ArticleId IdType=\"pmc\">PMC397973</ArticleId><ArticleId IdType=\"pubmed\">3159021</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer&#x2019;s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129&#x2013;40. 10.1523/JNEUROSCI.1202-06.2006</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1202-06.2006</ArticleId><ArticleId IdType=\"pmc\">PMC6674618</ArticleId><ArticleId IdType=\"pubmed\">17021169</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong H, Zheng J, Kurrasch D. The structural and functional complexity of the integrative hypothalamus. Science. 2023;382(6669):388&#x2013;94. 10.1126/science.adh8488</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.adh8488</ArticleId><ArticleId IdType=\"pubmed\">37883552</ArticleId></ArticleIdList></Reference><Reference><Citation>2023 Alzheimer's Disease Facts and Figures. Alzheimers Dement. 2023;19(4):1598&#x2013;1695.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36918389</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancy NN, Smith AM, Caramello A, Tsartsalis S, Davey K, Muirhead RCJ, McGarry A, Jenkyns MH, Schneegans E, Chau V, et al. Characterisation of premature cell senescence in Alzheimer&#x2019;s disease using single nuclear transcriptomics. Acta Neuropathol. 2024;147(1):78. 10.1007/s00401-024-02727-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-024-02727-9</ArticleId><ArticleId IdType=\"pmc\">PMC11065703</ArticleId><ArticleId IdType=\"pubmed\">38695952</ArticleId></ArticleIdList></Reference><Reference><Citation>Henningfield CM, Soni N, Lee RW, Sharma R, Cleland JL, Green KN. Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer&#x2019;s disease mouse model. Alzheimers Res Ther. 2024;16(1):101. 10.1186/s13195-024-01470-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-024-01470-3</ArticleId><ArticleId IdType=\"pmc\">PMC11071231</ArticleId><ArticleId IdType=\"pubmed\">38711159</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan RY, He L, Zhang J, Liu X, Liao Y, Gao J, Liao Y, Yan Y, Li Q, Zhou X, et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer&#x2019;s disease. Cell Metab. 2022;34(4):634-648 e636. 10.1016/j.cmet.2022.02.013</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2022.02.013</ArticleId><ArticleId IdType=\"pubmed\">35303422</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontana IC, Kumar A, Nordberg A. The role of astrocytic alpha7 nicotinic acetylcholine receptors in Alzheimer disease. Nat Rev Neurol. 2023;19(5):278&#x2013;88. 10.1038/s41582-023-00792-4</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41582-023-00792-4</ArticleId><ArticleId IdType=\"pubmed\">36977843</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Caceres C, Balland E, Prevot V, Luquet S, Woods SC, Koch M, Horvath TL, Yi CX, Chowen JA, Verkhratsky A, et al. Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism. Nat Neurosci. 2019;22(1):7&#x2013;14. 10.1038/s41593-018-0286-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41593-018-0286-y</ArticleId><ArticleId IdType=\"pubmed\">30531847</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullier A, Bouret SG, Prevot V, Dehouck B. Differential distribution of tight junction proteins suggests a role for tanycytes in blood-hypothalamus barrier regulation in the adult mouse brain. J Comp Neurol. 2010;518(7):943&#x2013;62. 10.1002/cne.22273</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cne.22273</ArticleId><ArticleId IdType=\"pmc\">PMC2892518</ArticleId><ArticleId IdType=\"pubmed\">20127760</ArticleId></ArticleIdList></Reference><Reference><Citation>Langlet F, Levin BE, Luquet S, Mazzone M, Messina A, Dunn-Meynell AA, Balland E, Lacombe A, Mazur D, Carmeliet P, et al. Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting. Cell Metab. 2013;17(4):607&#x2013;17. 10.1016/j.cmet.2013.03.004</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2013.03.004</ArticleId><ArticleId IdType=\"pmc\">PMC3695242</ArticleId><ArticleId IdType=\"pubmed\">23562080</ArticleId></ArticleIdList></Reference><Reference><Citation>Jais A, Bruning JC. Arcuate nucleus-dependent regulation of metabolism-pathways to obesity and diabetes mellitus. Endocr Rev. 2022;43(2):314&#x2013;28. 10.1210/endrev/bnab025</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1210/endrev/bnab025</ArticleId><ArticleId IdType=\"pmc\">PMC8905335</ArticleId><ArticleId IdType=\"pubmed\">34490882</ArticleId></ArticleIdList></Reference><Reference><Citation>Duquenne M, Folgueira C, Bourouh C, Millet M, Silva A, Clasadonte J, Imbernon M, Fernandois D, Martinez-Corral I, Kusumakshi S, et al. Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function. Nat Metab. 2021;3(8):1071&#x2013;90. 10.1038/s42255-021-00432-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s42255-021-00432-5</ArticleId><ArticleId IdType=\"pmc\">PMC7611554</ArticleId><ArticleId IdType=\"pubmed\">34341568</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo S, Cha D, Kim S, Jiang L, Cooke P, Adebesin M, Wolfe A, Riddle R, Aja S, Blackshaw S. Tanycyte ablation in the arcuate nucleus and median eminence increases obesity susceptibility by increasing body fat content in male mice. Glia. 2020;68(10):1987&#x2013;2000. 10.1002/glia.23817</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/glia.23817</ArticleId><ArticleId IdType=\"pmc\">PMC7423758</ArticleId><ArticleId IdType=\"pubmed\">32173924</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu WH, Li S, Xu JK, Guo XZ, Wu HD, Chen ZH, Qiao LY, Helfer G, Lu FL, Liu C, et al. Hypothalamic Rax(+) tanycytes contribute to tissue repair and tumorigenesis upon oncogene activation in mice. Nat Commun. 2021. 10.1038/s41467-021-22640-z. 10.1038/s41467-021-22640-z</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-021-22640-z</ArticleId><ArticleId IdType=\"pmc\">PMC8052410</ArticleId><ArticleId IdType=\"pubmed\">33863883</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Wang W, Chen HL, Zhang HY, Zhang NX. Interplay between Alzheimer&#x2019;s disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP/PS1 transgenic mice. Acta Pharmacol Sin. 2019;40(10):1259&#x2013;68. 10.1038/s41401-019-0239-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41401-019-0239-3</ArticleId><ArticleId IdType=\"pmc\">PMC6786352</ArticleId><ArticleId IdType=\"pubmed\">31089202</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight EM, Ruiz HH, Kim SH, Harte JC, Hsieh W, Glabe C, Klein WL, Attie AD, Buettner C, Ehrlich ME, et al. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer&#x2019;s APP/PSEN1 mice by gene targeting of diabetes/Alzheimer&#x2019;s-related Sorcs1. Acta Neuropathol Commun. 2016;4:16. 10.1186/s40478-016-0282-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-016-0282-y</ArticleId><ArticleId IdType=\"pmc\">PMC4766719</ArticleId><ArticleId IdType=\"pubmed\">26916443</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Zhou Q, Du Y, Li C, Xu PT, Lin L, Xiao J, Gao HC. The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer&#x2019;s disease. Bba-Mol Basis Dis. 2018;1864(1):263&#x2013;73.10.1016/j.bbadis.2017.10.028</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2017.10.028</ArticleId><ArticleId IdType=\"pubmed\">29107091</ArticleId></ArticleIdList></Reference><Reference><Citation>Robison LS, Gannon OJ, Salinero AE, Abi-Ghanem C, Kelly RD, Riccio DA, Mansour FM, Zuloaga KL. Sex differences in metabolic phenotype and hypothalamic inflammation in the 3xTg-AD mouse model of Alzheimer&#x2019;s disease. Biol Sex Differ. 2023;14(1):51. 10.1186/s13293-023-00536-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13293-023-00536-5</ArticleId><ArticleId IdType=\"pmc\">PMC10410820</ArticleId><ArticleId IdType=\"pubmed\">37559092</ArticleId></ArticleIdList></Reference><Reference><Citation>Freire-Regatillo A, Diaz-Pacheco S, Frago LM, Arevalo MA, Argente J, Garcia-Segura LM, de Ceballos ML, Chowen JA. Sex differences in hypothalamic changes and the metabolic response of TgAPP mice to a high fat diet. Front Neuroanat. 2022;16:910477. 10.3389/fnana.2022.910477</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnana.2022.910477</ArticleId><ArticleId IdType=\"pmc\">PMC9361789</ArticleId><ArticleId IdType=\"pubmed\">35958733</ArticleId></ArticleIdList></Reference><Reference><Citation>Robison LS, Gannon OJ, Thomas MA, Salinero AE, Abi-Ghanem C, Poitelon Y, Belin S, Zuloaga KL. Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer&#x2019;s disease. J Neuroinflammation. 2020;17(1):285. 10.1186/s12974-020-01956-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-020-01956-5</ArticleId><ArticleId IdType=\"pmc\">PMC7526387</ArticleId><ArticleId IdType=\"pubmed\">32993686</ArticleId></ArticleIdList></Reference><Reference><Citation>Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, Jaggi F, Wolburg H, Gengler S, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 2006;7(9):940&#x2013;6. 10.1038/sj.embor.7400784</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.embor.7400784</ArticleId><ArticleId IdType=\"pmc\">PMC1559665</ArticleId><ArticleId IdType=\"pubmed\">16906128</ArticleId></ArticleIdList></Reference><Reference><Citation>Li KY, Gong PF, Li JT, Xu NJ, Qin S. Morphological and molecular alterations of reactive astrocytes without proliferation in cerebral cortex of an APP/PS1 transgenic mouse model and Alzheimer&#x2019;s patients. Glia. 2020;68(11):2361&#x2013;76. 10.1002/glia.23845</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/glia.23845</ArticleId><ArticleId IdType=\"pubmed\">32469469</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong W, Gong P, Pan X, Liu Y, Qi G, Qi C, Qin S. Kruppel-like factor 7 deficiency disrupts corpus callosum development and neuronal migration in the developing mouse cerebral cortex. Brain Pathol. 2023;33(5): e13186. 10.1111/bpa.13186</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/bpa.13186</ArticleId><ArticleId IdType=\"pmc\">PMC10467035</ArticleId><ArticleId IdType=\"pubmed\">37401095</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon CH, Wong STN, Roy J, Wang Y, Chan HWH, Steinbusch H, Blokland A, Temel Y, Aquili L, Lim LW. Sex differences between neuronal loss and the early onset of amyloid deposits and behavioral consequences in 5xFAD transgenic mouse as a model for Alzheimer&#x2019;s disease. Cells-Basel. 2023;12(5):780.10.3390/cells12050780</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells12050780</ArticleId><ArticleId IdType=\"pmc\">PMC10000751</ArticleId><ArticleId IdType=\"pubmed\">36899916</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachmian N, Medina S, Cherqui U, Akiva H, Deitch D, Edilbi D, Croese T, Salame TM, Ramos JMP, Cahalon L, et al. Identification of senescent, TREM2-expressing microglia in aging and Alzheimer&#x2019;s disease model mouse brain. Nat Neurosci. 2024;5:335.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38637622</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gambero AJ, Martinez F, Salazar K, Cifuentes M, Nualart F. Brain glucose-sensing mechanism and energy homeostasis. Mol Neurobiol. 2019;56(2):769&#x2013;96. 10.1007/s12035-018-1099-4</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-018-1099-4</ArticleId><ArticleId IdType=\"pubmed\">29796992</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquettaz R, Kolotuev I, Rohrbach A, Gouelle C, Pellerin L, Langlet F. Peculiar protrusions along tanycyte processes face diverse neural and nonneural cell types in the hypothalamic parenchyma. J Compa Neurol. 2021;529(3):553&#x2013;75.10.1002/cne.24965</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cne.24965</ArticleId><ArticleId IdType=\"pmc\">PMC7818493</ArticleId><ArticleId IdType=\"pubmed\">32515035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lochhead JJ, Yang J, Ronaldson PT, Davis TP. Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders. Front Physiol. 2020;11:914. 10.3389/fphys.2020.00914</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphys.2020.00914</ArticleId><ArticleId IdType=\"pmc\">PMC7424030</ArticleId><ArticleId IdType=\"pubmed\">32848858</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Gu BJ, Masters CL, Wang YJ. A systemic view of Alzheimer disease&#x2014;insights from amyloid-beta metabolism beyond the brain. Nat Rev Neurol. 2017;13(11):703. 10.1038/nrneurol.2017.147</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrneurol.2017.147</ArticleId><ArticleId IdType=\"pubmed\">29027541</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S, Kong P, Nelson AR, et al. GLUT1 reductions exacerbate Alzheimer&#x2019;s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci. 2015;18(4):521&#x2013;30. 10.1038/nn.3966</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nn.3966</ArticleId><ArticleId IdType=\"pmc\">PMC4734893</ArticleId><ArticleId IdType=\"pubmed\">25730668</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W, Tan C, Mo L, Jiang J, Zhou W, Du J, Zhou X, Liu X, Chen L. Glucose transporter 3 in neuronal glucose metabolism: health and diseases. Metabolism. 2021;123:154869. 10.1016/j.metabol.2021.154869</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.metabol.2021.154869</ArticleId><ArticleId IdType=\"pubmed\">34425073</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon CH, Wang Y, Fung ML, Zhang C, Lim LW. Rodent models of amyloid-beta feature of Alzheimer&#x2019;s disease: development and potential treatment implications. Aging Dis. 2020;11(5):1235&#x2013;59. 10.14336/AD.2019.1026</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14336/AD.2019.1026</ArticleId><ArticleId IdType=\"pmc\">PMC7505263</ArticleId><ArticleId IdType=\"pubmed\">33014535</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrero L, Antequera D, Alcalde I, Megias D, Figueiro-Silva J, Merayo-Lloves J, Municio C, Carro E. Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer&#x2019;s disease. Acta Neuropathol Commun. 2023;11(1):55. 10.1186/s40478-023-01529-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-023-01529-6</ArticleId><ArticleId IdType=\"pmc\">PMC10067208</ArticleId><ArticleId IdType=\"pubmed\">37004084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsui KC, Roy J, Chau SC, Wong KH, Shi L, Poon CH, Wang Y, Strekalova T, Aquili L, Chang RC, et al. Distribution and inter-regional relationship of amyloid-beta plaque deposition in a 5xFAD mouse model of Alzheimer&#x2019;s disease. Front Aging Neurosci. 2022;14:964336. 10.3389/fnagi.2022.964336</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.964336</ArticleId><ArticleId IdType=\"pmc\">PMC9371463</ArticleId><ArticleId IdType=\"pubmed\">35966777</ArticleId></ArticleIdList></Reference><Reference><Citation>Senova S, Fomenko A, Gondard E, Lozano AM. Anatomy and function of the fornix in the context of its potential as a therapeutic target. J Neurol Neurosurg Psychiatry. 2020;91(5):547&#x2013;59. 10.1136/jnnp-2019-322375</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jnnp-2019-322375</ArticleId><ArticleId IdType=\"pmc\">PMC7231447</ArticleId><ArticleId IdType=\"pubmed\">32132227</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Zhang C, Rao Y, Yuan TF. Deep brain stimulation of fornix for memory improvement in Alzheimer&#x2019;s disease: a critical review. Ageing Res Rev. 2022;79:101668. 10.1016/j.arr.2022.101668</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2022.101668</ArticleId><ArticleId IdType=\"pubmed\">35705176</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Herrera R, Contreras A, Djebari S, Mulero-Franco J, Iborra-Lazaro G, Jeremic D, Navarro-Lopez J, Jimenez-Diaz L. Systematic characterization of a non-transgenic Abeta(1&#x2013;42) amyloidosis model: synaptic plasticity and memory deficits in female and male mice. Biol Sex Differ. 2023;14(1):59. 10.1186/s13293-023-00545-4</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13293-023-00545-4</ArticleId><ArticleId IdType=\"pmc\">PMC10504764</ArticleId><ArticleId IdType=\"pubmed\">37716988</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauty B, Durrleman S. Impact of sex and APOE-epsilon4 genotype on patterns of regional brain atrophy in Alzheimer&#x2019;s disease and healthy aging. Front Neurol. 2023;14:1161527. 10.3389/fneur.2023.1161527</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2023.1161527</ArticleId><ArticleId IdType=\"pmc\">PMC10272760</ArticleId><ArticleId IdType=\"pubmed\">37333001</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JT, Wang ZJ, Cai HY, Yuan L, Hu MM, Wu MN, Qi JS. Sex differences in neuropathology and cognitive behavior in APP/PS1/tau triple-transgenic mouse model of Alzheimer&#x2019;s disease. Neurosci Bull. 2018;34(5):736&#x2013;46. 10.1007/s12264-018-0268-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12264-018-0268-9</ArticleId><ArticleId IdType=\"pmc\">PMC6129237</ArticleId><ArticleId IdType=\"pubmed\">30099679</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper DG, Stopa EG, Kuo-Leblanc V, McKee AC, Asayama K, Volicer L, Kowall N, Satlin A. Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. Brain. 2008;131(Pt 6):1609&#x2013;17. 10.1093/brain/awn049</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awn049</ArticleId><ArticleId IdType=\"pmc\">PMC3286014</ArticleId><ArticleId IdType=\"pubmed\">18372313</ArticleId></ArticleIdList></Reference><Reference><Citation>Fronczek R, van Geest S, Frolich M, Overeem S, Roelandse FW, Lammers GJ, Swaab DF. Hypocretin (orexin) loss in Alzheimer&#x2019;s disease. Neurobiol Aging. 2012;33(8):1642&#x2013;50. 10.1016/j.neurobiolaging.2011.03.014</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2011.03.014</ArticleId><ArticleId IdType=\"pubmed\">21546124</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloyannis SJ, Mavroudis I, Baloyannis IS, Costa VG. Mammillary bodies in Alzheimer&#x2019;s disease: a golgi and electron microscope study. Am J Alzheimers Dis Other Demen. 2016;31(3):247&#x2013;56. 10.1177/1533317515602548</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1533317515602548</ArticleId><ArticleId IdType=\"pmc\">PMC10852917</ArticleId><ArticleId IdType=\"pubmed\">26399484</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloyannis SJ, Mavroudis I, Mitilineos D, Baloyannis IS, Costa VG. The hypothalamus in Alzheimer&#x2019;s disease: a golgi and electron microscope study. Am J Alzheimers Dis Other Demen. 2015;30(5):478&#x2013;87. 10.1177/1533317514556876</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1533317514556876</ArticleId><ArticleId IdType=\"pmc\">PMC10852817</ArticleId><ArticleId IdType=\"pubmed\">25380804</ArticleId></ArticleIdList></Reference><Reference><Citation>Trujillo-Estrada L, Davila JC, Sanchez-Mejias E, Sanchez-Varo R, Gomez-Arboledas A, Vizuete M, Vitorica J, Gutierrez A. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-beta accumulation in AbetaPP/PS1 Alzheimer&#x2019;s disease mice subiculum. J Alzheimers Dis. 2014;42(2):521&#x2013;41. 10.3233/JAD-140495</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-140495</ArticleId><ArticleId IdType=\"pubmed\">24927710</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Yang DS, Goulbourne CN, Im E, Stavrides P, Pensalfini A, Chan H, Bouchet-Marquis C, Bleiwas C, Berg MJ, et al. Faulty autolysosome acidification in Alzheimer&#x2019;s disease mouse models induces autophagic build-up of Abeta in neurons, yielding senile plaques. Nat Neurosci. 2022;25(6):688&#x2013;701. 10.1038/s41593-022-01084-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41593-022-01084-8</ArticleId><ArticleId IdType=\"pmc\">PMC9174056</ArticleId><ArticleId IdType=\"pubmed\">35654956</ArticleId></ArticleIdList></Reference><Reference><Citation>Uddin MS, Lim LW. Glial cells in Alzheimer&#x2019;s disease: from neuropathological changes to therapeutic implications. Ageing Res Rev. 2022;78:101622. 10.1016/j.arr.2022.101622</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2022.101622</ArticleId><ArticleId IdType=\"pubmed\">35427810</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Wu N, Wang S, Yao Z, Xiao F, Lu J, Chen B. Neuronal loss and microgliosis are restricted to the core of Abeta deposits in mouse models of Alzheimer&#x2019;s disease. Aging Cell. 2021;20(6): e13380. 10.1111/acel.13380</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/acel.13380</ArticleId><ArticleId IdType=\"pmc\">PMC8208784</ArticleId><ArticleId IdType=\"pubmed\">34080759</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Pavlou S, Du X, Bhuckory M, Xu H, Chen M. Glucose transporter 1 critically controls microglial activation through facilitating glycolysis. Mol Neurodegener. 2019;14(1):2. 10.1186/s13024-019-0305-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-019-0305-9</ArticleId><ArticleId IdType=\"pmc\">PMC6329071</ArticleId><ArticleId IdType=\"pubmed\">30634998</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Wu Y, Tian Y, Hu H, Zhao Y, Xue B, Sun Z, Wei A, Xie F, Qian LJ. GLUT1-mediated microglial proinflammatory activation contributes to the development of stress-induced spatial learning and memory dysfunction in mice. Cell Biosci. 2024;14(1):48. 10.1186/s13578-024-01229-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13578-024-01229-1</ArticleId><ArticleId IdType=\"pmc\">PMC11020476</ArticleId><ArticleId IdType=\"pubmed\">38627830</ArticleId></ArticleIdList></Reference><Reference><Citation>Raikwar SP, Bhagavan SM, Ramaswamy SB, Thangavel R, Dubova I, Selvakumar GP, Ahmed ME, Kempuraj D, Zaheer S, Iyer S, et al. Are tanycytes the missing link between type 2 diabetes and Alzheimer&#x2019;s disease? Mol Neurobiol. 2019;56(2):833&#x2013;43. 10.1007/s12035-018-1123-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-018-1123-8</ArticleId><ArticleId IdType=\"pmc\">PMC6344308</ArticleId><ArticleId IdType=\"pubmed\">29797185</ArticleId></ArticleIdList></Reference><Reference><Citation>Raikwar SP, Thangavel R, Dubova I, Ahmed ME, Selvakumar GP, Kempuraj D, Zaheer S, Iyer S, Zaheer A. Neuro-immuno-gene-and genome-editing-therapy for Alzheimer&#x2019;s disease: are we there yet? J Alzheimers Dis. 2018;65(2):321&#x2013;44. 10.3233/JAD-180422</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-180422</ArticleId><ArticleId IdType=\"pmc\">PMC6130335</ArticleId><ArticleId IdType=\"pubmed\">30040732</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez E, Guerra M, Peruzzo B, Blazquez JL. Tanycytes: a rich morphological history to underpin future molecular and physiological investigations. J Neuroendocrinol. 2019. 10.1111/jne.12690. 10.1111/jne.12690</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jne.12690</ArticleId><ArticleId IdType=\"pubmed\">30697830</ArticleId></ArticleIdList></Reference><Reference><Citation>Benevento M, Alpar A, Gundacker A, Afjehi L, Balueva K, Hevesi Z, Hanics J, Rehman S, Pollak DD, Lubec G, et al. A brainstem-hypothalamus neuronal circuit reduces feeding upon heat exposure. Nature. 2024;628(8009):826&#x2013;34. 10.1038/s41586-024-07232-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-024-07232-3</ArticleId><ArticleId IdType=\"pmc\">PMC11041654</ArticleId><ArticleId IdType=\"pubmed\">38538787</ArticleId></ArticleIdList></Reference><Reference><Citation>Imbernon M, Saponaro C, Helms HCC, Duquenne M, Fernandois D, Deligia E, Denis RGP, Chao DHM, Rasika S, Staels B, et al. Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions. Cell Metab. 2022;34(7):1054-1063 e1057. 10.1016/j.cmet.2022.06.002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2022.06.002</ArticleId><ArticleId IdType=\"pmc\">PMC7613793</ArticleId><ArticleId IdType=\"pubmed\">35716660</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolborea M, Pollatzek E, Benford H, Sotelo-Hitschfeld T, Dale N. Hypothalamic tanycytes generate acute hyperphagia through activation of the arcuate neuronal network. Proc Natl Acad Sci U S A. 2020;117(25):14473&#x2013;81. 10.1073/pnas.1919887117</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1919887117</ArticleId><ArticleId IdType=\"pmc\">PMC7322081</ArticleId><ArticleId IdType=\"pubmed\">32513737</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrbach A, Caron E, Dali R, Brunner M, Pasquettaz R, Kolotuev I, Santoni F, Thorens B, Langlet F. Ablation of glucokinase-expressing tanycytes impacts energy balance and increases adiposity in mice. Mol Metab. 2021;53:101311. 10.1016/j.molmet.2021.101311</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.molmet.2021.101311</ArticleId><ArticleId IdType=\"pmc\">PMC8379510</ArticleId><ArticleId IdType=\"pubmed\">34325016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan AI, Potthoff MJ, Flippo KH. Tany-Seq: integrated analysis of the mouse tanycyte transcriptome. Cells-Basel. 2022;11(9):1565.10.3390/cells11091565</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells11091565</ArticleId><ArticleId IdType=\"pmc\">PMC9104898</ArticleId><ArticleId IdType=\"pubmed\">35563871</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Q, Gamayun I, Wartenberg P, Zhang Q, Qiao S, Kusumakshi S, Candlish S, Gotz V, Wen S, Das D, et al. Bitter taste cells in the ventricular walls of the murine brain regulate glucose homeostasis. Nat Commun. 2023;14(1):1588. 10.1038/s41467-023-37099-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-023-37099-3</ArticleId><ArticleId IdType=\"pmc\">PMC10033832</ArticleId><ArticleId IdType=\"pubmed\">36949050</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan X, Nasaruddin MB, Elliott CT, McGuinness B, Passmore AP, Kehoe PG, Holscher C, McClean PL, Graham SF, Green BD. Alzheimer&#x2019;s disease-like pathology has transient effects on the brain and blood metabolome. Neurobiol Aging. 2016;38:151&#x2013;63. 10.1016/j.neurobiolaging.2015.11.014</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2015.11.014</ArticleId><ArticleId IdType=\"pubmed\">26827653</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii M, Iadecola C. Metabolic and non-cognitive manifestations of Alzheimer&#x2019;s disease: the hypothalamus as both culprit and target of pathology. Cell Metab. 2015;22(5):761&#x2013;76. 10.1016/j.cmet.2015.08.016</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2015.08.016</ArticleId><ArticleId IdType=\"pmc\">PMC4654127</ArticleId><ArticleId IdType=\"pubmed\">26365177</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo DC, Lee SH, Lee DW, Kim SY, Kim GY, Rhim HS, Choi CB, Kim HY, Lee CU, Choe BY. Regional metabolic alteration of Alzheimer&#x2019;s disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS. Behav Brain Res. 2010;211(1):125&#x2013;31. 10.1016/j.bbr.2010.03.026</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbr.2010.03.026</ArticleId><ArticleId IdType=\"pubmed\">20307581</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Monte SM, Tong M. Brain metabolic dysfunction at the core of Alzheimer&#x2019;s disease. Biochem Pharmacol. 2014;88(4):548&#x2013;59. 10.1016/j.bcp.2013.12.012</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bcp.2013.12.012</ArticleId><ArticleId IdType=\"pmc\">PMC4550323</ArticleId><ArticleId IdType=\"pubmed\">24380887</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gambero AJ, Rosell-Valle C, Medina-Vera D, Navarro JA, Vargas A, Rivera P, Sanjuan C, Rodriguez de Fonseca F, Suarez J. A negative energy balance is associated with metabolic dysfunctions in the hypothalamus of a humanized preclinical model of Alzheimer&#x2019;s disease, the 5XFAD mouse. Int J Mol Sci. 2021;22(10):5365. 10.3390/ijms22105365</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22105365</ArticleId><ArticleId IdType=\"pmc\">PMC8161294</ArticleId><ArticleId IdType=\"pubmed\">34065168</ArticleId></ArticleIdList></Reference><Reference><Citation>Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis. 2002;9(1):61&#x2013;8. 10.1006/nbdi.2001.0460</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/nbdi.2001.0460</ArticleId><ArticleId IdType=\"pubmed\">11848685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz HH, Chi T, Shin AC, Lindtner C, Hsieh W, Ehrlich M, Gandy S, Buettner C. Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer&#x2019;s disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels. Alzheimers Dement. 2016;12(8):851&#x2013;61. 10.1016/j.jalz.2016.01.008</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2016.01.008</ArticleId><ArticleId IdType=\"pmc\">PMC5358328</ArticleId><ArticleId IdType=\"pubmed\">26928090</ArticleId></ArticleIdList></Reference><Reference><Citation>Dockman RL, Carpenter JM, Diaz AN, Benbow RA, Filipov NM. Sex differences in behavior, response to LPS, and glucose homeostasis in middle-aged mice. Behav Brain Res. 2022;418:113628. 10.1016/j.bbr.2021.113628</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbr.2021.113628</ArticleId><ArticleId IdType=\"pmc\">PMC8671369</ArticleId><ArticleId IdType=\"pubmed\">34687827</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza GO, Wasinski F, Donato J Jr. Characterization of the metabolic differences between male and female C57BL/6 mice. Life Sci. 2022;301:120636. 10.1016/j.lfs.2022.120636</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lfs.2022.120636</ArticleId><ArticleId IdType=\"pubmed\">35568227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Gu BJ, Masters CL, Wang YJ. A systemic view of Alzheimer disease&#x2014;insights from amyloid-beta metabolism beyond the brain. Nat Rev Neurol. 2017;13(10):612&#x2013;23. 10.1038/nrneurol.2017.111</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrneurol.2017.111</ArticleId><ArticleId IdType=\"pubmed\">28960209</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary S, Zhornitsky S, Chao HH, van Dyck CH, Li CR. Hypothalamic functional connectivity and apathy in people with Alzheimer&#x2019;s disease and cognitively normal healthy controls. J Alzheimers Dis. 2022;90(4):1615&#x2013;28. 10.3233/JAD-220708</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-220708</ArticleId><ArticleId IdType=\"pmc\">PMC10064487</ArticleId><ArticleId IdType=\"pubmed\">36314209</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39271839</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Electronic\">1546-1696</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>42</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nature biotechnology</Title><ISOAbbreviation>Nat Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Genentech, Sangamo ink Alzheimer's deal.</ArticleTitle><Pagination><StartPage>1328</StartPage><MedlinePgn>1328</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41587-024-02413-x</ELocationID><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016433\">News</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Biotechnol</MedlineTA><NlmUniqueID>9604648</NlmUniqueID><ISSNLinking>1087-0156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D061067\">Antibodies, Monoclonal, Humanized</NameOfSubstance></Chemical><Chemical><RegistryNumber>105J35OE21</RegistryNumber><NameOfSubstance UI=\"C000600266\">aducanumab</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004345\" MajorTopicYN=\"Y\">Drug Industry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D061067\" MajorTopicYN=\"N\">Antibodies, Monoclonal, Humanized</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271839</ArticleId><ArticleId IdType=\"doi\">10.1038/s41587-024-02413-x</ArticleId><ArticleId IdType=\"pii\">10.1038/s41587-024-02413-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">39271821</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2399-3669</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Communications chemistry</Title><ISOAbbreviation>Commun Chem</ISOAbbreviation></Journal><ArticleTitle>Interface potential-induced natural antioxidant mimic system for the treatment of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>206</StartPage><MedlinePgn>206</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">206</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s42004-024-01299-9</ELocationID><Abstract><AbstractText>Although the pathogenesis of Alzheimer's disease (AD) is still unknown, the molecular pathological phenomena is clear, mainly due to mitochondrial dysfunction and central nervous system inflammation caused by imbalanced antioxidant capacity and synaptic dysfunction, so antioxidant therapy is still the preferred treatment for AD. However, although antioxidant enzymes have high catalytic efficiency, the substrate spectrum is narrow; Antioxidants have wider range of effects, but their efficiency is low. Since the antioxidant defense system in high-grade organisms is composed of both enzymatic and non-enzymatic systems, therefore we synthesized a metal-organic framework (MOF) with superoxide dismutase activity, and depending on the interface potential effect, curcumin was loaded to construct a synergistic antioxidant treatment system. More importantly, due to the complementary surface electrostatic potential between MOF and curcumin, the system exhibited both good antioxidant activity and efficient &#x3b2;-amyloid plaque scavenging ability, which slowed down the cognitive dysfunction in the brain of AD mice.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Kangning</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education and Faculty of Chemistry, Northeast Normal University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ding</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education and Faculty of Chemistry, Northeast Normal University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cao</LastName><ForeName>Doudou</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education and Faculty of Chemistry, Northeast Normal University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xi</LastName><ForeName>Enpeng</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education and Faculty of Chemistry, Northeast Normal University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhao</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education and Faculty of Chemistry, Northeast Normal University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gao</LastName><ForeName>Nan</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">0000-0001-7700-1544</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education and Faculty of Chemistry, Northeast Normal University, Changchun, China. gaon320@nenu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Yajie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Automobile Materials of Ministry of Education &amp; School of Materials Science and Engineering, Jilin University, Changchun, China. yangyajie@jlu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yuan</LastName><ForeName>Ye</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education and Faculty of Chemistry, Northeast Normal University, Changchun, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>22131004</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country/></Grant><Grant><GrantID>22077118</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Chem</MedlineTA><NlmUniqueID>101725670</NlmUniqueID><ISSNLinking>2399-3669</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271821</ArticleId><ArticleId IdType=\"doi\">10.1038/s42004-024-01299-9</ArticleId><ArticleId IdType=\"pii\">10.1038/s42004-024-01299-9</ArticleId><ArticleId IdType=\"pmc\">PMC11399259</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xu, H. et al. ADpred: A non-invasive model for three types of dementia and mild cognitive impairment. Innov. Med.1, 100026 (2023).10.59717/j.xinn-med.2023.100026</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.59717/j.xinn-med.2023.100026</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu, W. Y. &amp; Ip, N. Y. The role of genetic risk factors of Alzheimer&#x2019;s disease in synaptic dysfunction. Semin. Cell Dev. Biol.139, 3&#x2013;12 (2023). 10.1016/j.semcdb.2022.07.011</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.semcdb.2022.07.011</ArticleId><ArticleId IdType=\"pubmed\">35918217</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, D. et al. A dual-targeted multifunctional nanoformulation for potential prevention and therapy of Alzheimer&#x2019;s disease. Innovation2, 100160 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8640585</ArticleId><ArticleId IdType=\"pubmed\">34901904</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, Y. et al. Physiological beta-amyloid clearance by the liver and its therapeutic potential for Alzheimer&#x2019;s disease. Acta Neuropathol.145, 717&#x2013;731 (2023). 10.1007/s00401-023-02559-z</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-023-02559-z</ArticleId><ArticleId IdType=\"pubmed\">36964213</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, Y. et al. MiR-539-5p decreases amyloid beta-protein production, hyperphosphorylation of tau and memory impairment by regulating PI3K/Akt/GSK-3beta pathways in APP/PS1 double transgenic mice. Neurotox. Res.38, 524&#x2013;535 (2020). 10.1007/s12640-020-00217-w</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12640-020-00217-w</ArticleId><ArticleId IdType=\"pubmed\">32415525</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliandolo, A. et al. Delta (8)-THC protects against amyloid beta toxicity modulating ER stress in vitro: a transcriptomic analysis. Int. J. Mol. Sci.24, 6598 (2023). 10.3390/ijms24076598</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms24076598</ArticleId><ArticleId IdType=\"pmc\">PMC10095455</ArticleId><ArticleId IdType=\"pubmed\">37047608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau, V. et al. An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer&#x2019;s disease. Nat. Commun.14, 1670 (2023). 10.1038/s41467-023-37304-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-023-37304-3</ArticleId><ArticleId IdType=\"pmc\">PMC10039917</ArticleId><ArticleId IdType=\"pubmed\">36966157</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy, K. E. &amp; Park, J. J. Can co-activation of Nrf2 and neurotrophic signaling pathway slow Alzheimer&#x2019;s disease? Int. J. Mol. Sci.18, 1168 (2017). 10.3390/ijms18061168</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms18061168</ArticleId><ArticleId IdType=\"pmc\">PMC5485992</ArticleId><ArticleId IdType=\"pubmed\">28561773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, R. et al. Oxidative stress: the core pathogenesis and mechanism of Alzheimer&#x2019;s disease. Ageing Res. Rev.77, 101619 (2022). 10.1016/j.arr.2022.101619</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arr.2022.101619</ArticleId><ArticleId IdType=\"pubmed\">35395415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, R. et al. Advancing the battle against Alzheimer&#x2019;s disease: a focus ontargeting tau pathology by antisense oligonucleotide. Innov. Med.1, 100020 (2023).10.59717/j.xinn-med.2023.100020</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.59717/j.xinn-med.2023.100020</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonfili, L. et al. SLAB51 probiotic formulation activates SIRT1 pathway promoting antioxidant and neuroprotective effects in an AD mouse model. Mol. Neurobiol.55, 7987&#x2013;8000 (2018). 10.1007/s12035-018-0973-4</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-018-0973-4</ArticleId><ArticleId IdType=\"pmc\">PMC6132798</ArticleId><ArticleId IdType=\"pubmed\">29492848</ArticleId></ArticleIdList></Reference><Reference><Citation>Savelieff, M. G. et al. Development of multifunctional molecules as potential therapeutic candidates for Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and amyotrophic lateral sclerosis in the last decade. Chem. Rev.119, 1221&#x2013;1322 (2019). 10.1021/acs.chemrev.8b00138</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.chemrev.8b00138</ArticleId><ArticleId IdType=\"pubmed\">30095897</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. et al. Amyloid beta-based therapy for Alzheimer&#x2019;s disease: challenges, successes and future. Signal Transduct. Target. Ther.8, 248 (2023). 10.1038/s41392-023-01484-7</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41392-023-01484-7</ArticleId><ArticleId IdType=\"pmc\">PMC10310781</ArticleId><ArticleId IdType=\"pubmed\">37386015</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, S. K. et al. Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics16, 666&#x2013;674 (2019). 10.1007/s13311-019-00767-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13311-019-00767-8</ArticleId><ArticleId IdType=\"pmc\">PMC6694352</ArticleId><ArticleId IdType=\"pubmed\">31376068</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, C. et al. Continuously released Zn(2+) in 3D-printed PLGA/beta-TCP/Zn scaffolds for bone defect repair by improving osteoinductive and anti-inflammatory properties. Bioact. Mater.24, 361&#x2013;375 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9822837</ArticleId><ArticleId IdType=\"pubmed\">36632506</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian, J. et al. Corrosion-tailoring, osteogenic, anti-inflammatory, and antibacterial aspirin-loaded organometallic hydrogel composite coating on biodegradable Zn for orthopedic applications. Biomater. Adv.153, 213536 (2023). 10.1016/j.bioadv.2023.213536</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bioadv.2023.213536</ArticleId><ArticleId IdType=\"pubmed\">37418934</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, J. et al. Metal-organic framework (MOF)-based drug delivery. Curr. Med. Chem.27, 5949&#x2013;5969 (2020). 10.2174/0929867326666190618152518</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/0929867326666190618152518</ArticleId><ArticleId IdType=\"pubmed\">31215374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, S. et al. Green synthesis of metal&#x2013;organic frameworks: a state-of-the-art review of potential environmental and medical applications. Coord. Chem. Rev.420, 213407 (2020).10.1016/j.ccr.2020.213407</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ccr.2020.213407</ArticleId></ArticleIdList></Reference><Reference><Citation>Assi, A. A. et al. Protective effects of curcumin and Ginkgo biloba extract combination on a new model of Alzheimer&#x2019;s disease. Inflammopharmacology31, 1449&#x2013;1464 (2023). 10.1007/s10787-023-01164-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10787-023-01164-6</ArticleId><ArticleId IdType=\"pmc\">PMC10229698</ArticleId><ArticleId IdType=\"pubmed\">36856916</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, H. et al. Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3beta pathway. Nanoscale11, 7481&#x2013;7496 (2019). 10.1039/C9NR01255A</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C9NR01255A</ArticleId><ArticleId IdType=\"pubmed\">30942233</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, I. J. et al. A curcumin analog exhibits multiple biologic effects on the pathogenesis of Alzheimer&#x2019;s disease and improves behavior, inflammation, and beta-amyloid accumulation in a mouse model. Int. J. Mol. Sci.21, 5459 (2020). 10.3390/ijms21155459</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21155459</ArticleId><ArticleId IdType=\"pmc\">PMC7432838</ArticleId><ArticleId IdType=\"pubmed\">32751716</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv, H. et al. Application of curcumin nanoformulations in Alzheimer&#x2019;s disease: prevention, diagnosis and treatment. Nutr. Neurosci.26, 727&#x2013;742 (2023). 10.1080/1028415X.2022.2084550</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/1028415X.2022.2084550</ArticleId><ArticleId IdType=\"pubmed\">35694842</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiti, P. et al. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer&#x2019;s disease. BMC Neurosci.19, 7 (2018). 10.1186/s12868-018-0406-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12868-018-0406-3</ArticleId><ArticleId IdType=\"pmc\">PMC5824468</ArticleId><ArticleId IdType=\"pubmed\">29471781</ArticleId></ArticleIdList></Reference><Reference><Citation>Gegotek, A. &amp; Skrzydlewska, E. Antioxidative and anti-inflammatory activity of ascorbic acid. Antioxidants11, 1993 (2022). 10.3390/antiox11101993</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox11101993</ArticleId><ArticleId IdType=\"pmc\">PMC9598715</ArticleId><ArticleId IdType=\"pubmed\">36290716</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice, M E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci.23, 209&#x2013;216 (2000). 10.1016/S0166-2236(99)01543-X</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0166-2236(99)01543-X</ArticleId><ArticleId IdType=\"pubmed\">10782126</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39271754</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1476-5578</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Molecular psychiatry</Title><ISOAbbreviation>Mol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Transcriptomic profiles in major depressive disorder: the role of immunometabolic and cell-cycle-related pathways in depression with different levels of inflammation.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41380-024-02736-w</ELocationID><Abstract><AbstractText>Transcriptomic profiles are important indicators for molecular mechanisms and pathways involved in major depressive disorder (MDD) and its different phenotypes, such as immunometabolic depression. We performed whole-transcriptome and pathway analyses on 139 individuals from the observational, case-control, BIOmarkers in DEPression (BIODEP) study, 105 with MDD and 34 controls. We divided MDD participants based on levels of inflammation, as measured by serum high-sensitivity C-reactive protein (CRP), in n&#x2009;=&#x2009;39 'not inflamed' (CRP&#x2009;&lt;&#x2009;1&#x2009;mg/L), n&#x2009;=&#x2009;31 with 'elevated CRP' (1-3&#x2009;mg/L), and n&#x2009;=&#x2009;35 with 'low-grade inflammation' (&gt;3&#x2009;mg/L). We performed whole-blood RNA sequencing using Illumina NextSeq 550 and statistical analyses with the Deseq2 package for R statistics (RUV-corrected) and subsequent pathway analyses with Ingenuity Pathway Analysis. Immunometabolic pathways were activated in individuals with CRP&#x2009;&gt;&#x2009;1&#x2009;mg/L, although surprisingly the CRP 1-3 group showed stronger immune activation than the CRP&#x2009;&gt;&#x2009;3 group. The main pathways identified in the comparison between CRP&#x2009;&lt;&#x2009;1 group and controls were cell-cycle-related, which may be protective against immunometabolic abnormalities in this 'non-inflamed' depressed group. We further divided MDD participants based on exposure and response to antidepressants (n&#x2009;=&#x2009;47 non-responders, n&#x2009;=&#x2009;37 responders, and n&#x2009;=&#x2009;22 unmedicated), and identified specific immunomodulatory and neuroprotective pathways in responders (especially vs. non-responders), which could be relevant to treatment response. In further subgroup analyses, we found that the specific transcriptional profile of responders is independent of CRP levels, and that the inhibition of cell-cycle-related pathways in MDD with CRP&#x2009;&lt;&#x2009;1&#x2009;mg/L is present only in those who are currently depressed, and not in the responders. The present study demonstrates immunometabolic and cell-cycle-related transcriptomic pathways associated with MDD and different (CRP-based and treatment-based) MDD phenotypes, while shedding light on potential molecular mechanisms that could prevent or facilitate an individual's trajectory toward immunometabolic depression and/or treatment-non-responsive depression. The recognition and integration of these mechanisms will facilitate a precision-medicine approach in MDD.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Sforzini</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0001-6795-0391</Identifier><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, UK. luca.sforzini@kcl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK. luca.sforzini@kcl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Marizzoni</LastName><ForeName>Moira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biological Psychiatric Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bottanelli</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source=\"ORCID\">0000-0002-4772-6322</Identifier><AffiliationInfo><Affiliation>Biological Psychiatric Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125, Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, 20133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kun&#x161;tekov&#xe1;</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Biology, Faculty of Medicine, Slovak Medical University, Limbova 14, 833 03, Bratislava, Slovakia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zonca</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, 20133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Saleri</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biological Psychiatric Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kose</LastName><ForeName>Melisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lombardo</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mariani</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">0000-0001-7918-3492</Identifier><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nettis</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><Identifier Source=\"ORCID\">0000-0002-5401-8391</Identifier><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nikkheslat</LastName><ForeName>Naghmeh</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">0000-0002-9427-6715</Identifier><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Worrell</LastName><ForeName>Courtney</ForeName><Initials>C</Initials><Identifier Source=\"ORCID\">0000-0003-0539-2376</Identifier><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zajkowska</LastName><ForeName>Zuzanna</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pointon</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, CB2 0SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cowen</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><Identifier Source=\"ORCID\">0000-0001-5518-6138</Identifier><AffiliationInfo><Affiliation>University of Oxford Department of Psychiatry, Warneford Hospital, Oxford, OX3 7JX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cavanagh</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0003-0640-8050</Identifier><AffiliationInfo><Affiliation>Centre for Immunobiology, School of Infection &amp; Immunity, University of Glasgow, Glasgow, G12 8TF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Harrison</LastName><ForeName>Neil A</ForeName><Initials>NA</Initials><Identifier Source=\"ORCID\">0000-0002-9584-3769</Identifier><AffiliationInfo><Affiliation>School of Medicine, School of Psychology, Cardiff University Brain Research Imaging Centre, Maindy Road, Cardiff, CF24 4HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Riva</LastName><ForeName>Marco A</ForeName><Initials>MA</Initials><Identifier Source=\"ORCID\">0000-0002-1699-5060</Identifier><AffiliationInfo><Affiliation>Biological Psychiatric Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125, Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, 20133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mondelli</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><Identifier Source=\"ORCID\">0000-0001-8690-6839</Identifier><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bullmore</LastName><ForeName>Edward T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, CB2 0SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><CollectiveName>Neuroimmunology of Mood Disorders and Alzheimer&#x2019;s Disease (NIMA) Consortium</CollectiveName></Author><Author ValidYN=\"Y\"><LastName>Cattaneo</LastName><ForeName>Annamaria</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biological Psychiatric Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125, Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, 20133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pariante</LastName><ForeName>Carmine M</ForeName><Initials>CM</Initials><Identifier Source=\"ORCID\">0000-0002-9132-5091</Identifier><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>104025Z/14/Z</GrantID><Agency>Wellcome Trust (Wellcome)</Agency><Country/></Grant><Grant><GrantID>104025Z/14/Z</GrantID><Agency>Wellcome Trust (Wellcome)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Psychiatry</MedlineTA><NlmUniqueID>9607835</NlmUniqueID><ISSNLinking>1359-4184</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271754</ArticleId><ArticleId IdType=\"doi\">10.1038/s41380-024-02736-w</ArticleId><ArticleId IdType=\"pii\">10.1038/s41380-024-02736-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Athira KV, Bandopadhyay S, Samudrala PK, Naidu VGM, Lahkar M, Chakravarty S. An overview of the heterogeneity of major depressive disorder: current knowledge and future prospective. Curr Neuropharmacol. 2019;18:168&#x2013;87.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1570159X17666191001142934</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107:234&#x2013;56.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32553197</ArticleId><ArticleId IdType=\"pmc\">7381373</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neuron.2020.06.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5166 patients and 5083 controls. Brain Behav Immun. 2020;87:901.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32113908</ArticleId><ArticleId IdType=\"pmc\">7327519</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bbi.2020.02.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Strawbridge R, Arnone D, Danese A, Papadopoulos A, Herane Vives A, Cleare AJ. Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol. 2015;25:1532&#x2013;43.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26169573</ArticleId><ArticleId IdType=\"doi\">10.1016/j.euroneuro.2015.06.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamberlain SR, Cavanagh J, De Boer P, Mondelli V, Jones DNC, Drevets WC, et al. Treatment-resistant depression and peripheral C-reactive protein. Br J Psychiatry. 2019;214:11.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29764522</ArticleId><ArticleId IdType=\"pmc\">6124647</ArticleId><ArticleId IdType=\"doi\">10.1192/bjp.2018.66</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AH, Raison CL. Are anti-inflammatory therapies viable treatments for psychiatric disorders?: where the rubber meets the road. JAMA Psychiatry. 2015;72:527.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25853989</ArticleId><ArticleId IdType=\"pmc\">5542670</ArticleId><ArticleId IdType=\"doi\">10.1001/jamapsychiatry.2015.22</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones BDM, Daskalakis ZJ, Carvalho AF, Strawbridge R, Young AH, Mulsant BH, et al. Inflammation as a treatment target in mood disorders: review. BJPsych Open. 2020;6:e60.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32498754</ArticleId><ArticleId IdType=\"pmc\">7345526</ArticleId><ArticleId IdType=\"doi\">10.1192/bjo.2020.43</ArticleId></ArticleIdList></Reference><Reference><Citation>Milaneschi Y, Lamers F, Berk M, Penninx BWJH. Depression heterogeneity and its biological underpinnings: toward immunometabolic depression. Biol Psychiatry. 2020;88:369&#x2013;80.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32247527</ArticleId><ArticleId IdType=\"doi\">10.1016/j.biopsych.2020.01.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29706967</ArticleId><ArticleId IdType=\"pmc\">5908901</ArticleId><ArticleId IdType=\"doi\">10.3389/fimmu.2018.00754</ArticleId></ArticleIdList></Reference><Reference><Citation>Felger JC, Haroon E, Patel TA, Goldsmith DR, Wommack EC, Woolwine BJ, et al. What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry. 2020;25:1301.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29895893</ArticleId><ArticleId IdType=\"doi\">10.1038/s41380-018-0096-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease. Circulation. 2003;107:499&#x2013;511.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12551878</ArticleId><ArticleId IdType=\"doi\">10.1161/01.CIR.0000052939.59093.45</ArticleId></ArticleIdList></Reference><Reference><Citation>Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: A systematic review and meta-analysis of CRP levels. Psychol Med. 2019;49:1958&#x2013;70.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31258105</ArticleId><ArticleId IdType=\"pmc\">6712955</ArticleId><ArticleId IdType=\"doi\">10.1017/S0033291719001454</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitharouli MC, Hagenaars SP, Glanville KP, Coleman JRI, Hotopf M, Lewis CM, et al. Elevated C-Reactive protein in patients with depression, independent of genetic, health, and psychosocial factors: results from the UK Biobank. Am J Psychiatry. 2021;178:522&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33985349</ArticleId><ArticleId IdType=\"doi\">10.1176/appi.ajp.2020.20060947</ArticleId></ArticleIdList></Reference><Reference><Citation>Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivim&#xe4;ki M. Cumulative meta-analysis of interleukins 6 and 1&#x3b2;, tumour necrosis factor &#x3b1; and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26065825</ArticleId><ArticleId IdType=\"pmc\">4566946</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bbi.2015.06.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor-alpha antagonist infliximab in treatment resistant depression: role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70:31.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22945416</ArticleId><ArticleId IdType=\"pmc\">4015348</ArticleId><ArticleId IdType=\"doi\">10.1001/2013.jamapsychiatry.4</ArticleId></ArticleIdList></Reference><Reference><Citation>Nettis MA, Lombardo G, Hastings C, Zajkowska Z, Mariani N, Nikkheslat N, et al. Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial. Neuropsychopharmacology. 2021;46:939.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33504955</ArticleId><ArticleId IdType=\"pmc\">8096832</ArticleId><ArticleId IdType=\"doi\">10.1038/s41386-020-00948-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16316783</ArticleId><ArticleId IdType=\"doi\">10.1016/j.it.2005.11.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Buccitelli C, Selbach M. mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet. 2020;21:630&#x2013;44. 2020 21:10</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32709985</ArticleId><ArticleId IdType=\"doi\">10.1038/s41576-020-0258-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani N, Cattane N, Pariante C, Cattaneo A. Gene expression studies in Depression development and treatment: an overview of the underlying molecular mechanisms and biological processes to identify biomarkers. Transl Psychiatry. 2021;11:354.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34103475</ArticleId><ArticleId IdType=\"pmc\">8187383</ArticleId><ArticleId IdType=\"doi\">10.1038/s41398-021-01469-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Sforzini L, Cattaneo A, Ferrari C, Turner L, Mariani N, Enache D, et al. Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study. Transl Psychiatry. 2023;13:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41398-023-02438-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Amasi-Hartoonian N, Pariante CM, Cattaneo A, Sforzini L. Understanding treatment-resistant depression using &#x2018;omics&#x2019; techniques: a systematic review. J Affect Disord. 2022;318:423&#x2013;55.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36103934</ArticleId><ArticleId IdType=\"doi\">10.1016/j.jad.2022.09.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen R, Penninx BWJH, Madar V, Xia K, Milaneschi Y, Hottenga JJ, et al. Gene expression in major depressive disorder. Mol Psychiatry. 2015;21:339&#x2013;47.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26008736</ArticleId><ArticleId IdType=\"doi\">10.1038/mp.2015.57</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafavi S, Battle A, Zhu X, Potash JB, Weissman MM, Shi J, et al. Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing. Mol Psychiatry. 2013;19:1267&#x2013;74.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24296977</ArticleId><ArticleId IdType=\"pmc\">5404932</ArticleId><ArticleId IdType=\"doi\">10.1038/mp.2013.161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittenberg GM, Greene J, V&#xe9;rtes PE, Drevets WC, Bullmore ET. Major depressive disorder is associated with differential expression of innate immune and neutrophil-related gene networks in peripheral blood: a quantitative review of whole-genome transcriptional data from case-control studies. Biol Psychiatry. 2020;88:625&#x2013;37.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32653108</ArticleId><ArticleId IdType=\"doi\">10.1016/j.biopsych.2020.05.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Cathomas F, Bevilacqua L, Ramakrishnan A, Kronman H, Costi S, Schneider M, et al. Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression. Transl Psychiatry. 2022;12:12.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35013133</ArticleId><ArticleId IdType=\"pmc\">8748646</ArticleId><ArticleId IdType=\"doi\">10.1038/s41398-021-01712-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P, Srivastava A, Philip L, Ahuja SK, Shivangi, Rawat C, et al. Genome-wide transcriptomic and biochemical profiling of major depressive disorder: unravelling association with susceptibility, severity, and antidepressant response. Genomics. 2024;116:110772.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38158140</ArticleId><ArticleId IdType=\"doi\">10.1016/j.ygeno.2023.110772</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole JJ, McColl A, Shaw R, Lynall ME, Cowen PJ, de Boer P, et al. No evidence for differential gene expression in major depressive disorder PBMCs, but robust evidence of elevated biological ageing. Transl Psychiatry. 2021;11:404.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34294682</ArticleId><ArticleId IdType=\"pmc\">8298604</ArticleId><ArticleId IdType=\"doi\">10.1038/s41398-021-01506-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo A, Ferrari C, Turner L, Mariani N, Enache D, Hastings C, et al. Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study. Transl Psychiatry. 2020;10:232.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32699209</ArticleId><ArticleId IdType=\"pmc\">7376244</ArticleId><ArticleId IdType=\"doi\">10.1038/s41398-020-00874-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28263959</ArticleId><ArticleId IdType=\"pmc\">5600148</ArticleId><ArticleId IdType=\"doi\">10.1038/nmeth.4197</ArticleId></ArticleIdList></Reference><Reference><Citation>Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Research. 2016;4:1521.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">4712774</ArticleId><ArticleId IdType=\"doi\">10.12688/f1000research.7563.2</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13059-014-0550-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Risso D, Ngai J, Speed TP, Dudoit S. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat Biotechnol. 2014;32:896&#x2013;902.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25150836</ArticleId><ArticleId IdType=\"pmc\">4404308</ArticleId><ArticleId IdType=\"doi\">10.1038/nbt.2931</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289&#x2013;300.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas PD, Ebert D, Muruganujan A, Mushayahama T, Albou LP, Mi H. PANTHER: Making genome-scale phylogenetics accessible to all. Protein Sci. 2022;31:8&#x2013;22.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34717010</ArticleId><ArticleId IdType=\"doi\">10.1002/pro.4218</ArticleId></ArticleIdList></Reference><Reference><Citation>Croft M, Duan W, Choi H, Eun SY, Madireddi S, Mehta A. TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol. 2012;33:144&#x2013;52.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22169337</ArticleId><ArticleId IdType=\"doi\">10.1016/j.it.2011.10.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Palam LR, Baird TD, Wek RC. Phosphorylation of eIF2 facilitates ribosomal bypass of an inhibitory upstream ORF to enhance CHOP translation. J Biol Chem. 2011;286:10939&#x2013;49.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21285359</ArticleId><ArticleId IdType=\"pmc\">3064149</ArticleId><ArticleId IdType=\"doi\">10.1074/jbc.M110.216093</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha N, Bahnan W, Wiley DJ, Barber G, Fields KA, Schesser K. Eukaryotic Initiation Factor 2 (eIF2) signaling regulates proinflammatory cytokine expression and bacterial invasion. J Biol Chem. 2012;287:28738&#x2013;44.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22761422</ArticleId><ArticleId IdType=\"pmc\">3436510</ArticleId><ArticleId IdType=\"doi\">10.1074/jbc.M112.375915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I, H&#xfc;ttemann M. Energy crisis: The role of oxidative phosphorylation in acute inflammation and sepsis. Biochim Biophys Acta. 2014;1842:1579&#x2013;86.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24905734</ArticleId><ArticleId IdType=\"pmc\">4147665</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bbadis.2014.05.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkheimer FE, Veronese M, Mondelli V, Cash D, Pariante CM. Sickness behaviour and depression: an updated model of peripheral-central immunity interactions. Brain Behav Immun. 2023;111:202&#x2013;10.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37076054</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bbi.2023.03.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari-Heckler S, Robson SC, Longhi MS. Mitochondria drive immune responses in critical disease. Cells. 2022;11:4113.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36552877</ArticleId><ArticleId IdType=\"pmc\">9777392</ArticleId><ArticleId IdType=\"doi\">10.3390/cells11244113</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaini G, Mason BL, Diaz AP, Jha MK, Soares JC, Trivedi MH, et al. Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: does inflammation play a role? Mol Psychiatry. 2021;27:1095&#x2013;102.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34650203</ArticleId><ArticleId IdType=\"doi\">10.1038/s41380-021-01312-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma JH, Qin L, Li X. Role of STAT3 signaling pathway in breast cancer. Cell Commun Signal. 2020;18:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12964-020-0527-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Lint P, Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol. 2007;82:1375&#x2013;81.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17709402</ArticleId><ArticleId IdType=\"doi\">10.1189/jlb.0607338</ArticleId></ArticleIdList></Reference><Reference><Citation>Keegan AD, Leonard WJ, Zhu J. Recent advances in understanding the role of IL-4 signaling. Fac Rev. 2021;10:71.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34557875</ArticleId><ArticleId IdType=\"pmc\">8442009</ArticleId><ArticleId IdType=\"doi\">10.12703/r/10-71</ArticleId></ArticleIdList></Reference><Reference><Citation>Santagata S, Boggon TJ, Baird CL, Gomez CA, Zhao J, Shan WS, et al. G-protein signaling through tubby proteins. Science. 2001;292:2041&#x2013;50.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11375483</ArticleId><ArticleId IdType=\"doi\">10.1126/science.1061233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda A, Nishina PM, Naggert JK. The tubby-like proteins, a family with roles in neuronal development and function. J Cell Sci. 2002;115:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11801719</ArticleId><ArticleId IdType=\"doi\">10.1242/jcs.115.1.9</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Guan JL. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev. 2011;63:610&#x2013;5.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21118706</ArticleId><ArticleId IdType=\"doi\">10.1016/j.addr.2010.11.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy JM, Jeong K, Rodriguez YAR, Kim JH, Ahn EYE, Lim STS. FAK and Pyk2 activity promote TNF-&#x3b1; and IL-1&#x3b2;-mediated pro-inflammatory gene expression and vascular inflammation. Sci Rep. 2019;9:7617.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31110200</ArticleId><ArticleId IdType=\"pmc\">6527705</ArticleId><ArticleId IdType=\"doi\">10.1038/s41598-019-44098-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Orenstein SJ, Cuervo AM. Chaperone-mediated autophagy: Molecular mechanisms and physiological relevance. Semin Cell Dev Biol. 2010;21:719&#x2013;26.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20176123</ArticleId><ArticleId IdType=\"pmc\">2914824</ArticleId><ArticleId IdType=\"doi\">10.1016/j.semcdb.2010.02.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollio G, Hoozemans JJM, Andersen CA, Roncarati R, Rosi MC, van Haastert ES, et al. Increased expression of the oligopeptidase THOP1 is a neuroprotective response to Abeta toxicity. Neurobiol Dis. 2008;31:145&#x2013;58.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18571100</ArticleId><ArticleId IdType=\"doi\">10.1016/j.nbd.2008.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaur P, Munjal A, Lal SK. Influenza virus and cell signaling pathways. Med Sci Monit. 2011;17:RA148&#x2013;RA154.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21629204</ArticleId><ArticleId IdType=\"pmc\">3539548</ArticleId><ArticleId IdType=\"doi\">10.12659/MSM.881801</ArticleId></ArticleIdList></Reference><Reference><Citation>Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nature Immunology. 2005;6:1182&#x2013;90.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16369557</ArticleId><ArticleId IdType=\"doi\">10.1038/ni1275</ArticleId></ArticleIdList></Reference><Reference><Citation>Friuli M, Eramo B, Valenza M, Scuderi C, Provensi G, Romano A. Targeting the oxytocinergic system: a possible pharmacological strategy for the treatment of inflammation occurring in different chronic diseases. Int J Mol Sci. 2021;22:10250.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34638587</ArticleId><ArticleId IdType=\"pmc\">8508899</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms221910250</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachinger N, Fischer S, B&#xf6;hme I, Linck-Paulus L, Kuphal S, Kappelmann-Fenzl M, et al. Loss of gene information: discrepancies between RNA sequencing, cDNA microarray, and qrt-pcr. Int J Mol Sci. 2021;22:9349.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34502254</ArticleId><ArticleId IdType=\"pmc\">8430810</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms22179349</ArticleId></ArticleIdList></Reference><Reference><Citation>Coenye T. Do results obtained with RNA-sequencing require independent verification? Biofilm. 2021;3:100043.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33665610</ArticleId><ArticleId IdType=\"pmc\">7823214</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bioflm.2021.100043</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopizzo N, Tosato S, Begni V, Tomassi S, Cattane N, Barcella M, et al. Transcriptomic analyses and leukocyte telomere length measurement in subjects exposed to severe recent stressful life events. Transl Psychiatry. 2017;7:e1042.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28221367</ArticleId><ArticleId IdType=\"pmc\">5438034</ArticleId><ArticleId IdType=\"doi\">10.1038/tp.2017.5</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepgul N, Cattaneo A, Agarwal K, Baraldi S, Borsini A, Bufalino C, et al. Transcriptomics in interferon-&#x3b1;-treated patients identifies inflammation-, neuroplasticity- and oxidative stress-related signatures as predictors and correlates of depression. Neuropsychopharmacology. 2016;41:2502.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27067128</ArticleId><ArticleId IdType=\"pmc\">4983179</ArticleId><ArticleId IdType=\"doi\">10.1038/npp.2016.50</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank P, Jokela M, Batty GD, Cadar D, Steptoe A, Kivim&#xe4;ki M. Association between systemic inflammation and individual symptoms of depression: a pooled analysis of 15 population-based cohort studies. Am J Psychiatry. 2021;178:1107&#x2013;18.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34645276</ArticleId><ArticleId IdType=\"doi\">10.1176/appi.ajp.2021.20121776</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AH, Raison CL. Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies. Mol Psychiatry. 2022;28:68&#x2013;75.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36460725</ArticleId><ArticleId IdType=\"doi\">10.1038/s41380-022-01887-y</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39271753</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1476-5578</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Molecular psychiatry</Title><ISOAbbreviation>Mol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer's disease astrocytes.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41380-024-02746-8</ELocationID><Abstract><AbstractText>Abnormalities in cellular metabolism are seen early in Alzheimer's disease (AD). Astrocyte support for neuronal function has a high metabolic demand, and astrocyte glucose metabolism plays a key role in encoding memory. This indicates that astrocyte metabolic dysfunction might be an early event in the development of AD. In this paper we interrogate glycolytic and mitochondrial functional changes and mitochondrial structural alterations in patients' astrocytes derived with a highly efficient direct conversion protocol. In astrocytes derived from patients with sporadic (sAD) and familial AD (fAD) we identified reductions in extracellular lactate, total cellular ATP and an increase in mitochondrial reactive oxygen species. sAD and fAD astrocytes displayed significant reductions in mitochondrial spare respiratory capacity, have altered mitochondrial membrane potential and a stressed mitochondrial network. A reduction in glycolytic reserve and glycolytic capacity is seen. Interestingly, glycolytic reserve, mitochondrial spare respiratory capacity and extracellular lactate levels correlated positively with neuropsychological tests of episodic memory affected early in AD. We identified a deficit in the glycolytic enzyme hexokinase 1 (HK1), and correcting this deficit improved the metabolic phenotype in sAD not fAD astrocytes. Importantly, the amount of HK1 at the mitochondria was shown to be reduced in sAD astrocytes, and not in fAD astrocytes. Overexpression of HK1 in sAD astrocytes increases mitochondrial HK1 levels. In fAD astrocytes HK1 levels were unaltered at the mitochondria after overexpression. This study highlights a clear metabolic deficit in AD patient-derived astrocytes and indicates how HK1, with its roles in both oxidative phosphorylation and glycolysis, contributes to this.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Bell</LastName><ForeName>Simon M</ForeName><Initials>SM</Initials><Identifier Source=\"ORCID\">0000-0002-2781-6478</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK. s.m.bell@sheffield.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Sheffield Biomedical Research Centre, University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. s.m.bell@sheffield.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Firth Court, Sheffield, S10 2TN, UK. s.m.bell@sheffield.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wareing</LastName><ForeName>Hollie</ForeName><Initials>H</Initials><Identifier Source=\"ORCID\">0000-0003-0785-4116</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Capriglia</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hughes</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Barnes</LastName><ForeName>Katy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hamshaw</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0009-0000-2480-5653</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Adair</LastName><ForeName>Liam</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0002-9527-4869</Identifier><AffiliationInfo><Affiliation>School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, NSW, 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shaw</LastName><ForeName>Allan</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-7321-7994</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Olejnik</LastName><ForeName>Alicja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>De</LastName><ForeName>Suman</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0003-1675-0773</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>New</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, NSW, 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shaw</LastName><ForeName>Pamela J</ForeName><Initials>PJ</Initials><Identifier Source=\"ORCID\">0000-0002-8925-2567</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Sheffield Biomedical Research Centre, University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Firth Court, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>De Marco</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, Brunel University London, Uxbridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Venneri</LastName><ForeName>Annalena</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, Brunel University London, Uxbridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Blackburn</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Sheffield Biomedical Research Centre, University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ferraiuolo</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0001-9118-5714</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Firth Court, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mortiboys</LastName><ForeName>Heather</ForeName><Initials>H</Initials><Identifier Source=\"ORCID\">0000-0001-6439-0579</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience, School of Medicine and Population Health, University of Sheffield, 385a Glossop Rd, Sheffield, S10 2HQ, UK. H.Mortiboys@sheffield.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Firth Court, Sheffield, S10 2TN, UK. H.Mortiboys@sheffield.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>F1301</GrantID><Acronym>PUK_</Acronym><Agency>Parkinson's UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>216340/Z/19/Z</GrantID><Agency>Wellcome Trust (Wellcome)</Agency><Country/></Grant><Grant><GrantID>216340/Z/19/Z</GrantID><Agency>Wellcome Trust (Wellcome)</Agency><Country/></Grant><Grant><GrantID>ARUK-PCRF2016A-1</GrantID><Agency>Alzheimer's Research UK (ARUK)</Agency><Country/></Grant><Grant><GrantID>ARUK-PCRF2016A-1</GrantID><Agency>Alzheimer's Research UK (ARUK)</Agency><Country/></Grant><Grant><GrantID>SGL028\\1097</GrantID><Acronym>AMS_</Acronym><Agency>Academy of Medical Sciences</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>SGL028\\1097</GrantID><Acronym>AMS_</Acronym><Agency>Academy of Medical Sciences</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>NIHR 203321</GrantID><Agency>DH | National Institute for Health Research (NIHR)</Agency><Country/></Grant><Grant><GrantID>005021</GrantID><Agency>Michael J. Fox Foundation for Parkinson's Research (Michael J. Fox Foundation)</Agency><Country/></Grant><Grant><GrantID>CE200100012</GrantID><Agency>Department of Education and Training | ARC | Centre of Excellence for Integrative Brain Function, Australian Research Council (ARC Centre of Excellence for Integrative Brain Function)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Psychiatry</MedlineTA><NlmUniqueID>9607835</NlmUniqueID><ISSNLinking>1359-4184</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271753</ArticleId><ArticleId IdType=\"doi\">10.1038/s41380-024-02746-8</ArticleId><ArticleId IdType=\"pii\">10.1038/s41380-024-02746-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459&#x2013;80.</Citation></Reference><Reference><Citation>GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105&#x2013;e25.3.</Citation></Reference><Reference><Citation>Jeremic D, Navarro-L&#xf3;pez JD, Jim&#xe9;nez-D&#xed;az L. Efficacy and safety of anti-amyloid-&#x3b2; monoclonal antibodies in current Alzheimer&#x2019;s disease phase III clinical trials: A systematic review and interactive web app-based meta-analysis. Ageing Res Rev. 2023;90:102012.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37423541</ArticleId><ArticleId IdType=\"doi\">10.1016/j.arr.2023.102012</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacorte E, Ancidoni A, Zaccaria V, Remoli G, Tariciotti L, Bellomo G, et al. Safety and Efficacy of Monoclonal Antibodies for Alzheimer&#x2019;s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials. J Alzheimers Dis. 2022;87:101&#x2013;29.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35275549</ArticleId><ArticleId IdType=\"pmc\">9198746</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-220046</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins ND, Scheltens P. Treating Alzheimer&#x2019;s disease with monoclonal antibodies: current status and outlook for the future. Alzheimers Res Ther. 2013;5:56.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24216217</ArticleId><ArticleId IdType=\"pmc\">3978826</ArticleId><ArticleId IdType=\"doi\">10.1186/alzrt220</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer&#x2019;s Disease. N Engl J Med. 2022;388:9&#x2013;21.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36449413</ArticleId><ArticleId IdType=\"doi\">10.1056/NEJMoa2212948</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023;330:512&#x2013;27.</Citation></Reference><Reference><Citation>Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer&#x2019;s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25:7709&#x2013;17.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16120771</ArticleId><ArticleId IdType=\"pmc\">6725245</ArticleId><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.2177-05.2005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoenig MC, Bischof GN, Seemiller J, Hammes J, Kukolja J, Onur &#xd6;A, et al. Networks of tau distribution in Alzheimer&#x2019;s disease. Brain J Neurol. 2018;141:568&#x2013;81.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awx353</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye F, Funk Q, Rockers E, Shulman JM, Masdeu JC, Pascual B, et al. In Alzheimer-prone brain regions, metabolism and risk-gene expression are strongly correlated. Brain Commun. 2022;4:fcac216.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36092303</ArticleId><ArticleId IdType=\"pmc\">9453434</ArticleId><ArticleId IdType=\"doi\">10.1093/braincomms/fcac216</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow RH, Burns JM, Khan SM. The Alzheimer&#x2019;s disease mitochondrial cascade hypothesis. J Alzheimers Dis. 2010;20:S265&#x2013;S79.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20442494</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-2010-100339</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell SM, Barnes K, De Marco M, Shaw PJ, Ferraiuolo L, Blackburn DJ, et al. Mitochondrial Dysfunction in Alzheimer&#x2019;s Disease: A Biomarker of the Future? Biomedicines. 2021;9:63.</Citation></Reference><Reference><Citation>Bell SM, Burgess T, Lee J, Blackburn DJ, Allen SP, Mortiboys H. Peripheral Glycolysis in Neurodegenerative Diseases. Int J Mol Sci. 2020;21:8924.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33255513</ArticleId><ArticleId IdType=\"pmc\">7727792</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms21238924</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonntag K-C, Ryu W-I, Amirault KM, Healy RA, Siegel AJ, McPhie DL, et al. Late-onset Alzheimer&#x2019;s disease is associated with inherent changes in bioenergetics profiles. Sci Rep. 2017;7:14038.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29070876</ArticleId><ArticleId IdType=\"pmc\">5656579</ArticleId><ArticleId IdType=\"doi\">10.1038/s41598-017-14420-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell SM, Barnes K, Clemmens H, Al-Rafiah AR, Al-Ofi EA, Leech V, et al. Ursodeoxycholic Acid Improves Mitochondrial Function and Redistributes Drp1 in Fibroblasts from Patients with Either Sporadic or Familial Alzheimer&#x2019;s Disease. J Mol Biol. 2018;430:3942&#x2013;53.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30171839</ArticleId><ArticleId IdType=\"pmc\">6193139</ArticleId><ArticleId IdType=\"doi\">10.1016/j.jmb.2018.08.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorbi S, Piacentini S, Latorraca S, Piersanti P, Amaducci L. Alterations in metabolic properties in fibroblasts in Alzheimer disease. Alzheimer Dis Associated Disord. 1995;9:73&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00002093-199509020-00003</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Maestro P, Gargini R, Garc&#xed;a E, Perry G, Avila J. Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer&#x2019;s Disease. Oxid Med Cell Longev. 2017;2017:9302761.</Citation></Reference><Reference><Citation>Wang X, Su B, Fujioka H, Zhu X. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer&#x2019;s disease patients. Am J Pathol. 2008;173:470&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18599615</ArticleId><ArticleId IdType=\"pmc\">2475784</ArticleId><ArticleId IdType=\"doi\">10.2353/ajpath.2008.071208</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker WD, Parks J, Filley CM, Kleinschmidt-DeMasters BK. Electron transport chain defects in Alzheimer&#x2019;s disease brain. Neurology. 1994;44:1090&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8208407</ArticleId><ArticleId IdType=\"doi\">10.1212/WNL.44.6.1090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchi C, Fiorillo C, Sorbi S, Latorraca S, Nacmias B, Bagnoli S, et al. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer&#x2019;s patients. Free Radic Biol Med. 2002;33:1372&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12419469</ArticleId><ArticleId IdType=\"doi\">10.1016/S0891-5849(02)01049-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell MS, De Marco M, Barnes K, Shaw JP, Ferraiuolo L, Blackburn JD, et al. Deficits in Mitochondrial Spare Respiratory Capacity Contribute to the Neuropsychological Changes of Alzheimer&#x2019;s Disease. J Personalized Med. 2020;10:32.</Citation></Reference><Reference><Citation>Samanta S, Akhter F, Roy A, Chen D, Turner B, Wang Y, et al. New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer&#x2019;s disease. Brain. 2024;147:1710&#x2013;25.</Citation></Reference><Reference><Citation>Curti D, Rognoni F, Gasparini L, Cattaneo A, Paolillo M, Racchi M, et al. Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer&#x2019;s disease (AD) patients. Neurosci Lett. 1997;236:13&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9404940</ArticleId><ArticleId IdType=\"doi\">10.1016/S0304-3940(97)00741-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson G, Martins R, Blass J, Gandy S. Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients. Life Sci. 1996;59:477&#x2013;89.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8761336</ArticleId><ArticleId IdType=\"doi\">10.1016/0024-3205(96)00327-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Maestro P, Gargini R, A Sproul A, Garc&#xed;a E, Ant&#xf3;n LC, Noggle S, et al. Mitophagy Failure in Fibroblasts and iPSC-Derived Neurons of Alzheimer&#x2019;s Disease-Associated Presenilin 1 Mutation. Front Mol Neurosci. 2017;10:291.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28959184</ArticleId><ArticleId IdType=\"pmc\">5603661</ArticleId><ArticleId IdType=\"doi\">10.3389/fnmol.2017.00291</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez MJ, Ponce DP, Aranguiz A, Behrens MI, Quintanilla RA. Mitochondrial permeability transition pore contributes to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer&#x2019;s disease. Redox Biol. 2018;19:290&#x2013;300.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30199818</ArticleId><ArticleId IdType=\"pmc\">6129674</ArticleId><ArticleId IdType=\"doi\">10.1016/j.redox.2018.09.001</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez MJ, Ponce DP, Osorio-Fuentealba C, Behrens MI, Quintanilla RA. Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer&#x2019;s Disease. Front Neurosci. 2017;11:553.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29056898</ArticleId><ArticleId IdType=\"pmc\">5635042</ArticleId><ArticleId IdType=\"doi\">10.3389/fnins.2017.00553</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims NR, Finegan JM, Blass JP. Altered glucose metabolism in fibroblasts from patients with Alzheimer&#x2019;s disease. N Engl J Med. 1985;313:638&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">4022053</ArticleId><ArticleId IdType=\"doi\">10.1056/NEJM198509053131013</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims NR, Finegan JM, Blass JP. Altered metabolic properties of cultured skin fibroblasts in Alzheimer&#x2019;s disease. Ann Neurol. 1987;21:451&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3109316</ArticleId><ArticleId IdType=\"doi\">10.1002/ana.410210507</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose IA, Warms JVB. Mitochondrial Hexokinase: RELEASE, REBINDING, AND LOCATION. J Biol Chem. 1967;242:1635&#x2013;45.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">4225734</ArticleId><ArticleId IdType=\"doi\">10.1016/S0021-9258(18)96139-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Gardiner NJ, Fernyhough P. Blockade of hexokinase activity and binding to mitochondria inhibits neurite outgrowth in cultured adult rat sensory neurons. Neurosci Lett. 2008;434:6&#x2013;11.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18308470</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neulet.2008.01.057</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi A, Rigotto G, Valente G, Giorgio V, Basso E, Filadi R et al. Defective Mitochondrial Pyruvate Flux Affects Cell Bioenergetics in Alzheimer&#x2019;s Disease-Related Models. Cell Rep. 2020;30:2332&#x2013;48.e10.</Citation></Reference><Reference><Citation>Saraiva LM, Seixas da Silva GS, Galina A, da-Silva WS, Klein WL, Ferreira ST, et al. Amyloid-&#x3b2; triggers the release of neuronal hexokinase 1 from mitochondria. PLoS One. 2010;5:e15230.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21179577</ArticleId><ArticleId IdType=\"pmc\">3002973</ArticleId><ArticleId IdType=\"doi\">10.1371/journal.pone.0015230</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper C, Killick R, Lovestone S. The GSK3 hypothesis of Alzheimer&#x2019;s disease. J Neurochem. 2008;104:1433&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18088381</ArticleId><ArticleId IdType=\"pmc\">3073119</ArticleId><ArticleId IdType=\"doi\">10.1111/j.1471-4159.2007.05194.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy PH. Amyloid beta-induced glycogen synthase kinase 3&#x3b2; phosphorylated VDAC1 in Alzheimer&#x2019;s disease: implications for synaptic dysfunction and neuronal damage. Biochim Biophys Acta. 2013;1832:1913&#x2013;21.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23816568</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bbadis.2013.06.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S, He Z, Jacob C, Hu X, Liang X, Xiao W, et al. Effect of Increased IL-1&#x3b2; on Expression of HK in Alzheimer&#x2019;s Disease. Int J Mol Sci. 2021;22:1306.</Citation></Reference><Reference><Citation>Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001;21:1133&#x2013;45.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11598490</ArticleId><ArticleId IdType=\"doi\">10.1097/00004647-200110000-00001</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;langer M, Allaman I, Magistretti PJ. Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation. Cell Metab. 2011;14:724&#x2013;38.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22152301</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cmet.2011.08.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertz L, Peng L, Dienel GA. Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J Cereb Blood Flow Metab. 2007;27:219&#x2013;49.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16835632</ArticleId><ArticleId IdType=\"doi\">10.1038/sj.jcbfm.9600343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuijlaars J, Oyelami T, Diels A, Rohrbacher J, Versweyveld S, Meneghello G, et al. Sustained synchronized neuronal network activity in a human astrocyte co-culture system. Sci Rep. 2016;6:36529.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27819315</ArticleId><ArticleId IdType=\"pmc\">5098163</ArticleId><ArticleId IdType=\"doi\">10.1038/srep36529</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosworth AP, Allen NJ. The diverse actions of astrocytes during synaptic development. Curr Opin Neurobiol. 2017;47:38&#x2013;43.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28938161</ArticleId><ArticleId IdType=\"doi\">10.1016/j.conb.2017.08.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber B, Barros LF. The Astrocyte: Powerhouse and Recycling Center. Cold Spring Harbor Perspect Biol. 2015;7:a020396.</Citation></Reference><Reference><Citation>Garwood CJ, Ratcliffe LE, Simpson JE, Heath PR, Ince PG, Wharton SB. Review: Astrocytes in Alzheimer&#x2019;s disease and other age-associated dementias: a supporting player with a central role. Neuropathol Appl Neurobiol. 2017;43:281&#x2013;98.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27442752</ArticleId><ArticleId IdType=\"doi\">10.1111/nan.12338</ArticleId></ArticleIdList></Reference><Reference><Citation>Garwood CJ, Ratcliffe LE, Morgan SV, Simpson JE, Owens H, Vazquez-Villase&#xf1;or I, et al. Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors. Mol Brain. 2015;8:51.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26297026</ArticleId><ArticleId IdType=\"pmc\">4546315</ArticleId><ArticleId IdType=\"doi\">10.1186/s13041-015-0138-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones VC, Atkinson-Dell R, Verkhratsky A, Mohamet L. Aberrant iPSC-derived human astrocytes in Alzheimer&#x2019;s disease. Cell death Dis. 2017;8:e2696.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28333144</ArticleId><ArticleId IdType=\"pmc\">5386580</ArticleId><ArticleId IdType=\"doi\">10.1038/cddis.2017.89</ArticleId></ArticleIdList></Reference><Reference><Citation>Oksanen M, Petersen AJ, Naumenko N, Puttonen K, Lehtonen &#x160;, Gubert Oliv&#xe9; M, et al. PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer&#x2019;s Disease. Stem Cell Rep. 2017;9:1885&#x2013;97.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.stemcr.2017.10.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu W, Shi D, Westaway D, Jhamandas JH. Bioenergetic mechanisms in astrocytes may contribute to amyloid plaque deposition and toxicity. J Biol Chem. 2015;290:12504&#x2013;13.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25814669</ArticleId><ArticleId IdType=\"pmc\">4432272</ArticleId><ArticleId IdType=\"doi\">10.1074/jbc.M114.618157</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves C-A, Rodrigues L, Bobermin LD, Zanotto C, Vizuete A, Quincozes-Santos A, et al. Glycolysis-Derived Compounds From Astrocytes That Modulate Synaptic Communication. Front Neurosci. 2019;12:1035.</Citation></Reference><Reference><Citation>Dai DL, Li M, Lee EB. Human Alzheimer&#x2019;s disease reactive astrocytes exhibit a loss of homeostastic gene expression. Acta Neuropathologica Commun. 2023;11:127.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40478-023-01624-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib N, McCabe C, Medina S, Varshavsky M, Kitsberg D, Dvir-Szternfeld R, et al. Disease -associated astrocytes in Alzheimer&#x2019;s disease and aging. Nat Neurosci. 2020;23:701&#x2013;6.</Citation></Reference><Reference><Citation>Bellaver B, Povala G, Ferreira PCL, Ferrari-Souza JP, Leffa DT, Lussier FZ, et al. Astrocyte reactivity influences amyloid-&#x3b2; effects on tau pathology in preclinical Alzheimer&#x2019;s disease. Nat Med. 2023;29:1775&#x2013;81.</Citation></Reference><Reference><Citation>Gibbs ME, Anderson DG, Hertz L. Inhibition of glycogenolysis in astrocytes interrupts memory consolidation in young chickens. Glia. 2006;54:214&#x2013;22.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16819764</ArticleId><ArticleId IdType=\"doi\">10.1002/glia.20377</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman LA, Korol DL, Gold PE. Lactate produced by glycogenolysis in astrocytes regulates memory processing. PLoS One. 2011;6:e28427.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22180782</ArticleId><ArticleId IdType=\"pmc\">3236748</ArticleId><ArticleId IdType=\"doi\">10.1371/journal.pone.0028427</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, Magistretti PJ, et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell. 2011;144:810&#x2013;23.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21376239</ArticleId><ArticleId IdType=\"pmc\">3073831</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2011.02.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo S, Yarishkin O, Hwang YJ, Chun YE, Park M, Woo DH et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer&#x2019;s disease. Nat Med. 2014;20:886&#x2013;96.</Citation></Reference><Reference><Citation>Ju YH, Bhalla M, Hyeon SJ, Oh JE, Yoo S, Chae U et al. Astrocytic urea cycle detoxifies A&#x3b2;-derived ammonia while impairing memory in Alzheimer&#x2019;s disease. Cell Metab. 2022;34:1104&#x2013;20.e8.</Citation></Reference><Reference><Citation>Malik N, Rao MS. A review of the methods for human iPSC derivation. Methods Mol Biol. 2013;997:23&#x2013;33.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23546745</ArticleId><ArticleId IdType=\"pmc\">4176696</ArticleId><ArticleId IdType=\"doi\">10.1007/978-1-62703-348-0_3</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008;26:101&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18059259</ArticleId><ArticleId IdType=\"doi\">10.1038/nbt1374</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861&#x2013;72.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18035408</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2007.11.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663&#x2013;76.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16904174</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2006.07.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens J, Paquola ACM, Ku M, Hatch E, B&#xf6;hnke L, Ladjevardi S, et al. Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects. Cell Stem Cell. 2015;17:705&#x2013;18.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26456686</ArticleId><ArticleId IdType=\"pmc\">5929130</ArticleId><ArticleId IdType=\"doi\">10.1016/j.stem.2015.09.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K, Ferraiuolo L, Miranda CJ, Likhite S, McElroy S, Renusch S, et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci USA. 2014;111:829&#x2013;32.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24379375</ArticleId><ArticleId IdType=\"doi\">10.1073/pnas.1314085111</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto N, Dos Santos Souza C, Shaw AC, Bell SM, Myszczynska MA, Powers S, et al. Directly converted astrocytes retain the ageing features of the donor fibroblasts and elucidate the astrocytic contribution to human CNS health and disease. Aging Cell. 2021;20:e13281.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33314575</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.13281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Meyer K, Sherwood TW, Vick J, Likhite S, Frakes A, et al. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc Natl Acad Sci USA. 2016;113:E6496&#x2013;E505.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27688759</ArticleId><ArticleId IdType=\"pmc\">5081600</ArticleId><ArticleId IdType=\"doi\">10.1073/pnas.1607496113</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzentruber A, Boschian C, Lopes FM, Myszczynska MA, New EJ, Beyrath J, et al. Oxidative switch drives mitophagy defects in dopaminergic parkin mutant patient neurons. bioRxiv. 2020. https://www.biorxiv.org/content/10.1101/2020.05.29.115782v1.full .</Citation></Reference><Reference><Citation>Varcianna A, Myszczynska MA, Castelli LM, O&#x2019;Neill B, Kim Y, Talbot J, et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626&#x2013;35.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30711519</ArticleId><ArticleId IdType=\"pmc\">6413467</ArticleId><ArticleId IdType=\"doi\">10.1016/j.ebiom.2018.11.067</ArticleId></ArticleIdList></Reference><Reference><Citation>Diot A, Hinks-Roberts A, Lodge T, Liao C, Dombi E, Morten K, et al. A novel quantitative assay of mitophagy: Combining high content fluorescence microscopy and mitochondrial DNA load to quantify mitophagy and identify novel pharmacological tools against pathogenic heteroplasmic mtDNA. Pharmacol Res. 2015;100:24&#x2013;35.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26196248</ArticleId><ArticleId IdType=\"doi\">10.1016/j.phrs.2015.07.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredi G, Yang L, Gajewski CD, Mattiazzi M. Measurements of ATP in mammalian cells. Methods. 2002;26:317&#x2013;26.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12054922</ArticleId><ArticleId IdType=\"doi\">10.1016/S1046-2023(02)00037-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur A, Brigden KW, Cashman TF, Fraser ST, New EJ. Mitochondrially targeted redox probe reveals the variations in oxidative capacity of the haematopoietic cells. Org Biomol Chem. 2015;13:6686&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26006184</ArticleId><ArticleId IdType=\"doi\">10.1039/C5OB00928F</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Hall B, Castelli LM, Francis L, Woof R, Siskos AP, et al. Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain J Neurol. 2019;142:586&#x2013;605.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awy353</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Hall B, Woof R, Francis L, Gatto N, Shaw AC, et al. C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis. Brain J Neurol. 2019;142:3771&#x2013;90.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awz302</ArticleId></ArticleIdList></Reference><Reference><Citation>Irish M, Piguet O. The Pivotal Role of Semantic Memory in Remembering the Past and Imagining the Future. Front Behav Neurosci. 2013;7:27.</Citation></Reference><Reference><Citation>Giffard B, Desgranges B, Nore-Mary F, Lalev&#xe9;e C, de la Sayette V, Pasquier F, et al. The nature of semantic memory deficits in Alzheimer&#x2019;s disease: New insights from hyperpriming effects. Brain J Neurol. 2001;124:1522&#x2013;32.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/124.8.1522</ArticleId></ArticleIdList></Reference><Reference><Citation>Venneri A, Mitolo M, Beltrachini L, Varma S, Della Piet&#xe0; C, Jahn-Carta C, et al. Beyond episodic memory: Semantic processing as independent predictor of hippocampal/perirhinal volume in aging and mild cognitive impairment due to Alzheimer&#x2019;s disease. Neuropsychology. 2019;33:523&#x2013;33.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30777767</ArticleId><ArticleId IdType=\"doi\">10.1037/neu0000534</ArticleId></ArticleIdList></Reference><Reference><Citation>Venneri A, Mitolo M, De Marco M. Paradigm shift: semantic memory decline as a biomarker of preclinical Alzheimer&#x2019;s disease. Biomark Med. 2016;10:5&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26642376</ArticleId><ArticleId IdType=\"doi\">10.2217/bmm.15.53</ArticleId></ArticleIdList></Reference><Reference><Citation>Filadi R, Greotti E, Turacchio G, Luini A, Pozzan T, Pizzo P. Presenilin 2 Modulates Endoplasmic Reticulum-Mitochondria Coupling by Tuning the Antagonistic Effect of Mitofusin 2. Cell Rep. 2016;15:2226&#x2013;38.</Citation></Reference><Reference><Citation>Makarov M, Kushnireva L, Papa M, Korkotian E. Presenilins and mitochondria&#x2014;an intriguing link: mini-review. Front Neurosci. 2023;17:79.</Citation></Reference><Reference><Citation>Ryu WI, Bormann MK, Shen M, Kim D, Forester B, Park Y, et al. Brain cells derived from Alzheimer&#x2019;s disease patients have multiple specific innate abnormalities in energy metabolism. Mol Psychiatry. 2021;26:5702&#x2013;14.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33863993</ArticleId><ArticleId IdType=\"pmc\">8758493</ArticleId><ArticleId IdType=\"doi\">10.1038/s41380-021-01068-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks GA. Cell-cell and intracellular lactate shuttles. J Physiol. 2009;587:5591&#x2013;600.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19805739</ArticleId><ArticleId IdType=\"pmc\">2805372</ArticleId><ArticleId IdType=\"doi\">10.1113/jphysiol.2009.178350</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci. 1994;91:10625&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7938003</ArticleId><ArticleId IdType=\"pmc\">45074</ArticleId><ArticleId IdType=\"doi\">10.1073/pnas.91.22.10625</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero-Mendez A, Almeida A, Fern&#xe1;ndez E, Maestre C, Moncada S, Bola&#xf1;os JP. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol. 2009;11:747&#x2013;52.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19448625</ArticleId><ArticleId IdType=\"doi\">10.1038/ncb1881</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X, Ng CP, Jones O, Fung TS, Ryu K, Li D, et al. Lactate Activates the Mitochondrial Electron Transport Chain Independent of Its Metabolism. bioRxiv. 2023. https://doi.org/10.1101/2023.08.02.551712 .</Citation></Reference><Reference><Citation>Simpson JE, Ince PG, Minett T, Matthews FE, Heath PR, Shaw PJ, et al. Neuronal DNA damage response-associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of Alzheimer-type pathology. Neuropathol Appl Neurobiol. 2016;42:167&#x2013;79.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26095650</ArticleId><ArticleId IdType=\"doi\">10.1111/nan.12252</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunomura A, Tamaoki T, Motohashi N, Nakamura M, McKeel DW Jr, Tabaton M, et al. The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons. J Neuropathol Exp Neurol. 2012;71:233&#x2013;41.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22318126</ArticleId><ArticleId IdType=\"doi\">10.1097/NEN.0b013e318248e614</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer&#x2019;s disease. J Neurosci. 1999;19:1959&#x2013;64.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10066249</ArticleId><ArticleId IdType=\"pmc\">6782583</ArticleId><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.19-06-01959.1999</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota Y, Zanetti AT, Hallock RM. The role of astrocytes in the regulation of synaptic plasticity and memory formation. Neural Plast. 2013;2013:185463.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24369508</ArticleId><ArticleId IdType=\"pmc\">3867861</ArticleId><ArticleId IdType=\"doi\">10.1155/2013/185463</ArticleId></ArticleIdList></Reference><Reference><Citation>Pangr&#x161;i&#x10d; T, Potokar M, Stenovec M, Kreft M, Fabbretti E, Nistri A, et al. Exocytotic Release of ATP from Cultured Astrocytes. J Biol Chem. 2007;282:28749&#x2013;58.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17627942</ArticleId><ArticleId IdType=\"doi\">10.1074/jbc.M700290200</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Z, Liu Y, Xi W, Lou H-f, Zhu L, Guo Z, et al. Glia-derived ATP inversely regulates excitability of pyramidal and CCK-positive neurons. Nat Commun. 2017;8:13772.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28128211</ArticleId><ArticleId IdType=\"pmc\">5290168</ArticleId><ArticleId IdType=\"doi\">10.1038/ncomms13772</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman SJ, Gerevich Z. P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction. Neural Plast. 2016;2016:1207393.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27069691</ArticleId><ArticleId IdType=\"pmc\">4812485</ArticleId><ArticleId IdType=\"doi\">10.1155/2016/1207393</ArticleId></ArticleIdList></Reference><Reference><Citation>Konttinen H, Gureviciene I, Oksanen M, Grubman A, Loppi S, Huuskonen MT, et al. PPAR&#x3b2;/&#x3b4;-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1&#x394;E9 astrocytes. Glia. 2019;67:146&#x2013;59.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30453390</ArticleId><ArticleId IdType=\"doi\">10.1002/glia.23534</ArticleId></ArticleIdList></Reference><Reference><Citation>Liemburg-Apers DC, Willems PH, Koopman WJ, Grefte S. Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism. Arch Toxicol. 2015;89:1209&#x2013;26.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26047665</ArticleId><ArticleId IdType=\"pmc\">4508370</ArticleId><ArticleId IdType=\"doi\">10.1007/s00204-015-1520-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrisse S, Koehler RM, Chen JE, Patel GD, Vallurupalli VR, Ratliff BA, et al. Role of GLUT1 in regulation of reactive oxygen species. Redox Biol. 2014;2:746&#x2013;71.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39271711</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2041-1723</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Therapeutic efficacy of intracerebral hematopoietic stem cell gene therapy in an Alzheimer's disease mouse model.</ArticleTitle><Pagination><StartPage>8024</StartPage><MedlinePgn>8024</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">8024</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41467-024-52301-w</ELocationID><Abstract><AbstractText>The conditions supporting the generation of microglia-like cells in the central nervous system (CNS) after transplantation of hematopoietic stem/progenitor cells (HSPC) have been studied to advance the treatment of neurodegenerative disorders. Here, we explored the transplantation efficacy of different cell subsets and delivery routes with the goal of favoring the establishment of a stable and exclusive engraftment of HSPCs and their progeny in the CNS of female mice. In this setting, we show that the CNS environment drives the expansion, distribution and myeloid differentiation of the locally transplanted cells towards a microglia-like phenotype. Intra-CNS transplantation of HSPCs engineered to overexpress TREM2 decreased neuroinflammation, A&#x3b2; aggregation and improved memory in 5xFAD female mice. Our proof of concept study demonstrates the therapeutic potential of HSPC&#xa0;gene therapy for Alzheimer's disease.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Milazzo</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Hematology, Oncology and Stem Cell Transplantation, Department of Women and Child's Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>San Raffaele Telethon Institute for Gene Therapy, Division of Regenerative Medicine, Stem Cell and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Montepeloso</LastName><ForeName>Annita</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0003-3299-476X</Identifier><AffiliationInfo><Affiliation>Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kumar</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ferro</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>San Raffaele Telethon Institute for Gene Therapy, Division of Regenerative Medicine, Stem Cell and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cavalca</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>San Raffaele Telethon Institute for Gene Therapy, Division of Regenerative Medicine, Stem Cell and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rigoni</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><Identifier Source=\"ORCID\">0009-0007-1653-126X</Identifier><AffiliationInfo><Affiliation>Division of Hematology, Oncology and Stem Cell Transplantation, Department of Women and Child's Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cabras</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology \"L. Spallanzani\", Cellular and Molecular Neuropharmacology lab, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ciervo</LastName><ForeName>Yuri</ForeName><Initials>Y</Initials><Identifier Source=\"ORCID\">0000-0001-9546-7532</Identifier><AffiliationInfo><Affiliation>Division of Hematology, Oncology and Stem Cell Transplantation, Department of Women and Child's Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Das</LastName><ForeName>Sabyasachi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Capotondo</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>San Raffaele Telethon Institute for Gene Therapy, Division of Regenerative Medicine, Stem Cell and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pellin</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><Identifier Source=\"ORCID\">0000-0002-2647-0508</Identifier><AffiliationInfo><Affiliation>Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Peviani</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology and Biotechnology \"L. Spallanzani\", Cellular and Molecular Neuropharmacology lab, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Biffi</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-4610-0870</Identifier><AffiliationInfo><Affiliation>Division of Hematology, Oncology and Stem Cell Transplantation, Department of Women and Child's Health, University of Padua, Padua, Italy. alessandra.biffi@unipd.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>San Raffaele Telethon Institute for Gene Therapy, Division of Regenerative Medicine, Stem Cell and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy. alessandra.biffi@unipd.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. alessandra.biffi@unipd.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C498716\">Trem2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011971\">Receptors, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D008562\">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016229\">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D004195\" MajorTopicYN=\"Y\">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015316\" MajorTopicYN=\"Y\">Genetic Therapy</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018380\" MajorTopicYN=\"Y\">Hematopoietic Stem Cell Transplantation</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017628\" MajorTopicYN=\"Y\">Microglia</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006412\" MajorTopicYN=\"Y\">Hematopoietic Stem Cells</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008822\" MajorTopicYN=\"Y\">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011971\" MajorTopicYN=\"N\">Receptors, Immunologic</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008562\" MajorTopicYN=\"N\">Membrane Glycoproteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016229\" MajorTopicYN=\"N\">Amyloid beta-Peptides</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002454\" MajorTopicYN=\"N\">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008810\" MajorTopicYN=\"N\">Mice, Inbred C57BL</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>A.B., R.M., A.C. and M.P. are authors on a patent application related to this work (intracerebral transplantation of engineered HSCs) filed by Boston Children&#x2019;s Hospital, Dana Farber Cancer Institute, the San Raffaele Hospital and Politecnico of Milano (application no. PCT/US17/56774); A.B. and M.P. are authors of a provisional patent application related to this work (TREM2 HSC gene therapy for AD) filed by Boston Children&#x2019;s Hospital and Dana Farber Cancer Institute application no. PCT/US2020/053824). All other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271711</ArticleId><ArticleId IdType=\"doi\">10.1038/s41467-024-52301-w</ArticleId><ArticleId IdType=\"pii\">10.1038/s41467-024-52301-w</ArticleId><ArticleId IdType=\"pmc\">PMC11399302</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gomez Perdiguero, E., Schulz, C. &amp; Geissmann, F. Development and homeostasis of &#x201c;resident&#x201d; myeloid cells: the case of the microglia. Glia61, 112&#x2013;120 (2013). 10.1002/glia.22393</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/glia.22393</ArticleId><ArticleId IdType=\"pubmed\">22847963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science330, 841&#x2013;845 (2010). 10.1126/science.1194637</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1194637</ArticleId><ArticleId IdType=\"pmc\">PMC3719181</ArticleId><ArticleId IdType=\"pubmed\">20966214</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf, S. A., Boddeke, H. W. &amp; Kettenmann, H. Microglia in Physiology and Disease. Annu Rev. Physiol.79, 619&#x2013;643 (2017). 10.1146/annurev-physiol-022516-034406</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-physiol-022516-034406</ArticleId><ArticleId IdType=\"pubmed\">27959620</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y., Dissing-Olesen, L., MacVicar, B. A. &amp; Stevens, B. Microglia: Dynamic Mediators of Synapse Development and Plasticity. Trends Immunol.36, 605&#x2013;613 (2015). 10.1016/j.it.2015.08.008</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.it.2015.08.008</ArticleId><ArticleId IdType=\"pmc\">PMC4841266</ArticleId><ArticleId IdType=\"pubmed\">26431938</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli, R. C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science333, 1456&#x2013;1458 (2011). 10.1126/science.1202529</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1202529</ArticleId><ArticleId IdType=\"pubmed\">21778362</ArticleId></ArticleIdList></Reference><Reference><Citation>Capotondo, A. et al. Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells. Sci. Adv.3, e1701211 (2017). 10.1126/sciadv.1701211</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/sciadv.1701211</ArticleId><ArticleId IdType=\"pmc\">PMC5721728</ArticleId><ArticleId IdType=\"pubmed\">29226242</ArticleId></ArticleIdList></Reference><Reference><Citation>Capotondo, A. et al. Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation. Proc. Natl Acad. Sci. USA109, 15018&#x2013;15023 (2012). 10.1073/pnas.1205858109</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1205858109</ArticleId><ArticleId IdType=\"pmc\">PMC3443128</ArticleId><ArticleId IdType=\"pubmed\">22923692</ArticleId></ArticleIdList></Reference><Reference><Citation>Corti, S. et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain127, 2518&#x2013;2532 (2004). 10.1093/brain/awh273</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awh273</ArticleId><ArticleId IdType=\"pubmed\">15469951</ArticleId></ArticleIdList></Reference><Reference><Citation>Beam, D. et al. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol. Blood Marrow Transpl.13, 665&#x2013;674 (2007).10.1016/j.bbmt.2007.01.082</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbmt.2007.01.082</ArticleId><ArticleId IdType=\"pubmed\">17531776</ArticleId></ArticleIdList></Reference><Reference><Citation>Mildner, A. et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci.10, 1544&#x2013;1553 (2007). 10.1038/nn2015</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nn2015</ArticleId><ArticleId IdType=\"pubmed\">18026096</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson, C. D. et al. AAV-Mediated Gene Delivery to the Spinal Cord by Intrathecal Injection. Methods Mol. Biol.1950, 199&#x2013;207 (2019). 10.1007/978-1-4939-9139-6_11</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-1-4939-9139-6_11</ArticleId><ArticleId IdType=\"pubmed\">30783975</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichler, F. et al. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy. N. Engl. J. Med377, 1630&#x2013;1638 (2017). 10.1056/NEJMoa1700554</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa1700554</ArticleId><ArticleId IdType=\"pmc\">PMC5708849</ArticleId><ArticleId IdType=\"pubmed\">28976817</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessa, M. et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial. Lancet388, 476&#x2013;487 (2016). 10.1016/S0140-6736(16)30374-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(16)30374-9</ArticleId><ArticleId IdType=\"pubmed\">27289174</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungari, S. et al. Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy. Mol. Ther. Methods Clin. Dev.2, 15038 (2015). 10.1038/mtm.2015.38</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/mtm.2015.38</ArticleId><ArticleId IdType=\"pmc\">PMC4605225</ArticleId><ArticleId IdType=\"pubmed\">26509184</ArticleId></ArticleIdList></Reference><Reference><Citation>Biffi, A. et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science341, 1233158 (2013). 10.1126/science.1233158</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1233158</ArticleId><ArticleId IdType=\"pubmed\">23845948</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentner, B. et al. Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy. Sci. Transl. Med2, 58ra84 (2010). 10.1126/scitranslmed.3001522</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/scitranslmed.3001522</ArticleId><ArticleId IdType=\"pubmed\">21084719</ArticleId></ArticleIdList></Reference><Reference><Citation>Capotondo, A. et al. Safety of arylsulfatase A overexpression for gene therapy of metachromatic leukodystrophy. Hum. Gene Ther.18, 821&#x2013;836 (2007). 10.1089/hum.2007.048</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/hum.2007.048</ArticleId><ArticleId IdType=\"pubmed\">17845130</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartier, N. et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science326, 818&#x2013;823 (2009). 10.1126/science.1171242</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1171242</ArticleId><ArticleId IdType=\"pubmed\">19892975</ArticleId></ArticleIdList></Reference><Reference><Citation>Biffi, A. et al. Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice. J. Clin. Invest116, 3070&#x2013;3082 (2006). 10.1172/JCI28873</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1172/JCI28873</ArticleId><ArticleId IdType=\"pmc\">PMC1626132</ArticleId><ArticleId IdType=\"pubmed\">17080200</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocca, C. J. et al. CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich&#x2019;s Ataxia. Mol. Ther. Methods Clin. Dev.17, 1026&#x2013;1036 (2020). 10.1016/j.omtm.2020.04.018</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.omtm.2020.04.018</ArticleId><ArticleId IdType=\"pmc\">PMC7240056</ArticleId><ArticleId IdType=\"pubmed\">32462051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari, G., Thrasher, A. J. &amp; Aiuti, A. Gene therapy using haematopoietic stem and progenitor cells. Nat. Rev. Genet22, 216&#x2013;234 (2021). 10.1038/s41576-020-00298-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41576-020-00298-5</ArticleId><ArticleId IdType=\"pubmed\">33303992</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan, R. A., Gray, D., Lomova, A. &amp; Kohn, D. B. Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned. Cell Stem Cell21, 574&#x2013;590 (2017). 10.1016/j.stem.2017.10.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.stem.2017.10.010</ArticleId><ArticleId IdType=\"pmc\">PMC6039108</ArticleId><ArticleId IdType=\"pubmed\">29100011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrua, F. et al. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study. Lancet Haematol.6, e239&#x2013;e253 (2019). 10.1016/S2352-3026(19)30021-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S2352-3026(19)30021-3</ArticleId><ArticleId IdType=\"pmc\">PMC6494976</ArticleId><ArticleId IdType=\"pubmed\">30981783</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, M. et al. Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future. Biol. Blood Marrow Transpl.25, e226&#x2013;e246 (2019).10.1016/j.bbmt.2019.02.012</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbmt.2019.02.012</ArticleId><ArticleId IdType=\"pmc\">PMC6615945</ArticleId><ArticleId IdType=\"pubmed\">30772512</ArticleId></ArticleIdList></Reference><Reference><Citation>Stok, M. et al. Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe Disease. Mol. Ther. Methods Clin. Dev.17, 1014&#x2013;1025 (2020). 10.1016/j.omtm.2020.04.023</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.omtm.2020.04.023</ArticleId><ArticleId IdType=\"pmc\">PMC7240064</ArticleId><ArticleId IdType=\"pubmed\">32462050</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, C. et al. Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson&#x2019;s Disease. Mol. Ther. Methods Clin. Dev.17, 83&#x2013;98 (2020). 10.1016/j.omtm.2019.11.013</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.omtm.2019.11.013</ArticleId><ArticleId IdType=\"pmc\">PMC6931095</ArticleId><ArticleId IdType=\"pubmed\">31890743</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch, M. E. &amp; Kielian, T. Neuroinflammatory paradigms in lysosomal storage diseases. Front Neurosci.9, 417 (2015). 10.3389/fnins.2015.00417</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2015.00417</ArticleId><ArticleId IdType=\"pmc\">PMC4627351</ArticleId><ArticleId IdType=\"pubmed\">26578874</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalca, E. et al. Metallothioneins are neuroprotective agents in lysosomal storage disorders. Ann. Neurol.83, 418&#x2013;432 (2018). 10.1002/ana.25161</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.25161</ArticleId><ArticleId IdType=\"pubmed\">29369397</ArticleId></ArticleIdList></Reference><Reference><Citation>Holley, R. J. et al. Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy. Brain141, 99&#x2013;116 (2018). 10.1093/brain/awx311</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awx311</ArticleId><ArticleId IdType=\"pubmed\">29186350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sailor, K. A. et al. Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain. Nat. Med28, 517&#x2013;527 (2022). 10.1038/s41591-022-01691-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-022-01691-9</ArticleId><ArticleId IdType=\"pubmed\">35190726</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson, F. L. et al. Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation. Mol. Ther.21, 868&#x2013;876 (2013). 10.1038/mt.2013.29</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/mt.2013.29</ArticleId><ArticleId IdType=\"pmc\">PMC3616529</ArticleId><ArticleId IdType=\"pubmed\">23423338</ArticleId></ArticleIdList></Reference><Reference><Citation>Plasschaert, R. N. et al. High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing. Mol. Ther. 10.1016/j.ymthe.2022.05.022 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9552809</ArticleId><ArticleId IdType=\"pubmed\">35614857</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdonk, F. et al. Phenotypic clustering: a novel method for microglial morphology analysis. J. Neuroinflammation13, 153 (2016). 10.1186/s12974-016-0614-7</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-016-0614-7</ArticleId><ArticleId IdType=\"pmc\">PMC4912769</ArticleId><ArticleId IdType=\"pubmed\">27317566</ArticleId></ArticleIdList></Reference><Reference><Citation>Langhammer, C. G. et al. Automated Sholl analysis of digitized neuronal morphology at multiple scales: Whole cell Sholl analysis versus Sholl analysis of arbor subregions. Cytom. A77, 1160&#x2013;1168 (2010).10.1002/cyto.a.20954</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cyto.a.20954</ArticleId><ArticleId IdType=\"pmc\">PMC4619108</ArticleId><ArticleId IdType=\"pubmed\">20687200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett, M. L. et al. New tools for studying microglia in the mouse and human CNS. Proc. Natl Acad. Sci. USA113, E1738&#x2013;E1746 (2016). 10.1073/pnas.1525528113</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1525528113</ArticleId><ArticleId IdType=\"pmc\">PMC4812770</ArticleId><ArticleId IdType=\"pubmed\">26884166</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky, O. et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat. Neurosci.17, 131&#x2013;143 (2014). 10.1038/nn.3599</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nn.3599</ArticleId><ArticleId IdType=\"pmc\">PMC4066672</ArticleId><ArticleId IdType=\"pubmed\">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu, I. M. et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep.4, 385&#x2013;401 (2013). 10.1016/j.celrep.2013.06.018</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType=\"pmc\">PMC4272581</ArticleId><ArticleId IdType=\"pubmed\">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Grommes, C. et al. Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases. J. Neuroimmune Pharm.3, 130&#x2013;140 (2008).10.1007/s11481-007-9090-2</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11481-007-9090-2</ArticleId><ArticleId IdType=\"pmc\">PMC3653274</ArticleId><ArticleId IdType=\"pubmed\">18247125</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman, S. E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci.16, 1896&#x2013;1905 (2013). 10.1038/nn.3554</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nn.3554</ArticleId><ArticleId IdType=\"pmc\">PMC3840123</ArticleId><ArticleId IdType=\"pubmed\">24162652</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcovitch-Natan, O. et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science353, aad8670 (2016). 10.1126/science.aad8670</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.aad8670</ArticleId><ArticleId IdType=\"pubmed\">27338705</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund, H. et al. Competitive repopulation of an empty microglial niche yields functionally distinct subsets of microglia-like cells. Nat. Commun.9, 4845 (2018). 10.1038/s41467-018-07295-7</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-018-07295-7</ArticleId><ArticleId IdType=\"pmc\">PMC6242869</ArticleId><ArticleId IdType=\"pubmed\">30451869</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronk, J. C. et al. Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia. J. Exp. Med.215, 1627&#x2013;1647 (2018). 10.1084/jem.20180247</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1084/jem.20180247</ArticleId><ArticleId IdType=\"pmc\">PMC5987928</ArticleId><ArticleId IdType=\"pubmed\">29643186</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett, F. C. et al. A Combination of Ontogeny and CNS Environment Establishes Microglial Identity. Neuron98, 1170&#x2013;1183 e1178 (2018). 10.1016/j.neuron.2018.05.014</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2018.05.014</ArticleId><ArticleId IdType=\"pmc\">PMC6023731</ArticleId><ArticleId IdType=\"pubmed\">29861285</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruttger, J. et al. Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System. Immunity43, 92&#x2013;106 (2015). 10.1016/j.immuni.2015.06.012</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.immuni.2015.06.012</ArticleId><ArticleId IdType=\"pubmed\">26163371</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulland, T. K. &amp; Colonna, M. TREM2 - a key player in microglial biology and Alzheimer disease. Nat. Rev. Neurol.14, 667&#x2013;675 (2018). 10.1038/s41582-018-0072-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41582-018-0072-1</ArticleId><ArticleId IdType=\"pubmed\">30266932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, C. Y. D. et al. Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer&#x2019;s Disease Models. Neuron97, 1032&#x2013;1048 e1035 (2018). 10.1016/j.neuron.2018.02.002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2018.02.002</ArticleId><ArticleId IdType=\"pmc\">PMC5927822</ArticleId><ArticleId IdType=\"pubmed\">29518357</ArticleId></ArticleIdList></Reference><Reference><Citation>Benitez, B. A. et al. Missense variant in TREML2 protects against Alzheimer&#x2019;s disease. Neurobiol. Aging35, 1510 e1519&#x2013;1510 e1526 (2014).10.1016/j.neurobiolaging.2013.12.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2013.12.010</ArticleId><ArticleId IdType=\"pmc\">PMC3961557</ArticleId><ArticleId IdType=\"pubmed\">24439484</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley, H. et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer&#x2019;s disease mutations: potential factors in amyloid plaque formation. J. Neurosci.26, 10129&#x2013;10140 (2006). 10.1523/JNEUROSCI.1202-06.2006</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1202-06.2006</ArticleId><ArticleId IdType=\"pmc\">PMC6674618</ArticleId><ArticleId IdType=\"pubmed\">17021169</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawhar, S., Trawicka, A., Jenneckens, C., Bayer, T. A. &amp; Wirths, O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer&#x2019;s disease. Neurobiol. Aging33, 196 e129&#x2013;140 (2012).10.1016/j.neurobiolaging.2010.05.027</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2010.05.027</ArticleId><ArticleId IdType=\"pubmed\">20619937</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogg, S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharm. Biochem Behav.54, 21&#x2013;30 (1996).10.1016/0091-3057(95)02126-4</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0091-3057(95)02126-4</ArticleId><ArticleId IdType=\"pubmed\">8728535</ArticleId></ArticleIdList></Reference><Reference><Citation>Schambach, A. et al. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther.13, 641&#x2013;645 (2006). 10.1038/sj.gt.3302698</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.gt.3302698</ArticleId><ArticleId IdType=\"pubmed\">16355114</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiesjema, B. et al. Viral mediated neuropeptide Y expression in the rat paraventricular nucleus results in obesity. Obes. (Silver Spring)15, 2424&#x2013;2435 (2007).10.1038/oby.2007.288</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/oby.2007.288</ArticleId><ArticleId IdType=\"pubmed\">17925468</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagoo, P. &amp; Gaspar, H. B. The transformative potential of HSC gene therapy as a genetic medicine. Gene Ther. 10.1038/s41434-021-00261-x (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34040164</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartier, N., Lewis, C. A., Zhang, R. &amp; Rossi, F. M. The role of microglia in human disease: therapeutic tool or target? Acta Neuropathol.128, 363&#x2013;380 (2014). 10.1007/s00401-014-1330-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-014-1330-y</ArticleId><ArticleId IdType=\"pmc\">PMC4131134</ArticleId><ArticleId IdType=\"pubmed\">25107477</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, Z. et al. Efficient Strategies for Microglia Replacement in the Central Nervous System. Cell Rep.32, 108041 (2020). 10.1016/j.celrep.2020.108041</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2020.108041</ArticleId><ArticleId IdType=\"pubmed\">32783928</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohlen, C. J. et al. Diverse Requirements for Microglial Survival, Specification, and Function Revealed by Defined-Medium Cultures. Neuron94, 759&#x2013;773 e758 (2017). 10.1016/j.neuron.2017.04.043</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2017.04.043</ArticleId><ArticleId IdType=\"pmc\">PMC5523817</ArticleId><ArticleId IdType=\"pubmed\">28521131</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, R. et al. Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain. Nat. Commun.11, 1577 (2020). 10.1038/s41467-020-15411-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-020-15411-9</ArticleId><ArticleId IdType=\"pmc\">PMC7101330</ArticleId><ArticleId IdType=\"pubmed\">32221280</ArticleId></ArticleIdList></Reference><Reference><Citation>Parajuli, B. et al. Transnasal transplantation of human induced pluripotent stem cell-derived microglia to the brain of immunocompetent mice. Glia69, 2332&#x2013;2348 (2021). 10.1002/glia.23985</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/glia.23985</ArticleId><ArticleId IdType=\"pubmed\">34309082</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Pfeffer, J. L. et al. Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration. Pediatr. Neurol.67, 23&#x2013;35 (2017). 10.1016/j.pediatrneurol.2016.10.022</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pediatrneurol.2016.10.022</ArticleId><ArticleId IdType=\"pubmed\">28089765</ArticleId></ArticleIdList></Reference><Reference><Citation>Slavc, I. et al. Best practices for the use of intracerebroventricular drug delivery devices. Mol. Genet Metab.124, 184&#x2013;188 (2018). 10.1016/j.ymgme.2018.05.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ymgme.2018.05.003</ArticleId><ArticleId IdType=\"pubmed\">29793829</ArticleId></ArticleIdList></Reference><Reference><Citation>Duma, C. et al. Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients. Mol. Biol. Rep.46, 5257&#x2013;5272 (2019). 10.1007/s11033-019-04983-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11033-019-04983-5</ArticleId><ArticleId IdType=\"pubmed\">31327120</ArticleId></ArticleIdList></Reference><Reference><Citation>Villabona-Rueda, A., Erice, C., Pardo, C. A. &amp; Stins, M. F. The Evolving Concept of the Blood Brain Barrier (BBB): From a Single Static Barrier to a Heterogeneous and Dynamic Relay Center. Front. Cell Neurosci.13, 405 (2019). 10.3389/fncel.2019.00405</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2019.00405</ArticleId><ArticleId IdType=\"pmc\">PMC6763697</ArticleId><ArticleId IdType=\"pubmed\">31616251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge, S. &amp; Pachter, J. S. Isolation and culture of microvascular endothelial cells from murine spinal cord. J. Neuroimmunol.177, 209&#x2013;214 (2006). 10.1016/j.jneuroim.2006.05.012</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jneuroim.2006.05.012</ArticleId><ArticleId IdType=\"pubmed\">16806499</ArticleId></ArticleIdList></Reference><Reference><Citation>Bifari, F. et al. Neurogenic Radial Glia-like Cells in Meninges Migrate and Differentiate into Functionally Integrated Neurons in the Neonatal Cortex. Cell Stem Cell20, 360&#x2013;373 e367 (2017). 10.1016/j.stem.2016.10.020</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.stem.2016.10.020</ArticleId><ArticleId IdType=\"pubmed\">27889318</ArticleId></ArticleIdList></Reference><Reference><Citation>Benakis, C., Llovera, G. &amp; Liesz, A. The meningeal and choroidal infiltration routes for leukocytes in stroke. Ther. Adv. Neurol. Disord.11, 1756286418783708 (2018). 10.1177/1756286418783708</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1756286418783708</ArticleId><ArticleId IdType=\"pmc\">PMC6024265</ArticleId><ArticleId IdType=\"pubmed\">29977343</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlager, C. et al. Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid. Nature530, 349&#x2013;353 (2016). 10.1038/nature16939</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature16939</ArticleId><ArticleId IdType=\"pubmed\">26863192</ArticleId></ArticleIdList></Reference><Reference><Citation>Decimo, I. et al. Meninges: A Widespread Niche of Neural Progenitors for the Brain. Neuroscientist27, 506&#x2013;528 (2021). 10.1177/1073858420954826</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1073858420954826</ArticleId><ArticleId IdType=\"pmc\">PMC8442137</ArticleId><ArticleId IdType=\"pubmed\">32935634</ArticleId></ArticleIdList></Reference><Reference><Citation>Banisadr, G. et al. Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J. Comp. Neurol.489, 275&#x2013;292 (2005). 10.1002/cne.20598</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cne.20598</ArticleId><ArticleId IdType=\"pubmed\">16025454</ArticleId></ArticleIdList></Reference><Reference><Citation>Luskin, M. B. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron11, 173&#x2013;189 (1993). 10.1016/0896-6273(93)90281-U</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0896-6273(93)90281-U</ArticleId><ArticleId IdType=\"pubmed\">8338665</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlen, M. et al. Functional integration of adult-born neurons. Curr. Biol.12, 606&#x2013;608 (2002). 10.1016/S0960-9822(02)00771-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0960-9822(02)00771-6</ArticleId><ArticleId IdType=\"pubmed\">11937032</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeker, R. B., Williams, K., Killebrew, D. A. &amp; Hudson, L. C. Cell trafficking through the choroid plexus. Cell Adh Migr.6, 390&#x2013;396 (2012). 10.4161/cam.21054</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4161/cam.21054</ArticleId><ArticleId IdType=\"pmc\">PMC3496674</ArticleId><ArticleId IdType=\"pubmed\">22902764</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunis, G. et al. IFN-gamma-dependent activation of the brain&#x2019;s choroid plexus for CNS immune surveillance and repair. Brain136, 3427&#x2013;3440 (2013). 10.1093/brain/awt259</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awt259</ArticleId><ArticleId IdType=\"pubmed\">24088808</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselin, D. et al. An environment-dependent transcriptional network specifies human microglia identity. Science356, 10.1126/science.aal3222 (2017).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5858585</ArticleId><ArticleId IdType=\"pubmed\">28546318</ArticleId></ArticleIdList></Reference><Reference><Citation>Shemer, A. et al. Engrafted parenchymal brain macrophages differ from microglia in transcriptome, chromatin landscape and response to challenge. Nat. Commun.9, 5206 (2018). 10.1038/s41467-018-07548-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-018-07548-5</ArticleId><ArticleId IdType=\"pmc\">PMC6284018</ArticleId><ArticleId IdType=\"pubmed\">30523248</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohsfield, L. A. et al. Effects of long-term and brain-wide colonization of peripheral bone marrow-derived myeloid cells in the CNS. J. Neuroinflammation17, 279 (2020). 10.1186/s12974-020-01931-0</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12974-020-01931-0</ArticleId><ArticleId IdType=\"pmc\">PMC7504855</ArticleId><ArticleId IdType=\"pubmed\">32951604</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuadros, M. A., Sepulveda, M. R., Martin-Oliva, D., Marin-Teva, J. L. &amp; Neubrand, V. E. Microglia and Microglia-Like Cells: Similar but Different. Front Cell Neurosci.16, 816439 (2022). 10.3389/fncel.2022.816439</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2022.816439</ArticleId><ArticleId IdType=\"pmc\">PMC8859783</ArticleId><ArticleId IdType=\"pubmed\">35197828</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, C., Chen, Y. H. &amp; Zhang, K. Neuroprotective Properties and Therapeutic Potential of Bone Marrow-Derived Microglia in Alzheimer&#x2019;s Disease. Am. J. Alzheimers Dis. Other Demen35, 1533317520927169 (2020). 10.1177/1533317520927169</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1533317520927169</ArticleId><ArticleId IdType=\"pmc\">PMC10623913</ArticleId><ArticleId IdType=\"pubmed\">32536247</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra, P. et al. Rescue of Alzheimer&#x2019;s disease phenotype in a mouse model by transplantation of wild-type hematopoietic stem and progenitor cells. Cell Rep.42, 112956 (2023). 10.1016/j.celrep.2023.112956</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2023.112956</ArticleId><ArticleId IdType=\"pmc\">PMC10617121</ArticleId><ArticleId IdType=\"pubmed\">37561625</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard, A. R., Soulet, D., Gowing, G., Julien, J. P. &amp; Rivest, S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer&#x2019;s disease. Neuron49, 489&#x2013;502 (2006). 10.1016/j.neuron.2006.01.022</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2006.01.022</ArticleId><ArticleId IdType=\"pubmed\">16476660</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard, A. R. &amp; Rivest, S. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer&#x2019;s disease. Mol. Psychiatry11, 327&#x2013;335 (2006). 10.1038/sj.mp.4001809</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.mp.4001809</ArticleId><ArticleId IdType=\"pubmed\">16491130</ArticleId></ArticleIdList></Reference><Reference><Citation>Visigalli, I. et al. Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model. Blood116, 5130&#x2013;5139 (2010). 10.1182/blood-2010-04-278234</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1182/blood-2010-04-278234</ArticleId><ArticleId IdType=\"pmc\">PMC3709639</ArticleId><ArticleId IdType=\"pubmed\">20847202</ArticleId></ArticleIdList></Reference><Reference><Citation>Peviani, M. et al. Lipophilic dye-compatible brain clearing technique allowing correlative magnetic resonance/high-resolution fluorescence imaging in rat models of glioblastoma. Sci. Rep.10, 17974 (2020). 10.1038/s41598-020-75137-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-020-75137-y</ArticleId><ArticleId IdType=\"pmc\">PMC7578790</ArticleId><ArticleId IdType=\"pubmed\">33087842</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics29, 15&#x2013;21 (2013). 10.1093/bioinformatics/bts635</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType=\"pmc\">PMC3530905</ArticleId><ArticleId IdType=\"pubmed\">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Team, R. C. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, https://www.R-project.org/ (2013).</Citation></Reference><Reference><Citation>Love, M. I., Huber, W. &amp; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.15, 550 (2014). 10.1186/s13059-014-0550-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType=\"pmc\">PMC4302049</ArticleId><ArticleId IdType=\"pubmed\">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey, K. R. &amp; Crawley, J. N. In Methods of Behavior Analysis in Neuroscience Frontiers in Neuroscience (eds nd &amp; J. J. Buccafusco) (2009).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21204335</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman, J. L. et al. Sociability and motor functions in Shank1 mutant mice. Brain Res1380, 120&#x2013;137 (2011). 10.1016/j.brainres.2010.09.026</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.brainres.2010.09.026</ArticleId><ArticleId IdType=\"pmc\">PMC3041833</ArticleId><ArticleId IdType=\"pubmed\">20868654</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39271694</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2045-2322</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The biphasic impact of apolipoprotein E &#x3b5;4 allele on age-related hearing loss.</ArticleTitle><Pagination><StartPage>21420</StartPage><MedlinePgn>21420</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">21420</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41598-024-71774-9</ELocationID><Abstract><AbstractText>Both the &#x3b5;4 variant of the apolipoprotein E (APOE) gene and hearing loss are well-known risk factors for Alzheimer's disease. However, previous studies have produced inconsistent findings regarding the association between APOE genotypes and hearing levels, necessitating further investigation. The aim of this study was to investigate the relationship between APOE genotypes and hearing levels. This retrospective study analyzed clinical data from a clinical data warehouse of seven affiliated Catholic Medical Center hospitals. The study included 1,162 participants with records of APOE genotypes, audiometric tests, and cognitive function tests. In Generalized linear mixed model analysis, &#x3b5;4 carriers exhibited lower pure tone audiometry thresholds with an estimate of -0.353 (SE&#x2009;=&#x2009;0.126, p&#x2009;=&#x2009;0.005). However, the interaction term for age and APOE &#x3b5;4 had a coefficient of 0.577 (SE&#x2009;=&#x2009;0.214 p&#x2009;=&#x2009;0.006), suggesting that the APOE &#x3b5;4 gene may accelerate hearing deterioration with age. Subgroup analysis based on an age cut-off of 75 revealed that &#x3b5;4 carriers had better hearing at younger ages, but showed no significant difference at older ages. These results indicate that the &#x3b5;4 allele may have a biphasic effect on hearing levels depending on age.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Han</LastName><ForeName>Jae Sang</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-Daero, Seocho-gu, Seoul, 06591, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yoo</LastName><ForeName>Sung Goo</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lee</LastName><ForeName>Sun Jung</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lee</LastName><ForeName>Hyun Jin</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Choi</LastName><ForeName>In Young</ForeName><Initials>IY</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. iychoi@catholic.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. iychoi@catholic.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Park</LastName><ForeName>Kyoung Ho</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-Daero, Seocho-gu, Seoul, 06591, Republic of Korea. khpent@catholic.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>NRF-2019R1A5A2027588</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D053327\">Apolipoprotein E4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D053327\" MajorTopicYN=\"Y\">Apolipoprotein E4</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000483\" MajorTopicYN=\"Y\">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012189\" MajorTopicYN=\"N\">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D034381\" MajorTopicYN=\"Y\">Hearing Loss</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000369\" MajorTopicYN=\"N\">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005838\" MajorTopicYN=\"N\">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001301\" MajorTopicYN=\"N\">Audiometry, Pure-Tone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011304\" MajorTopicYN=\"N\">Presbycusis</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000375\" MajorTopicYN=\"N\">Aging</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Aging</Keyword><Keyword MajorTopicYN=\"N\">Apolipoprotein E</Keyword><Keyword MajorTopicYN=\"N\">Hearing loss</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271694</ArticleId><ArticleId IdType=\"doi\">10.1038/s41598-024-71774-9</ArticleId><ArticleId IdType=\"pii\">10.1038/s41598-024-71774-9</ArticleId><ArticleId IdType=\"pmc\">PMC11399432</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Man, J. et al. Global, regional, and national burden of age-related hearing loss from 1990 to 2019. Aging (Albany NY)13, 25944&#x2013;25959 (2021). 10.18632/aging.203782</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/aging.203782</ArticleId><ArticleId IdType=\"pmc\">PMC8751586</ArticleId><ArticleId IdType=\"pubmed\">34910687</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, J. C. S. et al. Hearing and dementia: From ears to brain. Brain144, 391&#x2013;401 (2021). 10.1093/brain/awaa429</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awaa429</ArticleId><ArticleId IdType=\"pmc\">PMC7940169</ArticleId><ArticleId IdType=\"pubmed\">33351095</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet396, 413&#x2013;446 (2020). 10.1016/S0140-6736(20)30367-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(20)30367-6</ArticleId><ArticleId IdType=\"pmc\">PMC7392084</ArticleId><ArticleId IdType=\"pubmed\">32738937</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama278, 1349&#x2013;1356 (1997). 10.1001/jama.1997.03550160069041</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.1997.03550160069041</ArticleId><ArticleId IdType=\"pubmed\">9343467</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y., Strickland, M. R., Soranno, A. &amp; Holtzman, D. M. Apolipoprotein E: Structural insights and links to Alzheimer disease pathogenesis. Neuron109, 205&#x2013;221 (2021). 10.1016/j.neuron.2020.10.008</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2020.10.008</ArticleId><ArticleId IdType=\"pmc\">PMC7931158</ArticleId><ArticleId IdType=\"pubmed\">33176118</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, Y., Zhang, C., Du, X., Nair, U. &amp; Yoo, T. J. Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice. Hear. Res.208, 54&#x2013;67 (2005). 10.1016/j.heares.2005.05.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.heares.2005.05.010</ArticleId><ArticleId IdType=\"pubmed\">16051453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, C. H., Son, K. J., Lee, J. H. &amp; Kim, J. H. Sex differences in the association between the APOE&#x3b5;4 allele and hearing impairment: A longitudinal memory clinic study. Arch. Gerontol. Geriatr.95, 104418 (2021). 10.1016/j.archger.2021.104418</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.archger.2021.104418</ArticleId><ArticleId IdType=\"pubmed\">33989962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurniawan, C. et al. Gene dose of apolipoprotein E and age-related hearing loss. Neurobiol. Aging33(2230), e2237-2230.e2212 (2012).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22542837</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawes, P. et al. No association between apolipoprotein E or N-acetyltransferase 2 gene polymorphisms and age-related hearing loss. Laryngoscope125, E33-38 (2015). 10.1002/lary.24898</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/lary.24898</ArticleId><ArticleId IdType=\"pmc\">PMC4758402</ArticleId><ArticleId IdType=\"pubmed\">25155015</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita, Y. et al. Age-related hearing loss is strongly associated with cognitive decline regardless of the APOE4 polymorphism. Otol. Neurotol.40, 1263&#x2013;1267 (2019). 10.1097/MAO.0000000000002415</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MAO.0000000000002415</ArticleId><ArticleId IdType=\"pubmed\">31664002</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Grady, G. et al. Apolipoprotein E alleles and sensorineural hearing loss. Int. J. Audiol.46, 183&#x2013;186 (2007). 10.1080/14992020601145294</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/14992020601145294</ArticleId><ArticleId IdType=\"pubmed\">17454231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarant, J. Z., Bowe, S. J., McEvoy, M. &amp; Attia, J. The apolipoprotein allele and sensorineural hearing loss in older community-dwelling adults in Australia. Ear. Hear.41, 622&#x2013;629 (2020). 10.1097/AUD.0000000000000788</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/AUD.0000000000000788</ArticleId><ArticleId IdType=\"pubmed\">31592904</ArticleId></ArticleIdList></Reference><Reference><Citation>Mener, D. J. et al. Apolipoprotein E allele and hearing thresholds in older adults. Am. J. Alzheimers Dis. Other. Demen.31, 34&#x2013;39 (2016). 10.1177/1533317514537549</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1533317514537549</ArticleId><ArticleId IdType=\"pmc\">PMC4258173</ArticleId><ArticleId IdType=\"pubmed\">24906966</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, S. J. et al. Machine learning prediction of dropping out of outpatients with alcohol use disorders. PLoS ONE16, e0255626 (2021). 10.1371/journal.pone.0255626</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0255626</ArticleId><ArticleId IdType=\"pmc\">PMC8328309</ArticleId><ArticleId IdType=\"pubmed\">34339461</ArticleId></ArticleIdList></Reference><Reference><Citation>Olusanya, B. O., Davis, A. C. &amp; Hoffman, H. J. Hearing loss grades and the International classification of functioning, disability and health. Bull. World Health Organ.97, 725&#x2013;728 (2019). 10.2471/BLT.19.230367</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2471/BLT.19.230367</ArticleId><ArticleId IdType=\"pmc\">PMC6796665</ArticleId><ArticleId IdType=\"pubmed\">31656340</ArticleId></ArticleIdList></Reference><Reference><Citation>Byun, S. W. Frequencies of Korean phonemes and reliability of Korean phonetically balanced word lists. Korean J. Otorhinolaryngol.-Head Neck Surg.44, 485&#x2013;489 (2001).</Citation></Reference><Reference><Citation>Yuan, G. et al. Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients. J. Neurooncol.133, 193&#x2013;201 (2017). 10.1007/s11060-017-2433-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11060-017-2433-9</ArticleId><ArticleId IdType=\"pubmed\">28516344</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamil, R. J., Genther, D. J. &amp; Lin, F. R. Factors associated with the accuracy of subjective assessments of hearing impairment. Ear. Hear.36, 164&#x2013;167 (2015). 10.1097/AUD.0000000000000075</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/AUD.0000000000000075</ArticleId><ArticleId IdType=\"pmc\">PMC4272625</ArticleId><ArticleId IdType=\"pubmed\">25158982</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiman, E. M. et al. Exceptionally low likelihood of Alzheimer&#x2019;s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat. Commun.11, 667 (2020). 10.1038/s41467-019-14279-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-019-14279-8</ArticleId><ArticleId IdType=\"pmc\">PMC6997393</ArticleId><ArticleId IdType=\"pubmed\">32015339</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacker, D. et al. ApoE-4 and age at onset of Alzheimer&#x2019;s disease: The NIMH genetics initiative. Neurology48, 139&#x2013;147 (1997). 10.1212/WNL.48.1.139</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.48.1.139</ArticleId><ArticleId IdType=\"pubmed\">9008509</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C. &amp; Bu, G. Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies. Nat. Rev. Neurol.15, 501&#x2013;518 (2019). 10.1038/s41582-019-0228-7</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41582-019-0228-7</ArticleId><ArticleId IdType=\"pmc\">PMC7055192</ArticleId><ArticleId IdType=\"pubmed\">31367008</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, M. et al. Worsening hearing was associated with higher &#x3b2;-amyloid and tau burden in age-related hearing loss. Sci. Rep.12, 10493 (2022). 10.1038/s41598-022-14466-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-022-14466-6</ArticleId><ArticleId IdType=\"pmc\">PMC9212197</ArticleId><ArticleId IdType=\"pubmed\">35729211</ArticleId></ArticleIdList></Reference><Reference><Citation>Omata, Y. et al. Expression of amyloid-&#x3b2; in mouse cochlear hair cells causes an early-onset auditory defect in high-frequency sound perception. Aging (Albany NY)8, 427&#x2013;439 (2016). 10.18632/aging.100899</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/aging.100899</ArticleId><ArticleId IdType=\"pmc\">PMC4833138</ArticleId><ArticleId IdType=\"pubmed\">26959388</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarant, J. Z. et al. No influence of age-related hearing loss on brain amyloid-&#x3b2;. J. Alzheimers Dis.85, 359&#x2013;367 (2022). 10.3233/JAD-215121</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-215121</ArticleId><ArticleId IdType=\"pmc\">PMC8842788</ArticleId><ArticleId IdType=\"pubmed\">34806606</ArticleId></ArticleIdList></Reference><Reference><Citation>Irace, A. L., Rippon, B. Q., Brickman, A. M., Luchsinger, J. A. &amp; Golub, J. S. The laterality of early age-related hearing loss and brain &#x3b2;-amyloid. Otol. Neurotol.43, e382&#x2013;e390 (2022). 10.1097/MAO.0000000000003454</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MAO.0000000000003454</ArticleId><ArticleId IdType=\"pmc\">PMC8852334</ArticleId><ArticleId IdType=\"pubmed\">35147609</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil, Y. A., Rab&#xe8;s, J. P., Boileau, C. &amp; Varret, M. APOE gene variants in primary dyslipidemia. Atherosclerosis328, 11&#x2013;22 (2021). 10.1016/j.atherosclerosis.2021.05.007</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.atherosclerosis.2021.05.007</ArticleId><ArticleId IdType=\"pubmed\">34058468</ArticleId></ArticleIdList></Reference><Reference><Citation>Malgrange, B., Varela-Nieto, I., de Medina, P. &amp; Paillasse, M. R. Targeting cholesterol homeostasis to fight hearing loss: A new perspective. Front. Aging Neurosci.7, 3 (2015). 10.3389/fnagi.2015.00003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2015.00003</ArticleId><ArticleId IdType=\"pmc\">PMC4310297</ArticleId><ArticleId IdType=\"pubmed\">25688206</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson, A. N., Matthews, L. J. &amp; Dubno, J. R. Lipid and C-reactive protein levels as risk factors for hearing loss in older adults. Otolaryngol. Head Neck Surg.148, 664&#x2013;670 (2013). 10.1177/0194599812473936</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0194599812473936</ArticleId><ArticleId IdType=\"pmc\">PMC3872056</ArticleId><ArticleId IdType=\"pubmed\">23322627</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumsden, A. L., Mulugeta, A., Zhou, A. &amp; Hypp&#xf6;nen, E. Apolipoprotein E (APOE) genotype-associated disease risks: A phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine59, 102954 (2020). 10.1016/j.ebiom.2020.102954</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ebiom.2020.102954</ArticleId><ArticleId IdType=\"pmc\">PMC7452404</ArticleId><ArticleId IdType=\"pubmed\">32818802</ArticleId></ArticleIdList></Reference><Reference><Citation>Martiskainen, H. et al. Decreased plasma C-reactive protein levels in APOE &#x3b5;4 allele carriers. Ann. Clin. Transl. Neurol.5, 1229&#x2013;1240 (2018). 10.1002/acn3.639</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/acn3.639</ArticleId><ArticleId IdType=\"pmc\">PMC6186931</ArticleId><ArticleId IdType=\"pubmed\">30349858</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia, A. R. et al. APOE4 is associated with elevated blood lipids and lower levels of innate immune biomarkers in a tropical Amerindian subsistence population. eLife10, e68231 (2021). 10.7554/eLife.68231</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7554/eLife.68231</ArticleId><ArticleId IdType=\"pmc\">PMC8480980</ArticleId><ArticleId IdType=\"pubmed\">34586066</ArticleId></ArticleIdList></Reference><Reference><Citation>Trumble, B. C. et al. Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden. Faseb. J.31, 1508&#x2013;1515 (2017). 10.1096/fj.201601084R</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1096/fj.201601084R</ArticleId><ArticleId IdType=\"pmc\">PMC5349792</ArticleId><ArticleId IdType=\"pubmed\">28031319</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, F. R., Thorpe, R., Gordon-Salant, S. &amp; Ferrucci, L. Hearing loss prevalence and risk factors among older adults in the United States. J. Gerontol.: Ser. A66A, 582&#x2013;590 (2011).10.1093/gerona/glr002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gerona/glr002</ArticleId><ArticleId IdType=\"pmc\">PMC3074958</ArticleId><ArticleId IdType=\"pubmed\">21357188</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal-Robledano, A. et al. Cognitive screening and hearing assessment in patients with chronic tinnitus. Clin. Exp. Otorhinolaryngol.17, 15 (2024). 10.21053/ceo.2023.00808</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.21053/ceo.2023.00808</ArticleId><ArticleId IdType=\"pmc\">PMC10933812</ArticleId><ArticleId IdType=\"pubmed\">37974057</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39271655</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2158-3188</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Translational psychiatry</Title><ISOAbbreviation>Transl Psychiatry</ISOAbbreviation></Journal><ArticleTitle>P-tau217 and other blood biomarkers of dementia: variation with time of day.</ArticleTitle><Pagination><StartPage>373</StartPage><MedlinePgn>373</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">373</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41398-024-03084-7</ELocationID><Abstract><AbstractText>Plasma biomarkers of dementia, including phosphorylated tau (p-tau217), offer promise as tools for diagnosis, stratification for clinical trials, monitoring disease progression, and assessing the success of interventions in those living with Alzheimer's disease. However, currently, it is unknown whether these dementia biomarker levels vary with the time of day, which could have implications for their clinical value. In two protocols, we studied 38 participants (70.8&#x2009;&#xb1;&#x2009;7.6 years; mean&#x2009;&#xb1;&#x2009;SD) in a 27-h laboratory protocol with either two samples taken 12&#x2009;h apart or 3-hourly blood sampling for 24&#x2009;h in the presence of a sleep-wake cycle. The study population comprised people living with mild Alzheimer's disease (PLWA, n&#x2009;=&#x2009;8), partners/caregivers of PLWA (n&#x2009;=&#x2009;6) and cognitively intact older adults (n&#x2009;=&#x2009;24). Single-molecule array technology was used to measure phosphorylated tau (p-tau217) (ALZpath), amyloid-beta 40 (A&#x3b2;40), amyloid-beta 42 (A&#x3b2;42), glial fibrillary acidic protein, and neurofilament light (NfL) (Neuro 4-Plex E). Analysis with a linear mixed model (SAS, PROC MIXED) revealed a significant effect of time of day for p-tau217, A&#x3b2;40, A&#x3b2;42, and NfL, and a significant effect of participant group for p-tau217. For p-tau217, the lowest levels were observed in the morning upon waking and the highest values in the afternoon/early evening. The magnitude of the diurnal variation for p-tau217 was similar to the reported increase in p-tau217 over one year in amyloid-&#x3b2;-positive mild cognitively impaired people. Currently, the factors driving this diurnal variation are unknown and could be related to sleep, circadian mechanisms, activity, posture, or meals. Overall, this work implies that the time of day of sample collection may be relevant in the implementation and interpretation of plasma biomarkers in dementia research and care.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Della Monica</LastName><ForeName>Ciro</ForeName><Initials>C</Initials><Identifier Source=\"ORCID\">0000-0003-0422-4872</Identifier><AffiliationInfo><Affiliation>Surrey Sleep Research Centre, University of Surrey, Surrey, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute Care Research &amp; Technology Centre, Imperial College London and University of Surrey, Surrey, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Revell</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Surrey Sleep Research Centre, University of Surrey, Surrey, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute Care Research &amp; Technology Centre, Imperial College London and University of Surrey, Surrey, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Atzori</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Surrey Sleep Research Centre, University of Surrey, Surrey, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute Care Research &amp; Technology Centre, Imperial College London and University of Surrey, Surrey, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Laban</LastName><ForeName>Rhiannon</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">0000-0002-5926-8357</Identifier><AffiliationInfo><Affiliation>UK Dementia Research Institute at UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Skene</LastName><ForeName>Simon S</ForeName><Initials>SS</Initials><Identifier Source=\"ORCID\">0000-0002-7828-3122</Identifier><AffiliationInfo><Affiliation>Surrey Clinical Trials Unit, University of Surrey, Surrey, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Heslegrave</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at UCL, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hassanin</LastName><ForeName>Hana</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute Care Research &amp; Technology Centre, Imperial College London and University of Surrey, Surrey, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surrey Clinical Research Facility, University of Surrey, Surrey, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Royal Surrey CRF, Guildford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nilforooshan</LastName><ForeName>Ramin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute Care Research &amp; Technology Centre, Imperial College London and University of Surrey, Surrey, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surrey and Borders Partnership NHS Foundation Trust Surrey, Surrey, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zetterberg</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at UCL, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dijk</LastName><ForeName>Derk-Jan</ForeName><Initials>DJ</Initials><Identifier Source=\"ORCID\">0000-0001-5314-1008</Identifier><AffiliationInfo><Affiliation>Surrey Sleep Research Centre, University of Surrey, Surrey, UK. d.j.dijk@surrey.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute Care Research &amp; Technology Centre, Imperial College London and University of Surrey, Surrey, UK. d.j.dijk@surrey.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transl Psychiatry</MedlineTA><NlmUniqueID>101562664</NlmUniqueID><ISSNLinking>2158-3188</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016875\">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016229\">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D010446\">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C054369\">MAPT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016900\">Neurofilament Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C044882\">neurofilament protein L</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C075222\">amyloid beta-protein (1-42)</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C078592\">amyloid beta-protein (1-40)</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C000628670\">GFAP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D005904\">Glial Fibrillary Acidic Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016875\" MajorTopicYN=\"Y\">tau Proteins</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015415\" MajorTopicYN=\"Y\">Biomarkers</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016229\" MajorTopicYN=\"Y\">Amyloid beta-Peptides</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D010766\" MajorTopicYN=\"N\">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002940\" MajorTopicYN=\"N\">Circadian Rhythm</DescriptorName><QualifierName UI=\"Q000502\" MajorTopicYN=\"N\">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010446\" MajorTopicYN=\"N\">Peptide Fragments</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016900\" MajorTopicYN=\"N\">Neurofilament Proteins</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000369\" MajorTopicYN=\"N\">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003704\" MajorTopicYN=\"N\">Dementia</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012890\" MajorTopicYN=\"N\">Sleep</DescriptorName><QualifierName UI=\"Q000502\" MajorTopicYN=\"N\">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017028\" MajorTopicYN=\"N\">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005904\" MajorTopicYN=\"N\">Glial Fibrillary Acidic Protein</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave; has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, and Roche; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). The other authors declare that they have no conflicts of interest related to this research.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271655</ArticleId><ArticleId IdType=\"doi\">10.1038/s41398-024-03084-7</ArticleId><ArticleId IdType=\"pii\">10.1038/s41398-024-03084-7</ArticleId><ArticleId IdType=\"pmc\">PMC11399374</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blennow K, Galasko D, Perneczky R, Quevenco FC, van der Flier WM, Akinwonmi A, et al. The potential clinical value of plasma biomarkers in Alzheimer&#x2019;s disease. Alzheimers Dement. 2023;19:5805&#x2013;16. 10.1002/alz.13455</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13455</ArticleId><ArticleId IdType=\"pubmed\">37694991</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer's Association Report. 2020 Alzheimeras disease facts and figures. Alzheimers Dement. 2020;16:391&#x2013;460.10.1002/alz.12068</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.12068</ArticleId></ArticleIdList></Reference><Reference><Citation>Bittner T. Editorial: What are the remaining challenges before blood-based biomarkers for Alzheimer&#x2019;s disease can be used in clinical practice? J Prev Alzheimers Dis. 2022;9:567&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36281660</ArticleId></ArticleIdList></Reference><Reference><Citation>Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer&#x2019;s disease. J Prev Alzheimers Dis. 2022;9:197&#x2013;210.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35542991</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer&#x2019;s disease. N Engl J Med. 2023;388:9&#x2013;21. 10.1056/NEJMoa2212948</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa2212948</ArticleId><ArticleId IdType=\"pubmed\">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330:512&#x2013;27. 10.1001/jama.2023.13239</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2023.13239</ArticleId><ArticleId IdType=\"pmc\">PMC10352931</ArticleId><ArticleId IdType=\"pubmed\">37459141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J, Aisen P, Apostolova LG, Atri A, Salloway S, Weiner M. Aducanumab: appropriate use recommendations. J Prev Alzheimers Dis. 2021;8:398&#x2013;410.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8835345</ArticleId><ArticleId IdType=\"pubmed\">34585212</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson-Carlgren N, Salvado G, Ashton NJ, Tideman P, Stomrud E, Zetterberg H, et al. Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers. JAMA Neurol. 2023;80:360&#x2013;9. 10.1001/jamaneurol.2022.5272</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaneurol.2022.5272</ArticleId><ArticleId IdType=\"pmc\">PMC10087054</ArticleId><ArticleId IdType=\"pubmed\">36745413</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontecorvo MJ, Lu M, Burnham SC, Schade AE, Dage JL, Shcherbinin S, et al. Association of donanemab treatment with exploratory plasma biomarkers in early symptomatic Alzheimer disease: a secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial. JAMA Neurol. 2022;79:1250&#x2013;9. 10.1001/jamaneurol.2022.3392</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaneurol.2022.3392</ArticleId><ArticleId IdType=\"pmc\">PMC9577883</ArticleId><ArticleId IdType=\"pubmed\">36251300</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo MS, Tissot C, Lantero-Rodriguez J, Snellman A, Therriault J, Rahmouni N, et al. Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-beta positive individuals. Alzheimers Dement. 2024;20:1166&#x2013;74. 10.1002/alz.13528</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13528</ArticleId><ArticleId IdType=\"pmc\">PMC10916953</ArticleId><ArticleId IdType=\"pubmed\">37920945</ArticleId></ArticleIdList></Reference><Reference><Citation>Durrington HJ, Gioan-Tavernier GO, Maidstone RJ, Krakowiak K, Loudon ASI, Blaikley JF, et al. Time of day affects eosinophil biomarkers in asthma: implications for diagnosis and treatment. Am J Respir Crit Care Med. 2018;198:1578&#x2013;81. 10.1164/rccm.201807-1289LE</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1164/rccm.201807-1289LE</ArticleId><ArticleId IdType=\"pmc\">PMC6298638</ArticleId><ArticleId IdType=\"pubmed\">30156881</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindran GKK, della Monica C, Atzori G, Lambert D, Hassanin H, Revell V, et al. Three contactless sleep technologies compared to actigraphy and polysomnography in a heterogenous group of older men and women in a model of mild sleep disturbance: a sleep laboratory study. JMIR Mhealth Uhealth. 2023;11:46338.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10632916</ArticleId><ArticleId IdType=\"pubmed\">37878360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindran KKG, della Monica C, Atzori G, Lambert D, Hassanin H, Revell V, et al. Contactless and longitudinal monitoring of nocturnal sleep and daytime naps in older men and women: a digital health technology evaluation study. Sleep. 2023;46:zsad194.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10566241</ArticleId><ArticleId IdType=\"pubmed\">37471049</ArticleId></ArticleIdList></Reference><Reference><Citation>della Monica C, Ravindran KK, Atzori G, Lambert DJ, Rodriguez T, Mahvash-Mohammadi S, et al. A protocol for evaluating digital technology for monitoring sleep and circadian rhythms in older people and people living with dementia in the community. Clocks Sleep. 2024;6:129&#x2013;55. 10.3390/clockssleep6010010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/clockssleep6010010</ArticleId><ArticleId IdType=\"pmc\">PMC10968838</ArticleId><ArticleId IdType=\"pubmed\">38534798</ArticleId></ArticleIdList></Reference><Reference><Citation>Molloy DW, Standish TI. A guide to the standardized mini-mental state examination. Int Psychogeriatr. 1997;9:87&#x2013;94. 10.1017/S1041610297004754</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S1041610297004754</ArticleId><ArticleId IdType=\"pubmed\">9447431</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilgel M, An Y, Walker KA, Moghekar AR, Ashton NJ, Kac PR, et al. Longitudinal changes in Alzheimer&#x2019;s-related plasma biomarkers and brain amyloid. Alzheimers Dement. 2023;19:4335&#x2013;45. 10.1002/alz.13157</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13157</ArticleId><ArticleId IdType=\"pmc\">PMC10592628</ArticleId><ArticleId IdType=\"pubmed\">37216632</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Han L, Li S, Hu T, Xu Z, Fan Y, et al. Plasma GFAP in Parkinson&#x2019;s disease with cognitive impairment and its potential to predict conversion to dementia. NPJ Parkinsons Dis. 2023;9:23. 10.1038/s41531-023-00447-7</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41531-023-00447-7</ArticleId><ArticleId IdType=\"pmc\">PMC9911758</ArticleId><ArticleId IdType=\"pubmed\">36759508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonatis E, et al. Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer&#x2019;s disease pathology. medRxiv: 2023.07.11.23292493 [Preprint]. 2023 [cited 2023 Nov 7]. Available from: 10.1101/2023.07.11.23292493</Citation></Reference><Reference><Citation>Bateman RJ, Wen G, Morris JC, Holtzman DM. Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker. Neurology. 2007;68:666&#x2013;9. 10.1212/01.wnl.0000256043.50901.e3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/01.wnl.0000256043.50901.e3</ArticleId><ArticleId IdType=\"pubmed\">17325273</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolska JA, Kasten T, Huang Y, Benzinger TL, Sigurdson W, Ovod V, et al. Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system. PLoS One. 2014;9:e89998. 10.1371/journal.pone.0089998</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0089998</ArticleId><ArticleId IdType=\"pmc\">PMC3960093</ArticleId><ArticleId IdType=\"pubmed\">24646516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucey BP, Fagan AM, Holtzman DM, Morris JC, Bateman RJ. Diurnal oscillation of CSF Abeta and other AD biomarkers. Mol Neurodegener. 2017;12:36. 10.1186/s13024-017-0161-4</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13024-017-0161-4</ArticleId><ArticleId IdType=\"pmc\">PMC5421331</ArticleId><ArticleId IdType=\"pubmed\">28478762</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324:772&#x2013;81. 10.1001/jama.2020.12134</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2020.12134</ArticleId><ArticleId IdType=\"pmc\">PMC7388060</ArticleId><ArticleId IdType=\"pubmed\">32722745</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson-Carlgren N, Janelidze S, Palmqvist S, Cullen N, Svenningsson AL, Strandberg O, et al. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer&#x2019;s disease. Brain. 2020;143:3234&#x2013;41. 10.1093/brain/awaa286</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awaa286</ArticleId><ArticleId IdType=\"pmc\">PMC7719022</ArticleId><ArticleId IdType=\"pubmed\">33068398</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber H, Ashton NJ, Schieren A, Montoliu-Gaya L, Molfetta GD, Brum WS, et al. Levels of Alzheimer&#x2019;s disease blood biomarkers are altered after food intake&#x2014;a pilot intervention study in healthy adults. Alzheimers Dement. 2023;19:5531&#x2013;40. 10.1002/alz.13163</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13163</ArticleId><ArticleId IdType=\"pubmed\">37243891</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39271623</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1559-1182</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>HMGCR Inhibitor Restores Mitochondrial Dynamics by Regulating Signaling Cascades in a Rodent Alzheimer's Disease Model.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s12035-024-04465-1</ELocationID><Abstract><AbstractText>Atorvastatin an HMGCR inhibitor may play a role in enhancing spatial and long-term memory and combating anxious behavior deficits induced by A&#x3b2;<sub>1-42</sub>. Behavioral deficit studies, immunoblotting for the antioxidant/apoptotic protein expression, flow cytometry (FACS) for mitochondrial ROS, membrane potential (&#x25b2;&#x3c8;m), and histopathological alterations were performed against A&#x3b2;<sub>1-42</sub> toxicity. A&#x3b2;<sub>1-42</sub> was infused directly into the brain through i.c.v for the establishment of the AD model. Atorvastatin (ATOR) was administered orally and was used to treat AD in adult male Wistar rats aged between 200 and 250&#xa0;g. We confirmed that ATOR administration significantly attenuates the A&#x3b2;<sub>1-42</sub>-induced cognitive decline targeted mitochondrial-mediated age-dependent disease progression. Nrf2 stabilizes to interact SOD2 antioxidant enzyme, allowing transcriptional activity by the steep increase in &#x25b2;&#x3c8;m and a reduction in ROS by activating mitochondrial superoxide scavenger and Nrf2-dependent pathway. These findings confirmed that ATOR has the potential efficacy to modulate the interference in cognitive decline induced by A&#x3b2;<sub>1-42</sub>.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Neha</LastName><AffiliationInfo><Affiliation>Department of Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pinky</LastName><AffiliationInfo><Affiliation>Department of Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Khan</LastName><ForeName>Sara Akhtar</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ali</LastName><ForeName>Mubashshir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ali</LastName><ForeName>Nemat</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, 11451, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shaquiquzzaman</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Parvez</LastName><ForeName>Suhel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India. sparvez@jamiahamdard.ac.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>File No. 45/14/2020/PHA/BMS</GrantID><Agency>Indian Council of Medical Research</Agency><Country/></Grant><Grant><GrantID>File No. 45/14/2020/PHA/BMS</GrantID><Agency>Indian Council of Medical Research</Agency><Country/></Grant><Grant><GrantID>RSPD2024R940</GrantID><Agency>King Saud University</Agency><Country/></Grant><Grant><GrantID>SR/FST/LS-I/2017/05[C]; SR/PURSE Phase 2/39[C])</GrantID><Agency>Department of Science and Technology, Ministry of Science and Technology, India</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Atorvastatin</Keyword><Keyword MajorTopicYN=\"N\">A&#x3b2;1&#x2013;42</Keyword><Keyword MajorTopicYN=\"N\">Neurodegeneration</Keyword><Keyword MajorTopicYN=\"N\">Neuroprotection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271623</ArticleId><ArticleId IdType=\"doi\">10.1007/s12035-024-04465-1</ArticleId><ArticleId IdType=\"pii\">10.1007/s12035-024-04465-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Conway ME (2020) Alzheimer&#x2019;s disease: targeting the glutamatergic system. Biogerontology 21</Citation></Reference><Reference><Citation>T&#xf6;nnies E, Trushina E (2017) Oxidative stress, synaptic dysfunction, and Alzheimer&#x2019;s disease. Journal of Alzheimer&#x2019;s Disease 57</Citation></Reference><Reference><Citation>Angelova PR, Abramov AY (2018) Role of mitochondrial ROS in the brain: from physiology to neurodegeneration. FEBS Lett 592</Citation></Reference><Reference><Citation>Liao Y, Dong Y, Cheng J (2017) The function of the mitochondrial calcium uniporter in neurodegenerative disorders. Int J Mol Sci 18</Citation></Reference><Reference><Citation>McKhann GM, Knopman DS, Chertkow H, et al (2011) The diagnosis of dementia due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimer&#x2019;s and Dementia 7. https://doi.org/10.1016/j.jalz.2011.03.005</Citation></Reference><Reference><Citation>Januska B (Betty) M (2011) Molecules and medicine. American Journal of Health-System Pharmacy 68:. https://doi.org/10.2146/br110001</Citation></Reference><Reference><Citation>Ferreira AM, Marques da Silva P (2017) Defining the place of ezetimibe/atorvastatin in the management of hyperlipidemia. American Journal of Cardiovascular Drugs 17</Citation></Reference><Reference><Citation>Zhang C (2018) Hazardous reagent substitution: a pharmaceutical perspective. Green Processing and Synthesis 7:. https://doi.org/10.1515/gps-2018-0079</Citation></Reference><Reference><Citation>Erickson RP, Larson-Thom&#xe9; K, Weberg L, et al (2008) Variation in NPC1, the gene encoding Niemann&#x2013;Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population. Neurosci Lett 447:. https://doi.org/10.1016/j.neulet.2008.09.046</Citation></Reference><Reference><Citation>Kivipelto M, Helkala EL, Laakso MP, et al (2001) Midlife vascular risk factors and Alzheimer&#x2019;s disease in later life: longitudinal, population based study. Br Med J 322:. https://doi.org/10.1136/bmj.322.7300.1447</Citation></Reference><Reference><Citation>Whitmer RA, Sidney S, Selby J, et al (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64:. https://doi.org/10.1212/01.WNL.0000149519.47454.F2</Citation></Reference><Reference><Citation>Refolo LM, Pappolla MA, Malester B, et al (2000) Hypercholesterolemia accelerates the Alzheimer&#x2019;s amyloid pathology in a transgenic mouse model. Neurobiol Dis 7:. https://doi.org/10.1006/nbdi.2000.0304</Citation></Reference><Reference><Citation>Vance JE (2012) Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. DMM Disease Models and Mechanisms 5</Citation></Reference><Reference><Citation>Olmastroni E, Molari G, De Beni N, et al (2022) Statin use and risk of dementia or Alzheimer&#x2019;s disease: a systematic review and meta-analysis of observational studies. Eur J Prev Cardiol 29</Citation></Reference><Reference><Citation>Damirchi M, Aghaie M, Sedighi S, et al (2023) The role of immunosuppression in the development of COVID-19 in systemic lupus erythematosus patients: a brief report. Iran J Med Sci 48:. https://doi.org/10.30476/ijms.2022.94402.2565</Citation></Reference><Reference><Citation>Fonseca ACRG, Resende R, Oliveira CR, Pereira CMF (2010) Cholesterol and statins in Alzheimer&#x2019;s disease: current controversies. Exp Neurol 223</Citation></Reference><Reference><Citation>Isingrini E, Desmidt T, Belzung C, Camus V (2009) Endothelial dysfunction: a potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer&#x2019;s disease? Current Opinion in Investigational Drugs 10</Citation></Reference><Reference><Citation>Evans BA, Evans JE, Baker SP, et al (2009) Long-term statin therapy and CSF cholesterol levels: implications for Alzheimer&#x2019;s disease. Dement Geriatr Cogn Disord 27:. https://doi.org/10.1159/000221835</Citation></Reference><Reference><Citation>Grimm A, Friedland K, Eckert A (2016) Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer&#x2019;s disease. Biogerontology 17</Citation></Reference><Reference><Citation>Santos RX, Correia SC, Zhu X, et al (2013) Mitochondrial DNA oxidative damage and repair in aging and Alzheimer&#x2019;s disease. Antioxid Redox Signal 18</Citation></Reference><Reference><Citation>Tyumentsev MA, Stefanova NA, Muraleva NA, et al (2018) Mitochondrial dysfunction as a predictor and driver of Alzheimer&#x2019;s disease-like pathology in OXYS rats. Journal of Alzheimer&#x2019;s Disease 63:. https://doi.org/10.3233/JAD-180065</Citation></Reference><Reference><Citation>Cenini G, Voos W (2019) Mitochondria as potential targets in Alzheimer disease therapy: an update. Front Pharmacol 10</Citation></Reference><Reference><Citation>Rossi MJ, Pekkurnaz G (2019) Powerhouse of the mind: mitochondrial plasticity at the synapse. Curr Opin Neurobiol 57</Citation></Reference><Reference><Citation>Volmering E, Niehusmann P, Peeva V, et al (2016) Neuropathological signs of inflammation correlate with mitochondrial DNA deletions in mesial temporal lobe epilepsy. Acta Neuropathol 132:. https://doi.org/10.1007/s00401-016-1561-1</Citation></Reference><Reference><Citation>P&#xe9;rez MJ, Ponce DP, Osorio-Fuentealba C, et al (2017) Mitochondrial bioenergetics is altered in fibroblasts from patients with sporadic Alzheimer&#x2019;s disease. Front Neurosci 11:. https://doi.org/10.3389/fnins.2017.00553</Citation></Reference><Reference><Citation>Fi&#x161;ar Z, Hans&#xed;kov&#xe1; H, K&#x159;&#xed;&#x17e;ov&#xe1; J, et al (2019) Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer&#x2019;s disease and depressive disorder. Mitochondrion 48:. https://doi.org/10.1016/j.mito.2019.07.013</Citation></Reference><Reference><Citation>Lyons A, Murphy KJ, Clarke R, Lynch MA (2011) Atorvastatin prevents age-related and amyloid-&#x3b2;-induced microglial activation by blocking interferon-&#x3b3; release from natural killer cells in the brain. J Neuroinflammation 8:. https://doi.org/10.1186/1742-2094-8-27</Citation></Reference><Reference><Citation>Zhang LL, Sui HJ, Liang B, et al (2014) Atorvastatin prevents amyloid-&#x3b2; peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway. Acta Pharmacol Sin 35:. https://doi.org/10.1038/aps.2013.203</Citation></Reference><Reference><Citation>Li X-H, Li X-H, Zhang Y-Y, et al (2013) Atorvastatin attenuates the production of IL-1&#x3b2;, IL-6, and TNF-&#x3b1; in the hippocampus of an amyloid &#x3b2;1-42-induced rat model of Alzheimer&#x2019;s disease. Clin Interv Aging https://doi.org/10.2147/cia.s40405</Citation></Reference><Reference><Citation>Xiao Y, Ma B, McElheny D, et al (2015) A&#x3b2;(1&#x2013;42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer&#x2019;s disease. Nat Struct Mol Biol 22:. https://doi.org/10.1038/nsmb.2991</Citation></Reference><Reference><Citation>Salman M, Akram M, Shahrukh M, et al (2022) Effects of pramipexole on beta-amyloid1&#x2013;42 memory deficits and evaluation of oxidative stress and mitochondrial function markers in the hippocampus of Wistar rat. Neurotoxicology 92:. https://doi.org/10.1016/j.neuro.2022.07.006</Citation></Reference><Reference><Citation>Jahn H (2013) Memory loss in Alzheimer&#x2019;s disease. Dialogues Clin Neurosci 15:. https://doi.org/10.31887/dcns.2013.15.4/hjahn</Citation></Reference><Reference><Citation>Tian H, Ding N, Guo M, et al (2019) Analysis of learning and memory ability in an Alzheimer&#x2019;s disease mouse model using the Morris water maze. J Visual Exp 2019. https://doi.org/10.3791/60055</Citation></Reference><Reference><Citation>Manju Gari, Manisha Varshney (2020) Evaluation of learning and memory in rats through elevated plus maze model. J Biomed Pharmaceut Res 9. https://doi.org/10.32553/jbpr.v9i2.727</Citation></Reference><Reference><Citation>Mailloux RJ (2021) An update on methods and approaches for interrogating mitochondrial reactive oxygen species production. Redox Biol 45</Citation></Reference><Reference><Citation>Salman M, Tabassum H, Parvez S (2020) Nrf2/HO-1 mediates the neuroprotective effects of pramipexole by attenuating oxidative damage and mitochondrial perturbation after traumatic brain injury in rats. DMM Disease Models Mech 13:. https://doi.org/10.1242/dmm.045021</Citation></Reference><Reference><Citation>Baracca A, Sgarbi G, Solaini G, Lenaz G (2003) Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F0 during ATP synthesis. Biochim Biophys Acta Bioenerg 1606:. https://doi.org/10.1016/S0005-2728(03)00110-5</Citation></Reference><Reference><Citation>Malhotra PA (2019) Impairments of attention in Alzheimer&#x2019;s disease. Curr Opin Psychol 29</Citation></Reference><Reference><Citation>Moujalled D, Strasser A, Liddell JR (2021) Molecular mechanisms of cell death in neurological diseases. Cell Death Differ 28</Citation></Reference><Reference><Citation>Salman M, Sharma P, Alam MI, et al (2022) Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced Huntington&#x2019;s disease like symptoms in rats. Nutr Neurosci 25:. https://doi.org/10.1080/1028415X.2021.1913319</Citation></Reference><Reference><Citation>Yu C, Xiao JH (2021) The Keap1-Nrf2 system: a mediator between oxidative stress and aging. Oxid Med Cell Longev 2021</Citation></Reference><Reference><Citation>Martins IVA, Rivers-Auty J, Allan SM, Lawrence CB (2017) Mitochondrial abnormalities and synaptic loss underlie memory deficits seen in mouse models of obesity and Alzheimer&#x2019;s disease. Journal of Alzheimer&#x2019;s Disease 55:. https://doi.org/10.3233/JAD-160640</Citation></Reference><Reference><Citation>Zafeer MF, Firdaus F, Anis E, Mobarak Hossain M (2019) Prolong treatment with Trans-ferulic acid mitigates bioenergetics loss and restores mitochondrial dynamics in streptozotocin-induced sporadic dementia of Alzheimer&#x2019;s type. Neurotoxicology 73:. https://doi.org/10.1016/j.neuro.2019.04.006</Citation></Reference><Reference><Citation>Smarr BL, Grant AD, Zucker I, et al (2017) Sex differences in variability across timescales in BALB/c mice. Biol Sex Differ 8:. https://doi.org/10.1186/s13293-016-0125-3</Citation></Reference><Reference><Citation>Pilipenko V, Narbute K, Amara I, et al (2019) GABA-containing compound gammapyrone protects against brain impairments in Alzheimer&#x2019;s disease model male rats and prevents mitochondrial dysfunction in cell culture. J Neurosci Res 97:. https://doi.org/10.1002/jnr.24396</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39271570</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2509-2723</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>Acarbose ameliorates Western diet-induced metabolic and cognitive impairments in the 3xTg mouse model of Alzheimer's disease.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s11357-024-01337-3</ELocationID><Abstract><AbstractText>Age is the greatest risk factor for Alzheimer's disease (AD) as well as for other disorders that increase the risk of AD such as diabetes and obesity. There is growing interest in determining if interventions that promote metabolic health can prevent or delay AD. Acarbose is an anti-diabetic drug that not only improves glucose homeostasis, but also extends the lifespan of wild-type mice. Here, we test the hypothesis that acarbose will not only preserve metabolic health, but also slow or prevent AD pathology and cognitive deficits in 3xTg mice, a model of AD, fed either a Control diet or a high-fat, high-sucrose Western diet (WD). We find that acarbose decreases the body weight and adiposity of WD-fed 3xTg mice, increasing energy expenditure while also stimulating food consumption, and improves glycemic control. Both male and female WD-fed 3xTg mice have worsened cognitive deficits than Control-fed mice, and these deficits are ameliorated by acarbose treatment. Molecular and histological analysis of tau and amyloid pathology identified sex-specific effects of acarbose which are uncoupled from the dramatic improvements in cognition in females, suggesting that the benefits of acarbose on AD may be largely driven by improved metabolic health. In conclusion, our results suggest that acarbose may be a promising intervention to prevent, delay, or even treat AD, especially in individuals consuming a WD.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to American Aging Association.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Sonsalla</LastName><ForeName>Michelle M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Comparative Biomedical Sciences, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Babygirija</LastName><ForeName>Reji</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cellular and Molecular Biology Graduate Program, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Johnson</LastName><ForeName>Madeline</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cai</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cole</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yeh</LastName><ForeName>Chung-Yang</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Grunow</LastName><ForeName>Isaac</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Endocrinology and Reproductive Physiology Program, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vertein</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Calubag</LastName><ForeName>Mariah F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cellular and Molecular Biology Graduate Program, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Trautman</LastName><ForeName>Michaela E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nutrition and Metabolism Graduate Program, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Green</LastName><ForeName>Cara L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rigby</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Waisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Puglielli</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Waisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI, 53705, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lamming</LastName><ForeName>Dudley W</ForeName><Initials>DW</Initials><Identifier Source=\"ORCID\">0000-0002-0079-4467</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA. dlamming@medicine.wisc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>William S. Middleton Memorial Veterans Hospital, Madison, WI, USA. dlamming@medicine.wisc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Comparative Biomedical Sciences, University of Wisconsin-Madison, Madison, WI, USA. dlamming@medicine.wisc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cellular and Molecular Biology Graduate Program, University of Wisconsin-Madison, Madison, WI, USA. dlamming@medicine.wisc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Endocrinology and Reproductive Physiology Program, University of Wisconsin-Madison, Madison, WI, USA. dlamming@medicine.wisc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nutrition and Metabolism Graduate Program, University of Wisconsin-Madison, Madison, WI, USA. dlamming@medicine.wisc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Wisconsin Carbone Cancer Center, Madison, WI, 53705, USA. dlamming@medicine.wisc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Wisconsin-Madison Comprehensive Diabetes Center, Madison, WI, 53705, USA. dlamming@medicine.wisc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>I01 BX004031</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA014520</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AG082504</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F99 AG083290</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062328</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F32 AG077916</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG000213</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG056771</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK125859</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K99 AG084921</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG081482</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>IS1 BX005524</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AG081115</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM148487</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS094154</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG085898</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG078794</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">3xTg</Keyword><Keyword MajorTopicYN=\"N\">Acarbose</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">Western diet</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271570</ArticleId><ArticleId IdType=\"doi\">10.1007/s11357-024-01337-3</ArticleId><ArticleId IdType=\"pii\">10.1007/s11357-024-01337-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Association. 2023 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement. 2023;19(4):1598&#x2013;1695.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibener L, Zaganjor I, Snyder HM, Bain LJ, Egge R, Carrillo MC. Alzheimer&#x2019;s Disease prevalence, costs, and prevention for military personnel and veterans. Alzheimer&#x2019;s Dementia. 2014;10(3 Suppl):S105&#x2013;10.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24924663</ArticleId></ArticleIdList></Reference><Reference><Citation>Duran-Aniotz C, Hetz C. Glucose metabolism: a sweet relief of alzheimer&#x2019;s disease. Curr Biol. 2016;26(17):R806&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27623263</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cub.2016.07.060</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhra V, Galappaththy SL, Bulchandani S, Cabandugama PK. Obesity and the western diet- how we got here. Mo Med. 2020;117(6):536&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33311784</ArticleId><ArticleId IdType=\"pmc\">7721435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieckowska-Gacek A, Mietelska-Porowska A, Wydrych M, Wojda U. Western diet as a trigger of Alzheimer&#x2019;s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration. Ageing Res Rev. 2021;70:101397.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34214643</ArticleId><ArticleId IdType=\"doi\">10.1016/j.arr.2021.101397</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopp W. How western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes Metab Syndr Obes. 2019;12:2221&#x2013;36.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31695465</ArticleId><ArticleId IdType=\"pmc\">6817492</ArticleId><ArticleId IdType=\"doi\">10.2147/DMSO.S216791</ArticleId></ArticleIdList></Reference><Reference><Citation>Demaria TM, Crepaldi LD, Costa-Bartuli E, Branco JR, Zancan P, Sola-Penna M. Once a week consumption of Western diet over twelve weeks promotes sustained insulin resistance and non-alcoholic fat liver disease in C57BL/6 J mice. Sci Rep. 2023;13(1):3058.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36810903</ArticleId><ArticleId IdType=\"pmc\">9942638</ArticleId><ArticleId IdType=\"doi\">10.1038/s41598-023-30254-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham LC, Harder JM, Soto I, de Vries WN, John SW, Howell GR. Chronic consumption of a western diet induces robust glial activation in aging mice and in a mouse model of Alzheimer&#x2019;s disease. Sci Rep. 2016;6:21568.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26888450</ArticleId><ArticleId IdType=\"pmc\">4757836</ArticleId><ArticleId IdType=\"doi\">10.1038/srep21568</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanoski SE, Davidson TL. Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiol Behav. 2011;103(1):59&#x2013;68.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21167850</ArticleId><ArticleId IdType=\"doi\">10.1016/j.physbeh.2010.12.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PM. Influence of Western diet and APOE genotype on Alzheimer&#x2019;s disease risk. Neurobiol Dis. 2020;138:104790.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32032732</ArticleId><ArticleId IdType=\"doi\">10.1016/j.nbd.2020.104790</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieckowska-Gacek A, Mietelska-Porowska A, Chutoranski D, Wydrych M, Dlugosz J, Wojda U. Western diet induces impairment of liver-brain axis accelerating neuroinflammation and amyloid pathology in alzheimer&#x2019;s disease. Front Aging Neurosci. 2021;13:654509.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33867971</ArticleId><ArticleId IdType=\"pmc\">8046915</ArticleId><ArticleId IdType=\"doi\">10.3389/fnagi.2021.654509</ArticleId></ArticleIdList></Reference><Reference><Citation>Altay M. Acarbose is again on the stage. World J Diabetes. 2022;13(1):1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35070055</ArticleId><ArticleId IdType=\"pmc\">8771266</ArticleId><ArticleId IdType=\"doi\">10.4239/wjd.v13.i1.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehmeier UF, Piepersberg W. Biotechnology and molecular biology of the alpha-glucosidase inhibitor acarbose. Appl Microbiol Biotechnol. 2004;63(6):613&#x2013;25.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14669056</ArticleId><ArticleId IdType=\"doi\">10.1007/s00253-003-1477-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359(9323):2072&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12086760</ArticleId><ArticleId IdType=\"doi\">10.1016/S0140-6736(02)08905-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodds SG, Parihar M, Javors M, Nie J, Musi N, Dave Sharp Z, et al. Acarbose improved survival for Apc(+/Min) mice. Aging Cell. 2020;19(2): e13088.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31903726</ArticleId><ArticleId IdType=\"pmc\">6996958</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.13088</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison DE, Strong R, Alavez S, Astle CM, DiGiovanni J, Fernandez E, et al. Acarbose improves health and lifespan in aging HET3 mice. Aging Cell. 2019;18(2):e12898.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30688027</ArticleId><ArticleId IdType=\"pmc\">6413665</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.12898</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison DE, Strong R, Allison DB, Ames BN, Astle CM, Atamna H, et al. Acarbose, 17-alpha-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell. 2014;13(2):273&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24245565</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.12170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Wang J, Hu J, Chen Y, Dong B, Wang Y. A comparative study of acarbose, vildagliptin and saxagliptin intended for better efficacy and safety on type 2 diabetes mellitus treatment. Life Sci. 2021;274:119069.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33460667</ArticleId><ArticleId IdType=\"doi\">10.1016/j.lfs.2021.119069</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Z, Hinson A, Miller RA, Garcia GG. Cap-independent translation: A shared mechanism for lifespan extension by rapamycin, acarbose, and 17alpha-estradiol. Aging Cell. 2021;20(5):e13345.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33742521</ArticleId><ArticleId IdType=\"pmc\">8135077</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.13345</ArticleId></ArticleIdList></Reference><Reference><Citation>Simcox J, Lamming DW. The central moTOR of metabolism. Dev Cell. 2022;57(6):691&#x2013;706.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35316619</ArticleId><ArticleId IdType=\"pmc\">9004513</ArticleId><ArticleId IdType=\"doi\">10.1016/j.devcel.2022.02.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannick JB, Lamming DW. Targeting the biology of aging with mTOR inhibitors. Nat Aging. 2023;3(6):642&#x2013;60.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37142830</ArticleId><ArticleId IdType=\"pmc\">10330278</ArticleId><ArticleId IdType=\"doi\">10.1038/s43587-023-00416-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A, Branca C, Talboom JS, Shaw DM, Turner D, Ma L, et al. Reducing ribosomal protein S6 kinase 1 expression improves spatial memory and synaptic plasticity in a mouse model of alzheimer&#x2019;s disease. J Neurosci. 2015;35(41):14042&#x2013;56.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26468204</ArticleId><ArticleId IdType=\"pmc\">4604237</ArticleId><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.2781-15.2015</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A, Magri A, Medina DX, Wisely EV, Lopez-Aranda MF, Silva AJ, et al. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer&#x2019;s disease and other tauopathies. Aging Cell. 2013;12(3):370&#x2013;80.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23425014</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.12057</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem. 2010;285(17):13107&#x2013;20.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20178983</ArticleId><ArticleId IdType=\"pmc\">2857107</ArticleId><ArticleId IdType=\"doi\">10.1074/jbc.M110.100420</ArticleId></ArticleIdList></Reference><Reference><Citation>Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer&#x2019;s disease. PLoS ONE. 2010;5(4):e9979.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20376313</ArticleId><ArticleId IdType=\"pmc\">2848616</ArticleId><ArticleId IdType=\"doi\">10.1371/journal.pone.0009979</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonsalla MM, Lamming DW. Geroprotective interventions in the 3xTg mouse model of Alzheimer&#x2019;s disease. Geroscience. 2023;45(3):1343&#x2013;81.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37022634</ArticleId><ArticleId IdType=\"pmc\">10400530</ArticleId><ArticleId IdType=\"doi\">10.1007/s11357-023-00782-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Garratt M, Bower B, Garcia GG, Miller RA. Sex differences in lifespan extension with acarbose and 17-alpha estradiol: gonadal hormones underlie male-specific improvements in glucose tolerance and mTORC2 signaling. Aging Cell. 2017;16(6):1256&#x2013;66.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28834262</ArticleId><ArticleId IdType=\"pmc\">5676051</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.12656</ArticleId></ArticleIdList></Reference><Reference><Citation>Querfurth H, Lee HK. Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration. Mol Neurodegener. 2021;16(1):44.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34215308</ArticleId><ArticleId IdType=\"pmc\">8252260</ArticleId><ArticleId IdType=\"doi\">10.1186/s13024-021-00428-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballesteros-Alvarez J, Andersen JK. mTORC2: The other mTOR in autophagy regulation. Aging Cell. 2021;20(8):e13431.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34250734</ArticleId><ArticleId IdType=\"pmc\">8373318</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.13431</ArticleId></ArticleIdList></Reference><Reference><Citation>Markaki M, Tavernarakis N. Metabolic control by target of rapamycin and autophagy during ageing - a mini-review. Gerontology. 2013;59(4):340&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23594965</ArticleId><ArticleId IdType=\"doi\">10.1159/000348599</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer AJ, Lorin S, Blommaart EF, Codogno P. Regulation of autophagy by amino acids and MTOR-dependent signal transduction. Amino Acids. 2015;47(10):2037&#x2013;63.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24880909</ArticleId><ArticleId IdType=\"doi\">10.1007/s00726-014-1765-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Wink L, Miller RA, Garcia GG. Rapamycin, Acarbose and 17alpha-estradiol share common mechanisms regulating the MAPK pathways involved in intracellular signaling and inflammation. Immun Ageing. 2022;19(1):8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35105357</ArticleId><ArticleId IdType=\"pmc\">8805398</ArticleId><ArticleId IdType=\"doi\">10.1186/s12979-022-00264-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadagurski M, Cady G, Miller RA. Anti-aging drugs reduce hypothalamic inflammation in a sex-specific manner. Aging Cell. 2017;16(4):652&#x2013;60.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28544365</ArticleId><ArticleId IdType=\"pmc\">5506421</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.12590</ArticleId></ArticleIdList></Reference><Reference><Citation>Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, et al. Temporal and regional progression of Alzheimer&#x2019;s disease-like pathology in 3xTg-AD mice. Aging Cell. 2019;18(1):e12873.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30488653</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.12873</ArticleId></ArticleIdList></Reference><Reference><Citation>Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer&#x2019;s disease. Neurobiol Aging. 2003;24(8):1063&#x2013;70.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14643377</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2003.08.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of alzheimer&#x2019;s disease with plaques and tangles. Neuron. 2003;39(3):409&#x2013;21.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12895417</ArticleId><ArticleId IdType=\"doi\">10.1016/S0896-6273(03)00434-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Barron AM, Rosario ER, Elteriefi R, Pike CJ. Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer&#x2019;s disease. PLoS ONE. 2013;8(10):e78554.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24205258</ArticleId><ArticleId IdType=\"pmc\">3810257</ArticleId><ArticleId IdType=\"doi\">10.1371/journal.pone.0078554</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien C, Tremblay C, Phivilay A, Berthiaume L, Emond V, Julien P, et al. High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol Aging. 2010;31(9):1516&#x2013;31.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18926603</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2008.08.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Robison LS, Gannon OJ, Thomas MA, Salinero AE, Abi-Ghanem C, Poitelon Y, et al. Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer&#x2019;s disease. J Neuroinflammation. 2020;17(1):285.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32993686</ArticleId><ArticleId IdType=\"pmc\">7526387</ArticleId><ArticleId IdType=\"doi\">10.1186/s12974-020-01956-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera JJ, Pifer K, Louzon S, Leander D, Fiehn O, Day SM, et al. Early or late-life treatment with acarbose or rapamycin improves physical performance and affects cardiac structure in aging mice. J Gerontol A Biol Sci Med Sci. 2023;78(3):397&#x2013;406.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36342748</ArticleId><ArticleId IdType=\"doi\">10.1093/gerona/glac221</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasek BE, Stewart LK, Henagan TM, Boudreau A, Lenard NR, Black C, et al. Dietary methionine restriction enhances metabolic flexibility and increases uncoupled respiration in both fed and fasted states. Am J Physiol Regul Integr Comp Physiol. 2010;299(3):R728&#x2013;39.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20538896</ArticleId><ArticleId IdType=\"pmc\">2944433</ArticleId><ArticleId IdType=\"doi\">10.1152/ajpregu.00837.2009</ArticleId></ArticleIdList></Reference><Reference><Citation>Pak HH, Haws SA, Green CL, Koller M, Lavarias MT, Richardson NE, et al. Fasting drives the metabolic, molecular and geroprotective effects of a calorie-restricted diet in mice. Nat Metab. 2021;3(10):1327&#x2013;41.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34663973</ArticleId><ArticleId IdType=\"pmc\">8544824</ArticleId><ArticleId IdType=\"doi\">10.1038/s42255-021-00466-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun YX, Ji X, Mao X, Xie L, Jia J, Galvan V, et al. Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer&#x2019;s disease. J Alzheimer&#x2019;s Dis: JAD. 2014;38(2):437&#x2013;44.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23979023</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-131124</ArticleId></ArticleIdList></Reference><Reference><Citation>Perluigi M, Di Domenico F, Barone E, Butterfield DA. mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder. Free Radic Biol Med. 2021;169:382&#x2013;96.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33933601</ArticleId><ArticleId IdType=\"pmc\">8145782</ArticleId><ArticleId IdType=\"doi\">10.1016/j.freeradbiomed.2021.04.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zheng W, Lu Y, Zheng Y, Pan L, Wu X, et al. BNIP3L/NIX-mediated mitophagy: molecular mechanisms and implications for human disease. Cell Death Dis. 2021;13(1):14.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34930907</ArticleId><ArticleId IdType=\"pmc\">8688453</ArticleId><ArticleId IdType=\"doi\">10.1038/s41419-021-04469-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Gimenez-Llort L, Arranz L, Mate I, De la Fuente M. Gender-specific neuroimmunoendocrine aging in a triple-transgenic 3xTg-AD mouse model for Alzheimer&#x2019;s disease and its relation with longevity. NeuroImmunoModulation. 2008;15(4&#x2013;6):331&#x2013;43.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19047809</ArticleId><ArticleId IdType=\"doi\">10.1159/000156475</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Mesa Y, Colie S, Corpas R, Cristofol R, Comellas F, Nebreda AR, et al. Oxidative stress is a central target for physical exercise neuroprotection against pathological brain aging. J Gerontol A Biol Sci Med Sci. 2016;71(1):40&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25720862</ArticleId><ArticleId IdType=\"doi\">10.1093/gerona/glv005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, et al. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res. 2008;1216:92&#x2013;103.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18486110</ArticleId><ArticleId IdType=\"doi\">10.1016/j.brainres.2008.03.079</ArticleId></ArticleIdList></Reference><Reference><Citation>Babygirija R, Sonsalla MM, Mill J, James I, Han JH, Green CL, et al. Protein restriction slows the development and progression of pathology in a mouse model of Alzheimer&#x2019;s disease. Nat Commun. 2024;15(1):5217.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38890307</ArticleId><ArticleId IdType=\"pmc\">11189507</ArticleId><ArticleId IdType=\"doi\">10.1038/s41467-024-49589-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewer RA. The alpha-glucosidase inhibitor acarbose as a calorie restriction mimetic to modify metabolic outcomes in mice. ProQuest Dissertations and Theses: University of Alabama at Birmingham; 2015. 1257. https://digitalcommons.library.uab.edu/etd-collection/1257 .</Citation></Reference><Reference><Citation>Mietelska-Porowska A, Domanska J, Want A, Wieckowska-Gacek A, Chutoranski D, Koperski M, et al. Induction of brain insulin resistance and alzheimer&#x2019;s molecular changes by Western diet. Int J Mol Sci. 2022;23(9):4744.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35563135</ArticleId><ArticleId IdType=\"pmc\">9102094</ArticleId><ArticleId IdType=\"doi\">10.3390/ijms23094744</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitto A, Grillo AS, Ito TK, Stanaway IB, Nguyen BMG, Ying K, et al. Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh syndrome. Nat Metab. 2023;5(6):955&#x2013;67.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37365290</ArticleId><ArticleId IdType=\"doi\">10.1038/s42255-023-00815-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahr H, Boberg M, Krause H, Maul W, M&#xfc;ller F, Ploschke H, et al. Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man. Arzneimittelforschung. 1989;39(10):1254&#x2013;60.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2610717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh Babu J, Lamar Seibenhener M, Peng J, Strom AL, Kemppainen R, Cox N, et al. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem. 2008;106(1):107&#x2013;20.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18346206</ArticleId><ArticleId IdType=\"doi\">10.1111/j.1471-4159.2008.05340.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Salminen A, Kaarniranta K, Haapasalo A, Hiltunen M, Soininen H, Alafuzoff I. Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer&#x2019;s disease. Prog Neurobiol. 2012;96(1):87&#x2013;95.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22138392</ArticleId><ArticleId IdType=\"doi\">10.1016/j.pneurobio.2011.11.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Su H, Wang X. Autophagy and p62 in cardiac protein quality control. Autophagy. 2011;7(11):1382&#x2013;3.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21997373</ArticleId><ArticleId IdType=\"pmc\">3242800</ArticleId><ArticleId IdType=\"doi\">10.4161/auto.7.11.17339</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorkoy G, Lamark T, Pankiv S, Overvatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol. 2009;452:181&#x2013;97.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19200883</ArticleId><ArticleId IdType=\"doi\">10.1016/S0076-6879(08)03612-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JM, Huang S, Wu TT, Foster NR, Sinicrope FA. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther. 2013;14(2):100&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23192274</ArticleId><ArticleId IdType=\"pmc\">3571991</ArticleId><ArticleId IdType=\"doi\">10.4161/cbt.22954</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado LS, da Rocha AS, Soares C, de Souza DG, Ramos VG, Bellaver B, et al. GFAP expression levels are associated with brain glucose metabolism in a rat model of Alzheimer&#x2019;s disease. Alzheimer's &amp; Dementia. 2022;18(S5). https://doi.org/10.1002/alz.065789 .</Citation></Reference><Reference><Citation>Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH, et al. Macroautophagy&#x2013;a novel Beta-amyloid peptide-generating pathway activated in Alzheimer&#x2019;s disease. J Cell Biol. 2005;171(1):87&#x2013;98.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16203860</ArticleId><ArticleId IdType=\"pmc\">2171227</ArticleId><ArticleId IdType=\"doi\">10.1083/jcb.200505082</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Cueva M, Antequera D, Ordonez-Gutierrez L, Wandosell F, Camins A, Carro E, et al. Amyloid-beta impairs mitochondrial dynamics and autophagy in Alzheimer&#x2019;s disease experimental models. Sci Rep. 2022;12(1):10092.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35710783</ArticleId><ArticleId IdType=\"pmc\">9203760</ArticleId><ArticleId IdType=\"doi\">10.1038/s41598-022-13683-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Oveisgharan S, Arvanitakis Z, Yu L, Farfel J, Schneider JA, Bennett DA. Sex differences in Alzheimer&#x2019;s disease and common neuropathologies of aging. Acta Neuropathol. 2018;136(6):887&#x2013;900.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30334074</ArticleId><ArticleId IdType=\"pmc\">6279593</ArticleId><ArticleId IdType=\"doi\">10.1007/s00401-018-1920-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong R, Miller RA, Antebi A, Astle CM, Bogue M, Denzel MS, et al. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an alpha-glucosidase inhibitor or a Nrf2-inducer. Aging Cell. 2016;15(5):872&#x2013;84.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27312235</ArticleId><ArticleId IdType=\"pmc\">5013015</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.12496</ArticleId></ArticleIdList></Reference><Reference><Citation>Arranz L, De Castro NM, Baeza I, Gimenez-Llort L, De la Fuente M. Effect of environmental enrichment on the immunoendocrine aging of male and female triple-transgenic 3xTg-AD mice for Alzheimer&#x2019;s disease. Journal of Alzheimer&#x2019;s disease&#x202f;: JAD. 2011;25(4):727&#x2013;37.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21593564</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-2011-110236</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal Abeta causes the onset of early Alzheimer&#x2019;s disease-related cognitive deficits in transgenic mice. Neuron. 2005;45(5):675&#x2013;88.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15748844</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neuron.2005.01.040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane AE, Shin S, Wong AA, Fertan E, Faustova NS, Howlett SE, et al. Sex differences in healthspan predict lifespan in the 3xTg-AD mouse model of alzheimer&#x2019;s disease. Front Aging Neurosci. 2018;10:172.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29946252</ArticleId><ArticleId IdType=\"pmc\">6005856</ArticleId><ArticleId IdType=\"doi\">10.3389/fnagi.2018.00172</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Lista V, De la Fuente M, Gimenez-Llort L. Survival curves and behavioral profiles of female 3xTg-AD mice surviving to 18-months of age as compared to mice with normal aging. J Alzheimers Dis Rep. 2017;1(1):47&#x2013;57.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30480229</ArticleId><ArticleId IdType=\"pmc\">6159713</ArticleId><ArticleId IdType=\"doi\">10.3233/ADR-170011</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, et al. Acarbose attenuates experimental non-alcoholic steatohepatitis. Biochem Biophys Res Commun. 2004;315(3):699&#x2013;703.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14975757</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bbrc.2004.01.116</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing Y, Ren X, Li X, Sui L, Shi X, Sun Y, et al. Baicalein Enhances the Effect of Acarbose on the Improvement of Nonalcoholic Fatty Liver Disease Associated with Prediabetes via the Inhibition of De Novo Lipogenesis. J Agric Food Chem. 2021;69(34):9822&#x2013;36.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34406004</ArticleId><ArticleId IdType=\"doi\">10.1021/acs.jafc.1c04194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DG, Krenz A, Toussaint LE, Maurer KJ, Robinson SA, Yan A, et al. Non-alcoholic fatty liver disease induces signs of Alzheimer&#x2019;s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model. J Neuroinflammation. 2016;13:1.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26728181</ArticleId><ArticleId IdType=\"pmc\">4700622</ArticleId><ArticleId IdType=\"doi\">10.1186/s12974-015-0467-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrada LD, Ahumada P, Cabrera D, Arab JP. Liver dysfunction as a novel player in alzheimer&#x2019;s progression: looking outside the brain. Front Aging Neurosci. 2019;11:174.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31379558</ArticleId><ArticleId IdType=\"pmc\">6650779</ArticleId><ArticleId IdType=\"doi\">10.3389/fnagi.2019.00174</ArticleId></ArticleIdList></Reference><Reference><Citation>Green CL, Lamming DW. We are more than what we eat. Nat Metab. 2021;3(9):1144&#x2013;5.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34552268</ArticleId><ArticleId IdType=\"doi\">10.1038/s42255-021-00434-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Green CL, Pak HH, Richardson NE, Flores V, Yu D, Tomasiewicz JL, et al. Sex and genetic background define the metabolic, physiologic, and molecular response to protein restriction. Cell Metab. 2022;34(2):209-265 e5.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35108511</ArticleId><ArticleId IdType=\"pmc\">8865085</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cmet.2021.12.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrington WT, Wulfridge P, Wells AE, Rojas CM, Howe SYF, Perry A, et al. Improving metabolic health through precision dietetics in mice. Genetics. 2018;208(1):399&#x2013;417.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29158425</ArticleId><ArticleId IdType=\"doi\">10.1534/genetics.117.300536</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S, Sleiman MB, Jha P, Ingels JF, Chapman CJ, McCarty MS, et al. Gene-by-environment modulation of lifespan and weight gain in the murine BXD family. Nat Metab. 2021;3(9):1217&#x2013;27.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34552269</ArticleId><ArticleId IdType=\"pmc\">8478125</ArticleId><ArticleId IdType=\"doi\">10.1038/s42255-021-00449-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellantuono I, de Cabo R, Ehninger D, Di Germanio C, Lawrie A, Miller J, et al. A toolbox for the longitudinal assessment of healthspan in aging mice. Nat Protoc. 2020;15(2):540&#x2013;74.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31915391</ArticleId><ArticleId IdType=\"pmc\">7002283</ArticleId><ArticleId IdType=\"doi\">10.1038/s41596-019-0256-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu D, Yang SE, Miller BR, Wisinski JA, Sherman DS, Brinkman JA, et al. Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms. FASEB J. 2018;32(6):3471&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29401631</ArticleId><ArticleId IdType=\"pmc\">5956241</ArticleId><ArticleId IdType=\"doi\">10.1096/fj.201701211R</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39271569</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2509-2723</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>Fixel-based and tensor-derived white matter abnormalities in relation to memory impairment and neurocognitive disorders.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s11357-024-01340-8</ELocationID><Abstract><AbstractText>Aging-related neurocognitive disorders, including Alzheimer's disease (AD) and mild cognitive impairment (MCI), have been characterised by altered brain white matter (WM), relying widely on diffusion tensor imaging (DTI). DTI's limited accuracy in assessing crossing fibres prompted novel methods that distinguish fibres crossing through same voxel-spaces, such as fixel-based analysis (FBA), highlighting subtle macrostructural and microstructural alterations in AD and MCI. We examined the FBA and DTI's specificity in determining WM features relevant to memory in the neurocognitive aging spectrum. Diffusion-weighted images were analysed in 560 participants with various neurocognitive diagnoses from the Alzheimer's Disease Neuroimaging Initiative (F:297; mean age: 73.2&#x2009;&#xb1;&#x2009;8). Verbal memory was measured in 488 participants using the Rey Auditory Verbal Learning Test. FBA-derived measures of fibre density (FD), fibre-bundle cross-section (FC), and their combination (FDC), DTI fractional anisotropy (FA) and mean diffusivity (MD) were examined in relation to diagnoses and memory scores, controlling for age, sex, and intracranial volume. MCI and AD groups significantly differed from controls, with lower FD and FDC in the fornix and bilateral fibres extending to the medial temporal lobes (MTL). Memory was positively associated with FD and FDC in the fornix and MTL fibres, and FC in the&#xa0;anterior commissure (AC). Widespread FA reductions and MD increases were observed in AD and MCI and widely associated with memory. Fixel-wise measures highlight fibre tracts that are altered distinctly at the macroscopic and microscopic level in neurocognitive aging, and reveals structures associated with memory performance that are more specifically located than tensor-derived measures.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to American Aging Association.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Billaud</LastName><ForeName>Charly Hugo Alexandre</ForeName><Initials>CHA</Initials><Identifier Source=\"ORCID\">0009-0001-3466-9963</Identifier><AffiliationInfo><Affiliation>School of Social Sciences, Nanyang Technological University, 48 Nanyang Avenue, PsychologySingapore, 639798, Singapore. charly.billaud@ntu.edu.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yu</LastName><ForeName>Junhong</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0002-2563-9658</Identifier><AffiliationInfo><Affiliation>School of Social Sciences, Nanyang Technological University, 48 Nanyang Avenue, PsychologySingapore, 639798, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><CollectiveName>Alzheimer&#x2019;s Disease Neuroimaging Initiative</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>021080-00001</GrantID><Agency>Nanyang Assistant Professorship</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Aging</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s</Keyword><Keyword MajorTopicYN=\"N\">Fixel-based</Keyword><Keyword MajorTopicYN=\"N\">Memory</Keyword><Keyword MajorTopicYN=\"N\">Mild cognitive impairment</Keyword><Keyword MajorTopicYN=\"N\">White matter</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271569</ArticleId><ArticleId IdType=\"doi\">10.1007/s11357-024-01340-8</ArticleId><ArticleId IdType=\"pii\">10.1007/s11357-024-01340-8</ArticleId></ArticleIdList><ReferenceList><Title>References&#xa0;&#xa0;</Title><Reference><Citation>Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP. A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer&#x2019;s disease. Neurobiol Aging. 2011;32(12):2322-e5. https://doi.org/10.1016/j.neurobiolaging.2010.05.019 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2010.05.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Lam CLM, Lee TMC. White matter microstructural abnormalities in amnestic mild cognitive impairment: a meta-analysis of whole-brain and ROI-based studies. Neurosci Biobehav Rev. 2017;83:405&#x2013;16. https://doi.org/10.1016/j.neubiorev.2017.10.026 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2017.10.026</ArticleId><ArticleId IdType=\"pubmed\">29092777</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci. 2003;4(6):469&#x2013;80. https://doi.org/10.1038/nrn1119 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrn1119</ArticleId><ArticleId IdType=\"pubmed\">12778119</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeurissen B, Leemans A, Tournier J, Jones DK, Sijbers J. Investigating the prevalence of complex fiber configurations in white matter tissue with diffusion magnetic resonance imaging. Hum Brain Mapp. 2013;34(11):2747&#x2013;66. https://doi.org/10.1002/hbm.22099 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/hbm.22099</ArticleId><ArticleId IdType=\"pubmed\">22611035</ArticleId></ArticleIdList></Reference><Reference><Citation>Mito R, et al. Fibre-specific white matter reductions in Alzheimer&#x2019;s disease and mild cognitive impairment. Brain. 2018;141(3):888&#x2013;902. https://doi.org/10.1093/brain/awx355 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awx355</ArticleId><ArticleId IdType=\"pubmed\">29309541</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhollander T, et al. Fixel-based analysis of diffusion MRI: methods, applications, challenges and opportunities. Neuroimage. 2021;241:118417. https://doi.org/10.1016/j.neuroimage.2021.118417 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2021.118417</ArticleId><ArticleId IdType=\"pubmed\">34298083</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffelt DA, et al. Investigating white matter fibre density and morphology using fixel-based analysis. Neuroimage. 2017;144:58&#x2013;73. https://doi.org/10.1016/j.neuroimage.2016.09.029 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2016.09.029</ArticleId><ArticleId IdType=\"pubmed\">27639350</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffelt DA, et al. Apparent fibre density: a novel measure for the analysis of diffusion-weighted magnetic resonance images. Neuroimage. 2012;59(4):3976&#x2013;94. https://doi.org/10.1016/j.neuroimage.2011.10.045 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2011.10.045</ArticleId><ArticleId IdType=\"pubmed\">22036682</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraldo DL, et al. Investigating tissue-specific abnormalities in Alzheimer&#x2019;s disease with multi-shell diffusion MRI. J Alzheimers Dis. 2022;90(4):1771&#x2013;91. https://doi.org/10.3233/JAD-220551 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-220551</ArticleId><ArticleId IdType=\"pubmed\">36336929</ArticleId><ArticleId IdType=\"pmc\">9789487</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X, et al. Distinct fiber-specific white matter reductions pattern in early-and late-onset Alzheimer&#x2019;s disease. Aging. 2021;13(9):12410. https://doi.org/10.18632/aging.202702 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/aging.202702</ArticleId><ArticleId IdType=\"pubmed\">33930871</ArticleId><ArticleId IdType=\"pmc\">8148465</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattarai A, Maillard P, Decarli C, Fan A. Fixel based analysis of white matter alterations in mild cognitive impairment and Alzheimer&#x2019;s disease. Alzheimers Dement. 2023;19:e079454. https://doi.org/10.1002/alz.079454 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.079454</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewenter A, et al. Disentangling the effects of Alzheimer&#x2019;s and small vessel disease on white matter fibre tracts. Brain. 2023;146(2):678&#x2013;89. https://doi.org/10.1093/brain/awac265 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awac265</ArticleId><ArticleId IdType=\"pubmed\">35859352</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Wen C, Li J, Chen J, Feng Y. Automated quantification of brain connectivity in Alzheimer&#x2019;s disease using ClusterMetric. Neurosci Lett. 2022;785:136724. https://doi.org/10.1016/j.neulet.2022.136724 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2022.136724</ArticleId><ArticleId IdType=\"pubmed\">35697157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi K et al. Fixel-based analysis reveals tau-related white matter changes in early stages of Alzheimer&#x2019;s disease. J Neurosci. 2024;44(18):e0538232024. https://doi.org/10.1523/JNEUROSCI.0538-23.2024 .</Citation></Reference><Reference><Citation>Radhakrishnan H, Stark SM, Stark CE. Microstructural alterations in hippocampal subfields mediate age-related memory decline in humans. Front Aging Neurosci. 2020;12:94. https://doi.org/10.3389/fnagi.2020.00094 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2020.00094</ArticleId><ArticleId IdType=\"pubmed\">32327992</ArticleId><ArticleId IdType=\"pmc\">7161377</ArticleId></ArticleIdList></Reference><Reference><Citation>Radhakrishnan V, et al. Cerebellar and basal ganglia structural connections in humans: effect of aging and relation with memory and learning. Front Aging Neurosci. 2023;15:1019239. https://doi.org/10.3389/fnagi.2023.1019239 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1019239</ArticleId><ArticleId IdType=\"pubmed\">36776439</ArticleId><ArticleId IdType=\"pmc\">9908607</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner MW, et al. The Alzheimer&#x2019;s Disease Neuroimaging Initiative 3: continued innovation for clinical trial improvement. Alzheimers Dement. 2017;13(5):561&#x2013;71. https://doi.org/10.1016/j.jalz.2016.10.006 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2016.10.006</ArticleId><ArticleId IdType=\"pubmed\">27931796</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Elst W, van Boxtel MPJ, van Breukelen GJP, Jolles J. Rey&#x2019;s verbal learning test: normative data for 1855 healthy participants aged 24&#x2013;81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc JINS. 2005;11(3):290&#x2013;302. https://doi.org/10.1017/S1355617705050344 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S1355617705050344</ArticleId><ArticleId IdType=\"pubmed\">15892905</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhollander T, Connelly A. A novel iterative approach to reap the benefits of multi-tissue CSD from just single-shell (+ b= 0) diffusion MRI data. Proc 24th Annu Meet Int Soc Magn Reson Med. 2016;24:3010.</Citation></Reference><Reference><Citation>Tournier J-D, et al. MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation. Neuroimage. 2019;202:116137. https://doi.org/10.1016/j.neuroimage.2019.116137 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2019.116137</ArticleId><ArticleId IdType=\"pubmed\">31473352</ArticleId></ArticleIdList></Reference><Reference><Citation>Veraart J, Novikov DS, Christiaens D, Ades-aron B, Sijbers J, Fieremans E. Denoising of diffusion MRI using random matrix theory. Neuroimage. 2016;142:394&#x2013;406. https://doi.org/10.1016/j.neuroimage.2016.08.016 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2016.08.016</ArticleId><ArticleId IdType=\"pubmed\">27523449</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellner E, Dhital B, Kiselev VG, Reisert M. Gibbs-ringing artifact removal based on local subvoxel-shifts. Magn Reson Med. 2016;76(5):1574&#x2013;81. https://doi.org/10.1002/mrm.26054 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mrm.26054</ArticleId><ArticleId IdType=\"pubmed\">26745823</ArticleId></ArticleIdList></Reference><Reference><Citation>Tustison NJ, et al. N4ITK: Improved N3 Bias Correction. IEEE Trans Med Imaging. 2010;29(6):1310&#x2013;20. https://doi.org/10.1109/TMI.2010.2046908 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/TMI.2010.2046908</ArticleId><ArticleId IdType=\"pubmed\">20378467</ArticleId><ArticleId IdType=\"pmc\">3071855</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhollander T, Mito R, Raffelt D, Connelly A. Improved white matter response function estimation for 3-tissue constrained spherical deconvolution. Proc Intl Soc Mag Reson Med. 2019;27:555. Retrieved from https://archive.ismrm.org/2019/0555.html .&#xa0;Accessed 10 Sept 2024.</Citation></Reference><Reference><Citation>Jeurissen B, Tournier J-D, Dhollander T, Connelly A, Sijbers J. Multi-tissue constrained spherical deconvolution for improved analysis of multi-shell diffusion MRI data. Neuroimage. 2014;103:411&#x2013;26. https://doi.org/10.1016/j.neuroimage.2014.07.061 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2014.07.061</ArticleId><ArticleId IdType=\"pubmed\">25109526</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B. FreeSurfer. Neuroimage. 2012;62(2):774&#x2013;81. https://doi.org/10.1016/j.neuroimage.2012.01.021 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2012.01.021</ArticleId><ArticleId IdType=\"pubmed\">22248573</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffelt DA, et al. Connectivity-based fixel enhancement: whole-brain statistical analysis of diffusion MRI measures in the presence of crossing fibres. Neuroimage. 2015;117:40&#x2013;55. https://doi.org/10.1016/j.neuroimage.2015.05.039 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2015.05.039</ArticleId><ArticleId IdType=\"pubmed\">26004503</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RE, Tournier J-D, Calamante F, Connelly A. SIFT: spherical-deconvolution informed filtering of tractograms. Neuroimage. 2013;67:298&#x2013;312. https://doi.org/10.1016/j.neuroimage.2012.11.049 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2012.11.049</ArticleId><ArticleId IdType=\"pubmed\">23238430</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006;31(4):1487&#x2013;505. https://doi.org/10.1016/j.neuroimage.2006.02.024 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2006.02.024</ArticleId><ArticleId IdType=\"pubmed\">16624579</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23:S208&#x2013;19. https://doi.org/10.1016/j.neuroimage.2004.07.051 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2004.07.051</ArticleId><ArticleId IdType=\"pubmed\">15501092</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosseel Y. lavaan: an R package for structural equation modeling. J Stat Softw. 2012;48:1&#x2013;36. https://doi.org/10.18637/JSS.V048.I02 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18637/JSS.V048.I02</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: a language and environment for statistical computing&#x2019;. Vienna: R Foundation for Statistical Computing; 2023. [Online]. Available: https://www.r-project.org/ .&#xa0;Accessed 29&#xa0;Aug 2024</Citation></Reference><Reference><Citation>Smith RE, Dhollander T, Connelly A. &#x2018;On the regression of intracranial volume in fixel-based analysis. 27th Int Soc Magn Reson Med. 2019;27:3385.</Citation></Reference><Reference><Citation>Buckner RL, et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage. 2004;23(2):724&#x2013;38. https://doi.org/10.1016/j.neuroimage.2004.06.018 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2004.06.018</ArticleId><ArticleId IdType=\"pubmed\">15488422</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE. Permutation inference for the general linear model. Neuroimage. 2014;92:381&#x2013;97. https://doi.org/10.1016/j.neuroimage.2014.01.060 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2014.01.060</ArticleId><ArticleId IdType=\"pubmed\">24530839</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandmaier AM. onyxR: interface to call Onyx from R. 2018. [Online]. Available: https://rdrr.io/github/brandmaier/onyxR/</Citation></Reference><Reference><Citation>Oh SL, et al. Fixel-based analysis effectively identifies white matter tract degeneration in Huntington&#x2019;s disease. Front Neurosci. 2021;15:711651. https://doi.org/10.3389/fnins.2021.711651 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2021.711651</ArticleId><ArticleId IdType=\"pubmed\">34588947</ArticleId><ArticleId IdType=\"pmc\">8473742</ArticleId></ArticleIdList></Reference><Reference><Citation>Rau Y-A, et al. A longitudinal fixel-based analysis of white matter alterations in patients with Parkinson&#x2019;s disease. NeuroImage Clin. 2019;24:102098. https://doi.org/10.1016/j.nicl.2019.102098 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nicl.2019.102098</ArticleId><ArticleId IdType=\"pubmed\">31795054</ArticleId><ArticleId IdType=\"pmc\">6889638</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Lee TM, Alzheimer&#x2019;s Disease Neuroimaging Initiative. Verbal memory and hippocampal volume predict subsequent fornix microstructure in those at risk for Alzheimer&#x2019;s disease. Brain Imaging Behav. 2020;14:2311&#x2013;22. https://doi.org/10.1007/s11682-019-00183-8 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11682-019-00183-8</ArticleId><ArticleId IdType=\"pubmed\">31494824</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiler M, de Campos BM, Nogueira MH, Damasceno BP, Cendes F, Balthazar ML. Structural connectivity of the default mode network and cognition in Alzheimer&#x5f3; s disease. Psychiatry Res Neuroimaging. 2014;223(1):15&#x2013;22. https://doi.org/10.1016/j.pscychresns.2014.04.008 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pscychresns.2014.04.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Q, et al. White matter alterations in early-stage Alzheimer&#x2019;s disease: a tract-specific study. Alzheimers Dement Diagn Assess Dis Monit. 2019;11:576&#x2013;87. https://doi.org/10.1016/j.dadm.2019.06.003 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.dadm.2019.06.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang SH, Kwon HG. Perspectives on the neural connectivity of the fornix in the human brain. Neural Regen Res. 2014;9(15):1434. https://doi.org/10.4103/1673-5374.139459 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/1673-5374.139459</ArticleId><ArticleId IdType=\"pubmed\">25317154</ArticleId><ArticleId IdType=\"pmc\">4192944</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang SH, Kwon HG. Neural connectivity of the anterior body of the fornix in the human brain: diffusion tensor imaging study. Neurosci Lett. 2014;559:72&#x2013;5. https://doi.org/10.1016/j.neulet.2013.06.017 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2013.06.017</ArticleId><ArticleId IdType=\"pubmed\">24304866</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo SS, Jang SH. Neural reorganization following bilateral injury of the fornix crus in a patient with traumatic brain injury. J Rehabil Med. 2013;45(6):595&#x2013;8. https://doi.org/10.2340/16501977-1145 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2340/16501977-1145</ArticleId><ArticleId IdType=\"pubmed\">23588891</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo CD, Mazerolle EL, Ritchie L, Fisk JD, Gawryluk JR. Longitudinal changes in microstructural white matter metrics in Alzheimer&#x2019;s disease. NeuroImage Clin. 2017;13:330&#x2013;8. https://doi.org/10.1016/j.nicl.2016.12.012 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nicl.2016.12.012</ArticleId><ArticleId IdType=\"pubmed\">28066707</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39271460</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Print\">0891-9887</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of geriatric psychiatry and neurology</Title><ISOAbbreviation>J Geriatr Psychiatry Neurol</ISOAbbreviation></Journal><ArticleTitle>Increased Systemic Immune-Inflammation Index as a Novel Indicator of Alzheimer's Disease Severity.</ArticleTitle><Pagination><StartPage>8919887241280880</StartPage><MedlinePgn>8919887241280880</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1177/08919887241280880</ELocationID><Abstract><AbstractText Label=\"INTRODUCTION\" NlmCategory=\"BACKGROUND\">Inflammatory processes and neurodegeneration are common features of Alzheimer's disease (AD). The systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) are easily accessible, cost-effective prognostic indicators of inflammation status. We assessed the diagnostic value of SII and compared the efficacies of NLR, PLR, and SII in predicting AD severity.</AbstractText><AbstractText Label=\"MATERIALS AND METHODS\" NlmCategory=\"METHODS\">Between January 2021 and December 2022, this prospective, cross-sectional clinical study included 175 patients with AD and 61 controls. SII, NLR, and PLR were calculated.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Age, white blood cell and lymphocyte counts, and NLR and PLR values were significantly different between the patient and control groups (<i>P</i> &lt;.05). Age, hemoglobin, neutrophil, NLR, and SII values were significantly different among dementia severity subgroups (<i>P</i> &lt;.05). Compared with PLR and SII, NLR was more strongly correlated with dementia severity. In the analysis of adjusted data by gender, it was found that hemoglobin level is significantly negatively associated with dementia severity in males, while in females, age and PLR are significantly positively associated with dementia severity, and lymphocyte count and SII are negatively associated.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">SII, a novel inflammatory marker, was associated with dementia severity in patients with AD. Compared with PLR and SII, NLR was more strongly correlated with dementia severity. In future studies with larger populations, SII and NLR values can be used to determine dementia severity and establish follow-up plans for patients with high dementia risk.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Algul</LastName><ForeName>Fatma E</ForeName><Initials>FE</Initials><Identifier Source=\"ORCID\">0000-0003-0318-7571</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Inonu University, Malatya, Turkey.</Affiliation><Identifier Source=\"RINGGOLD\">37520</Identifier></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kaplan</LastName><ForeName>Yuksel</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Inonu University, Malatya, Turkey.</Affiliation><Identifier Source=\"RINGGOLD\">37520</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Geriatr Psychiatry Neurol</MedlineTA><NlmUniqueID>8805645</NlmUniqueID><ISSNLinking>0891-9887</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">neutrophil-to-lymphocyte ratio</Keyword><Keyword MajorTopicYN=\"N\">platelet-to-lymphocyte ratio</Keyword><Keyword MajorTopicYN=\"N\">systemic immune-inflammation index</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>22</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271460</ArticleId><ArticleId IdType=\"doi\">10.1177/08919887241280880</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39271427</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1873-2720</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>Zoology (Jena, Germany)</Title><ISOAbbreviation>Zoology (Jena)</ISOAbbreviation></Journal><ArticleTitle>Multiple cranial pathologies in spotted hyaenas, Crocuta crocuta.</ArticleTitle><Pagination><StartPage>126201</StartPage><MedlinePgn>126201</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.zool.2024.126201</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0944-2006(24)00060-6</ELocationID><Abstract><AbstractText>Spotted hyaenas are generally considered to have resilience against injuries and pathogens, and the incidence of pathologies is scarcely reported. However, it is important for ecological studies and conservation efforts to have a clear overview of the physical threats that can occur in the life of a species. The present paper describes and interprets several osteopathologies in the crania of the spotted hyaena, Crocuta crocuta, in the collections of the Royal Museum for Central Africa (RMCA) in Tervuren, Belgium. Of the fifty-two specimens from central Africa examined, twenty-three (i.e., 44&#x202f;%) of them showed evidence of pathologies, including injuries, congenital pathologies, and disease. Selected specimens were scanned using Computed Tomography and their internal cranial structures were studied. Here we describe and discuss the different types of pathologies evident in the crania of these hyaenas: craniosynostosis, microtia, osteomyelitis and periodontitis, as well as a trauma indicated by cranial fractures, dental fractures, and bite puncture marks. Some pathologies reported herein are novel for hyaenas, and there are some instances of multiple pathologies in the same individual. Implications of these pathologies, including the social interactions of hyenas, conservational threats, as well as biased data sampling, are highlighted. This study improves our knowledge of disease and trauma experienced by hyaenids, and provides a better understanding of their biology, and the potential threats faced by these iconic animals. This case study offers a comparative base for similar studies in other carnivorans, to clarify the pathological background of apex predators.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier GmbH.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kargopoulos</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Cape Town,&#xa0;Cape Town, South Africa; Giraffe Conservation Foundation, Windhoek PO Box 86099,&#xa0;Namibia. Electronic address: nikoskargopoulos@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rabe</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Cape Town,&#xa0;Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gilissen</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of African Zoology, Royal Museum for Central Africa, Tervuren, Belgium; Alzheimer and other tauopathies research group, ULB Center for Diabetes Research (UCDR), Universit&#xe9; Libre de Bruxelles, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Coudyzer</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>University Hospitals Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chinsamy</LastName><ForeName>Anusuya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Cape Town,&#xa0;Cape Town, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Zoology (Jena)</MedlineTA><NlmUniqueID>9435608</NlmUniqueID><ISSNLinking>0944-2006</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Brachycephaly</Keyword><Keyword MajorTopicYN=\"N\">Carnivora</Keyword><Keyword MajorTopicYN=\"N\">Competition</Keyword><Keyword MajorTopicYN=\"N\">Ecology</Keyword><Keyword MajorTopicYN=\"N\">Hyaenidae</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Nikolaos Kargopoulos reports financial support was provided by SYNTHESYS. Caitlin Rabe reports financial support was provided by GENUS Department of Science and Innovation (DSI). Caitlin Rabe reports financial support was provided by The Oppenheimer Memorial Trust. Anusuya Chinsamy reports financial support was provided by National Research Foundation. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>21</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271427</ArticleId><ArticleId IdType=\"doi\">10.1016/j.zool.2024.126201</ArticleId><ArticleId IdType=\"pii\">S0944-2006(24)00060-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39271231</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Electronic\">1715-5258</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>70</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Canadian family physician Medecin de famille canadien</Title><ISOAbbreviation>Can Fam Physician</ISOAbbreviation></Journal><ArticleTitle>Potential of anti-amyloid therapies for patients with Alzheimer disease in Canada.</ArticleTitle><Pagination><StartPage>537</StartPage><EndPage>538</EndPage><MedlinePgn>537-538</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.46747/cfp.7009537</ELocationID><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Frank</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cognitive and behavioural neurologist with the Bruy&#xe8;re Research Institute at the &#xc9;lisabeth Bruy&#xe8;re Hospital in Ottawa, Ont, and Assistant Professor in the Department of Medicine at the University of Ottawa.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Frank</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Family physician focusing on care of the elderly and palliative care and Professor in the Department of Medicine at Queen's University in Kingston, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Molnar</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Specialist in geriatric medicine practising in the Department of Medicine at the University of Ottawa and at the Ottawa Hospital Research Institute.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can Fam Physician</MedlineTA><NlmUniqueID>0120300</NlmUniqueID><ISSNLinking>0008-350X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D061067\">Antibodies, Monoclonal, Humanized</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016229\">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>105J35OE21</RegistryNumber><NameOfSubstance UI=\"C000600266\">aducanumab</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002170\" MajorTopicYN=\"N\" Type=\"Geographic\">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D061067\" MajorTopicYN=\"N\">Antibodies, Monoclonal, Humanized</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016229\" MajorTopicYN=\"N\">Amyloid beta-Peptides</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271231</ArticleId><ArticleId IdType=\"doi\">10.46747/cfp.7009537</ArticleId><ArticleId IdType=\"pii\">70/9/537</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39271216</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Electronic\">1715-5258</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>70</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Canadian family physician Medecin de famille canadien</Title><ISOAbbreviation>Can Fam Physician</ISOAbbreviation></Journal><ArticleTitle>[Not Available].</ArticleTitle><Pagination><StartPage>e120</StartPage><EndPage>e122</EndPage><MedlinePgn>e120-e122</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.46747/cfp.7009e120</ELocationID><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Frank</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurologue cognitif et comportemental &#xe0; l'Institut de recherche Bruy&#xe8;re de l'H&#xf4;pital &#xc9;lisabeth-Bruy&#xe8;re &#xe0; Ottawa (Ontario) et professeur adjoint au D&#xe9;partement de m&#xe9;decine de l'Universit&#xe9; d'Ottawa.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Frank</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>M&#xe9;decin de famille; il se concentre sur les soins palliatifs et les soins aux personnes &#xe2;g&#xe9;es, et il est professeur au D&#xe9;partement de m&#xe9;decine de l'Universit&#xe9; Queen &#xe0; Kingston (Ontario).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Molnar</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sp&#xe9;cialiste en m&#xe9;decine g&#xe9;riatrique; il exerce au D&#xe9;partement de m&#xe9;decine de l'Universit&#xe9; d'Ottawa (Ontario) et &#xe0; l'Institut de recherche de l'H&#xf4;pital d'Ottawa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Le potentiel des th&#xe9;rapies anti-amylo&#xef;de pour les patients atteints de la maladie d&#x2019;Alzheimer au Canada.</VernacularTitle></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can Fam Physician</MedlineTA><NlmUniqueID>0120300</NlmUniqueID><ISSNLinking>0008-350X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D061067\">Antibodies, Monoclonal, Humanized</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016229\">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>105J35OE21</RegistryNumber><NameOfSubstance UI=\"C000600266\">aducanumab</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002170\" MajorTopicYN=\"N\" Type=\"Geographic\">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D061067\" MajorTopicYN=\"N\">Antibodies, Monoclonal, Humanized</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016229\" MajorTopicYN=\"N\">Amyloid beta-Peptides</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271216</ArticleId><ArticleId IdType=\"doi\">10.46747/cfp.7009e120</ArticleId><ArticleId IdType=\"pii\">70/9/e120</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39271187</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1550-9109</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Sleep</Title><ISOAbbreviation>Sleep</ISOAbbreviation></Journal><ArticleTitle>Nocturnal Sleep Dynamics Alterations in the Early Stages of Behavioral Variant Frontotemporal Dementia.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">zsae201</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1093/sleep/zsae201</ELocationID><Abstract><AbstractText Label=\"STUDY OBJECTIVES\" NlmCategory=\"OBJECTIVE\">Sleep disorders have been recognized as an integral component of the clinical syndrome in several neurodegenerative diseases, including Alzheimer's Disease (AD). However, limited data exists for rarer types of neurodegenerative diseases, such as behavioral variant Frontotemporal Dementia (bvFTD). This study aims to analyze EEG power spectra and sleep stage transitions in bvFTD patients, hypothesizing that bvFTD may show distinctive sleep stage transitions compared to patients with Alzheimer's Disease (AD).</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">Eighteen probable bvFTD patients and eighteen age- and sex-matched probable AD patients underwent overnight polysomnography (PSG) and completed sleep disorders questionnaires. Sleep questionnaires, full-night EEG spectra, and sleep stage transitions indexes were compared between groups.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">bvFTD patients had higher Insomnia Severity Index (ISI) scores (95%CI: 0, 5) and reported poorer sleep quality than AD patients (p&lt;0.01). Compared to AD, bvFTD patients showed higher N1 percentage (95%CI: 0.1, 6), lower N3 percentage (95%CI: -13.6, -0.6), higher sleep-wake transitions (95%CI: 1.49, 8.86) and N1 sleep-wake transitions (95%CI: 0.32, 6.1). EEG spectral analysis revealed higher spectral power in bvFTD compared to AD patients in faster rhythms, especially sigma rhythm, across all sleep stages. In bvFTD patients, sleep-wake transitions were positively associated with ISI.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">Patients with bvFTD present higher rates of transitions between wake and sleep than AD patients. The increased frequency of sleep transitions indicates a higher degree of sleep instability in bvFTD, which may reflect an imbalance in sleep-wake promoting systems. Sleep stage transitions analysis may provide novel insights into the sleep alterations of bvFTD patients.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of Sleep Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Gnoni</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><Identifier Source=\"ORCID\">0000-0003-3181-0842</Identifier><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, King's College London, Institute of Psychiatry, Psychology and Neuroscience, De Crespigny Park, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sleep and Brain Plasticity Centre, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tamburrino</LastName><ForeName>Ludovica</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Baldazzi</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0003-1275-4961</Identifier><AffiliationInfo><Affiliation>MeDSP Lab, Department of Electrical and Electronic Engineering, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdepartmental Sleep Disorder Research Center, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Urso</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, King's College London, Institute of Psychiatry, Psychology and Neuroscience, De Crespigny Park, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zoccolella</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, San Paolo Hospital, Azienda Sanitaria Locale (ASL) Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Giugno</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Figorilli</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Science and Public Health, Sleep Disorder Research Center, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nigro</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tafuri</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vilella</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vitulli</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zecca</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dell'Abate</LastName><ForeName>Maria Teresa</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pani</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>MeDSP Lab, Department of Electrical and Electronic Engineering, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdepartmental Sleep Disorder Research Center, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Puligheddu</LastName><ForeName>Monica</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0002-6837-6608</Identifier><AffiliationInfo><Affiliation>Department of Medical Science and Public Health, Sleep Disorder Research Center, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rosenzweig</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, King's College London, Institute of Psychiatry, Psychology and Neuroscience, De Crespigny Park, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sleep and Brain Plasticity Centre, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Filardi</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Logroscino</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione \"Card. G. Panico\", Tricase, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sleep</MedlineTA><NlmUniqueID>7809084</NlmUniqueID><ISSNLinking>0161-8105</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer's Disease</Keyword><Keyword MajorTopicYN=\"N\">EEG spectra</Keyword><Keyword MajorTopicYN=\"N\">behavioral variant Frontotemporal Dementia</Keyword><Keyword MajorTopicYN=\"N\">sleep questionnaires</Keyword><Keyword MajorTopicYN=\"N\">sleep stage transitions</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271187</ArticleId><ArticleId IdType=\"doi\">10.1093/sleep/zsae201</ArticleId><ArticleId IdType=\"pii\">7756821</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39271152</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1758-535X</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>The journals of gerontology. Series A, Biological sciences and medical sciences</Title><ISOAbbreviation>J Gerontol A Biol Sci Med Sci</ISOAbbreviation></Journal><ArticleTitle>Racial differences in the association between loneliness and cognitive impairment among older Black and White men.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">glae227</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1093/gerona/glae227</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Loneliness is a biopsychosocial stressor linked to poor health outcomes including dementia. Few studies have focused on this association among men and even fewer have examined racial disparities in loneliness and cognitive functioning among this group. The purpose of this study was to examine racial differences in the association between loneliness and cognitive functioning among men in the 2016 wave of the Health and Retirement Study (HRS).</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">This cross-sectional study included Black and White men who completed the core questionnaire and the Leave Behind Questionnaire (n=2227). Any cognitive impairment was the primary outcome and was measured by a dichotomous variable derived from a modified version of the Telephone Interview for Cognitive Status. Loneliness was the primary independent variable and was derived from the 3-item UCLA Loneliness Scale. Modified Poisson regression models with robust standard errors were estimated to generate prevalence ratios and corresponding 95% confidence intervals.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Black men comprised 18.4% of the study sample; however, the proportion of this group with scores indicating cognitive impairment (35.9%) doubled the corresponding percentage of white men (17.6%). Findings from race-stratified modified Poisson regression models indicated that loneliness was associated with a higher prevalence of any cognitive impairment for White men (PR=1.24, CI:1.05-1.47), but not for Black men (PR=0.92, CI:0.73-1.16).</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">Our results underscore the complexity of race when investigating the association between loneliness and cognitive impairment among older men. Additional studies are needed to further examine how loneliness may have racially distinct implications for cognitive outcomes among the population.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Beech</LastName><ForeName>Bettina M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>UH Population Health, University of Houston, Houston, TX.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Men's Health Collaboratory, UH Population Health, University of Houston, Houston, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bruce</LastName><ForeName>Marino A</ForeName><Initials>MA</Initials><Identifier Source=\"ORCID\">0000-0002-0643-1640</Identifier><AffiliationInfo><Affiliation>UH Population Health, University of Houston, Houston, TX.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Men's Health Collaboratory, UH Population Health, University of Houston, Houston, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Siddhanta</LastName><ForeName>Ankita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UH Population Health, University of Houston, Houston, TX.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sociology, University of Houston, Houston, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Marshall</LastName><ForeName>Gillian L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Dynamic and Innovative Research Solutions, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Whitfield</LastName><ForeName>Keith E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>University of Nevada-Las Vegas, Las Vegas, NV.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Thorpe</LastName><ForeName>Roland J</ForeName><Initials>RJ</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Program for Research on Men's Health, Hopkins Center for Health Disparities Solutions, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Johns Hopkins Alzheimer's Disease Resource Center for Minority Aging Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Gerontol A Biol Sci Med Sci</MedlineTA><NlmUniqueID>9502837</NlmUniqueID><ISSNLinking>1079-5006</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Cognitive Impairment</Keyword><Keyword MajorTopicYN=\"N\">Health Disparities</Keyword><Keyword MajorTopicYN=\"N\">Loneliness</Keyword><Keyword MajorTopicYN=\"N\">Men&#x2019;s Health</Keyword><Keyword MajorTopicYN=\"N\">Minority Health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>19</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271152</ArticleId><ArticleId IdType=\"doi\">10.1093/gerona/glae227</ArticleId><ArticleId IdType=\"pii\">7756756</ArticleId></ArticleIdList></PubmedData></PubmedArticle>\n",
      "<PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39271059</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1873-4995</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of controlled release : official journal of the Controlled Release Society</Title><ISOAbbreviation>J Control Release</ISOAbbreviation></Journal><ArticleTitle>Amyloid-&#x3b2;-targeting immunotherapies for Alzheimer's disease.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0168-3659(24)00622-9</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.jconrel.2024.09.012</ELocationID><Abstract><AbstractText>Recent advances in clinical passive immunotherapy have provided compelling evidence that eliminating amyloid-&#x3b2; (A&#x3b2;) slows cognitive decline in Alzheimer's disease (AD). However, the modest benefits and side effects observed in clinical trials indicate that current immunotherapy therapy is not a panacea, highlighting the need for a deeper understanding of AD mechanisms and the significance of early intervention through optimized immunotherapy or immunoprevention. This review focuses on the centrality of A&#x3b2; pathology in AD and summarizes recent clinical progress in passive and active immunotherapies targeting A&#x3b2;, discussing their lessons and failures to inform future anti-A&#x3b2; biotherapeutics design. Various delivery strategies to optimize A&#x3b2;-targeting immunotherapies are outlined, highlighting their benefits and drawbacks in overcoming challenges such as poor stability and limited tissue accessibility of anti-A&#x3b2; biotherapeutics. Additionally, the perspectives and challenges of immunotherapy and immunoprevention targeting A&#x3b2; are concluded in the end, aiming to guide the development of next-generation anti-A&#x3b2; immunotherapeutic agents towards improved efficacy and safety.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Jin</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Du</LastName><ForeName>Qiaofei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Song</LastName><ForeName>Mingjie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kang</LastName><ForeName>Ruixin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhou</LastName><ForeName>Jianping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Huaqing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. Electronic address: zhanghq0527@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ding</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. Electronic address: dydszyzf@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Control Release</MedlineTA><NlmUniqueID>8607908</NlmUniqueID><ISSNLinking>0168-3659</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">A&#x3b2; vaccine</Keyword><Keyword MajorTopicYN=\"N\">Blood-brain barrier</Keyword><Keyword MajorTopicYN=\"N\">Immunotherapy</Keyword><Keyword MajorTopicYN=\"N\">Monoclonal antibody</Keyword><Keyword MajorTopicYN=\"N\">&#x3b2;-amyloid</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>19</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39271059</ArticleId><ArticleId IdType=\"doi\">10.1016/j.jconrel.2024.09.012</ArticleId><ArticleId IdType=\"pii\">S0168-3659(24)00622-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39270994</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1872-6240</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Brain research</Title><ISOAbbreviation>Brain Res</ISOAbbreviation></Journal><ArticleTitle>Emoxypine succinate modulates behavioral and molecular responses in zebrafish model of iron Overload-Induced neuroinflammation via CDK5/GSK3- &#x3b2; and NLRP3 inflammasome pathway.</ArticleTitle><Pagination><StartPage>149236</StartPage><MedlinePgn>149236</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.brainres.2024.149236</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0006-8993(24)00490-6</ELocationID><Abstract><AbstractText>Excessive iron accumulation in the brain plays a significant role in neurodegenerative processes, contributing to the pathogenesis of Alzheimer's disease (AD). AD, a prominent neurological disorder affecting the central nervous system, is characterized by the accumulation of beta-amyloid (A&#x3b2;) and tau phosphorylation. This accumulation leads to the subsequent development of cognitive impairments, particularly in learning and memory functions. This study investigates the neuroprotective effects of emoxypine succinate in a zebrafish model of iron overload-induced neurodegeneration. Iron was administered to the zebrafish for 28&#x202f;days to induce neurodegeneration. Following induction, Emoxypine succinate was employed as a treatment intervention for 14&#x202f;days (concentrations of 4&#x202f;mg/L, 8&#x202f;mg/L, and 12&#x202f;mg/L). Following the end of the treatment, behavioral tests (Y maze test, Novel tank test) were conducted on the zebrafish, and the biochemical (MDA, Catalase, SOD, GSH) and molecular parameters (AchE, Iron levels, IL-1&#x3b2;, TNF-&#x3b1;, CDK-5, GSK-3&#x3b2; and NLRP3) of the zebrafish brain were also assessed. In the novel tank test, emoxypine succinate-treated groups exhibited significantly increased time in the upper zone (p&#x202f;&lt;&#x202f;0.001), higher distance travelled (p&#x202f;&lt;&#x202f;0.001), and shorter latency to the top (p&#x202f;&lt;&#x202f;0.001) compared to the negative control. Similarly, the Y-maze test revealed improved time in the novel arm (p&#x202f;&lt;&#x202f;0.001) and total distance travelled (p&#x202f;&lt;&#x202f;0.001) in treated groups versus the negative control. Assessment of oxidative stress parameters demonstrated significant reductions in oxidative stress in emoxypine succinate-treated groups. Furthermore, AChE activity decreased significantly (p&#x202f;&lt;&#x202f;0.001), and brain iron levels decreased substantially (p&#x202f;&lt;&#x202f;0.001) in treated groups, indicating positive therapeutic outcomes. Molecular analysis showed a significant reduction in pro-inflammatory markers like IL-1&#x3b2;, TNF-&#x3b1;, CDK-5, GSK-3&#x3b2; and NLRP3 (p&#x202f;&lt;&#x202f;0.001). This comprehensive study highlights the potential efficacy of emoxypine succinate in mitigating neurodegeneration associated with iron dysregulation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Bagwe Parab</LastName><ForeName>Siddhi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Shobhaben Pratapbhai Patel School of Pharmacy &amp; Technology Management, SVKM's Narsee Monjee Institute of Management Studies, Mumbai 56, India; Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, V. M. Road, Vile Parle (W), Mumbai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kaur</LastName><ForeName>Ginpreet</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Shobhaben Pratapbhai Patel School of Pharmacy &amp; Technology Management, SVKM's Narsee Monjee Institute of Management Studies, Mumbai 56, India. Electronic address: Ginpreet.Kaur@nmims.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Brain Res</MedlineTA><NlmUniqueID>0045503</NlmUniqueID><ISSNLinking>0006-8993</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Amyloid beta</Keyword><Keyword MajorTopicYN=\"N\">Brain iron overload</Keyword><Keyword MajorTopicYN=\"N\">Hydroxypyridine derivatives</Keyword><Keyword MajorTopicYN=\"N\">Iron chelators</Keyword><Keyword MajorTopicYN=\"N\">Neuroinflammation</Keyword><Keyword MajorTopicYN=\"N\">Zebrafish model</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39270994</ArticleId><ArticleId IdType=\"doi\">10.1016/j.brainres.2024.149236</ArticleId><ArticleId IdType=\"pii\">S0006-8993(24)00490-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39270656</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1097-4172</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Metformin decelerates aging clock in male monkeys.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0092-8674(24)00914-0</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.cell.2024.08.021</ELocationID><Abstract><AbstractText>In a rigorous 40-month study, we evaluated the geroprotective effects of metformin on adult male cynomolgus monkeys, addressing a gap in primate aging research. The study encompassed a comprehensive suite of physiological, imaging, histological, and molecular evaluations, substantiating metformin's influence on delaying age-related phenotypes at the organismal level. Specifically, we leveraged pan-tissue transcriptomics, DNA methylomics, plasma proteomics, and metabolomics to develop innovative monkey aging clocks and applied these to gauge metformin's effects on aging. The results highlighted a significant slowing of aging indicators, notably a roughly 6-year regression in brain aging. Metformin exerts a substantial neuroprotective effect, preserving brain structure and enhancing cognitive ability. The geroprotective effects on primate neurons were partially mediated by the activation of Nrf2, a transcription factor with anti-oxidative capabilities. Our research pioneers the systemic reduction of multi-dimensional biological age in primates through metformin, paving the way for advancing pharmaceutical strategies against human aging.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Yuanhan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lu</LastName><ForeName>Xiaoyong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>China National Center for Bioinformation, Beijing, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ma</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, CAS, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China; Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Zhiyi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Kuan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>China National Center for Bioinformation, Beijing, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jiang</LastName><ForeName>Mengmeng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, CAS, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zheng</LastName><ForeName>Zikai</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>China National Center for Bioinformation, Beijing, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qiao</LastName><ForeName>Yicheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hu</LastName><ForeName>Qinchao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Hospital of Stomatology, Guanghua School of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-Sen University, Guangzhou 510060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Huang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Chongqing Fifth People's Hospital, Chongqing 400060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Yiyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, CAS, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xiong</LastName><ForeName>Muzhao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>China National Center for Bioinformation, Beijing, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Lixiao</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>China National Center for Bioinformation, Beijing, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jiang</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Reddy</LastName><ForeName>Pradeep</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Altos Labs San Diego Institute of Science, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dong</LastName><ForeName>Xueda</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; Sino-Danish College, University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xu</LastName><ForeName>Fanshu</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Qiaoran</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>China National Center for Bioinformation, Beijing, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhao</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Disorders, Aging Translational Medicine Center, International Center for Aging and Cancer, Xuanwu Hospital Capital Medical University, Beijing 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lei</LastName><ForeName>Jinghui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Disorders, Aging Translational Medicine Center, International Center for Aging and Cancer, Xuanwu Hospital Capital Medical University, Beijing 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sun</LastName><ForeName>Shuhui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jing</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Disorders, Aging Translational Medicine Center, International Center for Aging and Cancer, Xuanwu Hospital Capital Medical University, Beijing 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Jingyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, CAS, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China; Aging Biomarker Consortium (ABC), Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cai</LastName><ForeName>Yusheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, CAS, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fan</LastName><ForeName>Yanling</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>China National Center for Bioinformation, Beijing, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yan</LastName><ForeName>Kaowen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, CAS, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jing</LastName><ForeName>Yaobin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, CAS, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China; International Center for Aging and Cancer, Hainan Medical University, Haikou 571199, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Haghani</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Altos Labs San Diego Institute of Science, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xing</LastName><ForeName>Mengen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Oujiang Laboratory, Center for Geriatric Medicine and Institute of Aging, Key Laboratory of Alzheimer's Disease of Zhejiang Province, Zhejiang Provincial Clinical Research for Mental Disorders, The First-Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Clinical Immunology Center, Chinese Academy of Medical Sciences, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhu</LastName><ForeName>Guodong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Gerontology, Guangzhou Geriatric Hospital, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Song</LastName><ForeName>Weihong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Oujiang Laboratory, Center for Geriatric Medicine and Institute of Aging, Key Laboratory of Alzheimer's Disease of Zhejiang Province, Zhejiang Provincial Clinical Research for Mental Disorders, The First-Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Horvath</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Altos Labs San Diego Institute of Science, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rodriguez Esteban</LastName><ForeName>Concepcion</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Altos Labs San Diego Institute of Science, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Song</LastName><ForeName>Moshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Si</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Disorders, Aging Translational Medicine Center, International Center for Aging and Cancer, Xuanwu Hospital Capital Medical University, Beijing 100053, China; Aging Biomarker Consortium (ABC), Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhao</LastName><ForeName>Guoguang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing 100053, China; National Medical Center for Neurological Diseases, Beijing 100053, China; Beijing Municipal Geriatric Medical Research Center, Beijing 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, CAS, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Izpisua Belmonte</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Altos Labs San Diego Institute of Science, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, CAS, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China; Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China; Aging Biomarker Consortium (ABC), Beijing 100101, China. Electronic address: qujing@ioz.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Weiqi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>China National Center for Bioinformation, Beijing, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China; Institute for Stem Cell and Regeneration, CAS, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China; Aging Biomarker Consortium (ABC), Beijing 100101, China. Electronic address: zhangwq@big.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Guang-Hui</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Membrane Biology, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Institute for Stem Cell and Regeneration, CAS, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China; National Clinical Research Center for Geriatric Disorders, Aging Translational Medicine Center, International Center for Aging and Cancer, Xuanwu Hospital Capital Medical University, Beijing 100053, China; University of Chinese Academy of Sciences, Beijing 100049, China; Aging Biomarker Consortium (ABC), Beijing 100101, China. Electronic address: ghliu@ioz.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">aging</Keyword><Keyword MajorTopicYN=\"N\">aging clock</Keyword><Keyword MajorTopicYN=\"N\">metformin</Keyword><Keyword MajorTopicYN=\"N\">primate</Keyword><Keyword MajorTopicYN=\"N\">senescence</Keyword></KeywordList><CoiStatement>Declaration of interests J.C.I.B., S.H., C.R.E., P.R., and A.H. are employees of Altos Labs. S.H. is a founder of the non-profit Epigenetic Clock Development Foundation, which has licensed several of his patents from UC Regents and distributes the mammalian methylation array.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39270656</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2024.08.021</ArticleId><ArticleId IdType=\"pii\">S0092-8674(24)00914-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39270646</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1878-3686</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Cancer cell</Title><ISOAbbreviation>Cancer Cell</ISOAbbreviation></Journal><ArticleTitle>Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1535-6108(24)00314-3</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.ccell.2024.08.015</ELocationID><Abstract><AbstractText>Brain metastasis, a serious complication of cancer, hinges on the initial survival, microenvironment adaptation, and outgrowth of disseminated cancer cells. To understand the early stages of brain colonization, we investigated two prevalent sources of cerebral relapse, triple-negative (TNBC) and HER2+ (HER2BC) breast cancers. Using mouse models and human tissue samples, we found that these tumor types colonize the brain, with a preference for distinctive tumor architectures, stromal interfaces, and autocrine programs. TNBC models tend to form perivascular sheaths with diffusive contact with astrocytes and microglia. In contrast, HER2BC models tend to form compact spheroids driven by autonomous tenascin C production, segregating stromal cells to the periphery. Single-cell transcriptomics of the tumor microenvironment revealed that these architectures evoke differential Alzheimer's disease-associated microglia (DAM) responses and engagement of the GAS6 receptor AXL. The spatial features of the two modes of brain colonization have relevance for leveraging the stroma to treat brain metastasis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Gan</LastName><ForeName>Siting</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Macalinao</LastName><ForeName>Danilo G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shahoei</LastName><ForeName>Sayyed Hamed</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tian</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jin</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang Province 310024, China; Research Center for Industries of the Future, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province 310024, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Basnet</LastName><ForeName>Harihar</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bibby</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Muller</LastName><ForeName>James T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Atri</LastName><ForeName>Pranita</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Computational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Seffar</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Computational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chatila</LastName><ForeName>Walid</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Computational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Karacay</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chanda</LastName><ForeName>Pharto</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hadjantonakis</LastName><ForeName>Anna-Katerina</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schultz</LastName><ForeName>Nikolaus</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Computational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brogi</LastName><ForeName>Edi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bale</LastName><ForeName>Tejus A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Moss</LastName><ForeName>Nelson S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Murali</LastName><ForeName>Rajmohan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pe'er</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Massagu&#xe9;</LastName><ForeName>Joan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: massaguj@mskcc.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Cell</MedlineTA><NlmUniqueID>101130617</NlmUniqueID><ISSNLinking>1535-6108</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">brain metastasis</Keyword><Keyword MajorTopicYN=\"N\">breast cancer</Keyword><Keyword MajorTopicYN=\"N\">extracellular matrix</Keyword><Keyword MajorTopicYN=\"N\">microglia</Keyword><Keyword MajorTopicYN=\"N\">tumor architecture</Keyword><Keyword MajorTopicYN=\"N\">tumor microenvironment</Keyword></KeywordList><CoiStatement>Declaration of interests N.S.M. has consulted for AstraZeneca. D.P. is on the scientific advisory board of Insitro. J.M. holds company stock of Scholar Rock, Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2023</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39270646</ArticleId><ArticleId IdType=\"doi\">10.1016/j.ccell.2024.08.015</ArticleId><ArticleId IdType=\"pii\">S1535-6108(24)00314-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39270580</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1878-562X</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>161</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>Bioelectrochemistry (Amsterdam, Netherlands)</Title><ISOAbbreviation>Bioelectrochemistry</ISOAbbreviation></Journal><ArticleTitle>Spectroelectrochemical studies of TDMQ20: A potential drug against Alzheimer's disease.</ArticleTitle><Pagination><StartPage>108814</StartPage><MedlinePgn>108814</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.bioelechem.2024.108814</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1567-5394(24)00176-2</ELocationID><Abstract><AbstractText>Alzheimer's Disease (AD), reported for the first time in 1906, is a common disease that remains incurable to this day. In the past, a family of treatments using Cu(II) chelators failed during clinical trials, evidencing the importance of pre-clinical studies. In this work, we performed electrochemical characterisation of TDMQ20, a new potential drug against AD, using electrochemistry and spectroelectrochemistry. On the basis of voltammetry, we determined that TDMQ20 undergoes a two-step irreversible oxidation process and a one-step irreversible reduction process. Both oxidation and reduction reactions are pH-sensitive. Bidimensional UV-Vis spectroelectrochemistry (UV-Vis-SEC) allowed us to confirm that oxidation of TDMQ20 can occur both on the aliphatic chain and on the aromatic ring. The results expand the knowledge of the TDMQ20 redox activity in the human body which is important from the point of view of the toxicity of the proposed therapy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wiloch</LastName><ForeName>Magdalena Z</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland. Electronic address: mwiloch@ichf.edu.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Perez-Estebanez</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Burgos, Pza. Misael Ba&#xf1;uelos s/n, E-09001 Burgos, Spain. Electronic address: mpestebanez@ubu.es.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Baran</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Heras</LastName><ForeName>Aranzazu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Burgos, Pza. Misael Ba&#xf1;uelos s/n, E-09001 Burgos, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>J&#xf6;nsson-Niedzi&#xf3;&#x142;ka</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Colina</LastName><ForeName>Alvaro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Burgos, Pza. Misael Ba&#xf1;uelos s/n, E-09001 Burgos, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Bioelectrochemistry</MedlineTA><NlmUniqueID>100953583</NlmUniqueID><ISSNLinking>1567-5394</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Spectroelectrochemistry</Keyword><Keyword MajorTopicYN=\"N\">TDMQ20</Keyword><Keyword MajorTopicYN=\"N\">Voltammetry</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39270580</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bioelechem.2024.108814</ArticleId><ArticleId IdType=\"pii\">S1567-5394(24)00176-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39270527</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1090-2120</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>153</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>Bioorganic chemistry</Title><ISOAbbreviation>Bioorg Chem</ISOAbbreviation></Journal><ArticleTitle>Design, synthesis, and biological evaluation of tetrahydropyrimidine analogue as GSK-3&#x3b2;/A&#x3b2; aggregation inhibitor and anti-Alzheimer's agent.</ArticleTitle><Pagination><StartPage>107811</StartPage><MedlinePgn>107811</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.bioorg.2024.107811</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0045-2068(24)00716-8</ELocationID><Abstract><AbstractText>The complex nature of Alzheimer's disease (AD) etiopathology is among the principal hurdles to developing effective anti-Alzheimer agents. Tau pathology and Amyloid-&#x3b2; (A&#x3b2;) accumulation are hallmarks and validated therapeutic strategies of AD. GSK-3&#x3b2; is a serine/threonine kinase involved in tau phosphorylation. Its excessive activity also contributes to the production of A&#x3b2; plaques, making GSK-3&#x3b2; an attractive AD target. Taking this into account, In this article, we outline the design, synthesis, and biological validation of a focused library of 1,2,3,4-tetrahydropyrimidine based derivatives as inhibitors of GSK-3&#x3b2;, tau phosphorylation, and A&#x3b2; accumulation. The inhibitory activity of forty nine synthetic compounds was tested against GSK-3&#x3b2; and other AD-relevant kinases. The kinetic experiments revealed the mode of GSK-3&#x3b2; inhibition by the most potent compound 44. The in- vitro drug metabolism and pharmacokinetic studies were thereafter performed. The anti-aggregation activity of the most potent GSK-3&#x3b2; inhibitor was tested using AD transgenic Caenorhabditis elegans (C. elegans) strain CL2006 for quantification of A&#x3b2; plaques and BR5706 C. elegans strain for tau pathology evaluation. We then evaluated the blood-brain barrier permeability and got promising results. Therefore, we present compound 44 as a potential ATP-competitive GSK-3&#x3b2; inhibitor with good metabolism and pharmacokinetic profile, anti-aggregation properties for amyloid beta protein, and reduction in tau-phosphorylation levels. We recommend more investigation into compound 44-based small molecules as possible targets for AD disease-modifying treatments.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Sukanya</LastName><ForeName>Sukanya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Central University of Rajasthan, Bandarsindari, Ajmer, Rajasthan 305817, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bellver-Sanchis</LastName><ForeName>Aina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pharmacology Section, Department of Pharmacology, Toxicology, and Therapeutic Chemistry. Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, University of Barcelona (NeuroUB), Av. Joan XXIII 27-31, 08028 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Singh Choudhary</LastName><ForeName>Bhanwar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Central University of Rajasthan, Bandarsindari, Ajmer, Rajasthan 305817, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kumar</LastName><ForeName>Sunil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Central University of Rajasthan, Bandarsindari, Ajmer, Rajasthan 305817, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>P&#xe9;rez</LastName><ForeName>Bel&#xe9;n</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Therapeutics and Toxicology, Institute of Neuroscience, Autonomous University of Barcelona, 08193 Bellaterra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Leandro Mart&#xed;nez Rodr&#xed;guez</LastName><ForeName>Ant&#xf3;n</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Innopharma screening platform, Biofarma research group. Centro de Investigaci&#xf3;n en Medicina Molecular y Enfermedades Cr&#xf3;nicas (CIMUS), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brea</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Innopharma screening platform, Biofarma research group. Centro de Investigaci&#xf3;n en Medicina Molecular y Enfermedades Cr&#xf3;nicas (CIMUS), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain; Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela (SERGAS), Trav. Choupana s/n, 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gri&#xf1;&#xe1;n-Ferr&#xe9;</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pharmacology Section, Department of Pharmacology, Toxicology, and Therapeutic Chemistry. Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, University of Barcelona (NeuroUB), Av. Joan XXIII 27-31, 08028 Barcelona, Spain; Centro de Investigaci&#xf3;n en Red, Enfermedades Neurodegenerativas (CIBERNED), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Malik</LastName><ForeName>Ruchi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Central University of Rajasthan, Bandarsindari, Ajmer, Rajasthan 305817, India. Electronic address: ruchimalik1976@curaj.ac.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Bioorg Chem</MedlineTA><NlmUniqueID>1303703</NlmUniqueID><ISSNLinking>0045-2068</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">ATP-competition</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s Disease</Keyword><Keyword MajorTopicYN=\"N\">A&#x3b2; aggregation</Keyword><Keyword MajorTopicYN=\"N\">BBB permeation</Keyword><Keyword MajorTopicYN=\"N\">GSK-3&#x3b2;</Keyword><Keyword MajorTopicYN=\"N\">Tau phosphorylation</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39270527</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bioorg.2024.107811</ArticleId><ArticleId IdType=\"pii\">S0045-2068(24)00716-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39270493</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1873-7072</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>463</Volume><Issue>Pt 2</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>Food chemistry</Title><ISOAbbreviation>Food Chem</ISOAbbreviation></Journal><ArticleTitle>Unlocking the in vitro neuroprotection of sloe residues phenolic extracts by bioanalytical and chemometric strategies.</ArticleTitle><Pagination><StartPage>141208</StartPage><MedlinePgn>141208</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.foodchem.2024.141208</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0308-8146(24)02858-9</ELocationID><Abstract><AbstractText>Wild fruits, particularly the underutilized sloe (Prunus spinosa), are gaining interest as natural antioxidants, with residues from liqueur production being a source of bioactive compounds. This study proposes a sustainable approach for valorizing sloe residues, seeds and skins, by employing an innovative green extraction method. HPLC-ESI-QTOF and spectrophotometric techniques were used to explore the phenolic profile, highlighting the predominance of quercetin, 2,3-dihydroxybenzoic and ferulic acids (9.7-57&#xa0;&#x3bc;g&#xb7;g<sup>-1</sup>). In addition, the presence of Cu, Zn and Ca was confirmed by atomic absorption spectroscopy. Simultaneously, their neuroprotective potential against Alzheimer's disease (AD) was studied by exploring the inhibition of beta-amyloid aggregation and oxidative stress cytoprotection in SH-SY5Y cell line, standing out 1&#xa0;&#x3bc;g&#xb7;g<sup>-1</sup> and 10&#xa0;&#x3bc;g&#xb7;g<sup>-1</sup> extracts of sloe skin. Phenolic composition was correlated with bioactivities by means of multivariate analysis. These results contributed to highlight the potential of this bio-residue as a neuroprotective agent against AD in pharmaceutical and nutraceutical industries.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>G&#xf3;mez-Mej&#xed;a</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Analytical Chemistry, Faculty of Chemistry Sciences, Complutense University of Madrid, 28040 Madrid, Spain. Electronic address: egomez03@ucm.es.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vicente-Zurdo</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Analytical Chemistry, Faculty of Chemistry Sciences, Complutense University of Madrid, 28040 Madrid, Spain; Centre for Metabolomics and Bioanalysis (CEMBIO), Department of Chemistry and Biochemistry, Faculty of Pharmacy, San Pablo-CEU Universities, CEU Universities, 28660, Boadilla Del Monte, Madrid, Spain. Electronic address: davidvic@ucm.es.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rosales-Conrado</LastName><ForeName>Noelia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Analytical Chemistry, Faculty of Chemistry Sciences, Complutense University of Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Le&#xf3;n-Gonz&#xe1;lez</LastName><ForeName>Mar&#xed;a Eugenia</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Analytical Chemistry, Faculty of Chemistry Sciences, Complutense University of Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food Chem</MedlineTA><NlmUniqueID>7702639</NlmUniqueID><ISSNLinking>0308-8146</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">A&#x3b2;(42)</Keyword><Keyword MajorTopicYN=\"N\">Chemometric tools</Keyword><Keyword MajorTopicYN=\"N\">Circular economy</Keyword><Keyword MajorTopicYN=\"N\">In vitro antioxidant</Keyword><Keyword MajorTopicYN=\"N\">Polyphenols</Keyword><Keyword MajorTopicYN=\"N\">Sloe bio-residues</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39270493</ArticleId><ArticleId IdType=\"doi\">10.1016/j.foodchem.2024.141208</ArticleId><ArticleId IdType=\"pii\">S0308-8146(24)02858-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39270367</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1873-3557</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>325</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy</Title><ISOAbbreviation>Spectrochim Acta A Mol Biomol Spectrosc</ISOAbbreviation></Journal><ArticleTitle>A highly effective curcumin-based fluorescent probe with single-wavelength excitation for simultaneous detection and bioimaging of Cys, Hcy and GSH.</ArticleTitle><Pagination><StartPage>125108</StartPage><MedlinePgn>125108</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.saa.2024.125108</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1386-1425(24)01274-5</ELocationID><Abstract><AbstractText>Cysteine (Cys), homocysteine (Hcy) and glutathione (GSH) act as significant roles in many physiological processes, and their abnormal proliferation will cause multiple diseases including Alzheimer's disease, Parkinson's disease, Cardiovascular disease, atherosclerosis, and soft tissue damage. However, It is challenging work to develop a efficient method for differentiating and detecting GSH, Cys and Hcy because of their significant similarity in structures and functions. In this work, a smart fluorescent probe FBCN based on curcumin was rationally devised and developed by etherifying the phenol hydroxyl group on FBC with NBD-Cl, which emitted strong green at 516&#xa0;nm. FBCN distinguished Hcy from Cys/GSH with naked eyes based on the color variation of probe solution in sunlight. Meanwhile, GSH induced the powerful fluorescence quenching of probe solution, but the fluorescence color of FBCN solution transformed from green to luminous yellow accompanied with emission wavelength redshifted from 516&#xa0;nm to 540&#xa0;nm or 553&#xa0;nm in the existence of Hcy and Cys, respectively. Probe FBCN had outstanding sensitivity and anti-interference, low detection limit (56.5&#xa0;nM, 77.7&#xa0;nM, and 288&#xa0;nM corresponded to Cys, Hcy, and GSH, respectively), short response time (the response time of FBCN to Cys, Hcy and GSH was 1 min, 2 min and 5 min, respectively). The DFT calculation and HRMS had verified the sensing mechanism of FBCN to biothiols. In addition, the probe was successfully utilized to detect three biothiols levels in living cell and zebrafish.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Du</LastName><ForeName>Wenhao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Jiangsu Co-innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhou</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Jiangsu Co-innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Chunjie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jiangsu Co-innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Zhonglong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Jiangsu Co-innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China. Electronic address: wang_zhonglong@njfu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Shifa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Jiangsu Co-innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China. Electronic address: wangshifa65@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Spectrochim Acta A Mol Biomol Spectrosc</MedlineTA><NlmUniqueID>9602533</NlmUniqueID><ISSNLinking>1386-1425</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Bioimaging</Keyword><Keyword MajorTopicYN=\"N\">Biothiols</Keyword><Keyword MajorTopicYN=\"N\">Curcumin</Keyword><Keyword MajorTopicYN=\"N\">Fluorescent probe</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39270367</ArticleId><ArticleId IdType=\"doi\">10.1016/j.saa.2024.125108</ArticleId><ArticleId IdType=\"pii\">S1386-1425(24)01274-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39270153</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1526-632X</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>103</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Core CSF Biomarker Profile in Cerebral Amyloid Angiopathy: Updated Meta-Analysis.</ArticleTitle><Pagination><StartPage>e209795</StartPage><MedlinePgn>e209795</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1212/WNL.0000000000209795</ELocationID><Abstract><AbstractText Label=\"BACKGROUND AND OBJECTIVES\" NlmCategory=\"OBJECTIVE\">There is a clear need to characterize and validate molecular biomarkers of cerebral amyloid angiopathy (CAA), in an effort to improve diagnostics, especially in the context of patients with Alzheimer disease (AD) receiving immunotherapies (for whom underlying CAA is the driver of amyloid-related imaging abnormalities). We performed an updated meta-analysis of 5 core CSF biomarkers (A&#x3b2;42, A&#x3b2;40, A&#x3b2;438, total tau [T-tau], and phosphorylated tau [P-tau]) to assess which of these are most altered in sporadic CAA.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">We systematically searched PubMed for eligible studies reporting data on CSF biomarkers reflecting APP metabolism (A&#x3b2;42, A&#x3b2;40, A&#x3b2;38), neurodegeneration (T-tau), and tangle pathology (P-tau), in symptomatic sporadic CAA cohorts (based on the Boston criteria) vs control groups and/or vs patients with AD. Biomarker performance was assessed in random-effects meta-analysis based on ratio of mean (RoM) biomarker concentrations in (1) patients with CAA to controls and (2) CAA to patients with AD. RoM &gt;1 indicates higher biomarker concentration in CAA vs comparison population, and RoM &lt;1 indicates higher concentration in comparison groups.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">8 studies met inclusion criteria: a total of 11 CAA cohorts (n = 289), 9 control cohorts (n = 310), and 8 AD cohorts (n = 339). Overall included studies were of medium quality based on our assessment tools. CAA to controls had lower mean level of all amyloid markers with CSF A&#x3b2;42, A&#x3b2;40, and A&#x3b2;38 RoMs of 0.46 (95% CI 0.38-0.55, <i>p</i> &lt; 0.0001), 0.70 (95% CI 0.63-0.78, <i>p</i> &lt; 0.0001), and 0.71 (95% CI 0.56-0.89, <i>p</i> = 0.003), respectively. CSF T-tau and P-tau RoMs of patients with CAA to controls were both greater than 1: 1.56 (95% CI 1.32-1.84, <i>p</i> &lt; 0.0001) and 1.31 (95% CI 1.13-1.51, <i>p</i> &lt; 0.0001), respectively. Differentiation between CAA and AD was strong for CSF A&#x3b2;40 (RoM 0.76, 95% CI 0.69-0.83, <i>p</i> &lt; 0.0001) and A&#x3b2;38 (RoM 0.55, 95% CI 0.38-0.81, <i>p</i> &lt; 0.0001), but not A&#x3b2;42 (RoM 1.00; 95% CI 0.81-1.23, <i>p</i> = 0.970). For T-tau and P-tau, average CSF ratios in patients with CAA vs AD were 0.64 (95% CI 0.58-0.71, <i>p</i> &lt; 0.0001) and 0.64 (95% CI 0.58-0.71, <i>p</i> &lt; 0.0001), respectively.</AbstractText><AbstractText Label=\"DISCUSSION\" NlmCategory=\"CONCLUSIONS\">Specific CSF patterns of A&#x3b2;42, A&#x3b2;40, A&#x3b2;38, T-tau, and P-tau might serve as molecular biomarkers of CAA, in research and clinical settings, offering the potential to improve the clinical diagnostic approach pathway in specific scenarios.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Charidimou</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0001-5891-337X</Identifier><AffiliationInfo><Affiliation>From the Department of Neurology (A.C.), Boston University Medical Center, Boston University School of Medicine, MA; and Diagnostic and Interventional Neuroradiology (G.B.), University Hospital, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Boulouis</LastName><ForeName>Gregoire</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0001-8422-9205</Identifier><AffiliationInfo><Affiliation>From the Department of Neurology (A.C.), Boston University Medical Center, Boston University School of Medicine, MA; and Diagnostic and Interventional Neuroradiology (G.B.), University Hospital, Tours, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D017418\">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016229\">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016875\">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D010446\">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C075222\">amyloid beta-protein (1-42)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016657\" MajorTopicYN=\"Y\">Cerebral Amyloid Angiopathy</DescriptorName><QualifierName UI=\"Q000134\" MajorTopicYN=\"N\">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015415\" MajorTopicYN=\"Y\">Biomarkers</DescriptorName><QualifierName UI=\"Q000134\" MajorTopicYN=\"N\">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016229\" MajorTopicYN=\"Y\">Amyloid beta-Peptides</DescriptorName><QualifierName UI=\"Q000134\" MajorTopicYN=\"N\">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016875\" MajorTopicYN=\"Y\">tau Proteins</DescriptorName><QualifierName UI=\"Q000134\" MajorTopicYN=\"N\">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D010446\" MajorTopicYN=\"N\">Peptide Fragments</DescriptorName><QualifierName UI=\"Q000134\" MajorTopicYN=\"N\">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"N\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000134\" MajorTopicYN=\"N\">cerebrospinal fluid</QualifierName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>16</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39270153</ArticleId><ArticleId IdType=\"doi\">10.1212/WNL.0000000000209795</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39270152</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1526-632X</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>103</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Association of Polygenic Risk Score With Lifetime Risk of Developing Multiple Sclerosis in a Population-Based Birth-Year Cohort.</ArticleTitle><Pagination><StartPage>e209663</StartPage><MedlinePgn>e209663</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">e209663</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1212/WNL.0000000000209663</ELocationID><Abstract><AbstractText Label=\"BACKGROUND AND OBJECTIVES\" NlmCategory=\"OBJECTIVE\">More than 200 genetic variants have been associated with multiple sclerosis (MS) susceptibility. However, it is unclear to what extent genetic factors influence lifetime risk of MS. Using a population-based birth-year cohort, we investigate the effect of genetics on lifetime risk of MS.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">In the Project Y study, we tracked down almost all persons with MS (pwMS) from birth year 1966 in the Netherlands. As control participants, we included non-MS participants from the Project Y cohort (born 1965-1967 in the Netherlands) and non-MS participants from the Amsterdam Dementia Cohort born between 1963 and 1969. Genetic variants associated with MS were determined in pwMS and control participants using genotyping or imputation methods. Polygenic risk scores (PRSs) based on variants and weights from the largest genetic study in MS were calculated for each participant and assigned into deciles based on the PRS distribution in the control participants. We examined the lifetime risk for each decile and the association between PRS and MS disease variables, including age at onset and time to secondary progression.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">MS-PRS was calculated for 285 pwMS (mean age 53.0 &#xb1; 0.9 years, 72.3% female) and 267 control participants (mean age 51.8 &#xb1; 3.2 years, 58.1% female). Based on the lifetime risk estimation, we observed that 1:2,739 of the women with the lowest 30% genetic risk developed MS, whereas 1:92 of the women with the top 10% highest risk developed MS. For men, only 1:7,900 developed MS in the lowest 30% genetic risk group, compared with 1:293 men with the top 10% genetic risk. The PRS was not significantly associated with age at onset and time to secondary progression in both sexes.</AbstractText><AbstractText Label=\"DISCUSSION\" NlmCategory=\"CONCLUSIONS\">Our results show that the lifetime risk of MS is strongly influenced by genetic factors. Our findings have the potential to support diagnostic certainty in individuals with suspected MS: a high PRS could strengthen a diagnosis, but especially a PRS from the lowest tail of the PRS distribution should be considered a red flag and could prevent misdiagnosing conditions that mimic MS.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Loonstra</LastName><ForeName>Floor C</ForeName><Initials>FC</Initials><Identifier Source=\"ORCID\">0000-0002-1644-4410</Identifier><AffiliationInfo><Affiliation>From the MS Center Amsterdam (F.C.L., E.M.M.S., B.U.), Neurology, Amsterdam Neuroscience, Genomics of Neurodegenerative Diseases and Aging (D.&#xc1;.S., N.T., H.H., A.N.S., M.H., S.J.V.D.L.), Human Genetics, and Alzheimer Center Amsterdam (H.H., S.J.V.D.L.), Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc; Delft Bioinformatics Lab (N.T., H.H.), Delft University of Technology; and Amsterdam Neuroscience (H.H., S.J.V.D.L.), Neurodegeneration, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>&#xc1;lvarez Sirvent</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the MS Center Amsterdam (F.C.L., E.M.M.S., B.U.), Neurology, Amsterdam Neuroscience, Genomics of Neurodegenerative Diseases and Aging (D.&#xc1;.S., N.T., H.H., A.N.S., M.H., S.J.V.D.L.), Human Genetics, and Alzheimer Center Amsterdam (H.H., S.J.V.D.L.), Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc; Delft Bioinformatics Lab (N.T., H.H.), Delft University of Technology; and Amsterdam Neuroscience (H.H., S.J.V.D.L.), Neurodegeneration, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tesi</LastName><ForeName>Niccol&#xf3;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>From the MS Center Amsterdam (F.C.L., E.M.M.S., B.U.), Neurology, Amsterdam Neuroscience, Genomics of Neurodegenerative Diseases and Aging (D.&#xc1;.S., N.T., H.H., A.N.S., M.H., S.J.V.D.L.), Human Genetics, and Alzheimer Center Amsterdam (H.H., S.J.V.D.L.), Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc; Delft Bioinformatics Lab (N.T., H.H.), Delft University of Technology; and Amsterdam Neuroscience (H.H., S.J.V.D.L.), Neurodegeneration, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Holstege</LastName><ForeName>Henne</ForeName><Initials>H</Initials><Identifier Source=\"ORCID\">0000-0002-7688-3087</Identifier><AffiliationInfo><Affiliation>From the MS Center Amsterdam (F.C.L., E.M.M.S., B.U.), Neurology, Amsterdam Neuroscience, Genomics of Neurodegenerative Diseases and Aging (D.&#xc1;.S., N.T., H.H., A.N.S., M.H., S.J.V.D.L.), Human Genetics, and Alzheimer Center Amsterdam (H.H., S.J.V.D.L.), Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc; Delft Bioinformatics Lab (N.T., H.H.), Delft University of Technology; and Amsterdam Neuroscience (H.H., S.J.V.D.L.), Neurodegeneration, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Strijbis</LastName><ForeName>Eva M M</ForeName><Initials>EMM</Initials><Identifier Source=\"ORCID\">0000-0001-6705-5864</Identifier><AffiliationInfo><Affiliation>From the MS Center Amsterdam (F.C.L., E.M.M.S., B.U.), Neurology, Amsterdam Neuroscience, Genomics of Neurodegenerative Diseases and Aging (D.&#xc1;.S., N.T., H.H., A.N.S., M.H., S.J.V.D.L.), Human Genetics, and Alzheimer Center Amsterdam (H.H., S.J.V.D.L.), Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc; Delft Bioinformatics Lab (N.T., H.H.), Delft University of Technology; and Amsterdam Neuroscience (H.H., S.J.V.D.L.), Neurodegeneration, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Salazar</LastName><ForeName>Alex N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>From the MS Center Amsterdam (F.C.L., E.M.M.S., B.U.), Neurology, Amsterdam Neuroscience, Genomics of Neurodegenerative Diseases and Aging (D.&#xc1;.S., N.T., H.H., A.N.S., M.H., S.J.V.D.L.), Human Genetics, and Alzheimer Center Amsterdam (H.H., S.J.V.D.L.), Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc; Delft Bioinformatics Lab (N.T., H.H.), Delft University of Technology; and Amsterdam Neuroscience (H.H., S.J.V.D.L.), Neurodegeneration, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hulsman</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the MS Center Amsterdam (F.C.L., E.M.M.S., B.U.), Neurology, Amsterdam Neuroscience, Genomics of Neurodegenerative Diseases and Aging (D.&#xc1;.S., N.T., H.H., A.N.S., M.H., S.J.V.D.L.), Human Genetics, and Alzheimer Center Amsterdam (H.H., S.J.V.D.L.), Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc; Delft Bioinformatics Lab (N.T., H.H.), Delft University of Technology; and Amsterdam Neuroscience (H.H., S.J.V.D.L.), Neurodegeneration, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Van Der Lee</LastName><ForeName>Sven J</ForeName><Initials>SJ</Initials><Identifier Source=\"ORCID\">0000-0003-1606-8643</Identifier><AffiliationInfo><Affiliation>From the MS Center Amsterdam (F.C.L., E.M.M.S., B.U.), Neurology, Amsterdam Neuroscience, Genomics of Neurodegenerative Diseases and Aging (D.&#xc1;.S., N.T., H.H., A.N.S., M.H., S.J.V.D.L.), Human Genetics, and Alzheimer Center Amsterdam (H.H., S.J.V.D.L.), Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc; Delft Bioinformatics Lab (N.T., H.H.), Delft University of Technology; and Amsterdam Neuroscience (H.H., S.J.V.D.L.), Neurodegeneration, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Uitdehaag</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><Identifier Source=\"ORCID\">0000-0002-9226-7364</Identifier><AffiliationInfo><Affiliation>From the MS Center Amsterdam (F.C.L., E.M.M.S., B.U.), Neurology, Amsterdam Neuroscience, Genomics of Neurodegenerative Diseases and Aging (D.&#xc1;.S., N.T., H.H., A.N.S., M.H., S.J.V.D.L.), Human Genetics, and Alzheimer Center Amsterdam (H.H., S.J.V.D.L.), Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc; Delft Bioinformatics Lab (N.T., H.H.), Delft University of Technology; and Amsterdam Neuroscience (H.H., S.J.V.D.L.), Neurodegeneration, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009103\" MajorTopicYN=\"Y\">Multiple Sclerosis</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020412\" MajorTopicYN=\"Y\">Multifactorial Inheritance</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D020022\" MajorTopicYN=\"Y\">Genetic Predisposition to Disease</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D009426\" MajorTopicYN=\"N\" Type=\"Geographic\">Netherlands</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000089822\" MajorTopicYN=\"N\">Birth Cohort</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017668\" MajorTopicYN=\"N\">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015331\" MajorTopicYN=\"N\">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012307\" MajorTopicYN=\"N\">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018450\" MajorTopicYN=\"N\">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000096442\" MajorTopicYN=\"N\">Genetic Risk Score</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>N. Tesi, H. Holstege, A.N. Salazar, M. Hulsman, and S.J. van der Lee are recipients of ABOARD, a public-private partnership receiving funding from ZonMW (#73305095007) and Health&#x223c;Holland, Topsector Life Sciences &amp; Health (PPP-allowance; #LSHM20106). H. Holstege received consultancy fees from Retromer Therapeutics and Muna Therapeutics. S.J. van der Lee is a recipient of ZonMW funding (#733050512). B.M.J. Uitdehaag received research support and/or consultancy fees from Biogen Idec, Genzyme, Merck Serono, Novartis, Roche, Teva and Immunic Therapeutics. All other authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>16</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39270152</ArticleId><ArticleId IdType=\"doi\">10.1212/WNL.0000000000209663</ArticleId><ArticleId IdType=\"pmc\">PMC11399064</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622-1636. doi:10.1016/S0140-6736(18)30481-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(18)30481-1</ArticleId><ArticleId IdType=\"pubmed\">29576504</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton C, King R, Rechtman L, et al. . Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816-1821. doi:10.1177/1352458520970841</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1352458520970841</ArticleId><ArticleId IdType=\"pmc\">PMC7720355</ArticleId><ArticleId IdType=\"pubmed\">33174475</ArticleId></ArticleIdList></Reference><Reference><Citation>International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365(6460):eaav7188. doi:10.1126/science.aav7188</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.aav7188</ArticleId><ArticleId IdType=\"pmc\">PMC7241648</ArticleId><ArticleId IdType=\"pubmed\">31604244</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jager PL, Chibnik LB, Cui J, et al. . Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol. 2009;8(12):1111-1119. doi:10.1016/S1474-4422(09)70275-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(09)70275-3</ArticleId><ArticleId IdType=\"pmc\">PMC3099419</ArticleId><ArticleId IdType=\"pubmed\">19879194</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson R, Ramagopalan S, Topping J, et al. . A risk score for predicting multiple sclerosis. PLoS One. 2016;11:e0164992. doi:10.1371/journal.pone.0164992</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0164992</ArticleId><ArticleId IdType=\"pmc\">PMC5089761</ArticleId><ArticleId IdType=\"pubmed\">27802296</ArticleId></ArticleIdList></Reference><Reference><Citation>International Multiple Sclerosis Genetics Consortium; MultipleMS Consortium. Locus for severity implicates CNS resilience in progression of multiple sclerosis. Nature. 2023;619(7969):323-331. doi:10.1038/s41586-023-06250-x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-023-06250-x</ArticleId><ArticleId IdType=\"pmc\">PMC10602210</ArticleId><ArticleId IdType=\"pubmed\">37380766</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies HT, Crombie IK, Tavakoli M. When can odds ratios mislead? BMJ. 1998;316(7136):989-991. doi:10.1136/bmj.316.7136.989</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.316.7136.989</ArticleId><ArticleId IdType=\"pmc\">PMC1112884</ArticleId><ArticleId IdType=\"pubmed\">9550961</ArticleId></ArticleIdList></Reference><Reference><Citation>Polman CH, Reingold SC, Banwell B, et al. . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. doi:10.1002/ana.22366</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.22366</ArticleId><ArticleId IdType=\"pmc\">PMC3084507</ArticleId><ArticleId IdType=\"pubmed\">21387374</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AJ, Banwell BL, Barkhof F, et al. . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. doi:10.1016/S1474-4422(17)30470-2</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(17)30470-2</ArticleId><ArticleId IdType=\"pubmed\">29275977</ArticleId></ArticleIdList></Reference><Reference><Citation>Loonstra FC, De Ruiter LRJ, Doesburg D, et al. . Project Y: the search for clues explaining phenotype variability in MS. Mult Scler Relat Disord. 2022;57:103337. doi:10.1016/j.msard.2021.103337</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.msard.2021.103337</ArticleId><ArticleId IdType=\"pubmed\">35158448</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistiek CBvd. Bevolking; kerncijfers [online]. Accessed February 27, 2023. opendata.cbs.nl/statline/#/CBS/nl/dataset/37296ned/table?ts=1677514839804.</Citation></Reference><Reference><Citation>van der Flier WM, Scheltens P. Amsterdam Dementia Cohort: performing research to optimize care. J Alzheimers Dis. 2018;62(3):1091-1111. doi:10.3233/JAD-170850</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-170850</ArticleId><ArticleId IdType=\"pmc\">PMC5870023</ArticleId><ArticleId IdType=\"pubmed\">29562540</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S, Forer L, Schonherr S, et al. . Next-generation genotype imputation service and methods. Nat Genet. 2016;48(10):1284-1287. doi:10.1038/ng.3656</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ng.3656</ArticleId><ArticleId IdType=\"pmc\">PMC5157836</ArticleId><ArticleId IdType=\"pubmed\">27571263</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesi N, van der Lee S, Hulsman M, et al. . Cognitively Healthy Centenarians are genetically protected against Alzheimer's disease specifically in immune and endo-lysosomal systems. medRxiv. 2023. doi:10.1101/2023.05.16.23290049</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/2023.05.16.23290049</ArticleId><ArticleId IdType=\"pmc\">PMC11180929</ArticleId><ArticleId IdType=\"pubmed\">38634500</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy S, Das S, Kretzschmar W, et al. . A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48(10):1279-1283. doi:10.1038/ng.3643</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ng.3643</ArticleId><ArticleId IdType=\"pmc\">PMC5388176</ArticleId><ArticleId IdType=\"pubmed\">27548312</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. Nat Protoc. 2010;5(9):1564-1573. doi:10.1038/nprot.2010.116</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nprot.2010.116</ArticleId><ArticleId IdType=\"pmc\">PMC3025522</ArticleId><ArticleId IdType=\"pubmed\">21085122</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomes Project C, Auton A, Brooks LD, et al. . A global reference for human genetic variation. Nature. 2015;526(7571):68-74. doi:10.1038/nature15393</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature15393</ArticleId><ArticleId IdType=\"pmc\">PMC4750478</ArticleId><ArticleId IdType=\"pubmed\">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Shen J, Cox C, et al. . HIBAG: HLA genotype imputation with attribute bagging. Pharmacogenomics J. 2014;14(2):192-200. doi:10.1038/tpj.2013.18</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/tpj.2013.18</ArticleId><ArticleId IdType=\"pmc\">PMC3772955</ArticleId><ArticleId IdType=\"pubmed\">23712092</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: a language and environment for statistical computing [online]. 2022. Accessed February 27, 2023. R-project.org/.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39270149</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1526-632X</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>103</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease.</ArticleTitle><Pagination><StartPage>e209766</StartPage><MedlinePgn>e209766</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">e209766</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1212/WNL.0000000000209766</ELocationID><Abstract><AbstractText Label=\"BACKGROUND AND OBJECTIVES\" NlmCategory=\"OBJECTIVE\">It remains unknown whether the associations between protective lifestyles and sporadic dementia risk reported in observational studies also affect age at symptom onset (AAO) in autosomal dominant Alzheimer disease (ADAD) with predominant genetic influences. We investigated the associations between resilience-related life experiences and interindividual AAO variability in ADAD.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">We performed a longitudinal and confirmatory analysis of the Dominantly Inherited Alzheimer Network prospective observational cohort (January 2009-June 2018, follow-up duration 2.13 &#xb1; 2.22 years), involving clinical, CSF, and lifestyle/behavioral assessments. We performed a 2-pronged comprehensive resilience assessment in each cohort. Cohort 1, incorporating the general resilience definition (cognitive maintenance [Clinical Dementia Rating = 0] despite high pathology), included carriers during the periods of significant CSF<sub>p-tau181</sub> variability and grouped into resilience/resistance outcome bins according to the dichotomous pathologic and cognitive statuses, subcategorized by the estimated years from expected symptom onset (EYO). Cohort 2, focused on ADAD-specific genetically determined time frame characterizing the onset predictability, included asymptomatic participants with available preclinical lifestyle data and AAO outcomes and grouped into delayed or earlier AAO relative to the parental AAO. Associations of cognitive, CSF<sub>p-tau181</sub>, and lifestyle/behavioral predictors with binary outcomes were investigated using logistic regression.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Of 320 carriers (age 38.19 &#xb1; 10.94 years, female 56.25%), cohort 1 included 218 participants (39.00 &#xb1; 9.37 years, 57.34%) and cohort 2 included 28 participants (43.34 &#xb1; 7.40 years, 71.43%). In cohort 1, 218 carriers after -20 EYO, when the interindividual variability (SD) of CSF<sub>p-tau181</sub> first became more than twice greater in carriers than in noncarriers, were grouped into low-risk control (asymptomatic, low pathology, n = 103), high-resilience (asymptomatic despite high pathology, n = 60), low-resilience (symptomatic despite low pathology, n = 15), and susceptible control (symptomatic, high pathology, n = 40) groups. Multivariable predictors of high resilience, controlling for age and depression, included higher conscientiousness (odds ratio 1.051 [95% CI 1.016-1.086], <i>p</i> = 0.004), openness to experience (1.068 [1.005-1.135], <i>p</i> = 0.03) (vs. susceptible controls), and agreeableness (1.082 [1.015-1.153], <i>p</i> = 0.02) (vs. low resilience). From 1 to 3 years before parental AAO (cohort 2), the multivariable predictor of delayed AAO, controlling for CSF<sub>p-tau181</sub>, was higher conscientiousness (0.916 [0.845-0.994], <i>p</i> = 0.036).</AbstractText><AbstractText Label=\"DISCUSSION\" NlmCategory=\"CONCLUSIONS\">Among the cognitively and socially integrated life experiences associated with resilience, measures of conscientiousness were useful indicators for evaluating resilience and predicting future dementia onset in late preclinical ADAD.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Son</LastName><ForeName>Hye Joo</ForeName><Initials>HJ</Initials><Identifier Source=\"ORCID\">0000-0003-1290-0949</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Jae Seung</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bateman</LastName><ForeName>Randall J</ForeName><Initials>RJ</Initials><Identifier Source=\"ORCID\">0000-0002-7729-1702</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Seonok</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Llibre-Guerra</LastName><ForeName>Jorge J</ForeName><Initials>JJ</Initials><Identifier Source=\"ORCID\">0000-0002-2137-7750</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Day</LastName><ForeName>Gregory S</ForeName><Initials>GS</Initials><Identifier Source=\"ORCID\">0000-0001-5133-5538</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chhatwal</LastName><ForeName>Jasmeer P</ForeName><Initials>JP</Initials><Identifier Source=\"ORCID\">0000-0002-7792-1698</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Berman</LastName><ForeName>Sarah B</ForeName><Initials>SB</Initials><Identifier Source=\"ORCID\">0000-0002-5096-4962</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schofield</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><Identifier Source=\"ORCID\">0000-0003-2967-9662</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jucker</LastName><ForeName>Mathias</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0001-9045-1072</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Levin</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0001-5092-4306</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lee</LastName><ForeName>Jae-Hong</ForeName><Initials>JH</Initials><Identifier Source=\"ORCID\">0000-0001-7368-4560</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Perrin</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><Identifier Source=\"ORCID\">0000-0002-3443-7716</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Morris</LastName><ForeName>John C</ForeName><Initials>JC</Initials><Identifier Source=\"ORCID\">0000-0001-9820-5618</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cruchaga</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source=\"ORCID\">0000-0002-0276-2899</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hassenstab</LastName><ForeName>Jason</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0002-7802-3371</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Salloway</LastName><ForeName>Stephen P</ForeName><Initials>SP</Initials><Identifier Source=\"ORCID\">0000-0002-2631-0942</Identifier><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lee</LastName><ForeName>Jai-Hyuen</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Daniels</LastName><ForeName>Alisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><CollectiveName>Dominantly Inherited Alzheimer Network (DIAN)</CollectiveName><AffiliationInfo><Affiliation>From the Department of Nuclear Medicine (H.J.S., Jai-Hyuen Lee), Dankook University College of Medicine, Cheonan, Chung Nam; Department of Nuclear Medicine (J.S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (R.J.B., J.J.L.-G., J.C.M., A.D.), Washington University School of Medicine, St. Louis, MO; Department of Clinical Epidemiology and Biostatistics (S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Neurology (G.S.D.), Mayo Clinic College of Medicine and Science, Jacksonville, FL; Department of Neurology (J.P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (S.B.B.), University of Pittsburgh School of Medicine, PA; Neuroscience Research Australia (P.R.S.); School of Medical Sciences (P.R.S.), University of New South Wales, Sydney, Australia; Department of Cellular Neurology (M.J.), Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen; German Center for Neurodegenerative Diseases (M.J.), T&#xfc;bingen; Department of Neurology (J.L.), Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen; German Center for Neurodegenerative Diseases (J.L.), Munich; Munich Cluster for Systems Neurology (SyNergy) (J.L.), Germany; Department of Neurology (Jae-Hong Lee), University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology and Immunology (R.J.P.), Knight Alzheimer's Disease Research Center (R.J.P., J.H.), and Department of Neurology (R.J.P., J.H.), Washington University in St. Louis; Department of Psychiatry (C.C.), Washington University School of Medicine; Department of Psychological and Brain Sciences (J.H.), Washington University, St. Louis, MO; and Department of Neurology (S.P.S.), The Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D064888\">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016875\">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D055500\" MajorTopicYN=\"Y\">Resilience, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017668\" MajorTopicYN=\"Y\">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008137\" MajorTopicYN=\"N\">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015331\" MajorTopicYN=\"N\">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011446\" MajorTopicYN=\"N\">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016875\" MajorTopicYN=\"N\">tau Proteins</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008019\" MajorTopicYN=\"N\">Life Style</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008016\" MajorTopicYN=\"N\">Life Change Events</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>H.J. Son and J.S. Kim report no disclosures relevant to the manuscript. R.J. Bateman has received research funding from the National Institute on Aging (NIA; UFAG032438 [DIAN - grant], R01AG068319 [DIAN-TU Next Generation Tau Trial - grant], UFAG032438 [DIAN - grant], RF1AG061900 [Blood Ab- grant], R56AG061900 [Blood Ab- grant], R21AG067559 [NfL - grant], and R01AG53627/R56AG53627 [DIAN-TU Next Generation Prevention Trial - Research Grant]), the Alzheimer's Association (DIAN-TU-OLE-21-725093 [DIAN-TU Open Label Extension - grant], DIAN-TU-Tau-21-822987 [DIAN-TU Tau Next Generation - grant], Biogen [Tau SILK Consortium member, NfL Consortium member], AbbVie [Tau SILK Consortium member, NfL Consortium member], Bristol Meyer Squibbs [NfL Consortium member], Novartis [Tau SILK Consortium member], NINDS/NIA R01NS095773 [CNS Tau - grant], Investigator Initiated Research Grants for Centene Corporation, Rainwater Foundation, Assn for Frontotemporal Degeneration FTD Biomarkers Initiative, Biogen, BrightFocus Foundation, Cure Alzheimer's Fund, Coins for Alzheimer's Research Trust Fund, Eisai, The Foundation for Barnes-Jewish Hospital, TargetALS, Good Ventures Foundation, DIAN-TU Pharma Consortium [active: Eli Lilly and Company/Avid Radiopharmaceuticals, Hoffman-La Roche/Genentech, Biogen, Eisai, Janssen; previous: Abbvie, Amgen, AstraZeneca, Forum, Mithridion, Novartis, Pfizer, United Neuroscience, Sanofi], Eli Lilly and Company [Tau SILK Consortium Member], Hoffman-La Roche [receipt of drugs and services, NfL Consortium Member], CogState [in-kind support] and Signant [in-kind support]), outside of the submitted work. He has received royalties from C2N Diagnostics, lecture fees from Korean Dementia Association, American Neurological Association, Fondazione Prada, and Weill Cornell Medical College, supports for meeting or travel from Hoffman-La Roche, Alzheimer's Association Roundtable, Duke Margolis Alzheimer's Roundtable, BrightFocus Foundation, Tau Consortium Investigator's Meeting, Fondazione Prada and NAPA Advisory Council on Alzheimer's Research and drugs and services from Eisai (DIAN-TU Next Generation Trial), Janssen (DIAN-TU Next Generation Trial) and Hoffman-La Roche (DIAN-TU Open Label Extension - Gantenerumab), outside of the submitted work. He has served as a Data Safety Monitoring Board for Hoffman-La Roche/Genentech, Biogen - Combination therapy for Alzheimer's disease, UK Dementia Research Institute at University College London, Stanford University, and Next Generation Translational Proteomics for Alzheimer's and Related Dementias and the scientific advisory board for C2N Diagnostics, outside of the submitted work. He has patents (Washington University w/RJB as coinventor) titled &#x201c;Methods for Measuring the Metabolism of CNS Derived Biomolecules In Vivo&#x201d; (US nonprovisional patent application 12/267,974), &#x201c;Methods for Measuring the Metabolism of neurally Derived Biomolecules in vivo&#x201d; (US nonprovisional patent application 13/005,233), &#x201c;Plasma based methods for detecting CNS Amyloid Disposition&#x201d; (US nonprovisional patent application 62/492,718), &#x201c;Plasma based methods for determining A-Beta Amyloidosis&#x201d; (US nonprovisional patent application 16/610,428), &#x201c;Methods of Treating Based on site-specific tau phosphorylation&#x201d; (US nonprovisional patent application 17/015,985) and &#x201c;Tau Kinetic Measurements&#x201d; (US nonprovisional patent application 15/515,909), outside of the submitted work. S. Kim, J.J. Llibre-Guerra, G.S. Day, J. Chhatwal, and S.B. Berman report no disclosures relevant to the manuscript. P.R. Schofield has received research funding from the NIH, Anonymous Foundation, Roth Charitable Foundation, NHMRC (Australia), MRFF (Australia) and NSW Health, outside of the submitted work. He has served as chief executive officer for Neuroscience Research Australia, company director for Neuroscience Research Australia Foundation, The Health-Science Alliance, Australian Association of Medical Research Institutes, the Australian Dementia Network (ADNeT) Ltd, and StandingTall Pty Ltd, company director/chief executive officer for Schizophrenia Research Institute, president for Australasian Neuroscience Society, member/steering committee for Maridulu Budyari Gumal - Sydney Partnership for Health Education, Research and Enterprise (SPHERE), chair/national medical advisory panel for The Judith Jane Mason &amp; Harold Stannett Williams Memorial Foundation and ambassador for Business Events Sydney, outside of the submitted work. M. Jucker reports no disclosures relevant to the manuscript. J. Levin has received research funding from the German Center for Neurodegenerative Diseases (DZNE) and consulting fees from Axon Neuroscience and Biogen, lecture fees from Biogen, Bayer Vital, and Roche, author fees from Thieme medical publishers and W. Kohlhammer GmbH medical publishers, and support for attending meetings from AbbVie and Biogen, outside of the submitted work. He has a pending patent, titled &#x201c;Pharmaceutical Composition and Methods of Use (EP 22 159 408.8),&#x201d; filed by MODAG GmbH, and has served as a Data Safety Monitoring Board for Axon Neuroscience and as a part-time CMO for MODAG GmbH, outside of the submitted work. J.H. Lee reports no disclosures relevant to the manuscript. R.J. Perrin and J.C. Morris have received research funding from the NIH (U19 AG032438). J.C. Morris has received research funding from the NIH (P30 AG066444, P01AG003991, P01AG026276), consulting fees from Barcelona Brain Research Center (BBRC) and Native Alzheimer Disease-Related Resource Center in Minority Aging Research (Ext Adv Board) and lecture fees from Montefiore Grand Rounds (NY) and Tetra-Inst ADRC seminar series (Grand Rds, NY), outside of the submitted work. He has served as a Data Safety Monitoring Board for Cure Alzheimer's Fund (the Research Strategy Council), Diverse VCID Observational Study Monitoring Board, and LEADS Advisory Board (Indiana University), outside of the submitted work. C. Cruchaga, J. Hassenstab, S.P. Salloway, J.H. Lee, and A. Daniels report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>16</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39270149</ArticleId><ArticleId IdType=\"doi\">10.1212/WNL.0000000000209766</ArticleId><ArticleId IdType=\"pmc\">PMC11399067</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ryman DC, Acosta-Baena N, Aisen PS, et al. . Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 2014;83(3):253-260. doi:10.1212/WNL.0000000000000596</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000000596</ArticleId><ArticleId IdType=\"pmc\">PMC4117367</ArticleId><ArticleId IdType=\"pubmed\">24928124</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Tortosa E, Barquero MS, Bar&#xf3;n M, et al. . Variability of age at onset in siblings with familial Alzheimer disease. Arch Neurol. 2007;64(12):1743-1748. doi:10.1001/archneur.64.12.1743</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archneur.64.12.1743</ArticleId><ArticleId IdType=\"pubmed\">18071037</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012;11(11):1006-1012. doi:10.1016/s1474-4422(12)70191-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s1474-4422(12)70191-6</ArticleId><ArticleId IdType=\"pmc\">PMC3507991</ArticleId><ArticleId IdType=\"pubmed\">23079557</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenaza-Urquijo EM, Vemuri P. Resistance vs resilience to Alzheimer disease: clarifying terminology for preclinical studies. Neurology. 2018;90(15):695-703. doi:10.1212/wnl.0000000000005303</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/wnl.0000000000005303</ArticleId><ArticleId IdType=\"pmc\">PMC5894932</ArticleId><ArticleId IdType=\"pubmed\">29592885</ArticleId></ArticleIdList></Reference><Reference><Citation>Vemuri P, Lesnick TG, Przybelski SA, et al. . Association of lifetime intellectual enrichment with cognitive decline in the older population. JAMA Neurol. 2014;71(8):1017-1024. doi:10.1001/jamaneurol.2014.963</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamaneurol.2014.963</ArticleId><ArticleId IdType=\"pmc\">PMC4266551</ArticleId><ArticleId IdType=\"pubmed\">25054282</ArticleId></ArticleIdList></Reference><Reference><Citation>Verghese J, Lipton RB, Katz MJ, et al. . Leisure activities and the risk of dementia in the elderly. N Engl J Med. 2003;348(25):2508-2516. doi:10.1056/NEJMoa022252</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa022252</ArticleId><ArticleId IdType=\"pubmed\">12815136</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerlad A, Sabia S, Livingston G, Kivim&#xe4;ki M, Lewis G, Singh-Manoux A. Leisure activity participation and risk of dementia: an 18-year follow-up of the Whitehall II study. Neurology. 2020;95(20):e2803-e2815. doi:10.1212/wnl.0000000000010966</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/wnl.0000000000010966</ArticleId><ArticleId IdType=\"pmc\">PMC7734721</ArticleId><ArticleId IdType=\"pubmed\">33115773</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovio S, K&#xe5;reholt I, Helkala EL, et al. . Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol. 2005;4(11):705-711. doi:10.1016/s1474-4422(05)70198-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s1474-4422(05)70198-8</ArticleId><ArticleId IdType=\"pubmed\">16239176</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondell SJ, Hammersley-Mather R, Veerman JL. Does physical activity prevent cognitive decline and dementia? A systematic review and meta-analysis of longitudinal studies. BMC Public Health. 2014;14:510. doi:10.1186/1471-2458-14-510</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2458-14-510</ArticleId><ArticleId IdType=\"pmc\">PMC4064273</ArticleId><ArticleId IdType=\"pubmed\">24885250</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B. Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet. 2000;355(9212):1315-1319. doi:10.1016/s0140-6736(00)02113-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s0140-6736(00)02113-9</ArticleId><ArticleId IdType=\"pubmed\">10776744</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HX, Karp A, Herlitz A, et al. . Personality and lifestyle in relation to dementia incidence. Neurology. 2009;72(3):253-259. doi:10.1212/01.wnl.0000339485.39246.87</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/01.wnl.0000339485.39246.87</ArticleId><ArticleId IdType=\"pubmed\">19153372</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck ED, Yoneda T, James BD, et al. . Personality predictors of dementia diagnosis and neuropathological burden: an individual participant data meta-analysis. Alzheimers Dement. 2024;20(3):1497-1514. doi:10.1002/alz.13523</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.13523</ArticleId><ArticleId IdType=\"pmc\">PMC10947984</ArticleId><ArticleId IdType=\"pubmed\">38018701</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngandu T, Lehtisalo J, Solomon A, et al. . A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255-2263. doi:10.1016/s0140-6736(15)60461-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s0140-6736(15)60461-5</ArticleId><ArticleId IdType=\"pubmed\">25771249</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrieu S, Guyonnet S, Coley N, et al. . Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017;16(5):377-389. doi:10.1016/s1474-4422(17)30040-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s1474-4422(17)30040-6</ArticleId><ArticleId IdType=\"pubmed\">28359749</ArticleId></ArticleIdList></Reference><Reference><Citation>Moll van Charante EP, Richard E, Eurelings LS, et al. . Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet. 2016;388(10046):797-805. doi:10.1016/s0140-6736(16)30950-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s0140-6736(16)30950-3</ArticleId><ArticleId IdType=\"pubmed\">27474376</ArticleId></ArticleIdList></Reference><Reference><Citation>Lourida I, Hannon E, Littlejohns TJ, et al. . Association of lifestyle and genetic risk with incidence of dementia. JAMA. 2019;322(5):430-437. doi:10.1001/jama.2019.9879</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.2019.9879</ArticleId><ArticleId IdType=\"pmc\">PMC6628594</ArticleId><ArticleId IdType=\"pubmed\">31302669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman RJ, Xiong C, Benzinger TL, et al. . Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012;367(9):795-804. doi:10.1056/NEJMoa1202753</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJMoa1202753</ArticleId><ArticleId IdType=\"pmc\">PMC3474597</ArticleId><ArticleId IdType=\"pubmed\">22784036</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, Aisen PS, Bateman RJ, et al. . Developing an international network for Alzheimer research: the dominantly inherited Alzheimer network. Clin Investig (Lond). 2012;2(10):975-984. doi:10.4155/cli.12.93</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4155/cli.12.93</ArticleId><ArticleId IdType=\"pmc\">PMC3489185</ArticleId><ArticleId IdType=\"pubmed\">23139856</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO guidelines approved by the guidelines review committee. In: World Health Organization, ed. Global Recommendations on Physical Activity for Health. WHO Press; 2010:1-60.</Citation></Reference><Reference><Citation>Garber CE, Blissmer B, Deschenes MR, et al. . American college of sports medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334-1359. doi:10.1249/MSS.0b013e318213fefb</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1249/MSS.0b013e318213fefb</ArticleId><ArticleId IdType=\"pubmed\">21694556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ainsworth BE, Haskell WL, Herrmann SD, et al. . 2011 compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575-1581. doi:10.1249/MSS.0b013e31821ece12</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1249/MSS.0b013e31821ece12</ArticleId><ArticleId IdType=\"pubmed\">21681120</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JA. Measuring thirty facets of the five factor model with a 120-item public domain inventory: development of the IPIP-NEO-120. J Res Pers. 2014;51:78-89. doi:10.1016/j.jrp.2014.05.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jrp.2014.05.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuner SM, Telpoukhovskaia M, Menon V, O'Connell KMS, Hohman TJ, Kaczorowski CC. Translational approaches to understanding resilience to Alzheimer's disease. Trends Neurosci. 2022;45(5):369-383. doi:10.1016/j.tins.2022.02.005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tins.2022.02.005</ArticleId><ArticleId IdType=\"pmc\">PMC9035083</ArticleId><ArticleId IdType=\"pubmed\">35307206</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocancea DI, Van Loenhoud AC, Groot C, Barkhof F, Van Der Flier WM, Ossenkoppele R. Measuring resilience and resistance in aging and Alzheimer disease using residual methods: a systematic review and meta-analysis. Neurology. 2021;97(10):474-488. doi:10.1212/wnl.0000000000012499</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/wnl.0000000000012499</ArticleId><ArticleId IdType=\"pmc\">PMC8448552</ArticleId><ArticleId IdType=\"pubmed\">34266918</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth&#xe9;lemy NR, Li Y, Joseph-Mathurin N, et al. . A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nat Med. 2020;26(3):398-407. doi:10.1038/s41591-020-0781-z</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-020-0781-z</ArticleId><ArticleId IdType=\"pmc\">PMC7309367</ArticleId><ArticleId IdType=\"pubmed\">32161412</ArticleId></ArticleIdList></Reference><Reference><Citation>Law LL, Rol RN, Schultz SA, et al. . Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease. Alzheimers Dement (Amst). 2018;10:188-195. doi:10.1016/j.dadm.2018.01.001</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.dadm.2018.01.001</ArticleId><ArticleId IdType=\"pmc\">PMC5842318</ArticleId><ArticleId IdType=\"pubmed\">29527551</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigiani LJ, Hamel E. An endothelial link between the benefits of physical exercise in dementia. J Cereb Blood Flow Metab. 2017;37(8):2649-2664. doi:10.1177/0271678x17714655</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0271678x17714655</ArticleId><ArticleId IdType=\"pmc\">PMC5536816</ArticleId><ArticleId IdType=\"pubmed\">28617071</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson KI, Hillman C, Stillman CM, et al. . Physical activity, cognition, and brain outcomes: a review of the 2018 physical activity guidelines. Med Sci Sports Exerc. 2019;51(6):1242-1251. doi:10.1249/mss.0000000000001936</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1249/mss.0000000000001936</ArticleId><ArticleId IdType=\"pmc\">PMC6527141</ArticleId><ArticleId IdType=\"pubmed\">31095081</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern Y, MacKay-Brandt A, Lee S, et al. . Effect of aerobic exercise on cognition in younger adults: a randomized clinical trial. Neurology. 2019;92(9):e905-e916. doi:10.1212/wnl.0000000000007003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/wnl.0000000000007003</ArticleId><ArticleId IdType=\"pmc\">PMC6404470</ArticleId><ArticleId IdType=\"pubmed\">30700591</ArticleId></ArticleIdList></Reference><Reference><Citation>Stillman CM, Esteban-Cornejo I, Brown B, Bender CM, Erickson KI. Effects of exercise on brain and cognition across age groups and health states. Trends Neurosci. 2020;43(7):533-543. doi:10.1016/j.tins.2020.04.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tins.2020.04.010</ArticleId><ArticleId IdType=\"pmc\">PMC9068803</ArticleId><ArticleId IdType=\"pubmed\">32409017</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts BW, Jackson JJ, Fayard JV, Edmonds G, Meints J. Conscientiousness. In: Leary MR, Hoyle RH, eds. Handbook of Individual Differences in Social Behavior. The Guilford Press; 2009:369-381.</Citation></Reference><Reference><Citation>Duchek JM, Aschenbrenner AJ, Fagan AM, Benzinger TLS, Morris JC, Balota DA. The relation between personality and biomarkers in sensitivity and conversion to Alzheimer-type dementia. J Int Neuropsychol Soc. 2020;26(6):596-606. doi:10.1017/s1355617719001358</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/s1355617719001358</ArticleId><ArticleId IdType=\"pmc\">PMC7286789</ArticleId><ArticleId IdType=\"pubmed\">31822309</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EK, James BD, Jackson KL, et al. . Associations between personality traits and cognitive resilience in older adults. J Gerontol B Psychol Sci Soc Sci. 2021;76(1):6-19. doi:10.1093/geronb/gbaa135</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/geronb/gbaa135</ArticleId><ArticleId IdType=\"pmc\">PMC8574296</ArticleId><ArticleId IdType=\"pubmed\">32969474</ArticleId></ArticleIdList></Reference><Reference><Citation>Terracciano A, Iacono D, O'Brien RJ, et al. . Personality and resilience to Alzheimer's disease neuropathology: a prospective autopsy study. Neurobiol Aging. 2013;34(4):1045-1050. doi:10.1016/j.neurobiolaging.2012.08.008</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2012.08.008</ArticleId><ArticleId IdType=\"pmc\">PMC3541457</ArticleId><ArticleId IdType=\"pubmed\">23040035</ArticleId></ArticleIdList></Reference><Reference><Citation>Terracciano A, Bilgel M, Aschwanden D, et al. . Personality associations with Amyloid and Tau: results from the Baltimore longitudinal study of aging and meta-analysis. Biol Psychiatry. 2022;91(4):359-369. doi:10.1016/j.biopsych.2021.08.021</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopsych.2021.08.021</ArticleId><ArticleId IdType=\"pmc\">PMC8792161</ArticleId><ArticleId IdType=\"pubmed\">34663503</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonneaud J, Bedetti C, Pichet Binette A, et al. . Association of education with A&#x3b2; burden in preclinical familial and sporadic Alzheimer disease. Neurology. 2020;95(11):e1554-e1564. doi:10.1212/wnl.0000000000010314</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/wnl.0000000000010314</ArticleId><ArticleId IdType=\"pmc\">PMC7713743</ArticleId><ArticleId IdType=\"pubmed\">32759192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobb JL, Wolf PA, Au R, White R, D'Agostino RB. The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham study. Neurology. 1995;45(9):1707-1712. doi:10.1212/wnl.45.9.1707</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/wnl.45.9.1707</ArticleId><ArticleId IdType=\"pubmed\">7675231</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann GM, Knopman DS, Chertkow H, et al. . The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association Workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263-269. doi:10.1016/j.jalz.2011.03.005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2011.03.005</ArticleId><ArticleId IdType=\"pmc\">PMC3312024</ArticleId><ArticleId IdType=\"pubmed\">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Terracciano A, An Y, Sutin AR, Thambisetty M, Resnick SM. Personality change in the preclinical phase of Alzheimer disease. JAMA Psychiatry. 2017;74(12):1259-1265. doi:10.1001/jamapsychiatry.2017.2816</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamapsychiatry.2017.2816</ArticleId><ArticleId IdType=\"pmc\">PMC5710607</ArticleId><ArticleId IdType=\"pubmed\">28975188</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratiglioni L, Marseglia A, Dekhtyar S. Ageing without dementia: can stimulating psychosocial and lifestyle experiences make a difference? Lancet Neurol. 2020;19(6):533-543. doi:10.1016/s1474-4422(20)30039-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s1474-4422(20)30039-9</ArticleId><ArticleId IdType=\"pubmed\">32470425</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleidorn W, Hill PL, Back MD, et al. . The policy relevance of personality traits. Am Psychol. 2019;74(9):1056-1067. doi:10.1037/amp0000503</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1037/amp0000503</ArticleId><ArticleId IdType=\"pubmed\">31829685</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspi A, Roberts BW, Shiner RL. Personality development: stability and change. Annu Rev Psychol. 2005;56:453-484. doi:10.1146/annurev.psych.55.090902.141913</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev.psych.55.090902.141913</ArticleId><ArticleId IdType=\"pubmed\">15709943</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa PT, McCrae RR, L&#xf6;ckenhoff CE. Personality across the life span. Annu Rev Psychol. 2019;70:423-448. doi:10.1146/annurev-psych-010418-103244</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-psych-010418-103244</ArticleId><ArticleId IdType=\"pubmed\">30231002</ArticleId></ArticleIdList></Reference><Reference><Citation>Damian RI, Spengler M, Sutu A, Roberts BW. Sixteen going on sixty-six: a longitudinal study of personality stability and change across 50 years. J Pers Soc Psychol. 2019;117(3):674-695. doi:10.1037/pspp0000210</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1037/pspp0000210</ArticleId><ArticleId IdType=\"pubmed\">30113194</ArticleId></ArticleIdList></Reference><Reference><Citation>McAdams DP, Olson BD. Personality development: continuity and change over the life course. Annu Rev Psychol. 2010;61:517-542. doi:10.1146/annurev.psych.093008.100507</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev.psych.093008.100507</ArticleId><ArticleId IdType=\"pubmed\">19534589</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts BW, DelVecchio WF. The rank-order consistency of personality traits from childhood to old age: a quantitative review of longitudinal studies. Psychol Bull. 2000;126(1):3-25. doi:10.1037/0033-2909.126.1.3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1037/0033-2909.126.1.3</ArticleId><ArticleId IdType=\"pubmed\">10668348</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts BW, Mroczek D. Personality trait change in adulthood. Curr Dir Psychol Sci. 2008;17(1):31-35. doi:10.1111/j.1467-8721.2008.00543.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1467-8721.2008.00543.x</ArticleId><ArticleId IdType=\"pmc\">PMC2743415</ArticleId><ArticleId IdType=\"pubmed\">19756219</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieger M, Fl&#xfc;ckiger C, R&#xfc;egger D, Kowatsch T, Roberts BW, Allemand M. Changing personality traits with the help of a digital personality change intervention. Proc Natl Acad Sci U S A. 2021;118(8):e2017548118. doi:10.1073/pnas.2017548118</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2017548118</ArticleId><ArticleId IdType=\"pmc\">PMC7923371</ArticleId><ArticleId IdType=\"pubmed\">33558417</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts BW, Luo J, Briley DA, Chow PI, Su R, Hill PL. A systematic review of personality trait change through intervention. Psychol Bull. 2017;143(2):117-141. doi:10.1037/bul0000088</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1037/bul0000088</ArticleId><ArticleId IdType=\"pubmed\">28054797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39270013</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2375-2548</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>10</Volume><Issue>37</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Evaluating the distinct effects of body mass index at childhood and adulthood on adult major psychiatric disorders.</ArticleTitle><Pagination><StartPage>eadq2452</StartPage><MedlinePgn>eadq2452</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">eadq2452</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1126/sciadv.adq2452</ELocationID><Abstract><AbstractText>Children with high body mass index (BMI) are at heightened risk of developing health issues in adulthood, yet the causality between childhood BMI and adult psychiatric disorders remains unclear. Using a life course Mendelian randomization (MR) framework, we investigated the causal effects of childhood and adulthood BMI on adult psychiatric disorders, including Alzheimer's disease, anxiety, major depressive disorder, obsessive-compulsive disorder (OCD), and schizophrenia, using data from the Psychiatric Genomics Consortium and FinnGen study. Childhood BMI was significantly associated with an increased risk of schizophrenia, while adulthood BMI was associated with a decreased risk of OCD and schizophrenia. Multivariable MR analyses indicated a direct causal effect of childhood BMI on schizophrenia, independent of adulthood BMI and lifestyle factors. No evidence of causal associations was found between childhood BMI and other psychiatric outcomes. The sensitivity analyses yielded broadly consistent findings. These findings highlight the critical importance of early-life interventions to mitigate the long-term consequences of childhood adiposity.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Xiao</LastName><ForeName>Pei</ForeName><Initials>P</Initials><Identifier Source=\"ORCID\">0000-0001-9976-7655</Identifier><AffiliationInfo><Affiliation>Center for Non-communicable Disease Management, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Chi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of AIDS/STD Control and Prevention, Shijingshan District Center for Disease Control and Prevention, Beijing 100043, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mi</LastName><ForeName>Jie</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0003-0630-8447</Identifier><AffiliationInfo><Affiliation>Center for Non-communicable Disease Management, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wu</LastName><ForeName>Jinyi</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0002-1601-1084</Identifier><AffiliationInfo><Affiliation>Department of Public Health, Wuhan Fourth Hospital, Wuhan 430000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, Fudan University, Shanghai 210000, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015992\" MajorTopicYN=\"Y\">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002648\" MajorTopicYN=\"N\">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001523\" MajorTopicYN=\"Y\">Mental Disorders</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D057182\" MajorTopicYN=\"N\">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012559\" MajorTopicYN=\"N\">Schizophrenia</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D003865\" MajorTopicYN=\"N\">Depressive Disorder, Major</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012307\" MajorTopicYN=\"N\">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000293\" MajorTopicYN=\"N\">Adolescent</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39270013</ArticleId><ArticleId IdType=\"pmc\">PMC11397431</ArticleId><ArticleId IdType=\"doi\">10.1126/sciadv.adq2452</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lister N. B., Baur L. A., Felix J. F., Hill A. J., Marcus C., Reinehr T., Summerbell C., Wabitsch M., Child and adolescent obesity. Nat. Rev. Dis. Primers. 9, 24 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37202378</ArticleId></ArticleIdList></Reference><Reference><Citation>Jebeile H., Kelly A. S., O&#x2019;Malley G., Baur L. A., Obesity in children and adolescents: Epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 10, 351&#x2013;365 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9831747</ArticleId><ArticleId IdType=\"pubmed\">35248172</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Fu Y., Yu Y., Tang M., Sun Y., Wang Y., Zhang K., Li H., Guo H., Wang B., Wang N., Lu Y., Investigating the shared genetic architecture between schizophrenia and body mass index. Mol. Psychiatry 28, 2312&#x2013;2319 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37202504</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltenhauser S., Weber C. F., Lin H., Mozayan A., Malhotra A., Constable R. T., Acosta J. N., Falcone G. J., Taylor S. N., Ment L. R., Sheth K. N., Payabvash S., Association of body mass index and waist circumference with Imaging metrics of brain integrity and functional connectivity in children aged 9 to 10 years in the US, 2016-2018. JAMA Netw. Open 6, e2314193 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10196880</ArticleId><ArticleId IdType=\"pubmed\">37200030</ArticleId></ArticleIdList></Reference><Reference><Citation>Rantanen A. T., Kautiainen H., Korhonen P. E., Depressive symptoms and mortality - effect variation by body mass index: A prospective study in a primary care population. Int. J. Obesity 47, 512&#x2013;519 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10212761</ArticleId><ArticleId IdType=\"pubmed\">36977790</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry B. I., Stochl J., Upthegrove R., Zammit S., Wareham N., Langenberg C., Winpenny E., Dunger D., Jones P. B., Khandaker G. M., Longitudinal trends in childhood insulin levels and body mass index and associations with risks of psychosis and depression in young adults. JAMA Psychiatry 78, 416 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7807390</ArticleId><ArticleId IdType=\"pubmed\">33439216</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokela M., Laakasuo M., Obesity as a causal risk factor for depression: Systematic review and meta-analysis of Mendelian Randomization studies and implications for population mental health. J. Psychiatr. Res. 163, 86&#x2013;92 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37207436</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher C., Pirkis J., Lambert K. A., Perret J. L., Ali G. B., Lodge C. J., Bowatte G., Hamilton G. S., Matheson M. C., Bui D. S., Abramson M. J., Walters E. H., Dharmage S. C., Erbas B., Life course BMI trajectories from childhood to mid-adulthood are differentially associated with anxiety and depression outcomes in middle age. Int. J. Obes. 47, 661&#x2013;668 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10359183</ArticleId><ArticleId IdType=\"pubmed\">37161067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson E., Glymour M. M., Holmes M. V., Kang H., Morrison J., Munaf&#xf2; M. R., Palmer T., Schooling C. M., Wallace C., Zhao Q., Davey Smith G., Mendelian randomization. Nat. Rev. Methods Primers 2, 10.1038/s43586-021-00092-5 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7614635</ArticleId><ArticleId IdType=\"pubmed\">37325194</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S., Scott R. A., Timpson N. J., Davey Smith G., Thompson S. G.; EPIC- InterAct Consortium , Using published data in Mendelian randomization: A blueprint for efficient identification of causal risk factors. Eur. J. Epidemiol. 30, 543&#x2013;552 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4516908</ArticleId><ArticleId IdType=\"pubmed\">25773750</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S., Thompson S. G., Multivariable Mendelian randomization: The use of pleiotropic genetic variants to estimate causal effects. Am. J. Epidemiol. 181, 251&#x2013;260 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4325677</ArticleId><ArticleId IdType=\"pubmed\">25632051</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson T. G., Sanderson E., Elsworth B., Tilling K., Davey Smith G., Use of genetic variation to separate the effects of early and later life adiposity on disease risk: Mendelian randomisation study. BMJ 369, m1203 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7201936</ArticleId><ArticleId IdType=\"pubmed\">32376654</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan S. S., Xu Q., Han B. X., Ni J. J., Wei X. T., Feng G. J., Zhang H., Zhang Y. J., Zhang L., Yu W. Y., Pei Y. F., Mendelian randomization analysis identified causal association of childhood obesity with adult major depressive disorder. Pediatr. Obes. 17, e12960 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35869568</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson T. G., Crouch D. J. M., Power G. M., Morales-Berstein F., Hazelwood E., Fang S., Cho Y., Inshaw J. R. J., Robertson C. C., Sidore C., Cucca F., Rich S. S., Todd J. A., Davey Smith G., Childhood body size directly increases type 1 diabetes risk based on a lifecourse Mendelian randomization approach. Nat. Commun. 13, 2337 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9051135</ArticleId><ArticleId IdType=\"pubmed\">35484151</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Nunain K., Park C., Urquijo H., Leyden G. M., Hughes A. D., Davey Smith G., Richardson T. G., A lifecourse mendelian randomization study highlights the long-term influence of childhood body size on later life heart structure. PLOS Biol. 20, e3001656 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9182693</ArticleId><ArticleId IdType=\"pubmed\">35679339</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson T. G., Mykk&#xe4;nen J., Pahkala K., Ala-Korpela M., Bell J. A., Taylor K., Viikari J., Lehtim&#xe4;ki T., Raitakari O., Davey Smith G., Evaluating the direct effects of childhood adiposity on adult systemic metabolism: A multivariable Mendelian randomization analysis. Int. J. Epidemiol. 50, 1580&#x2013;1592 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8580280</ArticleId><ArticleId IdType=\"pubmed\">33783488</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong S.-S., Zhang K., Guo Y., Ding J.-M., Rong Y., Feng J.-C., Yao S., Hao R.-H., Jiang F., Chen J.-B., Wu H., Chen X.-F., Yang T.-L., Phenome-wide investigation of the causal associations between childhood BMI and adult trait outcomes: A two-sample Mendelian randomization study. Genome Med. 13, 48 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8004431</ArticleId><ArticleId IdType=\"pubmed\">33771188</ArticleId></ArticleIdList></Reference><Reference><Citation>Karageorgiou V., Casanova F., O&#x2019;Loughlin J., Green H., McKinley T. J., Bowden J., Tyrrell J., Body mass index and inflammation in depression and treatment-resistant depression: A Mendelian randomisation study. BMC Med. 21, 355 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10502981</ArticleId><ArticleId IdType=\"pubmed\">37710313</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Feng J., Jiang S., Guo J., Zhang X., Zhang X., Wang C., Ma Y., Dong Z., Mendelian randomization analyses identify bidirectional causal relationships of obesity with psychiatric disorders. J. Affect. Disord. 339, 807&#x2013;814 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37474010</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistis G., Milaneschi Y., Vandeleur C. L., Lasserre A. M., Penninx B. W. J. H., Lamers F., Boomsma D. I., Hottenga J.-J., Marques-Vidal P., Vollenweider P., Waeber G., Aubry J.-M., Preisig M., Kutalik Z., Obesity and atypical depression symptoms: Findings from Mendelian randomization in two European cohorts. Transl. Psychiatry 11, 10.1038/s41398-021-01236-7 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7862438</ArticleId><ArticleId IdType=\"pubmed\">33542229</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C.-F., Rivera M., Craddock N., Owen M. J., Gill M., Korszun A., Maier W., Mors O., Preisig M., Rice J. P., Rietschel M., Jones L., Middleton L., Aitchison K. J., Davis O. S. P., Breen G., Lewis C., Farmer A., McGuffin P., Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study. Br. J. Psychiatry 205, 24&#x2013;28 (2014).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4076654</ArticleId><ArticleId IdType=\"pubmed\">24809401</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf8;devand L., Rahman Z., Hindley G. F. L., Smeland O. B., Frei O., Tekin T. F., Kutrolli G., Bahrami S., Hoseth E. Z., Shadrin A., Lin A., Djurovic S., Dale A. M., Steen N. E., Andreassen O. A., Characterizing the shared genetic underpinnings of schizophrenia and cardiovascular disease risk factors. Am. J. Psychiatry 180, 815&#x2013;826 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37752828</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki R., Saito T., Ninomiya K., Shimasaki A., Ashizawa T., Ito K., Ikeda M., Iwata N., Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets. Psychiatry Clin. Neurosci. 76, 361&#x2013;366 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9546074</ArticleId><ArticleId IdType=\"pubmed\">35536160</ArticleId></ArticleIdList></Reference><Reference><Citation>McWhinney S. R., Brosch K., Calhoun V. D., Crespo-Facorro B., Crossley N. A., Dannlowski U., Dickie E., Dietze L. M. F., Donohoe G., Du Plessis S., Ehrlich S., Emsley R., Furstova P., Glahn D. C., Gonzalez-Valderrama A., Grotegerd D., Holleran L., Kircher T. T. J., Knytl P., Kolenic M., Lencer R., Nenadi&#x107; I., Opel N., Pfarr J.-K., Rodrigue A. L., Rootes-Murdy K., Ross A. J., Sim K., &#x160;koch A., Spaniel F., Stein F., &#x160;vancer P., Tordesillas-Guti&#xe9;rrez D., Undurraga J., V&#xe1;zquez-Bourgon J., Voineskos A., Walton E., Weickert T. W., Weickert C. S., Thompson P. M., van Erp T. G. M., Turner J. A., Hajek T., Obesity and brain structure in schizophrenia&#x2013;ENIGMA study in 3021 individuals. Mol. Psychiatry 27, 3731&#x2013;3737 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9902274</ArticleId><ArticleId IdType=\"pubmed\">35739320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryan J. F., O&#x2019;Riordan K. J., Cowan C. S. M., Sandhu K. V., Bastiaanssen T. F. S., Boehme M., Codagnone M. G., Cussotto S., Fulling C., Golubeva A. V., Guzzetta K. E., Jaggar M., Long-Smith C. M., Lyte J. M., Martin J. A., Molinero-Perez A., Moloney G., Morelli E., Morillas E., O&#x2019;Connor R., Cruz-Pereira J. S., Peterson V. L., Rea K., Ritz N. L., Sherwin E., Spichak S., Teichman E. M., van de Wouw M., Ventura-Silva A. P., Wallace-Fitzsimons S. E., Hyland N., Clarke G., Dinan T. G., The microbiota-gut-brain axis. Physiol. Rev. 99, 1877&#x2013;2013 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31460832</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell G., Lightman S., The human stress response. Nat. Rev. Endocrinol. 15, 525&#x2013;534 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31249398</ArticleId></ArticleIdList></Reference><Reference><Citation>Pont S. J., Puhl R., Cook S. R., Slusser W., Stigma experienced by children and adolescents with obesity. Pediatrics 140, e20173034 (2017).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29158228</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin J. R., Sallis H. M., Schoeler T., Taylor M. J., Kwong A. S. F., Tielbeek J. J., Barkhuizen W., Warrier V., Howe L. D., Danese A., McCrory E., Rijsdijk F., Larsson H., Lundstr&#xf6;m S., Karlsson R., Lichtenstein P., Munaf&#xf2; M., Pingault J.-B., A genetically informed Registered Report on adverse childhood experiences and mental health. Nat. Hum. Behav. 7, 269&#x2013;290 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7614239</ArticleId><ArticleId IdType=\"pubmed\">36482079</ArticleId></ArticleIdList></Reference><Reference><Citation>Zammit S., Rasmussen F., Farahmand B., Gunnell D., Lewis G., Tynelius P., Brobert G. P., Height and body mass index in young adulthood and risk of schizophrenia: A longitudinal study of 1 347 520 Swedish men. Acta Psychiatr. Scand. 116, 378&#x2013;385 (2007).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17919157</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rensen H. J., Mortensen E. L., Reinisch J. M., Mednick S. A., Height, weight and body mass index in early adulthood and risk of schizophrenia. Acta Psychiatr. Scand. 114, 49&#x2013;54 (2006).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16774661</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramovitch A., Anholt G. E., Cooperman A., van Balkom A. J. L. M., Giltay E. J., Penninx B. W., van Oppen P., Body mass index in obsessive-compulsive disorder. J. Affect. Disord. 245, 145&#x2013;151 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30388557</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves V. F., Cuperfain A. B., Kennedy J. L., Sex differences in schizophrenia: Estrogen and mitochondria. Neuropsychopharmacology 44, 216&#x2013;217 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6235927</ArticleId><ArticleId IdType=\"pubmed\">30294000</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang P. Y., Tee S. F., Su K. P., Editorial: The link between nutrition and schizophrenia. Front. Psych. 13, 1074120 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9720389</ArticleId><ArticleId IdType=\"pubmed\">36479557</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Jiao Y., Xing M., Lin Y., Su Y., Ding W., Zhu C., Peng Y., Qi D., Cui D., Increased plasma leptin as a novel predictor for psychopathological depressive symptoms in chronic schizophrenia. Gen. Psychiatr. 31, e100018 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6371651</ArticleId><ArticleId IdType=\"pubmed\">30815631</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrivankova V. W., Richmond R. C., Woolf B. A. R., Yarmolinsky J., Davies N. M., Swanson S. A., VanderWeele T. J., Timpson N. J., Higgins J. P. T., Dimou N., Langenberg C., Loder E. W., Golub R. M., Gallo V., Tybjaerg-Hansen A., Egger M., Smith G. D., Richards J. B., Strengthening the reporting of observational studies in epidemiology using mendelian randomization: The STROBE-MR statement. JAMA 326, 1614&#x2013;1621 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34698778</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrivankova V. W., Richmond R. C., Woolf B. A. R., Davies N. M., Swanson S. A., VanderWeele T. J., Timpson N. J., Higgins J. P. T., Dimou N., Langenberg C., Loder E. W., Golub R. M., Egger M., Smith G. D., Richards J. B., Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): Explanation and elaboration. BMJ 375, n2233 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8546498</ArticleId><ArticleId IdType=\"pubmed\">34702754</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogelezang S., Bradfield J. P., Ahluwalia T. S., Curtin J. A., Lakka T. A., Grarup N., Scholz M., van der Most P. J., Monnereau C., Stergiakouli E., Heiskala A., Horikoshi M., Fedko I. O., Vilor-Tejedor N., Cousminer D. L., Standl M., Wang C. A., Viikari J., Geller F., &#xcd;&#xf1;iguez C., Pitk&#xe4;nen N., Chesi A., Bacelis J., Yengo L., Torrent M., Ntalla I., Helgeland &#xd8;., Selzam S., Vonk J. M., Zafarmand M. H., Heude B., Farooqi I. S., Alyass A., Beaumont R. N., Have C. T., Rzehak P., Bilbao J. R., Schnurr T. M., Barroso I., B&#xf8;nnelykke K., Beilin L. J., Carstensen L., Charles M. A., Chawes B., Cl&#xe9;ment K., Closa-Monasterolo R., Custovic A., Eriksson J. G., Escribano J., Groen-Blokhuis M., Grote V., Gruszfeld D., Hakonarson H., Hansen T., Hattersley A. T., Hollensted M., Hottenga J.-J., Hypp&#xf6;nen E., Johansson S., Joro R., K&#xe4;h&#xf6;nen M., Karhunen V., Kiess W., Knight B. A., Koletzko B., K&#xfc;hnapfel A., Landgraf K., Langhendries J.-P., Lehtim&#xe4;ki T., Leinonen J. T., Li A., Lindi V., Lowry E., Bustamante M., Medina-Gomez C., Melbye M., Michaelsen K. F., Morgen C. S., Mori T. A., Nielsen T. R. H., Niinikoski H., Oldehinkel A. J., Pahkala K., Panoutsopoulou K., Pedersen O., Pennell C. E., Power C., Reijneveld S. A., Rivadeneira F., Simpson A., Sly P. D., Stokholm J., Teo K. K., Thiering E., Timpson N. J., Uitterlinden A. G., van Beijsterveldt C. E. M., van Schaik B. D. C., Vaudel M., Verduci E., Vinding R. K., Vogel M., Zeggini E., Sebert S., Lind M. V., Brown C. D., Santa-Marina L., Reischl E., Frithioff-B&#xf8;js&#xf8;e C., Meyre D., Wheeler E., Ong K., Nohr E. A., Vrijkotte T. G. M., Koppelman G. H., Plomin R., Nj&#xf8;lstad P. R., Dedoussis G. D., Froguel P., S&#xf8;rensen T. I. A., Jacobsson B., Freathy R. M., Zemel B. S., Raitakari O., Vrijheid M., Feenstra B., Lyytik&#xe4;inen L. P., Snieder H., Kirsten H., Holt P. G., Heinrich J., Wid&#xe9;n E., Sunyer J., Boomsma D. I., J&#xe4;rvelin M. R., Korner A., Smith G. D., Holm J.-C., Atalay M., Murray C., Bisgaard H., McCarthy M. I., Genetics C. E. G., Jaddoe V. W. V., Grant S. F. A., Felix J. F., Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits. PLOS Genet 16, e1008718 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7581004</ArticleId><ArticleId IdType=\"pubmed\">33045005</ArticleId></ArticleIdList></Reference><Reference><Citation>Yengo L., Sidorenko J., Kemper K. E., Zheng Z., Wood A. R., Weedon M. N., Frayling T. M., Hirschhorn J., Yang J., Visscher P. M., Meta-analysis of genome-wide association studies for height and body mass index in &#x223c;700000 individuals of European ancestry. Hum. Mol. Genet. 27, 3641&#x2013;3649 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6488973</ArticleId><ArticleId IdType=\"pubmed\">30124842</ArticleId></ArticleIdList></Reference><Reference><Citation>Wightman D. P., Jansen I. E., Savage J. E., Shadrin A. A., Bahrami S., Holland D., Rongve A., B&#xf8;rte S., Winsvold B. S., Drange O. K., Martinsen A. E., Skogholt A. H., Willer C., Br&#xe5;then G., Bosnes I., Nielsen J. B., Fritsche L. G., Thomas L. F., Pedersen L. M., Gabrielsen M. E., Johnsen M. B., Meisingset T. W., Zhou W., Proitsi P., Hodges A., Dobson R., Velayudhan L., Heilbron K., Auton A., Agee M., Aslibekyan S., Babalola E., Bell R. K., Bielenberg J., Bryc K., Bullis E., Cameron B., Coker D., Partida G. C., Dhamija D., Das S., Elson S. L., Filshtein T., Fletez-Brant K., Fontanillas P., Freyman W., Gandhi P. M., Hicks B., Hinds D. A., Huber K. E., Jewett E. M., Jiang Y., Kleinman A., Kukar K., Lane V., Lin K.-H., Lowe M., Luff M. K., McCreight J. C., McIntyre M. H., McManus K. F., Micheletti S. J., Moreno M. E., Mountain J. L., Mozaffari S. V., Nandakumar P., Noblin E. S., O&#x2019;Connell J., Petrakovitz A. A., Poznik G. D., Schumacher M., Shastri A. J., Shelton J. F., Shi J., Shringarpure S., Tian C., Tran V., Tung J. Y., Wang X., Wang W., Weldon C. H., Wilton P., Sealock J. M., Davis L. K., Pedersen N. L., Reynolds C. A., Karlsson I. K., Magnusson S., Stefansson H., Thordardottir S., Jonsson P. V., Snaedal J., Zettergren A., Skoog I., Kern S., Waern M., Zetterberg H., Blennow K., Stordal E., Hveem K., Zwart J.-A., Athanasiu L., Selnes P., Saltvedt I., Sando S. B., Ulstein I., Djurovic S., Fladby T., Aarsland D., Selb&#xe6;k G., Ripke S., Stefansson K., Andreassen O. A., Posthuma D., A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer&#x2019;s disease. Nat. Genet. 53, 1276&#x2013;1282 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10243600</ArticleId><ArticleId IdType=\"pubmed\">34493870</ArticleId></ArticleIdList></Reference><Reference><Citation>Forstner A. J., Awasthi S., Wolf C., Maron E., Erhardt A., Czamara D., Eriksson E., Lavebratt C., Allgulander C., Friedrich N., Becker J., Hecker J., Rambau S., Conrad R., Geiser F., McMahon F. J., Moebus S., Hess T., Buerfent B. C., Hoffmann P., Herms S., Heilmann-Heimbach S., Kockum I., Olsson T., Alfredsson L., Weber H., Alpers G. W., Arolt V., Fehm L., Fydrich T., Gerlach A. L., Hamm A., Kircher T., Pan&#xe9;-Farr&#xe9; C. A., Pauli P., Rief W., Str&#xf6;hle A., Plag J., Lang T., Wittchen H.-U., Mattheisen M., Meier S., Metspalu A., Domschke K., Reif A., Hovatta I., Lindefors N., Andersson E., Schalling M., Mbarek H., Milaneschi Y., de Geus E. J. C., Boomsma D. I., Penninx B. W. J. H., Thorgeirsson T. E., Steinberg S., Stefansson K., Stefansson H., M&#xfc;ller-Myhsok B., Hansen T. F., B&#xf8;rglum A. D., Werge T., Mortensen P. B., Nordentoft M., Hougaard D. M., Hultman C. M., Sullivan P. F., N&#xf6;then M. M., Woldbye D. P. D., Mors O., Binder E. B., R&#xfc;ck C., Ripke S., Deckert J., Schumacher J., Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression. Mol. Psychiatry 26, 4179&#x2013;4190 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31712720</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard D. M., Adams M. J., Clarke T.-K., Hafferty J. D., Gibson J., Shirali M., Coleman J. R. I., Hagenaars S. P., Ward J., Wigmore E. M., Alloza C., Shen X., Barbu M. C., Xu E. Y., Whalley H. C., Marioni R. E., Porteous D. J., Davies G., Deary I. J., Hemani G., Berger K., Teismann H., Rawal R., Arolt V., Baune B. T., Dannlowski U., Domschke K., Tian C., Hinds D. A.; 23andMe Research Team; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Trzaskowski M., Byrne E. M., Ripke S., Smith D. J., Sullivan P. F., Wray N. R., Breen G., Lewis C. M., McIntosh A. M., Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343&#x2013;352 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6522363</ArticleId><ArticleId IdType=\"pubmed\">30718901</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu D., Sul J. H., Tsetsos F., Nawaz M. S., Huang A. Y., Zelaya I., Illmann C., Osiecki L., Darrow S. M., Hirschtritt M. E., Greenberg E., Muller-Vahl K. R., Stuhrmann M., Dion Y., Rouleau G., Aschauer H., Stamenkovic M., Schl&#xf6;gelhofer M., Sandor P., Barr C. L., Grados M., Singer H. S., N&#xf6;then M. M., Hebebrand J., Hinney A., King R. A., Fernandez T. V., Barta C., Tarnok Z., Nagy P., Depienne C., Worbe Y., Hartmann A., Budman C. L., Rizzo R., Lyon G. J., McMahon W. M., Batterson J. R., Cath D. C., Malaty I. A., Okun M. S., Berlin C., Woods D. W., Lee P. C., Jankovic J., Robertson M. M., Gilbert D. L., Brown L. W., Coffey B. J., Dietrich A., Hoekstra P. J., Kuperman S., Zinner S. H., Lu&#xf0;vigsson P., S&#xe6;mundsen E., Thorarensen &#xd3;., Atzmon G., Barzilai N., Wagner M., Moessner R., Ophoff R., Pato C. N., Pato M. T., Knowles J. A., Roffman J. L., Smoller J. W., Buckner R. L., Willsey A. J., Tischfield J. A., Heiman G. A., Stefansson H., Stefansson K., Posthuma D., Cox N. J., Pauls D. L., Freimer N. B., Neale B. M., Davis L. K., Paschou P., Coppola G., Mathews C. A., Scharf J. M.; Tourette Association of America International Consortium for Genetics; the Gilles de la Tourette GWAS Replication Initiative; the Tourette International Collaborative Genetics; the Psychiatric Genomics Consortium Tourette Syndrome Working Group , Interrogating the genetic determinants of Tourette&#x2019;s syndrome and other tic disorders through genome-wide association studies. Am. J. Psychiatry 176, 217&#x2013;227 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6677250</ArticleId><ArticleId IdType=\"pubmed\">30818990</ArticleId></ArticleIdList></Reference><Reference><Citation>Trubetskoy V., Pardi&#xf1;as A. F., Qi T., Panagiotaropoulou G., Awasthi S., Bigdeli T. B., Bryois J., Chen C.-Y., Dennison C. A., Hall L. S., Lam M., Watanabe K., Frei O., Ge T., Harwood J. C., Koopmans F., Magnusson S., Richards A. L., Sidorenko J., Wu Y., Zeng J., Grove J., Kim M., Li Z., Voloudakis G., Zhang W., Adams M., Agartz I., Atkinson E. G., Agerbo E., Al Eissa M., Albus M., Alexander M., Alizadeh B. Z., Alptekin K., Als T. D., Amin F., Arolt V., Arrojo M., Athanasiu L., Azevedo M. H., Bacanu S. A., Bass N. J., Begemann M., Belliveau R. A., Bene J., Benyamin B., Bergen S. E., Blasi G., Bobes J., Bonassi S., Braun A., Bressan R. A., Bromet E. J., Bruggeman R., Buckley P. F., Buckner R. L., Bybjerg-Grauholm J., Cahn W., Cairns M. J., Calkins M. E., Carr V. J., Castle D., Catts S. V., Chambert K. D., Chan R. C. K., Chaumette B., Cheng W., Cheung E. F. C., Chong S. A., Cohen D., Consoli A., Cordeiro Q., Costas J., Curtis C., Davidson M., Davis K. L., de Haan L., Degenhardt F., DeLisi L. E., Demontis D., Dickerson F., Dikeos D., Dinan T., Djurovic S., Duan J., Ducci G., Dudbridge F., Eriksson J. G., Fa&#xf1;an&#xe1;s L., Faraone S. V., Fiorentino A., Forstner A., Frank J., Freimer N. B., Fromer M., Frustaci A., Gadelha A., Genovese G., Gershon E. S., Giannitelli M., Giegling I., Giusti-Rodr&#xed;guez P., Godard S., Goldstein J. I., Pe&#xf1;as J. G., Gonz&#xe1;lez-Pinto A., Gopal S., Gratten J., Green M. F., Greenwood T. A., Guillin O., G&#xfc;l&#xf6;ks&#xfc;z S., Gur R. E., Gur R. C., Guti&#xe9;rrez B., Hahn E., Hakonarson H., Haroutunian V., Hartmann A. M., Harvey C., Hayward C., Henskens F. A., Herms S., Hoffmann P., Howrigan D. P., Ikeda M., Iyegbe C., Joa I., Juli&#xe0; A., K&#xe4;hler A. K., Kam-Thong T., Kamatani Y., Karachanak-Yankova S., Kebir O., Keller M. C., Kelly B. J., Khrunin A., Kim S.-W., Klovins J., Kondratiev N., Konte B., Kraft J., Kubo M., Ku&#x10d;inskas V., Ku&#x10d;inskiene Z. A., Kusumawardhani A., Kuzelova-Ptackova H., Landi S., Lazzeroni L. C., Lee P. H., Legge S. E., Lehrer D. S., Lencer R., Lerer B., Li M., Lieberman J., Light G. A., Limborska S., Liu C.-M., L&#xf6;nnqvist J., Loughland C. M., Lubinski J., Luykx J. J., Lynham A., Macek M. Jr., Mackinnon A., Magnusson P. K. E., Maher B. S., Maier W., Malaspina D., Mallet J., Marder S. R., Marsal S., Martin A. R., Martorell L., Mattheisen M., McCarley R. W., McDonald C., McGrath J. J., Medeiros H., Meier S., Melegh B., Melle I., Mesholam-Gately R. I., Metspalu A., Michie P. T., Milani L., Milanova V., Mitjans M., Molden E., Molina E., Molto M. D., Mondelli V., Moreno C., Morley C. P., Muntan&#xe9; G., Murphy K. C., Myin-Germeys I., Nenadi&#x107; I., Nestadt G., Nikitina-Zake L., Noto C., Nuechterlein K. H., O&#x2019;Brien N. L., O&#x2019;Neill F. A., Oh S.-Y., Olincy A., Ota V. K., Pantelis C., Papadimitriou G. N., Parellada M., Paunio T., Pellegrino R., Periyasamy S., Perkins D. O., Pfuhlmann B., Pietil&#xe4;inen O., Pimm J., Porteous D., Powell J., Quattrone D., Quested D., Radant A. D., Rampino A., Rapaport M. H., Rautanen A., Reichenberg A., Roe C., Roffman J. L., Roth J., Rothermundt M., Rutten B. P. F., Saker-Delye S., Salomaa V., Sanjuan J., Santoro M. L., Savitz A., Schall U., Scott R. J., Seidman L. J., Sharp S. I., Shi J., Siever L. J., Sigurdsson E., Sim K., Skarabis N., Slominsky P., So H.-C., Sobell J. L., S&#xf6;derman E., Stain H. J., Steen N. E., Steixner-Kumar A. A., St&#xf6;gmann E., Stone W. S., Straub R. E., Streit F., Strengman E., Stroup T. S., Subramaniam M., Sugar C. A., Suvisaari J., Svrakic D. M., Swerdlow N. R., Szatkiewicz J. P., Ta T. M. T., Takahashi A., Terao C., Thibaut F., Toncheva D., Tooney P. A., Torretta S., Tosato S., Tura G. B., Turetsky B. I., &#xdc;&#xe7;ok A., Vaaler A., van Amelsvoort T., van Winkel R., Veijola J., Waddington J., Walter H., Waterreus A., Webb B. T., Weiser M., Williams N. M., Witt S. H., Wormley B. K., Wu J. Q., Xu Z., Yolken R., Zai C. C., Zhou W., Zhu F., Zimprich F., Atba&#x15f;o&#x11f;lu E. C., Ayub M., Benner C., Bertolino A., Black D. W., Bray N. J., Breen G., Buccola N. G., Byerley W. F., Chen W. J., Cloninger C. R., Crespo-Facorro B., Donohoe G., Freedman R., Galletly C., Gandal M. J., Gennarelli M., Hougaard D. M., Hwu H.-G., Jablensky A. V., McCarroll S. A., Moran J. L., Mors O., Mortensen P. B., M&#xfc;ller-Myhsok B., Neil A. L., Nordentoft M., Pato M. T., Petryshen T. L., Pirinen M., Pulver A. E., Schulze T. G., Silverman J. M., Smoller J. W., Stahl E. A., Tsuang D. W., Vilella E., Wang S.-H., Xu S., Dai N., Wenwen Q., Wildenauer D. B., Agiananda F., Amir N., Antoni R., Arsianti T., Asmarahadi A., Diatri H., Djatmiko P., Irmansyah I., Khalimah S., Kusumadewi I., Kusumaningrum P., Lukman P. R., Nasrun M. W., Safyuni N. S., Prasetyawan P., Semen G., Siste K., Tobing H., Widiasih N., Wiguna T., Wulandari D., Evalina N., Hananto A. J., Ismoyo J. H., Marini T. M., Henuhili S., Reza M., Yusnadewi S., Abyzov A., Akbarian S., Ashley-Koch A., van Bakel H., Breen M., Brown M., Bryois J., Carlyle B., Charney A., Coetzee G., Crawford G., Dracheva S., Emani P., Farnham P., Fromer M., Galeev T., M. Gandal, M. Gerstein, Giase G., Girdhar K., Goes F., Grennan K., Gu M., Guerra B., Gursoy G., Hoffman G., Hyde T., Jaffe A., Jiang S., Jiang Y., Kefi A., Kim Y., Kitchen R., Knowles J. A., Lay F., Lee D., Li M., Liu C., Liu S., Mattei E., Navarro F., Pan X., Peters M. A., Pinto D., Pochareddy S., Polioudakis D., Purcaro M., Purcell S., Pratt H., Reddy T., Rhie S., Roussos P., Rozowsky J., Sanders S., Sestan N., Sethi A., Shi X., Shieh A., Swarup V., Szekely A., Wang D., Warrell J., Weissman S., Weng Z., White K., Wiseman J., Witt H., Won H., Wood S., Wu F., Xu X., Yao L., Zandi P., Arranz M. J., Bakker S., Bender S., Bramon E., Collier D. A., Crepo-Facorro B., Hall J., Iyegbe C., Kahn R., Lawrie S., Lewis C., Lin K., Linszen D. H., Mata I., McIntosh A., Murray R. M., Ophoff R. A., van Os J., Powell J., Rujescu D., Walshe M., Weisbrod M., Achsel T., Andres-Alonso M., Bagni C., Bay&#xe9;s &#xc0;., Biederer T., Brose N., Brown T. C., Chua J. J. E., Coba M. P., Cornelisse L. N., de Jong A. P. H., de Juan-Sanz J., Dieterich D. C., Feng G., Goldschmidt H. L., Gundelfinger E. D., Hoogenraad C., Huganir R. L., Hyman S. E., Imig C., Jahn R., Jung H., Kaeser P. S., Kim E., Koopmans F., Kreutz M. R., Lipstein N., MacGillavry H. D., Malenka R., McPherson P. S., O&#x2019;Connor V., Pielot R., Ryan T. A., Sahasrabudhe D., Sala C., Sheng M., Smalla K.-H., Smit A. B., S&#xfc;dhof T. C., Thomas P. D., Toonen R. F., van Weering J. R. T., Verhage M., Verpelli C., Adolfsson R., Arango C., Baune B. T., Belangero S. I., B&#xf8;rglum A. D., Braff D., Bramon E., Buxbaum J. D., Campion D., Cervilla J. A., Cichon S., Collier D. A., Corvin A., Curtis D., Forti M. D., Domenici E., Ehrenreich H., Escott-Price V., Esko T., Fanous A. H., Gareeva A., Gawlik M., Gejman P. V., Gill M., Glatt S. J., Golimbet V., Hong K. S., Hultman C. M., Hyman S. E., Iwata N., J&#xf6;nsson E. G., Kahn R. S., Kennedy J. L., Khusnutdinova E., Kirov G., Knowles J. A., Krebs M.-O., Laurent-Levinson C., Lee J., Lencz T., Levinson D. F., Li Q. S., Liu J., Malhotra A. K., Malhotra D., McIntosh A., McQuillin A., Menezes P. R., Morgan V. A., Morris D. W., Mowry B. J., Murray R. M., Nimgaonkar V., N&#xf6;then M. M., Ophoff R. A., Paciga S. A., Palotie A., Pato C. N., Qin S., Rietschel M., Riley B. P., Rivera M., Rujescu D., Saka M. C., Sanders A. R., Schwab S. G., Serretti A., Sham P. C., Shi Y., St Clair D., Stef&#xe1;nsson H., Stefansson K., Tsuang M. T., van Os J., Vawter M. P., Weinberger D. R., Werge T., Wildenauer D. B., Yu X., Yue W., Holmans P. A., Pocklington A. J., Roussos P., Vassos E., Verhage M., Visscher P. M., Yang J., Posthuma D., Andreassen O. A., Kendler K. S., Owen M. J., Wray N. R., Daly M. J., Huang H., Neale B. M., Sullivan P. F., Ripke S., Walters J. T. R., O&#x2019;Donovan M. C., de Haan L., van Amelsvoort T., van Winkel R., Gareeva A., Sham P. C., Shi Y., St Clair D., van Os J.; Schizophrenia Working Group of the Psychiatric Genomics Consortium , Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 604, 502&#x2013;508 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9392466</ArticleId><ArticleId IdType=\"pubmed\">35396580</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki M. I., Karjalainen J., Palta P., Sipil&#xe4; T. P., Kristiansson K., Donner K. M., Reeve M. P., Laivuori H., Aavikko M., Kaunisto M. A., Loukola A., Lahtela E., Mattsson H., Laiho P., Parolo P. D. B., Lehisto A. A., Kanai M., Mars N., R&#xe4;m&#xf6; J., Kiiskinen T., Heyne H. O., Veerapen K., R&#xfc;eger S., Lemmel&#xe4; S., Zhou W., Ruotsalainen S., P&#xe4;rn K., Hiekkalinna T., Koskelainen S., Paajanen T., Llorens V., Gracia-Tabuenca J., Siirtola H., Reis K., Elnahas A. G., Sun B., Foley C. N., Aalto-Set&#xe4;l&#xe4; K., Alasoo K., Arvas M., Auro K., Biswas S., Bizaki-Vallaskangas A., Carpen O., Chen C.-Y., Dada O. A., Ding Z., Ehm M. G., Eklund K., F&#xe4;rkkil&#xe4; M., Finucane H., Ganna A., Ghazal A., Graham R. R., Green E. M., Hakanen A., Hautalahti M., Hedman &#xc5;. K., Hiltunen M., Hinttala R., Hovatta I., Hu X., Huertas-Vazquez A., Huilaja L., Hunkapiller J., Jacob H., Jensen J.-N., Joensuu H., John S., Julkunen V., Jung M., Junttila J., Kaarniranta K., K&#xe4;h&#xf6;nen M., Kajanne R., Kallio L., K&#xe4;lvi&#xe4;inen R., Kaprio J.; FinnGen, Kerimov N., Kettunen J., Kilpel&#xe4;inen E., Kilpi T., Klinger K., Kosma V.-M., Kuopio T., Kurra V., Laisk T., Laukkanen J., Lawless N., Liu A., Longerich S., M&#xe4;gi R., M&#xe4;kel&#xe4; J., M&#xe4;kitie A., Malarstig A., Mannermaa A., Maranville J., Matakidou A., Meretoja T., Mozaffari S. V., Niemi M. E. K., Niemi M., Niiranen T., Donnell C. J. O., Obeidat M. E., Okafo G., Ollila H. M., Palom&#xe4;ki A., Palotie T., Partanen J., Paul D. S., Pelkonen M., Pendergrass R. K., Petrovski S., Pitk&#xe4;ranta A., Platt A., Pulford D., Punkka E., Pussinen P., Raghavan N., Rahimov F., Rajpal D., Renaud N. A., Riley-Gillis B., Rodosthenous R., Saarentaus E., Salminen A., Salminen E., Salomaa V., Schleutker J., Serpi R., Shen H.-Y., Siegel R., Silander K., Siltanen S., Soini S., Soininen H., Sul J. H., Tachmazidou I., Tasanen K., Tienari P., Toppila-Salmi S., Tukiainen T., Tuomi T., Turunen J. A., Ulirsch J. C., Vaura F., Virolainen P., Waring J., Waterworth D., Yang R., Nelis M., Reigo A., Metspalu A., Milani L., Esko T., Fox C., Havulinna A. S., Perola M., Ripatti S., Jalanko A., Laitinen T., M&#xe4;kel&#xe4; T. P., Plenge R., McCarthy M., Runz H., Daly M. J., Palotie A., FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508&#x2013;518 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9849126</ArticleId><ArticleId IdType=\"pubmed\">36653562</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G., Tilling K., Davey Smith G., Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLOS Genet. 13, e1007081 (2017).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5711033</ArticleId><ArticleId IdType=\"pubmed\">29149188</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan B. K., Loh P.-R., Finucane H. K., Ripke S., Yang J.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Patterson N., Daly M. J., Price A. L., Neale B. M., LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291&#x2013;295 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4495769</ArticleId><ArticleId IdType=\"pubmed\">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J., Spiller W., Del Greco. M F., Sheehan N., Thompson J., Minelli C., Smith G. D., Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int. J. Epidemiol. 47, 1264&#x2013;1278 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6124632</ArticleId><ArticleId IdType=\"pubmed\">29961852</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounier N., Kutalik Z., Bias correction for inverse variance weighting Mendelian randomization. Genet. Epidemiol. 47, 314&#x2013;331 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37036286</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant A. J., Burgess S., Pleiotropy robust methods for multivariable Mendelian randomization. Stat. Med. 40, 5813&#x2013;5830 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7612169</ArticleId><ArticleId IdType=\"pubmed\">34342032</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39269972</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">1932-6203</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>19</Volume><Issue>9</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Evaluating disparity of subjective cognitive decline between male veterans and non-veterans in the United States using propensity score matching estimation: A behavioral risk factor surveillance system survey cross-sectional study.</ArticleTitle><Pagination><StartPage>e0310102</StartPage><MedlinePgn>e0310102</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">e0310102</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1371/journal.pone.0310102</ELocationID><Abstract><AbstractText>Subjective cognitive decline (SCD) is one of the most important early onset symptoms of Alzheimer's Disease. Previous studies consistently reported that SCD is associated with quality of life, socio-economic factors, and related health comorbidities. However, the impact of veteran status on SCD has been little investigated. This study conducted a cross-sectional study to address disproportionate effects in subjective cognitive decline between veterans and non-veterans in the United States. Propensity score matching (PSM) was applied in this observational study to achieve covariate balancing and reduce selection bias, providing a more accurate estimate of the isolated effect of veteran status on SCD. Our study utilized 32,431 forty-five years or older non-institutionalized White, Black or African-American, and Hispanic or Latin-American male population from the 2019 Behavioral Risk Factor Surveillance System data. We first identified 10,685 paired PSM samples for the binary veteran status using the preselected covariates. Next, we performed a logistic regression for modeling the relationship between the veteran status and the SCD status using the PSM samples along with the covariates selected by a BIC-based stepwise selection. Our analyses revealed a statistically significant causal association between veteran status and SCD after PSM (odds ratio (OR): 1.16 and 95% confidence interval (CI): 1.06-1.27). We obtained a similar result before PSM with an OR of 1.20 and 95% CI of 1.10-1.31. When we focused on a minority group (Black or African-American males), we found a significantly increased veterans' risk of SCD, especially after propensity score matching (OR: 1.69, 95% CI: 1.16-2.45). We also found several factors such as employment status, difficulty dressing/walking/running errands, general health status, physical health status, unaffordability of medical costs, mental health status, and comorbid conditions including stroke, blindness, high cholesterol, and arthritis as statistically significantly associated with SCD (P-value &lt; 0.05). Similar to post-traumatic stress disorder and traumatic brain injury, our study demonstrated a causal association between SCD and military-related activities in the United States, which has a disproportionate impact on the minority population. This study sets the groundwork to further research in this domain to diagnose neurological diseases early among veterans.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Ifebirinachi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ifebirinachi</LastName><ForeName>Chinenye</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, North Carolina Agricultural &amp; Technical State University, Greensboro, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Park</LastName><ForeName>Man Sik</ForeName><Initials>MS</Initials><Identifier Source=\"ORCID\">0000-0002-1472-0071</Identifier><AffiliationInfo><Affiliation>Department of Statistics, Sungshin Women's University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Seong-Tae</ForeName><Initials>ST</Initials><Identifier Source=\"ORCID\">0000-0001-7436-1405</Identifier><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, North Carolina Agricultural &amp; Technical State University, Greensboro, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003430\" MajorTopicYN=\"N\">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D014728\" MajorTopicYN=\"Y\">Veterans</DescriptorName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D057216\" MajorTopicYN=\"Y\">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D014481\" MajorTopicYN=\"N\" Type=\"Geographic\">United States</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D060825\" MajorTopicYN=\"Y\">Cognitive Dysfunction</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D040343\" MajorTopicYN=\"N\">Behavioral Risk Factor Surveillance System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011788\" MajorTopicYN=\"N\">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269972</ArticleId><ArticleId IdType=\"pmc\">PMC11398683</ArticleId><ArticleId IdType=\"doi\">10.1371/journal.pone.0310102</ArticleId><ArticleId IdType=\"pii\">PONE-D-24-05325</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roehr S, Luck T, Pabst A, Bickel H, K&#xf6;nig HH, L&#xfc;hmann D, et al.. Subjective cognitive decline is longitudinally associated with lower health-related quality of life. Int Psychogeriatr. 2017. Dec;29(12):1939&#x2013;50. doi: 10.1017/S1041610217001399</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S1041610217001399</ArticleId><ArticleId IdType=\"pubmed\">28737118</ArticleId></ArticleIdList></Reference><Reference><Citation>Wortmann M. Dementia: a global health priority&#x2014;highlights from an ADI and World Health Organization report. Alz Res Therapy. 2012. Sep 21;4(5):40. doi: 10.1186/alzrt143</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/alzrt143</ArticleId><ArticleId IdType=\"pmc\">PMC3580397</ArticleId><ArticleId IdType=\"pubmed\">22995353</ArticleId></ArticleIdList></Reference><Reference><Citation>Akushevich I, Yashkin AP, Yashin AI, Kravchenko J. Geographic disparities in mortality from Alzheimer&#x2019;s disease and related dementias. J Am Geriatr Soc. 2021;69(8):2306&#x2013;15. doi: 10.1111/jgs.17215</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jgs.17215</ArticleId><ArticleId IdType=\"pmc\">PMC8373784</ArticleId><ArticleId IdType=\"pubmed\">34009643</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer&#x2019;s Disease. Arch Med Res. 2012. Nov 1;43(8):600&#x2013;8. doi: 10.1016/j.arcmed.2012.11.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.arcmed.2012.11.003</ArticleId><ArticleId IdType=\"pubmed\">23159715</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaffe K, Hoang TD, Byers AL, Barnes DE, Friedl KE. Lifestyle and health-related risk factors and risk of cognitive aging among older veterans. Alzheimers Dement (Amst). 2014;10(3S):S111&#x2013;21. doi: 10.1016/j.jalz.2014.04.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2014.04.010</ArticleId><ArticleId IdType=\"pubmed\">24924664</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong RA. Risk factors for Alzheimer&#x2019;s disease. Folia Neuropathol. 2019;57(2):87&#x2013;105. doi: 10.5114/fn.2019.85929</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5114/fn.2019.85929</ArticleId><ArticleId IdType=\"pubmed\">31556570</ArticleId></ArticleIdList></Reference><Reference><Citation>Povova J, Ambroz P, Bar M, Pavukova V, Sery O, Tomaskova H, et al.. Epidemiological of and risk factors for Alzheimer&#x2019;s disease: a review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012. Jun 1;156(2):108&#x2013;14. doi: 10.5507/bp.2012.055</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5507/bp.2012.055</ArticleId><ArticleId IdType=\"pubmed\">22837131</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards GA III, Gamez N, Escobedo G Jr, Calderon O, Moreno-Gonzalez I. Modifiable Risk Factors for Alzheimer&#x2019;s Disease.\n",
      "Frontiers in Aging Neuroscience [Internet].\n",
      "2019.  [cited 2023 Dec 3];11. Available from: https://www.frontiersin.org/articles/10.3389/fnagi.2019.00146. doi: 10.3389/fnagi.2019.00146\n",
      "\n",
      "</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2019.00146</ArticleId><ArticleId IdType=\"doi\">10.3389/fnagi.2019.00146</ArticleId><ArticleId IdType=\"pmc\">PMC6601685</ArticleId><ArticleId IdType=\"pubmed\">31293412</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmeidler J, Mastrogiacomo CN, Beeri MS, Rosendorff C, Silverman JM. Distinct age-related associations for body mass index and cognition in cognitively healthy very old veterans. Int Psychogeriatr. 2019. Jun;31(6):895&#x2013;9. doi: 10.1017/S1041610218001412</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S1041610218001412</ArticleId><ArticleId IdType=\"pmc\">PMC6625833</ArticleId><ArticleId IdType=\"pubmed\">30719960</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivari BS, Baumgart M, Taylor CA, McGuire LC. Population measures of subjective cognitive decline: A means of advancing public health policy to address cognitive health. Alzheimers Dement (N Y). 2021;7(1):e12142. doi: 10.1002/trc2.12142</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/trc2.12142</ArticleId><ArticleId IdType=\"pmc\">PMC7919133</ArticleId><ArticleId IdType=\"pubmed\">33681450</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder HM, Carare RO, DeKosky ST, de Leon MJ, Dykxhoorn D, Gan L, et al.. Military-related risk factors for dementia. Alzheimers Dement (Amst). 2018. Dec 1;14(12):1651&#x2013;62. doi: 10.1016/j.jalz.2018.08.011</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2018.08.011</ArticleId><ArticleId IdType=\"pmc\">PMC6281800</ArticleId><ArticleId IdType=\"pubmed\">30415806</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S. Subjective cognitive decline and comorbid chronic conditions among United States veterans, 2015&#x2013;2018. Alzheimers Dement (N Y). 2020;16(S10):e036351.</Citation></Reference><Reference><Citation>Chin AL, Negash S, Hamilton R. Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer Disease. Alzheimer Dis Assoc Disord. 2011. Sep;25(3):187. doi: 10.1097/WAD.0b013e318211c6c9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/WAD.0b013e318211c6c9</ArticleId><ArticleId IdType=\"pmc\">PMC3396146</ArticleId><ArticleId IdType=\"pubmed\">21399486</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson ME, Serdula M, Galuska DA, Gillespie C, Donehoo R, Macera C, et al.. Walking trends among U.S. adults: The Behavioral Risk Factor Surveillance System, 1987&#x2013;2000. Am J Prev Med. 2003. Aug 1;25(2):95&#x2013;100. doi: 10.1016/s0749-3797(03)00112-0</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s0749-3797(03)00112-0</ArticleId><ArticleId IdType=\"pubmed\">12880875</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C, Beckles GL. Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System. Am J Prev Med. 2004. Jul 1;27(1):1&#x2013;7. doi: 10.1016/j.amepre.2004.03.008</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.amepre.2004.03.008</ArticleId><ArticleId IdType=\"pubmed\">15212768</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SY, Grossman M, Saffer H. An economic analysis of adult obesity: results from the Behavioral Risk Factor Surveillance System. In: 19 An Economic Analysis of Adult Obesity: Results from the Behavioral Risk Factor Surveillance System [Internet]. Columbia University Press; 2017.  [cited 2023 Dec 1]. p. 666&#x2013;93. Available from: https://www.degruyter.com/document/doi/10.7312/gros17812-028/html.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7312/gros17812-028/html</ArticleId></ArticleIdList></Reference><Reference><Citation>Strine TW, Mokdad AH, Balluz LS, Gonzalez O, Crider R, Berry JT, et al.. Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. Psychiatr Serv. 2008. Dec;59(12):1383&#x2013;90. doi: 10.1176/ps.2008.59.12.1383</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1176/ps.2008.59.12.1383</ArticleId><ArticleId IdType=\"pubmed\">19033164</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahnd WE, Eberth JM. Lung cancer screening utilization: a Behavioral Risk Factor Surveillance System analysis. Am J Prev Med. 2019. Aug 1;57(2):250&#x2013;5. doi: 10.1016/j.amepre.2019.03.015</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.amepre.2019.03.015</ArticleId><ArticleId IdType=\"pubmed\">31248742</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011. May 31;46(3):399&#x2013;424. doi: 10.1080/00273171.2011.568786</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/00273171.2011.568786</ArticleId><ArticleId IdType=\"pmc\">PMC3144483</ArticleId><ArticleId IdType=\"pubmed\">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001. Dec 1;2(3):169&#x2013;88.</Citation></Reference><Reference><Citation>Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, St&#xfc;rmer T. Variable selection for propensity score models. Am J Epidemiol. 2006. Jun 15;163(12):1149&#x2013;56. doi: 10.1093/aje/kwj149</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/kwj149</ArticleId><ArticleId IdType=\"pmc\">PMC1513192</ArticleId><ArticleId IdType=\"pubmed\">16624967</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007;26(4):734&#x2013;53. doi: 10.1002/sim.2580</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/sim.2580</ArticleId><ArticleId IdType=\"pubmed\">16708349</ArticleId></ArticleIdList></Reference><Reference><Citation>Normand SLT, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, et al.. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001. Apr 1;54(4):387&#x2013;98. doi: 10.1016/s0895-4356(00)00321-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s0895-4356(00)00321-8</ArticleId><ArticleId IdType=\"pubmed\">11297888</ArticleId></ArticleIdList></Reference><Reference><Citation>Imbens GW. Nonparametric estimation of average treatment effects under exogeneity: a review. Rev Econ Stat. 2004. Feb 1;86(1):4&#x2013;29.</Citation></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983. Apr 1;70(1):41&#x2013;55.</Citation></Reference><Reference><Citation>Imai K, van Dyk DA. Causal inference with general treatment regimes: generalizing the propensity score. Journal of the American Statistical Association. 2004. Sep 1;99(467):854&#x2013;66.</Citation></Reference><Reference><Citation>Staff J, Patrick ME, Loken E, Maggs JL. Teenage alcohol use and educational attainment. J Stud Alcohol Drugs. 2008. Nov;69(6):848&#x2013;58. doi: 10.15288/jsad.2008.69.848</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15288/jsad.2008.69.848</ArticleId><ArticleId IdType=\"pmc\">PMC2583376</ArticleId><ArticleId IdType=\"pubmed\">18925343</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyse AE, Keesler V, Schneider B. Assessing the effects of small school size on mathematics achievement: a propensity score-matching approach. Teachers College Record. 2008. Sep 1;110(9):1879&#x2013;900.</Citation></Reference><Reference><Citation>Tamma PD, Conley AT, Cosgrove SE, Harris AD, Lautenbach E, Amoah J, et al.. Association of 30-day mortality with oral step-down vs continued intravenous therapy in patients hospitalized with enterobacteriaceae bacteremia. JAMA Intern Med. 2019. Mar 1;179(3):316&#x2013;23. doi: 10.1001/jamainternmed.2018.6226</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamainternmed.2018.6226</ArticleId><ArticleId IdType=\"pmc\">PMC6439703</ArticleId><ArticleId IdType=\"pubmed\">30667477</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeve BB, Smith AW, Arora NK, Hays RD. Reducing bias in cancer research: application of propensity score matching. Health Care Financ Rev. 2008;29(4):69&#x2013;80.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4195028</ArticleId><ArticleId IdType=\"pubmed\">18773615</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25(1):1&#x2013;21. doi: 10.1214/09-STS313</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1214/09-STS313</ArticleId><ArticleId IdType=\"pmc\">PMC2943670</ArticleId><ArticleId IdType=\"pubmed\">20871802</ArticleId></ArticleIdList></Reference><Reference><Citation>Fewell Z, Davey Smith G, Sterne JAC. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. American Journal of Epidemiology. 2007. Sep 15;166(6):646&#x2013;55. doi: 10.1093/aje/kwm165</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/aje/kwm165</ArticleId><ArticleId IdType=\"pubmed\">17615092</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Zhao Y, Lee AH. An investigation of the significance of residual confounding effect. BioMed Research International. 2014;2014(1):658056. doi: 10.1155/2014/658056</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2014/658056</ArticleId><ArticleId IdType=\"pmc\">PMC3947891</ArticleId><ArticleId IdType=\"pubmed\">24696862</ArticleId></ArticleIdList></Reference><Reference><Citation>Flury BK, Riedwyl H. Standard distance in univariate and multivariate analysis. Am Stat. 1986. Aug 1;40(3):249&#x2013;51.</Citation></Reference><Reference><Citation>CDC. BRFSS LLCP 2019: Codebook Report [Internet].\n",
      "2020.  [cited 2023 Dec 2]. Available from: https://www.cdc.gov/brfss/annual_data/2019/pdf/codebook19_llcp-v2-508.html.</Citation></Reference><Reference><Citation>CDC. 2019 BRFSS Survey Data and Documentation [Internet].\n",
      "2022.  [cited 2023 Dec 2]. Available from: https://www.cdc.gov/brfss/annual_data/annual_2019.html.</Citation></Reference><Reference><Citation>Peterson RL, Carvajal SC, McGuire LC, Fain MJ, Bell ML. State inequality, socioeconomic position and subjective cognitive decline in the United States. SSM Popul Health. 2019. Apr 1;7:100357. doi: 10.1016/j.ssmph.2019.100357</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ssmph.2019.100357</ArticleId><ArticleId IdType=\"pmc\">PMC6402371</ArticleId><ArticleId IdType=\"pubmed\">30886886</ArticleId></ArticleIdList></Reference><Reference><Citation>Brumback BA. Fundamentals of causal inference: with R. CRC Press; 2021. 249 p.</Citation></Reference><Reference><Citation>King G, Nielsen R. Why propensity scores should not be used for matching. Political Analysis. 2019. Oct;27(4):435&#x2013;54.</Citation></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. The American Statistician. 1985;39(1):33&#x2013;8.</Citation></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009. Nov 10;28(25):3083&#x2013;107. doi: 10.1002/sim.3697</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/sim.3697</ArticleId><ArticleId IdType=\"pmc\">PMC3472075</ArticleId><ArticleId IdType=\"pubmed\">19757444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J. To use or not to use propensity score matching? Pharmaceutical Statistics. 2021;20(1):15&#x2013;24. doi: 10.1002/pst.2051</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/pst.2051</ArticleId><ArticleId IdType=\"pubmed\">32776719</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Mamdani MM, Stukel TA, Anderson GM, Tu JV. The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med. 2005;24(10):1563&#x2013;78. doi: 10.1002/sim.2053</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/sim.2053</ArticleId><ArticleId IdType=\"pubmed\">15706581</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin K, McLeod E, P&#xe9;riard J, Rattray B, Keegan R, Pyne DB. The impact of environmental stress on cognitive performance: a systematic review. Hum Factors. 2019. Dec 1;61(8):1205&#x2013;46. doi: 10.1177/0018720819839817</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/0018720819839817</ArticleId><ArticleId IdType=\"pubmed\">31002273</ArticleId></ArticleIdList></Reference><Reference><Citation>Penk WE, Robinowitz R, Black J, Dolan M, Bell W, Dorsett D, et al.. Ethnicity: Post-Traumatic Stress Disorder (PTSD) differences among black, white, and Hispanic veterans who differ in degrees of exposure to combat in Vietnam. Journal of Clinical Psychology. 1989;45(5):729&#x2013;35. doi: 10.1002/1097-4679(198909)45:5&amp;lt;729::aid-jclp2270450507&amp;gt;3.0.co;2-h</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/1097-4679(198909)45:5&amp;lt;729::aid-jclp2270450507&amp;gt;3.0.co;2-h</ArticleId><ArticleId IdType=\"pubmed\">2808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuerk PW, Yoder M, Grubaugh A, Myrick H, Hamner M, Acierno R. Prolonged exposure therapy for combat-related posttraumatic stress disorder: an examination of treatment effectiveness for veterans of the wars in Afghanistan and Iraq. Journal of Anxiety Disorders. 2011. Apr 1;25(3):397&#x2013;403. doi: 10.1016/j.janxdis.2010.11.002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.janxdis.2010.11.002</ArticleId><ArticleId IdType=\"pmc\">PMC4547462</ArticleId><ArticleId IdType=\"pubmed\">21131170</ArticleId></ArticleIdList></Reference><Reference><Citation>Dismuke CE, Gebregziabher M, Yeager D, Egede LE. Racial/ethnic differences in combat- and non&#x2013;combat-associated traumatic brain injury severity in the veterans health administration: 2004&#x2013;2010. Am J Public Health. 2015. Aug;105(8):1696&#x2013;702. doi: 10.2105/AJPH.2014.302545</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2105/AJPH.2014.302545</ArticleId><ArticleId IdType=\"pmc\">PMC4504327</ArticleId><ArticleId IdType=\"pubmed\">26066928</ArticleId></ArticleIdList></Reference><Reference><Citation>Wooten KG, McGuire LC, Olivari BS, Jackson EM, Croft JB. Racial and ethnic differences in Subjective Cognitive Decline&#x2014;United States, 2015&#x2013;2020. Morbidity and Mortality Weekly Report. 2023;72(10):249. doi: 10.15585/mmwr.mm7210a1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15585/mmwr.mm7210a1</ArticleId><ArticleId IdType=\"pmc\">PMC10010752</ArticleId><ArticleId IdType=\"pubmed\">36893045</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsico R, Zakkar M, Bruno VD, Mansour S, Bryan AJ, Angelini GD. The impact of patient-prosthesis mismatch on early and long-term survival after aortic replacement with the Edwards Perimount valve: a propensity score-matched analysis. J Card Surg. 2021;36(7):2269&#x2013;76. doi: 10.1111/jocs.15534</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jocs.15534</ArticleId><ArticleId IdType=\"pubmed\">33821500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertefaie A, Asgharian M, Stephens DA. Variable selection in causal inference using a simultaneous penalization method.\n",
      "J Causal Inference [Internet].\n",
      "2018. \n",
      "Mar\n",
      "1 [cited 2023 Dec 1];6(1). Available from: https://www.degruyter.com/document/doi/10.1515/jci-2017-0010/html</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1515/jci-2017-0010/html</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Parmigiani G, Dominici F. Bayesian effect estimation accounting for adjustment uncertainty. Biometrics. 2012;68(3):661&#x2013;71. doi: 10.1111/j.1541-0420.2011.01731.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1541-0420.2011.01731.x</ArticleId><ArticleId IdType=\"pubmed\">22364439</ArticleId></ArticleIdList></Reference><Reference><Citation>Cefalu M, Dominici F, Arvold N, Parmigiani G. Model averaged double robust estimation. Biometrics. 2017;73(2):410&#x2013;21. doi: 10.1111/biom.12622</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/biom.12622</ArticleId><ArticleId IdType=\"pmc\">PMC5466877</ArticleId><ArticleId IdType=\"pubmed\">27893927</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch B, Vock DM, Wolfson J. Covariate selection with group lasso and doubly robust estimation of causal effects. Biometrics. 2018;74(1):8&#x2013;17. doi: 10.1111/biom.12736</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/biom.12736</ArticleId><ArticleId IdType=\"pmc\">PMC5740021</ArticleId><ArticleId IdType=\"pubmed\">28636276</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269887</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2161-7856</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Games for health journal</Title><ISOAbbreviation>Games Health J</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of Serious Games in Evaluating Cognitive Status of the Elderly: A Systematic Review And Meta-Analysis.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1089/g4h.2023.0106</ELocationID><Abstract><AbstractText>Early diagnosis of mild cognitive impairment (MCI) and Alzheimer's disease (AD) is very important in better management of these diseases, and serious games play an effective role in helping to diagnose these diseases more accurately owing to their innovative features. With respect to the diversity of available games, the purpose of this study was to investigate the effectiveness of using serious games to assess the cognitive status of the elderly at risk of MCI/AD. A systematic review was conducted and the correlation of serious game results with cognitive test scores were extracted from eligible studies for meta-analysis. We analyzed the correlation between the results of serious games with the scores of mini-mental state examination (MMSE), Addenbrooke's Cognitive Examination-revised edition (ACE-R), and Montreal Cognitive Assessment (MoCA) tests to evaluate cognitive status of the elderly at risk of MCI/AD, as well as the cognitive aspects examined by these tests. The random-effects model was used to obtain the overall correlation coefficient to assess the relationship between the results of serious games and the above mentioned paper-and-pencil tests. The correlation of game results with the MMSE, ACE-R, and MoCA was 0.604, 0.682, with 0.682, respectively. The correlation between the results of the games with the score of each cognitive aspect was also calculated. Overall, there is a positive correlation between serious game scores in terms of accurate patients' reactions with the scores of MMSE, ACE-R, and MoCA tests. Among the cognitive aspects, the highest correlation was obtained for fluency (0.591). For abstraction, however, the correlation was the lowest (0.036). In all three tests, the correlation was &gt;0.6 and in cognitive aspects was &lt;0.6. Thus, more studies should be conducted to develop serious games that are more in line with cognitive tests.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Sabermahani</LastName><ForeName>Farveh</ForeName><Initials>F</Initials><Identifier Source=\"ORCID\">0000-0002-0587-9734</Identifier><AffiliationInfo><Affiliation>Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Almasi-Dooghaee</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Department, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sheikhtaheri</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Games Health J</MedlineTA><NlmUniqueID>101583709</NlmUniqueID><ISSNLinking>2161-783X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Aging population</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Diagnosis</Keyword><Keyword MajorTopicYN=\"N\">Digital health</Keyword><Keyword MajorTopicYN=\"N\">Elderly</Keyword><Keyword MajorTopicYN=\"N\">Meta-analysis</Keyword><Keyword MajorTopicYN=\"N\">Mild cognitive impairment</Keyword><Keyword MajorTopicYN=\"N\">Serious game</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269887</ArticleId><ArticleId IdType=\"doi\">10.1089/g4h.2023.0106</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269844</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Correlation of the Serum Fatty Acids with Cognitive Function: An NHANES 2011-2014 and Multivariate Mendelian Randomization Analysis.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240715</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">The relationship between serum fatty acids and cognitive function has been the subject of extensive study.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">To analyze the relationship between serum fatty acids composition and cognitive function by NHANES database and multivariate Mendelian randomization (MR) analysis.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">A sub-cohort of 1,339 individuals with serum fatty acids and Digit Symbol Substitution Test (DSST) examinations from the 2011-2014 wave of the NHANES were analyzed using fully adjusted multiple linear regression models for associations between serum hydrolyzed fatty acid levels and cognitive function. Univariable and multivariable MR was used to analyze the correlation between 98 exposures related to serum fatty acids and cognitive function. Results from different database sources were combined using meta-analysis.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">The fully adjusted regression analysis showed that linoleic acid (LA), Omega 6, fatty acids (FAs), and LA/FAs were positively correlated with DSST. 27 exposures were included for univariate MR analysis. Ultimately, only 2 traits had IVW test p-values ranging between 0.0019 and 0.05, both of which were LA/FAs. The meta-analysis of univariate MR revealed that LA/FAs was positively associated with cognitive function (&#x3b2;: 0.040, 95% CI&#x200a;=&#x200a;0.013-0.067, p&#x200a;=&#x200a;0.0041). In multivariate MR analysis, after adjusting for education, ischemic stroke, and age, LA/FAs was positively independently associated with cognitive function (IVW &#x3b2;: 0.049, 95% CI&#x200a;=&#x200a;0.021-0.077, p&#x200a;=&#x200a;0.0006). The results of MVMR are well in line with the univariate results.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">Both the Cross-sectional observational analyses and MR-based studies supported a suggestive causal relationship between the serum ratio of Linoleic acid in fatty acids and cognitive function.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Zhao</LastName><ForeName>Huimin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Medicine, No. 970 Hospitalof the People's Liberation Army Joint Logistics Support Force, Yantai, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Changlin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of General Medicine, No. 970 Hospitalof the People's Liberation Army Joint Logistics Support Force, Yantai, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xing</LastName><ForeName>Fangkai</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit 71217 of People's Liberation Army, Yantai, Shandong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Mendelian randomization</Keyword><Keyword MajorTopicYN=\"N\">NHANES</Keyword><Keyword MajorTopicYN=\"N\">cognitive function</Keyword><Keyword MajorTopicYN=\"N\">fatty acids</Keyword><Keyword MajorTopicYN=\"N\">linoleic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269844</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240715</ArticleId><ArticleId IdType=\"pii\">JAD240715</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269843</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Diagnosis of Alzheimer's Disease in Clinical Practice: Time to Incorporate Biomarkers?</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240660</ELocationID><Abstract><AbstractText>Hippocampal dysfunction is associated with early clinical signs of Alzheimer's disease (AD). Due to the limited availability or invasiveness of current biomarkers, the AD diagnosis is usually based on cognitive assessment and structural brain imaging. The recent study by Lalive and colleagues examined the specificity of brain morphometry for the AD diagnosis in a memory clinic cohort with hippocampal-type amnestic syndrome. The results indicate that memory deficits and hippocampal atrophy are similar in AD and non-AD patients, highlighting their low diagnostic specificity. These findings challenge the traditional AD diagnosis and underscore the need for biomarkers to differentiate specific neuropathological entities.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Vyhnalek</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lacz&#xf3;</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lacz&#xf3;</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Lewy body dementia</Keyword><Keyword MajorTopicYN=\"N\">behavioral variant frontotemporal dementia</Keyword><Keyword MajorTopicYN=\"N\">cerebrospinal fluid</Keyword><Keyword MajorTopicYN=\"N\">limbic-predominant age-related TDP-43 encephalopathy</Keyword><Keyword MajorTopicYN=\"N\">mild cognitive impairment</Keyword><Keyword MajorTopicYN=\"N\">positron emission tomography</Keyword><Keyword MajorTopicYN=\"N\">primary age-related tauopathy</Keyword><Keyword MajorTopicYN=\"N\">subjective cognitive decline</Keyword><Keyword MajorTopicYN=\"N\">suspected non-Alzheimer&#x2019;s disease pathophysiology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269843</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240660</ArticleId><ArticleId IdType=\"pii\">JAD240660</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269842</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240623</ELocationID><Abstract><AbstractText>Anti-amyloid drugs for early Alzheimer's disease, including lecanemab, are associated with adverse events (AEs), such as amyloid-related imaging abnormalities (ARIA)-edema/effusion (E), ARIA-hemorrhage, and infusion-related reactions, which can indicate allocated arms in clinical trials. Herein, we evaluated the predictive value of AEs using a meta-analysis to estimate their incidence and simulated positive predictive value (PPV). The PPV for ARIA-E was high (0.915), but that for ARIA hemorrhage was low (0.630). Infusion-related reactions had a high PPV of 0.910, but with a wide confidence interval. Our results suggest the need to ameliorate the unblinding effects of AEs, particularly ARIA-E in trials.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Sato</LastName><ForeName>Kenichiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Niimi</LastName><ForeName>Yoshiki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Healthcare Economics and Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ihara</LastName><ForeName>Ryoko</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Iwata</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Iwatsubo</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Adverse event</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">anti-amyloid drug</Keyword><Keyword MajorTopicYN=\"N\">clinical trial</Keyword><Keyword MajorTopicYN=\"N\">unblinding</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269842</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240623</ArticleId><ArticleId IdType=\"pii\">JAD240623</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269841</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Alzheimer's Disease: An Attempt of Total Recall.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240620</ELocationID><Abstract><AbstractText>This review is an attempt to compile existing hypotheses on the mechanisms underlying the initiation and progression of Alzheimer's disease (AD), starting from sensory impairments observed in AD and concluding with molecular events that are typically associated with the disease. These events include spreading of amyloid plaques and tangles of hyperphosphorylated tau and formation of Hirano and Biondi bodies as well as the development of oxidative stress. We have detailed the degenerative changes that occur in several neuronal populations, including the cholinergic neurons in the nucleus basalis of Meynert, the histaminergic neurons in the tuberomammillary nucleus, the serotonergic neurons in the raphe nuclei, and the noradrenergic neurons in the locus coeruleus. Furthermore, we discuss the potential role of iron accumulation in the brains of subjects with AD in the disease progression which served as a basis for the idea that iron chelation in the brain may mitigate oxidative stress and decelerate disease development. We also draw attention to possible role of sympathetic system and, more specifically, noradrenergic neurons of the superior cervical ganglion in triggering of the disease. We also explore the alternative possibility of compensatory protective changes that may occur in these neurons to support cholinergic function in the forebrain of subjects with AD.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Bolshakov</LastName><ForeName>Alexey P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gerasimov</LastName><ForeName>Konstantin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Russian National Research Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dobryakova</LastName><ForeName>Yulia V</ForeName><Initials>YV</Initials><AffiliationInfo><Affiliation>Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">amyloid</Keyword><Keyword MajorTopicYN=\"N\">astrocytes</Keyword><Keyword MajorTopicYN=\"N\">cholinergic neurons</Keyword><Keyword MajorTopicYN=\"N\">neurodegeneration</Keyword><Keyword MajorTopicYN=\"N\">noradrenergic neurons</Keyword><Keyword MajorTopicYN=\"N\">oxidative stress</Keyword><Keyword MajorTopicYN=\"N\">sympathetic system</Keyword><Keyword MajorTopicYN=\"N\">tauopathy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269841</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240620</ArticleId><ArticleId IdType=\"pii\">JAD240620</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269840</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Toward Quantitative Neurology: Sensors to Assess Motor Deficits in Dementia.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240559</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Alzheimer's disease (AD) is the most common neurodegenerative disorder which primarily involves memory and cognitive functions. It is increasingly recognized that motor involvement is also a common and significant aspect of AD, contributing to functional decline and profoundly impacting quality of life. Motor impairment, either at early or later stages of cognitive disorders, can be considered as a proxy measure of cognitive impairment, and technological devices can provide objective measures for both diagnosis and prognosis purposes. However, compared to other neurodegenerative disorders, the use of technological tools in neurocognitive disorders, including AD, is still in its infancy.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">This report aims to evaluate the role of technological devices in assessing motor involvement across the AD spectrum and in other dementing conditions, providing an overview of the existing devices that show promise in this area and exploring their clinical applications.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">The evaluation involves a review of the existing literature in the PubMed, Web of Science, Scopus, and Cochrane databases on the effectiveness of these technologies. 21 studies were identified and categorized as: wearable inertial sensors/IMU, console/kinect, gait analysis, tapping device, tablet/mobile, and computer.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">We found several parameters, such as speed and stride length, that appear promising for detecting abnormal motor function in MCI or dementia. In addition, some studies have found correlations between these motor aspects and cognitive state.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">Clinical application of technological tools to assess motor function in people with cognitive impairments of a neurodegenerative nature, such as AD, may improve early detection and stratification of patients.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Hamedani</LastName><ForeName>Mehrnaz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Caneva</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mancardi</LastName><ForeName>Gian Luigi</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Al&#xec;</LastName><ForeName>Paolo Alessandro</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fiaschi</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Massa</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schenone</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pardini</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (DINOGMI), University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D000078182\">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">cognitive impairment</Keyword><Keyword MajorTopicYN=\"N\">dementia</Keyword><Keyword MajorTopicYN=\"N\">mild cognitive impairment</Keyword><Keyword MajorTopicYN=\"N\">motor function</Keyword><Keyword MajorTopicYN=\"N\">sensors</Keyword><Keyword MajorTopicYN=\"N\">technology assessment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269840</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240559</ArticleId><ArticleId IdType=\"pii\">JAD240559</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269839</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240400</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Transcranial alternating current stimulation (tACS) could improve cognition in patients with Alzheimer's disease (AD). However, the effects of tACS on brain activity remain unclear.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">The purpose is to investigate the change in regional neuronal activity after tACS in AD patients employing resting-state functional magnetic resonance imaging (rs-fMRI).</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">A total of 46 patients with mild AD were enrolled. Each patient received 30 one-hour sessions of real or sham tACS for three weeks (clinical trial: NCT03920826). The fractional amplitude of low-frequency fluctuations (fALFF) and the regional homogeneity (ReHo) measured by rs-fMRI were calculated to evaluate the regional brain activity.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">Compared to baseline, AD patients in the real group exhibited increased fALFF in the left middle frontal gyrus-orbital part and right inferior frontal gyrus-orbital part, as well as increased ReHo in the left precentral gyrus and right middle frontal gyrus at the end of intervention. At the 3-month follow-up, fALFF increased in the left superior parietal lobule and right inferior temporal gyrus, as well as ReHo, in the left middle frontal gyrus and right superior medial frontal gyrus. A higher fALFF in the right lingual gyrus and ReHo in the right parahippocampal gyrus were observed in the response group than in the nonresponse group.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">The findings demonstrated the beneficial effects of tACS on the neuronal activity of the prefrontal cortex and even more extensive regions and provided a neuroimaging biomarker of treatment response in AD patients.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yan</LastName><ForeName>Shaozhen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shan</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xing</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bi</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chen</LastName><ForeName>Zhigeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xi</LastName><ForeName>Hanyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xue</LastName><ForeName>Hanxiao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qi</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">functional magnetic resonance imaging</Keyword><Keyword MajorTopicYN=\"N\">transcranial alternating current stimulation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269839</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240400</ArticleId><ArticleId IdType=\"pii\">JAD240400</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269838</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Clinical and Neuropathological Correlates of Substance Use in American Football Players.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240300</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Chronic traumatic encephalopathy (CTE) is a neurodegenerative tauopathy more frequently found in deceased former football players. CTE has heterogeneous clinical presentations with multifactorial causes. Previous literature has shown substance use (alcohol/drug) can contribute to Alzheimer's disease and related tauopathies pathologically and clinically.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">To examine the association between substance use and clinical and neuropathological endpoints of CTE.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">Our sample included 429 deceased male football players. CTE was neuropathologically diagnosed. Informant interviews assessed features of substance use and history of treatment for substance use to define indicators: history of substance use treatment (yes vs no, primary variable), alcohol severity, and drug severity. Outcomes included scales that were completed by informants to assess cognition (Cognitive Difficulties Scale, BRIEF-A Metacognition Index), mood (Geriatric Depression Scale-15), behavioral regulation (BRIEF-A Behavioral Regulation Index, Barratt Impulsiveness Scale-11), functional ability (Functional Activities Questionnaire), as well as CTE status and cumulative p-tau burden. Regression models tested associations between substance use indicators and outcomes.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">Of the 429 football players (mean age&#x200a;=&#x200a;62.07), 313 (73%) had autopsy confirmed CTE and 100 (23%) had substance use treatment history. Substance use treatment and alcohol/drug severity were associated with measures of behavioral regulation (FDR-p-values&lt;0.05, &#x394;R2&#x200a;=&#x200a;0.04-0.18) and depression (FDR-p-values&lt;0.05, &#x394;R2&#x200a;=&#x200a;0.02-0.05). Substance use indicators had minimal associations with cognitive scales, whereas p-tau burden was associated with all cognitive scales (p-values &lt;0.05). Substance use treatment had no associations with neuropathological endpoints (FDR-p-values&gt;0.05).</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">Among deceased football players, substance use was common and associated with clinical symptoms.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Walsh</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Uretsky</LastName><ForeName>Madeline</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tripodis</LastName><ForeName>Yorghos</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nowinski</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Concussion Legacy Foundation, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rasch</LastName><ForeName>Abigail</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bruce</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ryder</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Martin</LastName><ForeName>Brett M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Palmisano</LastName><ForeName>Joseph N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Katz</LastName><ForeName>Douglas I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Braintree Rehabilitation Hospital, Braintree, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dwyer</LastName><ForeName>Brigid</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Braintree Rehabilitation Hospital, Braintree, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Daneshvar</LastName><ForeName>Daniel H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Walley</LastName><ForeName>Alexander Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Grayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston Medical Center, and Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Theresa W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Grayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston Medical Center, and Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Goldstein</LastName><ForeName>Lee E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Biomedical, Electrical &amp; Computer Engineering, Boston University College of Engineering, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stern</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy &amp; Neurobiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Alvarez</LastName><ForeName>Victor E</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Boston Healthcare System, U.S. Department of Veteran Affairs, Jamaica Plain, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for PTSD, VA Boston Healthcare, Jamaica Plain, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Bedford Healthcare System, Bedford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Framingham Heart Study, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Huber</LastName><ForeName>Bertrand Russell</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Boston Healthcare System, U.S. Department of Veteran Affairs, Jamaica Plain, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for PTSD, VA Boston Healthcare, Jamaica Plain, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>McKee</LastName><ForeName>Ann C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Boston Healthcare System, U.S. Department of Veteran Affairs, Jamaica Plain, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for PTSD, VA Boston Healthcare, Jamaica Plain, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Bedford Healthcare System, Bedford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Framingham Heart Study, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stein</LastName><ForeName>Thor D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Boston Healthcare System, U.S. Department of Veteran Affairs, Jamaica Plain, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for PTSD, VA Boston Healthcare, Jamaica Plain, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Bedford Healthcare System, Bedford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Framingham Heart Study, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mez</LastName><ForeName>Jesse</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Framingham Heart Study, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Alosco</LastName><ForeName>Michael L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease Research Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University CTE Center, Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy &amp; Neurobiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alcohol use</Keyword><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">chronic traumatic encephalopathy</Keyword><Keyword MajorTopicYN=\"N\">dementia</Keyword><Keyword MajorTopicYN=\"N\">repetitive head impacts</Keyword><Keyword MajorTopicYN=\"N\">substance use</Keyword><Keyword MajorTopicYN=\"N\">traumatic brain injury</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269838</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240300</ArticleId><ArticleId IdType=\"pii\">JAD240300</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269837</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Association Between Statin Use and Dementia, and Related Mechanisms: A Bibliometric Analysis from 2007 to 2023.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240270</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Emerging evidence suggests the potential of hydroxymethylglutaryl-coenzyme A (HMG-CoA, statins) as a therapeutic option for dementia.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">The primary objective of this study is to assess the current state of research on statins use in dementia, with a focus on identifying pivotal questions within the field.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">A systemic search for publications on statin use in dementia between 2007 and 2023 was conducted, utilizing the Web of Science Core Collection. The scientific output was analyzed from various perspectives through VOSviewer, CiteSpace, and the bibliometrics website (https://bibliometric.com/).</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">560 articles authored by 2,977 individuals and 999 institutions across 58 countries were included, which were published in 295 periodicals and cited 21,176 references from 16,424 authors. The annual publication output remained steady, while the number of citations increased consistently. The U.S. and Mayo Clinic emerged as the most significant country and institution, respectively. B. McGuinness and D.L. Sparks were the most eminent authors. Journal of Alzheimer's Disease was the most influential journal. Three sets of keywords and the top 10 references were identified, suggesting pivotal questions within the field.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">While statins show promising potential as a treatment option for dementia, their use remains uncertain due to the reported short-term cognitive impairment events and questionable long-term protective effects against dementia. The pivotal question is to ascertain the association between statins and cognition. The mechanisms underlying the effects of statins on cognition are multifaceted. This study provides insights into the current status within the field of statin use in dementia.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Sang</LastName><ForeName>Xian-Zheng</ForeName><Initials>XZ</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The Second Affiliated Hospital of Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chen</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The Second Affiliated Hospital of Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hou</LastName><ForeName>Xiao-Xiang</ForeName><Initials>XX</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The Second Affiliated Hospital of Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Chun-Hui</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, No. 905 Hospital of PLA Navy, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Dan-Feng</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The Second Affiliated Hospital of Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hou</LastName><ForeName>Li-Jun</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The Second Affiliated Hospital of Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">association</Keyword><Keyword MajorTopicYN=\"N\">bibliometrics</Keyword><Keyword MajorTopicYN=\"N\">dementia</Keyword><Keyword MajorTopicYN=\"N\">hydroxymethylglutaryl-CoA reductase inhibitors</Keyword><Keyword MajorTopicYN=\"N\">mechanism</Keyword><Keyword MajorTopicYN=\"N\">statins</Keyword><Keyword MajorTopicYN=\"N\">vascular dementia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269837</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240270</ArticleId><ArticleId IdType=\"pii\">JAD240270</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269836</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>The Relationship Between Physical Activity and Non-Modifiable Risk Factors on Alzheimer's Disease and Brain Health Markers: A UK Biobank Study.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240269</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Modifiable (physical activity) and non-modifiable (sex and genotype) risk factors interact to affect Alzheimer's disease (AD) risk. Further investigation is necessary to understand if these factors influence brain volume and cognition.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">The study aimed to assess the effect of physical activity, APOE genotype, and sex on AD risk, brain volume, and cognition.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">UK Biobank data from 2006 to 2023 was accessed. Physical activity was measured by accelerometers, and International Physical Activity Questionnaire. Outcomes were AD incidence; brain volume (ventricular cerebrospinal fluid and total brain); and cognition (executive function, memory, visuospatial ability, processing speed, and reaction time). Logistic and linear regression models were conducted.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">69,060 participants met inclusion criteria (mean age: 62.28 years, SD: 7.84; 54.64% female). Higher self-reported (OR&#x200a;=&#x200a;0.63, 95% CI [0.40, 1.00], p&#x200a;=&#x200a;0.047) and accelerometer-assessed (OR&#x200a;=&#x200a;0.96 [0.93, 0.98], p&#x200a;=&#x200a;0.002) physical activity was associated with lower disease incidence. Smaller ventricular cerebrospinal fluid volume (&#x3b2;=&#x200a;- 65.43 [- 109.68, - 17.40], p&#x200a;=&#x200a;0.007), and larger total brain volume (&#x3b2;=&#x200a;4398.46 [165.11, 8631.82], p&#x200a;&lt; &#x200a;0.001) was associated with increased accelerometer-assessed and self-reported physical activity respectively. Both brain volume analyses were moderated by sex. Increased accelerometer-assessed physical activity levels were associated with faster reaction time (&#x3b2;=&#x200a;- 0.43 [- 0.68, - 0.18], p&#x200a;=&#x200a;0.001); though poorer visuospatial ability (&#x3b2;=&#x200a;- 0.06 [- 0.09, - 0.03], p&#x200a;&lt; &#x200a;0.001), and executive function (&#x3b2;=&#x200a;0.49 [0.31, 0.66], p&#x200a;&lt; &#x200a;0.001; &#x3b2;=&#x200a;0.27 [0.10, 0.45], p&#x200a;=&#x200a;0.002) was related to self-reported physical activity levels.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">Higher levels of physical activity reduce AD risk independently of non-modifiable risk factors. Moderation of sex on brain volume highlighted the importance of incorporating non-modifiable risk factors in analysis.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Spencer</LastName><ForeName>Felicity S E</ForeName><Initials>FSE</Initials><AffiliationInfo><Affiliation>School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Elsworthy</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Breen</LastName><ForeName>Leigh</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bishop</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Birmingham Clinical Trials Unit, Institute of Applied Health Research, Public Health Building, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Morrissey</LastName><ForeName>Sol</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Aldred</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">UK Biobank</Keyword><Keyword MajorTopicYN=\"N\">apolipoprotein E4</Keyword><Keyword MajorTopicYN=\"N\">brain</Keyword><Keyword MajorTopicYN=\"N\">cognition</Keyword><Keyword MajorTopicYN=\"N\">exercise</Keyword><Keyword MajorTopicYN=\"N\">sex</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269836</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240269</ArticleId><ArticleId IdType=\"pii\">JAD240269</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269835</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Physical Activity in Mild Vascular Cognitive Impairment: Results of the AFIVASC Randomized Controlled Trial at 6 Months.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240246</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Vascular cognitive impairment is frequent, in mild (mVCI) or severe forms (vascular dementia).</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">To do a randomized controlled-trial to evaluate the impact of physical activity on cognition (primary outcome), neurocognitive measures, quality of life, functional status, and physical function (secondary outcomes), in patients with mVCI.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">A hundred and four patients with mVCI (mean age 71.2 years; 53 women) were randomized for a six-month intervention of moderate physical activity (60-minute sessions, 3 times/week) (n&#x200a;=&#x200a;53) or best-practice \"usual care\" (n&#x200a;=&#x200a;51). Comprehensive evaluations of primary and secondary outcomes included an objective measure of physical activity through accelerometry at baseline and after intervention.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">Mean session attendance was 58%. Adverse events were negligible. After 6 months, no significant primary outcome change was observed, either in the intervention or 'usual care' group. The intervention group improved significantly in some secondary outcomes in physical function - aerobic capacity (U&#x200a;=&#x200a;403; p&#x200a;=&#x200a;0.000) and agility (U&#x200a;=&#x200a;453; p&#x200a;=&#x200a;0.005) after 6 months. Regardless of randomization arm, a post-hoc analysis based on fulfilling at least 21.5 minutes/day of moderate or 10.7 minutes/day of vigorous physical activity (World Health Organization-WHO standards) revealed improvements. These were not only in motor capacity but also on the global measure of cognition, executive functions and memory.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">Physical activity was safe and beneficial regarding domains of physical function. No significant cognitive decline was registered over 6-months, regardless of intervention allocation. Larger samples, longer follow-ups and focus on intervention adherence are needed to fully analyze the impact of WHO recommendations for physical activity in mVCI populations.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Verdelho</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosciences and Mental Health, Hospital de Santa Maria, Unidade de Sa&#xfa;de Local de Santa Maria, Centro de Estudos Egas Moniz, Instituto de Sa&#xfa;de Ambiental - ISAMB, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Correia</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Service, Hospital de Santo Ant&#xf3;nio, Unidade Local de Sa&#xfa;de de Santo Ant&#xf3;nio, Centro Hospitalar Universit&#xe1;rio de Santo Ant&#xf3;nio and Instituto de Ci&#xea;ncias Biom&#xe9;dicas Abel Salazar (ICBAS), Universidade of Porto, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gon&#xe7;alves-Pereira</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>NOVA Medical School, Faculdade de Ci&#xea;ncias M&#xe9;dicas, Universidade Nova de Lisboa, CHRC, Associate Laboratory REAL (LA-REAL), Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Madureira</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Instituto Medicina Molecular Jo&#xe3;o Lobo Antunes (IMM), Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vilela</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Neuroradiology Department, Hospital da Luz, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Santos</LastName><ForeName>Ana Catarina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Hospital do Mar, Bobadela, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rodrigues</LastName><ForeName>M&#xe1;rio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto de Sa&#xfa;de Ambiental - ISAMB, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Borges</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto Medicina Molecular Jo&#xe3;o Lobo Antunes (IMM), Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ferro</LastName><ForeName>Jos&#xe9; M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Santa-Clara</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Exercise and Health Laboratory, Faculdade de Motricidade Humana, Centro Interdisciplinar de Estudo da Performance Humana - CIPER, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">intervention</Keyword><Keyword MajorTopicYN=\"N\">non-Alzheimer&#x2019;s disease neurocognitive disorder</Keyword><Keyword MajorTopicYN=\"N\">physical activity</Keyword><Keyword MajorTopicYN=\"N\">prevention</Keyword><Keyword MajorTopicYN=\"N\">vascular cognitive impairment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269835</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240246</ArticleId><ArticleId IdType=\"pii\">JAD240246</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269834</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>A Drug Repositioning Approach Reveals Ergotamine May Be a Potential Drug for the Treatment of Alzheimer's Disease.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240235</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Alzheimer's disease (AD) is a neurodegenerative disorder that is the most common form of dementia in the elderly. The drugs currently used to treat AD only have limited effects and are not able to cure the disease. Drug repositioning has increasingly become a promising approach to find potential drugs for diseases like AD.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">To screen potential drug candidates for AD based on the relationship between risk genes of AD and drugs.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">We collected the risk genes of AD and retrieved the information of known drugs from DrugBank. Then, the AD-related genes and the targets of each drug were mapped to the human protein-protein interaction network (PPIN) to represent AD and the drugs on the network. The network distances between each drug and AD were calculated to screen the drugs proximal to AD-related genes on PPIN, and the screened drug candidates were further analyzed by molecular docking and molecular dynamics simulations.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">We compiled a list of 714 genes associated with AD. From 5,833 drugs used for human diseases, we identified 1,044 drugs that could be potentially used to treat AD. Then, amyloid-&#x3b2; (A&#x3b2;) protein, the key molecule involved in the pathogenesis of AD was selected as the target to further screen drugs that may inhibit A&#x3b2; aggregation by molecular docking. We found that ergotamine and RAF-265 could bind stably with A&#x3b2;. In further analysis by molecular dynamics simulations, both drugs exhibited reasonable stability.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">Our work indicated that ergotamine and RAF-265 may be potential candidates for treating AD.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Qiuchen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fu</LastName><ForeName>Mengjie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gao</LastName><ForeName>Lihui</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yuan</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Ju</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">drug repositioning</Keyword><Keyword MajorTopicYN=\"N\">ergotamine</Keyword><Keyword MajorTopicYN=\"N\">molecular docking</Keyword><Keyword MajorTopicYN=\"N\">risk genes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269834</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240235</ArticleId><ArticleId IdType=\"pii\">JAD240235</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269833</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Molecular Gene Expression Testing to Identify Alzheimer's Disease with High Accuracy from Fingerstick Blood.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240174</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">There is no molecular test for Alzheimer's disease (AD) using self-collected samples, nor is there a definitive molecular test for AD. We demonstrate an accurate and potentially definitive TempO-Seq&#xae; gene expression test for AD using fingerstick blood spotted and dried on filter paper, a sample that can be collected in any doctor's office or can be self-collected.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">Demonstrate the feasibility of developing an accurate test for the classification of persons with AD from a minimally invasive sample of fingerstick blood spotted on filter paper which can be obtained in any doctor's office or self-collected to address health disparities.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">Fingerstick blood samples from patients clinically diagnosed with AD, Parkinson's disease (PD), or asymptomatic controls were spotted onto filter paper in the doctor's office, dried, and shipped to BioSpyder for testing. Three independent patient cohorts were used for training/retraining and testing/retesting AD and PD classification algorithms.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">After initially identifying a 770 gene classification signature, a minimum set of 68 genes was identified providing classification test areas under the ROC curve of 0.9 for classifying patients as having AD, and 0.94 for classifying patients as having PD.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">These data demonstrate the potential to develop a screening and/or definitive, minimally invasive, molecular diagnostic test for AD and PD using dried fingerstick blood spot samples that are collected in a doctor's office or clinic, or self-collected, and thus, can address health disparities. Whether the test can classify patients with AD earlier then possible with cognitive testing remains to be determined.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Seligmann</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>BioSpyder Technologies, Inc., Carlsbad, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Camiolo</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>BioSpyder Technologies, Inc., Carlsbad, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hernandez</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>BioSpyder Technologies, Inc., Carlsbad, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yeakley</LastName><ForeName>Joanne M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>BioSpyder Technologies, Inc., Carlsbad, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sahagian</LastName><ForeName>Gregory</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurology Center of Southern California, Carlsbad, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>McComb</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>BioSpyder Technologies, Inc., Carlsbad, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">TempO-seq</Keyword><Keyword MajorTopicYN=\"N\">dementia</Keyword><Keyword MajorTopicYN=\"N\">diagnostic classifier</Keyword><Keyword MajorTopicYN=\"N\">fingerstick blood</Keyword><Keyword MajorTopicYN=\"N\">gene expression signature</Keyword><Keyword MajorTopicYN=\"N\">health disparity</Keyword><Keyword MajorTopicYN=\"N\">self-test</Keyword><Keyword MajorTopicYN=\"N\">whole blood</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269833</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240174</ArticleId><ArticleId IdType=\"pii\">JAD240174</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269832</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Small Vessel Disease Burden Predicts Incident Dementia and Poor Functional Outcome in Independent Outpatients.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-240166</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Total small vessel disease (SVD) score is used to measure the burden of SVD.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">This study aimed to clarify the predictive value of total SVD score for incident dementia and functional outcomes in independent outpatients with vascular risk factors.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">We derived data from a Japanese cohort in which patients underwent magnetic resonance imaging and cognitive examinations. They were followed up until March 2023. The primary outcomes was dementia. Secondary outcome was functional outcomes. We measured a modified Rankin scale (mRS) score at the last visit and defined poor functional outcomes as mRS score &#x2265;3.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">After excluding those with a mRS score &#x2265;2, Mini-Mental State Examination score in Japanese version&#x200a;&lt;&#x200a;24, and missing T2* images, 692 patients were included. During a median follow-up period of 4.6 years, dementia occurred in 31 patients. In multivariate analysis, the score 4 group showed a significantly higher risk of incident dementia than the score 0-3 groups (adjusted hazard ratio, 6.25; 95% CI, 1.83-21.40, p&#x200a;=&#x200a;0.003). The total SVD score was also independently related to poor functional outcome.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">The total SVD score of 4, and &#x2265;1 could predict dementia and poor functional outcomes, respectively. Our results suggest intensive management of patients with SVD to prevent dementia and to maintain independent activities of daily living.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kitagawa</LastName><ForeName>Kazuo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Suita Municipal Hospital, Suita, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Toi</LastName><ForeName>Sono</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Tokyo Women's Medical University, Adachi Medical Center, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hosoya</LastName><ForeName>Megumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Seki</LastName><ForeName>Misa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yamagishi</LastName><ForeName>Sae</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hoshino</LastName><ForeName>Takao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yoshizawa</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">dementia</Keyword><Keyword MajorTopicYN=\"N\">functional outcome</Keyword><Keyword MajorTopicYN=\"N\">small vessel disease score</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269832</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-240166</ArticleId><ArticleId IdType=\"pii\">JAD240166</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269831</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>A Data-Driven Cognitive Composite Sensitive to Amyloid-&#x3b2; for Preclinical Alzheimer's Disease.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-231319</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Integrating scores from multiple cognitive tests into a single cognitive composite has been shown to improve sensitivity to detect AD-related cognitive impairment. However, existing composites have little sensitivity to amyloid-&#x3b2; status (A&#x3b2; +/-) in preclinical AD.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">Evaluate whether a data-driven approach for deriving cognitive composites can improve the sensitivity to detect A&#x3b2; status among cognitively unimpaired (CU) individuals compared to existing cognitive composites.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">Based on the data from the Anti-Amyloid Treatment in the Asymptomatic Alzheimer's Disease (A4) study, a novel composite, the Data-driven Preclinical Alzheimer's Cognitive Composite (D-PACC), was developed based on test scores and response durations selected using a machine learning algorithm from the Cogstate Brief Battery (CBB). The D-PACC was then compared with conventional composites in the follow-up A4 visits and in individuals from the Alzheimer's Disease Neuroimaging Initiative (ADNI).</AbstractText><AbstractText Label=\"RESULT\" NlmCategory=\"UNASSIGNED\">The D-PACC showed a comparable or significantly higher ability to discriminate A&#x3b2; status [median Cohen's d&#x200a;=&#x200a;0.172] than existing composites at the A4 baseline visit, with similar results at the second visit. The D-PACC demonstrated the most consistent sensitivity to A&#x3b2; status in both A4 and ADNI datasets.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"UNASSIGNED\">The D-PACC showed similar or improved sensitivity when screening for A&#x3b2;+ in CU populations compared to existing composites but with higher consistency across studies.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ARC Training Centre in Cognitive Computing for Medical Technologies, University of Melbourne, Carlton, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maruff</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CogState Ltd, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fedyashov</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>ARC Training Centre in Cognitive Computing for Medical Technologies, University of Melbourne, Carlton, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Masters</LastName><ForeName>Colin L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Goudey</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>ARC Training Centre in Cognitive Computing for Medical Technologies, University of Melbourne, Carlton, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">amyloid-&#x3b2; peptides</Keyword><Keyword MajorTopicYN=\"N\">machine learning</Keyword><Keyword MajorTopicYN=\"N\">neuropsychological tests</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269831</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-231319</ArticleId><ArticleId IdType=\"pii\">JAD231319</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269830</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1875-8908</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Moving Towards Ethical-Practical Recommendations for Alzheimer's Disease Prediction: Addressing Interindividual, Interprofessional, and Societal Aspects.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3233/JAD-231137</ELocationID><Abstract><AbstractText>Biomarkers for predicting Alzheimer's disease (AD) are advancing and their implementation in various healthcare systems is imminent. There is a need for ethical standards addressing information needs, socio-ethical concerns, and expectations of healthy and at-risk persons. We present an ethical approach that integrates different existing ethical frameworks and discussion of our empirical, cross-cultural findings in a multi-layered perspective by addressing three levels. The micro-level focuses on the communication between counseling professionals, persons at risk or in an early stage of dementia, and family members. The meso-level addresses interprofessional cooperation and exchange as a key element for best person-centered care. The macro-level considers public health promotion, the media, and public-funded research. This approach allows to address key ethical concepts including beneficence, non-maleficence, autonomy, informational self-determination, empowerment, and justice. Our contribution specifically examines the ethical challenges associated with AD prediction by means of biomarkers, based on insights from a German-Israeli comparison, and promotes a transdisciplinary discussion across different healthcare contexts. We propose a reflection on three levels to go beyond the clinical counseling context and to consider the rapidly evolving field of biomarkers in the coming years. Our ethical-practical recommendations should not be considered final, but rather procedural and will require continuous adaptation regarding culturally varying practices, new algorithms, meta-analyses, and re-evaluation of established recommendations.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Schicktanz</LastName><ForeName>Silke</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Ethics and History of Medicine, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Alpinar-Segawa</LastName><ForeName>Z&#xfc;mr&#xfc;t</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Medical Ethics and History of Medicine, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Ethics, History and Philosophy of Medicine, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ulitsa</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Ethics and History of Medicine, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Mental Health, Faculty of Social Welfare &amp; Health Sciences, University of Haifa, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Perry</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Ethics and History of Medicine, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Werner</LastName><ForeName>Perla</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Community Mental Health, Faculty of Social Welfare &amp; Health Sciences, University of Haifa, Haifa, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">communication</Keyword><Keyword MajorTopicYN=\"N\">counseling</Keyword><Keyword MajorTopicYN=\"N\">cross-cultural comparison</Keyword><Keyword MajorTopicYN=\"N\">dementia</Keyword><Keyword MajorTopicYN=\"N\">ethical recommendations</Keyword><Keyword MajorTopicYN=\"N\">literacy</Keyword><Keyword MajorTopicYN=\"N\">prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269830</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-231137</ArticleId><ArticleId IdType=\"pii\">JAD231137</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269584</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2509-2723</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>Activation of the muscle-to-brain axis ameliorates neurocognitive deficits in an Alzheimer's disease mouse model via enhancing neurotrophic and synaptic signaling.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s11357-024-01345-3</ELocationID><Abstract><AbstractText>Skeletal muscle regulates central nervous system (CNS) function and health, activating the muscle-to-brain axis through the secretion of skeletal muscle-originating factors (\"myokines\") with neuroprotective properties. However, the precise mechanisms underlying these benefits in the context of Alzheimer's disease (AD) remain poorly understood. To investigate muscle-to-brain axis signaling in response to amyloid &#x3b2; (A&#x3b2;)-induced toxicity, we generated 5xFAD transgenic female mice with enhanced skeletal muscle function (5xFAD;cTFEB;HSACre) at prodromal (4-months old) and late (8-months old) symptomatic stages. Skeletal muscle TFEB overexpression reduced A&#x3b2; plaque accumulation in the cortex and hippocampus at both ages and rescued behavioral neurocognitive deficits in 8-month-old 5xFAD mice. These changes were associated with transcriptional and protein remodeling of neurotrophic signaling and synaptic integrity, partially due to the CNS-targeting myokine prosaposin (PSAP). Our findings implicate the muscle-to-brain axis as a novel neuroprotective pathway against amyloid pathogenesis in AD.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Taha</LastName><ForeName>Hash Brown</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, 90007, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Birnbaum</LastName><ForeName>Allison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Matthews</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, 90007, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Aceituno</LastName><ForeName>Karel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, 90007, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Leon</LastName><ForeName>Jocelyne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, 90007, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Thorwald</LastName><ForeName>Max</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, 90007, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Godoy-Lugo</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, 90007, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cortes</LastName><ForeName>Constanza J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, 90007, USA. cjc_149@usc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>R01 912 AG077536 (</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG052374</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG052374</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AARF-21-851362</GrantID><Acronym>ALZ</Acronym><Agency>Alzheimer's Association</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Muscle</Keyword><Keyword MajorTopicYN=\"N\">Muscle-to-brain axis</Keyword><Keyword MajorTopicYN=\"N\">Myokines</Keyword><Keyword MajorTopicYN=\"N\">Plaques</Keyword><Keyword MajorTopicYN=\"N\">Synapse</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269584</ArticleId><ArticleId IdType=\"doi\">10.1007/s11357-024-01345-3</ArticleId><ArticleId IdType=\"pii\">10.1007/s11357-024-01345-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Subramanian J, Savage JC, Tremblay ME. Synaptic loss in Alzheimer&#x2019;s disease: mechanistic insights provided by two-photon in vivo imaging of transgenic mouse models. Front Cell Neurosci. 2020;14:592607.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33408613</ArticleId><ArticleId IdType=\"pmc\">7780885</ArticleId><ArticleId IdType=\"doi\">10.3389/fncel.2020.592607</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindowski K, Belarbi K, Buee L. Neurotrophic factors in Alzheimer&#x2019;s disease: role of axonal transport. Genes Brain Behav. 2008;7(Suppl 1):43&#x2013;56.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18184369</ArticleId><ArticleId IdType=\"doi\">10.1111/j.1601-183X.2007.00378.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L, Zhang Y, Sterling K, Song W. Brain-derived neurotrophic factor in Alzheimer&#x2019;s disease and its pharmaceutical potential. Transl Neurodegener. 2022;11:4.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35090576</ArticleId><ArticleId IdType=\"pmc\">8796548</ArticleId><ArticleId IdType=\"doi\">10.1186/s40035-022-00279-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths J, Grant SGN. Synapse pathology in Alzheimer&#x2019;s disease. Semin Cell Dev Biol. 2023;139:13&#x2013;23.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35690535</ArticleId><ArticleId IdType=\"doi\">10.1016/j.semcdb.2022.05.028</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews I, Birnbaum A, Gromova A, Huang AW, Liu K, Liu EA, et al. Skeletal muscle TFEB signaling promotes central nervous system function and reduces neuroinflammation during aging and neurodegenerative disease. Cell Rep. 2023;42:113436.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37952157</ArticleId><ArticleId IdType=\"pmc\">10841857</ArticleId><ArticleId IdType=\"doi\">10.1016/j.celrep.2023.113436</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, La Spada AR. Motor neuron degeneration in spinal and bulbar muscular atrophy is a skeletal muscle-driven process: relevance to therapy development and implications for related motor neuron diseases. Rare Dis. 2014;2:e962402.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26942099</ArticleId><ArticleId IdType=\"pmc\">4755247</ArticleId><ArticleId IdType=\"doi\">10.4161/2167549X.2014.962402</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, Miranda HC, Frankowski H, Batlevi Y, Young JE, Le A, et al. Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat Neurosci. 2014;17:1180&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25108912</ArticleId><ArticleId IdType=\"pmc\">4180729</ArticleId><ArticleId IdType=\"doi\">10.1038/nn.3787</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, Ling SC, Guo LT, Hung G, Tsunemi T, Ly L, et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron. 2014;82:295&#x2013;307.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24742458</ArticleId><ArticleId IdType=\"pmc\">4096235</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neuron.2014.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai M, Demontis F. Muscle-to-brain signaling via myokines and myometabolites. Brain Plast. 2022;8:43&#x2013;63.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36448045</ArticleId><ArticleId IdType=\"pmc\">9661353</ArticleId><ArticleId IdType=\"doi\">10.3233/BPL-210133</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow LS, Gerszten RE, Taylor JM, Pedersen BK, van Praag H, Trappe S, et al. Exerkines in health, resilience and disease. Nat Rev Endocrinol. 2022;18:273&#x2013;89.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35304603</ArticleId><ArticleId IdType=\"pmc\">9554896</ArticleId><ArticleId IdType=\"doi\">10.1038/s41574-022-00641-2</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Kaya I, Shariatgorji R, Lundkvist J, Wahlberg LU, Nilsson A, et al. Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents. Nat Commun. 2023;14:5804.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37726325</ArticleId><ArticleId IdType=\"pmc\">10509278</ArticleId><ArticleId IdType=\"doi\">10.1038/s41467-023-41539-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E, Kim H, Jedrychowski MP, Bakiasi G, Park J, Kruskop J, et al. Irisin reduces amyloid-beta by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling. Neuron. 2023;111(3619&#x2013;33):e8.</Citation></Reference><Reference><Citation>Kam TI, Park H, Chou SC, Van Vranken JG, Mittenbuhler MJ, Kim H, et al. Amelioration of pathologic alpha-synuclein-induced Parkinson&#x2019;s disease by irisin. Proc Natl Acad Sci U S A. 2022;119:e2204835119.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36044549</ArticleId><ArticleId IdType=\"pmc\">9457183</ArticleId><ArticleId IdType=\"doi\">10.1073/pnas.2204835119</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R, Khan R, Cortes CJ. Forgot to exercise? Exercise derived circulating myokines in Alzheimer&#x2019;s disease: a perspective. Front Neurol. 2021;12:649452.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34276532</ArticleId><ArticleId IdType=\"pmc\">8278015</ArticleId><ArticleId IdType=\"doi\">10.3389/fneur.2021.649452</ArticleId></ArticleIdList></Reference><Reference><Citation>de Laat B, Hoye J, Stanley G, Hespeler M, Ligi J, Mohan V, et al. Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson&#x2019;s disease. NPJ Parkinsons Dis. 2024;10:34.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38336768</ArticleId><ArticleId IdType=\"pmc\">10858031</ArticleId><ArticleId IdType=\"doi\">10.1038/s41531-024-00641-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen A, Pike CJ. Staining and quantification of beta-amyloid pathology in transgenic mouse models of Alzheimer&#x2019;s disease. Methods Mol Biol. 2020;2144:211&#x2013;21.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32410038</ArticleId><ArticleId IdType=\"pmc\">7299244</ArticleId><ArticleId IdType=\"doi\">10.1007/978-1-0716-0592-9_19</ArticleId></ArticleIdList></Reference><Reference><Citation>Deacon RM. Assessing nest building in mice. Nat Protoc. 2006;1:1117&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17406392</ArticleId><ArticleId IdType=\"doi\">10.1038/nprot.2006.170</ArticleId></ArticleIdList></Reference><Reference><Citation>Team RC. A language and environment for statistical computing. R Foundation for Statistical Computing. 2023</Citation></Reference><Reference><Citation>Rajkumar S, Bockers TM, Catanese A. Fast and efficient synaptosome isolation and post-synaptic density enrichment from hiPSC-motor neurons by biochemical sub-cellular fractionation. STAR Protoc. 2023;4:102061.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36853677</ArticleId><ArticleId IdType=\"pmc\">9898788</ArticleId><ArticleId IdType=\"doi\">10.1016/j.xpro.2023.102061</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorwald MA, Silva J, Head E, Finch CE. Amyloid futures in the expanding pathology of brain aging and dementia. Alzheimers Dement. 2023;19:2605&#x2013;17.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36536382</ArticleId><ArticleId IdType=\"doi\">10.1002/alz.12896</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer&#x2019;s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129&#x2013;40.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17021169</ArticleId><ArticleId IdType=\"pmc\">6674618</ArticleId><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1202-06.2006</ArticleId></ArticleIdList></Reference><Reference><Citation>Oblak AL, Lin PB, Kotredes KP, Pandey RS, Garceau D, Williams HM, et al. Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study. Front Aging Neurosci. 2021;13:713726.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34366832</ArticleId><ArticleId IdType=\"pmc\">8346252</ArticleId><ArticleId IdType=\"doi\">10.3389/fnagi.2021.713726</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Sidhu J, Goyal A, Tsao JW. Alzheimer disease. StatPearls. Treasure Island (FL)2024</Citation></Reference><Reference><Citation>Forner S, Kawauchi S, Balderrama-Gutierrez G, Kramar EA, Matheos DP, Phan J, et al. Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer&#x2019;s disease. Sci Data. 2021;8:270.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34654824</ArticleId><ArticleId IdType=\"pmc\">8519958</ArticleId><ArticleId IdType=\"doi\">10.1038/s41597-021-01054-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadleir KR, Eimer WA, Cole SL, Vassar R. Abeta reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level. Mol Neurodegener. 2015;10:1.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25567526</ArticleId><ArticleId IdType=\"pmc\">4297413</ArticleId><ArticleId IdType=\"doi\">10.1186/1750-1326-10-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominko K, Rastija A, Smiljanic K, Mladenovic A, Lesnjakovic L, Kanazir S, et al. Amyloid-ss plaque formation and BACE1 accumulation in the brains of a 5xFAD Alzheimer&#x2019;s disease mouse model is associated with altered distribution and not proteolysis of BACE1 substrates Sez6 and Sez6L. Mech Ageing Dev. 2022;207:111726.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35998821</ArticleId><ArticleId IdType=\"doi\">10.1016/j.mad.2022.111726</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Das B, Hou H, He W, Yan R. BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions. J Exp Med. 2018;215:927&#x2013;40.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29444819</ArticleId><ArticleId IdType=\"pmc\">5839766</ArticleId><ArticleId IdType=\"doi\">10.1084/jem.20171831</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadleir KR, Popovic J, Vassar R. ER stress is not elevated in the 5XFAD mouse model of Alzheimer&#x2019;s disease. J Biol Chem. 2018;293:18434&#x2013;43.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30315100</ArticleId><ArticleId IdType=\"pmc\">6290164</ArticleId><ArticleId IdType=\"doi\">10.1074/jbc.RA118.005769</ArticleId></ArticleIdList></Reference><Reference><Citation>Macyczko JR, Wang N, Lu W, Jeevaratnam S, Shue F, Martens Y, et al. Upregulation of sFRP1 is more profound in female than male 5xFAD mice and positively associated with amyloid pathology. J Alzheimers Dis. 2023;95:399&#x2013;405.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37545238</ArticleId><ArticleId IdType=\"pmc\">10709798</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-230218</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangasamy SB, Jana M, Dasarathi S, Kundu M, Pahan K. Treadmill workout activates PPARalpha in the hippocampus to upregulate ADAM10, decrease plaques and improve cognitive functions in 5XFAD mouse model of Alzheimer&#x2019;s disease. Brain Behav Immun. 2023;109:204&#x2013;18.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36682514</ArticleId><ArticleId IdType=\"pmc\">10023420</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bbi.2023.01.009</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Leary TP, Mantolino HM, Stover KR, Brown RE. Age-related deterioration of motor function in male and female 5xFAD mice from 3 to 16 months of age. Genes Brain Behav. 2020;19:e12538.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30426678</ArticleId><ArticleId IdType=\"doi\">10.1111/gbb.12538</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron WH, Fertan E, Pelletier S, Roddick KM, O&#x2019;Leary TP, Anini Y, et al. Age related weight loss in female 5xFAD mice from 3 to 12 months of age. Behav Brain Res. 2021;406:113214.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33677013</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bbr.2021.113214</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansueto G, Armani A, Viscomi C, D&#x2019;Orsi L, De Cegli R, Polishchuk EV, et al. Transcription factor EB controls metabolic flexibility during exercise. Cell Metab. 2017;25:182&#x2013;96.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28011087</ArticleId><ArticleId IdType=\"pmc\">5241227</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cmet.2016.11.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Keszycki R, Rodriguez G, Dunn JT, Locci A, Orellana H, Haupfear I, et al. Characterization of apathy-like behaviors in the 5xFAD mouse model of Alzheimer&#x2019;s disease. Neurobiol Aging. 2023;126:113&#x2013;22.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36989547</ArticleId><ArticleId IdType=\"pmc\">10106415</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2023.02.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez CQ, Schmitt FW, Curdt N, Westhoff AC, Banfer IWH, Bayer TA, et al. Search strategy analysis of 5xFAD Alzheimer mice in the Morris water maze reveals sex- and age-specific spatial navigation deficits. Biomedicines. 2023;11.</Citation></Reference><Reference><Citation>Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157&#x2013;72.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33318676</ArticleId><ArticleId IdType=\"doi\">10.1038/s41582-020-00435-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardestani PM, Evans AK, Yi B, Nguyen T, Coutellier L, Shamloo M. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer&#x2019;s disease using a biased and selective beta-1 adrenergic receptor partial agonist. Neuropharmacology. 2017;116:371&#x2013;86.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28089846</ArticleId><ArticleId IdType=\"pmc\">5385159</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neuropharm.2017.01.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasel P, Aisenberg WH, Bennett FC, Liddelow SA. Molecular and metabolic heterogeneity of astrocytes and microglia. Cell Metab. 2023;35:555&#x2013;70.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36958329</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cmet.2023.03.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen M, Carrasquillo MM, Funk C, Heavner BD, Zou F, Younkin CS, et al. Human whole genome genotype and transcriptome data for Alzheimer&#x2019;s and other neurodegenerative diseases. Sci Data. 2016;3:160089.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27727239</ArticleId><ArticleId IdType=\"pmc\">5058336</ArticleId><ArticleId IdType=\"doi\">10.1038/sdata.2016.89</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Beckmann ND, Roussos P, Wang E, Zhou X, Wang Q, et al. The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer&#x2019;s disease. Sci Data. 2018;5:180185.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30204156</ArticleId><ArticleId IdType=\"pmc\">6132187</ArticleId><ArticleId IdType=\"doi\">10.1038/sdata.2018.185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan YW, Al-Ouran R, Mangleburg CG, Perumal TM, Lee TV, Allison K, et al. Meta-analysis of the Alzheimer&#x2019;s disease human brain transcriptome and functional dissection in mouse models. Cell Rep. 2020;32:107908.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32668255</ArticleId><ArticleId IdType=\"pmc\">7428328</ArticleId><ArticleId IdType=\"doi\">10.1016/j.celrep.2020.107908</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Song F, Ma ZL, Xiong Q, Wang J, Guo D, et al. Bivalent copper ions promote fibrillar aggregation of KCTD1 and induce cytotoxicity. Sci Rep. 2016;6:32658.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27596723</ArticleId><ArticleId IdType=\"pmc\">5011690</ArticleId><ArticleId IdType=\"doi\">10.1038/srep32658</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Xie Y, Wang X, Abboud MI, Ma C, Ge W, et al. Exploring links between 2-oxoglutarate-dependent oxygenases and Alzheimer&#x2019;s disease. Alzheimers Dement. 2022;18:2637&#x2013;68.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35852137</ArticleId><ArticleId IdType=\"doi\">10.1002/alz.12733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito-Ishida A, Miura E, Emi K, Matsuda K, Iijima T, Kondo T, et al. Cbln1 regulates rapid formation and maintenance of excitatory synapses in mature cerebellar Purkinje cells in vitro and in vivo. J Neurosci. 2008;28:5920&#x2013;30.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18524896</ArticleId><ArticleId IdType=\"pmc\">6670322</ArticleId><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1030-08.2008</ArticleId></ArticleIdList></Reference><Reference><Citation>Landel V, Baranger K, Virard I, Loriod B, Khrestchatisky M, Rivera S, et al. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer&#x2019;s disease. Mol Neurodegener. 2014;9:33.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25213090</ArticleId><ArticleId IdType=\"pmc\">4237952</ArticleId><ArticleId IdType=\"doi\">10.1186/1750-1326-9-33</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin F. Lipid metabolism and Alzheimer&#x2019;s disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J. 2023;290:1420&#x2013;53.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34997690</ArticleId><ArticleId IdType=\"doi\">10.1111/febs.16344</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinan-Ferre C, Izquierdo V, Otero E, Puigoriol-Illamola D, Corpas R, Sanfeliu C, et al. Environmental enrichment improves cognitive deficits, AD hallmarks and epigenetic alterations presented in 5xFAD mouse model. Front Cell Neurosci. 2018;12:224.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30158856</ArticleId><ArticleId IdType=\"pmc\">6104164</ArticleId><ArticleId IdType=\"doi\">10.3389/fncel.2018.00224</ArticleId></ArticleIdList></Reference><Reference><Citation>de Pins B, Cifuentes-Diaz C, Farah AT, Lopez-Molina L, Montalban E, Sancho-Balsells A, et al. Conditional BDNF delivery from astrocytes rescues memory deficits, spine density, and synaptic properties in the 5xFAD mouse model of Alzheimer disease. J Neurosci. 2019;39:2441&#x2013;58.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30700530</ArticleId><ArticleId IdType=\"pmc\">6435824</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragkouli A, Tsilibary EC, Tzinia AK. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer&#x2019;s 5xFAD mice. Neurobiol Dis. 2014;70:179&#x2013;89.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25008761</ArticleId><ArticleId IdType=\"doi\">10.1016/j.nbd.2014.06.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Devi L, Ohno M. TrkB reduction exacerbates Alzheimer&#x2019;s disease-like signaling aberrations and memory deficits without affecting beta-amyloidosis in 5XFAD mice. Transl Psychiatry. 2015;5:e562.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25942043</ArticleId><ArticleId IdType=\"pmc\">4471286</ArticleId><ArticleId IdType=\"doi\">10.1038/tp.2015.55</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochiai T, Takenaka Y, Kuramoto Y, Kasuya M, Fukuda K, Kimura M, et al. Molecular mechanism for neuro-protective effect of prosaposin against oxidative stress: its regulation of dimeric transcription factor formation. Biochim Biophys Acta. 2008;1780:1441&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18706485</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bbagen.2008.07.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer RC, Giddens MM, Coleman BM, Hall RA. The protective role of prosaposin and its receptors in the nervous system. Brain Res. 2014;1585:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25130661</ArticleId><ArticleId IdType=\"pmc\">4529117</ArticleId><ArticleId IdType=\"doi\">10.1016/j.brainres.2014.08.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotani Y, Matsuda S, Sakanaka M, Kondoh K, Ueno S, Sano A. Prosaposin facilitates sciatic nerve regeneration in vivo. J Neurochem. 1996;66:2019&#x2013;25.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8780031</ArticleId><ArticleId IdType=\"doi\">10.1046/j.1471-4159.1996.66052019.x</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien JS, Carson GS, Seo HC, Hiraiwa M, Kishimoto Y. Identification of prosaposin as a neurotrophic factor. Proc Natl Acad Sci U S A. 1994;91:9593&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7937812</ArticleId><ArticleId IdType=\"pmc\">44859</ArticleId><ArticleId IdType=\"doi\">10.1073/pnas.91.20.9593</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita F, Wen TC, Tanaka J, Hata R, Desaki J, Sato K, et al. Protective effect of a prosaposin-derived, 18-mer peptide on slowly progressive neuronal degeneration after brief ischemia. J Cereb Blood Flow Metab. 2001;21:1295&#x2013;302.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11702044</ArticleId><ArticleId IdType=\"doi\">10.1097/00004647-200111000-00005</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao HL, Li C, Nabeka H, Shimokawa T, Saito S, Wang ZY, et al. Attenuation of MPTP/MPP(+) toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin. Neuroscience. 2013;236:373&#x2013;93.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23321539</ArticleId><ArticleId IdType=\"doi\">10.1016/j.neuroscience.2013.01.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu KJ, Hung TW, Wang YS, Chen YH, Bae EK, Yu SJ. Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson&#x2019;s disease. Sci Rep. 2023;13:8148.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37208379</ArticleId><ArticleId IdType=\"pmc\">10199088</ArticleId><ArticleId IdType=\"doi\">10.1038/s41598-023-35274-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittenbuhler MJ, Jedrychowski MP, Van Vranken JG, Sprenger HG, Wilensky S, Dumesic PA, et al. Isolation of extracellular fluids reveals novel secreted bioactive proteins from muscle and fat tissues. Cell Metab. 2023;35(535&#x2013;49):e7.</Citation></Reference><Reference><Citation>MoTr PACSG, Lead A, MoTr PACSG. Temporal dynamics of the multi-omic response to endurance exercise training. Nature. 2024;629:174&#x2013;83.</Citation></Reference><Reference><Citation>Schroer AB, Ventura PB, Sucharov J, Misra R, Chui MKK, Bieri G, et al. Platelet factors attenuate inflammation and rescue cognition in ageing. Nature. 2023;620:1071&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37587343</ArticleId><ArticleId IdType=\"pmc\">10468395</ArticleId><ArticleId IdType=\"doi\">10.1038/s41586-023-06436-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiter O, Brici D, Fletcher SJ, Yong XLH, Widagdo J, Matigian N, et al. Platelet-derived exerkine CXCL4/platelet factor 4 rejuvenates hippocampal neurogenesis and restores cognitive function in aged mice. Nat Commun. 2023;14:4375.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37587147</ArticleId><ArticleId IdType=\"pmc\">10432533</ArticleId><ArticleId IdType=\"doi\">10.1038/s41467-023-39873-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeda SA, Plambeck KE, Middeldorp J, Castellano JM, Mosher KI, Luo J, et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med. 2014;20:659&#x2013;63.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24793238</ArticleId><ArticleId IdType=\"pmc\">4224436</ArticleId><ArticleId IdType=\"doi\">10.1038/nm.3569</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D, et al. Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway. Cell Metab. 2013;18:649&#x2013;59.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24120943</ArticleId><ArticleId IdType=\"pmc\">3980968</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cmet.2013.09.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao HL, Li C, Nabeka H, Shimokawa T, Wang ZY, Cao YM, et al. An 18-mer peptide derived from prosaposin ameliorates the effects of Abeta1-42 neurotoxicity on hippocampal neurogenesis and memory deficit in mice. J Alzheimers Dis. 2016;53:1173&#x2013;92.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27372641</ArticleId><ArticleId IdType=\"doi\">10.3233/JAD-160093</ArticleId></ArticleIdList></Reference><Reference><Citation>van Praag H, Wrann CD. Special issue: peripheral factors and neural plasticity. Brain Plast. 2022;8:1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36448037</ArticleId><ArticleId IdType=\"pmc\">9661356</ArticleId><ArticleId IdType=\"doi\">10.3233/BPL-229001</ArticleId></ArticleIdList></Reference><Reference><Citation>Demontis F, Perrimon N. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell. 2010;143:813&#x2013;25.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21111239</ArticleId><ArticleId IdType=\"pmc\">3066043</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2010.10.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai M, Demontis F. Systemic nutrient and stress signaling via myokines and myometabolites. Annu Rev Physiol. 2016;78:85&#x2013;107.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26527185</ArticleId><ArticleId IdType=\"doi\">10.1146/annurev-physiol-021115-105305</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C, Hahn O, Gupta S, Moreno AJ, Marino F, Kedir B, et al. Platelet factors are induced by longevity factor klotho and enhance cognition in young and aging mice. Nat Aging. 2023;3:1067&#x2013;78.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37587231</ArticleId><ArticleId IdType=\"pmc\">10501899</ArticleId><ArticleId IdType=\"doi\">10.1038/s43587-023-00468-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz AM, Fan X, Bieri G, Smith LK, Sanchez-Diaz CI, Schroer AB, et al. Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain. Science. 2020;369:167&#x2013;73.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32646997</ArticleId><ArticleId IdType=\"pmc\">7879650</ArticleId><ArticleId IdType=\"doi\">10.1126/science.aaw2622</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews I, Taha HB, Cortes CJ. Prosaposin: a potential novel exerkine and therapeutic for neurodegenerative disease. Submitted for publication. 2024.</Citation></Reference><Reference><Citation>Taylor EM, Otero DA, Banks WA, O&#x2019;Brien JS. Retro-inverso prosaptide peptides retain bioactivity, are stable in vivo, and are blood-brain barrier permeable. J Pharmacol Exp Ther. 2000;295:190&#x2013;4.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10991978</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor EM, Otero DA, Banks WA, O&#x2019;Brien JS. Designing stable blood-brain barrier-permeable prosaptide peptides for treatment of central nervous system neurodegeneration. J Pharmacol Exp Ther. 2000;293:403&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10773009</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MR, Valaris S, Young MF, Haley EB, Luo R, Bond SF, et al. Exercise hormone irisin is a critical regulator of cognitive function. Nat Metab. 2021;3:1058&#x2013;70.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34417591</ArticleId><ArticleId IdType=\"pmc\">10317538</ArticleId><ArticleId IdType=\"doi\">10.1038/s42255-021-00438-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon HY, Becke A, Berron D, Becker B, Sah N, Benoni G, et al. Running-induced systemic cathepsin B secretion is associated with memory function. Cell Metab. 2016;24:332&#x2013;40.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27345423</ArticleId><ArticleId IdType=\"pmc\">6029441</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cmet.2016.05.025</ArticleId></ArticleIdList></Reference><Reference><Citation>De Miguel Z, Khoury N, Betley MJ, Lehallier B, Willoughby D, Olsson N, et al. Exercise plasma boosts memory and dampens brain inflammation via clusterin. Nature. 2021;600:494&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34880498</ArticleId><ArticleId IdType=\"pmc\">9721468</ArticleId><ArticleId IdType=\"doi\">10.1038/s41586-021-04183-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, De Miguel Z. Precision exercise medicine: sex specific differences in immune and CNS responses to physical activity. Brain Plast. 2022;8:65&#x2013;77.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36448044</ArticleId><ArticleId IdType=\"pmc\">9661359</ArticleId><ArticleId IdType=\"doi\">10.3233/BPL-220139</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitham M, Parker BL, Friedrichsen M, Hingst JR, Hjorth M, Hughes WE, et al. Extracellular vesicles provide a means for tissue crosstalk during exercise. Cell Metab. 2018;27(237&#x2013;51):e4.</Citation></Reference><Reference><Citation>Severinsen MCK, Pedersen BK. Muscle-organ crosstalk: the emerging roles of myokines. Endocr Rev. 2020;41:594&#x2013;609.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32393961</ArticleId><ArticleId IdType=\"pmc\">7288608</ArticleId><ArticleId IdType=\"doi\">10.1210/endrev/bnaa016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuller OK, Whitham M, Mathivanan S, Febbraio MA. The protective effect of exercise in neurodegenerative diseases: the potential role of extracellular vesicles. Cells. 2020;9.</Citation></Reference><Reference><Citation>Taha HB, Bogoniewski A. Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis. J Neurol. 2024;271:1680&#x2013;706.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38103086</ArticleId><ArticleId IdType=\"doi\">10.1007/s00415-023-12093-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AF. Extracellular vesicles and neurodegenerative diseases. J Neurosci. 2019;39:9269&#x2013;73.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31748282</ArticleId><ArticleId IdType=\"pmc\">6867808</ArticleId><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.0147-18.2019</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha HB. Extracellular vesicles for Alzheimer&#x2019;s disease and dementia diagnosis. medRxiv. 2024.</Citation></Reference><Reference><Citation>Taha HB, Bogoniewski A. Extracellular vesicles from bodily fluids for the accurate diagnosis of Parkinson&#x2019;s disease and related disorders: a systematic review and diagnostic meta-analysis. Journal of Extracellular Biology. 2023;2:e121.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38939363</ArticleId><ArticleId IdType=\"pmc\">11080888</ArticleId><ArticleId IdType=\"doi\">10.1002/jex2.121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez AR, Hoffman JM, Hernandez CM, Cortes CJ, Jumbo-Lucioni P, Baxter MG, et al. Reuniting the body &#x201c;neck up and neck down&#x201d; to understand cognitive aging: the nexus of geroscience and neuroscience. J Gerontol A Biol Sci Med Sci. 2022;77:e1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34309630</ArticleId><ArticleId IdType=\"doi\">10.1093/gerona/glab215</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269583</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2509-2723</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>Comprehensive analysis of molecular, physiological, and functional biomarkers of aging with neurological diseases using Mendelian randomization.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s11357-024-01334-6</ELocationID><Abstract><AbstractText>An increasing burden of neurological diseases (NDs) has been a public health challenge in an aging society. Age, especially biological age, is the most important risk factor for NDs. Identification of biomarkers of aging to capture NDs might lead to a better understanding of the underlying mechanisms of pathological brain aging and the implementation of effective intervention. We conducted a comprehensive two-sample Mendelian Randomization (MR) study to investigate the association between various biomarkers of aging and three leading causes of NDs: Alzheimer's disease (AD), vascular dementia (VaD), and ischemic stroke. Publicly available GWAS summary statistics on people from European ancestry were obtained for six molecular biomarkers, two physiological biomarkers, and eight functional biomarkers, and three NDs. Genetic variants serving as instrumental variables (IVs) were identified for each biomarker. The MR analysis included inverse variance weighted (IVW), weighted median, MR-Egger, and MR-PRESSO. We found that short telomere length and decrease in appendicular lean mass were associated with an increased risk for AD (OR IVW&#x2009;=&#x2009;1.12 per 1SD decrease, 95% confidence interval 1.02-1.22, and OR IVW&#x2009;=&#x2009;1.11, 1.06-1.16, respectively), whereas high frailty index showed a protective effect for AD. Accelerated BioAge appeared to be associated with increased risk for ischemic stroke (OR IVW&#x2009;=&#x2009;1.3 per year in BioAge acceleration, 95% CI 1.19-1.41). Our findings implied a causal association of short telomere length and a decrease in appendicular lean mass with an increased risk for AD, while BioAge appeared to be a good biomarker for ischemic stroke. Further studies are needed to validate these associations and explore underlying mechanisms.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Imahori</LastName><ForeName>Yume</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qin</LastName><ForeName>Chenxi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tang</LastName><ForeName>Bowen</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>H&#xe4;gg</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0002-2452-1500</Identifier><AffiliationInfo><Affiliation>The Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. sara.hagg@ki.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>2022-01608</GrantID><Agency>Vetenskapsr&#xe5;det</Agency><Country/></Grant><Grant><GrantID>R01AG067996</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Biological age</Keyword><Keyword MajorTopicYN=\"N\">Dementia</Keyword><Keyword MajorTopicYN=\"N\">Mendelian randomization</Keyword><Keyword MajorTopicYN=\"N\">Neurological disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269583</ArticleId><ArticleId IdType=\"doi\">10.1007/s11357-024-01334-6</ArticleId><ArticleId IdType=\"pii\">10.1007/s11357-024-01334-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garmany A, Yamada S, Terzic A. Longevity leap: mind the healthspan gap. NPJ Regen Med. 2021;6(1):57.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34556664</ArticleId><ArticleId IdType=\"pmc\">8460831</ArticleId><ArticleId IdType=\"doi\">10.1038/s41536-021-00169-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Lau S, Meijer E, Hu P. Living longer, with or without disability? A global and longitudinal perspective. J Gerontol Ser A. 2020;75(1):162&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gerona/glz007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565&#x2013;81.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31501588</ArticleId><ArticleId IdType=\"doi\">10.1038/s41582-019-0244-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccoli T, Partridge L. Ageing as a risk factor for disease. Curr Biol. 2012;22(17):R741&#x2013;52.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22975005</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cub.2012.07.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Moqri M, Herzog C, Poganik JR, Justice J, Belsky DW, Higgins-Chen A, et al. Biomarkers of aging for the identification and evaluation of longevity interventions. Cell. 2023;186(18):3758&#x2013;75.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37657418</ArticleId><ArticleId IdType=\"pmc\">11088934</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2023.08.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Jylh&#xe4;v&#xe4; J, Pedersen NL, H&#xe4;gg S. Biological age predictors. EBioMedicine. 2017;21:29&#x2013;36.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28396265</ArticleId><ArticleId IdType=\"pmc\">5514388</ArticleId><ArticleId IdType=\"doi\">10.1016/j.ebiom.2017.03.046</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Ot&#xed;n C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243&#x2013;78.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36599349</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2022.11.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Deuschl G, Beghi E, Fazekas F, Varga T, Christoforidi KA, Sipido E, et al. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017. Lancet Public Health. 2020;5(10):e551&#x2013;67.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33007212</ArticleId><ArticleId IdType=\"doi\">10.1016/S2468-2667(20)30190-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson DM, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693&#x2013;714.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36803602</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2022.12.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, et al. Mitophagy inhibits amyloid-&#x3b2; and tau pathology and reverses cognitive deficits in models of Alzheimer&#x2019;s disease. Nat Neurosci. 2019;22(3):401&#x2013;12.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30742114</ArticleId><ArticleId IdType=\"pmc\">6693625</ArticleId><ArticleId IdType=\"doi\">10.1038/s41593-018-0332-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Norat P, Soldozy S, Sokolowski JD, Gorick CM, Kumar JS, Chae Y, et al. Mitochondrial dysfunction in neurological disorders: exploring mitochondrial transplantation. NPJ Regen Med. 2020;5(1):22.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33298971</ArticleId><ArticleId IdType=\"pmc\">7683736</ArticleId><ArticleId IdType=\"doi\">10.1038/s41536-020-00107-x</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurran CE, Wang Y, Mak JKL, Karlsson IK, Tang B, Ploner A, et al. Advanced biological ageing predicts future risk for neurological diagnoses and clinical examination findings. Brain. 2023;146(12):4891&#x2013;902.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37490842</ArticleId><ArticleId IdType=\"pmc\">10690013</ArticleId><ArticleId IdType=\"doi\">10.1093/brain/awad252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak JKL, McMurran CE, H&#xe4;gg S. Clinical biomarker-based biological ageing and future risk of neurological disorders in the UK Biobank. J Neurol Neurosurg Psychiatry. 2024;95(5):481&#x2013;4. https://doi.org/10.1136/jnnp-2023-331917 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/jnnp-2023-331917</ArticleId><ArticleId IdType=\"pubmed\">37926442</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugden K, Caspi A, Elliott ML, Bourassa KJ, Chamarti K, Corcoran DL, et al. Association of pace of aging measured by blood-based DNA methylation with age-related cognitive impairment and dementia. Neurology. 2022;99(13):e1402&#x2013;13.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35794023</ArticleId><ArticleId IdType=\"pmc\">9576288</ArticleId><ArticleId IdType=\"doi\">10.1212/WNL.0000000000200898</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou A, Wu Z, Zaw Phyo AZ, Torres D, Vishwanath S, Ryan J. Epigenetic aging as a biomarker of dementia and related outcomes: a systematic review. Epigenomics. 2022;14(18):1125&#x2013;38.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36154448</ArticleId><ArticleId IdType=\"doi\">10.2217/epi-2022-0209</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GD, Ebrahim S. &#x2018;Mendelian randomization&#x2019;: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12689998</ArticleId><ArticleId IdType=\"doi\">10.1093/ije/dyg070</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021;375:n2233.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34702754</ArticleId><ArticleId IdType=\"pmc\">8546498</ArticleId><ArticleId IdType=\"doi\">10.1136/bmj.n2233</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30002074</ArticleId><ArticleId IdType=\"pmc\">6041728</ArticleId><ArticleId IdType=\"doi\">10.1136/bmj.k601</ArticleId></ArticleIdList></Reference><Reference><Citation>Codd V, Wang Q, Allara E, Musicha C, Kaptoge S, Stoma S, et al. Polygenic basis and biomedical consequences of telomere length variation. Nat Genet. 2021;53(10):1425&#x2013;33.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34611362</ArticleId><ArticleId IdType=\"pmc\">8492471</ArticleId><ArticleId IdType=\"doi\">10.1038/s41588-021-00944-6</ArticleId></ArticleIdList></Reference><Reference><Citation>McCartney DL, Min JL, Richmond RC, Lu AT, Sobczyk MK, Davies G, et al. Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging. Genome Biol. 2021;22:1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13059-021-02398-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Longchamps RJ, Yang SY, Castellani CA, Shi W, Lane J, Grove ML, et al. Genome-wide analysis of mitochondrial DNA copy number reveals loci implicated in nucleotide metabolism, platelet activation, and megakaryocyte proliferation. Hum Genet. 2022;141(1):127&#x2013;46.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34859289</ArticleId><ArticleId IdType=\"doi\">10.1007/s00439-021-02394-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo CL, Pilling LC, Liu Z, Atkins JL, Levine ME. Genetic associations for two biological age measures point to distinct aging phenotypes. Aging Cell. 2021;20(6):e13376.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34038024</ArticleId><ArticleId IdType=\"pmc\">8208797</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.13376</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei Y-F, Liu Y-Z, Yang X-L, Zhang H, Feng G-J, Wei X-T, et al. The genetic architecture of appendicular lean mass characterized by association analysis in the UK Biobank study. Communications biology. 2020;3(1):608.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33097823</ArticleId><ArticleId IdType=\"pmc\">7585446</ArticleId><ArticleId IdType=\"doi\">10.1038/s42003-020-01334-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Higbee DH, Granell R, Smith GD, Dodd JW. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis. Lancet Respir Med. 2022;10(2):149&#x2013;57.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34739861</ArticleId><ArticleId IdType=\"doi\">10.1016/S2213-2600(21)00369-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahadi S, Wilson KA, Babenko B, McLean CY, Bryant D, Pritchard O, et al. Longitudinal fundus imaging and its genome-wide association analysis provide evidence for a human retinal aging clock. Elife. 2023;12. https://doi.org/10.7554/eLife.82364</Citation></Reference><Reference><Citation>Lee JJ, Wedow R, Okbay A, Kong E, Maghzian O, Zacher M, et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet. 2018;50(8):1112&#x2013;21.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30038396</ArticleId><ArticleId IdType=\"pmc\">6393768</ArticleId><ArticleId IdType=\"doi\">10.1038/s41588-018-0147-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardsen EH, Vidal-Pi&#xf1;eiro D, Roe JM, Frei O, Shadrin AA, Iakunchykova O, et al. Genetic architecture of brain age and its causal relations with brain and mental disorders. Mol Psychiatry. 2023;28(7):3111&#x2013;20.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37165155</ArticleId><ArticleId IdType=\"pmc\">10615751</ArticleId><ArticleId IdType=\"doi\">10.1038/s41380-023-02087-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins JL, Jylh&#xe4;v&#xe4; J, Pedersen NL, Magnusson PK, Lu Y, Wang Y, et al. A genome-wide association study of the frailty index highlights brain pathways in ageing. Aging Cell. 2021;20(9):e13459.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34431594</ArticleId><ArticleId IdType=\"pmc\">8441299</ArticleId><ArticleId IdType=\"doi\">10.1111/acel.13459</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmers PR, Mounier N, Lall K, Fischer K, Ning Z, Feng X, et al. Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances. Elife. 2019;8:e39856.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30642433</ArticleId><ArticleId IdType=\"pmc\">6333444</ArticleId><ArticleId IdType=\"doi\">10.7554/eLife.39856</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C, K&#xfc;&#xe7;&#xfc;kali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat Genet. 2022;54(4):412&#x2013;36.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35379992</ArticleId><ArticleId IdType=\"pmc\">9005347</ArticleId><ArticleId IdType=\"doi\">10.1038/s41588-022-01024-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsworth B, Lyon M, Alexander T, Liu Y, Matthews P, Hallett J, et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv. 2020. https://doi.org/10.1101/2020.08.10.244293 .</Citation></Reference><Reference><Citation>Kurki MI, Karjalainen J, Palta P, Sipil&#xe4; TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508&#x2013;18.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36653562</ArticleId><ArticleId IdType=\"pmc\">9849126</ArticleId><ArticleId IdType=\"doi\">10.1038/s41586-022-05473-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524&#x2013;37.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29531354</ArticleId><ArticleId IdType=\"pmc\">5968830</ArticleId><ArticleId IdType=\"doi\">10.1038/s41588-018-0058-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49(2):359&#x2013;67.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23177740</ArticleId><ArticleId IdType=\"doi\">10.1016/j.molcel.2012.10.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19(6):371&#x2013;84.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29643443</ArticleId><ArticleId IdType=\"doi\">10.1038/s41576-018-0004-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (albany NY). 2018;10(4):573.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29676998</ArticleId><ArticleId IdType=\"doi\">10.18632/aging.101414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu AT, Quach A, Wilson JG, Reiner AP, Aviv A, Raj K, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (albany NY). 2019;11(2):303.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30669119</ArticleId><ArticleId IdType=\"doi\">10.18632/aging.101684</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine ME. Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age? J Gerontol Ser A Biomed Sci Med Sci. 2013;68(6):667&#x2013;74.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gerona/gls233</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteban-Cornejo I, Ho FK, Petermann-Rocha F, Lyall DM, Martinez-Gomez D, Cabanas-S&#xe1;nchez V, et al. Handgrip strength and all-cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study. J Cachexia Sarcopenia Muscle. 2022;13(3):1514&#x2013;25.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35445560</ArticleId><ArticleId IdType=\"pmc\">9178163</ArticleId><ArticleId IdType=\"doi\">10.1002/jcsm.12857</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70&#x2013;88.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31613151</ArticleId><ArticleId IdType=\"pmc\">6794117</ArticleId><ArticleId IdType=\"doi\">10.1164/rccm.201908-1590ST</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson E, Richardson TG, Hemani G, Davey SG. The use of negative control outcomes in Mendelian randomization to detect potential population stratification. Int J Epidemiol. 2021;50(4):1350&#x2013;61.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33570130</ArticleId><ArticleId IdType=\"pmc\">8407870</ArticleId><ArticleId IdType=\"doi\">10.1093/ije/dyaa288</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304&#x2013;14.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27061298</ArticleId><ArticleId IdType=\"pmc\">4849733</ArticleId><ArticleId IdType=\"doi\">10.1002/gepi.21965</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512&#x2013;25.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26050253</ArticleId><ArticleId IdType=\"pmc\">4469799</ArticleId><ArticleId IdType=\"doi\">10.1093/ije/dyv080</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29686387</ArticleId><ArticleId IdType=\"pmc\">6083837</ArticleId><ArticleId IdType=\"doi\">10.1038/s41588-018-0099-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Smith GD, Davies NM, Dudbridge F, Gill D, Glymour MM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2019;4:186.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32760811</ArticleId><ArticleId IdType=\"doi\">10.12688/wellcomeopenres.15555.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Forero DA, Gonz&#xe1;lez-Giraldo Y, L&#xf3;pez-Quintero C, Castro-Vega LJ, Barreto GE, Perry G. Meta-analysis of telomere length in Alzheimer&#x2019;s disease. J Gerontol Ser A Biomed Sci Med Sci. 2016;71(8):1069&#x2013;73.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gerona/glw053</ArticleId></ArticleIdList></Reference><Reference><Citation>Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, et al. Association between telomere length and risk of cancer and non-neoplastic diseases: a Mendelian randomization study. JAMA Oncol. 2017;3(5):636&#x2013;51.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28241208</ArticleId><ArticleId IdType=\"doi\">10.1001/jamaoncol.2016.5945</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeri MS, Leugrans SE, Delbono O, Bennett DA, Buchman AS. Sarcopenia is associated with incident Alzheimer&#x2019;s dementia, mild cognitive impairment, and cognitive decline. J Am Geriatr Soc. 2021;69(7):1826&#x2013;35.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33954985</ArticleId><ArticleId IdType=\"pmc\">8286176</ArticleId><ArticleId IdType=\"doi\">10.1111/jgs.17206</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui C, Mackey RH, Shaaban CE, Kuller LH, Lopez OL, Sekikawa A. Associations of body composition with incident dementia in older adults: Cardiovascular Health Study-Cognition Study. Alzheimers Dement. 2020;16(10):1402&#x2013;11.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32803916</ArticleId><ArticleId IdType=\"doi\">10.1002/alz.12125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima G, Taniguchi Y, Iliffe S, Walters K. Frailty as a predictor of Alzheimer disease, vascular dementia, and all dementia among community-dwelling older people: a systematic review and meta-analysis. J Am Med Dir Assoc. 2016;17(10):881&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27324809</ArticleId><ArticleId IdType=\"doi\">10.1016/j.jamda.2016.05.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges MK, Canevelli M, Cesari M, Aprahamian I. Frailty as a predictor of cognitive disorders: a systematic review and meta-analysis. Front Med. 2019;6:26.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmed.2019.00026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng L, Li G, Gao D, Wang S, Meng X, Wang C, et al. Cognitive frailty as a predictor of dementia among older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2020;87:103997.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31846833</ArticleId><ArticleId IdType=\"doi\">10.1016/j.archger.2019.103997</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima G, Iliffe S, Walters K. Frailty index as a predictor of mortality: a systematic review and meta-analysis. Age Ageing. 2018;47(2):193&#x2013;200.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29040347</ArticleId><ArticleId IdType=\"doi\">10.1093/ageing/afx162</ArticleId></ArticleIdList></Reference><Reference><Citation>Murabito JM, Zhao Q, Larson MG, Rong J, Lin H, Benjamin EJ, et al. Measures of biologic age in a community sample predict mortality and age-related disease: the Framingham Offspring Study. J Gerontol Ser A. 2018;73(6):757&#x2013;62.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gerona/glx144</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan MS, Arnold M, Offer A, Hammami I, Mafham M, Armitage J, et al. A biomarker-based biological age in UK Biobank: composition and prediction of mortality and hospital admissions. J Gerontol Ser A. 2021;76(7):1295&#x2013;302.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/gerona/glab069</ArticleId></ArticleIdList></Reference><Reference><Citation>Shay JW. Telomeres and aging. Curr Opin Cell Biol. 2018;52:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29253739</ArticleId><ArticleId IdType=\"doi\">10.1016/j.ceb.2017.12.001</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Ot&#xed;n C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194&#x2013;217.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23746838</ArticleId><ArticleId IdType=\"pmc\">3836174</ArticleId><ArticleId IdType=\"doi\">10.1016/j.cell.2013.05.039</ArticleId></ArticleIdList></Reference><Reference><Citation>Granic A, Suetterlin K, Shavlakadze T, Grounds MD, Sayer AA. Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men. Clin Sci. 2023;137(22):1721&#x2013;51.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/CS20230319</ArticleId></ArticleIdList></Reference><Reference><Citation>Arosio B, Calvani R, Ferri E, Coelho-Junior HJ, Carandina A, Campanelli F, et al. Sarcopenia and cognitive decline in older adults: targeting the muscle&#x2013;brain axis. Nutrients. 2023;15(8):1853.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37111070</ArticleId><ArticleId IdType=\"pmc\">10142447</ArticleId><ArticleId IdType=\"doi\">10.3390/nu15081853</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo D, Yoon G, Kim OY, Song J. A new paradigm in sarcopenia: cognitive impairment caused by imbalanced myokine secretion and vascular dysfunction. Biomed Pharmacother. 2022;147:112636.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35051857</ArticleId><ArticleId IdType=\"doi\">10.1016/j.biopha.2022.112636</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Gill D, Butterworth AS, Burgess S. An empirical investigation into the impact of winner&#x2019;s curse on estimates from Mendelian randomization. Int J Epidemiol. 2023;52(4):1209&#x2013;19.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36573802</ArticleId><ArticleId IdType=\"doi\">10.1093/ije/dyac233</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadreev II, Elsworth BL, Mitchell RE, Paternoster L, Sanderson E, Davies NM, et al. Navigating sample overlap, winner&#x2019;s curse and weak instrument bias in Mendelian randomization studies using the UK Biobank. MedRxiv. 2021:2021.06. 28.21259622. https://doi.org/10.1101/2021.06.28.21259622</Citation></Reference><Reference><Citation>Abdellaoui A, Hugh-Jones D, Yengo L, Kemper KE, Nivard MG, Veul L, et al. Genetic correlates of social stratification in Great Britain. Nat Hum Behav. 2019;3(12):1332&#x2013;42.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31636407</ArticleId><ArticleId IdType=\"doi\">10.1038/s41562-019-0757-5</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39269547</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1559-1182</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s12035-024-04469-x</ELocationID><Abstract><AbstractText>Mitochondria, essential organelles responsible for cellular energy production, emerge as a key factor in the pathogenesis of neurodegenerative disorders. This review explores advancements in mitochondrial biology studies that highlight the pivotal connection between mitochondrial dysfunctions and neurological conditions such as Alzheimer's, Parkinson's, Huntington's, ischemic stroke, and vascular dementia. Mitochondrial DNA mutations, impaired dynamics, and disruptions in the ETC contribute to compromised energy production and heightened oxidative stress. These factors, in turn, lead to neuronal damage and cell death. Recent research has unveiled potential therapeutic strategies targeting mitochondrial dysfunction, including mitochondria targeted therapies and antioxidants. Furthermore, the identification of reliable biomarkers for assessing mitochondrial dysfunction opens new avenues for early diagnosis and monitoring of disease progression. By delving into these advancements, this review underscores the significance of understanding mitochondrial biology in unraveling the mechanisms underlying neurodegenerative disorders. It lays the groundwork for developing targeted treatments to combat these devastating neurological conditions.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kathiresan</LastName><ForeName>Divya Sri</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, Nadu, Tamil, 641046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Balasubramani</LastName><ForeName>Rubadevi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, Nadu, Tamil, 641046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Marudhachalam</LastName><ForeName>Kamalesh</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, Nadu, Tamil, 641046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jaiswal</LastName><ForeName>Piyush</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, Nadu, Tamil, 641046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ramesh</LastName><ForeName>Nivedha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, Nadu, Tamil, 641046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sureshbabu</LastName><ForeName>Suruthi Gunna</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, Nadu, Tamil, 641046, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Puthamohan</LastName><ForeName>Vinayaga Moorthi</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, Nadu, Tamil, 641046, India. pvmhgmb@buc.edu.in.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vijayan</LastName><ForeName>Murali</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA. murali.vijayan@ttuhsc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Biogenesis</Keyword><Keyword MajorTopicYN=\"N\">Mitochondria</Keyword><Keyword MajorTopicYN=\"N\">MtDNA dynamics</Keyword><Keyword MajorTopicYN=\"N\">Neurodegeneration</Keyword><Keyword MajorTopicYN=\"N\">Oxidative stress</Keyword><Keyword MajorTopicYN=\"N\">Therapeutics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269547</ArticleId><ArticleId IdType=\"doi\">10.1007/s12035-024-04469-x</ArticleId><ArticleId IdType=\"pii\">10.1007/s12035-024-04469-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zimorski V, Ku C, Martin WF, Gould SB (2014) Endosymbiotic theory for organelle origins. Curr Opin Microbiol 22:38&#x2013;48. https://doi.org/10.1016/j.mib.2014.09.008</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mib.2014.09.008</ArticleId><ArticleId IdType=\"pubmed\">25306530</ArticleId></ArticleIdList></Reference><Reference><Citation>Archibald JM (2015) Endosymbiosis and eukaryotic cell evolution. Curr Biol 25(19):R911&#x2013;R921. https://doi.org/10.1016/j.cub.2015.07.055</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cub.2015.07.055</ArticleId><ArticleId IdType=\"pubmed\">26439354</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray MW, Burger G, Lang BF (1999) Mitochondrial evolution. Science 283(5407):1476&#x2013;1481. https://doi.org/10.1126/science.283.5407.1476</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.283.5407.1476</ArticleId><ArticleId IdType=\"pubmed\">10066161</ArticleId></ArticleIdList></Reference><Reference><Citation>Brindefalk B, Ettema TJG, Viklund J, Thollesson M, Andersson SGE (2011) A Phylometagenomic exploration of oceanic alphaproteobacteria reveals mitochondrial relatives unrelated to the SAR11 clade. PLoS ONE 6(9):e24457. https://doi.org/10.1371/journal.pone.0024457</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0024457</ArticleId><ArticleId IdType=\"pubmed\">21935411</ArticleId><ArticleId IdType=\"pmc\">3173451</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper GM (2000) The Cell: A Molecular Approach, 2nd edn. Sinauer Associates, Sunderland (MA)</Citation></Reference><Reference><Citation>Cogliati S, Enriquez JA, Scorrano L (2016) mitochondrial cristae: where beauty meets functionality. Trends Biochem Sci 41(3):261&#x2013;273. https://doi.org/10.1016/j.tibs.2016.01.001</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tibs.2016.01.001</ArticleId><ArticleId IdType=\"pubmed\">26857402</ArticleId></ArticleIdList></Reference><Reference><Citation>Formosa LE, Ryan MT (2018) Mitochondrial OXPHOS complex assembly lines. Nat Cell Biol 20(5):511&#x2013;513. https://doi.org/10.1038/s41556-018-0098-z</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41556-018-0098-z</ArticleId><ArticleId IdType=\"pubmed\">29662174</ArticleId></ArticleIdList></Reference><Reference><Citation>Chial H, Craig J (2008) mtDNA and mitochondrial diseases. Nat Educ 1(1):217</Citation></Reference><Reference><Citation>Wiedemann N, Pfanner N (2017) Mitochondrial machineries for protein import and assembly. Annu Rev Biochem 86(1):685&#x2013;714. https://doi.org/10.1146/annurev-biochem-060815-014352</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-biochem-060815-014352</ArticleId><ArticleId IdType=\"pubmed\">28301740</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparre G, Porcelli AM, Lenaz G, Romeo G (2013) Relevance of mitochondrial genetics and metabolism in cancer development. Cold Spring Harb Perspect Biol 5(2):a011411&#x2013;a011411. https://doi.org/10.1101/cshperspect.a011411</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/cshperspect.a011411</ArticleId><ArticleId IdType=\"pubmed\">23378588</ArticleId><ArticleId IdType=\"pmc\">3552507</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumas J-F, Peyta L, Couet C, Servais S (2013) Implication of liver cardiolipins in mitochondrial energy metabolism disorder in cancer cachexia. Biochimie 95(1):27&#x2013;32. https://doi.org/10.1016/j.biochi.2012.07.009</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biochi.2012.07.009</ArticleId><ArticleId IdType=\"pubmed\">22819940</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie M, Lazarou M, Thorburn DR, Ryan MT (2006) Mitochondrial respiratory chain supercomplexes are destabilized in Barth syndrome patients. J Mol Biol 361(3):462&#x2013;469. https://doi.org/10.1016/j.jmb.2006.06.057</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jmb.2006.06.057</ArticleId><ArticleId IdType=\"pubmed\">16857210</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie M, Lazarou M, Thorburn DR, Ryan MT (2007) Analysis of mitochondrial subunit assembly into respiratory chain complexes using blue native polyacrylamide gel electrophoresis. Anal Biochem 364(2):128&#x2013;137. https://doi.org/10.1016/j.ab.2007.02.022</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ab.2007.02.022</ArticleId><ArticleId IdType=\"pubmed\">17391635</ArticleId></ArticleIdList></Reference><Reference><Citation>Genova ML, Lenaz G (2015) The interplay between respiratory supercomplexes and ROS in aging. Antioxid Redox Signal 23(3):208&#x2013;238. https://doi.org/10.1089/ars.2014.6214</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/ars.2014.6214</ArticleId><ArticleId IdType=\"pubmed\">25711676</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauppila TES, Kauppila JHK, Larsson N-G (2017) Mammalian mitochondria and aging: an update. Cell Metab 25(1):57&#x2013;71. https://doi.org/10.1016/j.cmet.2016.09.017</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2016.09.017</ArticleId><ArticleId IdType=\"pubmed\">28094012</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosca M, Minkler P, Hoppel CL (2011) Cardiac mitochondria in heart failure: normal cardiolipin profile and increased threonine phosphorylation of complex IV. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1807(11): 1373&#x2013;1382s https://doi.org/10.1016/j.bbabio.2011.02.003 .</Citation></Reference><Reference><Citation>Del Dotto V, Mishra P, Vidoni S, Fogazza M, Maresca A, Caporali L, McCaffery JM, Cappelletti M et al (2017) OPA1 isoforms in the hierarchical organization of mitochondrial functions. Cell Rep 19(12):2557&#x2013;2571. https://doi.org/10.1016/j.celrep.2017.05.073</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2017.05.073</ArticleId><ArticleId IdType=\"pubmed\">28636943</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapa-Dubocq XR, Rodr&#xed;guez-Graciani KM, Garc&#xed;a-B&#xe1;ez J, Vadovsky A, Bazil JN, Javadov S (2023) The role of swelling in the regulation of OPA1-mediated mitochondrial function in the heart in vitro. Cells 12(16):2017. https://doi.org/10.3390/cells12162017</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells12162017</ArticleId><ArticleId IdType=\"pubmed\">37626827</ArticleId><ArticleId IdType=\"pmc\">10453793</ArticleId></ArticleIdList></Reference><Reference><Citation>Green DR, Galluzzi L, Kroemer G (2011) Mitochondria and the autophagy&#x2013;inflammation&#x2013;cell death axis in organismal aging. Science 333(6046):1109&#x2013;1112. https://doi.org/10.1126/science.1201940</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1201940</ArticleId><ArticleId IdType=\"pubmed\">21868666</ArticleId><ArticleId IdType=\"pmc\">3405151</ArticleId></ArticleIdList></Reference><Reference><Citation>Czabotar PE, Lessene G, Strasser A, Adams JM (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15(1):49&#x2013;63. https://doi.org/10.1038/nrm3722</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrm3722</ArticleId><ArticleId IdType=\"pubmed\">24355989</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvador-Gallego R, Mund M, Cosentino K, Schneider J, Unsay J, Schraermeyer U, Engelhardt J, Ries J et al (2016) Bax assembly into rings and arcs in apoptotic mitochondria is linked to membrane pores. The EMBO J 35(4):389&#x2013;401 https://doi.org/10.15252/embj.201593384</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/embj.201593384</ArticleId><ArticleId IdType=\"pubmed\">26783362</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Ren P, Chen Z, Ren Z, Lian T, Ma J (2017) Neural attentive session-based recommendation. In Proceedings of the 2017 ACM on Conference on Information and Knowledge Management.s ACM: Singapore Singapore pp 1419&#x2013;1428. https://doi.org/10.1145/3132847.3132926 .</Citation></Reference><Reference><Citation>Messina A, Reina S, Guarino F, De Pinto V (2012) VDAC isoforms in mammals. Biochimica et Biophysica Acta (BBA) Biomembranes 1818(6):1466&#x2013;1476 https://doi.org/10.1016/j.bbamem.2011.10.005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamem.2011.10.005</ArticleId><ArticleId IdType=\"pubmed\">22020053</ArticleId></ArticleIdList></Reference><Reference><Citation>De Stefani D, Rizzuto R, Pozzan T (2016) Enjoy the trip: calcium in mitochondria back and forth. Annu Rev Biochem 85(1):161&#x2013;192. https://doi.org/10.1146/annurev-biochem-060614-034216</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-biochem-060614-034216</ArticleId><ArticleId IdType=\"pubmed\">27145841</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinghirino F, Pappalardo XG, Messina A, Guarino F, De Pinto V (2020) Is the Secret of VDAC isoforms in their gene regulation? Characterization of human VDAC genes expression profile, promoter activity, and transcriptional regulators. IJMS 21(19):7388. https://doi.org/10.3390/ijms21197388</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms21197388</ArticleId><ArticleId IdType=\"pubmed\">33036380</ArticleId><ArticleId IdType=\"pmc\">7582299</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng EH-Y, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ (2003) VDAC2 Inhibits BAK activation and mitochondrial apoptosis. Science 301(5632):513&#x2013;517. https://doi.org/10.1126/science.1083995</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1083995</ArticleId><ArticleId IdType=\"pubmed\">12881569</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin S-L, Deng J, Lou D-D, Yu W-F, Pei J, Guan Z-Z (2015) The decreased expression of mitofusin-1 and increased fission-1 together with alterations in mitochondrial morphology in the kidney of rats with chronic fluorosis may involve elevated oxidative stress. J Trace Elem Med Biol 29:263&#x2013;268. https://doi.org/10.1016/j.jtemb.2014.06.001</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jtemb.2014.06.001</ArticleId><ArticleId IdType=\"pubmed\">24958380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Jeong S-Y, Karbowski M, Smith CL, Youle RJ (2004) Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. MBoC 15(11):5001&#x2013;5011. https://doi.org/10.1091/mbc.e04-04-0294</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1091/mbc.e04-04-0294</ArticleId><ArticleId IdType=\"pubmed\">15356267</ArticleId><ArticleId IdType=\"pmc\">524759</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YJ, McIntyre RL, Janssens GE, Houtkooper RH (2020) Mitochondrial fission and fusion: a dynamic role in aging and potential target for age-related disease. Mech Ageing Dev 186:111212. https://doi.org/10.1016/j.mad.2020.111212</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mad.2020.111212</ArticleId><ArticleId IdType=\"pubmed\">32017944</ArticleId></ArticleIdList></Reference><Reference><Citation>Truban D, Hou X, Caulfield TR, Fiesel FC, Springer W (2017) PINK1, Parkin, and mitochondrial quality control: what can we learn about Parkinson&#x2019;s disease pathobiology? JPD 7(1):13&#x2013;29. https://doi.org/10.3233/JPD-160989</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JPD-160989</ArticleId><ArticleId IdType=\"pubmed\">27911343</ArticleId></ArticleIdList></Reference><Reference><Citation>Venediktova N, Solomadin I, Starinets V (2023) Effect of thyroxine on the structural and dynamic features of cardiac mitochondria and mitophagy in rats. Cells 12(3):396. https://doi.org/10.3390/cells12030396</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells12030396</ArticleId><ArticleId IdType=\"pubmed\">36766738</ArticleId><ArticleId IdType=\"pmc\">9913912</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Sampson MJ, Decker WK, Craigen WJ (1999) Each mammalian mitochondrial outer membrane porin protein is dispensable: effects on cellular respiration. Biochimica et Biophysica Acta (BBA) Molecular Cell Research 1452(1):68&#x2013;78s</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0167-4889(99)00120-2</ArticleId><ArticleId IdType=\"pubmed\">10525161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly DP, Scarpulla RC (2004) Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 18(4):357&#x2013;368. https://doi.org/10.1101/gad.1177604</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1101/gad.1177604</ArticleId><ArticleId IdType=\"pubmed\">15004004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakowska P, Jans DC, Mohanraj K, Riedel D, Jakobs S, Chacinska A (2015) The oxidation status of Mic19 regulates MICOS assembly. Mol Cell Biol 35(24):4222&#x2013;4237. https://doi.org/10.1128/MCB.00578-15</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/MCB.00578-15</ArticleId><ArticleId IdType=\"pubmed\">26416881</ArticleId><ArticleId IdType=\"pmc\">4648825</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Ruan Y, Zhang K, Jian F, Hu C, Miao L, Gong L, Sun L et al (2016) Mic60/mitofilin determines MICOS assembly essential for mitochondrial dynamics and mtDNA nucleoid organization. Cell Death Differ 23(3):380&#x2013;392. https://doi.org/10.1038/cdd.2015.102</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/cdd.2015.102</ArticleId><ArticleId IdType=\"pubmed\">26250910</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacinska A, Koehler CM, Milenkovic D, Lithgow T, Pfanner N (2009) Importing mitochondrial proteins: machineries and mechanisms. Cell 138(4):628&#x2013;644. https://doi.org/10.1016/j.cell.2009.08.005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2009.08.005</ArticleId><ArticleId IdType=\"pubmed\">19703392</ArticleId><ArticleId IdType=\"pmc\">4099469</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila-Rodriguez M, Garcia-Segura LM, Hidalgo-lanussa O, Baez E, Gonzalez J, Barreto GE (2016) Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression. Mol Cell Endocrinol 433:35&#x2013;46. https://doi.org/10.1016/j.mce.2016.05.024</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mce.2016.05.024</ArticleId><ArticleId IdType=\"pubmed\">27250720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji W, Hatch AL, Merrill RA, Strack S, Higgs HN (2015) Actin filaments target the oligomeric maturation of the dynamin GTPase Drp1 to mitochondrial fission sites. eLife 4:e11553</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7554/eLife.11553</ArticleId><ArticleId IdType=\"pubmed\">26609810</ArticleId><ArticleId IdType=\"pmc\">4755738</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Guo S, Tang Y, Mou C, Hu X, Shao F, Yan W, Wu Q (2020) Mitochondrial fusion and fission in neuronal death induced by cerebral ischemia-reperfusion and its clinical application: a mini-review. Med Sci Monit 26s https://doi.org/10.12659/MSM.928651 .</Citation></Reference><Reference><Citation>Khayati F, P&#xe9;rez-Cano L, Maouche K, Sadoux A, Boutalbi Z, Podgorniak M-P, Maskos U, Setterblad N et al (2015) EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF. Oncotarget 6(12):9766&#x2013;9780ss</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.2870</ArticleId><ArticleId IdType=\"pubmed\">25825981</ArticleId><ArticleId IdType=\"pmc\">4496396</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong S-B, Kalkhoran SB, Hern&#xe1;ndez-Res&#xe9;ndiz S, Samangouei P, Ong S-G, Hausenloy DJ (2017) Mitochondrial-shaping proteins in cardiac health and disease &#x2013; the long and the short of it! Cardiovasc Drugs Ther 31(1):87&#x2013;107. https://doi.org/10.1007/s10557-016-6710-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10557-016-6710-1</ArticleId><ArticleId IdType=\"pubmed\">28190190</ArticleId><ArticleId IdType=\"pmc\">5346600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardie DG, Pan DA (2002) Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 30(6):1064&#x2013;1070. https://doi.org/10.1042/bst0301064</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/bst0301064</ArticleId><ArticleId IdType=\"pubmed\">12440973</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan T, Kondo S, Le W, Jankovic J (2008) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson&#x2019;s disease. Brain 131(8):1969&#x2013;1978. https://doi.org/10.1093/brain/awm318</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awm318</ArticleId><ArticleId IdType=\"pubmed\">18187492</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarffe LA, Stevens DA, Dawson VL, Dawson TM (2014) Parkin and PINK1: much more than mitophagy. Trends Neurosci 37(6):315&#x2013;324. https://doi.org/10.1016/j.tins.2014.03.004</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tins.2014.03.004</ArticleId><ArticleId IdType=\"pubmed\">24735649</ArticleId><ArticleId IdType=\"pmc\">4075431</ArticleId></ArticleIdList></Reference><Reference><Citation>Alano CC, Garnier P, Ying W, Higashi Y, Kauppinen TM, Swanson RA (2010) NAD <sup>+</sup> Depletion is necessary and sufficient forpoly(ADP-Ribose) polymerase-1-mediated neuronal death. J Neurosci 30(8):2967&#x2013;2978. https://doi.org/10.1523/JNEUROSCI.5552-09.2010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.5552-09.2010</ArticleId><ArticleId IdType=\"pubmed\">20181594</ArticleId><ArticleId IdType=\"pmc\">2864043</ArticleId></ArticleIdList></Reference><Reference><Citation>Abeti R, Abramov AY, Duchen MR (2011) &#x3b2;-Amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain 134(6):1658&#x2013;1672. https://doi.org/10.1093/brain/awr104</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awr104</ArticleId><ArticleId IdType=\"pubmed\">21616968</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Deng J, Dong J, Liu J, Bigio EH, Mesulam M, Wang T, Sun L et al (2019) TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet 15(5):e1007947. https://doi.org/10.1371/journal.pgen.1007947</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType=\"pubmed\">31100073</ArticleId><ArticleId IdType=\"pmc\">6524796</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Arakawa H, Wang L, Okolo O, Siedlak SL, Jiang Y, Gao J, Xie F et al (2017) Motor-coordinative and cognitive dysfunction caused by mutant TDP-43 could be reversed by inhibiting its mitochondrial localization. Mol Ther 25(1):127&#x2013;139. https://doi.org/10.1016/j.ymthe.2016.10.013</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ymthe.2016.10.013</ArticleId><ArticleId IdType=\"pubmed\">28129109</ArticleId><ArticleId IdType=\"pmc\">5363201</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatori I, Ferri A, Scaricamazza S, Giovannelli I, Serrano A, Rossi S, D&#x2019;Ambrosi N, Cozzolino M et al (2018) Differential toxicity of TAR DNA-binding protein 43 isoforms depends on their submitochondrial localization in neuronal cells. J Neurochem 146(5):585&#x2013;597. https://doi.org/10.1111/jnc.14465</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jnc.14465</ArticleId><ArticleId IdType=\"pubmed\">29779213</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu R, Lendahl U, Nist&#xe9;r M, Zhao J (2020) Regulation of mammalian mitochondrial dynamics: opportunities and challenges. Front Endocrinol 11:374. https://doi.org/10.3389/fendo.2020.00374</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fendo.2020.00374</ArticleId></ArticleIdList></Reference><Reference><Citation>Downward J (1999) How BAD phosphorylation is good for survival. Nat Cell Biol 1(2):E33&#x2013;E35. https://doi.org/10.1038/10026</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/10026</ArticleId><ArticleId IdType=\"pubmed\">10559890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalogeris T, Baines CP, Krenz M, Korthuis RJ (2012) Cell biology of ischemia/reperfusion injury. In International Review of Cell and Molecular Biology. Elsevier 298: pp 229&#x2013;317. https://doi.org/10.1016/B978-0-12-394309-5.00006-7 .</Citation></Reference><Reference><Citation>Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA et al (2005) Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1(4):223&#x2013;232. https://doi.org/10.1038/nchembio727</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nchembio727</ArticleId><ArticleId IdType=\"pubmed\">16408039</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster KA, Graham RM, Thompson JW, Spiga M-G, Frazier DP, Wilson A, Bishopric NH (2006) Redox stress and the contributions of BH3-only proteins to infarction. Antioxid Redox Signal 8(9&#x2013;10):1667&#x2013;1676. https://doi.org/10.1089/ars.2006.8.1667</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/ars.2006.8.1667</ArticleId><ArticleId IdType=\"pubmed\">16987020</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L, Morselli E, Kepp O, Kroemer G (2009) Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1787(5):402&#x2013;413</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbabio.2008.09.006</ArticleId><ArticleId IdType=\"pubmed\">18848916</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares ROS, Losada DM, Jordani MC, &#xc9;vora P, Castro-e-Silva O (2019) Ischemia/reperfusion injury revisited: an overview of the latest pharmacological strategies. IJMS 20(20):5034. https://doi.org/10.3390/ijms20205034</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms20205034</ArticleId><ArticleId IdType=\"pubmed\">31614478</ArticleId><ArticleId IdType=\"pmc\">6834141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahira K, Haspel JA, Rathinam VAK, Lee S-J, Dolinay T, Lam HC, Englert JA, Rabinovitch M et al (2011) Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12(3):222&#x2013;230. https://doi.org/10.1038/ni.1980</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ni.1980</ArticleId><ArticleId IdType=\"pubmed\">21151103</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Lu M, Zhang Y, Ji W, Lei L, Wang W, Fang L, Wang L et al (2019) Disrupted-in-schizophrenia-1 protects synaptic plasticity in a transgenic mouse model of Alzheimer&#x2019;s disease as a mitophagy receptor. Aging Cell 18(1):e12860. https://doi.org/10.1111/acel.12860</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/acel.12860</ArticleId><ArticleId IdType=\"pubmed\">30488644</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos KJ, M&#xf3;rotz GM, Stoica R, Tudor EL, Lau K-F, Ackerley S, Warley A, Shaw CE et al (2012) VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostsasis. Hum Mol Genet 21(6):1299&#x2013;1311. https://doi.org/10.1093/hmg/ddr559</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddr559</ArticleId><ArticleId IdType=\"pubmed\">22131369</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R, De Vos KJ, Paillusson S, Mueller S, Sancho RM, Lau K-F, Vizcay-Barrena G, Lin W-L et al (2014) ER&#x2013;mitochondria associations are regulated by the VAPB&#x2013;PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat Commun 5(1):3996. https://doi.org/10.1038/ncomms4996</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncomms4996</ArticleId><ArticleId IdType=\"pubmed\">24893131</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihofen A, Thomas KJ, Ostaszewski BL, Cookson MR, Selkoe DJ (2009) Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 48(9):2045&#x2013;2052. https://doi.org/10.1021/bi8019178</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/bi8019178</ArticleId><ArticleId IdType=\"pubmed\">19152501</ArticleId></ArticleIdList></Reference><Reference><Citation>Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A et al (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331(6016):456&#x2013;461. https://doi.org/10.1126/science.1196371</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1196371</ArticleId><ArticleId IdType=\"pubmed\">21205641</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N, Komatsu M (2011) Autophagy: renovation of cells and tissues. Cell 147(4):728&#x2013;741. https://doi.org/10.1016/j.cell.2011.10.026</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2011.10.026</ArticleId><ArticleId IdType=\"pubmed\">22078875</ArticleId></ArticleIdList></Reference><Reference><Citation>Minowa-Nozawa A, Nozawa T, Okamoto-Furuta K, Kohda H, Nakagawa I (2017) Rab35 GTPase recruits NDP52 to autophagy targets. The EMBO Journal 36(18):2790&#x2013;2807</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/embj.201796463</ArticleId><ArticleId IdType=\"pubmed\">28848034</ArticleId><ArticleId IdType=\"pmc\">5599792</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S, Vigi&#xe9; P, Youle RJ (2018) Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol 28(4):R170&#x2013;R185. https://doi.org/10.1016/j.cub.2018.01.004</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cub.2018.01.004</ArticleId><ArticleId IdType=\"pubmed\">29462587</ArticleId><ArticleId IdType=\"pmc\">7255410</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Feng D, Chen G, Chen M, Zheng Q, Song P, Ma Q, Zhu C et al (2012) Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol 14(2):177&#x2013;185. https://doi.org/10.1038/ncb2422</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncb2422</ArticleId><ArticleId IdType=\"pubmed\">22267086</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, Chiang W-C, Sumpter R, Mishra P, Levine B (2017) Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor. Cell 168(1&#x2013;2):224-238.e10. https://doi.org/10.1016/j.cell.2016.11.042</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2016.11.042</ArticleId><ArticleId IdType=\"pubmed\">28017329</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai R, Chen G, Shi HOW, Martin-DeLeon PA, Chen H (2017) Prohibitin involvement in the generation of mitochondrial superoxide at Complex I in human sperm. J Cellular Molecular Medi 21(1):121&#x2013;129</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jcmm.12945</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X-H, Chai R-R, Chen G-W, Zhang L-F, Tan-Tai W-J, Shi H-J, Martin-DeLeon P et al (2020) Prohibitin (PHB) Interacts with AKT in mitochondria to coordinately modulate sperm motility. Asian J Androl 22(6):583. https://doi.org/10.4103/aja.aja_46_20</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/aja.aja_46_20</ArticleId><ArticleId IdType=\"pubmed\">32859869</ArticleId><ArticleId IdType=\"pmc\">7705974</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermann B (2010) Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol 11(12):872&#x2013;884. https://doi.org/10.1038/nrm3013</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrm3013</ArticleId><ArticleId IdType=\"pubmed\">21102612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamer KJ, Mootha VK (2015) The molecular era of the mitochondrial calcium uniporter. Nat Rev Mol Cell Biol 16(9):545&#x2013;553. https://doi.org/10.1038/nrm4039</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrm4039</ArticleId><ArticleId IdType=\"pubmed\">26285678</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikoletopoulou V, Markaki M, Palikaras K (1833) Tavernarakis N (2013) Crosstalk between apoptosis, necrosis and autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 12:3448&#x2013;3459</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamcr.2013.06.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambold AS, Pearce EL (2018) Mitochondrial dynamics at the interface of immune cell metabolism and function. Trends Immunol 39(1):6&#x2013;18. https://doi.org/10.1016/j.it.2017.08.006</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.it.2017.08.006</ArticleId><ArticleId IdType=\"pubmed\">28923365</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F, Oxley D, Santos F et al (2014) Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 158(6):1254&#x2013;1269. https://doi.org/10.1016/j.cell.2014.08.029</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2014.08.029</ArticleId><ArticleId IdType=\"pubmed\">25215486</ArticleId><ArticleId IdType=\"pmc\">4162745</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli JB, Haigis MC (2018) The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol 20(7):745&#x2013;754. https://doi.org/10.1038/s41556-018-0124-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41556-018-0124-1</ArticleId><ArticleId IdType=\"pubmed\">29950572</ArticleId><ArticleId IdType=\"pmc\">6541229</ArticleId></ArticleIdList></Reference><Reference><Citation>Osellame LD, Blacker TS, Duchen MR (2012) Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab 26(6):711&#x2013;723. https://doi.org/10.1016/j.beem.2012.05.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.beem.2012.05.003</ArticleId><ArticleId IdType=\"pubmed\">23168274</ArticleId><ArticleId IdType=\"pmc\">3513836</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangaraju V, Lewis TL, Hirabayashi Y, Bergami M, Motori E, Cartoni R, Kwon S-K, Courchet J (2019) Pleiotropic mitochondria: the influence of mitochondria on neuronal development and disease. J Neurosci 39(42):8200&#x2013;8208. https://doi.org/10.1523/JNEUROSCI.1157-19.2019</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1157-19.2019</ArticleId><ArticleId IdType=\"pubmed\">31619488</ArticleId><ArticleId IdType=\"pmc\">6794931</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbauer AB, Zahedi RP, Sickmann A, Pfanner N, Meisinger C (2014) The protein import machinery of mitochondria&#x2014;a regulatory hub in metabolism, stress, and disease. Cell Metab 19(3):357&#x2013;372. https://doi.org/10.1016/j.cmet.2014.01.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2014.01.010</ArticleId><ArticleId IdType=\"pubmed\">24561263</ArticleId></ArticleIdList></Reference><Reference><Citation>Liesa M, Palac&#xed;n M, Zorzano A (2009) Mitochondrial dynamics in mammalian health and disease. Physiol Rev 89(3):799&#x2013;845. https://doi.org/10.1152/physrev.00030.2008</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/physrev.00030.2008</ArticleId><ArticleId IdType=\"pubmed\">19584314</ArticleId></ArticleIdList></Reference><Reference><Citation>Chocron ES, Munk&#xe1;csy E (1865) Pickering AM (2019) Cause or casualty: the role of mitochondrial DNA in aging and age-associated disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2:285&#x2013;297ss</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2018.09.035</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton DA (2000) Transcription and replication of mitochondrial DNA. Hum Reprod 15(suppl 2):11&#x2013;17. https://doi.org/10.1093/humrep/15.suppl_2.11</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/humrep/15.suppl_2.11</ArticleId><ArticleId IdType=\"pubmed\">11041509</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CB, Larsson N-G (2011) Mitochondrial DNA mutations in disease and aging. J Cell Biol 193(5):809&#x2013;818. https://doi.org/10.1083/jcb.201010024</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.201010024</ArticleId><ArticleId IdType=\"pubmed\">21606204</ArticleId><ArticleId IdType=\"pmc\">3105550</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong S-E, Walford GA, Sugiana C et al (2008) A Mitochondrial protein compendium elucidates complex I disease biology. Cell 134(1):112&#x2013;123. https://doi.org/10.1016/j.cell.2008.06.016</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2008.06.016</ArticleId><ArticleId IdType=\"pubmed\">18614015</ArticleId><ArticleId IdType=\"pmc\">2778844</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgenstern M, Stiller SB, L&#xfc;bbert P, Peikert CD, Dannenmaier S, Drepper F, Weill U, H&#xf6;&#xdf; P et al (2017) Definition of a high-confidence mitochondrial proteome at quantitative scale. Cell Rep 19(13):2836&#x2013;2852. https://doi.org/10.1016/j.celrep.2017.06.014</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.celrep.2017.06.014</ArticleId><ArticleId IdType=\"pubmed\">28658629</ArticleId><ArticleId IdType=\"pmc\">5494306</ArticleId></ArticleIdList></Reference><Reference><Citation>Srere PA, Sumegi B (1986) Organization of the mitochondrial matrix. In: Brautbar N (ed) Myocardial and Skeletal Muscle Bioenergetics. Advances in Experimental Medicine and Biology; Springer, US: Boston, MA, 194: pp 13&#x2013;25 https://doi.org/10.1007/978-1-4684-5107-8_2 .</Citation></Reference><Reference><Citation>Berger F, Lau C, Dahlmann M, Ziegler M (2005) Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem 280(43):36334&#x2013;36341. https://doi.org/10.1074/jbc.M508660200</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M508660200</ArticleId><ArticleId IdType=\"pubmed\">16118205</ArticleId></ArticleIdList></Reference><Reference><Citation>Luongo TS, Eller JM, Lu M-J, Niere M, Raith F, Perry C, Bornstein MR, Oliphint P et al (2020) SLC25A51 is a mammalian mitochondrial NAD+ transporter. Nature 588(7836):174&#x2013;179. https://doi.org/10.1038/s41586-020-2741-7</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-020-2741-7</ArticleId><ArticleId IdType=\"pubmed\">32906142</ArticleId><ArticleId IdType=\"pmc\">7718333</ArticleId></ArticleIdList></Reference><Reference><Citation>Agerholm M, Dall M, Jensen BAH, Prats C, Madsen S, Basse AL, Graae A-S, Risis S et al (2018) Perturbations of NAD <sup>+</sup> salvage systems impact mitochondrial function and energy homeostasis in mouse myoblasts and intact skeletal muscle. American Journal of Physiology-Endocrinology and Metabolism 314(4):E377&#x2013;E395. https://doi.org/10.1152/ajpendo.00213.2017</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpendo.00213.2017</ArticleId><ArticleId IdType=\"pubmed\">29208611</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederick DW, Loro E, Liu L, Davila A, Chellappa K, Silverman IM, Quinn WJ, Gosai SJ et al (2016) Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle. Cell Metab 24(2):269&#x2013;282. https://doi.org/10.1016/j.cmet.2016.07.005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2016.07.005</ArticleId><ArticleId IdType=\"pubmed\">27508874</ArticleId><ArticleId IdType=\"pmc\">4985182</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomello M, Pyakurel A, Glytsou C, Scorrano L (2020) The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol 21(4):204&#x2013;224. https://doi.org/10.1038/s41580-020-0210-7</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41580-020-0210-7</ArticleId><ArticleId IdType=\"pubmed\">32071438</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance JE (2015) Phospholipid synthesis and transport in mammalian cells. Traffic 16(1):1&#x2013;18. https://doi.org/10.1111/tra.12230</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/tra.12230</ArticleId><ArticleId IdType=\"pubmed\">25243850</ArticleId></ArticleIdList></Reference><Reference><Citation>Burri L, Vascotto K, Gentle IE, Chan NC, Beilharz T, Stapleton DI, Ramage L, Lithgow T (2006) Integral membrane proteins in the mitochondrial outer membrane of Saccharomyces Cerevisiae. FEBS J 273(7):1507&#x2013;1515. https://doi.org/10.1111/j.1742-4658.2006.05171.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1742-4658.2006.05171.x</ArticleId><ArticleId IdType=\"pubmed\">16689936</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker T, Song J, Pfanner N (2019) Versatility of preprotein transfer from the cytosol to mitochondria. Trends Cell Biol 29(7):534&#x2013;548. https://doi.org/10.1016/j.tcb.2019.03.007</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tcb.2019.03.007</ArticleId><ArticleId IdType=\"pubmed\">31030976</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen KG, Herrmann JM (2019) Transport of proteins into mitochondria. Protein J 38(3):330&#x2013;342. https://doi.org/10.1007/s10930-019-09819-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10930-019-09819-6</ArticleId><ArticleId IdType=\"pubmed\">30868341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutik S, Guiard B, Meyer HE, Wiedemann N, Pfanner N (2007) Cooperation of translocase complexes in mitochondrial protein import. J Cell Biol 179(4):585&#x2013;591. https://doi.org/10.1083/jcb.200708199</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.200708199</ArticleId><ArticleId IdType=\"pubmed\">17998403</ArticleId><ArticleId IdType=\"pmc\">2080918</ArticleId></ArticleIdList></Reference><Reference><Citation>Helle SCJ, Kanfer G, Kolar K, Lang A, Michel AH (1833) Kornmann B (2013) Organization and function of membrane contact sites. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 11:2526&#x2013;2541s</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamcr.2013.01.028</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg-Bord M, Shai N, Schuldiner M, Bohnert M (2016) A tether is a tether is a tether: tethering at membrane contact sites. Dev Cell 39(4):395&#x2013;409. https://doi.org/10.1016/j.devcel.2016.10.022</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.devcel.2016.10.022</ArticleId><ArticleId IdType=\"pubmed\">27875684</ArticleId></ArticleIdList></Reference><Reference><Citation>Sesaki H, Jensen RE (2001) UGO1 Encodes an outer membrane protein required for mitochondrial fusion. J Cell Biol 152(6):1123&#x2013;1134. https://doi.org/10.1083/jcb.152.6.1123</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.152.6.1123</ArticleId><ArticleId IdType=\"pubmed\">11257114</ArticleId><ArticleId IdType=\"pmc\">2199209</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinzel M, Tan T, Wendling P, Kalbacher H, &#xd6;zbalci C, Chelius X, Westermann B, Br&#xfc;gger B et al (2016) Mcp3 is a novel mitochondrial outer membrane protein that follows a unique IMP-dependent biogenesis pathway. EMBO Reports 17(7):965&#x2013;981</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/embr.201541273</ArticleId><ArticleId IdType=\"pubmed\">27226123</ArticleId><ArticleId IdType=\"pmc\">4931563</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;rtensson CU, Priesnitz C, Song J, Ellenrieder L, Doan KN, Boos F, Floerchinger A, Zufall N et al (2019) Mitochondrial protein translocation-associated degradation. Nature 569(7758):679&#x2013;683. https://doi.org/10.1038/s41586-019-1227-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-019-1227-y</ArticleId><ArticleId IdType=\"pubmed\">31118508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesnik C, Cohen Y, Atir-Lande A, Schuldiner M, Arava Y (2014) OM14 is a mitochondrial receptor for cytosolic ribosomes that supports co-translational import into mitochondria. Nat Commun 5(1):5711. https://doi.org/10.1038/ncomms6711</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncomms6711</ArticleId><ArticleId IdType=\"pubmed\">25487825</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph-Liauzun E, Delmas P, Shire D, Ferrara P (1998) Topological analysis of the peripheral benzodiazepine receptor in yeast mitochondrial membranes supports a five-transmembrane structure. J Biol Chem 273(4):2146&#x2013;2152. https://doi.org/10.1074/jbc.273.4.2146</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.273.4.2146</ArticleId><ArticleId IdType=\"pubmed\">9442055</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura N, Kimura Y, Tokuda M, Honda S, Hirose S (2006) MARCH-V is a novel Mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep 7(10):1019&#x2013;1022. https://doi.org/10.1038/sj.embor.7400790</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.embor.7400790</ArticleId><ArticleId IdType=\"pubmed\">16936636</ArticleId><ArticleId IdType=\"pmc\">1618377</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfanner N, Warscheid B, Wiedemann N (2019) Mitochondrial proteins: from biogenesis to functional networks. Nat Rev Mol Cell Biol 20(5):267&#x2013;284. https://doi.org/10.1038/s41580-018-0092-0</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41580-018-0092-0</ArticleId><ArticleId IdType=\"pubmed\">30626975</ArticleId><ArticleId IdType=\"pmc\">6684368</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke B (2007) Mitochondrial ion channels. Annu Rev Physiol 69(1):19&#x2013;49. https://doi.org/10.1146/annurev.physiol.69.031905.163804</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev.physiol.69.031905.163804</ArticleId><ArticleId IdType=\"pubmed\">17059356</ArticleId><ArticleId IdType=\"pmc\">2712118</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan M, Reddy PH (2022) Reduced VDAC1, Maintained mitochondrial dynamics and enhanced mitochondrial biogenesis in a transgenic tau mouse model of Alzheimer&#x2019;s disease. Int J Mol Sci 23(15):8561. https://doi.org/10.3390/ijms23158561</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23158561</ArticleId><ArticleId IdType=\"pubmed\">35955694</ArticleId><ArticleId IdType=\"pmc\">9368852</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan M, Alvir RV, Alvir RV, Bunquin LE, Pradeepkiran JA, Reddy PH (2022) A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic tau mouse model. Aging Cell 21(8):e13663. https://doi.org/10.1111/acel.13663</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/acel.13663</ArticleId><ArticleId IdType=\"pubmed\">35801276</ArticleId><ArticleId IdType=\"pmc\">9381918</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson MJ, Lovell RS, Craigen WJ (1996) Isolation, characterization, and mapping of two mouse mitochondrial voltage-dependent anion channel isoforms. Genomics 33(2):283&#x2013;288. https://doi.org/10.1006/geno.1996.0193</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1006/geno.1996.0193</ArticleId><ArticleId IdType=\"pubmed\">8660977</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo G, Serra I, Magr&#xed; A, Casu M, De Pinto V, Ceccarelli M, Scorciapino MA (2018) Folded structure and membrane affinity of the N-terminal domain of the three human isoforms of the mitochondrial voltage-dependent anion-selective channel. ACS Omega 3(9):11415&#x2013;11425. https://doi.org/10.1021/acsomega.8b01536</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsomega.8b01536</ArticleId><ArticleId IdType=\"pubmed\">30320261</ArticleId><ArticleId IdType=\"pmc\">6173511</ArticleId></ArticleIdList></Reference><Reference><Citation>Magri A, Messina A (2018) Interactions of VDAC with proteins involved in neurodegenerative aggregation: an opportunity for advancement on therapeutic molecules. CMC 24(40):4470&#x2013;4487. https://doi.org/10.2174/0929867324666170601073920</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/0929867324666170601073920</ArticleId></ArticleIdList></Reference><Reference><Citation>Benz R (1994) Permeation of hydrophilic solutes through mitochondrial outer membranes: review on mitochondrial porins. Biochimica et Biophysica Acta - Reviews on Biomembranes 1197(2):167&#x2013;196sss</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/0304-4157(94)90004-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostovtseva T, Colombini M (1997) VDAC channels mediate and gate the flow of ATP: implications for the regulation of mitochondrial function. Biophys J 72(5):1954&#x2013;1962. https://doi.org/10.1016/S0006-3495(97)78841-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0006-3495(97)78841-6</ArticleId><ArticleId IdType=\"pubmed\">9129800</ArticleId><ArticleId IdType=\"pmc\">1184392</ArticleId></ArticleIdList></Reference><Reference><Citation>Gincel D, Shoshan-Barmatz V (2004) Glutamate interacts with VDAC and modulates opening of the mitochondrial permeability transition pore. J Bioenerg Biomembr 36(2):179&#x2013;186. https://doi.org/10.1023/B:JOBB.0000023621.72873.9e</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1023/B:JOBB.0000023621.72873.9e</ArticleId><ArticleId IdType=\"pubmed\">15224967</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger V, Becker T, Becker L, Montilla-Martinez M, Ellenrieder L, V&#xf6;gtle F-N, Meyer HE, Ryan MT et al (2017) Identification of new channels by systematic analysis of the mitochondrial outer membrane. J Cell Biol 216(11):3485&#x2013;3495. https://doi.org/10.1083/jcb.201706043</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.201706043</ArticleId><ArticleId IdType=\"pubmed\">28916712</ArticleId><ArticleId IdType=\"pmc\">5674900</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469(7329):221&#x2013;225. https://doi.org/10.1038/nature09663</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature09663</ArticleId><ArticleId IdType=\"pubmed\">21124315</ArticleId></ArticleIdList></Reference><Reference><Citation>Reina S, Checchetto V, Saletti R, Gupta A, Chaturvedi D, Guardiani C, Guarino F, Scorciapino MA et al (2016) VDAC3 as a sensor of oxidative state of the intermembrane space of mitochondria: the putative role of cysteine residue modifications. Oncotarget 7(3):2249&#x2013;2268</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/oncotarget.6850</ArticleId><ArticleId IdType=\"pubmed\">26760765</ArticleId><ArticleId IdType=\"pmc\">4823033</ArticleId></ArticleIdList></Reference><Reference><Citation>Queralt-Mart&#xed;n M, Bergdoll L, Teijido O, Munshi N, Jacobs D, Kuszak AJ, Protchenko O, Reina S et al (2020) A lower affinity to cytosolic proteins reveals VDAC3 isoform-specific role in mitochondrial biology. J Gen Physiol 152(2):e201912501. https://doi.org/10.1085/jgp.201912501</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1085/jgp.201912501</ArticleId><ArticleId IdType=\"pubmed\">31935282</ArticleId><ArticleId IdType=\"pmc\">7062508</ArticleId></ArticleIdList></Reference><Reference><Citation>Saletti R, Reina S, Pittal&#xe0; MGG, Belfiore R, Cunsolo V, Messina A, De Pinto V (1859) Foti S (2017) High resolustion mass spectrometry characterization of the oxidation pattern of methionine and cysteine residues in rat liver mitochondria voltage-dependent anion selective channel 3 (VDAC3). Biochimica et Biophysica Acta (BBA) - Biomembranes 3:301&#x2013;311</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamem.2016.12.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogliati S, Frezza C, Soriano ME, Varanita T, Quintana-Cabrera R, Corrado M, Cipolat S, Costa V et al (2013) Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 155(1):160&#x2013;171. https://doi.org/10.1016/j.cell.2013.08.032</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2013.08.032</ArticleId><ArticleId IdType=\"pubmed\">24055366</ArticleId><ArticleId IdType=\"pmc\">3790458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackenbrock CR (1966) Ultrastructural bases for metabolically linked mechanical activity in mitochondria. J Cell Biol 30(2):269&#x2013;297. https://doi.org/10.1083/jcb.30.2.269</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.30.2.269</ArticleId><ArticleId IdType=\"pubmed\">5968972</ArticleId><ArticleId IdType=\"pmc\">2107001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackenbrock CR (1968) Ultrastructural bases for metabolically linked mechanical activity in mitochondria. J Cell Biol 37(2):345&#x2013;369. https://doi.org/10.1083/jcb.37.2.345</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.37.2.345</ArticleId><ArticleId IdType=\"pubmed\">5656397</ArticleId><ArticleId IdType=\"pmc\">2107416</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060&#x2013;1072. https://doi.org/10.1016/j.cell.2012.03.042</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2012.03.042</ArticleId><ArticleId IdType=\"pubmed\">22632970</ArticleId><ArticleId IdType=\"pmc\">3367386</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283(5407):1482&#x2013;1488. https://doi.org/10.1126/science.283.5407.1482</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.283.5407.1482</ArticleId><ArticleId IdType=\"pubmed\">10066162</ArticleId></ArticleIdList></Reference><Reference><Citation>Scacco S, Petruzzella V, Budde S, Vergari R, Tamborra R, Panelli D, Van Den Heuvel LP, Smeitink JA, et al (2003) Pathological mutations of the human NDUFS4 gene of the 18-kDa (AQDQ) subunit of complex I affect the expression of the protein and the assembly and function of the complex. Journal of Biological Chemistry 278(45): 44161&#x2013;44167. https://doi.org/10.1074/jbc.M307615200</Citation></Reference><Reference><Citation>Kahlh&#xf6;fer F, Kmita K, Wittig I, Zwicker K (1858) Zickermann V (2017) Accessory Subunit NUYM (NDUFS4) is required for stability of the electron input module and activity of mitochondrial complex I. Biochimica et Biophysica Acta (BBA) - Bioenergetics 2:175&#x2013;181</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbabio.2016.11.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker JE (1992) The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains. Quart Rev Biophys 25(3):253&#x2013;324. https://doi.org/10.1017/S003358350000425X</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1017/S003358350000425X</ArticleId></ArticleIdList></Reference><Reference><Citation>Papa S, De Rasmo D (2013) Complex I deficiencies in neurological disorders. Trends Mol Med 19(1):61&#x2013;69. https://doi.org/10.1016/j.molmed.2012.11.005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.molmed.2012.11.005</ArticleId><ArticleId IdType=\"pubmed\">23265841</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodenburg RJ (2016) Mitochondrial complex I-linked disease. Biochimica et Biophysica Acta - Bioenergetics 1857(7):938&#x2013;945</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbabio.2016.02.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramov AY, Angelova PR (2019) Cellular mechanisms of complex I-associated pathology. Biochem Soc Trans 47(6):1963&#x2013;1969. https://doi.org/10.1042/BST20191042</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/BST20191042</ArticleId><ArticleId IdType=\"pubmed\">31769488</ArticleId></ArticleIdList></Reference><Reference><Citation>Holper L, Ben-Shachar D, Mann JJ (2019) Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models. Eur Neuropsychopharmacol 29(9):986&#x2013;1002. https://doi.org/10.1016/j.euroneuro.2019.06.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.euroneuro.2019.06.010</ArticleId><ArticleId IdType=\"pubmed\">31320210</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Rodr&#xed;guez P, Zampese E, Stout KA, Guzman JN, Ilijic E, Yang B, Tkatch T, Stavarache MA et al (2021) Disruption of mitochondrial complex I induces progressive parkinsonism. Nature 599(7886):650&#x2013;656. https://doi.org/10.1038/s41586-021-04059-0</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-021-04059-0</ArticleId><ArticleId IdType=\"pubmed\">34732887</ArticleId><ArticleId IdType=\"pmc\">9189968</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchini G (2003) Function and structure of complex II of the respiratory chain. Annu Rev Biochem 72(1):77&#x2013;109. https://doi.org/10.1146/annurev.biochem.72.121801.161700</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev.biochem.72.121801.161700</ArticleId><ArticleId IdType=\"pubmed\">14527321</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyadera H, Shiomi K, Ui H, Yamaguchi Y, Masuma R, Tomoda H, Miyoshi H, Osanai A et al (2003) Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase). Proc Natl Acad Sci USA 100(2):473&#x2013;477. https://doi.org/10.1073/pnas.0237315100</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0237315100</ArticleId><ArticleId IdType=\"pubmed\">12515859</ArticleId><ArticleId IdType=\"pmc\">141019</ArticleId></ArticleIdList></Reference><Reference><Citation>Yankovskaya V, Horsefield R, T&#xf6;rnroth S, Luna-Chavez C, Miyoshi H, L&#xe9;ger C, Byrne B, Cecchini G et al (2003) Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 299(5607):700&#x2013;704. https://doi.org/10.1126/science.1079605</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1079605</ArticleId><ArticleId IdType=\"pubmed\">12560550</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadrava Vanova K, Kraus M, Neuzil J, Rohlena J (2020) Mitochondrial complex II and reactive oxygen species in disease and therapy. Redox Rep 25(1):26&#x2013;32. https://doi.org/10.1080/13510002.2020.1752002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/13510002.2020.1752002</ArticleId><ArticleId IdType=\"pubmed\">32290794</ArticleId><ArticleId IdType=\"pmc\">7178880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113):787&#x2013;795. https://doi.org/10.1038/nature05292</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature05292</ArticleId><ArticleId IdType=\"pubmed\">17051205</ArticleId></ArticleIdList></Reference><Reference><Citation>Iverson TM, Maklashina E, Cecchini G (2012) Structural basis for malfunction in complex II. J Biol Chem 287(42):35430&#x2013;35438. https://doi.org/10.1074/jbc.R112.408419</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.R112.408419</ArticleId><ArticleId IdType=\"pubmed\">22904323</ArticleId><ArticleId IdType=\"pmc\">3471735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Huang L, Shulmeister VM, Chi Y-I, Kim KK, Hung L-W, Crofts AR, Berry EA et al (1998) Electron transfer by domain movement in cytochrome Bc1. Nature 392(6677):677&#x2013;684. https://doi.org/10.1038/33612</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/33612</ArticleId><ArticleId IdType=\"pubmed\">9565029</ArticleId></ArticleIdList></Reference><Reference><Citation>Meunier B, Fisher N, Ransac S, Mazat J-P (1827) Brasseur G (2013) Respiratory complex III dysfunction in humans and the use of yeast as a model organism to study mitochondrial myopathy and associated diseases. Biochimica et Biophysica Acta (BBAs) - Bioenergetics 11&#x2013;12:1346&#x2013;1361 https://doi.org/10.1016/j.bbabio.2012.11.015</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbabio.2012.11.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell P (1961) Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 191(4784):144&#x2013;148. https://doi.org/10.1038/191144a0</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/191144a0</ArticleId><ArticleId IdType=\"pubmed\">13771349</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Sazanov LA (2019) Structure and conformational plasticity of the intact Thermus Thermophilus V/A-Type ATPase. Science 365(6455):eaaw9144 https://doi.org/10.1126/science.aaw9144</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.aaw9144</ArticleId><ArticleId IdType=\"pubmed\">31439765</ArticleId></ArticleIdList></Reference><Reference><Citation>Spikes TE, Montgomery MG, Walker JE (2020) Structure of the dimeric ATP synthase from bovine mitochondria. Proc Natl Acad Sci USA 117(38):23519&#x2013;23526. https://doi.org/10.1073/pnas.2013998117</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2013998117</ArticleId><ArticleId IdType=\"pubmed\">32900941</ArticleId><ArticleId IdType=\"pmc\">7519299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucharczyk R, Salin B, Di Rago J-P (2009) Introducing the human Leigh syndrome mutation T9176G into Saccharomyces cerevisiae mitochondrial DNA leads to severe defects in the incorporation of Atp6p into the ATP synthase and in the mitochondrial morphology. Hum Mol Genet 18(15):2889&#x2013;2898. https://doi.org/10.1093/hmg/ddp226</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddp226</ArticleId><ArticleId IdType=\"pubmed\">19454486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebanks B, Ingram TL, Chakrabarti L (2020) ATP synthase and Alzheimer&#x2019;s disease: putting a spin on the mitochondrial hypothesis. Aging 12(16):16647&#x2013;16662 https://doi.org/10.18632/aging.103867</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18632/aging.103867</ArticleId><ArticleId IdType=\"pubmed\">32853175</ArticleId><ArticleId IdType=\"pmc\">7485717</ArticleId></ArticleIdList></Reference><Reference><Citation>Mnatsakanyan N, Jonas EA (2020) The new role of F1Fo ATP synthase in mitochondria-mediated neurodegeneration and neuroprotection. Exp Neurol 332:113400. https://doi.org/10.1016/j.expneurol.2020.113400</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.expneurol.2020.113400</ArticleId><ArticleId IdType=\"pubmed\">32653453</ArticleId><ArticleId IdType=\"pmc\">7877222</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro S, Ratna S, Yamamoto HA, Ebenezer AT, Ferguson DS, Kaur A, McIntyre BC, Snow R et al (2021) ATP synsthase and mitochondrial bioenergetics dysfunction in Alzheimer&#x2019;s disease. IJMS 22(20):11185. https://doi.org/10.3390/ijms222011185</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms222011185</ArticleId><ArticleId IdType=\"pubmed\">34681851</ArticleId><ArticleId IdType=\"pmc\">8539681</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Wei X, Zhi X, Wang X, Meng D (2021) Drp1-dependent mitochondrial fission in cardiovascular disease. Acta Pharmacol Sin 42(5):655&#x2013;664. https://doi.org/10.1038/s41401-020-00518-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41401-020-00518-y</ArticleId><ArticleId IdType=\"pubmed\">32913266</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra K, Wunder C, Roysam B, Lin G, Lippincott-Schwartz J (2009) A Hyperfused mitochondrial state achieved at G <sub>1</sub> &#x2013;S regulates cyclin E buildup and entry into S phase. Proc Natl Acad Sci USA 106(29):11960&#x2013;11965. https://doi.org/10.1073/pnas.0904875106</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0904875106</ArticleId><ArticleId IdType=\"pubmed\">19617534</ArticleId><ArticleId IdType=\"pmc\">2710990</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson SM, De Camilli P (2012) Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol 13(2):75&#x2013;88. https://doi.org/10.1038/nrm3266</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrm3266</ArticleId><ArticleId IdType=\"pubmed\">22233676</ArticleId><ArticleId IdType=\"pmc\">3519936</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilokani L, Nagashima S, Paupe V, Prudent J (2018) Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem 62(3):341&#x2013;360. https://doi.org/10.1042/EBC20170104</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/EBC20170104</ArticleId><ArticleId IdType=\"pubmed\">30030364</ArticleId><ArticleId IdType=\"pmc\">6056715</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Sha H, Ji D, Zhang HL, Chen D, Cao Y, Zhu J (2014) Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases. Cell 157(7):1591&#x2013;1604. https://doi.org/10.1016/j.cell.2014.04.042</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2014.04.042</ArticleId><ArticleId IdType=\"pubmed\">24949971</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Hattab AW, Suleiman J, Almannai M, Scaglia F (2018) Mitochondrial dynamics: biological roles, molecular machinery, and related diseases. Mol Genet Metab 125(4):315&#x2013;321. https://doi.org/10.1016/j.ymgme.2018.10.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ymgme.2018.10.003</ArticleId><ArticleId IdType=\"pubmed\">30361041</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingerman E, Perkins EM, Marino M, Mears JA, McCaffery JM, Hinshaw JE, Nunnari J (2005) Dnm1 forms spirals that are structurally tailored to fit mitochondria. J Cell Biol 170(7):1021&#x2013;1027. https://doi.org/10.1083/jcb.200506078</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.200506078</ArticleId><ArticleId IdType=\"pubmed\">16186251</ArticleId><ArticleId IdType=\"pmc\">2171542</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandre-Babbe S, Van Der Bliek AM (2008) The novel tail-anchored membrane protein mff controls mitochondrial and peroxisomal fission in mammalian cells. MBoC 19(6):2402&#x2013;2412. https://doi.org/10.1091/mbc.e07-12-1287</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1091/mbc.e07-12-1287</ArticleId><ArticleId IdType=\"pubmed\">18353969</ArticleId><ArticleId IdType=\"pmc\">2397315</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman JR, Webster BM, Mastronarde DN, Verhey KJ, Voeltz GK (2010) ER sliding dynamics and ER&#x2013;mitochondrial contacts occur on acetylated microtubules. J Cell Biol 190(3):363&#x2013;375. https://doi.org/10.1083/jcb.200911024</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.200911024</ArticleId><ArticleId IdType=\"pubmed\">20696706</ArticleId><ArticleId IdType=\"pmc\">2922647</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendl N, Occhipinti A, M&#xfc;ller M, Wild P, Dikic I, Reichert AS (2011) Mitophagy in yeast is independent of mitochondrial fission and requires the stress response gene WHI2. J Cell Sci 124(8):1339&#x2013;1350. https://doi.org/10.1242/jcs.076406</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1242/jcs.076406</ArticleId><ArticleId IdType=\"pubmed\">21429936</ArticleId></ArticleIdList></Reference><Reference><Citation>Adaniya H, Rudek B, Osipov T, Haxton DJ, Weber T, Rescigno TN, McCurdy CW, Belkacem A, et al (2011) Reply: Phys. Rev. Lett. 106(4): 049302 https://doi.org/10.1103/PhysRevLett.106.049302 .</Citation></Reference><Reference><Citation>Anand R, Wai T, Baker MJ, Kladt N, Schauss AC, Rugarli E, Langer T (2014) The i -AAA Protease YME1L and OMA1 Cleave OPA1 to balance mitochondrial fusion and fission. J Cell Biol 204(6):919&#x2013;929. https://doi.org/10.1083/jcb.201308006</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.201308006</ArticleId><ArticleId IdType=\"pubmed\">24616225</ArticleId><ArticleId IdType=\"pmc\">3998800</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi Y, Itoh K, Yamada T, Cerveny KL, Suzuki TL, Macdonald P, Frohman MA, Ramachandran R et al (2016) Coincident phosphatidic acid interaction restrains Drp1 in mitochondrial division. Mol Cell 63(6):1034&#x2013;1043. https://doi.org/10.1016/j.molcel.2016.08.013</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.molcel.2016.08.013</ArticleId><ArticleId IdType=\"pubmed\">27635761</ArticleId><ArticleId IdType=\"pmc\">5028122</ArticleId></ArticleIdList></Reference><Reference><Citation>Bereiter-Hahn J (1990) Behavior of mitochondria in the living cell. In International Review of Cytology; Elsevier 122: pp 1&#x2013;63 https://doi.org/10.1016/S0074-7696(08)61205-X .</Citation></Reference><Reference><Citation>Chan DC (2006) Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol 22(1):79&#x2013;99. https://doi.org/10.1146/annurev.cellbio.22.010305.104638</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev.cellbio.22.010305.104638</ArticleId><ArticleId IdType=\"pubmed\">16704336</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;chner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E et al (2004) Mutations in the mitochondrial GTPase Mitofusin 2 cause charcot-marie-tooth neuropathy type 2A. Nat Genet 36(5):449&#x2013;451. https://doi.org/10.1038/ng1341</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ng1341</ArticleId><ArticleId IdType=\"pubmed\">15064763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bereiter-Hahn J, V&#xf6;th M (1994) Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microscopy Res &amp; Technique 27(3):198&#x2013;219. https://doi.org/10.1002/jemt.1070270303</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jemt.1070270303</ArticleId></ArticleIdList></Reference><Reference><Citation>Frazier AE, Kiu C, Stojanovski D, Hoogenraad NJ, Ryan MT (2006) Mitochondrial morphology and distribution in mammalian cells. Biol Chem 387(12):1551&#x2013;1558. https://doi.org/10.1515/BC.2006.193</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1515/BC.2006.193</ArticleId><ArticleId IdType=\"pubmed\">17132100</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong S-Y, Seol D-W (2008) The role of mitochondria in apoptosis. BMB Rep 41(1):11&#x2013;22. https://doi.org/10.5483/BMBRep.2008.41.1.011</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5483/BMBRep.2008.41.1.011</ArticleId><ArticleId IdType=\"pubmed\">18304445</ArticleId></ArticleIdList></Reference><Reference><Citation>Wai T, Langer T (2016) Mitochondrial dynamics and metabolic regulation. Trends Endocrinol Metab 27(2):105&#x2013;117. https://doi.org/10.1016/j.tem.2015.12.001</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tem.2015.12.001</ArticleId><ArticleId IdType=\"pubmed\">26754340</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J-A, Shin N, Shin HJ, Yin Y, Kwon HH, Park H, Shin J, Kim SI et al (2021) Protective effects of ShcA protein silencing for photothrombotic cerebral infarction. Transl Stroke Res 12(5):866&#x2013;878. https://doi.org/10.1007/s12975-020-00874-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12975-020-00874-1</ArticleId><ArticleId IdType=\"pubmed\">33242144</ArticleId></ArticleIdList></Reference><Reference><Citation>Los&#xf3;n OC, Song Z, Chen H, Chan DC (2013) Fis1, Mff, MiD49, and MiD51 Mediate Drp1 recruitment in mitochondrial fission. MBoC 24(5):659&#x2013;667. https://doi.org/10.1091/mbc.e12-10-0721</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1091/mbc.e12-10-0721</ArticleId><ArticleId IdType=\"pubmed\">23283981</ArticleId><ArticleId IdType=\"pmc\">3583668</ArticleId></ArticleIdList></Reference><Reference><Citation>Detmer SA, Chan DC (2007) Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol 8(11):870&#x2013;879. https://doi.org/10.1038/nrm2275</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrm2275</ArticleId><ArticleId IdType=\"pubmed\">17928812</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Chan DC (2017) Mitochondrial dynamics in regulating the unique phenotypes of cancer and stem cells. Cell Metab 26(1):39&#x2013;48. https://doi.org/10.1016/j.cmet.2017.05.016</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2017.05.016</ArticleId><ArticleId IdType=\"pubmed\">28648983</ArticleId><ArticleId IdType=\"pmc\">5539982</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu R, Jin S, Lendahl U, Nist&#xe9;r M, Zha J (2019) Human Fis1 regulates mitochondrial dynamics through inhibition of the fusion machinery. The EMBO Journal 38(8):e99748 https://doi.org/10.15252/embj.201899748</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/embj.201899748</ArticleId><ArticleId IdType=\"pubmed\">30842096</ArticleId><ArticleId IdType=\"pmc\">6463211</ArticleId></ArticleIdList></Reference><Reference><Citation>Otera H, Wang C, Cleland MM, Setoguchi K, Yokota S, Youle RJ, Mihara K (2010) Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol 191(6):1141&#x2013;1158. https://doi.org/10.1083/jcb.201007152</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.201007152</ArticleId><ArticleId IdType=\"pubmed\">21149567</ArticleId><ArticleId IdType=\"pmc\">3002033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Varghese M, Yemul S, Pan Y, Cheng A, Marano P, Hassan S, Vempati P et al (2011) Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1&#x3b1;) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol Neurodegeneration 6(1):51. https://doi.org/10.1186/1750-1326-6-51</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1750-1326-6-51</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer CS, Osellame LD, Laine D, Koutsopoulos OS, Frazier AE, Ryan MT (2011) MiD49 and MiD51, New components of the mitochondrial fission machinery. EMBO Rep 12(6):565&#x2013;573. https://doi.org/10.1038/embor.2011.54</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/embor.2011.54</ArticleId><ArticleId IdType=\"pubmed\">21508961</ArticleId><ArticleId IdType=\"pmc\">3128275</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch KB, Bereiter-Hahn J, Wittig I, Schagger H, Jendrach M (2006) Mitochondrial dynamics generate equal distribution but patchwork localization of respiratory complex I. Mol Membr Biol 23(6):509&#x2013;520. https://doi.org/10.1080/09687860600877292</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/09687860600877292</ArticleId><ArticleId IdType=\"pubmed\">17127623</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobs S (2006) High resolution imaging of live mitochondria. Biochimica et Biophysica Acta (BBA)- Molecular Cell Research 1763(5&#x2013;6):561&#x2013;575 https://doi.org/10.1016/j.bbamcr.2006.04.004</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbamcr.2006.04.004</ArticleId><ArticleId IdType=\"pubmed\">16750866</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobs S, Schauss AC, Hell SW (2003) Photoconversion of matrix targeted GFP enables analysis of continuity and intermixing of the mitochondrial lumen. FEBS Lett 554(1&#x2013;2):194&#x2013;200. https://doi.org/10.1016/S0014-5793(03)01170-0</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0014-5793(03)01170-0</ArticleId><ArticleId IdType=\"pubmed\">14596939</ArticleId></ArticleIdList></Reference><Reference><Citation>Karbowski M, Arnoult D, Chen H, Chan DC, Smith CL, Youle RJ (2004) Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J Cell Biol 164(4):493&#x2013;499. https://doi.org/10.1083/jcb.200309082</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.200309082</ArticleId><ArticleId IdType=\"pubmed\">14769861</ArticleId><ArticleId IdType=\"pmc\">2172000</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakada K, Inoue K, Ono T, Isobe K, Ogura A, Goto Y-I, Nonaka I, Hayashi J-I (2001) Inter-mitochondrial complementation: mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA. Nat Med 7(8):934&#x2013;940. https://doi.org/10.1038/90976</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/90976</ArticleId><ArticleId IdType=\"pubmed\">11479626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono T, Isobe K, Nakada K, Hayashi J-I (2001) Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria. Nat Genet 28(3):272&#x2013;275. https://doi.org/10.1038/90116.(181)</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/90116.(181)</ArticleId><ArticleId IdType=\"pubmed\">11431699</ArticleId></ArticleIdList></Reference><Reference><Citation>Twig G, Graf SA, Wikstrom JD, Mohamed H, Haigh SE, Elorza A, Deutsch M, Zurgil N et al (2006) Tagging and tracking individual networks within a complex mitochondrial web with photoactivatable GFP. Am J Physiol Cell Physiol 291(1):C176&#x2013;C184. https://doi.org/10.1152/ajpcell.00348.2005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpcell.00348.2005</ArticleId><ArticleId IdType=\"pubmed\">16481372</ArticleId></ArticleIdList></Reference><Reference><Citation>Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Gr&#xe4;ber S, Kovacs I, Lee WD et al (2006) Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 25(16):3900&#x2013;3911. https://doi.org/10.1038/sj.emboj.7601253</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.emboj.7601253</ArticleId><ArticleId IdType=\"pubmed\">16874299</ArticleId><ArticleId IdType=\"pmc\">1553198</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes LC, Scorrano L (2008) High levels of Fis1, a pro-fission mitochondrial protein, trigger autophagy. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1777(7&#x2013;8):860&#x2013;866 https://doi.org/10.1016/j.bbabio.2008.05.442</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbabio.2008.05.442</ArticleId><ArticleId IdType=\"pubmed\">18515060</ArticleId></ArticleIdList></Reference><Reference><Citation>Malena A, Loro E, Di Re M, Holt IJ, Vergani L (2009) Inhibition of mitochondrial fission favours mutant over wild-type mitochondrial DNA. Hum Mol Genet 18(18):3407&#x2013;3416. https://doi.org/10.1093/hmg/ddp281</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddp281</ArticleId><ArticleId IdType=\"pubmed\">19561330</ArticleId></ArticleIdList></Reference><Reference><Citation>Suen D-F, Narendra DP, Tanaka A, Manfredi G, Youle RJ (2010) Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells. Proc Natl Acad Sci USA 107(26):11835&#x2013;11840. https://doi.org/10.1073/pnas.0914569107</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0914569107</ArticleId><ArticleId IdType=\"pubmed\">20547844</ArticleId><ArticleId IdType=\"pmc\">2900690</ArticleId></ArticleIdList></Reference><Reference><Citation>Twig G, Elorza A, Molina AJA, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE et al (2008) Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27(2):433&#x2013;446. https://doi.org/10.1038/sj.emboj.7601963</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/sj.emboj.7601963</ArticleId><ArticleId IdType=\"pubmed\">18200046</ArticleId><ArticleId IdType=\"pmc\">2234339</ArticleId></ArticleIdList></Reference><Reference><Citation>Amchenkova AA, Bakeeva LE, Chentsov YS, Skulachev VP, Zorov DB (1988) Coupling Membranes as Energy-Transmitting Cables. I. Filamentous mitochondria in fibroblasts and mitochondrial clusters in cardiomyocytes. The Journal of cell biology 107(2):481&#x2013;495 https://doi.org/10.1083/jcb.107.2.481</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.107.2.481</ArticleId><ArticleId IdType=\"pubmed\">3417757</ArticleId></ArticleIdList></Reference><Reference><Citation>Aon MA, Cortassa S, O&#x2019;Rourke B (2004) Percolation and criticality in a mitochondrial network. Proc Natl Acad Sci USA 101(13):4447&#x2013;4452. https://doi.org/10.1073/pnas.0307156101</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0307156101</ArticleId><ArticleId IdType=\"pubmed\">15070738</ArticleId><ArticleId IdType=\"pmc\">384767</ArticleId></ArticleIdList></Reference><Reference><Citation>Frieden M, James D, Castelbou C, Danckaert A, Martinou J-C, Demaurex N (2004) Ca2+ Homeostasis during mitochondrial fragmentation and perinuclear clustering induced by hFis1. J Biol Chem 279(21):22704&#x2013;22714. https://doi.org/10.1074/jbc.M312366200</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M312366200</ArticleId><ArticleId IdType=\"pubmed\">15024001</ArticleId></ArticleIdList></Reference><Reference><Citation>Skulachev VP (2001) Mitochondrial filaments and clusters as intracellular power-transmitting cables. Trends Biochem Sci 26(1):23&#x2013;29. https://doi.org/10.1016/S0968-0004(00)01735-7</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0968-0004(00)01735-7</ArticleId><ArticleId IdType=\"pubmed\">11165513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kameoka S, Adachi Y, Okamoto K, Iijima M, Sesaki H (2018) Phosphatidic acid and cardiolipin coordinate mitochondrial dynamics. Trends Cell Biol 28(1):67&#x2013;76. https://doi.org/10.1016/j.tcb.2017.08.011</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tcb.2017.08.011</ArticleId><ArticleId IdType=\"pubmed\">28911913</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Hajn&#xf3;czky G (2009) Ca2+-dependent regulation of mitochondrial dynamics by the Miro-Milton complex. Int J Biochem Cell Biol 41(10):1972&#x2013;1976. https://doi.org/10.1016/j.biocel.2009.05.013</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biocel.2009.05.013</ArticleId><ArticleId IdType=\"pubmed\">19481172</ArticleId><ArticleId IdType=\"pmc\">2742205</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer JN, Leuthner TC, Luz AL (2017) Mitochondrial fusion, fission, and mitochondrial toxicity. Toxicology 391:42&#x2013;53. https://doi.org/10.1016/j.tox.2017.07.019</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tox.2017.07.019</ArticleId><ArticleId IdType=\"pubmed\">28789970</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan DC (2020) Mitochondrial dynamics and its involvement in disease. Annu Rev Pathol Mech Dis 15(1):235&#x2013;259. https://doi.org/10.1146/annurev-pathmechdis-012419-032711</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-pathmechdis-012419-032711</ArticleId></ArticleIdList></Reference><Reference><Citation>Pernas L, Scorrano L (2016) Mito-Morphosis: mitochondrial fusion, fission, and cristae remodeling as key mediators of cellular function. Annu Rev Physiol 78(1):505&#x2013;531. https://doi.org/10.1146/annurev-physiol-021115-105011</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-physiol-021115-105011</ArticleId><ArticleId IdType=\"pubmed\">26667075</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchis-Gomar F, Garcia-Gimenez J, Gomez-Cabrera M, Pallardo F (2014) Mitochondrial biogenesis in health and disease. Molecular and Therapeutic Approaches CPD 20(35):5619&#x2013;5633. https://doi.org/10.2174/1381612820666140306095106</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1381612820666140306095106</ArticleId></ArticleIdList></Reference><Reference><Citation>Uittenbogaard M, Chiaramello A (2014) Mitochondrial biogenesis: a therapeutic target for neurodevelopmental disorders and neurodegenerative diseases. CPD 20(35):5574&#x2013;5593. https://doi.org/10.2174/1381612820666140305224906</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1381612820666140305224906</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan M, Yin L, Reddy PH, Benamar K (2022) Behavioral evidence for a Tau and HIV-Gp120 interaction. IJMS 23(10):5514. https://doi.org/10.3390/ijms23105514</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23105514</ArticleId><ArticleId IdType=\"pubmed\">35628323</ArticleId><ArticleId IdType=\"pmc\">9146203</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan M, George M, Bunquin LE, Bose C, Reddy PH (2022) protective effects of a small-molecule inhibitor DDQ against Tau-induced toxicities in a transgenic Tau mouse model of Alzheimer&#x2019;s disease. Hum Mol Genet 31(7):1022&#x2013;1034. https://doi.org/10.1093/hmg/ddab285</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddab285</ArticleId><ArticleId IdType=\"pubmed\">34559191</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Chen M, Jiang J (2019) Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion 49:35&#x2013;45s https://doi.org/10.1016/j.mito.2019.07.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mito.2019.07.003</ArticleId><ArticleId IdType=\"pubmed\">31288090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson&#x2019;s disease. J Neurochem 139(S1):216&#x2013;231. https://doi.org/10.1111/jnc.13731</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jnc.13731</ArticleId><ArticleId IdType=\"pubmed\">27546335</ArticleId></ArticleIdList></Reference><Reference><Citation>Hroudov&#xe1; J, Singh N, Fi&#x161;ar Z (2014) Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer&#x2019;s disease. Biomed Res Int 2014:1&#x2013;9. https://doi.org/10.1155/2014/175062</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2014/175062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr JS, Adriaanse BA, Greig NH, Mattson MP, Cader MZ, Bohr VA, Fang EF (2017) Mitophagy and Alzheimer&#x2019;s disease: cellular and molecular mechanisms. Trends Neurosci 40(3):151&#x2013;166. https://doi.org/10.1016/j.tins.2017.01.002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.tins.2017.01.002</ArticleId><ArticleId IdType=\"pubmed\">28190529</ArticleId><ArticleId IdType=\"pmc\">5341618</ArticleId></ArticleIdList></Reference><Reference><Citation>Annesley SJ, Fisher PR (2021) Lymphoblastoid cell lines as models to study mitochondrial function in neurological disorders. IJMS 22(9):4536. https://doi.org/10.3390/ijms22094536</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22094536</ArticleId><ArticleId IdType=\"pubmed\">33926115</ArticleId><ArticleId IdType=\"pmc\">8123577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinovkina LA (2018) Mechanisms of mitochondrial DNA repair in mammals. Biochemistry Moscow 83(3):233&#x2013;249. https://doi.org/10.1134/S0006297918030045</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1134/S0006297918030045</ArticleId><ArticleId IdType=\"pubmed\">29625543</ArticleId></ArticleIdList></Reference><Reference><Citation>Allkanjari K, Baldock RA (2021) Beyond base excision repair: an evolving picture of mitochondrial DNA repair. Bioscience Reports 41(10):BSR20211320 https://doi.org/10.1042/BSR20211320</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/BSR20211320</ArticleId><ArticleId IdType=\"pubmed\">34608928</ArticleId><ArticleId IdType=\"pmc\">8527207</ArticleId></ArticleIdList></Reference><Reference><Citation>Coskun PE, Beal MF, Wallace DC (2004) Alzheimer&#x2019;s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 101(29):10726&#x2013;10731. https://doi.org/10.1073/pnas.0403649101</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.0403649101</ArticleId><ArticleId IdType=\"pubmed\">15247418</ArticleId><ArticleId IdType=\"pmc\">490002</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U (2010) Amyloid-&#x3b2; and mitochondria in aging and Alzheimer&#x2019;s disease: implications for synaptic damage and cognitive decline. JAD 20(s2):S499&#x2013;S512. https://doi.org/10.3233/JAD-2010-100504</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-2010-100504</ArticleId><ArticleId IdType=\"pubmed\">20413847</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcelino LA, Thilly WG (1999) Mitochondrial mutagenesis in human cells and tissues. Mutation Research/DNA Repair 434(3):177&#x2013;203. https://doi.org/10.1016/S0921-8777(99)00028-2</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0921-8777(99)00028-2</ArticleId><ArticleId IdType=\"pubmed\">10486591</ArticleId></ArticleIdList></Reference><Reference><Citation>Su B, Wang X, Zheng L, Perry G, Smith MA (1802) Zhu X 2010 Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1:135&#x2013;142sss https://doi.org/10.1016/j.bbadis.2009.09.013</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2009.09.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuppen HAL, Blakely EL, Turnbull DM, Taylor RW (2010) Mitochondrial DNA mutations and human disease. Biochimica et Biophysica Acta (BBAss) - Bioenergetics 1797(2):113&#x2013;128 https://doi.org/10.1016/j.bbabio.2009.09.005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbabio.2009.09.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS et al (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38(5):515&#x2013;517. https://doi.org/10.1038/ng1769</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ng1769</ArticleId><ArticleId IdType=\"pubmed\">16604074</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson N-G (2010) Somatic mitochondrial DNA mutations in mammalian aging. Annu Rev Biochem 79(1):683&#x2013;706. https://doi.org/10.1146/annurev-biochem-060408-093701</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-biochem-060408-093701</ArticleId><ArticleId IdType=\"pubmed\">20350166</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148(6):1145&#x2013;1159. https://doi.org/10.1016/j.cell.2012.02.035</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cell.2012.02.035</ArticleId><ArticleId IdType=\"pubmed\">22424226</ArticleId><ArticleId IdType=\"pmc\">5381524</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman BA, Durisic N, Mativetsky JM, Costantino S, Hancock MA, Grutter P, Shoubridge EA (2007) The mitochondrial transcription factor TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like structures. MBoC 18(9):3225&#x2013;3236. https://doi.org/10.1091/mbc.e07-05-0404</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1091/mbc.e07-05-0404</ArticleId><ArticleId IdType=\"pubmed\">17581862</ArticleId><ArticleId IdType=\"pmc\">1951767</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson CM, Falkenberg M, Larsson N-G (2016) Maintenance and expression of mammalian mitochondrial DNA. Annu Rev Biochem 85(1):133&#x2013;160. https://doi.org/10.1146/annurev-biochem-060815-014402</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-biochem-060815-014402</ArticleId><ArticleId IdType=\"pubmed\">27023847</ArticleId></ArticleIdList></Reference><Reference><Citation>Litonin D, Sologub M, Shi Y, Savkina M, Anikin M, Falkenberg M, Gustafsson CM, Temiakov D (2010) Human mitochondrial transcription revisited. J Biol Chem 285(24):18129&#x2013;18133. https://doi.org/10.1074/jbc.C110.128918</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.C110.128918</ArticleId><ArticleId IdType=\"pubmed\">20410300</ArticleId><ArticleId IdType=\"pmc\">2881736</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter B, Waddington CL, Ol&#xe1;hov&#xe1; M, Sommerville EW, Hopton S, Pyle A, Champion M, Ohlson M et al (2018) Defective mitochondrial protease LonP1 can cause classical mitochondrial disease. Hum Mol Genet 27(10):1743&#x2013;1753. https://doi.org/10.1093/hmg/ddy080</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddy080</ArticleId><ArticleId IdType=\"pubmed\">29518248</ArticleId><ArticleId IdType=\"pmc\">5932559</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson EM, Rehman AU, Walsh T, Clayton-Smith J, Lee K, Morell RJ, Drummond MC, Khan SN et al (2013) Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease. The American Journal of Human Genetics 92(4):605&#x2013;613. https://doi.org/10.1016/j.ajhg.2013.02.013</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajhg.2013.02.013</ArticleId><ArticleId IdType=\"pubmed\">23541340</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzispyrou IA, Alders M, Guerrero-Castillo S, Zapata Perez R, Haagmans MA, Mouchiroud L, Koster J, Ofman R et al (2017) A homozygous missense mutation in ERAL1, encoding a mitochondrial rRNA chaperone, causes Perrault syndrome. Hum Mol Genet 26(13):2541&#x2013;2550. https://doi.org/10.1093/hmg/ddx152</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddx152</ArticleId><ArticleId IdType=\"pubmed\">28449065</ArticleId><ArticleId IdType=\"pmc\">5965403</ArticleId></ArticleIdList></Reference><Reference><Citation>Monzio Compagnoni G, Di Fonzo A, Corti S, Comi GP, Bresolin N, Masliah E (2020) The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease. Mol Neurobiol 57(7):2959&#x2013;2980. https://doi.org/10.1007/s12035-020-01926-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-020-01926-1</ArticleId><ArticleId IdType=\"pubmed\">32445085</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17(3):157&#x2013;172. https://doi.org/10.1038/s41582-020-00435-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41582-020-00435-y</ArticleId><ArticleId IdType=\"pubmed\">33318676</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan SH, Karri V, Tay NWR, Chang KH, Ah HY, Ng PQ, Ho HS, Keh HW et al (2019) Emerging pathways to neurodegeneration: dissecting the critical molecular mechanisms in Alzheimer&#x2019;s disease. Parkinson&#x2019;s disease Biomed Pharmacother 111:765&#x2013;777. https://doi.org/10.1016/j.biopha.2018.12.101</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.biopha.2018.12.101</ArticleId><ArticleId IdType=\"pubmed\">30612001</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan M, Reddy PH (2016) Stroke, vascular dementia, and Alzheimer&#x2019;s disease: molecular links. J Alzheimers Dis 54(2):427&#x2013;443. https://doi.org/10.3233/JAD-160527</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-160527</ArticleId><ArticleId IdType=\"pubmed\">27567871</ArticleId><ArticleId IdType=\"pmc\">5793908</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS &#x3b2;-amyloid in Alzheimer&#x2019;s disease. Science 330(6012):1774&#x2013;1774. https://doi.org/10.1126/science.1197623</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1197623</ArticleId><ArticleId IdType=\"pubmed\">21148344</ArticleId><ArticleId IdType=\"pmc\">3073454</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiederholt R, Stainback GA, Paudel R, Khare Y, Naja M, Davis SE, Van Lent T (2020) Economic valuation of the ecological response to hydrologic restoration in the greater everglades ecosystem. Ecol Ind 117:106678. https://doi.org/10.1016/j.ecolind.2020.106678</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ecolind.2020.106678</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi RK, Flint Beal M (2013) Mitochondrial diseases of the brain. Free Radical Biol Med 63:1&#x2013;29. https://doi.org/10.1016/j.freeradbiomed.2013.03.018</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.freeradbiomed.2013.03.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S, Rauk A (2005) Alzheimer&#x2019;s disease and the &#x2018;ABSENT&#x2019; hypothesis: mechanism for amyloid &#x3b2; endothelial and neuronal toxicity. Med Hypotheses 65(1):123&#x2013;137. https://doi.org/10.1016/j.mehy.2004.08.031</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2004.08.031</ArticleId><ArticleId IdType=\"pubmed\">15893129</ArticleId></ArticleIdList></Reference><Reference><Citation>Du H, Guo L, Yan S, Sosunov AA, McKhann GM, ShiDu Yan S (2010) Early deficits in synaptic mitochondria in an Alzheimer&#x2019;s disease mouse model. Proc Natl Acad Sci USA 107(43):18670&#x2013;18675. https://doi.org/10.1073/pnas.1006586107</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1006586107</ArticleId><ArticleId IdType=\"pubmed\">20937894</ArticleId><ArticleId IdType=\"pmc\">2972922</ArticleId></ArticleIdList></Reference><Reference><Citation>Herholz K (2012) Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer&#x2019;s disease. Biomark Med 6(4):431&#x2013;439. https://doi.org/10.2217/bmm.12.51</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2217/bmm.12.51</ArticleId><ArticleId IdType=\"pubmed\">22917145</ArticleId></ArticleIdList></Reference><Reference><Citation>Manczak M, Kandimalla R, Yin X, Reddy PH (2018) Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer&#x2019;s disease. Hum Mol Genet 27(8):1332&#x2013;1342. https://doi.org/10.1093/hmg/ddy042</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddy042</ArticleId><ArticleId IdType=\"pubmed\">29408999</ArticleId><ArticleId IdType=\"pmc\">6455948</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmstr&#xf6;m KM, Kostov RV, Dinkova-Kostova AT (2016) The multifaceted role of Nrf2 in mitochondrial function. Current Opinion in Toxicology 1:80&#x2013;91. https://doi.org/10.1016/j.cotox.2016.10.002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cotox.2016.10.002</ArticleId><ArticleId IdType=\"pubmed\">28066829</ArticleId><ArticleId IdType=\"pmc\">5193490</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu G-Q et al (2007) Reducing endogenous Tau ameliorates amyloid ss-induced deficits in an Alzheimer&#x2019;s disease mouse model. Science 316(5825):750&#x2013;754. https://doi.org/10.1126/science.1141736</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.1141736</ArticleId><ArticleId IdType=\"pubmed\">17478722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamat PK, Kalani A, Rai S, Swarnkar S, Tota S, Nath C, Tyagi N (2016) Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer&#x2019;s disease: understanding the therapeutics strategies. Mol Neurobiol 53(1):648&#x2013;661. https://doi.org/10.1007/s12035-014-9053-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-014-9053-6</ArticleId><ArticleId IdType=\"pubmed\">25511446</ArticleId></ArticleIdList></Reference><Reference><Citation>Mani C, Acharya G, Kshirsagar S, Vijayan M, Khan H, Reddy PH, Palle K (2022) A novel role for BRIP1/FANCJ in neuronal cells health and in resolving oxidative stress-induced DNA lesions. J Alzheimers Dis 85(1):207&#x2013;221. https://doi.org/10.3233/JAD-215305</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-215305</ArticleId><ArticleId IdType=\"pubmed\">34776453</ArticleId></ArticleIdList></Reference><Reference><Citation>Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA (2002) &#x3b2;-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 80(1):91&#x2013;100. https://doi.org/10.1046/j.0022-3042.2001.00681.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1046/j.0022-3042.2001.00681.x</ArticleId><ArticleId IdType=\"pubmed\">11796747</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer&#x2019;s disease. Redox Biol 14:450&#x2013;464. https://doi.org/10.1016/j.redox.2017.10.014</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.redox.2017.10.014</ArticleId><ArticleId IdType=\"pubmed\">29080524</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Yin Y-L, Liu X-Z, Shen P, Zheng Y-G, Lan X-R, Lu C-B, Wang J-Z (2020) Current understanding of metal ions in the pathogenesis of Alzheimer&#x2019;s disease. Transl Neurodegener 9(1):10. https://doi.org/10.1186/s40035-020-00189-z</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40035-020-00189-z</ArticleId><ArticleId IdType=\"pubmed\">32266063</ArticleId><ArticleId IdType=\"pmc\">7119290</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Hassan DW, Li X, Ryan EI, Acott TS, Kelley MJ (2015) Induced pluripotent stem cells restore function in a human cell loss model of open-angle glaucoma. Stem Cells 33(3):751&#x2013;761. https://doi.org/10.1002/stem.1885</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/stem.1885</ArticleId><ArticleId IdType=\"pubmed\">25377070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelleher RJ, Soiza RL (2013) Evidence of endothelial dysfunction in the development of Alzheimer&#x2019;s disease: is Alzheimer&#x2019;s a vascular disorder? Am J Cardiovasc Dis 3(4):197&#x2013;226</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24224133</ArticleId><ArticleId IdType=\"pmc\">3819581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer&#x2019;s disease. Journal of Neuroscience 29(28):9090&#x2013;9103s https://doi.org/10.1523/JNEUROSCI.1357-09.2009</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1357-09.2009</ArticleId><ArticleId IdType=\"pubmed\">19605646</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho D-H, Nakamura T, Lipton SA (2010) Mitochondrial dynamics in cell death and neurodegeneration. Cell Mol Life Sci 67(20):3435&#x2013;3447. https://doi.org/10.1007/s00018-010-0435-2</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00018-010-0435-2</ArticleId><ArticleId IdType=\"pubmed\">20577776</ArticleId><ArticleId IdType=\"pmc\">11115814</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan M, Bose C, Reddy PH (2021) Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer&#x2019;s disease. Mitochondrion 59:17&#x2013;29. https://doi.org/10.1016/j.mito.2021.04.005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mito.2021.04.005</ArticleId><ArticleId IdType=\"pubmed\">33839321</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno AM, Huang JY, Bennett DA, Marr RA, Hastings ML, Stutzmann GE (2012) Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer&#x2019;s disease. Neurobiol Aging 33(5):1001.e1-1001.e6. https://doi.org/10.1016/j.neurobiolaging.2011.03.011</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2011.03.011</ArticleId><ArticleId IdType=\"pubmed\">21531043</ArticleId></ArticleIdList></Reference><Reference><Citation>Paula-Lima AC, Adasme T, SanMart&#xed;n C, Sebollela A, Hetz C, Carrasco MA, Ferreira ST, Hidalgo C (2011) Amyloid &#x3b2;-peptide oligomers stimulate RyR-mediated Ca <sup>2+</sup> release inducing mitochondrial fragmentation in hippocampal neurons and prevent RyR-mediated dendritic spine remodeling produced by BDNF. Antioxid Redox Signal 14(7):1209&#x2013;1223. https://doi.org/10.1089/ars.2010.3287</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/ars.2010.3287</ArticleId><ArticleId IdType=\"pubmed\">20712397</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakroborty S, Goussakov I, Miller MB, Stutzmann GE (2009) Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice. J Neurosci 29(30):9458&#x2013;9470. https://doi.org/10.1523/JNEUROSCI.2047-09.2009</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.2047-09.2009</ArticleId><ArticleId IdType=\"pubmed\">19641109</ArticleId><ArticleId IdType=\"pmc\">6666542</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Zhang H, Liu J, Popugaeva E, Xu N-J, Feske S, White CL, Bezprozvanny I (2014) Reduced synaptic STIM2 expression and impaired store-operated calcium entry cause destabilization of mature spines in mutant presenilin mice. Neuron 82(1):79&#x2013;93. https://doi.org/10.1016/j.neuron.2014.02.019</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2014.02.019</ArticleId><ArticleId IdType=\"pubmed\">24698269</ArticleId><ArticleId IdType=\"pmc\">4007018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Yu J, Chen Y, Liu L, Xu M, Sun L, Luo H, Wang Y et al (2018) Exogenous hydrogen sulfide supplement attenuates isoproterenol-induced myocardial hypertrophy in a sirtuin 3-dependent manner. Oxid Med Cell Longev 2018:1&#x2013;17. https://doi.org/10.1155/2018/9396089</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2018/9396089</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Perry G, Smith MA, Robertson D, Olson SJ, Graham DG, Montine TJ (1999) Parkinson&#x2019;s disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol 154(5):1423&#x2013;1429. https://doi.org/10.1016/S0002-9440(10)65396-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0002-9440(10)65396-5</ArticleId><ArticleId IdType=\"pubmed\">10329595</ArticleId><ArticleId IdType=\"pmc\">1866598</ArticleId></ArticleIdList></Reference><Reference><Citation>Puspita L, Chung SY, Shim J (2017) Oxidative stress and cellular pathologies in Parkinson&#x2019;s disease. Mol Brain 10(1):53. https://doi.org/10.1186/s13041-017-0340-9</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13041-017-0340-9</ArticleId><ArticleId IdType=\"pubmed\">29183391</ArticleId><ArticleId IdType=\"pmc\">5706368</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjari Moghaddam H, Valitabar Z, Ashraf-Ganjouei A, Mojtahed Zadeh M, Ghazi Sherbaf F, Aarabi MH (2018) Cerebrospinal fluid C-reactive protein in Parkinson&#x2019;s disease: associations with motor and non-motor symptoms. Neuromol Med 20(3):376&#x2013;385. https://doi.org/10.1007/s12017-018-8499-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12017-018-8499-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira ELG, Rial D, Aguiar AS, Figueiredo CP, Siqueira JM, DalB&#xf3; S, Horst H, De Oliveira J et al (2010) Proanthocyanidin-rich fraction from croton Celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson&#x2019;s disease. J Neural Transm 117(12):1337&#x2013;1351. https://doi.org/10.1007/s00702-010-0464-x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00702-010-0464-x</ArticleId><ArticleId IdType=\"pubmed\">20931248</ArticleId></ArticleIdList></Reference><Reference><Citation>Rani L, Mondal AC (2020) Emerging concepts of mitochondrial dysfunction in Parkinson&#x2019;s disease progression: pathogenic and therapeutic implications. Mitochondrion 50:25&#x2013;34. https://doi.org/10.1016/j.mito.2019.09.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mito.2019.09.010</ArticleId><ArticleId IdType=\"pubmed\">31654753</ArticleId></ArticleIdList></Reference><Reference><Citation>Narendra D, Tanaka A, Suen D-F, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183(5):795&#x2013;803. https://doi.org/10.1083/jcb.200809125</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.200809125</ArticleId><ArticleId IdType=\"pubmed\">19029340</ArticleId><ArticleId IdType=\"pmc\">2592826</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler S, Holmstr&#xf6;m KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, Springer W (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and P62/SQSTM1. Nat Cell Biol 12(2):119&#x2013;131. https://doi.org/10.1038/ncb2012</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/ncb2012</ArticleId><ArticleId IdType=\"pubmed\">20098416</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Suaga P, Bravo-San Pedro JM, Gonz&#xe1;lez-Polo RA, Fuentes JM, Niso-Santano M (2018) ER&#x2013;mitochondria signaling in Parkinson&#x2019;s disease. Cell Death Dis 9(3):337. https://doi.org/10.1038/s41419-017-0079-3</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41419-017-0079-3</ArticleId><ArticleId IdType=\"pubmed\">29497039</ArticleId><ArticleId IdType=\"pmc\">5832754</ArticleId></ArticleIdList></Reference><Reference><Citation>Oczkowska A, Kozubski W, Lianeri M, Dorszewska J (2014) Mutations in PRKN and SNCA genes important for the progress of Parkinson&#x2019;s disease. CG 14(8): 502&#x2013;517 https://doi.org/10.2174/1389202914666131210205839 .</Citation></Reference><Reference><Citation>Pandi S, Chinniah R, Sevak V, Ravi PM, Vijayan M, Vellaiappan NA, Karuppiah B (2020) Association of slow acetylator genotype of N-acetyltransferase 2 with Parkinson&#x2019;s disease in south Indian population. Neurosci Lett 735:135260. https://doi.org/10.1016/j.neulet.2020.135260</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2020.135260</ArticleId><ArticleId IdType=\"pubmed\">32682841</ArticleId></ArticleIdList></Reference><Reference><Citation>Youle RJ, Narendra DP (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12(1):9&#x2013;14. https://doi.org/10.1038/nrm3028</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrm3028</ArticleId><ArticleId IdType=\"pubmed\">21179058</ArticleId><ArticleId IdType=\"pmc\">4780047</ArticleId></ArticleIdList></Reference><Reference><Citation>Inamdar N, Arulmozhi D, Tandon A, Bodhankar S (2007) Parkinsons disease: genetics and beyond. CN 5(2):99&#x2013;113 https://doi.org/10.2174/157015907780866893</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/157015907780866893</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Sleiman PM, Muqit MMK, Wood NW (2006) Expanding insights of mitochondrial dysfunction in Parkinson&#x2019;s disease. Nat Rev Neurosci 7(3):207&#x2013;219. https://doi.org/10.1038/nrn1868</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nrn1868</ArticleId><ArticleId IdType=\"pubmed\">16495942</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin I, Dawson VL, Dawson TM (2011) Recent advances in the genetics of Parkinson&#x2019;s disease. Annu Rev Genom Hum Genet 12(1):301&#x2013;325. https://doi.org/10.1146/annurev-genom-082410-101440</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1146/annurev-genom-082410-101440</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai S, Juncker M, Kim C (2018) Regulation of Mitophagy by the ubiquitin pathway in neurodegenerative diseases. Exp Biol Med (Maywood) 243(6):554&#x2013;562. https://doi.org/10.1177/1535370217752351</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1535370217752351</ArticleId><ArticleId IdType=\"pubmed\">29316798</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler D, Bahr BA (2006) Oxidative stress and lysosomes: CNS-related consequences and implications for lysosomal enhancement strategies and induction of autophagy. Antioxid Redox Signal 8(1&#x2013;2):185&#x2013;196. https://doi.org/10.1089/ars.2006.8.185</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/ars.2006.8.185</ArticleId><ArticleId IdType=\"pubmed\">16487052</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagda RK, Cherra SJ, Kulich SM, Tandon A, Park D, Chu CT (2009) Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 284(20):13843&#x2013;13855. https://doi.org/10.1074/jbc.M808515200</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M808515200</ArticleId><ArticleId IdType=\"pubmed\">19279012</ArticleId><ArticleId IdType=\"pmc\">2679485</ArticleId></ArticleIdList></Reference><Reference><Citation>Pryde KR, Smith HL, Chau K-Y, Schapira AHV (2016) PINK1 disables the anti-fission machinery to segregate damaged mitochondria for mitophagy. J Cell Biol 213(2):163&#x2013;171. https://doi.org/10.1083/jcb.201509003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1083/jcb.201509003</ArticleId><ArticleId IdType=\"pubmed\">27091447</ArticleId><ArticleId IdType=\"pmc\">5084273</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Hattori N, Matsumine H, Kobayashi T, Yoshino H, Morioka A, Kitada T, Asakawa S et al (1999) Polymorphism in Theparkin gene in sporadic Parkinson&#x2019;s disease. Ann Neurol 45(5):655&#x2013;658. https://doi.org/10.1002/1531-8249(199905)45:5%3c655::AID-ANA15%3e3.0.CO;2-G</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/1531-8249(199905)45:5&lt;655::AID-ANA15&gt;3.0.CO;2-G</ArticleId><ArticleId IdType=\"pubmed\">10319889</ArticleId></ArticleIdList></Reference><Reference><Citation>Isobe C, Abe T, Terayama Y (2010) Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2&#x2032;-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson&#x2019;s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. Neurosci Lett 469(1):159&#x2013;163. https://doi.org/10.1016/j.neulet.2009.11.065</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2009.11.065</ArticleId><ArticleId IdType=\"pubmed\">19944739</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeve AK, Ludtmann MH, Angelova PR, Simcox EM, Horrocks MH, Klenerman D, Gandhi S, Turnbull DM et al (2015) Aggregated &#x3b1;-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons. Cell Death Dis 6(7):e1820&#x2013;e1820. https://doi.org/10.1038/cddis.2015.166</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/cddis.2015.166</ArticleId><ArticleId IdType=\"pubmed\">26181201</ArticleId><ArticleId IdType=\"pmc\">4650719</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao X, Wang F, Becerra-Calixto A, Soto C, Mukherjee A (2021) Induced pluripotent stem cell-derived dopaminergic neurons from familial Parkinson&#x2019;s disease patients display &#x3b1;-synuclein pathology and abnormal mitochondrial morphology. Cells 10(9):2402. https://doi.org/10.3390/cells10092402</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells10092402</ArticleId><ArticleId IdType=\"pubmed\">34572052</ArticleId><ArticleId IdType=\"pmc\">8467069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidransky E, Lopez G (2012) The link between the GBA gene and parkinsonism. The Lancet Neurology 11(11):986&#x2013;998. https://doi.org/10.1016/S1474-4422(12)70190-4</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(12)70190-4</ArticleId><ArticleId IdType=\"pubmed\">23079555</ArticleId><ArticleId IdType=\"pmc\">4141416</ArticleId></ArticleIdList></Reference><Reference><Citation>Osellame LD, Rahim AA, Hargreaves IP, Gegg ME, Richard-Londt A, Brandner S, Waddington SN, Schapira AHV et al (2013) mitochondria and quality control defects in a mouse model of Gaucher disease&#x2014;links to Parkinson&#x2019;s disease. Cell Metab 17(6):941&#x2013;953. https://doi.org/10.1016/j.cmet.2013.04.014</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cmet.2013.04.014</ArticleId><ArticleId IdType=\"pubmed\">23707074</ArticleId><ArticleId IdType=\"pmc\">3678026</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith L, Schapira AHV (2022) GBA Variants and Parkinson disease: mechanisms and treatments. Cells 11(8):1261. https://doi.org/10.3390/cells11081261</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells11081261</ArticleId><ArticleId IdType=\"pubmed\">35455941</ArticleId><ArticleId IdType=\"pmc\">9029385</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy KR, Kadlec RH, Flaig E, Gale PM (1999) Phosphorus retention in streams and wetlands: a review. Crit Rev Environ Sci Technol 29(1):83&#x2013;146. https://doi.org/10.1080/10643389991259182</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10643389991259182</ArticleId></ArticleIdList></Reference><Reference><Citation>Squitieri F, Falleni A, Cannella M, Orobello S, Fulceri F, Lenzi P, Fornai F (2010) Abnormal morphology of peripheral cell tissues from patients with Huntington disease. J Neural Transm 117(1):77&#x2013;83. https://doi.org/10.1007/s00702-009-0328-4</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00702-009-0328-4</ArticleId><ArticleId IdType=\"pubmed\">19834779</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha SK, Jha NK, Kumar D, Ambasta RK (1863) Kumar, P (2017) Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in neurodegeneration. Biochimica et Biophysica Acta - Molecular Basis of Disease 5:1132&#x2013;1146ss https://doi.org/10.1016/j.bbadis.2016.06.015</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2016.06.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang DTW, Rintoul GL, Pandipati S, Reynolds IJ (2006) Mutant Huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis 22(2):388&#x2013;400. https://doi.org/10.1016/j.nbd.2005.12.007</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbd.2005.12.007</ArticleId><ArticleId IdType=\"pubmed\">16473015</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco-Iborra S, Plaza-Zabala A, Montpeyo M, Sebastian D, Vila M, Martinez-Vicente M (2021) Mutant HTT (Huntingtin) impairs mitophagy in a cellular model of huntington disease. Autophagy 17(3):672&#x2013;689. https://doi.org/10.1080/15548627.2020.1728096</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/15548627.2020.1728096</ArticleId><ArticleId IdType=\"pubmed\">32093570</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH (2012) Mutant Huntingtin&#x2019;s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington&#x2019;s disease. Hum Mol Genet 21(2):406&#x2013;420. https://doi.org/10.1093/hmg/ddr475</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddr475</ArticleId><ArticleId IdType=\"pubmed\">21997870</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonsattel J-P, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP (1985) Neuropathological classification of Huntington&#x2bc;s disease. J Neuropathol Exp Neurol 44(6):559&#x2013;577. https://doi.org/10.1097/00005072-198511000-00003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00005072-198511000-00003</ArticleId><ArticleId IdType=\"pubmed\">2932539</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne SE, Beal MF (2006) Oxidative damage in Huntington&#x2019;s disease pathogenesis. Antioxid Redox Signal 8(11&#x2013;12):2061&#x2013;2073. https://doi.org/10.1089/ars.2006.8.2061</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/ars.2006.8.2061</ArticleId><ArticleId IdType=\"pubmed\">17034350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF, Greenamyre JT, Snyder SH et al (1999) Increased apoptosis of huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5(10):1194&#x2013;1198. https://doi.org/10.1038/13518</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/13518</ArticleId><ArticleId IdType=\"pubmed\">10502825</ArticleId></ArticleIdList></Reference><Reference><Citation>Mormone E, Matarrese P, Tinari A, Cannella M, Maglione V, Farrace MG, Piacentini M, Frati L et al (2006) Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington&#x2019;s disease. J Neurochem 98(4):1090&#x2013;1099. https://doi.org/10.1111/j.1471-4159.2006.03998.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1471-4159.2006.03998.x</ArticleId><ArticleId IdType=\"pubmed\">16895579</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglione V, Cannella M, Gradini R, Cislaghi G, Squitieri F (2006) Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington&#x2019;s disease mutation. Mech Ageing Dev 127(2):213&#x2013;216. https://doi.org/10.1016/j.mad.2005.09.011</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mad.2005.09.011</ArticleId><ArticleId IdType=\"pubmed\">16289252</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C-M, Wu Y-R, Cheng M-L, Liu J-L, Lee Y-M, Lee P-W, Soong B-W, Chiu DT-Y (2007) Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington&#x2019;s disease patients. Biochem Biophys Res Commun 359(2):335&#x2013;340. https://doi.org/10.1016/j.bbrc.2007.05.093</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2007.05.093</ArticleId><ArticleId IdType=\"pubmed\">17543886</ArticleId></ArticleIdList></Reference><Reference><Citation>Klepac N, Relja M, Klepac R, He&#x107;imovi&#x107; S, Babi&#x107; T, Trkulja V (2007) Oxidative stress parameters in plasma of Huntington&#x2019;s disease patients, asymptomatic Huntington&#x2019;s disease gene carriers and healthy subjects: a cross-sectional study. J Neurol 254(12):1676&#x2013;1683. https://doi.org/10.1007/s00415-007-0611-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00415-007-0611-y</ArticleId><ArticleId IdType=\"pubmed\">17990062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Kosaras B, Del Signore SJ, Cormier K, McKee A, Ratan RR, Kowall NW, Ryu H (2011) Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington&#x2019;s disease mice. Acta Neuropathol 121(4):487&#x2013;498. https://doi.org/10.1007/s00401-010-0788-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00401-010-0788-5</ArticleId><ArticleId IdType=\"pubmed\">21161248</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Severiano F, Rios C, Segovia J (2000) Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington&#x2019;s disease. Brain Research 862(1&#x2013;2):234&#x2013;237 https://doi.org/10.1016/S0006-8993(00)02082-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0006-8993(00)02082-5</ArticleId><ArticleId IdType=\"pubmed\">10799690</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Li X-J (2006) Optical burst switching with large switching overhead. Mol Neurodegeneration 1(1):19. https://doi.org/10.1186/1750-1326-1-19</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1750-1326-1-19</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin YN, Yu YV, Gundemir S, Jo C, Cui M, Tieu K, Johnson GVW (2013) Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin. PLoS ONE 8(3):e57932. https://doi.org/10.1371/journal.pone.0057932</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0057932</ArticleId><ArticleId IdType=\"pubmed\">23469253</ArticleId><ArticleId IdType=\"pmc\">3585875</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E et al (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413(6857):739&#x2013;743. https://doi.org/10.1038/35099568</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/35099568</ArticleId><ArticleId IdType=\"pubmed\">11607033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganner A, Pfeiffer Z-C, Wingendorf L, Kreis S, Klein M, Walz G, Neumann-Haefelin E (2020) The acetyltransferase P300 regulates NRF2 stability and localization. Biochem Biophys Res Commun 524(4):895&#x2013;902. https://doi.org/10.1016/j.bbrc.2020.02.006</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2020.02.006</ArticleId><ArticleId IdType=\"pubmed\">32057361</ArticleId></ArticleIdList></Reference><Reference><Citation>Intihar TA, Martinez EA, Gomez-Pastor R (2019) Mitochondrial dysfunction in Huntington&#x2019;s disease; interplay between HSF1, P53 and PGC-1&#x3b1; transcription factors. Front Cell Neurosci 13:103. https://doi.org/10.3389/fncel.2019.00103</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2019.00103</ArticleId><ArticleId IdType=\"pubmed\">30941017</ArticleId><ArticleId IdType=\"pmc\">6433789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bano D, Zanetti F, Mende Y, Nicotera P (2011) Neurodegenerative processes in Huntington&#x2019;s disease. Cell Death Dis 2(11):e228&#x2013;e228. https://doi.org/10.1038/cddis.2011.112</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/cddis.2011.112</ArticleId><ArticleId IdType=\"pubmed\">22071633</ArticleId><ArticleId IdType=\"pmc\">3223696</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidan E, Sims NR (1994) The calcium content of mitochondria from brain subregions following short-term forebrain ischemia and recirculation in the rat. J Neurochem 63(5):1812&#x2013;1819. https://doi.org/10.1046/j.1471-4159.1994.63051812.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1046/j.1471-4159.1994.63051812.x</ArticleId><ArticleId IdType=\"pubmed\">7931337</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan M, Alamri FF, Al Shoyaib A, Karamyan VT, Reddy PH (2019) Novel miRNA PC-5P-12969 in ischemic stroke. Mol Neurobiol 56(10):6976&#x2013;6985. https://doi.org/10.1007/s12035-019-1562-x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-019-1562-x</ArticleId><ArticleId IdType=\"pubmed\">30953313</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson TH, Reynolds CA, Kumar R, Przyklenk K, H&#xfc;ttemann M (2013) Molecular mechanisms of ischemia&#x2013;reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol 47(1):9&#x2013;23. https://doi.org/10.1007/s12035-012-8344-z</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-012-8344-z</ArticleId><ArticleId IdType=\"pubmed\">23011809</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradies G, Paradies V, Ruggiero FM, Petrosillo G (2018) Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection. American Journal of Physiology-Heart and Circulatory Physiology 315(5):H1341&#x2013;H1352. https://doi.org/10.1152/ajpheart.00028.2018</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/ajpheart.00028.2018</ArticleId><ArticleId IdType=\"pubmed\">30095969</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan M, Reddy PH (2020) Non-coding RNAs based molecular links in type 2 diabetes, ischemic stroke, and vascular dementia. J Alzheimers Dis 75(2):353&#x2013;383. https://doi.org/10.3233/JAD-200070</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-200070</ArticleId><ArticleId IdType=\"pubmed\">32310177</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender E, Kadenbach B (2000) The allosteric ATP-inhibition of cytochrome c oxidase activity is reversibly switched on by cAMP-dependent phosphorylation. FEBS Lett 466(1):130&#x2013;134. https://doi.org/10.1016/S0014-5793(99)01773-1</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0014-5793(99)01773-1</ArticleId><ArticleId IdType=\"pubmed\">10648827</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagan VE, Bay&#x131;r HA, Belikova NA, Kapralov O, Tyurina YY, Tyurin VA, Jiang J, Stoyanovsky DA et al (2009) Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radical Biol Med 46(11):1439&#x2013;1453. https://doi.org/10.1016/j.freeradbiomed.2009.03.004</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.freeradbiomed.2009.03.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan M, Kumar S, Yin X, Zafer D, Chanana V, Cengiz P, Reddy PH (2018) Identification of novel circulatory microRNA signatures linked to patients with ischemic stroke. Hum Mol Genet 27(13):2318&#x2013;2329. https://doi.org/10.1093/hmg/ddy136</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/hmg/ddy136</ArticleId><ArticleId IdType=\"pubmed\">29701837</ArticleId><ArticleId IdType=\"pmc\">6005038</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez P (2002) Shareholder value creation, basic concepts. In Valuation Methods and Shareholder Value Creation. Elsevier, pp 3&#x2013;20. https://doi.org/10.1016/B978-012253841-4.50002-0 .</Citation></Reference><Reference><Citation>Vijayan M, Chinniah R, Ravi PM, Sivanadham R, Mosses Joseph AK, Vellaiappan NA, Krishnan JI, Karuppiah B (2016) MTHFR (C677T) CT genotype and CT-apoE3/3 genotypic combination predisposes the risk of ischemic stroke. Gene 591(2):465&#x2013;470. https://doi.org/10.1016/j.gene.2016.06.062</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.gene.2016.06.062</ArticleId><ArticleId IdType=\"pubmed\">27378745</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan M, Reddy PH (2016) Peripheral biomarkers of stroke: focus on circulatory microRNAs. Biochim Biophys Acta 1862(10):1984&#x2013;1993. https://doi.org/10.1016/j.bbadis.2016.08.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2016.08.003</ArticleId><ArticleId IdType=\"pubmed\">27503360</ArticleId><ArticleId IdType=\"pmc\">5343760</ArticleId></ArticleIdList></Reference><Reference><Citation>Carinci M, Vezzani B, Patergnani S, Ludewig P, Lessmann K, Magnus T, Casetta I, Pugliatti M et al (2021) Different roles of mitochondria in cell death and inflammation: focusing on mitochondrial quality control in ischemic stroke and reperfusion. Biomedicines 9(2):169. https://doi.org/10.3390/biomedicines9020169</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines9020169</ArticleId><ArticleId IdType=\"pubmed\">33572080</ArticleId><ArticleId IdType=\"pmc\">7914955</ArticleId></ArticleIdList></Reference><Reference><Citation>Murali V, Rathika C, Ramgopal S, Padma Malini R, Arun Kumar MJ, Neethi Arasu V, Jeyaram Illiayaraja K, Balakrishnan K (2016) Susceptible and protective associations of HLA DRB1*/DQB1* alleles and haplotypes with ischaemic stroke. Int J Immunogenet 43(3):159&#x2013;165. https://doi.org/10.1111/iji.12266</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/iji.12266</ArticleId><ArticleId IdType=\"pubmed\">27105925</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, Folmes CDL, Wu J, Morey R, Mora-Castilla S, Ocampo A, Ma L, Poulton J et al (2015) Metabolic rescue in pluripotent cells from patients with mtDNA disease. Nature 524(7564):234&#x2013;238. https://doi.org/10.1038/nature14546</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nature14546</ArticleId><ArticleId IdType=\"pubmed\">26176921</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan M, Chinniah R, Ravi PM, Mosses Joseph AK, Vellaiappan NA, Krishnan JI, Karuppiah B (2014) ACE-II genotype and I allele predicts ischemic stroke among males in South India. Meta Gene 2:661&#x2013;669. https://doi.org/10.1016/j.mgene.2014.09.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mgene.2014.09.003</ArticleId><ArticleId IdType=\"pubmed\">25606450</ArticleId><ArticleId IdType=\"pmc\">4287818</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Marsboom G, Toth PT, Rehman J (2013) Mitochondrial respiration regulates adipogenic differentiation of human mesenchymal stem cells. PLoS ONE 8(10):e77077. https://doi.org/10.1371/journal.pone.0077077</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0077077</ArticleId><ArticleId IdType=\"pubmed\">24204740</ArticleId><ArticleId IdType=\"pmc\">3800007</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J, Lee G, Nahed P, Kambar MEZN, Zhong K, Fonseca J, et al. Alzheimer&#x2019;s disease drug development pipeline: 2022. A&amp;D Transl Res &amp; Clin Interv [Internet]. 2022 Jan [cited 2024 Mar 11];8(1):e12295. Available from: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.12295</Citation></Reference><Reference><Citation>McFarthing K, Rafaloff G, Baptista M, Mursaleen L, Fuest R, Wyse RK, et al. Parkinson&#x2019;s disease drug therapies in the clinical trial pipeline: 2022 Update. JPD [Internet]. 2022 May 24 [cited 2024 Mar 11];12(4):1073&#x2013;82. Available from: https://www.medra.org/servlet/aliasResolver?alias=iospress&amp;doi/10.3233/JPD-229002</Citation></Reference><Reference><Citation>Plascencia-Villa G, Perry G. Exploring molecular targets for mitochondrial therapies in neurodegenerative diseases. IJMS [Internet]. 2023 Aug 6 [cited 2024 Mar 11];24(15):12486. Available from: https://www.mdpi.com/1422-0067/24/15/12486</Citation></Reference><Reference><Citation>Qiu K, Zou W, Fang H, Hao M, Mehta K, Tian Z, et al. Light-activated mitochondrial fission through optogenetic control of mitochondria-lysosome contacts. Nat Commun [Internet]. 2022 Jul 25 [cited 2024 Mar 11];13(1):4303. Available from: https://www.nature.com/articles/s41467-022-31970-5</Citation></Reference><Reference><Citation>Valverde S, Vandecasteele M, Piette C, Derousseaux W, Gangarossa G, Aristieta Arbelaiz A, et al. Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms. Nat Commun [Internet]. 2020 May 13 [cited 2024 Mar 11];11(1):2388. Available from: https://www.nature.com/articles/s41467-020-16046-6</Citation></Reference><Reference><Citation>Magno LAV, Tenza-Ferrer H, Collodetti M, Aguiar MFG, Rodrigues APC, Da Silva RS, et al. Optogenetic stimulation of the M2 cortex reverts motor dysfunction in a mouse model of Parkinson&#x2019;s disease. J Neurosci [Internet]. 2019 Apr 24 [cited 2024 Mar 11];39(17):3234&#x2013;48. Available from: https://www.jneurosci.org/lookup/doi/10.1523/JNEUROSCI.2277-18.2019</Citation></Reference><Reference><Citation>Hussain SRA, Yalvac ME, Khoo B, Eckardt S, McLaughlin KJ. Adapting CRISPR/Cas9 system for targeting mitochondrial genome. Front Genet [Internet]. 2021 Apr 6 [cited 2024 Mar 11];12:627050. Available from: https://www.frontiersin.org/articles/10.3389/fgene.2021.627050/full</Citation></Reference><Reference><Citation>Condon KJ, Orozco JM, Adelmann CH, Spinelli JB, Van Der Helm PW, Roberts JM, et al. Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction. Proc Natl Acad Sci USA [Internet]. 2021 Jan 26 [cited 2024 Mar 11];118(4):e2022120118. Available from: https://pnas.org/doi/full/10.1073/pnas.2022120118</Citation></Reference><Reference><Citation>Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B (1842) Kanthasamy AG (2014) Mitochondria-targeted antioxidants for treatment of Parkinson&#x2019;s disease: preclinical and clinical outcomes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 8:1282&#x2013;1294 https://doi.org/10.1016/j.bbadis.2013.09.007</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbadis.2013.09.007</ArticleId></ArticleIdList></Reference><Reference><Citation>James AM, Cochem&#xe9; HM, Smith RAJ, Murphy MP (2005) Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. J Biol Chem 280(22):21295&#x2013;21312. https://doi.org/10.1074/jbc.M501527200</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1074/jbc.M501527200</ArticleId><ArticleId IdType=\"pubmed\">15788391</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Pan W (2015) The treatment strategies for neurodegenerative diseases by integrative medicine. Integr Med Int 1(4):223&#x2013;225. https://doi.org/10.1159/000381546</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000381546</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J, Chen L, Qin Z, Sheng R (2021) Structure, regulation, and biological functions of TIGAR and its role in diseases. Acta Pharmacol Sin 42(10):1547&#x2013;1555. https://doi.org/10.1038/s41401-020-00588-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41401-020-00588-y</ArticleId><ArticleId IdType=\"pubmed\">33510458</ArticleId><ArticleId IdType=\"pmc\">8463536</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelkader NF, Safar MM, Salem HA (2016) Ursodeoxycholic acid ameliorates apoptotic cascade in the rotenone model of Parkinson&#x2019;s disease: modulation of mitochondrial perturbations. Mol Neurobiol 53(2):810&#x2013;817. https://doi.org/10.1007/s12035-014-9043-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12035-014-9043-8</ArticleId><ArticleId IdType=\"pubmed\">25502462</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortiboys H, Furmston R, Bronstad G, Aasly J, Elliott C, Bandmann O (2015) UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2 <sup>G2019S</sup> carriers and in vivo. Neurology 85(10):846&#x2013;852. https://doi.org/10.1212/WNL.0000000000001905</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000001905</ArticleId><ArticleId IdType=\"pubmed\">26253449</ArticleId><ArticleId IdType=\"pmc\">4560055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammal Kaidery N, Thomas B (2018) Current perspective of mitochondrial biology in Parkinson&#x2019;s disease. Neurochem Int 117:91&#x2013;113. https://doi.org/10.1016/j.neuint.2018.03.001</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuint.2018.03.001</ArticleId><ArticleId IdType=\"pubmed\">29550604</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahuja M, Ammal Kaidery N, Yang L, Calingasan N, Smirnova N, Gaisin A, Gaisina IN, Gazaryan I et al (2016) Distinct Nrf2 signaling mechanisms of fumaric acid esters and their role in neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced experimental Parkinson&#x2019;s-like disease. J Neurosci 36(23):6332&#x2013;6351. https://doi.org/10.1523/JNEUROSCI.0426-16.2016</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.0426-16.2016</ArticleId><ArticleId IdType=\"pubmed\">27277809</ArticleId><ArticleId IdType=\"pmc\">4899530</ArticleId></ArticleIdList></Reference><Reference><Citation>Barini E, Miccoli A, Tinarelli F, Mulholland K, Kadri H, Khanim F, Stojanovski L, Read KD et al (2018) The anthelmintic drug niclosamide and its analogues activate the Parkinson&#x2019;s disease associated protein kinase PINK1. ChemBioChem 19(5):425&#x2013;429. https://doi.org/10.1002/cbic.201700500</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/cbic.201700500</ArticleId><ArticleId IdType=\"pubmed\">29226533</ArticleId><ArticleId IdType=\"pmc\">5901409</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Youngblood H, Wu C, Zhang Q (2020) Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation. Transl Neurodegener 9(1):19. https://doi.org/10.1186/s40035-020-00197-z</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40035-020-00197-z</ArticleId><ArticleId IdType=\"pubmed\">32475349</ArticleId><ArticleId IdType=\"pmc\">7262767</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal A, Balicza P, Weaver D, Naghdi S, Joseph SK, V&#xe1;rnai P, Gyuris T, Horv&#xe1;th A, Nagy L, Seifert EL, Molnar MJ, Hajn&#xf3;czky G (2017) MSTO 1 is a cytoplasmic pro-mitochondrial fusion protein. EMBO Mol Med 9(7):967&#x2013;984 https://doi.org/10.15252/emmm.201607058</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15252/emmm.201607058</ArticleId><ArticleId IdType=\"pubmed\">28554942</ArticleId><ArticleId IdType=\"pmc\">5494519</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail H, Shakkour Z, Tabet M, Abdelhady S, Kobaisi A, Abedi R, Nasrallah L, Pintus G et al (2020) Traumatic brain injury: oxidative stress and novel anti-oxidants such as mitoquinone and edaravone. Antioxidants 9(10):943. https://doi.org/10.3390/antiox9100943</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/antiox9100943</ArticleId><ArticleId IdType=\"pubmed\">33019512</ArticleId><ArticleId IdType=\"pmc\">7601591</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xdc;nal &#x130;, &#xc7;al&#x131;&#x15f;kan-Ak E, &#xdc;st&#xfc;nda&#x11f; &#xdc;V, Ate&#x15f; PS, Alturfan AA, Altinoz MA, Elmaci I, Emekli-Alturfan E (2020) Neuroprotective effects of mitoquinone and oleandrin on Parkinson&#x2019;s disease model in zebrafish. Int J Neurosci 130(6):574&#x2013;582. https://doi.org/10.1080/00207454.2019.1698567</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/00207454.2019.1698567</ArticleId><ArticleId IdType=\"pubmed\">31771386</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Wang H, Shen R, Fang J, Yang Y, Dai W, Zhu Y, Zhou M (2018) Mitochondrial-targeted antioxidant MitoQ provides neuroprotection and reduces neuronal apoptosis in experimental traumatic brain injury possibly via the Nrf2-ARE pathway. Am J Transl Res 10(6):1887&#x2013;1899</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30018728</ArticleId><ArticleId IdType=\"pmc\">6038061</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghili-Mehrizi S, Williams E, Yan S, Willman M, Willman J, Lucke-Wold B (2022) Secondary mechanisms of neurotrauma: a closer look at the evidence. Diseases 10(2):30. https://doi.org/10.3390/diseases10020030</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diseases10020030</ArticleId><ArticleId IdType=\"pubmed\">35645251</ArticleId><ArticleId IdType=\"pmc\">9149951</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, Kurth MJ, Shaw JT et al (2008) Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 14:193&#x2013;204</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.devcel.2007.11.019</ArticleId><ArticleId IdType=\"pubmed\">18267088</ArticleId><ArticleId IdType=\"pmc\">2267902</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer&#x2019;s disease. J Neurosci 29:9090&#x2013;9103</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.1357-09.2009</ArticleId><ArticleId IdType=\"pubmed\">19605646</ArticleId><ArticleId IdType=\"pmc\">2735241</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie N, Wang C, Lian Y, Zhang H, Wu C, Zhang Q (2013) A selective inhibitor of Drp1, mdivi-1, protects against cell death of hippocampal neurons in pilocarpine-induced seizures in rats. Neurosci Lett 545:64&#x2013;68</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2013.04.026</ArticleId><ArticleId IdType=\"pubmed\">23628672</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X, Cao L, Yang X, Zhao X, Liu X, Han Y, Xue Y, Jiang H et al (2013) Role of mitochondrial fission in neuronal injury in pilocarpine-induced epileptic rats. Neuroscience 245:157&#x2013;165</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroscience.2013.04.019</ArticleId><ArticleId IdType=\"pubmed\">23597828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N, Wang S, Li Y, Che L, Zhao Q (2013) A selective inhibitor of Drp1, mdivi-1, acts against cerebral ischemia/reperfusion injury via an anti-apoptotic pathway in rats. Neurosci Lett 535:104&#x2013;109</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2012.12.049</ArticleId><ArticleId IdType=\"pubmed\">23313133</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang WX, Wu WH, Qiu HY, Bo H, Huang SM (2013) Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of Drp-1 translocation. J Nephrol 26:1073&#x2013;1082</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5301/jn.5000268</ArticleId><ArticleId IdType=\"pubmed\">23553524</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SW, Kim KY, Lindsey JD, Dai Y, Heo H, Nguyen DH, Ellisman MH, Weinreb RN et al (2011) A selective inhibitor of drp1, mdivi-1, increases retinal ganglion cell survival in acute ischemic mouse retina. Invest Ophthalmol Vis Sci 52:2837&#x2013;2843</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1167/iovs.09-5010</ArticleId><ArticleId IdType=\"pubmed\">21372007</ArticleId><ArticleId IdType=\"pmc\">3088566</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam EW, Feigenbaum A, Addis JB, Blaser S, Mackay N, Al-Dosary M, Taylor RW, Ackerley C et al (2008) A novel mitochondrial DNA mutation in COX1 leads to strokes, seizures, and lactic acidosis. Neuropediatrics 39:328&#x2013;334</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1055/s-0029-1202287</ArticleId><ArticleId IdType=\"pubmed\">19568996</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;krti&#x107; M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z, Schimmer AD (2011) Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer cell 20(5):674&#x2013;688</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ccr.2011.10.015</ArticleId><ArticleId IdType=\"pubmed\">22094260</ArticleId><ArticleId IdType=\"pmc\">3221282</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira AM, Cardoso SM, Ribeiro M, Seixas RSGR, Silva AMS, Rego AC (2015) Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington&#x2019;s disease mouse striatal cells. Neurochem Int 91:1&#x2013;12. https://doi.org/10.1016/j.neuint.2015.10.004</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuint.2015.10.004</ArticleId><ArticleId IdType=\"pubmed\">26476055</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Wang H, Ding K, Zhang L, Wang C, Li T et al (2014) Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2&#x2013;ARE pathway. Free Radic Biol Med 71:186&#x2013;195. https://doi.org/10.1016/j.freeradbiomed.2014.03.009</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.freeradbiomed.2014.03.009</ArticleId><ArticleId IdType=\"pubmed\">24642087</ArticleId></ArticleIdList></Reference><Reference><Citation>Denton RM (2009) Regulation of mitochondrial dehydrogenases by calcium ions. Biochim Biophys Acta Bioenerg 1787:1309&#x2013;1316</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbabio.2009.01.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua K, Laurent F, Coombs G, Grayson ML, Howden B et al (2011) Clin Infect Dis 52(12):1472&#x2013;1472. https://doi.org/10.1093/cid/cir250</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cid/cir250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko A-R, Kang T-C (2017) TRPC6-mediated ERK1/2 phosphorylation prevents dentate granule cell degeneration via inhibiting mitochondrial elongation. Neuropharmacology 121:120&#x2013;129. https://doi.org/10.1016/j.neuropharm.2017.05.004</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuropharm.2017.05.004</ArticleId><ArticleId IdType=\"pubmed\">28479396</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang E-J, Park GH, Song K-S (2013) Neuroprotective effects of liquiritigenin isolated from licorice roots on glutamate-induced apoptosis in hippocampal neuronal cells. Neurotoxicology 39:114&#x2013;123. https://doi.org/10.1016/j.neuro.2013.08.012</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuro.2013.08.012</ArticleId><ArticleId IdType=\"pubmed\">24012889</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen L, Shi D, Zhou T, Tu J, He M, Jiang Y, Yang B (2020) Identification of two novel prenylated flavonoids in mulberry leaf and their bioactivities. Food Chem 315:126236. https://doi.org/10.1016/j.foodchem.2020.126236</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.foodchem.2020.126236</ArticleId><ArticleId IdType=\"pubmed\">32000079</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Xu L, Yang L, Sun C (2019) Anti-oxidative effects of catechins and theaflavins on glutamate-induced HT22 cell damage. RSC Adv 9(37):21418&#x2013;21428. https://doi.org/10.1039/C9RA02721A</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C9RA02721A</ArticleId><ArticleId IdType=\"pubmed\">35521307</ArticleId><ArticleId IdType=\"pmc\">9066190</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JH, Lee H-J, Kang KS (2019) Procyanidin C1 Activates the Nrf2/HO-1 signaling pathway to prevent glutamate-induced apoptotic HT22 cell death. IJMS 20(1):142. https://doi.org/10.3390/ijms20010142</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms20010142</ArticleId><ArticleId IdType=\"pubmed\">30609764</ArticleId><ArticleId IdType=\"pmc\">6337568</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao X-Y, Zhou H-H, Li X, Liu Z-Q (2016) Huperzine A alleviates oxidative glutamate toxicity in hippocampal HT22 cells via activating BDNF/TrkB-dependent PI3K/Akt/mTOR signaling pathway. Cell Mol Neurobiol 36(6):915&#x2013;925. https://doi.org/10.1007/s10571-015-0276-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10571-015-0276-5</ArticleId><ArticleId IdType=\"pubmed\">26440805</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Ren X, Qi W, Yuan D, Simpkins JW (2016) Geissoschizine methyl ether protects oxidative stress-mediated cytotoxicity in neurons through the &#x201c;Neuronal Warburg Effect.&#x201d; J Ethnopharmacol 187:249&#x2013;258. https://doi.org/10.1016/j.jep.2016.04.034</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jep.2016.04.034</ArticleId><ArticleId IdType=\"pubmed\">27114061</ArticleId><ArticleId IdType=\"pmc\">4887292</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SY, Jin ML, Kim YH, Kim C-M, Lee SJ, Park G (2014) Involvement of heme oxygenase-1 in neuroprotection by sanguinarine against glutamate-triggered apoptosis in HT22 neuronal cells. Environ Toxicol Pharmacol 38(3):701&#x2013;710. https://doi.org/10.1016/j.etap.2014.08.022</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.etap.2014.08.022</ArticleId><ArticleId IdType=\"pubmed\">25299846</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao F, Tao L, Zhang H (2019) Neuroprotective effect of natural alkaloid fangchinoline against oxidative glutamate toxicity: involvement of Keap1-Nrf2 axis regulation. Cell Mol Neurobiol 39(8):1177&#x2013;1186. https://doi.org/10.1007/s10571-019-00711-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10571-019-00711-6</ArticleId><ArticleId IdType=\"pubmed\">31270710</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Wang K, Zhang K, Lin X, Zhu L, Zhou F (2016) Puerarin protects human neuroblastoma SH-SY5Y cells against glutamate-induced oxidative stress and mitochondrial dysfunction. J Biochem Mol Toxicol 30(1):22&#x2013;28. https://doi.org/10.1002/jbt.21736</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jbt.21736</ArticleId><ArticleId IdType=\"pubmed\">26277993</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrich J, Saft C, Gerlach M, Schneider B, Arz A, Kuhn W, M&#xfc;ller Th (2004) Coenzyme Q10 serum levels in Huntington&#x2019;s disease. In Focus on Extrapyramidal Dysfunction; M&#xfc;ller, Th., Riederer, P., Eds.; Journal of Neural Transmission. Supplementa; Springer Vienna: Vienna, 68: pp 111&#x2013;116. https://doi.org/10.1007/978-3-7091-0579-5_13 .</Citation></Reference><Reference><Citation>Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM, Beal MF (2002) Therapeutic effects of coenzyme Q <sub>10</sub> and remacemide in transgenic mouse models of Huntington&#x2019;s disease. J Neurosci 22(5):1592&#x2013;1599. https://doi.org/10.1523/JNEUROSCI.22-05-01592.2002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.22-05-01592.2002</ArticleId><ArticleId IdType=\"pubmed\">11880489</ArticleId><ArticleId IdType=\"pmc\">6758854</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, Flint Beal M (2009) Combination therapy with coenzyme Q <sub>10</sub> and creatine produces additive neuroprotective effects in models of Parkinson&#x2019;s and Huntington&#x2019;s diseases. J Neurochem 109(5):1427&#x2013;1439. https://doi.org/10.1111/j.1471-4159.2009.06074.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1471-4159.2009.06074.x</ArticleId><ArticleId IdType=\"pubmed\">19476553</ArticleId><ArticleId IdType=\"pmc\">2866530</ArticleId></ArticleIdList></Reference><Reference><Citation>Steliou K. Mitochondria-Targeting Antioxidant Therapeutics. 8,741,853, 2014. https://patents.google.com/patent/US8741853B2/en .</Citation></Reference><Reference><Citation>Parameshwaran K, Irwin MH, Steliou K, Pinkert CA (2010) D -Galactose effectiveness in modeling aging and therapeutic antioxidant treatment in mice. Rejuvenation Res 13(6):729&#x2013;735. https://doi.org/10.1089/rej.2010.1020</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/rej.2010.1020</ArticleId><ArticleId IdType=\"pubmed\">21204654</ArticleId><ArticleId IdType=\"pmc\">3034100</ArticleId></ArticleIdList></Reference><Reference><Citation>Moos WH, Pinkert CA, Irwin MH, Faller DV, Kodukula K, Glavas IP, Steliou K (2017) Epigenetic treatment of persistent viral infections. Drug Dev Res 78(1):24&#x2013;36. https://doi.org/10.1002/ddr.21366</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ddr.21366</ArticleId><ArticleId IdType=\"pubmed\">27761936</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman R, Sultan LD, Saada A, Hirschberg J, Osterzetser-Biran O, Gruenbaum Y (2019) Astaxanthin Extends Lifespan via Altered Biogenesis of the Mitochondrial Respiratory Chain Complex III; preprint; Developmental Biology https://doi.org/10.1101/698001 .</Citation></Reference><Reference><Citation>Irwin MH, Moos WH, Faller DV, Steliou K, Pinkert CA (2016) Epigenetic treatment of neurodegenerative disorders: Alzheimer and Parkinson diseases. Drug Dev Res 77(3):109&#x2013;123. https://doi.org/10.1002/ddr.21294</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ddr.21294</ArticleId><ArticleId IdType=\"pubmed\">26899010</ArticleId></ArticleIdList></Reference><Reference><Citation>Paredes-Fuentes AJ, Oliva C, Urreizti R, Yubero D, Artuch R (2023) Laboratory testing for mitochondrial diseases: biomarkers for diagnosis and follow-up. Critical Reviews in Clinical Laboratory Sciences [Internet] [cited 2024 Mar 11];60(4):270&#x2013;89. Available from: https://www.tandfonline.com/doi/full/ https://doi.org/10.1080/10408363.2023.2166013</Citation></Reference><Reference><Citation>Mancuso M, Orsucci D, Coppede F, Nesti C, Choub A, Siciliano G (2009) Diagnostic approach to mitochondrial disorders: the need for a reliable biomarker. CMM [Internet] [cited 2024 Mar 11];9(9):1095&#x2013;107. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&amp;issn=1566-5240&amp;volume=9&amp;issue=9&amp;spage=1095</Citation></Reference><Reference><Citation>Van Kraaij SJW, Pereira DR, Smal B, Summo L, Konkel A, Lossie J, et al (2023) Identification of peripheral vascular function measures and circulating biomarkers of mitochondrial function in patients with mitochondrial disease. Clinical Translational Sci [Internet] [cited 2024 Mar 11];16(7):1258&#x2013;71. Available from: https://ascpt.onlinelibrary.wiley.com/doi/ https://doi.org/10.1111/cts.13530</Citation></Reference><Reference><Citation>Mancuso M, Orsucci D, Gori S, Ceravolo R, Siciliano G (2008) Mitochondrial DNA single deletion in a patient with postural tremor. Movement Disorders [Internet] [cited 2024 Mar 11];23(14):2098&#x2013;100. Available from: https://movementdisorders.onlinelibrary.wiley.com/doi/ https://doi.org/10.1002/mds.22050</Citation></Reference><Reference><Citation>Romo L, Gold NB, Walker MA (2024) Endocrine features of primary mitochondrial diseases. Current Opinion in Endocrinology, Diabetes &amp; Obesity [Internet] [cited 2024 Mar 11];31(1):34&#x2013;42. Available from: https://journals.lww.com/ https://doi.org/10.1097/MED.0000000000000848</Citation></Reference><Reference><Citation>Ng YS, Lim AZ, Panagiotou G, Turnbull DM, Walker M (2022) Endocrine manifestations and new developments in mitochondrial disease. Endocrine Reviews [Internet]. [cited 2024 Mar 11];43(3):583&#x2013;609. Available from: https://academic.oup.com/edrv/article/43/3/583/6396126</Citation></Reference><Reference><Citation>Saiki S, Hatano T, Fujimaki M, Ishikawa KI, Mori A, Oji Y, et al. Decreased long-chain acylcarnitines from insufficient &#x3b2;-oxidation as potential early diagnostic markers for Parkinson&#x2019;s disease. Sci Rep [Internet]. 2017 Aug 4 [cited 2024 Mar 11];7(1):7328. Available from: https://www.nature.com/articles/s41598-017-06767-y</Citation></Reference><Reference><Citation>Mantle D, Hargreaves IP (2022) Mitochondrial dysfunction and neurodegenerative disorders: role of nutritional supplementation. IJMS [Internet] [cited 2024 Mar 11];23(20):12603. Available from: https://www.mdpi.com/1422-0067/23/20/12603</Citation></Reference><Reference><Citation>Khan HA (2010) Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice. Neurochemistry International [Internet] [cited 2024 Mar 11];57(5):489&#x2013;91. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0197018610002159</Citation></Reference><Reference><Citation>Brakedal B, D&#xf6;lle C, Riemer F, Ma Y, Nido GS, Skeie GO, et al (2022) The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson&#x2019;s disease. Cell Metabolism [Internet] s[cited 2024 Mar 11];34(3):396&#x2013;407.e6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1550413122000456</Citation></Reference><Reference><Citation>Cardoso BR, Roberts BR, Malpas CB, Vivash L, Genc S, Saling MM, et al (2019) Supranutritional sodium selenate supplementation delivers selenium to the central nervous system: results from a randomized controlled pilot trial in Alzheimer&#x2019;s disease. Neurotherapeutics [Internet] [cited 2024 Mar 11];16(1):192&#x2013;202. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1878747923010097</Citation></Reference><Reference><Citation>Mimori Y, Katsuoka H, Nakamura S (1996) Thiamine therapy in Alzheimer&#x2019;s disease. Metab Brain Dis [Internet] [cited 2024 Mar 11];11(1):89&#x2013;94. Available from: http://link.springer.com/ https://doi.org/10.1007/BF0208s0934</Citation></Reference><Reference><Citation>Jia J, Hu J, Huo X, Miao R, Zhang Y, Ma F (2019) Effects of vitamin D supplementation on cognitive function and blood A&#x3b2;-related biomarkers in older adults with Alzheimer&#x2019;s disease: a randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry [Internet]s [cited 2024 Mar 11];jnnp-2018&#x2013;320199. Available from: https://jnnp.bmj.com/lookup/doi/ https://doi.org/10.1136/jnnp-2018-320199</Citation></Reference><Reference><Citation>Fava A, Pirritano D, Plastino M, Cristiano D, Puccio G, Colica C, et al (2013) The effect of lipoic acid therapy on cognitive functioning in patients with Alzheimer&#x2019;s disease. Journal of Neurodegenerative Diseases [Internet] [cited 2024 Mar 11];2013:1&#x2013;7. Available from: https://www.hindawi.com/journals/jnd/2013/454253/</Citation></Reference><Reference><Citation>Liu Z, Li Y, Li C, Yu L, Chang Y, Qu M (2021) Delivery of coenzyme Q10 with mitochondria-targeted nanocarrier attenuates renal ischemia-reperfusion injury in mice. Materials Science and Engineering: C [Internet] [cited 2024 Mar 11];131:112536. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0928493121006767</Citation></Reference><Reference><Citation>Buchke S, Sharma M, Bora A, Relekar M, Bhanu P, Kumar J (2022) Mitochondria-targeted, nanoparticle-based drug-delivery systems: therapeutics for mitochondrial disorders. Life [Internet] [cited 2024 Mar 11];12(5):657. Available from: https://www.mdpi.com/2075-1729/12/5/657</Citation></Reference><Reference><Citation>Xie C, Zhuang XX, Niu Z, Ai R, Lautrup S, Zheng S, et al (2022) Amelioration of Alzheimer&#x2019;s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nat Biomed Eng [Internet] [cited 2024 Mar 11];6(1):76&#x2013;93. Available from: https://www.nature.com/articles/s41551-021-00819-5</Citation></Reference><Reference><Citation>Boenzi S, Diodato D (2018) Biomarkers for mitochondrial energy metabolism diseases. Garone C, Minczuk M, editors. Essays in Biochemistry [Internet] [cited 2024 Mar 11];62(3):443&#x2013;54. Available from: https://portlandpress.com/essaysbiochem/article/62/3/443/78628/Biomarkers-for-mitochondrial-energy-metabolism</Citation></Reference><Reference><Citation>Mancuso M, Filosto M, Bosetti F, Ceravolo R, Rocchi A, Tognoni G, et al (2003) Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Experimental Neurology [Internet] [cited 2024 Mar 11];182(2):421&#x2013;6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S001448860300092X</Citation></Reference><Reference><Citation>Wortmann SB, Rodenburg RJT, Jonckheere A, De Vries MC, Huizing M, Heldt K, et al (2009) Biochemical and genetic analysis of 3-methylglutaconic aciduria type IV: a diagnostic strategy. Brain [Internet] [cited 2024 Mar 11];132(1):136&#x2013;46. Available from: https://academic.oup.com/brain/article-lookup/doi/ https://doi.org/10.1093/brain/awn296</Citation></Reference><Reference><Citation>Bianchi MC, Tosetti M, Siciliano G, Battini R, Leuzzi V, Mancuso M, et al (2000) La spettroscopia protonica nello studio delle malattie metaboliche in et&#xe0; pediatrica. Rivista di Neuroradiologia [Internet] [cited 2024 Mar 11];13(1):45&#x2013;50. Available from: http://journals.sagepub.com/doi/10.1177/197140090001300108</Citation></Reference><Reference><Citation>Chinnery P, Majamaa K, Turnbull D, Thorburn D (2006) Treatment for mitochondrial disorders. In: The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews [Internet]. Chichester, UK: John Wiley &amp; Sons, Ltd; [cited 2024 Mar 11]. p. CD004426.pub2. Available from: https://doi.wiley.com/doi.org/10.1002/14651858.CD004426.pub2</Citation></Reference><Reference><Citation>Kaufmann P, Engelstad K, Wei Y, Jhung S, Sano MC, Shungu DC, et al (2006) Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology [Internet] [cited 2024 Mar 11];66(3):324&#x2013;30. Available from: https://www.neurology.org/doi/10.1212/01.wnl.0000196641.05913.27</Citation></Reference><Reference><Citation>Shoop WK, Bacman SR, Barrera-Paez JD, Moraes CT (2023) Mitochondrial gene editing. Nat Rev Methods Primers [Internet] [cited 2024 Mar 11];3(1):19. Available from: https://www.nature.com/articles/s43586-023-00200-7</Citation></Reference><Reference><Citation>Niyazov DM, Kahler SG, Frye RE (2016) Primary mitochondrial disease and secondary mitochondrial dysfunction: importance of distinction for diagnosis and treatment. Mol Syndromol [Internet] [cited 2024 Mar 11];7(3):122&#x2013;37. Available from: https://www.karger.com/Article/FullText/446586</Citation></Reference><Reference><Citation>McCann MR, George De La Rosa MV, Rosania GR, Stringer KA (2021) L-Carnitine and acylcarnitines: mitochondrial biomarkers for precision medicine. Metabolites [Internet] [cited 2024 Mar 11];11(1):51. Available from: https://www.mdpi.com/2218-1989/11/1/51</Citation></Reference><Reference><Citation>Li L, Goel A, Wang X (2022) Novel paradigms of mitochondrial biology and function: potential clinical significance in the era of precision medicine. Cell Biol Toxicol [Internet] [cited 2024 Mar 11];38(3):371&#x2013;5. Available from: https://link.springer.com/doi.org/10.1007/s10565-022-09721-5</Citation></Reference><Reference><Citation>Lim K, Cho SI, Kim JS (2022) Nuclear and mitochondrial DNA editing in human cells with zinc finger deaminases. Nat Commun [Internet] [cited 2024 Mar 11];13(1):366. Available from: https://www.nature.com/articles/s41467-022-27962-0</Citation></Reference><Reference><Citation>Lee S, Lee H, Baek G, Kim JS (2023) Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors. Nat Biotechnol [Internet] [cited 2024 Mar 11];41(3):378&#x2013;86. Available from: https://www.nature.com/articles/s41587-022-01486-w</Citation></Reference><Reference><Citation>Willis JCW, Silva-Pinheiro P, Widdup L, Minczuk M, Liu DR (2022) Compact zinc finger base editors that edit mitochondrial or nuclear DNA in vitro and in vivo. Nat Commun [Internet] [cited 2024 Mar 11];13(1):7204. Available from: https://www.nature.com/articles/s41467-022-34784-7</Citation></Reference><Reference><Citation>Laura Craft (2017) Emerging Applications of Ai for Healthcare Providers GARTNER.s Available from:&#xa0; https://www.gartner.com/en/documents/3753763</Citation></Reference><Reference><Citation>Basu K, Sinha R, Ong A, Basu T (2020) Artificial intelligence: how is it changing medical sciences and its future? Indian J Dermatol 65(5):365&#x2013;370. https://doi.org/10.4103/ijd.IJD_421_20</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/ijd.IJD_421_20</ArticleId><ArticleId IdType=\"pubmed\">33165420</ArticleId><ArticleId IdType=\"pmc\">7640807</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R et al (2020) Artificial intelligence for Alzheimer&#x2019;s disease- promise or challenge. Front Neurol 11:1019</Citation></Reference><Reference><Citation>Dabbaghi KG, Khosravirad Z, Jamalnia S, GhorbaniNia R, Mahmoudikohani F, Zakeri H, Khastehband S (2023) The use of artificial intelligence in the management of neurodegenerative disorders; focus on Alzheimer&#x2019;s disease. Galen Medical Journal 12:1</Citation></Reference><Reference><Citation>Garcia DLF, Ritchie CW, Luz S (2020) Artificial intelligence, speech, and language processing approaches to monitoring Alzheimer&#x2019;s disease: a systematic review. J Alzheimer&#x2019;s Dis 78(4):1547&#x2013;1574</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-200888</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y et al (2021) Integrative gene expression analysis for the diagnosis of Parkinson&#x2019;s disease using machine learning and explainable AI. Sci Rep 11:102</Citation></Reference><Reference><Citation>Li X et al (2020) Use of magnetic resonance imaging and artificial intelligence in studies of diagnosis of Parkinson&#x2019;s disease. Front Neurol 11:1040</Citation></Reference><Reference><Citation>Lu Y et al (2021) Amelioration of Alzheimer&#x2019;s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nat Commun 12:2118</Citation></Reference><Reference><Citation>Serra-Mestres J et al (2020) Multi-layer picture of neurodegenerative diseases- lessons from the use of Big Data through artificial intelligence. Int J Mol Sci 21(23):9083</Citation></Reference><Reference><Citation>McMillan CT, Irwin DJ (2020) Decoding degeneration- the implementation of machine learning for clinical detection of neurodegenerative disorders. J Neurol Neurosurg Psychiatry 91(10):1067&#x2013;1076</Citation></Reference><Reference><Citation>Ghosh R, Cingreddy AR, Melapu V, Joginipelli S, Kar S (2021) Application of artificial intelligence and machine learning techniques in classifying extent of dementia across alzheimer&#x2019;s image data. IJQSPR 6(2):29&#x2013;46</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">39269300</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Print\">1997-7298</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>124</Volume><Issue>8</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova</Title><ISOAbbreviation>Zh Nevrol Psikhiatr Im S S Korsakova</ISOAbbreviation></Journal><ArticleTitle>[Immunological and neuroanatomic markers of the clinical dynamics of MCI and pre-MCI].</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>91</EndPage><MedlinePgn>81-91</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.17116/jnevro202412408181</ELocationID><Abstract><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"OBJECTIVE\">To study the relationship of the parameters of immunity and systemic inflammation with the structural magnetic resonance imaging (MRI) parameters in patients with mild cognitive impairment (MCI) and pre-MCI undergoing neurocognitive rehabilitation to search for candidate markers of its effectiveness.</AbstractText><AbstractText Label=\"MATERIAL AND METHODS\" NlmCategory=\"METHODS\">The main group included 49 patients, aged &#x2265;60 years, with MCI and pre-MCI with memory impairment, who underwent a course of neurorehabilitation for 5 weeks. The control group included 19 volunteers of similar age with a total MoCA score of &#x2265;25, who did not have cognitive impairment and immuno-inflammatory disorders. The parameters of cellular and humoral immunity and markers of inflammation were studied, and structural MRI was performed.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">The content of activated natural killer cells (NK-cells) was increased in MCI and pre-MCI (0.63&#xb1;0.12% vs. 0.22&#xb1;0.07% in the control group, <i>p</i>=2.2&#xb7;10<sup>-7</sup>). The level of immunoglobulin G (IgG) &lt;12.5 g/l in patients with MCI and pre-MCI with the Montreal Cognitive Assessment Scale (MoCA) score &lt;22 was associated with a decrease in the volume of the right nucleus accumbens (376&#xb1;35 mm<sup>3</sup> in patients with IgG &lt;12.5 g/l (<i>p</i>=0.0013) and 480&#xb1;44 mm<sup>3</sup> at IgG &lt;12.5 g/l, 480&#xb1;44 mm<sup>3</sup> in the control group), as well as with a decrease of the thickness and volume of a number of other cortical zones. A logistic regression model including the level of immunoglobulin G, NK cells, CD8+ NK cells and right amygdala volume was constructed to predict the number of MoCA scores 6 months after the course of rehabilitation (R<sup>2</sup>=0.57; <i>p</i>&lt;1&#xb7;10<sup>-5</sup>; standard error of estimate: 2.93).</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">As a result of this work, the perspectives of assessing the immunological parameters in combination with socio-demographic data and morphometric changes of the brain as potential prognostic markers of the dynamics of cognitive impairment in patients with MCI and pre-MCI after neurorehabilitation has been shown.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Malashenkova</LastName><ForeName>I K</ForeName><Initials>IK</Initials><Identifier Source=\"ORCID\">0000-0002-3604-9098</Identifier><AffiliationInfo><Affiliation>National Research Center &#xab;Kurchatov Institute&#xbb;, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Krynskiy</LastName><ForeName>S A</ForeName><Initials>SA</Initials><Identifier Source=\"ORCID\">0000-0003-4328-865X</Identifier><AffiliationInfo><Affiliation>National Research Center &#xab;Kurchatov Institute&#xbb;, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alekseev Psychiatric Clinical Hospital No. 1, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ogurtsov</LastName><ForeName>D P</ForeName><Initials>DP</Initials><Identifier Source=\"ORCID\">0000-0003-0257-4713</Identifier><AffiliationInfo><Affiliation>National Research Center &#xab;Kurchatov Institute&#xbb;, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Khailov</LastName><ForeName>N A</ForeName><Initials>NA</Initials><Identifier Source=\"ORCID\">0000-0002-3693-285X</Identifier><AffiliationInfo><Affiliation>National Research Center &#xab;Kurchatov Institute&#xbb;, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Filippova</LastName><ForeName>E A</ForeName><Initials>EA</Initials><Identifier Source=\"ORCID\">0000-0001-8132-7918</Identifier><AffiliationInfo><Affiliation>National Research Center &#xab;Kurchatov Institute&#xbb;, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Moskvina</LastName><ForeName>S N</ForeName><Initials>SN</Initials><Identifier Source=\"ORCID\">0000-0003-3901-674X</Identifier><AffiliationInfo><Affiliation>National Research Center &#xab;Kurchatov Institute&#xbb;, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ushakov</LastName><ForeName>V L</ForeName><Initials>VL</Initials><Identifier Source=\"ORCID\">0000-0002-4716-2109</Identifier><AffiliationInfo><Affiliation>Alekseev Psychiatric Clinical Hospital No. 1, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Research Nuclear University MEPhI, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lomonosov Moscow State University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Orlov</LastName><ForeName>V A</ForeName><Initials>VA</Initials><Identifier Source=\"ORCID\">0000-0002-4840-4499</Identifier><AffiliationInfo><Affiliation>National Research Center &#xab;Kurchatov Institute&#xbb;, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Andryushchenko</LastName><ForeName>A V</ForeName><Initials>AV</Initials><Identifier Source=\"ORCID\">0000-0002-7702-6343</Identifier><AffiliationInfo><Affiliation>Alekseev Psychiatric Clinical Hospital No. 1, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lomonosov Moscow State University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Osipova</LastName><ForeName>N G</ForeName><Initials>NG</Initials><Identifier Source=\"ORCID\">0000-0002-3023-2393</Identifier><AffiliationInfo><Affiliation>Alekseev Psychiatric Clinical Hospital No. 1, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Syunyakov</LastName><ForeName>T S</ForeName><Initials>TS</Initials><Identifier Source=\"ORCID\">0000-0002-4334-1601</Identifier><AffiliationInfo><Affiliation>Alekseev Psychiatric Clinical Hospital No. 1, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Republican Specialized Scientific-Practical Medical Center of Narcology, Salar, Uzbekistan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Samara State Medical University, Samara, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Savilov</LastName><ForeName>V B</ForeName><Initials>VB</Initials><Identifier Source=\"ORCID\">0000-0002-1425-1586</Identifier><AffiliationInfo><Affiliation>Alekseev Psychiatric Clinical Hospital No. 1, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Karpenko</LastName><ForeName>O A</ForeName><Initials>OA</Initials><Identifier Source=\"ORCID\">0000-0002-0958-0596</Identifier><AffiliationInfo><Affiliation>Alekseev Psychiatric Clinical Hospital No. 1, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kurmyshev</LastName><ForeName>M V</ForeName><Initials>MV</Initials><Identifier Source=\"ORCID\">0000-0001-7354-7216</Identifier><AffiliationInfo><Affiliation>Alekseev Psychiatric Clinical Hospital No. 1, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kostyuk</LastName><ForeName>G P</ForeName><Initials>GP</Initials><Identifier Source=\"ORCID\">0000-0003-4320-3644</Identifier><AffiliationInfo><Affiliation>Alekseev Psychiatric Clinical Hospital No. 1, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Didkovsky</LastName><ForeName>N A</ForeName><Initials>NA</Initials><Identifier Source=\"ORCID\">0000-0001-6567-5998</Identifier><AffiliationInfo><Affiliation>Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>rus</Language><PublicationTypeList><PublicationType UI=\"D004740\">English Abstract</PublicationType><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Immunologicheskie i neiroanatomicheskie markery dinamiki dodementnykh kognitivnykh rasstroistv pri neiroreabilitatsii.</VernacularTitle></Article><MedlineJournalInfo><Country>Russia (Federation)</Country><MedlineTA>Zh Nevrol Psikhiatr Im S S Korsakova</MedlineTA><NlmUniqueID>9712194</NlmUniqueID><ISSNLinking>1997-7298</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D007074\">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D060825\" MajorTopicYN=\"Y\">Cognitive Dysfunction</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008279\" MajorTopicYN=\"Y\">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007694\" MajorTopicYN=\"Y\">Killer Cells, Natural</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015415\" MajorTopicYN=\"Y\">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007074\" MajorTopicYN=\"N\">Immunoglobulin G</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"N\">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type=\"Publisher\" Language=\"rus\"><AbstractText Label=\"&#x426;&#x415;&#x41b;&#x42c; &#x418;&#x421;&#x421;&#x41b;&#x415;&#x414;&#x41e;&#x412;&#x410;&#x41d;&#x418;&#x42f;\" NlmCategory=\"UNASSIGNED\">&#x418;&#x437;&#x443;&#x447;&#x435;&#x43d;&#x438;&#x435; &#x441;&#x432;&#x44f;&#x437;&#x438; &#x43f;&#x430;&#x440;&#x430;&#x43c;&#x435;&#x442;&#x440;&#x43e;&#x432; &#x438;&#x43c;&#x43c;&#x443;&#x43d;&#x438;&#x442;&#x435;&#x442;&#x430; &#x438; &#x441;&#x438;&#x441;&#x442;&#x435;&#x43c;&#x43d;&#x43e;&#x433;&#x43e; &#x432;&#x43e;&#x441;&#x43f;&#x430;&#x43b;&#x435;&#x43d;&#x438;&#x44f; &#x441; &#x43f;&#x43e;&#x43a;&#x430;&#x437;&#x430;&#x442;&#x435;&#x43b;&#x44f;&#x43c;&#x438; &#x441;&#x442;&#x440;&#x443;&#x43a;&#x442;&#x443;&#x440;&#x43d;&#x43e;&#x439; &#x43c;&#x430;&#x433;&#x43d;&#x438;&#x442;&#x43d;&#x43e;-&#x440;&#x435;&#x437;&#x43e;&#x43d;&#x430;&#x43d;&#x441;&#x43d;&#x43e;&#x439; &#x442;&#x435;&#x440;&#x430;&#x43f;&#x438;&#x438; (&#x41c;&#x420;&#x422;) &#x443; &#x43f;&#x430;&#x446;&#x438;&#x435;&#x43d;&#x442;&#x43e;&#x432; &#x441; &#x434;&#x43e;&#x434;&#x435;&#x43c;&#x435;&#x43d;&#x442;&#x43d;&#x44b;&#x43c;&#x438; &#x43a;&#x43e;&#x433;&#x43d;&#x438;&#x442;&#x438;&#x432;&#x43d;&#x44b;&#x43c;&#x438; &#x440;&#x430;&#x441;&#x441;&#x442;&#x440;&#x43e;&#x439;&#x441;&#x442;&#x432;&#x430;&#x43c;&#x438; (&#x414;&#x41a;&#x420;) &#x432; &#x434;&#x438;&#x43d;&#x430;&#x43c;&#x438;&#x43a;&#x435; &#x43a;&#x443;&#x440;&#x441;&#x430; &#x43d;&#x435;&#x439;&#x440;&#x43e;&#x43a;&#x43e;&#x433;&#x43d;&#x438;&#x442;&#x438;&#x432;&#x43d;&#x43e;&#x439; &#x440;&#x435;&#x430;&#x431;&#x438;&#x43b;&#x438;&#x442;&#x430;&#x446;&#x438;&#x438; &#x434;&#x43b;&#x44f; &#x43f;&#x43e;&#x438;&#x441;&#x43a;&#x430; &#x43a;&#x430;&#x43d;&#x434;&#x438;&#x434;&#x430;&#x442;&#x43d;&#x44b;&#x445; &#x43c;&#x430;&#x440;&#x43a;&#x435;&#x440;&#x43e;&#x432; &#x435;&#x435; &#x44d;&#x444;&#x444;&#x435;&#x43a;&#x442;&#x438;&#x432;&#x43d;&#x43e;&#x441;&#x442;&#x438;.</AbstractText><AbstractText Label=\"&#x41c;&#x410;&#x422;&#x415;&#x420;&#x418;&#x410;&#x41b; &#x418; &#x41c;&#x415;&#x422;&#x41e;&#x414;&#x42b;\" NlmCategory=\"UNASSIGNED\">&#x412; &#x43e;&#x441;&#x43d;&#x43e;&#x432;&#x43d;&#x443;&#x44e; &#x433;&#x440;&#x443;&#x43f;&#x43f;&#x443; &#x432;&#x43e;&#x448;&#x43b;&#x438; 49 &#x43f;&#x430;&#x446;&#x438;&#x435;&#x43d;&#x442;&#x43e;&#x432; &#x441; &#x414;&#x41a;&#x420; &#x441; &#x43c;&#x43d;&#x435;&#x441;&#x442;&#x438;&#x447;&#x435;&#x441;&#x43a;&#x438;&#x43c;&#x438; &#x43d;&#x430;&#x440;&#x443;&#x448;&#x435;&#x43d;&#x438;&#x44f;&#x43c;&#x438; &#x432; &#x432;&#x43e;&#x437;&#x440;&#x430;&#x441;&#x442;&#x435; &#x43e;&#x442; 60 &#x43b;&#x435;&#x442; &#x438; &#x441;&#x442;&#x430;&#x440;&#x448;&#x435;, &#x43f;&#x440;&#x43e;&#x445;&#x43e;&#x434;&#x438;&#x432;&#x448;&#x438;&#x445; &#x43a;&#x443;&#x440;&#x441; &#x43d;&#x435;&#x439;&#x440;&#x43e;&#x440;&#x435;&#x430;&#x431;&#x438;&#x43b;&#x438;&#x442;&#x430;&#x446;&#x438;&#x438; 5 &#x43d;&#x435;&#x434;. &#x412; &#x433;&#x440;&#x443;&#x43f;&#x43f;&#x443; &#x43a;&#x43e;&#x43d;&#x442;&#x440;&#x43e;&#x43b;&#x44f; &#x432;&#x43e;&#x448;&#x43b;&#x438; 19 &#x434;&#x43e;&#x431;&#x440;&#x43e;&#x432;&#x43e;&#x43b;&#x44c;&#x446;&#x435;&#x432; &#x441;&#x445;&#x43e;&#x434;&#x43d;&#x43e;&#x433;&#x43e; &#x432;&#x43e;&#x437;&#x440;&#x430;&#x441;&#x442;&#x430;, &#x43d;&#x435; &#x438;&#x43c;&#x435;&#x44e;&#x449;&#x438;&#x445; &#x43a;&#x43e;&#x433;&#x43d;&#x438;&#x442;&#x438;&#x432;&#x43d;&#x44b;&#x445; &#x440;&#x430;&#x441;&#x441;&#x442;&#x440;&#x43e;&#x439;&#x441;&#x442;&#x432; &#x438; &#x438;&#x43c;&#x43c;&#x443;&#x43d;&#x43e;&#x432;&#x43e;&#x441;&#x43f;&#x430;&#x43b;&#x438;&#x442;&#x435;&#x43b;&#x44c;&#x43d;&#x44b;&#x445; &#x43d;&#x430;&#x440;&#x443;&#x448;&#x435;&#x43d;&#x438;&#x439;. &#x418;&#x441;&#x441;&#x43b;&#x435;&#x434;&#x43e;&#x432;&#x430;&#x43b;&#x438; &#x43f;&#x430;&#x440;&#x430;&#x43c;&#x435;&#x442;&#x440;&#x44b; &#x43a;&#x43b;&#x435;&#x442;&#x43e;&#x447;&#x43d;&#x43e;&#x433;&#x43e; &#x438; &#x433;&#x443;&#x43c;&#x43e;&#x440;&#x430;&#x43b;&#x44c;&#x43d;&#x43e;&#x433;&#x43e; &#x438;&#x43c;&#x43c;&#x443;&#x43d;&#x438;&#x442;&#x435;&#x442;&#x430;, &#x43c;&#x430;&#x440;&#x43a;&#x435;&#x440;&#x44b; &#x432;&#x43e;&#x441;&#x43f;&#x430;&#x43b;&#x435;&#x43d;&#x438;&#x44f;, &#x43f;&#x440;&#x43e;&#x432;&#x43e;&#x434;&#x438;&#x43b;&#x438; &#x441;&#x442;&#x440;&#x443;&#x43a;&#x442;&#x443;&#x440;&#x43d;&#x443;&#x44e; &#x41c;&#x420;&#x422;.</AbstractText><AbstractText Label=\"&#x420;&#x415;&#x417;&#x423;&#x41b;&#x42c;&#x422;&#x410;&#x422;&#x42b;\" NlmCategory=\"UNASSIGNED\">&#x412;&#x44b;&#x44f;&#x432;&#x43b;&#x435;&#x43d;&#x43e;, &#x447;&#x442;&#x43e; &#x43f;&#x440;&#x438; &#x414;&#x41a;&#x420; &#x43f;&#x43e;&#x432;&#x44b;&#x448;&#x435;&#x43d;&#x43e; &#x441;&#x43e;&#x434;&#x435;&#x440;&#x436;&#x430;&#x43d;&#x438;&#x435; &#x430;&#x43a;&#x442;&#x438;&#x432;&#x438;&#x440;&#x43e;&#x432;&#x430;&#x43d;&#x43d;&#x44b;&#x445; &#x435;&#x441;&#x442;&#x435;&#x441;&#x442;&#x432;&#x435;&#x43d;&#x43d;&#x44b;&#x445; &#x43a;&#x438;&#x43b;&#x43b;&#x435;&#x440;&#x43e;&#x432; (NK-&#x43a;&#x43b;&#x435;&#x442;&#x43e;&#x43a;) (0,63&#xb1;0,12% &#x43f;&#x440;&#x438; 0,22&#xb1;0,07% &#x432; &#x43a;&#x43e;&#x43d;&#x442;&#x440;&#x43e;&#x43b;&#x44c;&#x43d;&#x43e;&#x439; &#x433;&#x440;&#x443;&#x43f;&#x43f;&#x435;, <i>p</i>=2,2&#xb7;10<sup>&#x2013;7</sup>). &#x423;&#x441;&#x442;&#x430;&#x43d;&#x43e;&#x432;&#x43b;&#x435;&#x43d;&#x43e;, &#x447;&#x442;&#x43e; &#x443;&#x440;&#x43e;&#x432;&#x435;&#x43d;&#x44c; &#x438;&#x43c;&#x43c;&#x443;&#x43d;&#x43e;&#x433;&#x43b;&#x43e;&#x431;&#x443;&#x43b;&#x438;&#x43d;&#x430; G (IgG) &lt;12,5 &#x433;/&#x43b; &#x443; &#x43f;&#x430;&#x446;&#x438;&#x435;&#x43d;&#x442;&#x43e;&#x432; &#x441; &#x414;&#x41a;&#x420; &#x441; &#x43a;&#x43e;&#x43b;&#x438;&#x447;&#x435;&#x441;&#x442;&#x432;&#x43e;&#x43c; &#x431;&#x430;&#x43b;&#x43b;&#x43e;&#x432; &#x43f;&#x43e; &#x41c;&#x43e;&#x43d;&#x440;&#x435;&#x430;&#x43b;&#x44c;&#x441;&#x43a;&#x43e;&#x439; &#x448;&#x43a;&#x430;&#x43b;&#x435; &#x43e;&#x446;&#x435;&#x43d;&#x43a;&#x438; &#x43a;&#x43e;&#x433;&#x43d;&#x438;&#x442;&#x438;&#x432;&#x43d;&#x44b;&#x445; &#x444;&#x443;&#x43d;&#x43a;&#x446;&#x438;&#x439; (MoCA) &lt;22 &#x441;&#x432;&#x44f;&#x437;&#x430;&#x43d; &#x441;&#x43e; &#x441;&#x43d;&#x438;&#x436;&#x435;&#x43d;&#x438;&#x435;&#x43c; &#x43e;&#x431;&#x44a;&#x435;&#x43c;&#x430; &#x43f;&#x440;&#x430;&#x432;&#x43e;&#x439; &#x43e;&#x431;&#x43b;&#x430;&#x441;&#x442;&#x438; &#x43f;&#x440;&#x438;&#x43b;&#x435;&#x436;&#x430;&#x449;&#x435;&#x433;&#x43e; &#x44f;&#x434;&#x440;&#x430; (376&#xb1;35 &#x43c;&#x43c;<sup>3</sup> &#x43f;&#x440;&#x438; IgG &lt;12,5 &#x433;/&#x43b; (<i>p</i>=0,0013) &#x438; 480&#xb1;44 &#x43c;&#x43c;<sup>3</sup> &#x43f;&#x440;&#x438; IgG &lt;12,5 &#x433;/&#x43b;, 480&#xb1;44 &#x43c;&#x43c;<sup>3</sup> &#x432; &#x43a;&#x43e;&#x43d;&#x442;&#x440;&#x43e;&#x43b;&#x44c;&#x43d;&#x43e;&#x439; &#x433;&#x440;&#x443;&#x43f;&#x43f;&#x435;), &#x430; &#x442;&#x430;&#x43a;&#x436;&#x435; &#x442;&#x43e;&#x43b;&#x449;&#x438;&#x43d;&#x44b; &#x438; &#x43e;&#x431;&#x44a;&#x435;&#x43c;&#x430; &#x440;&#x44f;&#x434;&#x430; &#x434;&#x440;&#x443;&#x433;&#x438;&#x445; &#x437;&#x43e;&#x43d; &#x43a;&#x43e;&#x440;&#x44b;. &#x41f;&#x43e;&#x441;&#x442;&#x440;&#x43e;&#x435;&#x43d;&#x430; &#x43c;&#x43e;&#x434;&#x435;&#x43b;&#x44c; &#x43b;&#x43e;&#x433;&#x438;&#x441;&#x442;&#x438;&#x447;&#x435;&#x441;&#x43a;&#x43e;&#x439; &#x440;&#x435;&#x433;&#x440;&#x435;&#x441;&#x441;&#x438;&#x438; (R<sup>2</sup>=0,57; <i>p</i>&lt;1&#xb7;10<sup>&#x2013;5</sup>; &#x441;&#x442;&#x430;&#x43d;&#x434;&#x430;&#x440;&#x442;&#x43d;&#x430;&#x44f; &#x43e;&#x448;&#x438;&#x431;&#x43a;&#x430; &#x43e;&#x446;&#x435;&#x43d;&#x43a;&#x438;: 2,93), &#x432;&#x43a;&#x43b;&#x44e;&#x447;&#x430;&#x44e;&#x449;&#x430;&#x44f; &#x443;&#x440;&#x43e;&#x432;&#x435;&#x43d;&#x44c; &#x438;&#x43c;&#x43c;&#x443;&#x43d;&#x43e;&#x433;&#x43b;&#x43e;&#x431;&#x443;&#x43b;&#x438;&#x43d;&#x430; G, NK-&#x43a;&#x43b;&#x435;&#x442;&#x43e;&#x43a;, CD8+ NK-&#x43a;&#x43b;&#x435;&#x442;&#x43e;&#x43a; &#x438; &#x43e;&#x431;&#x44a;&#x435;&#x43c; &#x43f;&#x440;&#x430;&#x432;&#x43e;&#x439; &#x430;&#x43c;&#x438;&#x433;&#x434;&#x430;&#x43b;&#x44b;, &#x43f;&#x43e;&#x437;&#x432;&#x43e;&#x43b;&#x44f;&#x44e;&#x449;&#x430;&#x44f; &#x43f;&#x440;&#x43e;&#x433;&#x43d;&#x43e;&#x437;&#x438;&#x440;&#x43e;&#x432;&#x430;&#x442;&#x44c; &#x43a;&#x43e;&#x43b;&#x438;&#x447;&#x435;&#x441;&#x442;&#x432;&#x43e; &#x431;&#x430;&#x43b;&#x43b;&#x43e;&#x432; &#x43f;&#x43e; MoCA &#x447;&#x435;&#x440;&#x435;&#x437; 6 &#x43c;&#x435;&#x441; &#x43f;&#x43e;&#x441;&#x43b;&#x435; &#x43a;&#x443;&#x440;&#x441;&#x430; &#x440;&#x435;&#x430;&#x431;&#x438;&#x43b;&#x438;&#x442;&#x430;&#x446;&#x438;&#x438;.</AbstractText><AbstractText Label=\"&#x417;&#x410;&#x41a;&#x41b;&#x42e;&#x427;&#x415;&#x41d;&#x418;&#x415;\" NlmCategory=\"UNASSIGNED\">&#x412; &#x440;&#x430;&#x43c;&#x43a;&#x430;&#x445; &#x434;&#x430;&#x43d;&#x43d;&#x43e;&#x439; &#x440;&#x430;&#x431;&#x43e;&#x442;&#x44b; &#x432;&#x43f;&#x435;&#x440;&#x432;&#x44b;&#x435; &#x43f;&#x43e;&#x43a;&#x430;&#x437;&#x430;&#x43d;&#x430; &#x432;&#x44b;&#x441;&#x43e;&#x43a;&#x430;&#x44f; &#x437;&#x43d;&#x430;&#x447;&#x438;&#x43c;&#x43e;&#x441;&#x442;&#x44c; &#x43f;&#x430;&#x440;&#x430;&#x43c;&#x435;&#x442;&#x440;&#x43e;&#x432; &#x438;&#x43c;&#x43c;&#x443;&#x43d;&#x438;&#x442;&#x435;&#x442;&#x430; &#x432; &#x43a;&#x43e;&#x43c;&#x43f;&#x43b;&#x435;&#x43a;&#x441;&#x435; &#x441; &#x441;&#x43e;&#x446;&#x438;&#x430;&#x43b;&#x44c;&#x43d;&#x43e;-&#x434;&#x435;&#x43c;&#x43e;&#x433;&#x440;&#x430;&#x444;&#x438;&#x447;&#x435;&#x441;&#x43a;&#x438;&#x43c;&#x438; &#x434;&#x430;&#x43d;&#x43d;&#x44b;&#x43c;&#x438; &#x438; &#x43c;&#x43e;&#x440;&#x444;&#x43e;&#x43c;&#x435;&#x442;&#x440;&#x438;&#x447;&#x435;&#x441;&#x43a;&#x438;&#x43c;&#x438; &#x43f;&#x43e;&#x43a;&#x430;&#x437;&#x430;&#x442;&#x435;&#x43b;&#x44f;&#x43c;&#x438; &#x43c;&#x43e;&#x437;&#x433;&#x430; &#x432; &#x43a;&#x430;&#x447;&#x435;&#x441;&#x442;&#x432;&#x435; &#x43f;&#x43e;&#x442;&#x435;&#x43d;&#x446;&#x438;&#x430;&#x43b;&#x44c;&#x43d;&#x44b;&#x445; &#x43c;&#x430;&#x440;&#x43a;&#x435;&#x440;&#x43e;&#x432; &#x43f;&#x440;&#x43e;&#x433;&#x43d;&#x43e;&#x437;&#x430;, &#x43e;&#x442;&#x440;&#x430;&#x436;&#x430;&#x44e;&#x449;&#x438;&#x445; &#x43e;&#x442;&#x432;&#x435;&#x442; &#x43d;&#x430; &#x43d;&#x435;&#x439;&#x440;&#x43e;&#x440;&#x435;&#x430;&#x431;&#x438;&#x43b;&#x438;&#x442;&#x430;&#x446;&#x438;&#x44e;.</AbstractText></OtherAbstract><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN=\"N\">NK cells</Keyword><Keyword MajorTopicYN=\"N\">amygdala</Keyword><Keyword MajorTopicYN=\"N\">cell immunity</Keyword><Keyword MajorTopicYN=\"N\">immunoglobulin G</Keyword><Keyword MajorTopicYN=\"N\">magnetic resonance tomography</Keyword><Keyword MajorTopicYN=\"N\">mild cognitive impairment</Keyword><Keyword MajorTopicYN=\"N\">neurorehabilitation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>9</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269300</ArticleId><ArticleId IdType=\"doi\">10.17116/jnevro202412408181</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">39269041</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Print\">2079-4991</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>14</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Nanomaterials (Basel, Switzerland)</Title><ISOAbbreviation>Nanomaterials (Basel)</ISOAbbreviation></Journal><ArticleTitle>Metal-Organic Frameworks for Overcoming the Blood-Brain Barrier in the Treatment of Brain Diseases: A Review.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1379</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3390/nano14171379</ELocationID><Abstract><AbstractText>The blood-brain barrier (BBB) plays a vital role in safeguarding the central nervous system by selectively controlling the movement of substances between the bloodstream and the brain, presenting a substantial obstacle for the administration of therapeutic agents to the brain. Recent breakthroughs in nanoparticle-based delivery systems, particularly metal-organic frameworks (MOFs), provide promising solutions for addressing the BBB. MOFs have become valuable tools in delivering medications to the brain with their ability to efficiently load drugs, release them over time, and modify their surface properties. This review focuses on the recent advancements in molecular-based approaches for treating brain disorders, such as glioblastoma multiforme, stroke, Parkinson's disease, and Alzheimer's disease. This paper highlights the significant impact of MOFs in overcoming the shortcomings of conventional brain drug delivery techniques and provides valuable insights for future research in the field of neurotherapeutics.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Nabipour</LastName><ForeName>Hafezeh</ForeName><Initials>H</Initials><Identifier Source=\"ORCID\">0000-0002-3349-0363</Identifier><AffiliationInfo><Affiliation>Department of Chemical and Biochemical Engineering, University of Western Ontario, London, ON N6A 5B9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rohani</LastName><ForeName>Sohrab</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0002-1667-1736</Identifier><AffiliationInfo><Affiliation>Department of Chemical and Biochemical Engineering, University of Western Ontario, London, ON N6A 5B9, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nanomaterials (Basel)</MedlineTA><NlmUniqueID>101610216</NlmUniqueID><ISSNLinking>2079-4991</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">blood&#x2013;brain barrier</Keyword><Keyword MajorTopicYN=\"N\">brain diseases</Keyword><Keyword MajorTopicYN=\"N\">delivery systems</Keyword><Keyword MajorTopicYN=\"N\">metal&#x2013;organic frameworks</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39269041</ArticleId><ArticleId IdType=\"pmc\">PMC11397546</ArticleId><ArticleId IdType=\"doi\">10.3390/nano14171379</ArticleId><ArticleId IdType=\"pii\">nano14171379</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khare P., Edgecomb S.X., Hamadani C.M., Tanner E.E.L., Manickam D.S. Lipid nanoparticle-mediated drug delivery to the brain. Adv. Drug Deliv. Rev. 2023;197:114861. doi: 10.1016/j.addr.2023.114861.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.addr.2023.114861</ArticleId><ArticleId IdType=\"pubmed\">37150326</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian M., Ma Z., Yang G.Z. Micro/nanosystems for controllable drug delivery to the brain. Innovation. 2024;5:100548. doi: 10.1016/j.xinn.2023.100548.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.xinn.2023.100548</ArticleId><ArticleId IdType=\"pmc\">PMC10757293</ArticleId><ArticleId IdType=\"pubmed\">38161522</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigo D., Thornicroft G., Atun R. Estimating the true global burden of mental illness. Lancet Psychiatr. 2016;3:171&#x2013;178. doi: 10.1016/S2215-0366(15)00505-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S2215-0366(15)00505-2</ArticleId><ArticleId IdType=\"pubmed\">26851330</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao R., Fu C., Forgham H., Javed I., Huang X., Zhu J., Whittaker A.K., Davis T.P. Magnetic iron oxide nanoparticles for brain imaging and drug delivery. Adv. Drug Deliv. Rev. 2023;197:114822. doi: 10.1016/j.addr.2023.114822.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.addr.2023.114822</ArticleId><ArticleId IdType=\"pubmed\">37086918</ArticleId></ArticleIdList></Reference><Reference><Citation>Torchilin V.P. Liposomes as targetable drug carriers. Crit. Rev. Ther. Drug Carr. Syst. 1985;2:65&#x2013;115.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3913530</ArticleId></ArticleIdList></Reference><Reference><Citation>Torchilin V. Liposomes as delivery agents for medical imaging. Mol. Med. Today. 1996;2:242&#x2013;249. doi: 10.1016/1357-4310(96)88805-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/1357-4310(96)88805-8</ArticleId><ArticleId IdType=\"pubmed\">8796897</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimisiaris S.G., Marazioti A., Kannavou M., Natsaridis E., Gkartziou F., Kogkos G., Mourtas S. Overcoming barriers by local drug delivery with liposomes. Adv. Drug Deliv. Rev. 2021;174:53&#x2013;86. doi: 10.1016/j.addr.2021.01.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.addr.2021.01.019</ArticleId><ArticleId IdType=\"pubmed\">33539852</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdou E.M., Kandil S.M., Miniawy H.M.F.E. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion. Int. J. Pharm. 2017;529:667&#x2013;677. doi: 10.1016/j.ijpharm.2017.07.030.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijpharm.2017.07.030</ArticleId><ArticleId IdType=\"pubmed\">28729175</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel R.B., Patel M.R., Bhatt K.K., Patel B.G., Gaikwad R.V. Microemulsion-based drug delivery system for transnasal delivery of Carbamazepine: Preliminary brain-targeting study. Drug Deliv. 2016;23:207&#x2013;213. doi: 10.3109/10717544.2014.908980.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3109/10717544.2014.908980</ArticleId><ArticleId IdType=\"pubmed\">24825492</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunt D., Polaka S., Shrivas M., Misra M. Biodistribution and amyloid beta induced cell line toxicity study of intranasal Rivastigmine microemulsion enriched with Fish Oil and Butter oil. J. Drug Deliv. Sci. Technol. 2020;57:101661. doi: 10.1016/j.jddst.2020.101661.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jddst.2020.101661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad E., Lv Y., Zhu Q., Qi J., Dong X., Zhao W., Chen Z., Wu W., Lu Y. TAT modification facilitates nose-to-brain transport of intact mPEG-PDLLA micelles: Evidence from aggregation-caused quenching probes. Appl. Mater. Today. 2020;19:100556. doi: 10.1016/j.apmt.2020.100556.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.apmt.2020.100556</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokharkar V., Suryawanshi S., Dhapte-Pawar V. Exploring micellar-based polymeric systems for effective nose-to-brain drug delivery as potential neurotherapeutics. Drug Deliv. Transl. Res. 2019;10:1019&#x2013;1031. doi: 10.1007/s13346-019-00702-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s13346-019-00702-6</ArticleId><ArticleId IdType=\"pubmed\">31858442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen M.M., El-Salamouni N.S., El-Refaie W.M., Hazzah H.A., Ali M.M., Tosi G., Farid R.M., Blanco-Prieto M.J., Billa N., Hanafy A.S. Nanotechnology-based drug delivery systems for Alzheimer&#x2019;s disease management: Technical, industrial, and clinical challenges. J. Contr. Release. 2017;245:95&#x2013;107. doi: 10.1016/j.jconrel.2016.11.025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jconrel.2016.11.025</ArticleId><ArticleId IdType=\"pubmed\">27889394</ArticleId></ArticleIdList></Reference><Reference><Citation>Pailla S.R., Talluri S., Rangaraj N., Ramavath R., Challa V.S., Doijad N., Sampathi S. Intranasal Zotepine Nanosuspension: Intended for improved brain distribution in rats, DARU. J. Pharm. Sci. 2019;27:541&#x2013;556. doi: 10.1007/s40199-019-00281-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40199-019-00281-4</ArticleId><ArticleId IdType=\"pmc\">PMC6895326</ArticleId><ArticleId IdType=\"pubmed\">31256410</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Jayoush A.R., Hassan H.A.F.M., Asiri H., Jafar M., Saeed R., Harati R., Haider M. Niosomes for nose-to-brain delivery: A non-invasive versatile carrier system for drug delivery in neurodegenerative diseases. J. Drug Deliv. Sci. Technol. 2023;89:105007. doi: 10.1016/j.jddst.2023.105007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jddst.2023.105007</ArticleId></ArticleIdList></Reference><Reference><Citation>Nerli G., Robla S., Bartalesi M., Luceri C., D&#x2019;Ambrosio M., Csaba N., Maestrelli F. Chitosan coated niosomes for nose-to-brain delivery of clonazepam: Formulation, stability and permeability studies. Carbohydr. Polym. Technol. Appl. 2023;6:100332. doi: 10.1016/j.carpta.2023.100332.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.carpta.2023.100332</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan M.S.A., Parekh H.S., Pandey P., Siskind D.J., Falconer J.R. Nose-to-brain delivery of antipsychotics using nanotechnology: A review. Expet Opin. Drug Deliv. 2020;17:839&#x2013;853. doi: 10.1080/17425247.2020.1762563.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/17425247.2020.1762563</ArticleId><ArticleId IdType=\"pubmed\">32343186</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas H., Sayed N.S.E., Youssef N.A.H.A., MEGaafar P., Mousa M.R., Fayez A.M., Elsheikh M.A. Novel luteolin-loaded chitosan decorated nanoparticles for brain-targeting delivery in a sporadic Alzheimer&#x2019;s disease mouse model: Focus on antioxidant, anti-inflammatory, and amyloidogenic pathways. Pharmaceutics. 2022;14:1003. doi: 10.3390/pharmaceutics14051003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/pharmaceutics14051003</ArticleId><ArticleId IdType=\"pmc\">PMC9148113</ArticleId><ArticleId IdType=\"pubmed\">35631589</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabipour H., Qiu S., Wang X., Song L., Hu Y. Adenine as an efficient adsorbent for zinc ions removal from wastewater to in situ form bio-based metal&#x2013;organic frameworks: A novel approach to preparing fire-safe polymers. Compos. A Appl. Sci. Manuf. 2022;161:107099. doi: 10.1016/j.compositesa.2022.107099.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.compositesa.2022.107099</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabipour H., Hu Y. Development of fully bio-based pectin/curcumin@bio-MOF-11 for colon specific drug delivery. Chem. Pap. 2022;76:2969&#x2013;2979. doi: 10.1007/s11696-022-02081-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11696-022-02081-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabipour H., Aliakbari F., Volkening K., Strong M.J., Rohani S. New metal-organic framework coated sodium alginate for the delivery of curcumin as a sustainable drug delivery and cancer therapy system. Int. J. Biol. Macromol. 2024;259:128875. doi: 10.1016/j.ijbiomac.2023.128875.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijbiomac.2023.128875</ArticleId><ArticleId IdType=\"pubmed\">38154719</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabipour H., Aliakbari F., Volkening K., Strong M.J., Rohani S. The development of a bio-based metal-organic framework coated with carboxymethyl cellulose with the ability to deliver curcumin with anticancer properties. Mater. Today Chem. 2024;37:101976. doi: 10.1016/j.mtchem.2024.101976.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mtchem.2024.101976</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly B.M., Madden D.G., Wheatley A.E., Fairen-Jimenez D. Shaping the future of fuel: Monolithic metal&#x2013;organic frameworks for high-density gas storage. J. Am. Chem. Soc. 2020;142:8541&#x2013;8549. doi: 10.1021/jacs.0c00270.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jacs.0c00270</ArticleId><ArticleId IdType=\"pubmed\">32294384</ArticleId></ArticleIdList></Reference><Reference><Citation>Altass H.M., Ahmed S.A., Salama R.S., Moussa Z., Jassas R.S., Alsantali R.I., Al-Rooqi M.M., Ibrahim A.A., Khder M.A., Morad M. Low temperature CO oxidation over highly active gold nanoparticles supported on reduced graphene oxide@ Mg-BTC nanocomposite. Catal. Lett. 2023;153:876&#x2013;886. doi: 10.1007/s10562-022-04026-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10562-022-04026-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanikel N., Pei X.K., Chheda S., Lyu H., Jeong W., Sauer J., Gagliardi L., Yaghi O.M. Evolution of water structures in metal-organic frameworks for improved atmospheric water harvesting. Science. 2021;374:454&#x2013;459. doi: 10.1126/science.abj0890.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abj0890</ArticleId><ArticleId IdType=\"pubmed\">34672755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Liu Y., Wang H., Liu W., Li Y., Zhang J., Hou H., Yang J. Ultrathin NiCo-MOF nanosheets for high-performance supercapacitor electrodes. ACS Appl. Energy Mater. 2019;2:2063&#x2013;2071. doi: 10.1021/acsaem.8b02128.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsaem.8b02128</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R., Jian M., Ji Q., Hu C., Tang C., Liu R., Zhang X., Qu J. 2D water-stable zinc-benzimidazole framework nanosheets for ultrafast and selective removal of heavy metals. Chem. Eng. J. 2020;382:122658. doi: 10.1016/j.cej.2019.122658.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cej.2019.122658</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Z., Liu V., Farimani A.B. Water desalination with two-dimensional metal&#x2013;organic framework membranes. Nano Lett. 2019;19:8638&#x2013;8643. doi: 10.1021/acs.nanolett.9b03225.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.nanolett.9b03225</ArticleId><ArticleId IdType=\"pubmed\">31668075</ArticleId></ArticleIdList></Reference><Reference><Citation>Horcajada P., Gref R., Baati T., Allan P.K., Maurin G., Couvreur P., F&#xe9;rey G., Morris R.E., Serre C. Metal&#x2013;organic frameworks in biomedicine. Chem. Rev. 2012;112:1232&#x2013;1268. doi: 10.1021/cr200256v.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/cr200256v</ArticleId><ArticleId IdType=\"pubmed\">22168547</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lima L.S., Mortari M.R. Therapeutic nanoparticles in the brain: A review of types, physicochemical properties and challenges. Int. J. Pharm. 2022;612:121367. doi: 10.1016/j.ijpharm.2021.121367.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijpharm.2021.121367</ArticleId><ArticleId IdType=\"pubmed\">34896565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J., Gowda B.J., Almalki W.H., Gupta N., Sahebkar A., Kesharwani P. Recent advances in nanoparticle-based approaches for the treatment of brain tumors: Opportunities and challenges. Eur. Polym. J. 2023;193:112111. doi: 10.1016/j.eurpolymj.2023.112111.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.eurpolymj.2023.112111</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H., Huang Y.-L., Li D. Biological metal&#x2013;organic frameworks: Structures, host&#x2013;guest chemistry and bio-applications. Coord. Chem. Rev. 2019;378:207&#x2013;221. doi: 10.1016/j.ccr.2017.12.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ccr.2017.12.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N., Qutub S., Khashab N.M. Biocompatibility and biodegradability of metal organic frameworks for biomedical applications. J. Mater. Chem. B. 2021;9:5925&#x2013;5934. doi: 10.1039/D1TB01044A.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D1TB01044A</ArticleId><ArticleId IdType=\"pubmed\">34259304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali R.S., Meng H., Li Z. Zinc-based metal-organic frameworks in drug delivery, cell imaging, and sensing. Molecules. 2021;27:100. doi: 10.3390/molecules27010100.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/molecules27010100</ArticleId><ArticleId IdType=\"pmc\">PMC8746597</ArticleId><ArticleId IdType=\"pubmed\">35011330</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta J., Bhardwaj N., Bhardwaj S.K., Kim K.H., Deep A. Recent advances in enzyme immobilization techniques: Metal&#x2013;organic frameworks as novel substrates. Coord. Chem. Rev. 2016;322:30&#x2013;40. doi: 10.1016/j.ccr.2016.05.007.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ccr.2016.05.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadizadeh Z., Naimi-Jamal M.R., Panahi L. Mechanochemical Solvent-Free in Situ Synthesis of Drug-Loaded {Cu2(1,4-Bdc)2(Dabco)}n MOFs for Controlled Drug Delivery. J. Solid State Chem. 2018;259:35&#x2013;42. doi: 10.1016/j.jssc.2017.12.027.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jssc.2017.12.027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson H.D., Walton S.P., Chan C. Metal-Organic Frameworks for Drug Delivery: A Design Perspective. ACS Appl. Mater. Interfaces. 2021;6:7004&#x2013;7020. doi: 10.1021/acsami.1c01089.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsami.1c01089</ArticleId><ArticleId IdType=\"pubmed\">33554591</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Zhang Y., Liu L., Wan W., Guo P., Nystr&#xf6;m A.M., Zou X. One-pot Synthesis of Metal&#x2013;Organic Frameworks with Encapsulated Target Molecules and Their Applications for Controlled Drug Delivery. J. Am. Chem. Soc. 2016;138:962&#x2013;968. doi: 10.1021/jacs.5b11720.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jacs.5b11720</ArticleId><ArticleId IdType=\"pubmed\">26710234</ArticleId></ArticleIdList></Reference><Reference><Citation>Horcajada P., Chalati T., Serre C., Gillet B., Sebrie C., Baati T., Eubank J.F., Heurtaux D., Clayette P., Kreuz C., et al. Porous metal&#x2013;organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat. Mater. 2010;9:172&#x2013;178. doi: 10.1038/nmat2608.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/nmat2608</ArticleId><ArticleId IdType=\"pubmed\">20010827</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Bao T.Y., Yang X.Y., Zhu P.P., Wu L.H., Sha J.Q., Lan Y.Q. Controllable porosity conversion of metal-organic frameworks composed of natural ingredients for drug delivery. Chem. Commun. 2017;53:7804&#x2013;7807. doi: 10.1039/C7CC03673F.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C7CC03673F</ArticleId><ArticleId IdType=\"pubmed\">28653075</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., He Y., Han L., Singh V., Xu X., Guo T., Meng F., Xu X., York P., Liu Z., et al. Microwave-assisted rapid synthesis of &#x3b3;-cyclodextrin metal&#x2013;organic frameworks for size control and efficient drug loading. Cryst. Growth Des. 2017;17:1654&#x2013;1660. doi: 10.1021/acs.cgd.6b01658.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.cgd.6b01658</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Zheng M., Xie Z. Nanoscale metal&#x2013;organic frameworks for drug delivery: A conventional platform with new promise. J. Mater. Chem. B. 2018;6:707&#x2013;717. doi: 10.1039/C7TB02970E.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C7TB02970E</ArticleId><ArticleId IdType=\"pubmed\">32254257</ArticleId></ArticleIdList></Reference><Reference><Citation>Teplensky M.H., Fantham M., Li P., Wang T.C., Mehta J.P., Young L.J., Moghadam P.Z., Hupp J.T., Farha O.K., Kaminski C.F., et al. Temperature treatment of highly porous zirconium-containing metal&#x2013;organic frameworks extends drug delivery release. J. Am. Chem. Soc. 2017;139:7522&#x2013;7532. doi: 10.1021/jacs.7b01451.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jacs.7b01451</ArticleId><ArticleId IdType=\"pubmed\">28508624</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Cohen S.M. Postsynthetic modification of metal&#x2013;organic frameworks. Chem. Soc. Rev. 2009;38:1315&#x2013;1329. doi: 10.1039/b802258p.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/b802258p</ArticleId><ArticleId IdType=\"pubmed\">19384440</ArticleId></ArticleIdList></Reference><Reference><Citation>He S., Wu L., Li X., Sun H., Xiong T., Liu J., Huang C., Xu H., Sun H., Chen W., et al. Metal-Organic Frameworks for Advanced Drug Delivery. Acta Pharm. Sin. B. 2021;11:2362&#x2013;2395. doi: 10.1016/j.apsb.2021.03.019.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.apsb.2021.03.019</ArticleId><ArticleId IdType=\"pmc\">PMC8424373</ArticleId><ArticleId IdType=\"pubmed\">34522591</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris W., Briley W.E., Auyeung E., Cabezas M.D., Mirkin C.A. Nucleic Acid-Metal Organic Framework (MOF) Nanoparticle Conjugates. J. Am. Chem. Soc. 2014;20:7261&#x2013;7264. doi: 10.1021/ja503215w.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/ja503215w</ArticleId><ArticleId IdType=\"pubmed\">24818877</ArticleId></ArticleIdList></Reference><Reference><Citation>Christodoulou I., Serre C., Gref R. Metal-organic frameworks for drug delivery: Degradation mechanism and in vivo fate. Met. Fram. Biomed. Appl. 2020:467&#x2013;489. doi: 10.1016/B978-0-12-816984-1.00023-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/B978-0-12-816984-1.00023-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhettar P., Kale N., Pantwalawalkar J., Nangare S., Jadhav N. Metal-organic frameworks: Drug delivery applications and future prospects. ADMET DMPK. 2021;12:27&#x2013;62. doi: 10.5599/admet.2057.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5599/admet.2057</ArticleId><ArticleId IdType=\"pmc\">PMC10974818</ArticleId><ArticleId IdType=\"pubmed\">38560715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W., Cui Y., Yang Y., Hu Q., Qian G. A biocompatible metal-organic framework as a pH and temperature dual-responsive drug carrier. Dalton Trans. 2018;47:15882&#x2013;15887. doi: 10.1039/C8DT03202E.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/C8DT03202E</ArticleId><ArticleId IdType=\"pubmed\">30362496</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C.Y., Qin C., Wang X.L., Yang G.S., Shao K.Z., Lan Y.Q., Su Z.M., Huang P., Wang C.G., Wang E.B. Zeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle. Dalton Trans. 2012;41:6906&#x2013;6909. doi: 10.1039/c2dt30357d.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/c2dt30357d</ArticleId><ArticleId IdType=\"pubmed\">22580798</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z.J., Hou Y.K., Chen M.W., Yu X.Z., Chen S.Y., Yue Y.R., Guo X.T., Chen J.X., Zhou Q.A. pH-responsive metal-organic framework for the co-delivery of HIF-2&#x3b1; SiRNA and curcumin for enhanced therapy of osteoarthritis. J. Nanobiotechnol. 2021;21:18. doi: 10.1186/s12951-022-01758-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12951-022-01758-2</ArticleId><ArticleId IdType=\"pmc\">PMC9847079</ArticleId><ArticleId IdType=\"pubmed\">36650517</ArticleId></ArticleIdList></Reference><Reference><Citation>Coluccia M., Parisse V., Guglielmi P., Giannini G., Secci D. Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes. Eur. J. Med. Chem. 2022;244:114801. doi: 10.1016/j.ejmech.2022.114801.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ejmech.2022.114801</ArticleId><ArticleId IdType=\"pubmed\">36215860</ArticleId></ArticleIdList></Reference><Reference><Citation>Odom T.L., LeBroc H.D., Callmann C.E. Biomacromolecule-tagged nanoscale constructs for crossing the blood&#x2013;brain barrier. Nanoscale. 2024;16:3969&#x2013;3976. doi: 10.1039/D3NR06154J.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D3NR06154J</ArticleId><ArticleId IdType=\"pubmed\">38305381</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Q., Zhao S., Xu T., Wang Q., Lan M., Yan L., Chen X. Getting drugs to the brain: Advances and prospects of organic nanoparticle delivery systems for assisting drugs to cross the blood&#x2013;brain barrier. J. Mater. Chem. B. 2022;10:9314&#x2013;9333. doi: 10.1039/D2TB01440H.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D2TB01440H</ArticleId><ArticleId IdType=\"pubmed\">36349976</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy S., Tatiparti K., Sau S., Iyer A.K. Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors. Drug Discov. Today. 2021;26:1944&#x2013;1952. doi: 10.1016/j.drudis.2021.04.008.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.drudis.2021.04.008</ArticleId><ArticleId IdType=\"pubmed\">33865978</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Q., Zhao S., Xu T., Wang Q., Zhang M., Yan L., Chen X., Lan M. Inorganic nano-drug delivery systems for crossing the blood&#x2013;brain barrier: Advances and challenges. Coord. Chem. Rev. 2023;494:215344. doi: 10.1016/j.ccr.2023.215344.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ccr.2023.215344</ArticleId></ArticleIdList></Reference><Reference><Citation>Alahri M.B., Arshadizadeh R., Raeisi M., Khatami M., Sajadi M.S., Abdelbasset W.K., Akhmadeev R., Iravani S. Theranostic applications of metal&#x2013;organic frameworks (MOFs)-based materials in brain disorders: Recent advances and challenges. Inorg. Chem. Commun. 2021;134:108997. doi: 10.1016/j.inoche.2021.108997.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.inoche.2021.108997</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Z., Yuan M., Nguyen N., Zhou H., Hubbard J.E., Wang Y. Brain-specific targeted delivery of therapeutic agents using metal&#x2013;organic framework-based nanomedicine. Coord. Chem. Rev. 2024;514:215926. doi: 10.1016/j.ccr.2024.215926.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ccr.2024.215926</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao C.Q., Zhang R.L., Wang Y.D., Jia Q., Wang X.F., Yang Z., Xue T.F., Ji R.C., Cui X.F., Wang Z.L. Rabies virus-inspired metal-organic frameworks (MOFs) for targeted imaging and chemotherapy of glioma. Angew. Chem.-Int. Edit. 2020;59:16982&#x2013;16988. doi: 10.1002/anie.202007474.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/anie.202007474</ArticleId><ArticleId IdType=\"pubmed\">32608558</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu D.-Y., Liu X., Zheng X., Zhou M., Wang W., Su G., Liu T., Wang L., Xie Z. Polymer-metal-organic framework hybrids for bioimaging and cancer therapy. Coord. Chem. Rev. 2022;456:214393. doi: 10.1016/j.ccr.2021.214393.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ccr.2021.214393</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q.-X., Liang J.-L., Chen Q.-W., Jin X.-K., Niu M.-T., Dong C.-Y., Zhang X.-Z. Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma. Nano Today. 2023;51:101911. doi: 10.1016/j.nantod.2023.101911.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nantod.2023.101911</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulvirenti L., Monforte F., Presti F.L., Volti G.L., Carota G., Sinatra F., Bongiorno C., Mannino G., Cambria M.T., Condorelli G.G. Synthesis of MIL-modified Fe3O4 magnetic nanoparticles for enhancing uptake and efficiency of temozolomide in glioblastoma treatment. Int. J. Mol. Sci. 2022;23:2874. doi: 10.3390/ijms23052874.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms23052874</ArticleId><ArticleId IdType=\"pmc\">PMC8911361</ArticleId><ArticleId IdType=\"pubmed\">35270016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Kumar A., Li C., Hazari P.P., Mahajan S.D., Aalinkeel R., Sharma R.K., Swihart M.T. A cannabidiol-loaded Mg-gallate metal&#x2013;organic framework-based potential therapeutic for glioblastomas. J. Mater. Chem. B. 2021;9:2505&#x2013;2514. doi: 10.1039/D0TB02780D.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D0TB02780D</ArticleId><ArticleId IdType=\"pubmed\">33657198</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Hong H., Xue J., Luo J., Liu Q., Chen X., Pan Y., Zhou J., Liu Z., Chen T. Near-infrared radiation-assisted drug delivery nanoplatform to realize blood&#x2013;brain barrier crossing and protection for parkinsonian therapy. ACS Appl. Mater. Interfaces. 2021;13:37746&#x2013;37760. doi: 10.1021/acsami.1c12675.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsami.1c12675</ArticleId><ArticleId IdType=\"pubmed\">34318658</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W., Li Q., Zhang R., Li J., Lin Q., Li J., Zhou X., Yan X., Fan K. Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson&#x2019;s disease. Nat. Commun. 2023;14:8137. doi: 10.1038/s41467-023-43870-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41467-023-43870-3</ArticleId><ArticleId IdType=\"pmc\">PMC10709450</ArticleId><ArticleId IdType=\"pubmed\">38065945</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Ding X., Chang Z., Fan X., Pan J., Yang Y., Li X., Jiang W., Fan K. Metal&#x2013;organic framework based nanozyme system for NLRP3 inflammasome-mediated neuroinflammatory regulation in Parkinson&#x2019;s disease. Adv. Healthc. Mater. 2023;13:2303454. doi: 10.1002/adhm.202303454.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/adhm.202303454</ArticleId><ArticleId IdType=\"pubmed\">38031989</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Chen Y., Jia Z., Yuan X., Liu J. Electrostatic assembly of gold nanoparticle and metal-organic framework nanoparticles attenuates amyloid beta aggregate-mediated neurotoxicity. J. Mater. Chem. B. 2023;11:4453&#x2013;4463. doi: 10.1039/D3TB00281K.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1039/D3TB00281K</ArticleId><ArticleId IdType=\"pubmed\">37158054</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Yin F., Ji L., Wang C., Shi C., Liu X., Yang H., Wang X., Kong L. Development of a tau-targeted drug delivery system using a multifunctional nanoscale metal-organic framework for Alzheimer&#x2019;s disease therapy. ACS Appl. Mater. Interfaces. 2020;12:44447&#x2013;44458. doi: 10.1021/acsami.0c11064.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsami.0c11064</ArticleId><ArticleId IdType=\"pubmed\">32897042</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Fan Y., Tan Y., Zhao X., Zhang Y., Cheng C., Yang M. Porphyrinic metal&#x2013;organic framework PCN-224 nanoparticles for near-infrared-induced attenuation of aggregation and neurotoxicity of Alzheimer&#x2019;s amyloid-&#x3b2; peptide. ACS Appl. Mater. Interfaces. 2018;10:36615. doi: 10.1021/acsami.8b15452.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsami.8b15452</ArticleId><ArticleId IdType=\"pubmed\">30338980</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Huang Y., Kou Q., Lu L., Jiang H., Li X., Gui R., Huang R., Huang X., Ma J., et al. Study on the role of an erythrocyte membrane-coated nanotheranostic system in targeted immune regulation of Alzheimer&#x2019;s disease. Adv. Sci. 2023;10:e2301361. doi: 10.1002/advs.202301361.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/advs.202301361</ArticleId><ArticleId IdType=\"pmc\">PMC10288270</ArticleId><ArticleId IdType=\"pubmed\">37075744</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Gu Y., Liu X., Fan Y., Zhang Y., Yi C., Cheng C., Yang M. Near-infrared photothermally enhanced photo-oxygenation for inhibition of amyloid-beta aggregation based on RVG-conjugated porphyrinic metal-organic framework and indocyanine green nanoplatform. Int. J. Mol. Sci. 2022;23:10885. doi: 10.3390/ijms231810885.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms231810885</ArticleId><ArticleId IdType=\"pmc\">PMC9505608</ArticleId><ArticleId IdType=\"pubmed\">36142796</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Han M., Li J., Ke H., Kong Y., Wang W., Wang L., Ma W., Qiu J., Wang X., et al. Delivery of miRNAs through metal&#x2013;organic framework nanoparticles for assisting neural stem cell therapy for ischemic stroke. ACS Nano. 2022;16:14503&#x2013;14516. doi: 10.1021/acsnano.2c04886.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acsnano.2c04886</ArticleId><ArticleId IdType=\"pubmed\">36065995</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen C.L., Bayraktutan U. Oxidative stress and its role in the pathogenesis ofischaemic stroke. J. Stroke. 2009;4:461&#x2013;470. doi: 10.1111/j.1747-4949.2009.00387.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1747-4949.2009.00387.x</ArticleId><ArticleId IdType=\"pubmed\">19930058</ArticleId></ArticleIdList></Reference><Reference><Citation>He L., Huang G., Liu H., Sang C., Liu X., Chen T. Highly bioactive zeolitic imidazolate framework-8&#x2013;capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke. Sci. Adv. 2020;6:eaay9751. doi: 10.1126/sciadv.aay9751.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/sciadv.aay9751</ArticleId><ArticleId IdType=\"pmc\">PMC7080448</ArticleId><ArticleId IdType=\"pubmed\">32206718</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Qin Y., Peng Y., Mai R., Teng H., Qi Z., Mo J. Advancing stroke therapy: The potential of MOF-based nanozymes in biomedical applications. Front. Bioeng. Biotechnol. 2024;12:1363227. doi: 10.3389/fbioe.2024.1363227.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fbioe.2024.1363227</ArticleId><ArticleId IdType=\"pmc\">PMC11119330</ArticleId><ArticleId IdType=\"pubmed\">38798955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y., Jin Y., Peng T., Gao Y., Zang Y., He H., Li F., Zhang Y., Zhang H., Chen L. Fabrication of multifunctional metal&#x2013;organic frameworks nanoparticles via layer-by-layer self-assembly to efficiently discover PSD95-nNOS uncouplers for stroke treatment. J. Nanobiotechnol. 2022;20:379. doi: 10.1186/s12951-022-01583-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12951-022-01583-7</ArticleId><ArticleId IdType=\"pmc\">PMC9375364</ArticleId><ArticleId IdType=\"pubmed\">35964123</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren F., Yang B., Cai J., Jiang Y., Xu J., Wang S. Toxic effect of zinc nanoscale metal-organic frameworks on rat pheochromocytoma (PC12) cells in vitro. J. Hazard. Mater. 2014;271:283&#x2013;291. doi: 10.1016/j.jhazmat.2014.02.026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jhazmat.2014.02.026</ArticleId><ArticleId IdType=\"pubmed\">24637453</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu H., Chen J., Jin J., Qi X., Bai K., Shu C., Wu A., Xiao Y., Wu C., Bu H., et al. Engineering metalloporphyrin-integrated nanosystems for targeted sono-/chemo-dynamic therapy of leptomeningeal carcinomatosis through intrathecal administration. Chem. Eng. J. 2022;437:135373. doi: 10.1016/j.cej.2022.135373.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cej.2022.135373</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">39268786</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2366-9608</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Small methods</Title><ISOAbbreviation>Small Methods</ISOAbbreviation></Journal><ArticleTitle>Isotope-Labeled Chemoselective Probes for Labeling, Separation, and Comprehensive Quantitative Analysis of Sub-Metabolome.</ArticleTitle><Pagination><StartPage>e2400529</StartPage><MedlinePgn>e2400529</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1002/smtd.202400529</ELocationID><Abstract><AbstractText>The significance of small molecule metabolites as biomarkers for disease diagnosis and prognosis is growing increasingly evident, necessitating the development of highly sensitive qualitative and quantitative methods. Herein, multi-chemoselective probes are synthesized and applied for profiling metabolites, including carboxyl, phosphate, hydroxyl, amino, thiol, and carbonyl compounds. This approach seamlessly integrates magnetic solid-phase materials, orthogonal cleavage sites, isotopic tags, and selective coupling sites, minimizes matrix interference, and enhances quantitative accuracy. Meanwhile, a homemade program, High-Resolution Isotope-Assisted Identification and Quantitative (HRIAI<sub>Quant</sub>) is developed to process the data, which adeptly filters through 33,874 ion pairs present in human serum, leading to the identification of 701 known metabolites and a remarkable 1,062 potential novel ones. This method is successfully applied to analyze metabolites in multiple brain regions of SAMP8 and SAMR1 models, offering a novel tool for Alzheimer's disease research.</AbstractText><CopyrightInformation>&#xa9; 2024 Wiley&#x2010;VCH GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Tian</LastName><ForeName>Hongtao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences &amp; School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lai</LastName><ForeName>Zhizhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences &amp; School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Wenjia</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences &amp; School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Mo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences &amp; School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Xiaolin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences &amp; School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhou</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Analytical Instrumentation Center, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Zhili</ForeName><Initials>Z</Initials><Identifier Source=\"ORCID\">0000-0002-1190-7949</Identifier><AffiliationInfo><Affiliation>Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences &amp; School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>2022-I2M-1-012</GrantID><Agency>CAMS Innovation Fund for Medical Sciences</Agency><Country/></Grant><Grant><GrantID>2023-I2M-QJ-014</GrantID><Agency>CAMS Innovation Fund for Medical Sciences</Agency><Country/></Grant><Grant><GrantID>21976005</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Small Methods</MedlineTA><NlmUniqueID>101724536</NlmUniqueID><ISSNLinking>2366-9608</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">chemoselective probes</Keyword><Keyword MajorTopicYN=\"N\">quantitative analysis</Keyword><Keyword MajorTopicYN=\"N\">stable isotope labeling</Keyword><Keyword MajorTopicYN=\"N\">sub&#x2010;metabolome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"revised\"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>14</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39268786</ArticleId><ArticleId IdType=\"doi\">10.1002/smtd.202400529</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>a) L. Drew, Nature 2018, 559, S2;</Citation></Reference><Reference><Citation>b) P. Scheltens, B. De Strooper, M. Kivipelto, H. Holstege, G. Ch&#xe9;telat, C. E. Teunissen, J. Cummings, W. M. van der Flier, Lancet 2021, 397, 1577;</Citation></Reference><Reference><Citation>c) A. Gustavsson, N. Norton, T. Fast, L. Fr&#xf6;lich, J. Georges, D. Holzapfel, T. Kirabali, P. Krolak&#x2010;Salmon, P. M. Rossini, M. T. Ferretti, L. Lanman, A. S. Chadha, W. M. van der Flier, Alzheimers Dement. 2023, 19, 658.</Citation></Reference><Reference><Citation>a) J. A. Soria Lopez, H. M. Gonz&#xe1;lez, G. C. L&#xe9;ger, Handb. Clin. Neurol. 2019, 167, 231;</Citation></Reference><Reference><Citation>b) A. Iatrou, G. Kenis, B. P. Rutten, K. Lunnon, D. L. van den Hove, Cell. Mol. Life Sci. 2017, 74, 509;</Citation></Reference><Reference><Citation>c) R. Mayeux, Y. Stern, Cold Spring Harbor Perspect. Med. 2012, 2, a006239.</Citation></Reference><Reference><Citation>H. W. Querfurth, F. M. LaFerla, N. Engl. J. Med. 2010, 362, 329.</Citation></Reference><Reference><Citation>a) K. R. Thomas, K. J. Bangen, A. J. Weigand, E. C. Edmonds, C. G. Wong, S. Cooper, L. Delano&#x2010;Wood, M. W. Bondi, Neurology 2020, 94, e397;</Citation></Reference><Reference><Citation>b) A. Sturchio, A. K. Dwivedi, C. B. Young, T. Malm, L. Marsili, J. S. Sharma, A. Mahajan, E. J. Hill, S. E. Andaloussi, K. L. Poston, F. P. Manfredsson, L. S. Schneider, K. Ezzat, A. J. Espay, EClinicalMedicine 2021, 38, 100988.</Citation></Reference><Reference><Citation>M. Fox, Ageing Res. Rev. 2018, 47, 140.</Citation></Reference><Reference><Citation>a) B. Liu, J. Liu, J. S. Shi, J. Alzheimer's Dis. 2020, 75, 385;</Citation></Reference><Reference><Citation>b) F. J. Fern&#xe1;ndez&#x2010;G&#xf3;mez, E. Mu&#xf1;oz&#x2010;Delgado, M. F. Montenegro, F. J. Campoy, C. J. Vidal, J. Jord&#xe1;n, J. Neurosci. Res. 2010, 88, 155.</Citation></Reference><Reference><Citation>J. Graff&#x2010;Radford, K. X. X. Yong, L. G. Apostolova, F. H. Bouwman, M. Carrillo, B. C. Dickerson, G. D. Rabinovici, J. M. Schott, D. T. Jones, M. E. Murray, Lancet Neurol. 2021, 20, 222.</Citation></Reference><Reference><Citation>G. J. Patti, O. Yanes, G. Siuzdak, Nat. Rev. Mol. Cell Biol. 2012, 13, 263.</Citation></Reference><Reference><Citation>S. Rochfort, J. Nat. Prod. 2005, 68, 1813.</Citation></Reference><Reference><Citation>J. T. Cox, I. Marginean, R. D. Smith, K. Tang, J. Am. Soc. Mass Spectrom. 2015, 26, 55.</Citation></Reference><Reference><Citation>B. K. Matuszewski, M. L. Constanzer, C. M. Chavez&#x2010;Eng, Anal. Chem. 2003, 75, 3019.</Citation></Reference><Reference><Citation>a) T. Jankech, I. Gerhardtova, P. Majerova, J. Piestansky, J. Jampilek, A. Kovac, Anal. Chim. Acta 2024, 12, 1003;</Citation></Reference><Reference><Citation>b) H. Zeng, C.&#x2010;B. Qi, T. Liu, H.&#x2010;M. Xiao, Q.&#x2010;Y. Cheng, H.&#x2010;P. Jiang, B.&#x2010;F. Yuan, Y.&#x2010;Q. Feng, Anal. Chem. 2017, 89, 4153;</Citation></Reference><Reference><Citation>c) J. Klikarov&#xe1;, L. &#x10c;eslov&#xe1;, J. Fischer, J. Chromatogr. A 2021, 1644, 462134;</Citation></Reference><Reference><Citation>d) M. S. Russo, A. Napylov, A. Paquet, D. Vuckovic, Anal. Bioanal. Chem. 2020, 412, 1639;</Citation></Reference><Reference><Citation>e) M. Vogel, A. B&#xfc;ldt, U. Karst, Fresenius' J. Anal. Chem. 2000, 366, 781;</Citation></Reference><Reference><Citation>f) C. Liu, X. Sheng, Y. Wang, J. Yin, W. Huang, Y. Fan, Y. Li, Y. Zhang, RSC Adv. 2018, 8, 19713.</Citation></Reference><Reference><Citation>N. Zhang, Q. Chen, P. Zhang, K. Zhou, Y. Liu, H. Wang, S. Duan, Y. Xie, W. Yu, Z. Kong, L. Ren, W. Hou, J. Yang, X. Gong, L. Dong, X. Fang, L. Shi, Y. Yu, Y. Zheng, Genome Biol. 2024, 25, 34.</Citation></Reference><Reference><Citation>a) N. Garg, L. P. Conway, C. Ballet, M. S. P. Correia, F. K. S. Olsson, M. Vujasinovic, J. M. L&#xf6;hr, D. Globisch, Angew. Chem., Int. Ed. 2018, 57, 13805;</Citation></Reference><Reference><Citation>b) H. Tian, Z. Lai, M. Zhang, S. Liu, R. Zhang, J. Zhou, Z. Li, Anal. Chem. 2023, 95, 9539.</Citation></Reference><Reference><Citation>a) S. Arrivault, M. Guenther, S. C. Fry, M. M. Fuenfgeld, D. Veyel, T. Mettler&#x2010;Altmann, M. Stitt, J. E. Lunn, Anal. Chem. 2015, 87, 6896;</Citation></Reference><Reference><Citation>b) W. Lin, L. P. Conway, M. Vujasinovic, J. M. L&#xf6;hr, D. Globisch, Angew. Chem. Int. Ed. Engl. 2021, 60, 23232;</Citation></Reference><Reference><Citation>c) M. Zhang, Z. Lai, R. Zhang, S. Liu, H. Tian, Y. Qiu, D. Li, J. Zhou, Z. Li, Small 2023, 19, 2204734;</Citation></Reference><Reference><Citation>d) W. Lin, L. Gerullat, P. R. Braadland, A. Fournier, J. R. Hov, D. Globisch, Angew. Chem. Int. Ed. Engl. 2024, 63, 202318579.</Citation></Reference><Reference><Citation>a) S. Liu, M. Zhang, Z. Lai, H. Tian, Y. Qiu, Z. Li, ACS Appl. Mater. Interfaces 2022, 14, 32890;</Citation></Reference><Reference><Citation>b) X. Wang, P. Bai, Z. Li, Q.&#x2010;F. Zhu, Z. Wei, Y.&#x2010;Q. Feng, Angew. Chem., Int. Ed. 2022, 61, 202208138.</Citation></Reference><Reference><Citation>a) S. N. Mthembu, A. Sharma, F. Albericio, B. G. de la Torre, ChemBioChem 2020, 21, 1947;</Citation></Reference><Reference><Citation>b) E. E. Schillern, A. Pasch, M. Feelisch, F. Waanders, S. H. Hendriks, R. Mencke, G. Harms, K. H. Groenier, H. J. Bilo, J.&#x2010;L. Hillebrands, J. Clin. Transl. Endocrinol. 2019, 16, 100182.</Citation></Reference><Reference><Citation>a) S. K. Schum, L. E. Brown, L. R. Mazzoleni, Environ. Res. 2020, 191, 110114;</Citation></Reference><Reference><Citation>b) C. Ayala&#x2010;Ortiz, N. Graf&#x2010;Grachet, V. Freire&#x2010;Zapata, J. Fudyma, G. Hildebrand, R. AminiTabrizi, C. Howard&#x2010;Varona, Y. E. Corilo, N. Hess, M. B. Duhaime, M. B. Sullivan, M. M. Tfaily, Microbiome 2023, 11, 28.</Citation></Reference><Reference><Citation>E. A. Th&#xe9;venot, A. Roux, Y. Xu, E. Ezan, C. Junot, J. Proteome Res. 2015, 14, 3322.</Citation></Reference><Reference><Citation>J. B. Schulz, J. Lindenau, J. Seyfried, J. Dichgans, Eur. J. Biochem. 2000, 267, 4904.</Citation></Reference><Reference><Citation>P. K. Mandal, S. Saharan, M. Tripathi, G. Murari, Biol. Psychiatry 2015, 78, 702.</Citation></Reference><Reference><Citation>G. Yin, Y. Gan, H. Jiang, T. Yu, M. Liu, Y. Zhang, H. Li, P. Yin, S. Yao, Anal. Chem. 2021, 93, 9878.</Citation></Reference><Reference><Citation>a) D. W. Ellison, M. F. Beal, J. B. Martin, Brain Res. 1987, 417, 389;</Citation></Reference><Reference><Citation>b) A. Gwanyanya, C. N. Godsmark, R. Kelly&#x2010;Laubscher, CNS Neurol. Disord.: Drug Targets 2022, 21, 108.</Citation></Reference><Reference><Citation>a) M. J. Niciu, B. Kelmendi, G. Sanacora, Pharmacol., Biochem. Behav. 2012, 100, 656;</Citation></Reference><Reference><Citation>b) A. C. Paula&#x2010;Lima, J. Brito&#x2010;Moreira, S. T. Ferreira, J. Neurochem. 2013, 126, 191;</Citation></Reference><Reference><Citation>c) H. Targa Dias Anastacio, N. Matosin, L. Ooi, Transl. Psychiatry 2022, 12, 257.</Citation></Reference><Reference><Citation>H. S. Walton, P. R. Dodd, Neurochem. Int. 2007, 50, 1052.</Citation></Reference><Reference><Citation>D. Delwing, D. Delwing, R. J. Sanna, S. Wofchuk, A. T. Wyse, Life Sci. 2007, 81, 1645.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">39268367</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">1792-1015</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>28</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Experimental and therapeutic medicine</Title><ISOAbbreviation>Exp Ther Med</ISOAbbreviation></Journal><ArticleTitle>New insights on the link between Epstein&#x2011;Barr virus infection and cognitive decline in neurodegenerative diseases (Review).</ArticleTitle><Pagination><StartPage>413</StartPage><MedlinePgn>413</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">413</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3892/etm.2024.12702</ELocationID><Abstract><AbstractText>Cognitive decline is a frequent complaint in healthy controls and neurological patients, regardless of the underlying pathology. Whilst cognitive impairment can be easily diagnosed in the more advanced stages of neurodegenerative diseases, early detection can be challenging. This is mainly the consequence of the incomplete understanding of the underlying pathophysiological mechanisms. In addition, currently available neurological treatments do not specifically target cognitive decline, since other motor and non-motor symptoms, such as bradykinesia, tremor, autonomic disturbances and depression, are of greater relevance from a therapeutic perspective. In this context, prospective studies must address a number of issues, including the risk factors associated with cognitive deficits in neurodegenerative diseases. The present review aims to offer a novel perspective on the association between Epstein-Barr virus infection and cognitive decline found in patients with neurodegenerative disorders. Specifically, relevant epidemiological studies and clinical trials explaining this connection were reviewed, focusing on the most frequent neurodegenerative disorders. They are namely Alzheimer's disease, Parkinson's disease and multiple sclerosis. Despite their limitations, possible underlying pathophysiological mechanisms that explain the impact of Epstein-Barr virus infection on cognitive decline are expected to offer novel study directions on this clinically relevant topic.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Schreiner et al.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Schreiner</LastName><ForeName>Thomas Gabriel</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Medicine and Pharmacy 'Gr. T. Popa', 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Electrical Measurements and Materials, Faculty of Electrical Engineering and Information Technology, Gheorghe Asachi Technical University of Iasi, 700050 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Romanescu</LastName><ForeName>Constantin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Section IV, 'St. Parascheva' Infectious Disease Hospital, 700116 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schreiner</LastName><ForeName>Oliver Daniel</ForeName><Initials>OD</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Medicine and Pharmacy 'Gr. T. Popa', 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Oncology, Regional Institute of Oncology, 700483 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nhambasora</LastName><ForeName>Farai</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, St. Luke's Hospital, R95 FY71 Kilkenny, Republic of Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Exp Ther Med</MedlineTA><NlmUniqueID>101531947</NlmUniqueID><ISSNLinking>1792-0981</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">Epstein-Barr virus</Keyword><Keyword MajorTopicYN=\"N\">Parkinson's disease</Keyword><Keyword MajorTopicYN=\"N\">cognitive decline</Keyword><Keyword MajorTopicYN=\"N\">multiple sclerosis</Keyword><Keyword MajorTopicYN=\"N\">neurodegeneration</Keyword><Keyword MajorTopicYN=\"N\">neurodegenerative disorders</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39268367</ArticleId><ArticleId IdType=\"pmc\">PMC11391170</ArticleId><ArticleId IdType=\"doi\">10.3892/etm.2024.12702</ArticleId><ArticleId IdType=\"pii\">ETM-28-5-12702</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lyon P, Keijzer F, Arendt D, Levin M. Reframing cognition: Getting down to biological basics. Philos Trans R Soc Lond B Biol Sci. 2021;376(20190750) doi: 10.1098/rstb.2019.0750.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1098/rstb.2019.0750</ArticleId><ArticleId IdType=\"pmc\">PMC7935032</ArticleId><ArticleId IdType=\"pubmed\">33487107</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey PD. Domains of cognition and their assessment. Dialogues Clin Neurosci. 2019;21:227&#x2013;237. doi: 10.31887/DCNS.2019.21.3/pharvey.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.31887/DCNS.2019.21.3/pharvey</ArticleId><ArticleId IdType=\"pmc\">PMC6829170</ArticleId><ArticleId IdType=\"pubmed\">31749647</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-G&#xf3;mez ME, Zapico SC. Frailty, cognitive decline, neurodegenerative diseases and nutrition interventions. Int J Mol Sci. 2019;20(2842) doi: 10.3390/ijms20112842.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms20112842</ArticleId><ArticleId IdType=\"pmc\">PMC6600148</ArticleId><ArticleId IdType=\"pubmed\">31212645</ArticleId></ArticleIdList></Reference><Reference><Citation>McNicholas N, O'Connell K, Yap SM, Killeen RP, Hutchinson M, McGuigan C. Cognitive dysfunction in early multiple sclerosis: A review. QJM. 2018;111:359&#x2013;364. doi: 10.1093/qjmed/hcx070.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/qjmed/hcx070</ArticleId><ArticleId IdType=\"pubmed\">28371862</ArticleId></ArticleIdList></Reference><Reference><Citation>Elendu C, Amaechi DC, Elendu TC, Ibhiedu JO, Egbunu EO, Ndam AR, Ogala F, Ologunde T, Peterson JC, Boluwatife AI, et al. Stroke and cognitive impairment: Understanding the connection and managing symptoms. Ann Med Surg (Lond) 2023;85:6057&#x2013;6066. doi: 10.1097/MS9.0000000000001441.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MS9.0000000000001441</ArticleId><ArticleId IdType=\"pmc\">PMC10718363</ArticleId><ArticleId IdType=\"pubmed\">38098605</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo JW, Crawford JD, Desmond DW, Bae HJ, Lim JS, Godefroy O, Roussel M, Kang Y, Jahng S, K&#xf6;hler S, et al. Long-Term cognitive decline after stroke: An individual participant data meta-analysis. Stroke. 2022;53:1318&#x2013;1327. doi: 10.1161/STROKEAHA.121.035796.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1161/STROKEAHA.121.035796</ArticleId><ArticleId IdType=\"pubmed\">34775838</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho MH, Shin DW, Chang SA, Lee JE, Jeong SM, Kim SH, Yun JM, Son K. Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia. Sci Rep. 2018;8(11688) doi: 10.1038/s41598-018-29974-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-29974-7</ArticleId><ArticleId IdType=\"pmc\">PMC6076290</ArticleId><ArticleId IdType=\"pubmed\">30076332</ArticleId></ArticleIdList></Reference><Reference><Citation>Helvik AS, Barca ML, Bergh S, &#x160;altyt&#x117;-Benth J, Kirkevold &#xd8;, Borza T. The course of depressive symptoms with decline in cognitive function-A longitudinal study of older adults receiving in-home care at baseline. BMC Geriatr. 2019;19(231) doi: 10.1186/s12877-019-1226-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12877-019-1226-8</ArticleId><ArticleId IdType=\"pmc\">PMC6708209</ArticleId><ArticleId IdType=\"pubmed\">31443638</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain N, Wang Y, Zhang Y, Jacobsen E, Andreescu C, Snitz BE, Chang CH, Ganguli M. It goes both ways: The relationship between anxiety and mild cognitive impairment. Int J Geriatr Psychiatry. 2023;38(e5899) doi: 10.1002/gps.5899.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/gps.5899</ArticleId><ArticleId IdType=\"pubmed\">36855309</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon KY, Park S, Kim RO, Lee EJ, Lee M. Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson's disease. Sci Rep. 2022;12(11461) doi: 10.1038/s41598-022-15630-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-022-15630-8</ArticleId><ArticleId IdType=\"pmc\">PMC9259652</ArticleId><ArticleId IdType=\"pubmed\">35794147</ArticleId></ArticleIdList></Reference><Reference><Citation>Pais R, Ruano L, P Carvalho O, Barros H. Global cognitive impairment prevalence and incidence in community dwelling older adults-A systematic review. Geriatrics (Basel) 2020;5(84) doi: 10.3390/geriatrics5040084.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/geriatrics5040084</ArticleId><ArticleId IdType=\"pmc\">PMC7709591</ArticleId><ArticleId IdType=\"pubmed\">33121002</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q. The humanistic and economic burden of Alzheimer's disease. Neurol Ther. 2022;11:525&#x2013;551. doi: 10.1007/s40120-022-00335-x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40120-022-00335-x</ArticleId><ArticleId IdType=\"pmc\">PMC9095804</ArticleId><ArticleId IdType=\"pubmed\">35192176</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PJ, Neumann PJ. The economics of mild cognitive impairment. Alzheimers Dement. 2013;9:58&#x2013;62. doi: 10.1016/j.jalz.2012.05.2117.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2012.05.2117</ArticleId><ArticleId IdType=\"pubmed\">23141385</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu T, Dong W, Liu J, Yin P, Wang Z, Zhang L, Zhou M. Disease burden of Parkinson's disease in China and its provinces from 1990 to 2021: Findings from the global burden of disease study 2021. Lancet Reg Health West Pac. 2024;46(101078) doi: 10.1016/j.lanwpc.2024.101078.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.lanwpc.2024.101078</ArticleId><ArticleId IdType=\"pmc\">PMC11091691</ArticleId><ArticleId IdType=\"pubmed\">38745974</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26:1816&#x2013;1821. doi: 10.1177/1352458520970841.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1352458520970841</ArticleId><ArticleId IdType=\"pmc\">PMC7720355</ArticleId><ArticleId IdType=\"pubmed\">33174475</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1964;1:702&#x2013;703. doi: 10.1016/s0140-6736(64)91524-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/s0140-6736(64)91524-7</ArticleId><ArticleId IdType=\"pubmed\">14107961</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoover K, Higginbotham K. Epstein-Barr Virus. In: StatPearls (Internet). StatPearls Publishing, Treasure Island, FL, 2024.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32644711</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Cohen JI. Epstein-Barr virus and the human leukocyte antigen complex. Curr Clin Microbiol Rep. 2019;6:175&#x2013;181. doi: 10.1007/s40588-019-00120-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40588-019-00120-9</ArticleId><ArticleId IdType=\"pmc\">PMC7577584</ArticleId><ArticleId IdType=\"pubmed\">33094090</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin H, Qu J, Peng Q, Gan R. Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis. Med Microbiol Immunol. 2019;208:573&#x2013;583. doi: 10.1007/s00430-018-0570-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00430-018-0570-1</ArticleId><ArticleId IdType=\"pmc\">PMC6746687</ArticleId><ArticleId IdType=\"pubmed\">30386928</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N, Zuo Y, Jiang L, Peng Y, Huang X, Zuo L. Epstein-Barr virus and neurological diseases. Front Mol Biosci. 2022;8(816098) doi: 10.3389/fmolb.2021.816098.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmolb.2021.816098</ArticleId><ArticleId IdType=\"pmc\">PMC8784775</ArticleId><ArticleId IdType=\"pubmed\">35083281</ArticleId></ArticleIdList></Reference><Reference><Citation>Drouin E, Drouin G. The first report of Alzheimer's disease. Lancet Neurol. 2017;16(687) doi: 10.1016/S1474-4422(17)30258-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(17)30258-2</ArticleId><ArticleId IdType=\"pubmed\">28816117</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Flier WM, de Vugt ME, Smets EMA, Blom M, Teunissen CE. Towards a future where Alzheimer's disease pathology is stopped before the onset of dementia. Nat Aging. 2023;3:494&#x2013;505. doi: 10.1038/s43587-023-00404-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s43587-023-00404-2</ArticleId><ArticleId IdType=\"pubmed\">37202515</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Vergallo A, Farlow MR, Snyder PJ, Giacobini E, Khachaturian ZS. Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research. J Prev Alzheimers Dis. 2019;6:2&#x2013;15. doi: 10.14283/jpad.2018.43.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14283/jpad.2018.43</ArticleId><ArticleId IdType=\"pubmed\">30569080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue A, Komine O, Yamanaka K. Neuroinflammation in Alzheimer's disease: Microglial signature and their relevance to disease. Inflamm Regen. 2023;43(26) doi: 10.1186/s41232-023-00277-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s41232-023-00277-3</ArticleId><ArticleId IdType=\"pmc\">PMC10170691</ArticleId><ArticleId IdType=\"pubmed\">37165437</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiner TG, Popescu BO. Amyloid beta dynamics in biological fluids-Therapeutic impact. J Clin Med. 2021;10(5986) doi: 10.3390/jcm10245986.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm10245986</ArticleId><ArticleId IdType=\"pmc\">PMC8706225</ArticleId><ArticleId IdType=\"pubmed\">34945282</ArticleId></ArticleIdList></Reference><Reference><Citation>Muralidar S, Ambi SV, Sekaran S, Thirumalai D, Palaniappan B. Role of tau protein in Alzheimer's disease: The prime pathological player. Int J Biol Macromol. 2020;163:1599&#x2013;1617. doi: 10.1016/j.ijbiomac.2020.07.327.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ijbiomac.2020.07.327</ArticleId><ArticleId IdType=\"pubmed\">32784025</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick KL, Bell SL, Weindel CG, Watson RO. Exploring the &#x2018;multiple-hit hypothesis&#x2019; of neurodegenerative disease: Bacterial infection comes up to bat. Front Cell Infect Microbiol. 2019;9(138) doi: 10.3389/fcimb.2019.00138.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fcimb.2019.00138</ArticleId><ArticleId IdType=\"pmc\">PMC6546885</ArticleId><ArticleId IdType=\"pubmed\">31192157</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbone I, Lazzarotto T, Ianni M, Porcellini E, Forti P, Masliah E, Gabrielli L, Licastro F. Herpes virus in Alzheimer's disease: Relation to progression of the disease. Neurobiol Aging. 2014;35:122&#x2013;129. doi: 10.1016/j.neurobiolaging.2013.06.024.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2013.06.024</ArticleId><ArticleId IdType=\"pubmed\">23916950</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim SM, Cheon HS, Jo C, Koh YH, Song J, Jeon JP. Elevated Epstein-Barr virus antibody level is associated with cognitive decline in the Korean elderly. J Alzheimers Dis. 2017;55:293&#x2013;301. doi: 10.3233/JAD-160563.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-160563</ArticleId><ArticleId IdType=\"pubmed\">27589534</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SY, Yang YX, Kuo K, Li HQ, Shen XN, Chen SD, Cui M, Tan L, Dong Q, Yu JT. Herpesvirus infections and Alzheimer's disease: A Mendelian randomization study. Alzheimers Res Ther. 2021;13(158) doi: 10.1186/s13195-021-00905-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-021-00905-5</ArticleId><ArticleId IdType=\"pmc\">PMC8464096</ArticleId><ArticleId IdType=\"pubmed\">34560893</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardo S, Fregni F. Association of inflammation and cognition in the elderly: A systematic review and meta-analysis. Front Aging Neurosci. 2023;15(1069439) doi: 10.3389/fnagi.2023.1069439.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2023.1069439</ArticleId><ArticleId IdType=\"pmc\">PMC9939705</ArticleId><ArticleId IdType=\"pubmed\">36815174</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari D, Singh VK, Baral B, Pathak DK, Jayabalan J, Kumar R, Tapryal S, Jha HC. Indication of neurodegenerative cascade initiation by amyloid-like aggregate-forming EBV proteins and peptide in Alzheimer's disease. ACS Chem Neurosci. 2021;12:3957&#x2013;3967. doi: 10.1021/acschemneuro.1c00584.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acschemneuro.1c00584</ArticleId><ArticleId IdType=\"pubmed\">34609141</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakhmola S, Jha HC. Glial cell response to Epstein-Barr Virus infection: A plausible contribution to virus-associated inflammatory reactions in the brain. Virology. 2021;559:182&#x2013;195. doi: 10.1016/j.virol.2021.04.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.virol.2021.04.005</ArticleId><ArticleId IdType=\"pubmed\">33964684</ArticleId></ArticleIdList></Reference><Reference><Citation>Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, Chen K, Lehallier B, Channappa D, De Los Santos MB, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399&#x2013;404. doi: 10.1038/s41586-019-1895-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-019-1895-7</ArticleId><ArticleId IdType=\"pmc\">PMC7445078</ArticleId><ArticleId IdType=\"pubmed\">31915375</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari D, Mittal N, Jha HC. Unraveling the links between neurodegeneration and Epstein-Barr virus-mediated cell cycle dysregulation. Curr Res Neurobiol. 2022;3(100046) doi: 10.1016/j.crneur.2022.100046.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.crneur.2022.100046</ArticleId><ArticleId IdType=\"pmc\">PMC9846474</ArticleId><ArticleId IdType=\"pubmed\">36685766</ArticleId></ArticleIdList></Reference><Reference><Citation>Koseoglu MM, Norambuena A, Sharlow ER, Lazo JS, Bloom GS. Aberrant neuronal cell cycle re-entry: The pathological confluence of Alzheimer's Disease and brain insulin resistance, and its relation to cancer. J Alzheimers Dis. 2019;67:1&#x2013;11. doi: 10.3233/JAD-180874.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-180874</ArticleId><ArticleId IdType=\"pmc\">PMC8363205</ArticleId><ArticleId IdType=\"pubmed\">30452418</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhotra N, Gupta R, Kumar P. Pharmacological relevance of CDK inhibitors in Alzheimer's disease. Neurochem Int. 2021;148(105115) doi: 10.1016/j.neuint.2021.105115.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuint.2021.105115</ArticleId><ArticleId IdType=\"pubmed\">34182065</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Zhang H, Yao D, Xu Y, Jing Q, Cao S, Tian L, Li C. Integrated bioinformatics analysis identifies hub genes associated with viral infection and Alzheimer's disease. J Alzheimers Dis. 2022;85:1053&#x2013;1061. doi: 10.3233/JAD-215232.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-215232</ArticleId><ArticleId IdType=\"pubmed\">34924389</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizutani K, Miyata M, Shiotani H, Kameyama T, Takai Y. Nectin-2 in general and in the brain. Mol Cell Biochem. 2022;477:167&#x2013;180. doi: 10.1007/s11010-021-04241-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11010-021-04241-y</ArticleId><ArticleId IdType=\"pubmed\">34633611</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinjyo N, Kagaya W, Pekna M. Interaction between the complement system and infectious agents-A potential mechanistic link to neurodegeneration and dementia. Front Cell Neurosci. 2021;15(710390) doi: 10.3389/fncel.2021.710390.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fncel.2021.710390</ArticleId><ArticleId IdType=\"pmc\">PMC8365172</ArticleId><ArticleId IdType=\"pubmed\">34408631</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackhurst BM, Funk KE. Viral pathogens increase risk of neurodegenerative disease. Nat Rev Neurol. 2023;19:259&#x2013;260. doi: 10.1038/s41582-023-00790-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41582-023-00790-6</ArticleId><ArticleId IdType=\"pmc\">PMC9980857</ArticleId><ArticleId IdType=\"pubmed\">36864169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa H, Fujikura D, Namba H, Yamashita N, Honda T, Yamada M. Nectin-2 acts as a viral entry mediated molecule that binds to human herpesvirus 6B Glycoprotein B. Viruses. 2022;14(160) doi: 10.3390/v14010160.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/v14010160</ArticleId><ArticleId IdType=\"pmc\">PMC8779676</ArticleId><ArticleId IdType=\"pubmed\">35062364</ArticleId></ArticleIdList></Reference><Reference><Citation>Blujus JK, Korthauer LE, Awe E, Frahmand M, Driscoll I. Single nucleotide polymorphisms in Alzheimer's disease risk genes are associated with intrinsic connectivity in middle age. J Alzheimers Dis. 2020;78:309&#x2013;320. doi: 10.3233/JAD-200444.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-200444</ArticleId><ArticleId IdType=\"pubmed\">32986668</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu X, Dou M, Cao B, Jiang Z, Chen Y. Peripheral level of CD33 and Alzheimer's disease: A bidirectional two-sample Mendelian randomization study. Transl Psychiatry. 2022;12(427) doi: 10.1038/s41398-022-02205-4.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41398-022-02205-4</ArticleId><ArticleId IdType=\"pmc\">PMC9529877</ArticleId><ArticleId IdType=\"pubmed\">36192375</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouda NA, Elkamhawy A, Cho J. Emerging therapeutic strategies for Parkinson's disease and future prospects: A 2021 update. Biomedicines. 2022;10(371) doi: 10.3390/biomedicines10020371.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biomedicines10020371</ArticleId><ArticleId IdType=\"pmc\">PMC8962417</ArticleId><ArticleId IdType=\"pubmed\">35203580</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrijan T, Zmazek J, Menih M. Parkinson's disease non-motor subtypes classification in a group of Slovenian patients: Actuarial vs. data-driven approach. J Clin Med. 2023;12(7434) doi: 10.3390/jcm12237434.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/jcm12237434</ArticleId><ArticleId IdType=\"pmc\">PMC10707127</ArticleId><ArticleId IdType=\"pubmed\">38068486</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Latapi P, Bayram E, Litvan I, Marras C. Cognitive impairment in Parkinson's disease: Epidemiology, clinical profile, protective and risk factors. Behav Sci (Basel) 2021;11(74) doi: 10.3390/bs11050074.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/bs11050074</ArticleId><ArticleId IdType=\"pmc\">PMC8152515</ArticleId><ArticleId IdType=\"pubmed\">34068064</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldridge GM, Birnschein A, Denburg NL, Narayanan NS. Parkinson's disease dementia and dementia with Lewy bodies have similar neuropsychological profiles. Front Neurol. 2018;9(123) doi: 10.3389/fneur.2018.00123.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2018.00123</ArticleId><ArticleId IdType=\"pmc\">PMC5857567</ArticleId><ArticleId IdType=\"pubmed\">29593630</ArticleId></ArticleIdList></Reference><Reference><Citation>Woulfe J, Hoogendoorn H, Tarnopolsky M, Mu&#xf1;oz DG. Monoclonal antibodies against Epstein-Barr virus cross-react with alpha-synuclein in human brain. Neurology. 2000;55:1398&#x2013;1401. doi: 10.1212/wnl.55.9.1398.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/wnl.55.9.1398</ArticleId><ArticleId IdType=\"pubmed\">11087792</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu XL, Wang X, Xiang Y, Shen LL, Wang QH, Liu YH, Jiao SS, Wang YR, Cao HY, Yi X, et al. The association between infectious burden and Parkinson's disease: A case-control study. Parkinsonism Relat Disord. 2015;21:877&#x2013;881. doi: 10.1016/j.parkreldis.2015.05.015.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.parkreldis.2015.05.015</ArticleId><ArticleId IdType=\"pubmed\">26037459</ArticleId></ArticleIdList></Reference><Reference><Citation>Funayama M, Nishioka K, Li Y, Hattori N. Molecular genetics of Parkinson's disease: Contributions and global trends. J Hum Genet. 2023;68:125&#x2013;130. doi: 10.1038/s10038-022-01058-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s10038-022-01058-5</ArticleId><ArticleId IdType=\"pmc\">PMC9968657</ArticleId><ArticleId IdType=\"pubmed\">35821405</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon AJ, Marrie RA, Viswanathan S, Correale J, Magyari M, Robertson NP, Saylor DR, Kaye W, Rechtman L, Bae E, et al. Global barriers to the diagnosis of multiple sclerosis: Data from the multiple sclerosis International Federation Atlas of MS, Third Edition. Neurology. 2023;101:e624&#x2013;e635. doi: 10.1212/WNL.0000000000207481.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/WNL.0000000000207481</ArticleId><ArticleId IdType=\"pmc\">PMC10424832</ArticleId><ArticleId IdType=\"pubmed\">37321866</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Z, Li Y, Guan Z, Guo P, Zheng K, Du Y, Yin S, Chen B, Wang H, Jiang J, et al. Global, regional, and national burden of multiple sclerosis from 1990 to 2019: Findings of global burden of disease study 2019. Front Public Health. 2023;11(1073278) doi: 10.3389/fpubh.2023.1073278.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpubh.2023.1073278</ArticleId><ArticleId IdType=\"pmc\">PMC9982151</ArticleId><ArticleId IdType=\"pubmed\">36875359</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustavsen S, Olsson A, S&#xf8;ndergaard HB, Andresen SR, S&#xf8;rensen PS, Sellebjerg F, Oturai A. The association of selected multiple sclerosis symptoms with disability and quality of life: A large Danish self-report survey. BMC Neurol. 2021;21(317) doi: 10.1186/s12883-021-02344-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12883-021-02344-z</ArticleId><ArticleId IdType=\"pmc\">PMC8365982</ArticleId><ArticleId IdType=\"pubmed\">34399707</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeydan B, Kantarci OH. Progressive forms of multiple sclerosis: Distinct entity or age-dependent phenomena. Neurol Clin. 2018;36:163&#x2013;171. doi: 10.1016/j.ncl.2017.08.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ncl.2017.08.006</ArticleId><ArticleId IdType=\"pubmed\">29157397</ArticleId></ArticleIdList></Reference><Reference><Citation>Mato-Abad V, Labiano-Fontcuberta A, Rodr&#xed;guez-Y&#xe1;&#xf1;ez S, Garc&#xed;a-V&#xe1;zquez R, Munteanu CR, Andrade-Garda J, Domingo-Santos A, Gal&#xe1;n S&#xe1;nchez-Seco V, Aladro Y, Mart&#xed;nez-Gin&#xe9;s ML, et al. Classification of radiologically isolated syndrome and clinically isolated syndrome with machine-learning techniques. Eur J Neurol. 2019;26:1000&#x2013;1005. doi: 10.1111/ene.13923.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ene.13923</ArticleId><ArticleId IdType=\"pubmed\">30714276</ArticleId></ArticleIdList></Reference><Reference><Citation>Nourbakhsh B, Mowry EM. Multiple sclerosis risk factors and pathogenesis. Continuum (Minneap Minn) 2019;25:596&#x2013;610. doi: 10.1212/CON.0000000000000725.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1212/CON.0000000000000725</ArticleId><ArticleId IdType=\"pubmed\">31162307</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-Or A, Banwell B, Berger JR, Lieberman PM. Guilty by association: Epstein-Barr virus in multiple sclerosis. Nat Med. 2022;28:904&#x2013;906. doi: 10.1038/s41591-022-01823-1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-022-01823-1</ArticleId><ArticleId IdType=\"pubmed\">35538259</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375:296&#x2013;301. doi: 10.1126/science.abj8222.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/science.abj8222</ArticleId><ArticleId IdType=\"pubmed\">35025605</ArticleId></ArticleIdList></Reference><Reference><Citation>Pender MP, Csurhes PA, Burrows JM, Burrows SR. Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis. Clin Transl Immunology. 2017;6(e126) doi: 10.1038/cti.2016.87.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/cti.2016.87</ArticleId><ArticleId IdType=\"pmc\">PMC5292561</ArticleId><ArticleId IdType=\"pubmed\">28197337</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldan SS, Lieberman PM. Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol. 2023;21:51&#x2013;64. doi: 10.1038/s41579-022-00770-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41579-022-00770-5</ArticleId><ArticleId IdType=\"pmc\">PMC9362539</ArticleId><ArticleId IdType=\"pubmed\">35931816</ArticleId></ArticleIdList></Reference><Reference><Citation>van Langelaar J, Wierenga-Wolf AF, Samijn JPA, Luijks CJM, Siepman TA, van Doorn PA, Bell A, van Zelm MC, Smolders J, van Luijn MM. The association of Epstein-Barr virus infection with CXCR3+ B-cell development in multiple sclerosis: Impact of immunotherapies. Eur J Immunol. 2021;51:626&#x2013;633. doi: 10.1002/eji.202048739.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/eji.202048739</ArticleId><ArticleId IdType=\"pmc\">PMC7984177</ArticleId><ArticleId IdType=\"pubmed\">33152118</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrasiabi A, Parnell GP, Fewings N, Schibeci SD, Basuki MA, Chandramohan R, Zhou Y, Taylor B, Brown DA, Swaminathan S, et al. Evidence from genome-wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility. Genome Med. 2019;11(26) doi: 10.1186/s13073-019-0640-z.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13073-019-0640-z</ArticleId><ArticleId IdType=\"pmc\">PMC6492329</ArticleId><ArticleId IdType=\"pubmed\">31039804</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadigh-Eteghad S, Abbasi Garravnd N, Feizollahi M, Talebi M. The expanded disability status scale score and demographic indexes are correlated with the severity of cognitive impairment in multiple sclerosis patients. J Clin Neurol. 2021;17:113&#x2013;120. doi: 10.3988/jcn.2021.17.1.113.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3988/jcn.2021.17.1.113</ArticleId><ArticleId IdType=\"pmc\">PMC7840333</ArticleId><ArticleId IdType=\"pubmed\">33480206</ArticleId></ArticleIdList></Reference><Reference><Citation>Brochet B, Ruet A. Cognitive impairment in multiple sclerosis with regards to disease duration and clinical phenotypes. Front Neurol. 2019;10(261) doi: 10.3389/fneur.2019.00261.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2019.00261</ArticleId><ArticleId IdType=\"pmc\">PMC6435517</ArticleId><ArticleId IdType=\"pubmed\">30949122</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLuca GC, Yates RL, Beale H, Morrow SA. Cognitive impairment in multiple sclerosis: Clinical, radiologic and pathologic insights. Brain Pathol. 2015;25:79&#x2013;98. doi: 10.1111/bpa.12220.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/bpa.12220</ArticleId><ArticleId IdType=\"pmc\">PMC8029470</ArticleId><ArticleId IdType=\"pubmed\">25521179</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues. Lancet Neurol. 2020;19:860&#x2013;871. doi: 10.1016/S1474-4422(20)30277-5.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(20)30277-5</ArticleId><ArticleId IdType=\"pmc\">PMC10011205</ArticleId><ArticleId IdType=\"pubmed\">32949546</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacu-Florescu AI, Schreiner OD, Schreiner TG. doi: 10.37897/RJN.2022.4.1. Screening tests for the evaluation of cognitive impairment in multiple sclerosis patients. Ro J Neurol 21(4).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.37897/RJN.2022.4.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloisi F, Giovannoni G, Salvetti M. Epstein-Barr virus as a cause of multiple sclerosis: Opportunities for prevention and therapy. Lancet Neurol. 2023;22:338&#x2013;349. doi: 10.1016/S1474-4422(22)00471-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-4422(22)00471-9</ArticleId><ArticleId IdType=\"pubmed\">36764322</ArticleId></ArticleIdList></Reference><Reference><Citation>Vindegaard N, Petersen LV, Lyng-Rasmussen BI, Dalsgaard S, Benros ME. Infectious mononucleosis as a risk factor for depression: A nationwide cohort study. Brain Behav Immun. 2021;94:259&#x2013;265. doi: 10.1016/j.bbi.2021.01.035.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbi.2021.01.035</ArticleId><ArticleId IdType=\"pubmed\">33571632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D, Fernandes RA, Gomez AM, Nadj GS, Bartley CM, et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature. 2022;603:321&#x2013;327. doi: 10.1038/s41586-022-04432-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41586-022-04432-7</ArticleId><ArticleId IdType=\"pmc\">PMC9382663</ArticleId><ArticleId IdType=\"pubmed\">35073561</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley JB, Chen X, Pujato M, Miller D, Maddox A, Forney C, Magnusen AF, Lynch A, Chetal K, Yukawa M, et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet. 2018;50:699&#x2013;707. doi: 10.1038/s41588-018-0102-3.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41588-018-0102-3</ArticleId><ArticleId IdType=\"pmc\">PMC6022759</ArticleId><ArticleId IdType=\"pubmed\">29662164</ArticleId></ArticleIdList></Reference><Reference><Citation>Virtanen JO, Wohler J, Fenton K, Reich DS, Jacobson S. Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings. Mult Scler. 2014;20:27&#x2013;34. doi: 10.1177/1352458513490545.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1352458513490545</ArticleId><ArticleId IdType=\"pmc\">PMC5001156</ArticleId><ArticleId IdType=\"pubmed\">23722324</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, et al. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. PLoS Pathog. 2013;9(e1003220) doi: 10.1371/journal.ppat.1003220.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.ppat.1003220</ArticleId><ArticleId IdType=\"pmc\">PMC3623710</ArticleId><ArticleId IdType=\"pubmed\">23592979</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlasova G, Mraz M. The regulation and function of CD20: An &#x2018;enigma&#x2019; of B-cell biology and targeted therapy. Haematologica. 2020;105:1494&#x2013;1506. doi: 10.3324/haematol.2019.243543.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3324/haematol.2019.243543</ArticleId><ArticleId IdType=\"pmc\">PMC7271567</ArticleId><ArticleId IdType=\"pubmed\">32482755</ArticleId></ArticleIdList></Reference><Reference><Citation>de S&#xe8;ze J, Maillart E, Gueguen A, Laplaud DA, Michel L, Thouvenot E, Zephir H, Zimmer L, Biotti D, Liblau R. Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic. Front Immunol. 2023;14(1004795) doi: 10.3389/fimmu.2023.1004795.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2023.1004795</ArticleId><ArticleId IdType=\"pmc\">PMC10076836</ArticleId><ArticleId IdType=\"pubmed\">37033984</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger JR, Kakara M. The elimination of circulating Epstein-Barr virus infected B cells underlies anti-CD20 monoclonal antibody activity in multiple sclerosis: A hypothesis. Mult Scler Relat Disord. 2022;59(103678) doi: 10.1016/j.msard.2022.103678.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.msard.2022.103678</ArticleId><ArticleId IdType=\"pubmed\">35151986</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazziotta C, Tognon M, Martini F, Torreggiani E, Rotondo JC. Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells. 2023;12(184) doi: 10.3390/cells12010184.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/cells12010184</ArticleId><ArticleId IdType=\"pmc\">PMC9818925</ArticleId><ArticleId IdType=\"pubmed\">36611977</ArticleId></ArticleIdList></Reference><Reference><Citation>Hori T, Matsuda K, Oishi K. Probiotics: A dietary factor to modulate the gut microbiome, host immune system, and gut-brain interaction. Microorganisms. 2020;8(1401) doi: 10.3390/microorganisms8091401.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/microorganisms8091401</ArticleId><ArticleId IdType=\"pmc\">PMC7563712</ArticleId><ArticleId IdType=\"pubmed\">32933067</ArticleId></ArticleIdList></Reference><Reference><Citation>Intili G, Paladino L, Rappa F, Alberti G, Plicato A, Calabr&#xf2; F, Fucarino A, Cappello F, Bucchieri F, Tomasello G, et al. From dysbiosis to neurodegenerative diseases through different communication pathways: An overview. Biology (Basel) 2023;12(195) doi: 10.3390/biology12020195.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biology12020195</ArticleId><ArticleId IdType=\"pmc\">PMC9952972</ArticleId><ArticleId IdType=\"pubmed\">36829474</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">39267966</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">2296-858X</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>DeepCGAN: early Alzheimer's detection with deep convolutional generative adversarial networks.</ArticleTitle><Pagination><StartPage>1443151</StartPage><MedlinePgn>1443151</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1443151</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fmed.2024.1443151</ELocationID><Abstract><AbstractText Label=\"INTRODUCTION\" NlmCategory=\"UNASSIGNED\">Alzheimer's disease (AD) is a neurodegenerative disorder and the most prevailing cause of dementia. AD critically disturbs the daily routine, which usually needs to be detected at its early stage. Unfortunately, AD detection using magnetic resonance imaging is challenging because of the subtle physiological variations between normal and AD patients visible on magnetic resonance imaging.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">To cope with this challenge, we propose a deep convolutional generative adversarial network (DeepCGAN) for detecting early-stage AD in this article. The DeepCGAN is an unsupervised generative model that expands the dataset size in addition to its diversity by utilizing the generative adversarial network (GAN). The Generator of GAN follows the encoder-decoder framework and takes cognitive data as inputs, whereas the Discriminator follows a structure similar to the Generator's encoder. The last dense layer uses a softmax classifier to detect the labels indicating the AD.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">The proposed model attains an accuracy rate of 97.32%, significantly surpassing recent state-of-the-art models' performance, including Adaptive Voting, ResNet, AlexNet, GoogleNet, Deep Neural Networks, and Support Vector Machines.</AbstractText><AbstractText Label=\"DISCUSSION\" NlmCategory=\"UNASSIGNED\">The DeepCGAN significantly improves early AD detection accuracy and robustness by enhancing the dataset diversity and leveraging advanced GAN techniques, leading to better generalization and higher performance in comparison to traditional and contemporary methods. These results demonstrate the ecacy of DeepCGAN in enhancing early AD detection, thereby potentially improving patient outcomes through timely intervention.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Ali, Saleem, Alhussein, Zohra, Aurangzeb and Haq.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ali</LastName><ForeName>Imad</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of Swat, Swat, KP, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Saleem</LastName><ForeName>Nasir</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Electrical Engineering, Faculty of Engineering &amp; Technology (FET), Gomal University, Dera Ismail Khan, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Alhussein</LastName><ForeName>Musaed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Computer Engineering, College of Computer and Information Sciences, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zohra</LastName><ForeName>Benazeer</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anatomy, School of Medical Sciences and Research, Sharda University, Greater Noida, UP, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy, Noida International Institute of Medical Sciences, Noida International University, Greater Noida, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Aurangzeb</LastName><ForeName>Khursheed</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Computer Engineering, College of Computer and Information Sciences, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Haq</LastName><ForeName>Qazi Mazhar Ul</ForeName><Initials>QMU</Initials><AffiliationInfo><Affiliation>Department of International Bachelor Program in Informatics and Computer Science and Engineering, Yuan Ze University, Taoyuan City, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Alzheimer's disease</Keyword><Keyword MajorTopicYN=\"N\">CNN</Keyword><Keyword MajorTopicYN=\"N\">GAN</Keyword><Keyword MajorTopicYN=\"N\">cognitive features</Keyword><Keyword MajorTopicYN=\"N\">deep learning</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39267966</ArticleId><ArticleId IdType=\"pmc\">PMC11390560</ArticleId><ArticleId IdType=\"doi\">10.3389/fmed.2024.1443151</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pan Y, Liu M, Lian C, Zhou T, Xia Y, Shen D. Synthesizing missing PET from MRI with cycle-consistent generative adversarial networks for Alzheimer's disease diagnosis. In: Medical Image Computing and Computer Assisted Intervention-MICCAI 2018: 21st International Conference, Granada, Spain, September 16-20, 2018, Proceedings, Part III 11. Cham: Springer; (2018). p. 455&#x2013;63.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8336606</ArticleId><ArticleId IdType=\"pubmed\">34355223</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Lee H, Somer E, Grau V. Generation of amyloid PET images via conditional adversarial training for predicting progression to Alzheimer's disease. In: Predictive Intelligence in Medicine: First International Workshop, PRIME 2018, Held in Conjunction with MICCAI 2018, Granada, Spain, September 16, 2018, Proceedings 1. Cham: Springer; (2018). p. 26&#x2013;33.</Citation></Reference><Reference><Citation>Wang Y, Zhou L, Yu B, Wang L, Zu C, Lalush DS, et al. . 3D auto-context-based locality adaptive multi-modality GANs for PET synthesis. IEEE Trans Med Imaging. (2019) 38:1328&#x2013;39. 10.1109/TMI.2018.2884053</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/TMI.2018.2884053</ArticleId><ArticleId IdType=\"pmc\">PMC6541547</ArticleId><ArticleId IdType=\"pubmed\">30507527</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Yu B, Wang L, Zu C, Lalush DS, Lin W, et al. . 3D conditional generative adversarial networks for high-quality PET image estimation at low dose. Neuroimage. (2018) 174:550&#x2013;62. 10.1016/j.neuroimage.2018.03.045</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2018.03.045</ArticleId><ArticleId IdType=\"pmc\">PMC6410574</ArticleId><ArticleId IdType=\"pubmed\">29571715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang J, Chen KT, Gong E, Pauly J, Zaharchuk G. Ultra-low-dose PET reconstruction using a generative adversarial network with feature matching and task-specific perceptual loss. Med Phys. (2019) 46:3555&#x2013;64. 10.1117/12.2512946</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1117/12.2512946</ArticleId><ArticleId IdType=\"pmc\">PMC6692211</ArticleId><ArticleId IdType=\"pubmed\">31131901</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam J, Zhang Y. GAN-based synthetic brain PET image generation. Brain Inf . (2020) 7:1&#x2013;12. 10.1186/s40708-020-00104-2</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40708-020-00104-2</ArticleId><ArticleId IdType=\"pmc\">PMC7105582</ArticleId><ArticleId IdType=\"pubmed\">32232602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HW, Lee HE, Lee S, Oh KT, Yun M, Yoo SK. Slice-selective learning for Alzheimer's disease classification using a generative adversarial network: a feasibility study of external validation. Eur J Nucl Med Mol Imaging. (2020) 47:2197&#x2013;206. 10.1007/s00259-019-04676-y</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00259-019-04676-y</ArticleId><ArticleId IdType=\"pubmed\">31980910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H, Park JS, Cho K, Kang D-Y. Visual and quantitative evaluation of amyloid brain PET image synthesis with the generative adversarial network. Appl Sci. (2020) 10:2628. 10.3390/app10072628</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/app10072628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SK, Seo S, Shin SA, Byun MS, Lee DY, Kim YK, et al. . Adaptive template generation for amyloid PET using a deep learning approach. Hum Brain Mapp. (2018) 39:3769&#x2013;78. 10.1002/hbm.24210</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/hbm.24210</ArticleId><ArticleId IdType=\"pmc\">PMC6866631</ArticleId><ArticleId IdType=\"pubmed\">29752765</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha D, Kim JI, Kwon GR. Diagnosis of Alzheimer's disease using dual-tree complex wavelet transform, PCA, and feedforward neural network. J Healthc Eng. (2017) 2017:9060124. 10.1155/2017/9060124</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2017/9060124</ArticleId><ArticleId IdType=\"pmc\">PMC5499252</ArticleId><ArticleId IdType=\"pubmed\">29065663</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarraf S, Tofighi G. Classification of Alzheimer's disease structural MRI data by deep learning convolutional neural networks. arXiv [preprint] (2016). 10.48550/arXiv.1607.06583</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.48550/arXiv.1607.06583</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal S, Gupta P, Prasad LN, Kulkarni R. An empirical model for the classification of diabetes and diabetes_types using ensemble approaches. J Artif Intell Technol. (2023) 3:181&#x2013;6. 10.37965/jait.2023.0220</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.37965/jait.2023.0220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganaie MA, Hu M, Tanveer M, Suganthan PN. Ensemble deep learning: a review. arXiv [preprint] (2021). 10.1016/j.engappai.2022.105151</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.engappai.2022.105151</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Xu K, Hall P. A survey of image synthesis and editing with generative adversarial networks. Tsinghua Sci Technol. (2017) 22:660&#x2013;74. 10.23919/TST.2017.8195348</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.23919/TST.2017.8195348</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolterink JM, Dinkla AM, Savenije MHF, Seevinck PR, van den Berg CAT, I&#x161;gum I. Deep MR to CT synthesis using unpaired data. In:Gooya A, Frangi AF, Tsaftaris SA, Prince JL, editors. Simulation and Synthesis in Medical Imaging. Vol. 10557. Cham: Springer (2017). p. 14&#x2013;23.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi X, Walia E, Babyn P. Generative adversarial network in medical imaging: a review. Med Image Anal. (2019) 58:101552. 10.1016/j.media.2019.101552</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.media.2019.101552</ArticleId><ArticleId IdType=\"pubmed\">31521965</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorck N, Gomes CP, Selman B, Weinberger KQ. Understanding batch normalization. In: Advances in Neural Information Processing Systems. Vol. 31. Red Hook, NY: Curran Associates, Inc; (2018).</Citation></Reference><Reference><Citation>Dukler Y, Li W, Lin A, Mont&#xfa;far G. Wasserstein of Wasserstein loss for learning generative models. In: International Conference on Machine Learning. Cambridge, MA: PMLR; (2019). p. 1716&#x2013;25.</Citation></Reference><Reference><Citation>Jolicoeur-Martineau A. The relativistic discriminator: a key element missing from standard GAN. arXiv [preprint] (2018). 10.48550/arXiv.1807.00734</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.48550/arXiv.1807.00734</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vent NR, Agelink van Rentergem JA, Schmand BA, Murre JM, Huizenga HM, Consortium A. Advanced Neuropsychological Diagnostics Infrastructure (ANDI): a normative database created from control datasets. Front Psychol. (2016) 7:1601. 10.3389/fpsyg.2016.01601</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpsyg.2016.01601</ArticleId><ArticleId IdType=\"pmc\">PMC5071354</ArticleId><ArticleId IdType=\"pubmed\">27812340</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner MW, Veitch DP, Miller MJ, Aisen PS, Albala B, Beckett LA, et al. . Increasing participant diversity in AD research: plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4. Alzheimers Dement. (2023) 19:307&#x2013;17. 10.1002/alz.12797</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/alz.12797</ArticleId><ArticleId IdType=\"pmc\">PMC10042173</ArticleId><ArticleId IdType=\"pubmed\">36209495</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini-Asl E, Ghazal M, Mahmoud A, Aslantas A, Shalaby AM, Casanova MF, et al. . Alzheimer's disease diagnostics by a 3D deeply supervised adaptable convolutional network. Front Biosci. (2018) 23:584&#x2013;96. 10.2741/4606</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2741/4606</ArticleId><ArticleId IdType=\"pubmed\">28930562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingma DP, Ba J. Adam: a method for stochastic optimization. arXiv [preprint] (2014). 10.48550/arXiv.1412.6980</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.48550/arXiv.1412.6980</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini-asl E, Keynton R, El-baz A. Alzheimer's disease diagnostics by adaptation of 3D convolutional network. In: Proc. - Int Conf Image Process ICIP. Piscataway, NJ (2016). 502 p.</Citation></Reference><Reference><Citation>Zhan B, Li D, Wu X, Zhou J, Wang Y. Multi-modal MRI image synthesis via GAN with multi-scale gate mergence. IEEE J Biomed Health Inf . (2021) 26:17&#x2013;26. 10.1109/JBHI.2021.3088866</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1109/JBHI.2021.3088866</ArticleId><ArticleId IdType=\"pubmed\">34125692</ArticleId></ArticleIdList></Reference><Reference><Citation>Suganthi K. Review of medical image synthesis using GAN techniques. In: ITM Web of Conferences. Vol. 37. Les Ulis: EDP Sciences (2021). p. 01005.</Citation></Reference><Reference><Citation>Wang J, Shi M, Zhang X, Li Y, Yuan Y, Yang C, et al. . Incremental data stream classification with adaptive multi-task multi-view learning. Big Data Mining Anal. (2023) 7:87&#x2013;106. 10.26599/BDMA.2023.9020006</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.26599/BDMA.2023.9020006</ArticleId></ArticleIdList></Reference><Reference><Citation>KV S, Ravi V, Almeshari M, Alzamil Y, DS SK, et al. . A new deep learning model based on neuroimaging for predicting Alzheimer's disease. Open Bioinf J. (2023) 16:1&#x2013;9. 10.2174/0118750362260635230922051326</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/0118750362260635230922051326</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X, Yu Z, Cao W, Shi Y, Qianli MA. A survey on ensemble learning. Front Comput Sci. (2020) 14:241&#x2013;58. 10.1007/s11704-019-8208-z</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11704-019-8208-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash D, Madusanka N, Bhattacharjee S, Park HG, Kim CH, Choi HK, et al. . comparative study of Alzheimer's disease classification using multiple transfer learning models. J Multim Inf Syst. (2019) 6:209&#x2013;16. 10.33851/JMIS.2019.6.4.209</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.33851/JMIS.2019.6.4.209</ArticleId></ArticleIdList></Reference><Reference><Citation>Krizhevsky A, Sutskever I, Hinton GE. Imagenet classification with deep convolutional neural networks. Adv Neural Inf Process Syst. (2012) 25:1&#x2013;9. 10.1145/3065386</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1145/3065386</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonyan K, Zisserman A. Very deep convolutional networks for large-scale image recognition. arXiv [preprint] (2014). 10.48550/arXiv.1409.1556</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.48550/arXiv.1409.1556</ArticleId></ArticleIdList></Reference><Reference><Citation>Szegedy C, Liu W, Jia Y, Sermanet P, Reed S, Anguelov D, et al. . Going deeper with convolutions. In: Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition. Piscataway, NJ (2015). p. 1&#x2013;9.</Citation></Reference><Reference><Citation>He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. In: Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition. Piscataway, NJ (2016). p. 770&#x2013;8.</Citation></Reference><Reference><Citation>Gill S, Mouches P, Hu S, Rajashekar D, MacMaster FP, Smith EE, et al. . Using machine learning to predict dementia from neuropsychiatric symptom and neuroimaging data. J Alzheimers Dis. (2020) 75:277&#x2013;88. 10.3233/JAD-191169</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-191169</ArticleId><ArticleId IdType=\"pmc\">PMC7306896</ArticleId><ArticleId IdType=\"pubmed\">32250302</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">39267895</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Electronic\">2640-3498</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>238</Volume><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Proceedings of machine learning research</Title><ISOAbbreviation>Proc Mach Learn Res</ISOAbbreviation></Journal><ArticleTitle>SADI: Similarity-Aware Diffusion Model-Based Imputation for Incomplete Temporal EHR Data.</ArticleTitle><Pagination><StartPage>4195</StartPage><EndPage>4203</EndPage><MedlinePgn>4195-4203</MedlinePgn></Pagination><Abstract><AbstractText>Missing values are prevalent in temporal electronic health records (EHR) data and are known to complicate data analysis and lead to biased results. The current state-of-the-art (SOTA) models for imputing missing values in EHR primarily leverage correlations across time points and across features, which perform well when data have strong correlation across time points, such as in ICU data where high-frequency time series data are collected. However, this is often insufficient for temporal EHR data from non-ICU settings (e.g., outpatient visits for primary care or specialty care), where data are collected at substantially sparser time points, resulting in much weaker correlation across time points. To address this methodological gap, we propose the Similarity-Aware Diffusion Model-Based Imputation (SADI), a novel imputation method that leverages the diffusion model and utilizes information across dependent variables. We apply SADI to impute incomplete temporal EHR data and propose a similarity-aware denoising function, which includes a self-attention mechanism to model the correlations between time points, features, and similar patients. To the best of our knowledge, this is the first time that the information of similar patients is directly used to construct imputation for incomplete temporal EHR data. Our extensive experiments on two datasets, the Critical Path For Alzheimer's Disease (CPAD) data and the PhysioNet Challenge 2012 data, show that SADI outperforms the current SOTA under various missing data mechanisms, including missing completely at random (MCAR), missing at random (MAR), and missing not at random (MNAR).</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Dai</LastName><ForeName>Zongyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Getzen</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Long</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>R01 AG071174</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM124111</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG063481</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA274576</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Mach Learn Res</MedlineTA><NlmUniqueID>101735789</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>4</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39267895</ArticleId><ArticleId IdType=\"mid\">NIHMS2018391</ArticleId><ArticleId IdType=\"pmc\">PMC11391213</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berndt DJ and Clifford J (1994). Using dynamic time warping to find patterns in time series. In KDD workshop, volume 10, pages 359&#x2013;370. Seattle, WA, USA:.</Citation></Reference><Reference><Citation>Cao W, Wang D, Li J, Zhou H, Li L, and Li Y (2018). Brits: Bidirectional recurrent imputation for time series. Advances in neural information processing systems, 31.</Citation></Reference><Reference><Citation>Che Z, Purushotham S, Cho K, Sontag D, and Liu Y (2018). Recurrent neural networks for multivariate time series with missing values. Scientific reports, 8(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5904216</ArticleId><ArticleId IdType=\"pubmed\">29666385</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhang Y, Zen H, Weiss RJ, Norouzi M, and Chan W (2020). Wavegrad: Estimating gradients for waveform generation. arXiv preprint arXiv:2009.00713.</Citation></Reference><Reference><Citation>Cowie MR, Blomster JI, Curtis LH, Duclaux S, Ford I, Fritz F, Goldman S, Janmohamed S, Kreuzer J, Leenay M, et al. (2017). Electronic health records to facilitate clinical research. Clinical Research in Cardiology, 106:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5226988</ArticleId><ArticleId IdType=\"pubmed\">27557678</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortuin V, Baranchuk D, R&#xe4;tsch G, and Mandt S (2020). Gp-vae: Deep probabilistic time series imputation. In International conference on artificial intelligence and statistics, pages 1651&#x2013;1661. PMLR.</Citation></Reference><Reference><Citation>Getzen E, Ungar L, Mowery D, Jiang X, and Long Q (2023). Mining for equitable health: Assessing the impact of missing data in electronic health records. Journal of Biomedical Informatics, page 104269.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10391553</ArticleId><ArticleId IdType=\"pubmed\">36621750</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianfrancesco MA, Tamang S, Yazdany J, and Schmajuk G (2018). Potential biases in machine learning algorithms using electronic health record data. JAMA internal medicine, 178(11):1544&#x2013;1547.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6347576</ArticleId><ArticleId IdType=\"pubmed\">30128552</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;yrinen K, Saranto K, and Nyk&#xe4;nen P (2008). Definition, structure, content, use and impacts of electronic health records: a review of the research literature. International journal of medical informatics, 77(5):291&#x2013;304.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17951106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho J, Jain A, and Abbeel P (2020). Denoising diffusion probabilistic models. Advances in Neural Information Processing Systems, 33:6840&#x2013;6851.</Citation></Reference><Reference><Citation>Jensen PB, Jensen LJ, and Brunak S (2012). Mining electronic health records: towards better research applications and clinical care. Nature Reviews Genetics, 13(6):395&#x2013;405.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadkhodaie Z and Simoncelli EP (2020). Solving linear inverse problems using the prior implicit in a denoiser. arXiv preprint arXiv:2007.13640.</Citation></Reference><Reference><Citation>Khojandi A, Tansakul V, Li X, Koszalinski RS, and Paiva W (2018). Prediction of sepsis and in-hospital mortality using electronic health records. Methods of information in medicine, 57(04):185&#x2013;193.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30248708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong Z, Ping W, Huang J, Zhao K, and Catanzaro B (2020). Diffwave: A versatile diffusion model for audio synthesis. arXiv preprint arXiv:2009.09761.</Citation></Reference><Reference><Citation>Lauritsen SM, Kal&#xf8;r ME, Kongsgaard EL, Lauritsen KM, J&#xf8;rgensen MJ, Lange J, and Thiesson B (2020). Early detection of sepsis utilizing deep learning on electronic health record event sequences. Artificial Intelligence in Medicine, 104:101820.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32498999</ArticleId></ArticleIdList></Reference><Reference><Citation>Little RJ and Rubin DB (2019). Statistical analysis with missing data, volume 793. John Wiley &amp; Sons.</Citation></Reference><Reference><Citation>Luo Y, Cai X, Zhang Y, Xu J, et al. (2018). Multivariate time series imputation with generative adversarial networks. Advances in neural information processing systems, 31.</Citation></Reference><Reference><Citation>Luo Y, Zhang Y, Cai X, and Yuan X (2019). E2gan: End-to-end generative adversarial network for multivariate time series imputation. In Proceedings of the 28th international joint conference on artificial intelligence, pages 3094&#x2013;3100. AAAI Press.</Citation></Reference><Reference><Citation>Mittal G, Engel J, Hawthorne C, and Simon I (2021). Symbolic music generation with diffusion models. arXiv preprint arXiv:2103.16091.</Citation></Reference><Reference><Citation>Nalmpantis C and Vrakas D (2019). Signal2vec: Time series embedding representation. In International conference on engineering applications of neural networks, pages 80&#x2013;90. Springer.</Citation></Reference><Reference><Citation>Niu C, Song Y, Song J, Zhao S, Grover A, and Ermon S (2020). Permutation invariant graph generation via score-based generative modeling. In International Conference on Artificial Intelligence and Statistics, pages 4474&#x2013;4484. PMLR.</Citation></Reference><Reference><Citation>Ozer M, Sapienza A, Abeliuk A, Muric G, and Ferrara E (2020). Discovering patterns of online popularity from time series. Expert Systems with Applications, 151:113337.</Citation></Reference><Reference><Citation>Paparrizos J and Gravano L (2015). k-shape: Efficient and accurate clustering of time series. In Proceedings of the 2015 ACM SIGMOD international conference on management of data, pages 1855&#x2013;1870.</Citation></Reference><Reference><Citation>Paszke A, Gross S, Massa F, Lerer A, Bradbury J, Chanan G, Killeen T, Lin Z, Gimelshein N, Antiga L, et al. (2019). Pytorch: An imperative style, high-performance deep learning library. Advances in neural information processing systems, 32.</Citation></Reference><Reference><Citation>Rajkomar A, Hardt M, Howell MD, Corrado G, and Chin MH (2018a). Ensuring fairness in machine learning to advance health equity. Annals of internal medicine, 169(12):866&#x2013;872.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6594166</ArticleId><ArticleId IdType=\"pubmed\">30508424</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkomar A, Oren E, Chen K, Dai AM, Hajaj N, Hardt M, Liu PJ, Liu X, Marcus J, Sun M, et al. (2018b). Scalable and accurate deep learning with electronic health records. NPJ digital medicine, 1(1):18.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6550175</ArticleId><ArticleId IdType=\"pubmed\">31304302</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvador S and Chan P (2007). Toward accurate dynamic time warping in linear time and space. Intelligent Data Analysis, 11(5):561&#x2013;580.</Citation></Reference><Reference><Citation>Shukla SN and Marlin BM (2021). Multi-time attention networks for irregularly sampled time series. arXiv preprint arXiv:2101.10318.</Citation></Reference><Reference><Citation>Silva I, Moody G, Scott DJ, Celi LA, and Mark RG (2012). Predicting in-hospital mortality of icu patients: The physionet/computing in cardiology challenge 2012. In 2012 Computing in Cardiology, pages 245&#x2013;248. IEEE.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3965265</ArticleId><ArticleId IdType=\"pubmed\">24678516</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivakumaran S, Romero K, Hanan NJ, Sinha V, Haeberlein SB, and Gold M (2020). The critical path for alzheimer&#x2019;s disease (cpad): Precompetitive data sharing and generation of innovative high-impact quantitative tools to support alzheimer&#x2019;s disease drug development: Human/trial design. Alzheimer&#x2019;s &amp; Dementia, 16:e043919.</Citation></Reference><Reference><Citation>Sohl-Dickstein J, Weiss E, Maheswaranathan N, and Ganguli S (2015). Deep unsupervised learning using nonequilibrium thermodynamics. In International Conference on Machine Learning, pages 2256&#x2013;2265. PMLR.</Citation></Reference><Reference><Citation>Song Y and Ermon S (2019). Generative modeling by estimating gradients of the data distribution. Advances in neural information processing systems, 32.</Citation></Reference><Reference><Citation>Song Y, Sohl-Dickstein J, Kingma DP, Kumar A, Ermon S, and Poole B (2020). Score-based generative modeling through stochastic differential equations. arXiv preprint arXiv:2011.13456.</Citation></Reference><Reference><Citation>Steele AJ, Denaxas SC, Shah AD, Hemingway H, and Luscombe NM (2018). Machine learning models in electronic health records can outperform conventional survival models for predicting patient mortality in coronary artery disease. PloS one, 13(8):e0202344.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6118376</ArticleId><ArticleId IdType=\"pubmed\">30169498</ArticleId></ArticleIdList></Reference><Reference><Citation>Suo Q, Zhong W, Xun G, Sun J, Chen C, and Zhang A (2020). Glima: Global and local time series imputation with multi-directional attention learning. In 2020 IEEE International Conference on Big Data (Big Data), pages 798&#x2013;807. IEEE.</Citation></Reference><Reference><Citation>Tashiro Y, Song J, Song Y, and Ermon S (2021). Csdi: Conditional score-based diffusion models for probabilistic time series imputation. Advances in Neural Information Processing Systems, 34:24804&#x2013;24816.</Citation></Reference><Reference><Citation>Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN, Kaiser L, and Polosukhin I (2017). Attention is all you need. Advances in neural information processing systems, 30.</Citation></Reference><Reference><Citation>Wells BJ, Chagin KM, Nowacki AS, and Kattan MW (2013). Strategies for handling missing data in electronic health record derived data. Egems, 1(3).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4371484</ArticleId><ArticleId IdType=\"pubmed\">25848578</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J and Leskovec J (2011). Patterns of temporal variation in online media. In Proceedings of the fourth ACM international conference on Web search and data mining, pages 177&#x2013;186.</Citation></Reference><Reference><Citation>Yoon J, Zame WR, and van der Schaar M (2018). Estimating missing data in temporal data streams using multi-directional recurrent neural networks. IEEE Transactions on Biomedical Engineering, 66(5):1477&#x2013;1490.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30296210</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">39267723</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">1663-4365</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>16</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in aging neuroscience</Title><ISOAbbreviation>Front Aging Neurosci</ISOAbbreviation></Journal><ArticleTitle>Alteration in temporal-cerebellar effective connectivity can effectively distinguish stable and progressive mild cognitive impairment.</ArticleTitle><Pagination><StartPage>1442721</StartPage><MedlinePgn>1442721</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1442721</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fnagi.2024.1442721</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"UNASSIGNED\">Stable mild cognitive impairment (sMCI) and progressive mild cognitive impairment (pMCI) represent two distinct subtypes of mild cognitive impairment (MCI). Early and effective diagnosis and accurate differentiation between sMCI and pMCI are crucial for administering targeted early intervention and preventing cognitive decline. This study investigated the intrinsic dysconnectivity patterns in sMCI and pMCI based on degree centrality (DC) and effective connectivity (EC) analyses, with the goal of uncovering shared and distinct neuroimaging mechanisms between subtypes.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">Resting-state functional magnetic resonance imaging combined with DC analysis was used to explore the functional connectivity density in 42 patients with sMCI, 31 patients with pMCI, and 82 healthy control (HC) participants. Granger causality analysis was used to assess changes in EC based on the significant clusters found in DC. Furthermore, correlation analysis was conducted to examine the associations between altered DC/EC values and cognitive function. Receiver operating characteristic curve analysis was performed to determine the accuracy of abnormal DC and EC values in distinguishing sMCI from pMCI.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">Compared with the HC group, both pMCI and sMCI groups exhibited increased DC in the left inferior temporal gyrus (ITG), left posterior cerebellum lobe (CPL), and right cerebellum anterior lobe (CAL), along with decreased DC in the left medial frontal gyrus. Moreover, the sMCI group displayed reduced EC from the right CAL to bilateral CPL, left superior temporal gyrus, and bilateral caudate compared with HC. pMCI demonstrated elevated EC from the right CAL to left ITG, which was linked to episodic memory and executive function. Notably, the EC from the right CAL to the right ITG effectively distinguished sMCI from pMCI, with sensitivity, specificity, and accuracy of 0.5806, 0.9512, and 0.828, respectively.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"UNASSIGNED\">This study uncovered shared and distinct alterations in DC and EC between sMCI and pMCI, highlighting their involvement in cognitive function. Of particular significance are the unidirectional EC disruptions from the cerebellum to the temporal lobe, which serve as a discriminating factor between sMCI and pMCI and provide a new perspective for understanding the temporal-cerebellum. These findings offer novel insights into the neural circuit mechanisms involving the temporal-cerebellum connection in MCI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Xue, Zheng, Ruan, Guo and Hu.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Xue</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zheng</LastName><ForeName>Darui</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ruan</LastName><ForeName>Yiming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Radiology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Guo</LastName><ForeName>Wenxuan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Radiology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><CollectiveName>Alzheimer&#x2019;s Disease Neuroimaging Initiative</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Aging Neurosci</MedlineTA><NlmUniqueID>101525824</NlmUniqueID><ISSNLinking>1663-4365</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">degree centrality</Keyword><Keyword MajorTopicYN=\"N\">directed functional connectivity</Keyword><Keyword MajorTopicYN=\"N\">progressive mild cognitive impairment</Keyword><Keyword MajorTopicYN=\"N\">resting-state functional MRI</Keyword><Keyword MajorTopicYN=\"N\">stable mild cognitive impairment</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39267723</ArticleId><ArticleId IdType=\"pmc\">PMC11390694</ArticleId><ArticleId IdType=\"doi\">10.3389/fnagi.2024.1442721</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhembre N., Bonthron C., Opazo P. (2023). Synaptic compensatory plasticity in Alzheimer&#x2019;s disease. J. Neurosci. 43, 6833&#x2013;6840. doi: 10.1523/JNEUROSCI.0379-23.2023, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1523/JNEUROSCI.0379-23.2023</ArticleId><ArticleId IdType=\"pmc\">PMC10573755</ArticleId><ArticleId IdType=\"pubmed\">37821232</ArticleId></ArticleIdList></Reference><Reference><Citation>Caffarra P., Ghetti C., Ruffini L., Spallazzi M., Spotti A., Barocco F., et al. . (2016). Brain metabolism correlates of the free and cued selective reminding test in mild cognitive impairment. J. Alzheimers Dis. 51, 27&#x2013;31. doi: 10.3233/JAD-150418</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-150418</ArticleId><ArticleId IdType=\"pubmed\">26836012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai S., Peng Y., Chong T., Zhang Y., von Deneen K. M., Huang L., et al. . (2017). Differentiated effective connectivity patterns of the executive control network in progressive MCI: a potential biomarker for predicting AD. Curr. Alzheimer Res. 14, 937&#x2013;950. doi: 10.2174/1567205014666170309120200</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567205014666170309120200</ArticleId><ArticleId IdType=\"pubmed\">28290245</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Wu H., Song Y., Ge H., Yan Z., Xue C., et al. . (2023). Altered structural and functional homotopic connectivity associated with the progression from mild cognitive impairment to Alzheimer&#x2019;s disease. Psychiatry Res. 319:115000. doi: 10.1016/j.psychres.2022.115000, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.psychres.2022.115000</ArticleId><ArticleId IdType=\"pubmed\">36502711</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiesa P. A., Cavedo E., Vergallo A., Lista S., Potier M. C., Habert M. O., et al. . (2019). Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer&#x2019;s disease. Alzheimers Dement. 15, 940&#x2013;950. doi: 10.1016/j.jalz.2019.03.006</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2019.03.006</ArticleId><ArticleId IdType=\"pubmed\">31113760</ArticleId></ArticleIdList></Reference><Reference><Citation>Costumero V., d'Oleire Uquillas F., Diez I., Andorra M., Basaia S., Bueicheku E., et al. . (2020). Distance disintegration delineates the brain connectivity failure of Alzheimer&#x2019;s disease. Neurobiol. Aging 88, 51&#x2013;60. doi: 10.1016/j.neurobiolaging.2019.12.005, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2019.12.005</ArticleId><ArticleId IdType=\"pmc\">PMC7085436</ArticleId><ArticleId IdType=\"pubmed\">31941578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutando L., Puighermanal E., Castell L., Tarot P., Belle M., Bertaso F., et al. . (2022). Cerebellar dopamine D2 receptors regulate social behaviors. Nat. Neurosci. 25, 900&#x2013;911. doi: 10.1038/s41593-022-01092-8</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41593-022-01092-8</ArticleId><ArticleId IdType=\"pubmed\">35710984</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman N. P., Robbins T. W. (2022). The role of prefrontal cortex in cognitive control and executive function. Neuropsychopharmacology 47, 72&#x2013;89. doi: 10.1038/s41386-021-01132-0, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41386-021-01132-0</ArticleId><ArticleId IdType=\"pmc\">PMC8617292</ArticleId><ArticleId IdType=\"pubmed\">34408280</ArticleId></ArticleIdList></Reference><Reference><Citation>Friston K., Moran R., Seth A. K. (2013). Analysing connectivity with granger causality and dynamic causal modelling. Curr. Opin. Neurobiol. 23, 172&#x2013;178. doi: 10.1016/j.conb.2012.11.010, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.conb.2012.11.010</ArticleId><ArticleId IdType=\"pmc\">PMC3925802</ArticleId><ArticleId IdType=\"pubmed\">23265964</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y., Zhao X., Huang J., Wang S., Chen X., Li M., et al. . (2022). Abnormal regional homogeneity in right caudate as a potential neuroimaging biomarker for mild cognitive impairment: a resting-state fMRI study and support vector machine analysis. Front. Aging Neurosci. 14:979183. doi: 10.3389/fnagi.2022.979183, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.979183</ArticleId><ArticleId IdType=\"pmc\">PMC9475111</ArticleId><ArticleId IdType=\"pubmed\">36118689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaubert S., Raimondo F., Houot M., Corsi M. C., Naccache L., Diego Sitt J., et al. . (2019). EEG evidence of compensatory mechanisms in preclinical Alzheimer&#x2019;s disease. Brain 142, 2096&#x2013;2112. doi: 10.1093/brain/awz150, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/brain/awz150</ArticleId><ArticleId IdType=\"pubmed\">31211359</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellersen H. M., Guell X., Sami S. (2021). Differential vulnerability of the cerebellum in healthy ageing and Alzheimer&#x2019;s disease. Neuroimage Clin. 30:102605. doi: 10.1016/j.nicl.2021.102605, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nicl.2021.102605</ArticleId><ArticleId IdType=\"pmc\">PMC7974323</ArticleId><ArticleId IdType=\"pubmed\">33735787</ArticleId></ArticleIdList></Reference><Reference><Citation>Grahn J. A., Parkinson J. A., Owen A. M. (2008). The cognitive functions of the caudate nucleus. Prog. Neurobiol. 86, 141&#x2013;155. doi: 10.1016/j.pneurobio.2008.09.004</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pneurobio.2008.09.004</ArticleId><ArticleId IdType=\"pubmed\">18824075</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y., Lin Y., Huang L., Ma J., Zhang J., Xiao Y., et al. . (2020). Abnormal dynamic functional connectivity in Alzheimer&#x2019;s disease. CNS Neurosci. Ther. 26, 962&#x2013;971. doi: 10.1111/cns.13387, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cns.13387</ArticleId><ArticleId IdType=\"pmc\">PMC7415210</ArticleId><ArticleId IdType=\"pubmed\">32378335</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallam B., Chan J., Gonzalez Costafreda S., Bhome R., Huntley J. (2020). What are the neural correlates of meta-cognition and anosognosia in Alzheimer&#x2019;s disease? A systematic review. Neurobiol. Aging 94, 250&#x2013;264. doi: 10.1016/j.neurobiolaging.2020.06.011, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2020.06.011</ArticleId><ArticleId IdType=\"pmc\">PMC7903321</ArticleId><ArticleId IdType=\"pubmed\">32679396</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S. Y., Hsu J. L., Lin K. J., Liu H. L., Wey S. P., Hsiao I. T., et al. . (2018). Characteristic patterns of inter-and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer&#x2019;s disease. Sci. Rep. 8:13807. doi: 10.1038/s41598-018-31794-8, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-31794-8</ArticleId><ArticleId IdType=\"pmc\">PMC6138637</ArticleId><ArticleId IdType=\"pubmed\">30218083</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Zhang D., Wang P., Mao C., Miao Z., Liu C., et al. . (2021). Altered amygdala effective connectivity in migraine without aura: evidence from resting-state fMRI with granger causality analysis. J. Headache Pain 22:25. doi: 10.1186/s10194-021-01240-8, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s10194-021-01240-8</ArticleId><ArticleId IdType=\"pmc\">PMC8048057</ArticleId><ArticleId IdType=\"pubmed\">33858323</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingala S., Tomassen J., Collij L. E., Prent N., van 't Ent D., Ten Kate M., et al. . (2021). Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals. Brain Commun. 3:fcab201. doi: 10.1093/braincomms/fcab201, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/braincomms/fcab201</ArticleId><ArticleId IdType=\"pmc\">PMC8490784</ArticleId><ArticleId IdType=\"pubmed\">34617016</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson R. L., Bajada C. J., Rice G. E., Cloutman L. L., Lambon Ralph M. A. (2018). An emergent functional parcellation of the temporal cortex. NeuroImage 170, 385&#x2013;399. doi: 10.1016/j.neuroimage.2017.04.024, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuroimage.2017.04.024</ArticleId><ArticleId IdType=\"pubmed\">28419851</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen F., Amariglio R. E., van Boxtel M., Breteler M., Ceccaldi M., Chetelat G., et al. . (2014a). A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer&#x2019;s disease. Alzheimers Dement. 10, 844&#x2013;852. doi: 10.1016/j.jalz.2014.01.001, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2014.01.001</ArticleId><ArticleId IdType=\"pmc\">PMC4317324</ArticleId><ArticleId IdType=\"pubmed\">24798886</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen F., Wolfsgruber S., Wiese B., Bickel H., Mosch E., Kaduszkiewicz H., et al. . (2014b). AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement. 10, 76&#x2013;83. doi: 10.1016/j.jalz.2012.09.017, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2012.09.017</ArticleId><ArticleId IdType=\"pubmed\">23375567</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi K., Etchamendy N., Roy S., Marighetto A., Rajah N., Bohbot V. D. (2013). Decreased functional magnetic resonance imaging activity in the hippocampus in favor of the caudate nucleus in older adults tested in a virtual navigation task. Hippocampus 23, 1005&#x2013;1014. doi: 10.1002/hipo.22181, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/hipo.22181</ArticleId><ArticleId IdType=\"pubmed\">23929534</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W. J., Brown J. A., Kim H. R., La Joie R., Cho H., Lyoo C. H., et al. . (2022). Regional Abeta-tau interactions promote onset and acceleration of Alzheimer&#x2019;s disease tau spreading. Neuron 110, 1932&#x2013;1943.e5. doi: 10.1016/j.neuron.2022.03.034</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2022.03.034</ArticleId><ArticleId IdType=\"pmc\">PMC9233123</ArticleId><ArticleId IdType=\"pubmed\">35443153</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W., Mantini D., Zhang Z., Pan Z., Ding J., Gong Q., et al. . (2010). Evaluating the effective connectivity of resting state networks using conditional granger causality. Biol. Cybern. 102, 57&#x2013;69. doi: 10.1007/s00422-009-0350-5</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00422-009-0350-5</ArticleId><ArticleId IdType=\"pubmed\">19937337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou Y., Huang P., Li D., Cen Z., Wang B., Gao J., et al. . (2015). Altered brain network centrality in depressed Parkinson&#x2019;s disease patients. Mov. Disord. 30, 1777&#x2013;1784. doi: 10.1002/mds.26321, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/mds.26321</ArticleId><ArticleId IdType=\"pubmed\">26180026</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou W., Shi L., Wong A., Chu W. C., Mok V. C., Wang D. (2016). Changes of cerebral perfusion and functional brain network organization in patients with mild cognitive impairment. J. Alzheimers Dis. 54, 397&#x2013;409. doi: 10.3233/JAD-160201</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-160201</ArticleId><ArticleId IdType=\"pubmed\">27567823</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen S. K., Ho A. J., Hua X., Saharan P. S., Toga A. W., Jack C. R., Jr., et al. . (2010). 3D maps localize caudate nucleus atrophy in 400 Alzheimer&#x2019;s disease, mild cognitive impairment, and healthy elderly subjects. Neurobiol. Aging 31, 1312&#x2013;1325. doi: 10.1016/j.neurobiolaging.2010.05.002, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2010.05.002</ArticleId><ArticleId IdType=\"pmc\">PMC2903198</ArticleId><ArticleId IdType=\"pubmed\">20538376</ArticleId></ArticleIdList></Reference><Reference><Citation>Malotaux V., Dricot L., Quenon L., Lhommel R., Ivanoiu A., Hanseeuw B. (2023). Default-mode network connectivity changes during the progression toward Alzheimer&#x2019;s dementia: a longitudinal functional magnetic resonance imaging study. Brain Connect. 13, 287&#x2013;296. doi: 10.1089/brain.2022.0008, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/brain.2022.0008</ArticleId><ArticleId IdType=\"pubmed\">36103377</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren D. G., Sreenivasan A., Diamond E. L., Mitchell M. B., Van Dijk K. R., Deluca A. N., et al. . (2012). Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer&#x2019;s disease. Neurodegener. Dis. 9, 176&#x2013;186. doi: 10.1159/000335876, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000335876</ArticleId><ArticleId IdType=\"pmc\">PMC3369254</ArticleId><ArticleId IdType=\"pubmed\">22456451</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon V. (2023). 20 years of the default mode network: a review and synthesis. Neuron 111, 2469&#x2013;2487. doi: 10.1016/j.neuron.2023.04.023, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neuron.2023.04.023</ArticleId><ArticleId IdType=\"pmc\">PMC10524518</ArticleId><ArticleId IdType=\"pubmed\">37167968</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell A. J., Shiri-Feshki M. (2009). Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies. Acta Psychiatr. Scand. 119, 252&#x2013;265. doi: 10.1111/j.1600-0447.2008.01326.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1600-0447.2008.01326.x</ArticleId><ArticleId IdType=\"pubmed\">19236314</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivito G., Serra L., Marra C., Di Domenico C., Caltagirone C., Toniolo S., et al. . (2020). Cerebellar dentate nucleus functional connectivity with cerebral cortex in Alzheimer&#x2019;s disease and memory: a seed-based approach. Neurobiol. Aging 89, 32&#x2013;40. doi: 10.1016/j.neurobiolaging.2019.10.026, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2019.10.026</ArticleId><ArticleId IdType=\"pubmed\">32081466</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira J. B., Mijalkov M., Kakaei E., Mecocci P., Vellas B., Tsolaki M., et al. . (2016). Disrupted network topology in patients with stable and progressive mild cognitive impairment and Alzheimer&#x2019;s disease. Cereb. Cortex 26, 3476&#x2013;3493. doi: 10.1093/cercor/bhw128, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cercor/bhw128</ArticleId><ArticleId IdType=\"pmc\">PMC4961019</ArticleId><ArticleId IdType=\"pubmed\">27178195</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen R. C., Caracciolo B., Brayne C., Gauthier S., Jelic V., Fratiglioni L. (2014). Mild cognitive impairment: a concept in evolution. J. Intern. Med. 275, 214&#x2013;228. doi: 10.1111/joim.12190, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/joim.12190</ArticleId><ArticleId IdType=\"pmc\">PMC3967548</ArticleId><ArticleId IdType=\"pubmed\">24605806</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieckmann A., Johnson K. A., Sperling R. A., Buckner R. L., Hedden T. (2018). Dedifferentiation of caudate functional connectivity and striatal dopamine transporter density predict memory change in normal aging. Proc. Natl. Acad. Sci. USA 115, 10160&#x2013;10165. doi: 10.1073/pnas.1804641115, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.1804641115</ArticleId><ArticleId IdType=\"pmc\">PMC6176586</ArticleId><ArticleId IdType=\"pubmed\">30224467</ArticleId></ArticleIdList></Reference><Reference><Citation>Sereno M. I., Diedrichsen J., Tachrount M., Testa-Silva G., d'Arceuil H., De Zeeuw C. (2020). The human cerebellum has almost 80% of the surface area of the neocortex. Proc. Natl. Acad. Sci. USA 117, 19538&#x2013;19543. doi: 10.1073/pnas.2002896117, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1073/pnas.2002896117</ArticleId><ArticleId IdType=\"pmc\">PMC7431020</ArticleId><ArticleId IdType=\"pubmed\">32723827</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha Z., Xia M., Lin Q., Cao M., Tang Y., Xu K., et al. . (2018). Meta-connectomic analysis reveals commonly disrupted functional architectures in network modules and connectors across brain disorders. Cereb. Cortex 28, 4179&#x2013;4194. doi: 10.1093/cercor/bhx273, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cercor/bhx273</ArticleId><ArticleId IdType=\"pubmed\">29136110</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan A., Zhang H., Gao M., Wang L., Cao X., Gan C., et al. . (2023). Aberrant voxel-based degree centrality and functional connectivity in Parkinson&#x2019;s disease patients with fatigue. CNS Neurosci. Ther. 29, 2680&#x2013;2689. doi: 10.1111/cns.14212, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cns.14212</ArticleId><ArticleId IdType=\"pmc\">PMC10401083</ArticleId><ArticleId IdType=\"pubmed\">37032641</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang F., Zhu D., Ma W., Yao Q., Li Q., Shi J. (2021). Differences changes in cerebellar functional connectivity between mild cognitive impairment and Alzheimer&#x2019;s disease: a seed-based approach. Front. Neurol. 12:645171. doi: 10.3389/fneur.2021.645171, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2021.645171</ArticleId><ArticleId IdType=\"pmc\">PMC8248670</ArticleId><ArticleId IdType=\"pubmed\">34220669</ArticleId></ArticleIdList></Reference><Reference><Citation>Thung K. H., Wee C. Y., Yap P. T., Shen D. (2016). Identification of progressive mild cognitive impairment patients using incomplete longitudinal MRI scans. Brain Struct. Funct. 221, 3979&#x2013;3995. doi: 10.1007/s00429-015-1140-6, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00429-015-1140-6</ArticleId><ArticleId IdType=\"pmc\">PMC4879600</ArticleId><ArticleId IdType=\"pubmed\">26603378</ArticleId></ArticleIdList></Reference><Reference><Citation>Uwisengeyimana J. D., Nguchu B. A., Wang Y., Zhang D., Liu Y., Qiu B., et al. . (2020). Cognitive function and cerebellar morphometric changes relate to abnormal intra-cerebellar and cerebro-cerebellum functional connectivity in old adults. Exp. Gerontol. 140:111060. doi: 10.1016/j.exger.2020.111060, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.exger.2020.111060</ArticleId><ArticleId IdType=\"pubmed\">32814097</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Liang M., Wang L., Tian L., Zhang X., Li K., et al. . (2007). Altered functional connectivity in early Alzheimer&#x2019;s disease: a resting-state fMRI study. Hum. Brain Mapp. 28, 967&#x2013;978. doi: 10.1002/hbm.20324, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/hbm.20324</ArticleId><ArticleId IdType=\"pmc\">PMC6871392</ArticleId><ArticleId IdType=\"pubmed\">17133390</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Liao Z., Mao D., Zhang Q., Li Y., Yu E., et al. . (2017). Application of granger causality analysis of the directed functional connection in Alzheimer&#x2019;s disease and mild cognitive impairment. J. Vis. Exp. 126:56015. doi: 10.3791/56015, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3791/56015</ArticleId><ArticleId IdType=\"pmc\">PMC5614121</ArticleId><ArticleId IdType=\"pubmed\">28809833</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Miao L., Niu Y., Cao R., Li D., Yan P., et al. . (2018). Abnormal functional brain networks in mild cognitive impairment and Alzheimer&#x2019;s disease: a minimum spanning tree analysis. J. Alzheimers Dis. 65, 1093&#x2013;1107. doi: 10.3233/JAD-180603, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-180603</ArticleId><ArticleId IdType=\"pubmed\">30149457</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y. Q., Wang Y. N., Zhang L. J., Liu L. Q., Pan Y. C., Su T., et al. . (2022). Regional homogeneity in patients with mild cognitive impairment: a resting-state functional magnetic resonance imaging study. Front. Aging Neurosci. 14:877281. doi: 10.3389/fnagi.2022.877281, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.877281</ArticleId><ArticleId IdType=\"pmc\">PMC9050296</ArticleId><ArticleId IdType=\"pubmed\">35493938</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue J., Guo H., Gao Y., Wang X., Cui H., Chen Z., et al. . (2019). Altered directed functional connectivity of the Hippocampus in mild cognitive impairment and Alzheimer&#x2019;s disease: a resting-state fMRI study. Front. Aging Neurosci. 11:326. doi: 10.3389/fnagi.2019.00326, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2019.00326</ArticleId><ArticleId IdType=\"pmc\">PMC6905409</ArticleId><ArticleId IdType=\"pubmed\">31866850</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C., Sun H., Hu G., Qi W., Yue Y., Rao J., et al. . (2020). Disrupted patterns of rich-club and diverse-club organizations in subjective cognitive decline and amnestic mild cognitive impairment. Front. Neurosci. 14:575652. doi: 10.3389/fnins.2020.575652, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnins.2020.575652</ArticleId><ArticleId IdType=\"pmc\">PMC7593791</ArticleId><ArticleId IdType=\"pubmed\">33177982</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C., Sun H., Yue Y., Wang S., Qi W., Hu G., et al. . (2021). Structural and functional disruption of salience network in distinguishing subjective cognitive decline and amnestic mild cognitive impairment. ACS Chem. Neurosci. 12, 1384&#x2013;1394. doi: 10.1021/acschemneuro.1c00051</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acschemneuro.1c00051</ArticleId><ArticleId IdType=\"pubmed\">33825444</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C., Yuan B., Yue Y., Xu J., Wang S., Wu M., et al. . (2019). Distinct disruptive patterns of default mode subnetwork connectivity across the spectrum of preclinical Alzheimer&#x2019;s disease. Front. Aging Neurosci. 11:307. doi: 10.3389/fnagi.2019.00307, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2019.00307</ArticleId><ArticleId IdType=\"pmc\">PMC6863958</ArticleId><ArticleId IdType=\"pubmed\">31798440</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Caldwell J. Z. K., Cummings J. L., Ritter A., Kinney J. W., Cordes D., et al. . (2022). Sex modulates the pathological aging effect on caudate functional connectivity in mild cognitive impairment. Front. Psych. 13:804168. doi: 10.3389/fpsyt.2022.804168, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fpsyt.2022.804168</ArticleId><ArticleId IdType=\"pmc\">PMC9037326</ArticleId><ArticleId IdType=\"pubmed\">35479489</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu E., Liao Z., Tan Y., Qiu Y., Zhu J., Han Z., et al. . (2019). High-sensitivity neuroimaging biomarkers for the identification of amnestic mild cognitive impairment based on resting-state fMRI and a triple network model. Brain Imaging Behav. 13, 1&#x2013;14. doi: 10.1007/s11682-017-9727-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11682-017-9727-6</ArticleId><ArticleId IdType=\"pubmed\">28466439</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Li K., Luo X., Zeng Q., Jiaerken Y., Wang S., et al. . (2021). Distinct impaired patterns of intrinsic functional network centrality in patients with early-and late-onset Alzheimer&#x2019;s disease. Brain Imaging Behav. 15, 2661&#x2013;2670. doi: 10.1007/s11682-021-00470-3, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11682-021-00470-3</ArticleId><ArticleId IdType=\"pubmed\">33844192</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Lui Y. W. (2013). Small-world properties in mild cognitive impairment and early Alzheimer&#x2019;s disease: a cortical thickness MRI study. ISRN Geriatr. 2013, 1&#x2013;11. doi: 10.1155/2013/542080, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2013/542080</ArticleId><ArticleId IdType=\"pmc\">PMC4235771</ArticleId><ArticleId IdType=\"pubmed\">25414852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Zhu R., Shao W., Zhang S. J., Wang L., Ding X. J., et al. . (2021). Changes in resting-state functional connectivity of cerebellum in amnestic mild cognitive impairment and Alzheimer&#x2019;s disease: a case-control study. Front. Syst. Neurosci. 15:596221. doi: 10.3389/fnsys.2021.596221, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnsys.2021.596221</ArticleId><ArticleId IdType=\"pmc\">PMC8006280</ArticleId><ArticleId IdType=\"pubmed\">33790747</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo X. N., Ehmke R., Mennes M., Imperati D., Castellanos F. X., Sporns O., et al. . (2012). Network centrality in the human functional connectome. Cereb. Cortex 22, 1862&#x2013;1875. doi: 10.1093/cercor/bhr269</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cercor/bhr269</ArticleId><ArticleId IdType=\"pubmed\">21968567</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo X. N., Xing X. X. (2014). Test-retest reliabilities of resting-state FMRI measurements in human brain functional connectomics: a systems neuroscience perspective. Neurosci. Biobehav. Rev. 45, 100&#x2013;118. doi: 10.1016/j.neubiorev.2014.05.009, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neubiorev.2014.05.009</ArticleId><ArticleId IdType=\"pubmed\">24875392</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">39267722</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">1663-4365</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>16</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in aging neuroscience</Title><ISOAbbreviation>Front Aging Neurosci</ISOAbbreviation></Journal><ArticleTitle>Development of capillary dysfunction in Alzheimer's disease.</ArticleTitle><Pagination><StartPage>1458455</StartPage><MedlinePgn>1458455</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">1458455</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fnagi.2024.1458455</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is currently considered the major cause of cognitive impairment in older adults. This explains the close attention to the issue of AD research. The pathomorphological basis of the disease is a neurodegenerative process, the early stages of which are formed in the hippocampus and the morphofunctionally deep parts of the temporal lobes of the brain closely related to it. Several hypotheses have been advanced concerning the causes of neurodegeneration: the amyloid hypothesis, the calcium homeostasis impairment hypothesis, the inflammatory hypothesis, and the prion hypothesis. However, these hypotheses cannot explain the early stages of the pathogenesis of neurodegenerative diseases, in particular Alzheimer's disease. This health problem requires further comprehensive study of available data, as well as additional investigations to determine the nature of such a process. In this review, the data on microcirculatory disorders in the capillaries of the hippocampus and mediobasal structures of the temporal lobes of the brain, which may be an initiating factor that triggers neurodegenerative events, are analyzed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Vorobev, Yanishevskiy, Efimtsev, Sokolov and Dyachuk.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Vorobev</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenesis and Neurodevelopmental Disorders, World-Class Research Center for Personalized Medicine, Almazov Center, Saint-Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yanishevskiy</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenesis and Neurodevelopmental Disorders, World-Class Research Center for Personalized Medicine, Almazov Center, Saint-Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Efimtsev</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenesis and Neurodevelopmental Disorders, World-Class Research Center for Personalized Medicine, Almazov Center, Saint-Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sokolov</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenesis and Neurodevelopmental Disorders, World-Class Research Center for Personalized Medicine, Almazov Center, Saint-Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dyachuk</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenesis and Neurodevelopmental Disorders, World-Class Research Center for Personalized Medicine, Almazov Center, Saint-Petersburg, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2024</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Aging Neurosci</MedlineTA><NlmUniqueID>101525824</NlmUniqueID><ISSNLinking>1663-4365</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">BBB function</Keyword><Keyword MajorTopicYN=\"N\">amyloid &#x3b2; buildup</Keyword><Keyword MajorTopicYN=\"N\">capillary dysfunction</Keyword><Keyword MajorTopicYN=\"N\">glymphatic system</Keyword><Keyword MajorTopicYN=\"N\">mitochondrial dysfunction</Keyword><Keyword MajorTopicYN=\"N\">neurodegeneration</Keyword><Keyword MajorTopicYN=\"N\">oxidative stress</Keyword><Keyword MajorTopicYN=\"N\">&#x3b2;-secretase pathway</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">39267722</ArticleId><ArticleId IdType=\"pmc\">PMC11391207</ArticleId><ArticleId IdType=\"doi\">10.3389/fnagi.2024.1458455</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bezprozvanny I. (2022). Alzheimer&#x2019;s disease&#x2014;where do we go from here? Biochem. Biophys. Res. Commun. 633, 72&#x2013;76. doi: 10.1016/j.bbrc.2022.08.075</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2022.08.075</ArticleId><ArticleId IdType=\"pubmed\">36344168</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown W. R., Moody D. M., Thore C. R., Challa V. R., Anstrom J. A. (2007). Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J. Neurol. Sci. 257, 62&#x2013;66. doi: 10.1016/j.jns.2007.01.015, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jns.2007.01.015</ArticleId><ArticleId IdType=\"pmc\">PMC1989116</ArticleId><ArticleId IdType=\"pubmed\">17320909</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown W. R., Thore C. R. (2011). Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol. Appl. Neurobiol. 37, 56&#x2013;74. doi: 10.1111/j.1365-2990.2010.01139.x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2990.2010.01139.x</ArticleId><ArticleId IdType=\"pmc\">PMC3020267</ArticleId><ArticleId IdType=\"pubmed\">20946471</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant A. G., Manhard M. K., Salat D. H., Rosen B. R., Hyman B. T., Johnson K. A., et al. . (2021). Heterogeneity of tau deposition and microvascular involvement in MCI and AD. Curr. Alzheimer Res. 18, 711&#x2013;720. doi: 10.2174/1567205018666211126113904</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2174/1567205018666211126113904</ArticleId><ArticleId IdType=\"pmc\">PMC8822690</ArticleId><ArticleId IdType=\"pubmed\">34825871</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldeira M. V., Salazar I. L., Curcio M., Canzoniero L. M., Duarte C. B. (2014). Role of the ubiquitin-proteasome system in brain ischemia: friend or foe? Prog. Neurobiol. 112, 50&#x2013;69. doi: 10.1016/j.pneurobio.2013.10.003</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pneurobio.2013.10.003</ArticleId><ArticleId IdType=\"pubmed\">24157661</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov N. M., Luzina E. A., Demenkova I. S., Spirina M. A., Shamrova E. A., Makarova Y. A., et al. . (2020). Modern concept of pathogenesis of Alzheimer&#x2019;s disease. Mod. Probl. Sci. Educ. 2:164. doi: 10.17513/spno.29647</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17513/spno.29647</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornejo F., von Bernhardi R. (2016). Age-dependent changes in the activation and regulation of microglia. Adv. Exp. Med. Biol. 949, 205&#x2013;226. doi: 10.1007/978-3-319-40764-7_10, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-3-319-40764-7_10</ArticleId><ArticleId IdType=\"pubmed\">27714691</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhapola R., Beura S. K., Sharma P., Singh S. K., HariKrishnaReddy D. (2024). Oxidative stress in Alzheimer&#x2019;s disease: current knowledge of signaling pathways and therapeutics. Mol. Biol. Rep. 51:48. doi: 10.1007/s11033-023-09021-z, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11033-023-09021-z</ArticleId><ArticleId IdType=\"pubmed\">38165499</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdener &#x15e;. E., Dalkara T. (2019). Small vessels are a big problem in neurodegeneration and neuroprotection. Front. Neurol. 10:889. doi: 10.3389/fneur.2019.00889, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fneur.2019.00889</ArticleId><ArticleId IdType=\"pmc\">PMC6707104</ArticleId><ArticleId IdType=\"pubmed\">31474933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermilov V. V., Nesterova A. A. (2016). &#x3b2;-amyloidopathy in the pathogenesis of age-related macular degeneration in correlation with neurodegenerative diseases. Adv. Exp. Med. Biol. 854, 119&#x2013;125. doi: 10.1007/978-3-319-17121-0_17, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-3-319-17121-0_17</ArticleId><ArticleId IdType=\"pubmed\">26427402</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorelik E. V. (2014). Pathomorphological examination of hippocampus in the persons of the second period of mature age with cerebral atherosclerosis. J. New Med. Technol. 8, 1&#x2013;6. doi: 10.12737/5023</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.12737/5023</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman-Martinez L., Maccioni R. B., Andrade V., Navarrete L. P., Pastor M. G., Ramos-Escobar N. (2019). Neuroinflammation as a common feature of neurodegenerative disorders. Front. Pharmacol. 10:1008. doi: 10.3389/fphar.2019.01008, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fphar.2019.01008</ArticleId><ArticleId IdType=\"pmc\">PMC6751310</ArticleId><ArticleId IdType=\"pubmed\">31572186</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff J. J., Wang M., Liao Y., Plogg B. A., Peng W., Gundersen G. A., et al. . (2012). A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid &#x3b2;. Sci. Transl. Med. 4:147ra111. doi: 10.1126/scitranslmed.3003748, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1126/scitranslmed.3003748</ArticleId><ArticleId IdType=\"pmc\">PMC3551275</ArticleId><ArticleId IdType=\"pubmed\">22896675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirabali T., Rust R., Rigotti S., Siccoli A., Nitsch R. M., Kulic L. (2020). Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer&#x2019;s disease. Brain Pathol. 30, 1056&#x2013;1070. doi: 10.1111/bpa.12895, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/bpa.12895</ArticleId><ArticleId IdType=\"pmc\">PMC8018068</ArticleId><ArticleId IdType=\"pubmed\">32866303</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocki J., U&#x142;amek-Kozio&#x142; M., Bogucka-Kocka A., Januszewski S., Jab&#x142;o&#x144;ski M., Gil-Kulik P., et al. . (2015). Dysregulation of amyloid-&#x3b2; protein precursor, &#x3b2;-secretase, presenilin 1 and 2 genes in the rat selectively vulnerable CA1 subfield of Hippocampus following transient global brain ischemia. J. Alzheimers Dis. 47, 1047&#x2013;1056. doi: 10.3233/JAD-150299</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-150299</ArticleId><ArticleId IdType=\"pmc\">PMC4923727</ArticleId><ArticleId IdType=\"pubmed\">26401782</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosicek M., Wunderlich P., Walter J., Hecimovic S. (2014). GGA1 overexpression attenuates amyloidogenic processing of the amyloid precursor protein in Niemann&#x2013;Pick type C cells. Biochem. Biophys. Res. Commun. 450, 160&#x2013;165. doi: 10.1016/j.bbrc.2014.05.083</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.bbrc.2014.05.083</ArticleId><ArticleId IdType=\"pubmed\">24866237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kress B. T., Iliff J. J., Xia M., Wang M., Wei H., Zeppenfeld D., et al. . (2014). Impairment of paravascular clearance pathways in the aging brain. Ann. Neurol. 76, 845&#x2013;861. doi: 10.1002/ana.24271, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ana.24271</ArticleId><ArticleId IdType=\"pmc\">PMC4245362</ArticleId><ArticleId IdType=\"pubmed\">25204284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudriaeva A. A., Belogurov A. A. (2019). Proteasome: a nanomachinery of creative destruction. Biochemistry 84, 159&#x2013;192. doi: 10.1134/S0006297919140104, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1134/S0006297919140104</ArticleId><ArticleId IdType=\"pubmed\">31213201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushnireva L. A., Korkotian E. A., Semyanov A. V. (2019). Undeservedly forgotten: the place of glial cells among the hypothesis of Alzheimer&#x2019;s disease. Russ. J. Physiol. 105, 1067&#x2013;1095. doi: 10.1134/S0869813919090085</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1134/S0869813919090085</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvinenko I. V., Emelin A. Y., Lobzin V. Y., Kolmakova K. A., Naumov K. M., Lupanov I. A., et al. . (2019). Amyloid hypothesis of Alzheimer&#x2019;s disease: past and present, hopes and disappointments. Neurol. Neuropsychiatry Psychosom. 11, 4&#x2013;10. doi: 10.14412/2074-2711-2019-3-4-10</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14412/2074-2711-2019-3-4-10</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen L. S., Nielsen R. B., Parbo P., Ismail R., Mikkelsen I. K., Gottrup H., et al. . (2022). Capillary function progressively deteriorates in prodromal Alzheimer&#x2019;s disease: a longitudinal MRI perfusion study. Aging Brain 2:100035. doi: 10.1016/j.nbas.2022.100035, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.nbas.2022.100035</ArticleId><ArticleId IdType=\"pmc\">PMC9997144</ArticleId><ArticleId IdType=\"pubmed\">36908896</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen L. S., Parbo P., Ismail R., Gottrup H., &#xd8;stergaard L., Brooks D. J., et al. . (2023). Capillary dysfunction correlates with cortical amyloid load in early Alzheimer&#x2019;s disease. Neurobiol. Aging 123, 1&#x2013;9. doi: 10.1016/j.neurobiolaging.2022.12.006, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2022.12.006</ArticleId><ArticleId IdType=\"pubmed\">36610198</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuire P. J. (2019). Mitochondrial dysfunction and the aging immune system. Biology 8:E26. doi: 10.3390/biology8020026, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/biology8020026</ArticleId><ArticleId IdType=\"pmc\">PMC6627503</ArticleId><ArticleId IdType=\"pubmed\">31083529</ArticleId></ArticleIdList></Reference><Reference><Citation>Millien G., Wang H., Zhang Z., Alkon D. L., Hongpaisan J. (2022). PKC&#x3b5; activation restores loss of PKC&#x3b5;, manganese superoxide dismutase, vascular endothelial growth factor, and microvessels in aged and Alzheimer&#x2019;s disease hippocampus. Front. Aging Neurosci. 14:836634. doi: 10.3389/fnagi.2022.836634, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fnagi.2022.836634</ArticleId><ArticleId IdType=\"pmc\">PMC8922019</ArticleId><ArticleId IdType=\"pubmed\">35299945</ArticleId></ArticleIdList></Reference><Reference><Citation>Moeini M., Lu X., Avti P. K., Damseh R., B&#xe9;langer S., Picard F., et al. . (2018). Compromised microvascular oxygen delivery increases brain tissue vulnerability with age. Sci. Rep. 8:8219. doi: 10.1038/s41598-018-26543-w, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41598-018-26543-w</ArticleId><ArticleId IdType=\"pmc\">PMC5974237</ArticleId><ArticleId IdType=\"pubmed\">29844478</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagelhus E. A., Ottersen O. P. (2013). Physiological roles of aquaporin-4 in brain. Physiol. Rev. 93, 1543&#x2013;1562. doi: 10.1152/physrev.00011.2013, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1152/physrev.00011.2013</ArticleId><ArticleId IdType=\"pmc\">PMC3858210</ArticleId><ArticleId IdType=\"pubmed\">24137016</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalivaeva N. N. (2022). The effect of prenatal hypoxia on the metabolism of amyloid precursor protein. Neurochem. J. 16, 219&#x2013;227. doi: 10.1134/S1819712422030084</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1134/S1819712422030084</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen R. B., Egefjord L., Angleys H., Mouridsen K., Gejl M., M&#xf8;ller A., et al. . (2017). Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer&#x2019;s disease. Alzheimers Dement. 13, 1143&#x2013;1153. doi: 10.1016/j.jalz.2017.02.007</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jalz.2017.02.007</ArticleId><ArticleId IdType=\"pubmed\">28343848</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolenko V. N., Rizaeva N. A., Bulygin K. V., Anokhina V. M., Bolotskaya A. A. (2022). The role of oxidative stress in the development of Alzheimer&#x2019;s disease. Neurol. Neuropsychiatry Psychosom. 14, 68&#x2013;74. doi: 10.14412/2074-2711-2022-4-68-74</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.14412/2074-2711-2022-4-68-74</ArticleId></ArticleIdList></Reference><Reference><Citation>Novikov V. Y., Levchenkova O. S. (2013). Hypoxia-inducible factor as a pharmacological target. Rev. Clin. Pharmacol. Drug Ther. 11, 8&#x2013;16. doi: 10.17816/RCF1128-16</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17816/RCF1128-16</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong W. Y., Tanaka K., Dawe G. S., Ittner L. M., Farooqui A. A. (2013). Slow excitotoxicity in Alzheimer&#x2019;s disease. J. Alzheimers Dis. 35, 643&#x2013;668. doi: 10.3233/JAD-121990</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3233/JAD-121990</ArticleId><ArticleId IdType=\"pubmed\">23481689</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L., Aamand R., Guti&#xe9;rrez-Jim&#xe9;nez E., Ho Y. C., Blicher J. U., Madsen S. M., et al. . (2013). The capillary dysfunction hypothesis of Alzheimer&#x2019;s disease. Neurobiol. Aging 34, 1018&#x2013;1031. doi: 10.1016/j.neurobiolaging.2012.09.011</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neurobiolaging.2012.09.011</ArticleId><ArticleId IdType=\"pubmed\">23084084</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L., Jespersen S. N., Engedahl T., Guti&#xe9;rrez Jim&#xe9;nez E., Ashkanian M., Hansen M. B., et al. . (2015). Capillary dysfunction: its detection and causative role in dementias and stroke. Curr. Neurol. Neurosci. Rep. 15:37. doi: 10.1007/s11910-015-0557-x, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11910-015-0557-x</ArticleId><ArticleId IdType=\"pmc\">PMC4441906</ArticleId><ArticleId IdType=\"pubmed\">25956993</ArticleId></ArticleIdList></Reference><Reference><Citation>Paris D., Patel N., DelleDonne A., Quadros A., Smeed R., Mullan M. (2004). Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci. Lett. 366, 80&#x2013;85. doi: 10.1016/j.neulet.2004.05.017, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.neulet.2004.05.017</ArticleId><ArticleId IdType=\"pubmed\">15265595</ArticleId></ArticleIdList></Reference><Reference><Citation>Pigolkin Y. I., Zolotenkova G. V. (2014). Age-specific changes in the cerebral cortex capillaries. Sud. Med. Ekspert. 57, 4&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25275176</ArticleId></ArticleIdList></Reference><Reference><Citation>Popugaeva E., Pchitskaya E., Bezprozvanny I. (2018). Dysregulation of intracellular calcium signaling in Alzheimer&#x2019;s disease. Antioxid. Redox Signal. 29, 1176&#x2013;1188. doi: 10.1089/ars.2018.7506, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/ars.2018.7506</ArticleId><ArticleId IdType=\"pmc\">PMC6157344</ArticleId><ArticleId IdType=\"pubmed\">29890840</ArticleId></ArticleIdList></Reference><Reference><Citation>Riederer B. M., Leuba G., Vernay A., Riederer I. M. (2011). The role of the ubiquitin proteasome system in Alzheimer&#x2019;s disease. Exp. Biol. Med. 236, 268&#x2013;276. doi: 10.1258/ebm.2010.010327</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1258/ebm.2010.010327</ArticleId><ArticleId IdType=\"pubmed\">21383047</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon M., Wang M. X., Ismail O., Braun M., Schindler A. G., Reemmer J., et al. . (2022). Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid &#x3b2; plaque formation in mice. Alzheimers Res. Ther. 14:59. doi: 10.1186/s13195-022-00999-5, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13195-022-00999-5</ArticleId><ArticleId IdType=\"pmc\">PMC9040291</ArticleId><ArticleId IdType=\"pubmed\">35473943</ArticleId></ArticleIdList></Reference><Reference><Citation>Soman S., Raghavan S., Rajesh P. G., Varma R. P., Mohanan N., Ramachandran S. S., et al. . (2021). Relationship between cerebral perfusion on arterial spin labeling (ASL) MRI with brain volumetry and cognitive performance in mild cognitive impairment and dementia due to Alzheimer&#x2019;s disease. Ann. Indian Acad. Neurol. 24, 559&#x2013;565. doi: 10.4103/aian.AIAN_848_20, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4103/aian.AIAN_848_20</ArticleId><ArticleId IdType=\"pmc\">PMC8513975</ArticleId><ArticleId IdType=\"pubmed\">34728951</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Bromley-Brits K., Song W. (2012). Regulation of &#x3b2;-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer&#x2019;s disease. J. Neurochem. 120, 62&#x2013;70. doi: 10.1111/j.1471-4159.2011.07515.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1471-4159.2011.07515.x</ArticleId><ArticleId IdType=\"pubmed\">22122349</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan J., Evin G. (2012). &#x392;-site APP-cleaving enzyme 1 trafficking and Alzheimer&#x2019;s disease pathogenesis. J. Neurochem. 120, 869&#x2013;880. doi: 10.1111/j.1471-4159.2011.07623.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1471-4159.2011.07623.x</ArticleId><ArticleId IdType=\"pubmed\">22171895</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatarnikova O. G., Orlov M. A., Bobkova N. V. (2015). Beta-amyloid and tau-protein: structure, interaction, and prion-like properties. Biochemistry 80, 1800&#x2013;1819. doi: 10.1134/S000629791513012X, PMID:</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1134/S000629791513012X</ArticleId><ArticleId IdType=\"pubmed\">26878581</ArticleId></ArticleIdList></Reference><Reference><Citation>Vorobev S. V., Emelin A. Y., Kuzneczova R. N., Kudryavcev I. V. (2020). The role of the immune response in the pathogenesis of Alzheimer&#x2019;s disease and the possibility of anti-inflammatory therapy. Neurol. Bull. LII, 55&#x2013;62. doi: 10.17816/nb34654</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.17816/nb34654</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>\n",
      "Finished fetching and processing batches.\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import time\n",
    "import xml.etree.ElementTree as ET\n",
    "\n",
    "# Initialize base URL and query parameters\n",
    "query = \"Alzheimer's disease\"\n",
    "base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "api_key = \"14360a5489f9c6515569fae147b5295a3608\"  # Replace with your actual API key\n",
    "batch_size = 100\n",
    "total_articles_to_fetch = 5000  # Total number of articles you aim to fetch\n",
    "\n",
    "# Function to fetch IDs of articles matching the query\n",
    "def fetch_article_ids(query, total_articles_to_fetch, batch_size):\n",
    "    search_url = f\"{base_url}esearch.fcgi\"\n",
    "    params = {\n",
    "        \"db\": \"pubmed\",\n",
    "        \"term\": query,\n",
    "        \"retmode\": \"json\",\n",
    "        \"retmax\": total_articles_to_fetch,\n",
    "        \"api_key\": api_key\n",
    "    }\n",
    "    response = requests.get(search_url, params=params)\n",
    "    if response.status_code == 200:\n",
    "        data = response.json()\n",
    "        article_ids = data[\"esearchresult\"][\"idlist\"]\n",
    "        return article_ids[:total_articles_to_fetch]  # Return only the number of IDs we aim to process\n",
    "    else:\n",
    "        print(\"Failed to fetch article IDs:\", response.status_code)\n",
    "        return []\n",
    "\n",
    "# Function to fetch details for a batch of articles\n",
    "def fetch_batch_details(article_ids):\n",
    "    fetch_url = f\"{base_url}efetch.fcgi\"\n",
    "    ids_string = \",\".join(article_ids)\n",
    "    params = {\n",
    "        \"db\": \"pubmed\",\n",
    "        \"retmode\": \"xml\",\n",
    "        \"id\": ids_string,\n",
    "        \"api_key\": api_key\n",
    "    }\n",
    "    response = requests.get(fetch_url, params=params)\n",
    "    if response.status_code == 200:\n",
    "        return response.text\n",
    "    else:\n",
    "        print(\"Failed to fetch article details for batch:\", response.status_code)\n",
    "        return None\n",
    "\n",
    "# Main process\n",
    "article_ids = fetch_article_ids(query, total_articles_to_fetch, batch_size)\n",
    "\n",
    "for i in range(0, len(article_ids), batch_size):\n",
    "    batch_ids = article_ids[i:i+batch_size]\n",
    "    print(f\"Fetching batch {i//batch_size + 1}/{len(article_ids)//batch_size + 1}\")\n",
    "    batch_details = fetch_batch_details(batch_ids)\n",
    "    # Here, you would process the batch_details, e.g., parsing XML and extracting needed info\n",
    "    # For demonstration, let's just print a confirmation\n",
    "    print(f\"Batch {i//batch_size + 1} fetched and processed.\")\n",
    "    print(batch_details)\n",
    "    break\n",
    "    # Respectful pause to avoid overloading the server\n",
    "    time.sleep(1)  # Pause for 1 second; adjust as needed based on PubMed's guidelines\n",
    "\n",
    "print(\"Finished fetching and processing batches.\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Using the ID's we get data in batches. batch_size = 10, max_articles = 50 \n",
    "\n",
    "we can change this according to our need. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Title: Development and Evaluation of a Clinician-Vetted Dementia Caregiver Resources Website: Mixed Methods Approach.\n",
      "Abstract: About 11 million Americans are caregivers for the 6.7 million Americans currently living with dementia. They provide over 18 billion hours of unpaid care per year, yet most have no formal dementia education or support. It is extremely difficult for clinicians to keep up with the demand for caregiver education, especially as dementia is neurodegenerative in nature, requiring different information at different stages of the disease process. In this digital age, caregivers often seek dementia information on the internet, but clinicians lack a single, reliable compendium of expert-approved digital resources to provide to dementia caregivers.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Neuroimaging-guided diagnosis of possible FTLD-FUS pathology: a case report.\n",
      "Abstract: This case report presents a patient with progressive memory loss and choreiform movements.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer's disease.\n",
      "Abstract: Alzheimer's disease (AD) is a complex neurological disorder and no effective drug is available for its treatment. Numerous pathological conditions are believed to be responsible for the initiation and development of AD including c-Jun N-terminal kinases (JNKs). The JNKs are one of the enzymes from the mitogen-activated protein kinase (MAPK) family that controls the phosphorylation of various transcription factors on serine and threonine residues, and hold significant responsibilities in tasks like gene expression, cell proliferation, differentiation, and apoptosis. Since, JNK3 is primarily expressed in the brain hence its increased levels in the brain are associated with the AD pathology promoting neurofibrillary tangles, senile plaques, neuroinflammation, and nerve cell apoptosis. The current research work is focused on the development of novel JNK inhibitors as therapeutics for AD employing a structure-based virtual screening (SBVS) approach. The ZINC database (14634052 compounds) was investigated after employing pan assay interference (PAINs), drug-likeness, and diversity picking filter to distinguish molecules interacting with JNK3 by following three docking precision criteria: High Throughput Virtual Screening (HTVS), Standard Precision (SP), and Extra Precision (XP) & MMGBSA. Five lead molecules showed a better docking score in the range of -13.091 to -14.051 kcal/mol better than the reference compound (- 11.828 kcal/mol). The lead compounds displayed acceptable pharmacokinetic properties and were subjected to molecular dynamic simulations of 100 ns and binding free energy calculations. All the lead molecules showed stable RMSD and hydrogen bond interactions throughout the trajectory. The ∆G\n",
      "---------------------------------------------------------------------------\n",
      "Title: [Cortico-basal syndrome and cortico-basal degeneration: From the clinical diagnosis to the lesional substrate for an adapted care].\n",
      "Abstract: Cortico-basal degeneration is a relatively uncommon cause of degenerative parkinsonism in the elderly. From a clinical point of view, it manifests as a cortico-basal syndrome (CBS), featuring a highly asymmetrical akinetic-rigid syndrome, dystonia, myoclonus and cognitive-behavioral impairment with predominant apraxia. Other clinical phenotypes are possible, including variants with mainly language or behavioral impairment, or with axial, symmetrical parkinsonism resembling progressive supranuclear palsy (PSP). Current diagnostic criteria take into account the heterogeneity of clinical presentations. However, a diagnosis of certainty can only be reached by a pathological study, with the evidence of TAU-positive intraneuronal inclusions. Indeed SCB may be underpinned by other lesional substrates, ranging from frontotemporal degeneration to Alzheimer's disease. Symptom management must be early, multidisciplinary and adapted to the progression of the disorder. The identification of the pathological substrate is an essential prerequisite for pathophysiological therapeutic trials.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Deep brain stimulation for Alzheimer's disease - current status and next steps.\n",
      "Abstract: Alzheimer's disease (AD) requires novel therapeutic approaches due to limited efficacy of current treatments.\n",
      "---------------------------------------------------------------------------\n",
      "Title: The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs.\n",
      "Abstract: At present, increasing reports from different aspects indicated that cholinesterase inhibitors (ChEIs) may be effective on improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease (AD). However, no studies comprehensively and detailedly evaluated the effect of ChEIs on AD. The present analysis was designed to comprehensively evaluate the efficacy and safety of ChEIs for AD.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Chemistry, Biological Activities, and Pharmacological Properties of Gastrodin:  Mechanism insights.\n",
      "Abstract: Gastrodin, a bioactive compound derived from the rhizome of the orchid Gastrodia elata, exhibits a diverse range of biological activities. With documented neuroprotective, anti-inflammatory, antioxidant, anti-apoptotic, and anti-tumor effects, gastrodin stands out as a multifaceted therapeutic agent. Notably, it has demonstrated efficacy in protecting against neuronal damage and enhancing cognitive function in animal models of Alzheimer's disease, Parkinson's disease, and cerebral ischemia. Additionally, gastrodin showcases immunomodulatory effects by mitigating inflammation and suppressing the expression of inflammatory cytokines. Its cytotoxic activity involves the inhibition of angiogenesis, suppression of tumor growth, and induction of apoptosis. This comprehensive review seeks to elucidate the myriad potential effects of Gastrodin, delving into the intricate molecular mechanisms underpinning its pharmacological properties. The findings underscore the therapeutic potential of gastrodin in addressing various conditions linked to neuroinflammation and cancer.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Sex-specific associations between AD genotype and the microbiome of human amyloid beta knock-in (hAβ-KI) mice.\n",
      "Abstract: Emerging evidence links changes in the gut microbiome to late-onset Alzheimer's disease (LOAD), necessitating examination of AD mouse models with consideration of the microbiome.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Automatic classification of AD pathology in FTD phenotypes using natural speech.\n",
      "Abstract: Screening for Alzheimer's disease neuropathologic change (ADNC) in individuals with atypical presentations is challenging but essential for clinical management. We trained automatic speech-based classifiers to distinguish frontotemporal dementia (FTD) patients with ADNC from those with frontotemporal lobar degeneration (FTLD).\n",
      "---------------------------------------------------------------------------\n",
      "Title: Making sense of dementia: Older adults' subjective representations of dementia and Alzheimer's disease.\n",
      "Abstract: This research explores how the representations and meanings of living with dementia are constructed by older adults.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Trichostatin A relieves anxiety-and depression-like symptoms in APP/PS1 mice.\n",
      "Abstract: Cognitive deficits and behavioral disorders such as anxiety and depression are common manifestations of Alzheimer's disease (AD). Our previous work demonstrated that Trichostatin A (TSA) could alleviate neuroinflammatory plaques and improve cognitive disorders. AD, anxiety, and depression are all associated with microglial inflammation. However, whether TSA could attenuate anxiety- and depression-like behaviors in APP/PS1 mice through anti-inflammatory signaling is still unclearly.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Sex-specific changes in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer's disease.\n",
      "Abstract: Membrane transporters playing an important role in the passage of drugs, metabolites and nutrients across the membranes of the brain cells have been shown to be involved in pathogenesis of Alzheimer's disease (AD). However, little is known about sex-specific changes in transporter protein expression at the brain in AD. Here, we investigated sex-specific alterations in protein expression of three ATP-binding cassette (ABC) and five solute carriers (SLC) transporters in the prefrontal cortex of a commonly used model of familial AD (FAD), 5xFAD mice. Sensitive liquid chromatography tandem mass spectrometry-based quantitative targeted absolute proteomic analysis was applied for absolute quantification of transporter protein expression. We compared the changes in transporter protein expressions in 7-month-old male and female 5xFAD mice versus sex-matched wild-type mice. The study revealed a significant sex-specific increase in protein expression of ABCC1 (\n",
      "---------------------------------------------------------------------------\n",
      "Title: Development of the Longitudinal Study of Health and Ageing in Kenya (LOSHAK).\n",
      "Abstract: In Kenya, the number of adults aged ≥60 is expected to nearly quadruple by 2050, making it one of the most rapidly aging countries in Sub-Saharan Africa (SSA). Accordingly, we designed the Longitudinal Study of Health and Ageing in Kenya (LOSHAK) to generate novel data to address the health and economic consequences of this demographic transition. Specifically, LOSHAK will investigate the social, economic, environmental, biological, and policy processes that shape late-life health and economic well-being in Kenya. Modeled on the U.S. Health and Retirement Study (HRS), LOSHAK joins a network of harmonized studies on aging in >45 countries worldwide; however, LOSHAK will be only the 2nd such study in SSA. The current feasibility and pilot phase of LOSHAK will validate measures and data collection procedures in a purposive sample of Kenyan adults aged ≥45 years. We have linguistically and culturally translated instruments while aiming to maintain harmonization with both existing HRS network studies and the ongoing Kenya Life Panel Survey. The current phase of LOSHAK is nested within the Kaloleni/Rabai Community Health and Demographic Surveillance System on the coast of Kenya. LOSHAK will advance population aging research in low- and middle-income countries through the study of (a) \n",
      "---------------------------------------------------------------------------\n",
      "Title: Micro-RNA profiles of pathology and resilience in posterior cingulate cortex of cognitively intact elders.\n",
      "Abstract: The posterior cingulate cortex (PCC) is a key hub of the default mode network underlying autobiographical memory retrieval, which falters early in the progression of Alzheimer's disease (AD). We recently performed RNA sequencing of post-mortem PCC tissue samples from 26 elderly Rush Religious Orders Study participants who came to autopsy with an ante-mortem diagnosis of no cognitive impairment but who collectively displayed a range of Braak I-IV neurofibrillary tangle stages. Notably, cognitively unimpaired subjects displaying high Braak stages may represent cognitive resilience to AD pathology. Transcriptomic data revealed elevated synaptic and ATP-related gene expression in Braak Stages III/IV compared with Stages I/II, suggesting these pathways may be related to PCC resilience. We also mined expression profiles for small non-coding micro-RNAs (miRNAs), which regulate mRNA stability and may represent an underexplored potential mechanism of resilience through the fine-tuning of gene expression within complex cellular networks. Twelve miRNAs were identified as differentially expressed between Braak Stages I/II and III/IV. However, the extent to which the levels of all identified miRNAs were associated with subject demographics, neuropsychological test performance and/or neuropathological diagnostic criteria within this cohort was not explored. Here, we report that a total of 667 miRNAs are significantly associated (rho > 0.38, \n",
      "---------------------------------------------------------------------------\n",
      "Title: How Do Retinoids Affect Alzheimer's Disease and Can They Be Novel Drug Candidates?\n",
      "Abstract: Alzheimer's disease is a chronic, neurological condition that faces many challenges in its management and therapy nowadays highlighting the importance and urgent need of researching new ways of approaching this disease. Retinoic acid and its derivatives, collectively known as the retinoids, are considered promising agents that have disease-modifying properties in affecting Alzheimer's disease. This thesis aims to address the research questions of what the role of retinoids is in Alzheimer's disease, and whether they can be used as a novel drug candidate for treating this condition. Retinoids' properties and agonistic actions on the nuclear receptors retinoic acid receptor (RAR) and retinoic X receptor (RXR) affect various pathways as well as their underlying genetic factors that compose important pathophysiological hallmarks causing the progression of Alzheimer's disease as amyloid β (Aβ) production and deposition, neurofibrillary tangle (NFT) formation and phosphorylation, and inflammatory and autoimmune responses. Retinoic acid inhibits the amplification of these pathways and modifies the disease progression in animal models, proposing a solid basis for human trials. Hence, investigating retinoids as pharmacological agents in human trials has been conducted, and several synthetic analogues have been developed to address issues concerning retinoic acid's instability and short half-life, as well as adverse drug reactions. The most prominent of these analogues is tamibarotene, a stable retinoic acid derivative with a higher half-life, higher specificity to target receptors, and fewer adverse reactions. A number of criteria that explain what a novel drug candidate should have when managing Alzheimer's disease have been formulated, and which also explain why most novel drug candidates other than retinoic acid have failed in achieving clinical results. Most of these candidates share one common trait which is a single-target approach in targeting disease pathways. This means that when administering these agents, their actions are to target a single disease-causing pathway at a time but do not affect other pathways. On the other hand, tamibarotene is a novel drug candidate that targets a range of pathways at once and provides a more comprehensive approach in its pharmacological actions.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Repetitive transcranial magnetic stimulation for Alzheimer's disease: an overview of systematic reviews and meta-analysis.\n",
      "Abstract: Alzheimer's disease (AD) is a prevalent neurodegenerative condition that significantly impacts both individuals and society. This study aims to evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a treatment for AD by summarizing the evidence from systematic reviews (SRs) and meta-analyses (MAs).\n",
      "---------------------------------------------------------------------------\n",
      "Title: β-amyloid accumulation enhances microtubule associated protein tau pathology in an APP\n",
      "Abstract: The study of the pathophysiology study of Alzheimer's disease (AD) has been hampered by lack animal models that recapitulate the major AD pathologies, including extracellular -amyloid (A) deposition, intracellular aggregation of microtubule associated protein tau (MAPT), inflammation and neurodegeneration.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Fish - a scoping review for Nordic Nutrition Recommendations 2023.\n",
      "Abstract: The aim of this scoping review was to conduct evidence-based documentation between fish intake and health outcomes for food-based dietary guidelines (FBDGs) in the Nordic Nutrition Recommendations (NNR) 2023. For most health outcomes, the evidence for fish oil and n-3 long chain (LC) polyunsaturated fatty acids (PUFA) supplementation was included when examining evidence between fish intake and health. In this review, conclusions from qualified systematic reviews (qSR) approved by NNR2023 are included. In addition, conclusions of a \n",
      "---------------------------------------------------------------------------\n",
      "Title: None\n",
      "Abstract: A patient with the \n",
      "---------------------------------------------------------------------------\n",
      "Title: Comparing survival rates and mortality in operative versus nonoperative treatment for femoral neck fractures among Alzheimer's disease patients: A retrospective cohort study.\n",
      "Abstract: Addressing femoral neck fractures resulting from ground-level falls in older adults with Alzheimer's disease (AD) involves a personalized treatment plan. There is considerable ongoing debate concerning the relative advantages and disadvantages of surgical treatment (internal fixation or arthroplasty) vs nonoperative treatment for femoral neck fractures in older persons with AD.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Virgin coconut oil - its methods of extraction, properties and clinical usage: a review.\n",
      "Abstract: Virgin coconut oil (VCO) is a processed edible oil, which is removed from the mature coconuts. It is a colourless water insoluble liquid and obtained by the hot and cold extraction processes. The nutritional components of VCO are mainly contributed to by lauric acid, its primary content. VCO has shown its anticancer, antimicrobial, analgesic, antipyretic and antiinflammatory properties. Because of these medicinal properties, VCO has gained the wider attention among the medical field. Most evidently VCO has shown its potential antioxidant property, because of its phenolic compounds and medium chain fatty acids. It is one of the beneficial compounds used to prevent and treat the oxidative stress induced neurological disorders like stress, depression and Alzheimer's disease. Dietary supplementation of VCO is easy and economical and safer in daily life among all age groups. It is also beneficial for the cardiovascular, respiratory, dermatological, reproductive and bone health. It can also be applied to the skin as a moisturizer in the paediatric age group. Hence, exploration of antioxidant property as well as other beneficial effects of VCO in various health conditions will be valuable.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Human in vivo evidence of associations between herpes simplex virus and cerebral amyloid-beta load in normal aging.\n",
      "Abstract: Mounting data suggests that herpes simplex virus type 1 (HSV-1) is involved in the pathogenesis of AD, possibly instigating amyloid-beta (Aβ) accumulation decades before the onset of clinical symptoms. However, human in vivo evidence linking HSV-1 infection to AD pathology is lacking in normal aging, which may contribute to the elucidation of the role of HSV-1 infection as a potential AD risk factor.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer's disease and vascular dementia in a prospective study.\n",
      "Abstract: It is of interest whether inflammatory biomarkers can improve dementia prediction models, such as the widely used Cardiovascular Risk Factors, Aging and Dementia (CAIDE) model.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Cerebrospinal fluid amyloid-β and cerebral microbleed are associated with distinct neuropsychiatric sub-syndromes in cognitively impaired patients.\n",
      "Abstract: Neuropsychiatric symptoms (NPS) are prevalent in cognitively impaired individuals including Alzheimer's disease (AD) dementia and mild cognitive impairment (MCI). Whereas several studies have reported the associations between NPS with AD pathologic biomarkers and cerebral small vessel disease (SVD), but it remains unknown whether AD pathology and SVD contribute to different sub-syndromes independently or aggravate same symptoms synergistically.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Influences of amyloid-β and tau on white matter neurite alterations in dementia with Lewy bodies.\n",
      "Abstract: Dementia with Lewy bodies (DLB) is a neurodegenerative condition often co-occurring with Alzheimer's disease (AD) pathology. Characterizing white matter tissue microstructure using Neurite Orientation Dispersion and Density Imaging (NODDI) may help elucidate the biological underpinnings of white matter injury in individuals with DLB. In this study, diffusion tensor imaging (DTI) and NODDI metrics were compared in 45 patients within the dementia with Lewy bodies spectrum (mild cognitive impairment with Lewy bodies (n = 13) and probable dementia with Lewy bodies (n = 32)) against 45 matched controls using conditional logistic models. We evaluated the associations of tau and amyloid-β with DTI and NODDI parameters and examined the correlations of AD-related white matter injury with Clinical Dementia Rating (CDR). Structural equation models (SEM) explored relationships among age, APOE ε4, amyloid-β, tau, and white matter injury. The DLB spectrum group exhibited widespread white matter abnormalities, including reduced fractional anisotropy, increased mean diffusivity, and decreased neurite density index. Tau was significantly associated with limbic and temporal white matter injury, which was, in turn, associated with worse CDR. SEM revealed that amyloid-β exerted indirect effects on white matter injury through tau. We observed widespread disruptions in white matter tracts in DLB that were not attributed to AD pathologies, likely due to α-synuclein-related injury. However, a fraction of the white matter injury could be attributed to AD pathology. Our findings underscore the impact of AD pathology on white matter integrity in DLB and highlight the utility of NODDI in elucidating the biological basis of white matter injury in DLB.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway.\n",
      "Abstract: The biological substrate of persistent post-COVID-19 hyposmia is still unclear. However, as many neurodegenerative diseases present with smell impairment at onset, it may theoretically reflect degeneration within the central olfactory circuits. However, no data still exist regarding the post-COVID-19 patients. As the olfactory neurons (ONs) mirror pathological changes in the brain, allowing for tracking the underlying molecular events, here, we performed a broad analysis of ONs from patients with persistent post-COVID-19 OD to identify traces of potential neurodegeneration. ONs were collected through the non-invasive brushing of the olfactory mucosa from ten patients with persistent post-COVID-19 hyposmia (lasting > 6 months after infection) and ten age/sex-matched controls. Immunofluorescence staining for protein quantification and RT-PCR for gene expression levels were combined to measure ONs markers of α-synuclein, amyloid-β, and tau pathology, axonal injury, and mitochondrial network. Patients and controls had similar ONs levels of oligomeric α-synuclein, amyloid-β peptide, tau protein, neurofilament light chain (NfL), cytochrome C oxidase subunit 3 (COX3), and the heat shock protein 60 (HSP60). Our findings thus did not provide evidence for synucleinopathy and amyloid-β mismetabolism or gross traces of neuronal injury and mitochondrial dysfunction within the olfactory system in the early phase of persistent post-COVID-19 hyposmia.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions.\n",
      "Abstract: Neurodegenerative disorders are devastating disorders characterized by gradual loss of neurons and cognition or mobility impairment. The common pathological features of these diseases are associated with the accumulation of misfolded or aggregation of proteins. The pivotal roles of autophagy and proteostasis in maintaining cellular health and preventing the accumulation of misfolded proteins, which are associated with neurodegenerative diseases like Huntington's disease (HD), Alzheimer's disease (AD), and Parkinson's disease (PD). This article presents an in-depth examination of the interplay between autophagy and proteostasis, highlighting how these processes cooperatively contribute to cellular homeostasis and prevent pathogenic protein aggregate accumulation. Furthermore, the review emphasises the potential therapeutic implications of targeting autophagy and proteostasis to mitigate neurodegenerative diseases. While advancements in research hold promise for developing novel treatments, the article also addresses the challenges and complexities associated with modulating these intricate cellular pathways. Ultimately, advancing understanding of the underlying mechanism of autophagy and proteostasis in neurodegenerative disorders provides valuable insights into potential therapeutic avenues and future research directions.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer's disease.\n",
      "Abstract: Alzherimer's disease (AD) is an age-dependent ubiquitous ailment worldwide with limited therapies that only alleviate the symptoms of AD but do not cure them entirely because of the restricted blood-brain barrier passage of the drug. Hence with new advanced technology, nanoparticles can offer an opportunity as the active candidate to overcome the above limitations. Aurothioglucose, a synthetic glucose derivative of the gold compound, has been clinically proven to be an effective anti-inflammatory drug for rheumatic arthritis. Recently, several scientific groups have developed gold nanoparticle preparations and tested them for the treatment of dementia. This study was planned to prepare the PLGA nanoparticles of aurothioglucose (ATG) and check the neuroprotective potential against STZ-induced AD in rats. The nanoparticles were prepared using the double emulsion solvent evaporation method and characterized for various parameters such as drug-excipient interaction, particle size, zeta potential, and morphology. Then, rats were injected STZ (3 mg/kg/i.c.v., days 1 and 3) and ATG (5 and 10 mg/kg/s.c.), ATG NPs (2.5 and 5 mg/kg/s.c.) and donepezil (2 mg/kg/p.o) from 15th to 29th day. Behavior parameters were performed using an actophotometer, MWM, and ORT. On the 30th day, all the animals were sacrificed, and the brains were isolated for estimating biochemical, neurochemical, and proinflammatory markers. It was observed that ATG NPs significantly restored all behavior and neurotransmitter alterations caused by STZ. Also, it increased antioxidant levels and decreased inflammatory cytokines significantly, then ATG alone. Thus, the study suggests that ATG loaded PLGA NPs could be used as a novel therapeutic strategy to slow the process of AD.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Memory Circuits in Dementia: The Engram, Hippocampal Neurogenesis and Alzheimer's disease.\n",
      "Abstract: Here, we provide an in-depth consideration of our current understanding of engrams, spanning from molecular to network levels, and hippocampal neurogenesis, in health and Alzheimer's disease (AD). This review highlights novel findings in these emerging research fields and future research directions for novel therapeutic avenues for memory failure in dementia. Engrams, memory in AD, and hippocampal neurogenesis have each been extensively studied. The integration of these topics, however, has been relatively less deliberated, and is the focus of this review. We primarily focus on the dentate gyrus (DG) of the hippocampus, which is a key area of episodic memory formation. Episodic memory is significantly impaired in AD, and is also the site of adult hippocampal neurogenesis. Advancements in technology, especially opto- and chemogenetics, have made sophisticated manipulations of engram cells possible. Furthermore, innovative methods have emerged for monitoring neurons, even specific neuronal populations, in vivo while animals engage in tasks, such as calcium imaging. In vivo calcium imaging contributes to a more comprehensive understanding of engram cells. Critically, studies of the engram in the DG using these technologies have shown the important contribution of hippocampal neurogenesis for memory in both health and AD. Together, the discussion of these topics provides a holistic perspective that motivates questions for future research.\n",
      "---------------------------------------------------------------------------\n",
      "Title: The Beta secretase BACE1 drives fibroblasts activation in Systemic Sclerosis through the APP/β-catenin/Notch signalling axis.\n",
      "Abstract: The beta-amyloid precursor protein cleaving enzyme 1 (BACE1) is well known for its role in the development of Alzheimer's disease. Recent publications, including our own, have demonstrated a role for this enzyme in other chronic diseases. The aim of this study was to investigate the role of BACE1 in the autoimmune disease systemic sclerosis (SSc). BACE1 protein levels were elevated in SSc patient skin. Inhibition of BACE1 with small molecule inhibitors or siRNA blocked SSc and fibrotic stimuli mediated fibroblast activation. Furthermore, we show that BACE1 regulation of dermal fibroblast activation is dependent on β-catenin and Notch signalling. The Neurotropic factor BDNF negatively regulates BACE1 expression and activity in dermal fibroblasts. Finally, sera from SSc patients show higher Aβ and lower BDNF levels compared to healthy controls. The ability of BACE1 to regulate SSc fibroblast activation reveals a therapeutic target in SSc. Several BACE1 inhibitors have been shown to be safe in clinical trials for Alzheimer's disease and could be repurposed to ameliorate fibrosis progression.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Peripheral hearing loss at age 70 predicts brain atrophy and associated cognitive change.\n",
      "Abstract: Hearing loss has been proposed as a modifiable risk factor for dementia. However, the relationship between hearing, neurodegeneration, and cognitive change, and the extent to which pathological processes such as Alzheimer's disease and cerebrovascular disease influence these relationships, is unclear.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Supplements for cognitive ability in patients with mild cognitive impairment or Alzheimer's disease: a protocol for systematic review and network meta-analysis of randomised controlled trials.\n",
      "Abstract: Considering the increasing incidence of Alzheimer's disease (AD) and mild cognitive impairment (MCI) worldwide, there is an urgent need to identify efficacious, safe and convenient treatments. Numerous investigations have been conducted on the use of supplements in this domain, with oral supplementation emerging as a viable therapeutic approach for AD or MCI. Nevertheless, given the multitude of available supplements, it becomes imperative to identify the optimal treatment regimen.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Long-term exposure to major constituents of fine particulate matter and neurodegenerative diseases: A population-based survey in the Pearl River Delta Region, China.\n",
      "Abstract: Exposure to PM\n",
      "---------------------------------------------------------------------------\n",
      "Title: Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.\n",
      "Abstract: Recently, glycogen synthase kinase-3β (GSK-3β) has been considered as a critical factor implicated in Alzheimer's disease (AD). In a previous work, a 3D pharmacophore model for GSK-3β inhibitors was created and the results suggested that derivative ZINC67773573, VIII, may provide a promising lead for developing novel GSK-3β inhibitors for the AD's treatment. Consequently, in this work, novel series of quinolin-2-one derivatives were synthesized and assessed for their GSK-3β inhibitory properties. In vitro screening identified three compounds: 7c, 7e and 7f as promising GSK-3β inhibitors. Compounds 7c, 7e and 7f were found to exhibit superior inhibitory effect on GSK-3β with IC\n",
      "---------------------------------------------------------------------------\n",
      "Title: Gegen Qinlian tablets delay Alzheimer's disease progression via inhibiting glial neuroinflammation and remodeling gut microbiota homeostasis.\n",
      "Abstract: Current therapeutic agents for AD have limited efficacy and often induce undesirable side effects. Gegen Qinlian tablets (GGQLT) are a well-known clearingheat formula used in clinical treatment of inflammatory diseases. Based on traditional Chinese medicine (TCM) theory, the strategy of clearing-heat is then compatible with the treatment of AD. However, it remains unknown whether GGQLT can exert neuroprotective effects and alleviate neuroinflammation in AD.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Associations Between Age at Menopause, Vascular Risk, and 3-Year Cognitive Change in the Canadian Longitudinal Study on Aging.\n",
      "Abstract: Mounting evidence supports sex differences in Alzheimer disease (AD) risk. Vascular and hormonal factors may together contribute to AD risk in female adults. We investigated whether age at menopause, vascular risk, and history of hormone therapy (HT) containing estrogens together influence cognition over a 3-year follow-up period. We hypothesized that earlier menopause and elevated vascular risk would have a synergistic association with lower cognitive scores at follow-up and that HT containing estrogens would attenuate this synergistic association to preserve cognition.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Dementia-Related Disparities in Adult Day Centers: Results of a Bivariate Analysis.\n",
      "Abstract: Adult day services (ADS) are a valuable resource for people living with Alzheimer's disease and Alzheimer's disease and related dementias (AD/ADRD) and serve a large population of late-life immigrants, often with limited English proficiency (LEP). This secondary data analysis examined potential disparities in diagnosis, dementia severity, medical complexity, and dementia-related behavioral problems in persons with AD/ADRD with LEP within the ADS setting.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Health Trajectories of Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias: Evidence for Practicing Nurses.\n",
      "Abstract: Older adults with Alzheimer's disease and related dementias (ADRD) are at high risk for acute medical problems and their health trajectories frequently include hospital admission and care in a skilled nursing facility (SNF). Their health trajectories after SNF discharge are poorly understood. Therefore, in the current study, we sought to describe health trajectories and factors associated with hospital read-missions for older adults with ADRD during the 30 days following SNF discharge.\n",
      "---------------------------------------------------------------------------\n",
      "Title: CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly.\n",
      "Abstract: The immune system substantially influences age-related cognitive decline and Alzheimer's disease (AD) progression, affected by genetic and environmental factors. In a Mayo Clinic Study of Aging cohort, we examined how risk factors like APOE genotype, age, and sex affect inflammatory molecules and AD biomarkers in cerebrospinal fluid (CSF). Among cognitively unimpaired individuals over 65 (\n",
      "---------------------------------------------------------------------------\n",
      "Title: Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model.\n",
      "Abstract: Microglia help limit the progression of Alzheimer's disease (AD) by constraining amyloid-β (Aβ) pathology, effected through a balance of activating and inhibitory intracellular signals delivered by distinct cell surface receptors. Human leukocyte Ig-like receptor B4 (LILRB4) is an inhibitory receptor of the immunoglobulin (Ig) superfamily that is expressed on myeloid cells and recognizes apolipoprotein E (ApoE) among other ligands. Here, we find that LILRB4 is highly expressed in the microglia of patients with AD. Using mice that accumulate Aβ and carry a transgene encompassing a portion of the \n",
      "---------------------------------------------------------------------------\n",
      "Title: Precision proteoform design for 4R tau isoform selective templated aggregation.\n",
      "Abstract: Prion-like spread of disease-specific tau conformers is a hallmark of all tauopathies. A 19-residue probe peptide containing a P301L mutation and spanning the R2/R3 splice junction of tau folds and stacks into seeding-competent fibrils and induces aggregation of 4R, but not 3R tau. These tau peptide fibrils propagate aggregated intracellular tau over multiple generations, have a high β-sheet content, a colocalized lipid signal, and adopt a well-defined U-shaped fold found in 4R tauopathy brain-derived fibrils. Fully atomistic replica exchange molecular dynamics (MD) simulations were used to compute the free energy landscapes of the conformational ensemble of the peptide monomers. These identified an aggregation-prohibiting β-hairpin structure and an aggregation-competent U-fold unique to 4R tauopathy fibrils. Guided by MD simulations, we identified that the N-terminal-flanking residues to PHF6, which slightly vary between 4R and 3R isoforms, modulate seeding. Strikingly, when a single amino acid switch at position 305 replaced the serine of 4R tau with a lysine from the corresponding position in the first repeat of 3R tau, the seeding induced by the 19-residue peptide was markedly reduced. Conversely, a 4R tau mimic with three repeats, prepared by replacing those amino acids in the first repeat with those amino acids uniquely present in the second repeat, recovered aggregation when exposed to the 19-residue peptide. These peptide fibrils function as partial prions to recruit naive 4R tau-ten times the length of the peptide-and serve as a critical template for 4R tauopathy propagation. These results hint at opportunities for tau isoform-specific therapeutic interventions.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Directed Evolution and Immobilization of Lactobacillus brevis Alcohol Dehydrogenase for Chemo-enzymatic Synthesis of Rivastigmine.\n",
      "Abstract: Rivastigmine is one of the several pharmaceuticals widely prescribed for the treatment of Alzheimer's disease. However, its practical synthesis still faces many issues, such as the involvement of toxic metals and harsh reaction conditions. Herein, we report a chemo-enzymatic synthesis of Rivastigmine. The key chiral intermediate was synthesized by an engineered alcohol dehydrogenase from Lactobacillus brevis (LbADH). A semi-rational approach was employed to improve its catalytic activity and thermal stability. Several LbADH variants were obtained with a remarkable increase in activity and melting temperature. Exploration of the substrate scope of these variants demonstrated improved activities toward various ketones, especially acetophenone analogs. To further recycle and reuse the biocatalyst, one LbADH variant and glucose dehydrogenase were co-immobilized on nanoparticles. By integrating enzymatic and chemical steps, Rivastigmine was successfully synthesized with an overall yield of 66%. This study offers an efficient chemo-enzymatic route for Rivastigmine and provides several efficient LbADH variants with a broad range of potential applications.\n",
      "---------------------------------------------------------------------------\n",
      "Title: A Multi-modal Classification Method for Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease Using Three Paradigms with Various Task Difficulties.\n",
      "Abstract: Alzheimer's Disease (AD) accounts for the majority of dementia, and Mild Cognitive Impairment (MCI) is the early stage of AD. Early and accurate diagnosis of dementia plays a vital role in more targeted treatments and effectively halting disease progression. However, the clinical diagnosis of dementia requires various examinations, which are expensive and require a high level of expertise from the doctor. In this paper, we proposed a classification method based on multi-modal data including Electroencephalogram (EEG), eye tracking and behavioral data for early diagnosis of AD and MCI. Paradigms with various task difficulties were used to identify different severity of dementia: eye movement task and resting-state EEG tasks were used to detect AD, while eye movement task and delayed match-to-sample task were used to detect MCI. Besides, the effects of different features were compared and suitable EEG channels were selected for the detection. Furthermore, we proposed a data augmentation method to enlarge the dataset, designed an extra ERPNet feature extract layer to extract multi-modal features and used domain-adversarial neural network to improve the performance of MCI diagnosis. We achieved an average accuracy of 88.81% for MCI diagnosis and 100% for AD diagnosis. The results of this paper suggest that our classification method can provide a feasible and affordable way to diagnose dementia.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Deep Self-Reconstruction Fusion Similarity Hashing for the Diagnosis of Alzheimer's Disease on Multi-Modal Data.\n",
      "Abstract: The pathogenesis of Alzheimer's disease (AD) is extremely intricate, which makes AD patients almost incurable. Recent studies have demonstrated that analyzing multi-modal data can offer a comprehensive perspective on the different stages of AD progression, which is beneficial for early diagnosis of AD. In this paper, we propose a deep self-reconstruction fusion similarity hashing (DS-FSH) method to effectively capture the AD-related biomarkers from the multi-modal data and leverage them to diagnose AD. Given that most existing methods ignore the topological structure of the data, a deep self-reconstruction model based on random walk graph regularization is designed to reconstruct the multi-modal data, thereby learning the nonlinear relationship between samples. Additionally, a fused similarity hash based on anchor graph is proposed to generate discriminative binary hash codes for multi-modal reconstructed data. This allows sample fused similarity to be effectively modeled by a fusion similarity matrix based on anchor graph while modal correlation can be approximated by Hamming distance. Especially, extracted features from the multi-modal data are classified using deep sparse autoencoders classifier. Finally, experiments conduct on the AD Neuroimaging Initiative database show that DS-FSH outperforms comparable methods of AD classification. To conclude, DS-FSH identifies multi-modal features closely associated with AD, which are expected to contribute significantly to understanding of the pathogenesis of AD.\n",
      "---------------------------------------------------------------------------\n",
      "Title: pathCLIP: Detection of Genes and Gene Relations from Biological Pathway Figures through Image-Text Contrastive Learning.\n",
      "Abstract: In biomedical literature, biological pathways are commonly described through a combination of images and text. These pathways contain valuable information, including genes and their relationships, which provide insight into biological mechanisms and precision medicine. Curating pathway information across the literature enables the integration of this information to build a comprehensive knowledge base. While some studies have extracted pathway information from images and text independently, they often overlook the correspondence between the two modalities. In this paper, we present a pathway figure curation system named pathCLIP for identifying genes and gene relations from pathway figures. Our key innovation is the use of an image-text contrastive learning model to learn coordinated embeddings of image snippets and text descriptions of genes and gene relations, thereby improving curation. Our validation results, using pathway figures from PubMed, showed that our multimodal model outperforms models using only a single modality. Additionally, our system effectively curates genes and gene relations from multiple literature sources. Two case studies on extracting pathway information from literature of non-small cell lung cancer and Alzheimer's disease further demonstrate the usefulness of our curated pathway information in enhancing related pathways in the KEGG database.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias.\n",
      "Abstract: Reactive astrogliosis accompanies the two neuropathological hallmarks of Alzheimer's disease (AD)-Aβ plaques and neurofibrillary tangles-and parallels neurodegeneration in AD and AD-related dementias (ADRD). Thus, there is growing interest in developing imaging and fluid biomarkers of reactive astrogliosis for AD/ADRD diagnosis and prognostication. Monoamine oxidase-B (MAO-B) is emerging as a target for PET imaging radiotracers of reactive astrogliosis. However, a thorough characterization of MAO-B expression in postmortem control and AD/ADRD brains is lacking. We sought to: (1) identify the primary cell type(s) expressing MAO-B in control and AD brains; (2) quantify MAO-B immunoreactivity in multiple brain regions of control and AD donors as a proxy for PET radiotracer uptake; (3) correlate MAO-B level with local AD neuropathological changes, reactive glia, and cortical atrophy; (4) determine whether the MAOB rs1799836 SNP genotype impacts MAO-B expression level; (5) compare MAO-B immunoreactivity across AD/ADRD, including Lewy body diseases (LBD) and frontotemporal lobar degenerations with tau (FTLD-Tau) and TDP-43 (FTLD-TDP). We found that MAO-B is mainly expressed by subpial and perivascular cortical astrocytes as well as by fibrous white matter astrocytes in control brains, whereas in AD brains, MAO-B is significantly upregulated by both cortical reactive astrocytes and white matter astrocytes across temporal, frontal, and occipital lobes. By contrast, MAO-B expression level was unchanged and lowest in cerebellum. Cortical MAO-B expression was independently associated with cortical atrophy and local measures of reactive astrocytes and microglia, and significantly increased in reactive astrocytes surrounding Thioflavin-S+ dense-core Aβ plaques. MAO-B expression was not affected by the MAOB rs1799836 SNP genotype. MAO-B expression was also significantly increased in the frontal cortex and white matter of donors with corticobasal degeneration, Pick's disease, and FTLD-TDP, but not in LBD or progressive supranuclear palsy. These findings support ongoing efforts to develop MAO-B-based PET radiotracers to image reactive astrogliosis in AD/ADRD.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Exploring Imaging Genetic Markers of Alzheimer's Disease Based on a Novel Nonlinear Correlation Analysis Algorithm.\n",
      "Abstract: Alzheimer's disease (AD) is an irreversible neurological disorder characterized by insidious onset. Identifying potential markers in its emergence and progression is crucial for early diagnosis and treatment. Imaging genetics typically merges genetic variables with multiple imaging parameters, employing various association analysis algorithms to investigate the links between pathological phenotypes and genetic variations, and to unearth molecular-level insights from brain images. However, most existing imaging genetics algorithms based on sparse learning assume a linear relationship between genetic factors and brain functions, limiting their ability to discern complex nonlinear correlation patterns and resulting in reduced accuracy. To address these issues, we propose a novel nonlinear imaging genetic association analysis method, Deep Self-Reconstruction-based Adaptive Sparse Multi-view Deep Generalized Canonical Correlation Analysis (DSR-AdaSMDGCCA). This approach facilitates joint learning of the nonlinear relationships between pathological phenotypes and genetic variations by integrating three different types of data: structural magnetic resonance imaging (sMRI), single-nucleotide polymorphism (SNP), and gene expression data. By incorporating nonlinear transformations in DGCCA, our model effectively uncovers nonlinear associations across multiple data types. Additionally, the DSR algorithm clusters samples with identical labels, incorporating label information into the nonlinear feature extraction process and thus enhancing the performance of association analysis. The application of the DSR-AdaSMDGCCA algorithm on real data sets identified several AD risk regions (such as the hippocampus, parahippocampus, and fusiform gyrus) and risk genes (including VSIG4, NEDD4L, and PINK1), achieving maximum classification accuracy with the fewest selected features compared to baseline algorithms. Molecular biology enrichment analysis revealed that the pathways enriched by these top genes are intimately linked to AD progression, affirming that our algorithm not only improves correlation analysis performance but also identifies biologically significant markers.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential.\n",
      "Abstract: Neurodegeneration, which manifests as several chronic and incurable diseases, is an age-related condition that affects the central nervous system (CNS) and poses a significant threat to the public's health for the elderly. Recent decades have experienced an alarming increase in the incidence of neurodegenerative disorders (NDDs), a severe public health issue due to the ongoing development of people living in modern civilizations. Alzheimer's disease (AD) is a leading trigger of age-related dementia. Currently, there are no efficient therapeutics to delay, stop, or reverse the disease's course development. Several studies found that dietary bioactive phytochemicals, primarily flavonoids, influence the pathophysiological processes underlying AD. Flavonoids work well as a supplement to manufactured therapies for NDDs. Flavonoids are effective in complementing synthetic approaches to treat NDDs. They are biologically active phytochemicals with promising pharmacological activities, for instance, antiviral, anti-allergic, antiplatelet, anti-inflammatory, antitumor, anti-apoptotic, and antioxidant effects. The production of nitric oxide (NO), tumor necrosis factor (TNF-α), and oxidative stress (OS) are downregulated by flavonoids, which slow the course of AD. Hence, this research turned from preclinical evidence to feasible clinical applications to develop newer therapeutics, focusing on the therapeutic potential of flavonoids against AD.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Dysregulated AEBP1 and COLEC12 Genes in Late-Onset Alzheimer's Disease: Insights from Brain Cortex and Peripheral Blood Analysis.\n",
      "Abstract: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory and cognitive impairment, often accompanied by alterations in mood, confusion, and, ultimately, a state of acute mental disturbance. The cerebral cortex is considered a promising area for investigating the underlying causes of AD by analyzing transcriptional patterns, which could be complemented by investigating blood samples obtained from patients. We analyzed the RNA expression profiles of three distinct areas of the brain cortex, including the frontal cortex (FC), temporal cortex (TC), and entorhinal cortex (EC) in patients with AD. Functional enrichment analysis was performed on the differentially expressed genes (DEGs) across the three regions. The two genes with the most significant expression changes in the EC region were selected for assessing mRNA expression levels in the peripheral blood of late-onset AD patients using quantitative PCR (qPCR). We identified eight shared DEGs in these regions, including AEBP1 and COLEC12, which exhibited prominent changes in expression. Functional enrichment analysis uncovered a significant association of these DEGs with the transforming growth factor-β (TGF-β) signaling pathway and processes related to angiogenesis. Importantly, we established a robust connection between the up-regulation of AEBP1 and COLEC12 in both the brain and peripheral blood. Furthermore, we have demonstrated the potential of AEBP1 and COLEC12 genes as effective diagnostic tools for distinguishing between late-onset AD patients and healthy controls. This study unveils the intricate interplay between AEBP1 and COLEC12 in AD and underscores their potential as markers for disease detection and monitoring.\n",
      "---------------------------------------------------------------------------\n",
      "Title: Effects of a Person's Lactation History on Later-Life Development of Alzheimer's Disease: An Integrative Review.\n",
      "Abstract: None\n",
      "---------------------------------------------------------------------------\n",
      "Finished processing all articles.\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import xml.etree.ElementTree as ET\n",
    "import time\n",
    "\n",
    "def search_article_ids(query, api_key, max_articles):\n",
    "    \"\"\"\n",
    "    Search articles matching the query and return their IDs.\n",
    "    \"\"\"\n",
    "    search_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi\"\n",
    "    params = {\n",
    "        \"db\": \"pubmed\",\n",
    "        \"term\": query,\n",
    "        \"retmode\": \"json\",\n",
    "        \"api_key\": api_key,\n",
    "        \"retmax\": max_articles\n",
    "    }\n",
    "    response = requests.get(search_url, params=params)\n",
    "    if response.status_code == 200:\n",
    "        data = response.json()\n",
    "        article_ids = data[\"esearchresult\"][\"idlist\"]\n",
    "        return article_ids\n",
    "    else:\n",
    "        print(\"Failed to search article IDs:\", response.status_code)\n",
    "        return []\n",
    "\n",
    "def fetch_batch_details(article_ids, api_key):\n",
    "    \"\"\"\n",
    "    Fetch details for a batch of article IDs.\n",
    "    \"\"\"\n",
    "    fetch_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi\"\n",
    "    params = {\n",
    "        \"db\": \"pubmed\",\n",
    "        \"retmode\": \"xml\",\n",
    "        \"id\": \",\".join(article_ids),\n",
    "        \"api_key\": api_key\n",
    "    }\n",
    "    response = requests.get(fetch_url, params=params)\n",
    "    if response.status_code == 200:\n",
    "        return response.text\n",
    "    else:\n",
    "        print(f\"Failed to fetch article details: {response.status_code}\")\n",
    "        return None\n",
    "\n",
    "def parse_and_print_article_details(xml_data):\n",
    "    \"\"\"\n",
    "    Parse and print article titles and abstracts from XML data.\n",
    "    \"\"\"\n",
    "    root = ET.fromstring(xml_data)\n",
    "    for article in root.findall('.//PubmedArticle'):\n",
    "        title = article.find('.//ArticleTitle').text\n",
    "        abstract = article.find('.//Abstract/AbstractText')\n",
    "        abstract_text = abstract.text if abstract is not None else \"Abstract not available\"\n",
    "        \n",
    "        print(f\"Title: {title}\\nAbstract: {abstract_text}\")\n",
    "        print(\"-\" * 75)\n",
    "\n",
    "api_key = \"\"  # Replace with your actual API key\n",
    "query = \"Alzheimer's disease\"\n",
    "max_articles = 50  # Adjust based on how many articles you want to process\n",
    "\n",
    "# Step 1: Search for articles and get their IDs\n",
    "article_ids = search_article_ids(query, api_key, max_articles)\n",
    "\n",
    "# Step 2: Fetch and print details in batches\n",
    "batch_size = 10\n",
    "for i in range(0, len(article_ids), batch_size):\n",
    "    batch_ids = article_ids[i:i+batch_size]\n",
    "    xml_data = fetch_batch_details(batch_ids, api_key)\n",
    "    if xml_data:\n",
    "        parse_and_print_article_details(xml_data)\n",
    "    time.sleep(1)  # Be respectful to the server\n",
    "\n",
    "print(\"Finished processing all articles.\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Ok Finally we fetch some more info"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Title: Development and Evaluation of a Clinician-Vetted Dementia Caregiver Resources Website: Mixed Methods Approach.\n",
      "Abstract: About 11 million Americans are caregivers for the 6.7 million Americans currently living with dementia. They provide over 18 billion hours of unpaid care per year, yet most have no formal dementia education or support. It is extremely difficult for clinicians to keep up with the demand for caregiver education, especially as dementia is neurodegenerative in nature, requiring different information at different stages of the disease process. In this digital age, caregivers often seek dementia information on the internet, but clinicians lack a single, reliable compendium of expert-approved digital resources to provide to dementia caregivers.\n",
      "Keywords: Alzheimer disease, caregiver education, dementia, interdisciplinary, older adults, virtual resources, website development\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Neuroimaging-guided diagnosis of possible FTLD-FUS pathology: a case report.\n",
      "Abstract: This case report presents a patient with progressive memory loss and choreiform movements.\n",
      "Keywords: Chorea, FTLD-FUS pathology, Mild cognitive impairment, Neuroimaging, PET\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer's disease.\n",
      "Abstract: Alzheimer's disease (AD) is a complex neurological disorder and no effective drug is available for its treatment. Numerous pathological conditions are believed to be responsible for the initiation and development of AD including c-Jun N-terminal kinases (JNKs). The JNKs are one of the enzymes from the mitogen-activated protein kinase (MAPK) family that controls the phosphorylation of various transcription factors on serine and threonine residues, and hold significant responsibilities in tasks like gene expression, cell proliferation, differentiation, and apoptosis. Since, JNK3 is primarily expressed in the brain hence its increased levels in the brain are associated with the AD pathology promoting neurofibrillary tangles, senile plaques, neuroinflammation, and nerve cell apoptosis. The current research work is focused on the development of novel JNK inhibitors as therapeutics for AD employing a structure-based virtual screening (SBVS) approach. The ZINC database (14634052 compounds) was investigated after employing pan assay interference (PAINs), drug-likeness, and diversity picking filter to distinguish molecules interacting with JNK3 by following three docking precision criteria: High Throughput Virtual Screening (HTVS), Standard Precision (SP), and Extra Precision (XP) & MMGBSA. Five lead molecules showed a better docking score in the range of -13.091 to -14.051 kcal/mol better than the reference compound (- 11.828 kcal/mol). The lead compounds displayed acceptable pharmacokinetic properties and were subjected to molecular dynamic simulations of 100 ns and binding free energy calculations. All the lead molecules showed stable RMSD and hydrogen bond interactions throughout the trajectory. The ∆G\n",
      "Keywords: Alzheimer’s disease, Free Energy Landscape, HTVS, JNK3 inhibitors, MMGB/PBSA, Molecular dynamics simulation, Neurological disorders\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: [Cortico-basal syndrome and cortico-basal degeneration: From the clinical diagnosis to the lesional substrate for an adapted care].\n",
      "Abstract: Cortico-basal degeneration is a relatively uncommon cause of degenerative parkinsonism in the elderly. From a clinical point of view, it manifests as a cortico-basal syndrome (CBS), featuring a highly asymmetrical akinetic-rigid syndrome, dystonia, myoclonus and cognitive-behavioral impairment with predominant apraxia. Other clinical phenotypes are possible, including variants with mainly language or behavioral impairment, or with axial, symmetrical parkinsonism resembling progressive supranuclear palsy (PSP). Current diagnostic criteria take into account the heterogeneity of clinical presentations. However, a diagnosis of certainty can only be reached by a pathological study, with the evidence of TAU-positive intraneuronal inclusions. Indeed SCB may be underpinned by other lesional substrates, ranging from frontotemporal degeneration to Alzheimer's disease. Symptom management must be early, multidisciplinary and adapted to the progression of the disorder. The identification of the pathological substrate is an essential prerequisite for pathophysiological therapeutic trials.\n",
      "Keywords: biomarkers, corticobasal degeneration (CBD), corticobasal syndrome (CBS), frontotemporal lobar degeneration (FTLD), parkinsonism\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Deep brain stimulation for Alzheimer's disease - current status and next steps.\n",
      "Abstract: Alzheimer's disease (AD) requires novel therapeutic approaches due to limited efficacy of current treatments.\n",
      "Keywords: Alzheimer‘s disease, DBS, Papez, memory, neuromodulation\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs.\n",
      "Abstract: At present, increasing reports from different aspects indicated that cholinesterase inhibitors (ChEIs) may be effective on improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease (AD). However, no studies comprehensively and detailedly evaluated the effect of ChEIs on AD. The present analysis was designed to comprehensively evaluate the efficacy and safety of ChEIs for AD.\n",
      "Keywords: Keywords not available\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Chemistry, Biological Activities, and Pharmacological Properties of Gastrodin:  Mechanism insights.\n",
      "Abstract: Gastrodin, a bioactive compound derived from the rhizome of the orchid Gastrodia elata, exhibits a diverse range of biological activities. With documented neuroprotective, anti-inflammatory, antioxidant, anti-apoptotic, and anti-tumor effects, gastrodin stands out as a multifaceted therapeutic agent. Notably, it has demonstrated efficacy in protecting against neuronal damage and enhancing cognitive function in animal models of Alzheimer's disease, Parkinson's disease, and cerebral ischemia. Additionally, gastrodin showcases immunomodulatory effects by mitigating inflammation and suppressing the expression of inflammatory cytokines. Its cytotoxic activity involves the inhibition of angiogenesis, suppression of tumor growth, and induction of apoptosis. This comprehensive review seeks to elucidate the myriad potential effects of Gastrodin, delving into the intricate molecular mechanisms underpinning its pharmacological properties. The findings underscore the therapeutic potential of gastrodin in addressing various conditions linked to neuroinflammation and cancer.\n",
      "Keywords: Anticancer, Apoptosis, Gastrodin, anti-inflammatory, neuroprotective\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Sex-specific associations between AD genotype and the microbiome of human amyloid beta knock-in (hAβ-KI) mice.\n",
      "Abstract: Emerging evidence links changes in the gut microbiome to late-onset Alzheimer's disease (LOAD), necessitating examination of AD mouse models with consideration of the microbiome.\n",
      "Keywords: 3xTg‐AD, Alzheimer's disease, Turicibacter, cage effects, hAβ‐KI, late‐onset Alzheimer's disease, metabolomics, metagenomics, microbiome, mouse models for Alzheimer's disease\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Automatic classification of AD pathology in FTD phenotypes using natural speech.\n",
      "Abstract: Screening for Alzheimer's disease neuropathologic change (ADNC) in individuals with atypical presentations is challenging but essential for clinical management. We trained automatic speech-based classifiers to distinguish frontotemporal dementia (FTD) patients with ADNC from those with frontotemporal lobar degeneration (FTLD).\n",
      "Keywords: Alzheimer's disease, automated speech analysis, frontotemporal lobar degeneration, machine learning classification, natural speech, pathology\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Making sense of dementia: Older adults' subjective representations of dementia and Alzheimer's disease.\n",
      "Abstract: This research explores how the representations and meanings of living with dementia are constructed by older adults.\n",
      "Keywords: Dementia worry, Discourse, Fourth age, Language\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Trichostatin A relieves anxiety-and depression-like symptoms in APP/PS1 mice.\n",
      "Abstract: Cognitive deficits and behavioral disorders such as anxiety and depression are common manifestations of Alzheimer's disease (AD). Our previous work demonstrated that Trichostatin A (TSA) could alleviate neuroinflammatory plaques and improve cognitive disorders. AD, anxiety, and depression are all associated with microglial inflammation. However, whether TSA could attenuate anxiety- and depression-like behaviors in APP/PS1 mice through anti-inflammatory signaling is still unclearly.\n",
      "Keywords: APP/PS1 mice, Alzheimer’s disease, CST7, Trichostatin A, anxiety, depression\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Sex-specific changes in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer's disease.\n",
      "Abstract: Membrane transporters playing an important role in the passage of drugs, metabolites and nutrients across the membranes of the brain cells have been shown to be involved in pathogenesis of Alzheimer's disease (AD). However, little is known about sex-specific changes in transporter protein expression at the brain in AD. Here, we investigated sex-specific alterations in protein expression of three ATP-binding cassette (ABC) and five solute carriers (SLC) transporters in the prefrontal cortex of a commonly used model of familial AD (FAD), 5xFAD mice. Sensitive liquid chromatography tandem mass spectrometry-based quantitative targeted absolute proteomic analysis was applied for absolute quantification of transporter protein expression. We compared the changes in transporter protein expressions in 7-month-old male and female 5xFAD mice versus sex-matched wild-type mice. The study revealed a significant sex-specific increase in protein expression of ABCC1 (\n",
      "Keywords: 5XFAD mice, Alzheimer’s disease, age, animal model, brain, membrane transporters, sex\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Development of the Longitudinal Study of Health and Ageing in Kenya (LOSHAK).\n",
      "Abstract: In Kenya, the number of adults aged ≥60 is expected to nearly quadruple by 2050, making it one of the most rapidly aging countries in Sub-Saharan Africa (SSA). Accordingly, we designed the Longitudinal Study of Health and Ageing in Kenya (LOSHAK) to generate novel data to address the health and economic consequences of this demographic transition. Specifically, LOSHAK will investigate the social, economic, environmental, biological, and policy processes that shape late-life health and economic well-being in Kenya. Modeled on the U.S. Health and Retirement Study (HRS), LOSHAK joins a network of harmonized studies on aging in >45 countries worldwide; however, LOSHAK will be only the 2nd such study in SSA. The current feasibility and pilot phase of LOSHAK will validate measures and data collection procedures in a purposive sample of Kenyan adults aged ≥45 years. We have linguistically and culturally translated instruments while aiming to maintain harmonization with both existing HRS network studies and the ongoing Kenya Life Panel Survey. The current phase of LOSHAK is nested within the Kaloleni/Rabai Community Health and Demographic Surveillance System on the coast of Kenya. LOSHAK will advance population aging research in low- and middle-income countries through the study of (a) \n",
      "Keywords: Air pollution, Dementia, Health and Retirement Study, Healthy aging, Sub-Saharan Africa\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Micro-RNA profiles of pathology and resilience in posterior cingulate cortex of cognitively intact elders.\n",
      "Abstract: The posterior cingulate cortex (PCC) is a key hub of the default mode network underlying autobiographical memory retrieval, which falters early in the progression of Alzheimer's disease (AD). We recently performed RNA sequencing of post-mortem PCC tissue samples from 26 elderly Rush Religious Orders Study participants who came to autopsy with an ante-mortem diagnosis of no cognitive impairment but who collectively displayed a range of Braak I-IV neurofibrillary tangle stages. Notably, cognitively unimpaired subjects displaying high Braak stages may represent cognitive resilience to AD pathology. Transcriptomic data revealed elevated synaptic and ATP-related gene expression in Braak Stages III/IV compared with Stages I/II, suggesting these pathways may be related to PCC resilience. We also mined expression profiles for small non-coding micro-RNAs (miRNAs), which regulate mRNA stability and may represent an underexplored potential mechanism of resilience through the fine-tuning of gene expression within complex cellular networks. Twelve miRNAs were identified as differentially expressed between Braak Stages I/II and III/IV. However, the extent to which the levels of all identified miRNAs were associated with subject demographics, neuropsychological test performance and/or neuropathological diagnostic criteria within this cohort was not explored. Here, we report that a total of 667 miRNAs are significantly associated (rho > 0.38, \n",
      "Keywords: cognition, micro-RNA, posterior cingulate cortex, resilience, transcriptomics\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: How Do Retinoids Affect Alzheimer's Disease and Can They Be Novel Drug Candidates?\n",
      "Abstract: Alzheimer's disease is a chronic, neurological condition that faces many challenges in its management and therapy nowadays highlighting the importance and urgent need of researching new ways of approaching this disease. Retinoic acid and its derivatives, collectively known as the retinoids, are considered promising agents that have disease-modifying properties in affecting Alzheimer's disease. This thesis aims to address the research questions of what the role of retinoids is in Alzheimer's disease, and whether they can be used as a novel drug candidate for treating this condition. Retinoids' properties and agonistic actions on the nuclear receptors retinoic acid receptor (RAR) and retinoic X receptor (RXR) affect various pathways as well as their underlying genetic factors that compose important pathophysiological hallmarks causing the progression of Alzheimer's disease as amyloid β (Aβ) production and deposition, neurofibrillary tangle (NFT) formation and phosphorylation, and inflammatory and autoimmune responses. Retinoic acid inhibits the amplification of these pathways and modifies the disease progression in animal models, proposing a solid basis for human trials. Hence, investigating retinoids as pharmacological agents in human trials has been conducted, and several synthetic analogues have been developed to address issues concerning retinoic acid's instability and short half-life, as well as adverse drug reactions. The most prominent of these analogues is tamibarotene, a stable retinoic acid derivative with a higher half-life, higher specificity to target receptors, and fewer adverse reactions. A number of criteria that explain what a novel drug candidate should have when managing Alzheimer's disease have been formulated, and which also explain why most novel drug candidates other than retinoic acid have failed in achieving clinical results. Most of these candidates share one common trait which is a single-target approach in targeting disease pathways. This means that when administering these agents, their actions are to target a single disease-causing pathway at a time but do not affect other pathways. On the other hand, tamibarotene is a novel drug candidate that targets a range of pathways at once and provides a more comprehensive approach in its pharmacological actions.\n",
      "Keywords: alzheimer's disease, drug design, drug discovery, medicinal chemistry, retinoic acid, tamibarotene\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Repetitive transcranial magnetic stimulation for Alzheimer's disease: an overview of systematic reviews and meta-analysis.\n",
      "Abstract: Alzheimer's disease (AD) is a prevalent neurodegenerative condition that significantly impacts both individuals and society. This study aims to evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a treatment for AD by summarizing the evidence from systematic reviews (SRs) and meta-analyses (MAs).\n",
      "Keywords: Alzheimer’s disease, meta-analysis, noninvasive brain stimulation, overview, repetitive transcranial magnetic stimulation\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: β-amyloid accumulation enhances microtubule associated protein tau pathology in an APP\n",
      "Abstract: The study of the pathophysiology study of Alzheimer's disease (AD) has been hampered by lack animal models that recapitulate the major AD pathologies, including extracellular -amyloid (A) deposition, intracellular aggregation of microtubule associated protein tau (MAPT), inflammation and neurodegeneration.\n",
      "Keywords: RNA binding proteins, RNA methylation, clarity, neuritic plaques, neurodegeneration, neuropathology, tau oligomers, tauopathy\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Fish - a scoping review for Nordic Nutrition Recommendations 2023.\n",
      "Abstract: The aim of this scoping review was to conduct evidence-based documentation between fish intake and health outcomes for food-based dietary guidelines (FBDGs) in the Nordic Nutrition Recommendations (NNR) 2023. For most health outcomes, the evidence for fish oil and n-3 long chain (LC) polyunsaturated fatty acids (PUFA) supplementation was included when examining evidence between fish intake and health. In this review, conclusions from qualified systematic reviews (qSR) approved by NNR2023 are included. In addition, conclusions of a \n",
      "Keywords: dietary recommendations, fish, polyunsaturated fatty acids, seafood\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: None\n",
      "Abstract: A patient with the \n",
      "Keywords: Alzheimer’s disease, ApoE, ApoE Christchurch, CRISPR, Presenilin, Wnt signaling, iPS cells\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Comparing survival rates and mortality in operative versus nonoperative treatment for femoral neck fractures among Alzheimer's disease patients: A retrospective cohort study.\n",
      "Abstract: Addressing femoral neck fractures resulting from ground-level falls in older adults with Alzheimer's disease (AD) involves a personalized treatment plan. There is considerable ongoing debate concerning the relative advantages and disadvantages of surgical treatment (internal fixation or arthroplasty) vs nonoperative treatment for femoral neck fractures in older persons with AD.\n",
      "Keywords: Alzheimer's disease and Alzheimer's disease related dementias, arthroplasty, femoral neck fracture, internal fixation, non‐operative treatment\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Virgin coconut oil - its methods of extraction, properties and clinical usage: a review.\n",
      "Abstract: Virgin coconut oil (VCO) is a processed edible oil, which is removed from the mature coconuts. It is a colourless water insoluble liquid and obtained by the hot and cold extraction processes. The nutritional components of VCO are mainly contributed to by lauric acid, its primary content. VCO has shown its anticancer, antimicrobial, analgesic, antipyretic and antiinflammatory properties. Because of these medicinal properties, VCO has gained the wider attention among the medical field. Most evidently VCO has shown its potential antioxidant property, because of its phenolic compounds and medium chain fatty acids. It is one of the beneficial compounds used to prevent and treat the oxidative stress induced neurological disorders like stress, depression and Alzheimer's disease. Dietary supplementation of VCO is easy and economical and safer in daily life among all age groups. It is also beneficial for the cardiovascular, respiratory, dermatological, reproductive and bone health. It can also be applied to the skin as a moisturizer in the paediatric age group. Hence, exploration of antioxidant property as well as other beneficial effects of VCO in various health conditions will be valuable.\n",
      "Keywords: antioxidant, oxidative stress, virgin coconut oil\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Human in vivo evidence of associations between herpes simplex virus and cerebral amyloid-beta load in normal aging.\n",
      "Abstract: Mounting data suggests that herpes simplex virus type 1 (HSV-1) is involved in the pathogenesis of AD, possibly instigating amyloid-beta (Aβ) accumulation decades before the onset of clinical symptoms. However, human in vivo evidence linking HSV-1 infection to AD pathology is lacking in normal aging, which may contribute to the elucidation of the role of HSV-1 infection as a potential AD risk factor.\n",
      "Keywords: APOE4, Aging, Alzheimer’s disease, Amyloid PET, Amyloid-beta plaques, Herpes simplex virus, Neurodegeneration\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer's disease and vascular dementia in a prospective study.\n",
      "Abstract: It is of interest whether inflammatory biomarkers can improve dementia prediction models, such as the widely used Cardiovascular Risk Factors, Aging and Dementia (CAIDE) model.\n",
      "Keywords: Alzheimer’s disease, Cohort study, Dementia, Inflammation, Risk prediction, Vascular dementia\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Cerebrospinal fluid amyloid-β and cerebral microbleed are associated with distinct neuropsychiatric sub-syndromes in cognitively impaired patients.\n",
      "Abstract: Neuropsychiatric symptoms (NPS) are prevalent in cognitively impaired individuals including Alzheimer's disease (AD) dementia and mild cognitive impairment (MCI). Whereas several studies have reported the associations between NPS with AD pathologic biomarkers and cerebral small vessel disease (SVD), but it remains unknown whether AD pathology and SVD contribute to different sub-syndromes independently or aggravate same symptoms synergistically.\n",
      "Keywords: Alzheimer’s disease, Amyloid, Biomarkers, Neuropsychiatry, Small vessel disease\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Influences of amyloid-β and tau on white matter neurite alterations in dementia with Lewy bodies.\n",
      "Abstract: Dementia with Lewy bodies (DLB) is a neurodegenerative condition often co-occurring with Alzheimer's disease (AD) pathology. Characterizing white matter tissue microstructure using Neurite Orientation Dispersion and Density Imaging (NODDI) may help elucidate the biological underpinnings of white matter injury in individuals with DLB. In this study, diffusion tensor imaging (DTI) and NODDI metrics were compared in 45 patients within the dementia with Lewy bodies spectrum (mild cognitive impairment with Lewy bodies (n = 13) and probable dementia with Lewy bodies (n = 32)) against 45 matched controls using conditional logistic models. We evaluated the associations of tau and amyloid-β with DTI and NODDI parameters and examined the correlations of AD-related white matter injury with Clinical Dementia Rating (CDR). Structural equation models (SEM) explored relationships among age, APOE ε4, amyloid-β, tau, and white matter injury. The DLB spectrum group exhibited widespread white matter abnormalities, including reduced fractional anisotropy, increased mean diffusivity, and decreased neurite density index. Tau was significantly associated with limbic and temporal white matter injury, which was, in turn, associated with worse CDR. SEM revealed that amyloid-β exerted indirect effects on white matter injury through tau. We observed widespread disruptions in white matter tracts in DLB that were not attributed to AD pathologies, likely due to α-synuclein-related injury. However, a fraction of the white matter injury could be attributed to AD pathology. Our findings underscore the impact of AD pathology on white matter integrity in DLB and highlight the utility of NODDI in elucidating the biological basis of white matter injury in DLB.\n",
      "Keywords: Keywords not available\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway.\n",
      "Abstract: The biological substrate of persistent post-COVID-19 hyposmia is still unclear. However, as many neurodegenerative diseases present with smell impairment at onset, it may theoretically reflect degeneration within the central olfactory circuits. However, no data still exist regarding the post-COVID-19 patients. As the olfactory neurons (ONs) mirror pathological changes in the brain, allowing for tracking the underlying molecular events, here, we performed a broad analysis of ONs from patients with persistent post-COVID-19 OD to identify traces of potential neurodegeneration. ONs were collected through the non-invasive brushing of the olfactory mucosa from ten patients with persistent post-COVID-19 hyposmia (lasting > 6 months after infection) and ten age/sex-matched controls. Immunofluorescence staining for protein quantification and RT-PCR for gene expression levels were combined to measure ONs markers of α-synuclein, amyloid-β, and tau pathology, axonal injury, and mitochondrial network. Patients and controls had similar ONs levels of oligomeric α-synuclein, amyloid-β peptide, tau protein, neurofilament light chain (NfL), cytochrome C oxidase subunit 3 (COX3), and the heat shock protein 60 (HSP60). Our findings thus did not provide evidence for synucleinopathy and amyloid-β mismetabolism or gross traces of neuronal injury and mitochondrial dysfunction within the olfactory system in the early phase of persistent post-COVID-19 hyposmia.\n",
      "Keywords: Hyposmia, Long-COVID, Neurodegeneration, Olfactory dysfunction, Olfactory neurons, Post-COVID\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions.\n",
      "Abstract: Neurodegenerative disorders are devastating disorders characterized by gradual loss of neurons and cognition or mobility impairment. The common pathological features of these diseases are associated with the accumulation of misfolded or aggregation of proteins. The pivotal roles of autophagy and proteostasis in maintaining cellular health and preventing the accumulation of misfolded proteins, which are associated with neurodegenerative diseases like Huntington's disease (HD), Alzheimer's disease (AD), and Parkinson's disease (PD). This article presents an in-depth examination of the interplay between autophagy and proteostasis, highlighting how these processes cooperatively contribute to cellular homeostasis and prevent pathogenic protein aggregate accumulation. Furthermore, the review emphasises the potential therapeutic implications of targeting autophagy and proteostasis to mitigate neurodegenerative diseases. While advancements in research hold promise for developing novel treatments, the article also addresses the challenges and complexities associated with modulating these intricate cellular pathways. Ultimately, advancing understanding of the underlying mechanism of autophagy and proteostasis in neurodegenerative disorders provides valuable insights into potential therapeutic avenues and future research directions.\n",
      "Keywords: cellular homeostatis, neurodegenerative disorders, pathogenesis, proteostasis\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer's disease.\n",
      "Abstract: Alzherimer's disease (AD) is an age-dependent ubiquitous ailment worldwide with limited therapies that only alleviate the symptoms of AD but do not cure them entirely because of the restricted blood-brain barrier passage of the drug. Hence with new advanced technology, nanoparticles can offer an opportunity as the active candidate to overcome the above limitations. Aurothioglucose, a synthetic glucose derivative of the gold compound, has been clinically proven to be an effective anti-inflammatory drug for rheumatic arthritis. Recently, several scientific groups have developed gold nanoparticle preparations and tested them for the treatment of dementia. This study was planned to prepare the PLGA nanoparticles of aurothioglucose (ATG) and check the neuroprotective potential against STZ-induced AD in rats. The nanoparticles were prepared using the double emulsion solvent evaporation method and characterized for various parameters such as drug-excipient interaction, particle size, zeta potential, and morphology. Then, rats were injected STZ (3 mg/kg/i.c.v., days 1 and 3) and ATG (5 and 10 mg/kg/s.c.), ATG NPs (2.5 and 5 mg/kg/s.c.) and donepezil (2 mg/kg/p.o) from 15th to 29th day. Behavior parameters were performed using an actophotometer, MWM, and ORT. On the 30th day, all the animals were sacrificed, and the brains were isolated for estimating biochemical, neurochemical, and proinflammatory markers. It was observed that ATG NPs significantly restored all behavior and neurotransmitter alterations caused by STZ. Also, it increased antioxidant levels and decreased inflammatory cytokines significantly, then ATG alone. Thus, the study suggests that ATG loaded PLGA NPs could be used as a novel therapeutic strategy to slow the process of AD.\n",
      "Keywords: Alzheimer’s disease, Aurothioglucose, Nanoparticles, Neuroinflammation, PLGA, Streptozotocin\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Memory Circuits in Dementia: The Engram, Hippocampal Neurogenesis and Alzheimer's disease.\n",
      "Abstract: Here, we provide an in-depth consideration of our current understanding of engrams, spanning from molecular to network levels, and hippocampal neurogenesis, in health and Alzheimer's disease (AD). This review highlights novel findings in these emerging research fields and future research directions for novel therapeutic avenues for memory failure in dementia. Engrams, memory in AD, and hippocampal neurogenesis have each been extensively studied. The integration of these topics, however, has been relatively less deliberated, and is the focus of this review. We primarily focus on the dentate gyrus (DG) of the hippocampus, which is a key area of episodic memory formation. Episodic memory is significantly impaired in AD, and is also the site of adult hippocampal neurogenesis. Advancements in technology, especially opto- and chemogenetics, have made sophisticated manipulations of engram cells possible. Furthermore, innovative methods have emerged for monitoring neurons, even specific neuronal populations, in vivo while animals engage in tasks, such as calcium imaging. In vivo calcium imaging contributes to a more comprehensive understanding of engram cells. Critically, studies of the engram in the DG using these technologies have shown the important contribution of hippocampal neurogenesis for memory in both health and AD. Together, the discussion of these topics provides a holistic perspective that motivates questions for future research.\n",
      "Keywords: Alzheimer’s disease and related dementia, adult hippocampal neurogenesis, engram, hippocampus- dependent learning and memory\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: The Beta secretase BACE1 drives fibroblasts activation in Systemic Sclerosis through the APP/β-catenin/Notch signalling axis.\n",
      "Abstract: The beta-amyloid precursor protein cleaving enzyme 1 (BACE1) is well known for its role in the development of Alzheimer's disease. Recent publications, including our own, have demonstrated a role for this enzyme in other chronic diseases. The aim of this study was to investigate the role of BACE1 in the autoimmune disease systemic sclerosis (SSc). BACE1 protein levels were elevated in SSc patient skin. Inhibition of BACE1 with small molecule inhibitors or siRNA blocked SSc and fibrotic stimuli mediated fibroblast activation. Furthermore, we show that BACE1 regulation of dermal fibroblast activation is dependent on β-catenin and Notch signalling. The Neurotropic factor BDNF negatively regulates BACE1 expression and activity in dermal fibroblasts. Finally, sera from SSc patients show higher Aβ and lower BDNF levels compared to healthy controls. The ability of BACE1 to regulate SSc fibroblast activation reveals a therapeutic target in SSc. Several BACE1 inhibitors have been shown to be safe in clinical trials for Alzheimer's disease and could be repurposed to ameliorate fibrosis progression.\n",
      "Keywords: Autoimmunity, Fibrosis, Notch, Wnt\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Peripheral hearing loss at age 70 predicts brain atrophy and associated cognitive change.\n",
      "Abstract: Hearing loss has been proposed as a modifiable risk factor for dementia. However, the relationship between hearing, neurodegeneration, and cognitive change, and the extent to which pathological processes such as Alzheimer's disease and cerebrovascular disease influence these relationships, is unclear.\n",
      "Keywords: ALZHEIMER'S DISEASE, AMYLOID, CEREBROVASCULAR DISEASE, COGNITIVE NEUROPSYCHOLOGY, DEMENTIA\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Supplements for cognitive ability in patients with mild cognitive impairment or Alzheimer's disease: a protocol for systematic review and network meta-analysis of randomised controlled trials.\n",
      "Abstract: Considering the increasing incidence of Alzheimer's disease (AD) and mild cognitive impairment (MCI) worldwide, there is an urgent need to identify efficacious, safe and convenient treatments. Numerous investigations have been conducted on the use of supplements in this domain, with oral supplementation emerging as a viable therapeutic approach for AD or MCI. Nevertheless, given the multitude of available supplements, it becomes imperative to identify the optimal treatment regimen.\n",
      "Keywords: Aged, Dementia, NEUROLOGY, NUTRITION & DIETETICS\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Long-term exposure to major constituents of fine particulate matter and neurodegenerative diseases: A population-based survey in the Pearl River Delta Region, China.\n",
      "Abstract: Exposure to PM\n",
      "Keywords: Alzheimer’s disease, China, Health risk, PM(2.5) constituent, Parkinson’s disease\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.\n",
      "Abstract: Recently, glycogen synthase kinase-3β (GSK-3β) has been considered as a critical factor implicated in Alzheimer's disease (AD). In a previous work, a 3D pharmacophore model for GSK-3β inhibitors was created and the results suggested that derivative ZINC67773573, VIII, may provide a promising lead for developing novel GSK-3β inhibitors for the AD's treatment. Consequently, in this work, novel series of quinolin-2-one derivatives were synthesized and assessed for their GSK-3β inhibitory properties. In vitro screening identified three compounds: 7c, 7e and 7f as promising GSK-3β inhibitors. Compounds 7c, 7e and 7f were found to exhibit superior inhibitory effect on GSK-3β with IC\n",
      "Keywords: Alzheimer’s disease, Glycogen synthase kinase inhibitor, Quinolin-2-one, Tau hyperphosphorylation, ADME\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Gegen Qinlian tablets delay Alzheimer's disease progression via inhibiting glial neuroinflammation and remodeling gut microbiota homeostasis.\n",
      "Abstract: Current therapeutic agents for AD have limited efficacy and often induce undesirable side effects. Gegen Qinlian tablets (GGQLT) are a well-known clearingheat formula used in clinical treatment of inflammatory diseases. Based on traditional Chinese medicine (TCM) theory, the strategy of clearing-heat is then compatible with the treatment of AD. However, it remains unknown whether GGQLT can exert neuroprotective effects and alleviate neuroinflammation in AD.\n",
      "Keywords: Alzheimer's diseases, Gegen Qinlian tablets, Gut microbiota, NF-κB/MAPK signaling pathways, Neuroinflammation\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Associations Between Age at Menopause, Vascular Risk, and 3-Year Cognitive Change in the Canadian Longitudinal Study on Aging.\n",
      "Abstract: Mounting evidence supports sex differences in Alzheimer disease (AD) risk. Vascular and hormonal factors may together contribute to AD risk in female adults. We investigated whether age at menopause, vascular risk, and history of hormone therapy (HT) containing estrogens together influence cognition over a 3-year follow-up period. We hypothesized that earlier menopause and elevated vascular risk would have a synergistic association with lower cognitive scores at follow-up and that HT containing estrogens would attenuate this synergistic association to preserve cognition.\n",
      "Keywords: Keywords not available\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Dementia-Related Disparities in Adult Day Centers: Results of a Bivariate Analysis.\n",
      "Abstract: Adult day services (ADS) are a valuable resource for people living with Alzheimer's disease and Alzheimer's disease and related dementias (AD/ADRD) and serve a large population of late-life immigrants, often with limited English proficiency (LEP). This secondary data analysis examined potential disparities in diagnosis, dementia severity, medical complexity, and dementia-related behavioral problems in persons with AD/ADRD with LEP within the ADS setting.\n",
      "Keywords: Keywords not available\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Health Trajectories of Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias: Evidence for Practicing Nurses.\n",
      "Abstract: Older adults with Alzheimer's disease and related dementias (ADRD) are at high risk for acute medical problems and their health trajectories frequently include hospital admission and care in a skilled nursing facility (SNF). Their health trajectories after SNF discharge are poorly understood. Therefore, in the current study, we sought to describe health trajectories and factors associated with hospital read-missions for older adults with ADRD during the 30 days following SNF discharge.\n",
      "Keywords: Keywords not available\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly.\n",
      "Abstract: The immune system substantially influences age-related cognitive decline and Alzheimer's disease (AD) progression, affected by genetic and environmental factors. In a Mayo Clinic Study of Aging cohort, we examined how risk factors like APOE genotype, age, and sex affect inflammatory molecules and AD biomarkers in cerebrospinal fluid (CSF). Among cognitively unimpaired individuals over 65 (\n",
      "Keywords: Keywords not available\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model.\n",
      "Abstract: Microglia help limit the progression of Alzheimer's disease (AD) by constraining amyloid-β (Aβ) pathology, effected through a balance of activating and inhibitory intracellular signals delivered by distinct cell surface receptors. Human leukocyte Ig-like receptor B4 (LILRB4) is an inhibitory receptor of the immunoglobulin (Ig) superfamily that is expressed on myeloid cells and recognizes apolipoprotein E (ApoE) among other ligands. Here, we find that LILRB4 is highly expressed in the microglia of patients with AD. Using mice that accumulate Aβ and carry a transgene encompassing a portion of the \n",
      "Keywords: Keywords not available\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Precision proteoform design for 4R tau isoform selective templated aggregation.\n",
      "Abstract: Prion-like spread of disease-specific tau conformers is a hallmark of all tauopathies. A 19-residue probe peptide containing a P301L mutation and spanning the R2/R3 splice junction of tau folds and stacks into seeding-competent fibrils and induces aggregation of 4R, but not 3R tau. These tau peptide fibrils propagate aggregated intracellular tau over multiple generations, have a high β-sheet content, a colocalized lipid signal, and adopt a well-defined U-shaped fold found in 4R tauopathy brain-derived fibrils. Fully atomistic replica exchange molecular dynamics (MD) simulations were used to compute the free energy landscapes of the conformational ensemble of the peptide monomers. These identified an aggregation-prohibiting β-hairpin structure and an aggregation-competent U-fold unique to 4R tauopathy fibrils. Guided by MD simulations, we identified that the N-terminal-flanking residues to PHF6, which slightly vary between 4R and 3R isoforms, modulate seeding. Strikingly, when a single amino acid switch at position 305 replaced the serine of 4R tau with a lysine from the corresponding position in the first repeat of 3R tau, the seeding induced by the 19-residue peptide was markedly reduced. Conversely, a 4R tau mimic with three repeats, prepared by replacing those amino acids in the first repeat with those amino acids uniquely present in the second repeat, recovered aggregation when exposed to the 19-residue peptide. These peptide fibrils function as partial prions to recruit naive 4R tau-ten times the length of the peptide-and serve as a critical template for 4R tauopathy propagation. These results hint at opportunities for tau isoform-specific therapeutic interventions.\n",
      "Keywords: amyloidogenic core, prion-like templating, protein misfolding, tauopathies\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Directed Evolution and Immobilization of Lactobacillus brevis Alcohol Dehydrogenase for Chemo-enzymatic Synthesis of Rivastigmine.\n",
      "Abstract: Rivastigmine is one of the several pharmaceuticals widely prescribed for the treatment of Alzheimer's disease. However, its practical synthesis still faces many issues, such as the involvement of toxic metals and harsh reaction conditions. Herein, we report a chemo-enzymatic synthesis of Rivastigmine. The key chiral intermediate was synthesized by an engineered alcohol dehydrogenase from Lactobacillus brevis (LbADH). A semi-rational approach was employed to improve its catalytic activity and thermal stability. Several LbADH variants were obtained with a remarkable increase in activity and melting temperature. Exploration of the substrate scope of these variants demonstrated improved activities toward various ketones, especially acetophenone analogs. To further recycle and reuse the biocatalyst, one LbADH variant and glucose dehydrogenase were co-immobilized on nanoparticles. By integrating enzymatic and chemical steps, Rivastigmine was successfully synthesized with an overall yield of 66%. This study offers an efficient chemo-enzymatic route for Rivastigmine and provides several efficient LbADH variants with a broad range of potential applications.\n",
      "Keywords: Enzyme immobilization, alcohol dehydrogenase, biocatalysis, chemo-enzymatic synthesis, directed evolution\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: A Multi-modal Classification Method for Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease Using Three Paradigms with Various Task Difficulties.\n",
      "Abstract: Alzheimer's Disease (AD) accounts for the majority of dementia, and Mild Cognitive Impairment (MCI) is the early stage of AD. Early and accurate diagnosis of dementia plays a vital role in more targeted treatments and effectively halting disease progression. However, the clinical diagnosis of dementia requires various examinations, which are expensive and require a high level of expertise from the doctor. In this paper, we proposed a classification method based on multi-modal data including Electroencephalogram (EEG), eye tracking and behavioral data for early diagnosis of AD and MCI. Paradigms with various task difficulties were used to identify different severity of dementia: eye movement task and resting-state EEG tasks were used to detect AD, while eye movement task and delayed match-to-sample task were used to detect MCI. Besides, the effects of different features were compared and suitable EEG channels were selected for the detection. Furthermore, we proposed a data augmentation method to enlarge the dataset, designed an extra ERPNet feature extract layer to extract multi-modal features and used domain-adversarial neural network to improve the performance of MCI diagnosis. We achieved an average accuracy of 88.81% for MCI diagnosis and 100% for AD diagnosis. The results of this paper suggest that our classification method can provide a feasible and affordable way to diagnose dementia.\n",
      "Keywords: Keywords not available\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Deep Self-Reconstruction Fusion Similarity Hashing for the Diagnosis of Alzheimer's Disease on Multi-Modal Data.\n",
      "Abstract: The pathogenesis of Alzheimer's disease (AD) is extremely intricate, which makes AD patients almost incurable. Recent studies have demonstrated that analyzing multi-modal data can offer a comprehensive perspective on the different stages of AD progression, which is beneficial for early diagnosis of AD. In this paper, we propose a deep self-reconstruction fusion similarity hashing (DS-FSH) method to effectively capture the AD-related biomarkers from the multi-modal data and leverage them to diagnose AD. Given that most existing methods ignore the topological structure of the data, a deep self-reconstruction model based on random walk graph regularization is designed to reconstruct the multi-modal data, thereby learning the nonlinear relationship between samples. Additionally, a fused similarity hash based on anchor graph is proposed to generate discriminative binary hash codes for multi-modal reconstructed data. This allows sample fused similarity to be effectively modeled by a fusion similarity matrix based on anchor graph while modal correlation can be approximated by Hamming distance. Especially, extracted features from the multi-modal data are classified using deep sparse autoencoders classifier. Finally, experiments conduct on the AD Neuroimaging Initiative database show that DS-FSH outperforms comparable methods of AD classification. To conclude, DS-FSH identifies multi-modal features closely associated with AD, which are expected to contribute significantly to understanding of the pathogenesis of AD.\n",
      "Keywords: Keywords not available\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: pathCLIP: Detection of Genes and Gene Relations from Biological Pathway Figures through Image-Text Contrastive Learning.\n",
      "Abstract: In biomedical literature, biological pathways are commonly described through a combination of images and text. These pathways contain valuable information, including genes and their relationships, which provide insight into biological mechanisms and precision medicine. Curating pathway information across the literature enables the integration of this information to build a comprehensive knowledge base. While some studies have extracted pathway information from images and text independently, they often overlook the correspondence between the two modalities. In this paper, we present a pathway figure curation system named pathCLIP for identifying genes and gene relations from pathway figures. Our key innovation is the use of an image-text contrastive learning model to learn coordinated embeddings of image snippets and text descriptions of genes and gene relations, thereby improving curation. Our validation results, using pathway figures from PubMed, showed that our multimodal model outperforms models using only a single modality. Additionally, our system effectively curates genes and gene relations from multiple literature sources. Two case studies on extracting pathway information from literature of non-small cell lung cancer and Alzheimer's disease further demonstrate the usefulness of our curated pathway information in enhancing related pathways in the KEGG database.\n",
      "Keywords: Keywords not available\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias.\n",
      "Abstract: Reactive astrogliosis accompanies the two neuropathological hallmarks of Alzheimer's disease (AD)-Aβ plaques and neurofibrillary tangles-and parallels neurodegeneration in AD and AD-related dementias (ADRD). Thus, there is growing interest in developing imaging and fluid biomarkers of reactive astrogliosis for AD/ADRD diagnosis and prognostication. Monoamine oxidase-B (MAO-B) is emerging as a target for PET imaging radiotracers of reactive astrogliosis. However, a thorough characterization of MAO-B expression in postmortem control and AD/ADRD brains is lacking. We sought to: (1) identify the primary cell type(s) expressing MAO-B in control and AD brains; (2) quantify MAO-B immunoreactivity in multiple brain regions of control and AD donors as a proxy for PET radiotracer uptake; (3) correlate MAO-B level with local AD neuropathological changes, reactive glia, and cortical atrophy; (4) determine whether the MAOB rs1799836 SNP genotype impacts MAO-B expression level; (5) compare MAO-B immunoreactivity across AD/ADRD, including Lewy body diseases (LBD) and frontotemporal lobar degenerations with tau (FTLD-Tau) and TDP-43 (FTLD-TDP). We found that MAO-B is mainly expressed by subpial and perivascular cortical astrocytes as well as by fibrous white matter astrocytes in control brains, whereas in AD brains, MAO-B is significantly upregulated by both cortical reactive astrocytes and white matter astrocytes across temporal, frontal, and occipital lobes. By contrast, MAO-B expression level was unchanged and lowest in cerebellum. Cortical MAO-B expression was independently associated with cortical atrophy and local measures of reactive astrocytes and microglia, and significantly increased in reactive astrocytes surrounding Thioflavin-S+ dense-core Aβ plaques. MAO-B expression was not affected by the MAOB rs1799836 SNP genotype. MAO-B expression was also significantly increased in the frontal cortex and white matter of donors with corticobasal degeneration, Pick's disease, and FTLD-TDP, but not in LBD or progressive supranuclear palsy. These findings support ongoing efforts to develop MAO-B-based PET radiotracers to image reactive astrogliosis in AD/ADRD.\n",
      "Keywords: Alzheimer’s disease, Amyloid plaques, Astrocyte, Monoamine oxidase-B, Neurofibrillary tangles, Positron emission tomography\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Exploring Imaging Genetic Markers of Alzheimer's Disease Based on a Novel Nonlinear Correlation Analysis Algorithm.\n",
      "Abstract: Alzheimer's disease (AD) is an irreversible neurological disorder characterized by insidious onset. Identifying potential markers in its emergence and progression is crucial for early diagnosis and treatment. Imaging genetics typically merges genetic variables with multiple imaging parameters, employing various association analysis algorithms to investigate the links between pathological phenotypes and genetic variations, and to unearth molecular-level insights from brain images. However, most existing imaging genetics algorithms based on sparse learning assume a linear relationship between genetic factors and brain functions, limiting their ability to discern complex nonlinear correlation patterns and resulting in reduced accuracy. To address these issues, we propose a novel nonlinear imaging genetic association analysis method, Deep Self-Reconstruction-based Adaptive Sparse Multi-view Deep Generalized Canonical Correlation Analysis (DSR-AdaSMDGCCA). This approach facilitates joint learning of the nonlinear relationships between pathological phenotypes and genetic variations by integrating three different types of data: structural magnetic resonance imaging (sMRI), single-nucleotide polymorphism (SNP), and gene expression data. By incorporating nonlinear transformations in DGCCA, our model effectively uncovers nonlinear associations across multiple data types. Additionally, the DSR algorithm clusters samples with identical labels, incorporating label information into the nonlinear feature extraction process and thus enhancing the performance of association analysis. The application of the DSR-AdaSMDGCCA algorithm on real data sets identified several AD risk regions (such as the hippocampus, parahippocampus, and fusiform gyrus) and risk genes (including VSIG4, NEDD4L, and PINK1), achieving maximum classification accuracy with the fewest selected features compared to baseline algorithms. Molecular biology enrichment analysis revealed that the pathways enriched by these top genes are intimately linked to AD progression, affirming that our algorithm not only improves correlation analysis performance but also identifies biologically significant markers.\n",
      "Keywords: Alzheimer’s disease, Deep subspace reconstruction, Imaging genetics, Sparse canonical correlation analysis\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential.\n",
      "Abstract: Neurodegeneration, which manifests as several chronic and incurable diseases, is an age-related condition that affects the central nervous system (CNS) and poses a significant threat to the public's health for the elderly. Recent decades have experienced an alarming increase in the incidence of neurodegenerative disorders (NDDs), a severe public health issue due to the ongoing development of people living in modern civilizations. Alzheimer's disease (AD) is a leading trigger of age-related dementia. Currently, there are no efficient therapeutics to delay, stop, or reverse the disease's course development. Several studies found that dietary bioactive phytochemicals, primarily flavonoids, influence the pathophysiological processes underlying AD. Flavonoids work well as a supplement to manufactured therapies for NDDs. Flavonoids are effective in complementing synthetic approaches to treat NDDs. They are biologically active phytochemicals with promising pharmacological activities, for instance, antiviral, anti-allergic, antiplatelet, anti-inflammatory, antitumor, anti-apoptotic, and antioxidant effects. The production of nitric oxide (NO), tumor necrosis factor (TNF-α), and oxidative stress (OS) are downregulated by flavonoids, which slow the course of AD. Hence, this research turned from preclinical evidence to feasible clinical applications to develop newer therapeutics, focusing on the therapeutic potential of flavonoids against AD.\n",
      "Keywords: Alzheimer’s disease, Amyloid-beta, Flavonoids, Neurodegeneration, Neurofibrillary tangles, Neuroprotection, Oxidative stress, Reactive oxygen species\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Dysregulated AEBP1 and COLEC12 Genes in Late-Onset Alzheimer's Disease: Insights from Brain Cortex and Peripheral Blood Analysis.\n",
      "Abstract: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory and cognitive impairment, often accompanied by alterations in mood, confusion, and, ultimately, a state of acute mental disturbance. The cerebral cortex is considered a promising area for investigating the underlying causes of AD by analyzing transcriptional patterns, which could be complemented by investigating blood samples obtained from patients. We analyzed the RNA expression profiles of three distinct areas of the brain cortex, including the frontal cortex (FC), temporal cortex (TC), and entorhinal cortex (EC) in patients with AD. Functional enrichment analysis was performed on the differentially expressed genes (DEGs) across the three regions. The two genes with the most significant expression changes in the EC region were selected for assessing mRNA expression levels in the peripheral blood of late-onset AD patients using quantitative PCR (qPCR). We identified eight shared DEGs in these regions, including AEBP1 and COLEC12, which exhibited prominent changes in expression. Functional enrichment analysis uncovered a significant association of these DEGs with the transforming growth factor-β (TGF-β) signaling pathway and processes related to angiogenesis. Importantly, we established a robust connection between the up-regulation of AEBP1 and COLEC12 in both the brain and peripheral blood. Furthermore, we have demonstrated the potential of AEBP1 and COLEC12 genes as effective diagnostic tools for distinguishing between late-onset AD patients and healthy controls. This study unveils the intricate interplay between AEBP1 and COLEC12 in AD and underscores their potential as markers for disease detection and monitoring.\n",
      "Keywords: AEBP1, COLEC12, Alzheimer’s disease, Brain cortex, Diagnosis, mRNA expression profile\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Title: Effects of a Person's Lactation History on Later-Life Development of Alzheimer's Disease: An Integrative Review.\n",
      "Abstract: None\n",
      "Keywords: Alzheimer’s disease, breastfeeding, dementia, human lactation\n",
      "Publication Date: 2024\n",
      "---------------------------------------------------------------------------\n",
      "Finished processing all articles.\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import xml.etree.ElementTree as ET\n",
    "import time\n",
    "\n",
    "def search_article_ids(query, api_key, max_articles):\n",
    "    \"\"\"\n",
    "    Search articles matching the query and return their IDs.\n",
    "    \"\"\"\n",
    "    search_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi\"\n",
    "    params = {\n",
    "        \"db\": \"pubmed\",\n",
    "        \"term\": query,\n",
    "        \"retmode\": \"json\",\n",
    "        \"api_key\": api_key,\n",
    "        \"retmax\": max_articles\n",
    "    }\n",
    "    response = requests.get(search_url, params=params)\n",
    "    if response.status_code == 200:\n",
    "        data = response.json()\n",
    "        article_ids = data[\"esearchresult\"][\"idlist\"]\n",
    "        return article_ids\n",
    "    else:\n",
    "        print(\"Failed to search article IDs:\", response.status_code)\n",
    "        return []\n",
    "\n",
    "def fetch_batch_details(article_ids, api_key):\n",
    "    \"\"\"\n",
    "    Fetch details for a batch of article IDs.\n",
    "    \"\"\"\n",
    "    fetch_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi\"\n",
    "    params = {\n",
    "        \"db\": \"pubmed\",\n",
    "        \"retmode\": \"xml\",\n",
    "        \"id\": \",\".join(article_ids),\n",
    "        \"api_key\": api_key\n",
    "    }\n",
    "    response = requests.get(fetch_url, params=params)\n",
    "    if response.status_code == 200:\n",
    "        return response.text\n",
    "    else:\n",
    "        print(f\"Failed to fetch article details: {response.status_code}\")\n",
    "        return None\n",
    "\n",
    "def parse_and_print_article_details(xml_data):\n",
    "    \"\"\"\n",
    "    Parse and print article titles, abstracts, keywords, and publication dates from XML data.\n",
    "    \"\"\"\n",
    "    root = ET.fromstring(xml_data)\n",
    "    for article in root.findall('.//PubmedArticle'):\n",
    "        title = article.find('.//ArticleTitle').text\n",
    "        \n",
    "        abstract = article.find('.//Abstract/AbstractText')\n",
    "        abstract_text = abstract.text if abstract is not None else \"Abstract not available\"\n",
    "        \n",
    "        # Extracting Keywords\n",
    "        keywords = article.find('.//KeywordList')\n",
    "        if keywords is not None:\n",
    "            keywords_text = ', '.join([kw.text for kw in keywords.findall('.//Keyword')])\n",
    "        else:\n",
    "            keywords_text = \"Keywords not available\"\n",
    "        \n",
    "        # Extracting Publication Date\n",
    "        pub_date = article.find('.//PubDate')\n",
    "        year = pub_date.find('Year')\n",
    "        if year is not None:\n",
    "            publication_date = year.text\n",
    "        else:\n",
    "            medline_date = pub_date.find('MedlineDate')\n",
    "            publication_date = medline_date.text if medline_date is not None else \"Publication date not available\"\n",
    "        \n",
    "        print(f\"Title: {title}\\nAbstract: {abstract_text}\\nKeywords: {keywords_text}\\nPublication Date: {publication_date}\")\n",
    "        print(\"-\" * 75)\n",
    "\n",
    "api_key = \"\"  # Replace with your actual API key\n",
    "query = \"Alzheimer's disease\"\n",
    "max_articles = 50  # Adjust based on how many articles you want to process\n",
    "\n",
    "# Step 1: Search for articles and get their IDs\n",
    "article_ids = search_article_ids(query, api_key, max_articles)\n",
    "\n",
    "# Step 2: Fetch and print details in batches\n",
    "batch_size = 10\n",
    "for i in range(0, len(article_ids), batch_size):\n",
    "    batch_ids = article_ids[i:i+batch_size]\n",
    "    xml_data = fetch_batch_details(batch_ids, api_key)\n",
    "    if xml_data:\n",
    "        parse_and_print_article_details(xml_data)\n",
    "    time.sleep(1)  # Be respectful to the server\n",
    "\n",
    "print(\"Finished processing all articles.\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Modifying  the code to get information we needed."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Printing articles details to see what kind a information available for us to use"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<?xml version=\"1.0\" ?>\n",
      "<!DOCTYPE PubmedArticleSet\n",
      "  PUBLIC '-//NLM//DTD PubMedArticle, 1st January 2024//EN'\n",
      "  'https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd'>\n",
      "<PubmedArticleSet>\n",
      "\t\n",
      "\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Curated\">\n",
      "\t\t\t<PMID Version=\"1\">38441832</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2024</Year>\n",
      "\t\t\t\t<Month>06</Month>\n",
      "\t\t\t\t<Day>05</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2024</Year>\n",
      "\t\t\t\t<Month>06</Month>\n",
      "\t\t\t\t<Day>08</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">2190-3948</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>14</Volume>\n",
      "\t\t\t\t\t\t<Issue>7</Issue>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2024</Year>\n",
      "\t\t\t\t\t\t\t<Month>Jul</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Drug delivery and translational research</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Drug Deliv Transl Res</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>1776</StartPage>\n",
      "\t\t\t\t\t<EndPage>1793</EndPage>\n",
      "\t\t\t\t\t<MedlinePgn>1776-1793</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s13346-024-01558-1</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText>This comprehensive review delves into the potential of intranasal insulin delivery for managing Alzheimer's Disease (AD) while exploring the connection between AD and diabetes mellitus (DM). Both conditions share features of insulin signalling dysregulation and oxidative stress that accelerate inflammatory response. Given the physiological barriers to brain drug delivery, including the blood-brain barrier, intranasal administration emerges as a non-invasive alternative. Notably, intranasal insulin has shown neuroprotective effects, impacting Aβ clearance, tau phosphorylation, and synaptic plasticity. In preclinical studies and clinical trials, intranasally administered insulin achieved rapid and extensive distribution throughout the brain, with optimal formulations exhibiting minimal systemic circulation. The detailed mechanism of insulin transport through the nose-to-brain pathway is elucidated in the review, emphasizing the role of olfactory and trigeminal nerves. Despite promising prospects, challenges in delivering protein drugs from the nasal cavity to the brain remain, including enzymes, tight junctions, mucociliary clearance, and precise drug deposition, which hinder its translation to clinical settings. The review encompasses a discussion of the strategies to enhance the intranasal delivery of therapeutic proteins, such as tight junction modulators, cell-penetrating peptides, and nano-drug carrier systems. Moreover, successful translation of nose-to-brain drug delivery necessitates a holistic understanding of drug transport mechanisms, brain anatomy, and nasal formulation optimization. To date, no intranasal insulin formulation has received regulatory approval for AD treatment. Future research should address challenges related to drug absorption, nasal deposition, and the long-term effects of intranasal insulin. In this context, the evaluation of administration devices for nose-to-brain drug delivery becomes crucial in ensuring precise drug deposition patterns and enhancing bioavailability.</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>© 2024. The Author(s).</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Wong</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Chun Yuen Jerry</ForeName>\n",
      "\t\t\t\t\t\t<Initials>CYJ</Initials>\n",
      "\t\t\t\t\t\t<Identifier Source=\"ORCID\">0000-0001-6132-6432</Identifier>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Respiratory Technology, Woolcock Institute of Medical Research, Sydney, NSW, 2037, Australia.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Faculty of Medicine and Health Sciences, Macquarie Medical School, Macquarie University, Sydney, NSW, 2109, Australia.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Baldelli</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Alberto</ForeName>\n",
      "\t\t\t\t\t\t<Initials>A</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Faculty of Land and Food Systems, The University of British Columbia, 2357 Main Mall, Vancouver, BC, V6T 1Z4, Canada.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Hoyos</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Camilla M</ForeName>\n",
      "\t\t\t\t\t\t<Initials>CM</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Faculty of Medicine and Health Sciences, Macquarie Medical School, Macquarie University, Sydney, NSW, 2109, Australia.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>CIRUS Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, Sydney, NSW, 2037, Australia.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Tietz</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Ole</ForeName>\n",
      "\t\t\t\t\t\t<Initials>O</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Dementia Research Centre, Faculty of Medicine and Health Sciences, Macquarie Medical School, Macquarie University, Sydney, NSW, 2109, Australia.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Ong</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Hui Xin</ForeName>\n",
      "\t\t\t\t\t\t<Initials>HX</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Respiratory Technology, Woolcock Institute of Medical Research, Sydney, NSW, 2037, Australia. huixin.ong@mq.edu.au.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Faculty of Medicine and Health Sciences, Macquarie Medical School, Macquarie University, Sydney, NSW, 2109, Australia. huixin.ong@mq.edu.au.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Traini</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Daniela</ForeName>\n",
      "\t\t\t\t\t\t<Initials>D</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Respiratory Technology, Woolcock Institute of Medical Research, Sydney, NSW, 2037, Australia. daniela.traini@mq.edu.au.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Faculty of Medicine and Health Sciences, Macquarie Medical School, Macquarie University, Sydney, NSW, 2109, Australia. daniela.traini@mq.edu.au.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<GrantList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>APP1173363</GrantID>\n",
      "\t\t\t\t\t\t<Agency>National Health and Medical Research Council</Agency>\n",
      "\t\t\t\t\t\t<Country/>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t</GrantList>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016454\">Review</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2024</Year>\n",
      "\t\t\t\t\t<Month>03</Month>\n",
      "\t\t\t\t\t<Day>05</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t<MedlineTA>Drug Deliv Transl Res</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>101540061</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>2190-393X</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D007328\">Insulin</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D007004\">Hypoglycemic Agents</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000544\" MajorTopicYN=\"Y\">Alzheimer Disease</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000281\" MajorTopicYN=\"Y\">Administration, Intranasal</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007328\" MajorTopicYN=\"Y\">Insulin</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000008\" MajorTopicYN=\"N\">administration &amp; dosage</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000493\" MajorTopicYN=\"N\">pharmacokinetics</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001921\" MajorTopicYN=\"Y\">Brain</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D016503\" MajorTopicYN=\"N\">Drug Delivery Systems</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007004\" MajorTopicYN=\"N\">Hypoglycemic Agents</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000008\" MajorTopicYN=\"N\">administration &amp; dosage</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000493\" MajorTopicYN=\"N\">pharmacokinetics</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D009297\" MajorTopicYN=\"N\">Nasal Mucosa</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Alzheimer’s Disease</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Blood-brain barrier</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Insulin</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Nasal Delivery</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Peptides</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t\t<CoiStatement>The authors have no relevant financial or non-financial interests to disclose.</CoiStatement>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2024</Year>\n",
      "\t\t\t\t\t<Month>2</Month>\n",
      "\t\t\t\t\t<Day>19</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2024</Year>\n",
      "\t\t\t\t\t<Month>6</Month>\n",
      "\t\t\t\t\t<Day>5</Day>\n",
      "\t\t\t\t\t<Hour>13</Hour>\n",
      "\t\t\t\t\t<Minute>12</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2024</Year>\n",
      "\t\t\t\t\t<Month>3</Month>\n",
      "\t\t\t\t\t<Day>5</Day>\n",
      "\t\t\t\t\t<Hour>12</Hour>\n",
      "\t\t\t\t\t<Minute>43</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2024</Year>\n",
      "\t\t\t\t\t<Month>3</Month>\n",
      "\t\t\t\t\t<Day>5</Day>\n",
      "\t\t\t\t\t<Hour>11</Hour>\n",
      "\t\t\t\t\t<Minute>26</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pmc-release\">\n",
      "\t\t\t\t\t<Year>2024</Year>\n",
      "\t\t\t\t\t<Month>3</Month>\n",
      "\t\t\t\t\t<Day>5</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">38441832</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pmc\">PMC11153287</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1007/s13346-024-01558-1</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">10.1007/s13346-024-01558-1</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t\t<ReferenceList>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Salameh TS, et al. Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition. J Alzheimers Dis. 2015;47(3):715–728. doi: 10.3233/JAD-150307.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3233/JAD-150307</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6080853</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26401706</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Rosenbloom M, et al. A phase II, single-center, randomized, double-blind, placebo-controlled study of the safety and therapeutic efficacy of intranasal glulisine in amnestic mild cognitive impairment and probable mild alzheimer's disease. Drugs Aging. 2021;38(5):407–415. doi: 10.1007/s40266-021-00845-7.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1007/s40266-021-00845-7</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33719017</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Akel H, et al. In vitro comparative study of solid lipid and PLGA nanoparticles designed to facilitate nose-to-brain delivery of insulin. Int J Mol Sci. 2021;22(24):13258. doi: 10.3390/ijms222413258.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3390/ijms222413258</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8703723</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34948054</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Agrawal M, et al. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release. 2018;281:139–177. doi: 10.1016/j.jconrel.2018.05.011.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jconrel.2018.05.011</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29772289</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Maher MA, et al. Histopathological evaluation of insulin-DMSO formula designed for direct nose-to-brain delivery. Histol Histopathol. 2021;37(5):431–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35040114</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Gaddam M, et al. A Comprehensive Review of Intranasal Insulin and Its Effect on the Cognitive Function of Diabetics. Cureus. 2021;13(8):e17219.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8442633</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34540446</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Hölscher C. Insulin signaling impairment in the brain as a risk factor in alzheimer's disease. Front Aging Neurosci. 2019;11:88. doi: 10.3389/fnagi.2019.00088.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3389/fnagi.2019.00088</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6491455</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31068799</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Stockhorst U, et al. Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans. Physiol Behav. 2004;83(1):47–54. doi: 10.1016/S0031-9384(04)00348-8.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/S0031-9384(04)00348-8</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">15501490</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kamei N, Takeda-Morishita M. Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides. J Control Release. 2015;197:105–110. doi: 10.1016/j.jconrel.2014.11.004.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jconrel.2014.11.004</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">25445695</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Hoyos CM, et al. Brain oxidative stress and cognitive function in older adults with diabetes and pre-diabetes who are at risk for dementia. Diabetes Res Clin Pract. 2022;184:109178. doi: 10.1016/j.diabres.2021.109178.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.diabres.2021.109178</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34958845</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Hölscher C. Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases. Biochem Soc Trans. 2014;42(2):593–599. doi: 10.1042/BST20140016.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1042/BST20140016</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">24646283</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wingrove J, et al. Characterisation of nasal devices for delivery of insulin to the brain and evaluation in humans using functional magnetic resonance imaging. J Control Release. 2019;302:140–147. doi: 10.1016/j.jconrel.2019.03.032.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jconrel.2019.03.032</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30953665</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Dholakia J, Prabhakar B, Shende P. Strategies for the delivery of antidiabetic drugs via intranasal route. Int J Pharm. 2021;608:121068. doi: 10.1016/j.ijpharm.2021.121068.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2021.121068</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34481011</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Marso SP, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311–322. doi: 10.1056/NEJMoa1603827.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1056/NEJMoa1603827</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC4985288</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27295427</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Maigler F, et al. Selective CNS targeting and distribution with a refined region-specific intranasal delivery technique via the olfactory mucosa. Pharmaceutics. 2021;13(11):1904. doi: 10.3390/pharmaceutics13111904.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3390/pharmaceutics13111904</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8620656</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34834319</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Picone P, et al. Nose-to-brain delivery of insulin enhanced by a nanogel carrier. J Control Release. 2018;270:23–36. doi: 10.1016/j.jconrel.2017.11.040.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jconrel.2017.11.040</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29196041</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Nørgaard CH, et al. Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers. Alzheimers Dement (N Y) 2022;8(1):e12268. doi: 10.1002/trc2.12268.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1002/trc2.12268</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8864443</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35229024</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kamei N, et al. Investigation of the transport pathways associated with enhanced brain delivery of peptide drugs by intranasal coadministration with penetratin. Pharmaceutics. 2021;13(11):1745. doi: 10.3390/pharmaceutics13111745.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3390/pharmaceutics13111745</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8618983</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34834159</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Sabbagh F, et al. Recent progress in polymeric non-invasive insulin delivery. Int J Biol Macromol. 2022;203:222–243. doi: 10.1016/j.ijbiomac.2022.01.134.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijbiomac.2022.01.134</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35101478</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, Martinez J, Dass CR. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities. J Pharm Pharmacol. 2016;68(9):1093–1108. doi: 10.1111/jphp.12607.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1111/jphp.12607</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27364922</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, et al. In-vitro evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor. J Pharm Pharmacol. 2017;69(3):285–294. doi: 10.1111/jphp.12694.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1111/jphp.12694</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28155991</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, Al-Salami H, Dass CR. C2C12 cell model: its role in understanding of insulin resistance at the molecular level and pharmaceutical development at the preclinical stage. J Pharm Pharmacol. 2020;72(12):1667–1693. doi: 10.1111/jphp.13359.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1111/jphp.13359</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32812252</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, Al-Salami H, Dass CR. Fabrication techniques for the preparation of orally administered insulin nanoparticles. J Drug Target. 2021;29(4):365–386. doi: 10.1080/1061186X.2020.1817042.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/1061186X.2020.1817042</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32876505</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CYJ, Al-Salami H, Dass CR. β-Cyclodextrin-containing chitosan-oligonucleotide nanoparticles improve insulin bioactivity, gut cellular permeation and glucose consumption. J Pharm Pharmacol. 2021;73(6):726–739. doi: 10.1093/jpp/rgaa052.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1093/jpp/rgaa052</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33769519</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Hamidovic A. Targeting Mediators of Smoking Persistence with Intranasal Insulin. Front Pharmacol. 2017;8:706. doi: 10.3389/fphar.2017.00706.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3389/fphar.2017.00706</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5649209</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29085297</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kikuta S, Kuboki A, Yamasoba T. Protective effect of insulin in mouse nasal mucus against olfactory epithelium injury. Front Neural Circuits. 2021;15:803769. doi: 10.3389/fncir.2021.803769.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3389/fncir.2021.803769</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8733614</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35002636</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Lacroix MC, et al. Insulin but not leptin protects olfactory mucosa from apoptosis. J Neuroendocrinol. 2011;23(7):627–640. doi: 10.1111/j.1365-2826.2011.02154.x.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1111/j.1365-2826.2011.02154.x</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">21554433</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Henkin RI. Intranasal insulin: from nose to brain. Nutrition. 2010;26(6):624–633. doi: 10.1016/j.nut.2009.08.003.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.nut.2009.08.003</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20022470</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kashyap B, Hanson LR, Frey WH., II Intranasal insulin: a treatment strategy for addiction. Neurotherapeutics. 2020;17(1):105–115. doi: 10.1007/s13311-019-00822-4.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1007/s13311-019-00822-4</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7007475</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31898283</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Heni M, et al. Hypothalamic and striatal insulin action suppresses endogenous glucose production and may stimulate glucose uptake during hyperinsulinemia in lean but not in overweight men. Diabetes. 2017;66(7):1797–1806. doi: 10.2337/db16-1380.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.2337/db16-1380</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28174292</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Henkin RI. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action. Nutrition. 2010;26(1):33–39. doi: 10.1016/j.nut.2009.08.001.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.nut.2009.08.001</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20005465</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Gao M, et al. Effect of glyceryl monocaprylate-modified chitosan on the intranasal absorption of insulin in rats. J Pharm Sci. 2019;108(11):3623–3629. doi: 10.1016/j.xphs.2019.07.012.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.xphs.2019.07.012</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31356762</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Heni M, et al. Insulin action in the hypothalamus increases second-phase insulin secretion in humans. Neuroendocrinology. 2020;110(11–12):929–937. doi: 10.1159/000504551.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1159/000504551</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31689708</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Takano K, et al. A novel drug delivery system for the human nasal epithelium. Adv Otorhinolaryngol. 2016;77:67–74.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27116461</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zwanenburg RJ, et al. Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial. Eur J Hum Genet. 2016;24(12):1696–1701. doi: 10.1038/ejhg.2016.109.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1038/ejhg.2016.109</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5117914</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27577546</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Chung S, et al. The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters. Epilepsy Behav Rep. 2023;21:100581. doi: 10.1016/j.ebr.2022.100581.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ebr.2022.100581</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC9829802</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">36636458</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Illum L. Nasal clearance in health and disease. J Aerosol Med. 2006;19(1):92–99. doi: 10.1089/jam.2006.19.92.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1089/jam.2006.19.92</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">16551220</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Huang Y, Donovan MD. Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption. Adv Drug Deliv Rev. 1998;29(1–2):147–155.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">10837585</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Vazquez B, et al. Lack of observed impact of history or concomitant treatment of seasonal allergies or rhinitis on repeated doses of diazepam nasal spray administered per seizure episode in a day, safety, and tolerability: Interim results from a phase 3, open-label, 12-month repeat-dose safety study. Epilepsy Behav. 2021;118:107898. doi: 10.1016/j.yebeh.2021.107898.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.yebeh.2021.107898</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33752044</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Lochhead JJ, et al. Distribution of insulin in trigeminal nerve and brain after intranasal administration. Sci Rep. 2019;9(1):2621. doi: 10.1038/s41598-019-39191-5.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1038/s41598-019-39191-5</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6385374</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30796294</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Hinchcliffe M, Illum L. Intranasal insulin delivery and therapy. Adv Drug Deliv Rev. 1999;35(2–3):199–234. doi: 10.1016/S0169-409X(98)00073-8.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/S0169-409X(98)00073-8</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">10837698</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Shah RB, et al. Insulin delivery methods: Past, present and future. Int J Pharm Investig. 2016;6(1):1–9. doi: 10.4103/2230-973X.176456.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.4103/2230-973X.176456</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC4787057</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27014614</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kamei N, et al. Visualization and quantitative assessment of the brain distribution of insulin through nose-to-brain delivery based on the cell-penetrating peptide noncovalent strategy. Mol Pharm. 2016;13(3):1004–1011. doi: 10.1021/acs.molpharmaceut.5b00854.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1021/acs.molpharmaceut.5b00854</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26795701</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Gänger S, Schindowski K. Tailoring formulations for intranasal nose-to-brain delivery: A Review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics. 2018;10(3):116. doi: 10.3390/pharmaceutics10030116.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3390/pharmaceutics10030116</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6161189</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30081536</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Shah D, et al. Intranasal delivery of insulin by self-emulsified nanoemulsion system: In vitro and in vivo studies. Int J Pharm. 2022;616:121565. doi: 10.1016/j.ijpharm.2022.121565.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2022.121565</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35150847</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Goycoolea FM, et al. Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules. Biomacromol. 2009;10(7):1736–1743. doi: 10.1021/bm9001377.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1021/bm9001377</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">19545119</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zheng C, et al. Amphiphilic glycopolymer nanoparticles as vehicles for nasal delivery of peptides and proteins. Eur J Pharm Sci. 2013;49(4):474–482. doi: 10.1016/j.ejps.2013.04.027.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ejps.2013.04.027</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">23648782</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Jain AK, et al. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery. J Drug Target. 2007;15(6):417–427. doi: 10.1080/10611860701453653.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/10611860701453653</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">17613660</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Muramatsu K, et al. The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits. Drug Dev Ind Pharm. 1999;25(10):1099–1105. doi: 10.1081/DDC-100102275.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1081/DDC-100102275</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">10529890</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kojima T, et al. Claudin-binder C-CPE mutants enhance permeability of insulin across human nasal epithelial cells. Drug Deliv. 2016;23(8):2703–2710. doi: 10.3109/10717544.2015.1050530.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3109/10717544.2015.1050530</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26036653</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Nazar H, Tsibouklis J. Towards the nasal delivery of insulin. Ther Deliv. 2012;3(11):1241–1243. doi: 10.4155/tde.12.120.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.4155/tde.12.120</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">23259244</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Nazar H, et al. A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluation. Biomater Sci. 2013;1(3):306–314. doi: 10.1039/C2BM00132B.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1039/C2BM00132B</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32481855</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Krauland AH, Guggi D, Bernkop-Schnürch A. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. Int J Pharm. 2006;307(2):270–277. doi: 10.1016/j.ijpharm.2005.10.016.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2005.10.016</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">16300914</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Luppi B, et al. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery. J Pharm Pharmacol. 2009;61(2):151–157. doi: 10.1211/jpp.61.02.0003.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1211/jpp.61.02.0003</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">19178761</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Sajadi Tabassi SA, et al. Isolation, characterization and study of enhancing effects on nasal absorption of insulin in rat of the total saponin from Acanthophyllum squarrosum. Curr Drug Deliv. 2006;3(4):399–404. doi: 10.2174/156720106778559065.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.2174/156720106778559065</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">17076642</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Duan X, Mao S. New strategies to improve the intranasal absorption of insulin. Drug Discov Today. 2010;15(11–12):416–427. doi: 10.1016/j.drudis.2010.03.011.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.drudis.2010.03.011</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20359545</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Liu E, et al. CPP mediated insulin delivery: current status and promising future. Curr Pharm Biotechnol. 2014;15(3):240–255. doi: 10.2174/1389201015666140813125840.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.2174/1389201015666140813125840</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">25312540</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Natsheh H, Touitou E. Phospholipid Magnesome-a nasal vesicular carrier for delivery of drugs to brain. Drug Deliv Transl Res. 2018;8(3):806–819. doi: 10.1007/s13346-018-0503-y.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1007/s13346-018-0503-y</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29524165</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CYJ, Ong HX, Traini D. The application of in vitro cellular assays for analysis of electronic cigarettes impact on the airway. Life Sci. 2022;298:120487. doi: 10.1016/j.lfs.2022.120487.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.lfs.2022.120487</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35311658</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Illum L, Farraj NF, Davis SS. Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res. 1994;11(8):1186–1189. doi: 10.1023/A:1018901302450.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1023/A:1018901302450</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">7971722</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Jintapattanakit A, et al. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats. J Pharm Pharmacol. 2010;62(5):583–591. doi: 10.1211/jpp.62.05.0004.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1211/jpp.62.05.0004</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20609059</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>el Khafagy S, et al. Effect of cell-penetrating peptides on the nasal absorption of insulin. J Control Release. 2009;133(2):103–108. doi: 10.1016/j.jconrel.2008.09.076.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jconrel.2008.09.076</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">18930084</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Khafagy El-S, Morishita M, Takayama K. The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides. Int J Pharm. 2010;388(1):209–12. doi: 10.1016/j.ijpharm.2009.12.060.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2009.12.060</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20060451</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Bae HD, et al. Optimization of formulation for enhanced intranasal delivery of insulin with translationally controlled tumor protein-derived protein transduction domain. Drug Deliv. 2019;26(1):622–628. doi: 10.1080/10717544.2019.1628119.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/10717544.2019.1628119</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6586149</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31210056</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kamei N, et al. Noninvasive insulin delivery: the great potential of cell-penetrating peptides. Ther Deliv. 2013;4(3):315–326. doi: 10.4155/tde.12.164.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.4155/tde.12.164</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">23442079</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kim NA, et al. Enhanced intranasal insulin delivery by formulations and tumor protein-derived protein transduction domain as an absorption enhancer. J Control Release. 2019;294:226–236. doi: 10.1016/j.jconrel.2018.12.023.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jconrel.2018.12.023</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30557648</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Bae HD, et al. Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin. Drug Deliv. 2018;25(1):1025–1032. doi: 10.1080/10717544.2018.1464081.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/10717544.2018.1464081</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6058520</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29688087</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, Al-Salami H, Dass CR. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment. J Control Release. 2017;264:247–275. doi: 10.1016/j.jconrel.2017.09.003.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jconrel.2017.09.003</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28887133</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, Al-Salami H, Dass CR. Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin. Int J Pharm. 2018;537(1–2):223–244. doi: 10.1016/j.ijpharm.2017.12.036.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2017.12.036</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29288095</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, Al-Salami H, Dass CR. The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation. J Drug Target. 2018;26(7):551–562. doi: 10.1080/1061186X.2017.1400552.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/1061186X.2017.1400552</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29095650</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, Al-Salami H, Dass CR. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus. Int J Pharm. 2018;549(1–2):201–217. doi: 10.1016/j.ijpharm.2018.07.041.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2018.07.041</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30071309</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, et al. Quantification of BSA-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography. Anal Bioanal Chem. 2018;410(27):6991–7006. doi: 10.1007/s00216-018-1319-9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1007/s00216-018-1319-9</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30206665</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, et al. Bio-nanotechnological advancement of orally administered insulin nanoparticles: Comprehensive review of experimental design for physicochemical characterization. Int J Pharm. 2019;572:118720. doi: 10.1016/j.ijpharm.2019.118720.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2019.118720</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31715357</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, Al-Salami H, Dass CR. Lyophilisation improves bioactivity and stability of insulin-loaded polymeric-oligonucleotide nanoparticles for diabetes treatment. AAPS PharmSciTech. 2020;21(3):108. doi: 10.1208/s12249-020-01648-6.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1208/s12249-020-01648-6</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32215761</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, Al-Salami H, Dass CR. Formulation and characterisation of insulin-loaded chitosan nanoparticles capable of inducing glucose uptake in skeletal muscle cells in vitro. Journal of Drug Delivery Science and Technology. 2020;57:101738. doi: 10.1016/j.jddst.2020.101738.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jddst.2020.101738</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, Al-Salami H, Dass CR. Cellular assays and applied technologies for characterisation of orally administered protein nanoparticles: a systematic review. J Drug Target. 2020;28(6):585–599. doi: 10.1080/1061186X.2020.1726356.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/1061186X.2020.1726356</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32013626</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, et al. Development of orally administered insulin-loaded polymeric-oligonucleotide nanoparticles: Statistical optimization and physicochemical characterization. Drug Dev Ind Pharm. 2020;46(8):1238–1252. doi: 10.1080/03639045.2020.1788061.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/03639045.2020.1788061</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32597264</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CY, Al-Salami H, Dass CR. Current status and applications of animal models in pre-clinical development of orally administered insulin-loaded nanoparticles. J Drug Target. 2020;28(9):882–903. doi: 10.1080/1061186X.2020.1759078.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/1061186X.2020.1759078</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32310678</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Yu S, et al. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies. Int J Pharm. 2004;281(1–2):11–23. doi: 10.1016/j.ijpharm.2004.05.007.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2004.05.007</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">15288339</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Mauri E, et al. Synthesis of nanogels: Current trends and future outlook. Gels. 2021;7(2):36. doi: 10.3390/gels7020036.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3390/gels7020036</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8103252</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33805279</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Camlik G, et al. A new approach for the treatment of Alzheimer's disease: insulin-quantum dots. J Microencapsul. 2024;41(1):18–26. doi: 10.1080/02652048.2023.2282968.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/02652048.2023.2282968</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">37966713</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Le N, Kim K. Current advances in the biomedical applications of quantum dots: Promises and challenges. Int J Mol Sci. 2023;24(16):12682. doi: 10.3390/ijms241612682.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3390/ijms241612682</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC10454335</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">37628860</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Jha S, et al. Pharmaceutical potential of quantum dots. Artif Cells Nanomed Biotechnol. 2018;46(sup1):57–65. doi: 10.1080/21691401.2017.1411932.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/21691401.2017.1411932</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29216759</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zhao D, et al. Luminescent ZnO quantum dots for sensitive and selective detection of dopamine. Talanta. 2013;107:133–139. doi: 10.1016/j.talanta.2013.01.006.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.talanta.2013.01.006</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">23598203</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Liu Y, et al. Graphene quantum dots for the inhibition of β amyloid aggregation. Nanoscale. 2015;7(45):19060–19065. doi: 10.1039/C5NR06282A.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1039/C5NR06282A</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26515666</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Azam N, Najabat Ali M, Javaid Khan T. Carbon quantum dots for biomedical applications: Review and analysis. Front Mater. 2021;8:700403. doi: 10.3389/fmats.2021.700403.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3389/fmats.2021.700403</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Song Y, et al. Carbon quantum dots from roasted Atlantic salmon (Salmo salar L.): Formation, biodistribution and cytotoxicity. Food Chem. 2019;293:387–395. doi: 10.1016/j.foodchem.2019.05.017.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.foodchem.2019.05.017</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31151626</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Pringels E, et al. Influence of deposition and spray pattern of nasal powders on insulin bioavailability. Int J Pharm. 2006;310(1–2):1–7. doi: 10.1016/j.ijpharm.2005.10.049.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2005.10.049</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">16427222</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Moses AC, et al. Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects. Diabetes. 1983;32(11):1040–7. doi: 10.2337/diab.32.11.1040.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.2337/diab.32.11.1040</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">6357902</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Komalla V, et al. Advances in soft mist inhalers. Expert Opin Drug Deliv. 2023;20(8):1055–70. doi: 10.1080/17425247.2023.2231850.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/17425247.2023.2231850</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">37385962</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Baldelli A, et al. Impact of amino acids on the properties of nasal dry powders. J Drug Deliv Sci Technol. 2023;87:104848. doi: 10.1016/j.jddst.2023.104848.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jddst.2023.104848</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Claxton A, et al. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. J Alzheimers Dis. 2015;44(3):897–906. doi: 10.3233/JAD-141791.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3233/JAD-141791</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">25374101</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>El-Mekawy RE, Jassas RS. Recent trends in smart and flexible three-dimensional cross-linked polymers: Synthesis of chitosan-ZnO nanocomposite hydrogels for insulin drug delivery. Medchemcomm. 2017;8(5):897–906. doi: 10.1039/C6MD00580B.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1039/C6MD00580B</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6072029</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30108805</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Gao M, Shen X, Mao S. Factors influencing drug deposition in thenasal cavity upon delivery via nasal sprays. J Pharm Investig. 2020;50(3):251–259. doi: 10.1007/s40005-020-00482-z.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1007/s40005-020-00482-z</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Salzman R, et al. Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes. N Engl J Med. 1985;312(17):1078–84. doi: 10.1056/NEJM198504253121702.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1056/NEJM198504253121702</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">3885035</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Djupesland PG, et al. Breath actuated device improves felivery to target sites beyond the nasal valve. Laryngoscope. 2006;116(3):466–472. doi: 10.1097/01.MLG.0000199741.08517.99.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1097/01.MLG.0000199741.08517.99</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">16540911</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Siu J, et al. Comparison of sinus deposition from an aqueous nasal spray and pressurised MDI in a post-dndoscopic sinus surgery nasal replica. Pharm Res. 2022;39(2):317–327. doi: 10.1007/s11095-021-03129-2.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1007/s11095-021-03129-2</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8881262</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35137359</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Shahi SR, Pardeshi CV. Chapter 21 - A technology overview on advanced drug administration devices for effective nose-to-brain delivery, in Direct Nose-to-Brain Drug Delivery. In: Souto EB, editor. CV Pardeshi. Academic Press; 2021. pp. 417–27.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Renner DB, et al. Intranasal delivery of insulin via the olfactory nerve pathway. J Pharm Pharmacol. 2012;64(12):1709–1714. doi: 10.1111/j.2042-7158.2012.01555.x.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1111/j.2042-7158.2012.01555.x</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">23146033</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Pang Y, et al. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats. Neuroscience. 2016;318:157–165. doi: 10.1016/j.neuroscience.2016.01.020.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.neuroscience.2016.01.020</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC4753102</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26777890</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Plomgaard P, et al. Nasal insulin administration does not affect hepatic glucose production at systemic fasting insulin levels. Diabetes Obes Metab. 2019;21(4):993–1000. doi: 10.1111/dom.13615.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1111/dom.13615</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30552787</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Claxton A, et al. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. J Alzheimers Dis. 2013;35(4):789–797. doi: 10.3233/JAD-122308.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3233/JAD-122308</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC4144993</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">23507773</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Craft S, et al. Effects of regular and long-acting insulin on cognition and alzheimer’s disease biomarkers: A Pilot Clinical Trial. J Alzheimers Dis. 2017;57(4):1325–1334. doi: 10.3233/JAD-161256.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3233/JAD-161256</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5409050</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28372335</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Hölscher C. First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease. Alzheimers Dement. 2014;10(1 Suppl):S33–S37.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">24529523</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Heni M, et al. Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions. Diabetologia. 2012;55(6):1773–1782. doi: 10.1007/s00125-012-2528-y.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1007/s00125-012-2528-y</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">22434537</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Stein MS, et al. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease. J Alzheimers Dis. 2011;26(3):477–484. doi: 10.3233/JAD-2011-110149.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3233/JAD-2011-110149</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">21694461</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kullmann S, et al. Dose-dependent effects of intranasal insulin on resting-state brain activity. J Clin Endocrinol Metab. 2018;103(1):253–262. doi: 10.1210/jc.2017-01976.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1210/jc.2017-01976</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29095982</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Xiao C, et al. Effects of intranasal insulin on triglyceride-rich lipoprotein particle production in healthy men. Arterioscler Thromb Vasc Biol. 2017;37(9):1776–1781. doi: 10.1161/ATVBAHA.117.309705.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1161/ATVBAHA.117.309705</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28751575</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Lowe S, et al. An assessment of the central disposition of intranasally administered insulin lispro in the cerebrospinal fluid of healthy volunteers and beagle dogs. Drug Deliv Transl Res. 2017;7(1):11–15. doi: 10.1007/s13346-016-0325-8.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1007/s13346-016-0325-8</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27553192</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Callens C, et al. Rheological study on mucoadhesivity of some nasal powder formulations. Eur J Pharm Biopharm. 2003;55(3):323–328. doi: 10.1016/S0939-6411(03)00024-9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/S0939-6411(03)00024-9</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">12754007</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Craft S, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial. Arch Neurol. 2012;69(1):29–38. doi: 10.1001/archneurol.2011.233.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1001/archneurol.2011.233</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC3260944</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">21911655</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Schmid V, et al. Safety of intranasal human insulin: A review. Diabetes Obes Metab. 2018;20(7):1563–1577. doi: 10.1111/dom.13279.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1111/dom.13279</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29508509</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zhang K, et al. Adipose tissue insulin resistance is closely associated with metabolic syndrome in northern chinese populations. Diabetes Metab Syndr Obes. 2021;14:1117–1128. doi: 10.2147/DMSO.S291350.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.2147/DMSO.S291350</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7965693</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33737823</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Cernea S, Raz I. Insulin therapy: Future perspectives. Am J Ther. 2020;27(1):e121–e132. doi: 10.1097/MJT.0000000000001076.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1097/MJT.0000000000001076</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31567147</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Illum L, Davis SS. Intranasal insulin. Clinical pharmacokinetics. Clin Pharmacokinet. 1992;23(1):30–41. doi: 10.2165/00003088-199223010-00003.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.2165/00003088-199223010-00003</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">1617857</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Benedict C, et al. Immediate but not long-term intranasal administration of insulin raises blood pressure in human beings. Metabolism. 2005;54(10):1356–1361. doi: 10.1016/j.metabol.2005.04.026.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.metabol.2005.04.026</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">16154436</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Tanaka A, et al. Nasal absorption of macromolecules from powder formulations and effects of sodium carboxymethyl cellulose on their absorption. PLoS ONE. 2016;11(9):e0159150. doi: 10.1371/journal.pone.0159150.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1371/journal.pone.0159150</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5012702</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27598527</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Chaugule V, et al. Combining experimental and computational techniques to understand and improve dry powder inhalers. Expert Opin Drug Deliv. 2022;19(1):59–73. doi: 10.1080/17425247.2022.2026922.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/17425247.2022.2026922</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34989629</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Marasini N, et al. Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles. Int J Pharm. 2022;624:121989. doi: 10.1016/j.ijpharm.2022.121989.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2022.121989</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35809834</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong CYJ, et al. Validation of a cell integrated next-generation impactor to assess in vitro drug transport of physiologically relevant aerosolised particles. Int J Pharm. 2022;624:122024. doi: 10.1016/j.ijpharm.2022.122024.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2022.122024</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35843365</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zhang Y, et al. Microfluidics assembly of inhalable liposomal ciprofloxacin characterised by an innovative in vitro pulmonary model. Int J Pharm. 2023;635:122667. doi: 10.1016/j.ijpharm.2023.122667.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2023.122667</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">36738806</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wong C, et al. Engineered dry powders for the nose-to-brain delivery of transforming growth factor-beta. Eur J Pharm Biopharm. 2023;189:202–211. doi: 10.1016/j.ejpb.2023.06.015.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ejpb.2023.06.015</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">37364750</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Pillion DJ, Fyrberg MD, Meezan E. Nasal absorption of mixtures of fast-acting and long-acting insulins. Int J Pharm. 2010;388(1–2):202–208. doi: 10.1016/j.ijpharm.2010.01.013.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ijpharm.2010.01.013</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC2834479</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20080164</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t</ReferenceList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "</PubmedArticleSet>\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import xml.etree.ElementTree as ET\n",
    "from xml.dom.minidom import parseString\n",
    "\n",
    "def fetch_and_print_article_structure(article_ids, api_key):\n",
    "    \"\"\"\n",
    "    Fetch article details for the given IDs and print the structure of the first article.\n",
    "    \"\"\"\n",
    "    fetch_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi\"\n",
    "    params = {\n",
    "        \"db\": \"pubmed\",\n",
    "        \"retmode\": \"xml\",\n",
    "        \"id\": \",\".join(article_ids),\n",
    "        \"api_key\": api_key\n",
    "    }\n",
    "    response = requests.get(fetch_url, params=params)\n",
    "    if response.status_code == 200:\n",
    "        # Convert response to pretty XML format for easier reading\n",
    "        xml_str = response.text\n",
    "        xml_parse = parseString(xml_str)\n",
    "        pretty_xml_as_string = xml_parse.toprettyxml()\n",
    "        \n",
    "        print(pretty_xml_as_string)\n",
    "    else:\n",
    "        print(f\"Failed to fetch article details: {response.status_code}\")\n",
    "\n",
    "# Example usage\n",
    "api_key = \"\"  # Replace with your actual API key\n",
    "article_ids = [\"38441832\"]  # Example article ID; replace with IDs of interest\n",
    "fetch_and_print_article_structure(article_ids, api_key)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This XML snippet from a PubMed article provides a detailed view of the rich information available for each article in the PubMed database.I just tried for 1 article to get the overview. The structure includes a wide range of fields, from basic bibliographic details to more specific scientific and clinical information. Here's an overview of key fields you can extract for your analysis, especially for research on Alzheimer's disease:\n",
    "\n",
    "\n",
    "* **PMID (PubMed ID)**: The unique identifier for the article.\n",
    "\n",
    "* *Article Title*: The title of the research article.\n",
    "\n",
    "* *Abstract*: A summary of the research findings, often structured into subsections.\n",
    "\n",
    "* *Authors*: List of authors, including their names, initials, affiliations, and sometimes identifiers like ORCID.\n",
    "\n",
    "* *Journal Information*: Details about the journal, including ISSN, title, abbreviation, and issue details.\n",
    "\n",
    "* *Publication Type*: Describes the type of publication, such as Journal Article or Review.\n",
    "\n",
    "* *Language*: The language in which the article is published.\n",
    "\n",
    "* *Keywords*: Keywords associated with the article, which can be crucial for thematic analysis.\n",
    "\n",
    "* *Grant List*: Funding information, including grant IDs and funding agencies.\n",
    "\n",
    "* *Publication Status*: Indicates the publication stage, e.g., \"aheadofprint\".\n",
    "\n",
    "* *References*: Cited references, providing a trail for further exploration or understanding of the research context.\n",
    "\n",
    "* *DOI (Digital Object Identifier)*: A permanent identifier that provides a direct link to the article's online location."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Searching for articles on biomarker: p-tau 181\n",
      "Searching for articles on biomarker: p-tau 205\n",
      "Searching for articles on biomarker: p-tau 217\n",
      "Searching for articles on biomarker: p-tau 231\n",
      "Searching for articles on biomarker: p-tau 243\n",
      "Searching for articles on biomarker: p-tau new/unstated\n",
      "No articles found for biomarker: p-tau new/unstated\n",
      "                                                 title  \\\n",
      "0    The neutrophil to lymphocyte ratio associates ...   \n",
      "1    Associations between multidomain modifiable de...   \n",
      "2    Sensitive detection of multiple blood biomarke...   \n",
      "3    Strong cathode electroluminescence biosensor b...   \n",
      "4    Lifetime Stressful Events Associated with Alzh...   \n",
      "..                                                 ...   \n",
      "281  Differential diagnosis of Alzheimer disease wi...   \n",
      "282  CSF MTBR-tau243 is a specific biomarker of tau...   \n",
      "283  Comparison of the clinical value of MRI and pl...   \n",
      "284  High tau levels in cerebrospinal fluid predict...   \n",
      "285  CSF biomarker levels in early and late onset A...   \n",
      "\n",
      "                                              abstract publication_year  \\\n",
      "0    An elevated neutrophil-lymphocyte ratio (NLR) ...             2024   \n",
      "1    This study aimed to determine associations bet...             2024   \n",
      "2    Blood exosomes are emerging as potential bioma...             2024   \n",
      "3    Electrochemiluminescence (ECL) biosensors prov...             2024   \n",
      "4    Along with the known effects of stress on brai...             2024   \n",
      "..                                                 ...              ...   \n",
      "281  Phosphorylation of tau protein at threonine 23...             2002   \n",
      "282  Aggregated insoluble tau is one of two definin...             2023   \n",
      "283  Dementia has become the main cause of disabili...             2023   \n",
      "284  Increased concentrations of cerebrospinal flui...             2016   \n",
      "285  To compare CSF levels of beta-amyloid 1-42 (Ab...             2009   \n",
      "\n",
      "                                               authors  \n",
      "0    Jacobs, T; Jacobson, SR; Fortea, J; Berger, JS...  \n",
      "1    Bransby, L; Yassi, N; Rosenich, E; Buckley, R;...  \n",
      "2    Hu, S; Zhang, L; Su, Y; Liang, X; Yang, J; Luo...  \n",
      "3    Jiang, YQ; Wei, YP; Liu, XP; Chen, JS; Mao, CJ...  \n",
      "4    Palpatzis, E; Akinci, M; Aguilar-Dominguez, P;...  \n",
      "..                                                 ...  \n",
      "281  Buerger, K; Zinkowski, R; Teipel, SJ; Tapiola,...  \n",
      "282  Horie, K; Salvadó, G; Barthélemy, NR; Janelidz...  \n",
      "283       Wang, W; Shi, L; Ma, H; Zhu, S; Ge, Y; Xu, K  \n",
      "284  Degerman Gunnarsson, M; Ingelsson, M; Blennow,...  \n",
      "285  Bouwman, FH; Schoonenboom, NS; Verwey, NA; van...  \n",
      "\n",
      "[286 rows x 4 columns]\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import xml.etree.ElementTree as ET\n",
    "import pandas as pd\n",
    "import time\n",
    "\n",
    "def search_article_ids(query, api_key, max_articles, biomarker_type):\n",
    "    \"\"\"\n",
    "    Search articles matching the query and biomarker type, return their IDs.\n",
    "    \"\"\"\n",
    "    search_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi\"\n",
    "    params = {\n",
    "        \"db\": \"pubmed\",\n",
    "        \"term\": f\"{query} AND {biomarker_type}[Title/Abstract]\",\n",
    "        \"retmode\": \"json\",\n",
    "        \"api_key\": api_key,\n",
    "        \"retmax\": max_articles\n",
    "    }\n",
    "    response = requests.get(search_url, params=params)\n",
    "    if response.status_code == 200:\n",
    "        data = response.json()\n",
    "        article_ids = data[\"esearchresult\"][\"idlist\"]\n",
    "        return article_ids\n",
    "    else:\n",
    "        print(f\"Failed to search article IDs for {biomarker_type}: {response.status_code}\")\n",
    "        return []\n",
    "\n",
    "def fetch_batch_details(article_ids, api_key):\n",
    "    \"\"\"\n",
    "    Fetch details for a batch of article IDs.\n",
    "    \"\"\"\n",
    "    fetch_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi\"\n",
    "    params = {\n",
    "        \"db\": \"pubmed\",\n",
    "        \"retmode\": \"xml\",\n",
    "        \"id\": \",\".join(article_ids),\n",
    "        \"api_key\": api_key\n",
    "    }\n",
    "    response = requests.get(fetch_url, params=params)\n",
    "    if response.status_code == 200:\n",
    "        return response.text\n",
    "    else:\n",
    "        print(f\"Failed to fetch article details: {response.status_code}\")\n",
    "        return None\n",
    "\n",
    "def parse_article_details(xml_data):\n",
    "    \"\"\"\n",
    "    Parse and collect article details including title, abstract, and potentially other fields.\n",
    "    \"\"\"\n",
    "    root = ET.fromstring(xml_data)\n",
    "    articles_info = []\n",
    "\n",
    "    for article in root.findall('.//PubmedArticle'):\n",
    "        article_info = {\n",
    "            'title': article.find('.//ArticleTitle').text,\n",
    "            'abstract': article.find('.//Abstract/AbstractText').text if article.find('.//Abstract/AbstractText') is not None else \"No abstract\",\n",
    "            # Extend as needed for additional fields\n",
    "        }\n",
    "        # Example: Adding publication date extraction\n",
    "        pub_date = article.find('.//PubDate')\n",
    "        year = pub_date.find('Year').text if pub_date.find('Year') is not None else \"No year\"\n",
    "        article_info['publication_year'] = year\n",
    "        \n",
    "        # Example: Adding author extraction\n",
    "        authors = article.findall('.//Author')\n",
    "        author_list = []\n",
    "        for author in authors:\n",
    "            last_name = author.find('LastName')\n",
    "            initials = author.find('Initials')\n",
    "            if last_name is not None and initials is not None:\n",
    "                author_list.append(f\"{last_name.text}, {initials.text}\")\n",
    "        article_info['authors'] = \"; \".join(author_list)\n",
    "        \n",
    "        articles_info.append(article_info)\n",
    "\n",
    "    return articles_info\n",
    "\n",
    "def main(api_key, query, biomarker_types, max_articles=10):\n",
    "    \"\"\"\n",
    "    Main function to orchestrate the search and data extraction process.\n",
    "    \"\"\"\n",
    "    all_articles_info = []\n",
    "    \n",
    "    for biomarker_type in biomarker_types:\n",
    "        print(f\"Searching for articles on biomarker: {biomarker_type}\")\n",
    "        article_ids = search_article_ids(query, api_key, max_articles, biomarker_type)\n",
    "        if article_ids:\n",
    "            xml_data = fetch_batch_details(article_ids, api_key)\n",
    "            if xml_data:\n",
    "                articles_info = parse_article_details(xml_data)\n",
    "                all_articles_info.extend(articles_info)\n",
    "            time.sleep(1)  # Be respectful to the server\n",
    "        else:\n",
    "            print(f\"No articles found for biomarker: {biomarker_type}\")\n",
    "\n",
    "    # Convert to DataFrame for easier analysis and export\n",
    "    df = pd.DataFrame(all_articles_info)\n",
    "    print(df)\n",
    "    # Optionally, save the DataFrame to a CSV file\n",
    "    #df.to_csv(\"pubmed_articles.csv\", index=False)\n",
    "\n",
    "# Example usage\n",
    "api_key = \"\"\n",
    "query = \"Alzheimer's disease\"\n",
    "biomarker_types = [\"p-tau 181\", \"p-tau 205\", \"p-tau 217\", \"p-tau 231\", \"p-tau 243\", \"p-tau new/unstated\"]\n",
    "main(api_key, query, biomarker_types, max_articles=1000)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Here are some key biomarkers for Alzheimer's disease:\n",
    "\n",
    "\n",
    "Amyloid Beta (Aβ) Peptides: Abnormal accumulation of Aβ peptides in the brain forms plaques, a hallmark of Alzheimer's disease. Biomarkers related to amyloid-beta include:\n",
    "\n",
    "Cerebrospinal Fluid (CSF) Aβ42: Lower levels in the CSF suggest amyloid plaque deposition in the brain.\n",
    "Amyloid PET Imaging: A specialized brain imaging technique that can visualize amyloid plaque accumulation.\n",
    "Tau Proteins: Tau is a protein that, when it becomes hyperphosphorylated, forms tangles inside neurons, disrupting their function and contributing to their death.\n",
    "\n",
    "CSF Total Tau (t-tau) and Phosphorylated Tau (p-tau): Increased levels in the CSF are indicators of neuronal damage and tau pathology.\n",
    "Tau PET Imaging: Allows for the visualization of tau tangles in the brain.\n",
    "Neurodegeneration Markers: Indicators of neuronal loss or brain atrophy.\n",
    "\n",
    "Neurofilament Light Chain (NfL): Elevated levels in the CSF or blood indicate axonal damage.\n",
    "MRI Scans: Structural MRI can show areas of brain atrophy, especially in regions important for memory, such as the hippocampus.\n",
    "Inflammatory Markers: Inflammation is involved in Alzheimer's disease, and certain markers can indicate this process.\n",
    "\n",
    "YKL-40: Elevated levels in the CSF may reflect glial activation and inflammation.\n",
    "Genetic Markers: Certain genes are associated with an increased risk of developing Alzheimer's disease.\n",
    "\n",
    "Apolipoprotein E (APOE) ε4 Allele: The presence of this gene variant is the strongest known genetic risk factor for late-onset Alzheimer's diseas"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This script aims to fetch all articles discussing biomarkers for Alzheimer's disease from PubMed, respecting their usage policies.\n",
    "\n",
    "We also fetch MeSH (Medical Subject Headings) terms for Alzheimer's disease research we think it is highly highly beneficial "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found and saved 9276 articles.\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import xml.etree.ElementTree as ET\n",
    "import pandas as pd\n",
    "import time\n",
    "import os\n",
    "\n",
    "def search_article_ids(query, api_key, max_articles_per_query):\n",
    "    \"\"\"\n",
    "    Search articles matching the query, return their IDs with pagination.\n",
    "    \"\"\"\n",
    "    search_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi\"\n",
    "    all_article_ids = []\n",
    "    for start in range(0, max_articles_per_query, 100):\n",
    "        params = {\n",
    "            \"db\": \"pubmed\",\n",
    "            \"term\": query,\n",
    "            \"retmode\": \"json\",\n",
    "            \"api_key\": api_key,\n",
    "            \"retstart\": start,\n",
    "            \"retmax\": 100\n",
    "        }\n",
    "        response = requests.get(search_url, params=params)\n",
    "        if response.status_code == 200:\n",
    "            data = response.json()\n",
    "            article_ids = data[\"esearchresult\"][\"idlist\"]\n",
    "            if not article_ids:\n",
    "                break  # No more articles found\n",
    "            all_article_ids.extend(article_ids)\n",
    "            time.sleep(0.33)  # To respect PubMed's rate limit\n",
    "        else:\n",
    "            print(f\"Failed to search article IDs: {response.status_code}\")\n",
    "            break\n",
    "    return all_article_ids\n",
    "\n",
    "def fetch_batch_details(article_ids, api_key):\n",
    "    \"\"\"\n",
    "    Fetch details for a batch of article IDs.\n",
    "    \"\"\"\n",
    "    fetch_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi\"\n",
    "    articles_info = []\n",
    "    # Process in smaller batches if needed\n",
    "    batch_size = 100\n",
    "    for i in range(0, len(article_ids), batch_size):\n",
    "        batch_ids = article_ids[i:i + batch_size]\n",
    "        params = {\n",
    "            \"db\": \"pubmed\",\n",
    "            \"retmode\": \"xml\",\n",
    "            \"id\": \",\".join(batch_ids),\n",
    "            \"api_key\": api_key\n",
    "        }\n",
    "        response = requests.get(fetch_url, params=params)\n",
    "        if response.status_code == 200:\n",
    "            articles_info.extend(parse_article_details(response.text))\n",
    "            time.sleep(0.33)  # To respect PubMed's rate limit\n",
    "        else:\n",
    "            print(f\"Failed to fetch article details: {response.status_code}\")\n",
    "    return articles_info\n",
    "\n",
    "def parse_article_details(xml_data):\n",
    "    \"\"\"\n",
    "    Parse and collect article details including title, abstract, publication year,\n",
    "    keywords, MeSH terms, and authors.\n",
    "    \"\"\"\n",
    "    root = ET.fromstring(xml_data)\n",
    "    articles_info = []\n",
    "\n",
    "    for article in root.findall('.//PubmedArticle'):\n",
    "        article_info = {\n",
    "            'title': article.find('.//ArticleTitle').text,\n",
    "            'abstract': article.find('.//Abstract/AbstractText').text if article.find('.//Abstract/AbstractText') is not None else \"No abstract\",\n",
    "        }\n",
    "\n",
    "        # Publication Year\n",
    "        pub_date = article.find('.//PubDate')\n",
    "        article_date = article.find('.//ArticleDate')\n",
    "        year = pub_date.find('Year').text if pub_date is not None and pub_date.find('Year') is not None else (article_date.find('Year').text if article_date is not None else \"Unknown\")\n",
    "        article_info['publication_year'] = year\n",
    "\n",
    "        # Keywords\n",
    "        # After modification to filter out None values\n",
    "        keywords = [kw.text for kw in article.findall('.//KeywordList/Keyword') if kw.text is not None]\n",
    "        article_info['keywords'] = \"; \".join(keywords)\n",
    "\n",
    "       \n",
    "        # MeSH Terms\n",
    "        mesh_terms = [mh.find('DescriptorName').text for mh in article.findall('.//MeshHeadingList/MeshHeading')]\n",
    "        article_info['mesh_terms'] = \"; \".join(mesh_terms)\n",
    "\n",
    "        # Authors\n",
    "        authors = article.findall('.//Author')\n",
    "        author_list = []\n",
    "        for author in authors:\n",
    "            last_name = author.find('LastName')\n",
    "            initials = author.find('Initials')\n",
    "            if last_name is not None and initials is not None:\n",
    "                author_list.append(f\"{last_name.text}, {initials.text}\")\n",
    "        article_info['authors'] = \"; \".join(author_list)\n",
    "\n",
    "        articles_info.append(article_info)\n",
    "\n",
    "    return articles_info\n",
    "\n",
    "def main(api_key, query, max_articles=1000):\n",
    "    \"\"\"\n",
    "    Main function to orchestrate the search and data extraction process.\n",
    "    \"\"\"\n",
    "    article_ids = search_article_ids(query, api_key, max_articles)\n",
    "    if article_ids:\n",
    "        articles_info = fetch_batch_details(article_ids, api_key)\n",
    "        df = pd.DataFrame(articles_info)\n",
    "        # Save to CSV\n",
    "        df.to_csv(\"Pubmed_alzheimers_diesease_biomarkers_50000.csv\", index=False)\n",
    "        print(f\"Found and saved {len(df)} articles.\")\n",
    "    else:\n",
    "        print(\"No articles found.\")\n",
    "\n",
    "# Example usage\n",
    "api_key = \"\"\n",
    "query =  \"Alzheimer's disease AND (fluid biomarker[Title/Abstract] OR cerebrospinal fluid[Title/Abstract] OR blood biomarker[Title/Abstract])\"\n",
    "main(api_key, query, max_articles=10000)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "we were getting Error during the parsing of article details where not all articles had keywords, or some keywords were missing a text value\n",
    "\n",
    "we made  adjustment ensures that only the keywords which actually have a text value are included in the keywords list, thereby preventing the TypeError when you attempt to join these keywords into a single string."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This query focuses on articles that mention:\n",
    "\n",
    "Fluid biomarkers in general (fluid biomarker[Title/Abstract]),\n",
    "Biomarkers in cerebrospinal fluid specifically (cerebrospinal fluid[Title/Abstract]),\n",
    "Or biomarkers found in blood (blood biomarker[Title/Abstract])."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We were able to store 5000 articles with this query into CSV file"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "What We are thinking Now, \n",
    "\n",
    "Advance serch technique, to get relevant information like \n",
    "\n",
    "1. boolean operators, AND OR AND  NOT etc., \n",
    "2. Parentheses for Grouping.\n",
    "Parentheses help structure our query and control the order of operations in Boolean searches, much like in mathematics. \n",
    "For example, \"Alzheimer's AND (biomarker OR diagnostic) AND NOT imaging\" will first combine the results for \"biomarker OR diagnostic\" and then include those that also mention Alzheimer's, but exclude any that mention imaging.\n",
    "\n",
    "3. MESH Browser\n",
    " MeSH Browser to find specific MeSH terms related to the topic. we can then use these terms to construct more precise and comprehensive searches.\n",
    "\n",
    "For example we can modify the \n",
    "\n",
    "Query = (\"Alzheimer Disease\"[MeSH] OR Alzheimer's[Title/Abstract]) AND (\"Biomarkers, Pharmacological\"[MeSH] OR biomarker[Title/Abstract]) NOT \"Magnetic Resonance Imaging\"[MeSH]\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Fetching full-text articles directly through PubMed can be challenging because PubMed itself primarily serves as a database of abstracts and references rather than a full-text article repository. However, PubMed often provides links to full-text articles available on publisher websites or other databases, such as PubMed Central (PMC), which is a free full-text archive of biomedical and life sciences journal literature at the U.S. National Institutes of Health's National Library of Medicine (NIH/NLM).\n",
    "\n",
    "1. PubMed Central (PMC)\n",
    "For articles available in PMC, the PubMed record includes a link to the full text in PMC. When you're fetching article details using the PubMed API, you can look for the PMC reference number (PMCID) and then programmatically access the full text from PMC if it's open access.\n",
    "\n",
    "There are also other, like publisher websites,and Institutional Subscriptions,which might give us access to  the full text of articles if they have been published"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Implementing Full-Text Access in Python"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found and saved details for 4998 articles.\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import xml.etree.ElementTree as ET\n",
    "import pandas as pd\n",
    "import time\n",
    "\n",
    "def search_article_ids(query, api_key, max_articles_per_query):\n",
    "    \"\"\"\n",
    "    Search articles matching the query, return their IDs with pagination.\n",
    "    \"\"\"\n",
    "    search_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi\"\n",
    "    all_article_ids = []\n",
    "    for start in range(0, max_articles_per_query, 5000):\n",
    "        params = {\n",
    "            \"db\": \"pubmed\",\n",
    "            \"term\": query,\n",
    "            \"retmode\": \"json\",\n",
    "            \"api_key\": api_key,\n",
    "            \"retstart\": start,\n",
    "            \"retmax\": 5000\n",
    "        }\n",
    "        response = requests.get(search_url, params=params)\n",
    "        if response.status_code == 200:\n",
    "            data = response.json()\n",
    "            article_ids = data[\"esearchresult\"][\"idlist\"]\n",
    "            if not article_ids:\n",
    "                break\n",
    "            all_article_ids.extend(article_ids)\n",
    "            time.sleep(0.33)\n",
    "        else:\n",
    "            print(f\"Failed to search article IDs: {response.status_code}\")\n",
    "            break\n",
    "    return all_article_ids\n",
    "\n",
    "def fetch_batch_details(article_ids, api_key):\n",
    "    \"\"\"\n",
    "    Modified to fetch PMC IDs in addition to the existing details.\n",
    "    \"\"\"\n",
    "    fetch_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi\"\n",
    "    articles_info = []\n",
    "    batch_size = 100\n",
    "    for i in range(0, len(article_ids), batch_size):\n",
    "        batch_ids = article_ids[i:i + batch_size]\n",
    "        params = {\n",
    "            \"db\": \"pubmed\",\n",
    "            \"retmode\": \"xml\",\n",
    "            \"id\": \",\".join(batch_ids),\n",
    "            \"api_key\": api_key\n",
    "        }\n",
    "        response = requests.get(fetch_url, params=params)\n",
    "        if response.status_code == 200:\n",
    "            articles_info.extend(parse_article_details(response.text))\n",
    "            time.sleep(0.33)\n",
    "        else:\n",
    "            print(f\"Failed to fetch article details: {response.status_code}\")\n",
    "    return articles_info\n",
    "\n",
    "def parse_article_details(xml_data):\n",
    "    \"\"\"\n",
    "    Parse to include PMC IDs if available.\n",
    "    \"\"\"\n",
    "    root = ET.fromstring(xml_data)\n",
    "    articles_info = []\n",
    "\n",
    "    for article in root.findall('.//PubmedArticle'):\n",
    "        article_info = {\n",
    "            'title': article.find('.//ArticleTitle').text,\n",
    "            'abstract': article.find('.//Abstract/AbstractText').text if article.find('.//Abstract/AbstractText') is not None else \"No abstract\",\n",
    "        }\n",
    "        # Other details omitted for brevity\n",
    "\n",
    "        # PMC ID\n",
    "        pmc_id = article.find(\".//ArticleIdList/ArticleId[@IdType='pmc']\")\n",
    "        article_info['pmc_id'] = pmc_id.text if pmc_id is not None else \"Not available\"\n",
    "\n",
    "        articles_info.append(article_info)\n",
    "\n",
    "    return articles_info\n",
    "\n",
    "def main(api_key, query, max_articles=5000):\n",
    "    \"\"\"\n",
    "    Main function updated to include PMC ID fetching.\n",
    "    \"\"\"\n",
    "    article_ids = search_article_ids(query, api_key, max_articles)\n",
    "    if article_ids:\n",
    "        articles_info = fetch_batch_details(article_ids, api_key)\n",
    "        df = pd.DataFrame(articles_info)\n",
    "        # Save to CSV\n",
    "        df.to_csv(\"Pubmed_articles_with_PMC_IDs_1.csv\", index=False)\n",
    "        print(f\"Found and saved details for {len(df)} articles.\")\n",
    "    else:\n",
    "        print(\"No articles found.\")\n",
    "\n",
    "# Example usage parameters\n",
    "api_key = \"\"\n",
    "query = \"Alzheimer's disease\"\n",
    "main(api_key, query, max_articles=5000)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Successfully fetched full text.\n",
      "<?xml version=\"1.0\" ?>\n",
      "<!DOCTYPE pmc-articleset PUBLIC \"-//NLM//DTD ARTICLE SET 2.0//EN\" \"https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd\">\n",
      "<pmc-articleset><article xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" dtd-version=\"1.3\" id=\"trc212464\" xml:lang=\"en\" article-type=\"research-article\">\n",
      "  <?properties open_access?>\n",
      "  <processing-meta base-tagset=\"archiving\" mathml-version=\"3.0\" table-model=\"xhtml\" tagset-family=\"jats\">\n",
      "    <restri\n",
      "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10999950/\n",
      "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11002765/\n",
      "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10999946/\n",
      "https://www.ncbi.nlm.nih.gov/pmc/articles/8686688/\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import time\n",
    "\n",
    "def fetch_full_text_pmc(pmc_id, api_key):\n",
    "    \"\"\"\n",
    "    Fetch the full text of a single article from PubMed Central using the PMC ID.\n",
    "    \"\"\"\n",
    "    fetch_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi\"\n",
    "    params = {\n",
    "        \"db\": \"pmc\",\n",
    "        \"id\": pmc_id,\n",
    "        \"retmode\": \"xml\",  # You can change this depending on the format you need\n",
    "        \"api_key\": api_key\n",
    "    }\n",
    "    response = requests.get(fetch_url, params=params)\n",
    "    if response.status_code == 200:\n",
    "        # The response text is the full text of the article in XML format\n",
    "        full_text_xml = response.text\n",
    "        return full_text_xml\n",
    "    else:\n",
    "        print(f\"Failed to fetch full text for PMC ID {pmc_id}: {response.status_code}\")\n",
    "        return None\n",
    "\n",
    "# Example usage\n",
    "api_key = \"\"  # Replace with your actual NCBI API key\n",
    "pmc_id = \"PMC10999950\"  # Replace with an actual PMC ID\n",
    "full_text_xml = fetch_full_text_pmc(pmc_id, api_key)\n",
    "\n",
    "if full_text_xml:\n",
    "    # Here you can save the XML, parse it, or process it as needed\n",
    "    print(\"Successfully fetched full text.\")\n",
    "    # For demonstration, we'll just show the first 500 characters\n",
    "    print(full_text_xml[:500])\n",
    "else:\n",
    "    print(\"Could not fetch full text.\")\n",
    "\n",
    "\n",
    "def generate_pmc_url(pmc_id):\n",
    "    \"\"\"\n",
    "    Generate a URL for the article's landing page on PubMed Central using the PMC ID.\n",
    "    \"\"\"\n",
    "    base_url = \"https://www.ncbi.nlm.nih.gov/pmc/articles/\"\n",
    "    # Construct the URL by appending the PMC ID to the base URL\n",
    "    article_url = f\"{base_url}{pmc_id}/\"\n",
    "    return article_url\n",
    "\n",
    "# Example usage\n",
    "pmc_ids = [\"PMC10999950\", \"PMC11002765\" , \"PMC10999946\", \"8686688\"]   # Example PMC IDs; replace with actual IDs you have\n",
    "article_urls = [generate_pmc_url(pmc_id) for pmc_id in pmc_ids]\n",
    "\n",
    "# Print or process the URLs\n",
    "for url in article_urls:\n",
    "    print(url)\n",
    "    \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "def parse_article_details(xml_data):\n",
    "    \"\"\"\n",
    "    Parse and collect article details including title, abstract, publication year,\n",
    "    keywords, MeSH terms, authors, and PMC ID for full-text access where available.\n",
    "    \"\"\"\n",
    "    root = ET.fromstring(xml_data)\n",
    "    articles_info = []\n",
    "\n",
    "    for article in root.findall('.//PubmedArticle'):\n",
    "        article_info = {\n",
    "            'title': article.find('.//ArticleTitle').text,\n",
    "            'abstract': article.find('.//Abstract/AbstractText').text if article.find('.//Abstract/AbstractText') is not None else \"No abstract\",\n",
    "            # Initialize other fields here...\n",
    "        }\n",
    "\n",
    "        # Publication Year\n",
    "        pub_date = article.find('.//PubDate')\n",
    "        article_date = article.find('.//ArticleDate')\n",
    "        year = pub_date.find('Year').text if pub_date is not None and pub_date.find('Year') is not None else (article_date.find('Year').text if article_date is not None else \"Unknown\")\n",
    "        article_info['publication_year'] = year\n",
    "\n",
    "        # Keywords\n",
    "        keywords = [kw.text for kw in article.findall('.//KeywordList/Keyword')]\n",
    "        article_info['keywords'] = \"; \".join(keywords)\n",
    "\n",
    "        # MeSH Terms\n",
    "        mesh_terms = [mh.find('DescriptorName').text for mh in article.findall('.//MeshHeadingList/MeshHeading')]\n",
    "        article_info['mesh_terms'] = \"; \".join(mesh_terms)\n",
    "\n",
    "        # Authors\n",
    "        authors = article.findall('.//Author')\n",
    "        author_list = []\n",
    "        for author in authors:\n",
    "            last_name = author.find('LastName')\n",
    "            initials = author.find('Initials')\n",
    "            if last_name is not None and initials is not None:\n",
    "                author_list.append(f\"{last_name.text}, {initials.text}\")\n",
    "        article_info['authors'] = \"; \".join(author_list)\n",
    "\n",
    "        # PMC ID\n",
    "        pmc_id = article.find('.//ArticleIdList/ArticleId[@IdType=\"pmc\"]')\n",
    "        pmc_id_text = pmc_id.text if pmc_id is not None else \"Not Available\"\n",
    "        article_info['pmc_id'] = pmc_id_text\n",
    "\n",
    "        articles_info.append(article_info)\n",
    "\n",
    "    return articles_info\n",
    "\n",
    "def print_pmc_urls(articles_info):\n",
    "    \"\"\"\n",
    "    Print PMC URLs for articles with a valid PMC ID.\n",
    "    \"\"\"\n",
    "    base_url = \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC\"\n",
    "    \n",
    "    for article in articles_info:\n",
    "        pmc_id = article.get('pmc_id')\n",
    "        if pmc_id and pmc_id != \"Not Available\":\n",
    "            # Construct and print the full URL\n",
    "            full_url = f\"{base_url}{pmc_id}/\"\n",
    "            print(f\"Article Title: {article['title']}\")\n",
    "            print(f\"PMC Full Text URL: {full_url}\\n\")\n",
    "\n",
    "# Assuming `articles_info` is your list of article dictionaries\n",
    "# print_pmc_urls(articles_info)\n",
    "\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
